PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jesudason, CG				Jesudason, Christopher Gunaseelan			One-Particle Representation of Heat Conduction Described within the Scope of the Second Law	PLOS ONE			English	Article							STATISTICAL-MECHANICAL THEORY; STEADY-STATE SYSTEMS; LENNARD-JONES FLUID; RECIPROCAL RELATIONS; NONEQUILIBRIUM MEASUREMENTS; IRREVERSIBLE-PROCESSES; COMPUTER-SIMULATION; CLAUSIUS INEQUALITY; EQUILIBRIUM; THERMODYNAMICS	The Carnot cycle and its deduction of maximum conversion efficiency of heat inputted and outputted isothermally at different temperatures necessitated the construction of isothermal and adiabatic pathways within the cycle that were mechanically "reversible", leading eventually to the Kelvin-Clausius development of the entropy function S with differential dS = dq/T such that closed integral(C) dS = 0 where the heat absorption occurs at the isothermal paths of the elementary Carnot cycle. Another required condition is that the heat transfer processes take place infinitely slowly and "reversibly", implying that rates of transfer are not explicitly featured in the theory. The definition of 'heat' as that form of energy that is transferred as a result of a temperature difference suggests that the local mode of transfer of "heat" in the isothermal segments of the pathway implies a Fourier-like heat conduction mechanism which is apparently irreversible, leading to an increase in entropy of the combined reservoirs at either end of the conducting material, and which is deemed reversible mechanically. These paradoxes are circumvented here by first clarifying the terms used before modeling heat transfer as a thermodynamically reversible but mechanically irreversible process and applied to a one dimensional atomic lattice chain of interacting particles subjected to a temperature difference exemplifying Fourier heat conduction. The basis of a "recoverable trajectory" i.e. that which follows a zero entropy trajectory is identified. The Second Law is strictly maintained in this development. A corollary to this zero entropy trajectory is the generalization of the Zeroth law for steady state non-equilibrium systems with varying temperature, and thus to a statement about "equilibrium" in steady state non-thermostatic conditions. An energy transfer rate term is explicitly identified for each particle and agrees quantitatively (and independently) with the rate of heat absorbed at the reservoirs held at different temperatures and located at the two ends of the lattice chain in MD simulations, where all energy terms in the simulation refer to a single particle interacting with its neighbors. These results validate the theoretical model and provides the necessary boundary conditions (for instance with regard to temperature differentials and force fields) that thermodynamical variables must comply with to satisfy the conditions for a recoverable trajectory, and thus determines the solution of the differential and integral equations that are used to model these processes. These developments and results, if fully pursued would imply that not only can the Carnot cycle be viewed as describing a local process of energy-work conversion by a single interacting particle which feature rates of energy transfer and conversion not possible in the classical Carnot development, but that even irreversible local processes might be brought within the scope of this cycle, implying a unified treatment of thermodynamically (i) irreversible (ii) reversible (iii) isothermal and (iv) adiabatic processes by conflating the classically distinct concept of work and heat energy into a single particle interactional process. A resolution to the fundamental and long-standing conjecture of Benofy and Quay concerning the Fourier principle is one consequence of the analysis.	[Jesudason, Christopher Gunaseelan] Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia; [Jesudason, Christopher Gunaseelan] Univ Malaya, Ctr Theoret & Computat Phys, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Jesudason, CG (corresponding author), Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia.	jesu@um.edu.my			University of Malaya (Kuala Lumpur, Malaysia) [UMRG (RG293/14AFR)]; University of Malaya [UMRG(RG293/14AFR)]	University of Malaya (Kuala Lumpur, Malaysia)(Universiti Malaya); University of Malaya(Universiti Malaya)	The author is being funded by University of Malaya (Kuala Lumpur, Malaysia), grant number: UMRG (RG293/14AFR) administered by the Advanced Fundamental Research Cluster (http://afr.um.edu.my/) of the same university. The funder above (i.e. University of Malaya, with grant number UMRG (RG293/14AFR)) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by University of Malaya Grant UMRG(RG293/14AFR). I thank the organizers in general of ICNPAA 2014 (Narvik, Norway), for notifying me of this excellent conference series in 2012 which encouraged me to work on the heat conduction problem presented in more rudimentary form at the conference but which appears here in greater detail. Finally, I thank in general the National Chemical Institute, Ljubljana, Slovenia for hospitality during a research visit where an early draft of the work was prepared.	Alamino RC, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052123; Allen MP., 1990, COMPUTER SIMULATION; [Anonymous], THERMODYNAMICS MEETS; Antonopoulos CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089585; Attard P, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2203069; Attard P, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1942491; Attard P, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1873572; Attard P, 2004, J CHEM PHYS, V121, P7076, DOI 10.1063/1.1792573; Attard P, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2839883; Bastug T, 2007, CHEM PHYS LETT, V436, P383, DOI 10.1016/j.cplett.2007.01.078; Bedeaux D, 2004, CHEM ENG SCI, V59, P109, DOI 10.1016/j.ces.2003.09.028; Benofy S. J., 1982, PHYS NATURAL PHILOS, P7; BENOFY SJ, 1983, J CHEM PHYS, V78, P3177, DOI 10.1063/1.445233; Bhalekar AA, 2000, ASIAN J CHEM, V12, P417; Bodineau T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.180601; Bonetto F, 2000, MATH PHYS 2000 UNPUB, P128; Bonetto F, 2000, ARXIVMATHPH2000P0020; BRILLOUIN L, 1951, J APPL PHYS, V22, P334, DOI 10.1063/1.1699951; Calkin MG, 2001, LAGRANGIAN HAMILTONI; Caratheodory C, 1909, MATH ANN, V67, P355, DOI 10.1007/BF01450409; Caratheodory Constantin, 1976, BENCHMARK PAPERS ENE, P229; Carnot Sadi, 1897, REFLECTIONS MOTIVE P; Chuang TJ, 1983, SURF SCI REP, V3, P1, DOI 10.1016/0167-5729(83)90005-5; Clapeyron E, 1976, 2 LAW THERMODYNAMICS, V5, P36; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; Das SG, 2014, J STAT PHYS, V154, P204, DOI 10.1007/s10955-013-0871-0; De Groot S. R., 1984, NONEQUILIBRIUM THERM; DePree J, 1988, INTRO REAL ANAL; Dhar A, 2008, ADV PHYS, V57, P457, DOI 10.1080/00018730802538522; Feynman R.P., 1963, FEYNMAN LECT PHYS; Fox R., 1971, CALORIC THEORY GASES; Fox RF, 2003, P NATL ACAD SCI USA, V100, P12537, DOI 10.1073/pnas.2336065100; Gruber C, 2005, PHYSICA A, V351, P358, DOI 10.1016/j.physa.2004.12.022; Hanggi P, 2015, NAT PHYS, V11, P108; HAFSKJOLD B, 1995, FLUID PHASE EQUILIBR, V104, P173, DOI 10.1016/0378-3812(94)02647-J; HAFSKJOLD B, 1995, J STAT PHYS, V78, P463, DOI 10.1007/BF02183360; Hill T.L., 1956, STAT MECH PRINCIPLES; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; Jarzynski C, 2015, NAT PHYS, V11, P105, DOI 10.1038/nphys3229; Jesudason C. G., 2000, Asian Journal of Physics, V9, P1; Jesudason C. G., 2003, Entropy, V5, DOI 10.3390/e5030252; JESUDASON CG, 1989, CURR SCI INDIA, V58, P1181; Jesudason CG, 2006, J MATH CHEM, V39, P201, DOI 10.1007/s10910-005-9018-0; Jesudason CG, 2004, STOCH ANAL APPL, V22, P1131, DOI 10.1081/SAP-120039658; JESUDASON CG, 1991, INDIAN J PURE AP PHY, V29, P163; Jesudason CG, 2003, STOCH ANAL APPL, V21, P1097, DOI 10.1081/SAP-120024705; JESUDASON CG, 1991, INDIAN J PURE AP PHY, V29, P88; JESUDASON CG, 1991, INDIAN J PURE AP PHY, V29, P9; Jesudason CG, 1999, APEIRON, V6, P9; Jesudason CG, 2006, JURNAL FIZIK MALAYSI, V27, P103; Jesudason CG, 1998, ANALELE U DIN TIMISO, VXXXVII, P8; Jesudason CG, 1986, THESIS; Jesudason CG, 1991, INDIAN J PURE AP PHY, V28, P632; Jesudason CG, 1999, APEIRON, V6, P172; Jesudason CG, 2014, J STAT PHYS, V154, P204; Jesudason CG, 1996, SURFACE SCI HETEROGE, P235; Jesudason CG, 1998, INDIAN J PHYS PT-B, V72(B), P1; Jesudason CG, 2008, J MATH CHEM, V43, P976, DOI 10.1007/s10910-007-9320-0; Jesudason CG, 2007, J MATH CHEM, V42, P859, DOI 10.1007/s10910-006-9146-1; Jesudason CG, 2007, J MATH CHEM, V42, P893, DOI 10.1007/s10910-006-9147-0; Jesudason CG, 2011, AIP CONF PROC, V1411, DOI 10.1063/1.3665245; Jesudason CG, 2011, AIP CONF PROC, V1411, DOI 10.1063/1.3665246; Jesudason CG, 2005, NONLINEAR ANAL-THEOR, V63, pE541, DOI 10.1016/j.na.2005.02.078; Jesudason CG, 2009, MATH COMPUT MODEL, V49, P835, DOI 10.1016/j.mcm.2008.05.055; Kestin J., 1976, BENCHMARK PAPERS ENE; Khinchin A.Y., 1949, MATH FDN STAT MECH; Kim C, 2015, J KOREAN PHYS SOC, V67, P273, DOI 10.3938/jkps.67.273; Koga T, 1970, INT SERIES MONOGRAPH; KONDEPUDI DK, 1987, FOUND PHYS, V17, P713, DOI 10.1007/BF01889544; Landsberg P.T., 1990, THERMODYNAMICS STAT; Lees JP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.211801; Li BW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.044301; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; MAGNASCO MO, 1993, PHYS REV LETT, V71, P1477, DOI 10.1103/PhysRevLett.71.1477; Mai T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.184301; Maxwell James Clerk, 1902, THEORY HEAT; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; Onsager L, 1931, PHYS REV, V38, P2265, DOI 10.1103/PhysRev.38.2265; Pagonabarraga I, 1997, PHYSICA A, V237, P205, DOI 10.1016/S0378-4371(96)00377-9; Parks SGKHR, 2013, IMPLICIT FUNCTION TH; Parrondo JMR, 2015, NAT PHYS, V11, P131, DOI 10.1038/NPHYS3230; Patel PP, 2014, PHYS LETT A, V378, P2524, DOI 10.1016/j.physleta.2014.07.005; Pathria R.K., 2011, STAT MECH, V3rd ed.; Pekola JP, 2015, NAT PHYS, V11, P118, DOI [10.1038/nphys3169, 10.1038/NPHYS3169]; Prigogine I, 1967, INTRO THERMODYNAMICS; PROSEN T, 1992, J PHYS A-MATH GEN, V25, P3449, DOI 10.1088/0305-4470/25/12/009; Redhead P., 1962, VACUUM, V12, P203, DOI [10.1016/0042-207X(62)90978-8, DOI 10.1016/0042-207X(62)90978-8]; Reichl L. E., 1998, MODERN COURSE STAT P; Reif F., 1965, STAT THERMAL PHYS; RIEDER Z, 1967, J MATH PHYS, V8, P1073, DOI 10.1063/1.1705319; Saad D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032131; Sekimoto K, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.060103; Shah S, 2014, SOLID STATE PHENOMEN, V209, P129, DOI 10.4028/www.scientific.net/SSP.209.129; Shah TN, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40225-x; Shah TN, 2013, COMMUN THEOR PHYS, V59, P361, DOI 10.1088/0253-6102/59/3/19; Shah TN, 2012, PHYS LETT A, V376, P438, DOI 10.1016/j.physleta.2011.11.052; Spohn H., 1991, LARGE SCALE DYNAMICS; SWOPE WC, 1982, J CHEM PHYS, V76, P637, DOI 10.1063/1.442716; Vilar JMG, 2001, P NATL ACAD SCI USA, V98, P11081, DOI 10.1073/pnas.191360398; Ya P. Terletskii, 1971, STAT PHYS; Yakowitz S., 1989, INTRO NUMERICAL COMP, V2nd, P18; Yourgrau W, 1982, TREATISE IRREVERSIBL; ZEIRI Y, 1985, PHYS REV LETT, V55, P634, DOI 10.1103/PhysRevLett.55.634; Zemansky M. W., 1968, HEAT THERMODYNAMICS; Zemansky MW., 1997, HEAT THERMODYNAMICS; ZON BA, 1991, PHYS LETT A, V160, P213, DOI 10.1016/0375-9601(91)90764-Y	108	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145026	10.1371/journal.pone.0145026	http://dx.doi.org/10.1371/journal.pone.0145026			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760507	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100007
J	Totoson, P; Maguin-Gate, K; Nappey, M; Wendling, D; Demougeot, C				Totoson, Perle; Maguin-Gate, Katy; Nappey, Maude; Wendling, Daniel; Demougeot, Celine			Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARDIOVASCULAR-DISEASE; OSTEOPROTEGERIN CONCENTRATIONS; CAROTID ATHEROSCLEROSIS; OXIDATIVE STRESS; CROSS-TALK; RISK; RESISTANCE; INTERLEUKIN-1-BETA; ASSOCIATION	Objectives To determine mechanisms involved in endothelial dysfunction (ED) during the course of arthritis and to investigate the link between cytokines, chemokines and osteoprotegerin. Approach and Results Experiments were conducted on aortic rings at day 4 (preclinical), day 11 (onset of disease), day 33 (acute disease) and day 90 (chronic disease) after adjuvant-induced arthritis (AIA) in Lewis rats. At day 4, the unique vascular abnormality was a reduced norepinephrine-induced constriction. At day 11, endothelial function assessed by the relaxation to acetylcholine was normal despite increased cyclo-oxygenase-2 activity (COX-2) and overproduction of superoxide anions that was compensated by increased nitric oxide synthase (NOS) activity. At day 33, ED apparition coincides with the normalization of NOS activity. At day 90, ED was only observed in rats with a persisting imbalance between endothelial NOS and COX-2 pathways and higher plasma levels of IL-1 beta and TNF alpha. Plasma levels of IL-1 beta, TNF alpha and MIP-1 alpha negatively correlated with Ach-induced relaxation throughout the course of AIA. Conclusions Our data identified increased endothelial NOS activity as an important compensatory response that opposes the ED in the early arthritis. Thereafter, a cross-talk between endothelial COX-2/NOS pathways appears as an important element for the occurrence of ED. Our results encourage determining the clinical value of IL-1 beta, TNF alpha and MIP-1 alpha as biomarkers of ED in RA.	[Totoson, Perle; Maguin-Gate, Katy; Nappey, Maude; Demougeot, Celine] Univ Bourgogne Franche Comte, FHU INCREASE, EA FDE 4267, Besancon, France; [Wendling, Daniel] CHRU, Serv Rhumatol, Besancon, France; [Wendling, Daniel] Univ Bourgogne Franche Comte, EA 4266, Besancon, France	Universite de Franche-Comte; CHU Besancon	Demougeot, C (corresponding author), Univ Bourgogne Franche Comte, FHU INCREASE, EA FDE 4267, Besancon, France.	cdemouge@univ-fcomte.fr		Demougeot, Celine/0000-0003-0639-9756; Totoson, Perle/0000-0002-5012-4330	French Ministry for Higher Education and Research of Totoson Thesis project	French Ministry for Higher Education and Research of Totoson Thesis project	This work was supported by funding from the French Ministry for Higher Education and Research of Totoson Thesis project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN NR, 1979, ARTHRITIS RHEUM, V22, P1365, DOI 10.1002/art.1780221208; Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; Bagnost T, 2008, J HYPERTENS, V26, P1110, DOI 10.1097/HJH.0b013e3282fcc357; Carter JL, 2011, J NEUROIMMUNOL, V230, P85, DOI 10.1016/j.jneuroim.2010.09.005; Clancy R, 2000, J IMMUNOL, V165, P1582, DOI 10.4049/jimmunol.165.3.1582; Cohen RA, 2010, J CARDIOVASC PHARM, V55, P308, DOI 10.1097/FJC.0b013e3181d89670; de Groot L, 2015, RHEUMATOLOGY, V54, P1257, DOI 10.1093/rheumatology/keu459; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Dessein PH, 2014, J RHEUMATOL, V41, P429, DOI 10.3899/jrheum.131037; Dessein PH, 2005, ARTHRITIS RES THER, V7, pR634, DOI 10.1186/ar1717; Foster W, 2012, EUR J CLIN INVEST, V42, P510, DOI 10.1111/j.1365-2362.2011.02607.x; Gori T, 2011, EUR HEART J, V32, P784, DOI 10.1093/eurheartj/ehq412; He M, 2013, ARTERIOSCL THROM VAS, V33, P1384, DOI 10.1161/ATVBAHA.113.301490; Hink U, 2006, CIRC RES, V98, P1344, DOI 10.1161/01.res.0000228471.38761.93; Iwamoto T, 2008, FEBS J, V275, P4448, DOI 10.1111/j.1742-4658.2008.06580.x; Jimenez-Altayo F, 2006, J PHARMACOL EXP THER, V316, P42, DOI 10.1124/jpet.105.088435; Joshi A, 2012, N-S ARCH PHARMACOL, V385, P1083, DOI 10.1007/s00210-012-0794-3; Klimek E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/681635; Koc E, 2009, MINI-REV MED CHEM, V9, P611, DOI 10.2174/138955709788167556; Lopez-Mejias R, 2015, J RHEUMATOL, V42, P39, DOI 10.3899/jrheum.140690; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Mason JC, 2015, EUR HEART J, V36, P482, DOI 10.1093/eurheartj/ehu403; Montagnana M, 2013, ANN MED, V45, P254, DOI 10.3109/07853890.2012.727019; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Pepene CE, 2011, EUR J ENDOCRINOL, V164, P61, DOI 10.1530/EJE-10-0720; Prati C, 2014, JOINT BONE SPINE, V81, P386, DOI 10.1016/j.jbspin.2014.01.014; Reynolds SL, 2012, BRIT J PHARMACOL, V167, P505, DOI 10.1111/j.1476-5381.2012.01988.x; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sandoo A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3847; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Stamatelopoulos KS, 2009, ARTERIOSCL THROM VAS, V29, P1702, DOI 10.1161/ATVBAHA.109.190108; Stolina M, 2009, J CLIN IMMUNOL, V29, P158, DOI 10.1007/s10875-008-9238-8; Totoson P, 2015, ARTHRITIS RHEUMATOL, V67, P1203, DOI 10.1002/art.39065; Totoson P, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4450; van Breukelen-van der Stoep DF, 2013, ATHEROSCLEROSIS, V231, P163, DOI 10.1016/j.atherosclerosis.2013.09.006; van Halm VP, 2007, ANN RHEUM DIS, V66, P184, DOI 10.1136/ard.2006.051672; Vaziri ND, 2001, J PHARMACOL EXP THER, V298, P679; Wang HH, 2015, MOD RHEUMATOL, V25, P123, DOI 10.3109/14397595.2014.926852; Wimalasundera R, 2003, BRIT J PHARMACOL, V138, P1285, DOI 10.1038/sj.bjp.0705168; Yki-Jarvinen H, 2003, ANN RHEUM DIS, V62, P630, DOI 10.1136/ard.62.7.630	42	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146744	10.1371/journal.pone.0146744	http://dx.doi.org/10.1371/journal.pone.0146744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761790	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100040
J	Campagne, A; Fradcourt, B; Pichat, C; Baciu, M; Kauffmann, L; Peyrin, C				Campagne, Aurelie; Fradcourt, Benoit; Pichat, Cedric; Baciu, Monica; Kauffmann, Louise; Peyrin, Carole			Cerebral Correlates of Emotional and Action Appraisals During Visual Processing of Emotional Scenes Depending on Spatial Frequency: A Pilot Study	PLOS ONE			English	Article							SUPERIOR PARIETAL LOBULE; EVENT-RELATED POTENTIALS; FACIAL EXPRESSIONS; AMYGDALA RESPONSE; MOTOR IMAGERY; CORTEX; ATTENTION; FACES; FEAR; PERCEPTION	Visual processing of emotional stimuli critically depends on the type of cognitive appraisal involved. The present fMRI pilot study aimed to investigate the cerebral correlates involved in the visual processing of emotional scenes in two tasks, one emotional, based on the appraisal of personal emotional experience, and the other motivational, based on the appraisal of the tendency to action. Given that the use of spatial frequency information is relatively flexible during the visual processing of emotional stimuli depending on the task's demands, we also explored the effect of the type of spatial frequency in visual stimuli in each task by using emotional scenes filtered in low spatial frequency (LSF) and high spatial frequencies (HSF). Activation was observed in the visual areas of the fusiform gyrus for all emotional scenes in both tasks, and in the amygdala for unpleasant scenes only. The motivational task induced additional activation in frontal motor-related areas (e.g. premotor cortex, SMA) and parietal regions (e.g. superior and inferior parietal lobules). Parietal regions were recruited particularly during the motivational appraisal of approach in response to pleasant scenes. These frontal and parietal activations, respectively, suggest that motor and navigation processes play a specific role in the identification of the tendency to action in the motivational task. Furthermore, activity observed in the motivational task, in response to both pleasant and unpleasant scenes, was significantly greater for HSF than for LSF scenes, suggesting that the tendency to action is driven mainly by the detailed information contained in scenes. Results for the emotional task suggest that spatial frequencies play only a small role in the evaluation of unpleasant and pleasant emotions. Our preliminary study revealed a partial distinction between visual processing of emotional scenes during identification of the tendency to action, and during identification of personal emotional experiences. It also illustrates flexible use of the spatial frequencies contained in scenes depending on their emotional valence and on task demands.	[Campagne, Aurelie; Fradcourt, Benoit; Pichat, Cedric; Baciu, Monica; Kauffmann, Louise; Peyrin, Carole] Univ Grenoble Alpes, Lab Psychol & Neurocognit LPNC, Grenoble, France; [Campagne, Aurelie; Fradcourt, Benoit; Pichat, Cedric; Baciu, Monica; Kauffmann, Louise; Peyrin, Carole] CNRS, LPNC, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Campagne, A (corresponding author), Univ Grenoble Alpes, Lab Psychol & Neurocognit LPNC, Grenoble, France.	aurelie.campagne@univ-grenoble-alpes.fr	Pichat, Cédric/ABC-8392-2021; Baciu, Monica/AAE-4011-2020	Pichat, Cédric/0000-0002-0291-5998; Baciu, Monica/0000-0002-6842-1317; Peyrin, Carole/0000-0001-7792-092X	Pole Grenoble Cognition; French program "Investissement d'Avenir"; grant 'Infrastructure d'avenir en Biologie Sante [ANR-11-INBS-0006]	Pole Grenoble Cognition; French program "Investissement d'Avenir"(French National Research Agency (ANR)); grant 'Infrastructure d'avenir en Biologie Sante	This study was funded by Pole Grenoble Cognition. (http://www.grenoblecognition.fr/index.php/animation/projets). Grant 1, AC. Grenoble MRI facility IRMaGe was partly funded by the French program "Investissement d'Avenir" run by the 'Agence Nationale pour la Recherche'; grant 'Infrastructure d'avenir en Biologie Sante - ANR-11-INBS-0006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Alorda C, 2007, NEUROPSYCHOLOGIA, V45, P3223, DOI 10.1016/j.neuropsychologia.2007.06.017; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Beer JS, 2006, PSYCHOL SCI, V17, P448, DOI 10.1111/j.1467-9280.2006.01726.x; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; Bocanegra BR, 2011, J EXP PSYCHOL GEN, V140, P272, DOI 10.1037/a0023188; Bocanegra BR, 2009, PSYCHOL SCI, V20, P707, DOI 10.1111/j.1467-9280.2009.02354.x; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bzdok D, 2013, HUM BRAIN MAPP, V34, P3247, DOI 10.1002/hbm.22138; Carretie L, 2007, NEUROPSYCHOLOGIA, V45, P1187, DOI 10.1016/j.neuropsychologia.2006.10.013; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Delord S, 1998, VIS COGN, V5, P313, DOI 10.1080/713756789; Deruelle C, 2005, J EXP CHILD PSYCHOL, V90, P172, DOI 10.1016/j.jecp.2004.09.001; Edmiston EK, 2013, J NEUROSCI, V33, P11023, DOI 10.1523/JNEUROSCI.0401-13.2013; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Felician O, 2004, ANN NEUROL, V55, P749, DOI 10.1002/ana.20109; Ferrari V, 2008, J COGNITIVE NEUROSCI, V20, P1753, DOI 10.1162/jocn.2008.20121; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fradcourt B, 2013, BRAIN COGNITION, V83, P104, DOI 10.1016/j.bandc.2013.07.009; Frijda N.H., 1987, COGNITION EMOTION, V1, P115, DOI [https://doi.org/10.1080/02699938708408043, DOI 10.1080/02699938708408043]; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Gschwind M, 2012, CEREB CORTEX, V22, P1564, DOI 10.1093/cercor/bhr226; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Harmon-Jones E, 2006, PSYCHOL SCI, V17, P434, DOI 10.1111/j.1467-9280.2006.01724.x; Hasanein P, 2008, BRAIN RES, V1241, P36, DOI 10.1016/j.brainres.2008.09.041; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Hoffstaedter F, 2014, HUM BRAIN MAPP, V35, P2741, DOI 10.1002/hbm.22363; Holmes A, 2005, COGNITIVE BRAIN RES, V25, P508, DOI 10.1016/j.cogbrainres.2005.08.003; Holmes A, 2005, COGNITION EMOTION, V19, P899, DOI 10.1080/02699930441000454; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Hutcherson CA, 2005, NEUROIMAGE, V27, P656, DOI 10.1016/j.neuroimage.2005.04.028; Ino T, 2002, NEUROSCI LETT, V322, P182, DOI 10.1016/S0304-3940(02)00019-8; Jacques PS, 2010, NEUROBIOL AGING, V31, P315, DOI 10.1016/j.neurobiolaging.2008.03.012; Keightley ML, 2003, NEUROPSYCHOLOGIA, V41, P585, DOI 10.1016/S0028-3932(02)00199-9; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Lang P.J., 2008, A8 U FLOR; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Lang PJ, 2010, BIOL PSYCHOL, V50, P372; Lee KH, 2012, SOC COGN AFFECT NEUR, V7, P521, DOI 10.1093/scan/nsp001; Lester BD, 2014, J COGNITIVE NEUROSCI, V26, P2201, DOI 10.1162/jocn_a_00636; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Lorey B, 2009, EXP BRAIN RES, V194, P233, DOI 10.1007/s00221-008-1693-1; Lundqvist D., 1998, KAROLINSKA DIRECTED; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maratos FA, 2009, COGN AFFECT BEHAV NE, V9, P133, DOI 10.3758/CABN.9.2.133; Mathieu NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099523; Mermillod M, 2010, PSYCHOL SCI, V21, P1429, DOI 10.1177/0956797610381503; Mermillod M, 2010, NEUROCOMPUTING, V73, P2522, DOI 10.1016/j.neucom.2010.06.002; Mermillod M, 2009, CONNECT SCI, V21, P75, DOI 10.1080/09540090802213974; Mobbs D, 2007, SCIENCE, V317, P1079, DOI 10.1126/science.1144298; Mobbs D, 2009, J NEUROSCI, V29, P12236, DOI 10.1523/JNEUROSCI.2378-09.2009; Morecraft RJ, 1998, BRAIN RES BULL, V45, P209, DOI 10.1016/S0361-9230(97)00344-4; O'Doherty JP, 2007, ANN NY ACAD SCI, V1121, P254, DOI 10.1196/annals.1401.036; Ochsner KN, 2009, PSYCHOL SCI, V20, P1322, DOI 10.1111/j.1467-9280.2009.02459.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Packard MG, 2001, CURR OPIN NEUROBIOL, V11, P752, DOI 10.1016/S0959-4388(01)00280-X; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pichon S, 2012, CEREB CORTEX, V22, P274, DOI 10.1093/cercor/bhr060; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rotshtein P, 2010, J VISION, V10, DOI 10.1167/10.10.25; Rotshtein P, 2010, HUM BRAIN MAPP, V31, P1089, DOI 10.1002/hbm.20921; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sabatinelli D, 2005, NEUROIMAGE, V24, P1265, DOI 10.1016/j.neuroimage.2004.12.015; Sabatinelli D, 2013, BIOL PSYCHOL, V92, P513, DOI 10.1016/j.biopsycho.2012.04.005; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sabatinelli D, 2009, J NEUROSCI, V29, P14864, DOI 10.1523/JNEUROSCI.3278-09.2009; Sack AT, 2009, BEHAV BRAIN RES, V202, P153, DOI 10.1016/j.bbr.2009.03.012; Sander D, REV NEUROSCI, V14, P303; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Sharma N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00564; Stadler W, 2011, HUM BRAIN MAPP, V32, P677, DOI 10.1002/hbm.20949; Stolarova M, 2006, CEREB CORTEX, V16, P876, DOI 10.1093/cercor/bhj031; Todd RM, 2013, OXFORD HDB COGNITIVE, V2, P11; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Vrticka P, 2011, NEUROPSYCHOLOGIA, V49, P1067, DOI 10.1016/j.neuropsychologia.2011.02.020; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Weierich MR, 2010, NEUROIMAGE, V49, P2871, DOI 10.1016/j.neuroimage.2009.09.047; Wendt J, 2011, BIOL PSYCHOL, V86, P203, DOI 10.1016/j.biopsycho.2010.11.009; WILSON JR, 1993, ACTA ANAT, V147, P1; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zotev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079184	116	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0144393	10.1371/journal.pone.0144393	http://dx.doi.org/10.1371/journal.pone.0144393			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CG	26757433	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800001
J	Yamamoto, M; Hikosaka, K; Mahmood, A; Tobe, K; Shojaku, H; Inohara, H; Nakagawa, T				Yamamoto, Masashi; Hikosaka, Keisuke; Mahmood, Arshad; Tobe, Kazuyuki; Shojaku, Hideo; Inohara, Hidenori; Nakagawa, Takashi			Nmnat3 Is Dispensable in Mitochondrial NAD Level Maintenance In Vivo	PLOS ONE			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; RAT-LIVER MITOCHONDRIA; PERMEABILITY TRANSITION; PYRIDINE-NUCLEOTIDE; SUBCELLULAR COMPARTMENTATION; NMN/NAMN ADENYLYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; ADENINE-DINUCLEOTIDE; CELL-DEATH; METABOLISM	Nicotinamide adenine dinucleotide (NAD) is an essential co-enzyme mediating various enzymatic reactions. Mitochondrial NAD particularly occupies a considerable amount of total NAD in cells, and serves as a co-enzyme in tricarboxylic acid cycle (TCA cycle), beta-oxidation, and oxidative phosphorylation. Despite the importance of mitochondrial NAD, its synthesis pathway remains unknown. It has been proposed that NAD synthesis enzyme, Nmnat3, was localized in mitochondria, but its physiological relevance to the metabolism in mitochondria was not fully elucidated. Previously, we have reported that murine Nmnat3 protein was strongly expressed in the cytoplasm of mature erythrocytes, in which mitochondria were absent, and Nmnat3-deficient mice (Nmnat3-KO mice) exhibited splenomegaly and hemolytic anemia due to reduced NAD levels in mature erythrocytes. These results challenged the role of Nmnat3 in mitochondrial NAD synthesis. In this study, we demonstrated that mitochondrial NAD levels in various tissues, except for red blood cells, were unchanged in Nmnat3-KO mice. We also analyzed the metabolites in glycolysis and TCA cycle and found that there were no differences between Nmnat3-KO and WT mice. In addition, the aged Nmnat3-KO mice had comparable NAD levels to that observed in WT mice. Our results indicated that Nmnat3 is dispensable in the maintenance of mitochondrial NAD levels, and that other NAD regulatory pathways may exist in mitochondria.	[Yamamoto, Masashi; Hikosaka, Keisuke; Mahmood, Arshad; Nakagawa, Takashi] Toyama Univ, Frontier Res Core Life Sci, Toyama 9300194, Japan; [Yamamoto, Masashi; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka 5650871, Japan; [Mahmood, Arshad; Tobe, Kazuyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Internal Med 1, Toyama 9300194, Japan; [Shojaku, Hideo] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Otorhinol Head & Neck Surg, Toyama 9300194, Japan	University of Toyama; Osaka University; University of Toyama; University of Toyama	Nakagawa, T (corresponding author), Toyama Univ, Frontier Res Core Life Sci, Toyama 9300194, Japan.	nakagawa@med.u-toyama.ac.jp	Nakagawa, Takashi/F-3015-2010	Nakagawa, Takashi/0000-0001-5539-7605	JSPS [24609019]; Novartis Foundation for the Promotion of Science; Naito Foundation; Cell Science Research Foundation; Grants-in-Aid for Scientific Research [24689019] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Novartis Foundation for the Promotion of Science; Naito Foundation(Naito Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by JSPS KAKENHI (Grant Number 24609019), and the grant from The Novartis Foundation for the Promotion of Science, The Naito Foundation, and The Cell Science Research Foundation to T.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barile M, 1996, BIOCHEM MOL BIOL INT, V38, P297; BEHR A, 1981, BIOCHEM BIOPH RES CO, V101, P767, DOI 10.1016/0006-291X(81)91817-9; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; CHANCE B, 1959, J BIOL CHEM, V234, P3044; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Di Stefano M, 2010, BLOOD CELL MOL DIS, V45, P33, DOI 10.1016/j.bcmd.2010.04.003; Di Stefano M, 2013, FEBS J, V280, P4711, DOI 10.1111/febs.12433; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Felici R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076938; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; GREENSPA.MD, 1965, BIOCHIM BIOPHYS ACTA, V99, P167, DOI 10.1016/S0926-6593(65)80017-0; GREENSPAN MD, 1968, J BIOL CHEM, V243, P2921; GRUNICKE H, 1975, EUR J BIOCHEM, V53, P41, DOI 10.1111/j.1432-1033.1975.tb04039.x; Hikosaka K, 2014, J BIOL CHEM, V289, P14796, DOI 10.1074/jbc.M114.554378; HOGEBOOM GH, 1952, J BIOL CHEM, V197, P611; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Kato M, 2014, J BIOL CHEM, V289, P15577, DOI 10.1074/jbc.M114.558643; Lange R A, 1976, Biochem Biophys Res Commun, V76, P424; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Orsomando G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053271; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Petrelli R, 2011, CURR MED CHEM, V18, P1973, DOI 10.2174/092986711795590048; PURVIS JL, 1961, J BIOL CHEM, V236, P2794; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; TISCHLER ME, 1977, ARCH BIOCHEM BIOPHYS, V184, P222, DOI 10.1016/0003-9861(77)90346-0; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Yalowitz JA, 2004, BIOCHEM J, V377, P317, DOI 10.1042/BJ20030518; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	40	44	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0147037	10.1371/journal.pone.0147037	http://dx.doi.org/10.1371/journal.pone.0147037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756334	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800043
J	Ayalew, S; Mamo, H; Animut, A; Erko, B				Ayalew, Seble; Mamo, Hassen; Animut, Abebe; Erko, Berhanu			Assessment of Current Malaria Status in Light of the Ongoing Control Interventions, Socio-Demographic and Environmental Variables in Jiga Area, Northwest Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; FEBRILE ILLNESSES; PREVALENCE; HOUSEHOLD	Following substantial decline in malaria burden in Ethiopia, the country is planning to eliminate malaria in certain low transmission settings by 2020. To evaluate the attainability of this goal in-depth examination of malaria parasite carriage at community level is necessary. This study was, therefore, aimed at assessing the current situation of malaria in relation to ongoing control interventions in Jiga area, Jabi Tehnan District in northwest Ethiopia. A cross-sectional household (HH) survey was conducted in November-December 2013. Out of 2,574 HHs (11,815 people) in the entire Jabi Tehnan District, 392 (accommodating 1911 people) were randomly selected from three purposely selected villages. One randomly selected member from each selected HH was tested for malaria using rapid diagnostic test (mRDT). All participants tested for malaria (n = 392) were afebrile (axillary temperature <37.5 degrees C). Eleven individuals (2.8%, 95% confidence interval (CI): 1.2-4.4%) were found to be mRDT positive. Most HHs (95.9%, 95% CI: 93.5-97.5%) had at least 1 long-lasting insecticidal net (LLIN). Insecticide residual spraying (IRS) coverage the last six months was 85.5% (95% CI: 82.0-88.9%). Malaria prevalence remains unexpectedly high despite high HH coverage of control interventions.	[Ayalew, Seble; Mamo, Hassen] Univ Addis Ababa, Dept Microbial Cellular & Mol Biol, Coll Nat Sci, Addis Ababa, Ethiopia; [Animut, Abebe; Erko, Berhanu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Mamo, H (corresponding author), Univ Addis Ababa, Dept Microbial Cellular & Mol Biol, Coll Nat Sci, POB 1176, Addis Ababa, Ethiopia.	binmamo@yahoo.com	Mamo, Hassen/AAX-3481-2020	Mamo, Hassen/0000-0001-9541-8976	Office of Academic Vice President at Addis Ababa University	Office of Academic Vice President at Addis Ababa University	The Office of Academic Vice President at Addis Ababa University supported this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SI, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-97; Alemu A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-173; Animut A, 2009, JPN J INFECT DIS, V62, P107; [Anonymous], 2012, P 3 ANN MAL CONTR PR; [Anonymous], 2004, MAL DIAGN TREATM GUI; Ayele DG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-195; Daniel WW., 2004, BIOSTATISTICS FDN AN; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; Federal Ministry of Health, 2014, NAT MAL PROGR MON EV; FMoH, 2006, FED DEM REP ETH MIN, P1; FMoH, 2004, MAL PREV CONTR EXT P; Graves PM, 2009, T R SOC TROP MED HYG, V11; Guthmann JP, 2007, EMERG INFECT DIS, V13, P140, DOI 10.3201/eid1301.060546; Ilombe G, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-308; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; MIS, 2011, ETH NAT MAL SURV IND; Negash K, 2005, East Afr Med J, V82, P186; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; Peterson I, 2009, AM J TROP MED HYG, V80, P103, DOI 10.4269/ajtmh.2009.80.103; Sintasath DM, 2005, AM J TROP MED HYG, V72, P682, DOI 10.4269/ajtmh.2005.72.682; Tadesse FG, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0821-1; TTC, 2013, P 4 ANN MAL CONTR PR; WHO, WORLD MAL REP 2013; Winskill P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-98	24	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146214	10.1371/journal.pone.0146214	http://dx.doi.org/10.1371/journal.pone.0146214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751687	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100051
J	Carroll, EL; Fewster, RM; Childerhouse, SJ; Patenaude, NJ; Boren, L; Baker, CS				Carroll, E. L.; Fewster, R. M.; Childerhouse, S. J.; Patenaude, N. J.; Boren, L.; Baker, C. S.			First Direct Evidence for Natal Wintering Ground Fidelity and Estimate of Juvenile Survival in the New Zealand Southern Right Whale Eubalaena australis	PLOS ONE			English	Article							CAPTURE-RECAPTURE; MICROSATELLITE LOCI; HUMPBACK WHALES; PHOTOGRAPHIC IDENTIFICATION; DEMOGRAPHIC PARAMETERS; GENOTYPING ERRORS; MODEL SELECTION; BIOPSY SYSTEM; MARK; AMPLIFICATION	Juvenile survival and recruitment can be more sensitive to environmental, ecological and anthropogenic factors than adult survival, influencing population-level processes like recruitment and growth rate in long-lived, iteroparous species such as southern right whales. Conventionally, Southern right whales are individually identified using callosity patterns, which do not stabilise until 6-12 months, by which time the whale has left its natal wintering grounds. Here we use DNA profiling of skin biopsy samples to identify individual Southern right whales from year of birth and document their return to the species' primary wintering ground in New Zealand waters, the Subantarctic Auckland Islands. We find evidence of natal fidelity to the New Zealand wintering ground by the recapture of 15 of 57 whales, first sampled in year of birth and available for subsequent recapture, during winter surveys to the Auckland Islands in 1995-1998 and 2006-2009. Four individuals were recaptured at the ages of 9 to 11, including two females first sampled as calves in 1998 and subsequently resampled as cows with calves in 2007. Using these capture-recapture records of known-age individuals, we estimate changes in survival with age using Cormack-Jolly-Seber models. Survival is modelled using discrete age classes and as a continuous function of age. Using a bootstrap method to account for uncertainty in model selection and fitting, we provide the first direct estimate of juvenile survival for this population. Our analyses indicate a high annual apparent survival for juveniles at between 0.87 (standard error (SE) 0.17, to age 1) and 0.95 (SE 0.05: ages 2-8). Individual identification by DNA profiling is an effective method for long-term demographic and genetic monitoring, particularly in animals that change identifiable features as they develop or experience tag loss over time.	[Carroll, E. L.; Baker, C. S.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Carroll, E. L.] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Fewster, R. M.] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Childerhouse, S. J.] Blue Planet Marine, Hobart, Tas, Australia; [Patenaude, N. J.] Collegial Int St Anne, Montreal, PQ, Canada; [Boren, L.] New Zealand Dept Conservat, Wellington, New Zealand; [Baker, C. S.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR USA; [Baker, C. S.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR USA	University of Auckland; University of St Andrews; University of Auckland; Oregon State University; Oregon State University	Carroll, EL (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	elc6@st-andrews.ac.uk	Carroll, Emma/U-9133-2019	Carroll, Emma/0000-0003-3193-7288; Fewster, Rachel/0000-0002-4384-978X	Whale and Dolphin Conservation Society; U.S. Department of State (Program for Cooperative US/New Zealand Antarctic Research); Auckland University Research Council; New Zealand Marsden Fund; Winifred Violet Scott Estate Research Grant Fund; Australian Antarctic Division; Marine Conservation Action Fund; Blue Planet Marine New Zealand Ltd; Holsworth Wildlife Research endowment; New Zealand Ministry of Foreign Affairs; New Zealand Department of Conservation (DOC); South Pacific Whale Research Consortium; National Geographic Society; Brian Skerry Photography; Heseltine Trust; DOC; Tertiary Education Commission Top Achiever Scholarship; School of Biological Sciences, University of Auckland; Blue Planet Marine; OMV New Zealand Ltd Scholarship	Whale and Dolphin Conservation Society; U.S. Department of State (Program for Cooperative US/New Zealand Antarctic Research); Auckland University Research Council; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Winifred Violet Scott Estate Research Grant Fund; Australian Antarctic Division; Marine Conservation Action Fund; Blue Planet Marine New Zealand Ltd; Holsworth Wildlife Research endowment; New Zealand Ministry of Foreign Affairs; New Zealand Department of Conservation (DOC); South Pacific Whale Research Consortium; National Geographic Society(National Geographic Society); Brian Skerry Photography; Heseltine Trust; DOC; Tertiary Education Commission Top Achiever Scholarship; School of Biological Sciences, University of Auckland(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Blue Planet Marine; OMV New Zealand Ltd Scholarship	The 1995-1998 Auckland Islands field trips were funded by the Whale and Dolphin Conservation Society, the U.S. Department of State (Program for Cooperative US/New Zealand Antarctic Research), the Auckland University Research Council, and the New Zealand Marsden Fund. The 2006-2009 field seasons were funded by a Winifred Violet Scott Estate Research Grant Fund, the Australian Antarctic Division, the Marine Conservation Action Fund, Blue Planet Marine New Zealand Ltd, Holsworth Wildlife Research endowment, New Zealand Ministry of Foreign Affairs, New Zealand Department of Conservation (DOC), South Pacific Whale Research Consortium, the National Geographic Society, and Brian Skerry Photography. Lab work was funded by the New Zealand Marsden Fund, DOC, and the Heseltine Trust. E. Carroll was supported by a Tertiary Education Commission Top Achiever Scholarship, an OMV New Zealand Ltd Scholarship and the School of Biological Sciences, University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Blue Planet Marine provided support in the form of salary for authors SJC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; Akaike H., 1973, P 2 INT S INF THEOR; Amstrup SC, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P1; Baker CS, 2008, MOL ECOL, V17, P3985, DOI 10.1111/j.1365-294X.2008.03867.x; Baker CS, 1998, MOL ECOL, V7, P695, DOI 10.1046/j.1365-294x.1998.00384.x; BAKER CS, 1994, MOL ECOL, V3, P313, DOI 10.1111/j.1365-294X.1994.tb00071.x; Barlow J, 1997, ECOLOGY, V78, P535; Berube M, 2000, MOL ECOL, V9, P2181; Best PB, 2005, J WILDLIFE MANAGE, V69, P1171, DOI 10.2193/0022-541X(2005)069[1171:BSRWTR]2.0.CO;2; BEST PB, 1993, MAR MAMMAL SCI, V9, P227, DOI 10.1111/j.1748-7692.1993.tb00451.x; BEST PB, 1990, S AFR J ZOOL, V25, P114; Best PB, 2000, S AFR J MARINE SCI, V22, P43, DOI 10.2989/025776100784125618; BEST PB, 1992, J ZOOL, V228, P595, DOI 10.1111/j.1469-7998.1992.tb04458.x; Biomatters, 2012, GEN V6 1; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bradford AL, 2006, MAR ECOL PROG SER, V315, P293, DOI 10.3354/meps315293; Brandao A, 2010, SCI COMM INT WHAL CO; Brandao A, 2013, SCI COMM INT WHAL CO; Broquet T, 2007, CONSERV GENET, V8, P249, DOI 10.1007/s10592-006-9146-5; Buckland S.T., 2001, pi; Buckland ST, 2004, ECOL MODEL, V171, P157, DOI 10.1016/j.ecolmodel.2003.08.002; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnell SR, 2008, SCI COMM INT WHAL CO; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burns D, 2013, MAR MAMMAL SCI, V29, P228, DOI 10.1111/j.1748-7692.2011.00557.x; Carroll E, 2011, MAR ECOL PROG SER, V432, P257, DOI 10.3354/meps09145; Carroll EL, 2013, ECOL APPL, V23, P1677, DOI 10.1890/12-1657.1; Carroll EL, 2011, MAR BIOL, V158, P2565, DOI 10.1007/s00227-011-1757-9; Carroll EL, 2011, THESIS; Carroll EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093789; Carroll EL, 2014, MAR MAMMAL SCI, V30, P206, DOI 10.1111/mms.12031; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; Cawthorn M., 1993, REP INT WHAL COMM, V43, P286; Ceugniet M, 2004, PRIMATES, V45, P119, DOI 10.1007/s10329-003-0067-3; Charrier I, 2009, ANIM BEHAV, V78, P1127, DOI 10.1016/j.anbehav.2009.07.032; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cooke J, 2003, SCI COMM INT WHAL CO; Cooke J. G., 2001, Journal of Cetacean Research and Management Special Issue, P125; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Dixon DR, 2003, MAMMAL REV, V33, P92, DOI 10.1046/j.1365-2907.2003.00001.x; Dybala KE, 2013, ECOLOGY, V94, P1584, DOI 10.1890/12-1443.1; Ebert T, 1998, PLANT ANIMAL POPULAT; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; EVETT IW, 1998, INTERPRETING DNA EVI; Fewster RM, 2013, J MULTIVARIATE ANAL, V120, P34, DOI 10.1016/j.jmva.2013.05.010; Forcada J, 2000, MAR MAMMAL SCI, V16, P767, DOI 10.1111/j.1748-7692.2000.tb00971.x; Ford JH, 2012, METHODS ECOL EVOL, V3, P1047, DOI 10.1111/j.2041-210X.2012.00243.x; Fortune SME, 2012, J MAMMAL, V93, P1342, DOI 10.1644/11-MAMM-A-297.1; Frasier TR, 2006, MOL ECOL NOTES, V6, P1025, DOI 10.1111/j.1471-8286.2006.01417.x; Gabriele CM, 2001, CAN J ZOOL, V79, P589, DOI 10.1139/cjz-79-4-589; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; Gilson A, 1998, CALIF FISH GAME, V84, P159; Goswami VR, 2007, ANIM CONSERV, V10, P391, DOI 10.1111/j.1469-1795.2007.00124.x; Haaland OA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-36; HAMMOND PS, 1990, MAMMAL REV, V20, P17, DOI 10.1111/j.1365-2907.1990.tb00099.x; Henderson SD, 2014, MAR MAMMAL SCI, V30, P1067, DOI 10.1111/mms.12109; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Kalinowski S., 2007, MOL ECOL, V9, P801; Karanth KU, 2004, ANIM CONSERV, V7, P285, DOI 10.1017/S1367943004001477; Krause S. J., 1986, Rapid Thermal Processing, P145; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Kuhl HS, 2013, TRENDS ECOL EVOL, V28, P432, DOI 10.1016/j.tree.2013.02.013; LAMBERTSEN RH, 1987, J MAMMAL, V68, P443, DOI 10.2307/1381495; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; Loos A, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-49; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; Morin PA, 2010, J HERED, V101, P1, DOI 10.1093/jhered/esp107; Neubert MG, 2000, J MATH BIOL, V41, P103, DOI 10.1007/s002850070001; Norris K, 2004, J APPL ECOL, V41, P413, DOI 10.1111/j.0021-8901.2004.00910.x; Ogutu JO, 2006, J ZOOL, V269, P161, DOI 10.1111/j.1469-7998.2006.00058.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; Palsboll PJ, 1997, NATURE, V388, P767, DOI 10.1038/42005; Palsboll PJ, 1997, MOL ECOL, V6, P893; Patenaude Nathalie J., 2001, Journal of Cetacean Research and Management Special Issue, V2, P111; Patenaude NJ, 1998, MAR MAMMAL SCI, V14, P350, DOI 10.1111/j.1748-7692.1998.tb00726.x; Patenaude NJ, 2002, THESIS; Payne R., 1983, COMMUNICATION BEHAV, P371; Perez T, 2009, CONSERV GENET, V10, P291, DOI 10.1007/s10592-008-9578-1; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rayment W, 2012, NEW ZEAL J MAR FRESH, V46, P431, DOI 10.1080/00288330.2012.697072; Rowntree VJ, 2013, MAR ECOL PROG SER, V493, P275, DOI 10.3354/meps10506; Rowntree Victoria J., 2001, Journal of Cetacean Research and Management Special Issue, V2, P133; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Tarwater CE, 2011, ECOLOGY, V92, P1271, DOI 10.1890/10-1386.1; Taylor BL, 2007, ADM REP; THOMAS PO, 1984, BEHAVIOUR, V88, P42, DOI 10.1163/156853984X00470; Vale RTR, 2014, BIOMETRICS, V70, P962, DOI 10.1111/biom.12195; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Waits JL, 2000, ANIM CONSERV, V3, P191, DOI 10.1017/S1367943000000901; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Waldick RC, 1999, MOL ECOL, V8, P1763, DOI 10.1046/j.1365-294x.1999.00723-6.x; Weinrich M, 2009, BIOL CONSERV, V142, P2931, DOI 10.1016/j.biocon.2009.07.018; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 1982, LA8787NERP LOS AL NA; Witteveen Briana H., 2011, Endangered Species Research, V14, P217, DOI 10.3354/esr00351; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43	101	12	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146590	10.1371/journal.pone.0146590	http://dx.doi.org/10.1371/journal.pone.0146590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751689	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100107
J	Cote, NML; Daligault, J; Pruvost, M; Bennett, EA; Gorge, O; Guimaraes, S; Capelli, N; Le Bailly, M; Geigl, EM; Grange, T				Cote, Nathalie M. L.; Daligault, Julien; Pruvost, Melanie; Bennett, E. Andrew; Gorge, Olivier; Guimaraes, Silvia; Capelli, Nicolas; Le Bailly, Matthieu; Geigl, Eva-Maria; Grange, Thierry			A New High-Throughput Approach to Genotype Ancient Human Gastrointestinal Parasites	PLOS ONE			English	Article							SEQUENCE; PERFORMANCE; ASCARIASIS; INFECTIONS; REMAINS; DNA	Human gastrointestinal parasites are good indicators for hygienic conditions and health status of past and present individuals and communities. While microscopic analysis of eggs in sediments of archeological sites often allows their taxonomic identification, this method is rarely effective at the species level, and requires both the survival of intact eggs and their proper identification. Genotyping via PCR-based approaches has the potential to achieve a precise species-level taxonomic determination. However, so far it has mostly been applied to individual eggs isolated from archeological samples. To increase the throughput and taxonomic accuracy, as well as reduce costs of genotyping methods, we adapted a PCR-based approach coupled with next-generation sequencing to perform precise taxonomic identification of parasitic helminths directly from archeological sediments. Our study of twenty-five 100 to 7,200 year-old archeological samples proved this to be a powerful, reliable and efficient approach for species determination even in the absence of preserved eggs, either as a stand-alone method or as a complement to microscopic studies.	[Cote, Nathalie M. L.; Daligault, Julien; Pruvost, Melanie; Bennett, E. Andrew; Gorge, Olivier; Guimaraes, Silvia; Geigl, Eva-Maria; Grange, Thierry] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592,Epigenome & Paleogenome Grp, F-75205 Paris 13, France; [Cote, Nathalie M. L.; Capelli, Nicolas; Le Bailly, Matthieu] Univ Bourgogne Franche Comte, CNRS UMR Chronoenvironm 6249, F-25030 Besancon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte	Geigl, EM (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592,Epigenome & Paleogenome Grp, 15 Rue Helene Brion, F-75205 Paris 13, France.	eva-maria.geigl@ijm.fr; thierry.grange@ijm.fr	Le Bailly, Matthieu/AAA-2977-2019	Guimaraes, Silvia/0000-0002-3778-3315; Pruvost, Melanie/0000-0001-7824-2155; Geigl, Eva-Maria/0000-0001-6376-2094; Le Bailly, Matthieu/0000-0001-6320-6741; Grange, Thierry/0000-0001-8700-3092	Franche-Comte region; French National Research Center (CNRS); Faculty of Sciences and Techniques of the Franche-Comte University, Besancon; Franche-Comte region, France; University Paris Diderot; Fondation pour la Recherche Medicale [DGE20111123014]; Region Ile-de-France [11015901]	Franche-Comte region(Region Bourgogne-Franche-Comte); French National Research Center (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Faculty of Sciences and Techniques of the Franche-Comte University, Besancon; Franche-Comte region, France(Region Bourgogne-Franche-Comte); University Paris Diderot; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Ile-de-France(Region Ile-de-France)	Nathalie M.L. Cote was supported by a PhD fellowship from the Franche-Comte region. The financial support for the project was obtained from the French National Research Center (CNRS, TG, EMG), the Faculty of Sciences and Techniques of the Franche-Comte University, Besancon (MLB, NC), and the Franche-Comte region, France (MLB, NC). The sequencing facility of the Jacques Monod Institute, Paris, is supported by grants to TG from the University Paris Diderot, the "Fondation pour la Recherche Medicale" (DGE20111123014), and the "Region Ile-de-France" (grant 11015901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash L, 2007, ASH ORIHELS ATLAS HU; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bennett EA, 2014, BIOTECHNIQUES, V56, P289, DOI 10.2144/000114176; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Betson M, 2014, J INFECT DIS, V210, P932, DOI 10.1093/infdis/jiu193; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P47, DOI 10.1590/S0074-02762003000900009; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P95, DOI 10.1590/S0074-02762003000900015; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Cano RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106833; CDC, 2015, PARASITES; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Cleeland LM, 2013, J ARCHAEOL SCI, V40, P3060, DOI 10.1016/j.jas.2013.03.010; Dorny P, 2009, VET PARASITOL, V163, P196, DOI 10.1016/j.vetpar.2009.05.026; Dufour B, 2013, INT J PALEOPATHOL, V3, P199, DOI 10.1016/j.ijpp.2013.03.008; Guimaraes S, MOL ECOLOGY RE UNPUB; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Iniguez AM, 2006, INT J PARASITOL, V36, P1419, DOI 10.1016/j.ijpara.2006.07.005; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Le Bailly M, 2012, J PARASITOL, V98, P1273, DOI 10.1645/GE-3200.1; Le Bailly M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109543; Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Mehlhorn H, 2008, ENCY PARASITOLOGY; Pruvost M, 2008, PALAEOGEOGR PALAEOCL, V266, P211, DOI 10.1016/j.palaeo.2008.03.041; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Sianto L, 2009, REV INST MED TROP SP, V51, P119, DOI 10.1590/S0036-46652009000300001	29	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146230	10.1371/journal.pone.0146230	http://dx.doi.org/10.1371/journal.pone.0146230			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752051	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100054
J	Del-Cid, A; Gil-Duran, C; Vaca, I; Rojas-Aedo, JF; Garcia-Rico, RO; Levican, G; Chavez, R				Del-Cid, Abdiel; Gil-Duran, Carlos; Vaca, Inmaculada; Rojas-Aedo, Juan F.; Garcia-Rico, Ramon O.; Levican, Gloria; Chavez, Renato			Identification and Functional Analysis of the Mycophenolic Acid Gene Cluster of Penicillium roqueforti	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; IMP DEHYDROGENASE; CHEESE; MYCOTOXINS; FUNGI; BIOSYNTHESIS; IMMUNOSUPPRESSANT; CHRYSOGENUM; EXPRESSION; STRAINS	The filamentous fungus Penicillium roqueforti is widely known as the ripening agent of blue-veined cheeses. Additionally, this fungus is able to produce several secondary metabolites, including the meroterpenoid compound mycophenolic acid (MPA). Cheeses ripened with P. roqueforti are usually contaminated with MPA. On the other hand, MPA is a commercially valuable immunosuppressant. However, to date the molecular basis of the production of MPA by P. roqueforti is still unknown. Using a bioinformatic approach, we have identified a genomic region of approximately 24.4 kbp containing a seven-gene cluster that may be involved in the MPA biosynthesis in P. roqueforti. Gene silencing of each of these seven genes (named mpaA, mpaB, mpaC, mpaDE, mpaF, mpaG and mpaH) resulted in dramatic reductions in MPA production, confirming that all of these genes are involved in the biosynthesis of the compound. Interestingly, the mpaF gene, originally described in P. brevicompactum as a MPA self-resistance gene, also exerts the same function in P. roqueforti, suggesting that this gene has a dual function in MPA metabolism. The knowledge of the biosynthetic pathway of MPA in P. roqueforti will be important for the future control of MPA contamination in cheeses and the improvement of MPA production for commercial purposes.	[Del-Cid, Abdiel; Gil-Duran, Carlos; Rojas-Aedo, Juan F.; Levican, Gloria; Chavez, Renato] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile; [Vaca, Inmaculada] Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile; [Garcia-Rico, Ramon O.] Univ Pamplona, Fac Basic Sci, Dept Microbiol, GIMBIO Grp, Pamplona, Colombia	Universidad de Santiago de Chile; Universidad de Chile	Chavez, R (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile.	renato.chavez@usach.cl	Garcia-Rico, Ramon Ovidio/N-4289-2019; García-Rico, Ramón Ovidio/E-6404-2014; Levican, Gloria/R-5191-2019; Vaca, Inmaculada/I-2758-2013	Garcia-Rico, Ramon Ovidio/0000-0002-2451-7958; García-Rico, Ramón Ovidio/0000-0002-2451-7958; Levican, Gloria/0000-0002-1275-7399; Gil-Duran, Carlos Andres/0000-0001-9638-6902; Vaca, Inmaculada/0000-0002-8952-9036; Chavez, Renato/0000-0003-1754-3610	project FONDECYT [1120833]; DICYT-USACH; CONICYT-PFCHA/Doctorado Nacional [2014-63140056, 2013-21130251]; University of Pamplona; Microbiology and Biotechnology Research Group (GIMBIO)	project FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DICYT-USACH; CONICYT-PFCHA/Doctorado Nacional; University of Pamplona; Microbiology and Biotechnology Research Group (GIMBIO)	This work was supported by project FONDECYT grant 1120833 (RC) and DICYT-USACH (GL, RC). CGD and JFRA have received doctoral fellowships CONICYT-PFCHA/Doctorado Nacional/2014-63140056 and CONICYT-PFCHA/Doctorado Nacional/2013-21130251, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R. O. G.-R. thanks the University of Pamplona and the Microbiology and Biotechnology Research Group (GIMBIO) for their support. The technical assistance of Miss Dania Batista Salinas is kindly acknowledged.	Alexander NJ, 1999, MOL GEN GENET, V261, P977, DOI 10.1007/s004380051046; Bentley R, 2000, CHEM REV, V100, P3801, DOI 10.1021/cr990097b; Cakmakci S, 2015, FOOD ADDIT CONTAM A, V32, P245, DOI 10.1080/19440049.2014.997808; Cheeseman K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3876; ENGEL G, 1982, APPL ENVIRON MICROB, V43, P1034, DOI 10.1128/AEM.43.5.1034-1040.1982; Frisvad JC, 2004, STUD MYCOL, P201; Garcia-Rico RO, 2009, INT MICROBIOL, V12, P123, DOI 10.2436/20.1501.01.89; Gil-Duran C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120740; Hansen BG, 2012, BIOCHEM J, V441, P219, DOI 10.1042/BJ20111278; Hansen BG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-202; Hansen BG, 2012, APPL ENVIRON MICROB, V78, P4908, DOI 10.1128/AEM.07955-11; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Hidalgo PI, 2014, FUNGAL GENET BIOL, V62, P11, DOI 10.1016/j.fgb.2013.10.009; Hymery N, 2014, COMPR REV FOOD SCI F, V13, P437, DOI 10.1111/1541-4337.12069; Ismaiel AA, 2014, WORLD J MICROB BIOT, V30, P2625, DOI 10.1007/s11274-014-1685-1; Kokkonen M, 2005, FOOD ADDIT CONTAM A, V22, P449, DOI 10.1080/02652030500089861; LAFONT P, 1979, APPL ENVIRON MICROB, V37, P365, DOI 10.1128/AEM.37.3.365-368.1979; LAFONT P, 1979, FOOD COSMET TOXICOL, V17, P147, DOI 10.1016/0015-6264(79)90214-1; LopezDiaz TM, 1996, INT J FOOD MICROBIOL, V30, P391, DOI 10.1016/0168-1605(96)00957-9; Nielsen MS, 1998, J FOOD PROTECT, V61, P1023, DOI 10.4315/0362-028X-61.8.1023; O'Brien M, 2006, J AGR FOOD CHEM, V54, P9268, DOI 10.1021/jf0621018; Puel O, 2005, APPL ENVIRON MICROB, V71, P550, DOI 10.1128/AEM.71.1.550-553.2005; Ravanal MC, 2012, MYCOSCIENCE, V53, P152, DOI 10.1007/s10267-011-0144-1; Regueira TB, 2011, APPL ENVIRON MICROB, V77, P3035, DOI 10.1128/AEM.03015-10; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000952; Shipkova M, 1999, BRIT J PHARMACOL, V126, P1075, DOI 10.1038/sj.bjp.0702399; Ullan RV, 2008, J MICROBIOL METH, V75, P209, DOI 10.1016/j.mimet.2008.06.001; Usleber E, 2008, J AGR FOOD CHEM, V56, P6857, DOI 10.1021/jf801063w; Vinokurova NG, 2005, APPL BIOCHEM MICRO+, V41, P83, DOI 10.1007/s10438-005-0015-7; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Zambonin CG, 2002, FOOD CHEM, V78, P249, DOI 10.1016/S0308-8146(02)00108-5; Zhang W, 2015, CHEMBIOCHEM, V16, P565, DOI 10.1002/cbic.201402600	32	26	33	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0147047	10.1371/journal.pone.0147047	http://dx.doi.org/10.1371/journal.pone.0147047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751579	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100190
J	Frauenknecht, K; Diederich, K; Leukel, P; Bauer, H; Schabitz, WR; Sommer, CJ; Minnerup, J				Frauenknecht, Katrin; Diederich, Kai; Leukel, Petra; Bauer, Henrike; Schaebitz, Wolf-Ruediger; Sommer, Clemens J.; Minnerup, Jens			Functional Improvement after Photothrombotic Stroke in Rats Is Associated with Different Patterns of Dendritic Plasticity after G-CSF Treatment and G-CSF Treatment Combined with Concomitant or Sequential Constraint-Induced Movement Therapy	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ISCHEMIC-STROKE; PYRAMIDAL NEURONS; ANIMAL-MODELS; ADULT RATS; BRAIN; RECOVERY; CORTEX; CELLS; EFFICACY	We have previously shown that granulocyte-colony stimulating factor (G-CSF) treatment alone, or in combination with constraint movement therapy (CIMT) either sequentially or concomitantly, results in significantly improved sensorimotor recovery after photothrombotic stroke in rats in comparison to untreated control animals. CIMT alone did not result in any significant differences compared to the control group (Diederich et al., Stroke, 2012;43:185-192). Using a subset of rat brains from this former experiment the present study was designed to evaluate whether dendritic plasticity would parallel improved functional outcomes. Five treatment groups were analyzed (n = 6 each) (i) ischemic control (saline); (ii) CIMT (CIMT between post-stroke days 2 and 11); (iii) G-CSF (10 mu g/kg G-CSF daily between post-stroke days 2 and 11); (iv) combined concurrent group (CIMT plus G-CSF) and (v) combined sequential group (CIMT between post-stroke days 2 and 11; 10 mu g/kg G-CSF daily between post-stroke days 12 and 21, respectively). After impregnation of rat brains with a modified Golgi-Cox protocol layer V pyramidal neurons in the peri-infarct cortex as well as the corresponding contralateral cortex were analyzed. Surprisingly, animals with a similar degree of behavioral recovery exhibited quite different patterns of dendritic plasticity in both peri-lesional and contralesional areas. The cause for these patterns is not easily to explain but puts the simple assumption that increased dendritic complexity after stroke necessarily results in increased functional outcome into perspective.	[Frauenknecht, Katrin; Leukel, Petra; Bauer, Henrike; Sommer, Clemens J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neuropathol, D-55122 Mainz, Germany; [Diederich, Kai; Schaebitz, Wolf-Ruediger; Minnerup, Jens] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Schaebitz, Wolf-Ruediger] EVKB, Bethel, Neurol, Bielefeld, Germany	Johannes Gutenberg University of Mainz; University of Munster; Evangelical Hospital Bethel (EvKB) - House Gilead I	Sommer, CJ (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neuropathol, D-55122 Mainz, Germany.	clemens.sommer@unimedizin-mainz.de	Frauenknecht, Katrin/AAF-1638-2020	Frauenknecht, Katrin/0000-0002-1372-3297; Diederich, Kai/0000-0002-6550-9460	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [SO 908/3-1, SCH 787/5-1]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	CS and WRS were supported from a grant by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; SO 908/3-1, SCH 787/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred RP, 2010, BEHAV NEUROSCI, V124, P124, DOI 10.1037/a0018457; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Cui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064684; Diederich K, 2012, STROKE, V43, P185, DOI 10.1161/STROKEAHA.111.622159; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Frauenknecht K, 2015, NEUROPATH APPL NEURO, V41, P657, DOI 10.1111/nan.12180; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Gonzalez CLR, 2006, NEUROPHARMACOLOGY, V50, P777, DOI 10.1016/j.neuropharm.2005.11.018; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Grotta JC, 2015, STROKE; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; JONES TA, 1994, J NEUROSCI, V14, P2140; Kolb B, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00015; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Kwakkel G, 2015, LANCET NEUROL, V14, P224, DOI 10.1016/S1474-4422(14)70160-7; Liu ZW, 2010, J CEREBR BLOOD F MET, V30, P1288, DOI 10.1038/jcbfm.2010.8; Minnerup Jens, 2009, Exp Transl Stroke Med, V1, P2, DOI 10.1186/2040-7378-1-2; Mostany R, 2011, J NEUROSCI, V31, P1734, DOI 10.1523/JNEUROSCI.4386-10.2011; Papadopoulos CM, 2006, CEREB CORTEX, V16, P529, DOI 10.1093/cercor/bhi132; Rowntree S, 1997, EUR J NEUROSCI, V9, P2432, DOI 10.1111/j.1460-9568.1997.tb01660.x; Schmidt A, 2014, STROKE, V45, P239, DOI 10.1161/STROKEAHA.113.002048; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Shanina EV, 2006, NEUROSCIENCE, V139, P1495, DOI 10.1016/j.neuroscience.2006.01.016; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Silasi G, 2008, BEHAV BRAIN RES, V188, P219, DOI 10.1016/j.bbr.2007.10.030; Spratling M W, 2002, Behav Cogn Neurosci Rev, V1, P219, DOI 10.1177/1534582302001003003; Sprigg N, 2006, STROKE, V37, P2979, DOI 10.1161/01.STR.0000248763.49831.c3; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Ueno Y, 2012, STROKE, V43, P2221, DOI 10.1161/STROKEAHA.111.646224; Zeiler SR, 2013, CURR OPIN NEUROL, V26, P609, DOI 10.1097/WCO.0000000000000025	34	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146679	10.1371/journal.pone.0146679	http://dx.doi.org/10.1371/journal.pone.0146679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752421	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100127
J	Gu, LD; Hitzel, J; Moll, F; Kruse, C; Malik, RA; Preussner, J; Looso, M; Leisegang, MS; Steinhilber, D; Brandes, RP; Fork, C				Gu, Lunda; Hitzel, Juliane; Moll, Franziska; Kruse, Christoph; Malik, Randa Abdel; Preussner, Jens; Looso, Mario; Leisegang, Matthias S.; Steinhilber, Dieter; Brandes, Ralf P.; Fork, Christian			The Histone Demethylase PHF8 Is Essential for Endothelial Cell Migration	PLOS ONE			English	Article							EPIGENETIC REGULATION; MENTAL-RETARDATION; JUMONJI DOMAIN; GENE; TRANSCRIPTION; EXPRESSION; PROTEIN; E2F4; ACTIVATION; REPRESSION	Epigenetic marks critically control gene expression and thus the cellular activity state. The functions of many epigenetic modifiers in the vascular system have not yet been studied. We screened for histone modifiers in endothelial cells and observed a fairly high expression of the histone plant homeodomain finger protein 8 (PHF8). Given its high expression, we hypothesize that this histone demethylase is important for endothelial cell function. Overexpression of PHF8 catalyzed the removal of methyl-groups from histone 3 lysine 9 (H3K9) and H4K20, whereas knockdown of the enzyme increased H3K9 methylation. Knockdown of PHF8 by RNAi also attenuated endothelial proliferation and survival. As a functional readout endothelial migration and tube formation was studied. PHF8 siRNA attenuated the capacity for migration and developing of capillary-like structures. Given the impact of PHF8 on cell cycle genes, endothelial E2F transcription factors were screened, which led to the identification of the gene repressor E2F4 to be controlled by PHF8. Importantly, PHF8 maintains E2F4 but not E2F1 expression in endothelial cells. Consistently, chromatin immunoprecipitation revealed that PHF8 reduces the H3K9me2 level at the E2F4 transcriptional start site, demonstrating a direct function of PHF8 in endothelial E2F4 gene regulation. Conclusion: PHF8 by controlling E2F4 expression maintains endothelial function.	[Gu, Lunda; Hitzel, Juliane; Moll, Franziska; Kruse, Christoph; Leisegang, Matthias S.; Brandes, Ralf P.; Fork, Christian] Goethe Univ Frankfurt, Fac Med, Inst Cardiovasc Physiol, D-60054 Frankfurt, Germany; [Malik, Randa Abdel] Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, D-60054 Frankfurt, Germany; [Preussner, Jens; Looso, Mario] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Steinhilber, Dieter] Goethe Univ Frankfurt, ZAFES, Inst Pharmaceut Chem, D-60054 Frankfurt, Germany; [Hitzel, Juliane; Moll, Franziska; Kruse, Christoph; Malik, Randa Abdel; Preussner, Jens; Looso, Mario; Leisegang, Matthias S.; Brandes, Ralf P.; Fork, Christian] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; Goethe University Frankfurt; German Centre for Cardiovascular Research	Fork, C (corresponding author), Goethe Univ Frankfurt, Fac Med, Inst Cardiovasc Physiol, D-60054 Frankfurt, Germany.	fork@vrc.uni-frankfurt.de	Brandes, Ralf P/L-3058-2017; Leisegang, Matthias S./ABD-8062-2021; Steinhilber, Dieter/J-3221-2012; Leisegang, Matthias S./P-6006-2017	Brandes, Ralf P/0000-0002-8035-0048; Leisegang, Matthias S./0000-0002-6084-6484; Leisegang, Matthias S./0000-0002-6084-6484; Preussner, Jens/0000-0003-1927-3458; Looso, Mario/0000-0003-1495-9530	Goethe-University Frankfurt; Excellence cluster ECCPS of the German Research Function; DFG [Sonderforschungsbereiche SFB834, SFB1038]; China Scholarship Council (CSC)	Goethe-University Frankfurt; Excellence cluster ECCPS of the German Research Function; DFG(German Research Foundation (DFG)); China Scholarship Council (CSC)(China Scholarship Council)	This study was supported by a grant of the Goethe-University Frankfurt to C.F., by the Excellence cluster ECCPS of the German Research Function as well as the DFG Sonderforschungsbereiche SFB834 (TP A2 to RPB) and SFB1038 (TP A1 to RPB and DS). L.G. was supported by a fellowship from China Scholarship Council (CSC).	Abidi FE, 2007, CLIN GENET, V72, P19, DOI 10.1111/j.1399-0004.2007.00817.x; Andrusiak MG, 2011, MOL CELL BIOL, V31, P238, DOI 10.1128/MCB.00378-10; Asensio-Juan E, 2012, NUCLEIC ACIDS RES, V40, P9429, DOI 10.1093/nar/gks716; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Bjorkman M, 2012, ONCOGENE, V31, P3444, DOI 10.1038/onc.2011.512; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Bornfeldt KE, 2003, CIRC RES, V92, P345, DOI 10.1161/01.RES.0000061765.06145.10; Crea F, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-52; Denchi EL, 2005, EMBO REP, V6, P661, DOI 10.1038/sj.embor.7400452; Dingar D, 2012, J MOL CELL CARDIOL, V53, P820, DOI 10.1016/j.yjmcc.2012.09.004; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fork C, 2015, ARTERIOSCL THROM VAS, V35, P1645, DOI 10.1161/ATVBAHA.115.305561; Fraineau S, 2015, FEBS J, V282, P1605, DOI 10.1111/febs.13183; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Gupta J, 2012, BIOCHIMIE, V94, P2656, DOI 10.1016/j.biochi.2012.08.011; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Koivisto AM, 2007, CLIN GENET, V72, P145, DOI 10.1111/j.1399-0004.2007.00836.x; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Lim HJ, 2013, MOL CELL BIOL, V33, P4166, DOI 10.1128/MCB.00689-13; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; McClellan KA, 2007, CELL CYCLE, V6, P2917, DOI 10.4161/cc.6.23.4997; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Osawa T, 2011, P NATL ACAD SCI USA, V108, P20725, DOI 10.1073/pnas.1108462109; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Shen YZ, 2014, BIOCHEM BIOPH RES CO, V451, P119, DOI 10.1016/j.bbrc.2014.07.076; Sun LP, 2015, J BIOL CHEM, V290, P4075, DOI 10.1074/jbc.M114.602532; Sun XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077353; Trikha P, 2016, ONCOGENE, V35, P3636, DOI 10.1038/onc.2015.429; Turgeon Paul J, 2014, Med Epigenet, V2, P37; Wang DW, 2000, MOL CELL BIOL, V20, P3417, DOI 10.1128/MCB.20.10.3417-3424.2000; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Winn RK, 2005, J THROMB HAEMOST, V3, P1815, DOI 10.1111/j.1538-7836.2005.01378.x; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Yuan Z, 2015, J BIOL CHEM, V290, P14927, DOI 10.1074/jbc.M115.658419; Yue WW, 2010, FEBS LETT, V584, P825, DOI 10.1016/j.febslet.2009.12.055; Zhu GC, 2015, EPIGENOMICS-UK, V7, P143, DOI [10.2217/EPI.14.82, 10.2217/epi.14.82]; Zhu ZQ, 2010, CELL RES, V20, P794, DOI 10.1038/cr.2010.75	42	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146645	10.1371/journal.pone.0146645	http://dx.doi.org/10.1371/journal.pone.0146645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751588	gold, Green Published			2022-12-27	WOS:000367888100120
J	Lima-Perim, JE; Romagnoli, EM; Dini-Andreote, F; Durrer, A; Dias, ACF; Andreote, FD				Lima-Perim, Julia Elidia; Romagnoli, Emiliana Manesco; Dini-Andreote, Francisco; Durrer, Ademir; Franco Dias, Armando Cavalcante; Andreote, Fernando Dini			Linking the Composition of Bacterial and Archaeal Communities to Characteristics of Soil and Flora Composition in the Atlantic Rainforest	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; 16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; DIVERSITY; ABUNDANCE; PH; DIFFERENTIATION; OXIDATION; PATTERNS; NICHES	The description of microbiomes as intrinsic fractions of any given ecosystem is an important issue, for instance, by linking their compositions and functions with other biotic and abiotic components of natural systems and hosts. Here we describe the archaeal and bacterial communities from soils of the Atlantic Rainforest in Brazil. Based on the comparison of three areas located along an altitudinal gradient-namely, Santa Virginia, Picinguaba and Restinga-we detected the most abundant groups of Bacteria (Acidobacteria and Proteobacteria) and Archaea (Thaumarchaeota, Crenarchaeota and Euryarchaeota). The particular composition of such communities in each of these areas was first evidenced by PCR-DGGE patterns [determined for Bacteria, Archaea and ammonia-oxidizing organisms- ammonia-oxidizing archaea (AOA) and bacteria (AOB)]. Moreover, sequence-based analysis provided a better resolution of communities, which indicated distinct frequencies of archaeal phyla and bacterial OTUs across areas. We found, as indicated by the Mantel test and multivariate analyses, a potential effect of the flora composition that outpaces the effect of soil characteristics (either physical and chemical) influencing the assembly of these microbial communities in soils. Our results indicate a collective role of the ecosystem underlying observed differences in microbial communities in these soils. Particularly, we posit that rainforest preservation also needs to take into account the maintenance of the soil biodiversity, as this is prompted to influence major processes that affect ecosystem functioning.	[Lima-Perim, Julia Elidia; Romagnoli, Emiliana Manesco; Durrer, Ademir; Franco Dias, Armando Cavalcante; Andreote, Fernando Dini] Univ Sao Paulo, Dept Soil Sci, ESALQ, Piracicaba, Brazil; [Dini-Andreote, Francisco] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Genom Res Ecol & Evolut Nat GREEN, Microbial Ecol Grp, Groningen, Netherlands	Universidade de Sao Paulo; University of Groningen	Andreote, FD (corresponding author), Univ Sao Paulo, Dept Soil Sci, ESALQ, Piracicaba, Brazil.	fdandreo@gmail.com	Romagnoli, Emiliana Manesco/J-2004-2016; Dini-Andreote, Francisco/M-6176-2017; Dias, Armando Cavalcante Franco/O-1477-2019; Dias, Armando Cavalcante Franco/F-5878-2012; Andreote, Fernando Dini/B-8499-2012	Romagnoli, Emiliana Manesco/0000-0002-2260-074X; Dini-Andreote, Francisco/0000-0002-6654-0769; Dias, Armando Cavalcante Franco/0000-0002-2651-6270; Dias, Armando Cavalcante Franco/0000-0002-2651-6270; Andreote, Fernando Dini/0000-0002-9883-9968	FAPESP [08/50824-1]; ACFD [2012/14534-4]; CNPq [132094/2010-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ACFD; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank FAPESP (grant 08/50824-1), ACFD (project 2012/14534-4) and CNPq (grant 132094/2010-0) for the financial support.	Andreote FD, 2009, APPL ENVIRON MICROB, V75, P3396, DOI 10.1128/AEM.00491-09; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Bruce T, 2010, MICROB ECOL, V60, P840, DOI 10.1007/s00248-010-9750-2; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cantrell Sharon A., 2013, Ecological Bulletins, V54, P87; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cheng F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067353; Clarke KR, 2001, GORLEY PRIMER V5 USE; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; DeAngelis KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00104; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eichorst SA, 2011, APPL ENVIRON MICROB, V77, P586, DOI 10.1128/AEM.01080-10; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Faoro H, 2010, APPL ENVIRON MICROB, V76, P4744, DOI 10.1128/AEM.03025-09; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer O, 2008, PALAEONTOLIA ELECT, V4, P9; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Hermansson A, 2001, APPL ENVIRON MICROB, V67, P972, DOI 10.1128/AEM.67.2.972-976.2001; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jin T, 2011, APPL MICROBIOL BIOT, V90, P1137, DOI 10.1007/s00253-011-3107-8; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; Ke XB, 2013, ENVIRON MICROBIOL, V15, P2275, DOI 10.1111/1462-2920.12098; Kemnitz D, 2007, FEMS MICROBIOL ECOL, V60, P442, DOI 10.1111/j.1574-6941.2007.00310.x; Kowalchuk GA, 1997, APPL ENVIRON MICROB, V63, P1489, DOI 10.1128/AEM.63.4.1489-1497.1997; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; KRZANOWSKI WJ, 1990, J CLASSIF, V7, P81, DOI 10.1007/BF01889705; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lehtovirta LE, 2009, FEMS MICROBIOL ECOL, V70, P367, DOI 10.1111/j.1574-6941.2009.00748.x; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mantel N, 1967, BIOMETRICS RANKING P; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Mendes LW, 2015, MICROB ECOL, V70, P255, DOI 10.1007/s00248-014-0559-2; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Muyzer G, 1993, APPL ENVIRON MICROB, V62, P2676; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Pacchioni RG, 2014, MICROBIOLOGYOPEN, V3, P299, DOI 10.1002/mbo3.169; Silva MCPE, 2013, SOIL BIOL BIOCHEM, V57, P995, DOI 10.1016/j.soilbio.2012.10.002; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Rademaker JL, 2004, MOL MICROBIAL ECOLOG, P3299; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos EC, 2014, SOIL BIOL BIOCHEM, V69, P101, DOI 10.1016/j.soilbio.2013.10.049; Schleper C, 2010, ISME J, V4, P1092, DOI 10.1038/ismej.2010.111; Silva FAS, 2002, BRAZ J AGROINDUSTR P, V4, P71; Silva MT, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00071; Silva RC, 2007, REV BRAS CIENC SOLO, V31, P101, DOI 10.1590/S0100-06832007000100011; Sundqvist MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027056; Szukics U, 2009, BIOL FERT SOILS, V45, P855, DOI 10.1007/s00374-009-0396-5; Tago K, 2015, MICROBES ENVIRON, V30, P21, DOI 10.1264/jsme2.ME14137; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tripathi BM, 2013, FEMS MICROBIOL ECOL, V86, P303, DOI 10.1111/1574-6941.12163; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; van Raij B, 2001, ANAILISE QUIIMICA AV; Vasconcellos RLF, 2013, ECOL ENG, V53, P313, DOI 10.1016/j.ecoleng.2012.12.067; Vega-Avila AD, 2015, ANTON LEEUW INT J G, V107, P575, DOI 10.1007/s10482-014-0353-7; Wagai R, 2011, ECOL RES, V26, P627, DOI 10.1007/s11284-011-0822-7; Wang J, 2015, J SOIL SEDIMENT, V15, P880, DOI 10.1007/s11368-014-1053-7; Xia WW, 2011, ISME J, V5, P1226, DOI 10.1038/ismej.2011.5; Yao H, 2011, APPL ENVIRON MICROB, V77, P4618, DOI 10.1128/AEM.00136-11; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076500	74	13	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146566	10.1371/journal.pone.0146566	http://dx.doi.org/10.1371/journal.pone.0146566			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752633	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100101
J	Ma, YY; Zhu, XF; He, XG; Lu, LN; Zhu, JF; Zou, HD				Ma, Yingyan; Zhu, Xiaofeng; He, Xiangui; Lu, Lina; Zhu, Jianfeng; Zou, Haidong			Corneal Thickness Profile and Associations in Chinese Children Aged 7 to 15 Years Old	PLOS ONE			English	Article							OPTICAL-COHERENCE-TOMOGRAPHY; INTRAOCULAR-PRESSURE; KERATOCONUS; CURVATURE; GLAUCOMA; EYE; TENSION; ADULTS; MYOPIA	Corneal thickness (CT) maps of the central (2-mm diameter), para-central (2 to 5-mm diameter), peripheral (5 to 6-mm diameter), and minimum (5-mm diameter) cornea were measured in normal Chinese school children aged 7 to 15 years old using Fourier-domain optical coherence tomography. Multiple regression analyses were performed to explore the effect of associated factors [age, gender, refraction, axial length and corneal curvature radius (CCR)] on CT and the relationship between central corneal thickness (CCT) and intraocular pressure (IOP). A total of 1228 eyes from 614 children were analyzed. The average CCT was 532.96 +/- 28.33 mu m for right eyes and 532.70 +/- 28.45 mu m for left eyes. With a 10 mum increase in CCT, the IOP was elevated by 0.37 mm Hg, as measured by noncontact tonometry. The CT increased gradually from the center to the periphery. The superior and superior nasal regions had the thickest CTs, while the thinnest points were primarily located in the inferior temporal cornea. The CCT was associated with CCR (p = 0.008) but not with gender (p = 0.075), age (p = 0.286), axial length (p = 0.405), or refraction (p = 0.985). In the para-central region and the peripheral cornea, increased CT was associated with younger age, male gender, and a flatter cornea.	[Ma, Yingyan; He, Xiangui; Lu, Lina; Zhu, Jianfeng; Zou, Haidong] Shanghai Eye Hosp, Shanghai Eye Dis Prevent & Treatment Ctr, Shanghai, Peoples R China; [Ma, Yingyan; Zhu, Xiaofeng; Zou, Haidong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China; [He, Xiangui] Fudan Univ, Dept Maternal & Child Hlth, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University	Zou, HD (corresponding author), Shanghai Eye Hosp, Shanghai Eye Dis Prevent & Treatment Ctr, Shanghai, Peoples R China.	zouhaidong@263.net		Zou, Haidong/0000-0002-6831-7560	Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System [2011-15]; National Natural Science Foundation of China [81402695]; Cutting-Edge Technology Combined PR Project of Shanghai Shen Kang Hospital Development Centre [SHDC12014114]; Shanghai Natural Science Foundation [15ZR1438400]; Shanghai Municipal Health Bureau [0134263]	Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cutting-Edge Technology Combined PR Project of Shanghai Shen Kang Hospital Development Centre; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Municipal Health Bureau	This study was funded by Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System (2011-2013) (Grant no. 2011-15), National Natural Science Foundation of China for Young Staff (Grant no. 81402695), The Cutting-Edge Technology Combined PR Project of Shanghai Shen Kang Hospital Development Centre (Grant No. SHDC12014114), Shanghai Natural Science Foundation (Grant no. 15ZR1438400), and Shanghai Municipal Health Bureau (Grant no. 0134263). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwin PT, 2009, CONTACT LENS ANTERIO, V32, P64, DOI 10.1016/j.clae.2008.07.006; Aslan L, 2013, J AAPOS, V17, P149, DOI 10.1016/j.jaapos.2012.10.020; Bradfield YS, 2011, ARCH OPHTHALMOL-CHIC, V129, P1132, DOI 10.1001/archophthalmol.2011.225; Chang SW, 2015, OPTOM VIS SCI; Chen SH, 2012, ACTA OPHTHALMOL, V90, P449, DOI 10.1111/j.1755-3768.2010.01947.x; Cheng HC, 2014, OPTOMETRY VISION SCI, V91, P1113, DOI 10.1097/OPX.0000000000000339; Dai E, 2006, J AAPOS, V10, P22, DOI 10.1016/j.jaapos.2005.12.007; Dutta D, 2013, OPHTHALMOLOGY, V120, P457, DOI 10.1016/j.ophtha.2012.08.036; Fam HB, 2006, BRIT J OPHTHALMOL, V90, P1451, DOI 10.1136/bjo.2006.101170; Fecarotta CM, 2010, CURR OPIN OPHTHALMOL, V21, P350, DOI 10.1097/ICU.0b013e32833c5d19; Feng CS, 2015, AM J OPHTHALMOL, V160, P937, DOI 10.1016/j.ajo.2015.07.029; Fern KD, 2012, OPTOMETRY VISION SCI, V89, P1225, DOI 10.1097/OPX.0b013e3182639fc7; Galletti JD, 2015, J REFRACT SURG, V31, P116, DOI 10.3928/1081597X-20150122-07; Haque S, 2008, OPTOMETRY VISION SCI, V85, P963, DOI 10.1097/OPX.0b013e318188892c; Harada Y, 2008, J GLAUCOMA, V17, P619, DOI 10.1097/IJG.0b013e3181634f0f; Hashemi H, 2011, CORNEA, V30, P1409, DOI 10.1097/ICO.0b013e31822018dd; Herndon LW, 2004, ARCH OPHTHALMOL-CHIC, V122, P17, DOI 10.1001/archopht.122.1.17; Hoffmann EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066158; Huang J, EFFECT CYCLOPLEGIA L; Huang JH, 2013, OPHTHALMOLOGY, V120, P1951, DOI 10.1016/j.ophtha.2013.02.022; Hussein MAW, 2004, AM J OPHTHALMOL, V138, P744, DOI 10.1016/j.ajo.2004.06.030; Jonuscheit S, 2009, INVEST OPHTH VIS SCI, V50, P4121, DOI 10.1167/iovs.08-3298; Kanellopoulos AJ, 2014, J CATARACT REFR SURG, V40, P1603, DOI 10.1016/j.jcrs.2014.01.041; Linke SJ, 2011, J CATARACT REFR SURG, V37, P2175, DOI 10.1016/j.jcrs.2011.06.033; Ma YY, 2013, OPTOMETRY VISION SCI, V90, P1479, DOI 10.1097/OPX.0000000000000095; Machin D, 1997, SAMPLE SIZE TABLES C; MARTOLA EL, 1968, ARCH OPHTHALMOL-CHIC, V79, P28, DOI 10.1001/archopht.1968.03850040030009; Nalcacioglu-Yuksekkaya P, 2014, EUR J OPHTHALMOL, V24, P309, DOI 10.5301/ejo.5000390; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Ortiz Sara, 2014, J Optom, V7, P44, DOI 10.1016/j.optom.2013.03.005; Park JH, 2015, BRIT J OPHTHALMOL, V99, P746, DOI 10.1136/bjophthalmol-2014-305962; Prasad A, 2011, CORNEA, V30, P553, DOI 10.1097/ICO.0b013e3181fb880c; Rapuano C J, 1993, Insight, V18, P16; Reddy SP, 2013, J PEDIAT OPHTH STRAB, V50, P304, DOI 10.3928/01913913-20130806-02; Rufer F, 2009, CORNEA, V28, P177, DOI 10.1097/ICO.0b013e3181861c29; Saenz-Fraoces F, 2014, INT J OPHTHALMOL-CHI, V7, P668, DOI 10.3980/j.issn.2222-3959.2014.04.15; Shimmyo M, 2003, AM J OPHTHALMOL, V136, P603, DOI 10.1016/S0002-9394(03)00424-0; Song Y, 2008, AM J OPHTHALMOL, V145, P819, DOI 10.1016/j.ajo.2007.12.034; Su DHW, 2009, AM J OPHTHALMOL, V147, P709, DOI 10.1016/j.ajo.2008.10.013; Tang ML, 2005, AM J OPHTHALMOL, V140, P993, DOI 10.1016/j.ajo.2005.06.026; Tong L, 2004, INVEST OPHTH VIS SCI, V45, P4004, DOI 10.1167/iovs.04-0121; Ucakhan O, 2008, J CATARACT REFR SURG, V34, P1900, DOI 10.1016/j.jcrs.2008.07.018; Wang XG, 2013, OPHTHALMOLOGY, V120, P703, DOI 10.1016/j.ophtha.2012.09.034; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104842; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592, DOI 10.1016/S0002-9394(14)71455-2; Xu L, 2008, J GLAUCOMA, V17, P647, DOI 10.1097/IJG.0b013e3181666582; Zheng YF, 2008, CORNEA, V27, P776, DOI 10.1097/ICO.0b013e31816f62d3	47	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146847	10.1371/journal.pone.0146847	http://dx.doi.org/10.1371/journal.pone.0146847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751798	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100164
J	Medeiros, MS; Schumacher-Schuh, A; Cardoso, AM; Bochi, GV; Baldissarelli, J; Kegler, A; Santana, D; Chaves, CMMBS; Schetinger, MRC; Moresco, RN; Rieder, CRM; Fighera, MR				Medeiros, Marcio S.; Schumacher-Schuh, Arthur; Cardoso, Andreia Machado; Bochi, Guilherme Vargas; Baldissarelli, Jucimara; Kegler, Aline; Santana, Daniel; Martins Behle Soares Chaves, Carolina Maria; Chitolina Schetinger, Maria Rosa; Moresco, Rafael Noal; Rieder, Carlos R. M.; Fighera, Michele Rechia			Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers	PLOS ONE			English	Article							ISCHEMIA-MODIFIED ALBUMIN; FLUID NITRATE LEVELS; NITRIC-OXIDE; CEREBROSPINAL-FLUID; NEURODEGENERATIVE DISORDERS; ALZHEIMERS-DISEASE; PROTEIN; BRAIN; INFLAMMATION; ASSOCIATION	Parkinson's disease (PD) is characterized by progressive motor impairment attributed to progressive loss of dopaminergic neurons in the substantia nigra (SN) pars compacta. In addition to an accumulation of iron, there is also an increased production of reactive oxygen/nitrogen species (ROS/RNS) and inflammatory markers. These observations suggest that iron dyshomeostasis may be playing a key role in neurodegeneration. However, the mechanisms underlying this metal-associated oxidative stress and neuronal damage have not been fully elucidated. To determine peripheral levels of iron, ferritin, and transferrin in PD patients and its possible relation with oxidative/nitrosative parameters, whilst attempting to identify a profile of peripheral biomarkers in this neurological condition. Forty PD patients and 46 controls were recruited to compare serum levels of iron, ferritin, transferrin, oxidative stress markers (superoxide dismutase (SOD), catalase (CAT), nitrosative stress marker (NOx), thiobarbituric acid reactive substances (TBARS), non-protein thiols (NPSH), advanced oxidation protein products (AOPP), ferric reducing ability of plasma (FRAP) and vitamin C) as well as inflammatory markers (NTPDases, ecto-5'-nucleotidase, adenosine deaminase (ADA), ischemic-modified albumin (IMA) and myeloperoxidase). Iron levels were lower in PD patients, whereas there was no difference in ferritin and transferrin. Oxidative stress (TBARS and AOPP) and inflammatory markers (NTPDases, IMA, and myeloperoxidase) were significantly higher in PD, while antioxidants FRAP, vitamin C, and nonprotein thiols were significantly lower in PD. The enzymes SOD, CAT, and ecto-5'-nucleotidase were not different among the groups, although NOx and ADA levels were significantly higher in the controls. Our data corroborate the idea that ROS/RNS production and neuroinflammation may dysregulate iron homeostasis and collaborate to reduce the periphery levels of this ion, contributing to alterations observed in the pathophysiology of PD.	[Medeiros, Marcio S.; Schumacher-Schuh, Arthur; Rieder, Carlos R. M.] Hosp Clin Porto Alegre, Neurol Serv, Porto Alegre, RS, Brazil; [Cardoso, Andreia Machado; Baldissarelli, Jucimara; Kegler, Aline; Chitolina Schetinger, Maria Rosa; Fighera, Michele Rechia] Univ Fed Santa Maria, Nat & Exact Sci Ctr, Grad Program Life Sci Toxicol Biochem, BR-97119900 Santa Maria, RS, Brazil; [Bochi, Guilherme Vargas; Moresco, Rafael Noal] Univ Fed Santa Maria, Hlth Sci Ctr, Dept Clin & Toxicol Anal, BR-97119900 Santa Maria, RS, Brazil; [Kegler, Aline; Santana, Daniel; Martins Behle Soares Chaves, Carolina Maria; Fighera, Michele Rechia] Univ Fed Santa Maria, Univ Hosp, Neuropsychiat Dept, Hlth Sci Ctr, BR-97119900 Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM)	Fighera, MR (corresponding author), Univ Fed Santa Maria, Nat & Exact Sci Ctr, Grad Program Life Sci Toxicol Biochem, BR-97119900 Santa Maria, RS, Brazil.	mrfighera@yahoo.com.br	Cardoso, Andréia M/ABH-9732-2020; Fighera, Michele R/J-9576-2014; Schumacher-Schuh, Artur F/J-2023-2014; Schetinger, Maria Rosa Chitolina/I-7658-2019; Rieder, Carlos Roberto M/O-6600-2018; Baldissarelli, Jucimara/U-4563-2017; Moresco, Rafael/K-6118-2017	Cardoso, Andréia M/0000-0003-4243-8855; Schumacher-Schuh, Artur F/0000-0002-8722-0908; Rieder, Carlos Roberto M/0000-0003-2950-7211; Baldissarelli, Jucimara/0000-0002-1114-0063; Moresco, Rafael/0000-0003-3072-5080; Chitolina Schetinger, Maria Rosa/0000-0002-5240-8935; Fighera, Michele/0000-0002-3111-7530; Bochi, Guilherme/0000-0003-1871-1356	CNPq [477587/2011-336 9, 477587/2011-9]; CNPq fellowships; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (grant: 477587/2011-336 9), M. R. Fighera, M. R. C. Schetinger, R. N. Moresco and D. Santana are the recipients of CNPq fellowships. A. Kleger is the recipient of CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work supported by CNPq (grant: 477587/2011-9), M.R. Fighera, M.R.C. Schetinger, R.N. Moresco and D. Santana are the recipients of CNPq fellowships. A. Kegler is the recipient of CAPES. The authors are grateful to the study participant Natacha Fleck.	Anatoliotakis N, 2013, CURR TOP MED CHEM, V13, P115, DOI 10.2174/1568026611313020004; Ayton S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7760; Ayton S, 2015, J NEUROSCI, V35, P3591, DOI 10.1523/JNEUROSCI.3439-14.2015; Baser H, 2015, ENDOCRINE, V48, P916, DOI 10.1007/s12020-014-0399-3; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Berg D, 2002, ARCH NEUROL-CHICAGO, V59, P999, DOI 10.1001/archneur.59.6.999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brisevac D, 2013, J MOL NEUROSCI, V51, P871, DOI 10.1007/s12031-013-0088-3; Chtourou Y, 2010, BIOMETALS, V23, P985, DOI 10.1007/s10534-010-9345-x; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Danielson SR, 2008, FREE RADICAL BIO MED, V44, P1787, DOI 10.1016/j.freeradbiomed.2008.03.005; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; Desai V, 2014, J CLIN DIAGN RES, V8, pCC1, DOI 10.7860/JCDR/2014/8125.4530; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Ellidag HY, 2013, GUT LIVER, V7, P675, DOI 10.5009/gnl.2013.7.6.675; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emed TCXS, 2006, REV BRASILEIRA NUTR; Friedman A, 2011, PARKINSONISM RELAT D, V17, P423, DOI 10.1016/j.parkreldis.2011.03.016; Gerlach M, 2012, J NEURAL TRANSM, V119, P39, DOI 10.1007/s00702-011-0682-x; GIUSTI G, 1971, ENZYME, V12, P417, DOI 10.1159/000459567; Han M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032383; Hanasand M, 2012, CLIN CHIM ACTA, V413, P901, DOI 10.1016/j.cca.2012.01.038; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Huskic J, 2005, BOSNIAN J BASIC MED, V5, P86; Jacques-Silva MC, 2001, PHARMACOL TOXICOL, V88, P119, DOI 10.1034/j.1600-0773.2001.d01-92.x; JAFFREY SR, 1994, P NATL ACAD SCI USA, V91, P12994, DOI 10.1073/pnas.91.26.12994; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Kaefer M, 2010, CLIN BIOCHEM, V43, P450, DOI 10.1016/j.clinbiochem.2009.11.018; Kavya R, 2006, NITRIC OXIDE-BIOL CH, V15, P280, DOI 10.1016/j.niox.2006.07.003; Kouti L, 2013, EUR REV MED PHARMACO, V17, P964; KUIPER MA, 1994, J NEUROL SCI, V121, P46, DOI 10.1016/0022-510X(94)90155-4; Lenaz G, 2012, ADV EXP MED BIOL, V942, P93, DOI 10.1007/978-94-007-2869-1_5; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Logroscino G, 2006, MOVEMENT DISORD, V21, P835, DOI 10.1002/mds.20826; Lunkes GIL, 2004, DIABETES RES CLIN PR, V65, P1, DOI 10.1016/j.diabres.2003.11.016; Madenci G, 2012, NEUROCHEM RES, V37, P1436, DOI 10.1007/s11064-012-0729-x; Mahajan M, 2013, INDIAN J CLIN BIOCHE, V28, P51, DOI 10.1007/s12291-012-0244-5; Manukhina EB, 2000, PHYSIOL RES, V49, P89; Mariani S, 2013, NEUROBIOL AGING, V34, P632, DOI 10.1016/j.neurobiolaging.2012.05.015; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Metcalf J, 1986, LAB MANUAL NEUTROPHI, P87; Molina JA, 1996, ACTA NEUROL SCAND, V93, P123; Nakazato T, 2007, CLIN CANCER RES, V13, P5436, DOI 10.1158/1078-0432.CCR-07-0481; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; PARE S, 1992, AM J CLIN NUTR, V55, P701, DOI 10.1093/ajcn/55.3.701; Pasquali L, 2015, CLIN BIOCHEM, V48, P19, DOI 10.1016/j.clinbiochem.2014.09.024; Perfeito R, 2012, FREE RADICAL BIO MED, V53, P1791, DOI 10.1016/j.freeradbiomed.2012.08.569; Pichler I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001462; Ricart-Jane D, 2002, NITRIC OXIDE-BIOL CH, V6, P178, DOI 10.1006/niox.2001.0392; Savica R, 2009, NEUROLOGY, V73, P1381, DOI 10.1212/WNL.0b013e3181bd80c1; Shukla R, 2006, INT J NEUROSCI, V116, P1391, DOI 10.1080/00207450500513989; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001; Spanevello RM, 2010, J NEUROL, V257, P24, DOI 10.1007/s00415-009-5258-4; Sudha K, 2003, NEUROL INDIA, V51, P60; Tatsch E, 2011, CLIN BIOCHEM, V44, P348, DOI 10.1016/j.clinbiochem.2010.12.011; Tuncel D, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/132464; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vinish M, 2011, ACTA BIOCHIM POL, V58, P165; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Yoshida O, 2013, HEPATOLOGY, V58, P2163, DOI 10.1002/hep.26593; Younes-Mhenni S, 2007, EUR NEUROL, V58, P78, DOI 10.1159/000103641	66	91	94	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146129	10.1371/journal.pone.0146129	http://dx.doi.org/10.1371/journal.pone.0146129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751079	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100047
J	Said, HM; Kushner, N; Omar, SV; Dreyer, AW; Koornhof, H; Erasmus, L; Gardee, Y; Rukasha, I; Shashkina, E; Beylis, N; Kaplan, G; Fallows, D; Ismail, NA				Said, Halima M.; Kushner, Nicole; Omar, Shaheed V.; Dreyer, Andries W.; Koornhof, Hendrik; Erasmus, Linda; Gardee, Yasmin; Rukasha, Ivy; Shashkina, Elena; Beylis, Natalie; Kaplan, Gilla; Fallows, Dorothy; Ismail, Nazir A.			A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; MYCOBACTERIUM-TUBERCULOSIS; SOUTH-AFRICA; PYRAZINAMIDE RESISTANCE; PNCA GENE; NEW-YORK; STRAIN; SPREAD; EPIDEMIOLOGY; DIFFERENTIATION	Background In South Africa and other high prevalence countries, transmission is a significant contributor to rising rates of multidrug resistant tuberculosis (MDR-TB). Thus, there is a need to develop an early detection system for transmission clusters suitable for high burden settings. We have evaluated the discriminatory power and clustering concordance of a novel and simple genotyping approach, combining spoligotyping with pncA sequencing (SpoNC), against two well-established methods: IS6110-RFLP and 24-loci MIRU-VNTR. Methods A total of 216 MDR-TB isolates collected from January to June 2010 from the NHLS Central TB referral laboratory in Braamfontein, Johannesburg, representing a diversity of strains from South Africa, were included. The isolates were submitted for genotyping, pncA sequencing and analysis to the Centre for Tuberculosis in South Africa and the Public Health Research Institute Tuberculosis Center at Rutgers University in the United States. Clustering rates, Hunter-Gaston Discriminatory Indexes (HGI) and Wallace coefficients were compared between the methods. Results Overall clustering rates were high by both IS6110-RFLP (52.8%) and MIRU-VNTR (45.8%), indicative of on-going transmission. Both 24-loci MIRU-VNTR and IS6110-RFLP had similar HGI (0.972 and 0.973, respectively), with close numbers of unique profiles (87 vs. 70), clustered isolates (129 vs. 146), and cluster sizes (2 to 26 vs. 2 to 25 isolates). Spoligotyping alone was the least discriminatory (80.1% clustering, HGI 0.903), with 28 unique types. However, the discriminatory power of spoligotyping was improved when combined with pncA sequencing using the SpoNC approach (61.8% clustering, HGI 0.958). A high proportion of MDR-TB isolates had mutations in pncA (68%, n = 145), and pncA mutations were significantly associated with clustering (p = 0.007 and p = 0.0013 by 24-loci MIRU-VNTR and IS6110-RFLP, respectively), suggesting high rates of resistance to pyrazinamide among all MDR-TB cases and particularly among clustered cases. Conclusion We conclude that SpoNC provides good discrimination for MDR-TB surveillance and early identification of outbreaks in South Africa, with 24-loci MIRU-VNTR applied for pncA wildtype strains as needed.	[Said, Halima M.; Omar, Shaheed V.; Dreyer, Andries W.; Koornhof, Hendrik; Erasmus, Linda; Gardee, Yasmin; Rukasha, Ivy; Ismail, Nazir A.] Natl Inst Communicable Dis, Ctr TB, Johannesburg, South Africa; [Ismail, Nazir A.] Univ Pretoria, Fac Hlth Sci, Dept Med Microbiol, ZA-0002 Pretoria, South Africa; [Kushner, Nicole; Shashkina, Elena; Fallows, Dorothy] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA; [Beylis, Natalie] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Kaplan, Gilla] Bill & Melinda Gates Fdn, Seattle, WA USA	National Institute for Communicable Diseases (NICD); University of Pretoria; Rutgers State University Newark; Rutgers State University New Brunswick; University of Cape Town; Bill & Melinda Gates Foundation	Said, HM (corresponding author), Natl Inst Communicable Dis, Ctr TB, Johannesburg, South Africa.	halimas@nicd.ac.za	Rukasha, IVY/H-2992-2016; Omar, Shaheed Vally/AAB-5071-2020; Said, Halima/GWV-3962-2022	Rukasha, IVY/0000-0002-6279-6409; Omar, Shaheed Vally/0000-0001-6983-1636; Said, Halima/0000-0003-4843-9541	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080737] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI080737] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bishop KS, 2001, INT J TUBERC LUNG D, V5, P952; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; Cheng SJ, 2000, ANTIMICROB AGENTS CH, V44, P528, DOI 10.1128/AAC.44.3.528-532.2000; Chihota VN, 2012, J CLIN MICROBIOL, V50, P995, DOI 10.1128/JCM.05832-11; Cole ST, 2002, MICROBIOL-SGM, V148, P2919, DOI 10.1099/00221287-148-10-2919; Dowdy DW, 2014, CLIN INFECT DIS, V59, P1123, DOI 10.1093/cid/ciu506; Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hirano K, 1997, Tuber Lung Dis, V78, P117; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Johnson R, 2010, INT J TUBERC LUNG D, V14, P119; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Louw GE, 2006, INT J TUBERC LUNG D, V10, P802; Marais BJ, 2013, J CLIN MICROBIOL, V51, P1818, DOI 10.1128/JCM.00200-13; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Moodley P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017513; Morlock GP, 2000, ANTIMICROB AGENTS CH, V44, P2291, DOI 10.1128/AAC.44.9.2291-2295.2000; Moss AR, 1997, INT J TUBERC LUNG D, V1, P115; Mphahlele M, 2008, J CLIN MICROBIOL, V46, P3459, DOI 10.1128/JCM.00973-08; Muller B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070919; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Said HM, 2012, J CLIN MICROBIOL, V50, P2857, DOI 10.1128/JCM.00358-12; Sanchez-Padilla E, 2012, EMERG INFECT DIS, V18, P29, DOI 10.3201/eid1801.110850; Schurch AC, 2012, INFECT GENET EVOL, V12, P602, DOI 10.1016/j.meegid.2011.08.032; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Strauss OJ, 2008, J CLIN MICROBIOL, V46, P1514, DOI 10.1128/JCM.01938-07; Streicher EM, 2014, J CLIN MICROBIOL, V52, P4056, DOI 10.1128/JCM.02438-14; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Van Soolingen D, 2001, J MED MICROBIOL, V50, P749, DOI 10.1099/0022-1317-50-9-749; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Verdugo D, 2015, ANTIMICROB AGENTS CH, V59, P6140, DOI 10.1128/AAC.00764-15; WALLACE DL, 1983, J AM STAT ASSOC, V78, P569, DOI 10.2307/2288118; Whitfield MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133869; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2014, 67 WORLD HLTH ASS 20	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146106	10.1371/journal.pone.0146106	http://dx.doi.org/10.1371/journal.pone.0146106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752297	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100042
J	Yamada, H; Masuko, H; Yatagai, Y; Sakamoto, T; Kaneko, Y; Iijima, H; Naito, T; Noguchi, E; Konno, S; Nishimura, M; Hirota, T; Tamari, M; Hizawa, N				Yamada, Hideyasu; Masuko, Hironori; Yatagai, Yohei; Sakamoto, Tohru; Kaneko, Yoshiko; Iijima, Hiroaki; Naito, Takashi; Noguchi, Emiko; Konno, Satoshi; Nishimura, Masaharu; Hirota, Tomomitsu; Tamari, Mayumi; Hizawa, Nobuyuki			Role of Lung Function Genes in the Development of Asthma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ANNUAL DECLINE; PHENOTYPES; SUSCEPTIBILITY; SMOKING; BIRTH; COPD; FEV1	Although our previous GWAS failed to identify SNPs associated with pulmonary function at the level of genomewide significance, it did show that the heritability for FEV1/FVC was 41.6% in a Japanese population, suggesting that the heritability of pulmonary function traits can be explained by the additive effects of multiple common SNPs. In addition, our previous study indicated that pulmonary function genes identified in previous GWASs in non-Japanese populations accounted for 4.3% to 12.0% of the entire estimated heritability of FEV1/FVC in a Japanese population. Therefore, given that many loci with individual weak effects may contribute to asthma risk, in this study, we created a quantitative score of genetic load based on 16 SNPs implicated in lower lung function in both Japanese and non-Japanese populations. This genetic risk score (GRS) for lower FEV1/FVC was consistently associated with the onset of asthma (P = 9.6 x 10(-4)) in 2 independent Japanese populations as well as with the onset of COPD (P = 0.042). Clustering of asthma patients based on GRS levels indicated that an increased GRS may be responsible for the development of a particular phenotype of asthma characterized by early onset, atopy, and severer airflow obstruction.	[Yamada, Hideyasu; Masuko, Hironori; Yatagai, Yohei; Sakamoto, Tohru; Kaneko, Yoshiko; Hizawa, Nobuyuki] Univ Tsukuba, Dept Pulmonol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Iijima, Hiroaki; Naito, Takashi] Tsukuba Med Ctr, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Med Genet, Tsukuba, Ibaraki, Japan; [Konno, Satoshi; Nishimura, Masaharu] Inst Phys & Chem Res, Ctr Genom Med, Lab Resp Dis, Tsurumi, Kanagawa, Japan; [Hirota, Tomomitsu; Tamari, Mayumi] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan	University of Tsukuba; University of Tsukuba; RIKEN; Hokkaido University	Hizawa, N (corresponding author), Univ Tsukuba, Dept Pulmonol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan.	hironori816@yahoo.co.jp	Nishimura, Masaharu/A-4062-2012; Tamari, Mayumi/N-5378-2015	Nishimura, Masaharu/0000-0002-6456-4361; Sakamoto, Tohru/0000-0002-8876-1466				[Anonymous], 2004, Nihon Kokyuki Gakkai Zasshi, VSuppl, P1; [Anonymous], 2014, R LANG ENV STAT COMP; Bartis D, 2014, THORAX, V69, P760, DOI 10.1136/thoraxjnl-2013-204608; Carlsen KCL, 2014, J ALLERGY CLIN IMMUN, V134, P917, DOI 10.1016/j.jaci.2014.05.020; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Gibson PG, 2015, THORAX, V70, P683, DOI 10.1136/thoraxjnl-2014-206740; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Kaneko Y, 2013, ALLERGOL INT, V62, P113, DOI 10.2332/allergolint.12-OA-0467; Kaneko Y, 2013, INT J CHRONIC OBSTR, V8, P65, DOI 10.2147/COPD.S39617; Kreiner-Moller E, 2014, J ALLERGY CLIN IMMUN, V134, P1036, DOI 10.1016/j.jaci.2014.04.003; Makita H, 2007, THORAX, V62, P932, DOI 10.1136/thx.2006.072777; Masuko H, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-97; Masuko H, 2011, INT J CHRONIC OBSTR, V6, P181, DOI 10.2147/COPD.S16383; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Raychaudhuri S, 2011, BIOINFORMATICS, V27, P1589, DOI 10.1093/bioinformatics/btr185; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Sharma S, 2015, AM J RESP CELL MOL, V52, P543, DOI 10.1165/rcmb.2014-0109OC; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Stocks J, 2013, LANCET RESP MED, V1, P728, DOI 10.1016/S2213-2600(13)70118-8; Taniguchi N, 2013, ANN ALLERG ASTHMA IM, V111, P376, DOI 10.1016/j.anai.2013.08.005; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Yamada H, 2015, RESPIR INVESTIG, V53, P60, DOI 10.1016/j.resinv.2014.10.004; Yao TC, 2014, J ALLERGY CLIN IMMUN, V133, P248, DOI 10.1016/j.jaci.2013.06.018; Yatagai Y, 2014, CLIN EXP ALLERGY, V44, P1327, DOI 10.1111/cea.12415	29	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145832	10.1371/journal.pone.0145832	http://dx.doi.org/10.1371/journal.pone.0145832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752288	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100028
J	Sun, ZL; Lu, YH; Zhang, H; Kumar, D; Liu, B; Gong, YC; Zhu, M; Zhu, LY; Liang, Z; Kuang, S; Chen, F; Hu, XL; Cao, GL; Xue, RY; Gong, CL				Sun, Zhenli; Lu, Yahong; Zhang, Hao; Kumar, Dhiraj; Liu, Bo; Gong, Yongchang; Zhu, Min; Zhu, Liyuan; Liang, Zi; Kuang, Sulan; Chen, Fei; Hu, Xiaolong; Cao, Guangli; Xue, Renyu; Gong, Chengliang			Effects of BmCPV Infection on Silkworm Bombyx mori Intestinal Bacteria	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; GUT BACTERIA; DIVERSITY; COMMUNITY; SEX; IDENTIFICATION; PROTECTION; SYMBIONTS; PATHOGEN; CRICKET	The gut microbiota has a crucial role in the growth, development and environmental adaptation in the host insect. The objective of our work was to investigate the microbiota of the healthy silkworm Bombyx mori gut and changes after the infection of B. mori cypovirus (BmCPV). Intestinal contents of the infected and healthy larvae of B. mori of fifth instar were collected at 24, 72 and 144 h post infection with BmCPV. The gut bacteria were analyzed by pyrosequencing of the 16S rRNA gene. 147(135) and 113(103) genera were found in the gut content of the healthy control female (male) larvae and BmCPV-infected female (male) larvae, respectively. In general, the microbial communities in the gut content of healthy larvae were dominated by Enterococcus, Delftia, Pelomonas, Ralstonia and Staphylococcus, however the abundance change of each genus was depended on the developmental stage and gender. Microbial diversity reached minimum at 144 h of fifth instar larvae. The abundance of Enterococcus in the females was substantially lower and the abundance of Delftia, Aurantimonas and Staphylococcus was substantially higher compared to the males. Bacterial diversity in the intestinal contents decreased after post infection with BmCPV, whereas the abundance of both Enterococcus and Staphylococcus which belongs to Gram-positive were increased. Therefore, our findings suggested that observed changes in relative abundance was related to the immune response of silkworm to BmCPV infection. Relevance analysis of plenty of the predominant genera showed the abundance of the Enterococcus genus was in negative correlation with the abundance of the most predominant genera. These results provided insight into the relationship between the gut microbiota and development of the BmCPV-infected silkworm.	[Sun, Zhenli; Lu, Yahong; Zhang, Hao; Kumar, Dhiraj; Liu, Bo; Gong, Yongchang; Zhu, Min; Zhu, Liyuan; Liang, Zi; Kuang, Sulan; Chen, Fei; Hu, Xiaolong; Cao, Guangli; Xue, Renyu; Gong, Chengliang] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215123, Peoples R China; [Hu, Xiaolong; Cao, Guangli; Xue, Renyu; Gong, Chengliang] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China	Soochow University - China; Soochow University - China	Gong, CL (corresponding author), Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215123, Peoples R China.	gongcl@suda.edu.cn			National Natural Science Foundation of China [31072085]; National Basic Research Program of China [2012CB114600]; Specialized Research Fund for the Doctoral Program of Higher Education [20113201130002]; Priority Academic Program of Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program of Development of Jiangsu Higher Education Institutions	The authors gratefully acknowledge the financial support of the National Natural Science Foundation of China (31072085), the National Basic Research Program of China (973 Program, 2012CB114600), the Specialized Research Fund for the Doctoral Program of Higher Education (20113201130002), and a project funded by the Priority Academic Program of Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Braak Ter C., 1998, CANOCO REFERENCE MAN; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro M., 2008, INT J PROBIOTICS PRE, V3, P25; Castro MS, 2012, INT ARCH ALLERGY IMM, V157, P11, DOI 10.1159/000324673; Castro MS, 2010, J APPL MICROBIOL, V109, P1234, DOI 10.1111/j.1365-2672.2010.04747.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Dennis PG, 2013, BIORESOURCE TECHNOL, V129, P599, DOI 10.1016/j.biortech.2012.11.098; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gonchar N V, 2015, Eksp Klin Gastroenterol, P48; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; He C, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.16501; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Kodama R, 1968, J SERICULTURAL SCI J, V37, P477; Kolliopoulou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121447; Li S, 2004, BIOINFORMATICS, V20, P2865, DOI 10.1093/bioinformatics/bth302; [鲁兴萌 Lu Xingmeng], 2003, [蚕业科学, Acta Sericologica Sinica], V29, P151; [鲁光萌 Lu Xingmeng], 2002, [蚕业科学, Science of Sericulture], V28, P126; Lu XM, 1999, SCI SERICULTURE, V25, P158; LYSENKO O, 1958, J GEN MICROBIOL, V18, P774, DOI 10.1099/00221287-18-3-774; Manero A, 1999, APPL ENVIRON MICROB, V65, P4425; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; MEAD LJ, 1988, APPL ENVIRON MICROB, V54, P1174, DOI 10.1128/AEM.54.5.1174-1181.1988; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moore AJ, 1996, J ANTIMICROB CHEMOTH, V37, P1077, DOI 10.1093/jac/37.6.1077; Moreno-Garcia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133240; Motegi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076800; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398; Rantala MJ, 2006, J EVOLUTION BIOL, V19, P834, DOI 10.1111/j.1420-9101.2005.01048.x; Sabree ZL, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-138; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schmid RB, 2014, ENVIRON ENTOMOL, V43, P896, DOI 10.1603/EN13311; SCHMIDT TM, 1994, METHOD ENZYMOL, V235, P205; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sun XQ, 1996, SICHUAN SILK, V24, P13; Takatsuka J, 2000, J INVERTEBR PATHOL, V76, P222, DOI 10.1006/jipa.2000.4973; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; [田贞华 TIAN ZhenHua], 2007, [蚕业科学, Acta Sericologica Sinica], V33, P592; Wang FW, 2003, SCI SERICULTURE, V29, P157; Wier A, 2002, P NATL ACAD SCI USA, V99, P1410, DOI 10.1073/pnas.022643899; WILSON GR, 1993, J INVERTEBR PATHOL, V62, P87, DOI 10.1006/jipa.1993.1079; Xiang Hui, 2007, Acta Entomologica Sinica, V50, P222; [向芸庆 Xiang Yunqing], 2010, [生态学报, Acta Ecologica Sinica], V30, P3875; Xue wei, 2009, STAT ANAL METHODS AP, P34; Yuan Zhi-hui, 2006, Weishengwu Xuebao, V46, P285; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	57	52	58	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146313	10.1371/journal.pone.0146313	http://dx.doi.org/10.1371/journal.pone.0146313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745627	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600039
J	Marra, S; Coppa, S; Camedda, A; Mazzoldi, C; Wrachien, F; Massaro, G; de Lucia, GA				Marra, Stefano; Coppa, Stefania; Camedda, Andrea; Mazzoldi, Carlotta; Wrachien, Francesco; Massaro, Giorgio; de Lucia, G. Andrea			Recovery Trends of Commercial Fish: The Case of an Underperforming Mediterranean Marine Protected Area	PLOS ONE			English	Article							PARACENTROTUS-LIVIDUS; HABITAT STRUCTURE; LIFE-HISTORY; RESERVES; CONSERVATION; POPULATIONS; FISHERIES; IMPACTS; SEA; BIODIVERSITY	Temporal trends in the recovery of exploited species in marine protected areas (MPAs) are useful for a proper assessment of the efficacy of protection measures. The effects of protection on the fish assemblages of the sublittoral rocky reefs in the "Penisola del Sinis-Isola di Mal di Ventre" MPA (W. Sardinia, Italy) were evaluated using a multi-year series of data. Four surveys, conducted 7, 10, 13 and 15 years after the area was designated as an MPA and carried out in the period spanning June and July, were used to estimate the abundance and biomass of commercial species. The surveys were carried out in zones with decreasing levels of fishing restrictions within the MPA (zones A, B, C) and in unprotected zones (OUT1 and OUT2), and underwater video visual census techniques were used. Protected zones only occasionally showed higher levels of abundance or biomass, and the trajectories of those metrics were not consistent across the years. In addition, the zone with the highest level of protection (zone A) never presented levels of abundance and biomass higher than those in zones B and C. This study shows that even 15 years after designation, protection has had no appreciable effect in the MPA studied. It is argued that this is emblematic of several shortcomings in the planning, regulation and enforcement frameworks of the MPA.	[Marra, Stefano; Coppa, Stefania; Camedda, Andrea; de Lucia, G. Andrea] Natl Res Council IAMC CNR, Inst Coastal Marine Environm, Oristano, Italy; [Marra, Stefano] Univ Tuscia, Dept Ecol & Biol, Viterbo, Italy; [Mazzoldi, Carlotta] Univ Padua, Dept Biol, Padua, Italy; [Wrachien, Francesco; Massaro, Giorgio] Marine Protected Area Penisola del Sinis Isola di, Cabras, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Tuscia University; University of Padua	Marra, S (corresponding author), Natl Res Council IAMC CNR, Inst Coastal Marine Environm, Oristano, Italy.	s.marra@iamc.cnr.it	Coppa, Stefania/F-5089-2016; Camedda, Andrea/P-8328-2018; Mazzoldi, Carlotta/AAU-8628-2020; de Lucia, Giuseppe/F-5100-2016	Coppa, Stefania/0000-0003-2055-6375; Camedda, Andrea/0000-0002-6837-5680; de Lucia, Giuseppe/0000-0002-6841-3923; Massaro, Giorgio/0000-0003-3984-3630; MAZZOLDI, CARLOTTA/0000-0002-2798-3030	"Penisola del Sinis-Isola di Mal di Ventre" MPA through the Italian Ministry of Environment [DPN/2006, DPN/2009/0016436]; Regional Environmental Action Plan (P.O.R. FESR, Axis IV) [170/AM]	"Penisola del Sinis-Isola di Mal di Ventre" MPA through the Italian Ministry of Environment; Regional Environmental Action Plan (P.O.R. FESR, Axis IV)	This study was conducted with the support of funding from "Penisola del Sinis-Isola di Mal di Ventre" MPA through the Italian Ministry of Environment (Grant Agreements No: DPN/2006, DPN/2009/0016436) and the Regional Environmental Action Plan (P.O.R. FESR 2007-2013, Axis IV; Grant Agreements No. 170/AM) [www.areamarinasinis.it]; [www.minambiente.it]; [www.regione.sardegna.it].	Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Addison PFE, 2015, J ENVIRON MANAGE, V149, P148, DOI 10.1016/j.jenvman.2014.10.023; Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Alos J, 2013, FISH RES, V137, P88, DOI 10.1016/j.fishres.2012.09.007; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Bell JJ, 2008, BIOL CONSERV, V141, P2807, DOI 10.1016/j.biocon.2008.08.017; Brown K, 2001, ECOL ECON, V37, P417, DOI 10.1016/S0921-8009(00)00293-7; Camedda A., 2011, Biologia Marina Mediterranea, V18, P296; Ceccherelli G, 2011, MAR BIOL, V158, P845, DOI 10.1007/s00227-010-1611-5; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Coleman MA, 2013, BIOL CONSERV, V167, P257, DOI 10.1016/j.biocon.2013.08.033; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Coppa S, 2016, AQUAT CONSERV, V26, P623, DOI 10.1002/aqc.2579; Costello MJ, 2015, TRENDS ECOL EVOL, V30, P507, DOI 10.1016/j.tree.2015.06.011; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; Currie JC, 2012, AFR J MAR SCI, V34, P269, DOI 10.2989/1814232X.2012.709963; De Girolamo M, 2001, MAR ENVIRON RES, V51, P1, DOI 10.1016/S0141-1136(00)00028-3; De Leo GA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0276; Denny CM, 2004, BIOL CONSERV, V116, P119, DOI 10.1016/S0006-3207(03)00183-6; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Fox HE, 2012, CONSERV LETT, V5, P1, DOI 10.1111/j.1755-263X.2011.00207.x; FRANCOUR P, 1994, OCEANOL ACTA, V17, P309; Fraschetti S, 2002, MAR ECOL-P S Z N I, V23, P190, DOI 10.1111/j.1439-0485.2002.tb00018.x; Frisch AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051938; Garcia Charton JA, ESTUDIOS SEGUIMIENTO; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; Garcia-Rubies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073922; Guidetti P, 2004, HELGOLAND MAR RES, V58, P110, DOI 10.1007/s10152-004-0176-4; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Guidetti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091841; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hutchings JA, 2005, PHILOS T R SOC B, V360, P315, DOI 10.1098/rstb.2004.1586; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Lenfant P, 2003, CYBIUM, V27, P27; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Lloret J, 2008, FISH RES, V94, P84, DOI 10.1016/j.fishres.2008.07.002; Lundquist CJ, 2005, CONSERV BIOL, V19, P1771, DOI 10.1111/j.1523-1739.2005.00279.x; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Ojeda-Martinez C, 2007, MAR BIOL, V151, P1153, DOI 10.1007/s00227-006-0557-0; Pierpaolo C, 2013, J SEA RES, V79, P20, DOI 10.1016/j.seares.2013.01.004; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Planes S, 2000, ENVIRON CONSERV, V27, P126, DOI 10.1017/S0376892900000175; Relini G, 2009, BIOL MAR MEDITERR SU, V16; Rife AN, 2013, J ENVIRON MANAGE, V117, P276, DOI 10.1016/j.jenvman.2012.12.029; Rius M, 2007, SCI MAR, V71, P499, DOI 10.3989/scimar.2007.71n3499; Rossiter JS, 2014, MAR POLICY, V44, P196, DOI 10.1016/j.marpol.2013.08.022; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 2003, ECOL APPL, V13, P1553, DOI 10.1890/01-5341; Sala E, 1997, MAR BIOL, V129, P531, DOI 10.1007/s002270050194; Sciberras M, 2015, FISH FISH, V16, P58, DOI 10.1111/faf.12044; Stelzenmuller V, 2009, AQUAT CONSERV, V19, P554, DOI 10.1002/aqc.1003; Tessier E, 2005, J EXP MAR BIOL ECOL, V315, P17, DOI 10.1016/j.jembe.2004.08.027; Hackradt CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098206; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	72	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146391	10.1371/journal.pone.0146391	http://dx.doi.org/10.1371/journal.pone.0146391			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741959	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600037
J	Ozcelikkale, A; Han, B				Ozcelikkale, Altug; Han, Bumsoo			Thermal Destabilization of Collagen Matrix Hierarchical Structure by Freeze/Thaw	PLOS ONE			English	Article							COLD DENATURATION; EXTRACELLULAR-MATRIX; FIBRILS; CRYOPRESERVATION; TEMPERATURE; MOLECULES; EQUILIBRIUM; KINETICS; HEAT	This study aims to characterize and understand the effects of freezing on collagen structures and functionality. Specifically, thermodynamic destabilization of collagen at molecular- and fibril-levels by combination of low temperatures and freezing were experimentally characterized using modulated differential scanning calorimetry. In order to delineate the effects of sub-zero temperature and water-ice phase change, we hypothesized that the extent of destabilization can be determined based on post-thaw heat induced thermal denaturation of collagen. It is found that thermal denaturation temperature of collagen in hydrogel decreases by 1.4-1.6 degrees C after freeze/thaw while no such decrease is observed in the case of molecular solution. The destabilization is predominantly due to ice formation. Exposure to low temperatures in the absence of ice has only minimal effect. Calorimetry measurements combined with morphological examination of collagen matrices by scanning electron microscopy suggest that freezing results in destabilization of collagen fibrils due to expansion of intrafibrillar space by ice formation. This fibril-level damage can be alleviated by use of cryoprotectant DMSO at concentrations as low as 0.5 M. A theoretical model explaining the change in collagen post-thaw thermal stability by freezing-induced fibril expansion is also proposed.	[Ozcelikkale, Altug; Han, Bumsoo] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Han, Bumsoo] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Han, Bumsoo] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Han, B (corresponding author), Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA.	bumsoo@purdue.edu	Ozcelikkale, Altug/ABA-2198-2020	Ozcelikkale, Altug/0000-0002-1783-4445; Han, Bumsoo/0000-0001-9487-1090	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering [R01 EB008388]; National Science Foundation [CBET-1009465]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008388] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was funded by Grant R01 EB008388 from National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering, and Grant CBET-1009465 from National Science Foundation.	[Anonymous], 2004, CELL PRESERV TECHNOL, DOI DOI 10.1089/153834404774101945; Babu CR, 2004, NAT STRUCT MOL BIOL, V11, P352, DOI 10.1038/nsmb739; Bakhach J, 2009, ORGANOGENESIS, V5, P119, DOI 10.4161/org.5.3.9583; Bhatnagar BS, 2007, PHARM DEV TECHNOL, V12, P505, DOI 10.1080/10837450701481157; Bischof JC, 2002, CRYOBIOLOGY, V45, P22, DOI 10.1016/S0011-2240(02)00103-7; Bischof JC, 2005, ANN NY ACAD SCI, V1066, P12, DOI 10.1196/annals.1363.003; Bozec L, 2005, BIOPHYS J, V88, P4223, DOI 10.1529/biophysj.104.055228; Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001; Chen JZY, 2013, MACROMOLECULES, V46, P9837, DOI 10.1021/ma4020824; Davidovic M, 2009, J AM CHEM SOC, V131, P1025, DOI 10.1021/ja8056419; Doi M., 1986, THEORY POLYM DYNAMIC; Feng YB, 1998, BIOPOLYMERS, V45, P347; Findenegg GH, 2008, CHEMPHYSCHEM, V9, P2651, DOI 10.1002/cphc.200800616; FRANKS F, 1995, ADV PROTEIN CHEM, V46, P105, DOI 10.1016/S0065-3233(08)60333-2; Fratzl P., 2008, P1, DOI 10.1007/978-0-387-73906-9_1; Gelber PE, 2008, KNEE SURG SPORT TR A, V16, P353, DOI 10.1007/s00167-007-0457-y; Giannini S, 2008, INT ORTHOP, V32, P145, DOI 10.1007/s00264-006-0297-2; Grant CA, 2009, BIOPHYS J, V97, P2985, DOI 10.1016/j.bpj.2009.09.010; Graziano G, 1997, J BIOCHEM, V122, P395; GRIKO YV, 1992, BIOCHEMISTRY-US, V31, P8810, DOI 10.1021/bi00152a017; Gutsmann T, 2003, BIOPHYS J, V84, P2593, DOI 10.1016/S0006-3495(03)75064-4; Habash Riadh W. Y., 2006, Critical Reviews in Biomedical Engineering, V34, P459, DOI 10.1615/CritRevBiomedEng.v34.i6.20; Hadi MF, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007097; Han B, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005170; HULMES DJS, 1979, NATURE, V282, P878, DOI 10.1038/282878a0; Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jahnert S, 2008, PHYS CHEM CHEM PHYS, V10, P6039, DOI 10.1039/b809438c; Kaptay G, 2012, J NANOSCI NANOTECHNO, V12, P2625, DOI 10.1166/jnn.2012.5774; LOVELOCK JE, 1957, PROC R SOC SER B-BIO, V147, P427, DOI 10.1098/rspb.1957.0062; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035; Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X; Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001; Neidert MR, 2004, TISSUE ENG, V10, P23, DOI 10.1089/107632704322791664; Orgel JPRO, 2011, CONNECT TISSUE RES, V52, P18, DOI 10.3109/03008207.2010.511354; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Park HJ, 2009, CELL TISSUE BANK, V10, P11, DOI 10.1007/s10561-008-9109-9; Park S, 2015, J MECH BEHAV BIOMED, V45, P32, DOI 10.1016/j.jmbbm.2015.01.014; Pastore A, 2007, J AM CHEM SOC, V129, P5374, DOI 10.1021/ja0714538; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Reading M, 2006, HOT TOPICS IN THERMA; Reategui E, 2010, PHYS CHEM CHEM PHYS, V12, P10161, DOI 10.1039/c003517c; Rhee S, 2007, ADV DRUG DELIVER REV, V59, P1299, DOI 10.1016/j.addr.2007.08.006; Rubinsky B, 2000, ANNU REV BIOMED ENG, V2, P157, DOI 10.1146/annurev.bioeng.2.1.157; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seawright A, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024571; Smyda MR, 2012, J PHYS CHEM B, V116, P10928, DOI 10.1021/jp302807r; Spitzner EC, 2015, ACS NANO, V9, P5683, DOI 10.1021/nn503637q; Teo KY, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000875; Tiktopulo EI, 1998, BIOCHEMISTRY-US, V37, P8147, DOI 10.1021/bi980360n; Venkatasubramanian RT, 2010, ANN BIOMED ENG, V38, P694, DOI 10.1007/s10439-010-9921-9; Veres SP, 2014, MATRIX BIOL, V33, P54, DOI 10.1016/j.matbio.2013.07.003; Vyazovkin S, 2007, MACROMOL BIOSCI, V7, P1181, DOI 10.1002/mabi.200700162; Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034; Wess T. J., 2008, P49, DOI 10.1007/978-0-387-73906-9_3; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Winzor DJ, 2006, J MOL RECOGNIT, V19, P389, DOI 10.1002/jmr.799; Wright NT, 2002, ANNU REV BIOMED ENG, V4, P109, DOI 10.1146/annurev.bioeng.4.101001.131546; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	60	23	23	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146660	10.1371/journal.pone.0146660	http://dx.doi.org/10.1371/journal.pone.0146660			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765741	Green Submitted, gold, Green Published			2022-12-27	WOS:000368459300032
J	Benson, AJ; Cooper, AB; Carruthers, TR				Benson, Ashleen Julia; Cooper, Andrew B.; Carruthers, Thomas R.			An Evaluation of Rebuilding Policies for US Fisheries	PLOS ONE			English	Article							MANAGEMENT; RECOVERY; PROGRESS	Rebuilding depleted fish populations is a priority of modern fisheries management. In the U.S., strong statutory mandates extend to both the goals and process by which stocks are to be rebuilt. However, the National Standard Guidelines that govern the implementation of the Magnuson-Stevens Fishery Conservation and Management Act may change to increase flexibility in rebuilding requirements. In this study we evaluate performance of the status quo approach to fish stock rebuilding in the United States against 3 alternatives that have been proposed to improve rebuilding outcomes. These alternatives either simplify the analytical requirements of rebuilding analyses or apply 'best practices' in fisheries management, thereby avoiding the need for rebuilding analyses altogether. We use a Management Strategy Evaluation framework to evaluate rebuilding options across 6 fish life history types and 5 possible real-world fishery scenarios that include options for stock assessment quality, multiple fleets, and the degree to which the stocks are overfished at the start of the analysis. We show that the status quo rebuilding plan and a harvest control rule that reduces harvest rates at low stock size generally achieve the best rebuilding outcomes across all life-history types and fishery scenarios. Both approaches constrain fishing in the short term, but achieve high catches in the medium and long term as stocks rebuild to productive levels. These results support a growing body of literature that indicates that efforts to end overfishing early pay off in the medium-to long-term with higher cumulative catches than the alternative.	[Benson, Ashleen Julia] Univ New Brunswick, Dept Biol, Canadian Fisheries Res Network, Fredericton, NB E3B 6E1, Canada; [Cooper, Andrew B.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; [Carruthers, Thomas R.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	University of New Brunswick; Simon Fraser University; University of British Columbia	Cooper, AB (corresponding author), Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada.	Andrew_Cooper@sfu.ca			Pew Charitable Trusts;  [27399]	Pew Charitable Trusts; 	Support for this project was provided by Pew Charitable Trusts (http://www.pewtrusts.org) and managed by The Ocean Foundation (http://oceanfdn.org/projects/host-project/rebuilding-strategies-us-fisheries-project) (Agreement #27399). Funders assisted in the initial design of the study by helping authors scope their initial question. Funders played no role in the analysis of data, interpretation of results, decision to publish, or preparation of the manuscript.; We would like to thank M. Moore and A. Rogers for coordination of this work and helpful discussions throughout. Support for this project was provided by Pew Charitable Trusts and managed by The Ocean Foundation (Agreement # 27399).	[Anonymous], 1996, SUST FISH ACT MAGN S; Babcock EA, 2007, N AM J FISH MANAGE, V27, P1326, DOI 10.1577/M06-124.1; Berkson J., 2011, NMFSSEFSC616 NOAA; Butterworth DS, 2010, ICES J MAR SCI, V67, P567, DOI 10.1093/icesjms/fsq009; Butterworth DS, 1999, ICES J MAR SCI, V56, P985, DOI 10.1006/jmsc.1999.0532; Carruthers TR, 2014, FISH RES, V153, P48, DOI 10.1016/j.fishres.2013.12.014; Cochrane KL, 1998, REV FISH BIOL FISHER, V8, P177, DOI 10.1023/A:1008894011847; Federal Register, 2015, FED REGISTER, V80, P2786; Federal Register, 1998, FED REGISTER, V63, P24212; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Milazzo MJ, 2012, REV FISH BIOL FISHER, V22, P273, DOI 10.1007/s11160-011-9219-5; National Research Council, 2013, EV EFF FISH STOCK RE; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; New Zealand Ministry of Fisheries, 2014, OP GUID NZ HARV STRA; Pacific Fishery Management Council, 2012, TERMS REF GROUNDF CO; Patrick WS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112232; Punt AE, 2005, LOW WAKE FI, V21, P571; Punt AE, 2007, LOW WAKE FI, V23, P329; R Core Team, 2021, R LANGUAGE ENV STAT; Restrepo V.R., 1998, NOAA TECHNICAL MEMOR, V56; Restrepo VR, 1999, ICES J MAR SCI, V56, P846, DOI 10.1006/jmsc.1999.0546; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; Shertzer KW, 2007, ICES J MAR SCI, V64, P149, DOI 10.1093/icesjms/fsl005; United Nations, 2002, WORLD SUMMIT SUSTAIN; Vert-pre KA, 2013, P NATL ACAD SCI USA, V110, P1779, DOI 10.1073/pnas.1214879110	25	11	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146278	10.1371/journal.pone.0146278	http://dx.doi.org/10.1371/journal.pone.0146278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761442	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100029
J	Engi, SA; Planeta, CS; Crestani, CC				Engi, Sheila A.; Planeta, Cleopatra S.; Crestani, Carlos C.			Effect of Voluntary Ethanol Consumption Combined with Testosterone Treatment on Cardiovascular Function in Rats: Influence of Exercise Training	PLOS ONE			English	Article							ANABOLIC-ANDROGENIC STEROIDS; INDUCED HYPERTENSION; BLOOD-PRESSURE; ALCOHOL INTAKE; RUNNING WHEEL; HEART-RATE; BAROREFLEX FUNCTION; NITRIC-OXIDE; TIME-COURSE; RESPONSES	This study evaluated the effects of voluntary ethanol consumption combined with testosterone treatment on cardiovascular function in rats. Moreover, we investigated the influence of exercise training on these effects. To this end, male rats were submitted to low-intensity training on a treadmill or kept sedentary while concurrently being treated with ethanol for 6 weeks. For voluntary ethanol intake, rats were given access to two bottles, one containing ethanol and other containing water, three 24-hour sessions per week. In the last two weeks (weeks 5 and 6), animals underwent testosterone treatment concurrently with exercise training and exposure to ethanol. Ethanol consumption was not affected by either testosterone treatment or exercise training. Also, drug treatments did not influence the treadmill performance improvement evoked by training. However, testosterone alone, but not in combination with ethanol, reduced resting heart rate. Moreover, combined treatment with testosterone and ethanol reduced the pressor response to the selective alpha(1)-adrenoceptor agonist phenylephrine. Treatment with either testosterone or ethanol alone also affected baroreflex activity and enhanced depressor response to acetylcholine, but these effects were inhibited when drugs were coadministrated. Exercise training restored most cardiovascular effects evoked by drug treatments. Furthermore, both drugs administrated alone increased pressor response to phenylephrine in trained animals. Also, drug treatments inhibited the beneficial effects of training on baroreflex function. In conclusion, the present results suggest a potential interaction between toxic effects of testosterone and ethanol on cardiovascular function. Data also indicate that exercise training is an important factor influencing the effects of these substances.	[Engi, Sheila A.; Planeta, Cleopatra S.; Crestani, Carlos C.] Univ Estadual Paulista UNESP, Sch Pharmaceut Sci, Pharmacol Lab, Araraquara, SP, Brazil; [Engi, Sheila A.; Planeta, Cleopatra S.; Crestani, Carlos C.] Joint UFSCar UNESP Grad Program Physiol Sci, Sao Carlos, SP, Brazil	Universidade Estadual Paulista	Crestani, CC (corresponding author), Univ Estadual Paulista UNESP, Sch Pharmaceut Sci, Pharmacol Lab, Araraquara, SP, Brazil.	cccrestani@yahoo.com.br	Scavone, Cristoforo/C-1580-2012; ENGI, SHEILA A/O-2141-2013; Crestani, Carlos C/E-4161-2012; Planeta, Cleopatra/Z-5255-2019	Scavone, Cristoforo/0000-0002-1206-0882; ENGI, SHEILA A/0000-0002-5025-0177; Crestani, Carlos C/0000-0002-1942-858X; Planeta, Cleopatra/0000-0002-1378-6327	Sao Paulo Research Foundation (FAPESP) [2013/09715-2, 2012/14723-1, 2012/14376-0]; National Counsel of Technological and Scientific Development (CNPq) [456405/2014-3 CNPq, 456405/2014-3]; PADC-FCF UNESP	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PADC-FCF UNESP	This work was supported by the Sao Paulo Research Foundation (FAPESP) grants # 2013/09715-2, 2012/14723-1, and 2012/14376-0; National Counsel of Technological and Scientific Development (CNPq) grant # 456405/2014-3 CNPq, and PADC-FCF UNESP. CSP is a CNPq research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Elisabete Z. P. Lepera and Rosana F. P. Silva for technical assistance. This work was supported by Sao Paulo Research Foundation (FAPESP) grants # 2013/09715-2, 2012/14723-1, and 2012/14376-0; National Counsel of Technological and Scientific Development (CNPq) grant # 456405/2014-3, and PADC-FCF UNESP. CSP is a CNPq research fellow.	ABDELRAHMAN AA, 1987, HYPERTENSION, V10, P67, DOI 10.1161/01.HYP.10.1.67; ABDELRAHMAN ARA, 1985, J PHARMACOL EXP THER, V232, P194; ARDIES CM, 1989, J APPL PHYSIOL, V66, P555, DOI 10.1152/jappl.1989.66.2.555; Bahrke MS, 2004, CURR OPIN PHARMACOL, V4, P614, DOI 10.1016/j.coph.2004.05.006; Barry AE, 2012, J AM COLL HEALTH, V60, P236, DOI 10.1080/07448481.2011.587487; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Beutel A, 2005, J STEROID BIOCHEM, V93, P43, DOI 10.1016/j.jsbmb.2004.11.003; Bocalini DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087106; Brager AJ, 2012, PHYSIOL BEHAV, V107, P418, DOI 10.1016/j.physbeh.2012.09.011; CADOUXHUDSON TA, 1985, EUR J APPL PHYSIOL O, V54, P321, DOI 10.1007/BF00426153; Camargo LHA, 2013, EUR J PHARMACOL, V713, P16, DOI 10.1016/j.ejphar.2013.04.046; CHAN TCK, 1983, LIFE SCI, V33, P1965, DOI 10.1016/0024-3205(83)90734-8; Chang HR, 2002, CLIN EXP PHARMACOL P, V29, P275, DOI 10.1046/j.1440-1681.2002.03643.x; Chen CY, 1996, AM J PHYSIOL-HEART C, V271, pH1840, DOI 10.1152/ajpheart.1996.271.5.H1840; Crestani CC, 2014, TOXICOL APPL PHARM, V280, P245, DOI 10.1016/j.taap.2014.08.012; Crestani CC, 2010, NEUROSCI RES, V67, P317, DOI 10.1016/j.neures.2010.05.001; Cruz FC, 2013, NEUROSCIENCE, V253, P29, DOI 10.1016/j.neuroscience.2013.08.034; Cruz FC, 2012, J PSYCHOPHARMACOL, V26, P1366, DOI 10.1177/0269881112453210; da Silva AL, 2013, ALCOHOL ALCOHOLISM, V48, P495, DOI 10.1093/alcalc/agt040; Darlington TM, 2014, BEHAV BRAIN RES, V259, P313, DOI 10.1016/j.bbr.2013.11.011; Davel AP, 2012, J VASC RES, V49, P342, DOI 10.1159/000337486; Ehringer MA, 2009, ALCOHOL, V43, P443, DOI 10.1016/j.alcohol.2009.06.003; Engi SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105172; Engi SA, 2012, J CARDIOVASC PHARM, V59, P231, DOI 10.1097/FJC.0b013e31823cc58b; Fernandez-Sola J., 2015, NAT REV CARDIOL; French MT, 2009, AM J HEALTH PROMOT, V24, P2, DOI 10.4278/ajhp.0801104; GORLICK DL, 1986, DEV BRAIN RES, V26, P193, DOI 10.1016/0165-3806(86)90283-X; Grassi G, 2006, PROG CARDIOVASC DIS, V48, P407, DOI 10.1016/j.pcad.2006.03.002; Grassi G, 2004, J HYPERTENS, V22, P1747, DOI 10.1097/00004872-200409000-00019; Gurkovskaya OV, 2009, ALCOHOL CLIN EXP RES, V33, P1252, DOI 10.1111/j.1530-0277.2009.00951.x; HABOUBI NA, 1986, ANN CLIN BIOCHEM, V23, P458, DOI 10.1177/000456328602300413; Hammer SB, 2010, ALCOHOL CLIN EXP RES, V34, P1651, DOI 10.1111/j.1530-0277.2010.01251.x; HARTUNG GH, 1990, HYPERTENSION, V16, P501, DOI 10.1161/01.HYP.16.5.501; Husain K, 1998, PROG NEURO-PSYCHOPH, V22, P411, DOI 10.1016/S0278-5846(98)00013-X; Husain K, 2006, ALCOHOL ALCOHOLISM, V41, P247, DOI 10.1093/alcalc/agl005; Husain K, 2006, MOL CELL BIOCHEM, V289, P175, DOI 10.1007/s11010-006-9161-3; Husain K, 2014, WORLD J CARDIOL, V6, P245, DOI 10.4330/wjc.v6.i5.245; Johansson P, 2000, PHARMACOL BIOCHEM BE, V67, P271, DOI 10.1016/S0091-3057(00)00365-8; Kahonen M, 1999, AM J PHYSIOL-HEART C, V276, pH464, DOI 10.1152/ajpheart.1999.276.2.H464; Kanayama G, 2009, ADDICTION, V104, P1966, DOI 10.1111/j.1360-0443.2009.02734.x; Kawano Y, 2010, HYPERTENS RES, V33, P181, DOI 10.1038/hr.2009.226; KUMAI T, 1994, JPN J PHARMACOL, V66, P439, DOI 10.1254/jjp.66.439; Ladipo CO, 2002, CLIN EXP PHARMACOL P, V29, P707, DOI 10.1046/j.1440-1681.2002.03721.x; LAKOZA GN, 1980, B NARCOTICS, V32, P41; Maior AS, 2010, J STRENGTH COND RES, V24, P1688, DOI 10.1519/JSC.0b013e3181dc46c9; Marchi KC, 2014, WORLD J CARDIOL, V6, P283, DOI 10.4330/wjc.v6.i5.283; Masson GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094927; McAllister RM, 2005, J APPL PHYSIOL, V98, P753, DOI 10.1152/japplphysiol.01263.2003; McCabe SE, 2007, DRUG ALCOHOL DEPEN, V90, P243, DOI 10.1016/j.drugalcdep.2007.04.004; McGinnis MY, 2007, PHYSIOL BEHAV, V92, P1010, DOI 10.1016/j.physbeh.2007.07.010; MCMILLAN DE, 1995, DRUG ALCOHOL DEPEN, V40, P1, DOI 10.1016/0376-8716(95)01162-5; MEILMAN PW, 1995, J AM COLL HEALTH, V44, P98, DOI 10.1080/07448481.1995.9939101; Miller Peter M, 2005, J Clin Hypertens (Greenwich), V7, P346, DOI 10.1111/j.1524-6175.2004.04463.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Perusquia M, 2010, AM J PHYSIOL-HEART C, V298, pH1301, DOI 10.1152/ajpheart.00753.2009; Piazza-Gardner Anna K, 2012, Am J Health Promot, V26, pe95, DOI 10.4278/ajhp.100929-LIT-328; Puddey IB, 2001, CLIN EXP PHARMACOL P, V28, P1020, DOI 10.1046/j.1440-1681.2001.03572.x; Resstel LBM, 2006, LIFE SCI, V78, P2179, DOI 10.1016/j.lfs.2005.09.021; Resstel LBM, 2008, AM J HYPERTENS, V21, P930, DOI 10.1038/ajh.2008.189; Rocha FL, 2007, AM J PHYSIOL-HEART C, V293, pH3575, DOI 10.1152/ajpheart.01251.2006; ROGERS PJ, 1991, J APPL PHYSIOL, V71, P2346, DOI 10.1152/jappl.1991.71.6.2346; RUSS R, 1991, ALCOHOL, V8, P301, DOI 10.1016/0741-8329(91)90433-W; Sanches IC, 2015, J APPL PHYSL; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; SPARROW MG, 1987, LIFE SCI, V40, P2551, DOI 10.1016/0024-3205(87)90078-6; Sun MW, 2013, CARDIOVASC RES, V97, P686, DOI 10.1093/cvr/cvs423; Tagarakis CVM, 2000, MED SCI SPORT EXER, V32, P946; Tirapelli CR, 2008, BRIT J PHARMACOL, V154, P971, DOI 10.1038/bjp.2008.157; UNODC United Nations Office on Drugs and Crime Vienna, 2010, WORLD DRUG REP 2010; van Amsterdam J, 2010, REGUL TOXICOL PHARM, V57, P117, DOI 10.1016/j.yrtph.2010.02.001; WHEELER GD, 1984, JAMA-J AM MED ASSOC, V252, P514, DOI 10.1001/jama.252.4.514; Whiteford H. A., 2013, LANCET; Wood RI, 2002, HORM BEHAV, V41, P247, DOI 10.1006/hbeh.2002.1769; YESALIS CE, 1993, JAMA-J AM MED ASSOC, V270, P1217, DOI 10.1001/jama.270.10.1217; ZHANG X, 1988, P SOC EXP BIOL MED, V187, P14	76	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146974	10.1371/journal.pone.0146974	http://dx.doi.org/10.1371/journal.pone.0146974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760038	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100059
J	Zhang, W; Freichel, M; van der Hoeven, F; Nawroth, PP; Katus, H; Kalble, F; Zitron, E; Schwenger, V				Zhang, Wei; Freichel, Marc; van der Hoeven, Frank; Nawroth, Peter Paul; Katus, Hugo; Kaelble, Florian; Zitron, Edgar; Schwenger, Vedat			Novel Endothelial Cell-Specific AQP1 Knockout Mice Confirm the Crucial Role of Endothelial AQP1 in Ultrafiltration during Peritoneal Dialysis	PLOS ONE			English	Article							AQUAPORIN WATER CHANNELS; MESOTHELIAL CELLS; SOLUTE TRANSPORT; MEMBRANE; MODEL; FLUID; CAPD; PERMEABILITY; SIMULATIONS; EXPRESSION	The water channel aquaporin-1 (AQP1) mediates about 50% ultrafiltration during a 2-hour hypertonic dwell in global AQP1 knockout (AQP1(-/-)) mice. Although AQP1 is widely expressed in various cell types including mesothelial cells, the ultrafiltration has been assumed to be mediated via endothelial AQP1 of the peritoneum. The partial embryonic lethality and reduced body weight in AQP1(-/-) mice may reflect potential confounding phenotypic effects evoked by ubiquitous AQP1 deletion, which may interfere with functional analysis of endothelial AQP1. Using a Cre/loxP approach, we generated and characterised endothelial cell-and time-specific AQP1 knockout (AQP1(fl/fl); Cdh5-Cre(+)) mice. Compared to controls, AQP1(fl/fl); Cdh5-Cre(+) mice showed no difference in an initial clinical and biological analysis at baseline, including body weight and survival. During a 1-hour 3.86% miniperitoneal equilibration test (mini-PET), AQP1(fl/fl); Cdh5-Cre(+) mice exhibited strongly decreased indices for AQP1-related transcellular water transport (43.0% in net ultrafiltration, 93.0% in sodium sieving and 57.9% in free water transport) compared to controls. The transport rates for small solutes of urea and glucose were not significantly altered. Our data provide the first direct experimental evidence for the functional relevance of endothelial AQP1 to the fluid transport in peritoneal dialysis and thereby further validate essential predictions of the three-pore model of peritoneal transport.	[Zhang, Wei; Kaelble, Florian; Schwenger, Vedat] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany; [Freichel, Marc] Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany; [van der Hoeven, Frank] German Canc Res Ctr, Transgen Serv, Heidelberg, Germany; [Nawroth, Peter Paul] Heidelberg Univ, Dept Endocrinol & Metab, Heidelberg, Germany; [Nawroth, Peter Paul] German Ctr Diabet Res DZD, Neuherberg, Germany; [Katus, Hugo; Zitron, Edgar] Heidelberg Univ, Dept Cardiol, Heidelberg, Germany; [Schwenger, Vedat] Klinikum Stuttgart, Dept Nephrol, Stuttgart, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Klinikum Stuttgart	Zhang, W (corresponding author), Heidelberg Univ, Dept Nephrol, Heidelberg, Germany.	wzhang@ix.urz.uni-heidelberg.de			Deutsche Forschungsgemeinschaft (DFG) [SCHW 1469/31];  [Sonderforschungsbereich 1118]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); 	This study was supported by the Deutsche Forschungsgemeinschaft (VS: DFG, SCHW 1469/31) and Sonderforschungsbereich 1118 (WZ, MF, PPN, VS-SFB 1118).	Benga G, 2012, MOL ASPECTS MED, V33, P518, DOI 10.1016/j.mam.2012.06.001; Bergqvist I, 1998, FEBS LETT, V438, P76, DOI 10.1016/S0014-5793(98)01272-1; Cano F, 2013, PEDIATR NEPHROL, V28, P1121, DOI 10.1007/s00467-013-2447-2; Carlsson O, 1996, AM J PHYSIOL-HEART C, V271, pH2254, DOI 10.1152/ajpheart.1996.271.6.H2254; Combet S, 1999, J AM SOC NEPHROL, V10, P2185; Davies SJ, 2011, SEMIN NEPHROL, V31, P172, DOI 10.1016/j.semnephrol.2011.01.006; Devuyst O, 2005, BIOL CELL, V97, P667, DOI 10.1042/BC30040132; Devuyst O, 2014, KIDNEY INT, V85, P750, DOI 10.1038/ki.2013.250; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; La Milia V, 2005, KIDNEY INT, V68, P840, DOI 10.1111/j.1523-1755.2005.00465.x; Lai KN, 2001, J AM SOC NEPHROL, V12, P1036, DOI 10.1681/ASN.V1251036; Liu LH, 2014, EXP LUNG RES, V40, P145, DOI 10.3109/01902148.2013.859333; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ni J, 2006, KIDNEY INT, V69, P1518, DOI 10.1038/sj.ki.5000285; Ni J, 2005, KIDNEY INT, V67, P2021, DOI 10.1111/j.1523-1755.2005.00304.x; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Nishino T, 2008, PFLUG ARCH EUR J PHY, V456, P721, DOI 10.1007/s00424-007-0402-4; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Rippe B, 1993, Perit Dial Int, V13 Suppl 2, pS35; RIPPE B, 1989, KIDNEY INT, V35, P1234, DOI 10.1038/ki.1989.115; Rippe B, 2004, PERITON DIALYSIS INT, V24, P10; RIPPE B, 1991, KIDNEY INT, V40, P315, DOI 10.1038/ki.1991.216; Smit W, 2004, KIDNEY INT, V66, P849, DOI 10.1111/j.1523-1755.2004.00815.x; Song YL, 2000, AM J PHYSIOL-CELL PH, V279, pC1744, DOI 10.1152/ajpcell.2000.279.6.C1744; Verkman AS, 1999, J AM SOC NEPHROL, V10, P1126; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Westra Wytske M, 2003, Adv Perit Dial, V19, P6; Winiarski BK, 2011, MICROCIRCULATION, V18, P635, DOI 10.1111/j.1549-8719.2011.00128.x; Yang BX, 1999, AM J PHYSIOL-CELL PH, V276, pC76, DOI 10.1152/ajpcell.1999.276.1.C76; Zhai YH, 2012, PEDIATR NEPHROL, V27, P1165, DOI 10.1007/s00467-012-2120-1	30	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145513	10.1371/journal.pone.0145513	http://dx.doi.org/10.1371/journal.pone.0145513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760974	Green Submitted, gold, Green Published			2022-12-27	WOS:000368033100018
J	Lai, SS; Wei, S; Zhao, BT; Ouyang, Z; Zhang, QJ; Fan, NN; Liu, ZM; Zhao, Y; Yan, QM; Zhou, XQ; Li, L; Xin, JG; Zeng, YZ; Lai, LX; Zou, QJ				Lai, Sisi; Wei, Shu; Zhao, Bentian; Ouyang, Zhen; Zhang, Quanjun; Fan, Nana; Liu, Zhaoming; Zhao, Yu; Yan, Quanmei; Zhou, Xiaoqing; Li, Li; Xin, Jige; Zeng, Yangzhi; Lai, Liangxue; Zou, Qingjian			Generation of Knock-In Pigs Carrying Oct4-tdTomato Reporter through CRISPR/Cas9-Mediated Genome Engineering	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DERIVATION; SYSTEM; MICE	The porcine pluripotent cells that can generate germline chimeras have not been developed. The Oct4 promoter-based fluorescent reporter system, which can be used to monitor pluripotency, is an important tool to generate authentic porcine pluripotent cells. In this study, we established a porcine Oct4 reporter system, wherein the endogenous Oct4 promoter directly controls red fluorescent protein (RFP). 2A-tdTomato sequence was inserted to replace the stop codon of the porcine Oct4 gene by homogenous recombination (HR). Thus, the fluorescence can accurately show the activation of endogenous Oct4. Porcine fetal fibroblast (PFF) lines with knock-in (KI) of the tdTomato gene in the downstream of endogenous Oct4 promoter were achieved using the CRISPR/CAS9 system. Transgenic PFFs were used as donor cells for somatic cell nuclear transfer (SCNT). Strong RFP expression was detected in the blastocysts and genital ridges of SCNT fetuses but not in other tissues. Two viable transgenic piglets were also produced by SCNT. Reprogramming of fibroblasts from the fetuses and piglets by another round of SCNT resulted in tdTomato reactivation in reconstructed blastocysts. Result indicated that a KI porcine reporter system to monitor the pluripotent status of cells was successfully developed.	[Lai, Sisi; Wei, Shu; Zhao, Bentian; Ouyang, Zhen; Zhang, Quanjun; Fan, Nana; Liu, Zhaoming; Zhao, Yu; Yan, Quanmei; Zhou, Xiaoqing; Li, Li; Lai, Liangxue; Zou, Qingjian] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Lai, Liangxue] Jilin Univ, Coll Vet Med, Inst Zoonosis, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China; [Xin, Jige; Zeng, Yangzhi] Yunnan Agr Univ, Anim Sci & Technol Coll, Key Lab Banna Mini Pig Inbred Line Yunnan Prov, Kunming, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Jilin University; Yunnan Agricultural University	Zeng, YZ (corresponding author), Yunnan Agr Univ, Anim Sci & Technol Coll, Key Lab Banna Mini Pig Inbred Line Yunnan Prov, Kunming, Peoples R China.	bnwxzjjx@yahoo.com.cn; lai_liangxue@gibh.ac.cn; zou_qingjian@gibh.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDA010201070]; Ministry of Science and Technology National Basic Research Program of China [2011CB944204, 2011CB944203]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology National Basic Research Program of China	This work was supported in part by Strategic Priority Research Program of the Chinese Academy of Sciences (http://www.cas.cn/) Grant XDA010201070 and by Ministry of Science and Technology National Basic Research Program of China (http://www.most.gov.cn/index.htm) Grants 2011CB944204 and 2011CB944203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank for Xiaomin Wang and Huilin Zhong for excellent technical assistance. This work was supported in part by Strategic Priority Research Program of the Chinese Academy of Sciences (http://www.cas.cn/) Grant XDA010201070 and by Ministry of Science and Technology National Basic Research Program of China (http://www.most.gov.cn/index.htm) Grants 2011CB944204 and 2011CB944203.	Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Froschauer A, 2013, MOL REPROD DEV, V80, P48, DOI 10.1002/mrd.22135; Huang LZ, 2011, CELL REPROGRAM, V13, P93, DOI 10.1089/cell.2010.0069; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Krentz NAJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114275; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Nowak-Imialek M, 2011, STEM CELLS DEV, V20, P1564, DOI 10.1089/scd.2010.0399; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Quan LQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109728; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Shi GL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt39; Sui DD, 2014, STEM CELL REP, V2, P721, DOI 10.1016/j.stemcr.2014.03.013; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zeng R, 2005, ANIM GENET, V36, P267, DOI 10.1111/j.1365-2052.2005.01277.x; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	22	30	42	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146562	10.1371/journal.pone.0146562	http://dx.doi.org/10.1371/journal.pone.0146562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756580	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800015
J	Gruse, J; Kanitz, E; Weitzel, JM; Tuchscherer, A; Stefaniak, T; Jawor, P; Wolffram, S; Hammon, HM				Gruse, Jeannine; Kanitz, Ellen; Weitzel, Joachim M.; Tuchscherer, Armin; Stefaniak, Tadeusz; Jawor, Paulina; Wolffram, Siegfried; Hammon, Harald M.			Quercetin Feeding in Newborn Dairy Calves Cannot Compensate Colostrum Deprivation: Study on Metabolic, Antioxidative and Inflammatory Traits	PLOS ONE			English	Article							NEONATAL CALVES; OXIDATIVE STRESS; GASTROINTESTINAL-TRACT; FLAVONOL QUERCETIN; GLUCOSE-METABOLISM; ENDOCRINE TRAITS; INTRADUODENAL SUPPLEMENTATION; GROWTH-PERFORMANCE; BOVINE COLOSTRUM; MILK REPLACER	Immaturity of the neonatal immune system is causative for high morbidity in calves and colostrum intake is crucial for acquiring passive immunity. Pathogenesis is promoted by reactive oxygen species accumulating at birth if counter-regulation is inadequate. The flavonol quercetin exerts antioxidative and anti-inflammatory effects that may enhance neonatal health. The aim of this work was to study effects of quercetin feeding on metabolic, antioxidative and inflammatory parameters in neonatal calves to investigate whether quercetin could compensate for insufficient colostrum supply. Twenty-eight newborn calves were assigned to two dietary groups fed colostrum or milk-based formula on day 1 and 2 and milk replacer thereafter. From day 2 onwards, 7 calves per diet group were additionally fed quercetin aglycone (50 mg/(kg body weight x day)). Blood samples were taken repeatedly to measure plasma concentrations of flavonols, glucose, lactate, total protein, albumin, urea, non-esterified fatty acids, triglycerides, cholesterol, insulin, glucagon, cortisol, immunoglobulins, fibrinogen, haptoglobin and serum amyloid A. Trolox equivalent antioxidative capacity, ferric reducing ability of plasma, thiobarbituric acid reactive species and F2-isoprostanes were analyzed to evaluate plasma antioxidative status. Expression of tumor necrosis factor, interleukin-1 alpha, interleukin-1 beta, serum amyloid A, haptoglobin, fibrinogen, C-reactive protein, catalase, glutathione peroxidase and superoxide dismutase mRNA were measured in liver tissue on day 8. Plasma flavonol concentrations were detectable only after quercetin-feeding without differences between colostrum and formula feeding. Plasma glucose, lactate, total protein, immunoglobulins, triglycerides, cholesterol, trolox equivalent antioxidative capacity and thiobarbituric acid reactive species were higher after colostrum feeding. Body temperature, fecal fluidity and plasma concentrations of cortisol and haptoglobin were higher in formula-than in colostrum-fed groups. Hepatic mRNA expression of tumor necrosis factor was higher after quercetin feeding and expression of C-reactive protein was higher after formula feeding. Data confirm that colostrum improves neonatal health and indicate that quercetin feeding cannot compensate for insufficient colostrum supply.	[Gruse, Jeannine; Hammon, Harald M.] Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Kanitz, Ellen] Leibniz Inst Farm Anim Biol FBN, Inst Behav Physiol, Dummerstorf, Germany; [Weitzel, Joachim M.] Leibniz Inst Farm Anim Biol FBN, Inst Reprod Biol, Dummerstorf, Germany; [Tuchscherer, Armin] Leibniz Inst Farm Anim Biol FBN, Inst Genet & Biometry, Dummerstorf, Germany; [Stefaniak, Tadeusz; Jawor, Paulina] Wroclaw Univ Environm & Life Sci, Dept Immunol Pathophysiol & Vet Prevent Med, Fac Vet Med, Wroclaw, Poland; [Wolffram, Siegfried] Univ Kiel, Inst Anim Nutr & Physiol, Fac Agr & Nutr Sci, Kiel, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Wroclaw University of Environmental & Life Sciences; University of Kiel	Hammon, HM (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany.	hammon@fbn-dummerstorf.de	Hammon, Harald/AAD-9990-2020; Jawor, Paulina E/M-4500-2014; Stefaniak, Tadeusz/A-1897-2017	Jawor, Paulina E/0000-0003-3141-6722; Stefaniak, Tadeusz/0000-0002-8982-211X; Weitzel, Joachim/0000-0002-4073-6691	Federal Ministry of Education and Research, Germany (BMFT) [0315538B]	Federal Ministry of Education and Research, Germany (BMFT)	This work is part of the joint research project Food Chain Plus (FoCus) and was financially supported by the Federal Ministry of Education and Research, Germany (BMFT grant no. 0315538B). http://www.bmbf.de.	Abuelo A, 2014, VET J, V199, P295, DOI 10.1016/j.tvjl.2013.10.032; Albera E, 2011, REPROD DOMEST ANIM, V46, P763, DOI 10.1111/j.1439-0531.2010.01737.x; ALSEMGEEST SPM, 1995, VET QUART, V17, P9, DOI 10.1080/01652176.1995.9694521; Granado-Serrano AB, 2012, NUTR CANCER, V64, P588, DOI 10.1080/01635581.2012.661513; Berger LM, 2012, J DAIRY SCI, V95, P5047, DOI 10.3168/jds.2012-5439; BESSER TE, 1988, J VIROL, V62, P2234, DOI 10.1128/JVI.62.7.2234-2237.1988; Blattler U, 2001, J NUTR, V131, P1256; Boesch-Saadatmandi C, 2011, J NUTR BIOCHEM, V22, P293, DOI 10.1016/j.jnutbio.2010.02.008; CAPASSO A, 1991, PHYTOTHER RES, V5, P85, DOI 10.1002/ptr.2650050210; Cermak R, 2003, J NUTR, V133, P2802, DOI 10.1093/jn/133.9.2802; Chase CCL, 2008, VET CLIN N AM-FOOD A, V24, P87, DOI 10.1016/j.cvfa.2007.11.001; DICARLO G, 1994, PHYTOTHER RES, V8, P42, DOI 10.1002/ptr.2650080110; Gaal T, 2006, COMP BIOCHEM PHYS B, V143, P391, DOI 10.1016/j.cbpb.2005.12.014; Ganheim C, 2007, VET J, V173, P645, DOI 10.1016/j.tvjl.2006.01.011; Gasowska A., 2003, Folia Universitatis Agriculturae Stetinensis, Zootechnica, P87; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gohlke A, 2013, J DAIRY SCI, V96, P6986, DOI 10.3168/jds.2013-6852; Gohlke A, 2013, J DAIRY SCI, V96, P2303, DOI 10.3168/jds.2012-6234; Gruse J, 2015, J NUTR, V145, P2486, DOI 10.3945/jn.115.218271; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P37; Gulliksen SM, 2009, J DAIRY SCI, V92, P2782, DOI 10.3168/jds.2008-1807; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; Hammon HM, 1998, J NUTR, V128, P624, DOI 10.1093/jn/128.3.624; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hyder I, 2013, LIVEST SCI, V152, P63, DOI 10.1016/j.livsci.2012.12.005; Inanami O, 1999, AM J VET RES, V60, P452; JONES GE, 1984, RES VET SCI, V37, P87, DOI 10.1016/S0034-5288(18)31933-7; Kamada H, 2007, J DAIRY SCI, V90, P5665, DOI 10.3168/jds.2007-0348; Kane AD, 2014, J PHYSIOL-LONDON, V592, P475, DOI 10.1113/jphysiol.2013.264275; Kania BF, 1999, J ANIM FEED SCI, V8, P233; Kankofer M, 2008, ACTA VET-BEOGRAD, V58, P231, DOI 10.2298/AVB0803231K; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Kuhne S, 2000, J ANIM SCI, V78, P609; LARSON LL, 1977, J DAIRY SCI, V60, P989, DOI 10.3168/jds.S0022-0302(77)83975-1; Lee SD, 2013, LIVEST SCI, V154, P117, DOI 10.1016/j.livsci.2013.02.001; Liao YR, 2014, J AGR FOOD CHEM, V62, P2872, DOI 10.1021/jf405630h; Liu HN, 2014, POULTRY SCI, V93, P347, DOI 10.3382/ps.2013-03225; Lorenz I, 2011, IRISH VET J, V64, DOI 10.1186/2046-0481-64-10; Lozoya X, 2002, J ETHNOPHARMACOL, V83, P19, DOI 10.1016/S0378-8741(02)00185-X; Luehring M, 2011, ANIM FEED SCI TECH, V169, P199, DOI 10.1016/j.anifeedsci.2011.06.006; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Maciej J, 2016, J DAIRY SCI, V99, P805, DOI 10.3168/jds.2015-9906; Maciej J, 2015, J DAIRY SCI, V98, P3906, DOI 10.3168/jds.2015-9361; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mancini G, 1963, SINGLE RADIAL DIFFUS, P370; Middleton E, 2000, PHARMACOL REV, V52, P673; MILLAR HR, 1971, J CLIN PATHOL, V24, P827, DOI 10.1136/jcp.24.9.827; Miller J.K.E., 1993, 1993 J DAIRY SCI, V76, P2812, DOI DOI 10.3168/JDS.S0022-0302(93)77620-1; Miller NJ, 1996, FEBS LETT, V384, P240, DOI 10.1016/0014-5793(96)00323-7; Montuschi P, 2007, CURR MED CHEM, V14, P703, DOI 10.2174/092986707780059607; Mutinati M, 2014, REPROD DOMEST ANIM, V49, P7, DOI 10.1111/rda.12230; Parkar SG, 2008, INT J FOOD MICROBIOL, V124, P295, DOI 10.1016/j.ijfoodmicro.2008.03.017; Pourjafar M., 2011, Bulgarian Journal of Veterinary Medicine, V14, P142; Provenza FD, 2010, SMALL RUMINANT RES, V89, P131, DOI 10.1016/j.smallrumres.2009.12.035; Przybylska J, 2007, REPROD DOMEST ANIM, V42, P402, DOI 10.1111/j.1439-0531.2006.00799.x; Rauprich ABE, 2000, J ANIM SCI, V78, P896; Rauprich ABE, 2000, BIOL NEONATE, V78, P53, DOI 10.1159/000014247; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Retskii M. I., 2010, Russian Agricultural Sciences, V36, P127, DOI 10.3103/S1068367410020151; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; Rochfort S, 2008, PHYTOCHEMISTRY, V69, P299, DOI 10.1016/j.phytochem.2007.08.017; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Schroedl W, 2003, J DAIRY SCI, V86, P3313, DOI 10.3168/jds.S0022-0302(03)73933-2; Sergent T, 2010, CHEM-BIOL INTERACT, V188, P659, DOI 10.1016/j.cbi.2010.08.007; Sordillo LM, 2009, VET IMMUNOL IMMUNOP, V128, P104, DOI 10.1016/j.vetimm.2008.10.305; Spencer JPE, 1999, FEBS LETT, V458, P224, DOI 10.1016/S0014-5793(99)01160-6; Steinhoff-Wagner J, 2011, J DAIRY SCI, V94, P5111, DOI 10.3168/jds.2011-4355; Steinhoff-Wagner J, 2011, J NUTR, V141, P48, DOI 10.3945/jn.110.128652; Stohrer M, 2001, VIT ZUS ERN MENSCH T; Stoldt AK, 2015, J DAIRY SCI, V98, P4509, DOI 10.3168/jds.2014-9053; Svensson C, 2006, J DAIRY SCI, V89, P4769, DOI 10.3168/jds.S0022-0302(06)72526-7; Weaver DM, 2000, J VET INTERN MED, V14, P569, DOI 10.1892/0891-6640(2000)014&lt;0569:PTOCII&gt;2.3.CO;2	72	20	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146932	10.1371/journal.pone.0146932	http://dx.doi.org/10.1371/journal.pone.0146932			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752173	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100181
J	Ishida, T; Kotani, H; Miyao, M; Kawai, C; Jemail, L; Abiru, H; Tamaki, K				Ishida, Tokiko; Kotani, Hirokazu; Miyao, Masashi; Kawai, Chihiro; Jemail, Leila; Abiru, Hitoshi; Tamaki, Keiji			Renal Impairment with Sublethal Tubular Cell Injury in a Chronic Liver Disease Mouse Model	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; SCLEROSING CHOLANGITIS; OXIDATIVE STRESS; BILIARY FIBROSIS; NITRIC-OXIDE; ABNORMALITIES; DYSFUNCTION; ISCHEMIA; FAILURE; CYCLE	The pathogenesis of renal impairment in chronic liver diseases (CLDs) has been primarily studied in the advanced stages of hepatic injury. Meanwhile, the pathology of renal impairment in the early phase of CLDs is poorly understood, and animal models to elucidate its mechanisms are needed. Thus, we investigated whether an existing mouse model of CLD induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) shows renal impairment in the early phase. Renal injury markers, renal histology (including immunohistochemistry for tubular injury markers and transmission electron microscopy), autophagy, and oxidative stress were studied longitudinally in DDC-and standard diet-fed BALB/c mice. Slight but significant renal dysfunction was evident in DDC-fed mice from the early phase. Meanwhile, histological examinations of the kidneys with routine light microscopy did not show definitive morphological findings, and electron microscopic analyses were required to detect limited injuries such as loss of brush border microvilli and mitochondrial deformities. Limited injuries have been recently designated as sublethal tubular cell injury. As humans with renal impairment, either with or without CLD, often show almost normal tubules, sublethal injury has been of particular interest. In this study, the injuries were associated with mitochondrial aberrations and oxidative stress, a possible mechanism for sublethal injury. Intriguingly, two defense mechanisms were associated with this injury that prevent it from progressing to apparent cell death: autophagy and single-cell extrusion with regeneration. Furthermore, the renal impairment of this model progressed to chronic kidney disease with interstitial fibrosis after long-term DDC feeding. These findings indicated that DDC induces renal impairment with sublethal tubular cell injury from the early phase, leading to chronic kidney disease. Importantly, this CLD mouse model could be useful for studying the pathophysiological mechanisms of sublethal tubular cell injury.	[Ishida, Tokiko; Kotani, Hirokazu; Miyao, Masashi; Kawai, Chihiro; Jemail, Leila; Abiru, Hitoshi; Tamaki, Keiji] Kyoto Univ, Dept Forens Med, Grad Sch Med, Kyoto, Japan	Kyoto University	Kotani, H (corresponding author), Kyoto Univ, Dept Forens Med, Grad Sch Med, Kyoto, Japan.	kotani@fp.med.kyoto-u.ac.jp			Japan Society for the Promotion of Science [26460877]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a grant from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) KAKENHI (Grant-in-Aid for Scientific Research) Grant Number 26460877 to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu U, 2011, CONTRIB NEPHROL, V174, P119, DOI 10.1159/000329249; Tabara LC, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.14; Castaneda MP, 2003, TRANSPLANTATION, V76, P50, DOI 10.1097/01.TP.0000069835.95442.9F; Desai MS, 2010, HEPATOLOGY, V51, P2097, DOI 10.1002/hep.23585; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Fickert P, 2013, HEPATOLOGY, V58, P2056, DOI 10.1002/hep.26599; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Heyman SN, 2011, CONTRIB NEPHROL, V169, P286, DOI 10.1159/000313957; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Jorres A, 2010, MANAGEMENT OF ACUTE KIDNEY PROBLEMS, P1; Katoh H, 2012, CURR BIOL, V22, pR453, DOI 10.1016/j.cub.2012.04.036; Kwiecien S, 2014, J PHYSIOL PHARMACOL, V65, P613; Ling LF, 2013, CIRC-CARDIOVASC IMAG, V6, P363, DOI 10.1161/CIRCIMAGING.112.000138; Liu Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449, DOI 10.1152/ajpgi.00199.2012; Lyoumi S, 2011, GASTROENTEROLOGY, V141, P1509, DOI 10.1053/j.gastro.2011.06.078; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Markus R, 2004, BRAIN, V127, P1427, DOI 10.1093/brain/awh162; Martin-Llahi M, 2011, GASTROENTEROLOGY, V140, P488, DOI 10.1053/j.gastro.2010.07.043; Miyao M, 2015, LAB INVEST, V95, P1130, DOI 10.1038/labinvest.2015.95; Miyao M, 2013, DIGEST LIVER DIS, V45, P216, DOI 10.1016/j.dld.2012.09.007; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V50, P1368, DOI 10.1016/j.freeradbiomed.2011.02.021; National Research Council, 2011, GUIDE CARE USE LAB A; Parikh SM, 2013, CURR OPIN CRIT CARE, V19, P554, DOI 10.1097/MCC.0000000000000038; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rosen S, 2008, J AM SOC NEPHROL, V19, P871, DOI 10.1681/ASN.2007080913; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; Shimizu A, 2013, AM J NEPHROL, V37, P378, DOI 10.1159/000348567; Sukhotnik I, 2011, J PEDIATR SURG, V46, P1495, DOI 10.1016/j.jpedsurg.2011.04.007; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Wong F, 2012, NAT REV GASTRO HEPAT, V9, P382, DOI 10.1038/nrgastro.2012.96; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zsengeller ZK, 2012, J HISTOCHEM CYTOCHEM, V60, P521, DOI 10.1369/0022155412446227	36	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146871	10.1371/journal.pone.0146871	http://dx.doi.org/10.1371/journal.pone.0146871			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752420	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100169
J	Kauff, M; Schmid, K; Lolliot, S; Al Ramiah, A; Hewstone, M				Kauff, Mathias; Schmid, Katharina; Lolliot, Simon; Al Ramiah, Ananthi; Hewstone, Miles			Intergroup Contact Effects via Ingroup Distancing among Majority and Minority Groups: Moderation by Social Dominance Orientation	PLOS ONE			English	Article							RIGHT-WING AUTHORITARIANISM; GROUP IDENTIFICATION; NORTHERN-IRELAND; PREJUDICE; ATTITUDES; IDENTITY; IMPACT; SIZE; PERSONALITY; FRIENDSHIPS	Five studies tested whether intergroup contact reduces negative outgroup attitudes through a process of ingroup distancing. Based on the deprovincialization hypothesis and Social Dominance Theory, we hypothesized that the indirect effect of cross-group friendship on outgroup attitudes via reduced ingroup identification is moderated by individuals' Social Dominance Orientation (SDO), and occurs only for members of high status majority groups. We tested these predictions in three different intergroup contexts, involving conflictual relations between social groups in Germany (Study 1; N = 150; longitudinal Study 2: N = 753), Northern Ireland (Study 3: N = 160; Study 4: N = 1,948), and England (Study 5; N = 594). Cross-group friendship was associated with reduced ingroup identification and the link between reduced ingroup identification and improved outgroup attitudes was moderated by SDO (the indirect effect of cross-group friendship on outgroup attitudes via reduced ingroup only occurred for individuals scoring high, but not low, in SDO). Although there was a consistent moderating effect of SDO in high-status majority groups (Studies 1-5), but not lowstatus minority groups (Studies 3, 4, and 5), the interaction by SDO was not reliably stronger in high-than low-status groups. Findings are discussed in terms of better understanding deprovincialization effects of contact.	[Kauff, Mathias] Fernuniv, Inst Psychol, Hagen, Germany; [Schmid, Katharina] Ramon Llull Univ, ESADE Business Sch, Barcelona, Spain; [Lolliot, Simon] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Hewstone, Miles] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	Fern University Hagen; Universitat Ramon Llull; Escuela Superior de Administracion y Direccion de Empresas (ESADE); University of British Columbia; University of Oxford	Kauff, M (corresponding author), Fernuniv, Inst Psychol, Hagen, Germany.	mathias.kauff@fernuni-hagen.de	Ramiah, Ananthi/GNH-4022-2022; Schmid, Katharina/AAB-1398-2019	Hewstone, Miles/0000-0002-8861-0465; Kauff, Mathias/0000-0003-3803-3521	Deutsche Forschungsgemeinschaft [GRK 884, KA 4028/2-1]; Alexander von Humboldt Foundation; Economic and Social Research Council; Leverhulme Trust; Volkswagen Stiftung; Freudenberg Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme Trust(Leverhulme Trust); Volkswagen Stiftung(Volkswagen); Freudenberg Stiftung	The research reported in this paper was in part supported by the Deutsche Forschungsgemeinschaft (GRK 884 and KA 4028/2-1, fellowship and grant to M. Kauff; www.dfg.de), the Alexander von Humboldt Foundation (fellowship to M. Kauff; www.humboldt-foundation.de), a grant from the Economic and Social Research Council as part of its 'Identities and Social Action' Programme (awarded to M. Hewstone, enabled data collection; www.esrc.ac.uk), as well as a grant on 'Ethno-religious diversity and trust in educational and residential settings' from the Leverhulme Trust (awarded to M. Hewstone, enabled data collection; www.leverhulme.ac.uk). Data collection for Study 2 was supported by the Volkswagen Stiftung and the Freudenberg Stiftung (awarded to Wilhelm Heitmeyer, University of Bielefeld; www.volkswagenstiftung.de, www.freudenbergstiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ramiah A, 2013, BRIT J EDUC PSYCHOL, V83, P57, DOI 10.1111/j.2044-8279.2011.02054.x; [Anonymous], 2003, APPL MULTIPLE CORREL; Asbrock F, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014532819; Asbrock F, 2012, PERS SOC PSYCHOL B, V38, P477, DOI 10.1177/0146167211429747; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Binder J, 2009, J PERS SOC PSYCHOL, V96, P843, DOI 10.1037/a0013470; Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037/0022-3514.77.1.135; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Campbell, 1976, ETHNOCENTRISM INTERG; Cohrs J.Christopher., 2005, ANAL SOC ISS PUB POL, V5, P263, DOI DOI 10.1111/J.1530-2415.2005.00071.X; Cole DA, 2003, J ABNORM PSYCHOL, V112, P558, DOI 10.1037/0021-843X.112.4.558; Davies K, 2011, PERS SOC PSYCHOL REV, V15, P332, DOI 10.1177/1088868311411103; Dhont K, 2009, PERS INDIV DIFFER, V46, P172, DOI 10.1016/j.paid.2008.09.022; Dovidio JF, 2007, EUR REV SOC PSYCHOL, V18, P296, DOI 10.1080/10463280701726132; Duckitt J, 2001, ADV EXP SOC PSYCHOL, V33, P41, DOI 10.1016/S0065-2601(01)80004-6; Ekehammar B, 2004, EUR J PERSONALITY, V18, P463, DOI 10.1002/per.526; Eller A, 2004, EUR J SOC PSYCHOL, V34, P229, DOI 10.1002/ejsp.194; Finkel S. E., 1995, CAUSAL ANAL PANEL DA; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Gavaghan DJ, 2000, PAIN, V85, P415, DOI 10.1016/S0304-3959(99)00302-4; Gonzalez R, 2006, J EXP SOC PSYCHOL, V42, P753, DOI 10.1016/j.jesp.2005.11.008; Hayes AF, 2013, PSYCHOL SCI, V24, P1918, DOI 10.1177/0956797613480187; Henry PJ, 2005, POLIT PSYCHOL, V26, P569, DOI 10.1111/j.1467-9221.2005.00432.x; Hinkle S., 1990, SOCIAL IDENTITY THEO, P48; Hodson G, 2013, ADVANCES IN INTERGROUP CONTACT, P1; Hodson G, 2008, BRIT J SOC PSYCHOL, V47, P325, DOI 10.1348/014466607X231109; Jackson JW, 2002, SELF IDENTITY, V1, P11, DOI 10.1080/152988602317232777; Jetten J., 2012, SOCIAL CURE IDENTITY; Kauff M, 2012, SOC PSYCHOL PERS SCI, V3, P714, DOI 10.1177/1948550611435942; Kugler MB, 2010, SOC JUSTICE RES, V23, P117, DOI 10.1007/s11211-010-0112-5; Levin S, 1998, POLIT PSYCHOL, V19, P373, DOI 10.1111/0162-895X.00109; Levin S, 1999, POLIT PSYCHOL, V20, P99, DOI 10.1111/0162-895X.00138; Levin S, 2002, PERS SOC PSYCHOL B, V28, P144, DOI 10.1177/0146167202282002; Levin S, 2012, J EXP SOC PSYCHOL, V48, P207, DOI 10.1016/j.jesp.2011.06.019; Lipsey MW, 2011, PRACTICAL METAANALYS; Lolliot S, 2015, MEASURES OF PERSONALITY AND SOCIAL PSYCHOLOGICAL CONSTRUCTS, P652, DOI 10.1016/B978-0-12-386915-9.00023-1; Lolliot S, 2013, ADVANCES IN INTERGROUP CONTACT, P81; Lucken M, 2005, J EXP SOC PSYCHOL, V41, P396, DOI 10.1016/j.jesp.2004.08.006; Mummendey A, 1999, Pers Soc Psychol Rev, V3, P158, DOI 10.1207/s15327957pspr0302_4; Mummendey A, 2001, BRIT J SOC PSYCHOL, V40, P159, DOI 10.1348/014466601164740; Nguyen AMD, 2010, PSYCHOL SOCIAL CULTU, P84; Office for National Statistics, 2011, 2011 CENS ENGL WAL; Overbeck JR, 2004, GROUP PROCESS INTERG, V7, P35, DOI 10.1177/1368430204039972; Perry R, 2011, J INDIVID DIFFER, V32, P110, DOI 10.1027/1614-0001/a000042; Pettigrew T. F., 2011, GROUPS MEET DYNAMICS; Pettigrew TF, 1998, ANNU REV PSYCHOL, V49, P65, DOI 10.1146/annurev.psych.49.1.65; Pettigrew TF, 1997, PERS SOC PSYCHOL B, V23, P173, DOI 10.1177/0146167297232006; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Pettigrew TF, 2009, SOC PSYCHOL-GERMANY, V40, P55, DOI 10.1027/1864-9335.40.2.55; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Pratto F., 2006, EUROPEAN REV SOCIAL, V17, P271, DOI [10.1080/10463280601055772, DOI 10.1080/10463280601055772]; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Raudenbush S.W., 2009, HDB RES SYNTHESIS ME, P295; Richeson JA, 2004, J EXP SOC PSYCHOL, V40, P417, DOI 10.1016/j.jesp.2003.09.002; Roccas S, 2002, PERS SOC PSYCHOL REV, V6, P88, DOI 10.1207/S15327957PSPR0602_01; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schmid K, 2013, BRIT J SOCIAL PSYCHO; Schmid K, 2015, POLIT PSYCHOL, V36, P75, DOI 10.1111/pops.12073; Schmid K, 2012, SOC PSYCHOL QUART, V75, P28, DOI 10.1177/0190272511430235; Schmid K, 2009, PERS SOC PSYCHOL B, V35, P1085, DOI 10.1177/0146167209337037; Schmitt MT, 2003, BRIT J SOC PSYCHOL, V42, P161, DOI 10.1348/014466603322127166; Schmitt MT, 2003, BRIT J SOC PSYCHOL, V42, P215, DOI 10.1348/014466603322127201; Sibley CG, 2007, POLIT PSYCHOL, V28, P357, DOI 10.1111/j.1467-9221.2007.00572.x; Sibley CG, 2006, POLIT PSYCHOL, V27, P755, DOI 10.1111/j.1467-9221.2006.00531.x; SIDANIUS J, 1994, J APPL SOC PSYCHOL, V24, P338, DOI 10.1111/j.1559-1816.1994.tb00586.x; Sidanius J., 1999, SOCIAL DOMINANCE INT; Simon Bernd Birgit, 2001, BLACKWELL HDB SOCIAL, P303; Southern N, 2007, J ETHN MIGR STUD, V33, P159, DOI 10.1080/13691830601043588; Stephan W. G., 2000, REDUCING PREJUDICE D, P23; Swart H, 2011, J PERS SOC PSYCHOL, V101, P1221, DOI 10.1037/a0024450; Tausch N, 2007, POLIT PSYCHOL, V28, P53, DOI 10.1111/j.1467-9221.2007.00551.x; Tausch N, 2010, J PERS SOC PSYCHOL, V99, P282, DOI 10.1037/a0018553; Turner JC, 2003, BRIT J SOC PSYCHOL, V42, P199, DOI 10.1348/014466603322127184; Verkuyten M, 2006, J CROSS CULT PSYCHOL, V37, P312, DOI 10.1177/0022022106286926; Verkuyten M, 2010, SOC PSYCHOL QUART, V73, P398, DOI 10.1177/0190272510389015; Wilson D. B., 2005, METAANALYSIS MACROS; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; Zick A, 2008, J SOC ISSUES, V64, P363, DOI 10.1111/j.1540-4560.2008.00566.x	78	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146895	10.1371/journal.pone.0146895	http://dx.doi.org/10.1371/journal.pone.0146895			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751203	Green Published, gold			2022-12-27	WOS:000367888100174
J	Pennington, CR; Heim, D; Levy, AR; Larkin, DT				Pennington, Charlotte R.; Heim, Derek; Levy, Andrew R.; Larkin, Derek T.			Twenty Years of Stereotype Threat Research: A Review of Psychological Mediators	PLOS ONE			English	Article							MULTIPLE SOCIAL IDENTITIES; WORKING-MEMORY; TEST-PERFORMANCE; SOLO STATUS; INDIVIDUAL-DIFFERENCES; RACIAL IDENTITY; MODERATING ROLE; SELF-EFFICACY; GENDER-GAP; MATH	This systematic literature review appraises critically the mediating variables of stereotype threat. A bibliographic search was conducted across electronic databases between 1995 and 2015. The search identified 45 experiments from 38 articles and 17 unique proposed mediators that were categorized into affective/subjective (n = 6), cognitive (n = 7) and motivational mechanisms (n = 4). Empirical support was accrued for mediators such as anxiety, negative thinking, and mind-wandering, which are suggested to co-opt working memory resources under stereotype threat. Other research points to the assertion that stereotype threatened individuals may be motivated to disconfirm negative stereotypes, which can have a paradoxical effect of hampering performance. However, stereotype threat appears to affect diverse social groups in different ways, with no one mediator providing unequivocal empirical support. Underpinned by the multi-threat framework, the discussion postulates that different forms of stereotype threat may be mediated by distinct mechanisms.	[Pennington, Charlotte R.; Heim, Derek; Levy, Andrew R.; Larkin, Derek T.] Edge Hill Univ, Dept Psychol, Ormskirk, Lancs, England	Edge Hill University	Pennington, CR (corresponding author), Edge Hill Univ, Dept Psychol, Ormskirk, Lancs, England.	penninc@edgehill.ac.uk	Pennington, Charlotte/W-7115-2019; Larkin, Derek/F-6556-2011	Pennington, Charlotte/0000-0002-5259-642X; Levy, Andrew/0000-0002-6709-4190; Larkin, Derek/0000-0001-9684-2699	Graduate School and the Department of Psychology at Edge Hill University	Graduate School and the Department of Psychology at Edge Hill University	The authors acknowledge support toward open access publishing by the Graduate School and the Department of Psychology at Edge Hill University. The funders had no role in the systematic review, data collection or analysis, decision to publish, or preparation of the manuscript.	Appel M, 2011, EUR J SOC PSYCHOL, V41, P904, DOI 10.1002/ejsp.835; Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; Aronson J, 2004, PSYCHOL SCI, V15, P829, DOI 10.1111/j.0956-7976.2004.00763.x; Bandura A., 1986, SOCIAL FOUNDATIONS O; Bandura A, 2006, PERSPECT PSYCHOL SCI, V1, P164, DOI 10.1111/j.1745-6916.2006.00011.x; Beaton A, 2007, EUR J PSYCHOL EDUC, V22, P291, DOI 10.1007/BF03173427; Beilock SL, 2007, J EXP PSYCHOL GEN, V136, P256, DOI 10.1037/0096-3445.136.2.256; Beilock SL, 2006, PERS SOC PSYCHOL B, V32, P1059, DOI 10.1177/0146167206288489; BENBOW C P, 1980, Science (Washington D C), V210, P1262, DOI 10.1126/science.7434028; Berjot S, 2011, PSYCHOL REP, V108, P585, DOI 10.2466/04.07.21.PR0.108.2.585-598; Bosson JK, 2004, J EXP SOC PSYCHOL, V40, P247, DOI 10.1016/S0022-1031(03)00099-4; Brodish AB, 2009, J EXP SOC PSYCHOL, V45, P180, DOI 10.1016/j.jesp.2008.08.005; Brown RP, 2003, J EXP SOC PSYCHOL, V39, P626, DOI 10.1016/S0022-1031(03)00039-8; Cadinu M, 2006, EUR J SOC PSYCHOL, V36, P183, DOI 10.1002/ejsp.303; Cadinu M, 2005, PSYCHOL SCI, V16, P572, DOI 10.1111/j.0956-7976.2005.01577.x; Cadinu M, 2003, EUR J SOC PSYCHOL, V33, P267, DOI 10.1002/ejsp.145; Chalabaev A, 2008, J SPORT EXERCISE PSY, V30, P143, DOI 10.1123/jsep.30.2.143; Chung BG, 2010, GROUP ORGAN MANAGE, V35, P77, DOI 10.1177/1059601109354839; Cohen GL, 2005, J PERS SOC PSYCHOL, V89, P566, DOI 10.1037/0022-3514.89.4.566; CROCKER J, 1989, PSYCHOL REV, V96, P608, DOI 10.1037/0033-295X.96.4.608; Croizet JC, 2004, PERS SOC PSYCHOL B, V30, P721, DOI 10.1177/0146167204263961; Cronin Patricia, 2008, Br J Nurs, V17, P38; Davis C, 2006, J BLACK PSYCHOL, V32, P399, DOI 10.1177/0095798406292464; Derks B, 2008, GROUP PROCESS INTERG, V11, P163, DOI 10.1177/1368430207088036; Devine PG, 2003, PSYCHOL INQ, V14, P196, DOI 10.1207/S15327965PLI1403&4_3; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P11; Drach-Zahavy A, 2002, ORGAN BEHAV HUM DEC, V88, P667, DOI 10.1016/S0749-5978(02)00004-3; Elizaga RA, 2008, CURR PSYCHOL, V27, P290, DOI 10.1007/s12144-008-9041-y; Elliot AJ, 1997, J PERS SOC PSYCHOL, V72, P218, DOI 10.1037/0022-3514.72.1.218; Fiske ST, 2003, PSYCHOL INQ, V14, P203, DOI 10.1207/S15327965PLI1403&4_4; Frey FE, 2006, PERS SOC PSYCHOL REV, V10, P265, DOI 10.1207/s15327957pspr1003_5; Galdi S, 2014, CHILD DEV, V85, P250, DOI 10.1111/cdev.12128; Gerstenberg FXR, 2012, EUR J PERSONALITY, V26, P588, DOI 10.1002/per.1836; Hayes A. F., 2013, INTRODUCTION TO MEDI; Hess TM, 2009, EXP AGING RES, V35, P153, DOI 10.1080/03610730802716413; Hess TM, 2003, J GERONTOL B-PSYCHOL, V58, pP3, DOI 10.1093/geronb/58.1.P3; Hirsh JB, 2016, PERS SOC PSYCHOL REV, V20, P223, DOI 10.1177/1088868315589475; Jamieson JP, 2007, J PERS SOC PSYCHOL, V93, P544, DOI 10.1037/0022-3514.93.4.544; Jamieson JP, 2012, GROUP PROCESS INTERG, V15, P291, DOI 10.1177/1368430211417833; Johns M, 2008, J EXP PSYCHOL GEN, V137, P691, DOI 10.1037/a0013834; Keller J, 2003, PERS SOC PSYCHOL B, V29, P371, DOI 10.1177/0146167202250218; Keller J, 2002, SEX ROLES, V47, P193, DOI 10.1023/A:1021003307511; Keller J, 2008, EUR J SOC PSYCHOL, V38, P1044, DOI 10.1002/ejsp.490; Keller J, 2007, BRIT J EDUC PSYCHOL, V77, P323, DOI 10.1348/000709906X113662; Khan KS, 2009, SYSTEMTIC REV, P1; Kiefer AK, 2007, J EXP SOC PSYCHOL, V43, P825, DOI 10.1016/j.jesp.2006.08.004; Kray LJ, 2001, J PERS SOC PSYCHOL, V80, P942, DOI 10.1037/0022-3514.80.6.942; Laurin R, 2013, J SOC PSYCHOL, V153, P687, DOI 10.1080/00224545.2013.821098; Lazarus R. S., 1984, STRESS APPRAISAL AND; Leary MR, 2009, PERS SOC PSYCHOL REV, V13, P151, DOI 10.1177/1088868309342595; Levy B, 1996, J PERS SOC PSYCHOL, V71, P1092, DOI 10.1037/0022-3514.71.6.1092; Leyens JP, 2000, PERS SOC PSYCHOL B, V26, P1189, DOI 10.1177/0146167200262002; Logel C, 2009, J EXP SOC PSYCHOL, V45, P299, DOI 10.1016/j.jesp.2008.07.016; Maddux J.E., 1993, J APPL SPORT PSYCHOL, V5, P116, DOI DOI 10.1080/10413209308411310; Mandler G., 2004, INFORMATION PROCESSI, P1; Marx DM, 2005, J PERS SOC PSYCHOL, V88, P432, DOI 10.1037/0022-3514.88.3.432; Mayer DM, 2003, HUM PERFORM, V16, P207, DOI 10.1207/S15327043HUP1603_3; McKown C, 2003, CHILD DEV, V74, P498, DOI 10.1111/1467-8624.7402012; Miller GA, 1962, PSYCHOLOGY THE SCIEN; Moe A, 2006, LEARN INDIVID DIFFER, V16, P369, DOI 10.1016/j.lindif.2007.01.002; Moe A, 2012, LEARN INDIVID DIFFER, V22, P20, DOI 10.1016/j.lindif.2011.11.001; Moe A, 2010, LEARN INDIVID DIFFER, V20, P464, DOI 10.1016/j.lindif.2010.03.004; Moe A, 2009, PERS INDIV DIFFER, V46, P187, DOI 10.1016/j.paid.2008.09.030; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mrazek MD, 2011, J EXP SOC PSYCHOL, V47, P1243, DOI 10.1016/j.jesp.2011.05.011; Nguyen HHD, 2008, J APPL PSYCHOL, V93, P1314, DOI 10.1037/a0012702; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Nosek BA, 2002, J PERS SOC PSYCHOL, V83, P44, DOI 10.1037//0022-3514.83.1.44; O'Brien LT, 2003, PERS SOC PSYCHOL B, V29, P782, DOI 10.1177/0146167203029006010; Osborne J. W., 2006, J RES ED PSYCHOL, V8, P109; Oyserman D, 2003, SOC PSYCHOL QUART, V66, P333, DOI 10.2307/1519833; Oyserman D, 2001, INT J BEHAV DEV, V25, P379, DOI 10.1080/01650250042000401; Pavlova MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114802; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Regner I, 2010, PSYCHOL SCI, V21, P1646, DOI 10.1177/0956797610386619; Rosenthal HES, 2007, EUR J SOC PSYCHOL, V37, P586, DOI 10.1002/ejsp.379; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Rydell RJ, 2014, PERS SOC PSYCHOL B, V40, P377, DOI 10.1177/0146167213513475; Rydell RJ, 2010, PERS SOC PSYCHOL B, V36, P239, DOI 10.1177/0146167209355062; Rydell RJ, 2009, J PERS SOC PSYCHOL, V96, P949, DOI 10.1037/a0014846; Schmader, 2012, STEREOTYPE THREAT TH, P71, DOI DOI 10.1093/ACPROF:OSO/9780199732449.003.0005; Schmader T, 2004, SEX ROLES, V50, P835, DOI 10.1023/B:SERS.0000029101.74557.a0; Schmader T, 2003, J PERS SOC PSYCHOL, V85, P440, DOI 10.1037/0022-3514.85.3.440; Schmader T, 2002, J EXP SOC PSYCHOL, V38, P194, DOI 10.1006/jesp.2001.1500; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Schunk DH, 1989, EDUC PSYCHOL REV, V1, P173, DOI 10.1007/BF01320134; Schuster C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122207; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Seibt B, 2004, J PERS SOC PSYCHOL, V87, P38, DOI 10.1037/0022-3514.87.1.38; Sekaquaptewa D, 2003, J EXP SOC PSYCHOL, V39, P68, DOI 10.1016/S0022-1031(02)00508-5; Shapiro JR, 2007, PERS SOC PSYCHOL REV, V11, P107, DOI 10.1177/1088868306294790; Shapiro JR, 2013, J PERS SOC PSYCHOL, V104, P277, DOI 10.1037/a0030461; Shapiro JR, 2011, PERS SOC PSYCHOL B, V37, P464, DOI 10.1177/0146167211398140; Skorich DP, 2013, ACCIDENT ANAL PREV, V54, P39, DOI 10.1016/j.aap.2013.02.002; Smith JL, 2004, EDUC PSYCHOL REV, V16, P177, DOI 10.1023/B:EDPR.0000034020.20317.89; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Steele CM, 2003, HUM PERFORM, V16, P311, DOI 10.1207/S15327043HUP1603_7; Steele CM, 2002, ADV EXP SOC PSYCHOL, V34, P379, DOI 10.1016/S0065-2601(02)80009-0; Sternberg RJ, 2005, AM PSYCHOL, V60, P46, DOI 10.1037/0003-066X.60.1.46; Stoet G, 2012, REV GEN PSYCHOL, V16, P93, DOI 10.1037/a0026617; Stone J, 1999, J PERS SOC PSYCHOL, V77, P1213, DOI 10.1037/0022-3514.77.6.1213; Stone J, 2002, PERS SOC PSYCHOL B, V28, P1667, DOI 10.1177/014616702237648; Stone J, 2008, J EXP SOC PSYCHOL, V44, P445, DOI 10.1016/j.jesp.2007.02.006; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tempel T, 2014, SOC PSYCHOL EDUC, V17, P491, DOI 10.1007/s11218-014-9263-9; Townsend SSM, 2011, PERS SOC PSYCHOL B, V37, P151, DOI 10.1177/0146167210392384; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Walton GM, 2009, PSYCHOL SCI, V20, P1132, DOI 10.1111/j.1467-9280.2009.02417.x; Wegner DM, 2002, THE ILLUSION OF CONS; Wheeler SC, 2007, PERS SOC PSYCHOL REV, V11, P234, DOI 10.1177/1088868307302223; Wheeler SC, 2001, J EXP SOC PSYCHOL, V37, P173, DOI 10.1006/jesp.2000.1448; White JB, 2008, PERS SOC PSYCHOL B, V34, P1171, DOI 10.1177/0146167208318404; Wraga M, 2006, PSYCHON B REV, V13, P813, DOI 10.3758/BF03194002; Yeung NCJ, 2008, ACCIDENT ANAL PREV, V40, P667, DOI 10.1016/j.aap.2007.09.003	120	119	120	5	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146487	10.1371/journal.pone.0146487	http://dx.doi.org/10.1371/journal.pone.0146487			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26752551	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000367888100086
J	Picavet, HSJ; Pas, LW; van Oostrom, SH; van der Ploeg, HP; Verschuren, WMM; Proper, KI				Picavet, H. Susan J.; Pas, L. Willemijn; van Oostrom, Sandra H.; van der Ploeg, Hidde P.; Verschuren, W. M. Monique; Proper, Karin I.			The Relation between Occupational Sitting and Mental, Cardiometabolic, and Musculoskeletal Health over a Period of 15 Years - The Doetinchem Cohort Study	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; TIME; ADULTS; OBESITY; WORK; ASSOCIATIONS; VALIDITY; OUTCOMES	Objective Sedentary behaviors are reported to impose health risks. Since occupational exposure is a major proportion of total sedentary time, we studied the association between occupational sitting and a number of health problems. Methods From the longitudinal Doetinchem Cohort Study, we selected those working at baseline with complete data (n = 1,509). Participants were examined four times at 5 year-intervals between 1993 and 2012. We characterized occupational sitting as follows: 1) stable sitters and stable non sitters over a 15-year period, based on job characteristics and (2) having a job with a low, moderate or high amount of sitting, based on tertiles of self-reported number of hours per week of occupational sitting, measured at wave 5. Linear and logistic regression models were used. Outcomes were self-reported mental health, low-back or upper extremity pain, and objectively measured cardiometabolic health (overweight, hypertension, hypercholesterolemia). Results Compared to stable non sitters, a lower risk of chronic upper extremity pain was observed for stable sitters (OR 0.75, 95% CI: 0.57; 1.00) as well as for those in the two upper tertiles for hours of occupational sitting (>4 hr/wk) (OR 0.65; 95% CI 0.50-0.86). For the other health outcomes studied, no significant associations were found with occupational sitting. Conclusion Our findings do not support the hypothesis that occupational sitting is associated with health problems. The finding that occupational sitting is associated with less upper extremity pain might be due to the association of occupational sitting with less physical load.	[Picavet, H. Susan J.; Pas, L. Willemijn; van Oostrom, Sandra H.; Verschuren, W. M. Monique; Proper, Karin I.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands; [van der Ploeg, Hidde P.; Proper, Karin I.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam	Proper, KI (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands.	karin.proper@rivm.nl	van der Ploeg, Hidde/ABD-6402-2021; van der Ploeg, Hidde P/B-2599-2013	van der Ploeg, Hidde P/0000-0002-3719-5249; Picavet, Susan/0000-0002-6895-165X	Dutch Ministry of Social Affairs and Employment	Dutch Ministry of Social Affairs and Employment	This study was funded by the Dutch Ministry of Social Affairs and Employment. The funders had no role in study design, data collection and analysis,	Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Blokstra A, 2010, CHANGES IN LIFESTYLE; Brown WJ, 2003, INT J OBESITY, V27, P1340, DOI 10.1038/sj.ijo.0802426; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Chau JY, 2012, MED SCI SPORT EXER, V44, P118, DOI 10.1249/MSS.0b013e3182251060; Chau JY, 2011, BRIT J SPORT MED, V45, P1216, DOI 10.1136/bjsports-2011-090214; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Choi B, 2010, AM J IND MED, V53, P1088, DOI 10.1002/ajim.20886; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Clark BK, 2011, MED SCI SPORT EXER, V43, P1907, DOI 10.1249/MSS.0b013e31821820a2; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Jancey J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-762; Jans MP, 2007, AM J PREV MED, V33, P450, DOI 10.1016/j.amepre.2007.07.033; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lagersted-Olsen J, 2014, INT J SPORTS MED, V35, P534, DOI 10.1055/s-0033-1358467; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; Miller R, 2004, INT J BEHAV MED, V11, P219, DOI 10.1207/s15327558ijbm1104_5; Miranda H, 2001, OCCUP ENVIRON MED, V58, P528, DOI 10.1136/oem.58.8.528; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Perenboom R, 2000, LIFE EXPECTANCY GOOD; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Proper KI, 2012, J OBES, V2012, DOI 10.1155/2012/607908; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Saidj M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070213; Stamatakis E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006034; Teychenne M, 2011, INT J BEHAV MED, V17, P246, DOI 10.1007/s12529-010-9075-z; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; Van der Zee KI, 1993, METEN ALGEMENE GEZON; Van Hulst R, LONG TERM PATT UNPUB; van Oostrom SH, 2011, EUR J PAIN, V15, P993, DOI 10.1016/j.ejpain.2011.02.007; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Waters TR, 2007, J OCCUP ENVIRON MED, V49, P172, DOI 10.1097/JOM.0b013e3180322559; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; World Health Organization (WHO), 2000, WHO TECHN REP SER, P256, DOI DOI 10.1007/978-0-387-71799-9_454	39	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146639	10.1371/journal.pone.0146639	http://dx.doi.org/10.1371/journal.pone.0146639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26752695	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100116
J	Riwanto, M; Kapoor, S; Rodriguez, D; Edenhofer, I; Segerer, S; Wuthrich, RP				Riwanto, Meliana; Kapoor, Sarika; Rodriguez, Daniel; Edenhofer, Ilka; Segerer, Stephan; Wuethrich, Rudolf P.			Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease	PLOS ONE			English	Article							CANCER RADIOTHERAPY; DOSE-ESCALATION; 2-DEOXY-D-GLUCOSE; METABOLISM; APOPTOSIS; SIROLIMUS; CHLORIDE; MODELS; GROWTH; CELLS	Dysregulated signaling cascades alter energy metabolism and promote cell proliferation and cyst expansion in polycystic kidney disease (PKD). Here we tested whether metabolic reprogramming towards aerobic glycolysis ("Warburg effect") plays a pathogenic role in male heterozygous Han:SPRD rats (Cy/+), a chronic progressive model of PKD. Using microarray analysis and qPCR, we found an upregulation of genes involved in glycolysis (Hk1, Hk2, Ldha) and a downregulation of genes involved in gluconeogenesis (G6pc, Lbp1) in cystic kidneys of Cy/+ rats compared with wild-type (+/+) rats. We then tested the effect of inhibiting glycolysis with 2-deoxyglucose (2DG) on renal functional loss and cyst progression in 5-week-old male Cy/+ rats. Treatment with 2DG (500 mg/kg/day) for 5 weeks resulted in significantly lower kidney weights (-27%) and 2-kidney/total-body-weight ratios (-20%) and decreased renal cyst index (-48%) compared with vehicle treatment. Cy/+ rats treated with 2DG also showed higher clearances of creatinine (1.98 +/- 0.67 vs 1.41 +/- 0.37 ml/min), BUN (0.69 +/- 0.26 vs 0.40 +/- 0.10 ml/min) and uric acid (0.38 +/- 0.20 vs 0.21 +/- 0.10 ml/min), and reduced albuminuria. Immunoblotting analysis of kidney tissues harvested from 2DG-treated Cy/+ rats showed increased phosphorylation of AMPK-alpha, a negative regulator of mTOR, and restoration of ERK signaling. Assessment of Ki-67 staining indicated that 2DG limits cyst progression through inhibition of epithelial cell proliferation. Taken together, our results show that targeting the glycolytic pathway may represent a promising therapeutic strategy to control cyst growth in PKD.	[Riwanto, Meliana; Kapoor, Sarika; Rodriguez, Daniel; Edenhofer, Ilka; Segerer, Stephan; Wuethrich, Rudolf P.] Univ Zurich, Inst Physiol, Nephrol, Zurich, Switzerland; [Riwanto, Meliana; Segerer, Stephan; Wuethrich, Rudolf P.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital	Wuthrich, RP (corresponding author), Univ Zurich, Inst Physiol, Nephrol, Zurich, Switzerland.	rudolf.wuethrich@usz.ch		Rodriguez Gutierrez, Daniel/0000-0002-2979-0769; Segerer, Stephan/0000-0002-1936-9719	Forschungkredit Postdoc grant; CKM-Stiftung and Fundacao Pesquisa e Desenvolvimento Humanitario; Novartis Foundation for medical-biological research; Swiss National Science Foundation [320030_144093]	Forschungkredit Postdoc grant; CKM-Stiftung and Fundacao Pesquisa e Desenvolvimento Humanitario; Novartis Foundation for medical-biological research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by funding from the Forschungkredit Postdoc grant to MR, grants by the CKM-Stiftung and Fundacao Pesquisa e Desenvolvimento Humanitario to SS, the Novartis Foundation for medical-biological research and the Swiss National Science Foundation (grant number 320030_144093) to RPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt WM, 2007, AM J PATHOL, V170, P830, DOI 10.2353/ajpath.2007.060455; Berthier CC, 2006, KIDNEY INT, V69, P358, DOI 10.1038/sj.ki.5000049; Berthier CC, 2008, NEPHROL DIAL TRANSPL, V23, P880, DOI 10.1093/ndt/gfm697; BROWN J, 1962, METABOLISM, V11, P1098; Brown JH, 2005, J AM SOC NEPHROL, V16, P3517, DOI 10.1681/ASN.2005060601; Buchholz B, 2014, J AM SOC NEPHROL, V25, P465, DOI 10.1681/ASN.2013030209; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Center for Drug Evaluation and Research Center for Biologics Evaluation and Research, 2002, EST SAF START DOS CL; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Chiaravalli M., 2015, J AM SOC NEPHROL; Devuyst O, 2013, CURR OPIN NEPHROL HY, V22, P459, DOI 10.1097/MNH.0b013e3283621510; Ecder T, 2002, KIDNEY INT, V61, P1220, DOI 10.1046/j.1523-1755.2002.00250.x; Esteve JM, 1999, FASEB J, V13, P1055, DOI 10.1096/fasebj.13.9.1055; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Gretz N, 1996, NEPHROL DIAL TRANSPL, V11, P46; Guay-Woodford LM, 2003, AM J PHYSIOL-RENAL, V285, pF1034, DOI 10.1152/ajprenal.00195.2003; Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Li QW, 2012, PROTEOMICS, V12, P2556, DOI 10.1002/pmic.201100590; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Rowe I, 2014, NEPHROL DIAL TRANSPL, V29, P1480, DOI 10.1093/ndt/gft521; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Wallace DP, 1996, KIDNEY INT, V50, P1327, DOI 10.1038/ki.1996.445; Wang XQ, 2013, KIDNEY INT, V84, P962, DOI 10.1038/ki.2013.199; Weindruch R, 2001, J GERONTOL A-BIOL, V56, P20, DOI 10.1093/gerona/56.suppl_1.20; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Wuthrich RP, 2014, EXPERT OPIN PHARMACO, V15, P1085, DOI 10.1517/14656566.2014.903923; Wuthrich RP, 2010, TRANSPL P, V42, pS44, DOI 10.1016/j.transproceed.2010.07.008; Xu RH, 2005, CANCER RES, V65, P613; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533	39	65	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146654	10.1371/journal.pone.0146654	http://dx.doi.org/10.1371/journal.pone.0146654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752072	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100124
J	Stevanato, L; Thanabalasundaram, L; Vysokov, N; Sinden, JD				Stevanato, Lara; Thanabalasundaram, Lavaniya; Vysokov, Nickolai; Sinden, John D.			Investigation of Content, Stoichiometry and Transfer of miRNA from Human Neural Stem Cell Line Derived Exosomes	PLOS ONE			English	Article							IN-VITRO; MICRORNA; VESICLES; MIR-1246; CANCER; IDENTIFICATION; MECHANISM; PROTEINS; TARGET; VIVO	Exosomes are small (30-100 nm) membrane vesicles secreted by a variety of cell types and only recently have emerged as a new avenue for cell-to-cell communication. They are natural shuttles of RNA and protein cargo, making them attractive as potential therapeutic delivery vehicles. MicroRNAs (miRNAs) are short non-coding RNAs which regulate biological processes and can be found in exosomes. Here we characterized the miRNA contents of exosomes derived from human neural stem cells (hNSCs). Our investigated hNSC line is a clonal, conditionally immortalized cell line, compliant with good manufacturing practice (GMP), and in clinical trials for stroke and critical limb ischemia in the UK (clinicaltrials.gov: NCT01151124, NCT02117635, and NCT01916369). By using next generation sequencing (NGS) technology we identified the presence of a variety of miRNAs in both exosomal and cellular preparations. Many of these miRNAs were enriched in exosomes indicating that cells specifically sort them for extracellular release. Although exosomes have been proven to contain miRNAs, the copy number quantification per exosome of a given miRNA remains unclear. Herein we quantified by real-time PCR a highly shuttled exosomal miRNA subtype (hsa-miR-1246) in order to assess its stoichiometry per exosome. Furthermore, we utilized an in vitro system to confirm its functional transfer by measuring the reduction in luciferase expression using a 3' untranslated region dual luciferase reporter assay. In summary, NGS analysis allowed the identification of a unique set of hNSC derived exosomal miRNAs. Stoichiometry and functional transfer analysis of one of the most abundant identified miRNA, hsa-miR-1246, were measured to support biological relevance of exosomal miRNA delivery.	[Stevanato, Lara; Thanabalasundaram, Lavaniya; Vysokov, Nickolai; Sinden, John D.] ReNeuron, Stem Cell Discovery, Guildford, Surrey, England; [Vysokov, Nickolai] Kings Coll London, Wolfson CARD, London, England	University of London; King's College London	Stevanato, L (corresponding author), ReNeuron, Stem Cell Discovery, Guildford, Surrey, England.	Lara-stevanato@reneuron.com			ReNeuron Ltd; ReNeuron (RENE.L)	ReNeuron Ltd; ReNeuron (RENE.L)	ReNeuron Ltd provided support in the form of salaries for authors (LS, LT and JDS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was supported by ReNeuron (RENE.L). We thank Dr Stefano Pluchino and Dr Tommaso Leonardi, University of Cambridge, for their critical contribution on the NGS data set, Dr Randolph Corteling and Dr Hayley Mulhall for their technical contribution on the NTA and Dr Camille Roesch for kindly contributing to the qNano measurements.	Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chen Tian Sheng, 2013, Methods Mol Biol, V1024, P69, DOI 10.1007/978-1-62703-453-1_6; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Eminaga Seda, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0417s103; Enright AJ, 2004, GENOME BIOL, V5; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Gray WD, 2015, CIRC RES, V116, P255, DOI 10.1161/CIRCRESAHA.116.304360; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hicks C, 2013, CELL TRANSPLANT, V22, P1541, DOI 10.3727/096368912X657936; Hill AF, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22859; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Jin Yi, 2013, Methods Mol Biol, V936, P117; Jones CI, 2012, BRIT J CANCER, V107, P1987, DOI 10.1038/bjc.2012.525; Katare R, 2014, ARTERIOSCL THROM VAS, V34, P408, DOI 10.1161/ATVBAHA.113.302592; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li W, 2014, MOL CELL BIOCHEM, V394, P299, DOI 10.1007/s11010-014-2108-1; Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270; Liao JM, 2012, CELL CYCLE, V11, P2624, DOI 10.4161/cc.20809; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Martinez T, 2014, MOL THER, V22, P81, DOI 10.1038/mt.2013.216; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Stevanato L, 2015, JOVE-J VIS EXP, DOI 10.3791/52410; Stevanato L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt437; Sverdlov ED, 2012, BIOESSAYS, V34, P873, DOI 10.1002/bies.201200045; Tam S, 2014, LAB INVEST, V94, P350, DOI 10.1038/labinvest.2013.157; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Xu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095272; Yang Y, 2015, GYNECOL ONCOL, V138, P683, DOI 10.1016/j.ygyno.2015.06.015; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98	43	79	84	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146353	10.1371/journal.pone.0146353	http://dx.doi.org/10.1371/journal.pone.0146353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752061	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100068
J	van den Heuvel, J; English, S; Uller, T				van den Heuvel, Joost; English, Sinead; Uller, Tobias			Disposable Soma Theory and the Evolution of Maternal Effects on Ageing	PLOS ONE			English	Article							LIFE-HISTORY; OFFSPRING SURVIVAL; OXIDATIVE STRESS; LIVE-BEARING; TRADE-OFF; AGE; GROWTH; DAMAGE; SENESCENCE; NUTRITION	Maternal effects are ubiquitous in nature and affect a wide range of offspring phenotypes. Recent research suggests that maternal effects also contribute to ageing, but the theoretical basis for these observations is poorly understood. Here we develop a simple model to derive expectations for (i) if maternal effects on ageing evolve; (ii) the strength of maternal effects on ageing relative to direct environmental effects; and (iii) the predicted relationships between environmental quality, maternal age and offspring lifespan. Our model is based on the disposable soma theory of ageing, and the key assumption is thus that mothers trade off their own somatic maintenance against investment in offspring. This trade-off affects the biological age of offspring at birth in terms of accumulated damage, as indicated by bio-markers such as oxidative stress or telomere length. We find that the optimal allocation between investment in maternal somatic investment and investment in offspring results in old mothers and mothers with low resource availability producing offspring with reduced life span. Furthermore, the effects are interactive, such that the strongest maternal age effects on offspring lifespan are found under low resource availability. These findings are broadly consistent with results from laboratory studies investigating the onset and rate of ageing and field studies examining maternal effects on ageing in the wild.	[van den Heuvel, Joost] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [van den Heuvel, Joost] Wageningen Univ, Genet Lab, Plant Sci Grp, NL-6708 PB Wageningen, Netherlands; [English, Sinead; Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford, England; [English, Sinead] Univ Cambridge, Dept Zool, Behav Ecol Grp, Cambridge CB2 3EJ, England; [Uller, Tobias] Lund Univ, Dept Biol, Lund, Sweden	Newcastle University - UK; Wageningen University & Research; University of Oxford; University of Cambridge; Lund University	van den Heuvel, J (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.	jvdh.science@gmail.com	English, Sinead/N-6348-2014	English, Sinead/0000-0003-2898-2301	European Union [259679]; Royal Society of London; Knut and Alice Wallenberg Foundation	European Union(European Commission); Royal Society of London(Royal Society of London); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This research was funded by the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreement no 259679 (IDEAL). TU is supported by the Royal Society of London and the Knut and Alice Wallenberg Foundation.	Asghar M, 2015, SCIENCE, V347, P436, DOI 10.1126/science.1261121; Asghar M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2263; Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005; Beamonte-Barrientos R, 2014, AM NAT, V175, P469; Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Bernardo J, 1996, AM ZOOL, V36, P83; Blount JD, 2016, BIOL REV, V91, P483, DOI 10.1111/brv.12179; Boonekamp JJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3287; Bouwhuis S, 2010, J EVOLUTION BIOL, V23, P636, DOI 10.1111/j.1420-9101.2009.01929.x; Bouwhuis S, 2015, EVOLUTION, V69, P1760, DOI 10.1111/evo.12692; Brakefield PM, 2005, MECH AGEING DEV, V126, P431, DOI 10.1016/j.mad.2004.07.013; Burton T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0311; Cadby CD, 2011, J EXP BIOL, V214, P4234, DOI 10.1242/jeb.057349; Noguera JC, 2012, BIOL LETTERS, V8, P61, DOI 10.1098/rsbl.2011.0756; Champagne FA, 2011, HORM BEHAV, V60, P4, DOI 10.1016/j.yhbeh.2011.02.016; Clark CW, 2000, OX ECOL EV; COX DR, 1972, J R STAT SOC B, V34, P187; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; de Rooij SR, 2010, P NATL ACAD SCI USA, V107, P16881, DOI 10.1073/pnas.1009459107; Dowling DK, 2014, J EVOLUTION BIOL, V27, P88, DOI 10.1111/jeb.12276; Ducatez S, 2012, EVOLUTION, V66, P3558, DOI 10.1111/j.1558-5646.2012.01704.x; Entringer S, 2011, PNAS, V108, pES13; Gavrilov LA, 2004, ANN NY ACAD SCI, V1019, P496, DOI 10.1196/annals.1297.091; Geiger S, 2012, MOL ECOL, V21, P1500, DOI 10.1111/j.1365-294X.2011.05331.x; Gillespie DOS, 2013, EVOLUTION, V67, P1964, DOI 10.1111/evo.12078; Gribble KE, 2014, AGING CELL, V13, P623, DOI 10.1111/acel.12217; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Halliwell B., FREE RADICALS BIOL M; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Hayward AD, 2010, PARASITOLOGY, V137, P1261, DOI 10.1017/S0031182010000193; Hayward Adam D., 2013, Evolution Medicine and Public Health, P106, DOI 10.1093/emph/eot007; Hayward LS, 2006, GEN COMP ENDOCR, V146, P144, DOI 10.1016/j.ygcen.2005.10.016; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Houston AI, 1999, MODELS ADAPTIVE BEHA; Isaksson C, 2011, BIOSCIENCE, V61, P194, DOI 10.1525/bio.2011.61.3.5; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Jorgensen C, 2011, AM NAT, V177, pE119, DOI 10.1086/659622; Kindsvater HK, 2010, EVOL ECOL RES, V12, P327; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; LaMontagne JM, 2001, ECOL LETT, V4, P64, DOI 10.1046/j.1461-0248.2001.00197.x; LANSING AI, 1947, J GERONTOL, V2, P228; Lee WS, 2011, AM NAT, V178, P774, DOI 10.1086/662671; Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233; Lindholm AK, 2006, BIOL LETTERS, V2, P586, DOI 10.1098/rsbl.2006.0546; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Love OP, 2008, HORM BEHAV, V54, P496, DOI 10.1016/j.yhbeh.2008.01.006; Maestripieri D., 2010, MATERNAL EFFECTS MAM; Mangel M, 2008, FUNCT ECOL, V22, P422, DOI 10.1111/j.1365-2435.2008.01410.x; Mangel M, 2001, J THEOR BIOL, V213, P559, DOI 10.1006/jtbi.2001.2431; Mangel M., 1988, DYNAMIC MODELING BEH; Mangel M, 2005, AM NATURALIST, V166; McNamara JM, 2005, BEHAV ECOL, V16, P1008, DOI 10.1093/beheco/ari087; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nussey DH, 2007, CURR BIOL, V17, pR1000, DOI 10.1016/j.cub.2007.10.005; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Plaistow SJ, 2006, AM NAT, V167, P206, DOI 10.1086/499380; Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x; Reid JM, 2010, J ANIM ECOL, V79, P851, DOI 10.1111/j.1365-2656.2010.01669.x; Reznick D, 1996, AM ZOOL, V36, P147; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Schroeder J, 2015, P NATL ACAD SCI USA, V112, P4021, DOI 10.1073/pnas.1422715112; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Tarry-Adkins JL, 2014, P NUTR SOC, V73, P289, DOI 10.1017/S002966511300387X; Tissier ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097705; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; Uller T, 2012, EVOLUTION OF PARENTAL CARE, P247; van Abeelen AFM, 2012, AM J CLIN NUTR, V95, P179, DOI 10.3945/ajcn.111.022038; van den Heuvel J, 2013, AM NAT, V181, pE28, DOI 10.1086/668818; Wilkin TA, 2009, CURR BIOL, V19, P1998, DOI 10.1016/j.cub.2009.09.065; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Yearsley JM, 2005, J THEOR BIOL, V235, P305, DOI 10.1016/j.jtbi.2005.01.009	80	19	19	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145544	10.1371/journal.pone.0145544	http://dx.doi.org/10.1371/journal.pone.0145544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752635	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100017
J	van der Torren, CR; Stuart, AAV; Lee, D; Meerding, J; van de Velde, U; Pipeleers, D; Gillard, P; Keymeulen, B; de Jager, W; Roep, BO				van der Torren, Cornelis R.; Stuart, Annemarie A. Verrijn; Lee, DaHae; Meerding, Jenny; van de Velde, Ursule; Pipeleers, Daniel; Gillard, Pieter; Keymeulen, Bart; de Jager, Wilco; Roep, Bart O.			Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes	PLOS ONE			English	Article							KIDNEY INJURY MOLECULE-1; EFFECTOR T-CELLS; INFLAMMATORY CYTOKINES; MULTIPLEX IMMUNOASSAY; PANCREAS; DIFFERENTIATION; PROGRESSION; ALLOGRAFT; RELEVANCE; MELLITUS	Background Islet cell transplantation holds a potential cure for type 1 diabetes, but many islet recipients do not reach long-lasting insulin independence. In this exploratory study, we investigated whether serum cytokines, chemokines and adipokines are associated with the clinical outcome of islet transplantation. Methods Thirteen islet transplant patients were selected on basis of good graft function (reaching insulin independence) or insufficient engraftment (insulin requiring) from our cohort receiving standardized grafts and immune suppressive therapy. Patients reaching insulin independence were divided in those with continued (>12 months) versus transient (<6 months) insulin independence. A panel of 94 proteins including cytokines and adipokines was measured in sera taken before and at one year after transplantation using a validated multiplex immunoassay platform. Results Ninety serum proteins were detectable in concentrations varying markedly among patients at either time point. Thirteen markers changed after transplantation, while another seven markers changed in a clinical subpopulation. All other markers remained unaffected after transplantation under generalized immunosuppression. Patterns of cytokines could distinguish good graft function from insufficient function including IFN-alpha, LIF, SCF and IL-1RII before and after transplantation, by IL-16, CCL3, BDNF and M-CSF only before and by IL-22, IL-33, KIM-1, S100A12 and sCD14 after transplantation. Three other proteins (Leptin, Cathepsin L and S100A12) associated with loss of temporary graft function before or after transplantation. Conclusions Distinct cytokine signatures could be identified in serum that predict or associate with clinical outcome. These serum markers may help guiding patient selection and choice of immunotherapy, or act as novel drug targets in islet transplantation.	[van der Torren, Cornelis R.; Roep, Bart O.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Stuart, Annemarie A. Verrijn; Meerding, Jenny; de Jager, Wilco] Univ Med Ctr Utrecht, Dept Pediat Immunol, Dept Pediat Endocrinol, Wilhelmina Childrens Hosp, NL-3584 CX Utrecht, Netherlands; [Stuart, Annemarie A. Verrijn; Meerding, Jenny; de Jager, Wilco] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Lab Translat Immunol & Multiplex Core Facil, NL-3584 CX Utrecht, Netherlands; [Lee, DaHae; Gillard, Pieter] Katholieke Univ Leuven, Univ Hosp, Dept Endocrinol, B-3000 Leuven, Belgium; [van de Velde, Ursule; Pipeleers, Daniel; Keymeulen, Bart] Vrije Univ Brussel, Diabet Res Ctr, Free Univ, B-1090 Brussels, Belgium; [van de Velde, Ursule; Pipeleers, Daniel; Keymeulen, Bart] Vrije Univ Brussel, Acad Hosp, Free Univ, B-1090 Brussels, Belgium; [van der Torren, Cornelis R.; Lee, DaHae; van de Velde, Ursule; Gillard, Pieter; Keymeulen, Bart; Roep, Bart O.] Juvenile Diabet Res Fdn, Ctr Beta Cell Therapy Diabet, New York, NY 10014 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; KU Leuven; Vrije Universiteit Brussel; Vrije Universiteit Brussel	Roep, BO (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands.	boroep@lumc.nl	Gillard, Pieter/AAA-9820-2020; Roep, Bart/AAD-7609-2021; Gillard, Pieter/GPX-1490-2022; Gillard, Pieter/AAY-1483-2020	Gillard, Pieter/0000-0001-9111-4561; Gillard, Pieter/0000-0001-9111-4561; Keymeulen, Bart/0000-0002-8671-4527; Pipeleers, Daniel/0000-0002-6440-2485; de Jager, Wilco/0000-0002-0014-0682	European Union [241883]; Dutch Diabetes Research Foundation; ReumaFonds [LLP-10] Funding Source: researchfish	European Union(European Commission); Dutch Diabetes Research Foundation; ReumaFonds	This work was financially supported by European Union Framework Programme 7 (BetaCellTherapy, number 241883) and the Dutch Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Citro A, 2012, J CLIN INVEST, V122, P3647, DOI 10.1172/JCI63089; Conway BR, 2012, KIDNEY INT, V82, P812, DOI 10.1038/ki.2012.218; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Dong HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050265; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Fiorina P, 2005, DIABETES CARE, V28, P1358, DOI 10.2337/diacare.28.6.1358; Fiorina P, 2005, DIABETES CARE, V28, P1303, DOI 10.2337/diacare.28.6.1303; Gao W, 2009, CELL CYCLE, V8, P1444, DOI 10.4161/cc.8.9.8348; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hilbrands R, 2009, DIABETES, V58, P2267, DOI 10.2337/db09-0160; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Huurman VAL, 2009, AM J TRANSPLANT, V9, P382, DOI 10.1111/j.1600-6143.2008.02479.x; Huurman VAL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002435; Jin ZK, 2013, MOL IMMUNOL, V54, P457, DOI 10.1016/j.molimm.2013.01.013; Keymeulen B, 2006, P NATL ACAD SCI USA, V103, P17444, DOI 10.1073/pnas.0608141103; Kiely A, 2007, J ENDOCRINOL, V195, P113, DOI 10.1677/JOE-07-0306; Koblas T, 2012, FOLIA BIOL-PRAGUE, V58, P98; Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639; Miller AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047830; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Nanji SA, 2004, BIODRUGS, V18, P315, DOI 10.2165/00063030-200418050-00004; Nielsen SE, 2010, DIABETIC MED, V27, P1144, DOI 10.1111/j.1464-5491.2010.03083.x; Pfleger C, 2011, CLIN IMMUNOL, V138, P154, DOI 10.1016/j.clim.2010.10.008; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Piemonti L, 2013, DIABETES, V62, P1656, DOI 10.2337/db12-1258; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Poggioli R, 2006, AM J TRANSPLANT, V6, P371, DOI 10.1111/j.1600-6143.2005.01174.x; Roelen DL, 2009, CLIN EXP IMMUNOL, V156, P141, DOI 10.1111/j.1365-2249.2008.03812.x; Roep BO, 1996, DIABETES, V45, P1147, DOI 10.2337/diabetes.45.9.1147; Roep BO, 1999, DIABETES, V48, P484, DOI 10.2337/diabetes.48.3.484; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Schipper HS, 2010, CLIN CHEM, V56, P1320, DOI 10.1373/clinchem.2010.146118; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Thompson DM, 2008, TRANSPLANTATION, V85, P1400, DOI 10.1097/TP.0b013e318172ca07; van de Linde Pieter, 2005, Am J Ther, V12, P573, DOI 10.1097/01.mjt.0000178768.44987.cb; Velthuis JH, 2009, DIABETOLOGIA, V52, P494, DOI 10.1007/s00125-008-1237-z; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Warnock GL, 2008, TRANSPLANTATION, V86, P1762, DOI 10.1097/TP.0b013e318190b052; Yang QT, 2011, EUR J IMMUNOL, V41, P3351, DOI 10.1002/eji.201141629	49	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146649	10.1371/journal.pone.0146649	http://dx.doi.org/10.1371/journal.pone.0146649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751709	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100121
J	Figueroa-Lara, A; Gonzalez-Block, MA; Alarcon-Irigoyen, J				Figueroa-Lara, Alejandro; Angel Gonzalez-Block, Miguel; Alarcon-Irigoyen, Jose			Medical Expenditure for Chronic Diseases in Mexico: The Case of Selected Diagnoses Treated by the Largest Care Providers	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; HEALTH-CARE; LATIN-AMERICA; BURDEN; SYSTEM; INTERVENTIONS; POPULATION; INJURIES; REGIONS; COST	Background Chronic diseases (CD) are a public health emergency in Mexico. Despite concern regarding the financial burden of CDs in the country, economic studies have focused only on diabetes, hypertension, and cancer. Furthermore, these estimated financial burdens were based on hypothetical epidemiology models or ideal healthcare scenarios. The present study estimates the annual expenditure per patient and the financial burden for the nine most prevalent CDs, excluding cancer, for each of the two largest public health providers in the country: the Ministry of Health (MoH) and the Mexican Institute of Social Security (IMSS). Methods Using the Mexican National Health and Nutrition Survey 2012 (ENSANUT) as the main source of data, health services consumption related to CDs was obtained from patient reports. Unit costs for each provided health service (e.g. consultation, drugs, hospitalization) were obtained from official reports. Prevalence data was obtained from the published literature. Annual expenditure due to health services consumption was calculated by multiplying the quantity of services consumed by the unit cost of each health service. Results The most expensive CD in both health institutions was chronic kidney disease (CKD), with an annual unit cost for MoH per patient of US$ 8,966 while for IMSS the expenditure was US$ 9,091. Four CDs (CKD, arterial hypertension, type 2 diabetes, and chronic ischemic heart disease) accounted for 88% of the total CDs financial burden (US$ 1.42 billion) in MoH and 85% (US$ 3.96 billion) in IMSS. The financial burden of the nine CDs analyzed represents 8% and 25% of the total annual MoH and IMSS health expenditure, respectively. Conclusions/Significance The financial burden from the nine most prevalent CDs, excluding cancer, is already high in Mexico. This finding by itself argues for the need to improve health promotion and disease detection, diagnosis, and treatment to ensure CD primary and secondary prevention. If the status quo remains, the financial burden could be higher.	[Figueroa-Lara, Alejandro] Mexican Social Secur Inst, Div Technol Management & Innovat, Mexico City, DF, Mexico; [Figueroa-Lara, Alejandro] Escuela Mil Grad Sanidad, Mexico City, DF, Mexico; [Angel Gonzalez-Block, Miguel] Univ Anahuac, Mexico City, DF, Mexico; [Angel Gonzalez-Block, Miguel] PwC, Hlth Policy & Program Design, Mexico City, DF, Mexico; [Alarcon-Irigoyen, Jose] PwC, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; Universidad Anahuac	Gonzalez-Block, MA (corresponding author), Univ Anahuac, Mexico City, DF, Mexico.	miguel.gonzalezblock@gmail.com	Gonzalez-Block, Miguel/N-6526-2019; Figueroa-Lara, Alejandro/AAH-5978-2021	Gonzalez-Block, Miguel Angel/0000-0002-7215-4768	PwC Mexico	PwC Mexico	The authors received no specific funding for this work. PwC Mexico provided support in the form of salaries for AFL, JAI, and MABG but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Afrashtehfar CDM, 2012, REV SANID MILIT MEX, V66, P219; Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; Amato DK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09702.x; [Anonymous], 2014, TRAT SUST FUNC REN D; [Anonymous], 2013, DIABETES ATLAS; Arredondo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068443; Arredondo A, 2012, CAD SAUDE PUBLICA, V28, P497, DOI 10.1590/S0102-311X2012000300010; Atun R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-780; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Burgos-Vargas R, 2014, REUMATOL CLIN, V10, P152, DOI 10.1016/j.reuma.2013.07.013; Campos-Nonato I, 2013, SALUD PUBLICA MEXICO, V55, pS144, DOI 10.21149/spm.v55s2.5110; Carlos F, 2009, SALUD PUBLICA MEXICO, V51, pS108; Consejo Nacional de Evaluation de la Politica de Desarrollo Social, 2014, INDICADORES DE ACCES; Consejo Nacional de Poblacion, IND DEM REP MEX 1990; Cordova-Villalobos JA, 2008, SALUD PUBLICA MEXICO, V50, P419, DOI 10.1590/s0036-36342008000500015; Cortes-Sanabria L, 2013, ARCH MED RES, V44, P655, DOI 10.1016/j.arcmed.2013.10.017; [Credito Publico de Mexico Secretaria de Hacienda], 2013, TAB CUOT REC HOSP GE; [Credito Publico de Mexico Secretaria de Hacienda], 2014, IND NAC PREC CONS 20; Cusumano AM, 2008, CLIN J AM SOC NEPHRO, V3, P594, DOI 10.2215/CJN.03420807; Demaio A., 2013, PLOS CURR, V5, DOI [10.1371/currents.dis.53e08b951d59ff913ab8b9bb51c4d0de, DOI 10.1371/CURRENTS.DIS.53E08B951D59FF913AB8B9BB51C4D0DE]; Diario Oficial de la Federation, 2014, LEY SEG SOC; Duran-Arenas L, 2011, SALUD PUBLICA MEXICO, V53, pS516, DOI 10.1590/S0036-36342011001000016; Escobedo-de la Pena Jorge, 2011, Cir Cir, V79, P424; Garcia-Sancho C, 2012, SALUD PUBLICA MEXICO, V54, P425, DOI 10.1590/S0036-36342012000400013; Garrido-Latorre F, 2008, SALUD PUBLICA MEXICO, V50, pS429, DOI 10.1590/S0036-36342008001000003; Gonzalez-Pier E, 2007, SALUD PUBLICA MEXICO, V49, pS37; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Herrera-Goepfert R, 1999, REV I NACL CANC, V45, P24; Institute for Health Metrics and Evaluation, 2013, GBD COMPARE; Instituto Mexicano del Seguro Social, 2014, PORTAL DE COMPRAS DE; Instituto Mexicano del Seguro Social, 2014, INF EJ FED C UN SIT; Instituto Mexicano del Seguro Social, 2011, GRUPOS RELACIONADOS; Instituto Nacional de Salud Publica, 2012, ENC NAC SAL NUTR 201; International Monetary Fund, 2014, EXCH RAT ARCH MONTH; Sanchez-Barriga JJ, 2013, GAC MED MEX, V149, P576; Jimenez-Corona A, 2013, SALUD PUBLICA MEXICO, V55, pS137, DOI 10.21149/spm.v55s2.5109; Juan-Lopez M, 2013, SALUD PUBLICA MEXICO, V55, P79; Levesque JF, 2013, INT J PUBLIC HEALTH, V58, P435, DOI 10.1007/s00038-013-0446-5; Lopes Antonia, 2012, Graph Transformations. Proceedings 6th International Conference, ICGT 2012, P1, DOI 10.1007/978-3-642-33654-6_1; Lozano R, 2013, SALUD PUBLICA MEXICO, V55, P580; Lozano R, 2011, SALUD PUBLICA MEXICO, V53, pS295; Knaul FM, 2009, SALUD PUBLICA MEXICO, V51, pS335, DOI 10.1590/S0036-36342009000800026; Medina-Mora ME, 2009, ESTUDIO TRASTORNOS M; Mendez-Hernandez P, 2012, SALUD PUBLICA MEXICO, V54, P20, DOI 10.1590/s0036-36342012000100004; Meneses-Garcia Abelardo, 2012, Rev Med Inst Mex Seguro Soc, V50, P19; Ministry of health of Mexico, 2014, NAT HLTH INF SYST NU; Ministry of health of Mexico-General Directorate of Epidemiology, 2011, EP BRIEF; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Neffen H, 2010, J INVEST ALLERG CLIN, V20, P596; Pelaez-Ballestas I, 2011, J RHEUMATOL, V38, P3, DOI 10.3899/jrheum.100951; Ramsey JM, 2014, PLOS NEGLECT TROP D, V8, pe2776, DOI DOI 10.1371/journal.pntd.0002776; Reyes-Morales H, 2013, SALUD PUBLICA MEXICO, V55, pS100, DOI 10.21149/spm.v55s2.5104; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; Rosa-Diez G, 2014, CLIN KIDNEY J, V7, DOI 10.1093/ckj/sfu039; Secretana de Gobernacion de Mexico, 2012, LIN ADQ MED AS CAT U; Secretaria de Salud, 2008, PROGR ACC ESP 2007 2; Secretaria de Salud, 2013, SIST PROT SOC SAL; Secretaria de Salud de Mexico, 2014, CAT MAESTR GUIAS PRA; Secretaria de Salud de Mexico, 2015, BAS DAT EGR HOSP; Secretaria de salud de Mexico, 2011, PROF DIAGN TRAT GAST; Secretaria de Salud de Mexico, 2012, TAB CAT UN SERV SAL; Secretaria de Salud de Mexico, 2005, MAN PROC EL PRES APL; Secretaria de Salud de Mexico, 2013, SIST NAC INF SAL REC; Secretaria Gobernacion de Mexico, 2014, DIAR OF FED MART 29; Secretariade Salud de Mexico, 2013, SIST NAC INF SAL PRI; Sistema Nacional de Informacion en Salud, 2015, B INF EST; Tapia A.M., 2009, REV I NAC ENF RESP, V22, P182; Valenzuela J, 2004, Gastroenterol Hepatol, V27, P325, DOI 10.1157/13060695; Valerio-Urena J, 2010, REV GASTROENTEROL ME, V71, P36; Vazquez-Martinez Jose Luis, 2006, Rev Med Inst Mex Seguro Soc, V44, P13; WHO, 2011, GLOBAL STATUS REPORT; World Economic Forum, 2010, GLOBAL RISK 2010; World Federation for Mental Health, 2012, DEPRESSION AGLOBAL C; World Health Organization, 2015, INTERNATIONAL CLASSI; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	75	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145177	10.1371/journal.pone.0145177	http://dx.doi.org/10.1371/journal.pone.0145177			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA5AX	26744844	gold, Green Published, Green Submitted			2022-12-27	WOS:000367815600004
J	Kohrs, C; Angenstein, N; Brechmann, A				Kohrs, Christin; Angenstein, Nicole; Brechmann, Andre			Delays in Human-Computer Interaction and Their Effects on Brain Activity	PLOS ONE			English	Article							SYSTEM RESPONSE-TIMES; PREDICTION ERRORS; CINGULATE CORTEX; AWARENESS; BEHAVIOR; SETS	The temporal contingency of feedback is an essential requirement of successful human-computer interactions. The timing of feedback not only affects the behavior of a user but is also accompanied by changes in psychophysiology and neural activity. In three fMRI experiments we systematically studied the impact of delayed feedback on brain activity while subjects performed an auditory categorization task. In the first fMRI experiment, we analyzed the effects of rare and thus unexpected delays of different delay duration on brain activity. In the second experiment, we investigated if users can adapt to frequent delays. Therefore, delays were presented as often as immediate feedback. In a third experiment, the influence of interaction outage was analyzed by measuring the effect of infrequent omissions of feedback on brain activity. The results show that unexpected delays in feedback presentation compared to immediate feedback stronger activate inter alia bilateral the anterior insular cortex, the posterior medial frontal cortex, the left inferior parietal lobule and the right inferior frontal junction. The strength of this activation increases with the duration of the delay. Thus, delays interrupt the course of an interaction and trigger an orienting response that in turn activates brain regions of action control. If delays occur frequently, users can adapt, delays become expectable, and the brain activity in the observed network diminishes over the course of the interaction. However, introducing rare omissions of expected feedback reduces the system's trustworthiness which leads to an increase in brain activity not only in response to such omissions but also following frequently occurring and thus expected delays.	[Kohrs, Christin; Angenstein, Nicole; Brechmann, Andre] Leibniz Inst Neurobiol, Special Lab Noninvas Brain Imaging, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN)	Brechmann, A (corresponding author), Leibniz Inst Neurobiol, Special Lab Noninvas Brain Imaging, Magdeburg, Germany.	andre.brechmann@lin-magdeburg.de	Angenstein, Nicole/GXH-1110-2022	Angenstein, Nicole/0000-0002-1677-7063; Brechmann, Andre/0000-0003-3903-0840	Transregional Collaborative Research Centre - German Research Foundation (DFG) [SFB/TRR 62]	Transregional Collaborative Research Centre - German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by Transregional Collaborative Research Centre SFB/TRR 62 "Companion-Technology for Cognitive Technical Systems" funded by the German Research Foundation (DFG) http://www.sfb-trr-62.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Barry RJ, 2013, INT J PSYCHOPHYSIOL, V89, P366, DOI 10.1016/j.ijpsycho.2013.01.016; Baumgart F, 1998, MED PHYS, V25, P2068, DOI 10.1118/1.598368; BENSHAKHAR G, 1994, PSYCHOPHYSIOLOGY, V31, P402, DOI 10.1111/j.1469-8986.1994.tb02448.x; Cieslik EC, 2015, NEUROSCI BIOBEHAV R, V48, P22, DOI 10.1016/j.neubiorev.2014.11.003; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 2011, AUTON NEUROSCI-BASIC, V161, P34, DOI 10.1016/j.autneu.2010.09.005; Dabrowski J, 2011, INTERACT COMPUT, V23, P555, DOI 10.1016/j.intcom.2011.05.008; Daniel R, 2012, NEUROIMAGE, V59, P3457, DOI 10.1016/j.neuroimage.2011.11.058; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Forster SE, 2011, NEUROIMAGE, V55, P253, DOI 10.1016/j.neuroimage.2010.11.035; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hester R, 2005, NEUROIMAGE, V27, P602, DOI 10.1016/j.neuroimage.2005.04.035; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Jakobs O, 2009, NEUROIMAGE, V47, P667, DOI 10.1016/j.neuroimage.2009.04.065; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kohrs C, 2014, PSYCHOPHYSIOLOGY, V51, P1178, DOI 10.1111/psyp.12253; Kohrs C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00243; KUHMANN W, 1987, ERGONOMICS, V30, P933, DOI 10.1080/00140138708969789; Limongi R, 2013, NEUROIMAGE, V71, P147, DOI 10.1016/j.neuroimage.2012.12.078; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; Mars RB, 2007, CEREB CORTEX, V17, P2972, DOI 10.1093/cercor/bhm022; Miller R.B., 1968, AFIPS 68 1, P267, DOI [10.1145/1476589.1476628, DOI 10.1145/1476589.1476628]; Mutschler I, 2009, NEUROSCI LETT, V457, P66, DOI 10.1016/j.neulet.2009.03.101; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Plaisant C, 2005, QUALITY SERVICES DES, P453; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Schaefer F., 1995, Work with Display Units 94. Selected Papers of the Fourth International Scientific Conference on Work with Display Units, P241; Seow S. C., 2008, DESIGNING ENG TIME P; THUM M, 1995, ERGONOMICS, V38, P1342, DOI 10.1080/00140139508925192; Ullsperger M, 2014, PHYSIOL REV, V94, P35, DOI 10.1152/physrev.00041.2012	36	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146250	10.1371/journal.pone.0146250	http://dx.doi.org/10.1371/journal.pone.0146250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA5AX	26745874	Green Published, gold			2022-12-27	WOS:000367815600032
J	Li, Y; Hu, YH; Dong, CC; Lu, HC; Zhang, C; Hu, Q; Li, SF; Qin, H; Li, Z; Wang, YB				Li, Yuan; Hu, Yanhui; Dong, Congcong; Lu, Hongchao; Zhang, Chang; Hu, Qi; Li, Shifeng; Qin, Heng; Li, Zhong; Wang, Yubang			Vimentin-Mediated Steroidogenesis Induced by Phthalate Esters: Involvement of DNA Demethylation and Nuclear Factor kappa B	PLOS ONE			English	Article							N-BUTYL-PHTHALATE; RAINBOWFISH MELANOTAENIA-FLUVIATILIS; ACUTE REGULATORY PROTEIN; STEROID-HORMONES; LEYDIG-CELLS; BREAST-MILK; EXPOSURE; CHOLESTEROL; RAT; PUBERTY	Di-n-butyl phthalate (DBP) and its active metabolite, monobutyl phthalate (MBP) are the most common endocrine disrupting chemicals. Many studies indicate that high-doses of DBP and/or MBP exhibit toxicity on testicular function, however, little attention have been paid to the effects of low levels of DBP/MBP on steroidogenesis. As we all know, the steroidogenic acute regulatory protein (StAR) is a key regulator involved in the steroidogenesis. Here we found that, in addition to StAR, MBP/DBP increased the steroidogenesis by a cytoskeletal protein, vimentin. Briefly, in murine adrenocortical tumor (Y1) and the mouse Leydig tumor (MLTC-1) cells, vimentin regulated the secretion of progesterone. When these two cells were exposure to MBP, the DNA demethylation in the vimentin promoter was observed. In addition, MBP also induced the activation of nuclear factor kappa B (NF-kappa B, a transcriptional regulator of vimentin). These two processes improved the transcriptional elevation of vimentin. Knockdown of NF-kappa B/vimentin signaling blocked the DBP/MBP-induced steroidogenesis. These in vitro results were also confirmed via an in vivo model. By identifying a mechanism whereby DBP/MBP regulates vimentin, our results expand the understanding of the endocrine disrupting potential of phthalate esters.	[Li, Yuan; Hu, Yanhui; Dong, Congcong; Lu, Hongchao; Zhang, Chang; Hu, Qi; Li, Shifeng; Qin, Heng; Li, Zhong; Wang, Yubang] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Medical University	Wang, YB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing 211166, Jiangsu, Peoples R China.	drybwang@hotmail.com			National Natural Science Foundation of China [81373041, 81402667]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (81373041 to Yubang Wang and 81402667 to Yuan Li) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMAHBOBI G, 1993, J REPROD FERTIL, V98, P209; Bao AM, 2011, ASIAN J ANDROL, V13, P702, DOI 10.1038/aja.2011.76; Bhatia H, 2014, AQUAT TOXICOL, V149, P103, DOI 10.1016/j.aquatox.2014.01.025; Bhatia H, 2013, ENVIRON TOXICOL CHEM, V32, P2335, DOI 10.1002/etc.2304; Brown DB, 2013, WORLD J PEDIATR, V9, P103, DOI 10.1007/s12519-013-0411-7; CHEN CT, 1995, DNA CELL BIOL, V14, P803, DOI 10.1089/dna.1995.14.803; Cherradi N, 1997, J BIOL CHEM, V272, P7899, DOI 10.1074/jbc.272.12.7899; Colaco Prisca, 1997, Indian Journal of Pediatrics, V64, P165, DOI 10.1007/BF02752439; Dobrzyiska MM, 2011, BIOMED ENVIRON SCI, V24, P569, DOI 10.3967/0895-3988.2011.05.017; Du J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035957; Enke U, 2013, INT J HYG ENVIR HEAL, V216, P735, DOI 10.1016/j.ijheh.2013.01.006; Fromme H, 2011, ENVIRON INT, V37, P715, DOI 10.1016/j.envint.2011.02.008; Ge RS, 2007, J ANDROL, V28, P513, DOI 10.2164/jandrol.106.001909; Grote K, 2006, TOXICOLOGY, V222, P17, DOI 10.1016/j.tox.2006.01.008; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Jiang F, 2014, TOXICOL LETT, V231, P55, DOI 10.1016/j.toxlet.2014.08.024; Kay VR, 2013, CRIT REV TOXICOL, V43, P200, DOI 10.3109/10408444.2013.766149; Kostka G, 2010, TOXICOL IND HEALTH, V26, P407, DOI 10.1177/0748233710369124; Kraemer FB, 2013, MOL CELL ENDOCRINOL, V371, P15, DOI 10.1016/j.mce.2012.10.012; Kulshreshtha Bindu, 2012, Indian J Endocrinol Metab, V16, P395, DOI 10.4103/2230-8210.95681; Mendoza-Villarroel RE, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.115790; Parent AS, 2005, HORM RES, V64, P41, DOI 10.1159/000087753; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Schimmer BP, 2011, MOL CELL ENDOCRINOL, V336, P85, DOI 10.1016/j.mce.2010.11.024; Sewer MB, 2013, MOL CELL ENDOCRINOL, V371, P79, DOI 10.1016/j.mce.2012.11.014; Sewer M, 2008, LIPIDS, V43, P1109, DOI 10.1007/s11745-008-3221-2; Shen OX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019159; Shen WJ, 2012, ENDOCRINOLOGY, V153, P3249, DOI 10.1210/en.2012-1048; Toppari J, 2010, MOL CELL ENDOCRINOL, V324, P39, DOI 10.1016/j.mce.2010.03.011; Wang YB, 2007, J TOXICOL ENV HEAL A, V70, P947, DOI 10.1080/15287390701290717; Wu J, 2010, ENVIRON TOXICOL, V25, P284, DOI 10.1002/tox.20498; Zachariah RM, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/415825	34	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146138	10.1371/journal.pone.0146138	http://dx.doi.org/10.1371/journal.pone.0146138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745512	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600028
J	Monzani, A; Rapa, A; Prodam, F; Fuiano, N; Diddi, G; Petri, A; Bellone, S; Bona, G				Monzani, Alice; Rapa, Anna; Prodam, Flavia; Fuiano, Nicola; Diddi, Giuliana; Petri, Antonella; Bellone, Simonetta; Bona, Gianni			High Discrepancy in Abdominal Obesity Prevalence According to Different Waist Circumference Cut-Offs and Measurement Methods in Children: Need for Age-Risk-Weighted Standardized Cut-Offs?	PLOS ONE			English	Article							METABOLIC SYNDROME; ADOLESCENTS; PERCENTILES; OVERWEIGHT; FATNESS; HEIGHT; CHOLESTEROL; WORLDWIDE; CURVES; RATIOS	Background Waist circumference (WC) is a good proxy measure of central adiposity. Due to the multiplicity of existing WC cut-offs and different measurement methods, the decision to use one rather than another WC chart may lead to different prevalence estimates of abdominal obesity in the same population. Aim of our study was to assess how much the prevalence of abdominal obesity varies in Italian schoolchildren using the different available WC cut-offs. Methods We measured WC at just above the uppermost lateral border of the right ilium in 1062 Italian schoolchildren aged 7-14 years, 499 living in Northern Italy and 563 in Southern Italy. Abdominal obesity was defined as WC >= 90th percentile for gender and age according to nine WC charts. Results We found an extremely high variability in the prevalence of abdominal obesity detected in our study-populations according to the different WC charts, ranging in the overall group from 9.1% to 61.4%. In Northern Italy children it varied from 2.4% to 35.7%, and in Southern ones from 15.1% to 84.2%. Conclusions On the basis of the chosen WC cut-offs the prevalence of abdominal obesity varies widely, because percentile-charts are strongly influenced by the population status in a particular moment. A further rate of variability may lay on the site of WC measurement and on the statistical method used to calculate WC cut-offs. Risk-weighted WC cut- offs measured in a standardized anatomic site and calculated by the appropriate method are needed to simply identify by WC measurement those children at high risk of cardio-metabolic complications to whom specific and prompt health interventions should be addressed.	[Monzani, Alice; Rapa, Anna; Prodam, Flavia; Petri, Antonella; Bellone, Simonetta; Bona, Gianni] Univ Piemonte Orientale, Div Pediat, Dept Hlth Sci, Novara, Italy; [Fuiano, Nicola; Diddi, Giuliana] ASL FG, Pediat Unit, Prevent & Publ Hlth, Foggia, Italy	University of Eastern Piedmont Amedeo Avogadro	Monzani, A (corresponding author), Univ Piemonte Orientale, Div Pediat, Dept Hlth Sci, Novara, Italy.	alice.monzani@med.unipmn.it	Petri, Antonella/GPF-8056-2022; Rapa, Anna/R-5678-2019; Monzani, Alice/K-2804-2016; Rapa, Anna/B-8878-2013; Bellone, Simonetta/K-2196-2016	Monzani, Alice/0000-0002-6676-5773; Rapa, Anna/0000-0002-5523-5224; Prodam, Flavia/0000-0001-9660-5335; BELLONE, Simonetta/0000-0001-8521-497X	Kiwanis International Foundation	Kiwanis International Foundation	This work was supported by the Kiwanis International Foundation, http://www.kiwanis.it/chisiamo/il-kiwanis-storia-ed-obiettivi/foundation.html, GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ali O, 2014, PEDIATR OBES, V9, pE58, DOI 10.1111/j.2047-6310.2014.218.x; Andersen LB, 2008, INT J PEDIATR OBES, V3, P58, DOI 10.1080/17477160801896366; Azizi F, 2009, ANN NUTR METAB, V54, P189, DOI 10.1159/000217816; Bennasar-Veny M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063999; Bozzola M, 2012, Ig Sanita Pubbl, V68, P473; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Capizzi M, 2011, CIRCULATION, V123, P1757, DOI 10.1161/CIRCULATIONAHA.110.012898; Castillo EH, 2007, J ADOLESCENT HEALTH, V40, P521, DOI 10.1016/j.jadohealth.2006.12.015; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cruz ML, 2004, J CLIN ENDOCR METAB, V89, P108, DOI 10.1210/jc.2003-031188; Daratha KB, 2009, ARCH PEDIAT ADOL MED, V163, P365, DOI 10.1001/archpediatrics.2009.6; de Moraes ACF, 2011, OBES REV, V12, P69, DOI 10.1111/j.1467-789X.2010.00753.x; [dell&rsquo;Universita e della Ricerca Ministero della Salute Ministero dell&rsquo;lstruzione], 2012, PROM SAL CRESC SAN N; Dwyer T, 1996, INT J OBESITY, V20, P472; Eisenmann JC, 2005, ACTA PAEDIATR, V94, P1182, DOI 10.1080/08035250510029352; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Fredriks AM, 2005, EUR J PEDIATR, V164, P216, DOI 10.1007/s00431-004-1586-7; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Goodman E, 2004, J PEDIATR-US, V145, P445, DOI 10.1016/j.jpeds.2004.04.059; Hatipoglu N, 2008, EUR J PEDIATR, V167, P383, DOI 10.1007/s00431-007-0502-3; Higgins PB, 2001, OBES RES, V9, P233, DOI 10.1038/oby.2001.27; Johnson ST, 2010, J PEDIATR-US, V156, P247, DOI 10.1016/j.jpeds.2009.08.010; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Nagy P, 2014, INT J OBESITY, V38, pS15, DOI 10.1038/ijo.2014.131; Ostrowska-Nawarycz L, 2010, OBES REV, V11, P281, DOI 10.1111/j.1467-789X.2009.00694.x; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Pedrozo W, 2008, REV PANAM SALUD PUBL, V24, P149, DOI 10.1590/S1020-49892008000900001; Pinto AM, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.7; Savva SC, 2001, OBES RES, V9, P754, DOI 10.1038/oby.2001.104; Singh R, 2007, DIABETIC MED, V24, P195, DOI 10.1111/j.1464-5491.2007.02066.x; Sung RYT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-324; Valerio G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083793; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; Wang ZQ, 2010, NUTR RES REV, V23, P191, DOI 10.1017/S0954422410000120; WILLIAMS DP, 1992, AM J PUBLIC HEALTH, V82, P358, DOI 10.2105/AJPH.82.3.358; Zannolli R, 1996, ACTA PAEDIATR, V85, P1368, DOI 10.1111/j.1651-2227.1996.tb13928.x; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	43	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146579	10.1371/journal.pone.0146579	http://dx.doi.org/10.1371/journal.pone.0146579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745148	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600065
J	Noveski, P; Madjunkova, S; Stefanovska, ES; Geshkovska, NM; Kuzmanovska, M; Dimovski, A; Plaseska-Karanfilska, D				Noveski, Predrag; Madjunkova, Svetlana; Stefanovska, Emilija Sukarova; Geshkovska, Nadica Matevska; Kuzmanovska, Maja; Dimovski, Aleksandar; Plaseska-Karanfilska, Dijana			Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CLONAL HEMATOPOIESIS; BONE-MARROW; MOSAIC LOSS; SEX TEST; AGE; AMELOGENIN; LEUKEMIA; CELLS; POPULATION	Background Although age-related loss of chromosome Y (LOY) in normal hematopoietic cells is a well-known phenomenon, the phenotypic consequences of LOY have been elusive. However, LOY has been found in association with smoking, shorter survival and higher risk of cancer. It was suggested that LOY in blood cells could become a predictive biomarker of male carcinogenesis. Aims, Methods & Findings To investigate the association of LOY in blood cells with the risk for development of colorectal (CC) and prostate cancers (PC), we have analyzed DNA samples fromperipheral blood of 101 CCmale patients (mean age 60.5 +/- 11.9 yrs), 70 PC patients (mean age 68.8 +/- 8.0 yrs) and 93 healthy control males (mean age 65.8 +/- 16.6 yrs). The methodology included co-amplification of homologous sequences on chromosome Y and other chromosomes using multiplex quantitative fluorescent (QF) PCR followed by automatic detection and analysis on ABI 3500 Genetic Analyzer. The mean Y/X ratio was significantly lower in the whole group of cancer patients (0.907 +/- 0.12; p = 1.17x10(-9)) in comparison to the controls (1.015 +/- 0.15), as well as in CC (0.884 +/- 0.15; p = 3.76x10(-9)) and PC patients (0.941 +/- 0.06; p = 0.00012), when analyzed separately. Multivariate logistic regression analysis adjusting for LOY and age showed that LOY is a more significant predictor of cancer presence than age, and that age probably does not contribute to the increased number of subjects with detectable LOY in cancer patients cohort. Conclusion In conclusion, our results support the recent findings of association of LOY in blood cells with carcinogenesis in males.	[Noveski, Predrag; Madjunkova, Svetlana; Stefanovska, Emilija Sukarova; Kuzmanovska, Maja; Plaseska-Karanfilska, Dijana] Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol Georgi D Efremov, Skopje, Macedonia; [Geshkovska, Nadica Matevska; Dimovski, Aleksandar] Univ Ss Cyril & Methodius, Fac Pharm, Ctr Biomol Pharmaceut Anal, Skopje, Macedonia	Saints Cyril & Methodius University of Skopje	Plaseska-Karanfilska, D (corresponding author), Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol Georgi D Efremov, Skopje, Macedonia.	dijana@manu.edu.mk	Karanfilska, Dijana Plaseska/P-6096-2018; Madjunkova, Svetlana/AAV-2941-2020	Karanfilska, Dijana Plaseska/0000-0001-8877-2416; Madjunkova, Svetlana/0000-0001-8233-6621; Noveski, Predrag/0000-0002-3882-9821; Dimovski, Aleksandar/0000-0002-3059-0246; Matevska-Geshkovska, Nadica/0000-0001-6222-8973	Ministry of Education and Science, Republic of Macedonia [133595/1]	Ministry of Education and Science, Republic of Macedonia	This study was supported by project 133595/1 from Ministry of Education and Science, Republic of Macedonia (to DPK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandran S, 2007, PHARMAZIE, V62, P4, DOI 10.1691/ph.2007.1.5064; Chang YM, 2003, J FORENSIC SCI, V48, P1309; Chang YM, 2007, FORENSIC SCI INT, V166, P115, DOI 10.1016/j.forsciint.2006.04.013; Chapiro E, 2014, GENE CHROMOSOME CANC, V53, P240, DOI 10.1002/gcc.22134; Donaghue C, 2005, PRENATAL DIAG, V25, P65, DOI 10.1002/pd.1086; Dumanski JP, 2015, SCIENCE, V347, P81, DOI 10.1126/science.1262092; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Ganster C, 2015, GENE CHROMOSOME CANC, V54, P717, DOI 10.1002/gcc.22282; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; GRIFFITHS MJ, 1992, GENE CHROMOSOME CANC, V5, P83; GUTTENBACH M, 1995, AM J HUM GENET, V57, P1143; HOLMES RI, 1985, CANCER GENET CYTOGEN, V17, P269, DOI 10.1016/0165-4608(85)90018-4; HUNTER S, 1993, GENE CHROMOSOME CANC, V8, P172, DOI 10.1002/gcc.2870080306; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jacobs PA, 2013, BRIT J CANCER, V108, P959, DOI 10.1038/bjc.2012.577; JACOBS PA, 1963, NATURE, V197, P1080, DOI 10.1038/1971080a0; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; Korkmaz DT, 2015, PATHOL ONCOL RES, V21, P1157, DOI 10.1007/s12253-015-9934-7; Lippert E, 2010, HAEMATOL-HEMATOL J, V95, P1604, DOI 10.3324/haematol.2009.019109; Lleo A, 2013, J AUTOIMMUN, V41, P87, DOI 10.1016/j.jaut.2012.12.008; Minner S, 2010, PATHOLOGY, V42, P356, DOI 10.3109/00313021003767298; Mitchell RJ, 2006, ANN HUM BIOL, V33, P227, DOI 10.1080/03014460600594620; ORIORDAN ML, 1970, BRIT J HAEMATOL, V19, P83, DOI 10.1111/j.1365-2141.1970.tb01603.x; Park SJ, 2006, CANCER GENET CYTOGEN, V166, P56, DOI 10.1016/j.cancergencyto.2005.08.022; Persani L, 2012, J AUTOIMMUN, V38, pJ193, DOI 10.1016/j.jaut.2011.11.011; PIERRE RV, 1972, CANCER, V30, P889, DOI 10.1002/1097-0142(197210)30:4<889::AID-CNCR2820300405>3.0.CO;2-1; Plaseska-Karanfilska D, 2011, HUMAN GENETIC DIS, P203; Plaseski T, 2008, GENET TEST, V12, P595, DOI 10.1089/gte.2008.0068; RISKE CB, 1994, CANCER GENET CYTOGEN, V72, P44, DOI 10.1016/0165-4608(94)90108-2; Rozhok AI, 2015, P NATL ACAD SCI USA, V112, P8914, DOI 10.1073/pnas.1501713112; Veiga LCS, 2012, BRAZ J MED BIOL RES, V45, P172, DOI 10.1590/S0100-879X2012007500004; STONE JF, 1995, MUTAT RES-DNAGING G, V338, P107, DOI 10.1016/0921-8734(95)00016-Y; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Wallrapp C, 2001, INT J CANCER, V91, P340, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1014>3.0.CO;2-U; Wiktor A, 2000, GENE CHROMOSOME CANC, V27, P11, DOI 10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I; Wong AK, 2008, ARCH PATHOL LAB MED, V132, P1329, DOI 10.1043/1543-2165(2008)132[1329:LOTYCA]2.0.CO;2; Zhang LJ, 2007, CHINESE MED J-PEKING, V120, P2002, DOI 10.1097/00029330-200711020-00012	38	55	56	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146264	10.1371/journal.pone.0146264	http://dx.doi.org/10.1371/journal.pone.0146264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745889	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600033
J	Boratynski, F; Dancewicz, K; Paprocka, M; Gabrys, B; Wawrzenczyk, C				Boratynski, Filip; Dancewicz, Katarzyna; Paprocka, Marlena; Gabrys, Beata; Wawrzenczyk, Czeslaw			Chemo-Enzymatic Synthesis of Optically Active gamma- and delta-Decalactones and Their Effect on Aphid Probing, Feeding and Settling Behavior	PLOS ONE			English	Article							P-MENTHANE SYSTEM; MICROBIAL LACTONIZATION; TERPENOID LACTONES; OSMODERMA-EREMITA; FLAVOR COMPOUNDS; SEX-PHEROMONE; ODOR; ESTERS	The enantiomerically enriched gamma- and delta-decalactones (4a and 4b) were prepared from corresponding racemic primary-secondary 1,4-and 1,5-diols (1a and 1b), as products of enzymatic oxidation catalyzed by different alcohol dehydrogenases. The results of biotransformations indicated that the oxidation processes catalyzed by alcohol dehydrogenase (HLADH), both isolated from horse liver and recombinant in Escherichia coli, were characterized by the highest degree of conversion with moderate enantioselectivity of the reaction. Useful, environmentally friendly extraction procedure of decalactones (4a and 4b) based on hydrodistillation using a Deryng apparatus was developed. Both racemic lactones (4a and 4b), as well as their enantiomerically enriched isomers, were tested for feeding deterrent activity against Myzus persicae. The effect of these compounds on probing, feeding and settling behavior of M. persicae was studied in vivo. The deterrent activity of decalactones (4a and 4b) against aphids depended on the size of the lactone ring and the enantiomeric purity of the compounds. delta-Decalactone (4b) appeared inactive against M. persicae while gamma-decalactone (4a) restrained aphid probing at ingestional phase. Only (-)-(S)-gamma-decalactone (4a) had strong and durable (i. e. lasting for at least 24 hours) limiting effect, expressed at phloem level.	[Boratynski, Filip; Wawrzenczyk, Czeslaw] Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland; [Dancewicz, Katarzyna; Paprocka, Marlena; Gabrys, Beata] Univ Zielona Gora, Dept Biol & Ecol, Zielona Gora, Poland	Wroclaw University of Environmental & Life Sciences; University of Zielona Gora	Boratynski, F (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland.	filip.boratynski@up.wroc.pl	Gabrys, Beata/ABB-5330-2021; Boratyński, Filip/B-6247-2017; Wawrzeńczyk, Czesław CW/C-2679-2017	Gabrys, Beata/0000-0001-8255-3570; Boratynski, Filip/0000-0002-3216-9527; Dancewicz, Katarzyna/0000-0001-6341-5914	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	Publication was supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018 (http://know.wroc.pl).	Alvarez AE, 2006, ENTOMOL EXP APPL, V121, P145, DOI 10.1111/j.1570-8703.2006.00464.x; Boratynski F, 2013, FOOD CHEM, V141, P419, DOI 10.1016/j.foodchem.2013.02.106; Boratynski F, 2010, J MOL CATAL B-ENZYM, V65, P30, DOI 10.1016/j.molcatb.2010.01.025; Brenna E, 2011, CHEM REV, V111, P4036, DOI 10.1021/cr100289r; Dams I, 2004, J AGR FOOD CHEM, V52, P1630, DOI 10.1021/jf035272a; DUFOSSE L, 1994, SCI ALIMENT, V14, P17; Gabrys B, 1999, ENTOMOL EXP APPL, V91, P105, DOI 10.1023/A:1003632820782; Grudniewska A, 2013, J AGR FOOD CHEM, V61, P3364, DOI 10.1021/jf3052219; HARDIE J, 1992, ENTOMOL EXP APPL, V62, P233, DOI 10.1007/BF00353442; Harrewijn P., 1990, RESISTANCE MECH PLAN; James DG, 2003, J CHEM ECOL, V29, P2189, DOI 10.1023/A:1026210111334; Kishimoto Noriaki, 2005, Biocontrol Science, V10, P31; Larsson MC, 2003, J CHEM ECOL, V29, P575, DOI 10.1023/A:1022850704500; Lesniak A, 2014, J MOL CATAL B-ENZYM, V106, P32, DOI 10.1016/j.molcatb.2014.04.014; Li G, 1997, J CHEM ECOL, V23, P2737, DOI 10.1023/A:1022511026529; Lopez LC, 1997, J CHEM ECOL, V23, P705, DOI 10.1023/B:JOEC.0000006405.26872.ef; MAGA J A, 1976, Critical Reviews in Food Science and Nutrition, V8, P1, DOI 10.1080/10408397609527216; Mayoral AM, 1996, ENTOMOL EXP APPL, V78, P341, DOI 10.1111/j.1570-7458.1996.tb00799.x; Mazur M, 2014, PEST MANAG SCI, V70, P286, DOI 10.1002/ps.3557; Mori K, 2007, LECT NOTES COMPUT SC, V4526, P1; MOSANDL A, 1989, J AGR FOOD CHEM, V37, P413, DOI 10.1021/jf00086a031; Neerman M. F., 2003, International Journal of Aromatherapy, V13, P114, DOI 10.1016/S0962-4562(03)00078-X; Olejniczak T, 2004, TETRAHEDRON-ASYMMETR, V15, P3743, DOI 10.1016/j.tetasy.2004.10.023; Olejniczak T, 2001, CHIRALITY, V13, P302, DOI 10.1002/chir.1035; Paruch E, 2001, PEST MANAG SCI, V57, P776, DOI 10.1002/ps.353; Paruch E, 2000, J AGR FOOD CHEM, V48, P4973, DOI 10.1021/jf991307o; Pettersson J, 2007, APHIDS AS CROP PESTS, P87, DOI 10.1079/9780851998190.0087; Ratus B, 2009, ENZYME MICROB TECH, V45, P156, DOI 10.1016/j.enzmictec.2009.04.008; Schrader J, 2004, BIOTECHNOL LETT, V26, P463, DOI 10.1023/B:BILE.0000019576.80594.0e; SIEK TJ, 1971, J DAIRY SCI, V54, P1, DOI 10.3168/jds.S0022-0302(71)85770-3; Skaltsa H, 2000, PHYTOCHEMISTRY, V55, P903, DOI 10.1016/S0031-9422(00)00254-5; Svensson GP, 2004, J CHEM ECOL, V30, P353, DOI 10.1023/B:JOEC.0000017982.51642.8c; Szczepanik M, 2014, PEST MANAG SCI, V70, P953, DOI 10.1002/ps.3634; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Verdaguer X, 1997, J ORG CHEM, V62, P8522, DOI 10.1021/jo971560s	35	12	12	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146160	10.1371/journal.pone.0146160	http://dx.doi.org/10.1371/journal.pone.0146160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741824	gold, Green Submitted, Green Published			2022-12-27	WOS:000367810600022
J	Bivigou-Mboumba, B; Francois-Souquiere, S; Deleplancque, L; Sica, J; Mouinga-Ondeme, A; Amougou-Atsama, M; Chaix, ML; Njouom, R; Rouet, F				Bivigou-Mboumba, Berthold; Francois-Souquiere, Sandrine; Deleplancque, Luc; Sica, Jeanne; Mouinga-Ondeme, Augustin; Amougou-Atsama, Marie; Chaix, Marie-Laure; Njouom, Richard; Rouet, Francois			Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; DELTA-VIRUS; GENOTYPE-A; INFECTION; PREVALENCE; ANTIGEN; REACTIVATION; COINFECTION; DIVERSITY	Integrated data on hepatitis B virus (HBV) patterns, HBV genotypes and mutations are lacking in human immunodeficiency virus type 1 (HIV-1) co-infected patients from Africa. This survey was conducted in 2010-2013 among 762 HIV-1-positive adults from Gabon who were predominantly treated with 3TC-based antiretroviral treatment. HBV patterns were identified using immunoassays detecting total antibody to hepatitis B core antigen (HBcAb), hepatitis B surface antigen (HBsAg), IgM HBcAb, hepatitis B e antigen (HBeAg), antibody to HBsAg (HBsAb) and an in-house real-time PCR test for HBV DNA quantification. Occult hepatitis B (OBI) was defined by the presence of isolated anti-HBc with detectable serum HBV DNA. HBV genotypes and HBV mutations were analyzed by PCR-direct sequencing method. Seventy-one (9.3%) patients tested positive for HBsAg, including one with acute hepatitis B (0.1%; 95% CI, 0.0%-0.2%), nine with HBeAg-positive chronic hepatitis B (CHB) (1.2%; 95% CI, 0.6%-2.2%), 16 with HBeAg-negative CHB (2.1%; 95% CI, 1.2%-3.3%) and 45 inactive HBV carriers (5.9%; 95% CI, 4.4%-7.8%). Sixty-one (8.0%; 95% CI, 6.2%-10.1%) patients showed OBI. Treated patients showed similar HBV DNA levels to those obtained in untreated patients, regardless of HBV patterns. Around 15.0% of OBI patients showed high (> 1,000 UI/mL) viremia. The mutation M204V/I conferring resistance to 3TC was more common in HBV/A (47.4%) than in HBV/E isolates (0%) (P =.04). Our findings encouraged clinicians to promote HBV vaccination in patients with no exposure to HBV and to switch 3TC to universal TDF in those with CHB.	[Bivigou-Mboumba, Berthold; Deleplancque, Luc; Mouinga-Ondeme, Augustin; Rouet, Francois] CIRMF, Lab Retrovirol, Franceville, Gabon; [Bivigou-Mboumba, Berthold; Francois-Souquiere, Sandrine] CIRMF, UMR VIH MIA, Libreville, Gabon; [Sica, Jeanne] CTA, Franceville, Gabon; [Amougou-Atsama, Marie; Njouom, Richard] Ctr Pasteur Cameroun, Serv Virol, Yaounde, Cameroon; [Chaix, Marie-Laure] Univ Paris Diderot, Ctr Natl Reference VIH, Hop St Louis, Lab Virol,AP HP,INSERM,U941,Lab Associe, Paris, France	Centre Pasteur du Cameroun; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bivigou-Mboumba, B (corresponding author), CIRMF, Lab Retrovirol, Franceville, Gabon.	bivigou.berthold@yahoo.fr			Gabonese Government; Total Gabon; French Foreign Ministry	Gabonese Government; Total Gabon(Total SA); French Foreign Ministry	The Centre International de Recherches Medicales de Franceville (CIRMF), Gabon, is funded by the Gabonese Government, Total Gabon and the French Foreign Ministry. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amponsah-Dacosta E, 2015, J CLIN VIROL, V63, P12, DOI 10.1016/j.jcv.2014.11.032; Aoudjane S, 2014, CLIN INFECT DIS, V59, P1618, DOI 10.1093/cid/ciu630; Ategbo Simon, 2010, Sante, V20, P215; Attia KA, 2012, WORLD J HEPATOL, V4, P218, DOI 10.4254/wjh.v4.i7.218; Azmi AN, 2014, WORLD J GASTROENTERO, V20, P12045, DOI 10.3748/wjg.v20.i34.12045; Bagaglio S, 2010, INFECTION, V38, P417, DOI 10.1007/s15010-010-0032-1; Bell TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045750; Bian T, 2013, J VIROL, V87, P12196, DOI 10.1128/JVI.02127-13; Chaiklang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080409; Costantini A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-310; Forbi JC, 2013, J CLIN VIROL, V58, P59, DOI 10.1016/j.jcv.2013.06.028; Foupouapouognigni Y, 2011, J CLIN MICROBIOL, V49, P737, DOI 10.1128/JCM.01475-10; Hamers RL, 2013, JAIDS-J ACQ IMM DEF, V64, P174, DOI 10.1097/QAI.0b013e3182a60f7d; Hannoun C, 2005, J GEN VIROL, V86, P2163, DOI 10.1099/vir.0.80972-0; Inuzuka T, 2014, J HEPATOL, V61, P492, DOI 10.1016/j.jhep.2014.04.033; Khamduang W, 2013, CLIN INFECT DIS, V56, P1704, DOI 10.1093/cid/cit166; Kim DY, 2013, GUT LIVER, V7, P329, DOI 10.5009/gnl.2013.7.3.329; Kouanfack C, 2012, ANTIVIR THER, V17, P321, DOI 10.3851/IMP1911; Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796; Launay O, 2011, J VIRAL HEPATITIS, V18, P721, DOI 10.1111/j.1365-2893.2011.01482.x; Lazarevic I, 2014, WORLD J GASTROENTERO, V20, P7653, DOI 10.3748/wjg.v20.i24.7653; Lemoine M, 2015, J HEPATOL, V62, P469, DOI 10.1016/j.jhep.2014.10.008; Liegeois F, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17985; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Makondo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046345; Makuwa M, 2008, J CLIN MICROBIOL, V46, P754, DOI 10.1128/JCM.02142-07; Makuwa M, 2009, J CLIN MICROBIOL, V47, P2265, DOI 10.1128/JCM.02012-08; Menendez-Arias L, 2014, CURR OPIN VIROL, V8, P1, DOI 10.1016/j.coviro.2014.04.005; Mirandola S, 2011, J VIRAL HEPATITIS, V18, pE212, DOI 10.1111/j.1365-2893.2011.01435.x; Ochwoto M, 2013, INFECT GENET EVOL, V20, P103, DOI 10.1016/j.meegid.2013.08.013; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Parvez MK, 2015, WORLD J HEPATOL, V7, P121, DOI 10.4254/wjh.v7.i1.121; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Price H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068152; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist Fredrik, 2006, Science, V312, P367; Rouet F, 2008, CLIN INFECT DIS, V46, P361, DOI 10.1086/525531; Rouet F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116975; Servant-Delmas A, 2012, J CLIN VIROL, V53, P338, DOI 10.1016/j.jcv.2012.01.003; TAKAHASHI K, 1995, J GEN VIROL, V76, P3159, DOI 10.1099/0022-1317-76-12-3159; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WHO, HEP B FACT SHEET 204; Wilkins E, 2013, HIV MED, V14, P1, DOI 10.1111/hiv.12106	44	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0143869	10.1371/journal.pone.0143869	http://dx.doi.org/10.1371/journal.pone.0143869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764909	Green Submitted, gold, Green Published			2022-12-27	WOS:000368459300003
J	Spagnol, ST; Dahl, KN				Spagnol, Stephen T.; Dahl, Kris Noel			Spatially Resolved Quantification of Chromatin Condensation through Differential Local Rheology in Cell Nuclei Fluorescence Lifetime Imaging	PLOS ONE			English	Article							GLYCOL)-INDUCED DNA CONDENSATION; PAIR CORRELATION-ANALYSIS; LIVING CELLS; MOLECULAR-FLOW; ORGANIZATION; DYNAMICS; BINDING; AQUEOUS/METHANOL; ARCHITECTURE; CHROMOSOMES	The linear sequence of DNA encodes access to the complete set of proteins that carry out cellular functions. Yet, much of the functionality appropriate for each cell is nested within layers of dynamic regulation and organization, including a hierarchy of chromatin structural states and spatial arrangement within the nucleus. There remain limitations in our understanding of gene expression within the context of nuclear organization from an inability to characterize hierarchical chromatin organization in situ. Here we demonstrate the use of fluorescence lifetime imaging microscopy (FLIM) to quantify and spatially resolve chromatin condensation state using cell-permeable, DNA-binding dyes (Hoechst 33342 and PicoGreen). Through in vitro and in situ experiments we demonstrate the sensitivity of fluorescence lifetime to condensation state through the mechanical effects that accompany the structural changes and are reflected through altered viscosity. The establishment of FLIM for resolving and quantifying chromatin condensation state opens the door for single-measurement mechanical studies of the nucleus and for characterizing the role of genome structure and organization in nuclear processes that accompany physiological and pathological changes.	[Spagnol, Stephen T.; Dahl, Kris Noel] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; [Dahl, Kris Noel] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Dahl, KN (corresponding author), Carnegie Mellon Univ, Dept Chem Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	krisdahl@cmu.edu		Dahl, Kris/0000-0002-3874-1547	National Science Foundation-Civil, Mechanical and Manufacturing Initiative [1300476];  [NSF-CMMI-1300476]	National Science Foundation-Civil, Mechanical and Manufacturing Initiative; 	This work was supported by National Science Foundation-Civil, Mechanical and Manufacturing Initiative - 1300476.; We gratefully acknowledge use of the multiphoton confocal imaging system from Mohammad Islam and help with use and analysis by Brian Holt (Carnegie Mellon, Materials Science and Engineering). Additional thanks to Lynn Walker for her insight into the polymer characterization and rheology as well as Melissa Dao for help with the rheometry experiments (Carnegie Mellon Chemical Engineering). This work is supported by NSF-CMMI-1300476.	Alberts B, 2008, MOL BIOL CELL; ARNOLD K, 1985, BIOCHIM BIOPHYS ACTA, V815, P515, DOI 10.1016/0005-2736(85)90381-5; Bacskai BJ, 2003, J BIOMED OPT, V8, P368, DOI 10.1117/1.1584442; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Bintu L, 2012, CELL, V151, P738, DOI 10.1016/j.cell.2012.10.009; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; Chalut KJ, 2012, BIOPHYS J, V103, P2060, DOI 10.1016/j.bpj.2012.10.015; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Dahl KN, 2010, J BIOMECH, V43, P2, DOI 10.1016/j.jbiomech.2009.09.002; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Fedorova E, 2008, BBA-MOL CELL RES, V1783, P2174, DOI 10.1016/j.bbamcr.2008.07.018; Fedorova E, 2009, CURR OPIN GENET DEV, V19, P166, DOI 10.1016/j.gde.2009.02.003; Geyer PK, 2011, CURR OPIN CELL BIOL, V23, P354, DOI 10.1016/j.ceb.2011.03.002; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Hihara S, 2012, CELL REP, V2, P1645, DOI 10.1016/j.celrep.2012.11.008; Hinde E, 2011, BIOPHYS J, V100, P1829, DOI 10.1016/j.bpj.2011.02.024; Hinde E, 2010, P NATL ACAD SCI USA, V107, P16560, DOI 10.1073/pnas.1006731107; Hirano K, 2012, NUCLEIC ACIDS RES, V40, P284, DOI 10.1093/nar/gkr712; Hud NV, 2005, ANNU REV BIOPH BIOM, V34, P295, DOI 10.1146/annurev.biophys.34.040204.144500; Iyer KV, 2012, BIOPHYS J, V103, P1416, DOI 10.1016/j.bpj.2012.08.041; Kleideiter G, 1999, POLYMER, V40, P4013, DOI 10.1016/S0032-3861(98)00643-0; Kleideiter G, 1999, POLYMER, V40, P4025, DOI 10.1016/S0032-3861(98)00644-2; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lever E, 2010, J PATHOL, V220, P114, DOI 10.1002/path.2651; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Martin C, 2009, J CELL SCI, V122, P1551, DOI 10.1242/jcs.046284; Martin RM, 2010, FASEB J, V24, P1066, DOI 10.1096/fj.08-128959; Meldi L, 2011, TRENDS CELL BIOL, V21, P701, DOI 10.1016/j.tcb.2011.08.001; Misteli T, 2010, COLD SPRING HARBOR P, V2; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Mora-Bermudez F, 2007, METHODS, V41, P158, DOI 10.1016/j.ymeth.2006.07.035; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Platani M, 2002, MOL BIOL CELL, V13, p376A; Pliss A, 2010, BIOPHYS J, V99, P3483, DOI 10.1016/j.bpj.2010.06.069; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Boer DR, 2009, DALTON T, P399, DOI 10.1039/b809873p; Seidal T, 2001, AM J SURG PATHOL, V25, P1204, DOI 10.1097/00000478-200109000-00013; Spagnol ST, 2014, INTEGR BIOL-UK, V6, P523, DOI 10.1039/c3ib40226f; Streit JK, 2013, ANAL CHEM, V85, P1337, DOI 10.1021/ac303713z; Tseng Y, 2004, J CELL SCI, V117, P2159, DOI 10.1242/jcs.01073; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Woodcock CL, 2010, COLD SPRING HARBOR P, V2; Yaron PN, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-45; Zidovska A, 2013, P NATL ACAD SCI USA, V110, P15555, DOI 10.1073/pnas.1220313110; ZIMMER C, 1986, PROG BIOPHYS MOL BIO, V47, P31, DOI 10.1016/0079-6107(86)90005-2; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	52	29	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146244	10.1371/journal.pone.0146244	http://dx.doi.org/10.1371/journal.pone.0146244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765322	Green Published, gold			2022-12-27	WOS:000368459300017
J	Kim, K; Omori, R; Ueno, K; Iida, S; Ito, K				Kim, Kiyeon; Omori, Ryosuke; Ueno, Keisuke; Iida, Sayaka; Ito, Kimihito			Host-Specific and Segment-Specific Evolutionary Dynamics of Avian and Human Influenza A Viruses: A Systematic Review	PLOS ONE			English	Article							DNA POLYMORPHISM; SWINE	Understanding the evolutionary dynamics of influenza viruses is essential to control both avian and human influenza. Here, we analyze host-specific and segment-specific Tajima's D trends of influenza A virus through a systematic review using viral sequences registered in the National Center for Biotechnology Information. To avoid bias from viral population subdivision, viral sequences were stratified according to their sampling locations and sampling years. As a result, we obtained a total of 580 datasets each of which consists of nucleotide sequences of influenza A viruses isolated from a single population of hosts at a single sampling site within a single year. By analyzing nucleotide sequences in the datasets, we found that Tajima's D values of viral sequences were different depending on hosts and gene segments. Tajima's D values of viruses isolated from chicken and human samples showed negative, suggesting purifying selection or a rapid population growth of the viruses. The negative Tajima's D values in rapidly growing viral population were also observed in computer simulations. Tajima's D values of PB2, PB1, PA, NP, and M genes of the viruses circulating in wild mallards were close to zero, suggesting that these genes have undergone neutral selection in constant-sized population. On the other hand, Tajima's D values of HA and NA genes of these viruses were positive, indicating HA and NA have undergone balancing selection in wild mallards. Taken together, these results indicated the existence of unknown factors that maintain viral subtypes in wild mallards.	[Kim, Kiyeon; Omori, Ryosuke; Iida, Sayaka; Ito, Kimihito] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Omori, Ryosuke] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Ueno, Keisuke] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia	Hokkaido University; Japan Science & Technology Agency (JST); King Abdullah University of Science & Technology	Ito, K (corresponding author), Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.	itok@czc.hokudai.ac.jp	Ito, Kimihito/E-9975-2012	Ito, Kimihito/0000-0003-4986-1795	Ministry of Education, Culture, Sports, Science, and Technology in Japan [25280080]; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25280080] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST (KI) and PRESTO (RO) from Japan Science and Technology Agency (http://www.jst.go.jp/), and by Grants-in-Aid for Scientific Research (B) (KI, 25280080) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Capua I, 2004, AVIAN PATHOL, V33, P393, DOI 10.1080/03079450410001724085; Chen RB, 2010, J MOL EVOL, V70, P98, DOI 10.1007/s00239-009-9312-8; Dugan VG, 2008, EVOL GENET, V4, DOI [10.1371/journal.ppat.1000076, DOI 10.1371/JOURNAL.PPAT.1000076]; Freidl G. S., 2014, EUROSURVEILLANCE, P19; Frost SDW, 2001, P NATL ACAD SCI USA, V98, P6975, DOI 10.1073/pnas.131056998; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Innan H, 2000, LETT EDITOR COALESCE, P3; JUKES T H, 1969, P21; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KIDA H, 1980, INFECT IMMUN, V30, P547; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pybus OG, 2000, GENETICS, V155, P1429; Robinson DA, 2010, BACTERIAL POPULATION; SIMONSEN KL, 1995, GENETICS, V141, P413; Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Thomas JC, 2012, MOL BIOL EVOL, V29, P1175, DOI 10.1093/molbev/msr286; Vincent AL, 2014, METHODS MOL BIOL, V1161, P243, DOI 10.1007/978-1-4939-0758-8_20; Volz EM, 2009, GENETICS, V183, P1421, DOI 10.1534/genetics.109.106021; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 2014, ANN NY ACAD SCI, V1323, P115, DOI 10.1111/nyas.12462; Wu Y, 2014, TRENDS MICROBIOL, V22, P183, DOI 10.1016/j.tim.2014.01.010	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147021	10.1371/journal.pone.0147021	http://dx.doi.org/10.1371/journal.pone.0147021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760775	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100062
J	Lytle, KA; Jump, DB				Lytle, Kelli A.; Jump, Donald B.			Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr(-/-) Mice Reversible?	PLOS ONE			English	Article							FATTY LIVER-DISEASE; HEPATIC GENE-EXPRESSION; TOLL-LIKE RECEPTORS; STELLATE CELLS; MOUSE MODEL; FIBROSIS; INFLAMMATION; RESOLUTION; EPIDEMIOLOGY; FIBROGENESIS	Background Nonalcoholic fatty liver disease (NAFLD) is a major public health burden in western societies. The progressive form of NAFLD, nonalcoholic steatohepatitis (NASH), is characterized by hepatosteatosis, inflammation, oxidative stress, and hepatic damage that can progress to fibrosis and cirrhosis; risk factors for hepatocellular carcinoma. Given the scope of NASH, validating treatment protocols (i.e., low fat diets and weight loss) is imperative. Methods We evaluated the efficacy of two diets, a non-purified chow (NP) and purified (low-fat low-cholesterol, LFLC) diet to reverse western diet (WD)-induced NASH and fibrosis in Ldlr(-/-) mice. Results Mice fed WD for 22-24 weeks developed robust hepatosteatosis with mild fibrosis, while mice maintained on the WD an additional 7-8 weeks developed NASH with moderate fibrosis. Returning WD-fed mice to the NP or LFLC diets significantly reduced body weight and plasma markers of metabolic syndrome (dyslipidemia, hyperglycemia) and hepatic gene expression markers of inflammation (Mcp1), oxidative stress (Nox2), fibrosis (Col1A, LoxL2, Timp1) and collagen crosslinking (hydroxyproline). Time course analyses established that plasma triglycerides and hepatic Col1A1 mRNA were rapidly reduced following the switch from the WD to the LFLC diet. However, hepatic triglyceride content and fibrosis did not return to normal levels 8 weeks after the change to the LFLC diet. Time course studies further revealed a strong association (r(2) >= 0.52) between plasma markers of inflammation (TLR2 activators) and hepatic fibrosis markers (Col1A, Timp1, LoxL2). Inflammation and fibrosis markers were inversely associated (r(2) >= 0.32) with diet-induced changes in hepatic omega 3 and omega 6 polyunsaturated fatty acids (PUFA) content. Conclusion These studies establish a temporal link between plasma markers of inflammation and hepatic PUFA and fibrosis. Low-fat low-cholesterol diets promote reversal of many, but not all, features associated with WD-induced NASH and fibrosis in Ldlr(-/-) mice.	[Lytle, Kelli A.; Jump, Donald B.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA; [Lytle, Kelli A.; Jump, Donald B.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Jump, DB (corresponding author), Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA.	Donald.Jump@oregonstate.edu			NIH [DK094600]; USDA National Institute of Food and Agriculture Grant [2009-65200-05846]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA National Institute of Food and Agriculture Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH DK094600 and USDA National Institute of Food and Agriculture Grant (2009-65200-05846).	Arendt BM, 2015, HEPATOLOGY, V61, P1565, DOI 10.1002/hep.27695; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Cengiz M, 2015, J GASTROEN HEPATOL, V30, P1190, DOI 10.1111/jgh.12924; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Depner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083756; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Depner CM, 2012, J NUTR, V142, P1495, DOI 10.3945/jn.112.158865; Dixon JB, 2004, HEPATOLOGY, V39, P1647, DOI 10.1002/hep.20251; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jump DB, 2011, BIOCHEM PHARMACOL, V81, P649, DOI 10.1016/j.bcp.2010.12.014; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Lassailly G, 2015, GASTROENTEROLOGY, V149, P379, DOI 10.1053/j.gastro.2015.04.014; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu Y, 2012, DIGEST DIS SCI, V57, P390, DOI 10.1007/s10620-011-1902-9; Lytle KA, 2015, J LIPID RES, V56, P1936, DOI 10.1194/jlr.M061275; Magkos F, 2015, PATHOGENESIS HEPATIC, P89; Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013; Marcellin P, 2013, J GASTROEN HEPATOL, V28, P912, DOI 10.1111/jgh.12213; Mattar SG, 2005, ANN SURG, V242, P610, DOI 10.1097/01.sla.0000179652.07502.3f; McCullough AJ, 2011, J DIGEST DIS, V12, P333, DOI 10.1111/j.1751-2980.2010.00469.x; Michelsen KS, 2004, J IMMUNOL, V173, P5901, DOI 10.4049/jimmunol.173.10.5901; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Moylan CA, 2014, HEPATOLOGY, V59, P471, DOI 10.1002/hep.26661; Pagliassotti MJ, 1996, AM J PHYSIOL-REG I, V271, pR1319, DOI 10.1152/ajpregu.1996.271.5.R1319; Park HG, 2015, BIOCH BIOPHYS ACTA M, V186, P91; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Pickens MK, 2009, J LIPID RES, V50, P2072, DOI 10.1194/jlr.M900022-JLR200; Popov Y, 2010, AM J PHYSIOL-GASTR L, V298, pG323, DOI 10.1152/ajpgi.00394.2009; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Ramachandran P, 2012, QJM-INT J MED, V105, P813, DOI 10.1093/qjmed/hcs069; RicardBlum S, 1996, GASTROENTEROLOGY, V111, P172, DOI 10.1053/gast.1996.v111.pm8698196; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Roh YS, 2013, J GASTROEN HEPATOL, V28, P38, DOI 10.1111/jgh.12019; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Suter M, 2006, OBES SURG, V16, P829, DOI 10.1381/096089206777822359; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tripathy S, 2013, J LIPID RES, V54, P71, DOI 10.1194/jlr.M028787; Tripathy S, 2010, J LIPID RES, V51, P2642, DOI 10.1194/jlr.M006080; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Welsh JA, 2012, J PEDIAT, V162, P496, DOI DOI 10.1016/J; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zois CD, 2008, ALIMENT PHARM THER, V28, P1175, DOI 10.1111/j.1365-2036.2008.03840.x	58	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146942	10.1371/journal.pone.0146942	http://dx.doi.org/10.1371/journal.pone.0146942			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761430	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100056
J	Huang, YH; Yang, YC; Lu, FH; Sun, ZJ; Wu, JS; Chang, CJ				Huang, Yao-Hsien; Yang, Yi-Ching; Lu, Feng-Hwa; Sun, Zih-Jie; Wu, Jin-Shang; Chang, Chih-Jen			Serum Bilirubin Is Inversely Associated with Increased Arterial Stiffness in Men with Pre-Hypertension but Not Normotension	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; CARDIOVASCULAR-DISEASE; ESTROGEN; RISK; ATHEROSCLEROSIS; MARKERS; EVENTS; INDEX; YOUNG	Objective Serum bilirubin level has shown to be inversely associated with coronary atherosclerosis, and may serve as a protective biomarker of coronary artery disease. Serum bilirubin has also been shown to be negatively associated with brachial-ankle pulse wave velocity (baPWV) in men without a history of hypertension, and in men with hypertension. It is unknown whether such associations can be observed in the pre-hypertensive or normotensive population. This study thus aimed to investigate the relationship between serum bilirubin level and increased arterial stiffness in subjects with pre-hypertension and normotension for both genders. Methods A cross-sectional sample of 3,399 apparently healthy subjects undergoing a medical check-up at National Cheng Kung University Hospital was enrolled between October 2006 and August 2009, after excluding subjects with serum total bilirubin level greater than 20.52 mu mol/L. Increased arterial stiffness was defined as baPWV of 1,400 cm/s or higher as the dichotomous variable and bilirubin as the continuous variable. Results Based on multiple linear regression analysis, serum bilirubin level was inversely associated with baPWV in non-hypertensive men (beta = -0.066, p < 0.001) but not in non-hypertensive women. In addition, the inverse relationship between bilirubin level and baPWV was found statistically significant only in pre-hypertensive men (beta = -0.110, p < 0.001). Multiple logistic regression analysis showed that serum bilirubin was inversely associated with increased arterial stiffness in men with pre-hypertension (odds ratio = 0.955, 95% confidence interval = 0.916-0.996, p < 0.05) but not normotension after adjustment for other confounding factors. However, the relationship between total bilirubin level and increased arterial stiffness did not reach statistical significance for female subjects with pre-hypertension and normotension. Conclusion Serum bilirubin is inversely associated with increased arterial stiffness in men with prehypertension but not normotension. The association between bilirubin level and arterial stiffness was not found significant in women.	[Huang, Yao-Hsien; Yang, Yi-Ching; Lu, Feng-Hwa; Sun, Zih-Jie; Wu, Jin-Shang; Chang, Chih-Jen] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Yang, Yi-Ching; Lu, Feng-Hwa; Sun, Zih-Jie; Wu, Jin-Shang; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan; [Sun, Zih-Jie] Natl Cheng Kung Univ Hosp, Dou Liou Branch, Dept Family Med, Yunlin, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Wu, JS (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.	jins@mail.ncku.edu.tw; changcj.ncku@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Department of Family Medicine; National Cheng-Kung University Hospital [NCKUHFM-101-001]	Department of Family Medicine; National Cheng-Kung University Hospital	This study was supported by the grants from the Department of Family Medicine, National Cheng-Kung University Hospital (NCKUHFM-101-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chrysohoou C, 2007, ATHEROSCLEROSIS, V192, P169, DOI 10.1016/j.atherosclerosis.2006.04.030; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.011; Guo XF, 2013, CURR HYPERTENS REP, V15, P703, DOI 10.1007/s11906-013-0403-y; Huang Hui-ming, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P950; Huang YL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-177; Kang SJ, 2013, ATHEROSCLEROSIS, V230, P242, DOI 10.1016/j.atherosclerosis.2013.06.021; Kawai T, 2014, HEART VESSELS; Li Y, 2013, NUTR METAB CARDIOVAS, V23, P375, DOI 10.1016/j.numecd.2011.09.004; Luquita MG, 2001, J PHARMACOL EXP THER, V298, P49; Lydrup ML, 2003, ACTA OBSTET GYN SCAN, V82, P610, DOI 10.1034/j.1600-0412.2003.00209.x; Mahabadi AA, 2014, CLIN RES CARDIOL; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Rossi P, 2011, J HYPERTENS, V29, P1023, DOI 10.1097/HJH.0b013e328344da5e; Shin JY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-30; Stojanov M, 2013, CLIN BIOCHEM, V46, P1516, DOI 10.1016/j.clinbiochem.2013.06.020; Takashima N, 2014, J HUM HYPERTENS, V28, P323, DOI 10.1038/jhh.2013.103; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Tsai WC, 2009, HEART VESSELS, V24, P371, DOI 10.1007/s00380-008-1127-9; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; WALDEN CE, 1986, AM J EPIDEMIOL, V123, P517, DOI 10.1093/oxfordjournals.aje.a114267; Wildman RP, 2003, HYPERTENSION, V42, P468, DOI 10.1161/01.HYP.0000090360.78539.CD; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Zhang ZY, 2013, HEART VESSELS, V28, P453, DOI 10.1007/s00380-012-0261-6; Zhang ZY, 2012, CLIN CARDIOL, V35, P301, DOI 10.1002/clc.21964	35	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146226	10.1371/journal.pone.0146226	http://dx.doi.org/10.1371/journal.pone.0146226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757267	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888800010
J	Xi, Y; Cheng, D; Zeng, XQ; Cao, JK; Jiang, WB				Xi, Yu; Cheng, Dai; Zeng, Xiangquan; Cao, Jiankang; Jiang, Weibo			Evidences for Chlorogenic Acid-A Major Endogenous Polyphenol Involved in Regulation of Ripening and Senescence of Apple Fruit	PLOS ONE			English	Article							UDP-GLUCOSE PYROPHOSPHORYLASE; PATHOGENESIS-RELATED PROTEINS; RESPIRATORY METABOLISM; ANTIOXIDANT PROPERTIES; PHENOLIC-COMPOUNDS; GENE-EXPRESSION; TOMATO FRUIT; CULTIVARS; QUALITY; RESPONSES	To learn how the endogenous polyphenols may play a role in fruit ripening and senescence, apple pulp discs were used as a model to study the influences of chlorogenic acid (CHA, a major polyphenol in apple pulp) on fruit ripening and senescence. Apple ('Golden Delicious') pulp discs prepared from pre-climacteric fruit were treated with 50 mg L-1 CHA and incubated in flasks with 10 mM MES buffer (pH 6.0, 11% sorbitol). Compared to the control samples, treatment with CHA significantly reduced ethylene production and respiration rate, and enhanced levels of firmness and soluble solids content of the pulp discs during incubation at 25 degrees C. These results suggested that CHA could retard senescence of the apple pulp discs. Proteomics analysis with sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry (MALDI-TOF/TOF) revealed that the expressions of several key proteins correlated to fruit ripening and senescence were affected by the treatment with CHA. Further study showed that treating the pulp discs with CHA remarkably reduced levels of lipoxygenase, beta-galactosidase, NADP-malic enzyme, and enzymatic activities of lipoxygenase and UDP-glucose pyrophosphorylase, all of which are known as promoters of fruit ripening and senescence. These results could provide new insights into the functions of endogenous phenolic compounds in fruit ripening and senescence.	[Xi, Yu; Cheng, Dai; Zeng, Xiangquan; Cao, Jiankang; Jiang, Weibo] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China	China Agricultural University	Jiang, WB (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, 17 Qinghua Donglu, Beijing 100083, Peoples R China.	jwb@cau.edu.cn			National Basic Research Program (973) of China [2013CB127106]	National Basic Research Program (973) of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program (973) of China (2013CB127106) to WJ (http://www.most.gov.cn/index.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Basic Research Program (973) of China (2013CB127106).	Aaby K, 2012, FOOD CHEM, V132, P86, DOI 10.1016/j.foodchem.2011.10.037; ALI ZM, 1995, PHYTOCHEMISTRY, V38, P1109, DOI 10.1016/0031-9422(94)00804-3; Alique R, 2005, POSTHARVEST BIOL TEC, V35, P153, DOI 10.1016/j.postharvbio.2004.07.003; BIGGS MS, 1986, PLANT PHYSIOL, V81, P395, DOI 10.1104/pp.81.2.395; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Cai C, 2006, POSTHARVEST BIOL TEC, V40, P155, DOI 10.1016/j.postharvbio.2005.12.014; CAMPBELL AD, 1990, PLANT PHYSIOL, V94, P1582, DOI 10.1104/pp.94.4.1582; Campbell OE, 2013, J AGR FOOD CHEM, V61, P12700, DOI 10.1021/jf403644r; Cao JP, 2015, FOOD CHEM, V173, P855, DOI 10.1016/j.foodchem.2014.10.094; Ceymann M, 2012, J FOOD COMPOS ANAL, V26, P128, DOI 10.1016/j.jfca.2011.12.002; Cheng D, 2014, NEUROTOXICOLOGY, V45, P111, DOI 10.1016/j.neuro.2014.10.006; Cheynier V, 2005, AM J CLIN NUTR, V81, p223S, DOI 10.1093/ajcn/81.1.223S; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Cui T, 2005, J AGR FOOD CHEM, V53, P3882, DOI 10.1021/jf047878k; DESIMON BF, 1993, FOOD CHEM, V47, P47, DOI 10.1016/0308-8146(93)90301-U; EDWARDS GE, 1992, PHYTOCHEMISTRY, V31, P1845, DOI 10.1016/0031-9422(92)80322-6; Famiani F, 2000, J EXP BOT, V51, P675, DOI 10.1093/jexbot/51.345.675; Fan XT, 1998, PLANTA, V204, P444, DOI 10.1007/s004250050278; FEYS M, 1980, PHYTOCHEMISTRY, V19, P1009, DOI 10.1016/0031-9422(80)83048-2; Gibeaut DM, 2000, PLANT PHYSIOL BIOCH, V38, P69, DOI 10.1016/S0981-9428(00)00167-4; Gokmen V, 2002, EUR FOOD RES TECHNOL, V215, P42, DOI 10.1007/s00217-002-0518-x; Goulao LF, 2007, POSTHARVEST BIOL TEC, V43, P307, DOI 10.1016/j.postharvbio.2006.10.002; JIANG WB, 1994, PLANT GROWTH REGUL, V14, P133, DOI 10.1007/BF00025214; Katalinic V, 2010, FOOD CHEM, V119, P715, DOI 10.1016/j.foodchem.2009.07.019; KLECZKOWSKI LA, 1994, PHYTOCHEMISTRY, V37, P1507, DOI 10.1016/S0031-9422(00)89568-0; Liu H, 2015, LWT-FOOD SCI TECHNOL, V63, P1042, DOI 10.1016/j.lwt.2015.04.052; Mathooko FM, 1996, POSTHARVEST BIOL TEC, V9, P247, DOI 10.1016/S0925-5214(96)00019-1; PALIYATH G, 1992, PLANT PHYSIOL BIOCH, V30, P789; Scattino C, 2014, FOOD CHEM, V163, P51, DOI 10.1016/j.foodchem.2014.04.077; SONNEWALD U, 1992, PLANT J, V2, P571; SOWOKINOS JR, 1976, PLANT PHYSIOL, V57, P63, DOI 10.1104/pp.57.1.63; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Tian SP, 2002, POSTHARVEST BIOL TEC, V24, P335, DOI 10.1016/S0925-5214(01)00153-3; Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298; VIGERS AJ, 1992, PLANT SCI, V83, P155, DOI 10.1016/0168-9452(92)90074-V; Viswanath V, 2009, FOOD CHEM, V114, P340, DOI 10.1016/j.foodchem.2008.09.053; Wang LF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004568; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wisniewski ME, 2006, TREE PHYSIOL, V26, P575, DOI 10.1093/treephys/26.5.575; Zhang Y, 2007, MICROBIOL-SGM, V153, P3713, DOI 10.1099/mic.0.2007/011403-0; Zhang ZK, 2015, FOOD CHEM, V171, P191, DOI 10.1016/j.foodchem.2014.09.001	43	7	8	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146940	10.1371/journal.pone.0146940	http://dx.doi.org/10.1371/journal.pone.0146940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756813	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800037
J	Banerjee, S; Mitra, S; Shankar, BU; Hayashi, Y				Banerjee, Subhashis; Mitra, Sushmita; Shankar, B. Uma; Hayashi, Yoichi			A Novel GBM Saliency Detection Model Using Multi-Channel MRI	PLOS ONE			English	Article							FRAMEWORK; ATTENTION	The automatic computerized detection of regions of interest (ROI) is an important step in the process of medical image processing and analysis. The reasons are many, and include an increasing amount of available medical imaging data, existence of inter-observer and inter-scanner variability, and to improve the accuracy in automatic detection in order to assist doctors in diagnosing faster and on time. A novel algorithm, based on visual saliency, is developed here for the identification of tumor regions from MR images of the brain. The GBM saliency detection model is designed by taking cue from the concept of visual saliency in natural scenes. A visually salient region is typically rare in an image, and contains highly discriminating information, with attention getting immediately focused upon it. Although color is typically considered as the most important feature in a bottom-up saliency detection model, we circumvent this issue in the inherently gray scale MR framework. We develop a novel pseudo-coloring scheme, based on the three MRI sequences, viz. FLAIR, T2 and T1C (contrast enhanced with Gadolinium). A bottom-up strategy, based on a new pseudo-color distance and spatial distance between image patches, is defined for highlighting the salient regions in the image. This multi-channel representation of the image and saliency detection model help in automatically and quickly isolating the tumor region, for subsequent delineation, as is necessary in medical diagnosis. The effectiveness of the proposed model is evaluated on MRI of 80 subjects from the BRATS database in terms of the saliency map values. Using ground truth of the tumor regions for both high-and low-grade gliomas, the results are compared with four highly referred saliency detection models from literature. In all cases the AUC scores from the ROC analysis are found to be more than 0.999 +/- 0.001 over different tumor grades, sizes and positions.	[Banerjee, Subhashis; Mitra, Sushmita; Shankar, B. Uma] Indian Stat Inst, Machine Intelligence Unit, Kolkata, India; [Hayashi, Yoichi] Meiji Univ, Dept Comp Sci, Kawasaki, Kanagawa, Japan	Indian Statistical Institute; Indian Statistical Institute Kolkata; Meiji University	Banerjee, S (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Kolkata, India.	mail.sb88@gmail.com		Banerjee, Subhashis/0000-0002-2358-2096; Mitra, Sushmita/0000-0001-9285-1117; SHANKAR, B. UMA/0000-0003-0332-2294				Achanta R, 2008, LECT NOTES COMPUT SC, V5008, P66; Bian P, 2009, LECT NOTES COMPUT SC, V5506, P251, DOI 10.1007/978-3-642-02490-0_31; Erdem E, 2013, J VISION, V13, DOI 10.1167/13.4.11; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jain A.K., 1989, FUNDAMENTALS DIGITAL, V3; Jampani V., 2012, P 8 IND C COMP VIS G, P80; Kistler M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2930; Ma Y.-F, 2003, P 11 ACM INT C MULTI, P374; Matsumoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028928; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Mitra S, 2015, INFORM SCIENCES, V306, P111, DOI 10.1016/j.ins.2015.02.015; Nodine C F, 1987, Radiographics, V7, P1241; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Quellec G, 2011, IEEE T MED IMAGING, V30, P523, DOI 10.1109/TMI.2010.2089383; Rosin PL, 2009, PATTERN RECOGN, V42, P2363, DOI 10.1016/j.patcog.2009.04.021; Ujjwal, 2013, I S BIOMED IMAGING, P1436; Ullman S., 1988, P 2 INT C COMP VIS, P321, DOI DOI 10.1109/CCV.1988.590008; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Zhang L, 2013, IEEE IMAGE PROC, P171, DOI 10.1109/ICIP.2013.6738036; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32; Zinn PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041522	24	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146388	10.1371/journal.pone.0146388	http://dx.doi.org/10.1371/journal.pone.0146388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752735	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100074
J	Beauquier-Maccotta, B; Chalouhi, GE; Picquet, AL; Carrier, A; Bussieres, L; Golse, B; Ville, Y				Beauquier-Maccotta, Berengere; Chalouhi, Gihad E.; Picquet, Anne-Laure; Carrier, Aude; Bussieres, Laurence; Golse, Bernard; Ville, Yves			Impact of Monochorionicity and Twin to Twin Transfusion Syndrome on Prenatal Attachment, Post Traumatic Stress Disorder, Anxiety and Depressive Symptoms	PLOS ONE			English	Article							POSTNATAL DEPRESSION; PSYCHOMETRIC PROPERTIES; POSTPARTUM DEPRESSION; FRENCH VERSION; SCALE EPDS; PREGNANCIES; VALIDATION; RISK; WOMEN; PREVALENCE	Monochronioric (MC) twin pregnancies are considered as high-risk pregnancies with potential complications requiring in-utero interventions. We aimed to assess prenatal attachment, anxiety, post-traumatic stress disorder (PTSD) and depressive symptoms in MC pregnancies complicated with Twin-To-Twin-transfusion syndrome (TTTS) in comparison to uncomplicated monochorionic (UMC) and dichorionic pregnancies (DC). Auto-questionnaires were filled out at diagnosis of TTTS and at successive milestones. Prenatal attachment, PTSD, anxiety and perinatal depression were evaluated respectively by the Prenatal Attachment Inventory (PAI) completed for each twin, the Post-traumatic Checklist Scale (PCLS), the State-Trait Anxiety Inventory (STAI) and the Edinburgh Perinatal Depression Scale (EPDS). There was no significant difference in the PAI scores between the two twins. In the DC and UMC groups, PAI scores increased throughout pregnancy, whilst it didn't for TTTS group. TTTS and DC had a similar prenatal attachment while MC mothers expressed a significantly higher attachment to their fetuses and expressed it earlier. At the announcement of TTTS, 72% of the patients present a score over the threshold at the EPDS Scale, with a higher score for TTTS than for DC (p = 0.005), and UMC (p = 0.007) at the same GA. 30% of mothers in TTTS group have PTSD during pregnancy. 50% of TTTS-patients present an anxiety score over the threshold (STAI-Scale), with a score significantly higher in TTTS than in UMC (p < 0.001) or DC (p < 0.001). The proportion of subject with a STAI-State over the threshold is also significantly higher in TTTS than in DC at 20 GW(p = 0.01) and at 26 GW(p < 0.05). The STAI-state scores in UMC and DC increase progressively during pregnancy while they decrease significantly in TTTS. TTTS announcement constitutes a traumatic event during a pregnancy with an important risk of PTSD, high level of anxiety and an alteration of the prenatal attachment. These results should guide the psychological support provided to these patients.	[Beauquier-Maccotta, Berengere; Golse, Bernard] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Child & Adolescent Psychiat,Sorbonne Paris C, Paris, France; [Chalouhi, Gihad E.; Carrier, Aude; Ville, Yves] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Obstet & Fetal Med Dept,Sorbonne Paris Cite, Paris, France; [Chalouhi, Gihad E.; Picquet, Anne-Laure; Carrier, Aude; Bussieres, Laurence; Ville, Yves] Hop Necker Enfants Malad, AP HP, Rare Dis Ctr TTTS, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Beauquier-Maccotta, B (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Child & Adolescent Psychiat,Sorbonne Paris C, Paris, France.	berengere.beauquier@aphp.fr	beauquier-Maccotta, berengere/I-4214-2019	beauquier-Maccotta, berengere/0000-0002-3113-0073				Adouard F, 2005, ARCH WOMEN MENT HLTH, V8, P89, DOI 10.1007/s00737-005-0077-9; Akkermans J, 2014, METAANALYSIS FETAL D; Ammaniti M, 1999, MATERNIT GROSSESSE M; Apter G, 2013, EUR J OBSTET GYN R B, V171, P35, DOI 10.1016/j.ejogrb.2013.08.013; Beauquier-Maccotta B, 2014, DYNAMIQUE PSYCHIQUE; Benute GRG, 2013, TWIN RES HUM GENET, V16, P629, DOI 10.1017/thg.2012.153; Beretta E, 2007, Minerva Ginecol, V59, P571; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brandon AR, 2008, J CLIN PSYCHIAT, V69, P635, DOI 10.4088/JCP.v69n0417; Brouwers EPM, 2001, J PSYCHOSOM RES, V51, P659, DOI 10.1016/S0022-3999(01)00245-8; Bruchon-Schweitzer M, 1990, PAULHAN TRADUCTION F; Cannella BL, 2005, J ADV NURS, V50, P60, DOI 10.1111/j.1365-2648.2004.03349.x; Chalouhi GE, 2013, PRENATAL DIAG, V33, P109, DOI 10.1002/pd.4031; Chalouhi GE, 2011, PRENATAL DIAG, V31, P637, DOI 10.1002/pd.2803; Chalouhi GE, 2010, SEMIN FETAL NEONAT M, V15, P349, DOI 10.1016/j.siny.2010.09.003; Cordero Leandro, 2005, J Perinatol, V25, P753, DOI 10.1038/sj.jp.7211405; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; CRANLEY MS, 1981, NURS RES, V30, P281, DOI 10.1097/00006199-198109000-00008; Damato E G, 2000, J Obstet Gynecol Neonatal Nurs, V29, P598, DOI 10.1111/j.1552-6909.2000.tb02073.x; Damato EG, 2004, JOGNN-J OBST GYN NEO, V33, P436, DOI 10.1177/0884217504266894; Damato Elizabeth G, 2004, Adv Neonatal Care, V4, P274, DOI 10.1016/j.adnc.2004.07.005; ERIKSON M, 1996, ONLINE J KNOWLEDGE S, V3, P56, DOI DOI 10.1111/J.1524-475X.1996.00056.X; Ferreira CR., 2014, ARCH GYNECOL OBSTET; Goecke TW, 2012, ARCH GYNECOL OBSTET, V286, P309, DOI 10.1007/s00404-012-2286-6; Guedeney N, 1998, EUR PSYCHIAT, V13, P83, DOI 10.1016/S0924-9338(98)80023-0; Jardri R, 2004, DEVENIR, V16, P245; Jurgens MA, 2010, ENCEPHALE, V36, P219, DOI 10.1016/j.encep.2009.06.006; Lawson KL, 2006, J PSYCHOSOM RES, V60, P371, DOI 10.1016/j.jpsychores.2006.01.010; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; Missonnier S., 2011, EMC PSYCHIATRIE, V8, P1; Muller M E, 1993, West J Nurs Res, V15, P199, DOI 10.1177/019394599301500205; Narita S, 1993, Nihon Kango Kagakkaishi, V13, P1; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Pierrehumbert B, 2003, ARCH DIS CHILD-FETAL, V88, pF400, DOI 10.1136/fn.88.5.F400; Pinborg A, 2005, HUM REPROD UPDATE, V11, P575, DOI 10.1093/humupd/dmi027; Dolores H, 2006, J ULTRAS MED, V25, P1411, DOI 10.7863/jum.2006.25.11.1411; Robyr R, 2006, AM J OBSTET GYNECOL, V194, P796, DOI 10.1016/j.ajog.2005.08.069; Senat MV, 2004, NEW ENGL J MED, V351, P136, DOI 10.1056/NEJMoa032597; Siddiqui A, 2000, EARLY HUM DEV, V59, P13, DOI 10.1016/S0378-3782(00)00076-1; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Staraci S, 2013, PSYCHIAT ENFANT, V55, P347; Ventureyra VAG, 2002, PSYCHOTHER PSYCHOSOM, V71, P47, DOI 10.1159/000049343; Vilska S, 2009, HUM REPROD, V24, P367, DOI 10.1093/humrep/den427; Yao SN, 2003, ENCEPHALE, V29, P232; Yarcheski A, 2009, INT J NURS STUD, V46, P708, DOI 10.1016/j.ijnurstu.2008.10.013; Yonkers KA, 2014, JAMA PSYCHIAT, V71, P897, DOI 10.1001/jamapsychiatry.2014.558	46	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145649	10.1371/journal.pone.0145649	http://dx.doi.org/10.1371/journal.pone.0145649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751570	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100022
J	Lipner, EM; Garcia, BJ; Strong, M				Lipner, Ettie M.; Garcia, Benjamin J.; Strong, Michael			Network Analysis of Human Genes Influencing Susceptibility to Mycobacterial Infections	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; GENOME-WIDE ASSOCIATION; LUNG-DISEASE; TUBERCULOSIS-SUSCEPTIBILITY; PULMONARY TUBERCULOSIS; RHEUMATOID-ARTHRITIS; NONTUBERCULOUS MYCOBACTERIA; ANTIMICROBIAL ACTIVITY; IL12B POLYMORPHISMS	Tuberculosis and nontuberculous mycobacterial infections constitute a high burden of pulmonary disease in humans, resulting in over 1.5 million deaths per year. Building on the premise that genetic factors influence the instance, progression, and defense of infectious disease, we undertook a systems biology approach to investigate relationships among genetic factors that may play a role in increased susceptibility or control of mycobacterial infections. We combined literature and database mining with network analysis and pathway enrichment analysis to examine genes, pathways, and networks, involved in the human response to Mycobacterium tuberculosis and nontuberculous mycobacterial infections. This approach allowed us to examine functional relationships among reported genes, and to identify novel genes and enriched pathways that may play a role in mycobacterial susceptibility or control. Our findings suggest that the primary pathways and genes influencing mycobacterial infection control involve an interplay between innate and adaptive immune proteins and pathways. Signaling pathways involved in autoimmune disease were significantly enriched as revealed in our networks. Mycobacterial disease susceptibility networks were also examined within the context of gene-chemical relationships, in order to identify putative drugs and nutrients with potential beneficial immunomodulatory or anti-mycobacterial effects.	[Lipner, Ettie M.; Garcia, Benjamin J.; Strong, Michael] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA; [Lipner, Ettie M.; Garcia, Benjamin J.; Strong, Michael] Univ Colorado Denver, Sch Med, Computat Biosci Program, Aurora, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Strong, M (corresponding author), Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA.	StrongM@NJHealth.org		Garcia, Benjamin/0000-0001-5524-6946	Boettcher Foundation Webb Waring Award; NLM Institutional Training Grant, NIH [5T15LM009451]; NATIONAL LIBRARY OF MEDICINE [T15LM009451] Funding Source: NIH RePORTER	Boettcher Foundation Webb Waring Award; NLM Institutional Training Grant, NIH; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	MS acknowledges funding from the Boettcher Foundation Webb Waring Award. EML and BJG acknowledge support from a NLM Institutional Training Grant, NIH 5T15LM009451.	Abe Y, 2001, RESPIRATION, V68, P496, DOI 10.1159/000050557; Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Ali S, 2013, J MED GENET, V50, P34, DOI 10.1136/jmedgenet-2012-101214; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Ates O, 2009, INT J IMMUNOGENET, V36, P15, DOI 10.1111/j.1744-313X.2008.00814.x; Bahmanpour S., 2013, GOOD CLIN PRACT E; Bai XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061925; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6; Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118; Bolhuis MS, 2013, EUR RESPIR J, V42, P1614, DOI 10.1183/09031936.00001913; Bosne-David S, 2000, J ANTIMICROB CHEMOTH, V46, P391, DOI 10.1093/jac/46.3.391; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Cervino ACL, 2002, HUM MOL GENET, V11, P1599, DOI 10.1093/hmg/11.14.1599; Colombo RE, 2010, CHEST, V137, P629, DOI 10.1378/chest.09-1173; Cooke GS, 2008, AM J RESP CRIT CARE, V178, P203, DOI 10.1164/rccm.200710-1554OC; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; De Groote MA, 2014, J ANTIMICROB CHEMOTH, V69, P1057, DOI 10.1093/jac/dkt451; de Wit E, 2011, MAMM GENOME, V22, P100, DOI 10.1007/s00335-010-9280-8; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dooley KE, 2009, AM J TROP MED HYG, V80, P634, DOI 10.4269/ajtmh.2009.80.634; Esposito L, 1998, DIABETES, V47, P1797, DOI 10.2337/diabetes.47.11.1797; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Feola DJ, 2010, ANTIMICROB AGENTS CH, V54, P2437, DOI 10.1128/AAC.01424-09; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Garcia B, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-34; Ghassemi M, 1999, CELL IMMUNOL, V191, P117, DOI 10.1006/cimm.1998.1419; Giri DK, 1998, J IMMUNOL, V161, P4834; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Griffith DE, 2006, AM J RESP CRIT CARE, V174, P928, DOI 10.1164/rccm.200603-450OC; Griffith DE, 2001, CLIN INFECT DIS, V32, P1547, DOI 10.1086/320512; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Hall MA, 2000, GENES IMMUN, V1, P219, DOI 10.1038/sj.gene.6363661; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hoal EG, 2004, INT J TUBERC LUNG D, V8, P1464; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2012, RESPIROLOGY, V17, P802, DOI 10.1111/j.1440-1843.2012.02135.x; Hwang JH, 2007, TUBERCULOSIS, V87, P166, DOI 10.1016/j.tube.2006.07.003; Jeon K, 2013, RESPIROLOGY, V18, P983, DOI 10.1111/resp.12109; Jepson A, 2001, INFECT IMMUN, V69, P3989, DOI 10.1128/IAI.69.6.3989-3994.2001; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Karlsson S, 2008, ANESTH ANALG, V106, P1820, DOI 10.1213/ane.0b013e31816a643f; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kendall BA, 2013, SEMIN RESP CRIT CARE, V34, P87, DOI 10.1055/s-0033-1333567; KENNEDY TP, 1994, AM J RESP CRIT CARE, V149, P1654, DOI 10.1164/ajrccm.149.6.8004325; Kim KS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-363; Koh WJ, 2005, CHEST, V128, P94, DOI 10.1378/chest.128.1.94; Kumar V, 2008, J CHEMOTHERAPY, V20, P609, DOI 10.1179/joc.2008.20.5.609; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Leemans JC, 2005, J INFECT DIS, V191, P65, DOI 10.1086/426395; Li XX, 2002, EXP HEMATOL, V30, P285, DOI 10.1016/S0301-472X(02)00777-4; Liu H, 2012, AM J HUM GENET, V91, P935, DOI 10.1016/j.ajhg.2012.09.010; Lu XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080602; LUNAHERRERA J, 1995, ANTIMICROB AGENTS CH, V39, P2692, DOI 10.1128/AAC.39.12.2692; Ma X, 2003, J INFECT DIS, V188, P1116, DOI 10.1086/378674; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; Manry J, 2011, HUM MUTAT, V32, P633, DOI 10.1002/humu.21484; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Matsuyama W, 2000, AM J RESP CRIT CARE, V162, P1120, DOI 10.1164/ajrccm.162.3.9911010; Mobley JL, 2004, MED HYPOTHESES, V62, P839, DOI 10.1016/j.mehy.2003.12.006; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Moller M, 2009, TUBERCULOSIS, V89, P189, DOI 10.1016/j.tube.2008.10.001; Morahan G, 2007, TISSUE ANTIGENS, V69, P234, DOI 10.1111/j.1399-0039.2006.773_3.x; Murphy BS, 2008, J ANTIMICROB CHEMOTH, V61, P554, DOI 10.1093/jac/dkn007; Nixon MR, 2014, CHEM BIOL, V21, P819, DOI 10.1016/j.chembiol.2014.04.009; ONWUBALILI JK, 1985, CLIN EXP IMMUNOL, V59, P405; Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5; Pan H, 2012, INT J IMMUNOGENET, V39, P233, DOI 10.1111/j.1744-313X.2011.01079.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5; Prammananan T, 2005, INT J TUBERC LUNG D, V9, P216; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Reich-Slotky R, 2009, J BACTERIOL, V191, P5262, DOI 10.1128/JB.00175-09; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Rossouw M, 2003, LANCET, V361, P1871, DOI 10.1016/S0140-6736(03)13491-5; Ryu YJ, 2006, CLIN VACCINE IMMUNOL, V13, P818, DOI 10.1128/CVI.00025-06; Sathupan P, 2007, ANN TROP PAEDIATR, V27, P179, DOI 10.1179/146532807X220280; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Searle S, 1999, J MED GENET, V36, P295; Sha WC, 1998, J EXP MED, V187, P143, DOI 10.1084/jem.187.2.143; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Shaw MA, 1996, J MED GENET, V33, P672, DOI 10.1136/jmg.33.8.672; Shiratsuchi H, 2008, CELL TISSUE RES, V332, P237, DOI 10.1007/s00441-008-0594-8; Simonds B, 1957, Eugen Rev, V49, P25; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006086.pub3; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Srikiatkhachorn A, 2007, J VIROL, V81, P1592, DOI 10.1128/JVI.01642-06; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Thomas Sterling, 2010, Human Genomics, V4, P353; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tseng CS, 2005, FEMS IMMUNOL MED MIC, V43, P99, DOI 10.1016/j.femsim.2004.10.004; Tso HW, 2004, J INFECT DIS, V190, P913, DOI 10.1086/422693; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Um SW, 2009, LUNG, V187, P136, DOI 10.1007/s00408-009-9136-8; Vallinoto ACR, 2010, HUM IMMUNOL, V71, P692, DOI 10.1016/j.humimm.2010.03.008; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; van Halsema C, 2014, EUR RESPIR J, V43, P292, DOI 10.1183/09031936.00128613; Vilcheze C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2898; Wagner D, 2004, INFECTION, V32, P257, DOI 10.1007/s15010-004-4001-4; Watt B, 1996, J ANTIMICROB CHEMOTH, V38, P539, DOI 10.1093/jac/38.3.539; Weiss DJ, 2008, AM J VET RES, V69, P804, DOI 10.2460/ajvr.69.6.804; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; Wheelwright M, 2014, J IMMUNOL, V192, P2280, DOI 10.4049/jimmunol.1301686; WHO, 2014, GLOB TUB REP 2014; Winthrop KL, 2013, NAT REV RHEUMATOL, V9, P524, DOI 10.1038/nrrheum.2013.82; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu G, 1995, Kansenshogaku Zasshi, V69, P864; Yamada H, 2001, INFECT IMMUN, V69, P7100, DOI 10.1128/IAI.69.11.7100-7105.2001; Yang DG, 2014, INFLAMMATION, V37, P1028, DOI 10.1007/s10753-014-9825-1; Yeh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110922; Yesupriya A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-31; Yim JJ, 2008, HUM IMMUNOL, V69, P572, DOI 10.1016/j.humimm.2008.06.003; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zhang H, 2008, BRIT MED BULL, V87, P17, DOI 10.1093/bmb/ldn031; ZHANG M, 1995, INFECT IMMUN, V63, P3231, DOI 10.1128/IAI.63.8.3231-3234.1995; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhu KJ, 2013, RHEUMATOL INT, V33, P1785, DOI 10.1007/s00296-012-2637-4; Zink AR, 2003, EPIDEMIOL INFECT, V130, P239, DOI 10.1017/S0950268802008257	127	9	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146585	10.1371/journal.pone.0146585	http://dx.doi.org/10.1371/journal.pone.0146585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751573	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100106
J	Mosconi, P; Colombo, C; Satolli, R; Carzaniga, S				Mosconi, Paola; Colombo, Cinzia; Satolli, Roberto; Carzaniga, Sara		Steering Comm; Sci Comm	Involving a Citizens' Jury in Decisions on Individual Screening for Prostate Cancer	PLOS ONE			English	Article							SERVICES TASK-FORCE; RECOMMENDATION; MORTALITY; BENEFITS; JURIES; HEALTH; POLICY	Aims Most public health agencies and learned societies agree that the prostate-specific antigen (PSA) test in asymptomatic men should not be recommended, on account of its potential for harm. Yet PSA is still widely used as a screening test and is not being abandoned. This remains a significant public health issue, and citizens' engagement is needed. This study was designed to produce a deliberation on the PSA screening test by a citizens' jury. Methods Fifteen citizens were selected and balanced for sex, age, and education. They received an information booklet and participated in a two-day meeting with experts to reach a deliberation on the question "Should the National Health Service discourage or recommend PSA as an individual screening test for prostate cancer in men 55-69 years old?". A facilitator ran the jurors' discussion. Results All except three of the jurors decided that the National Health Service should discourage the use of PSA as an individual screening test for prostate cancer in 55-69 year-old men. The jury was particularly convinced by the uncertainty of the test outcomes, the utility of the test, and its cost/benefit ratio. Before the meeting 60% of jurors would have recommended the test to a relative, and all the male jurors would have done so. After the meeting these percentages fell to 15% and 12%. Conclusions This experience confirms the feasibility and effectiveness of delegating to a group of citizens the responsibility to decide on public health issues on behalf of the community. Public health authorities should invest in information campaigns aimed at the public and in educational initiatives for physicians. This also provided an opportunity to disseminate information on screening, over-diagnosis, and over-treatment.	[Mosconi, Paola; Colombo, Cinzia] IRCCS Ist Ric Farmacol Mario Negri, Lab Med Res & Consumer Involvement, Milan, Italy; [Satolli, Roberto] Agenzia Editoria Sci Zadig, Milan, Italy; [Carzaniga, Sara] Agenzia Nazl Serv Sanitari Reg Agenas, Rome, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Mosconi, P (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Lab Med Res & Consumer Involvement, Milan, Italy.	paola.mosconi@marionegri.it	Valdagni, Riccardo/K-1361-2016; Paola, Mosconi/K-5596-2016; COLOMBO, CINZIA/ABG-6433-2020; Colombo, Cinzia/K-8981-2016	Valdagni, Riccardo/0000-0001-5140-9728; Paola, Mosconi/0000-0003-0415-3744; COLOMBO, CINZIA/0000-0001-6639-694X; Colombo, Cinzia/0000-0001-6639-694X	Agenzia Nazionale per i Servizi Sanitari Regionali Agenas [CIG 0536828C77, CUP I85J10000400005]; Agenzia di Editoria Scientifica Zadig	Agenzia Nazionale per i Servizi Sanitari Regionali Agenas; Agenzia di Editoria Scientifica Zadig	This work was funded by Agenzia Nazionale per i Servizi Sanitari Regionali Agenas, CIG 0536828C77, CUP I85J10000400005. The funder had no role in study design, data collection and analysis, but participated in all the phases of the project and during the preparation of the manuscript. Agenzia di Editoria Scientifica Zadig provided support in the form of a salary for author RS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abelson J, 2003, SOC SCI MED, V57, P239, DOI 10.1016/S0277-9536(02)00343-X; American Academy of Family Physicians, 15 THINGS PHYS PAT S; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Andriole GL, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4538; Carlsson S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2296; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; D'Ambrosio GG, 2010, EUR J CANCER PREV, V19, P413, DOI 10.1097/CEJ.0b013e32833d944b; Daghio MM, 2007, SALUTE SOC, V10, P158; Djulbegovic M, 2011, BMJ-BRIT MED J, V341, pc4543, DOI DOI 10.1136/BMJ.C4543; Domenighetti G, 2003, INT J EPIDEMIOL, V32, P816, DOI 10.1093/ije/dyg257; Elwood P, 2010, J EPIDEMIOL COMMUN H, V64, P761, DOI 10.1136/jech.2009.087767; Hamoen EHJ, 2013, FAM PRACT, V30, P648, DOI 10.1093/fampra/cmt045; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Heidenreich A, 2013, EUR UROL, V64, P347, DOI 10.1016/j.eururo.2013.06.051; Henderson J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-596; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Katz MH, 2013, JAMA INTERN MED, V173, P847, DOI 10.1001/jamainternmed.2013.1164; Lenaghan J, 1996, BRIT MED J, V312, P1591, DOI 10.1136/bmj.312.7046.1591; Lenzer J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6479; McCarthy M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2982; Merenstein D, 2004, JAMA-J AM MED ASSOC, V291, P15, DOI 10.1001/jama.291.1.15; Mosconi P, 2013, RIV SOC ITALIANA MED, V3, P11; Mosconi P, 2007, HEALTH EXPECT, V10, P194, DOI 10.1111/j.1369-7625.2007.00444.x; Mosconi P, 2015, HEALTH EXPECT, V18, P1956, DOI 10.1111/hex.12261; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Paul C, 2008, HEALTH POLICY, V85, P314, DOI 10.1016/j.healthpol.2007.08.007; Rychetnik L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004682; Rychetnik L, 2013, JNCI-J NATL CANCER I, V105, P380, DOI 10.1093/jnci/djs649; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; The Jefferson Centre, 2004, CIT JUR HDB; Wilt TJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2559	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0143176	10.1371/journal.pone.0143176	http://dx.doi.org/10.1371/journal.pone.0143176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751212	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100006
J	Singh, S; Vedi, S; Samrat, SK; Li, W; Kumar, R; Agrawal, B				Singh, Shakti; Vedi, Satish; Samrat, Subodh Kumar; Li, Wen; Kumar, Rakesh; Agrawal, Babita			Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNOLOGICAL DETERMINANTS; NEUTRALIZING ANTIBODIES; VIRAL PERSISTENCE; DENDRITIC CELLS; GENE-THERAPY; INFECTION; CLEARANCE; PEPTIDE; PROMISCUITY	Adenoviruses (Ad) are commonly used as vectors for gene therapy and/or vaccine delivery. Recombinant Ad vectors are being tested as vaccines for many pathogens. We have made a surprising observation that peptides derived from various hepatitis C virus (HCV) antigens contain extensive regions of homology with multiple adenovirus proteins, and conclusively demonstrate that adenovirus vector can induce robust, heterologous cellular and humoral immune responses against multiple HCV antigens. Intriguingly, the induction of this cross-reactive immunity leads to significant reduction of viral loads in a recombinant vaccinia-HCV virus infected mouse model, supporting their role in antiviral immunity against HCV. Healthy human subjects with Ad-specific pre-existing immunity demonstrated cross-reactive cellular and humoral immune responses against multiple HCV antigens. These findings reveal the potential of a previously uncharacterized property of natural human adenovirus infection to dictate, modulate and/or alter the course of HCV infection upon exposure. This intrinsic property of adenovirus vectors to cross-prime HCV immunity can also be exploited to develop a prophylactic and/or therapeutic vaccine against HCV.	[Singh, Shakti; Vedi, Satish; Samrat, Subodh Kumar; Li, Wen; Agrawal, Babita] Univ Alberta, Dept Surg, Fac Med & Dent, Edmonton, AB, Canada; [Vedi, Satish; Kumar, Rakesh] Univ Alberta, Dept Lab Med & Pathol, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta; University of Alberta	Agrawal, B (corresponding author), Univ Alberta, Dept Surg, Fac Med & Dent, Edmonton, AB, Canada.	bagrawal@ualberta.ca	singh, shakti/D-4070-2014; samrat, subodh/AAN-1043-2021; Samrat, Subodh/AAA-2083-2021	singh, shakti/0000-0001-6521-0998; Samrat, Subodh/0000-0002-8600-3901	Canadian Institutes of Health Research (CIHR) [MOP 79327]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The study was funded by Canadian Institutes of Health Research (CIHR) grant to BA (MOP 79327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Amrani A, 2001, J IMMUNOL, V167, P655, DOI 10.4049/jimmunol.167.2.655; Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; Asefa B, 2010, VACCINE, V28, P3617, DOI 10.1016/j.vaccine.2009.12.047; Casadevall A, 2012, NAT IMMUNOL, V13, P21, DOI 10.1038/ni.2184; Cashman SB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00550; Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Cuendet MA, 2011, PROTEINS, V79, P3007, DOI 10.1002/prot.23104; Daniels KA, 2014, VIROLOGY, V464, P213, DOI 10.1016/j.virol.2014.07.012; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Gruner NH, 2000, J INFECT DIS, V181, P1528, DOI 10.1086/315450; Hao Y, 2006, J EXP MED, V203, P1643, DOI 10.1084/jem.20052174; Heim MH, 2014, J HEPATOL, V61, pS14, DOI 10.1016/j.jhep.2014.06.035; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Hemmer B, 2000, J IMMUNOL, V164, P861, DOI 10.4049/jimmunol.164.2.861; Hendrickx R, 2014, HUM GENE THER, V25, P265, DOI 10.1089/hum.2014.001; Holz L, 2015, ANTIVIR RES, V114, P96, DOI 10.1016/j.antiviral.2014.11.009; Jooss K, 2003, GENE THER, V10, P955, DOI 10.1038/sj.gt.3302037; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Krishnadas DK, 2010, INT IMMUNOL, V22, P491, DOI 10.1093/intimm/dxq033; Krishnadas DK, 2010, VACCINE, V28, P2104, DOI 10.1016/j.vaccine.2009.12.037; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Li W, 2008, INT IMMUNOL, V20, P89, DOI 10.1093/intimm/dxm121; Li W, 2006, J IMMUNOL, V176, P6065, DOI 10.4049/jimmunol.176.10.6065; Majhen D, 2014, HUM GENE THER, V25, P301, DOI 10.1089/hum.2013.235; Marchalonis JJ, 2001, J MOL RECOGNIT, V14, P110, DOI 10.1002/jmr.527; McHutchison JG, 2005, AM J MANAG CARE, V11, pS286; Nakagawa Y, 2007, BIOPHYS J, V92, P2570, DOI 10.1529/biophysj.106.095208; Neumann-Haefelin C, 2008, HEPATOLOGY, V47, P1824, DOI 10.1002/hep.22242; (NIAID) NIoAaID, CLINICALTRIALSGOV; Nie SW, 2010, AM J PATHOL, V176, P2107, DOI 10.2353/ajpath.2010.090656; Nilges K, 2003, J VIROL, V77, P5464, DOI 10.1128/JVI.77.9.5464-5474.2003; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Park SH, 2014, IMMUNITY, V40, P13, DOI 10.1016/j.immuni.2013.12.010; Raghuraman S, 2012, J INFECT DIS, V205, P763, DOI 10.1093/infdis/jir835; Rehermann B, 2005, J EXP MED, V201, P667, DOI 10.1084/jem.20050220; Roomp K, 2011, MOL IMMUNOL, V48, P553, DOI 10.1016/j.molimm.2010.10.014; Roy S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024859; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Samrat SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086567; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; Shen ZT, 2013, J IMMUNOL, V191, P5139, DOI 10.4049/jimmunol.1300852; Singh S, 2014, VACCINE, V32, P2712, DOI 10.1016/j.vaccine.2014.02.080; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Venturi V, 2013, CURR OPIN IMMUNOL, V25, P639, DOI 10.1016/j.coi.2013.07.001; Wahid A, 2013, J VIRAL HEPATITIS, V20, P369, DOI 10.1111/jvh.12094; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	52	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146404	10.1371/journal.pone.0146404	http://dx.doi.org/10.1371/journal.pone.0146404			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751211	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100076
J	Timsuksai, P; Rambo, AT				Timsuksai, Pijika; Rambo, A. Terry			The Influence of Culture on Agroecosystem Structure: A Comparison of the Spatial Patterns of Homegardens of Different Ethnic Groups in Thailand and Vietnam	PLOS ONE			English	Article							TROPICAL HOME-GARDENS; SPECIES COMPOSITION; AGRICULTURE; DIVERSITY	Different ethnic groups have evolved distinctive cultural models which guide their interactions with the environment, including their agroecosystems. Although it is probable that variations in the structures of homegardens among separate ethnic groups reflect differences in the cultural models of the farmers, empirical support for this assumption is limited. In this paper the modal horizontal structural patterns of the homegardens of 8 ethnic groups in Northeast Thailand and Vietnam are described. Six of these groups (5 speaking Tai languages and 1 speaking Vietnamese) live in close proximity to each other in separate villages in Northeast Thailand, and 2 of the groups (one Tai-speaking and one Vietnamese-speaking) live in different parts of Vietnam. Detailed information on the horizontal structure of homegardens was collected from samples of households belonging to each group. Although each ethnic group has a somewhat distinctive modal structure, the groups cluster into 2 different types. The Tai speaking Cao Lan, Kalaeng, Lao, Nyaw, and Yoy make up Type I while both of the Vietnamese groups, along with the Tai speaking Phu Thai, belong to Type II. Type I gardens have predominantly organic shapes, indeterminate boundaries, polycentric planting patterns, and multi-species composition within planting areas. Type II homegardens have geometric shapes, sharp boundaries, lineal planting patterns, and mono-species composition of planting areas. That the homegardens of most of the Tai ethnic groups share a relatively similar horizontal structural pattern that is quite different from the pattern shared by both of the Vietnamese groups suggests that the spatial layout of homegardens is strongly influenced by their different cultural models.	[Timsuksai, Pijika] Sakon Nakhon Rajabhat Univ, Fac Agr Technol, Sakon Nakhon 47000, Thailand; [Timsuksai, Pijika; Rambo, A. Terry] Khon Kaen Univ, Program Syst Approaches Agr, Fac Agr, Khon Kaen 40002, Thailand; [Rambo, A. Terry] East West Ctr, Honolulu, HI 96848 USA	Sakon Nakhon Rajabhat University; Khon Kaen University; East West Center	Rambo, AT (corresponding author), Khon Kaen Univ, Program Syst Approaches Agr, Fac Agr, Khon Kaen 40002, Thailand.	trryrambo@yahoo.com			Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission (HERP-NRU); Thailand Research Fund (TRF) [BRG5680008]	Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission (HERP-NRU); Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This research was supported by a fellowship granted to the first author by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission (HERP-NRU) (URL: http://www.inter.mua.go.th/main2/index.php) which was administered by Sakon Nakhon Rajabhat University. Writing of this paper was partially funded by a grant (BRG5680008) from the Thailand Research Fund (TRF) (URL: http://www.trf.or.th/) Basic Research Program to the corresponding author but the views expressed in it are those of the authors and are not necessarily shared by TRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRRIESS CA, 1994, GEOGR REV, V84, P16, DOI 10.2307/215778; [Anonymous], 1963, AGR INVOLUTION PROCE; Brosius P, 1986, TRADITIONAL AGR SE A; Brummelhuis Ht, 1984, STRATEGIES STRUCTURE, P39; Chandavimol P., 1998, WIEDNAAMNAIMUANGTHAI; Clarkson JD, 1968, 114 DEP GEOGR U CHIC; dan toc hoc Vien, 1978, CAC DAN TOC IT NGUOI; Dang Nghiem Van, 2000, ETHNIC MINORITIES VI; Embree JF, 1950, AM ANTHROPOL, V52, P181, DOI 10.1525/aa.1950.52.2.02a00030; Ethnologue, 2013, LANG WORLD THAIL; FERNANDES ECM, 1986, AGR SYST, V21, P279, DOI 10.1016/0308-521X(86)90104-6; FOSTER G, 1987, RURAL SOCIOL, V52, P365; Grandstaff T. B., 1988, Sustainable rural development in Asia. Proceedings of the SUAN IV regional symposium on agroecosystem research, held at Khon Kaen University, July 4-7, 1988., P11; Haviland William, 2008, CULTURAL ANTHR HUMAN; Huai HY, 2011, ECON BOT, V65, P345, DOI 10.1007/s12231-011-9172-1; Huff LW, 1967, SE ASIAN TRIBES MINO, P425; Jamieson N, 1993, UNDERSTANDING VIETNA; KING FH, 1911, FARMERS 40 CENTURIES; KIRSCH AT, 1966, ASIAN SURV, V6, P370, DOI 10.1525/as.1966.6.7.01p01873; Korale-Gedara P, 2013, SRI LANKAN J AG EC, V14, P17; Kumar BM, 2004, AGROFOREST SYST, V61-2, P135, DOI 10.1023/B:AGFO.0000028995.13227.ca; Lamont SR, 1999, ECON BOT, V53, P312, DOI 10.1007/BF02866644; MACKINTOSH J, 1990, AGR HIST, V64, P59; Nair PKR, 2001, AGROFOREST SYST, V53, P239, DOI 10.1023/A:1013388806993; NINEZ V, 1987, AGR SYST, V23, P167, DOI 10.1016/0308-521X(87)90064-3; Norman D., 1997, KANSAS SUSTAIN AGR S, V1, P1; OConnor RA, 1995, J ASIAN STUD, V54, P968, DOI 10.2307/2059956; Poole PA, 1970, VIETNAMESE THAILAND; Rambo AT, 1973, MONOGRAPH 3 CTR VIET; Rambo AT., 2009, ASIAPACIFIC ISSUES, V88; RICOGRAY V, 1990, ECON BOT, V44, P470, DOI 10.1007/BF02859784; SALAMON S, 1985, RURAL SOCIOL, V50, P323; Schliesinger Joachim, 2001, TAI GROUPS THAILAND, V2; SOEMARWOTO O, 1984, INTRO HUMAN ECOLOGY, P254; Srithi K, 2012, ECON BOT, V66, P192, DOI 10.1007/s12231-012-9199-y; TERRA G. J. A., 1958, NETHERLANDS JOUR AGRIC SCI, V6, P157; Terra GJA, 1954, MALAYAN J TROPICAL G, V3, P33; Terra GJA, 1952, INDONESIE, V6, P439; Terra GJA, 1952, INDONESIE, V6, P297; Thongchai W, 1994, SIAM MAPPED HIST GEO; Timsuksai P, SE ASIAN ST IN PRESS; Wallace AFC, 1952, AM SOCIOL REV, V17, P747, DOI 10.2307/2088054; Wallace Anthony F.C., 1952, SMITHSONIAN I BUREAU, V150; Wallace BJ, 1970, HILL VALLEY FARMERS; WOJTKOWSKI PA, 1993, AGROFOREST SYST, V24, P215, DOI 10.1007/BF00706893	45	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146118	10.1371/journal.pone.0146118	http://dx.doi.org/10.1371/journal.pone.0146118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26752564	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100044
J	Voesenek, CJ; Pieters, RPM; van Leeuwen, JL				Voesenek, Cees J.; Pieters, Remco P. M.; van Leeuwen, Johan L.			Automated Reconstruction of Three-Dimensional Fish Motion, Forces, and Torques	PLOS ONE			English	Article							LARVAL ZEBRAFISH; SWIMMING FISH; SIMPLEX-METHOD; KINEMATICS; DYNAMICS; TRACKING; HYDRODYNAMICS; ONTOGENY; MODEL	Fish can move freely through the water column and make complex three-dimensional motions to explore their environment, escape or feed. Nevertheless, the majority of swimming studies is currently limited to two-dimensional analyses. Accurate experimental quantification of changes in body shape, position and orientation (swimming kinematics) in three dimensions is therefore essential to advance biomechanical research of fish swimming. Here, we present a validated method that automatically tracks a swimming fish in three dimensions from multi-camera high-speed video. We use an optimisation procedure to fit a parameterised, morphology-based fish model to each set of video images. This results in a time sequence of position, orientation and body curvature. We post-process this data to derive additional kinematic parameters (e.g. velocities, accelerations) and propose an inverse-dynamics method to compute the resultant forces and torques during swimming. The presented method for quantifying 3D fish motion paves the way for future analyses of swimming biomechanics.	[Voesenek, Cees J.; Pieters, Remco P. M.; van Leeuwen, Johan L.] Wageningen Univ, Dept Anim Sci, Expt Zool, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Voesenek, CJ (corresponding author), Wageningen Univ, Dept Anim Sci, Expt Zool, NL-6700 AP Wageningen, Netherlands.	cees.voesenek@wur.nl	van Leeuwen, Johan L/B-7897-2011; van Leeuwen, Johan/N-3437-2019	van Leeuwen, Johan/0000-0002-4433-880X; Voesenek, Cees/0000-0002-5467-8963	NWO-ALW grant [824.15.001]	NWO-ALW grant	This work was partly supported by NWO-ALW grant 824.15.001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borazjani I, 2008, J EXP BIOL, V211, P1541, DOI 10.1242/jeb.015644; Butail S, 2012, J R SOC INTERFACE, V9, P77, DOI 10.1098/rsif.2011.0113; CHENG JY, 1994, J THEOR BIOL, V168, P337, DOI 10.1006/jtbi.1994.1114; Dobrovolskis AR, 1996, ICARUS, V124, P698, DOI 10.1006/icar.1996.0243; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Eloy C, 2012, J FLUID STRUCT, V30, P205, DOI 10.1016/j.jfluidstructs.2012.02.008; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; Green MH, 2011, J EXP BIOL, V214, P3111, DOI 10.1242/jeb.057497; HESS F, 1984, J EXP BIOL, V109, P229; Hughes NF, 1996, CAN J FISH AQUAT SCI, V53, P2473, DOI 10.1139/cjfas-53-11-2473; Hunter JR, 1972, FISH B, V70, P1; KASAPI MA, 1993, CAN J ZOOL, V71, P189, DOI 10.1139/z93-026; KOOPMAN B, 1995, J BIOMECH, V28, P1369, DOI 10.1016/0021-9290(94)00185-7; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Li G, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0848; Li G, 2012, J EXP BIOL, V215, P4015, DOI 10.1242/jeb.071837; Liao JC, 2003, J EXP BIOL, V206, P1059, DOI 10.1242/jeb.00209; MacIver MA, 2000, J NEUROSCI METH, V95, P133, DOI 10.1016/S0165-0270(99)00161-2; Muijres FT, 2015, J EXP BIOL, V218, P864, DOI 10.1242/jeb.114280; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; SIMO JC, 1995, INT J NUMER METH ENG, V38, P1431, DOI 10.1002/nme.1620380903; Stickel JJ, 2010, COMPUT CHEM ENG, V34, P467, DOI 10.1016/j.compchemeng.2009.10.007; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; Tytell ED, 2002, J EXP BIOL, V205, P2591; van den Boogaart JGM, 2012, J EXP BIOL, V215, P2359, DOI 10.1242/jeb.065615; van Leeuwen JL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0479; Xiong G, 2014, ZOOLOGY, V117, P269, DOI 10.1016/j.zool.2014.03.002; Zupan E, 2011, ADV ENG SOFTW, V42, P723, DOI 10.1016/j.advengsoft.2011.05.010	30	28	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146682	10.1371/journal.pone.0146682	http://dx.doi.org/10.1371/journal.pone.0146682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752597	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100128
J	Wen, D; He, NP; Zhang, JJ				Wen, Ding; He, Nianpeng; Zhang, Jinjing			Dynamics of Soil Organic Carbon and Aggregate Stability with Grazing Exclusion in the Inner Mongolian Grasslands	PLOS ONE			English	Article							MANAGEMENT-INDUCED CHANGES; LAND-USE CHANGE; MATTER FRACTIONS; SEMIARID STEPPE; EARLY INDICATORS; NITROGEN; STORAGE; SEQUESTRATION; STABILIZATION; SATURATION	Grazing exclusion (GE) has been deemed as an important approach to enhance the soil carbon storage of semiarid grasslands in China; however, it remains unclear how different organic carbon (OC) components in soils vary with the duration of GE. Here, we observed the changing trends of different OC components in soils with increased GE duration in five grassland succession series plots, ranging from free grazing to 31-year GE. Specifically, we measured microbial biomass carbon (MBC), easily oxidizable OC (EOC), water-soluble OC (WSOC), and OC in water stable aggregates (macroaggregates [250-2000 mu m], microaggregates [53-250 mu m], and mineral fraction [< 53 mu m]) at 0-20 cm soil depths. The results showed that GE significantly enhanced EOC and WSOC contents in soils, but caused a decline of MBC at the three decade scale. Macroaggregate content (F = 425.8, P < 0.001), OC stored in macroaggregates (F = 84.1, P < 0.001), and the mean weight diameter (MWD) of soil aggregates (F = 371.3, P < 0.001) increased linearly with increasing GE duration. These findings indicate that OC stored in soil increases under three-decade GE with soil organic matter (SOM) stability improving to some extent. Long-term GE practices enhance the formation of soil aggregates through higher SOM input and an exclusion of animal trampling. Therefore, the practice of GE may be further encouraged to realize the soil carbon sequestration potential of semi-arid grasslands, China.	[Wen, Ding; He, Nianpeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China; [Wen, Ding] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Jinjing] Jilin Agr Univ, Coll Resource & Environm Sci, Changchun 130118, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jilin Agricultural University	He, NP (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China.	henp@igsnrr.ac.cn; zhangjinjing@126.com		he, nianpeng/0000-0002-0458-5953	Natural Science Foundation of China [31270519, 31470506]; Program for "Kezhen" Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences [2013RC102]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for "Kezhen" Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences	Funding (No. 31270519, 31470506) came from the Natural Science Foundation of China by N. H. (http://www.nsfc.gov.cn/); Funding (No. 2013RC102) came from the Program for "Kezhen" Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences by N. H. (http://www.igsnrr.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Denef K, 2007, SOIL BIOL BIOCHEM, V39, P1165, DOI 10.1016/j.soilbio.2006.12.024; Embacher A, 2007, GEODERMA, V139, P11, DOI 10.1016/j.geoderma.2006.12.002; GALLAHER RN, 1976, SOIL SCI SOC AM J, V40, P887, DOI 10.2136/sssaj1976.03615995004000060026x; Gardenas AI, 2011, SOIL BIOL BIOCHEM, V43, P702, DOI 10.1016/j.soilbio.2010.04.006; Gulde S, 2008, SOIL SCI SOC AM J, V72, P605, DOI 10.2136/sssaj2007.0251; Guodong HD, 2008, AGR ECOSYST ENVIRON, V125, P21, DOI 10.1016/j.agee.2007.11.009; He NP, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00017.1; He NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077241; He NP, 2012, J GEOGR SCI, V22, P859, DOI 10.1007/s11442-012-0968-4; He NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026506; He NP, 2009, GEODERMA, V150, P302, DOI 10.1016/j.geoderma.2009.02.004; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; He NP, 2013, ECOLOGY EVOLUTION, V3, DOI [10.1002/ece1003.1881, DOI 10.1002/ECE1003.1881]; He Y, 2008, GEODERMA, V147, P116, DOI 10.1016/j.geoderma.2008.08.002; IUSS Working Group WRB, 2006, WORLD REF BAS SOIL R, V103; Jiang PK, 2006, PEDOSPHERE, V16, P505, DOI 10.1016/S1002-0160(06)60081-7; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; Kong AYY, 2005, SOIL SCI SOC AM J, V69, P1078, DOI 10.2136/sssaj2004.0215; Leifeld J, 2005, GEODERMA, V124, P143, DOI 10.1016/j.geoderma.2004.04.009; Li XG, 2007, SOIL TILL RES, V95, P172, DOI 10.1016/j.still.2006.12.005; Lichter K, 2008, PLANT SOIL, V305, P237, DOI 10.1007/s11104-008-9557-9; Linsler D, 2013, SOIL TILL RES, V126, P90, DOI 10.1016/j.still.2012.07.017; Lisboa CC, 2009, ECOSYSTEMS, V12, P1212, DOI 10.1007/s10021-009-9288-7; Nelson DW, 1982, METHODS SOIL ANAL, P1; Phosphorus Kuo S, 1996, SOIL SCI SOC AM AM S, P869; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Sequeira CH, 2011, SOIL SCI SOC AM J, V75, P1766, DOI 10.2136/sssaj2011.0067; Six J, 2002, SOIL SCI SOC AM J, V66, P1981, DOI 10.2136/sssaj2002.1981; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Sollins P, 1996, GEODERMA, V74, P65, DOI 10.1016/S0016-7061(96)00036-5; Steffens M, 2009, EUR J SOIL SCI, V60, P198, DOI 10.1111/j.1365-2389.2008.01104.x; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Su YZ, 2009, ENVIRON MANAGE, V43, P1061, DOI 10.1007/s00267-009-9284-x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Verchot LV, 2011, GEODERMA, V161, P182, DOI 10.1016/j.geoderma.2010.12.017; Wang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128837; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117033; Wang SP, 2011, AGR ECOSYST ENVIRON, V142, P329, DOI 10.1016/j.agee.2011.06.002; Wei XR, 2013, SOIL BIOL BIOCHEM, V57, P876, DOI 10.1016/j.soilbio.2012.10.020; West TO, 2007, CLIMATIC CHANGE, V80, P25, DOI [10.1007/s10584-006-9173-8, 10.1007/s105S4-006-9173-8]; Wiesmeier M, 2012, EUR J SOIL SCI, V63, P22, DOI 10.1111/j.1365-2389.2011.01418.x; Wu HH, 2012, BIOL FERT SOILS, V48, P305, DOI 10.1007/s00374-011-0627-4; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196; Zhang SR, 2012, ECOL ENG, V40, P27, DOI 10.1016/j.ecoleng.2011.12.001; Zhou ZY, 2007, BIOGEOCHEMISTRY, V82, P127, DOI 10.1007/s10533-006-9058-y	48	21	25	12	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146757	10.1371/journal.pone.0146757	http://dx.doi.org/10.1371/journal.pone.0146757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751370	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100147
J	Zhan, QQ; Chen, XJ				Zhan, Qiqin; Chen, Xiaojun			Boolean Combinations of Implicit Functions for Model Clipping in Computer-Assisted Surgical Planning	PLOS ONE			English	Article							MESH SEGMENTATION	This paper proposes an interactive method of model clipping for computer-assisted surgical planning. The model is separated by a data filter that is defined by the implicit function of the clipping path. Being interactive to surgeons, the clipping path that is composed of the plane widgets can be manually repositioned along the desirable presurgical path, which means that surgeons can produce any accurate shape of the clipped model. The implicit function is acquired through a recursive algorithm based on the Boolean combinations (including Boolean union and Boolean intersection) of a series of plane widgets' implicit functions. The algorithm is evaluated as highly efficient because the best time performance of the algorithm is linear, which applies to most of the cases in the computer-assisted surgical planning. Based on the above stated algorithm, a user-friendly module named SmartModelClip is developed on the basis of Slicer platform and VTK. A number of arbitrary clipping paths have been tested. Experimental results of presurgical planning for three types of Le Fort fractures and for tumor removal demonstrate the high reliability and efficiency of our recursive algorithm and robustness of the module.	[Zhan, Qiqin; Chen, Xiaojun] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Chen, XJ (corresponding author), Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200030, Peoples R China.	xiaojunchen@sjtu.edu.cn		Chen, Xiaojun/0000-0002-0298-4491	Natural Science Foundation of China [81171429, 81511130089]; Foundation of Science and Technology Commission of Shanghai Municipality [14441901002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by Natural Science Foundation of China (http://www.nsfc.gov.cn/, 81171429, 81511130089) and Foundation of Science and Technology Commission of Shanghai Municipality (http://www.stcsm.gov.cn/, 14441901002).	Agoston Max K, 2005, COMPUTER GRAPHICS GE, P69; Alexa O., 2013, E HLTH BIOENG C EHB, P1; Attene M, 2006, VISUAL COMPUT, V22, P181, DOI 10.1007/s00371-006-0375-x; David K, 2008, Orthopaedic Surgery Planning, Patent No. [US 7388972 B2, 7388972]; Fan XQ, 2007, J CRANIOFAC SURG, V18, P665, DOI 10.1097/scs.0b013e31803ffaaa; Fang LP, 2013, 2013 INTERNATIONAL CONFERENCE ON COMPUTER SCIENCES AND APPLICATIONS (CSA), P469, DOI 10.1109/CSA.2013.115; Hoffman DD, 1997, COGNITION, V63, P29, DOI 10.1016/S0010-0277(96)00791-3; Hong J, 2009, IEEE T BIO-MED ENG, V56, P426, DOI 10.1109/TBME.2008.2008168; Jagannathan A, 2007, IEEE T PATTERN ANAL, V29, P2195, DOI 10.1109/TPAMI.2007.1125; Kikinis R, 2011, IEEE ENG MED BIO, P6982, DOI 10.1109/IEMBS.2011.6091765; Liu R, 2007, COMPUT GRAPH FORUM, V26, P385, DOI 10.1111/j.1467-8659.2007.01061.x; Longjiang E, 2013, P IEEE, P1; Mangan AP, 1999, IEEE T VIS COMPUT GR, V5, P308, DOI 10.1109/2945.817348; Mirzaee H, 2013, SIAM J SCI COMPUT, V35, pA212, DOI 10.1137/120874059; Rong Jian, 2010, Proceedings 2010 International Conference on Optoelectronics and Image Processing (ICOIP 2010), P145, DOI 10.1109/ICOIP.2010.271; Shlafman S, 2002, COMPUT GRAPH FORUM, V21, P219, DOI 10.1111/1467-8659.00581; Sun MM, 2013, PROCEEDINGS OF 2013 IEEE INTERNATIONAL CONFERENCE ON MEDICAL IMAGING PHYSICS AND ENGINEERING (ICMIPE), P231, DOI 10.1109/ICMIPE.2013.6864541; SUTHERLAND IE, 1974, COMMUN ACM, V17, P32, DOI 10.1145/360767.360802; VATTI BR, 1992, COMMUN ACM, V35, P56, DOI 10.1145/129902.129906; Weiler K., 1977, COMPUT GRAPH, V11, P214, DOI DOI 10.1145/965141.563896; Yeniaras E, 2014, INT J COMPUT ASS RAD, V9, P659, DOI 10.1007/s11548-013-0948-x; Zhang JY, 2011, IEEE T VIS COMPUT GR, V17, P357, DOI 10.1109/TVCG.2010.57; Zheng YY, 2010, COMPUT GRAPH FORUM, V29, P527, DOI 10.1111/j.1467-8659.2009.01622.x	23	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145987	10.1371/journal.pone.0145987	http://dx.doi.org/10.1371/journal.pone.0145987			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751685	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100037
J	Calanzani, N; Higginson, IJ; Koffman, J; Gomes, B				Calanzani, Natalia; Higginson, Irene J.; Koffman, Jonathan; Gomes, Barbara			Factors Associated with Participation, Active Refusals and Reasons for Not Taking Part in a Mortality Followback Survey Evaluating End-of-Life Care	PLOS ONE			English	Article							AFTER-DEATH INTERVIEWS; BEREAVEMENT RESEARCH; POSTAL QUESTIONNAIRES; PALLIATIVE CARE; CANCER-PATIENTS; RESPONSE RATES; SAMPLE CHARACTERISTICS; METHODOLOGICAL ISSUES; NONRESPONSE BIAS; PREFERRED PLACE	Background Examination of factors independently associated with participation in mortality followback surveys is rare, even though these surveys are frequently used to evaluate end-of-life care. We aimed to identify factors associated with 1) participation versus non-participation and 2) provision of an active refusal versus a silent refusal; and systematically examine reasons for refusal in a population-based mortality followback survey. Methods Postal survey about the end-of-life care received by 1516 people who died from cancer (aged >= 18), identified through death registrations in London, England (response rate 39.3%). The informant of death (a relative in 95.3% of cases) was contacted 4-10 months after the patient died. We used multivariate logistic regression to identify factors associated with participation/active refusals and content analysis to examine refusal reasons provided by 205 nonparticipants. Findings The odds of partaking were higher for patients aged 90+ (AOR 3.48, 95% CI: 1.52-8.00, ref: 20-49yrs) and female informants (AOR 1.70, 95% CI: 1.33-2.16). Odds were lower for hospital deaths (AOR 0.62, 95% CI: 0.46-0.84, ref: home) and proxies other than spouses/partners (AORs 0.28 to 0.57). Proxies of patients born overseas were less likely to provide an active refusal (AOR 0.49; 95% CI: 0.32-0.77). Refusal reasons were often multidimensional, most commonly study-related (36.0%), proxy-related and grief-related (25.1% each). One limitation of this analysis is the large number of nonparticipants who did not provide reasons for refusal (715/920). Conclusions Our survey better reached proxies of older patients while those dying in hospitals were underrepresented. Proxy characteristics played a role, with higher participation from women and spouses/partners. More information is needed about the care received by underrepresented groups. Study design improvements may guide future questionnaire development and help develop strategies to increase response rates.	[Calanzani, Natalia; Higginson, Irene J.; Koffman, Jonathan; Gomes, Barbara] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Calanzani, Natalia] Univ Edinburgh, Sch Med, Usher Inst Populat Hlth Sci & Informat, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	University of London; King's College London; University of Edinburgh	Calanzani, N (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.	natalia.calanzani@ed.ac.uk	Calanzani, Natalia/AAK-2007-2020; Higginson, Irene Julie/C-7309-2012	Calanzani, Natalia/0000-0002-5068-2543; Koffman, Jonathan/0000-0001-8513-5681; Higginson, Irene Julie/0000-0002-3687-1313; Gomes, Barbara/0000-0001-8149-1806	charity Cicely Saunders International; MRC [G0802654] Funding Source: UKRI; Medical Research Council [G0802654] Funding Source: researchfish	charity Cicely Saunders International; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the charity Cicely Saunders International (cicelysaundersinternational.org) as part of Dr Barbara Gomes' PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington-Hall J, 1998, J EPIDEMIOL COMMUN H, V52, P802, DOI 10.1136/jech.52.12.802; Addington-Hall J, 2002, EUR J CANCER CARE, V11, P220, DOI 10.1046/j.1365-2354.2002.00343.x; Addington- Hall J, 1999, POLICY; ADDINGTONHALL J, 1995, PALLIATIVE MED, V9, P27, DOI 10.1177/026921639500900105; Altman D.G., 1991, PRACTICAL STATISTIC; [Anonymous], 2012, NAT STAT; [Anonymous], 2013, NAT STAT; [Anonymous], 2010, PUBLIC HLTH REPORT; [Anonymous], 2009, INFORMATION; [Anonymous], BEREAVEMENT; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Barriball KL, 1999, J ADV NURS, V30, P677, DOI 10.1046/j.1365-2648.1999.01117.x; Beccaro M, 2006, J EPIDEMIOL COMMUN H, V60, P412, DOI 10.1136/jech.2005.043646; Beck AM, 2007, DEATH STUD, V31, P783, DOI 10.1080/07481180701537220; Burt J, 2010, AGE AGEING, V39, P86, DOI 10.1093/ageing/afp212; Calanzani N, 2013, ATTACHMENT; CARTWRIGHT A, 1986, J EPIDEMIOL COMMUN H, V40, P267, DOI 10.1136/jech.40.3.267; Casarett D, 2010, J AM GERIATR SOC, V58, P2381, DOI 10.1111/j.1532-5415.2010.03175.x; Caserta M, 2010, HEALTH; COOK AS, 1995, DEATH STUD, V19, P157, DOI 10.1080/07481189508252722; Costantini M, 2005, PALLIATIVE MED, V19, P628, DOI 10.1191/0269216305pm1086oa; Curtis JR, 2002, J PAIN SYMPTOM MANAG, V24, P17, DOI 10.1016/S0885-3924(02)00419-0; Department for Communities and Local Government, 2009, IMPACT ASSESSMENT; Edwards P, 2004, CONTROL CLIN TRIALS, V25, P31, DOI 10.1016/j.cct.2003.08.013; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Emanuel EJ, 2004, ARCH INTERN MED, V164, P1999, DOI 10.1001/archinte.164.18.1999; Escobar Pinzon LC, 2010, BMC PALLIAT CARE, V9, P16, DOI [10.1186/1472-684X-9-16, DOI 10.1186/1472-684X-9-16]; Eurostat, 2014, HEALTH; Evans C, 2015, BMJ SUPPORT PALLIAT, V5, P116; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Gomes B, 2011, LIVING AGEING DYING, P3; Gomes B, 2013, SUPPORT CARE CANCER, P1; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gomes B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0466-5; Gomes B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-400; Grande G, 2008, PALLIATIVE MED, V22, P971, DOI 10.1177/0269216308098805; Grande GE, 2009, PALLIATIVE MED, V23, P248, DOI 10.1177/0269216309102620; Groves RM, 2008, PUBLIC OPIN QUART, V72, P167, DOI 10.1093/poq/nfn011; Hanratty B, 2000, BRIT J GEN PRACT, V50, P653; Higginson IJ, 2010, PALLIATIVE MED, V24, P352, DOI 10.1177/0269216309360489; Hunt KJ, 2011, VOICES REDESIGN TEST; Ingleton C, 2004, HEALTH SOC CARE COMM, V12, P43, DOI 10.1111/j.1365-2524.2004.00467.x; Jacoby A, 1999, PALLIATIVE MED, V13, P285, DOI 10.1191/026921699674259562; Kendall M, 2007, BMJ-BRIT MED J, V334, P521, DOI 10.1136/bmj.39097.582639.55; Koffman J, 2012, PALLIATIVE MED, V26, P379, DOI 10.1177/0269216311405091; Koopman L, 2013, J CLIN EPIDEMIOL, V66, P340, DOI 10.1016/j.jclinepi.2012.09.012; Kross EK, 2009, CHEST, V136, P1496, DOI 10.1378/chest.09-0589; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lund D, 1993, PRESS, P240; MacDonald SE, 2009, PUBLIC HEALTH NURS, V26, P95, DOI 10.1111/j.1525-1446.2008.00758.x; McLennan D, 2011, SOC POLICY; Menaca A, EUROPE, V82, P387; Miyashita M, 2008, J CLIN ONCOL, V26, P3845, DOI 10.1200/JCO.2007.15.8287; Neal MB, 1996, RES AGING, V18, P219, DOI 10.1177/0164027596182004; Office for National Statistics, 2010, NAT STAT; Office for National Statistics, 2011, NAT STAT; Office for National Statistics, 2014, NAT STAT; PARKES CM, 1995, DEATH STUD, V19, P171, DOI 10.1080/07481189508252723; Parkes CM, 2010, BEREAVEMENT STUDIES, P137; Perneger TV, 2005, MED CARE, V43, P374, DOI 10.1097/01.mlr.0000156856.36901.40; Phipps Etienne J, 2002, Gerontologist, V42 Spec No 3, P104; Pring A, 2012, NETWORK; Scott P, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-111; SEEMAN I, 1989, PUBLIC HEALTH REP, V104, P183; Skulason Bragi, 2010, BMC Palliat Care, V9, P7, DOI 10.1186/1472-684X-9-7; Stroebe M, 2003, PALLIATIVE MED, V17, P235, DOI 10.1191/0269216303pm768rr; STROEBE MS, 1989, OMEGA-J DEATH DYING, V20, P1, DOI 10.2190/C3JE-C9L1-5R91-DWDU; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno Joan M, 2005, J Palliat Med, V8 Suppl 1, pS42; Williams BR, 2008, DEATH STUD, V32, P197, DOI 10.1080/07481180701881297; World Health Organisation, 1992, ORGANISATION	73	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146134	10.1371/journal.pone.0146134	http://dx.doi.org/10.1371/journal.pone.0146134			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA5AX	26745379	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600027
J	Lowet, E; Roberts, MJ; Bonizzi, P; Karel, J; De Weerd, P				Lowet, Eric; Roberts, Mark J.; Bonizzi, Pietro; Karel, Joel; De Weerd, Peter			Quantifying Neural Oscillatory Synchronization: A Comparison between Spectral Coherence and Phase-Locking Value Approaches	PLOS ONE			English	Article							GAMMA-BAND SYNCHRONIZATION; NEURONAL OSCILLATIONS; THETA-OSCILLATIONS; VISUAL-CORTEX; FREQUENCY; AMPLITUDE; DYNAMICS; RHYTHM; POWER; TIME	Synchronization or phase-locking between oscillating neuronal groups is considered to be important for coordination of information among cortical networks. Spectral coherence is a commonly used approach to quantify phase locking between neural signals. We systematically explored the validity of spectral coherence measures for quantifying synchronization among neural oscillators. To that aim, we simulated coupled oscillatory signals that exhibited synchronization dynamics using an abstract phase-oscillator model as well as interacting gamma-generating spiking neural networks. We found that, within a large parameter range, the spectral coherence measure deviated substantially from the expected phase-locking. Moreover, spectral coherence did not converge to the expected value with increasing signal-to-noise ratio. We found that spectral coherence particularly failed when oscillators were in the partially (intermittent) synchronized state, which we expect to be the most likely state for neural synchronization. The failure was due to the fast frequency and amplitude changes induced by synchronization forces. We then investigated whether spectral coherence reflected the information flow among networks measured by transfer entropy (TE) of spike trains. We found that spectral coherence failed to robustly reflect changes in synchrony-mediated information flow between neural networks in many instances. As an alternative approach we explored a phase-locking value (PLV) method based on the reconstruction of the instantaneous phase. As one approach for reconstructing instantaneous phase, we used the Hilbert Transform (HT) preceded by Singular Spectrum Decomposition (SSD) of the signal. PLV estimates have broad applicability as they do not rely on stationarity, and, unlike spectral coherence, they enable more accurate estimations of oscillatory synchronization across a wide range of different synchronization regimes, and better tracking of synchronization-mediated information flow among networks.	[Lowet, Eric; Roberts, Mark J.; De Weerd, Peter] Maastricht Univ, Dept Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands; [Bonizzi, Pietro; Karel, Joel] Maastricht Univ, Dept Knowledge Engn, NL-6200 MD Maastricht, Netherlands; [Lowet, Eric; Roberts, Mark J.; De Weerd, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Maastricht University; Maastricht University; Radboud University Nijmegen	Lowet, E (corresponding author), Maastricht Univ, Dept Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands.	eric.lowet@maastrichtuniversity.nl	Roberts, Mark/C-7011-2018	Karel, Joel/0000-0001-6209-3589; Roberts, Mark/0000-0001-7513-1281	NWO [453-04-002, 451-09-025]; Maastricht University	NWO(Netherlands Organization for Scientific Research (NWO)); Maastricht University	Research was supported by NWO VICI grant to P.D.W. (#453-04-002), NWO VENI grant to M.R. (#451-09-025), and Maastricht University Graduate funding in cooperation with Donders Institute for Brain Behavior and Cognition to P.D.W.	Aru J, 2014, BIORXIV, DOI [10.1101/005926, DOI 10.1101/005926]; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Aydore S, 2013, NEUROIMAGE, V74, P231, DOI 10.1016/j.neuroimage.2013.02.008; Barardi A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003723; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Battaglia D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002438; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Bendels MHK, 2007, J COMPUT NEUROSCI, V22, P173, DOI 10.1007/s10827-006-0006-6; Bennett M, 2002, P ROY SOC A-MATH PHY, V458, P563, DOI 10.1098/rspa.2001.0888; Berman JI, 2012, BRAIN CONNECT, V2, P155, DOI 10.1089/brain.2012.0085; BOASHASH B, 1992, P IEEE, V80, P520, DOI 10.1109/5.135376; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Bonizzi P, 2014, ADV DATA SCI ADAPT, V6, DOI 10.1142/S1793536914500113; Bonizzi P, 2012, IEEE ENG MED BIO, P2945, DOI 10.1109/EMBC.2012.6346581; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; Breakspear M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00190; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Brunet N, 2013, CEREB CORTEX, V25, P1, DOI [DOI 10.1093/CERC0R/BHT280, 10.1093/cercor/bht280]; Brunet NM, 2014, P NATL ACAD SCI USA, V111, P3626, DOI 10.1073/pnas.1309714111; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; Buehlmann A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000934; Burns SP, 2011, J NEUROSCI, V31, P9658, DOI 10.1523/JNEUROSCI.0660-11.2011; Burns SP, 2010, J NEUROSCI, V30, P4033, DOI 10.1523/JNEUROSCI.5319-09.2010; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; CARTER GC, 1973, IEEE T ACOUST SPEECH, VAU21, P337, DOI 10.1109/TAU.1973.1162496; Cohen MX, 2014, J NEUROSCI, V34, P8988, DOI 10.1523/JNEUROSCI.0261-14.2014; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Coombes S, 1999, PHYS REV E, V60, P2086, DOI 10.1103/PhysRevE.60.2086; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; Engel AK, 1999, CONSCIOUS COGN, V8, P128, DOI 10.1006/ccog.1999.0389; ERMENTROUT GB, 1984, SIAM J MATH ANAL, V15, P215, DOI 10.1137/0515019; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Galan RF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158101; Gilgen H., 2006, UNIVARIATE TIME SERI, DOI [10.1007/3-540-30968-3., DOI 10.1007/3-540-30968-3, 10.1007/3-540:-30968-3]; Gong P, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011904; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hadjipapas A, 2015, NEUROIMAGE, V112, P327, DOI 10.1016/j.neuroimage.2015.02.062; Hansel D, 2011, PLOS COMPUT BIOL, V7, DOI [10.1371/journaL.pcbi.1002176, DOI 10.1371/J0URNAL.PCBI.1002176]; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hoppensteadt FC, 1998, BIOSYSTEMS, V48, P85, DOI 10.1016/S0303-2647(98)00053-7; Hoppensteadt FC, 1996, BIOL CYBERN, V75, P117, DOI 10.1007/s004220050279; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang NE, 2005, INTERD MATH SCI, V5, P1; Huang NE, 2009, ADV DATA SCI ADAPT, V1, P177, DOI 10.1142/S1793536909000096; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Ito J, 2011, BMC NEUROSCI, pP132, DOI [10.1186/1471-2202-12-S1-P132, DOI 10.1186/1471-2202-12-S1-P132]; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jia XX, 2013, J NEUROSCI, V33, P17, DOI 10.1523/JNEUROSCI.1687-12.2013; Kozma R, 2008, CHAOS, V18, DOI 10.1063/1.2979694; Lachaux JP, 2002, NEUROPHYSIOL CLIN, V32, P157, DOI 10.1016/S0987-7053(02)00301-5; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Lepage KQ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/140837; Lepage KQ, 2013, NEURAL COMPUT, V25, P901, DOI 10.1162/NECO_a_00422; Loukas M, 2011, NEUROSURGERY, V68, P6, DOI 10.1227/NEU.0b013e3181fc5cac; Lowet E, 2016, EUR J NEUROSCI, V43, P1286, DOI 10.1111/ejn.13126; Lowet E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004072; Martinez-Conde S., 2013, NAT REV; Melloni L, 2009, TRENDS COGN SCI, V13, P239, DOI 10.1016/j.tics.2009.03.007; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Nakata S, 2009, J PHYS CHEM A, V113, P6876, DOI 10.1021/jp9020189; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Penny WD, 2009, J NEUROSCI METH, V183, P19, DOI 10.1016/j.jneumeth.2009.06.029; Picinbono B, 1997, IEEE T SIGNAL PROCES, V45, P552, DOI 10.1109/78.558469; Pikovsky A., 2002, AAPT, V70, P655, DOI DOI 10.1119/1.1475332; PRIESTLE.MB, 1969, J ROY STAT SOC B, V31, P140; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Roberts MJ, 2013, NEURON, V78, P523, DOI 10.1016/j.neuron.2013.03.003; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Scafetta N., 2014, PATTERN RECOGN PHYS, V2, P1, DOI [DOI 10.5194/PRP-2-1-2014, 10.5194/prp-2-1-2014]; Schwemmer MA, 2012, SPR SER COMPUT NEURO, V6, P3, DOI 10.1007/978-1-4614-0739-3_1; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Spaak E, 2012, CURR BIOL, V22, P2313, DOI 10.1016/j.cub.2012.10.020; Srinath R, 2014, J NEUROPHYSIOL, V112, P741, DOI 10.1152/jn.00851.2013; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Tiesinga PH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00196; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; von Sachs R, 2000, J TIME SER ANAL, V21, P597, DOI 10.1111/1467-9892.00200; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Zou W, 2009, FRONT PHYS CHINA, V4, P97, DOI 10.1007/s11467-009-0009-7	104	66	68	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146443	10.1371/journal.pone.0146443	http://dx.doi.org/10.1371/journal.pone.0146443			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745498	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600048
J	Turra, A; Pombo, M; Petracco, M; Siegle, E; Fonseca, M; Denadai, MR				Turra, Alexander; Pombo, Maira; Petracco, Marcelo; Siegle, Eduardo; Fonseca, Mariana; Denadai, Marcia R.			Frequency, Magnitude, and Possible Causes of Stranding and Mass-Mortality Events of the Beach Clam Tivela mactroides (Bivalvia: Veneridae)	PLOS ONE			English	Article							SANDY BEACHES; LIFE-HISTORY; MESODESMA-MACTROIDES; YELLOW CLAM; NORTHERN; DONACIUM; COAST; HYPOTHESIS; PARAMETERS; COMMUNITY	Stranding combined with mass-mortality events of sandy-beach organisms is a frequent but little-understood phenomenon, which is generally studied based on discrete episodes. The frequency, magnitude, and possible causes of stranding and mass-mortality events of the trigonal clam Tivela mactroides were assessed based on censuses of stranded individuals, every four days from September 2007 through December 2008, in Caraguatatuba Bay, southeastern Brazil. Stranded clams were classified as dying (closed valves did not open when forced) or dead (closed valves were easily opened). Information on wave parameters and the living intertidal clam population was used to assess possible causes of stranding. This fine-scale monitoring showed that stranding occurred widely along the shore and year-round, with peaks interspersed with periods of low or no mortality. Dead clams showed higher mean density than dying individuals, but a lower mean shell length, attributed to a higher tolerance to desiccation of larger individuals. Wave height had a significant negative relationship to the density of dying individuals, presumed to be due to the accretive nature of low-energy waves: when digging out, clams would be more prone to be carried upward and unable to return; while larger waves, breaking farther from the beach and with a stronger backwash, would prevent stranding in the uppermost areas. This ecological finding highlights the need for refined temporal studies on mortality events, in order to understand them more clearly. Last, the similar size structure of stranded clams and the living population indicated that the stranded individuals are from the intertidal or shallow subtidal zone, and reinforces the ecological and behavioral components of this process, which have important ecological and socioeconomic implications for the management of this population.	[Turra, Alexander; Pombo, Maira; Siegle, Eduardo; Denadai, Marcia R.] Univ Sao Paulo, Inst Oceanog, Sao Paulo, Brazil; [Petracco, Marcelo] Fed Univ Para, Inst Geociencias, Posgrad Ecol, Fac Oceanog, BR-66059 Belem, Para, Brazil; [Fonseca, Mariana; Denadai, Marcia R.] Ctr Univ Modulo, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Para	Petracco, M (corresponding author), Fed Univ Para, Inst Geociencias, Posgrad Ecol, Fac Oceanog, BR-66059 Belem, Para, Brazil.	mpetracco@uol.com.br	Petracco, Marcelo/D-6180-2017; Pombo, Maíra/J-7791-2015; Siegle, Eduardo/F-5408-2010; Petracco, Marcelo/AAF-3066-2019; Petracco, Marcelo/E-8204-2016; Turra, Alexander/G-1352-2012	Siegle, Eduardo/0000-0003-3926-1710; Petracco, Marcelo/0000-0001-6501-0099; Petracco, Marcelo/0000-0001-6501-0099; Turra, Alexander/0000-0003-2225-8371	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [05/60041-6]; FAPESP [06/57575-1]; Instituto Costa Brasilis - Desenvolvimento Socio-Ambiental; Centro Universitario Modulo; CNPq	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Costa Brasilis - Desenvolvimento Socio-Ambiental; Centro Universitario Modulo; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP, Proc. no. 05/60041-6). We also thank FAPESP for the "Programa Jovem Pesquisador em Centro Emergente" grant awarded to M.R.D. (FAPESP Proc. no. 06/57575-1). Logistical support was provided by the Instituto Costa Brasilis - Desenvolvimento Socio-Ambiental and also by the Centro Universitario Modulo.; This study was supported by the Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP, Proc. no. 05/60041-6). We also thank FAPESP for the "Programa Jovem Pesquisador em Centro Emergente" grant awarded to M.R.D. (FAPESP Proc. no. 06/57575-1). We are grateful for the logistical support provided by the Instituto Costa Brasilis-Desenvolvimento Socio-Ambiental and also by the Centro Universitario Modulo. Thanks to L.C. Bernadochi and C.C. Paschoal for their help in the field work. Thanks also to P.C. Paiva for valuable discussions. Alexander Turra and Eduardo Siegle are sponsored by CNPq research fellowships. The authors are also grateful to Dr. Ilana Zalmon and two anonymous reviewers for providing useful comments that improved the manuscript, and to Dr. Janet W. Reid for editing the English text.	Aburto J, 2013, OCEAN COAST MANAGE, V71, P88, DOI 10.1016/j.ocecoaman.2012.10.013; Arntz W. E., 1985, IMARPE B EXTRAORFINA, P91; ARNTZ WE, 1987, S AFR J MARINE SCI, V5, P645, DOI 10.2989/025776187784522504; Arrieche D, 2006, CIENC MAR, V32, P285, DOI 10.7773/cm.v32i21.1061; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Caddy J.F., 2003, ENHANCING RESTORING; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Castilla JC, 2001, REV FISH BIOL FISHER, V11, P1, DOI 10.1023/A:1014235924952; Crescini Roberta, 2012, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V51, P85; Dadon JR, 2005, CONTRIB ZOOL, V74, P27, DOI 10.1163/18759866-0740102002; Defeo O, 2003, J MAR BIOL ASSOC UK, V83, P331, DOI 10.1017/S0025315403007161h; Defeo O, 2001, MAR ECOL PROG SER, V212, P159, DOI 10.3354/meps212159; DEFEO O, 1993, BIOL PESQUERA, V22, P41; Defeo O, 2013, ECOL SOC, V18, DOI 10.5751/ES-05971-180430; Defeo O, 2003, J COASTAL RES, P56; Denadai MR, 2015, MAR BIOL RES, V11, P847, DOI 10.1080/17451000.2015.1024130; Denadai MR, 2015, MAR COAST FISH, V7, P103, DOI 10.1080/19425120.2015.1007183; Denadai MR, 2005, J NAT HIST, V39, P3275, DOI 10.1080/00222930500126156; Dyrynda E. A., 1997, Developmental and Comparative Immunology, V21, P124, DOI 10.1016/S0145-305X(97)88577-1; Fiori S, 2004, J SHELLFISH RES, V23, P451; Fiori SM, 1999, BIOL CONSERV, V89, P305, DOI 10.1016/S0006-3207(98)00151-7; Gonzalez SA, 2001, J SHELLFISH RES, V20, P85; Greenfield DI, 2002, MAR BIOL, V141, P1045, DOI 10.1007/s00227-002-0890-x; Herrera A, 2011, LAT AM J AQUAT RES, V39, P56, DOI 10.3856/vol39-issue1-fulltext-6; Holthuijsen L., 1993, P 2 INT S OCEAN WAVE, P630; JOHNSON PT, 1968, J INVERTEBR PATHOL, V12, P349, DOI 10.1016/0022-2011(68)90339-X; Lopez RA, 2008, J COASTAL RES, V24, P925, DOI 10.2112/05-0621.1; Masselink G, 2006, CONT SHELF RES, V26, P661, DOI 10.1016/j.csr.2006.01.015; McLachlan A, 1996, OCEANOGR MAR BIOL, V34, P163; McLachlan A., 2010, ECOLOGY SANDY SHORES, DOI DOI 10.1016/B978-0-12-372569-1.X5000-9; Mendoza Jeremy J., 2000, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V39, P79; NARCHI W, 1972, B MAR SCI, V22, P643; Odebrecht C., 1995, P213; OLIVIER SR, 1971, PROYECTO DESARROLLO, V27, P1; Ortega L, 2012, MAR ECOL PROG SER, V469, P71, DOI 10.3354/meps10016; PENN D, 1995, ANIM BEHAV, V49, P1531, DOI 10.1016/0003-3472(95)90074-8; Pinheiro J, 2015, NLME LINEAR NONLINEA; Rees H.L., 1993, Fisheries Research Data Report, V33, P1; Riascos JM, 2008, J SEA RES, V59, P217, DOI 10.1016/j.seares.2008.01.003; Riascos JM, 2011, ICES J MAR SCI, V68, P823, DOI 10.1093/icesjms/fsr026; Riascos JM, 2009, MAR ECOL PROG SER, V385, P151, DOI 10.3354/meps08042; RIOS E.C., 1985, SEASHELLS BRAZIL; Schlacher TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068221; Sherman BH, 2000, MAR POLLUT BULL, V41, P232, DOI 10.1016/S0025-326X(00)00113-2; Tata A., 1991, CARIBB J SCI, V21, P63; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Tolman H.L, 2002, USER MANUAL SYSTEM D, V222, P133; TRUEMAN ER, 1966, J EXP BIOL, V44, P469; Turra A, 2015, ESTUAR COAST SHELF S; Turra A, 2016, FISH RES, V174, P58, DOI 10.1016/j.fishres.2015.08.026; Turra A, 2015, MAR ECOL-EVOL PERSP, V36, P221, DOI 10.1111/maec.12137; Turra A, 2014, ESTUAR COAST SHELF S, V150, P157, DOI 10.1016/j.ecss.2013.06.004; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zar JH., 2010, BIOSTAT ANAL, V5th; Zuur Alain F., 2009, P1	55	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146323	10.1371/journal.pone.0146323	http://dx.doi.org/10.1371/journal.pone.0146323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745804	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600041
J	Wandinger, SK; Lahortiga, I; Jacobs, K; Klammer, M; Jordan, N; Elschenbroich, S; Parade, M; Jacoby, E; Linders, JTM; Brehmer, D; Cools, J; Daub, H				Wandinger, Sebastian K.; Lahortiga, Idoya; Jacobs, Kris; Klammer, Martin; Jordan, Nicole; Elschenbroich, Sarah; Parade, Marc; Jacoby, Edgar; Linders, Joannes T. M.; Brehmer, Dirk; Cools, Jan; Daub, Henrik			Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling	PLOS ONE			English	Article							RIBOSOMAL S6 KINASE; BREAST-CANCER CELLS; ORBITRAP MASS-SPECTROMETER; OVARIAN-CANCER; IN-VIVO; FEEDBACK PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; PROTEIN-PHOSPHORYLATION; INTRACELLULAR DOMAIN; BAD PHOSPHORYLATION	The four members of the epidermal growth factor receptor (EGFR/ERBB) family form homo-and heterodimers which mediate ligand-specific regulation of many key cellular processes in normal and cancer tissues. While signaling through the EGFR has been extensively studied on the molecular level, signal transduction through ERBB3/ERBB4 heterodimers is less well understood. Here, we generated isogenic mouse Ba/F3 cells that express full-length and functional membrane-integrated ERBB3 and ERBB4 or ERBB4 alone, to serve as a defined cellular model for biological and phosphoproteomics analysis of ERBB3/ERBB4 signaling. ERBB3 co-expression significantly enhanced Ba/F3 cell proliferation upon neuregulin-1 (NRG1) treatment. For comprehensive signaling studies we performed quantitative mass spectrometry (MS) experiments to compare the basal ERBB3/ERBB4 cell phosphoproteome to NRG1 treatment of ERBB3/ERBB4 and ERBB4 cells. We employed a workflow comprising differential isotope labeling with mTRAQ reagents followed by chromatographic peptide separation and final phosphopeptide enrichment prior to MS analysis. Overall, we identified 9686 phosphorylation sites which could be confidently localized to specific residues. Statistical analysis of three replicate experiments revealed 492 phosphorylation sites which were significantly changed in NRG1-treated ERBB3/ ERBB4 cells. Bioinformatics data analysis recapitulated regulation of mitogen-activated protein kinase and Akt pathways, but also indicated signaling links to cytoskeletal functions and nuclear biology. Comparative assessment of NRG1-stimulated ERBB4 Ba/F3 cells revealed that ERBB3 did not trigger defined signaling pathways but more broadly enhanced phosphoproteome regulation in cells expressing both receptors. In conclusion, our data provide the first global picture of ERBB3/ERBB4 signaling and provide numerous potential starting points for further mechanistic studies.	[Wandinger, Sebastian K.; Klammer, Martin; Jordan, Nicole; Elschenbroich, Sarah; Daub, Henrik] Evotech Munchen GmbH, Martinsried, Germany; [Lahortiga, Idoya; Jacobs, Kris; Cools, Jan] VIB Ctr Biol Dis, Leuven, Belgium; [Lahortiga, Idoya; Jacobs, Kris; Cools, Jan] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Parade, Marc; Jacoby, Edgar; Linders, Joannes T. M.; Brehmer, Dirk] Janssen Pharmaceut NV, Janssen Res & Dev, Oncol Drug Discovery, Beerse, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Johnson & Johnson; Janssen Pharmaceuticals	Cools, J (corresponding author), VIB Ctr Biol Dis, Leuven, Belgium.	jan.cools@cme.vib-kuleuven.be; henrik.daub@evotec.com		Cools, Jan/0000-0001-6626-5843	Belgian government agency for Innovation by Science and Technology (IWT) [IWT 110431]	Belgian government agency for Innovation by Science and Technology (IWT)	This work was funded by the Belgian government agency for Innovation by Science and Technology (IWT) Grant number IWT 110431, awarded to DB (URL: http://www.iwt.be). The funder provided support including salaries for authors SKW and IL, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Evotec (Munchen) GmbH and Janssen Pharmaceutica provided support in the form of salaries for authors MK, NJ, SE, HD, MP, EJ, JTML and DB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that both approved publication of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank our colleagues Stefan Muller, Andreas Tebbe, Christoph Schaab and Klaus Godl for stimulating discussions and Stephanie Blencke for excellent technical assistance. This work was supported by a research project grant (IWT 110431) by the Belgian government agency for Innovation by Science and Technology (IWT) awarded to DB.	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Davies S, 2014, INT J GYNECOL PATHOL, V33, P402, DOI 10.1097/PGP.0000000000000081; De Keersmaecker K, 2005, BLOOD, V105, P4849, DOI 10.1182/blood-2004-12-4897; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Fattore L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-180; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Hayakawa J, 2000, CANCER RES, V60, P5988; Hegde GV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004438; Hollmen M, 2009, ONCOGENE, V28, P1309, DOI 10.1038/onc.2008.481; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kang UB, 2010, J PROTEOME RES, V9, P3750, DOI 10.1021/pr9011014; Klammer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104504; Klammer M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-351; Lazer G, 2010, J BIOL CHEM, V285, P23073, DOI 10.1074/jbc.M109.094508; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mok TSK, 2011, NAT REV CLIN ONCOL, V8, P661, DOI 10.1038/nrclinonc.2011.126; Nafi SNM, 2014, ONCOTARGET, V5, P5934; Naresh A, 2008, CANCER RES, V68, P6387, DOI 10.1158/0008-5472.CAN-08-0538; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Nielsen TO, 2014, MELANOMA RES, V24, P88, DOI 10.1097/CMR.0000000000000040; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Oppermann FS, 2013, J PROTEOME RES, V12, P4089, DOI 10.1021/pr400417g; Paatero I, 2013, GYNECOL ONCOL, V129, P179, DOI 10.1016/j.ygyno.2012.12.044; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sartor CI, 2001, MOL CELL BIOL, V21, P4265, DOI 10.1128/MCB.21.13.4265-4275.2001; Sasaoka T, 2001, ENDOCRINOLOGY, V142, P5226, DOI 10.1210/en.142.12.5226; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tang CK, 1999, CANCER RES, V59, P5315; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van der Horst EH, 2005, INT J CANCER, V113, P689, DOI 10.1002/ijc.20643; Veikkolainen V, 2011, CELL CYCLE, V10, P2647, DOI 10.4161/cc.10.16.17194; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; Weiss FU, 1997, J CELL PHYSIOL, V173, P187, DOI 10.1002/(SICI)1097-4652(199711)173:2<187::AID-JCP19>3.0.CO;2-D; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Yang XP, 2005, CANCER RES, V65, P7338, DOI 10.1158/0008-5472.CAN-04-2263; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Zhou WL, 2000, J BIOL CHEM, V275, P34737, DOI 10.1074/jbc.M003756200; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421	63	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146100	10.1371/journal.pone.0146100	http://dx.doi.org/10.1371/journal.pone.0146100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745281	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600026
J	Yamada, N; Okamoto, N; Kataoka, H; Mizoguchi, A				Yamada, Nobuto; Okamoto, Naoki; Kataoka, Hiroshi; Mizoguchi, Akira			Endocrine Mechanisms Regulating Post-Diapause Development in the Cabbage Armyworm, Mamestra brassicae	PLOS ONE			English	Article							PROTHORACICOTROPIC HORMONE PTTH; BOMBYX-MORI; JUVENILE-HORMONE; NEUROSECRETORY-CELLS; DIAPAUSE; HEMOLYMPH; SILKWORM; BRAIN; PEPTIDES; ECDYSTEROIDOGENESIS	Diapause, a programmed developmental arrest at a specific stage, is common in insects and is regulated by hormones. It is well established that in pupal diapause, cessation of ecdysteroid secretion from the prothoracic glands (PGs) after pupal ecdysis leads to diapause initiation, while resumption of its secretion induces post-diapause development. However, what regulates the activity of the glands is poorly understood, especially for the glands of diapause-terminated pupae. In the present study, we investigate the mechanisms by which post-diapause development is regulated in the cabbage armyworm Mamestra brassicae. We demonstrate that the brain is necessary for the initiation of post-diapause development and that the factor in the brain responsible for the activation of the PGs is the prothoracicotropic hormone (PTTH). Further, through measuring the hemolymph PTTH titers by time-resolved fluoroimmunoassay, we show that PTTH is actually released into the hemolymph prior to the activation of the PGs. Although its peak titer is much lower than expected, this low concentration of PTTH is most likely still effective to activate the PGs of post-diapause pupae, because the responsiveness to PTTH of the glands at this stage is very high compared to that of nondiapause pupal PGs. These results strongly suggest that in M. brassicae, PTTH serves as a trigger to initiate pupa-adult development after diapause termination by stimulating the PGs to secrete ecdysteroid.	[Yamada, Nobuto; Okamoto, Naoki; Mizoguchi, Akira] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan; [Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	Nagoya University; University of Tokyo	Mizoguchi, A (corresponding author), Aichi Gakuin Univ, Div Liberal Arts & Sci, Nisshin, Aichi, Japan.	amizo@dpc.agu.ac.jp			Japan Society for the Promotion of Science (JSPS) [26660266, 15H04610]; Naito Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation)	This work was supported in part by Japan Society for the Promotion of Science (JSPS KAKENHI Grant Numbers 26660266, 15H04610 to AM; https://www.jsps.go.jp/). NO is supported by Japan Society for the Promotion of Science (JSPS Postdoctoral Fellowship for Research Abroad; https://www.jsps.go.jp/) and the Naito Foundation (https://www.naito-f.or.jp/).	BODNARYK RP, 1985, J INSECT PHYSIOL, V31, P53, DOI 10.1016/0022-1910(85)90042-3; BOLLENBACHER WE, 1979, P NATL ACAD SCI USA, V76, P5148, DOI 10.1073/pnas.76.10.5148; CYMBOROWSKI B, 1979, J INSECT PHYSIOL, V25, P939, DOI 10.1016/0022-1910(79)90106-9; Denlinger D.L., 1985, P353; DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239, DOI 10.1146/annurev.en.31.010186.001323; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Endo K, 1997, ZOOL SCI, V14, P127, DOI 10.2108/zsj.14.127; HIRUMA K, 1980, GEN COMP ENDOCR, V41, P392, DOI 10.1016/0016-6480(80)90084-2; ISHIZAKI H, 1983, DEV GROWTH DIFFER, V25, P593; JUNGREIS AM, 1973, J INSECT PHYSIOL, V19, P225, DOI 10.1016/0022-1910(73)90235-7; KATAOKA H, 1987, AGR BIOL CHEM TOKYO, V51, P1067, DOI 10.1080/00021369.1987.10868149; KATAOKA H, 1991, AGR BIOL CHEM TOKYO, V55, P73, DOI 10.1080/00021369.1991.10870535; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; KONO Y, 1977, J INSECT PHYSIOL, V23, P1461, DOI 10.1016/0022-1910(77)90173-1; LOEB MJ, 1982, J INSECT PHYSIOL, V28, P667, DOI 10.1016/0022-1910(82)90144-5; MCDANIEL CN, 1979, J INSECT PHYSIOL, V25, P143, DOI 10.1016/0022-1910(79)90092-1; MIZOGUCHI A, 1990, DEV GROWTH DIFFER, V32, P591; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; Mizoguchi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060824; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; SAFRANEK L, 1980, BIOL BULL, V158, P248, DOI 10.2307/1540934; Schiesari L, 2013, CURR TOP DEV BIOL, V105, P213, DOI 10.1016/B978-0-12-396968-2.00008-7; Smith WA, 2012, INSECT ENDOCRINOLOGY, P1, DOI [10.1016/B978-0-12-384749-2.10001-9, DOI 10.1016/B978-0-12-384749-2.10001-9]; Watanabe K, 2007, MOL CELL ENDOCRINOL, V273, P51, DOI 10.1016/j.mce.2007.05.008; WILLIAMS CM, 1952, BIOL BULL, V103, P120, DOI 10.2307/1538411; WILLIAMS CM, 1946, BIOL BULL, V90, P234, DOI 10.2307/1538121; WILLIAMS CM, 1947, BIOL BULL, V93, P89, DOI 10.2307/1538279; WILLIAMS CM, 1959, BIOL BULL, V116, P323, DOI 10.2307/1539218; Yamanaka N, 2011, J COMP NEUROL, V519, P238, DOI 10.1002/cne.22517; Zhang TY, 2004, J INSECT PHYSIOL, V50, P547, DOI 10.1016/j.jinsphys.2004.03.011	31	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146619	10.1371/journal.pone.0146619	http://dx.doi.org/10.1371/journal.pone.0146619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745499	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600068
J	Poggiogalle, E; Lubrano, C; Gnessi, L; Mariani, S; Lenzi, A; Donini, LM				Poggiogalle, Eleonora; Lubrano, Carla; Gnessi, Lucio; Mariani, Stefania; Lenzi, Andrea; Donini, Lorenzo Maria			Fatty Liver Index Associates with Relative Sarcopenia and GH/IGF-1 Status in Obese Subjects	PLOS ONE			English	Article							GROWTH-FACTOR-I; SKELETAL-MUSCLE MASS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; METABOLIC SYNDROME; ECTOPIC FAT; DISEASE; POPULATION; HORMONE; AXIS	Introduction Recently the association between hepatic steatosis and sarcopenia has been described. GH/IGF-1 axis has been postulated to play a role in linking fatty liver and low muscle mass. The aim of our study was to explore the association between fatty liver index, sarcopenic obesity, insulin sensitivity, and GH/IGF-1 status. Methods 427 subjects [age: 45.65 +/- 13.94 years, BMI: 36.92 +/- 6.43 kg/m(2)] were enrolled. Participants were divided into three groups: fatty liver index (FLI) < 20, 20 >= FLI < 60, and FLI >= 60. Body composition was assessed by DXA. The truncal fat mass (TrFM) to appendicular skeletal muscle (ASM) ratio was used as an indicator of sarcopenic obesity. ISI-Matsuda index was used. Results BMI, fat mass, and the TrFM/ASM ratio were higher in subjects with FLI >= 60. GH, IGF-1 and ISI-Matsuda were lower in the high FLI group (all p < 0.05). A significantly positive correlation between FLI and TrFM/ASM ratio (r = 0.221, p < 0.001) was found, whereas FLI levels were negatively correlated with ISI-Matsuda (r = -0.335, p < 0.001), GH (r = -0.200, p = 0.006), and IGF-1 levels (r = -0.157, p = 0.028). Stepwise linear regression analysis showed that GH levels were significantly negatively correlated with FLI, while the TrFM/ASM ratio was positively associated with FLI, after adjustment for age, BMI, total fat mass, truncal fat mass, fat-free mass, and ISI-Matsuda. Conclusions Impairment of GH/IGF-1 axis seems to be associated to the risk of the development of sarcopenic obesity and ectopic fat deposition in the liver. Metabolic and hormonal derangements as determinants of ectopic fat deposition and body composition deserve to be evaluated in obese subjects.	[Poggiogalle, Eleonora; Lubrano, Carla; Gnessi, Lucio; Mariani, Stefania; Lenzi, Andrea; Donini, Lorenzo Maria] Univ Roma La Sapienza, Dept Expt Med Med Pathophysiol, Food Sci & Endocrinol Sect, I-00185 Rome, Italy	Sapienza University Rome	Poggiogalle, E (corresponding author), Univ Roma La Sapienza, Dept Expt Med Med Pathophysiol, Food Sci & Endocrinol Sect, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	eleonora.poggiogalle@uniroma1.it	Donini, Lorenzo/AAS-3873-2020; Poggiogalle, Eleonora/AAB-9338-2019; Gnessi, Lucio/K-8025-2016	Donini, Lorenzo/0000-0003-4692-4754; Gnessi, Lucio/0000-0001-8217-2372				Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Berryman DE, 2013, NAT REV ENDOCRINOL, V9, P346, DOI 10.1038/nrendo.2013.64; Bredella MA, 2009, J CLIN ENDOCR METAB, V94, P3995, DOI 10.1210/jc.2009-0438; Brick DJ, 2010, EUR J ENDOCRINOL, V163, P185, DOI 10.1530/EJE-10-0365; Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034; Cuthbertson DJ, 2014, EUR J ENDOCRINOL, V171, P561, DOI 10.1530/EJE-14-0112; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008; Donini LM, 2013, MEDITERR J NUTR META, V6, P191, DOI 10.1007/s12349-013-0135-1; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Franco C, 2006, EUR J ENDOCRINOL, V155, P261, DOI 10.1530/eje.1.02211; Gallagher Dympna, 2011, JPEN J Parenter Enteral Nutr, V35, p21S, DOI 10.1177/0148607111413773; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Gielen E, 2015, J CACHEXIA SARCOPENI, V6, P242, DOI 10.1002/jcsm.12030; Guichelaar MMJ, 2014, HEPATOLOGY, V59, P1668, DOI 10.1002/hep.27058; Guillet C, 2005, DIABETES METAB, V31, pS20, DOI 10.1016/S1262-3636(05)73648-X; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Kim TN, 2013, CLIN ENDOCRINOL, V78, P525, DOI 10.1111/j.1365-2265.2012.04433.x; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Lohman TJ, 2002, MED SCI SPORTS EXERC, V24, P952; Lubrano C, 2015, ENDOCRINE, V49, P503, DOI 10.1007/s12020-015-0530-0; Martinez-Hervas S, 2011, METABOLISM, V60, P740, DOI 10.1016/j.metabol.2010.07.024; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Moon JS, 2013, DIABETES METAB J, V37, P278, DOI 10.4093/dmj.2013.37.4.278; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; Poggiogalle E, 2014, ENDOCRINE, V47, P699, DOI 10.1007/s12020-014-0315-x; Prado CMM, 2012, CLIN NUTR, V31, P583, DOI 10.1016/j.clnu.2012.06.010; Runchey SS, 2014, J GASTROEN HEPATOL, V29, P589, DOI 10.1111/jgh.12437; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Siervo M, 2014, PUBLIC HEALTH NUTR, V18, P1; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Takahashi Y, 2012, ENDOCR J, V59, P955, DOI 10.1507/endocrj.EJ12-0322; Volzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374; Waters DL, 2011, CLIN GERIATR MED, V27, P401, DOI 10.1016/j.cger.2011.03.007; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044136	39	26	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145811	10.1371/journal.pone.0145811	http://dx.doi.org/10.1371/journal.pone.0145811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741958	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600009
J	Chen, X; Wei, SY; Li, JS; Zhang, QF; Wang, YX; Zhao, SL; Yu, J; Wang, C; Qin, Y; Wei, QJ; Lv, GX; Li, B				Chen, Xiao; Wei, Shi-Yao; Li, Jian-Si; Zhang, Qing-Fang; Wang, Yu-Xiao; Zhao, Shi-Lei; Yu, Jing; Wang, Chang; Qin, Ying; Wei, Qiu-Ju; Lv, Gui-Xiang; Li, Bing			Overexpression of Heme Oxygenase-1 Prevents Renal Interstitial Inflammation and Fibrosis Induced by Unilateral Ureter Obstruction	PLOS ONE			English	Article							KIDNEY REPAIR; ISCHEMIA/REPERFUSION INJURY; CELLS; ACTIVATION; EXPRESSION; PROTECTS; MYOFIBROBLASTS; REGENERATION; RAREFACTION; MACROPHAGES	Renal fibrosis plays an important role in the onset and progression of chronic kidney diseases. Many studies have demonstrated that heme oxygenase-1 (HO-1) is involved in diverse biological processes as a cytoprotective molecule, including anti-inflammatory, antioxidant, anti-apoptotic, antiproliferative, and immunomodulatory effects. However, the mechanisms of HO-1 prevention in renal interstitial fibrosis remain unknown. In this study, HO-1 transgenic (TG) mice were employed to investigate the effect of HO-1 on renal fibrosis using a unilateral ureter obstruction (UUO) model and to explore the potential mechanisms. We found that HO-1 was adaptively upregulated in kidneys of both TG and wild type (WT) mice after UUO. The levels of HO-1 mRNA and protein were increased in TG mice compared with WT mice under normal conditions. HO-1 expression was further enhanced after UUO and remained high during the entire experimental process. Renal interstitial fibrosis in the TG group was significantly attenuated compared with that in the WT group after UUO. Moreover, overexpression of HO-1 inhibited the loss of peritubular capillaries. In addition, UUO-induced activation and proliferation of myofibroblasts were suppressed by HO-1 overexpression. Furthermore, HO-1 restrained tubulointerstitial infiltration of macrophages and regulated the secretion of inflammatory cytokines in UUO mice. We also found that high expression of HO-1 inhibited reactivation of Wnt/beta-catenin signaling, which could play a crucial role in attenuating renal fibrosis. In conclusion, these data suggest that HO-1 prevents renal tubulointerstitial fibrosis possibly by regulating the inflammatory response and Wnt/beta-catenin signaling. This study provides evidence that augmentation of HO-1 levels may be a therapeutic strategy against renal interstitial fibrosis.	[Chen, Xiao; Wei, Shi-Yao; Li, Jian-Si; Zhang, Qing-Fang; Wang, Yu-Xiao; Zhao, Shi-Lei; Yu, Jing; Wang, Chang; Qin, Ying; Wei, Qiu-Ju; Li, Bing] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China; [Lv, Gui-Xiang] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Lv, GX (corresponding author), Harbin Med Univ, Dept Biochem & Mol Biol, Harbin, Peoples R China.	lvguixianghyd@163.com; icecreamlee@hotmail.com		Zhao, Shilei/0000-0002-8168-8112	National Natural Science Foundation of China [81370812]; National Basic Research Program of China 973 Program [2012CB517602]; Doctoral Program of the Ministry of Education of China [20122307110018]; Special Grade of China Postdoctoral Science Foundation [201003463]; Heilongjiang Postdoctoral Science Research Foundation [LBHQ10028]; Heilongjiang Undergraduate Innovation Program [201310226036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Doctoral Program of the Ministry of Education of China(Ministry of Education, China); Special Grade of China Postdoctoral Science Foundation; Heilongjiang Postdoctoral Science Research Foundation; Heilongjiang Undergraduate Innovation Program	This study was supported by research grants from the National Natural Science Foundation of China (No. 81370812), the National Basic Research Program of China 973 Program (No. 2012CB517602), the Doctoral Program of the Ministry of Education of China (20122307110018), the Special Grade of China Postdoctoral Science Foundation (No. 201003463), the Heilongjiang Postdoctoral Science Research Foundation (No. LBHQ10028), and the Heilongjiang Undergraduate Innovation Program (201310226036).	Agarwal Anupam, 2013, Trans Am Clin Climatol Assoc, V124, P111; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Cui R, 2014, NEPHRON EXP NEPHROL, V128, P57, DOI 10.1159/000366481; Duffield JS, 2011, J AM SOC NEPHROL, V22, P199, DOI 10.1681/ASN.2010121301; Esson ML, 2002, ANN INTERN MED, V137, P744, DOI 10.7326/0003-4819-137-9-200211050-00010; Fligny C, 2013, CURR OPIN RHEUMATOL, V25, P78, DOI 10.1097/BOR.0b013e32835b656b; Grande MT, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-19; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hui Y, 2011, J ALZHEIMERS DIS, V26, P299, DOI 10.3233/JAD-2011-102061; Jung M, 2012, KIDNEY INT, V81, P969, DOI 10.1038/ki.2011.446; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Kida Y, 2013, J AM SOC NEPHROL, V24, P559, DOI 10.1681/ASN.2012080871; Kie JH, 2008, J AM SOC NEPHROL, V19, P1681, DOI 10.1681/ASN.2007101099; Kim JH, 2006, J AM SOC NEPHROL, V17, P1373, DOI 10.1681/ASN.2005091001; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Lakkis FG, 1996, KIDNEY INT, V49, P117, DOI 10.1038/ki.1996.16; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Lien YHH, 2003, LIFE SCI, V74, P543, DOI 10.1016/j.lfs.2003.08.001; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Liu LL, 2012, AM J NEPHROL, V36, P386, DOI 10.1159/000343283; Morimoto K, 2001, KIDNEY INT, V60, P1858, DOI 10.1046/j.1523-1755.2001.01000.x; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Nath KA, 2014, CURR OPIN NEPHROL HY, V23, P17, DOI 10.1097/01.mnh.0000437613.88158.d3; Peng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106164; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Schrimpf C, 2012, J AM SOC NEPHROL, V23, P868, DOI 10.1681/ASN.2011080851; Song SM, 2012, NEPHROL DIAL TRANSPL, V27, P2712, DOI 10.1093/ndt/gfr621; Vanella L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt176; Vernon MA, 2010, SEMIN NEPHROL, V30, P302, DOI 10.1016/j.semnephrol.2010.03.004; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Wu BJ, 2009, ARTERIOSCL THROM VAS, V29, P1537, DOI 10.1161/ATVBAHA.109.184713; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	40	41	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147084	10.1371/journal.pone.0147084	http://dx.doi.org/10.1371/journal.pone.0147084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765329	Green Published, gold			2022-12-27	WOS:000368459300065
J	de Terline, DM; Hejblum, G; Fernandez, C; Cohen, A; Antignac, M				de Terline, Diane Macquart; Hejblum, Gilles; Fernandez, Christine; Cohen, Ariel; Antignac, Marie			Discrepancies between Patients' Preferences and Educational Programs on Oral Anticoagulant Therapy: A Survey in Community Pharmacies and Hospital Consultations	PLOS ONE			English	Article							SELF-MANAGEMENT; BLEEDING COMPLICATIONS; INFORMATION NEEDS; UNMET INFORMATION; WARFARIN; PREVENTION; SERVICES; DELIVERY	Background Oral anticoagulation therapy is increasingly used for the prevention and treatment of thromboembolic complications in various clinical situations. Nowadays, education programs for patients treated with anticoagulants constitute an integrated component of their management. However, such programs are usually based on the healthcare providers' perceptions of what patients should know, rather than on patients' preferences. Objective To investigate patients' viewpoints on educational needs and preferred modalities of information delivery. Methods We conducted an observational study based on a self-administered questionnaire. To explore several profiles of patients, the study was designed for enrolling patients in two settings: during outpatient consultations in a cardiology department (Saint Antoine Hospital, Paris, France) and in community pharmacies throughout France. Results Of the 371 patients who completed the questionnaire, 187 (50.4%) were recruited during an outpatient consultation and 184 (49.6%) were recruited in community pharmacies. 84.1% of patients were receiving a vitamin K antagonist and 15.6% a direct oral anticoagulant. Patients ranked 16 of 21 (76.2%) questionnaire items on information about their treatment as important or essential; information on adverse effects of treatment was the highest ranked domain (mean score 2.38, 95% CI 2.30-2.46). Pharmacists (1.69, 1.58-1.80), nurses (1.05, 0.95-1.16), and patient associations (0.36, 0.29-0.44), along with group sessions (0.85, 0.75-0.95), the internet (0.77, 0.67-0.88), and delivery of material at the patient's home (1.26, 1.14-1.38), were ranked poorly in terms of delivering educational material. Conclusion This study revealed substantial discrepancies between patient preferences and current educational programs. These findings should be useful for tailoring future educational programs that are better adapted to patients, with a potential associated enhancement of their effectiveness.	[de Terline, Diane Macquart; Fernandez, Christine; Antignac, Marie] Hop St Antoine, AP HP, Serv Pharm, F-75571 Paris, France; [Hejblum, Gilles; Fernandez, Christine] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ IPLESP, INSERM, Paris, France; [Fernandez, Christine] Univ Paris 11, Fac Pharm, F-92290 Chatenay Malabry, France; [Cohen, Ariel] Hop St Antoine, AP HP, Serv Cardiol, F-75571 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	de Terline, DM (corresponding author), Hop St Antoine, AP HP, Serv Pharm, F-75571 Paris, France.	diane.macquart-de-terline@sat.aphp.fr	Hejblum, Gilles/N-6337-2017	Hejblum, Gilles/0000-0003-0127-1964	AstraZeneca; Bayer Pharma; Bohringer-Ingelheim; Daiichi Sankyo; GlaxoSmithKline; sanofi-aventis	AstraZeneca(AstraZeneca); Bayer Pharma; Bohringer-Ingelheim; Daiichi Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); sanofi-aventis(Sanofi-Aventis)	Diane Macquart de Terline, Gilles Hejblum, Christine Fernandez and Marie Antignac have declared that no competing interests exist. The authors have read the journal's policy and an author of this manuscript has the following competing interests: Dr. Cohen has received consultant and lecture fees from AstraZeneca, Bayer Pharma, Bohringer-Ingelheim, Daiichi Sankyo, GlaxoSmithKline, and sanofi-aventis. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Agence Nationale de Securite des Medicaments et des Produits de Sante, ANT FRANC 2014 ET LI; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Boberg EW, 2003, PATIENT EDUC COUNS, V49, P233, DOI 10.1016/S0738-3991(02)00183-0; Breukink-Engbers WGM, 1999, SEMIN THROMB HEMOST, V25, P37, DOI 10.1055/s-2007-996422; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Clarkesmith DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074037; Clarkesmith DE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008600.pub2; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cromheecke ME, 2000, LANCET, V356, P97, DOI 10.1016/S0140-6736(00)02470-3; CRPV, 2007, EFF IND MED INC RISQ; Direction de la Recherche des Etudes de l'Evaluation et des Statistiques, ENQ NAT EV IND GRAV; Gadisseur APA, 2003, ARCH INTERN MED, V163, P2639, DOI 10.1001/archinte.163.21.2639; Garcia-Alamino Josep M, 2010, COCHRANE DATABASE SY; Germano G, 2012, EUR HEART J, V33, P137; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; HIRSH J, 1991, NEW ENGL J MED, V324, P1865; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; HOLLANDER M, 1999, NONPARAMETRIC STAT M, P295; Hoving C, 2010, PATIENT EDUC COUNS, V78, P275, DOI 10.1016/j.pec.2010.01.015; Hua TD, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-17; Kohlmann S, 2013, PATIENT EDUC COUNS, V91, P378, DOI 10.1016/j.pec.2013.01.002; Kreps GL, 2010, PATIENT EDUC COUNS, V78, P329, DOI 10.1016/j.pec.2010.01.013; Kyrle PA, 2012, LANCET, V379, P292, DOI 10.1016/S0140-6736(11)61748-0; Lip GYH, 2006, THROMB RES, V118, P321, DOI 10.1016/j.thromres.2005.08.007; Matsuyama RK, 2013, PATIENT EDUC COUNS, V90, P96, DOI 10.1016/j.pec.2012.09.009; Meesters J, 2011, PATIENT EDUC COUNS, V85, P299, DOI 10.1016/j.pec.2010.10.004; Meesters JJL, 2009, CLIN RHEUMATOL, V28, P1073, DOI 10.1007/s10067-009-1190-3; Montori VM, 2013, JAMA-J AM MED ASSOC, V310, P2503, DOI 10.1001/jama.2013.281422; Nutescu EA, 2003, J THROMB THROMBOLYS, V16, P61, DOI 10.1023/B:THRO.0000014595.46367.89; Papadakos J, 2012, GYNECOL ONCOL, V124, P452, DOI 10.1016/j.ygyno.2011.10.030; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Powell J, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1600; Sawicki PT, 1999, JAMA-J AM MED ASSOC, V281, P145, DOI 10.1001/jama.281.2.145; Wang Y, 2014, THROMB RES, V133, P550, DOI 10.1016/j.thromres.2014.01.002; Wintz L, 2010, HAEMOPHILIA, V16, P447, DOI 10.1111/j.1365-2516.2009.02163.x; Wofford JL, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-40; Wong PYH, 2013, J THROMB HAEMOST, V11, P491, DOI 10.1111/jth.12107; World Health Organization, 2007, PEER SUPP PROGR DIAB; World Health Organization (WHO), 1998, THERAPEUTIC PATIENT; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Zandbelt LC, 2007, PATIENT EDUC COUNS, V65, P396, DOI 10.1016/j.pec.2006.09.011	43	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146927	10.1371/journal.pone.0146927	http://dx.doi.org/10.1371/journal.pone.0146927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB4CC	26765105	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300052
J	Gerin, D; Angelini, RMD; Pollastro, S; Faretra, F				Gerin, Donato; Angelini, Rita M. De Miccolis; Pollastro, Stefania; Faretra, Francesco			RNA-Seq Reveals OTA-Related Gene Transcriptional Changes in Aspergillus carbonarius	PLOS ONE			English	Article							OCHRATOXIN-A; INCREASED EXPRESSION; CLUSTER PROTEIN; BIOSYNTHESIS; NIDULANS; PATHWAY; BINDING; NIGER; AFLR; ANNOTATION	Ochratoxin A (OTA) is a mycotoxin harmful for animals and humans. Aspergillus carbonarius is the main responsible for OTA contamination of grapes and derived products. Gene transcriptional profiling of 4 A. carbonarius strains was carried out by RNA-Seq analysis to study transcriptome changes associated with OTA production. By comparing OTA inducing (OTAI) vs. non-inducing (OTAN) cultural conditions, a total of 3,705 differentially expressed genes (DEGs) (fold change > vertical bar 2 vertical bar and FDR <= 0.05) were identified. Several genes involved in primary metabolic processes, with particular regard to carbohydrate and amino acid metabolisms, secondary metabolic processes, transport, response to stress and sporulation were up-regulated by OTAI conditions at all the analysed sampling times (4, 6 and 8 DAI) or starting from 6 DAI. Highly up-regulated DEGs encoding enzymes involved in biosynthesis of secondary metabolites, oxidoreductases, transporters and transcription factors were examined for their potential involvement in OTA biosynthesis and related metabolic pathways. Differential expression of genes encoding polyketide synthases (pks), non-ribosomal peptide synthetases (nrps) and chloroperoxidase (cpo) was validated by RT-qPCR. Among clusters of co-regulated genes involved in SM biosynthesis, one putative OTA-gene cluster, including both pks and nrps genes, was detected in the A. carbonarius genome.	[Gerin, Donato; Angelini, Rita M. De Miccolis; Pollastro, Stefania; Faretra, Francesco] Univ Bari Aldo Moro, Sect Plant Pathol, Dept Soil Plant & Food Sci, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Angelini, RMD (corresponding author), Univ Bari Aldo Moro, Sect Plant Pathol, Dept Soil Plant & Food Sci, Bari, Italy.	ritamilvia.demiccolisangelini@uniba.it		Gerin, Donato/0000-0002-6520-2311; De Miccolis Angelini, Rita Milvia/0000-0002-5130-0076	Distretto Agroalimentare Regionale - D.A.Re.s.c.ar.l.; Apulia Region, PO FESR-Axis I, Line of intervention 1.2., Action 1.2.1 [14]	Distretto Agroalimentare Regionale - D.A.Re.s.c.ar.l.; Apulia Region, PO FESR-Axis I, Line of intervention 1.2., Action 1.2.1	The work was partially carried out in the framework of the Projects: "Laboratory network for the selection, characterization and conservation of germplasm and for preventing the spread of economically-relevant and quarantine pests (SELGE) No. 14", founded by the Apulia Region, PO FESR 2007-2013-Axis I, Line of intervention 1.2., Action 1.2.1; "Promotion of ECO-friendly processes for the enhancement of quality of apulian food productions" granted by the "Distretto Agroalimentare Regionale - D.A.Re.s.c.ar.l.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca ML, 2003, J FOOD PROTECT, V66, P504, DOI 10.4315/0362-028X-66.3.504; Alexander NJ, 2009, TOXIN REV, V28, P198, DOI 10.1080/15569540903092142; Alexander NJ, 1999, MOL GEN GENET, V261, P977, DOI 10.1007/s004380051046; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Anli E, 2010, J I BREWING, V116, P23, DOI 10.1002/j.2050-0416.2010.tb00394.x; Bacha N, 2009, FUNGAL GENET BIOL, V46, P77, DOI 10.1016/j.fgb.2008.09.015; BACON CW, 1975, APPL MICROBIOL, V29, P317, DOI 10.1128/AEM.29.3.317-322.1975; Battilani P, 2003, EUR J PLANT PATHOL, V109, P715, DOI 10.1023/A:1026030408338; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Botton A, 2008, INT J FOOD MICROBIOL, V127, P105, DOI 10.1016/j.ijfoodmicro.2008.06.037; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Brown DW, 2007, EUKARYOT CELL, V6, P1210, DOI 10.1128/EC.00400-06; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Buchanan RL, 1988, NITROGEN SOURCE CONT, P137; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cabanes FJ, 2002, INT J FOOD MICROBIOL, V79, P213, DOI 10.1016/S0168-1605(02)00087-9; Cabanes FJ, 2015, SCI REP, V5, P1; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; CHANG PK, 1995, APPL ENVIRON MICROB, V61, P2372, DOI 10.1128/AEM.61.6.2372-2377.1995; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crespo-Sempere A, 2013, INT J FOOD MICROBIOL, V166, P479, DOI 10.1016/j.ijfoodmicro.2013.07.027; Crespo-Sempere A, 2011, INT J FOOD MICROBIOL, V147, P162, DOI 10.1016/j.ijfoodmicro.2011.03.021; Crespo-Sernpere A, 2010, INT J FOOD MICROBIOL, V142, P170, DOI 10.1016/j.ijfoodmicro.2010.06.019; Ehrlich KC, 1999, GENE, V230, P249, DOI 10.1016/S0378-1119(99)00075-X; el Khoury A, 2010, TOXINS, V2, P461, DOI 10.3390/toxins2040461; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Gallo A, 2009, INT J FOOD MICROBIOL, V129, P8, DOI 10.1016/j.ijfoodmicro.2008.10.022; Gallo A, 2014, INT J FOOD MICROBIOL, V179, P10, DOI 10.1016/j.ijfoodmicro.2014.03.013; Gallo A, 2012, APPL ENVIRON MICROB, V78, P8208, DOI 10.1128/AEM.02508-12; Geisen R, 2006, Mycotoxin Res, V22, P134, DOI 10.1007/BF02956777; GuzmandePena D, 1997, FUNGAL GENET BIOL, V21, P198, DOI 10.1006/fgbi.1996.0945; HAGGBLOM PE, 1985, APPL ENVIRON MICROB, V49, P787; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Huffman J, 2010, BIOPOLYMERS, V93, P764, DOI 10.1002/bip.21483; Inglis DO, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-91; INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V56, P489; Karolewiez A, 2005, SYST APPL MICROBIOL, V28, P588, DOI 10.1016/j.syapm.2005.03.008; Krijgsheld P, 2013, STUD MYCOL, P1, DOI 10.3114/sim0006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARQUARDT RR, 1992, J ANIM SCI, V70, P3968, DOI 10.2527/1992.70123968x; Martin JF, 2005, CURR OPIN MICROBIOL, V8, P282, DOI 10.1016/j.mib.2005.04.009; Mateo R, 2007, INT J FOOD MICROBIOL, V119, P79, DOI 10.1016/j.ijfoodmicro.2007.07.029; Medina A, 2005, J CHROMATOGR A, V1083, P7, DOI 10.1016/j.chroma.2005.05.089; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Novodvorska M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-246; O'Callaghan J, 2006, FUNGAL GENET BIOL, V43, P213, DOI 10.1016/j.fgb.2005.11.005; O'Callaghan J, 2003, MICROBIOL-SGM, V149, P3485, DOI 10.1099/mic.0.26619-0; Ogawa M, 2010, FUNGAL GENET BIOL, V47, P10, DOI 10.1016/j.fgb.2009.10.004; Ozden S, 2012, FOOD CONTROL, V25, P69, DOI 10.1016/j.foodcont.2011.10.015; Pardo E, 2004, FOOD SCI TECHNOL INT, V10, P45, DOI 10.1177/1082013204041509; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pollastro S, 2003, J PLANT PATHOL, V85, P281; Reverberi M, 2012, APPL MICROBIOL BIOT, V95, P1293, DOI 10.1007/s00253-012-3985-4; Rozen S, 2000, Methods Mol Biol, V132, P365; SANDERSON KE, 1965, AM J BOT, V52, P72, DOI 10.2307/2439977; Shundo L, 2009, FOOD CONTROL, V20, P1099, DOI 10.1016/j.foodcont.2009.02.008; Slaven JW, 2002, FUNGAL GENET BIOL, V36, P199, DOI 10.1016/S1087-1845(02)00016-6; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004; Zimmerli B, 1996, FOOD ADDIT CONTAM, V13, P655, DOI 10.1080/02652039609374451	62	21	22	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147089	10.1371/journal.pone.0147089	http://dx.doi.org/10.1371/journal.pone.0147089			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765536	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300066
J	Vartoukian, SR; Adamowska, A; Lawlor, M; Moazzez, R; Dewhirst, FE; Wade, WG				Vartoukian, Sonia R.; Adamowska, Aleksandra; Lawlor, Megan; Moazzez, Rebecca; Dewhirst, Floyd E.; Wade, William G.			In Vitro Cultivation of 'Unculturable' Oral Bacteria, Facilitated by Community Culture and Media Supplementation with Siderophores	PLOS ONE			English	Article							BIOFILM FORMATION; SUBGINGIVAL MICROBIOME; CYSTIC-FIBROSIS; DIVERSITY; DISEASE; GROWTH; PERIODONTITIS; HEALTH; MICROORGANISMS; PATHOGENESIS	Over a third of oral bacteria are as-yet-uncultivated in-vitro. Siderophores have been previously shown to enable in-vitro growth of previously uncultivated bacteria. The objective of this study was to cultivate novel oral bacteria in siderophore-supplemented culture media. Various compounds with siderophore activity, including pyoverdines-Fe-complex, desferricoprogen and salicylic acid, were found to stimulate the growth of difficult-to-culture strains Prevotella sp. HOT-376 and Fretibacterium fastidiosum. Furthermore, pyrosequencing analysis demonstrated increased proportions of the as-yet-uncultivated phylotypes Dialister sp. HOT-119 and Megasphaera sp. HOT-123 on mixed culture plates supplemented with siderophores. Therefore a culture model was developed, which incorporated 15 mu g siderophore (pyoverdines-Fe-complex or desferricoprogen) or 150 mu l neat subgingival-plaque suspension into a central well on agar plates that were inoculated with heavily-diluted subgingival-plaque samples from subjects with periodontitis. Colonies showing satellitism were passaged onto fresh plates in co-culture with selected helper strains. Five novel strains, representatives of three previously-uncultivated taxa (Anaerolineae bacterium HOT-439, the first oral taxon from the Chloroflexi phylum to have been cultivated; Bacteroidetes bacterium HOT-365; and Peptostreptococcaceae bacterium HOT-091) were successfully isolated. All novel isolates required helper strains for growth, implying dependence on a biofilm lifestyle. Their characterisation will further our understanding of the human oral microbiome.	[Vartoukian, Sonia R.; Adamowska, Aleksandra; Lawlor, Megan; Wade, William G.] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Moazzez, Rebecca] Kings Coll London, Inst Dent, London WC2R 2LS, England; [Dewhirst, Floyd E.] Forsyth Inst, Cambridge, MA USA; [Dewhirst, Floyd E.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA	University of London; Queen Mary University London; University of London; King's College London; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Wade, WG (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.	w.wade@qmul.ac.uk		Dewhirst, Floyd E./0000-0003-4427-7928; Moazzez, Rebecca/0000-0002-3673-2604	National Institute of Dental and Craniofacial Research of the National Institutes of Health [R37DE016937, R01DE024468]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE016937, R01DE024468] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research reported in this publication was supported by The National Institute of Dental and Craniofacial Research of the National Institutes of Health under awards R37DE016937 and R01DE024468. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported in this publication was supported by The National Institute of Dental and Craniofacial Research of the National Institutes of Health under awards R37DE016937 and R01DE024468. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Bikel S, 2015, COMPUT STRUCT BIOTEC, V13, P390, DOI 10.1016/j.csbj.2015.06.001; Bollmann A, 2010, APPL ENVIRON MICROB, V76, P7413, DOI 10.1128/AEM.00376-10; Camanocha A, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.25468; Campbell AG, 2014, ENVIRON MICROBIOL, V16, P2635, DOI 10.1111/1462-2920.12461; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Guan L L, 2001, BMC Microbiol, V1, P27, DOI 10.1186/1471-2180-1-27; Hardie J, 1971, ISOLATION ANAEROBES; Harrison F, 2009, ISME J, V3, P632, DOI 10.1038/ismej.2009.9; He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112; Jakiela S, 2013, ANGEW CHEM INT EDIT, V52, P8908, DOI 10.1002/anie.201301524; Jung D, 2014, FEMS MICROBIOL ECOL, V90, P417, DOI 10.1111/1574-6941.12399; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kapil V, 2013, FREE RADICAL BIO MED, V55, P93, DOI 10.1016/j.freeradbiomed.2012.11.013; Kummerli R, 2009, J EVOLUTION BIOL, V22, P589, DOI 10.1111/j.1420-9101.2008.01666.x; Kummerli R, 2014, ECOL LETT, V17, P1536, DOI 10.1111/ele.12371; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Lewis K, 2010, J ANTIBIOT, V63, P468, DOI 10.1038/ja.2010.87; Mihai MM, 2015, CURR TOP MED CHEM, V15, P1552; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Mossialos D, 2009, INT J MED MICROBIOL, V299, P87, DOI 10.1016/j.ijmm.2008.06.008; Nichols D, 2008, APPL ENVIRON MICROB, V74, P4889, DOI 10.1128/AEM.00393-08; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Szafranski SP, 2015, APPL ENVIRON MICROB, V81, P1047, DOI 10.1128/AEM.03534-14; Tanaka Y, 2015, MICROBIOL IMMUNOL, V59, P63, DOI 10.1111/1348-0421.12220; Thompson H, 2015, APPL ENV MICROBIOL; Vartoukian SR, 2010, ENVIRON MICROBIOL, V12, P916, DOI 10.1111/j.1462-2920.2009.02135.x; Vartoukian SR, 2009, APPL ENVIRON MICROB, V75, P3777, DOI 10.1128/AEM.02763-08; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006	40	48	50	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146926	10.1371/journal.pone.0146926	http://dx.doi.org/10.1371/journal.pone.0146926			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764907	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300051
J	Hong, H; Brown, CE; Ostberg, JR; Priceman, SJ; Chang, WC; Weng, LH; Lin, P; Wakabayashi, MT; Jensen, MC; Forman, SJ				Hong, Hao; Brown, Christine E.; Ostberg, Julie R.; Priceman, Saul J.; Chang, Wen-Chung; Weng, Lihong; Lin, Paul; Wakabayashi, Mark T.; Jensen, Michael C.; Forman, Stephen J.			L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice	PLOS ONE			English	Article							ADOPTIVE TRANSFER; HUMAN TUMORS; EXPRESSION; L1-CAM; MEMORY; MARKER; PERSISTENCE; APOPTOSIS; SELECTION; SURVIVAL	New therapeutic modalities are needed for ovarian cancer, the most lethal gynecologic malignancy. Recent clinical trials have demonstrated the impressive therapeutic potential of adoptive therapy using chimeric antigen receptor (CAR)-redirected T cells to target hematological cancers, and emerging studies suggest a similar impact may be achieved for solid cancers. We sought determine whether genetically-modified T cells targeting the CE7-epitope of L1-CAM, a cell adhesion molecule aberrantly expressed in several cancers, have promise as an immunotherapy for ovarian cancer, first demonstrating that L1-CAM was highly over-expressed on a panel of ovarian cancer cell lines, primary ovarian tumor tissue specimens, and ascites-derived primary cancer cells. Human central memory derived T cells (T-CM) were then genetically modified to express an anti-L1-CAM CAR (CE7R), which directed effector function upon tumor antigen stimulation as assessed by in vitro cytokine secretion and cytotoxicity assays. We also found that CE7R(+) T cells were able to target primary ovarian cancer cells. Intraperitoneal (i.p.) administration of CE7R(+) TCM induced a significant regression of i.p. established SK-OV-3 xenograft tumors in mice, inhibited ascites formation, and conferred a significant survival advantage compared with control-treated animals. Taken together, these studies indicate that adoptive transfer of L1-CAM-specific CE7R(+) T cells may offer a novel and effective immunotherapy strategy for advanced ovarian cancer.	[Hong, Hao; Brown, Christine E.; Ostberg, Julie R.; Priceman, Saul J.; Chang, Wen-Chung; Weng, Lihong; Forman, Stephen J.] City Hope Natl Med, Dept Canc Immunotherapeut & Tumor Immunol & Hemat, Beckman Res Inst, Duarte, CA USA; [Lin, Paul; Wakabayashi, Mark T.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Gynecol Oncol, Duarte, CA 91010 USA; [Jensen, Michael C.] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA 98101 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Seattle Children's Hospital	Jensen, MC (corresponding author), Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA 98101 USA.	michael.jensen@seattlechildrens.org; sforman@coh.org		Brown, Christine/0000-0003-4915-8207	Hoeven Family Kidney Cancer Research Fund; NCI Cancer Center Support Grant [P30 CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	Hoeven Family Kidney Cancer Research Fund; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Hoeven Family Kidney Cancer Research Fund, and the NCI Cancer Center Support Grant (P30 CA33572).	Allory Y, 2005, CLIN CANCER RES, V11, P1190; Andersson E, 2012, CANCER IMMUNOL IMMUN, V61, P1243, DOI 10.1007/s00262-012-1201-0; Arlt MJE, 2006, CANCER RES, V66, P936, DOI 10.1158/0008-5472.CAN-05-1818; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bondong S, 2012, ANN ONCOL, V23, P1795, DOI 10.1093/annonc/mdr568; Boo YJ, 2007, ANN SURG ONCOL, V14, P1703, DOI 10.1245/s10434-006-9281-8; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Cheadle EJ, 2014, IMMUNOL REV, V257, P91, DOI 10.1111/imr.12126; Chekmasova AA, 2010, CLIN CANCER RES, V16, P3594, DOI 10.1158/1078-0432.CCR-10-0192; Cooper LJN, 2003, BLOOD, V101, P1637, DOI 10.1182/blood-2002-07-1989; Daponte A, 2008, EUR J GYNAECOL ONCOL, V29, P26; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Dinh P, 2008, CRIT REV ONCOL HEMAT, V67, P103, DOI 10.1016/j.critrevonc.2008.01.012; Doberstein K, 2011, CARCINOGENESIS, V32, P262, DOI 10.1093/carcin/bgq249; Fischer E, 2012, INT J CANCER, V130, P2715, DOI 10.1002/ijc.26321; Gast D, 2008, ONCOGENE, V27, P1281, DOI 10.1038/sj.onc.1210747; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gavert N, 2008, EXPERT OPIN BIOL TH, V8, P1749, DOI 10.1517/14712598.8.11.1749 ; Gonzalez S, 2004, J GENE MED, V6, P704, DOI 10.1002/jgm.489; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Hegde M, 2013, MOL THER, V21, P2087, DOI 10.1038/mt.2013.185; Hong H, 2014, J IMMUNOTHER, V37, P93, DOI 10.1097/CJI.0000000000000018; Huszar M, 2006, HUM PATHOL, V37, P1000, DOI 10.1016/j.humpath.2006.03.014; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Jonnalagadda M, 2013, GENE THER, V20, P853, DOI 10.1038/gt.2012.97; Jonnalagadda M, 2015, MOL THER, V23, P757, DOI 10.1038/mt.2014.208; Kahlon KS, 2004, CANCER RES, V64, P9160, DOI 10.1158/0008-5472.CAN-04-0454; Kaifi JT, 2006, WORLD J GASTROENTERO, V12, P94, DOI 10.3748/wjg.v12.i1.94; Kakarla S, 2014, CANCER J, V20, P151, DOI 10.1097/PPO.0000000000000032; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Kunkele A, 2015, CANCER IMMUNOL RES, V3, P368, DOI 10.1158/2326-6066.CIR-14-0200; Lanitis E, 2013, CANCER IMMUNOL RES, V1, P43, DOI 10.1158/2326-6066.CIR-13-0008; Li S, 2009, CLIN CANCER RES, V15, P7345, DOI 10.1158/1078-0432.CCR-09-0959; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Murkoster SS, 2007, ONCOGENE, V26, P2759, DOI 10.1038/sj.onc.1210076; Nguyen P, 2003, BLOOD, V102, P4320, DOI 10.1182/blood-2003-04-1255; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Ramos CA, 2014, CANCER J, V20, P112, DOI 10.1097/PPO.0000000000000031; Schroder C, 2009, ONCOL REP, V22, P1109, DOI 10.3892/or_00000543; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stoeck A, 2007, GYNECOL ONCOL, V104, P461, DOI 10.1016/j.ygyno.2006.08.038; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Wang XL, 2012, J IMMUNOTHER, V35, P689, DOI 10.1097/CJI.0b013e318270dec7; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Wefers C, 2015, GYNECOL ONCOL; Zeechini S, 2008, CANCER RES, V68, P1110, DOI 10.1158/0008-5472.CAN-07-2897; Zhao YB, 2010, CANCER RES, V70, P9053, DOI 10.1158/0008-5472.CAN-10-2880; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	50	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146885	10.1371/journal.pone.0146885	http://dx.doi.org/10.1371/journal.pone.0146885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761817	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100049
J	Davids, M; Hugenholtz, F; dos Santos, VM; Smidt, H; Kleerebezem, M; Schaap, PJ				Davids, Mark; Hugenholtz, Floor; dos Santos, Vitor Martins; Smidt, Hauke; Kleerebezem, Michiel; Schaap, Peter J.			Functional Profiling of Unfamiliar Microbial Communities Using a Validated De Novo Assembly Metatranscriptome Pipeline	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; GENE-EXPRESSION; PROTEIN; GENERATION; RNA; ANNOTATION; OBESITY; RECONSTRUCTION; ENTEROTYPES; ALGORITHMS	Background Metatranscriptomic landscapes can provide insights in functional relationships within natural microbial communities. Analysis of complex metatranscriptome datasets of these communities poses a considerable bioinformatic challenge since they are non-restricted with a varying number of participating strains and species. For RNA-Seq data a standard approach is to align the generated reads to a set of closely related reference genomes. This only works well for microbial communities for which a near complete catalogue of reference genomes is available at a small evolutionary distance. In this study, we focus on the design of a validated de novo metatranscriptome assembly pipeline for single-end Illumina RNASeq data to obtain functional and taxonomic profiles of murine microbial communities. Results The here developed de novo assembly metatranscriptome pipeline combined rRNA removal, IDBA-UD assembler, functional annotation and taxonomic classification. Different assemblers were tested and validated using RNA-Seq data from an in silico generated mock community and in vivo RNA-Seq data from a restricted microbial community taken from a mouse model colonized with Altered Schaedler Flora (ASF). Precision and recall of resulting gene expression, functional and taxonomic profiles were compared to those obtained with a standard alignment method. The validated pipeline was subsequently used to generate expression profiles from non-restricted cecal communities of four C57BL/6J mice fed on a high-fat high-protein diet spiked with an RNA-Seq data set from a well-characterized human sample. The spike in control was used to estimate precision and recall at assembly, functional and taxonomic level of non-restricted communities. Conclusions A generic de novo assembly pipeline for metatranscriptome data analysis was designed for microbial ecosystems, which can be applied for microbial metatranscriptome analysis in any chosen niche.	[Davids, Mark; dos Santos, Vitor Martins; Schaap, Peter J.] Wageningen Univ, Lab Syst & Synthet Biol, NL-6700 AP Wageningen, Netherlands; [Hugenholtz, Floor; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, NL-6700 AP Wageningen, Netherlands; [Davids, Mark; Hugenholtz, Floor; dos Santos, Vitor Martins; Smidt, Hauke; Kleerebezem, Michiel; Schaap, Peter J.] Netherlands Consortium Syst Biol TI Food & Nutr, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Top Institute Food & Nutrition	Schaap, PJ (corresponding author), Wageningen Univ, Lab Syst & Synthet Biol, Dreijenpl 10, NL-6700 AP Wageningen, Netherlands.	peter.schaap@wur.nl	Kleerebezem, Michiel/AAT-2078-2021; Smidt, Hauke/D-7054-2014	Smidt, Hauke/0000-0002-6138-5026; Davids, Mark/0000-0003-3081-9124; Hugenholtz, Floor/0000-0001-8173-197X; martins dos santos, vitor/0000-0002-2352-9017; Schaap, Peter/0000-0002-4346-6084; Kleerebezem, Michiel/0000-0001-8552-2235	Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative / Netherlands Organization for Scientific Research	Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative / Netherlands Organization for Scientific Research	This work was (co) financed by the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative / Netherlands Organization for Scientific Research.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Celaj A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-39; Chang D, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-304; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee FJ, 2015, ENVIRON MICROBIOL, V17, P796, DOI 10.1111/1462-2920.12526; Leimena MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-530; Leimena MM, 2012, APPL ENVIRON MICROB, V78, P4141, DOI 10.1128/AEM.00470-12; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Leung HCM, 2013, J COMPUT BIOL, V20, P540, DOI 10.1089/cmb.2013.0042; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lozupone C, 2012, GENOME RES, V22, P1974, DOI 10.1101/gr.138198.112; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nadkarni Prakash M, 2012, J Clin Bioinforma, V2, P9, DOI 10.1186/2043-9113-2-9; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Peng Y, IDBA PRACTICAL ITERA; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pittet V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073627; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richards VP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-920; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schwab C, 2014, MICROB BIOTECHNOL, V7, P347, DOI 10.1111/1751-7915.12126; Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047303; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Toseland A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-901; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang Y, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-138; Wannemuehler MJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00287-14; Westerterp-Plantenga MS, 2012, BRIT J NUTR, V108, pS105, DOI 10.1017/S0007114512002589; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xiong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036009; Yamada T, 2011, NUCLEIC ACIDS RES, V39, pW412, DOI 10.1093/nar/gkr313; Yang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-328; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zoetendal EG, 2006, NAT PROTOC, V1, P954, DOI 10.1038/nprot.2006.143	61	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146423	10.1371/journal.pone.0146423	http://dx.doi.org/10.1371/journal.pone.0146423			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756338	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888800013
J	Mothe, D; Ferretti, MP; Avilla, LS				Mothe, Dimila; Ferretti, Marco P.; Avilla, Leonardo S.			The Dance of Tusks: Rediscovery of Lower Incisors in the Pan-American Proboscidean Cuvieronius hyodon Revises Incisor Evolution in Elephantimorpha	PLOS ONE			English	Article							GOMPHOTHERIUM ANGUSTIDENS CUVIER; MAMMALIA; PLEISTOCENE; MIOCENE; CLIMATE; ANATOMY; GERS	The incisors of proboscideans (tusks and tushes) are one of the most important feature in conservation, ecology and evolutionary history of these mammals. Although the absence of upper incisors is rare in proboscideans (occurring only in deinotheres), the independent losses of lower incisors are recognized for most of its lineages (dibelodont condition). The presence of lower incisors in the Pan-American gomphothere Cuvieronius hyodon was reported a few times in literature, but it was neglected in systematic studies. We analyzed several specimens of Cuvieronius hyodon from the Americas and recognized that immature individuals had lower incisors during very early post-natal developmental stages. Subsequently, these are lost and lower incisors alveoli close during later developmental stages, before maturity. Moreover, for the first time in a formal cladistic analysis of non-amebelodontine trilophodont gomphotheres, Rhynchotherium and Cuvieronius were recovered as sister- taxa. Among several non-ambiguous synapomorphies, the presence of lower incisors diagnoses this clade. We recognize that the presence of lower incisors in Cuvieronius and Rhynchotherium is an unique case of taxic atavism among the Elephantimorpha, since these structures are lost at the origin of the ingroup. The rediscovery of the lower incisors in Cuvieronius hyodon, their ontogenetic interpretation and the inclusion of this feature in a revised phylogenetic analysis of trilophodont gomphotheres brought a better understanding for the evolutionary history of these proboscideans.	[Mothe, Dimila; Avilla, Leonardo S.] Univ Fed Estado Rio de Janeiro, Inst Biociencias, Dept Zool, Lab Mastozool, BR-22290240 Rio De Janeiro, Brazil; [Mothe, Dimila] Univ Fed Rio de Janeiro, Museu Nacl, Programa Posgrad Ciencias Biol Zool, BR-20940040 Rio de Janeiro, Brazil; [Ferretti, Marco P.] Univ Florence, Dipartimento Sci Terra, I-50121 Florence, Italy; Univ Florence, Museo Storia Nat, Sez Geol & Paleontol, I-50121 Florence, Italy; [Avilla, Leonardo S.] Univ Fed Estado Rio de Janeiro, Inst Biociencias, Programa Posgrad Biodiversidade Neotrop, BR-22290240 Rio De Janeiro, Brazil	Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University of Florence; University of Florence; Universidade Federal do Estado do Rio de Janeiro	Mothe, D (corresponding author), Univ Fed Estado Rio de Janeiro, Inst Biociencias, Dept Zool, Lab Mastozool, Ave Pasteur 458,501, BR-22290240 Rio De Janeiro, Brazil.	dimothe@hotmail.com	Mothé, Dimila/ABE-8262-2020	Mothé, Dimila/0000-0002-4073-5963; Avilla, LEONARDO/0000-0001-5547-5757	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [140453/2012-01, 201081/2014-8, 248772/2013-9]; Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/100.246/2014, 204036-E_ 25/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (140453/2012-01, 201081/2014-8 - DM; 248772/2013-9 - LSA), www.cnpq.br, and Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro (E-26/100.246/2014 - DM; 204036-E_ 25/2014-Jovem Cientista do Nosso Estado - LSA), www.faperj.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RH, 2011, NEW MEX MUS NAT HIST, V53, P498; Alberdi MT, 2004, NEUES JAHRB GEOL P-A, V231, P423, DOI 10.1127/njgpa/231/2004/423; Boule M, 1920, MAMMIFERES FOSSILES; Buchtova M, 2012, J DENT RES, V91, P491, DOI 10.1177/0022034512442896; Cozzuol MA, 2012, QUATERN INT, V255, P36, DOI 10.1016/j.quaint.2011.01.038; Drehmer Cesar Jaeger, 2006, Neotropical Biology and Conservation, V1, P72; Dudley PN, 2013, J EXP ZOOL, V9999, P1; Eronen JT, 2012, GEOLOGY, V40, P823, DOI 10.1130/G33147.1; Ferretti MP, 2008, J MAMM EVOL, V15, P37, DOI 10.1007/s10914-007-9057-3; Ferretti MP, 2010, GEODIVERSITAS, V32, P663, DOI 10.5252/g2010n4a3; Foster GL, 2012, EARTH PLANET SC LETT, V341, P243, DOI 10.1016/j.epsl.2012.06.007; Frick C, 1933, B AM MUS NAT HIST, V59, P505; Gatesy J, 2003, SYST BIOL, V52, P403, DOI 10.1080/10635150390197037; Gheerbrant E, 2009, CR PALEVOL, V8, P281, DOI 10.1016/j.crpv.2008.08.003; Gohlich UB, 2010, PALAEONTOL Z, V84, P163, DOI 10.1007/s12542-010-0053-1; Goloboff P, 2008, CLADISTICS, V24, P91; Green JL, 2005, J VERTEBR PALEONTOL, V25, P702, DOI 10.1671/0272-4634(2005)025[0702:TDPOMA]2.0.CO;2; HALL BK, 1984, BIOL REV, V59, P89, DOI 10.1111/j.1469-185X.1984.tb00402.x; Haynes G., 1991, MAMMOTHS MASTODONTS; Hoffstetter R., 1952, MEMOIRES SOC GEOLOGI, V31; Jakubinek MB, 2006, J MATER RES, V21, P287, DOI 10.1557/JMR.2006.0029; Janis CM, 2002, PALAEOGEOGR PALAEOCL, V177, P183, DOI 10.1016/S0031-0182(01)00359-5; KINGSLEY MCS, 1988, ARCTIC, V41, P236; Kohn MJ, 2008, GEOLOGY, V36, P783, DOI 10.1130/G24928A.1; Laurito CA, 1990, REV GEOL AM CENT, V11, P41; Liendo-Lazarte M, 1946, ALGUNAS CONSIDERACIO, P1; Lucas S.G., 2008, NEW MEXICO MUSEUM NA, V44, P71; Lucas S.G., 2008, NEW MEXICO MUSEUM NA, V44, P399; LUCAS SG, 2009, N MEX NAT HIST SCI M, V44, P409; Lucas SG, 2013, J PALAEOGEOG-ENGLISH, V2, P19, DOI 10.3724/SP.J.1261.2013.00015; Lucas Spencer G., 2010, Revista Geologica de America Central, V42, P9; Prado JL, 2008, PALAEONTOLOGY, V51, P903, DOI 10.1111/j.1475-4983.2008.00785.x; Matalova E, 2008, J DENT RES, V87, P617, DOI 10.1177/154405910808700715; Miller W.E., 1990, Brigham Young University Geology Studies, V36, P57; Montellano-Ballesteros M, 2002, J PALEONTOL, V76, P578, DOI 10.1666/0022-3360(2002)076<0578:NCFFTP>2.0.CO;2; Mothe D, AN ACAD BRA IN PRESS; Mothe D, 2015, QUATERNARY SCI REV, V110, P23, DOI 10.1016/j.quascirev.2014.12.013; Mothe D, 2013, J MAMM EVOL, V20, P23, DOI 10.1007/s10914-012-9192-3; Mothe D, 2012, QUATERN INT, V276, P2, DOI 10.1016/j.quaint.2011.05.018; Mothe D, 2010, AN ACAD BRAS CIENC, V82, P983, DOI 10.1590/S0001-37652010005000001; Nordenskiold E, 1903, MASTODON ANDIUM CUV, V37, P1; Osborn HF, 1936, B AM MUS NAT HIST, V802; Peterkova R, 2006, J EXP ZOOL PART B, V306B, P234, DOI 10.1002/jez.b.21093; Prado Jose Luis, 2003, Deinsea, V9, P347; Sanchez G, 2014, P NATL ACAD SCI USA, V111, P10972, DOI 10.1073/pnas.1404546111; Schwarz W, 2010, ELEFANTENTREICH FOSS; Shoshani J., 1996, PROBOSCIDEA EVOLUTIO; STIASSNY MLJ, 1992, NETH J ZOOL, V42, P260, DOI 10.1163/156854291X00324; Stromberg CAE, 2002, PALAEOGEOGR PALAEOCL, V177, P59, DOI 10.1016/S0031-0182(01)00352-2; TASSY P, 1987, AM MUS NOVIT, P1; TASSY P, 1985, THESIS; Tassy P, 2014, GEODIVERSITAS, V36, P35, DOI 10.5252/g2014n1a2; Tassy P, 2013, GEODIVERSITAS, V35, P377, DOI 10.5252/g2013n2a6; van Nievelt AFH, 2005, PALEOBIOLOGY, V31, P324, DOI 10.1666/0094-8373(2005)031[0324:TRONTR]2.0.CO;2; Wang Y, 2012, CHINESE SCI BULL, V57, P4726, DOI 10.1007/s11434-012-5519-y; WILLIAMS TM, 1990, J ZOOL, V222, P235, DOI 10.1111/j.1469-7998.1990.tb05674.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	57	10	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0147009	10.1371/journal.pone.0147009	http://dx.doi.org/10.1371/journal.pone.0147009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756209	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800042
J	Agrawal, D; Karsai, I				Agrawal, Devanshu; Karsai, Istvan			The Mechanisms of Water Exchange: The Regulatory Roles of Multiple Interactions in Social Wasps	PLOS ONE			English	Article							NEST CONSTRUCTION BEHAVIOR; DIVISION-OF-LABOR; INSECT SOCIETIES; POLISTES-DOMINULUS; QUEUING DELAY; PAPER WASPS; TASK; ORGANIZATION; INFORMATION; MODEL	Evolutionary benefits of task fidelity and improving information acquisition via multiple transfers of materials between individuals in a task partitioned system have been shown before, but in this paper we provide a mechanistic explanation of these phenomena. Using a simple mathematical model describing the individual interactions of the wasps, we explain the functioning of the common stomach, an information center, which governs construction behavior and task change. Our central hypothesis is a symmetry between foragers who deposit water and foragers who withdraw water into and out of the common stomach. We combine this with a trade-off between acceptance and resistance to water transfer. We ultimately derive a mathematical function that relates the number of interactions that foragers complete with common stomach wasps during a foraging cycle. We use field data and additional model assumptions to calculate values of our model parameters, and we use these to explain why the fullness of the common stomach stabilizes just below 50 percent, why the average number of successful interactions between foragers and the wasps forming the common stomach is between 5 and 7, and why there is a variation in this number of interactions over time. Our explanation is that our proposed water exchange mechanism places natural bounds on the number of successful interactions possible, water exchange is set to optimize mediation of water through the common stomach, and the chance that foragers abort their task prematurely is very low.	[Agrawal, Devanshu] E Tennessee State Univ, Dept Math & Stat, Johnson City, TN 37614 USA; [Karsai, Istvan] E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA	East Tennessee State University; East Tennessee State University	Karsai, I (corresponding author), E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA.	karsai@etsu.edu			Honors College of East Tennessee State University; East Tennessee State University Research Development Grant	Honors College of East Tennessee State University; East Tennessee State University Research Development Grant	DA is supported by the Honors College of East Tennessee State University, http://www.etsu.edu/honors/ug_research/. IK is supported by East Tennessee State University Research Development Grant, http://www.etsu.edu/research/rdc/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 1999, AM NAT, V154, P521, DOI 10.1086/303255; Anderson C, 2002, INSECT SOC, V49, P171, DOI 10.1007/s00040-002-8298-7; Calabi P., 1988, P237; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; de Weerdt M., 2007, P AUT AG MULT SYST C, P500; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Hamann H, 2013, B MATH BIOL, V75, P1181, DOI 10.1007/s11538-013-9851-4; Hart AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P244, DOI 10.1007/s002650000306; Holldobler B., 2008, SUPERORGANISM BEAUTY; Jeanne RL, 1996, ANIM BEHAV, V52, P473, DOI 10.1006/anbe.1996.0191; JEANNE RL, 1975, Q REV BIOL, V50, P267, DOI 10.1086/408564; Karsai I, 2000, J INSECT BEHAV, V13, P111, DOI 10.1023/A:1007771727503; Karsai I, 1998, P NATL ACAD SCI USA, V95, P8665, DOI 10.1073/pnas.95.15.8665; Karsai I, 1996, BEHAV ECOL SOCIOBIOL, V39, P97, DOI 10.1007/s002650050271; Karsai I, 1996, INSECT SOC, V43, P277, DOI 10.1007/BF01242929; KARSAI I, 1995, SOCIOBIOLOGY, V26, P83; KARSAI I, 1995, ANIM BEHAV, V50, P1429, DOI 10.1016/0003-3472(95)80059-X; Karsai I, 1999, ARTIF LIFE, V5, P117, DOI 10.1162/106454699568719; Karsai I, 1998, P ROY SOC B-BIOL SCI, V265, P1261, DOI 10.1098/rspb.1998.0428; KARSAI I, 1993, J THEOR BIOL, V161, P505, DOI 10.1006/jtbi.1993.1070; Karsai I, 2011, BEHAV ECOL, V22, P819, DOI 10.1093/beheco/arr060; Karsai I, 2002, J THEOR BIOL, V218, P549, DOI 10.1006/jtbi.2002.3099; Karsai I, 2012, MATH COMP MODEL DYN, V18, P13, DOI 10.1080/13873954.2011.601423; Karsai I, 2012, J THEOR BIOL, V294, P98, DOI 10.1016/j.jtbi.2011.10.037; O'Donnell S, 2007, INSECT SOC, V54, P203, DOI 10.1007/s00040-007-0945-6; ODONNELL S, 1992, ANIM BEHAV, V44, P1021, DOI 10.1016/S0003-3472(05)80314-8; Oster G. F., 1979, CASTE ECOLOGY SOCIAL, DOI DOI 10.1007/BF00046355; Ratnieks FLW, 1999, INSECT SOC, V46, P95, DOI 10.1007/s000400050119; Ratnieks FLW, 1999, AM NAT, V154, P536, DOI 10.1086/303256; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Schmickl T, 2016, J THEOR BIOL, V389, P274, DOI 10.1016/j.jtbi.2015.10.036; Schmickl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114611; SEELEY TD, 1989, BEHAV ECOL SOCIOBIOL, V24, P181, DOI 10.1007/BF00292101; Seeley TD, 1998, APIDOLOGIE, V29, P67, DOI 10.1051/apido:19980104; SEELEY TD, 1985, FORTS ZOOL, V31, P75; Sinha N, 2006, J NEUROPHYSIOL, V95, P3146, DOI 10.1152/jn.01184.2005; Wahl LM, 2002, J THEOR BIOL, V219, P371, DOI 10.1006/jtbi.2002.3133; Wenzel J.W., 1991, P480; Wilson E.O, 1990, SUCCESS DOMINANCE EC	39	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145560	10.1371/journal.pone.0145560	http://dx.doi.org/10.1371/journal.pone.0145560			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751076	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100019
J	Chen, JF; Jono, T; Cui, JG; Yue, XZ; Tang, YZ				Chen, Jingfeng; Jono, Teppei; Cui, Jianguo; Yue, Xizi; Tang, Yezhong			The Acoustic Properties of Low Intensity Vocalizations Match Hearing Sensitivity in the Webbed-Toed Gecko, Gekko subpalmatus	PLOS ONE			English	Article							BRAIN-STEM RESPONSE; MIDDLE-EAR; AUDITORY-SENSITIVITY; REPRODUCTIVE-CYCLES; ADVERTISEMENT CALLS; CRICKET FROGS; HOUSE GECKO; BODY-SIZE; EVOLUTION; COMMUNICATION	The design of acoustic signals and hearing sensitivity in socially communicating species would normally be expected to closely match in order to minimize signal degradation and attenuation during signal propagation. Nevertheless, other factors such as sensory biases as well as morphological and physiological constraints may affect strict correspondence between signal features and hearing sensitivity. Thus study of the relationships between sender and receiver characteristics in species utilizing acoustic communication can provide information about how acoustic communication systems evolve. The genus Gekko includes species emitting high-amplitude vocalizations for long-range communication (loud callers) as well as species producing only low-amplitude vocalizations when in close contact with conspecifics (quiet callers) which have rarely been investigated. In order to investigate relationships between auditory physiology and the frequency characteristics of acoustic signals in a quiet caller, Gekko subpalmatus we measured the subjects' vocal signal characteristics as well as auditory brainstem responses (ABRs) to assess auditory sensitivity. The results show that G. subpalmatus males emit low amplitude calls when encountering females, ranging in dominant frequency from 2.47 to 4.17 kHz with an average at 3.35 kHz. The auditory range with highest sensitivity closely matches the dominant frequency of the vocalizations. This correspondence is consistent with the notion that quiet and loud calling species are under similar selection pressures for matching auditory sensitivity with spectral characteristics of vocalizations.	[Chen, Jingfeng; Jono, Teppei; Cui, Jianguo; Yue, Xizi; Tang, Yezhong] Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Chen, JF (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China.	chenjf@cib.ac.cn; tangyz@cib.ac.cn			National Natural Science Foundation of China [31370431, 31270042, 31272304]; Chinese Academy of Sciences [31350110508]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was financially supported by the National Natural Science Foundation of China (31370431) to JFC, (31270042) to JGC, (31272304) to YZT, http://www.nsfc.gov.cn/publish/portal1/; and the Fellowship for Young International Scientists of the Chinese Academy of Sciences (31350110508) to TJ.	Amezquita A, 2006, EVOLUTION, V60, P1874; Amezquita A, 2011, P NATL ACAD SCI USA, V108, P17058, DOI 10.1073/pnas.1104773108; ARAK A, 1995, PHILOS T R SOC B, V349, P337, DOI 10.1098/rstb.1995.0122; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Brittan-Powell EF, 2010, J ACOUST SOC AM, V128, P787, DOI 10.1121/1.3458813; Capranica RR, 1983, ADV VERTEBRATE NEURO, P701, DOI DOI 10.1007/978-1-4684-4412-4_36; Christensen-Dalsgaard J, 2012, P ROY SOC B-BIOL SCI, V279, P2816, DOI 10.1098/rspb.2012.0290; CORWIN JT, 1982, ELECTROEN CLIN NEURO, V54, P629, DOI 10.1016/0013-4694(82)90117-1; DODD F, 1992, HEARING RES, V62, P173, DOI 10.1016/0378-5955(92)90183-N; Dooling RJ, 2000, SPR HDB AUD, V13, P308; Du Y, 2011, NEUROSCI BIOBEHAV R, V35, P2046, DOI 10.1016/j.neubiorev.2011.05.008; ENDLER JA, 1992, AM NAT, V139, pS1; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; FRANKENBERG E, 1982, COPEIA, P770; Gall MD, 2010, J COMP PHYSIOL A, V196, P559, DOI 10.1007/s00359-010-0543-3; Gerhardt H. Carl, 2001, P73; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gunther A.C.L.G., 1864, REPTILES BRIT INDIA; Hall JW, 1992, HDB AUDITORY EVOKED; Henry KS, 2008, ANIM BEHAV, V76, P1659, DOI 10.1016/j.anbehav.2008.08.003; Hibbitts TJ, 2007, BEHAV ECOL SOCIOBIOL, V61, P1169, DOI 10.1007/s00265-006-0330-x; Ikeuchi I, 2004, J HERPETOL, V38, P269, DOI 10.1670/84-03A-N; Jono T, 2012, COPEIA, P145, DOI 10.1643/CE-10-169; KEDDYHECTOR AC, 1992, BRAIN BEHAV EVOLUT, V39, P238, DOI 10.1159/000114121; Lechner W, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-10; Lu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079348; Manley GA, 2002, J NEUROBIOL, V53, P202, DOI 10.1002/neu.10115; Manley GA., 1990, PERIPHERAL HEARING M; Manley GA, 2014, SPRINGER HANDB AUDIT, V49, P111, DOI 10.1007/2506_2013_27; Manley GA, 2010, J EXP BIOL, V213, P1876, DOI 10.1242/jeb.040196; MARCELLINI D L, 1974, Herpetologica, V30, P44; NEELY ST, 1988, J ACOUST SOC AM, V83, P652, DOI 10.1121/1.396542; Okada S, 2002, J HERPETOL, V36, P473, DOI 10.2307/1566192; Phongkangsananan N, 2014, HERPETOL CONSERV BIO, V9, P285; Regalado R, 2003, CARIBB J SCI, V39, P307; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; RYAN MJ, 1992, AM NAT, V139, P1370, DOI 10.1086/285391; Ryan MJ, 2003, SPR HDB AUD, V16, P225; RYAN MJ, 1988, SCIENCE, V240, P1786, DOI 10.1126/science.240.4860.1786; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Tang YZ, 2001, COPEIA, P248; Werner YL, 2002, HEARING RES, V167, P33, DOI 10.1016/S0378-5955(02)00331-3; Werner YL, 1998, J EXP BIOL, V201, P487; WILCZYNSKI W, 1992, BRAIN BEHAV EVOLUT, V39, P229, DOI 10.1159/000114120; Wu G., 1984, Acta Herpetologica Sinica, V3, P61; Young BA, 2014, SPRINGER HANDB AUDIT, V49, P323, DOI 10.1007/2506_2013_30; Yu X, 2011, ETHOL ECOL EVOL, V23, P211, DOI 10.1080/03949370.2011.566581; Zhang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045792; Zhao E.M., 1999, FAUNA SINICA REPTILI	49	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146677	10.1371/journal.pone.0146677	http://dx.doi.org/10.1371/journal.pone.0146677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752301	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100126
J	Hsu, TY; Lin, H; Hung, HN; Yang, KD; Ou, CY; Tsai, CC; Cheng, HH; Chung, SH; Cheng, BH; Wong, YH; Chou, AK; Hsiao, CC				Hsu, Te-Yao; Lin, Hao; Hung, Hsuan-Ning; Yang, Kuender D.; Ou, Chia-Yu; Tsai, Ching-Chang; Cheng, Hsin-Hsin; Chung, Su-Hai; Cheng, Bi-Hua; Wong, Yi-Hsun; Chou, An Kuo; Hsiao, Chang-Chun			Two-Dimensional Differential Gel Electrophoresis to Identify Protein Biomarkers in Amniotic Fluid of Edwards Syndrome (Trisomy 18) Pregnancies	PLOS ONE			English	Article							POSSIBLE DIAGNOSTIC-TOOL; FACTOR-BINDING-PROTEINS; DOWN-SYNDROME; GROWTH-FACTORS; EXPRESSED PROTEINS; PROTEOMIC ANALYSIS; SERUM; FETUSES; IGF; IDENTIFICATION	Background Edwards syndrome (ES) is a severe chromosomal abnormality with a prevalence of about 0.8 in 10,000 infants born alive. The aims of this study were to identify candidate proteins associated with ES pregnancies from amniotic fluid supernatant (AFS) using proteomics, and to explore the role of biological networks in the pathophysiology of ES. Methods AFS from six second trimester pregnancies with ES fetuses and six normal cases were included in this study. Fluorescence-based two-dimensional difference gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) were used for comparative proteomic analysis. The identified proteins were further validated by Western blotting and the role of biological networks was analyzed. Results Twelve protein spots were differentially expressed by more than 1.5-fold in the AFS of the ES pregnancies. MALDI-TOF/MS identified one up-regulated protein: apolipoprotein A1 (ApoA1), and four under-regulated proteins: vitamin D binding protein (VDBP), alpha-1-antitrypsin (A1AT), insulin-like growth factor-binding protein 1 (IGFBP-1), and transthyretin (TTR). Western blot and densitometric analysis of ApoA1, A1AT, IGFBP-1, and TTR confirmed the alteration of these proteins in the amniotic fluid samples. Biological network analysis revealed that the proteins of the ES AFS were involved mainly in lipid and hormone metabolism, immune response, and cardiovascular disease. Conclusions These five proteins may be involved in the pathogenesis of ES. Further studies are needed to explore.	[Hsu, Te-Yao; Lin, Hao; Hung, Hsuan-Ning; Ou, Chia-Yu; Tsai, Ching-Chang; Cheng, Hsin-Hsin; Chung, Su-Hai; Cheng, Bi-Hua; Wong, Yi-Hsun] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Yang, Kuender D.] Chang Bing Show Chwan Mem Hosp, Dept Pediat, Changhua, Taiwan; [Chou, An Kuo] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesia, Kaohsiung, Taiwan; [Hsiao, Chang-Chun] Kaohsiung Chang Gung Mem Hosp, Genom Med Res Core Lab, Kaohsiung, Taiwan; [Hsu, Te-Yao; Lin, Hao; Ou, Chia-Yu; Tsai, Ching-Chang; Cheng, Hsin-Hsin; Cheng, Bi-Hua; Chou, An Kuo; Hsiao, Chang-Chun] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Bing Show Chwan Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Hsu, TY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan.	tyhsu@adm.cgmh.org.tw		Hsiao, Chang-Chun/0000-0002-7275-4675	Chang Gung Memorial Hospital Research Grant [CMRPG870171]	Chang Gung Memorial Hospital Research Grant(Chang Gung Memorial Hospital)	This study was supported by the Chang Gung Memorial Hospital Research Grant CMRPG870171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostopoulos AK, 2010, J PROTEOMICS, V73, P943, DOI 10.1016/j.jprot.2009.12.009; Baken L, 2013, ULTRASOUND OBST GYN, V41, P521, DOI 10.1002/uog.12365; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967, DOI 10.1152/ajpendo.2000.278.6.E967; Cereda A, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-81; Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022; Fraisier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068318; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; HERBERT J, 1986, NEUROLOGY, V36, P900, DOI 10.1212/WNL.36.7.900; Hernandez C, 2013, DIABETES-METAB RES, V29, P499, DOI 10.1002/dmrr.2419; Hsu TY, 2015, TAIWAN J OBSTET GYNE, V54, P499, DOI 10.1016/j.tjog.2014.01.007; Huang JTJ, 2008, MOL PSYCHIATR, V13, P1118, DOI 10.1038/sj.mp.4002108; Huang JTJ, 2006, PLOS MED, V3, P2145, DOI 10.1371/journal.pmed.0030428; Karowicz-Bilinska A, 2007, FREE RADICAL RES, V41, P870, DOI 10.1080/10715760701291647; Keeney JTR, 2013, PROTEOM CLIN APPL, V7, P109, DOI 10.1002/prca.201200087; Kolialexi A, 2008, PRENATAL DIAG, V28, P691, DOI 10.1002/pd.2040; Lam WWK, 2006, EUR J MED GENET, V49, P195, DOI 10.1016/j.ejmg.2005.05.011; LASSARRE C, 1991, PEDIATR RES, V29, P219, DOI 10.1203/00006450-199103000-00001; Law KP, 2015, INT J MOL SCI, V16, P10952, DOI 10.3390/ijms160510952; LOLIS D, 1995, GYNECOL OBSTET INVES, V40, P231, DOI 10.1159/000292343; MAKRYDIMAS G, 1994, PRENATAL DIAG, V14, P239, DOI 10.1002/pd.1970140403; Malt Eva Albertsen, 2013, Tidsskr Nor Laegeforen, V133, P290, DOI 10.4045/tidsskr.12.0390; Maruyama K, 2006, PEDIATR INT, V48, P646, DOI 10.1111/j.1442-200X.2006.02286.x; Miell JP, 1997, J CLIN ENDOCR METAB, V82, P287, DOI 10.1210/jc.82.1.287; Nagasawa H, 2005, ANTICANCER RES, V25, P3689; NONOSHITA LD, 1994, J CLIN ENDOCR METAB, V79, P1249, DOI 10.1210/jc.79.5.1249; Oh JE, 2004, PROTEOMICS, V4, P1145, DOI 10.1002/pmic.200300654; Oromendia AB, 2014, DIS MODEL MECH, V7, P15, DOI 10.1242/dmm.013391; Perluigi M, 2011, PROTEOM CLIN APPL, V5, P167, DOI 10.1002/prca.201000121; Petit FM, 2009, EUR J HUM GENET, V17, P387, DOI 10.1038/ejhg.2008.186; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sifakis S, 2011, EUR J OBSTET GYN R B, V157, P166, DOI 10.1016/j.ejogrb.2011.03.029; Springett AL, 2014, J MED SCREEN, V21, P113, DOI 10.1177/0969141314543128; STAPLES AJ, 1991, AM J HUM GENET, V49, P1025; Tisi DK, 2005, J NUTR, V135, P1667, DOI 10.1093/jn/135.7.1667; Tsangaris GT, 2006, PROTEOMICS, V6, P4410, DOI 10.1002/pmic.200600085; Van den Bergh G, 2003, ELECTROPHORESIS, V24, P1471, DOI 10.1002/elps.200390189; Verboven C, 2002, NAT STRUCT BIOL, V9, P131, DOI 10.1038/nsb754; Wang TH, 2009, FERTIL STERIL, V92, P96, DOI 10.1016/j.fertnstert.2008.05.038; Wasan KM, 2008, NAT REV DRUG DISCOV, V7, P84, DOI 10.1038/nrd2353; WATHEN NC, 1992, EARLY HUM DEV, V28, P105, DOI 10.1016/0378-3782(92)90105-P; Wu J, 2013, AM J MED GENET A, V161, P2512, DOI DOI 10.1002/AJMG.A.36127; Zeldenrust SR, 2010, PROTEIN MISFOLDING D, DOI [10.1002/9780470572702.ch36, DOI 10.1002/9780470572702.CH36]; Zizka Z, 2006, FETAL DIAGN THER, V21, P510, DOI 10.1159/000095663	45	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145908	10.1371/journal.pone.0145908	http://dx.doi.org/10.1371/journal.pone.0145908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752631	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100031
J	Li, W; O'Brien, JE; Snyder, SM; Howard, MO				Li, Wen; O'Brien, Jennifer E.; Snyder, Susan M.; Howard, Matthew O.			Diagnostic Criteria for Problematic Internet Use among US University Students: A Mixed-Methods Evaluation	PLOS ONE			English	Article							COLLEGE-STUDENTS; PSYCHOMETRIC PROPERTIES; ADDICTION TEST; ASSOCIATION; SYMPTOMS; SAMPLE; SCALE; YOUTH	Empirical studies have identified increasing rates of problematic Internet use worldwide and a host of related negative consequences. However, researchers disagree as to whether problematic Internet use is a subtype of behavioral addiction. Thus, there are not yet widely accepted and validated diagnostic criteria for problematic Internet use. To address this gap, we used mixed-methods to examine the extent to which signs and symptoms of problematic Internet use mirror DSM-5 diagnostic criteria for substance use disorder, gambling disorder, and Internet gaming disorder. A total of 27 university students, who self-identified as intensive Internet users and who reported Internet-use-associated health and/or psychosocial problems were recruited. Students completed two measures that assess problematic Internet use (Young's Diagnostic Questionnaire and the Compulsive Internet Use Scale) and participated in focus groups exploring their experiences with problematic Internet use. Results of standardized measures and focus group discussions indicated substantial overlap between students' experiences of problematic Internet use and the signs and symptoms reflected in the DSM-5 criteria for substance use disorder, gambling disorder, and Internet gaming disorder. These signs and symptoms included: a) use Internet longer than intended, b) preoccupation with the Internet, c) withdrawal symptoms when unable to access the Internet, d) unsuccessful attempts to stop or reduce Internet use, e) craving, f) loss of interest in hobbies or activities other than the Internet, g) excessive Internet use despite the knowledge of related problems, g) use of the Internet to escape or relieve a negative mood, and h) lying about Internet use. Tolerance, withdrawal symptoms, and recurrent Internet use in hazardous situations were uniquely manifested in the context of problematic Internet use. Implications for research and practice are discussed.	[Li, Wen; O'Brien, Jennifer E.; Howard, Matthew O.] Univ N Carolina, Sch Social Work, Chapel Hill, NC 27515 USA; [Snyder, Susan M.] Georgia State Univ, Sch Social Work, Atlanta, GA 30303 USA	University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Georgia State University	Li, W (corresponding author), Univ N Carolina, Sch Social Work, Chapel Hill, NC 27515 USA.	wenli@email.unc.edu	Snyder, Susan M/AAN-2386-2021	Snyder, Susan M/0000-0002-6909-336X; , Wen/0000-0003-1631-0161				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Canan F, 2010, CYBERPSYCH BEH SOC N, V13, P317, DOI 10.1089/cyber.2009.0160; Christakis Dimitri A, 2011, BMC Med, V9, P77, DOI 10.1186/1741-7015-9-77; DeCuir-Gunby JT, 2011, FIELD METHOD, V23, P136, DOI 10.1177/1525822X10388468; Derbyshire KL, 2013, COMPR PSYCHIAT, V54, P415, DOI 10.1016/j.comppsych.2012.11.003; Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014703; Dowling NA, 2009, CYBERPSYCHOL BEHAV, V12, P21, DOI 10.1089/cpb.2008.0162; Gallagher KE, 2014, PSYCHOL VIOLENCE, V4, P78, DOI 10.1037/a0032304; Guertler D, 2014, EUR ADDICT RES, V20, P75, DOI 10.1159/000355076; Jelenchick LA, 2012, PSYCHIAT RES, V196, P296, DOI 10.1016/j.psychres.2011.09.007; Kardefelt-Winther D, 2014, COMPUT HUM BEHAV, V31, P351, DOI 10.1016/j.chb.2013.10.059; Kerkhof P, 2011, HUM COMMUN RES, V37, P147, DOI 10.1111/j.1468-2958.2010.01397.x; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Ko CH, 2009, J ADOLESCENT HEALTH, V44, P598, DOI 10.1016/j.jadohealth.2008.11.011; Kuhn S, 2015, ADDICT BIOL, V20, P415, DOI 10.1111/adb.12128; Lam LT, 2009, INJURY PREV, V15, P403, DOI 10.1136/ip.2009.021949; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; Lee HW, 2012, CYBERPSYCH BEH SOC N, V15, P373, DOI 10.1089/cyber.2012.0063; Li W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117372; Li W, 2014, COMPUT HUM BEHAV, V31, P393, DOI 10.1016/j.chb.2013.11.004; Liu T, 2007, CNS SPECTRUMS, V12, P453, DOI 10.1017/S1092852900015339; Lortie CL, 2013, ADDICTION, V108, P1207, DOI 10.1111/add.12202; Meerkerk GJ, 2009, CYBERPSYCHOL BEHAV, V12, P1, DOI 10.1089/cpb.2008.0181; Moreno MA, 2011, ARCH PEDIAT ADOL MED, V165, P797, DOI 10.1001/archpediatrics.2011.58; Padgett D.K., 2017, QUALITATIVE METHODS; Park S, 2013, AUST NZ J PSYCHIAT, V47, P153, DOI 10.1177/0004867412463613; Patton M, 2002, QUALITATIVE RES EVAL, V3rd ed., P339; Petry NM, 2014, ADDICTION, V109, P1399, DOI 10.1111/add.12457; Scherer K, 1997, J COLL STUDENT DEV, V38, P655; Sim T, 2012, INT J MENT HEALTH AD, V10, P748, DOI 10.1007/s11469-011-9369-7; Starcevic V, 2013, AUST NZ J PSYCHIAT, V47, P16, DOI 10.1177/0004867412461693; Sun P, 2012, INT J ENV RES PUB HE, V9, P660, DOI 10.3390/ijerph9030660; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; Vandelanotte C, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1084; Weinstein A, 2014, BEHAVIORAL ADDICTIONS: CRITERIA, EVIDENCE, AND TREATMENT, P99, DOI 10.1016/B978-0-12-407724-9.00005-7; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; Widyanto L, 2011, CYBERPSYCH BEH SOC N, V14, P141, DOI 10.1089/cyber.2010.0151; Yen JY, 2009, PSYCHIAT CLIN NEUROS, V63, P218, DOI 10.1111/j.1440-1819.2009.01943.x; Yen JY, 2009, CYBERPSYCHOL BEHAV, V12, P187, DOI 10.1089/cpb.2008.0113; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	41	18	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145981	10.1371/journal.pone.0145981	http://dx.doi.org/10.1371/journal.pone.0145981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751569	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100036
J	Schellenberg, JJ; Jayaprakash, TP; Gamage, NW; Patterson, MH; Vaneechoutte, M; Hill, JE				Schellenberg, John J.; Jayaprakash, Teenus Paramel; Gamage, Niradha Withana; Patterson, Mo H.; Vaneechoutte, Mario; Hill, Janet E.			Gardnerella vaginalis Subgroups Defined by cpn60 Sequencing and Sialidase Activity in Isolates from Canada, Belgium and Kenya	PLOS ONE			English	Article							CHAPERONIN-60 UNIVERSAL TARGET; BACTERIAL VAGINOSIS; INFECTION; WOMEN; DEFINITION; MICROBIOTA; VAGINITIS; HEALTHY	Increased abundance of Gardnerella vaginalis and sialidase activity in vaginal fluid is associated with bacterial vaginosis (BV), a common but poorly understood clinical entity associated with poor reproductive health outcomes. Since most women are colonized with G. vaginalis, its status as a normal member of the vaginal microbiota or pathogen causing BV remains controversial, and numerous classification schemes have been described. Since 2005, sequencing of the chaperonin-60 universal target (cpn60 UT) has distinguished four subgroups in isolate collections, clone libraries and deep sequencing datasets. To clarify potential clinical and diagnostic significance of cpn60 subgroups, we undertook phenotypic and molecular characterization of 112 G. vaginalis isolates from three continents. A total of 36 subgroup A, 33 B, 35 C and 8 D isolates were identified through phylogenetic analysis of cpn60 sequences as corresponding to four "clades" identified in a recently published study, based on sequencing 473 genes across 17 isolates. cpn60 subgroups were compared with other previously described molecular methods for classification of Gardnerella subgroups, including amplified ribosomal DNA restriction analysis (ARDRA) and real-time PCR assays designed to quantify subgroups in vaginal samples. Although two ARDRA patterns were observed in isolates, each was observed in three cpn60 subgroups (A/B/D and B/C/D). Real-time PCR assays corroborated cpn60 subgroups overall, but 13 isolates from subgroups A, B and D were negative in all assays. A putative sialidase gene was detected in all subgroup B, C and D isolates, but only in a single subgroup A isolate. In contrast, sialidase activity was observed in all subgroup B isolates, 3 (9%) subgroup C isolates and no subgroup A or D isolates. These observations suggest distinct roles for G. vaginalis subgroups in BV pathogenesis. We conclude that cpn60 UT sequencing is a robust approach for defining G. vaginalis subgroups within the vaginal microbiome.	[Schellenberg, John J.; Jayaprakash, Teenus Paramel; Gamage, Niradha Withana; Patterson, Mo H.; Hill, Janet E.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Vaneechoutte, Mario] Univ Ghent, Lab Bacteriol Res, B-9000 Ghent, Belgium	University of Saskatchewan; Ghent University	Hill, JE (corresponding author), Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada.	Janet.Hill@usask.ca	Hill, Janet E./B-5001-2011; Vaneechoutte, Mario/A-6189-2009	Hill, Janet E./0000-0002-2187-6277; Vaneechoutte, Mario/0000-0002-4586-203X; Schellenberg, John/0000-0003-3970-1608	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Saskatchewan Health Research Foundation; NSERC; University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Saskatchewan Health Research Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Saskatchewan	This research was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) and Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) to JEH. JJS was supported by concurrent fellowships from the Canadian Institutes of Health Research and the Saskatchewan Health Research Foundation (http://www.shrf.ca). MHP was supported by an NSERC Undergraduate Research Award and a University of Saskatchewan Undergraduate Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Albert AYK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135620; Balashov SV, 2014, J MED MICROBIOL, V63, P162, DOI 10.1099/jmm.0.066407-0; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bradshaw CS, 2005, J CLIN MICROBIOL, V43, P1304, DOI 10.1128/JCM.43.3.1304-1308.2005; Chaban B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-23; Donders GGG, 2005, INT CONGR SER, V1279, P118, DOI 10.1016/j.ics.2005.02.064; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hickey RJ, 2014, J INFECT DIS, V210, P1682, DOI 10.1093/infdis/jiu303; Hill JE, 2005, AM J OBSTET GYNECOL, V193, P682, DOI 10.1016/j.ajog.2005.02.094; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Ingianni A, 1997, FEMS IMMUNOL MED MIC, V18, P61, DOI 10.1111/j.1574-695X.1997.tb01028.x; Jayaprakash TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043009; Katyal I, 2015, MICROBIAL ECOL; Larsson PG, 2005, APMIS, V113, P233, DOI 10.1111/j.1600-0463.2005.apm_01.x; LEOPOLD SIDNEY, 1953, U S ARMED FORCES MED JOUR, V4, P263; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; Mehta SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116894; PIOT P, 1984, J CLIN MICROBIOL, V20, P677, DOI 10.1128/JCM.20.4.677-679.1984; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; R Core Team, 2013, R LANG ENV STAT COMP; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schellenberg JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041217; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Swidsinski A, 2014, HISTOL HISTOPATHOL, V29, P567, DOI 10.14670/HH-29.10.567; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Verbeke TJ, 2011, SYST APPL MICROBIOL, V34, P171, DOI 10.1016/j.syapm.2010.11.019; VONNICOLAI H, 1984, ZBL BAKT-INT J MED M, V258, P20, DOI 10.1016/S0176-6724(84)80003-6	36	128	132	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146510	10.1371/journal.pone.0146510	http://dx.doi.org/10.1371/journal.pone.0146510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751374	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888100091
J	Semedo-Lemsaddek, T; Tavares, M; Sao Braz, B; Tavares, L; Oliveira, M				Semedo-Lemsaddek, Teresa; Tavares, Marta; Sao Braz, Berta; Tavares, Luis; Oliveira, Manuela			Enterococcal Infective Endocarditis following Periodontal Disease in Dogs	PLOS ONE			English	Article							BACTERIAL-ENDOCARDITIS; VIRULENCE DETERMINANTS; FAECALIS; FOOD; PCR	In humans, one of the major factors associated with infective endocarditis (IE) is the concurrent presence of periodontal disease (PD). However, in veterinary medicine, the relevance of PD in the evolution of dogs' endocarditis remains poorly understood. In order to try to establish a correlation between mouth-associated Enterococcus spp. and infective endocarditis in dogs, the present study evaluated the presence and diversity of enterococci in the gum and heart of dogs with PD. Samples were collected during necropsy of 32 dogs with PD and visually diagnosed with IE, which died of natural causes or euthanasia. Enterococci were isolated, identified and further characterized by Pulsed-Field Gel Electrophoresis (PFGE); susceptibility to antimicrobial agents and pathogenicity potential was also evaluated. In seven sampled animals, PFGE-patterns, resistance and virulence profiles were found to be identical between mouth and heart enterococci obtained from the same dog, allowing the establishment of an association between enterococcal periodontal disease and endocarditis in dogs. These findings represent a crucial step towards understanding the pathogenesis of PD-driven IE, and constitute a major progress in veterinary medicine.	[Semedo-Lemsaddek, Teresa; Tavares, Marta; Sao Braz, Berta; Tavares, Luis; Oliveira, Manuela] Univ Lisbon, Interdisciplinary Ctr Res Anim Hlth CIISA, Fac Vet Med, P-1300477 Lisbon, Portugal	Universidade de Lisboa	Oliveira, M (corresponding author), Univ Lisbon, Interdisciplinary Ctr Res Anim Hlth CIISA, Fac Vet Med, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	moliveira@fmv.ulisboa.pt	Semedo-Lemsaddek, Teresa ML/J-3010-2013; Sâo Braz, Berta/D-2518-2010; Semedo-Lemsaddek, Teresa/ABA-8475-2021	Semedo-Lemsaddek, Teresa ML/0000-0002-8349-3802; Sâo Braz, Berta/0000-0003-2688-0459; Semedo-Lemsaddek, Teresa/0000-0002-8349-3802; Tavares, Luis/0000-0001-8671-6285	Fundacao para a Ciencia e Tecnologia - FCT [UID/CVT/00276/2013]; Program "Ciencia" from FCT	Fundacao para a Ciencia e Tecnologia - FCT(Portuguese Foundation for Science and Technology); Program "Ciencia" from FCT	This study was performed on "Centro de Investigacao Interdisciplinar em Sanidade Animal" (CIISA/FMV) from Faculdade de Medicina Veterinaria da Universidade de Lisboa (Faculty of Veterinary Medicine, University of Lisbon), through Project UID/CVT/00276/2013 from "Fundacao para a Ciencia e Tecnologia - FCT". Teresa Semedo-Lemsaddek was financially supported by Program "Ciencia" from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque C, 2012, VET J, V191, P299, DOI 10.1016/j.tvjl.2011.08.017; [Anonymous], 2013, VET01A4 CLSI, V33; Baldassarri L, 2004, CLIN MICROBIOL INFEC, V10, P1006, DOI 10.1111/j.1469-0691.2004.00999.x; Cavaguchi DK, 2010, SEMIN-CIENC AGRAR, V31, P183, DOI 10.5433/1679-0359.2010v31n1p183; Creti R, 2004, J MED MICROBIOL, V53, P13, DOI 10.1099/jmm.0.05353-0; Dahlen Gunnar, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10855; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; Extremina CI, 2011, J MICROBIOL METH, V84, P167, DOI 10.1016/j.mimet.2010.11.007; Ferreira FBD, 2006, ORAL SURG ORAL MED O, V102, P564, DOI 10.1016/j.tripleo.2005.08.041; Glickman LT, 2009, JAVMA-J AM VET MED A, V234, P486, DOI 10.2460/javma.234.4.486; Hoesley CJ, 1999, J INFECT DIS, V179, pS360, DOI 10.1086/513840; Inaba H, 2010, J PHARMACOL SCI, V113, P103, DOI 10.1254/jphs.09R23FM; Ito HO, 2006, J MED INVESTIG, V53, P189, DOI 10.2152/jmi.53.189; Jackson CR, 2004, J CLIN MICROBIOL, V42, P3558, DOI 10.1128/JCM.42.8.3558-3565.2004; Ke DB, 1999, J CLIN MICROBIOL, V37, P3497, DOI 10.1128/JCM.37.11.3497-3503.1999; MacDonald K, 2010, VET CLIN N AM-SMALL, V40, P665, DOI 10.1016/j.cvsm.2010.03.010; Marshall MD, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-166; Morris JA, 2007, CURR DIAGN PATHOL, V13, P65, DOI DOI 10.1016/J.CDIP.2006.07.005; Munita JM, 2012, CURR INFECT DIS REP, V14, P339, DOI 10.1007/s11908-012-0270-8; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2911, DOI 10.1128/IAI.00039-11; Niemiec BA, 2008, TOP COMPANION ANIM M, V23, P72, DOI 10.1053/j.tcam.2008.02.003; Okui A, 2015, INTERNAL MED, V54, P1809, DOI 10.2169/internalmedicine.54.3223; Peddle GD, 2009, JAVMA-J AM VET MED A, V234, P100, DOI 10.2460/javma.234.1.100; Pericas JM, 2015, FUTURE MICROBIOL, V10, P1215, DOI 10.2217/fmb.15.46; Riedel S, 2014, J CLIN MICROBIOL, V52, P1028, DOI 10.1128/JCM.03102-13; Roberts FJ, 1998, EUR J CLIN MICROBIOL, V17, P821, DOI 10.1007/s100960050200; Salah Randa, 2008, BMC Oral Health, V8, P17, DOI 10.1186/1472-6831-8-17; Semedo T, 2003, J CLIN MICROBIOL, V41, P2569, DOI 10.1128/JCM.41.6.2569-2576.2003; Semedo-Lemsaddek T, 2013, VET MICROBIOL, V163, P378, DOI 10.1016/j.vetmic.2012.12.032; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Turabelidze D, 2000, J CLIN MICROBIOL, V38, P4242, DOI 10.1128/JCM.38.11.4242-4245.2000	31	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146860	10.1371/journal.pone.0146860	http://dx.doi.org/10.1371/journal.pone.0146860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752198	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100167
J	Thormar, J; Hasler-Sheetal, H; Baden, S; Bostrom, C; Clausen, KK; Krause-Jensen, D; Olesen, B; Rasmussen, JR; Svensson, CJ; Holmer, M				Thormar, Jonas; Hasler-Sheetal, Harald; Baden, Susanne; Bostrom, Christoffer; Clausen, Kevin Kuhlmann; Krause-Jensen, Dorte; Olesen, Birgit; Rasmussen, Jonas Ribergaard; Svensson, Carl Johan; Holmer, Marianne			Eelgrass (Zostera marina) Food Web Structure in Different Environmental Settings	PLOS ONE			English	Article							JELLYFISH AURELIA-AURITA; COVE KERTINGE-NOR; STABLE-ISOTOPES; TROPHIC INTERACTIONS; SEAGRASS LANDSCAPES; BIODIVERSITY LOSS; CURRENT VELOCITY; STABILITY; ABUNDANCE; SULFIDE	This study compares the structure of eelgrass (Zostera marina L.) meadows and associated food webs in two eelgrass habitats in Denmark, differing in exposure, connection to the open sea, nutrient enrichment and water transparency. Meadow structure strongly reflected the environmental conditions in each habitat. The eutrophicated, protected site had higher biomass of filamentous algae, lower eelgrass biomass and shoot density, longer and narrower leaves, and higher above to below ground biomass ratio compared to the less nutrient-enriched and more exposed site. The faunal community composition and food web structure also differed markedly between sites with the eutrophicated, enclosed site having higher biomass of consumers and less complex food web. These relationships resulted in a column shaped biomass distribution of the consumers at the eutrophicated site whereas the less nutrient-rich site showed a pyramidal biomass distribution of consumers coupled with a more diverse consumer community. The differences in meadow and food web structure of the two seagrass habitats, suggest how physical setting may shape ecosystem response and resilience to anthropogenic pressure. We encourage larger, replicated studies to further disentangle the effects of different environmental variables on seagrass food web structure.	[Thormar, Jonas] Univ Oslo, Dept Biosci, Oslo, Norway; [Hasler-Sheetal, Harald; Holmer, Marianne] Univ Southern Denmark, Dept Biol, Odense, Denmark; [Hasler-Sheetal, Harald] Univ Southern Denmark, Nord Ctr Earth Evolut NordCEE, Odense, Denmark; [Baden, Susanne] Univ Gothenburg, Dept Biol & Environm Sci, Fiskebackskil, Sweden; [Bostrom, Christoffer] Abo Akad Univ, Dept Biosci Environm & Marine Biol, Turku, Finland; [Clausen, Kevin Kuhlmann] Aarhus Univ, Dept Biosci, Kalo, Denmark; [Krause-Jensen, Dorte] Aarhus Univ, Dept Biosci, Silkeborg, Denmark; [Olesen, Birgit; Rasmussen, Jonas Ribergaard] Aarhus Univ, Dept Biosci, Aarhus C, Denmark; [Svensson, Carl Johan] Univ Gothenburg, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden	University of Oslo; University of Southern Denmark; University of Southern Denmark; University of Gothenburg; Abo Akademi University; Aarhus University; Aarhus University; Aarhus University; University of Gothenburg	Thormar, J (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	jonasthormar@hotmail.com	Holmer, Marianne/M-6989-2014; Thormar, Jonas/F-3103-2010; Krause-Jensen, Dorte/J-5666-2013; Olesen, Birgit/K-1997-2013; Clausen, Kevin Kuhlmann/J-5683-2013; Bostrom, Christoffer/U-6679-2017; Hasler-Sheetal, Harald/J-2422-2012	Holmer, Marianne/0000-0002-6095-5488; Thormar, Jonas/0000-0002-7925-3822; Krause-Jensen, Dorte/0000-0001-9792-256X; Olesen, Birgit/0000-0002-8864-6716; Baden, Susanne/0000-0002-2126-8941; Svensson, Carl Johan/0000-0002-8265-9313; Clausen, Kevin Kuhlmann/0000-0003-3636-5442; Bostrom, Christoffer/0000-0003-2845-8331; Hasler-Sheetal, Harald/0000-0002-9171-1451	Nordic Seagrass Network, NordForsk project [9260]; Danish Council for Independent Research \ Natural Sciences [FNU 12-127012]; "Nutrient cocktails in the coastal zone of the Baltic Sea (COCOA) project under "The joint Baltic Sea research and development programme (BONUS)" [Art. 185]; EU; Danish Research Council; Development of innovative Tools for understanding marine biodiversity and assessing good environmental status "DEVOTES" [FP-308392]; Villum Fonden [00007292] Funding Source: researchfish	Nordic Seagrass Network, NordForsk project; Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); "Nutrient cocktails in the coastal zone of the Baltic Sea (COCOA) project under "The joint Baltic Sea research and development programme (BONUS)"; EU(European Commission); Danish Research Council(Det Frie Forskningsrad (DFF)); Development of innovative Tools for understanding marine biodiversity and assessing good environmental status "DEVOTES"; Villum Fonden(Villum Fonden)	This work was supported by the Nordic Seagrass Network, NordForsk project no. 9260, http://www.nordforsk.org/en/programmes/projects/nordic-seagrass-network. MH was supported by the Danish Council for Independent Research vertical bar Natural Sciences (FNU 12-127012) http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council-1/the-danish-council-for-independent-research-natural-sciences. DKJ received support from 1) the "Nutrient cocktails in the coastal zone of the Baltic Sea (COCOA) project http://cocoa.au.dk/ under "The joint Baltic Sea research and development programme (Art. 185) (BONUS)", funded jointly by the EU 7th framework program (FP7) and the Danish Research Council; and 2) Development of innovative Tools for understanding marine biodiversity and assessing good environmental status "DEVOTES" http://www.devotes-project.eu/ under FP7 (contract #FP-308392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2005, MILLENIUM ECOSYSTEM; [Anonymous], 2014, VANDPLAN 2009 2015; [Anonymous], 2004, KYSTVANDE 2003; Baden S, 2003, AMBIO, V32, P374, DOI 10.1639/0044-7447(2003)032[0374:VSZMLI]2.0.CO;2; BADEN SP, 1984, OPHELIA, V23, P65, DOI 10.1080/00785236.1984.10426605; BADEN SP, 1990, NETH J SEA RES, V27, P81; Baden S, 2012, MAR ECOL PROG SER, V451, P61, DOI 10.3354/meps09585; Begon M., 2009, ECOLOGY INDIVIDUALS; Blegvad H., 1916, REP DAN BIOL STN, V24, P17; Bobsien IC, 2006, THESIS; Borum J, 1996, OIKOS, V76, P406, DOI 10.2307/3546213; Bostrom C, 2006, ESTUAR COAST SHELF S, V68, P383, DOI 10.1016/j.ecss.2006.01.026; Bostrom C, 2014, AQUAT CONSERV, V24, P410, DOI 10.1002/aqc.2424; BOWER CE, 1980, CAN J FISH AQUAT SCI, V37, P794, DOI 10.1139/f80-106; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; CEBRIAN J, 1995, SCIENCE, V268, P1606, DOI 10.1126/science.268.5217.1606; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Coll M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022591; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; DAVANZO C, 1994, ESTUARIES, V17, P131, DOI 10.2307/1352562; Deegan LA, 2002, AQUAT CONSERV, V12, P193, DOI 10.1002/aqc.490; Del Giorgio PA, 1999, ECOLOGY, V80, P1422, DOI 10.1890/0012-9658(1999)080[1422:LPBAMT]2.0.CO;2; DUARTE CM, 1995, OPHELIA, V41, P87, DOI 10.1080/00785236.1995.10422039; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Duffy JE, 2015, ECOL LETT, V18, P696, DOI 10.1111/ele.12448; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Duffy JE, 2003, ECOL LETT, V6, P637; Elton C., 1927, ANIMAL ECOLOGY; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fonseca MS, 1998, MAR ECOL PROG SER, V171, P109, DOI 10.3354/meps171109; FONSECA MS, 1983, ESTUAR COAST SHELF S, V17, P367, DOI 10.1016/0272-7714(83)90123-3; France KE, 2006, NATURE, V441, P1139, DOI 10.1038/nature04729; France RL, 2014, HYDROBIOLOGIA, V722, P1, DOI 10.1007/s10750-013-1710-7; France RL, 1997, CAN J FISH AQUAT SCI, V54, P1255, DOI 10.1139/f97-044; Frederiksen MS, 2006, LIMNOL OCEANOGR, V51, P2308, DOI 10.4319/lo.2006.51.5.2308; Fredriksen S, 2004, SARSIA, V89, P218, DOI 10.1080/00364820410005593; Grober-Dunsmore R, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P493, DOI 10.1007/978-90-481-2406-0_14; Gullstrom M, 2012, MAR BIOL, V159, P413, DOI 10.1007/s00227-011-1819-z; Gustafsson C, 2009, J EXP MAR BIOL ECOL, V382, P8, DOI 10.1016/j.jembe.2009.10.013; Gutierrez JL, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 7: FUNCTIONING OF ECOSYSTEMS AT THE LAND-OCEAN INTERFACE, P53; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Hauxwell J, 2001, ECOLOGY, V82, P1007, DOI 10.2307/2679899; Heck KL, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P537; Heck KL, 2000, LIMNOL OCEANOGR, V45, P1041, DOI 10.4319/lo.2000.45.5.1041; Hemminga MA, 1998, J SEA RES, V39, P183, DOI 10.1016/S1385-1101(98)00004-5; Holmer M, 2001, AQUAT BOT, V70, P29, DOI 10.1016/S0304-3770(00)00142-X; Hoshika A, 2006, AQUAT BOT, V85, P191, DOI 10.1016/j.aquabot.2006.03.005; Hovel KA, 2002, MAR ECOL PROG SER, V243, P11, DOI 10.3354/meps243011; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaschinski S, 2008, MAR ECOL PROG SER, V358, P103, DOI 10.3354/meps07327; Jephson T, 2008, MAR ECOL PROG SER, V369, P63, DOI 10.3354/meps07646; Jones J. Iwan, 2007, P118, DOI 10.1017/CBO9780511611223.008; JURGENSEN C, 1995, OPHELIA, V42, P163; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kharlamenko VI, 2001, MAR ECOL PROG SER, V220, P103, DOI 10.3354/meps220103; Krause-Jensen D, 2012, ESTUAR COAST, V35, P527, DOI 10.1007/s12237-011-9443-1; KrauseJensen D, 1996, MAR ECOL PROG SER, V134, P207, DOI 10.3354/meps134207; Larsen GR, 1994, KERTINGE NOR KERTEMI; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LeCraw RM, 2014, OECOLOGIA, V176, P903, DOI 10.1007/s00442-014-3083-7; LIVINGSTON RJ, 1984, ESTUARIES, V7, P377, DOI 10.2307/1351620; Ljunggren L, 2010, ICES J MAR SCI, V67, P1587, DOI 10.1093/icesjms/fsq109; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Menezes RF, 2015, FRESHWATER BIOL, V60, P745, DOI 10.1111/fwb.12526; MIRON G, 1993, MAR ECOL PROG SER, V93, P143, DOI 10.3354/meps093143; Mittermayr A, 2014, MAR ECOL PROG SER, V497, P93, DOI 10.3354/meps10569; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Muus B. J., 1967, Meddelelser fra Danmarks Fiskeri- og Havundersogelser NS, V5, P1; Nagata RM, 2015, MAR ECOL PROG SER, V519, P13, DOI 10.3354/meps11071; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; O'Gorman EJ, 2009, P NATL ACAD SCI USA, V106, P13393, DOI 10.1073/pnas.0903682106; Ochieng CA, 2010, J EXP MAR BIOL ECOL, V382, P117, DOI 10.1016/j.jembe.2009.11.007; ODUM E P, 1971, P574; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; OLESEN NJ, 1995, MAR ECOL PROG SER, V124, P63, DOI 10.3354/meps124063; PAINE RT, 1980, J ANIM ECOL, V49, P667; Papadimitriou S, 2006, ORG GEOCHEM, V37, P1343, DOI 10.1016/j.orggeochem.2006.01.007; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Peralta G, 2006, MAR ECOL PROG SER, V327, P135, DOI 10.3354/meps327135; Petersen JK, 2012, MAR ECOL PROG SER, V463, P127, DOI 10.3354/meps09809; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pihl L, 2006, ESTUAR COAST SHELF S, V67, P123, DOI 10.1016/j.ecss.2005.10.016; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Raffaelli D, 2002, SCIENCE, V296, P1035, DOI 10.1126/science.1072080; Rasmussen MB, 2002, VEGETATION I FARVAND; Reichle D.E., 1981, DYNAMIC PROPERTIES F; Reynolds PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036196; Ricciardi A, 1998, MAR ECOL PROG SER, V163, P245, DOI 10.3354/meps163245; Riisgard H. U., 2008, V197, P361, DOI 10.1007/978-3-540-73524-3_16; Riisgard HU, 2010, AQUAT INVASIONS, V5, P347, DOI 10.3391/ai.2010.5.4.03; RIISGARD HU, 1995, OPHELIA, V41, P329, DOI 10.1080/00785236.1995.10422051; Riisgard HU, 1994, KERTINGE NOR KERTEMI; Rogers AD, 2013, MAR POLLUT BULL, V74, P491, DOI 10.1016/j.marpolbul.2013.06.057; Ronnback P, 2007, AMBIO, V36, P534, DOI 10.1579/0044-7447(2007)36[534:EGASFS]2.0.CO;2; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Rubegni F, 2013, MAR POLLUT BULL, V70, P54, DOI 10.1016/j.marpolbul.2013.02.012; Rumohr H., 1987, BALT MAR BIOL, V9, P1; Schanz A, 2002, MAR BIOL, V141, P287, DOI 10.1007/s00227-002-0823-8; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P155; SHORT FT, 1995, LIMNOL OCEANOGR, V40, P740, DOI 10.4319/lo.1995.40.4.0740; SMIT H, 1993, FRESHWATER BIOL, V29, P37, DOI 10.1111/j.1365-2427.1993.tb00742.x; Svensson CJ, 2007, MAR ENVIRON RES, V64, P286, DOI 10.1016/j.marenvres.2007.02.002; Svensson CJ, 2012, MAR ECOL PROG SER, V471, P61, DOI 10.3354/meps10014; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; WADA E, 1991, CRIT REV FOOD SCI, V30, P361, DOI 10.1080/10408399109527547; Wang H, 2009, ECOL MODEL, V220, P1376, DOI 10.1016/j.ecolmodel.2009.03.005; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003; WoRMS Editorial Board, 2015, WORLD REGISTER MARIN	117	26	26	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146479	10.1371/journal.pone.0146479	http://dx.doi.org/10.1371/journal.pone.0146479			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752412	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100085
J	Uno, I; Kozaka, T; Miwa, D; Kitamura, Y; Anwar-ul Azim, M; Ogawa, K; Taki, J; Kinuya, S; Shiba, K				Uno, Izumi; Kozaka, Takashi; Miwa, Daisuke; Kitamura, Yoji; Anwar-ul Azim, Mohammad; Ogawa, Kazuma; Taki, Junichi; Kinuya, Seigo; Shiba, Kazuhiro			In Vivo Differences between Two Optical Isomers of Radioiodinated o-iodo-trans-decalinvesamicol for Use as a Radioligand for the Vesicular Acetylcholine Transporter	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TAUOPATHY MOUSE MODEL; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; CHOLINERGIC NEURONS; AUTORADIOGRAPHIC DISTRIBUTION; POTENTIAL RADIOLIGAND; COGNITIVE IMPAIRMENT; AMYLOID DEPOSITION; VESAMICOL RECEPTOR	Purpose To develop a superior VAChT imaging probe for SPECT, radiolabeled (-)-OIDV and (+)-OIDV were isolated and investigated for differences in their binding affinity and selectivity to VAChT, as well as their in vivo activities. Procedures Radioiodinated o-iodo-trans-decalinvesamicol ([I-125] OIDV) has a high binding affinity for vesicular acetylcholine transporter (VAChT) both in vitro and in vivo. Racemic [I-125] OIDV was separated into its two optical isomers (-)-[I-125] OIDV and (+)-[I-125] OIDV by HPLC. To investigate VAChT binding affinity (Ki) of two OIDV isomers, in vitro binding assays were performed. In vivo biodistribution study of each [I-125] OIDV isomer in blood, brain regions and major organs of rats was performed at 2,30 and 60 min post-injection. In vivo blocking study were performed to reveal the binding selectivity of two [I-125] OIDV isomers to VAChT in vivo. Ex vivo autoradiography were performed to reveal the regional brain distribution of two [I-125] OIDV isomers and (-)-[I-123] OIDV for SPECT at 60 min postinjection. Results VAChT binding affinity (Ki) of (-)-[I-125] OIDV and (+)-[I-125] OIDV was 22.1 nM and 79.0 nM, respectively. At 2 min post-injection, accumulation of (-)-[I-125] OIDV was the same as that of (+)-[I-125] OIDV. However, (+)-[I-125] OIDV clearance from the brain was faster than (-)-[I-125] OIDV. At 30 min post-injection, accumulation of (-)-[I-125] OIDV (0.62 +/- 0.10% ID/g) was higher than (+)-[I-125] OIDV (0.46 +/- 0.07% ID/g) in the cortex. Inhibition of OIDV binding showed that (-)-[I-125] OIDV was selectively accumulated in regions known to express VAChT in the rat brain, and ex vivo autoradiography further confirmed these results showing similar accumulation of (-)-[I-125] OIDV in these regions. Furthermore, (-)-[I-123] OIDV for SPECT showed the same regional brain distribution as (-)-[I-125] OIDV. Conclusion These results suggest that radioiodinated (-)-OIDV may be a potentially useful tool for studying presynaptic cholinergic neurons in the brain.	[Uno, Izumi; Kozaka, Takashi; Miwa, Daisuke; Kitamura, Yoji; Shiba, Kazuhiro] Kanazawa Univ, Adv Sci Res Ctr, Div Tracer Kinet, Kanazawa, Ishikawa 9208640, Japan; [Miwa, Daisuke; Ogawa, Kazuma; Taki, Junichi; Kinuya, Seigo] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9208640, Japan; [Uno, Izumi] Kanazawa Univ Hosp, Clin Lab, Kanazawa, Ishikawa 9208640, Japan; [Anwar-ul Azim, Mohammad] Natl Inst Nucl Med & Allied Sci, Dhaka 1000, Bangladesh; [Anwar-ul Azim, Mohammad] Bangladesh Atom Energy Commiss, Dhaka 1000, Bangladesh	Kanazawa University; Kanazawa University; Kanazawa University	Shiba, K (corresponding author), Kanazawa Univ, Adv Sci Res Ctr, Div Tracer Kinet, Kanazawa, Ishikawa 9208640, Japan.	shiba@med.kanazawa-u.ac.jp	Ogawa, Kazuma/D-8406-2015	Ogawa, Kazuma/0000-0002-1691-7302	Ministry of Education, Culture, Sports, Science and Technology of Japan [26293273]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 26293273) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Allan IL, 1991, J NEUROSCI, V11, P3218; Alter CA, 1988, SYNAPSE, V2, P486; Archer HA, 2006, ANN NEUROL, V60, P145, DOI 10.1002/ana.20889; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bar BA, 1986, P NATL ACAD SCI USA, V83, P2267; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; BUTCHER LL, 1993, PROG BRAIN RES, V98, P1; Efange SMN, 1997, NEUROBIOL AGING, V18, P407, DOI 10.1016/S0197-4580(97)00038-9; EFANGE SMN, 1993, J MED CHEM, V36, P1754, DOI 10.1021/jm00064a009; EFANGE SMN, 1994, APPL RADIAT ISOTOPES, V45, P465, DOI 10.1016/0969-8043(94)90113-9; EFANGE SMN, 1995, BIOCHEM PHARMACOL, V49, P791, DOI 10.1016/0006-2952(94)00541-S; Fripp J, 2008, NEUROIMAGE, V43, P430, DOI 10.1016/j.neuroimage.2008.07.053; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Harada Y, 1994, EUR J PHARMACOL, P321; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hatashita S, 2010, J ALZHEIMERS DIS, V21, P995, DOI 10.3233/JAD-2010-100222; JUNG YW, 1990, J MED CHEM, V33, P2065, DOI 10.1021/jm00170a002; Kozaka T, 2014, SYNAPSE, V68, P107, DOI 10.1002/syn.21720; Kozaka T, 2012, BIOORGAN MED CHEM, V20, P4936, DOI 10.1016/j.bmc.2012.06.040; Kuhl DE, 1996, ANN NEUROL, V40, P399, DOI 10.1002/ana.410400309; Li JF, 2013, J MED CHEM, V56, P6216, DOI 10.1021/jm400664x; MARSHALL IG, 1987, TRENDS NEUROSCI, V10, P174, DOI 10.1016/0166-2236(87)90044-0; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Masters CL, 2006, J NEUROCHEM, V97, P1700, DOI 10.1111/j.1471-4159.2006.03989.x; McCormick DA., 1989, ACETYLCHOLINE DISTRI; MCGEER PL, 1984, CAN J PHYSIOL PHARM, V62, P741, DOI 10.1139/y84-123; Molerings GJ, 1996, NAUNYA SCHMIEDEBERGS, V354, P245; Mulholland GK, 1998, SYNAPSE, V30, P263, DOI 10.1002/(SICI)1098-2396(199811)30:3<263::AID-SYN4>3.0.CO;2-9; Nishiyama S, 2014, SYNAPSE, V68, P283, DOI 10.1002/syn.21743; PASCUAL J, 1991, BRAIN RES, V552, P170, DOI 10.1016/0006-8993(91)90676-M; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; QUIRION R, 1987, SYNAPSE, V1, P293, DOI 10.1002/syn.890010403; QUIRION R, 1993, PROG BRAIN RES, V98, P85; QUIRION R, 1992, TRENDS PHARMACOL SCI, V13, P85, DOI 10.1016/0165-6147(92)90030-A; REINIKAINEN KJ, 1990, J NEUROSCI RES, V27, P576, DOI 10.1002/jnr.490270419; ROGERS GA, 1989, J MED CHEM, V32, P1217, DOI 10.1021/jm00126a013; ROTTER A, 1981, BRAIN RES BULL, V6, P525, DOI 10.1016/S0361-9230(81)80027-5; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Shiba K, 2003, ANN NUCL MED, V17, P451, DOI 10.1007/BF03006433; Shiba K, 2002, LIFE SCI, V71, P1591, DOI 10.1016/S0024-3205(02)01919-7; Shiba K, 1996, NUCL MED COMMUN, V17, P485, DOI 10.1097/00006231-199606000-00006; Shiba K, 2009, SYNAPSE, V63, P167, DOI 10.1002/syn.20590; Sorger D, 2000, NUCL MED BIOL, V27, P23, DOI 10.1016/S0969-8051(99)00087-6; Sorger D, 2009, NUCL MED BIOL, V36, P17, DOI 10.1016/j.nucmedbio.2008.10.006; VILARO MT, 1993, PROG BRAIN RES, V98, P95; WOOLF NJ, 1983, NEUROSCI LETT, V40, P93, DOI 10.1016/0304-3940(83)90285-9; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	49	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146719	10.1371/journal.pone.0146719	http://dx.doi.org/10.1371/journal.pone.0146719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752172	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100139
J	Wang, P; Wang, YF; Qiao, YJ; Zhou, SJ; Liang, XH; Liu, ZS				Wang, Pei; Wang, Yufei; Qiao, Yingjin; Zhou, Sijie; Liang, Xianhui; Liu, Zhangsuo			A Retrospective Study of Preferable Alternative Route to Right Internal Jugular Vein for Placing Tunneled Dialysis Catheters: Right External Jugular Vein versus Left Internal Jugular Vein	PLOS ONE			English	Article							HEMODIALYSIS CATHETERS; VASCULAR ACCESS; VENOUS ACCESS; BLOOD-FLOW; STENOSIS; THROMBOSIS	Background Right internal jugular vein (IJV) is a preferred access route for tunneled (cuffed) dialysis catheters (TDCs), and both right external jugular vein (EJV) and left IJV are alternative routes for patients in case the right IJV isn't available for TDC placement. This retrospective study aimed to determine if a disparity exists between the two alternative routes in hemodialysis patients in terms of outcomes of TDCs. Methods 49 hemodialysis patients who required TDCs through right EJV (n = 21) or left IJV (n = 28) as long-term vascular access were included in this study. The primary end point was cumulative catheter patency. Secondary end points include primary catheter patency, proportion of patients that never required urokinase and incidence of catheter-related bloodstream infections (CRBSI). Results A total of 20,870 catheter-days were evaluated and the median was 384 (interquartile range, 262-605) catheter-days. Fewer catheters were removed in the right EJV group than in the left IJV group (P = 0.007). Mean cumulative catheter patency was higher in the right EJV group compared with the left IJV group (P = 0.031). There was no significant difference between the two groups in the incidence of CRBSI, primary catheter patency or proportion of patients that never required urokinase use. Total indwell time of antecedent catheters was identified as an independent risk factor for cumulative catheter patency by Cox regression hazards test with an HR of 2.212 (95% CI, 1.363-3.588; p = 0.001). Conclusions Right EJV might be superior to left IJV as an alternative insertion route for TDC placement in hemodialysis patients whose right IJVs are unavailable.	[Wang, Pei; Wang, Yufei; Qiao, Yingjin; Zhou, Sijie; Liang, Xianhui; Liu, Zhangsuo] Zhengzhou Univ, Affiliated Hosp 1, Blood Purificat Ctr, Dept Nephrol, Zhengzhou 450052, Peoples R China	Zhengzhou University	Wang, P (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Blood Purificat Ctr, Dept Nephrol, Zhengzhou 450052, Peoples R China.	wpei@zzu.edu.cn			Technology Innovation Team Program of Zhengzhou City [10CXTD142]	Technology Innovation Team Program of Zhengzhou City	This study was supported by a grant from the Technology Innovation Team Program of Zhengzhou City (No. 10CXTD142).	Agarwal AK, 2013, AM J KIDNEY DIS, V61, P1001, DOI 10.1053/j.ajkd.2012.10.024; Allon M, 2015, NAT REV NEPHROL, V11, P323, DOI 10.1038/nrneph.2015.56; Bannon MP, 2011, RISK MANAG HEALTHC P, V4, P27, DOI 10.2147/RMHP.S10383; Camins BC, 2013, SEMIN DIALYSIS, V26, P476, DOI 10.1111/sdi.12117; Cho SK, 2006, J VASC INTERV RADIOL, V17, P823, DOI 10.1097/01.RVI.0000218048.28960.9E; Forauer AR, 2000, AM J ROENTGENOL, V174, P361, DOI 10.2214/ajr.174.2.1740361; Ge BH, 2015, SEMIN INTERVENT RAD, V32, P108, DOI 10.1055/s-0035-1549375; Grant JP, 2006, JPEN-PARENTER ENTER, V30, pS7, DOI 10.1177/01486071060300S1S7; Kato K, 2014, J INVEST SURG, V27, P176, DOI 10.3109/08941939.2013.865818; Labropoulos N, 2007, J VASC SURG, V46, P101, DOI 10.1016/j.jvs.2007.02.062; Lee T, 2011, SEMIN DIALYSIS, V24, P515, DOI 10.1111/j.1525-139X.2011.00969.x; MacRae JM, 2005, ASAIO J, V51, P77, DOI 10.1097/01.MAT.0000151921.95165.1E; Moist LM, 2006, CLIN J AM SOC NEPHRO, V1, P965, DOI 10.2215/CJN.01090306; Naroienejad M, 2010, SAUDI J KIDNEY DIS T, V21, P975; Pisoni RL, 2015, AM J KIDNEY DIS, V65, P905, DOI 10.1053/j.ajkd.2014.12.014; Riella MC, 2013, NAT REV NEPHROL, V9, P348, DOI 10.1038/nrneph.2013.76; Salgado OJ, 2004, ARTIF ORGANS, V28, P728, DOI 10.1111/j.1525-1594.2004.07316.x; Shingarev R, 2013, J VASC INTERV RADIOL, V24, P1289, DOI 10.1016/j.jvir.2013.05.034; Shingarev R, 2012, AM J KIDNEY DIS, V60, P983, DOI 10.1053/j.ajkd.2012.06.014; Skandalos I, 2007, J VASC ACCESS, V8, P12, DOI 10.1177/112972980700800103; Trerotola SO, 2000, RADIOLOGY, V217, P89, DOI 10.1148/radiology.217.1.r00oc2789; Van der Meersch H, 2014, AM J KIDNEY DIS, V64, P902, DOI 10.1053/j.ajkd.2014.02.017; *VASC ACC WORK GRO, 2006, AM J KIDNEY DIS S, V48, pS248, DOI DOI 10.1053/J.AJKD.2006.04.040.MEDLINE; Vats HS, 2012, J VASC ACCESS, V13, P51, DOI 10.5301/JVA.2011.8444; Wilkin TD, 2003, RADIOLOGY, V228, P697, DOI 10.1148/radiol.2283020681	25	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146411	10.1371/journal.pone.0146411	http://dx.doi.org/10.1371/journal.pone.0146411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751380	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100077
J	Zhao, Y; Bao, L; Chan, LS; DiPietro, LA; Chen, L				Zhao, Yan; Bao, Lei; Chan, Lawrence S.; DiPietro, Luisa A.; Chen, Lin			Aberrant Wound Healing in an Epidermal Interleukin-4 Transgenic Mouse Model of Atopic Dermatitis	PLOS ONE			English	Article							GENE-EXPRESSION; CELL ACTIVATION; UP-REGULATION; INFLAMMATORY CELLS; TISSUE-REPAIR; ORAL-MUCOSA; T-CELLS; SKIN; FIBROBLASTS; MIGRATION	Wound healing in a pre-existing Th2-dominated skin milieu was assessed by using an epidermal specific interleukin-4 (IL-4) transgenic (Tg) mouse model, which develops a pruritic inflammatory skin condition resembling human atopic dermatitis. Our results demonstrated that IL-4 Tg mice had delayed wound closure and re-epithelialization even though these mice exhibited higher degrees of epithelial cell proliferation. Wounds in IL-4 Tg mice also showed a marked enhancement in expression of inflammatory cytokines/chemokines, elevated infiltration of inflammatory cells including neutrophils, macrophages, CD3+ lymphocytes, and epidermal dendritic T lymphocytes. In addition, these mice exhibited a significantly higher level of angiogenesis as compared to wild type mice. Furthermore, wounds in IL-4 Tg mice presented with larger amounts of granulation tissue, but had less expression and deposition of collagen. Taken together, an inflamed skin condition induced by IL-4 has a pronounced negative influence on the healing process. Understanding more about the pathogenesis of wound healing in a Th2-dominated environment may help investigators explore new potential therapeutic strategies.	[Zhao, Yan; DiPietro, Luisa A.; Chen, Lin] Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60608 USA; [Bao, Lei; Chan, Lawrence S.] Univ Illinois, Coll Med, Dept Dermatol, Chicago, IL 60680 USA; [Chan, Lawrence S.] Univ Illinois, Coll Med, Dept Immunol, Chicago, IL USA; [Chan, Lawrence S.] Univ Illinois, Coll Med, Dept Microbiol, Chicago, IL USA; [Chan, Lawrence S.] Jesse Brown Vet Affairs Med Ctr, Med Serv, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Chen, L (corresponding author), Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60608 USA.	chenlin@uic.edu	Chen, Lin/AAW-8207-2020	Chen, Lin/0000-0001-8530-2363	NIH [R01GM50875]; College of Dentistry, University of Illinois at Chicago; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Dentistry, University of Illinois at Chicago; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH Grants R01GM50875 (LAD), College of Dentistry, University of Illinois at Chicago (LC, YZ, and LAD), Dr. Orville J. Stone Endowed Professorship (LSC), and the Albert H. and Mary Jane Slepyan Endowed Fellowship (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Lei, 2013, JAKSTAT, V2, pe24137, DOI 10.4161/jkst.24137; Bao L, 2013, CYTOKINE, V61, P419, DOI 10.1016/j.cyto.2012.10.031; BARBUL A, 1989, ANN SURG, V209, P479, DOI 10.1097/00000658-198904000-00015; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/721608; Barron L, 2011, AM J PHYSIOL-GASTR L, V300, pG723, DOI 10.1152/ajpgi.00414.2010; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; Chan LS, 2001, J INVEST DERMATOL, V117, P977, DOI 10.1046/j.0022-202x.2001.01484.x; Chen L, 2005, CLIN EXP IMMUNOL, V142, P21, DOI 10.1111/j.1365-2249.2005.02894.x; Chen L, 2005, CLIN EXP IMMUNOL, V139, P189, DOI 10.1111/j.1365-2249.2004.02691.x; Chen L, 2004, CLIN EXP IMMUNOL, V138, P375, DOI 10.1111/j.1365-2249.2004.02649.x; Chen L, 2008, MICROCIRCULATION, V15, P49, DOI 10.1080/10739680701418416; Chen L, 2006, INT IMMUNOL, V18, P1233, DOI 10.1093/intimm/dxl054; Chen L, 2014, EXP DERMATOL, V23, P189, DOI 10.1111/exd.12346; Chen L, 2013, J INVEST DERMATOL, V133, P258, DOI 10.1038/jid.2012.267; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Chen L, 2010, IMMUNOL CELL BIOL, V88, P334, DOI 10.1038/icb.2009.107; Davis PA, 2001, BRIT J SURG, V88, P298, DOI 10.1046/j.1365-2168.2001.01665.x; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; DUNCAN MR, 1991, J INVEST DERMATOL, V97, P686, DOI 10.1111/1523-1747.ep12483971; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; FERTIN C, 1991, CELL MOL BIOL, V37, P823; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; GILLERY P, 1992, FEBS LETT, V302, P231, DOI 10.1016/0014-5793(92)80448-P; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gordon GM, 2011, J CELL PHYSIOL, V226, P1461, DOI 10.1002/jcp.22306; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Harvima IT, 2008, J INVEST DERMATOL, V128, P2748, DOI 10.1038/jid.2008.331; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jetten N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102994; Kucukcelebi Ahmet, 1995, Wound Repair and Regeneration, V3, P49, DOI 10.1046/j.1524-475X.1995.30110.x; Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]; Lopez-Navarrete G, 2011, INT J BIOL SCI, V7, P1273, DOI 10.7150/ijbs.7.1273; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; MODLIN RL, 1994, J INVEST DERMATOL, V102, P828, DOI 10.1111/1523-1747.ep12381958; Nielsen BS, 1996, INT J CANCER, V65, P57, DOI 10.1002/(SICI)1097-0215(19960103)65:1<57::AID-IJC10>3.0.CO;2-F; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Ong PY, 2006, CURR ALLERGY ASTHM R, V6, P384, DOI 10.1007/s11882-996-0008-5; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Peplow PV, 2013, CYTOKINE, V62, P1, DOI 10.1016/j.cyto.2013.02.015; POSTLETHWAITE AE, 1992, J CLIN INVEST, V90, P1479, DOI 10.1172/JCI116015; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Ranzer MJ, 2011, ALCOHOL CLIN EXP RES, V35, P83, DOI 10.1111/j.1530-0277.2010.01324.x; Reichle ME, 2011, J INVEST DERMATOL, V131, P791, DOI 10.1038/jid.2010.382; Romagnani S, 1996, CLIN IMMUNOL IMMUNOP, V80, P225, DOI 10.1006/clin.1996.0118; Salmon-Ehr V, 2000, LAB INVEST, V80, P1337, DOI 10.1038/labinvest.3780141; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Tochio T, 2010, J DERMATOL SCI, V58, P123, DOI 10.1016/j.jdermsci.2010.02.012; Tsuboi Ryoji, 1992, Journal of Dermatology (Tokyo), V19, P652; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Wilgus TA, 2007, OSTOMY WOUND MANAG, V53, P16; Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x; Wong VW, 2014, ANN SURG, V260, P1138, DOI 10.1097/SLA.0000000000000219	59	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146451	10.1371/journal.pone.0146451	http://dx.doi.org/10.1371/journal.pone.0146451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752054	Green Published, gold			2022-12-27	WOS:000367888100082
J	Santos, CAB; de Albuquerque, UP; Souto, WMS; Alves, RRN				Batista Santos, Carlos Alberto; de Albuquerque, Ulysses Paulino; Silva Souto, Wedson Medeiros; Nobrega Alves, Romulo Romeu			Assessing the Effects of Indigenous Migration on Zootherapeutic Practices in the Semiarid Region of Brazil	PLOS ONE			English	Article							ANIMAL-DERIVED REMEDIES; COMPLEMENTARY MEDICINE; FISHING COMMUNITIES; KNOWLEDGE; PHARMACOPEIA; MARKETS; MAMMALS; TRADE; CRATO; NE	Human migration implies adaptations to new environments, such as ways to benefit from the available biodiversity. This study focused on the use of animal-derived remedies, and we investigated the effects of migration on the traditional medical system of the indigenous Truka people. This ethnic group lives in Northeast Brazil and is currently distributed in four distinct villages. In these villages, the zootherapeutic knowledge of 54 indigenous people was determined through semi-structured questionnaires given from September 2013 to January 2014. The interviewees indicated 137 zootherapeutic uses involving 21 animal species. The variety of species and their uses have a higher similarity between villages that are closer to each other, which can be a reflection of geographic and environmental factors. However, even close villages showed a low similarity in the zootherapeutic uses recorded, which reflects a strong idiosyncrasy regarding the knowledge of each village. Hence, each village may be influenced by the physical environment and contact with other cultures, which may maintain or reduce the contact of younger villages with the original village.	[Batista Santos, Carlos Alberto; de Albuquerque, Ulysses Paulino; Nobrega Alves, Romulo Romeu] Univ Fed Rural Pernambuco, Dept Ciencias Biol, Programa Pos Grad Etnobiol & Conservacao Nat, BR-52171900 Recife, PE, Brazil; [Batista Santos, Carlos Alberto] Univ Estado Bahia, Dept Tecnol & Ciencias Sociais, BR-48905680 Juazeiro, BA, Brazil; [Silva Souto, Wedson Medeiros] Univ Fed Piaui, BR-64800000 Floriano, PI, Brazil; [Silva Souto, Wedson Medeiros; Nobrega Alves, Romulo Romeu] Univ Fed Paraiba UFPB, Programa Posgrad Ciencias Biol Zool, Dept Sistemat & Ecol, Ctr Ciencias Exatas & Nat, BR-58051900 Joao Pessoa, Paraiba, Brazil; [Nobrega Alves, Romulo Romeu] Univ Estadual Paraiba, Dept Biol, BR-58109753 Campina Grande, PB, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade do Estado Bahia; Universidade Federal do Piaui; Universidade Estadual da Paraiba	Alves, RRN (corresponding author), Univ Fed Rural Pernambuco, Dept Ciencias Biol, Programa Pos Grad Etnobiol & Conservacao Nat, Rua Dom Manoel de Medeiros S-N, BR-52171900 Recife, PE, Brazil.	romulo_nobrega@yahoo.com.br	Alves, Rômulo Romeu Nóbrega/A-7026-2009; Albuquerque, Ulysses P/I-5037-2012	Alves, Rômulo Romeu Nóbrega/0000-0001-6824-0797; Albuquerque, Ulysses P/0000-0002-8131-8429	National Council for Scientific and Technological Development (CNPq) [476460/2012-3]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the National Council for Scientific and Technological Development (CNPq) (grant number 476460/2012-3).	Adeodato S, 2014, CAATINGA SELVAGEM LE; Albuquerque U.P., 2014, METHODS TECHNIQUES E; Albuquerque Ulysses Paulino De, 1998, Anales del Jardin Botanico de Madrid, V56, P107; Alves RRN, 2007, BIOSCIENCE, V57, P949, DOI 10.1641/B571107; Alves RRN, 2007, J ETHNOPHARMACOL, V113, P541, DOI 10.1016/j.jep.2007.07.015; Alves RRN, 2007, J ETHNOPHARMACOL, V111, P82, DOI 10.1016/j.jep.2006.10.033; Alves RRN, 2006, J ETHNOPHARMACOL, V107, P259, DOI 10.1016/j.jep.2006.03.007; Alves RRN, 2009, J ETHNOPHARMACOL, V124, P600, DOI 10.1016/j.jep.2009.04.049; Alves RRN, 2009, J ETHNOBIOL ETHNOMED, V5, DOI [10.1186/1746-4269-5-1, 10.1186/1746-4269-5-12]; Bailey K.D., 1994, METHODS SOCIAL RES, V4th; Batista MRR., 2005, THESIS; Belliard JC, 2005, HISPANIC J BEHAV SCI, V27, P267, DOI 10.1177/0739986305278130; Berg ME, 1991, B MUSEU PARAENSE E B, V7, P485; Campos E, 1967, MED POPULAR NORDESTE; Ceuterick M, 2008, J ETHNOPHARMACOL, V120, P342, DOI 10.1016/j.jep.2008.09.004; Costa-Neto EM, 1999, ACTUAL BIOL, V21, P69; de Medeiros PM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/807452; Fernandes V.N., 2012, THESIS; Ferreira FS, 2013, BIODIVERS CONSERV, V22, P839, DOI 10.1007/s10531-013-0475-7; Ferreira FS, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-21; Ferreira FS, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-17; Ferreira FS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/126938; Vieira HTG, 2013, SAUDE SOC-SAO PAULO, V22, P566, DOI 10.1590/S0104-12902013000200025; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; KRUSKAL WH, 1953, J AM STAT ASSOC, V48, P907, DOI 10.2307/2281082; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lacuna-Richman C, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-36; Lima JRB, 2010, ETNOBIOLOGIA, V8, P39; Machado Antonio Thomaz da Mata, 2008, Estud. av., V22, P195, DOI 10.1590/S0103-40142008000200013; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MARES MA, 1985, J BIOGEOGR, V12, P57, DOI 10.2307/2845029; Marques JGW, 2006, ECOLOGIAS SAO FRANCI; Martine G, 2010, POPULACAO CIDADES SU, P11; Martinez GJ, 2013, ETHNOBIOL CONSERV, V2, DOI 10.15451/ec2013-8-2.2-1-43; Medeiros P.M., 2014, INTRO ETHNOBIOLOGIA, P157; Nesheim I, 2006, HUM ECOL, V34, P99, DOI 10.1007/s10745-005-9004-y; Alves RRN, 2010, HUM ECOL, V38, P691, DOI 10.1007/s10745-010-9352-0; Novick S, 2008, MIGRACIONES AM LATIN; de Souza RSO, 2008, BRAZ ARCH BIOL TECHN, V51, P937, DOI 10.1590/S1516-89132008000500010; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Oliveira ES, 2010, J ETHNOPHARMACOL, V130, P54, DOI 10.1016/j.jep.2010.04.010; OLIVEIRA J. A., 2003, ECOLOGIA CONSERVACAO, P275; ONU ONU, 2013, INT MIGRATION; Ribeiro D., 1995, POVO BRASILEIRO FORM; Rodrigues M. T., 2003, ECOLOGIA CONSERVACAO, P181; Rosa I., 2013, ANIMALS TRADITIONAL, P109, DOI DOI 10.1007/978-3-642-29026-8; Sa-Menezes J, 1957, MED INDIGENA; Santos SC, 1981, 44 IWGIA; Servico Geologico do Brasil SGB, 2005, PROJ CAD FONT AB AG; SGB, 2005, PROJ CAD FONT AB AG; Silva TFS, 2005, MAMIFEROS BAHIA ESPE; Sousa GS, 1971, TRATADO DESCRITIVO B, V1587; Souto WMS, 2011, J ETHNOPHARMACOL, V134, P753, DOI 10.1016/j.jep.2011.01.041; Vandebroek I, 2010, ECON BOT, V64, P303, DOI 10.1007/s12231-010-9135-y; Volpato G, 2009, HUM ECOL, V37, P43, DOI 10.1007/s10745-008-9211-4; Waldstein A, 2006, J ETHNOPHARMACOL, V108, P299, DOI 10.1016/j.jep.2006.07.011; WILLIG M R, 1989, Revista Brasileira de Biologia, V49, P361; [No title captured]	58	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146657	10.1371/journal.pone.0146657	http://dx.doi.org/10.1371/journal.pone.0146657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA5AX	26745882	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600073
J	Han, KT; Jang, SY; Park, S; Cho, KH; Yoo, KB; Choi, Y; Park, EC				Han, Kyu-Tae; Jang, Suk Yong; Park, Sohee; Cho, Kyung Hee; Yoo, Ki-Bong; Choi, Young; Park, Eun-Cheol			Social Welfare Centers Protect Outpatients with Mood Disorders from Risk of Hospital Admission	PLOS ONE			English	Article							MENTAL-HEALTH; SUICIDE RISK; QUALITY; SUPPORT; STRESS; CARE	Background South Korea faces difficulties in the management of mental disorders, and those difficulties are expected to gradually worsen. Therefore, we analyzed the relationship between social welfare centers and hospital admission after outpatient treatment for mood disorders. Methods We used data from the National Health Insurance Service National Sample Cohort 2002-2013, which included all medical claims filed for the 50,160 patients who were newly diagnosed with a mood disorder among the 1,025,340 individuals in a nationally representative sample. We performed a logistic regression analysis using generalized estimating equation (GEE) models to examine the relationship between social welfare centers and hospital admission after outpatient treatment for mood disorders (ICD-10: F3). Results There was a 3.9% admission rate among a total of 99,533 person-years. Outpatients who lived in regions with more social welfare centers were less likely to be admitted to a hospital (per increase of five social welfare centers per 100,000 people; OR: 0.958; 95% CI: 0.919-0.999). Social welfare centers had an especially strong protective effect on patients with relatively mild mood disorders and those who were vulnerable to medical expenditures. Conclusions Considering the protective role of social welfare centers in managing patients with mood disorders, health-policy makers need to consider strategies for activating mental healthcare.	[Han, Kyu-Tae; Jang, Suk Yong; Cho, Kyung Hee; Choi, Young] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; [Han, Kyu-Tae; Jang, Suk Yong; Cho, Kyung Hee; Choi, Young; Park, Eun-Cheol] Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea; [Park, Sohee] Yonsei Univ, Dept Biostat, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Yoo, Ki-Bong] Eulji Univ, Dept Hosp Management, Songnam, South Korea; [Jang, Suk Yong; Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Eulji University; Yonsei University; Yonsei University Health System	Park, EC (corresponding author), Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea.	ecpark@yuhs.ac	Park, Eun-Cheol/O-5644-2019	Park, Eun-Cheol/0000-0002-2306-5398; Jang, Suk-Yong/0000-0003-0558-1505; Park, Sohee/0000-0001-8513-5163; Han, Kyu-Tae/0000-0002-5817-1203				Amaddeo F, 2001, SOC PSYCH PSYCH EPID, V36, P500, DOI 10.1007/s001270170015; Baca-Garcia E, 2007, BRIT J PSYCHIAT, V190, P210, DOI 10.1192/bjp.bp.106.024026; Cho MJ, 2011, J KOREAN MED SCI, V26, P1, DOI 10.3346/jkms.2011.26.1.1; Curyto KJ, 2001, AM J GERIAT PSYCHIAT, V9, P141, DOI 10.1176/appi.ajgp.9.2.141; Dussault Gilles, 2003, Hum Resour Health, V1, P1, DOI 10.1186/1478-4491-1-1; GUNNELL DJ, 1995, BRIT MED J, V311, P226, DOI 10.1136/bmj.311.6999.226; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Han KT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0109-0; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Health Insurance Review & Assessment Service, 2009, STAT DIS 2009 13; Kim KM, 2012, ASIA PAC EDUC REV, V13, P273, DOI 10.1007/s12564-011-9192-7; Kim NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139924; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; LEE CK, 1990, J NERV MENT DIS, V178, P242, DOI 10.1097/00005053-199004000-00004; Lee JS, 2004, INT J INTERCULT REL, V28, P399, DOI 10.1016/j.ijintrel.2004.08.005; Ministry of Health & Welfare, 2001, EP SURV MENT DIS KOR; NORDSTROM P, 1995, ACTA PSYCHIAT SCAND, V92, P345, DOI 10.1111/j.1600-0447.1995.tb09595.x; OECD, 2013, HLTH GLANC 2013 OECD, DOI [10.1787/health_glance-2013-49-en, DOI 10.1787/HEALTH_GLANCE-2013-49-EN]; PADGETT D, 1990, MED CARE, V28, P805, DOI 10.1097/00005650-199009000-00010; Powell J, 2000, BRIT J PSYCHIAT, V176, P266, DOI 10.1192/bjp.176.3.266; Rihmer Z, 2007, CURR OPIN PSYCHIATR, V20, P17, DOI 10.1097/YCO.0b013e3280106868; Rost K, 2002, MED CARE RES REV, V59, P231, DOI 10.1177/1077558702059003001; Ruth U., 2013, GER J PSYCHIAT, V16, P1; Sadock BJ, 2015, SYNOPSIS PSYCHIAT BE; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Song Y.J., 2009, JAPAN MED ASS J, V52, P206, DOI 10.3345/kjp.2009.52.7.752; Swigar M E, 1991, Int J Soc Psychiatry, V37, P259, DOI 10.1177/002076409103700405; Taylor SE, 2004, J PERS SOC PSYCHOL, V87, P354, DOI 10.1037/0022-3514.87.3.354; Tyssen R, 2000, MED EDUC, V34, P374, DOI 10.1046/j.1365-2923.2000.00540.x	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146754	10.1371/journal.pone.0146754	http://dx.doi.org/10.1371/journal.pone.0146754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA5AX	26745728	Green Submitted, gold, Green Published			2022-12-27	WOS:000367815600080
J	He, Y; Shao, FY; Pi, WD; Shi, C; Chen, YJ; Gong, DP; Wang, BJ; Cao, ZW; Tang, KL				He, Yuan; Shao, Fangyang; Pi, Weidong; Shi, Cong; Chen, Yujia; Gong, Diping; Wang, Bingjie; Cao, Zhiwei; Tang, Kailin			Largescale Transcriptomics Analysis Suggests Over-Expression of BGH3, MMP9 and PDIA3 in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; IN-VITRO; IDENTIFICATION; GROWTH; GENES; SIGNATURE; DATABASE; HEAD; MATRIX-METALLOPROTEINASE-9; OVEREXPRESSION	Oral squamous cell carcinoma (OSCC) has been reported as the most prevalent cancer of the head and neck region, while early diagnosis remains challenging. Here we took a comprehensive bioinformatics study on microarray data of 326 OSCC clinical samples with control of 165 normal tissues. The cell interaction pathways of ECM-receptor interaction and focal adhesion were found to be significantly regulated in OSCC samples. Further analysis of the topological properties and expression consistency identified that three hub genes in the gene interaction network, MMP9, PDIA3 and BGH3, were consistently up-expressed in OSCC samples. When being validated on additional microarray datasets of 41 OSCC samples, the validation rate of over-expressed BGH3, MMP9, and PDIA3 reached 90%, 90% and 84% respectively. At last, immuno-histochemical assays were done to test the protein expression of the three genes on newly collected clinical samples of 35 OSCC, 20 samples of pre-OSCC stage, and 12 normal oral mucosa specimens. Their protein expression levels were also found to progressively increase from normal mucosa to pre-OSCC stage and further to OSCC (ANOVA rho = 0.000), suggesting their key roles in OSCC pathogenesis. Based on above solid validation, we propose BGH3, MMP9 and PDIA3 might be further explored as potential biomarkers to aid OSCC diagnosis.	[He, Yuan; Shao, Fangyang; Shi, Cong; Gong, Diping; Wang, Bingjie] Tongji Univ, Sch Stomatol, Dept Oral Med, Shanghai 200092, Peoples R China; [Pi, Weidong; Chen, Yujia; Cao, Zhiwei] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Tang, Kailin] Tongji Univ, Adv Inst Translat Med, Shanghai 200092, Peoples R China	Tongji University; Tongji University; Tongji University	Tang, KL (corresponding author), Tongji Univ, Adv Inst Translat Med, Shanghai 200092, Peoples R China.	kltang@tongji.edu.cn		/0000-0003-2487-8195; Tang, KaiLin/0000-0002-0508-6056	Fundamental Research Funds for the Central Universities; Natural Science Foundation of Shanghai Science and Technology Commission [14ZR1443600]; Shanghai Science and Technology Commission [14411971800]; Science Foundation of Shanghai Health Bureau [201440274]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Shanghai Science and Technology Commission(Natural Science Foundation of Shanghai); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Science Foundation of Shanghai Health Bureau	This work was partly supported by the Fundamental Research Funds for the Central Universities to KLT, the Natural Science Foundation of Shanghai Science and Technology Commission (14ZR1443600), the guided project from Shanghai Science and Technology Commission (14411971800) and the Science Foundation of Shanghai Health Bureau (201440274) to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambatipudi S, 2012, GENE CHROMOSOME CANC, V51, P161, DOI 10.1002/gcc.20940; Aureli C, 2013, GENE, V524, P390, DOI 10.1016/j.gene.2013.04.004; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bhagirath D, 2012, CLIN CHIM ACTA, V413, P1641, DOI 10.1016/j.cca.2012.05.005; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bitu CC, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-146; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chakraborty S, 2010, INDIA J SURG ONCOL, V1, P284, DOI 10.1007/s13193-011-0054-x; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chay D, 2010, INT J ONCOL, V37; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Colovic ZI P-PV, 2013, COLLEGIUM ANTROPOL, V37; Estilo CL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-11; Fan HX, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-90; Gambardella G, 2013, BIOINFORMATICS, V29, P1776, DOI 10.1093/bioinformatics/btt290; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Hansen NUB, 2015, EXP MOL PATHOL, V98, P286, DOI 10.1016/j.yexmp.2015.01.006; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang PC, 2013, WORLD J GASTROENTERO, V19, P8630, DOI 10.3748/wjg.v19.i46.8630; Kaiser MF, 2013, BLOOD, V122, P219, DOI 10.1182/blood-2013-03-487884; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim YH, 2012, J BIOL CHEM, V287, P38957, DOI 10.1074/jbc.M112.357863; Latty T, 2011, J R SOC INTERFACE, V8, P1298, DOI 10.1098/rsif.2010.0612; Lee MJ, 2013, INT J BIOCHEM CELL B, V45, P1869, DOI 10.1016/j.biocel.2013.05.027; Liao CJ, 2011, CANCER SCI, V102, P2255, DOI 10.1111/j.1349-7006.2011.02102.x; Lim KP, 2011, J PATHOL, V223, P459, DOI 10.1002/path.2841; Lohavanichbutr P, 2013, CLIN CANCER RES, V19, P1197, DOI 10.1158/1078-0432.CCR-12-2647; Lu JG, 2011, J CANCER RES CLIN, V137, P1613, DOI 10.1007/s00432-011-1024-y; Lwin ZM, 2012, ANAT REC, V295, P410, DOI 10.1002/ar.22413; Markus Krupp ca, 2011, BMC MED GENOMICS, V4; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; Nakashiro K, 2015, INT J ONCOL, V47, P1273, DOI 10.3892/ijo.2015.3134; Ni YH, 2015, PROTEOM CLIN APPL, V9, P86, DOI 10.1002/prca.201400091; O-charoenrat P, 2000, CANCER RES, V60, P1121; Pavon MA, 2012, CARCINOGENESIS, V33, P1707, DOI 10.1093/carcin/bgs207; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reis PP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-437; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scully C, 2009, ORAL ONCOL, V45, P301, DOI 10.1016/j.oraloncology.2009.01.004; Sutinen M, 1998, BRIT J CANCER, V77, P2239, DOI 10.1038/bjc.1998.372; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Toruner GA, 2004, CANCER GENET CYTOGEN, V154, P27, DOI 10.1016/j.cancergencyto.2004.01.026; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; Wu CY, 2007, CELL ADHES MIGR, V1, P13; Yamatoji M, 2012, INT J CANCER, V130, P2903, DOI 10.1002/ijc.26328; Yang Y, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-54; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Yong-Deok K, 2015, MED ORAL PATOL ORAL, V20, pE167, DOI 10.4317/medoral.20229	52	18	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146530	10.1371/journal.pone.0146530	http://dx.doi.org/10.1371/journal.pone.0146530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745629	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600059
J	Kan, A; Pavlyshyn, D; Markham, JF; Dowling, MR; Heinzel, S; Zhou, JHS; Marchingo, JM; Hodgkin, PD				Kan, Andrey; Pavlyshyn, Damian; Markham, John F.; Dowling, Mark R.; Heinzel, Susanne; Zhou, Jie H. S.; Marchingo, Julia M.; Hodgkin, Philip D.			Stochastic Measurement Models for Quantifying Lymphocyte Responses Using Flow Cytometry	PLOS ONE			English	Article							PROLIFERATION IN-VITRO; CELL; DIFFERENTIATION; DIVISION	Adaptive immune responses are complex dynamic processes whereby B and T cells undergo division and differentiation triggered by pathogenic stimuli. Deregulation of the response can lead to severe consequences for the host organism ranging from immune deficiencies to autoimmunity. Tracking cell division and differentiation by flow cytometry using fluorescent probes is a major method for measuring progression of lymphocyte responses, both in vitro and in vivo. In turn, mathematical modeling of cell numbers derived from such measurements has led to significant biological discoveries, and plays an increasingly important role in lymphocyte research. Fitting an appropriate parameterized model to such data is the goal of these studies but significant challenges are presented by the variability in measurements. This variation results from the sum of experimental noise and intrinsic probabilistic differences in cells and is difficult to characterize analytically. Current model fitting methods adopt different simplifying assumptions to describe the distribution of such measurements and these assumptions have not been tested directly. To help inform the choice and application of appropriate methods of model fitting to such data we studied the errors associated with flow cytometry measurements from a wide variety of experiments. We found that the mean and variance of the noise were related by a power law with an exponent between 1.3 and 1.8 for different datasets. This violated the assumptions inherent to commonly used least squares, linear variance scaling and log-transformation based methods. As a result of these findings we propose a new measurement model that we justify both theoretically, from the maximum entropy standpoint, and empirically using collected data. Our evaluation suggests that the new model can be reliably used for model fitting across a variety of conditions. Our work provides a foundation for modeling measurements in flow cytometry experiments thus facilitating progress in quantitative studies of lymphocyte responses.	[Kan, Andrey; Pavlyshyn, Damian; Markham, John F.; Dowling, Mark R.; Heinzel, Susanne; Zhou, Jie H. S.; Marchingo, Julia M.; Hodgkin, Philip D.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia; [Kan, Andrey; Pavlyshyn, Damian; Markham, John F.; Dowling, Mark R.; Heinzel, Susanne; Zhou, Jie H. S.; Marchingo, Julia M.; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Hodgkin, PD (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia.	hodgkin@wehi.edu.au	Marchingo, Julia/AAQ-6970-2021	Zhou, Jie/0000-0002-9113-800X; Marchingo, Julia/0000-0001-8823-9718; Markham, John/0000-0002-5738-3861; Heinzel, Susanne/0000-0001-9524-2835; Hodgkin, Philip/0000-0002-8604-1940; Dowling, Mark/0000-0002-8056-5348	National Health and Medical Research Council (NHMRC) [1010654, 1054925]; Human Frontier Science Program grant [RGP0060/2012]; Victorian Life Science Computational Initiative; Australian Postgraduate Award; WEHI Edith Moffat Scholarship; Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council of Victoria	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program grant(Human Frontier Science Program); Victorian Life Science Computational Initiative; Australian Postgraduate Award(Australian Government); WEHI Edith Moffat Scholarship; Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	This work was supported by the National Health and Medical Research Council (NHMRC) through project grant 1010654, program grant 1054925, and fellowships to M.R.D. and P.D.H (https://www.nhmrc.gov.au/). P.D.H. was also supported in part by Human Frontier Science Program grant RGP0060/2012 (http://www.hfsp.org/). D.P. was supported by Victorian Life Science Computational Initiative (https://www.vlsci.org.au/). J.H.S.Z. was a recipient of an Australian Postgraduate Award (https://education.gov.au/australian-postgraduate-awards). J.M.M. was the recipient of an Australian Postgraduate Award, WEHI Edith Moffat Scholarship and Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council of Victoria (https://education.gov.au/australianpostgraduate-awards). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker C, 2005, APPL NUMERICAL; Banks HT, 2013, J BIOL DYNAM, V7, P96, DOI 10.1080/17513758.2013.812753; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; De Boer RJ, 2013, J THEOR BIOL, V327, P45, DOI 10.1016/j.jtbi.2012.12.025; Dempster A, 1972, BIOMETRICS; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Hasbold J, 1999, IMMUNOL CELL BIOL, V77, P516, DOI 10.1046/j.1440-1711.1999.00874.x; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hawkins ED, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3406; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hyrien O, 2005, BIOMETRICS, V61, P199, DOI 10.1111/j.0006-341X.2005.031210.x; Hyrien O, 2008, J AM STAT ASSOC, V103, P222, DOI 10.1198/016214507000000194; Inokuma MS, 2013, J IMMUNOL METHODS, V397, P8, DOI 10.1016/j.jim.2013.08.003; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kendal WS, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-3; Kendal WS, 2001, P NATL ACAD SCI USA, V98, P837, DOI 10.1073/pnas.021347898; Leon K, 2004, J THEOR BIOL, V229, P455, DOI 10.1016/j.jtbi.2004.04.011; Luzyanina T, 2013, JOURNAL OF MATHEMATI; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marchingo JM, 2014, SCIENCE, V346, P1123, DOI 10.1126/science.1260044; Miao HY, 2012, B MATH BIOL, V74, P300, DOI 10.1007/s11538-011-9668-y; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Quah BJC, 2012, J IMMUNOL METHODS, V379, P1, DOI 10.1016/j.jim.2012.02.012; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Shokhirev MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067620; Subramanian VG, 2008, J MATH BIOL, V56, P861, DOI 10.1007/s00285-007-0142-2; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Yates A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-196	33	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146227	10.1371/journal.pone.0146227	http://dx.doi.org/10.1371/journal.pone.0146227			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26742110	Green Published, gold			2022-12-27	WOS:000367810600024
J	Haque, MN; Noman, N; Berretta, R; Moscato, P				Haque, Mohammad Nazmul; Noman, Nasimul; Berretta, Regina; Moscato, Pablo			Heterogeneous Ensemble Combination Search Using Genetic Algorithm for Class Imbalanced Data Classification	PLOS ONE			English	Article							EVOLUTIONARY SEARCH; DIVERSE ENSEMBLES; CLASSIFIERS; SELECTION; SIGNATURES; DIAGNOSIS; DISEASE; MODEL	Classification of datasets with imbalanced sample distributions has always been a challenge. In general, a popular approach for enhancing classification performance is the construction of an ensemble of classifiers. However, the performance of an ensemble is dependent on the choice of constituent base classifiers. Therefore, we propose a genetic algorithm-based search method for finding the optimum combination from a pool of base classifiers to form a heterogeneous ensemble. The algorithm, called GA-EoC, utilises 10 fold-cross validation on training data for evaluating the quality of each candidate ensembles. In order to combine the base classifiers decision into ensemble's output, we used the simple and widely used majority voting approach. The proposed algorithm, along with the random sub-sampling approach to balance the class distribution, has been used for classifying class-imbalanced datasets. Additionally, if a feature set was not available, we used the (alpha, beta) - k Feature Set method to select a better subset of features for classification. We have tested GA-EoC with three benchmarking datasets from the UCI-Machine Learning repository, one Alzheimer's disease dataset and a subset of the PubFig database of Columbia University. In general, the performance of the proposed method on the chosen datasets is robust and better than that of the constituent base classifiers and many other well-known ensembles. Based on our empirical study we claim that a genetic algorithm is a superior and reliable approach to heterogeneous ensemble construction and we expect that the proposed GA-EoC would perform consistently in other cases.	[Haque, Mohammad Nazmul; Noman, Nasimul; Berretta, Regina; Moscato, Pablo] Hunter Med Res Inst, Prior Res Ctr Bioinformat Biomarker Discovery & I, New Lambton Hts, NSW, Australia; [Haque, Mohammad Nazmul; Noman, Nasimul; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Fac Engn & Built Environm, Sch Elect Engn & Comp Sci, Callaghan, NSW 2308, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Moscato, P (corresponding author), Hunter Med Res Inst, Prior Res Ctr Bioinformat Biomarker Discovery & I, New Lambton Hts, NSW, Australia.	Pablo.Moscato@newcastle.edu.au	Haque, Mohammad Nazmul/S-3630-2019	Haque, Mohammad Nazmul/0000-0002-0598-0867; Berretta, Regina/0000-0002-4420-3446; Moscato, Pablo/0000-0003-2570-5966; Noman, Nasimul/0000-0002-8566-0870	Australian Research Council [DP120102576, DP140104183, FT120100060]; National Health and Medical Research Council (Australia) (NHMRC Grant) [512423]	Australian Research Council(Australian Research Council); National Health and Medical Research Council (Australia) (NHMRC Grant)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council (Discovery Project DP120102576, Discovery Project DP140104183, Future Fellowship FT120100060) and National Health and Medical Research Council (Australia) (NHMRC Grant 512423).	Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Berretta R, 2007, J RES PRACT INF TECH, V39, P287; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Bhatnagar V, 2014, PROG ARTIF INTELL, V2, P97, DOI 10.1007/s13748-014-0042-9; Bhatt N, 2013, INT J COMPUT APPL, V69, P31, DOI DOI 10.5120/12089-8269; Bhowan U, 2013, IEEE T EVOLUT COMPUT, V17, P368, DOI 10.1109/TEVC.2012.2199119; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Caruana R., 2004, P 21 INT C MACHINE L, P18, DOI [10.1145/1015330.1015432, DOI 10.1145/1015330.1015432]; Chen P, 2014, LECT NOTES COMPUT SC, V8481, P70, DOI 10.1007/978-3-319-07455-9_8; Chiachia G, 2014, IEEE T INF FOREN SEC, V9, P2089, DOI 10.1109/TIFS.2014.2359543; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; Cox D., 2011, Proceedings 2011 IEEE International Conference on Automatic Face & Gesture Recognition (FG 2011), P8, DOI 10.1109/FG.2011.5771385; Cox E., 2005, MORGAN KAUFMANN SERI; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Dutt R, 2012, COMPUT BIOL MED, V42, P1026, DOI 10.1016/j.compbiomed.2012.08.006; Ekbal A., 2010, RES LANGUAGE COMPUTA, V8, P73, DOI DOI 10.1007/S11168-010-9071-0; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Galar M, 2012, IEEE T SYST MAN CY C, V42, P463, DOI 10.1109/TSMCC.2011.2161285; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hoens TR, 2010, LECT NOTES ARTIF INT, V6119, P488; Hourani Mou'ath, 2008, V453, P379, DOI 10.1007/978-1-60327-429-6_20; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041882; Kim YW, 2008, PATTERN RECOGN LETT, V29, P796, DOI 10.1016/j.patrec.2007.12.013; Krawczyk B, 2013, INF EL VIS ICIEV 201, P1; Kuncheva L I, 2004, COMBINING PATTERN CL; Liao JJ, 2014, ECON MODEL, V37, P175, DOI 10.1016/j.econmod.2013.11.013; Lichman M, 2013, UCI MACHINE LEARNING; MANGASARIAN OL, 1995, OPER RES, V43, P570, DOI 10.1287/opre.43.4.570; Margineantu DD, 1997, ICML, V97, P211, DOI DOI 10.5555/645526.757762; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Moscato P, 2005, LECT NOTES COMPUT SC, V3449, P84; Nanni L, 2007, PATTERN RECOGN LETT, V28, P622, DOI 10.1016/j.patrec.2006.10.012; Niculescu-Mizil A., 2009, INT C KDD CUP, V7, P23; Nikulin V, 2009, LECT NOTES ARTIF INT, V5866, P291, DOI 10.1007/978-3-642-10439-8_30; Oza NC, 2006, ENCY DATA WAREHOUSIN, V1, P448; Partalas I, 2008, FRONT ARTIF INTEL AP, V178, P117, DOI 10.3233/978-1-58603-891-5-117; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Rosso OA, 2009, J NEUROSCI METH, V181, P257, DOI 10.1016/j.jneumeth.2009.04.028; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Stehman SV, 1997, REMOTE SENS ENVIRON, V62, P77, DOI 10.1016/S0034-4257(97)00083-7; Thammasiri D, 2012, ADV MATER RES-SWITZ, V433-440, P6572, DOI 10.4028/www.scientific.net/AMR.433-440.6572; Tuarob S, 2014, J BIOMED INFORM, V49, P255, DOI 10.1016/j.jbi.2014.03.005; Wolpert DH, 1996, NEURAL COMPUT, V8, P1341, DOI 10.1162/neco.1996.8.7.1341; Woods K, 1997, IEEE T PATTERN ANAL, V19, P405, DOI 10.1109/34.588027; Yin QY, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/358942	50	35	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146116	10.1371/journal.pone.0146116	http://dx.doi.org/10.1371/journal.pone.0146116			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764911	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300015
J	Nassal, DM; Wan, XP; Liu, HY; Deschenes, I				Nassal, Drew M.; Wan, Xiaoping; Liu, Haiyan; Deschenes, Isabelle			Myocardial KChIP2 Expression in Guinea Pig Resolves an Expanded Electrophysiologic Role	PLOS ONE			English	Article							TRANSIENT OUTWARD CURRENT; CELL-SURFACE EXPRESSION; POTASSIUM CHANNELS; I-TO; HEART-FAILURE; GENE-EXPRESSION; BETA-SUBUNIT; K+ CURRENT; PROTEIN; KV4	Cardiac ion channels and their respective accessory subunits are critical in maintaining proper electrical activity of the heart. Studies have indicated that the K+ channel interacting protein 2 (KChIP2), originally identified as an auxiliary subunit for the channel Kv4, a component of the transient outward K+ channel (I-to), is a Ca2+ binding protein whose regulatory function does not appear restricted to Kv4 modulation. Indeed, the guinea pig myocardium does not express Kv4, yet we show that it still maintains expression of KChIP2, suggesting roles for KChIP2 beyond this canonical auxiliary interaction with Kv4 to modulate I-to. In this study, we capitalize on the guinea pig as a system for investigating how KChIP2 influences the cardiac action potential, independent of effects otherwise attributed to I-to, given the endogenous absence of the current in this species. By performing whole cell patch clamp recordings on isolated adult guinea pig myocytes, we observe that knock down of KChIP2 significantly prolongs the cardiac action potential. This prolongation was not attributed to compromised repolarizing currents, as I-Kr and I-Ks were unchanged, but was the result of enhanced L-type Ca2+ current due to an increase in Cav1.2 protein. In addition, cells with reduced KChIP2 also displayed lowered I-Na from reduced Nav1.5 protein. Historically, rodent models have been used to investigate the role of KChIP2, where dramatic changes to the primary repolarizing current I-to may mask more subtle effects of KChIP2. Evaluation in the guinea pig where I-to is absent, has unveiled additional functions for KChIP2 beyond its canonical regulation of I-to, which defines KChIP2 as a master regulator of cardiac repolarization and depolarization.	[Nassal, Drew M.; Wan, Xiaoping; Liu, Haiyan; Deschenes, Isabelle] Case Western Reserve Univ, Dept Med, Heart & Vasc Res Ctr, Cleveland, OH 44106 USA; [Nassal, Drew M.; Deschenes, Isabelle] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Deschenes, I (corresponding author), Case Western Reserve Univ, Dept Med, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA.	isabelle.deschenes@case.edu			National Heart, Lung, and Blood Institute [R01HL096962, HL105338-01]; American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate [13PRE17060106]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096962, T32HL105338] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (R01HL096962) (ID) and T32 Training Grant from the same institution (HL105338-01) (DMN) (http://www.nhlbi.nih.gov/), as well as an American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate 13PRE17060106 (DMN) (http://www.heart.org/HEARTORG/Affiliate/Philadelphia/Pennsylvania/Home_UCM_GRA076_AffiliatePage.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba T, 2010, CURR OPIN CARDIOL, V25, P29, DOI 10.1097/HCO.0b013e328333d3d6; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Calloe K, 2010, J MOL CELL CARDIOL, V48, P191, DOI 10.1016/j.yjmcc.2009.07.017; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cordeiro JM, 2012, J MOL CELL CARDIOL, V52, P1291, DOI 10.1016/j.yjmcc.2012.03.001; Decher N, 2001, CARDIOVASC RES, V52, P255, DOI 10.1016/S0008-6363(01)00374-1; Deschenes I, 2002, CIRCULATION, V106, P423, DOI 10.1161/01.CIR.0000025417.65658.B6; Deschenes I, 2008, J MOL CELL CARDIOL, V45, P336, DOI 10.1016/j.yjmcc.2008.05.001; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Findlay I, 2003, AM J PHYSIOL-HEART C, V284, pH598, DOI 10.1152/ajpheart.00687.2002; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Greenstein JL, 2000, CIRC RES, V87, P1026, DOI 10.1161/01.RES.87.11.1026; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jin HW, 2010, J MOL CELL CARDIOL, V48, P1169, DOI 10.1016/j.yjmcc.2009.12.019; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kobayashi T, 2003, J MOL CELL CARDIOL, V35, P1073, DOI 10.1016/S0022-2828(03)00199-8; Li HL, 2005, J MOL CELL CARDIOL, V39, P121, DOI 10.1016/j.yjmcc.2005.03.013; Link WA, 2004, J NEUROSCI, V24, P5346, DOI 10.1523/JNEUROSCI.1460-04.2004; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Patel SP, 2002, J PHYSIOL-LONDON, V539, P649, DOI 10.1113/jphysiol.2001.015156; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Teutsch C, 2007, CARDIOVASC RES, V73, P739, DOI 10.1016/j.cardiores.2006.11.034; Thomsen MB, 2009, CHANNELS, V3, P308, DOI 10.4161/chan.3.5.9560; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Wang YG, 2007, J CARDIOVASC ELECTR, V18, P869, DOI 10.1111/j.1540-8167.2007.00864.x	36	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146561	10.1371/journal.pone.0146561	http://dx.doi.org/10.1371/journal.pone.0146561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764482	gold, Green Submitted, Green Published			2022-12-27	WOS:000368459300026
J	Nafee, SS; Shaheen, SA; Al-Ramady, AM				Nafee, Sherif S.; Shaheen, Salem A.; Al-Ramady, Amir M.			Nuclear Data Evaluation for Mass Chain A=217:Odd-Proton Nuclei	PLOS ONE			English	Article							DECAY PROPERTIES; ISOTOPES; FRAGMENTATION; SPECTROSCOPY; REGION; U-238	Thallium (Tl-217(81)), Bismuth (Bi-217(83)), Astatine (At-217(85)), Francium (Fr-217(87)), Actinium (Ac-217(89)) and Protactinium ((217) Pa-91) are of odd-proton numbers among the mass chain A = 217. In the present work, the half-lives and gamma transitions for the six nuclei have been studied and adopted based on the recently published interactions or unevaluated nuclear data sets XUNDL. The Q (a) has been updated based on the recent published work of the Atomic Mass Evaluation AME2012 as well. Moreover, the total conversion electrons as well as the K-Shell to L-Shell, L-Shell to M-Shell and L-Shell to N-Shell Conversion Electron Ratios have been calculated using BrIcc code v2.3. An updated skeleton decay scheme for each of the above nuclei has been presented here. The decay hindrance factors (HF) calculated using the ALPHAD program, which is available from Brookhaven National Laboratory's website, have been calculated for the a-decay data sets for Fr-221-, Ac-221-and Pa-221-alpha-decays.	[Nafee, Sherif S.; Shaheen, Salem A.] King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah 20589, Saudi Arabia; [Nafee, Sherif S.] Univ Alexandria, Dept Phys, Fac Sci, Alexandria 21221, Egypt; [Al-Ramady, Amir M.] King Abdulaziz Univ, Deanship Grad Studies, Jeddah 20589, Saudi Arabia	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Alexandria University; King Abdulaziz University	Nafee, SS (corresponding author), King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah 20589, Saudi Arabia.	snafee@kau.edu.sa	Nafee, Sherif S/J-6067-2012	Nafee, Sherif S/0000-0001-5717-0818	King Abdulaziz City for Science and Technology (KASCT); Long-Term Comprehensive National Plan for Science, Technology and Innovations; King Abdulaziz University (KAU), Saudi Arabia [11-MAT2037-03]	King Abdulaziz City for Science and Technology (KASCT); Long-Term Comprehensive National Plan for Science, Technology and Innovations; King Abdulaziz University (KAU), Saudi Arabia	The authors would like to thank the authorities of King Abdulaziz City for Science and Technology (KASCT); Long-Term Comprehensive National Plan for Science, Technology and Innovations; and King Abdulaziz University (KAU), Saudi Arabia, for funding this project, contract number "11-MAT2037-03."; The authors would like to thank the authorities of King Abdulaziz City for Science and Technology (KASCT), Long-Term Comprehensive National Plan for Science, Technology and Innovations, and King Abdulaziz University (KAU), Saudi Arabia, for funding this project, contract number "11-MAT2037-03". The authors also, acknowledge with thanks Science and Technology Unit, King Abdulaziz University, for technical support. In addition, we express our deepest appreciations to Dr. J. Tuli, National Nuclear Data Center (NNDC), Brookhaven National Laboratory (BNL) Upton, NY, USA, for supervising this work and valuable discussions throughout the evaluation process.	Aiche M, 1988, J PHYS G, V14, P1991; Akovali YA, 2003, NUCL DATA SHEETS, V100, P141, DOI 10.1006/ndsh.2003.0015; Alvarez-Pol H, 2010, PHYS REV C, V82, P1; Andreev A. N., 1996, Bulletin of the Russian Academy of Sciences. Physics, V60, P119; Andreev AN, 1995, ANN C NUCL SPECTR ST, P109; Andreyev A.N., 1992, P 9 INT C AT MASS FU, P759; ANDREYEV AN, 1990, Z PHYS A-HADRON NUCL, V337, P229, DOI 10.1007/BF01294296; Andreyev AN, 1990, INT NUCL INFORM SYST, V22, P1; Astier A, 2013, PHYS REV C, V87, P1; Audi G, 1995, NUCL PHYS A, V595, P409, DOI 10.1016/0375-9474(95)00445-9; BORGGREEN J, 1970, PHYS REV C, V2, P1841, DOI 10.1103/PhysRevC.2.1841; DECMAN DJ, 1985, NUCL PHYS A, V436, P311, DOI 10.1016/0375-9474(85)90201-5; ENGLISH AC, 1947, PHYS REV, V72, P253, DOI 10.1103/PhysRev.72.253; Fry C, 2013, ATOM DATA NUCL DATA, V99, P497, DOI 10.1016/j.adt.2012.05.003; Gono Y., 1982, PROCINTERNSYMP DYNAM, P283; Gottardo A, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.034317; Gromov K. Y., 2002, Bulletin of the Russian Academy of Sciences. Physics, V66, P1519; Gromov K. Ya., 1999, B RUSS ACAD SCI PHYS, V63, P385; HAGEMANN F, 1947, PHYS REV, V72, P252, DOI 10.1103/PhysRev.72.252; HAHN RL, 1968, NUCL PHYS A, VA113, P206, DOI 10.1016/0375-9474(68)90894-4; Hessberger FP, 2002, EUR PHYS J A, V15, P335, DOI 10.1140/epja/i2002-10038-4; Hessberger FP, 2000, EUR PHYS J A, V8, P521, DOI 10.1007/s100500070075; Kibedi T, 2008, NUCL INSTRUM METH A, V589, P202, DOI 10.1016/j.nima.2008.02.051; Kurpeta J, 2003, EUR PHYS J A, V18, P5, DOI 10.1140/epja/i2003-10065-7; LEANG CF, 1968, CR ACAD SCI B PHYS, V266, P629; Liu Z, 2005, NUCL INSTRUM METH A, V543, P591, DOI 10.1016/j.nima.2004.12.023; Meyerhof W.E., 1967, ELEMENTS NUCL PHYS; Moller P, 1997, ATOM DATA NUCL DATA, V66, P131, DOI 10.1006/adnd.1997.0746; Morales AI, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.022702; Morales AI, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.014324; MOSZKOWSKI SA, 1951, PHYS REV, V82, P35, DOI 10.1103/PhysRev.82.35; Ni D, 2009, PHYS REV C, V80, P1; Ninov V, 1995, ANN C NUCL SPECTR ST, P108; NOMURA T, 1972, PHYS LETT B, VB 40, P543, DOI 10.1016/0370-2693(72)90477-7; Pfutzner M, 1998, PHYS LETT B, V444, P32, DOI 10.1016/S0370-2693(98)01332-X; PRESTON MA, 1947, PHYS REV, V71, P865, DOI 10.1103/PhysRev.71.865; RAMAN S, 1973, PHYS REV C, V7, P1995, DOI 10.1103/PhysRevC.7.1995; SCHMIDT KH, 1979, NUCL PHYS A, V318, P253, DOI 10.1016/0375-9474(79)90482-2; Sheline RK, 2002, CZECH J PHYS, V52, P695, DOI 10.1023/A:1015582628467; Simpson GS, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.132502; Singh B., 1998, Nuclear Data Sheets, V84, P487, DOI 10.1006/ndsh.1998.0015; Suliman G, 2013, APPL RADIAT ISOTOPES, V77, P32, DOI 10.1016/j.apradiso.2013.02.008; VALLI K, 1968, PHYS REV, V176, P1377, DOI 10.1103/PhysRev.176.1377	43	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146182	10.1371/journal.pone.0146182	http://dx.doi.org/10.1371/journal.pone.0146182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761207	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100028
J	Agrawal, R; Salman, M; Tan, KA; Karampelas, M; Sim, DA; Keane, PA; Pavesio, C				Agrawal, Rupesh; Salman, Mohammed; Tan, Kara-Anne; Karampelas, Michael; Sim, Dawn A.; Keane, Pearse A.; Pavesio, Carlos			Choroidal Vascularity Index (CVI) - A Novel Optical Coherence Tomography Parameter for Monitoring Patients with Panuveitis?	PLOS ONE			English	Article							INDOCYANINE GREEN ANGIOGRAPHY; KOYANAGI-HARADA DISEASE; POSTERIOR UVEITIS; QUANTITATIVE SUBANALYSIS; MACULAR DEGENERATION; ENDOGENOUS UVEITIS; MANAGEMENT; THICKNESS; VASCULATURE; DIAGNOSIS	Purpose To compute choroidal vascularity index (CVI) using an image binarization tool on enhanced depth imaging (EDI)-optical coherence tomography (OCT) scans as a non-invasive optical tool to monitor progression in panuveitis and to investigate the utility of volumetric data from EDI-OCT scans using custom image analysis software. Materials and Methods In this retrospective cohort study, segmented EDI-OCT scans of both eyes in 19 patients with panuveitis were taken at baseline and at 3-month follow-up and were compared with EDI-OCT scans of normal eyes. Subfoveal choroidal area was segmented into luminal (LA) and stromal interstitial area (SA). Choroidal vascularity index (CVI) was defined as the proportion of LA to the total circumscribed subfoveal choroidal area (TCA). Results The mean choroidal thickness was 265.5 +/- 100.1 mu mat baseline and 278.4 +/- 102.6 mu m at 3 months follow up (p = 0.06). There was no statistically significant difference in TCA between study and control eyes (p = 0.08). CVI in the control group was 66.9 +/- 1.5% at baseline and 66.4 +/- 1.5% at follow up. CVI was 74.1 +/- 4.7% at baseline and 69.4 +/- 4.8% at 3months follow up for uveitic eyes (p < 0.001). The% change in CVI was 6.2 +/- 3.8 (4.3 to 8.0) for uveitic eyes, which was significantly higher from% change in CVI for control eyes (0.7 +/- 1.1, 0.2 to 1.3, p < 0.001). Conclusion The study reports composite OCT-derived parameters and CVI as a possible novel tool in monitoring progression in panuveitis. CVI may be further validated in larger studies as a novel optical tool to quantify choroidal vascular status.	[Agrawal, Rupesh; Karampelas, Michael; Sim, Dawn A.; Keane, Pearse A.; Pavesio, Carlos] NHS Fdn Trust, Moorfields Eye Hosp, London, England; [Agrawal, Rupesh; Salman, Mohammed; Sim, Dawn A.; Keane, Pearse A.; Pavesio, Carlos] UCL, Inst Ophthalmol, London, England; [Agrawal, Rupesh] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore, Singapore; [Tan, Kara-Anne] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Karampelas, Michael] West Hertfordshire NHS Trust, London, England; [Keane, Pearse A.] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England	Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Tan Tock Seng Hospital; National University of Singapore; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Agrawal, R (corresponding author), NHS Fdn Trust, Moorfields Eye Hosp, London, England.	Rupesh_agrawal@ttsh.com.sg	Keane, Pearse/AAE-5709-2019	Keane, Pearse/0000-0002-9239-745X	NMRC overseas research training fellowship at Institute of Ophthalmology and Moorfields Eye Hospital, London; National Healthcare Group, Singapore; National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; National Institute for Health Research [CS-2014-14-023, CL-2010-18-004] Funding Source: researchfish	NMRC overseas research training fellowship at Institute of Ophthalmology and Moorfields Eye Hospital, London; National Healthcare Group, Singapore; National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; National Institute for Health Research(National Institute for Health Research (NIHR))	RA was on NMRC overseas research training fellowship at Institute of Ophthalmology and Moorfields Eye Hospital, London. RA is currently funded by Clinician Scientist Career Scheme Grant by National Healthcare Group, Singapore. This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Agrawal R, 2014, ENVIRON ENG MANAG J, P1; Agrawal RV, 2013, INDIAN J OPHTHALMOL, V61, P148, DOI 10.4103/0301-4738.112159; Araki M, 1977, Nippon Ganka Gakkai Zasshi, V81, P982; Atas M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/865394; BAARSMA GS, 1992, CURR EYE RES, V11, P1, DOI 10.3109/02713689208999505; Behdad B, 2015, INT OPHTHALMOL; Bittencourt MG, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/s12348-014-0014-z; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Campbell JP, 2012, AM J OPHTHALMOL, V154, P908, DOI 10.1016/j.ajo.2012.05.019; Cui Y, 2014, OPTOMETRY VISION SCI, V91, P1335, DOI 10.1097/OPX.0000000000000399; da Silva FT, 2013, BRIT J OPHTHALMOL, V97, P70, DOI 10.1136/bjophthalmol-2012-302089; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Durrani K, 2012, SEMIN OPHTHALMOL, V27, P228, DOI 10.3109/08820538.2012.711414; Flower RW, 2000, J FR OPHTALMOL, V23, P756; Forrester John V, 2007, Chem Immunol Allergy, V92, P228, DOI 10.1159/000099274; Gallagher MJ, 2007, BRIT J OPHTHALMOL, V91, P1680, DOI 10.1136/bjo.2007.124099; Gehl Z, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-103; Gupta P, 2015, AM J OPHTHALMOL, V159, P293, DOI 10.1016/j.ajo.2014.10.034; Gupta P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096661; HAYREH SS, 1975, BRIT J OPHTHALMOL, V59, P631, DOI 10.1136/bjo.59.11.631; HENDERLY DE, 1987, AM J OPHTHALMOL, V103, P131, DOI 10.1016/S0002-9394(14)74217-5; Herbort CP, 1998, OPHTHALMOLOGY, V105, P432, DOI 10.1016/S0161-6420(98)93024-X; Howe LJ, 2004, OCUL IMMUNOL INFLAMM, V12, P1, DOI 10.1076/ocii.12.1.1.28064; Hunter RS, 2012, SEMIN OPHTHALMOL, V27, P236, DOI 10.3109/08820538.2012.708813; HYVARINE.L, 1969, AM J OPHTHALMOL, V67, P653, DOI 10.1016/S0002-9394(69)90987-8; Ikuno Y, 2011, INVEST OPHTH VIS SCI, V52, P5536, DOI 10.1167/iovs.10-6811; Ishikawa S, 2014, BRIT J OPHTHALMOL, V98, P1508, DOI 10.1136/bjophthalmol-2014-305333; Joeres S, 2007, INVEST OPHTH VIS SCI, V48, P4300, DOI 10.1167/iovs.07-0179; Karampelas M, 2013, GRAEF ARCH CLIN EXP, V251, P2029, DOI 10.1007/s00417-013-2330-7; Keane PA, 2010, EYE, V24, P422, DOI 10.1038/eye.2009.309; Keane PA, 2008, INVEST OPHTH VIS SCI, V49, P3115, DOI 10.1167/iovs.08-1689; Keane PA, 2013, JAMA OPHTHALMOL, V131, P341, DOI 10.1001/jamaophthalmol.2013.1724; Li Lue, 2012, Zhonghua Yan Ke Za Zhi, V48, P819; Mahajan NR, 2013, IEEE ENG MED BIO, P3355, DOI 10.1109/EMBC.2013.6610260; Mahendradas P, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/s12348-014-0018-8; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Mrejen Sarah, 2012, Int Ophthalmol Clin, V52, P67, DOI 10.1097/IIO.0b013e318265f676; Nazari H, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/1869-5760-4-9; Onal S, 2013, INT OPHTHALMOL; Onal S, 2014, INT OPHTHALMOL, V34, P401, DOI 10.1007/s10792-013-9822-7; Pakzad-Vaezi K, 2014, CAN J OPHTHALMOL, V49, P18, DOI 10.1016/j.jcjo.2013.10.005; PivettiPezzi P, 1996, OPHTHALMOLOGICA, V210, P234, DOI 10.1159/000310715; Pleyer U, 2014, EXPERT OPIN BIOL TH, P1; Sadda SR, 2007, INVEST OPHTH VIS SCI, V48, P839, DOI 10.1167/iovs.06-0554; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Sonoda S, 2015, AM J OPHTHALMOL; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2014, AM J OPHTHALMOL, V158, P649, DOI 10.1016/j.ajo.2014.07.001; Spaide RF, 2013, RETINA-J RET VIT DIS, V33, P1315, DOI 10.1097/IAE.0b013e318286cc77; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Sudharshan S, 2010, INDIAN J OPHTHALMOL, V58, P29, DOI 10.4103/0301-4738.58470; Zarranz-Ventura J, 2014, OPHTHALMOLOGY; Zhao Chan, 2012, Chinese Medical Sciences Journal, V27, P29	56	119	119	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146344	10.1371/journal.pone.0146344	http://dx.doi.org/10.1371/journal.pone.0146344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751702	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100065
J	Du, HX; Xiao, WH; Wang, Y; Zhou, X; Zhang, Y; Liu, D; Yuan, YJ				Du, Hao-Xing; Xiao, Wen-Hai; Wang, Ying; Zhou, Xiao; Zhang, Yu; Liu, Duo; Yuan, Ying-Jin			Engineering Yarrowia lipolytica for Campesterol Overproduction	PLOS ONE			English	Article							LIPID-ACCUMULATION; CARBON SOURCE; CITRIC-ACID; YEAST; BIOSYNTHESIS; LATHOSTEROL; CHOLESTEROL; SUFFICIENT; PROMOTER; GLYCEROL	Campesterol is an important precursor for many sterol drugs, e.g. progesterone and hydrocortisone. In order to produce campesterol in Yarrowia lipolytica, C-22 desaturase encoding gene ERG5 was disrupted and the heterologous 7-dehydrocholesterol reductase (DHCR7) encoding gene was constitutively expressed. The codon-optimized DHCR7 from Rallus norvegicus, Oryza saliva and Xenapus laevis were explored and the strain with the gene DHCR7 from X. laevis achieved the highest titer of campesterol due to D409 in substrate binding sites. In presence of glucose as the carbon source, higher biomass conversion yield and product yield were achieved in shake flask compared to that using glycerol and sunflower seed oil. Nevertheless, better cell growth rate was observed in medium with sunflower seed oil as the sole carbon source. Through high cell density fed-batch fermentation under carbon source restriction strategy, a titer of 453 +/- 24.7 mg/L campesterol was achieved with sunflower seed oil as the carbon source, which is the highest reported microbial titer known. Our study has greatly enhanced campesterol accumulation in Y. lipolytica, providing new insight into producing complex and desired molecules in microbes.	[Du, Hao-Xing; Xiao, Wen-Hai; Wang, Ying; Zhou, Xiao; Zhang, Yu; Liu, Duo; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Du, Hao-Xing; Xiao, Wen-Hai; Wang, Ying; Zhou, Xiao; Zhang, Yu; Liu, Duo; Yuan, Ying-Jin] Tianjin Univ, Sch Chem Engn & Technol, SynBio Res Platform, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Yuan, YJ (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn		Wang, Ying/0000-0003-2311-015X	Ministry of Science and Technology of China ("863" Program) [2012AA02A701]; National Natural Science Foundation of China [21390203, 21206114]; Natural Science Foundation of Tianjin [12JCQNJC03800]	Ministry of Science and Technology of China ("863" Program)(Ministry of Science and Technology, ChinaNational High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the Ministry of Science and Technology of China ("863" Program: 2012AA02A701), the National Natural Science Foundation of China (21390203 and 21206114) and Natural Science Foundation of Tianjin (12JCQNJC03800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggelis G, 1997, FOLIA MICROBIOL, V42, P117, DOI 10.1007/BF02898718; Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Beopoulos A, 2009, BIOCHIMIE, V91, P692, DOI 10.1016/j.biochi.2009.02.004; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; Ding MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109348; Dulermo T, 2013, BBA-MOL CELL BIOL L, V1831, P1486, DOI 10.1016/j.bbalip.2013.07.001; Duport C, 1998, NAT BIOTECHNOL, V16, P186, DOI 10.1038/nbt0298-186; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao SL, 2014, BIOTECHNOL LETT, V36, P2523, DOI 10.1007/s10529-014-1634-y; HOLZSCHU DL, 1979, SABOURAUDIA, V17, P71; Jacquier N, 2012, J STEROID BIOCHEM, V129, P70, DOI 10.1016/j.jsbmb.2010.11.014; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Li XC, 2015, NATURE, V517, P104, DOI 10.1038/nature13797; Lin QH, 2015, ACS SYNTH BIOL, V4, P213, DOI 10.1021/sb500241e; Makri A, 2010, BIORESOURCE TECHNOL, V101, P2351, DOI 10.1016/j.biortech.2009.11.024; MATOBA S, 1988, MOL CELL BIOL, V8, P4904, DOI 10.1128/MCB.8.11.4904; Matthaus F, 2014, APPL ENVIRON MICROB, V80, P1660, DOI 10.1128/AEM.03167-13; Mlickova K, 2004, APPL ENVIRON MICROB, V70, P3918, DOI 10.1128/AEM.70.7.3918-3924.2004; Morin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027966; Naruse R, 2015, OBES RES CLIN PRACT, V9, P67, DOI 10.1016/j.orcp.2014.02.001; Papanikolaou S, 2006, CURR MICROBIOL, V52, P134, DOI 10.1007/s00284-005-0223-7; Papanikolaou S, 2002, J APPL MICROBIOL, V92, P737, DOI 10.1046/j.1365-2672.2002.01577.x; Papanikolaou S, 2001, ANTON LEEUW INT J G, V80, P215, DOI 10.1023/A:1013083211405; Papanikolaou S, 2011, EUR J LIPID SCI TECH, V113, P1031, DOI 10.1002/ejlt.201100014; Rywinska A, 2010, WORLD J MICROB BIOT, V26, P1217, DOI 10.1007/s11274-009-0291-0; Sestric R, 2014, BIORESOURCE TECHNOL, V164, P41, DOI 10.1016/j.biortech.2014.04.016; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Sitepu IR, 2013, BIORESOURCE TECHNOL, V144, P360, DOI 10.1016/j.biortech.2013.06.047; Souza CM, 2011, METAB ENG, V13, P555, DOI 10.1016/j.ymben.2011.06.006; Su W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130840; Szczebara FM, 2003, NAT BIOTECHNOL, V21, P143, DOI 10.1038/nbt775; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang GS, 2012, APPL ENVIRON MICROB, V78, P7205, DOI 10.1128/AEM.00545-12; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Witsch-Baumgartner M, 2001, HUM MUTAT, V17, P172, DOI 10.1002/humu.2; Wu AHB, 2014, CLIN CHIM ACTA, V430, P43, DOI 10.1016/j.cca.2013.12.040; Xue ZX, 2013, NAT BIOTECHNOL, V31, P734, DOI 10.1038/nbt.2622; Zou L, 2011, J STEROID BIOCHEM, V127, P435, DOI 10.1016/j.jsbmb.2011.06.011	40	26	30	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146773	10.1371/journal.pone.0146773	http://dx.doi.org/10.1371/journal.pone.0146773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751680	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100149
J	Fryxell, RTT; DeBruyn, JM				Fryxell, R. T. Trout; DeBruyn, J. M.			The Microbiome of Ehrlichia-Infected and Uninfected Lone Star Ticks (Amblyomma americanum)	PLOS ONE			English	Article							FEVER GROUP RICKETTSIAE; DERMACENTOR-VARIABILIS; BORRELIA-BURGDORFERI; BACTERIAL DIVERSITY; VECTOR; ACARI; IXODIDAE; DISEASES; IDENTIFICATION; CHAFFEENSIS	The Lone Star tick, Amblyomma americanum, transmits several bacterial pathogens including species of Anaplasma and Ehrlichia. Amblyomma americanum also hosts a number of non-pathogenic bacterial endosymbionts. Recent studies of other arthropod and insect vectors have documented that commensal microflora can influence transmission of vectorborne pathogens; however, little is known about tick microbiomes and their possible influence on tick-borne diseases. Our objective was to compare bacterial communities associated with A. americanum, comparing Anaplasma/Ehrlichia -infected and uninfected ticks. Field-collected questing specimens (n = 50) were used in the analyses, of which 17 were identified as Anaplasma/Ehrlichia infected based on PCR amplification and sequencing of groEL genes. Bacterial communities from each specimen were characterized using Illumina sequencing of 16S rRNA gene amplicon libraries. There was a broad range in diversity between samples, with inverse Simpson's Diversity indices ranging from 1.28-89.5. There were no statistical differences in the overall microbial community structure between PCR diagnosed Anaplasma/Ehrlichia-positive and negative ticks, but there were differences based on collection method (P < 0.05), collection site (P < 0.05), and sex (P < 0.1) suggesting that environmental factors may structure A. americanum microbiomes. Interestingly, there was not always agreement between Illumina sequencing and PCR diagnostics: Ehrlichia was identified in 16S rRNA gene libraries from three PCR-negative specimens; conversely, Ehrlichia was not found in libraries of six PCR-positive ticks. Illumina sequencing also helped identify co-infections, for example, one specimen had both Ehrlichia and Anaplasma. Other taxa of interest in these specimens included Coxiella, Borrelia, and Rickettsia. Identification of bacterial community differences between specimens of a single tick species from a single geographical site indicates that intra-species differences in microbiomes were not due solely to pathogen presence/absence, but may be also driven by vector life history factors, including environment, life stage, population structure, and host choice.	[Fryxell, R. T. Trout] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [DeBruyn, J. M.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Fryxell, RTT (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	RFryxell@utk.edu	DeBruyn, Jennifer M./A-8813-2010	DeBruyn, Jennifer M./0000-0002-2993-4144; Trout Fryxell, Rebecca/0000-0003-2133-0220	University of Tennessee Institute of Agriculture; Center of Excellence UTIA Veterinary Medicine; USDA Tennessee Hatch Project [TN00433]	University of Tennessee Institute of Agriculture; Center of Excellence UTIA Veterinary Medicine; USDA Tennessee Hatch Project	Funding for this project came from the University of Tennessee Institute of Agriculture, a seed grant from the Center of Excellence UTIA Veterinary Medicine, and USDA Tennessee Hatch Project (TN00433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S., 1995, Insect Molecular Biology, V4, P23, DOI 10.1111/j.1365-2583.1995.tb00004.x; ANDERSON BE, 1993, AM J TROP MED HYG, V49, P239, DOI 10.4269/ajtmh.1993.49.239; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; [Anonymous], [No title captured]; Buller RS, 1999, NEW ENGL J MED, V341, P148, DOI 10.1056/NEJM199907153410303; Burkot TR, 2001, EMERG INFECT DIS, V7, P471, DOI 10.3201/eid0703.017323; Carmichael JR, 2010, VECTOR-BORNE ZOONOT, V10, P111, DOI 10.1089/vbz.2008.0083; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Christova I, 2003, EUR J CLIN MICROBIOL, V22, P535, DOI 10.1007/s10096-003-0988-1; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Clarke KR, 2006, J EXP MAR BIOL ECOL, V338, P179, DOI 10.1016/j.jembe.2006.06.019; Clarke KR, 2001, GETTING STARTED V6; Cohen SB, 2010, VECTOR-BORNE ZOONOT, V10, P435, DOI 10.1089/vbz.2009.0058; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cooley RA, 1945, N AM NATL I HLTH B, V184; Crotti E, 2012, MICROB BIOTECHNOL, V5, P307, DOI 10.1111/j.1751-7915.2011.00312.x; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; EWING SA, 1995, J MED ENTOMOL, V32, P368, DOI 10.1093/jmedent/32.3.368; Fuqua C., 2010, CRITICAL NEEDS GAPS; GODDARD J, 1986, J MED ENTOMOL, V23, P465, DOI 10.1093/jmedent/23.5.465; Goddard J, 2009, VET PARASITOL, V160, P1, DOI 10.1016/j.vetpar.2008.10.089; Harmon JR, 2015, TICKS TICK-BORNE DIS, V6, P246, DOI 10.1016/j.ttbdis.2015.01.004; Hawlena H, 2012, ARTHROPOD VERTEBRATE, V7, P221; Heise SR, 2010, J MED ENTOMOL, V47, P258, DOI 10.1603/ME09197; Hendricks B, 2013, IDENTIFICATION CHARA; HOLLAND CJ, 1985, INFECT IMMUN, V48, P366, DOI 10.1128/IAI.48.2.366-371.1985; Hopla CE, 1955, AM J EPIDEMIOL, V61, P871; Jasinskas A, 2007, APPL ENVIRON MICROB, V73, P334, DOI 10.1128/AEM.02009-06; Kagemann J, 2013, J MED ENTOMOL, V50, P155, DOI 10.1603/ME12086; KEIRANS JE, 1989, J MED ENTOMOL, V26, P435, DOI 10.1093/jmedent/26.5.435; Keirans JE, 1998, J MED ENTOMOL, V35, P489, DOI 10.1093/jmedent/35.4.489; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Klyachko O, 2007, APPL ENVIRON MICROB, V73, P6584, DOI 10.1128/AEM.00537-07; Kuttler AKL, 1983, J WILDLIFE DIS, V20, P12; Lefcort H, 1996, PARASITOLOGY, V113, P97, DOI 10.1017/S0031182000066336; Loftis AD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-54; Menchaca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067129; Mixson TR, 2006, J MED ENTOMOL, V43, P1261, DOI 10.1603/0022-2585(2006)43[1261:POEBAR]2.0.CO;2; Munderloh UG, 2005, TICK-BORNE DISEASES OF HUMANS, P37; Narasimhan S, 2015, TRENDS PARASITOL, V31, P315, DOI 10.1016/j.pt.2015.03.010; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Perez de Leon AA, 2014, OUTLOOKS PEST MANAG, P382; Pompo K, 2015, J PARASITOL IN PRESS; Ponnusamy L, 2014, APPL ENVIRON MICROB, V80, P354, DOI 10.1128/AEM.02987-13; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Rynkiewicz EC, 2015, MOL ECOL, V24, P2566, DOI 10.1111/mec.13187; Sauer JR, 2000, J INSECT PHYSIOL, V46, P1069, DOI 10.1016/S0022-1910(99)00210-3; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; STANDAERT SM, 1995, NEW ENGL J MED, V333, P420, DOI 10.1056/NEJM199508173330704; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; Stromdahl EY, 2011, VECTOR-BORNE ZOONOT, V11, P969, DOI 10.1089/vbz.2010.0099; Sun JM, 2008, VECTOR-BORNE ZOONOT, V8, P791, DOI 10.1089/vbz.2008.0005; Tabara K, 2007, MICROBIOL IMMUNOL, V51, P359, DOI 10.1111/j.1348-0421.2007.tb03923.x; Takano A, 2009, MICROBIOL IMMUNOL, V53, P101, DOI 10.1111/j.1348-0421.2008.00093.x; Team RC, 2012, R LANG ENV STAT COMP; Thomas DW, 1987, SOILS SURVEY HARDEMA, P15; Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14; Trout RT., 2010, THESIS; USDA, USDA GEOSP GAT; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Weiss BL, 2012, J IMMUNOL, V188, P3395, DOI 10.4049/jimmunol.1103691; WOODY BJ, 1991, VET CLIN N AM-SMALL, V21, P75, DOI 10.1016/S0195-5616(91)50009-7; Zouache K, 2012, MOL ECOL, V21, P2297, DOI 10.1111/j.1365-294X.2012.05526.x	66	37	37	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146651	10.1371/journal.pone.0146651	http://dx.doi.org/10.1371/journal.pone.0146651			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751816	Green Published, gold			2022-12-27	WOS:000367888100122
J	Gou, L; Wei, B; Sadiq, R; Sadiq, Y; Deng, Y				Gou, Li; Wei, Bo; Sadiq, Rehan; Sadiq, Yong; Deng, Yong			Topological Vulnerability Evaluation Model Based on Fractal Dimension of Complex Networks	PLOS ONE			English	Article							SCALE-FREE NETWORKS; ATTACK VULNERABILITY; SELF-SIMILARITY; ROBUSTNESS; EFFICIENCY; SYSTEMS	With an increasing emphasis on network security, much more attentions have been attracted to the vulnerability of complex networks. In this paper, the fractal dimension, which can reflect space-filling capacity of networks, is redefined as the origin moment of the edge betweenness to obtain a more reasonable evaluation of vulnerability. The proposed model combining multiple evaluation indexes not only overcomes the shortage of average edge betweenness's failing to evaluate vulnerability of some special networks, but also characterizes the topological structure and highlights the space-filling capacity of networks. The applications to six US airline networks illustrate the practicality and effectiveness of our proposed method, and the comparisons with three other commonly used methods further validate the superiority of our proposed method.	[Gou, Li; Wei, Bo; Deng, Yong] Southwest Univ, Sch Comp & Informat Sci, Chongqing 400715, Peoples R China; [Gou, Li] Michigan Technol Univ, Dept Comp Sci, Houghton, MI 49931 USA; [Sadiq, Rehan; Sadiq, Yong] Univ British Columbia Okanagan, Sch Engn, Kelowna, BC V1V 1V7, Canada; [Deng, Yong] Vanderbilt Univ, Sch Engn, Nashville, TN 37235 USA	Southwest University - China; Michigan Technological University; University of British Columbia; University of British Columbia Okanagan; Vanderbilt University	Deng, Y (corresponding author), Southwest Univ, Sch Comp & Informat Sci, Chongqing 400715, Peoples R China.	ydeng@swu.edu.cn	Deng, Yong/A-9193-2015	Deng, Yong/0000-0001-9286-2123	National High Technology Research and Development Program of China (863 Program) [2013AA013801]; National Natural Science Foundation of China [61174022, 61573290, 61503237]; China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University [BUAA-VR-14KF-02]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University	The work is partially supported by National High Technology Research and Development Program of China (863 Program) (grant no. 2013AA013801), National Natural Science Foundation of China (grant nos. 61174022, 61573290, 61503237), China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University (grant no. BUAA-VR-14KF-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Boccaletti S, 2007, CHAOS, V17, DOI 10.1063/1.2801687; Crucitti P, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.045104; Deng XY, 2014, EXPERT SYST APPL, V41, P156, DOI 10.1016/j.eswa.2013.07.018; Deng Y, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/878024; Deng Y, 2015, INT J UNCONV COMPUT, V11, P227; Deng Y, 2015, APPL INTELL, V43, P530, DOI 10.1007/s10489-015-0661-2; Deng Y, 2011, EXPERT SYST APPL, V38, P571, DOI 10.1016/j.eswa.2010.07.004; Du WB, 2013, PHYSICA A, V392, P3505, DOI 10.1016/j.physa.2013.03.032; ERDOS P, 1960, B INT STATIST INST, V38, P343; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Goh KI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018701; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Holmgren AJ, 2006, RISK ANAL, V26, P955, DOI 10.1111/j.1539-6924.2006.00791.x; Jiang W, 2015, INT J COMPUT COMMUN, V10, P333, DOI 10.15837/ijccc.2015.3.1656; Jiang W, 2015, J INTELL FUZZY SYST, V28, P2343, DOI 10.3233/IFS-151639; Li DQ, 2011, NAT PHYS, V7, P481, DOI [10.1038/NPHYS1932, 10.1038/nphys1932]; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Mandelbrot B. B, 1983, FRACTAL GEOMETRY NAT, V173; Mishkovski I, 2011, COMMUN NONLINEAR SCI, V16, P341, DOI 10.1016/j.cnsns.2010.03.018; Mokbel M.F., 2008, ENCY GIS, P1068, DOI DOI 10.1007/978-0-387-35973-1_1233; Monfared MAS, 2014, PHYSICA A, V406, P24, DOI 10.1016/j.physa.2014.03.031; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ouyang M, 2014, PHYSICA A, V396, P204, DOI 10.1016/j.physa.2013.10.041; Qi X, 2010, MOD PHYS LETT B, V24, P1549, DOI 10.1142/S0217984910023347; Shanker O, 2008, MOD PHYS LETT B, V22, P459, DOI 10.1142/S0217984908015048; Shanker O, 2007, MOD PHYS LETT B, V21, P639, DOI 10.1142/S0217984907013146; Song CM, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/03/P03006; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Su XY, 2015, RISK ANAL, V35, P1296, DOI 10.1111/risa.12347; Tang Q, 2011, MOD PHYS LETT B, V25, P1889, DOI 10.1142/S0217984911027133; Wang JW, 2011, SAFETY SCI, V49, P807, DOI 10.1016/j.ssci.2010.10.003; Wang JW, 2009, SAFETY SCI, V47, P1332, DOI 10.1016/j.ssci.2009.02.002; Wang JW, 2009, INT J MOD PHYS C, V20, P1291, DOI 10.1142/S0129183109014357; Wang JB, 2009, MOD PHYS LETT B, V23, P1781, DOI 10.1142/S0217984909019946; Wang JW, 2013, INT J MOD PHYS C, V24, DOI 10.1142/S0129183113500769; Wang JW, 2013, SAFETY SCI, V53, P219, DOI 10.1016/j.ssci.2012.09.011; Wang SL, 2013, SAFETY SCI, V51, P328, DOI 10.1016/j.ssci.2012.07.003; Wang Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052813; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Wei DJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03049; Wei DJ, 2014, PHYS LETT A, V378, P1091, DOI 10.1016/j.physleta.2014.02.010; Yong Deng, 2015, Mathematical Problems in Engineering, V2015, DOI 10.1155/2015/212794; Zhang JH, 2012, SAFETY SCI, V50, P443, DOI 10.1016/j.ssci.2011.10.005	49	15	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146896	10.1371/journal.pone.0146896	http://dx.doi.org/10.1371/journal.pone.0146896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751371	Green Published, gold			2022-12-27	WOS:000367888100175
J	Krishnarajah, G; Duh, MS; Korves, C; Demissie, K				Krishnarajah, Girishanthy; Duh, Mei Sheng; Korves, Caroline; Demissie, Kitaw			Public Health Impact of Complete and Incomplete Rotavirus Vaccination among Commercially and Medicaid Insured Children in the United States	PLOS ONE			English	Article							COST-EFFECTIVENESS; US CHILDREN; HOSPITALIZATIONS; GASTROENTERITIS; DIARRHEA; PENTAVALENT; INFANTS; SURVEILLANCE; PREVENTION; CODE	Background This study (NCT01682005) aims to assess clinical and cost impacts of complete and incomplete rotavirus (RV) vaccination. Methods Beneficiaries who continuously received medical and pharmacy benefits since birth were identified separately in Truven Commercial Claims and Encounters (2000-2011) and Truven Medicaid Claims (2002-2010) and observed until the first of end of insurance eligibility or five years. Infants with >= 1 RV vaccine within the vaccination window (6 weeks-8 months) were divided into completely and incompletely vaccinated cohorts. Historically unvaccinated (before 2007) and contemporarily unvaccinated (2007 and after) cohorts included children without RV vaccine. Claims with International Classification of Disease 9th edition (ICD-9) codes for diarrhea and RV were identified. First RV episode incidence, RV-related and diarrhea-related healthcare resource utilization after 8 months old were calculated and compared across groups. Poisson regressions were used to generate incidence rates with 95% confidence intervals (CIs). Mean total, inpatient, outpatient and emergency room costs for first RV and diarrhea episodes were calculated; bootstrapping was used to construct 95% CIs to evaluate cost differences. Results 1,069,485 Commercial and 515,557 Medicaid patients met inclusion criteria. Among commercially insured, RV incidence per 10,000 person-years was 3.3 (95% CI 2.8-3.9) for completely, 4.0 (95% CI 3.3-5.0) for incompletely vaccinated, and 20.9 (95% CI 19.5-22.4) for contemporarily and 40.3 (95% CI 38.6-42.1) for historically unvaccinated. Rates in Medicaid were 7.5 (95% CI 4.8-11.8) for completely, 9.0 (95% CI 6.5-12.3) for incompletely vaccinated, and 14.6 (95% CI 12.8-16.7) for contemporarily and 52.0 (95% CI 50.2-53.8) for historically unvaccinated. Mean cost for first RV episode per cohort member was $15.33 (95% CI $12.99-$18.03) and $4.26 ($95% CI $2.34-$6.35) lower for completely vaccinated versus contemporarily unvaccinated in Commercial and Medicaid, respectively. Conclusions RV vaccination results in significant reduction in RV infection. There is evidence of indirect benefit to unvaccinated individuals.	[Krishnarajah, Girishanthy] GlaxoSmithKline Vaccines, King Of Prussia, PA 19406 USA; [Duh, Mei Sheng; Korves, Caroline] Anal Grp Inc, Boston, MA USA; [Demissie, Kitaw] Rutgers State Univ, Sch Publ Hlth, Piscataway, NJ USA; [Demissie, Kitaw] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA	GlaxoSmithKline; Analysis Group Inc.; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Krishnarajah, G (corresponding author), GlaxoSmithKline Vaccines, King Of Prussia, PA 19406 USA.	girishanthy.x.krishnarajah@gsk.com			GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	GlaxoSmithKline Biologicals SA funded this study/research and was involved in all stages of study conduct, including analysis of the data. GlaxoSmithKline Biologicals SA also took in charge all costs associated with the development and publication of this manuscript.	[Anonymous], 2013, WKLY EPIDEMIOL REC H, V88, P49; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Barker Nancy, 2005, P PHARM US SOFTW EXC; Bernstein D, 2007, US PEDIAT REV, P39; Black Carla L., 2011, Morbidity and Mortality Weekly Report, V60, P1157; Bocchini JA, 2009, PEDIATRICS, V123, P1412, DOI 10.1542/peds.2009-0466; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Center for Disease Control and Prevention, 2014, ROT TRANSM; Center for Disease Control and Prevention, 2014, BIRTHS AND NATALITY; Centers for Disease Control and Prevention, 2013, VACC IMM; Charles MD, 2006, PEDIATR INFECT DIS J, V25, P489, DOI 10.1097/01.inf.0000215234.91997.21; Cohen T, 2008, EPIDEMIOLOGY, V19, P588, DOI 10.1097/EDE.0b013e31817734ba; Cortes JE, 2011, NEW ENGL J MED, V365, P1108, DOI 10.1056/NEJMoa1000446; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Hsu VP, 2005, PEDIATRICS, V115, P78, DOI 10.1542/peds.2004-0860; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Lopman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041720; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Malek MA, 2006, PEDIATRICS, V117, P1887, DOI 10.1542/peds.2005-2351; Parashar UD, 1998, J INFECT DIS, V177, P13, DOI 10.1086/513808; Payne DC, 2013, CLIN INFECT DIS, V57, P13, DOI 10.1093/cid/cit164; Staat MA, 2010, PEDIATR INFECT DIS J, V29, P1083, DOI 10.1097/INF.0b013e3181fb8f7b; The Henry J. Kaiser Family Foundation, 2014, HEALTH INSURANCE COV; The Henry J. Kaiser Family Foundation, 2014, CHILDR HLTH COV MED; The Henry J. Kaiser Family Foundation, 2014, MED MOV FORW; Tucker AW, 1998, JAMA-J AM MED ASSOC, V279, P1371, DOI 10.1001/jama.279.17.1371; Wang FT, 2010, PEDIATRICS, V125, pE208, DOI 10.1542/peds.2009-1246; Widdowson MA, 2007, PEDIATRICS, V119, P684, DOI 10.1542/peds.2006-2876; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	29	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145977	10.1371/journal.pone.0145977	http://dx.doi.org/10.1371/journal.pone.0145977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751375	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100035
J	Lemos, CN; de Souza, JG; Simao, PS; Lopez, RFV				Lemos, Camila Nunes; de Souza, Joel Goncalves; Simao, Patricia Sper; Vianna Lopez, Renata Fonseca			Iontophoresis Improved Growth Reduction of Invasive Squamous Cell Carcinoma in Topical Photodynamic Therapy	PLOS ONE			English	Article							5-AMINOLEVULINIC ACID; DRUG-DELIVERY; SKIN-CANCER; IN-VITRO; TRANSDERMAL IONTOPHORESIS; SOLID TUMORS; ELECTROOSMOSIS; PENETRATION; LONTOPHORESIS; NANOPARTICLES	This study examined the potential of iontophoresis in topical photodynamic therapy (PDT) of human invasive squamous cells carcinomas (SCC). SCC was induced in nude BALB/c mice by subcutaneous injection of A431 cells. Tumor penetration and distribution of the photosensitizer tetrasulfonated zinc phthalocyanine (ZnPcS4) was investigated after 10 and 30 min of in vivo iontophoresis of a gel containing ZnPcS4. PDT was performed immediately after iontophoresis using laser at 660 nm with a dose of irradiation of 100 J/cm(2) and irradiance of 48 mW/cm(2) while tumor growth was measured for 30 days. Iontophoresis increased ZnPcS4 penetration into tumors by 6-fold after 30 min when compared with passive delivery. Confocal microscopy analysis showed that ZnPcS4 was homogeneous distributed within deep regions of the tumor after iontophoresis. Irradiation of the tumors immediately after iontophoresis showed reduction in tumor size by more than 2-fold when compared to non-treated tumors. Iontophoretic-PDT treated tumors presented large areas of necrosis. The study concluded that iontophoretic delivery of photosensitizers could be a valuable strategy for topical PDT of invasive SCC.	[Lemos, Camila Nunes; de Souza, Joel Goncalves; Simao, Patricia Sper; Vianna Lopez, Renata Fonseca] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo	Lopez, RFV (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Sao Paulo, Brazil.	rvianna@fcfrp.usp.br	Lopez, Renata/B-9646-2012; Souza, Joel/F-1999-2014	Lopez, Renata/0000-0002-6448-6711; Nunes Lemos, Camila/0000-0003-0437-9516	Sao Paulo Research Foundation (FAPESP) [2011/21411-3, 2014/22451-7]; Brazilian National Council for Scientific and Technological Development (CNPq) [480962/2013-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CNL likes to thank the Sao Paulo Research Foundation (FAPESP grant #2011/21411-3) and the Brazilian National Council for Scientific and Technological Development (CNPq grant #480962/2013-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Sao Paulo Research Foundation (FAPESP grant #2014/22451-7) and the Brazilian National Council for Scientific and Technological Development (CNPq grant #480962/2013-8). CNL was supported by FAPESP grant #2011/21411-3.	Baldea I, 2012, J PHYSIOL PHARMACOL, V63, P109; Cakir D, 2015, DALTON T, V44, P9646, DOI 10.1039/c5dt00747j; Calzavara-Pinton PG, 2008, BRIT J DERMATOL, V159, P137, DOI 10.1111/j.1365-2133.2008.08593.x; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Dobler-Girdziunaite D., 1995, Strahlentherapie und Onkologie, V171, P622; Gelfuso GM, 2011, EUR J PHARM BIOPHARM, V77, P249, DOI 10.1016/j.ejpb.2010.11.018; Gratieri T, 2008, QUIM NOVA, V31, P1490, DOI 10.1590/S0100-40422008000600040; Guy RH, 2000, J CONTROL RELEASE, V64, P129, DOI 10.1016/S0168-3659(99)00132-7; Haywood-Small SL, 2006, BIOCHEM BIOPH RES CO, V339, P569, DOI 10.1016/j.bbrc.2005.11.046; Huang Z, 2008, TECHNOL CANCER RES T, V7, P309, DOI 10.1177/153303460800700405; Huber LA, 2015, J BIOMED NANOTECHNOL, V11, P1975, DOI 10.1166/jbn.2015.2139; Kalia YN, 2004, ADV DRUG DELIVER REV, V56, P619, DOI 10.1016/j.addr.2003.10.026; Krishnan G, 2014, DRUG DELIV TRANSL RE, V4, P222, DOI 10.1007/s13346-013-0181-8; Krishnan G, 2011, BIOPOLYMERS, V96, P166, DOI 10.1002/bip.21520; Li XN, 2015, ONCOL LETT, V9, P2805, DOI 10.3892/ol.2015.3089; Lopez RFV, 2004, ADV DRUG DELIVER REV, V56, P77, DOI 10.1016/j.addr.2003.09.002; Lopez RFV, 2003, PHOTOCHEM PHOTOBIOL, V77, P304, DOI 10.1562/0031-8655(2003)077<0304:EDOAAE>2.0.CO;2; Lopez RFV, 2001, PHARMACEUT RES, V18, P311, DOI 10.1023/A:1011050829531; Lopez RFV, 2012, PHYS METHODS INCREAS, V1, P191; Marro D, 2001, PHARM RES-DORDR, V18, P1701, DOI 10.1023/A:1013318412527; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Morton C, 2015, EUROPEAN J DERMATOLO; Mudry B, 2006, BIOPHYS J, V90, P2822, DOI 10.1529/biophysj.105.074609; Nakanishi T, 2015, J PHARM SCI; Navarrete-Dechent C, 2015, J AM ACAD DERMATOL, V73, P127, DOI 10.1016/j.jaad.2015.03.039; Porceddu Sandro V, 2015, Am Soc Clin Oncol Educ Book, pe513, DOI 10.14694/EdBook_AM.2015.35.e513; Ricci-Junior E, 2006, INT J PHARMACEUT, V310, P187, DOI 10.1016/j.ijpharm.2005.10.048; ROBERTS DJH, 1995, BRIT J PLAST SURG, V48, P360, DOI 10.1016/S0007-1226(95)90065-9; Sieg A, 2004, BIOPHYS J, V87, P3344, DOI 10.1529/biophysj.104.044792; Souza JG, 2011, ANTI-CANCER DRUG, V22, P783, DOI 10.1097/CAD.0b013e3283468979; Susan M, 2011, INT J DERMATOL, V50, P280, DOI 10.1111/j.1365-4632.2010.04700.x; Sylvestre JP, 2008, PHYS THER, V88, P1177, DOI 10.2522/ptj.20080043; Taveira SF, 2009, J CONTROL RELEASE, V134, P35, DOI 10.1016/j.jconrel.2008.11.002	33	15	15	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145922	10.1371/journal.pone.0145922	http://dx.doi.org/10.1371/journal.pone.0145922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752697	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100032
J	Raghav, K; French, JT; Ueno, NT; Lei, X; Krishnamurthy, S; Reuben, JM; Valero, V; Ibrahim, NK				Raghav, K.; French, J. T.; Ueno, N. T.; Lei, X.; Krishnamurthy, S.; Reuben, J. M.; Valero, V.; Ibrahim, N. K.			Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; MICROARRAY ANALYSIS; LOBULAR CARCINOMA; DIFFERENTIATION; SURVIVAL; OUTCOMES; BIOLOGY; DISEASE; RISK	Introduction Although well recognized in breast oncology literature, histologic subtypes have not been previously described in inflammatory breast cancer (IBC). The purpose of this study was to describe lobular subtype in IBC and assess the impact of histology on patient outcomes. Methods We performed a retrospective analysis of 659 IBC patients at MD Anderson Cancer Center between January 1984 and December 2009. Patients with Invasive Lobular, Mixed Invasive Ductal and Lobular, or Invasive Ducal Carcinomas (ILC, MIC, IDC, respectively) comprise the subject of this report. Patient characteristics and survival estimates were compared by using chi-square test and Kaplan-Meier method with log-rank statistic. Cox proportional hazards models were fit to determine association of histology with outcomes after adjustment for other characteristics. Results A total of 30, 37, and 592 patients were seen to have invasive lobular, mixed, or ductal histology, respectively. Grade 3 tumors were more common in the ductal group (78%) than in the lobular (60%) or mixed (61%) group (P = 0.01). The 3-year overall survival rates were 68%, 64%, and 62% in the lobular, mixed, and ductal groups, respectively (P = 0.68). After adjustment, histology did not have a significant effect on death in the lobular group (HR = 0.70, 95% confidence interval [CI]: 0.26-1.94; P = 0.50) or mixed group (HR = 0.53, 95% CI: 0.25-1.13; P = 0.10) compared with the ductal group. Conclusion In this cohort of IBC patients, lobular histology was seen in 4.5% cases. Histology does not appear to have a significant effect on survival outcomes in IBC patients, unlike in patients with non-inflammatory breast cancer (n-IBC), indicating the distinct biological behavior of the IBC phenotype.	[Raghav, K.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Div Canc Med, Houston, TX 77030 USA; [French, J. T.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Ueno, N. T.; Valero, V.; Ibrahim, N. K.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Div Canc Med, Houston, TX 77030 USA; [Ueno, N. T.] Univ Texas MD Anderson Canc Ctr, Dept Morgan Welch Inflammatory Breast Canc Res Pr, Div Canc Med, Houston, TX 77030 USA; [Lei, X.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Div Canc Med, Houston, TX 77030 USA; [Krishnamurthy, S.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Div Canc Med, Houston, TX 77030 USA; [Reuben, J. M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Div Canc Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ibrahim, NK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Div Canc Med, Houston, TX 77030 USA.	nibrahim@mdanderson.org		Lei, Xiudong/0000-0002-5346-2992	The Morgan Welch Inflammatory Breast Cancer Research Program; State of Texas Rare and Aggressive Breast Cancer Research Program; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	The Morgan Welch Inflammatory Breast Cancer Research Program; State of Texas Rare and Aggressive Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Morgan Welch Inflammatory Breast Cancer Research Program, and State of Texas Rare and Aggressive Breast Cancer Research Program Grant supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertucci F, 2004, CANCER RES, V64, P8558, DOI 10.1158/0008-5472.CAN-04-2696; Cristofanilli M, 2005, J CLIN ONCOL, V23, P41, DOI 10.1200/JCO.2005.03.111; Cristofanilli M, 2007, CANCER-AM CANCER SOC, V110, P1436, DOI 10.1002/cncr.22927; DROULIAS CA, 1976, ANN SURG, V184, P217, DOI 10.1097/00000658-197608000-00014; Gonzalez-Angulo AM, 2004, CANCER-AM CANCER SOC, V101, P1760, DOI 10.1002/cncr.20530; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; Hwang ES, 2011, ONCOLOGY WILLISTON P, V25, P364; JAIYESIMI IA, 1992, J CLIN ONCOL, V10, P1014, DOI 10.1200/JCO.1992.10.6.1014; Korkola JE, 2003, CANCER RES, V63, P7167; Le Monique G, 2005, Clin Breast Cancer, V6, P439, DOI 10.3816/CBC.2005.n.049; Li CI, 2005, BRIT J CANCER, V93, P1046, DOI 10.1038/sj.bjc.6602787; Li CI, 2003, ARCH INTERN MED, V163, P2149, DOI 10.1001/archinte.163.18.2149; Lips EH, 2012, BREAST CANCER RES TR, V136, P35, DOI 10.1007/s10549-012-2233-z; Masuda H, 2014, ANN ONCOL, V25, P384, DOI 10.1093/annonc/mdt525; Pai K, 2013, J CLIN DIAGN RES, V7, P721, DOI [10.7860/JCDR/2013/5759.2892, 10.7860/JCDR/2013/5755.2954]; Petrelli F, 2013, BREAST CANCER RES TR, V142, P227, DOI 10.1007/s10549-013-2751-3; Reis JS, 2006, J CLIN PATHOL, V59, P225, DOI 10.1136/jcp.2005.028324; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Taneja P, 2010, CLIN MED INSIGHTS-ON, V4, P15; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Winchester DJ, 1998, J AM COLL SURGEONS, V186, P416, DOI 10.1016/S1072-7515(98)00051-9; Yamauchi H, 2009, NAT REV CLIN ONCOL, V6, P387, DOI 10.1038/nrclinonc.2009.73; Ye Y, 2010, ANTICANCER RES, V30, P3903	23	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145534	10.1371/journal.pone.0145534	http://dx.doi.org/10.1371/journal.pone.0145534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752563	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888100016
J	Zafari, Z; Sadatsafavi, M; Marra, CA; Chen, WJ; FitzGerald, JM				Zafari, Zafar; Sadatsafavi, Mohsen; Marra, Carlo A.; Chen, Wenjia; FitzGerald, J. Mark			Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma	PLOS ONE			English	Article							ANTI-IGE ANTIBODY; ADD-ON THERAPY; SEVERE PERSISTENT; UNCONTROLLED ASTHMA; HEALTH; ADULTS; SAFETY; EFFICACY; CORTICOSTEROIDS; EXACERBATIONS	Background Bronchial thermoplasty (BT) is a recently developed treatment for patients with moderate-to-severe asthma. A few studies have suggested the clinical efficacy of this intervention. However, no study has evaluated the cost-effectiveness of BT compared to other alternative treatments for moderate-to-severe allergic asthma, which currently include omalizumab and standard therapy. Objective To evaluate the cost-effectiveness of standard therapy, BT, and omalizumab for moderate-to-severe allergic asthma in the USA. Methods A probabilistic Markov model with weekly cycles was developed to reflect the course of asthma progression over a 5-year time horizon. The study population was adults with moderate-to-severe allergic asthma whose asthma remained uncontrolled despite using high-dose inhaled corticosteroids (ICS, with or without long-acting beta-agonists [LABA]). A perspective of the health-care system was adopted with asthma-related costs as well as quality-adjusted life years (QALYs) and exacerbations as the outcomes. Results For standard therapy, BT, and omalizumab, the discounted 5-year costs and QALYs were $15,400 and 3.08, $28,100 and 3.24, and $117,000 and 3.26, respectively. The incremental cost-effectiveness ratio (ICER) of BT versus standard therapy and omalizumab versus BT was $78,700/QALY and $3.86 million/QALY, respectively. At the willingness-to-pay (WTP) of $50,000/QALY and $100,000/QALY, the probability of BT being cost-effective was 9%, and 67%, respectively. The corresponding expected value of perfect information (EVPI) was $155 and $1,530 per individual at these thresholds. In sensitivity analyses, increasing the costs of BT from $14,900 to $30,000 increased its ICER relative to standard therapy to $178,000/QALY, and decreased the ICER of omalizumab relative to BT to $3.06 million/QALY. Reducing the costs of omalizumab by 25% decreased its ICER relative to BT by 29%. Conclusions Based on the available evidence, our study suggests that there is more than 60% chance that BT becomes cost-effective relative to omalizumab and standard therapy at the WTP of $100,000/QALY in patients with moderate-to-severe allergic asthma. However, there is a substantial uncertainty in the underlying evidence, indicating the need for future research towards reducing such uncertainty.	[Zafari, Zafar; Sadatsafavi, Mohsen; FitzGerald, J. Mark] Univ British Columbia, Fac Med, IHLH, Vancouver, BC, Canada; [Zafari, Zafar; Sadatsafavi, Mohsen; FitzGerald, J. Mark] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver Coastal Hlth Inst, Vancouver, BC V5Z 1M9, Canada; [Sadatsafavi, Mohsen; FitzGerald, J. Mark] Univ British Columbia, Fac Med, Div Resp Med, Vancouver, BC, Canada; [Marra, Carlo A.] Mem Univ Newfoundland, Sch Pharm, St John, NF, Canada; [Chen, Wenjia] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; Memorial University Newfoundland; University of British Columbia	Zafari, Z (corresponding author), Univ British Columbia, Fac Med, IHLH, Vancouver, BC, Canada.	zafar.zafari@ubc.ca	Sadatsafayi, Mohsen/AAZ-1593-2020; Marra, Carlo/AAE-4904-2021	Sadatsafayi, Mohsen/0000-0002-0419-7862; Marra, Carlo/0000-0002-2625-2121; Chen, Wenjia/0000-0001-8201-7145	University of British Columbia, Vancouver; Canadian Respiratory Disease Network; National Sanitarium Association; Allergen	University of British Columbia, Vancouver; Canadian Respiratory Disease Network; National Sanitarium Association; Allergen	Z.Z. received a 4-year doctoral fellowship award for his PhD studies from the University of British Columbia, Vancouver. His PhD research is partly funded by Canadian Respiratory Disease Network. M.S. received salary support from National Sanitarium Association. J.M.F. received a grant from Allergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Arias E., 2007, US LIFE TABLES; Ayres JG, 2004, ALLERGY, V59, P701, DOI 10.1111/j.1398-9995.2004.00533.x; Bousquet J, 2005, ALLERGY, V60, P302, DOI 10.1111/j.1398-9995.2004.00770.x; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brown R, 2007, ALLERGY, V62, P149, DOI 10.1111/j.1398-9995.2006.01310.x; Campbell JD, 2010, ALLERGY, V65, P1141, DOI 10.1111/j.1398-9995.2010.02336.x; Cangelosi MJ, 2014, COST EFFECTIVENESS B, P1; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; Chan KKW, 2014, MED DECIS MAKING, V34, P863, DOI 10.1177/0272989X13517750; Chung KF, 1999, EUR RESPIR J, V13, P1198; Cox G, 2007, NEW ENGL J MED, V356, P1327, DOI 10.1056/NEJMoa064707; Dewilde S, 2006, CURR MED RES OPIN, V22, P1765, DOI 10.1185/030079906X132389; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Gildea TR, 2011, CLEV CLIN J MED, V78, P477, DOI 10.3949/ccjm.78a.10185; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Humbert M, 2005, ALLERGY, V60, P309, DOI 10.1111/j.1398-9995.2004.00772.x; Morishima Toshitaka, 2013, Value Health Reg Issues, V2, P29, DOI 10.1016/j.vhri.2013.01.007; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; NICE, 2013, OM TREAT SEV PERS AL; Oba Y, 2004, J ALLERGY CLIN IMMUN, V114, P265, DOI 10.1016/j.jaci.2004.05.049; Paltiel AD, 2001, J ALLERGY CLIN IMMUN, V108, P39, DOI 10.1067/mai.2001.116289; Pavord ID, 2007, AM J RESP CRIT CARE, V176, P1185, DOI 10.1164/rccm.200704-571OC; Pavord ID, 2013, ANN ALLERG ASTHMA IM, V111, P402, DOI 10.1016/j.anai.2013.05.002; Price DBR, 2004, PRIM CARE RESP, V13, P113; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodrigo GJ, 2011, CHEST, V139, P28, DOI 10.1378/chest.10-1194; Sadatsafavi M, 2014, CHEST, V145, P787, DOI 10.1378/chest.13-1619; Severens JL, 2004, VALUE HEALTH, V7, P397, DOI 10.1111/j.1524-4733.2004.74002.x; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; Sullivan SD, 2007, ALLERGY, V62, P126, DOI 10.1111/j.1398-9995.2006.01254.x; Sullivan S. D., 2009, RISK IOF MORTALITY A; Sullivan SD, 2003, J ALLERGY CLIN IMMUN, V112, P1229, DOI 10.1016/j.jaci.2003.09.025; Thomson NC, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-8; Torrego A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009910.pub2; Tsuchiya A, 2002, SHEFFIELD HLTH EC GR; van Nooten Floortje, 2013, J Med Econ, V16, P342, DOI 10.3111/13696998.2012.756398; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wu AC, 2007, J ALLERGY CLIN IMMUN, V120, P1146, DOI 10.1016/j.jaci.2007.07.055; Zafari Z, 2014, J ALLERGY CLIN IMMUN, V134, P908, DOI 10.1016/j.jaci.2014.04.009	40	46	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146003	10.1371/journal.pone.0146003	http://dx.doi.org/10.1371/journal.pone.0146003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751790	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100038
J	Hafeez, S; Urooj, M; Saleem, S; Gillani, Z; Shaheen, S; Qazi, MH; Naseer, MI; Iqbal, Z; Ansari, SA; Haque, A; Asif, M; Mir, MA; Ali, A; Pushparaj, PN; Jamal, MS; Rasool, M				Hafeez, Samra; Urooj, Mahwish; Saleem, Shamiala; Gillani, Zeeshan; Shaheen, Sumaira; Qazi, Mahmood Husain; Naseer, Muhammad Imran; Iqbal, Zafar; Ansari, Shakeel Ahmed; Haque, Absarul; Asif, Muhammad; Mir, Manzoor Ahmad; Ali, Ashraf; Pushparaj, Peter Natesan; Jamal, Mohammad Sarwar; Rasool, Mahmood			BAD, a Proapoptotic Protein, Escapes ERK/RSK Phosphorylation in Deguelin and siRNA-Treated HeLa Cells	PLOS ONE			English	Article							CANCER CELLS; GASTRIC-CANCER; APOPTOSIS; INHIBITOR; GROWTH	This study has been undertaken to explore the therapeutic effects of deguelin and specific siRNAs in HeLa cells. The data provided clearly show the silencing of ERK 1/2 with siRNAs and inhibition of ERK1/2 with deguelin treatment in HeLa cells. Additionally, we are providing information that deguelin binds directly to anti-apoptotic Bcl-2, Bcl-xl and Mcl-1 in the hydrophobic grooves, thereby releasing BAD and BAX from dimerization with these proteins. This results in increased apoptotic activity through the intrinsic pathway involved in rupture of mitochondrial membrane and release of cytochrome C. Evidence for inhibition of ERK1/2 by deguelin and escape of BAD phosphorylation at serine 112 through ERK/RSK pathway has been further fortified by obtaining similar results by silencing ERK 1/2 each with specific siRNAs. Increase in BAD after treatment with deguelin or siRNAs has been interpreted to mean that deguelin acts through several alternative pathways and therefore can be used as effective therapeutic agent.	[Hafeez, Samra; Urooj, Mahwish; Saleem, Shamiala; Gillani, Zeeshan; Shaheen, Sumaira; Qazi, Mahmood Husain] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan; [Hafeez, Samra; Urooj, Mahwish; Saleem, Shamiala; Gillani, Zeeshan; Shaheen, Sumaira; Qazi, Mahmood Husain] Univ Lahore, Ctr Res Mol Med, Lahore, Pakistan; [Naseer, Muhammad Imran; Ansari, Shakeel Ahmed; Pushparaj, Peter Natesan; Rasool, Mahmood] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia; [Iqbal, Zafar] King Saud Bin Abdulaziz Univ Hlth Sci, Natl Guards Hlth Affairs, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Haque, Absarul; Ali, Ashraf; Jamal, Mohammad Sarwar] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Asif, Muhammad] BUITEMS, Dept Biotechnol, Quetta, Pakistan; [Mir, Manzoor Ahmad] Al Majmaah Univ, Coll Appl Med Sci, Majmaah City, Saudi Arabia	University of Lahore; University of Lahore; King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz University; Balochistan University of Information Technology, Engineering & Management Sciences BUITEMS; Majmaah University	Jamal, MS (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.	sarwar4u@gmail.com; mahmoodrasool@yahoo.com	Jamal, Mohammad Sarwar/K-3842-2013; Asif, Muhammad/AAF-3615-2020; Saleem, Shamaila/X-9970-2019; Naseer, Muhammad Imran/AAG-4921-2020; Iqbal, Zafar/S-9011-2018; Naseer, Muhammad Imran/H-9477-2012; HAQUE, ABSARUL/H-9610-2012; Mir, Manzoor A/W-8905-2018; Ali, Ashraf/HDM-9287-2022; Ansari, Shakeel A/H-9478-2012; Ali, Ashraf/H-9630-2012; Rasool, Mahmood/H-9475-2012; Pushparaj, Peter Natesan/H-9871-2012	Asif, Muhammad/0000-0003-4761-837X; Mir, Manzoor A/0000-0003-3297-1402; Ali, Ashraf/0000-0001-5267-2608; Rasool, Mahmood/0000-0003-2997-5891; Pushparaj, Peter Natesan/0000-0001-7574-1880; Iqbal, Zafar/0000-0002-1334-6372; Naseer, Muhammad Imran/0000-0002-9343-5825	National Plan for Science, Technology and Innovation (MAARIFAH)-King Abdulaziz City for Science and Technologythe Kingdom of Saudi Arabia [12-BIO2267-03]	National Plan for Science, Technology and Innovation (MAARIFAH)-King Abdulaziz City for Science and Technologythe Kingdom of Saudi Arabia	This work was funded by the National Plan for Science, Technology and Innovation (MAARIFAH)-King Abdulaziz City for Science and Technologythe Kingdom of Saudi Arabia-award number 12-BIO2267-03. The authors also acknowledge with thanks the Science and Technology Unit (STU), King Abdulaziz University for their excellent technical support.	Bolt MW, 1997, ANAL BIOCHEM, V247, P185, DOI 10.1006/abio.1997.2061; Cho Y-Y, 2013, FRONTIERS ONCOLOGY, V3; Chun KH, 2003, JNCI-J NATL CANCER I, V95, P291, DOI 10.1093/jnci/95.4.291; Feng L, 2011, ASIAN PAC J CANCER P, V12, P403; Hayakawa J, 2000, CANCER RES, V60, P5988; Kang HW, 2012, DIGEST DIS SCI, V57, P2873, DOI 10.1007/s10620-012-2237-x; Lee H, 2010, ONCOL REP, V24, P957, DOI 10.3892/or_00000942; Li HL, 2012, ASIAN PAC J CANCER P, V13, P1425, DOI 10.7314/APJCP.2012.13.4.1425; Li ZG, 2012, ONCOL LETT, V4, P677, DOI 10.3892/ol.2012.790; Lindsay J, 2011, BBA-MOL CELL RES, V1813, P532, DOI 10.1016/j.bbamcr.2010.10.017; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Thamilselvan V, 2011, INT J CANCER, V129, P2916, DOI 10.1002/ijc.25949; Wang Y, 2013, MOL CLIN ONCOL, V1, P215, DOI 10.3892/mco.2012.36; Yang YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054736, 10.1371/journal.pone.0055384, 10.1371/journal.pone.0067755]	17	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145780	10.1371/journal.pone.0145780	http://dx.doi.org/10.1371/journal.pone.0145780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745145	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600015
J	Kobayashi, N; Shinagawa, S; Nagata, T; Shimada, K; Shibata, N; Ohnuma, T; Kasanuki, K; Arai, H; Yamada, H; Nakayama, K; Kondo, K				Kobayashi, Nobuyuki; Shinagawa, Shunichiro; Nagata, Tomoyuki; Shimada, Kazuya; Shibata, Nobuto; Ohnuma, Tohru; Kasanuki, Koji; Arai, Heii; Yamada, Hisashi; Nakayama, Kazuhiko; Kondo, Kazuhiro			Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment	PLOS ONE			English	Article							FRONTAL ASSESSMENT BATTERY; EXECUTIVE FUNCTION; ASSOCIATION; METAANALYSIS; DEMENTIA; BRAIN; POLYMORPHISM; POPULATION; PREVALENCE; PATHOLOGY	From the standpoint of early interventions for dementia, a convenient method of diagnosis using biomarkers is required for Alzheimer's disease (AD) in the early stage as well as amnesic mild cognitive impairment (aMCI). Focusing on differences in DNA methylation due to AD and aMCI, in the present study, we first conducted genome-wide screening, measuring blood DNA methylation levels by the Illumina Infinium HD Methylation Assay in 3 small age-and gender-matched groups consisting of 4 subjects each: normal controls (NC), aMCI and AD. The genome-wide analysis produced 11 DNA methylation loci that distinguished the 3 groups. For confirmation, we increased group sizes and examined samples by pyrosequencing which revealed that DNA methylation in the NCAPH2/LMF2 promoter region was significantly decreased in the AD (n = 30) and aMCI (n = 28) groups as compared to the NC group (n = 30) (P < 0.0001, ANCOVA). No association was found between methylation levels and APOE genotype. NCAPH2/LMF2 methylation levels were considered to potentially be a convenient and useful biomarker for diagnosis of AD and aMCI.	[Kobayashi, Nobuyuki; Shimada, Kazuya; Kondo, Kazuhiro] Jikei Univ, Sch Med, Dept Virol, Tokyo, Japan; [Shinagawa, Shunichiro; Nagata, Tomoyuki; Nakayama, Kazuhiko] Jikei Univ, Sch Med, Dept Psychiat, Tokyo, Japan; [Nagata, Tomoyuki; Yamada, Hisashi] Jikei Univ, Sch Med, Div Mol Genet, Tokyo, Japan; [Shibata, Nobuto; Ohnuma, Tohru; Kasanuki, Koji; Arai, Heii] Juntendo Univ, Sch Med, Dept Psychiat, Tokyo 113, Japan	Jikei University; Jikei University; Jikei University; Juntendo University	Kobayashi, N (corresponding author), Jikei Univ, Sch Med, Dept Virol, Tokyo, Japan.	kobayashi-n@jikei.ac.jp	Ohnuma, Tohru/AAN-2363-2020; Shibata, Nobuto/AAB-9366-2020; Kobayashi, Nobuyuki/AAS-9795-2021	Kobayashi, Nobuyuki/0000-0001-8627-515X; Ohnuma, Tohru/0000-0003-1522-3832; dao tian, he ye/0000-0003-1471-8067	Japan Society for the Promotion of Science (JSPS) [25893251]; Jikei University Research Fund; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [S1201032]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Jikei University Research Fund(Jikei University); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The present work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 25893251, TN, https://www.jsps.go.jp/j-grantsinaid/), the Jikei University Research Fund (SS, http://www.jikei.ac.jp), The Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (grant number S1201032, co-researcher: K. Kondo, http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisch RS, 2014, J NEUROSCI, V34, P15548, DOI 10.1523/JNEUROSCI.3338-14.2014; Baudic S, 2006, ARCH CLIN NEUROPSYCH, V21, P15, DOI 10.1016/j.acn.2005.07.002; Candiloro ILM, 2011, EPIGENETICS-US, V6, P501, DOI 10.4161/epi.6.4.14853; Cure S, 2014, J ALZHEIMERS DIS, V42, P169, DOI 10.3233/JAD-131559; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Kawai E, 2015, NEUROMOL MED, V17, P170, DOI 10.1007/s12017-015-8348-8; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Lashley T, 2015, NEUROPATH APPL NEURO, V41, P497, DOI 10.1111/nan.12183; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nagata T, 2015, DEMENT GER COGN D EX, V5, P64, DOI 10.1159/000375367; Nagata T, 2012, DEMENT GERIATR COGN, V33, P266, DOI 10.1159/000339358; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Ossenkoppele R, 2015, JAMA-J AM MED ASSOC, V313, P1939, DOI 10.1001/jama.2015.4669; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; REISBERG B, 1987, J CLIN PSYCHIAT, V48, P9; Ringman JM, 2009, CURR ALZHEIMER RES, V6, P341, DOI 10.2174/156720509788929336; Ritchie C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008782.pub4; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; Yamao A, 2011, PSYCHOGERIATRICS, V11, P235, DOI 10.1111/j.1479-8301.2011.00377.x; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049	30	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146449	10.1371/journal.pone.0146449	http://dx.doi.org/10.1371/journal.pone.0146449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26742120	Green Submitted, Green Published, gold			2022-12-27	WOS:000367810600045
J	McNamee, AP; Sabapathy, S; Singh, I; Horobin, J; Guerrero, J; Simmonds, MJ				McNamee, Antony P.; Sabapathy, Surendran; Singh, Indu; Horobin, Jarod; Guerrero, Janelle; Simmonds, Michael J.			Acute Free-Iron Exposure Does Not Explain the Impaired Haemorheology Associated with Haemochromatosis	PLOS ONE			English	Article							RED-BLOOD-CELLS; HEREDITARY HEMOCHROMATOSIS; OXIDATIVE STRESS; MUTATION; C282Y; RISK; AGGREGATION; HOMEOSTASIS; RHEOLOGY; RELEASE	Introduction Given the severity of the current imbalance between blood donor supply and recipient demand, discarded blood drawn from the routine venesections of haemochromatosis (HFE-HH) patients may serve as a valuable alternative source for blood banks and transfusion. We investigated whether functional or biochemical differences existed between HFE-HH and control blood samples, with particular focus upon the haemorheological properties, to investigate the viability of venesected blood being subsequently harvested for blood products. Methods Blood samples were collected from HFE-HH patients undergoing venesection treatment (n = 19) and healthy volunteers (n = 8). Moreover, a second experiment investigated the effects of a dose-response of iron (0, 40, 80, 320 mM FeCl3) on haemorheology in healthy blood samples (n = 7). Dependent variables included basic haematology, iron status, haematocrit, red blood cell (RBC) aggregation (native and standardised haematocrit) and "aggregability" (RBC tendency to aggregate in a standard aggregating medium; 0.4 L/L haematocrit in a Dx70), and RBC deformability. Results Indices of RBC deformability were significantly decreased for HFE-HH when compared with healthy controls: RBC deformability was significantly decreased at 1-7 Pa (p < 0.05), and the shear stress required for half maximal deformability was significantly increased (p < 0.05) for HFE-HH. RBC aggregation in plasma was significantly increased (p < 0.001) for HFE-HH, although when RBC were suspended in plasma-free Dx70 no differences were detected. No differences in RBC deformability or RBC aggregation/aggregability were detected when healthy RBC were incubated with varying dose of FeCl3. Conclusion HFE-HH impairs the haemorheological properties of blood; however, RBC aggregability was similar between HFE-HH and controls when cells were suspended in a plasma-free medium, indicating that plasma factor(s) may explain the altered haemorheology in HFEHH patients. Acute exposure to elevated iron levels does not appear (in isolation) to account for these differences. Further consideration is required prior to utilising routine venesection blood for harvesting RBC concentrates due to the potential risk of microvascular disorders arising from impaired haemorheology.	[McNamee, Antony P.; Horobin, Jarod] Griffith Univ, Sch Allied Hlth Sci, Nathan, Qld 4111, Australia; [Sabapathy, Surendran; Simmonds, Michael J.] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld 4111, Australia; [Singh, Indu; Guerrero, Janelle] Griffith Univ, Sch Med Sci, Nathan, Qld 4111, Australia	Griffith University; Griffith University; Griffith University	Simmonds, MJ (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld 4111, Australia.	mike@thesimmonds.id.au	; Simmonds, Michael/U-9339-2017	Sabapathy, Surendran/0000-0003-1267-6035; Singh, Indu/0000-0002-0498-4209; Horobin, Jarod/0000-0002-9684-1562; Simmonds, Michael/0000-0001-8145-6787				Adams PC, 2010, BLOOD, V116, P317, DOI 10.1182/blood-2010-01-261875; Baskurt OK, 2009, SCAND J CLIN LAB INV, V69, P777, DOI 10.3109/00365510903266069; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Camaschella C, 2005, BLOOD, V106, P3710, DOI 10.1182/blood-2005-05-1857; Ciccoli L, 1999, FREE RADICAL RES, V30, P407, DOI 10.1080/10715769900300441; Comporti M, 2002, FREE RADICAL BIO MED, V32, P568, DOI 10.1016/S0891-5849(02)00759-1; Emanuele D, 2014, J AM ASSOC NURSE PRA, V26, P113, DOI 10.1002/2327-6924.12106; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Gaenzer H, 2002, J AM COLL CARDIOL, V40, P2189, DOI 10.1016/S0735-1097(02)02611-6; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; Ghoti H, 2007, EUR J HAEMATOL, V79, P463, DOI 10.1111/j.1600-0609.2007.00972.x; Halis H, 2009, PEDIATR HEMAT ONCOL, V26, P108, DOI 10.1080/08880010902754909; KIRKING MH, 1991, CLIN PHARMACY, V10, P775; Lekakis J, 1999, VASC MED, V4, P147, DOI 10.1191/135886399675689098; Lipinski B, 2012, ULTRASTRUCT PATHOL, V36, P79, DOI 10.3109/01913123.2011.627491; Lynch S, 2012, PLATELETS, V23, P611, DOI 10.3109/09537104.2011.634933; Masser B, 2010, TRANSFUS APHER SCI, V43, P291, DOI 10.1016/j.transci.2010.09.017; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; Pankow JS, 2008, TRANSL RES, V152, P3, DOI 10.1016/j.trsl.2008.05.005; Peterlin B, 2003, J HUM GENET, V48, P646, DOI 10.1007/s10038-003-0094-3; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pretorius E, 2013, BLOOD, V121, P9, DOI 10.1182/blood-2012-09-454793; Pretorius E, 2014, INTEGR BIOL-UK, V6, P486, DOI 10.1039/c4ib00025k; Pretorius E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085271; Pretorius E, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-63; Schmid-Schonbein H, 1977, Bibl Anat, P484; Simmonds MJ, 2013, J GERIATR CARDIOL, V10, P291, DOI 10.3969/j.issn.1671-5411.2013.03.010; Simmonds MJ, 2011, BIORHEOLOGY, V48, P293, DOI 10.3233/BIR-2012-0599; Simmonds MJ, 2010, CLIN HEMORHEOL MICRO, V46, P57, DOI 10.3233/CH-2010-1333; Sousa L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132852; Swaminathan S, 2007, DIABETES CARE, V30, P1926, DOI 10.2337/dc06-2625; Toner RW, 2011, APPL HEALTH ECON HEA, V9, P29, DOI 10.2165/11530740-000000000-00000; Waters JR, 2007, ANESTH ANALG, V104, P869, DOI 10.1213/01.ane.0000258039.79028.7c; Zamboni P, 2005, J VASC SURG, V42, P309, DOI 10.1016/j.jvs.2005.04.003; Zimmermann J, 1996, CLIN NEPHROL, V46, P230	36	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146448	10.1371/journal.pone.0146448	http://dx.doi.org/10.1371/journal.pone.0146448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741993	gold, Green Published, Green Submitted			2022-12-27	WOS:000367810600044
J	Kuo, TT; Lee, MR; Liao, YY; Chen, JP; Hsu, YW; Yeh, CK				Kuo, Tai-Tzung; Lee, Ming-Ru; Liao, Yin-Yin; Chen, Jiann-Perng; Hsu, Yen-Wei; Yeh, Chih-Kuang			Assessment of Median Nerve Mobility by Ultrasound Dynamic Imaging for Diagnosing Carpal Tunnel Syndrome	PLOS ONE			English	Article							SUBSYNOVIAL CONNECTIVE-TISSUE; CROSS-SECTIONAL AREA; MAGNETIC-RESONANCE NEUROGRAPHY; HIGH-RESOLUTION SONOGRAPHY; PRACTICE PARAMETER; FLEXOR TENDON; LONGITUDINAL EXCURSION; PERIPHERAL-NERVES; MOTION; STRAIN	Carpal tunnel syndrome (CTS) is the most common peripheral neuropathy and is characterized by median nerve entrapment at the wrist and the resulting median nerve dysfunction. CTS is diagnosed clinically as the gold standard and confirmed with nerve conduction studies (NCS). Complementing NCS, ultrasound imaging could provide additional anatomical information on pathological and motion changes of the median nerve. The purpose of this study was to estimate the transverse sliding patterns of the median nerve during finger movements by analyzing ultrasound dynamic images to distinguish between normal subjects and CTS patients. Transverse ultrasound images were acquired, and a speckle-tracking algorithm was used to determine the lateral displacements of the median nerve in radial-ulnar plane in B-mode images utilizing the multilevel block-sum pyramid algorithm and averaging. All of the averaged lateral displacements at separate acquisition times within a single flexion-extension cycle were accumulated to obtain the cumulative lateral displacements, which were curve-fitted with a second-order polynomial function. The fitted curve was regarded as the transverse sliding pattern of the median nerve. The R-2 value, curvature, and amplitude of the fitted curves were computed to evaluate the goodness, variation and maximum value of the fit, respectively. Box plots, the receiver operating characteristic (ROC) curve, and a fuzzy c-means clustering algorithm were utilized for statistical analysis. The transverse sliding of the median nerve during finger movements was greater and had a steeper fitted curve in the normal subjects than in the patients with mild or severe CTS. The temporal changes in transverse sliding of the median nerve within the carpal tunnel were found to be correlated with the presence of CTS and its severity. The representative transverse sliding patterns of the median nerve during finger movements were demonstrated to be useful for quantitatively estimating median nerve dysfunction in CTS patients.	[Kuo, Tai-Tzung; Lee, Ming-Ru; Liao, Yin-Yin; Yeh, Chih-Kuang] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Kuo, Tai-Tzung] Hsin Chu Mackay Mem Hosp, Dept Neurosurg, Hsinchu, Taiwan; [Liao, Yin-Yin] Hungkuang Univ, Dept Biomed Engn, Taichung, Taiwan; [Chen, Jiann-Perng] Hsin Chu Mackay Mem Hosp, Dept Phys, Hsinchu, Taiwan; [Hsu, Yen-Wei] Hsin Chu Mackay Mem Hosp, Dept Neurol, Hsinchu, Taiwan	National Tsing Hua University; Mackay Memorial Hospital; Hungkuang University; Mackay Memorial Hospital; Mackay Memorial Hospital	Yeh, CK (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	ckyeh@mx.nthu.edu.tw		Yeh, Chih-Kuang/0000-0002-2880-6327	Ministry of Science and Technology, Taiwan [102-2221-E-007-020-MY3]; National Tsing Hua University [102N2745E1]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University	This work was funded by Ministry of Science and Technology, Taiwan, under Grants 102-2221-E-007-020-MY3, and National Tsing Hua University under Grant 102N2745E1.; The authors gratefully acknowledge the support of the Ministry of Science and Technology, Taiwan under Grants 102-2221-E-007-020-MY3 and National Tsing Hua University under Grant 102N2745E1.	ALTROCCHI PH, 1993, NEUROLOGY, V43, P2406; American Academy of Orthopaedic Surgeons Work Group Panel, 2007, CLIN GUID DIAGN CARP; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Beekman R, 2003, MUSCLE NERVE, V27, P26, DOI 10.1002/mus.10227; BUCHBERGER W, 1991, J ULTRAS MED, V10, P531, DOI 10.7863/jum.1991.10.10.531; BUCHBERGER W, 1992, AM J ROENTGENOL, V159, P793, DOI 10.2214/ajr.159.4.1529845; Buschbacher RM, 2006, MANUAL NERVE CONDUCT, V2nd; Dilley A, 2001, ULTRASOUND MED BIOL, V27, P1211, DOI 10.1016/S0301-5629(01)00413-6; Duncan I, 1999, AM J ROENTGENOL, V173, P681, DOI 10.2214/ajr.173.3.10470903; Erel E, 2003, J HAND SURG-BRIT EUR, V28B, P439, DOI 10.1016/S0266-7681(03)00107-4; Ettema AM, 2004, J BONE JOINT SURG AM, V86A, P1458, DOI 10.2106/00004623-200407000-00014; Ettema AM, 2007, CLIN ANAT, V20, P292, DOI 10.1002/ca.20379; Filler AG, 2004, NEUROL CLIN, V22, P643, DOI 10.1016/j.ncl.2004.03.005; Filler AG, 1996, J NEUROSURG, V85, P299, DOI 10.3171/jns.1996.85.2.0299; Fowler JR, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01250; Fowler JR, 2011, CLIN ORTHOP RELAT R, V469, P1089, DOI 10.1007/s11999-010-1637-5; Freeland AE, 2002, MICROSURG, V22, P378, DOI 10.1002/micr.10065; Gellberman RH, 1992, SCAND J PLAST RECONS, V26, P257; Guimberteau JC, 2001, AQUITAINE DOMAINE; Hammer HB, 2006, RHEUMATOLOGY, V45, P584, DOI 10.1093/rheumatology/kei218; Hobson-Webb LD, 2008, CLIN NEUROPHYSIOL, V119, P1353, DOI 10.1016/j.clinph.2008.01.101; Horch RE, 1997, NEUROSURGERY, V41, P76, DOI 10.1097/00006123-199707000-00016; Hough AD, 2000, J HAND SURG-BRIT EUR, V25B, P585, DOI 10.1054/jhsb.2000.0453; Hough AD, 2007, ARCH PHYS MED REHAB, V88, P569, DOI 10.1016/j.apmr.2007.02.015; HOWE FA, 1994, BRIT J RADIOL, V67, P1169, DOI 10.1259/0007-1285-67-804-1169; Ibrahim I, 2012, Open Orthop J, V6, P69, DOI 10.2174/1874325001206010069; Jablecki CK, 2002, MUSCLE NERVE, V25, P918, DOI 10.1002/mus.10185; Jablecki CK, 2002, NEUROLOGY, V58, P1589, DOI 10.1212/WNL.58.11.1589; Jarvik JG, 2008, J NEUROSURG, V108, P541, DOI 10.3171/JNS/2008/108/3/0541; Kele H, 2003, NEUROLOGY, V61, P389, DOI 10.1212/01.WNL.0000073101.04845.22; Klauser AS, 2009, RADIOLOGY, V250, P171, DOI 10.1148/radiol.2501080397; Kleindienst A, 1996, ACTA NEUROCHIR, V138, P228, DOI 10.1007/BF01411366; Korstanje JWH, 2012, MUSCLE NERVE, V45, P721, DOI 10.1002/mus.23246; Kouyoumdjian JA, 1999, ARQ NEURO-PSIQUIAT, V57, P382, DOI 10.1590/S0004-282X1999000300007; Koyuncuoglu HR, 2005, EUR J RADIOL, V56, P365, DOI 10.1016/j.ejrad.2005.05.013; Kwon BC, 2008, J HAND SURG-AM, V33A, P65, DOI 10.1016/j.jhsa.2007.10.014; Lee D, 1999, RADIOL CLIN N AM, V37, P859, DOI 10.1016/S0033-8389(05)70132-9; Li PC, 2002, ULTRASONIC IMAGING, V24, P215, DOI 10.1177/016173460202400402; Li PC, 2002, IEEE T ULTRASON FERR, V49, P39, DOI 10.1109/58.981382; Liao YY, 2015, RADIOLOGY, V275, P205, DOI 10.1148/radiol.14140017; Liao YY, 2012, MED PHYS, V39, P7402, DOI 10.1118/1.4767754; Liao YY, 2012, MED PHYS, V39, P2325, DOI 10.1118/1.3700167; LLUCH AL, 1992, J HAND SURG-BRIT EUR, V17B, P209, DOI 10.1016/0266-7681(92)90091-F; Lopes MM, 2011, CLIN BIOMECH, V26, P930, DOI 10.1016/j.clinbiomech.2011.03.014; MCLELLAN DL, 1976, J NEUROL NEUROSUR PS, V39, P566, DOI 10.1136/jnnp.39.6.566; Moran L, 2009, J CLIN ULTRASOUND, V37, P125, DOI 10.1002/jcu.20551; Nakamichi K, 1998, J HAND SURG-AM, V23A, P1015, DOI 10.1016/S0363-5023(98)80009-9; NAKAMICHI K, 1992, J HAND SURG-BRIT EUR, V17B, P213, DOI 10.1016/0266-7681(92)90092-G; NAKAMICHI K, 1995, J HAND SURG-BRIT EUR, V20B, P460, DOI 10.1016/S0266-7681(05)80153-6; Nakamichi KI, 2000, MUSCLE NERVE, V23, P1713, DOI 10.1002/1097-4598(200011)23:11<1713::AID-MUS7>3.3.CO;2-7; NEAL NC, 1987, J HAND SURG-BRIT EUR, V12B, P229, DOI 10.1016/0266-7681(87)90020-9; Osamura N, 2007, CLIN BIOMECH, V22, P999, DOI 10.1016/j.clinbiomech.2007.07.009; Padua L, 2008, CLIN NEUROPHYSIOL, V119, P2064, DOI 10.1016/j.clinph.2008.05.004; Paget J., 1854, LECT SURG PATHOLOGY, V2nd ed.; Radack DM, 1997, AM J ROENTGENOL, V169, P1649, DOI 10.2214/ajr.169.6.9393185; Sarria L, 2000, EUR RADIOL, V10, P1920, DOI 10.1007/s003300000502; SZABO RM, 1994, J HAND SURG-AM, V19A, P901, DOI 10.1016/0363-5023(94)90087-6; Tucci M A, 1997, Biomed Sci Instrum, V33, P246; van Doesburg MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037081; van Doesburg MHM, 2010, J ORTHOP RES, V28, P1387, DOI 10.1002/jor.21131; Visser LH, 2008, J NEUROL NEUROSUR PS, V79, P63, DOI 10.1136/jnnp.2007.115337; Wiesler ER, 2006, J HAND SURG-AM, V31A, P726, DOI 10.1016/j.jhsa.2006.01.020; WILGIS EFS, 1986, HAND CLIN, V2, P761; Witt JC, 2004, MUSCLE NERVE, V29, P515, DOI 10.1002/mus.20019; Wong SM, 2004, RADIOLOGY, V232, P93, DOI 10.1148/radiol.2321030071; Wright TW, 1996, J BONE JOINT SURG AM, V78A, P1897, DOI 10.2106/00004623-199612000-00013; Yesildag A, 2004, CLIN RADIOL, V59, P910, DOI 10.1016/j.crad.2004.03.020; Yoshii YC, 2011, J ORTHOP RES, V29, P62, DOI 10.1002/jor.21181; Yoshii Y, 2009, J BONE JOINT SURG AM, V91A, P2922, DOI 10.2106/JBJS.H.01653; Ziswiler HR, 2005, ARTHRITIS RHEUM-US, V52, P304, DOI 10.1002/art.20723	70	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147051	10.1371/journal.pone.0147051	http://dx.doi.org/10.1371/journal.pone.0147051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764488	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300062
J	de Sa, FP; Zina, J; Haddad, CFB				de Sa, Fabio P.; Zina, Juliana; Haddad, Celio F. B.			Sophisticated Communication in the Brazilian Torrent Frog Hylodes japi	PLOS ONE			English	Article							WATER-WAVE COMMUNICATION; ACOUSTIC COMMUNICATION; MULTIMODAL COURTSHIP; SOCIAL INTERACTIONS; WESTERN-GHATS; STREAM FROG; VOCAL SAC; ANURA; BEHAVIOR; SIGNALS	Intraspecific communication in frogs plays an important role in the recognition of conspecifics in general and of potential rivals or mates in particular and therefore with relevant consequences for pre-zygotic reproductive isolation. We investigate intraspecific communication in Hylodes japi, an endemic Brazilian torrent frog with territorial males and an elaborate courtship behavior. We describe its repertoire of acoustic signals as well as one of the most complex repertoires of visual displays known in anurans, including five new visual displays. Previously unknown in frogs, we also describe a bimodal inter-sexual communication system where the female stimulates the male to emit a courtship call. As another novelty for frogs, we show that in addition to choosing which limb to signal with, males choose which of their two vocal sacs will be used for visual signaling. We explain how and why this is accomplished. Control of inflation also provides additional evidence that vocal sac movement and color must be important for visual communication, even while producing sound. Through the current knowledge on visual signaling in Neotropical torrent frogs (i.e. hylodids), we discuss and highlight the behavioral diversity in the family Hylodidae. Our findings indicate that communication in species of Hylodes is undoubtedly more sophisticated than we expected and that visual communication in anurans is more widespread than previously thought. This is especially true in tropical regions, most likely due to the higher number of species and phylogenetic groups and/or to ecological factors, such as higher microhabitat diversity.	[de Sa, Fabio P.; Haddad, Celio F. B.] Univ Estadual Paulista, Dept Zool, Lab Herpetol, Sao Paulo, Brazil; [Zina, Juliana] Univ Estadual Sudoeste Bahia, Dept Ciencias Biol, Jequie, BA, Brazil	Universidade Estadual Paulista; Universidade Estadual do Sudoeste da Bahia	de Sa, FP (corresponding author), Univ Estadual Paulista, Dept Zool, Lab Herpetol, Sao Paulo, Brazil.	fperin.sa@gmail.com	de Sá, Fábio Perin/G-4284-2012; Haddad, Célio F. B./C-4267-2012; Zina, Juliana/G-6202-2012	de Sá, Fábio Perin/0000-0002-3830-6422; Haddad, Célio F. B./0000-0002-7044-5764; 	Sao Paulo Research Foundation (FAPESP) [2010/14117-9, 2008/50928-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded to FPS by the Master fellowship # 2010/14117-9, Sao Paulo Research Foundation (FAPESP), and to CFBH by the grant # 2008/50928-1, Sao Paulo Research Foundation (FAPESP), and by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). Sao Paulo Research Foundation: http://www.fapesp.br/. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico: http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 1992, HIST NATURAL SERRA J; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Arch VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005413; Beltramin A S, 2014, THESIS; Biju S.D., 2014, Ceylon Journal of Science Biological Sciences, V43, P37; Boeckle M, 2009, HERPETOLOGICA, V65, P154, DOI 10.1655/07-071R1.1; Bradbury Jack W., 1998, pi; Caldart VM, 2014, BEHAVIOUR, V151, P719, DOI 10.1163/1568539X-00003165; Caldwell MS, 2010, CURR BIOL, V20, P1012, DOI 10.1016/j.cub.2010.03.069; da Silva HR, 2008, REV BRAS ZOOL, V25, P89, DOI 10.1590/S0101-81752008000100013; Dalziell AH, 2013, CURR BIOL, V23, P1132, DOI 10.1016/j.cub.2013.05.018; de Sa FP, 2015, HERPETOLOGICA, V71, P58, DOI 10.1655/HERPETOLOGICA-D-13-00053; Dorcas M.E., 2009, AMPHIBIAN ECOLOGY CO, P281; Faria D M, 1993, LIVRO DE RESUMOS, P150; Filho Julio C. de Oliveira, 2008, Iheringia Serie Zoologia, V98, P508; Forti Lucas Rodriguez, 2012, Herpetological Bulletin, P17; Forti LR, 2013, J NAT HIST, V47, P2363, DOI 10.1080/00222933.2013.773099; Frost D R, 2015, AM MUSEUM NATURAL HI; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Giasson LOM, 2006, J HERPETOL, V40, P171, DOI 10.1670/205-05A.1; Gomez D, 2011, BIOL J LINN SOC, V103, P633, DOI 10.1111/j.1095-8312.2011.01662.x; Grafe TU, 2007, ETHOLOGY, V113, P772, DOI 10.1111/j.1439-0310.2007.01378.x; Grafe TU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037965; Grant T., 2006, B AM MUS NAT HIST, V299, P1, DOI DOI 10.1206/0003-0090(2006)299[; Gururaja Kotambylu Vasudeva, 2010, Zootaxa, V2642, P45; Haddad C.F.B., 1992, HIST NATURAL SERRA J, P188; Haddad CFB, 2005, AMPHIBIA-REPTILIA, V26, P87, DOI 10.1163/1568538053693224; Haddad CFB, 1999, HERPETOLOGICA, V55, P324; Haddad CFB, 2000, BIOTROPICA, V32, P862; Halfwerk W, 2014, CURR BIOL, V24, P1751, DOI 10.1016/j.cub.2014.05.068; Hartmann Marília T., 2006, Pap. Avulsos Zool. (São Paulo), V46, P203, DOI 10.1590/S0031-10492006001700001; Hartmann MT, 2005, J NAT HIST, V39, P1675, DOI 10.1080/00222930400008744; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hebets EA, 2013, BEHAV ECOL SOCIOBIOL, V67, P1483, DOI 10.1007/s00265-013-1519-4; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; Hodl W., 1997, FOOT FLAGGING DISPLA; Hoedl Walter, 2001, P121; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Krishna SN, 2006, AMPHIBIA-REPTILIA, V27, P143, DOI 10.1163/156853806776052056; Lee JSF, 2002, COPEIA, P679; Lehner PN, 1996, HDB ETHOLOGICAL METH; Leitao-Filho HL., 1992, HIST NATURAL SERRA J, P40; Lindquist Erik D., 1998, Animal Cognition, V1, P83, DOI 10.1007/s100710050012; Lingnau R, 2003, THESIS; Lingnau R, 2008, COPEIA, P595, DOI 10.1643/CH-07-091; Lingnau R, 2007, J NAT HIST, V41, P1227, DOI 10.1080/00222930701395626; Lingnau R, 2013, STUD NEOTROP FAUNA E, V48, P76, DOI 10.1080/01650521.2013.788285; MARTINS M, 1988, Revista Brasileira de Biologia, V48, P969; Maruska KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037612; Mclennan DA, 2003, BIOL J LINN SOC, V80, P555, DOI 10.1111/j.1095-8312.2003.00254.x; Montanarin A, 2011, ETHOL ECOL EVOL, V23, P141, DOI 10.1080/03949370.2011.554884; Narins P.M., 2006, HEARING SOUND COMMUN, DOI DOI 10.1007/978-0-387-47796-1; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; Narvaes P, 1997, THESIS; Narvaes Patricia, 2005, Phyllomedusa, V4, P147; Partan SR, 2010, CURR ZOOL, V56, P313, DOI 10.1093/czoolo/56.3.313; Partan SR, 2009, ANIM BEHAV, V77, P1127, DOI 10.1016/j.anbehav.2008.12.029; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Pavan Dante, 2001, Papeis Avulsos de Zoologia (Sao Paulo), V41, P407; POMBAL JP, 1994, J HERPETOL, V28, P516, DOI 10.2307/1564972; Preininger D, 2013, CURR SCI INDIA, V105, P1735; Preininger D, 2013, BEHAV ECOL SOCIOBIOL, V67, P1449, DOI 10.1007/s00265-013-1489-6; Preininger D, 2009, HERPETOLOGICA, V65, P166, DOI 10.1655/08-037R.1; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rosenthal GG, 2004, ANIM BEHAV, V68, P55, DOI 10.1016/j.anbehav.2003.07.013; SEIBT U, 1977, Z TIERPSYCHOL, V43, P180; Seidel B, 2001, ADV SPACE RES, V28, P589, DOI 10.1016/S0273-1177(01)00386-6; Seidel B, 1999, J HERPETOL, V33, P457, DOI 10.2307/1565643; Starnberger I, 2014, ANIM BEHAV, V97, P281, DOI 10.1016/j.anbehav.2014.07.027; Starnberger I, 2011, HERPETOLOGICA, V67, P124, DOI 10.1655/HERPETOLOGICA-D-10-00017.1; Summers K, 2014, CURR ZOOL, V60, P37, DOI 10.1093/czoolo/60.1.37; Taylor PW, 2005, J ETHOL, V23, P71, DOI 10.1007/s10164-004-0129-z; Taylor RC, 2008, ANIM BEHAV, V76, P1089, DOI 10.1016/j.anbehav.2008.01.031; Tyler M. J., 1971, R Trans R Soc S Aust, V95, P49; Vasconcellos-Neto J, 2012, NOVOS OLHARES NOVOS; Vasudevan Karthikeyan, 2001, Cobra (Chennai), V44, P25; Waldman B, 2004, BEHAV ECOL, V15, P88, DOI 10.1093/beheco/arg071; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; WEYGOLDT P, 1992, Amphibia-Reptilia, V13, P35, DOI 10.1163/156853892X00210; Wogel H, 2004, AMPHIBIA-REPTILIA, V25, P219, DOI 10.1163/1568538041231184; Zina Juliana, 2007, Herpetological Review, V38, P282	82	30	31	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145444	10.1371/journal.pone.0145444	http://dx.doi.org/10.1371/journal.pone.0145444			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760304	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100015
J	Fu, TS; Jing, RW; Fu, WW; Cusimano, MD				Fu, Terence S.; Jing, Ruwei; Fu, Wayne W.; Cusimano, Michael D.			Epidemiological Trends of Traumatic Brain Injury Identified in the Emergency Department in a Publicly-Insured Population, 2002-2010	PLOS ONE			English	Article							UNITED-STATES; VISITS; CONCUSSIONS; ADMISSION	Objectives To examine epidemiological trends of Traumatic Brain Injury (TBI) treated in the Emergency Department (ED), identify demographic groups at risk of TBI, and determine the factors associated with hospitalization following an ED visit for TBI. Methods A province-wide database was used to identify all ED visits for TBI in Ontario, Canada between April 2002 and March 2010. Trends were analyzed using linear regression, and predictors of hospital admission were evaluated using logistic regression. Results There were 986,194 ED visits for TBI over the eight-year study period, resulting in 49,290 hospitalizations and 1,072 deaths. The age- and sex-adjusted rate of TBI decreased by 3%, from 1,013.9 per 100,000 (95% CI 1,008.3-1,010.6) to 979.1 per 100,000 (95% CI 973.7-984.4; p = 0.11). We found trends towards increasing age, comorbidity level, length of stay, and ambulatory transport use. Children and young adults (ages 5-24) sustained peak rates of motor vehicle crash (MVC) and bicyclist-related TBI, but also experienced the greatest decline in these rates (p = 0.003 and p = 0.005). In contrast, peak rates of fall-related TBI occurred among the youngest (ages 0-4) and oldest (ages 85+) segments of the population, but rates remained stable over time (p = 0.52 and 0.54). The 5-24 age group also sustained the highest rates of sports-related TBI but rates remained stable (p = 0.80). On multivariate analysis, the odds of hospital admission decreased by 1% for each year over the study period (OR = 0.991, 95% CI = 0.987-0.995). Increasing age and comorbidity, male sex, and ambulatory transport were significant predictors of hospital admission. Conclusions ED visits for TBI are involving older populations with increasingly complex comorbidities. While TBI rates are either stable or declining among vulnerable groups such as young drivers, youth athletes, and the elderly, these populations remain key targets for focused injury prevention and surveillance. Clinicians in the ED setting should be cognizant of factors associated with hospitalization following TBI.	[Fu, Terence S.; Jing, Ruwei; Fu, Wayne W.; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Fu, Terence S.; Jing, Ruwei; Fu, Wayne W.; Cusimano, Michael D.] Univ Toronto, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto	Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Cusimano, Michael/GWR-1025-2022		Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research [TIR-103946]; Ontario Neurotrauma Foundation	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research (#TIR-103946), and the Ontario Neurotrauma Foundation.	Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Cameron ID, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub3; Canadian Institute of Health Information (CIHI), 2008, DAT QUAL STUD EM DEP, VII; Canadian Institute of Health Information (CIHI), 2006, HEAD INJ CAN DEC CHA; Centers for Disease Control and Prevention,, 2014, DAT STAT WISQARS COS; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CIHI, 2007, BURD NEUR DIS DIS IN; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fingerhut L, 2002, EXTERNAL CAUSES INJU; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fu TS, 2015, CAN J NEURO IN PRESS; Gillespie LD, 2012, COCHRANE DB SYST REV; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hanson HR, 2013, PEDIATRICS, V132, pE859, DOI 10.1542/peds.2013-1704; Klein KS, 2005, INJURY PREV, V11, P288, DOI 10.1136/ip.2004.007013; Macpherson A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub2; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayhew D.R., 2005, BEST PRACTICES GRADU; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Ponsky TA, 2005, J TRAUMA, V59, P1292, DOI 10.1097/01.ta.0000197439.19171.25; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Russell KF, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003300.pub3; Schull MJ, 2012, ACAD EMERG MED, V19, P828, DOI 10.1111/j.1553-2712.2012.01396.x; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Simniceanu A, 2014, TRAFFIC INJ PREV, V15, P734, DOI 10.1080/15389588.2013.867483; Solomon R, 2014, CAN PUBLIC POL, V40, P15, DOI 10.3138/cpp.2012-102; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	33	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145469	10.1371/journal.pone.0145469	http://dx.doi.org/10.1371/journal.pone.0145469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760779	Green Published, gold			2022-12-27	WOS:000368033100017
J	Guo, L; Peng, W; Tao, J; Lan, Z; Hei, HY; Tian, LL; Pan, WM; Wang, L; Zhang, XM				Guo, Lin; Peng, Wen; Tao, Jie; Lan, Zhen; Hei, Hongya; Tian, Lulu; Pan, Wanma; Wang, Li; Zhang, Xuemei			Hydrogen Sulfide Inhibits Transforming Growth Factor-beta 1-Induced EMT via Wnt/Catenin Pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA SIGNALING PATHWAYS; E-CADHERIN; CATENIN; INVASION	Hydrogen sulfide (H2S) has anti-fibrotic potential in lung, kidney and other organs. The exogenous H2S is released from sodium hydrosulfide (NaHS) and can influence the renal fibrosis by blocking the differentiation of quiescent renal fibroblasts to myofibroblasts. But whether H2S affects renal epithelial-to-mesenchymal transition (EMT) and the underlying mechanisms remain unknown. Our study is aimed at investigating the in vitro effects of H2S on transforming growth factor-beta 1 (TGF-beta 1)-induced EMT in renal tubular epithelial cells (HK-2 cells) and the associated mechanisms. The induced EMT is assessed by Western blotting analysis on the expressions of alpha-SMA, E-cadherin and fibronectin. HK-2 cells were treated with NaHS before incubating with TGF-beta 1 to investigate its effect on EMT and the related molecular mechanism. Results demonstrated that NaHS decreased the expression of alpha-SMA and fibronectin, and increased the expression of E-cadherin. NaHS reduced the expression of TGF-beta receptor type I (T beta R I) and TGF-beta receptor type II (T beta R II). In addition, NaHS attenuated TGF-beta 1-induced increase of beta-catenin expression and ERK phosphorylation. Moreover, it inhibited the TGF-beta 1-induced nuclear translocation of beta beta-catenin. These effects of NaHS on fibronectin, E-cadherin and T beta R I were abolished by the ERK inhibitor U0126 or beta-catenin inhibitor XAV939, or beta-catenin siRNA interference. We get the conclusion that NaHS attenuated TGF-beta 1-induced EMT in HK-2 cells through both ERK-dependent and beta-catenin-dependent pathways.	[Guo, Lin; Hei, Hongya; Tian, Lulu; Pan, Wanma; Zhang, Xuemei] Fudan Univ, Dept Pharmacol, Sch Pharm, Shanghai 201203, Peoples R China; [Peng, Wen; Tao, Jie; Lan, Zhen; Wang, Li] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, Shanghai 200062, Peoples R China	Fudan University; Shanghai University of Traditional Chinese Medicine	Zhang, XM (corresponding author), Fudan Univ, Dept Pharmacol, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.	xuemzhang@fudan.edu.cn			National Science Foundation of China [81370979]; Shanghai Science and Technology Innovation Grant [14140903202, 14431905102]; Talent Project of Integrative Medicine of Shanghai Municipal Health Bureau [ZYSNXD012-RC-ZXY]; Key Medical Discipline Project of Shanghai Municipal Health Bureau [ZK2012A34]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Innovation Grant; Talent Project of Integrative Medicine of Shanghai Municipal Health Bureau; Key Medical Discipline Project of Shanghai Municipal Health Bureau	This work is supported by the National Science Foundation of China No. 81370979 (X. Zhang), Shanghai Science and Technology Innovation Grants 14140903202 and 14431905102 (X. Zhang), Talent Project of Integrative Medicine of Shanghai Municipal Health Bureau (ZYSNXD012-RC-ZXY) and Key Medical Discipline Project of Shanghai Municipal Health Bureau (ZK2012A34).	Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Fang LP, 2010, PHARMACOL RES, V61, P298, DOI 10.1016/j.phrs.2009.10.008; He HY, 2014, ADV ANAT PATHOL, V21, P174, DOI 10.1097/PAP.0000000000000018; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jung KJ, 2013, BBA-MOL BASIS DIS, V1832, P1989, DOI 10.1016/j.bbadis.2013.06.015; Kim CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063186; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058848; Lv M, 2014, MOL MED REP, V10, P341, DOI 10.3892/mmr.2014.2161; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449; Sun LL, 2014, MOL MED, V20, P503, DOI 10.2119/molmed.2013.00096; Tian YC, 2002, AM J PATHOL, V160, P1619, DOI 10.1016/S0002-9440(10)61109-1; Vandiver MS, 2012, J MOL MED, V90, P255, DOI 10.1007/s00109-012-0873-4; Wang LB, 2014, J CANCER RES CLIN, V140, P1997, DOI 10.1007/s00432-014-1753-9; Weinberg RA, 2008, NAT CELL BIOL, V10, P1021, DOI 10.1038/ncb0908-1021; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yu XH, 2014, CLIN CHIM ACTA, V437, P78, DOI 10.1016/j.cca.2014.07.012; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou QD, 2012, J MOL MED, V90, P563, DOI 10.1007/s00109-011-0833-4	24	43	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147018	10.1371/journal.pone.0147018	http://dx.doi.org/10.1371/journal.pone.0147018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760502	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100061
J	Kane, AL; Al-Shayeb, B; Holec, PV; Rajan, S; Le Mieux, NE; Heinsch, SC; Psarska, S; Aukema, KG; Sarkar, CA; Nater, EA; Gralnick, JA				Kane, Aunica L.; Al-Shayeb, Basem; Holec, Patrick V.; Rajan, Srijay; Le Mieux, Nicholas E.; Heinsch, Stephen C.; Psarska, Sona; Aukema, Kelly G.; Sarkar, Casim A.; Nater, Edward A.; Gralnick, Jeffrey A.			Toward Bioremediation of Methylmercury Using Silica Encapsulated Escherichia coli Harboring the mer Operon	PLOS ONE			English	Article							MERCURY RESISTANCE; WASTE-WATER; BACTERIA; REMOVAL; CELLS	Mercury is a highly toxic heavy metal and the ability of the neurotoxin methylmercury to bio-magnify in the food chain is a serious concern for both public and environmental health globally. Because thousands of tons of mercury are released into the environment each year, remediation strategies are urgently needed and prompted this study. To facilitate remediation of both organic and inorganic forms of mercury, Escherichia coli was engineered to harbor a subset of genes (merRTPAB) from the mercury resistance operon. Protein products of the mer operon enable transport of mercury into the cell, cleavage of organic C-Hg bonds, and subsequent reduction of ionic mercury to the less toxic elemental form, Hg(0). E. coli containing merRTPAB was then encapsulated in silica beads resulting in a biological-based filtration material. Performing encapsulation in aerated mineral oil yielded silica beads that were smooth, spherical, and similar in diameter. Following encapsulation, E. coli containing merRTPAB retained the ability to degrade methylmercury and performed similarly to non-encapsulated cells. Due to the versatility of both the engineered mercury resistant strain and silica bead technology, this study provides a strong foundation for use of the resulting biological-based filtration material for methylmercury remediation.	[Kane, Aunica L.; Al-Shayeb, Basem; Holec, Patrick V.; Rajan, Srijay; Le Mieux, Nicholas E.; Heinsch, Stephen C.; Aukema, Kelly G.; Sarkar, Casim A.; Gralnick, Jeffrey A.] Univ Minnesota Twin Cities, Inst Biotechnol, St Paul, MN 55105 USA; [Kane, Aunica L.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Psarska, Sona; Nater, Edward A.] Univ Minnesota Twin Cities, Dept Soil Water & Climate, St Paul, MN USA; [Sarkar, Casim A.] Univ Minnesota Twin Cities, Dept Biomed Engn, Minneapolis, MN USA; [Gralnick, Jeffrey A.] Univ Minnesota Twin Cities, Dept Microbiol & Immunol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Gralnick, JA (corresponding author), Univ Minnesota Twin Cities, Inst Biotechnol, St Paul, MN 55105 USA.	gralnick@umn.edu		Heinsch, Stephen/0000-0003-0406-8734; Gralnick, Jeffrey/0000-0001-9250-7770; Al-Shayeb, Basem/0000-0002-3120-3201	Office of Naval Research [N000141210309]; University of Minnesota MnDRIVE initiative: Advancing industry, conserving our environment	Office of Naval Research(Office of Naval Research); University of Minnesota MnDRIVE initiative: Advancing industry, conserving our environment	This project was supported by the Office of Naval Research (Award N000141210309 to JAG) and the University of Minnesota MnDRIVE initiative: Advancing industry, conserving our environment (https://mndrive.umn.edu/environment). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was conducted by the 2014 iGEM team at the University of Minnesota and was supported by the Office of Naval Research (Award N000141210309 to JAG) and the University of Minnesota MnDRIVE initiative: Advancing industry, conserving our environment. We would like to thank Dr. Anne Summers (University of Georgia) for providing pDU1358, safety protocols, and project guidance. We would also like to thank Professor Alptekin Aksan and Dr. Baris Mutlu (University of Minnesota) for initial discussions concerning encapsulation protocols, and Gail Celio (University of Minnesota Imaging Center) for assistance with microscopy.	[Anonymous], 2012, ENV CHEM TOXICOLOGY; Aukema KG, 2014, APPL ENVIRON MICROB, V80, P4968, DOI 10.1128/AEM.01100-14; Bae W, 2003, APPL ENVIRON MICROB, V69, P3176, DOI 10.1128/AEM.69.6.3176-3180.2003; Bae W, 2001, APPL ENVIRON MICROB, V67, P5335, DOI 10.1128/AEM.67.11.5335-5338.2001; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Brim H, 2000, NAT BIOTECHNOL, V18, P85, DOI 10.1038/71986; Brim H, 2003, APPL ENVIRON MICROB, V69, P4575, DOI 10.1128/AEM.69.8.4575-4582.2003; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Chen SL, 1997, APPL ENVIRON MICROB, V63, P2442, DOI 10.1128/AEM.63.6.2442-2445.1997; Deng X, 2011, BIORESOURCE TECHNOL, V102, P3083, DOI 10.1016/j.biortech.2010.10.051; GRIFFIN HG, 1987, P NATL ACAD SCI USA, V84, P3112, DOI 10.1073/pnas.84.10.3112; Guedron S, 2011, APPL GEOCHEM, V26, P222, DOI 10.1016/j.apgeochem.2010.11.022; HORN JM, 1994, APPL ENVIRON MICROB, V60, P357, DOI 10.1128/AEM.60.1.357-362.1994; Kiyono M, 2003, APPL MICROBIOL BIOT, V62, P274, DOI 10.1007/s00253-003-1282-y; Lafrance-Vanasse J, 2009, J BIOL CHEM, V284, P938, DOI 10.1074/jbc.M807143200; Leopold K, 2010, ANAL CHIM ACTA, V663, P127, DOI 10.1016/j.aca.2010.01.048; Lin KH, 2010, APPL MICROBIOL BIOT, V87, P561, DOI 10.1007/s00253-010-2466-x; Mutlu BR, 2015, CHEM ENG J, V259, P574, DOI 10.1016/j.cej.2014.07.130; Mutlu BR, 2013, J MATER CHEM A, V1, P11051, DOI 10.1039/c3ta12303k; Pan-Hou H, 2002, FEMS MICROBIOL LETT, V207, P159, DOI 10.1016/S0378-1097(01)00583-3; Reategui E, 2012, APPL MICROBIOL BIOT, V96, P231, DOI 10.1007/s00253-011-3821-2; Ruiz ON, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-82; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Sousa C, 1998, J BACTERIOL, V180, P2280, DOI 10.1128/JB.180.9.2280-2284.1998; Tchounwou PB, 2003, ENVIRON TOXICOL, V18, P149, DOI 10.1002/tox.10116; United Nations Environment Programme, 2013, GLOB MERC ASS 2013 S, P1; Vick JE, 2011, APPL MICROBIOL BIOT, V92, P1275, DOI 10.1007/s00253-011-3633-4; von Canstein H, 1999, APPL ENVIRON MICROB, V65, P5279; Wagner-Dobler I, 2000, ENVIRON SCI TECHNOL, V34, P4628, DOI 10.1021/es0000652; Wagner-Dobler I, 2013, BIOREMEDIATION OF MERCURY: CURRENT RESARCH AND INDUSTRIAL APPLICATIONS, P1; Yeom S, 2015, APPL ENVIRON MICROB, V81, P6660, DOI 10.1128/AEM.02175-15; Zhang T, 2010, NAT GEOSCI, V3, P473, DOI 10.1038/NGEO892	33	10	10	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147036	10.1371/journal.pone.0147036	http://dx.doi.org/10.1371/journal.pone.0147036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761437	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100065
J	Hannibal, J; Georg, B; Fahrenkrug, J				Hannibal, Jens; Georg, Birgitte; Fahrenkrug, Jan			Altered Circadian Food Anticipatory Activity Rhythms in PACAP Receptor 1 (PAC1) Deficient Mice	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; SUPRACHIASMATIC NUCLEI; NOCTURNAL RODENTS; GANGLION-CELLS; LIGHT; MASKING; CLOCK; ENTRAINMENT; PEPTIDE; LACKING	Light signals from intrinsically photosensitive retinal ganglion cells (ipRGCs) entrain the circadian clock and regulate negative masking. Two neurotransmitters, glutamate and Pituitary Adenylate Cyclase Activating Polypeptide (PACAP), found in the ipRGCs transmit light signals to the brain via glutamate receptors and the specific PACAP type 1 (PAC1) receptor. Light entrainment occurs during the twilight zones and has little effect on clock phase during daytime. When nocturnal animals have access to food only for a few hours during the resting phase at daytime, they adapt behavior to the restricted feeding (RF) paradigm and show food anticipatory activity (FAA). A recent study in mice and rats demonstrating that light regulates FAA prompted us to investigate the role of PACAP/PAC1 signaling in the light mediated regulation of FAA. PAC1 receptor knock out (PAC1-/-) and wild type (PAC1+/+) mice placed in running wheels were examined in a full photoperiod (FPP) of 12:12 h light/dark (LD) and a skeleton photoperiod (SPP) 1:11:1:11 h L:DD:L:DD at 300 and 10 lux light intensity. Both PAC1-/- mice and PAC1+/+ littermates entrained to FPP and SPP at both light intensities. However, when placed in RF with access to food for 4-5 h during the subjective day, a significant change in behavior was observed in PAC1-/- mice compared to PAC1+/+ mice. While PAC1-/- mice showed similar FAA as PAC1+/+ animals in FPP at 300 lux, PAC1-/- mice demonstrated an advanced onset of FAA with a nearly 3-fold increase in amplitude compared to PAC1+/+ mice when placed in SPP at 300 lux. The same pattern of FAA was observed at 10 lux during both FPP and SPP. The present study indicates a role of PACAP/PAC1 signaling during light regulated FAA. Most likely, PACAP found in ipRGCs mediating non-image forming light information to the brain is involved.	[Hannibal, Jens; Georg, Birgitte; Fahrenkrug, Jan] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Hannibal, J (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark.	j.hannibal@dadlnet.dk	Hannibal, Jens/H-5482-2019	Hannibal, Jens/0000-0001-9416-0125	Danish Biotechnology Center for Cellular Communication	Danish Biotechnology Center for Cellular Communication	The Danish Biotechnology Center for Cellular Communication supported this work.	Challet E, 2010, J COMP PHYSIOL B, V180, P631, DOI 10.1007/s00360-010-0451-4; Cutler DJ, 1999, PEPTIDES, V20, P1455, DOI 10.1016/S0196-9781(99)00157-6; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Daan Serge, 2001, Handbook of Behavioral Neurobiology, V12, P7; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Edelstein K, 1999, J NEUROSCI, V19, P372, DOI 10.1523/JNEUROSCI.19-01-00372.1999; Engelund A, 2012, BRAIN RES, V1453, P17, DOI 10.1016/j.brainres.2012.03.005; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hannibal J, 2001, J BIOL RHYTHM, V16, P457, DOI 10.1177/074873001129002132; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; HANNIBAL J, 2006, ADV ANAT EMBRYOL CEL, V182, P1; Hannibal J, 2006, INT REV CYTOL, V251, P1, DOI 10.1016/S0074-7696(06)51001-0; Hannibal J, 2008, AM J PHYSIOL-REG I, V295, pR2050, DOI 10.1152/ajpregu.90563.2008; Iemolo A, 2015, NEUROPSYCHOPHARMACOL, V40, P1846, DOI 10.1038/npp.2015.34; Jamen F, 2000, J CLIN INVEST, V105, P1307, DOI 10.1172/JCI9387; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Legradi G, 1997, J CHEM NEUROANAT, V13, P265, DOI 10.1016/S0891-0618(97)10002-3; Marston OJ, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-19; Matsuda K, 2013, OBES RES CLIN PRACT, V7, pE1, DOI 10.1016/j.orcp.2012.10.002; Mendoza J, 2005, J NEUROSCI, V25, P1514, DOI 10.1523/JNEUROSCI.4397-04.2005; Mendoza J, 2007, EUR J NEUROSCI, V25, P3691, DOI 10.1111/j.1460-9568.2007.05626.x; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mistlberger RE, 1999, BRAIN RES, V842, P73, DOI 10.1016/S0006-8993(99)01836-3; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Morin LP, 2013, J BIOL RHYTHM, V28, P95, DOI 10.1177/0748730413481921; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Patton DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081588; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Peyron C, 1998, J NEUROSCI, V18, P9996; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; Resch JM, 2014, PHYSIOL BEHAV, V133, P230, DOI 10.1016/j.physbeh.2014.05.029; Sand A, 2012, PROG RETIN EYE RES; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284	38	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146981	10.1371/journal.pone.0146981	http://dx.doi.org/10.1371/journal.pone.0146981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757053	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888800039
J	Dorenkamp, S; Mesters, I; de Bie, R; Teijink, J; van Breukelen, G				Dorenkamp, Sarah; Mesters, Ilse; de Bie, Rob; Teijink, Joep; van Breukelen, Gerard			Patient Characteristics and Comorbidities Influence Walking Distances in Symptomatic Peripheral Arterial Disease: A Large One-Year Physiotherapy Cohort Study	PLOS ONE			English	Article							HEMOGLOBIN OXYGEN-SATURATION; SUPERVISED EXERCISE THERAPY; INTERMITTENT CLAUDICATION; OLDER; CAPACITY	Objectives The aim of this study is to investigate the association between age, gender, body-mass index, smoking behavior, orthopedic comorbidity, neurologic comorbidity, cardiac comorbidity, vascular comorbidity, pulmonic comorbidity, internal comorbidity and Initial Claudication Distance during and after Supervised Exercise Therapy at 1, 3, 6 and 12 months in a large sample of patients with Intermittent Claudication. Methods Data was prospectively collected in standard physiotherapy care. Patients received Supervised Exercise Therapy according to the guideline Intermittent Claudication of the Royal Dutch Society for Physiotherapy. Three-level mixed linear regression analysis was carried out to analyze the association between patient characteristics, comorbidities and Initial Claudication Distance at 1, 3, 6 and 12 months. Results Data from 2995 patients was analyzed. Results showed that being female, advanced age and a high body-mass index were associated with lower Initial Claudication Distance at all-time points (p = 0.000). Besides, a negative association between cardiac comorbidity and Initial Claudication Distance was revealed (p = 0.011). The interaction time by age, time by body-mass index and time by vascular comorbidity were significantly associated with Initial Claudication Distance (p <= 0.05). Per year increase in age (range: 33-93 years), the reduction in Initial Claudication Distance was 8m after 12 months of Supervised Exercise Therapy. One unit increase in body-mass index (range: 16-44 kg/m(2)) led to 10m less improvement in Initial Claudication Distance after 12 months and for vascular comorbidity the reduction in improvement was 85m after 12 months. Conclusions This study reveals that females, patients at advanced age, patients with a high body-mass index and cardiac comorbidity are more likely to show less improvement in Initial Claudication Distances (ICD) after 1, 3, 6 and 12 months of Supervised Exercise Therapy. Further research should elucidate treatment adaptations that optimize treatment outcomes for these subgroups.	[Dorenkamp, Sarah; Mesters, Ilse; de Bie, Rob; Teijink, Joep] Maastricht Univ, Dept Epidemiol, Functioning & Rehabil Programme, CAPRHI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Teijink, Joep] Catharina Hosp, Dept Vasc Surg, Eindhoven, Netherlands; [van Breukelen, Gerard] Maastricht Univ, CAPRHI Sch Publ Hlth & Primary Care, Dept Methodol & Stat, Maastricht, Netherlands	Maastricht University; Catharina Hospital; Maastricht University	Dorenkamp, S (corresponding author), Maastricht Univ, Dept Epidemiol, Functioning & Rehabil Programme, CAPRHI Sch Publ Hlth & Primary Care, Maastricht, Netherlands.	sarah.dorenkamp@maastrichtuniversity.nl	van+Breukelen, Gerard/ACJ-5895-2022; mesters, Ilse/AAN-2824-2021	van+Breukelen, Gerard/0000-0003-0949-0272; mesters, Ilse/0000-0003-0605-6286	Netherlands Organisation for Scientific Research (NWO) Graduate Programme grant [022.003.036]	Netherlands Organisation for Scientific Research (NWO) Graduate Programme grant(Netherlands Organization for Scientific Research (NWO))	This study was made possible by a Netherlands Organisation for Scientific Research (NWO) Graduate Programme grant (grant number 022.003.036); URL: http://www.nwo.nl/en/funding/our-funding-instruments/nwo/graduate-programme/graduate-programme.html; authors who received funding: RdB; PhD Candidate funded by this grant SD.	Afaq A, 2007, VASC MED, V12, P167, DOI 10.1177/1358863x07081317; Amighi J, 2004, EUR J VASC ENDOVASC, V27, P254, DOI 10.1016/j.ejvs.2003.12.005; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bendermacher BLW, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005263.pub2; Bendermacher BL, 2007, J VASC SURG, V45, P1192, DOI 10.1016/j.jvs.2007.01.059; Davison KK, 2002, J AM GERIATR SOC, V50, P1802, DOI 10.1046/j.1532-5415.2002.50508.x; Dolan NC, 2002, DIABETES CARE, V25, P113, DOI 10.2337/diacare.25.1.113; Farah BQ, 2014, ANN VASC SURG, V28, P279, DOI 10.1016/j.avsg.2013.01.020; Field A., 2013, DISCOVERING STAT USI, P543; Fox J, 1997, APPL REGRESSION ANAL, P117; Gardner AW, 2010, J VASC SURG, V51, P610, DOI 10.1016/j.jvs.2009.09.059; Gardner AW, 2009, J VASC SURG, V50, P77, DOI 10.1016/j.jvs.2008.12.065; GARDNER AW, 1991, MED SCI SPORT EXER, V23, P402; Jankowski CM, 2008, OBESITY, V16, P1039, DOI 10.1038/oby.2007.84; Jonkert M, 2003, NED TIJD FYSIOTHER S, V113, P3; Katzel LI, 2001, VASC MED, V6, P157, DOI 10.1177/1358836X0100600306; Kruidenier LM, 2009, EUR J VASC ENDOVASC, V38, P449, DOI 10.1016/j.ejvs.2009.04.020; Lane R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000990.pub3; LAUGHLIN MH, 1999, AM J PHYSIOL, V277, P244; Newman AB, 2003, J GERONTOL A-BIOL, V58, P715; Parmenter BJ, 2015, SPORTS MED, V45, P231, DOI 10.1007/s40279-014-0261-z; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Powell JT, 1997, ATHEROSCLEROSIS, V129, P41, DOI 10.1016/S0021-9150(96)06012-1; Robeer GG, 1998, EUR J VASC ENDOVASC, V15, P36, DOI 10.1016/S1078-5884(98)80070-1; Snijders T, 2014, INT ENCY STAT SCI, P879; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Verbeke G, 2000, LINEAR MIXED MODELS, P19, DOI [10.1007/978-0-387-22775-7_3, DOI 10.1007/978-1-4419-0300-6]; Versluis B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031514; Willigendael EM, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-49	29	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146828	10.1371/journal.pone.0146828	http://dx.doi.org/10.1371/journal.pone.0146828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751074	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100159
J	Hua, YJ; Xu, ZQ; Qiu, W; Wu, Q				Hua, Yanjun; Xu, Zequan; Qiu, Wei; Wu, Qiang			Precision (Repeatability and Reproducibility) and Agreement of Corneal Power Measurements Obtained by Topcon KR-1W and iTrace	PLOS ONE			English	Article							INTRAOCULAR-LENS POWER; LASER REFRACTIVE SURGERY; OPTICAL COHERENCE TOMOGRAPHY; CONTACT-LENS; ORBSCAN-II; PHOTOREFRACTIVE KERATECTOMY; SIMULATED KERATOMETRY; SCHEIMPFLUG CAMERA; PENTACAM; EYES	Purpose To evaluate the repeatability and reproducibility of corneal power measurements obtained by Topcon KR-1W and iTrace, and assess the agreement with measurements obtained by Allegro Topolyzer and IOLMaster. Methods The right eyes of 100 normal subjects were prospectively scanned 3 times using all the 4 devices. Another observer performed additional 3 consecutive scans using the Topcon KR-1W and iTrace in the same session. About one week later, the first observer repeated the measurements using the Topcon KR-1W and iTrace. The steep keratometry (Ks), flat keratometry (Kf), mean keratometry (Km), J0 and J45 were analyzed. Repeatability and reproducibility of measurements were evaluated by the within-subject standard deviation (Sw), coefficient of variation (CoV), test-retest repeatability (2.77Sw), and intraclass correlation coefficient (ICC). Agreements between devices were assessed using Bland-Altman analysis and 95% limits of agreement (LoA). Results Intraobserver repeatability and interobserver and intersession reproducibility of the Ks, Kf and Km showed a CoV of no more than 0.5%, a 2.77Sw of 0.70 D or less, and an ICC of no less than 0.99. However, J0 and J45 showed poor intraobserver repeatability and interobserver and intersession reproducibility (all ICCs not greater than 0.446). Statistically significant differences existed between Topcon KR-1W and IOLMaster, Topcon KR-1W and iTrace, Topcon KR-1W and Topolyzer, iTrace and Topolyzer, iTrace and IOLMaster for Ks, Kf and Km measurements (all P < 0.05). The mean differences between Topcon KR-1W, iTrace, and the other 2 devices were small. The 95% LoA were approximately 1.0 D to 1.5 D for all measurements. Conclusions The Ks, Kf and Km obtained by Topcon KR-1W and iTrace showed excellent intraobserver repeatability and interobserver and intersession reproducibility in normal eyes. The agreement between Topcon KR-1W and Topolyzer, Topcon KR-1W and IOLMaster, iTrace and Topolyzer, iTrace and IOLMaster, Topcon KR-1W and iTrace were not so good, they should not be interchangeable in clinical application. Given that the intraobserver repeatability and interobserver and intersession reproducibility of corneal astigmatism measurements obtained by Topcon KR-1W and iTrace were poor, it should be cautious that Topcon KR-1W and iTrace were applied for the preparation of toric lens implantation.	[Hua, Yanjun; Xu, Zequan; Qiu, Wei; Wu, Qiang] Shanghai Jiao Tong Univ, Dept Ophthalmol, Peoples Hosp 6, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University	Wu, Q (corresponding author), Shanghai Jiao Tong Univ, Dept Ophthalmol, Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	qiangwumd@163.com		HUA, YANJUN/0000-0001-6461-3576	Health Bureau of Shanghai City [201440029]	Health Bureau of Shanghai City	Financial support provided by the Health Bureau of Shanghai City (201440029) to Q. Wu, http://www.wsjsw.gov.cn/wsj/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2005, OPHTHAL PHYSL OPT, V25, P52, DOI 10.1111/j.1475-1313.2004.00251.x; Arce CG, 2007, J CATARACT REFR SURG, V33, P1348, DOI 10.1016/j.jcrs.2007.03.062; Bland JM, 1996, BRIT MED J, V313, P744; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chan CCK, 2006, CLIN EXP OPHTHALMOL, V34, P640, DOI 10.1111/j.1442-9071.2006.01316.x; Collins MJ, 2006, ACTA OPHTHALMOL SCAN, V84, P216, DOI 10.1111/j.1600-0420.2005.00547.x; Crawford AZ, 2013, AM J OPHTHALMOL, V156, P53, DOI 10.1016/j.ajo.2013.01.029; De Bernardo M, 2014, CORNEA, V33, pE2, DOI 10.1097/ICO.0000000000000112; Falavarjani KG, 2010, CLIN EXP OPHTHALMOL, V38, P341, DOI 10.1111/j.1442-9071.2010.02286.x; Fam HB, 2007, J CATARACT REFR SURG, V33, P686, DOI 10.1016/j.jcrs.2006.11.023; Gatinel D, 2002, J FR OPHTALMOL, V25, P81; Haigis W, 2003, J CATARACT REFR SURG, V29, P1397, DOI 10.1016/S0886-3350(02)02044-8; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Ho JD, 2008, J CATARACT REFR SURG, V34, P137, DOI 10.1016/j.jcrs.2007.09.033; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang David, 2013, Trans Am Ophthalmol Soc, V111, P34; Huang JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0109414; Huang JH, 2011, J CATARACT REFR SURG, V37, P341, DOI 10.1016/j.jcrs.2010.08.044; Jin HY, 2012, J CATARACT REFR SURG, V38, P1749, DOI 10.1016/j.jcrs.2012.06.048; Joslin CE, 2005, J CATARACT REFR SURG, V31, P2287, DOI 10.1016/j.jcrs.2005.06.049; Kalyani SD, 2008, CURR OPIN OPHTHALMOL, V19, P357, DOI 10.1097/ICU.0b013e3282fec43e; Kim SW, 2009, J REFRACT SURG, V25, P285, DOI 10.3928/1081597X-20090301-08; Langenbucher A, 2007, CURR EYE RES, V32, P421, DOI 10.1080/02713680701329313; Leyland M, 2004, EYE, V18, P357, DOI 10.1038/sj.eye.6700659; Liu YJ, 2012, OPHTHAL PHYSL OPT, V32, P355, DOI 10.1111/j.1475-1313.2012.00921.x; Lopez-Miguel A, 2013, J CATARACT REFR SURG, V39, P242, DOI 10.1016/j.jcrs.2012.08.061; Mao XJ, 2013, J CATARACT REFR SURG, V39, P1561, DOI 10.1016/j.jcrs.2013.04.029; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P7731, DOI 10.1167/iovs.10-7093; Molebny VV, 2000, J REFRACT SURG, V16, pS572; Pinero DP, 2011, OPTOMETRY VISION SCI, V88, P1099, DOI 10.1097/OPX.0b013e3182223788; Pinero DP, 2011, J REFRACT SURG, V27, P509, DOI 10.3928/1081597X-20101214-01; Rosa N, 2011, J REFRACT SURG, V27, P293, DOI 10.3928/1081597X-20100707-01; Savini G, 2015, INVEST OPHTH VIS SCI, V56, P827, DOI 10.1167/iovs.14-15903; Savini G, 2014, J CATARACT REFR SURG, V40, P1109, DOI 10.1016/j.jcrs.2013.11.032; Savini G, 2012, J CATARACT REFR SURG, V38, P787, DOI 10.1016/j.jcrs.2011.11.037; Savini G, 2009, J CATARACT REFR SURG, V35, P1193, DOI 10.1016/j.jcrs.2009.02.031; Savini G, 2009, J REFRACT SURG, V25, P534, DOI 10.3928/1081597X-20090512-07; Shirayama M, 2009, AM J OPHTHALMOL, V148, P528, DOI 10.1016/j.ajo.2009.04.028; Srivannaboon S, 2012, J CATARACT REFR SURG, V38, P2088, DOI 10.1016/j.jcrs.2012.07.024; Tang ML, 2010, J CATARACT REFR SURG, V36, P2115, DOI 10.1016/j.jcrs.2010.07.018; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Visser N, 2011, INVEST OPHTH VIS SCI, V52, P1302, DOI 10.1167/iovs.10-5841; Vogel A, 2001, J CATARACT REFR SURG, V27, P1961, DOI 10.1016/S0886-3350(01)01214-7	43	11	13	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0147086	10.1371/journal.pone.0147086	http://dx.doi.org/10.1371/journal.pone.0147086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752059	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888100194
J	van Raan, AFJ; van der Meulen, G; Goedhart, W				van Raan, Anthony F. J.; van der Meulen, Gerwin; Goedhart, Willem			Urban Scaling of Cities in the Netherlands	PLOS ONE			English	Article								We investigated the socioeconomic scaling behavior of all cities with more than 50,000 inhabitants in the Netherlands and found significant superlinear scaling of the gross urban product with population size. Of these cities, 22 major cities have urban agglomerations and urban areas defined by the Netherlands Central Bureau of Statistics. For these major cities we investigated the superlinear scaling for three separate modalities: the cities defined as municipalities, their urban agglomerations and their urban areas. We find superlinearity with power-law exponents of around 1.15. But remarkably, both types of agglomerations underperform if we compare for the same size of population an agglomeration with a city as a municipality. In other words, an urban system as one formal municipality performs better as compared to an urban agglomeration with the same population size. This effect is larger for the second type of agglomerations, the urban areas. We think this finding has important implications for urban policy, in particular municipal reorganizations. A residual analysis suggests that cities with a municipal reorganization recently and in the past decades have a higher probability to perform better than cities without municipal restructuring.	[van Raan, Anthony F. J.] Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands; [van der Meulen, Gerwin; Goedhart, Willem] Decisio Econ Consulting, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC	van Raan, AFJ (corresponding author), Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands.	vanraan@cwts.leidenuniv.nl		van Raan, Anthony/0000-0001-8980-5937	Netherlands Ministry of the Interior and Kingdom Relations; Decisio	Netherlands Ministry of the Interior and Kingdom Relations; Decisio	This work has been supported by the Netherlands Ministry of the Interior and Kingdom Relations. The Ministry did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. During the course of the study GvdM and WG received support in the form of salaries from Decisio.	Alderson AS, 2004, AM J SOCIOL, V109, P811, DOI 10.1086/378930; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; Batty M, 2013, SCIENCE, V340, P1418, DOI 10.1126/science.1239870; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Crucitti P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036125; Florida R., 2004, CITIES CREATIVE CLAS, P1, DOI [10.4324/9780203997673, DOI 10.4324/9780203997673]; Galster G, 2001, HOUS POLICY DEBATE, V12, P681, DOI 10.1080/10511482.2001.9521426; Holland JH, 1995, HIDDEN ORDERS ADAPTA; Jamtveit B, 2009, P NATL ACAD SCI USA, V106, P13160, DOI 10.1073/pnas.0903190106; Lee K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014279; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Martin T, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052808; Mulligan GF, 2012, ANN REGIONAL SCI, V48, P405, DOI 10.1007/s00168-011-0496-7; Newbold P, 1995, STAT BUSINESS EC, P566; Nomaler O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110805; Pan W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2961; Pumain D., 2006, CYBERGEO REV EUROPEE, V343, P1; Pumain D, 2012, COMPLEXITY THEORIES; Pumain D, 2004, SCALING LAWS URBAN S; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; Van der Meulen G, 2014, URBAN SCALING NEDERL; Van Noorden R, 2010, NATURE, V468, P1011, DOI 10.1038/4681011a; van Raan AFJ, 2006, J AM SOC INF SCI TEC, V57, P1919, DOI 10.1002/asi.20389; van Raan AFJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059384	28	21	21	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146775	10.1371/journal.pone.0146775	http://dx.doi.org/10.1371/journal.pone.0146775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751785	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100150
J	Islam, NN; Hannan, MA; Mohamed, A; Shareef, H				Islam, Naz Niamul; Hannan, M. A.; Mohamed, Azah; Shareef, Hussain			Improved Power System Stability Using Backtracking Search Algorithm for Coordination Design of PSS and TCSC Damping Controller	PLOS ONE			English	Article							OPTIMIZATION ALGORITHM	Power system oscillation is a serious threat to the stability of multimachine power systems. The coordinated control of power system stabilizers (PSS) and thyristor-controlled series compensation (TCSC) damping controllers is a commonly used technique to provide the required damping over different modes of growing oscillations. However, their coordinated design is a complex multimodal optimization problem that is very hard to solve using traditional tuning techniques. In addition, several limitations of traditionally used techniques prevent the optimum design of coordinated controllers. In this paper, an alternate technique for robust damping over oscillation is presented using backtracking search algorithm (BSA). A 5-area 16-machine benchmark power system is considered to evaluate the design efficiency. The complete design process is conducted in a linear time-invariant (LTI) model of a power system. It includes the design formulation into a multi-objective function from the system eigenvalues. Later on, nonlinear time-domain simulations are used to compare the damping performances for different local and inter-area modes of power system oscillations. The performance of the BSA technique is compared against that of the popular particle swarm optimization (PSO) for coordinated design efficiency. Damping performances using different design techniques are compared in term of settling time and overshoot of oscillations. The results obtained verify that the BSA-based design improves the system stability significantly. The stability of the multimachine power system is improved by up to 74.47% and 79.93% for an inter-area mode and a local mode of oscillation, respectively. Thus, the proposed technique for coordinated design has great potential to improve power system stability and to maintain its secure operation.	[Islam, Naz Niamul; Hannan, M. A.; Mohamed, Azah] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia; [Shareef, Hussain] United Arab Emirates Univ, Coll Engn, Dept Elect Engn, Al Ain, U Arab Emirates	Universiti Kebangsaan Malaysia; United Arab Emirates University	Islam, NN (corresponding author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia.	niamul@eng.ukm.my	Shareef, Hussain/AFK-9223-2022; Mohamed, Azah/D-3635-2011; Hannan, M/O-8579-2019; Shareef, Hussain/AAN-5968-2020	Shareef, Hussain/0000-0001-7708-6904; Mohamed, Azah/0000-0003-3028-4633; Hannan, M/0000-0001-8367-4112; Shareef, Hussain/0000-0001-7708-6904; Islam, Md Naz Niamul/0000-0003-0413-4041	Universiti Kebangsaan Malaysia [06-01-02-SF1060, GUP-2014-072, DIP-2014-028]	Universiti Kebangsaan Malaysia	This research has been financed by the Universiti Kebangsaan Malaysia under Grants 06-01-02-SF1060, GUP-2014-072 and DIP-2014-028. The authors gratefully acknowledge the support. The funder's website: http://www.ukm.my/.	Abido MA, 2000, INT J ELEC POWER, V22, P543, DOI 10.1016/S0142-0615(00)00027-2; Ali ES, 2012, INT J ELEC POWER, V36, P84, DOI 10.1016/j.ijepes.2011.10.027; Cai LJ, 2005, IEEE T POWER SYST, V20, P294, DOI 10.1109/TPWRS.2004.841177; Chow J., 2000, POWER SYSTEM TOOLBOX; CHOW JH, 1992, IEEE T POWER SYST, V7, P1559, DOI 10.1109/59.207380; Civicioglu P, 2013, APPL MATH COMPUT, V219, P8121, DOI 10.1016/j.amc.2013.02.017; Del Rosso AD, 2003, IEEE T POWER SYST, V18, P1487, DOI 10.1109/TPWRS.2003.818703; Islam NN, 2014, SCI WORLD J, DOI 10.1155/2014/549094; Kundur P., 2007, POWER SYSTEM STABILI, V10; Lei XZ, 2001, IEEE T POWER SYST, V16, P473, DOI 10.1109/59.932284; Mahapatra S, 2012, 2012 2ND INTERNATIONAL CONFERENCE ON POWER, CONTROL AND EMBEDDED SYSTEMS (ICPCES 2012); Mithulananthan N, 2003, IEEE T POWER SYST, V18, P786, DOI 10.1109/TPWRS.2003.811181; Pourbeik P, 1998, IEEE T POWER SYST, V13, P473, DOI 10.1109/59.667371; Radman G, 2008, ELECTR POW SYST RES, V78, P361, DOI 10.1016/j.epsr.2007.03.004; Rogers G, 1996, IEEE COMPUT APPL POW, V9, P30, DOI 10.1109/67.526851; Rogers G., 2012, POWER SYSTEM OSCILLA; Shahgholian G, 2015, INT J CONTROL AUTOM, V13, P398, DOI 10.1007/s12555-013-0387-z; Shayeghi H, 2010, ENERG CONVERS MANAGE, V51, P2930, DOI 10.1016/j.enconman.2010.06.034; Tripathy M, 2015, INT J ELEC POWER, V66, P97, DOI 10.1016/j.ijepes.2014.10.022; Vanfretti L, POWER SYSTEM TOOLBOX; YANG XQ, 1995, IEEE T POWER SYST, V10, P1271, DOI 10.1109/59.466527	21	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146277	10.1371/journal.pone.0146277	http://dx.doi.org/10.1371/journal.pone.0146277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745265	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600036
J	Wang, Y; Wang, DS; Guo, DW				Wang, Ye; Wang, Desheng; Guo, Dawen			MiR-124 Promote Neurogenic Transdifferentiation of Adipose Derived Mesenchymal Stromal Cells Partly through RhoA/ROCK1, but Not ROCK2 Signaling Pathway	PLOS ONE			English	Article							STEM-CELLS; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; HUMAN FIBROBLASTS; MESSENGER-RNA; EXPRESSION; NICHE; RHOA	Objective Some recent studies suggest that multiple miRNAs might regulate neurogenic transdifferentiation of mesenchymal stromal cells (MSCs). In the present study, we hypothesized that the miR-124 can repress the expression of RhoA upon the neurogenesis of adipose derived MSCs (ADMSCs). Methods MiRNA expression dynamics during neurogenic transdifferentiation of ADMSCs were measured. The expression of neuron-specific enolase (NSE), Tuj-1 (Neuron-specific class III beta-tubulin) and glial fibrillary acidic protein (GFAP), as well as electrophysiological properties, were detected after neurogenic transdifferentiation. The targeting of miR-124 over RhoA was verified by dual luciferase assay, qRT-PCR and western blot. The functions of miR-124 and the RhoA/ROCK signaling pathway were studied using gain and loss of function experiments in vitro. Results MiR-124 is significantly upregulated during neurogenic transdifferentiation of ADMSCs. Knockdown of endogenous miR-124 hampered neurogenic transdifferentiation and the acquired electrophysiological properties. MiR-124 could directly target RHOA mRNA and repress its expression, through which it increased the proportion of transdifferentiated (transdiff.) cells with positive NSE, Tuj-1 and GFAP. RhoA/ROCK1, but not ROCK2 is a downstream signaling pathway of miR-124 in the process of transdifferentiation. Conclusion MiR-124 is an important miRNA modulating neurogenic transdifferentiation of ADMSCs at least partly via the miR-124/RhoA/ROCK1 signaling pathway. These findings provided some fundamental information for future use of ADMSCs as an agent for regenerative medicine and cell therapy for neurological diseases.	[Wang, Ye; Wang, Desheng] Harbin Med Univ, Dept Neurol, Affiliated Hosp 1, Harbin 150001, Heilongjiang, Peoples R China; [Guo, Dawen] Harbin Med Univ, Dept Clin Lab, Affiliated Hosp 1, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Guo, DW (corresponding author), Harbin Med Univ, Dept Clin Lab, Affiliated Hosp 1, Harbin 150001, Heilongjiang, Peoples R China.	dawen_guo@163.com						Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Bacci A, 1999, EUR J NEUROSCI, V11, P389, DOI 10.1046/j.1460-9568.1999.00440.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bossio C, 2013, J MOL NEUROSCI, V51, P274, DOI 10.1007/s12031-013-9985-8; Cao WY, 2015, MED SCI MONITOR, V21, P2190, DOI 10.12659/MSM.895081; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11909; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; de Girolamo L, 2013, CURR PHARM DESIGN, V19, P2459, DOI 10.2174/1381612811319130015; Duan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097684; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Gu X, 2014, J MOL NEUROSCI, V52, P156, DOI 10.1007/s12031-013-0190-6; Leong WS, 2012, J TISSUE ENG REGEN M, V6, ps68, DOI 10.1002/term.1548; Lin X, 2014, J BONE MINER RES, V29, P1575, DOI 10.1002/jbmr.2163; Liu X, 2014, J MOL HISTOL, V45, P707, DOI 10.1007/s10735-014-9594-z; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mareschi K, 2009, CYTOTHERAPY, V11, P534, DOI 10.1080/14653240902974024; Mondanizadeh M, 2015, J CELL BIOCHEM, V116, P943, DOI 10.1002/jcb.25045; Neo WH, 2014, J BIOL CHEM, V289, P20788, DOI 10.1074/jbc.M113.525493; Pacary E, 2007, MOL CELL NEUROSCI, V35, P409, DOI 10.1016/j.mcn.2007.04.002; Salehi H, 2016, STEM CELL REV REP, V12, P26, DOI 10.1007/s12015-015-9631-7; Santos MCT, 2016, STEM CELLS, V34, P220, DOI 10.1002/stem.2204; Secunda R, 2015, CYTOTECHNOLOGY, V67, P793, DOI 10.1007/s10616-014-9718-z; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Subbarao RB, 2015, INT J MOL SCI, V16, P10934, DOI 10.3390/ijms160510934; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhao CF, 2013, DEV NEUROSCI-BASEL, V35, P373, DOI 10.1159/000350715; Zou DF, 2014, NEURAL REGEN RES, V9, P1241, DOI 10.4103/1673-5374.135333	30	12	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146646	10.1371/journal.pone.0146646	http://dx.doi.org/10.1371/journal.pone.0146646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745800	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600071
J	Black, B; Granja-Vazquez, R; Johnston, BR; Jones, E; Romero-Ortega, M				Black, Bryan; Granja-Vazquez, Rafael; Johnston, Benjamin R.; Jones, Erick; Romero-Ortega, Mario			RETRACTED: Anthropogenic Radio-Frequency Electromagnetic Fields Elicit Neuropathic Pain in an Amputation Model(Retracted article. See vol. 13, art no e0191082, 2018)	PLOS ONE			English	Article; Retracted Publication							ION CHANNELS; RADIATION; EXPOSURE; PROTEIN; BRAIN	Anecdotal and clinical reports have suggested that radio-frequency electromagnetic fields (RF EMFs) may serve as a trigger for neuropathic pain. However, these reports have been widely disregarded, as the epidemiological effects of electromagnetic fields have not been systematically proven, and are highly controversial. Here, we demonstrate that anthropogenic RF EMFs elicit post-neurotomy pain in a tibial neuroma transposition model. Behavioral assays indicate a persistent and significant pain response to RF EMFs when compared to SHAM surgery groups. Laser thermometry revealed a transient skin temperature increase during stimulation. Furthermore, immunofluorescence revealed an increased expression of temperature sensitive cation channels (TRPV4) in the neuroma bulb, suggesting that RF EMF-induced pain may be due to cytokine-mediated channel dysregulation and hypersensitization, leading to thermal allodynia. Additional behavioral assays were performed using an infrared heating lamp in place of the RF stimulus. While thermally-induced pain responses were observed, the response frequency and progression did not recapitulate the RF EMF effects. In vitro calcium imaging experiments demonstrated that our RF EMF stimulus is sufficient to directly contribute to the depolarization of dissociated sensory neurons. Furthermore, the perfusion of inflammatory cytokine TNF-alpha resulted in a significantly higher percentage of active sensory neurons during RF EMF stimulation. These results substantiate patient reports of RF EMF-pain, in the case of peripheral nerve injury, while confirming the public and scientific consensus that anthropogenic RF EMFs engender no adverse sensory effects in the general population.	[Black, Bryan; Granja-Vazquez, Rafael; Romero-Ortega, Mario] Univ Texas Dallas, Dept Bioengn, 800 W Campbell Rd, Richardson, TX 75080 USA; [Johnston, Benjamin R.] Brown Univ, Alpert Med Sch, Providence, RI 02903 USA; [Jones, Erick] Univ Texas Arlington, Dept Ind Mfg & Syst Engn, Arlington, TX 76019 USA	University of Texas System; University of Texas Dallas; Brown University; University of Texas System; University of Texas Arlington	Romero-Ortega, M (corresponding author), Univ Texas Dallas, Dept Bioengn, 800 W Campbell Rd, Richardson, TX 75080 USA.	mir140030@utdallas.edu	Romero-Ortega, Mario/K-6097-2019; Romero-Ortega, Mario I/T-2520-2018; Jones, Erick C/V-5529-2019	Romero-Ortega, Mario/0000-0003-2576-2629; Romero-Ortega, Mario I/0000-0003-2576-2629; Jones, Erick C/0000-0002-0931-1935				Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Bakker JF, 2011, PHYS MED BIOL, V56, P4967, DOI 10.1088/0031-9155/56/15/020; Belyaev IY, 2005, BIOELECTROMAGNETICS, V26, P173, DOI 10.1002/bem.20103; Blackman CF, 2006, ELECTROMAGN BIOL MED, V25, P217, DOI 10.1080/15368370601034086; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; Consales Claudia, 2012, Int J Cell Biol, V2012, P683897; Cotgreave IA, 2005, ARCH BIOCHEM BIOPHYS, V435, P227, DOI 10.1016/j.abb.2004.12.004; Czeschik JC, 2008, NEUROSCI LETT, V434, P293, DOI 10.1016/j.neulet.2008.01.070; Dorsi MJ, 2008, PAIN, V134, P320, DOI 10.1016/j.pain.2007.06.030; Foltan R, 2008, MED HYPOTHESES, V71, P572, DOI 10.1016/j.mehy.2008.05.010; Formica D, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-11; FREY AH, 1993, FASEB J, V7, P272, DOI 10.1096/fasebj.7.2.8440406; Gerner C, 2010, INT ARCH OCC ENV HEA, V83, P691, DOI 10.1007/s00420-010-0513-7; Gherardini L, 2014, INT J MOL SCI, V15, P5366, DOI 10.3390/ijms15045366; Guler AD, 2002, J NEUROSCI, V22, P6408; Jia HB, 2011, NAT PROTOC, V6, P28, DOI 10.1038/nprot.2010.169; Johansen C, 2001, JNCI-J NATL CANCER I, V93, P203, DOI 10.1093/jnci/93.3.203; Kress M., 2000, INVOLVEMENT PROINFLA, V20, P6289; Lagorio S, 2014, BIOELECTROMAGNETICS, V35, P79, DOI 10.1002/bem.21829; Lai H, 1997, BIOELECTROMAGNETICS, V18, P446, DOI 10.1002/(SICI)1521-186X(1997)18:6<446::AID-BEM7>3.0.CO;2-2; Lin JC, 1989, ELECTROMAGNETIC INTE, DOI [10.1007/978-1-4684-8059-7, DOI 10.1007/978-1-4684-8059-7]; Mason P. A., 2001, PROC ASIAN OCEAN REG, P1; Merlynn F, 2013, KANSAS J MED, P84; Nam KC, 2009, BIOELECTROMAGNETICS, V30, P641, DOI 10.1002/bem.20518; NELSON AW, 1977, J SURG RES, V23, P215, DOI 10.1016/0022-4804(77)90024-5; Obreja O, 2002, FASEB J, V16, P1497, DOI 10.1096/fj.02-0101com; Paysant J, 2004, ARCH PHYS MED REHAB, V85, P737, DOI 10.1016/j.apmr.2003.06.024; Rajapaksha TW, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-88; Rajput K, 2012, CLIN J PAIN, V28, P639, DOI 10.1097/AJP.0b013e31823d30a2; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; Rubin GJ, 2011, BIOELECTROMAGNETICS, V32, P593, DOI 10.1002/bem.20690; Schafers M, 2008, NEUROSCI LETT, V437, P188, DOI 10.1016/j.neulet.2008.03.052; Schafers M, 2003, J NEUROSCI, V23, P2517; Schafers M, 2003, J NEUROSCI, V23, P3028; Velizarov S, 1999, BIOELECTROCH BIOENER, V48, P177, DOI 10.1016/S0302-4598(98)00238-4; Wang J, 2015, NEUROSCI LETT, V588, P159, DOI 10.1016/j.neulet.2015.01.010; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; YUH WTC, 1992, JMRI-J MAGN RESON IM, V2, P221, DOI 10.1002/jmri.1880020216	39	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0144268	10.1371/journal.pone.0144268	http://dx.doi.org/10.1371/journal.pone.0144268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760033	Green Published, gold			2022-12-27	WOS:000368033100005
J	Jiang, Q; Yu, T; Huang, KL; Lu, J; Zhang, H; Hu, SS				Jiang, Qin; Yu, Tao; Huang, Keli; Lu, Jing; Zhang, Hao; Hu, Shengshou			Remote Ischemic Postconditioning Ameliorates the Mesenchymal Stem Cells Engraftment in Reperfused Myocardium	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; STROMAL CELLS; INJURY; INFARCTION; CARDIOPROTECTION; MECHANISMS; APOPTOSIS; SURVIVAL; THERAPY; DISEASE	Objectives Remote Ischemic postconditioning (RIPoC) is a cardioprotective strategy for alleviating the reperfusion injury. We hypothesized that RIPoC or ischemic postconditioning (IPoC) could protect the engrafted mesenchymal stem cells (MSCs) in reperfusion myocardium. Methods Female Sprague-Dawley rats were subject to 30 minutes of occlusion of left anterior descending (LAD). Ischemia reperfusion (IR) received reperfusion without interruption after ischemia. RIPoC received 3 cycles of 30 seconds reperfusion and re-occlusion on the limb at the onset of reperfusion. IPoC received 3 cycles of 30 seconds reperfusion and re-occlusion on the LAD at the same time. Male MSCs were intramyocardially administered after ischemia. Results Compared with that in IR group, ischemic myocardium in RIPoC+IPoC group, RIPoC group and IPoC group were found to have higher anti-oxidative stress and mitochondrial function level, lower lipid peroxidation and inflammational injury level, higher level of stromal cell derived factor-1 alpha and vascular endothelium growth factor gene expression at 3 days later. By immunohistochemical examination and quantitative polymerase chain reaction, more engrafted MSCs, better cardiac function and less cardiac fibrosis in RIPoC+IPoC group, RIPoC group and IPoC group were detected at 3 weeks after delivery. There were no significant differences between RIPoC and RIPoC+IPoC group. Conclusions Combination therapy using intramyocardial MSCs transplantation with RIPoC enhanced transplantation efficiency and cardiac function, and reduced cardiac fibrosis. These beneficial effects were mainly attributed to hospitable milieu for engrafted cells. IPoC could not render additional effect on MSCs engraftment elicited by RIPoC.	[Jiang, Qin; Yu, Tao; Huang, Keli] Univ Elect Sci & Technol, Affiliated Hosp, Sichuan Prov Peoples Hosp, Dept Cardiac Surg, Chengdu, Peoples R China; [Lu, Jing] Univ Elect Sci & Technol, Affiliated Hosp, Sichuan Prov Peoples Hosp, Dept Anesthesiol, Chengdu, Peoples R China; [Zhang, Hao; Hu, Shengshou] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhang, Hao; Hu, Shengshou] Peking Union Med Coll, Beijing 100021, Peoples R China	Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Huang, KL (corresponding author), Univ Elect Sci & Technol, Affiliated Hosp, Sichuan Prov Peoples Hosp, Dept Cardiac Surg, Chengdu, Peoples R China.	kelihuang028@hotmail.com; 51600244@qq.com			Sichuan Provincial People's Hospital [30305030842]	Sichuan Provincial People's Hospital	This work was supported by a doctorate grant of Sichuan Provincial People's Hospital (30305030842; http://www.samsph.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Huang WH, 2014, CARDIOVASC RES, V101, P266, DOI 10.1093/cvr/cvt250; Jiang Q, 2013, J MOL CELL CARDIOL, V56, P1, DOI 10.1016/j.yjmcc.2012.12.016; Karantalis V, 2015, CIRC RES, V116, P1413, DOI 10.1161/CIRCRESAHA.116.303614; Karantalis V, 2014, CIRC RES, V114, P1302, DOI 10.1161/CIRCRESAHA.114.303180; Liu JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126715; Luo ZY, 1997, ANN THORAC SURG, V64, P993, DOI 10.1016/S0003-4975(97)00715-7; Mansour Z, 2012, J VASC SURG, V56, P774, DOI 10.1016/j.jvs.2012.01.079; Meybohm P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007588; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Ong SG, 2014, CARDIOVASC RES, V104, P24, DOI 10.1093/cvr/cvu172; Ovize M, 2013, CIRC RES, V113, P439, DOI 10.1161/CIRCRESAHA.113.300764; Prunier F, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0400-y; Shahzad T, 2013, J MOL CELL CARDIOL, V58, P209, DOI 10.1016/j.yjmcc.2013.01.003; Shi WW, 2012, CARDIOVASC RES, V94, P206, DOI 10.1093/cvr/cvs088; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; van Domburg RT, 2005, J AM COLL CARDIOL, V46, P15, DOI 10.1016/j.jacc.2005.03.047; Wang W, 2011, REGEN MED, V6, P179, DOI [10.2217/rme.10.104, 10.2217/RME.10.104]; Wang W, 2010, CELL TRANSPLANT, V19, P1599, DOI 10.3727/096368910X513982; Xie L, 2015, J MOL CELL CARDIOL, V80, P156, DOI 10.1016/j.yjmcc.2015.01.007; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134666; Zhang H, 2010, J CELL MOL MED, V14, P1975, DOI 10.1111/j.1582-4934.2009.00886.x; Zhang H, 2010, J CELL MOL MED, V14, P1078, DOI 10.1111/j.1582-4934.2010.01076.x; Zhu M, 2006, CARDIOVASC RES, V72, P152, DOI 10.1016/j.cardiores.2006.06.027	29	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146074	10.1371/journal.pone.0146074	http://dx.doi.org/10.1371/journal.pone.0146074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760781	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100026
J	Mitaka, Y; Kobayashi, K; Mikheyev, A; Tin, MMY; Watanabe, Y; Matsuura, K				Mitaka, Yuki; Kobayashi, Kazuya; Mikheyev, Alexander; Tin, Mandy M. Y.; Watanabe, Yutaka; Matsuura, Kenji			Caste-Specific and Sex-Specific Expression of Chemoreceptor Genes in a Termite	PLOS ONE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; ODORANT-BINDING PROTEINS; CHEMOSENSORY PROTEINS; SOCIAL INSECTS; QUEEN SUCCESSION; GENOME SEQUENCE; APIS-MELLIFERA; HONEY-BEE; FAMILY; IDENTIFICATION	The sophisticated colony organization of eusocial insects is primarily maintained through the utilization of pheromones. The regulation of these complex social interactions requires intricate chemoreception systems. The recent publication of the genome of Zootermopsis nevadensis opened a new avenue to study molecular basis of termite caste systems. Although there has been a growing interest in the termite chemoreception system that regulates their sophisticated caste system, the relationship between division of labor and expression of chemoreceptor genes remains to be explored. Using high-throughput mRNA sequencing (RNA-seq), we found several chemoreceptors that are differentially expressed among castes and between sexes in a subterranean termite Reticulitermes speratus. In total, 53 chemoreception-related genes were annotated, including 22 odorant receptors, 7 gustatory receptors, 12 ionotropic receptors, 9 odorant-binding proteins, and 3 chemosensory proteins. Most of the chemoreception-related genes had caste-related and sex-related expression patterns; in particular, some chemoreception genes showed king-biased or queen-biased expression patterns. Moreover, more than half of the genes showed significant age-dependent differences in their expression in female and/or male reproductives. These results reveal a strong relationship between the evolution of the division of labor and the regulation of chemoreceptor gene expression, thereby demonstrating the chemical communication and underlining chemoreception mechanism in social insects.	[Mitaka, Yuki; Kobayashi, Kazuya; Matsuura, Kenji] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Insect Ecol, Kyoto 6068502, Japan; [Mikheyev, Alexander; Tin, Mandy M. Y.; Watanabe, Yutaka] Okinawa Inst Sci & Technol Grad Univ, Ecol & Evolut Unit, Okinawa 9040495, Japan	Kyoto University; Okinawa Institute of Science & Technology Graduate University	Matsuura, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Insect Ecol, Kyoto 6068502, Japan.	kenjijpn@kais.kyoto-u.ac.jp	Matsuura, Kenji/H-8364-2019; Mikheyev, Alexander/E-7999-2013; Mitaka, Yuki/AAS-2227-2020; kobayashi, kazuya/J-5507-2013	Matsuura, Kenji/0000-0002-9099-6694; Mikheyev, Alexander/0000-0003-4369-1019; Mitaka, Yuki/0000-0002-3399-3470; kobayashi, kazuya/0000-0002-9475-6807	Japan Society for the Promotion of Science [25221206]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html, No. 25221206 to KM).	Abdel-Latief M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001319; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; [Anonymous], 1971, INSECT SOC; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jacquin-Joly E, 2004, J CHEM ECOL, V30, P2359, DOI 10.1007/s10886-004-7941-3; Jin X, 2006, ARTHROPOD STRUCT DEV, V35, P47, DOI 10.1016/j.asd.2005.11.001; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Light SF, 1944, EXPT STUDIES ECTOHOR; Lucher M., 1961, SOCIAL CONTROL POLYM; LUSCHER M, 1952, Z VERGL PHYSIOL, V34, P123; Matsuura K, 2001, INSECT SOC, V48, P378, DOI 10.1007/PL00001795; Matsuura K, 2010, P NATL ACAD SCI USA, V107, P12963, DOI 10.1073/pnas.1004675107; Matsuura K, 2009, SCIENCE, V323, P1687, DOI 10.1126/science.1169702; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964; Mitchell RF, 2012, INSECT BIOCHEM MOLEC, V42, P499, DOI 10.1016/j.ibmb.2012.03.007; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato Koji, 2009, Folia Pharmacologica Japonica, V134, P248; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Sun HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107059; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WILSON EO, 1965, SCIENCE, V149, P1064, DOI 10.1126/science.149.3688.1064; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, DOI 10.1017/CBO9780511615061; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yamamoto Y, 2012, BEHAV ECOL SOCIOBIOL, V66, P39, DOI 10.1007/s00265-011-1249-4; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Yashiro T, 2014, P NATL ACAD SCI USA, V111, P17212, DOI 10.1073/pnas.1412481111	56	25	25	3	966	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146125	10.1371/journal.pone.0146125	http://dx.doi.org/10.1371/journal.pone.0146125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760975	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100027
J	Richter, J; Panayiotou, C; Tryfonos, C; Koptides, D; Koliou, M; Kalogirou, N; Georgiou, E; Christodoulou, C				Richter, Jan; Panayiotou, Christakis; Tryfonos, Christina; Koptides, Dana; Koliou, Maria; Kalogirou, Nikolas; Georgiou, Eleni; Christodoulou, Christina			Aetiology of Acute Respiratory Tract Infections in Hospitalised Children in Cyprus	PLOS ONE			English	Article							REAL-TIME PCR; INFLUENZA-LIKE ILLNESS; SYNCYTIAL-VIRUS; VIRAL ETIOLOGY; EPIDEMIOLOGY; DIAGNOSIS; COINFECTION; SEASONALITY; PNEUMONIA	In order to improve clinical management and prevention of viral infections in hospitalised children improved etiological insight is needed. The aim of the present study was to assess the spectrum of respiratory viral pathogens in children admitted to hospital with acute respiratory tract infections in Cyprus. For this purpose nasopharyngeal swab samples from 424 children less than 12 years of age with acute respiratory tract infections were collected over three epidemic seasons and were analysed for the presence of the most common 15 respiratory viruses. A viral pathogen was identified in 86% of the samples, with multiple infections being observed in almost 20% of the samples. The most frequently detected viruses were RSV (30.4%) and Rhinovirus (27.4%). RSV exhibited a clear seasonality with marked peaks in January/February, while rhinovirus infections did not exhibit a pronounced seasonality being detected almost throughout the year. While RSV and PIV3 incidence decreased significantly with age, the opposite was observed for influenza A and B as well as adenovirus infections. The data presented expand our understanding of the epidemiology of viral respiratory tract infections in Cypriot children and will be helpful to the clinicians and researchers interested in the treatment and control of viral respiratory tract infections.	[Richter, Jan; Panayiotou, Christakis; Tryfonos, Christina; Koptides, Dana; Christodoulou, Christina] Cyprus Inst Neurol & Genet, Dept Mol Virol, Nicosia, Cyprus; [Koliou, Maria; Kalogirou, Nikolas; Georgiou, Eleni] Archbishop Makarios III Hosp, Dept Pediat, Nicosia, Cyprus		Richter, J (corresponding author), Cyprus Inst Neurol & Genet, Dept Mol Virol, Nicosia, Cyprus.	richter@cing.ac.cy			European Regional Development Fund; Republic of Cyprus through the Research Promotion Foundation [YGammaEIA/DeltaYGammaEIA/0609(BIE/25)]; Republic of Cyprus	European Regional Development Fund(European Commission); Republic of Cyprus through the Research Promotion Foundation; Republic of Cyprus	The work was co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation grant number Y Gamma EIA/Delta Y Gamma EIA/0609(BIE/25). ("Co-funded" refers to the fact that the money came from both the European Regional Development Fund AND the Republic of Cyprus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Berry M, 2015, VIRUSES-BASEL, V7, P996, DOI 10.3390/v7030996; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Cho HJ, 2013, PEDIATR INT, V55, P49, DOI 10.1111/j.1442-200X.2012.03727.x; Cui BL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0863-6; Essa S, 2015, ADV VIROL, V2015, DOI 10.1155/2015/714062; Farley R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub4; Fry AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015098; Halasa N, 2015, VACCINE; Harada Y, 2013, PEDIATR INFECT DIS J, V32, P441, DOI 10.1097/INF.0b013e31828ba08c; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hoare Z, 2006, BMJ-BRIT MED J, V332, P1077, DOI 10.1136/bmj.332.7549.1077; Hombrouck A, 2012, EUR J CLIN MICROBIOL, V31, P999, DOI 10.1007/s10096-011-1398-4; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Kesson AM, 2007, PAEDIATR RESPIR REV, V8, P240, DOI 10.1016/j.prrv.2007.07.003; Khadadah M, 2010, J MED VIROL, V82, P1462, DOI 10.1002/jmv.21823; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068081; Kim JK, 2013, J MICROBIOL BIOTECHN, V23, P267, DOI 10.4014/jmb.1212.12050; Louie JK, 2009, PEDIATR INFECT DIS J, V28, P337, DOI 10.1097/INF.0b013e31818ffc1b; Low D, 2008, CLIN MICROBIOL INFEC, V14, P298, DOI 10.1111/j.1469-0691.2007.01910.x; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Lu YQ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/210490; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Pierangeli A, 2007, J MED VIROL, V79, P463, DOI 10.1002/jmv.20832; Puzelli S, 2009, J MED VIROL, V81, P2066, DOI 10.1002/jmv.21610; Regamey N, 2008, PEDIATR INFECT DIS J, V27, P100, DOI 10.1097/INF.0b013e31815922c8; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Richards J. C., 2014, ENGLISH FOREIGN LANG, P1; Schlaudecker EP, 2012, PEDIATR INFECT DIS J, V31, P1113, DOI 10.1097/INF.0b013e31826052eb; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Tryfonos C, 2011, J MED MICROBIOL, V60, P1433, DOI 10.1099/jmm.0.029892-0; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Wenzel RP, 2006, NEW ENGL J MED, V355, P2125, DOI 10.1056/NEJMcp061493; World Health Organization, 2009, CDC PROT REALT RTPCR; Wu XD, 2015, RESPIRATION, V89, P343, DOI 10.1159/000369561; Zaas AK, 2014, TRENDS MOL MED, V20, P579, DOI 10.1016/j.molmed.2014.08.001	41	29	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147041	10.1371/journal.pone.0147041	http://dx.doi.org/10.1371/journal.pone.0147041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761647	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100066
J	Seifert, L; Wiechmann, I; Harbeck, M; Thomas, A; Grupe, G; Projahn, M; Scholz, HC; Riehm, JM				Seifert, Lisa; Wiechmann, Ingrid; Harbeck, Michaela; Thomas, Astrid; Grupe, Gisela; Projahn, Michaela; Scholz, Holger C.; Riehm, Julia M.			Genotyping Yersinia pestis in Historical Plague: Evidence for Long-Term Persistence of Y-pestis in Europe from the 14th to the 17th Century	PLOS ONE			English	Article							GENOME; DNA	Ancient DNA (aDNA) recovered from plague victims of the second plague pandemic (14th to 17th century), excavated from two different burial sites in Germany, and spanning a time period of more than 300 years, was characterized using single nucleotide polymorphism (SNP) analysis. Of 30 tested skeletons 8 were positive for Yersinia pestis-specific nucleic acid, as determined by qPCR targeting the pla gene. In one individual (MP-19-II), the pla copy number in DNA extracted from tooth pulp was as high as 700 gene copies/mu l, indicating severe generalized infection. All positive individuals were identical in all 16 SNP positions, separating phylogenetic branches within nodes N07_N10 (14 SNPs), N07_N08 (SNP s19) and N06_N07 (s545), and were highly similar to previously investigated plague victims from other European countries. Thus, beside the assumed continuous reintroduction of Y. pestis from central Asia in multiple waves during the second pandemic, long-term persistence of Y. pestis in Europe in a yet unknown reservoir host has also to be considered.	[Seifert, Lisa; Wiechmann, Ingrid; Grupe, Gisela] Univ Munich, Munich, Germany; [Harbeck, Michaela] State Collect Anthropol & Palaeoanat, Munich, Germany; [Thomas, Astrid; Projahn, Michaela; Scholz, Holger C.; Riehm, Julia M.] Bundeswehr Inst Microbiol, Munich, Germany	University of Munich; Bundeswehr Institute of Microbiology (IMB)	Scholz, HC (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	Holger1scholz@bundeswehr.org	Projahn, Michaela/O-7430-2018; Projahn, Michaela/GSD-6357-2022	Projahn, Michaela/0000-0002-3896-3561; 	US Department of Homeland Security Science and Technology Directorate [DHS-09-ST-108-001]	US Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS))	MP was funded by the US Department of Homeland Security Science and Technology Directorate via award DHS-09-ST-108-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyadurai S, 2010, EMERG INFECT DIS, V16, P892, DOI 10.3201/eid1605.091280; Bergdolt Klaus, 2006, PEST GESCH SCHWARZEN; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Dalitz S, 2011, 21 HIST VER BRAND, P67; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Duncan CJ, 2005, POSTGRAD MED J, V81, P315, DOI 10.1136/pgmj.2004.024075; Gutsmiedl-Schumann D, EUROPEAN J IN PRESS; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Harbeck M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003349; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Schmid BV, 2015, P NATL ACAD SCI USA, V112, P3020, DOI 10.1073/pnas.1412887112; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Seifert L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075742; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2; Wiechmann I, 2010, EMERG INFECT DIS, V16, P1806, DOI 10.3201/eid1611.100598	17	40	41	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145194	10.1371/journal.pone.0145194	http://dx.doi.org/10.1371/journal.pone.0145194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760973	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100009
J	Weatherdon, LV; Ota, Y; Jones, MC; Close, DA; Cheung, WWL				Weatherdon, Lauren V.; Ota, Yoshitaka; Jones, Miranda C.; Close, David A.; Cheung, William W. L.			Projected Scenarios for Coastal First Nations' Fisheries Catch Potential under Climate Change: Management Challenges and Opportunities	PLOS ONE			English	Article								Studies have demonstrated ways in which climate-related shifts in the distributions and relative abundances of marine species are expected to alter the dynamics and catch potential of global fisheries. While these studies assess impacts on large-scale commercial fisheries, few efforts have been made to quantitatively project impacts on small-scale subsistence and commercial fisheries that are economically, socially and culturally important to many coastal communities. This study uses a dynamic bioclimate envelope model to project scenarios of climate-related changes in the relative abundance, distribution and richness of 98 exploited marine fishes and invertebrates of commercial and cultural importance to First Nations in coastal British Columbia, Canada. Declines in abundance are projected for most of the sampled species under both the lower (Representative Concentration Pathway [RCP] 2.6) and higher (RCP 8.5) emission scenarios (-15.0% to -20.8%, respectively), with poleward range shifts occurring at a median rate of 10.3 to 18.0 km decade(-1) by 2050 relative to 2000. While a cumulative decline in catch potential is projected coastwide (-4.5 to -10.7%), estimates suggest a strong positive correlation between the change in relative catch potential and latitude, with First Nations' territories along the northern and central coasts of British Columbia likely to experience less severe declines than those to the south. Furthermore, a strong negative correlation is projected between latitude and the number of species exhibiting declining abundance. These trends are shown to be robust to alternative species distribution models. This study concludes by discussing corresponding management challenges that are likely to be encountered under climate change, and by highlighting the value of joint-management frameworks and traditional fisheries management approaches that could aid in offsetting impacts and developing site-specific mitigation and adaptation strategies derived from local fishers' knowledge.	[Weatherdon, Lauren V.; Jones, Miranda C.; Cheung, William W. L.] Univ British Columbia, Changing Ocean Res Unit, Global Fisheries Cluster, Inst Oceans & Fisheries, Vancouver, BC V5Z 1M9, Canada; [Weatherdon, Lauren V.] UNEP World Conservat Monitoring Ctr, Cambridge, England; [Ota, Yoshitaka; Jones, Miranda C.; Cheung, William W. L.] Univ British Columbia, NF UBC Nereus Program, Inst Oceans & Fisheries, Vancouver, BC V5Z 1M9, Canada; [Ota, Yoshitaka; Close, David A.] Univ British Columbia, Aboriginal Fisheries Res Unit, Inst Oceans & Fisheries, Vancouver, BC V5Z 1M9, Canada; [Jones, Miranda C.] Univ Cambridge, Dept Zool, Cambridge, England	University of British Columbia; University of British Columbia; University of British Columbia; University of Cambridge	Weatherdon, LV (corresponding author), Univ British Columbia, Changing Ocean Res Unit, Global Fisheries Cluster, Inst Oceans & Fisheries, Vancouver, BC V5Z 1M9, Canada.	lauren.weatherdon@unep-wcmc.org		Weatherdon, Lauren V./0000-0002-3989-027X	Canada Graduate Scholarship from the Social Sciences and Humanities Research Council of Canada [766-2013-0832]; Natural Sciences and Engineering Research Council of Canada [22R68146]; NF-UBC Nereus Program	Canada Graduate Scholarship from the Social Sciences and Humanities Research Council of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NF-UBC Nereus Program	This study was funded by a Canada Graduate Scholarship from the Social Sciences and Humanities Research Council of Canada (http://www.sshrc-crsh.gc.ca/; #766-2013-0832; LVW), a grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/; #22R68146; WWLC), and financial support from the NF-UBC Nereus Program (http://www.nereusprogram.org/; YO WWLC LVW). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145285	10.1371/journal.pone.0145285	http://dx.doi.org/10.1371/journal.pone.0145285			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761439	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100011
J	Kwon, Y; Norby, FL; Jensen, PN; Agarwal, SK; Soliman, EZ; Lip, GYH; Longstreth, WT; Alonso, A; Heckbert, SR; Chen, LY				Kwon, Younghoon; Norby, Faye L.; Jensen, Paul N.; Agarwal, Sunil K.; Soliman, Elsayed Z.; Lip, Gregory Y. H.; Longstreth, W. T., Jr.; Alonso, Alvaro; Heckbert, Susan R.; Chen, Lin Y.			Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; STRATIFICATION SCHEMES; PREDICTING STROKE; MORTALITY; THROMBOEMBOLISM; ANTICOAGULATION; CONSUMPTION; ADULTS; PARTICIPANTS; VALIDATION	Atrial fibrillation (AF) is associated with an increased risk of ischemic stroke and cardiovascular (CV) death. Whether modifiable lifestyle risk factors are associated with these CV outcomes in AF is unknown. Among Atherosclerosis Risk in Communities (ARIC) study and Cardiovascular Health Study (CHS) participants with incident AF, we estimated the risk of composite endpoint of ischemic stroke or CV death associated with candidate modifiable risk factor (smoking, heavy alcohol consumption, or high body mass index [BMI]), and computed the C-statistic, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) of incorporating each factor into the CHA(2)DS(2)-VASc. Among 1222 ARIC (mean age: 63.4) and 756 CHS (mean age: 79.1) participants with incident AF, during mean follow-up of 6.9 years and 5.7 years, there were 332 and 335 composite events respectively. Compared with never smokers, current smokers had a higher incidence of the composite endpoint in ARIC [HR: 1.65 (1.21-2.26)] but not in CHS [HR: 1.05 (0.69-1.61)]. In ARIC, the addition of current smoking did not improve risk prediction over and above the CHA(2)DS(2)-VASc. No significant associations were observed with alcohol consumption or BMI with CVD outcomes in AF patients from either cohort. Smoking is associated with an increased risk of ischemic stroke or CV death in ARIC, which comprised mostly middle-aged to young-old (65-74 years), but not in CHS, which comprised mostly middle-old or oldest-old (>= 75 years) adults with AF. However, addition of smoking to the CHA(2)DS(2)-VASc score did not improve risk prediction of these outcomes.	[Kwon, Younghoon; Chen, Lin Y.] Univ Minnesota, Dept Med, Div Cardiovasc Med, Minneapolis, MN 55455 USA; [Norby, Faye L.; Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Jensen, Paul N.; Longstreth, W. T., Jr.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Agarwal, Sunil K.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Med Cardiol, Winston Salem, NC USA; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; Johns Hopkins University; Wake Forest University; Wake Forest University; University of Birmingham; Aalborg University; University of Washington; University of Washington Seattle	Kwon, Y (corresponding author), Univ Virginia, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22903 USA.	yk2j@hscmail.mcc.virginia.edu	Soliman, Elsayed Z/AAD-7135-2020; Alonso, Alvaro/A-4917-2010; Norby, Faye/FNA-7255-2022	Soliman, Elsayed Z/0000-0001-5632-8150; Alonso, Alvaro/0000-0002-2225-8323; Norby, Faye/0000-0002-1975-0405; Chen, Lin/0000-0002-0700-814X	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN26820110 0009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, U01HL080295, HL102214]; National Institute on Aging (NIA) [R01AG023629];  [T32-HL069764]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL102214, T32HL069764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042660, R01AG023629] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Atherosclerosis Risk in Communities Study was carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN26820110 0009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The Cardiovascular Health Study was supported by contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, and grants U01HL080295 and HL102214 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by R01AG023629 from the National Institute on Aging (NIA). The first author was supported by T32-HL069764. A full list of principal CHS investigators and institutions can be found at CHS-NHLBI.org.	Albertsen IE, 2014, CHEST, V145, P559, DOI 10.1378/chest.13-1740; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Apiyasawat S, 2015, INT J CARDIOL, V185, P293, DOI 10.1016/j.ijcard.2015.03.180; Badheka AO, 2010, AM J MED, V123, P646, DOI 10.1016/j.amjmed.2009.11.026; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; ERIKSSON H, 1987, EUR HEART J, V8, P1007, DOI 10.1093/oxfordjournals.eurheartj.a062365; Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fuchs FD, 2001, HYPERTENSION, V37, P1242, DOI 10.1161/01.HYP.37.5.1242; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Lip GYH, 2015, J AM COLL CARDIOL, V65, P1385, DOI 10.1016/j.jacc.2015.01.044; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Longstreth WT, 2001, NEUROLOGY, V56, P368, DOI 10.1212/WNL.56.3.368; Manolio TA, 1996, STROKE, V27, P1479, DOI 10.1161/01.STR.27.9.1479; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Newman AB, 2009, J GERONTOL A-BIOL, V64, P1251, DOI 10.1093/gerona/glp127; Overvad TF, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.11.024; Overvad TF, 2013, HEART, V99, P1093, DOI 10.1136/heartjnl-2013-304036; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Psaty BM, 1997, CIRCULATION, V96, P2455; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Streppel MT, 2009, J EPIDEMIOL COMMUN H, V63, P534, DOI 10.1136/jech.2008.082198; Svendsen JH, 2013, HEART, V99, P843, DOI 10.1136/heartjnl-2013-303695; Tolstrup JS, 2014, AM J PUBLIC HEALTH, V104, P96, DOI 10.2105/AJPH.2012.301091; Wanahita N, 2008, AM HEART J, V155, P310, DOI 10.1016/j.ahj.2007.10.004; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wattanakit K, 2005, ATHEROSCLEROSIS, V180, P389, DOI 10.1016/j.atherosclerosis.2004.11.024; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	35	37	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0147065	10.1371/journal.pone.0147065	http://dx.doi.org/10.1371/journal.pone.0147065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CG	26756465	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800044
J	Vasquez, A; Cabieses, B; Tunstall, H				Vasquez, Andrea; Cabieses, Baltica; Tunstall, Helena			Where Are Socioeconomically Deprived Immigrants Located in Chile? A Spatial Analysis of Census Data Using an Index of Multiple Deprivation from the Last Three Decades (1992-2012)	PLOS ONE			English	Article								Introduction and Purpose of the Study Immigrants in Chile have diverse characteristics and include socioeconomically deprived populations. The location of socioeconomically deprived immigrants is important for the development of public policy intelligence at the local and national levels but their areas of residence have not been mapped in Chile. This study explored the spatial distribution of socioeconomic deprivation among immigrants in Chile, 1992-2012, and compared it to the total population. Material and Methods Areas with socioeconomically deprived populations were identified with a deprivation index which we developed modelled upon the Index of Multiple Deprivation (IMD) for England. Our IMD was based upon the indicators of unemployment, low educational level (primary) and disability from Census data at county level for the three decades 1992, 2002 and 2012, for 332, 339 and 343 counties respectively. We developed two versions of the IMD one based on disadvantage among the total population and another focused upon the circumstances of immigrants only. We generated a spatial representation of the IMD using GIS, for the overall IMD score and for each dimension of the index, separately. We also compared the immigrants 'IMD to the total population's IMD using Pearson's correlation test. Results Results showed that socioeconomically deprived immigrants tended to be concentrated in counties in the northern and central area of Chile, in particular within the Metropolitan Region of Santiago. These were the same counties where there was the greatest concentration of socioeconomic deprivation for the total population during the same time periods. Since 1992 there have been significant change in the location of the socioeconomically deprived populations within the Metropolitan Region of Santiago with the highest IMD scores for both the total population and immigrants becoming increasingly concentrated in the central and eastern counties of the Region. Conclusion This is the first study analysing the spatial distribution of socioeconomic deprivation among international immigrants and the total population in a Latin American country. Findings could inform policy makers about location of areas of higher need of social protection in Chile, for both immigrants and the total resident population in the country.	[Vasquez, Andrea; Cabieses, Baltica] Univ Desarrollo, Fac Med Clin Alemana, Santiago, Chile; [Vasquez, Andrea] Pontificia Univ Catolica Chile, Natl Res Ctr Integrated Nat Disaster Management C, Fondap 15110017, Sch Engn, Santiago, Chile; [Cabieses, Baltica] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Tunstall, Helena] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland	Universidad del Desarrollo; Pontificia Universidad Catolica de Chile; University of York - UK; University of Edinburgh	Vasquez, A (corresponding author), Univ Desarrollo, Fac Med Clin Alemana, Santiago, Chile.	andrea.vasquez@cigiden.cl	Cabieses, Baltica/V-5024-2017	Cabieses, Baltica/0000-0003-0756-1954	Universidad del Desarrollo; Fondecyt [11130042]; Conicyt, Chile	Universidad del Desarrollo; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was conducted with the support of the Universidad del Desarrollo research-funding award 2012 BC (URL:http://www.udd.cl/), and the Fondecyt research grant number 11130042 from Conicyt, Chile (2013-2017) BC (URL: http://www.conicyt.cl/fondecyt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albala C, 1995, PUBLIC HEALTH, V109, P431, DOI 10.1016/S0033-3506(95)80048-4; [Anonymous], 2002, CENS HOUS POP; [Anonymous], 2011, REPORT SELECTED COUN; Arteaga Óscar, 2002, Rev Panam Salud Publica, V11, P374, DOI 10.1590/S1020-49892002000500012; Bradshaw J, 2009, CHILD INDIC RES, V2, P201, DOI 10.1007/s12187-008-9022-6; Buchan James, 2006, HLTH WORKER MIGRATIO; CARSTAIRS V, 1989, COMMUNITY MED, V11, P210, DOI 10.1093/oxfordjournals.pubmed.a042469; Centro Latinoamericano y Caribenho de Demografia, 2008, LAT AM CAR INT MIGR; Chackiel J, 2010, NOTAS POBLACION CEPA, P43; De Jong G. F., 1999, MIGRATION RESTRUCTUR, P273; Departamento de Extranjeria y Migracion, 2014, REV SUR; Departamento de Extranjeria y Migracion, 2007, DES FEN MIGR CHIL EV; EASTERLIN RA, 1961, ECON DEV CULT CHANGE, V9, P331, DOI 10.1086/449911; Faist T, 2000, VOLUME DYNAMICS INT, P50; Galabuzi GE, 2010, SOCIAL COHESION SOCI; Gordon D, 1995, J EPIDEMIOL COMMUN H, V49, pS39, DOI 10.1136/jech.49.Suppl_2.S39; Gordon D., 2003, NEIGHBORHOODS HLTH; GREENWOOD MJ, 1985, J REGIONAL SCI, V25, P521, DOI 10.1111/j.1467-9787.1985.tb00321.x; Haisken-DeNew J, 2007, SOCIAL DEPRIVATION E; Haisken-DeNew J, 2010, REV INCOME WEALTH, V56, P715, DOI 10.1111/j.1475-4991.2010.00417.x; Infante A, 2000, Rev Panam Salud Publica, V8, P13, DOI 10.1590/S1020-49892000000700005; International Organization for Migration Ministerio de Salud de Chile, 2008, MIGR SAL CHIL EST SA; JuanCarlos Feres, 2001, SERIES ESTUDIOS ESTA; Kiljoong K., 2013, SPATIALITY IMMIGRANT; Krieger N, 2003, NEIGHBORHOODS HLTH; Labonte R, 2007, GLOBAL HLTH, P1; Ley D, 2000, URBAN STUD, V37, P37, DOI 10.1080/0042098002285; Martine G., 2000, ASPECTOS SOCIALES MI; Martinez J, 2014, CEPAL SERIE POBLACIO, P3; National Institute of Statistics (Chile), 2012, SINT GEOGR NAC; National Institute of Statistics (Chile), DEM VIT PROD EST; National Institute of Statistics (Chile), 2010, LOS CENS EN CHIL; National Institute of Statistics (Chile), 2012, SINT GEOGR REG; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; Organization of American States, 2011, 1 ORG AM STAT INT MI; Pyle Jean L., 2006, GLOBALIZATIONS, V3, P283; Scharf Thomas, 2005, Eur J Ageing, V2, P76, DOI 10.1007/s10433-005-0025-6; Schiappacasse Cambiaso Paulina, 2008, Rev. geogr. Norte Gd., P21; Schrecker T, 2008, LANCET, V372, P1670, DOI 10.1016/S0140-6736(08)61691-8; Stefoni C., 2001, REPRESENTACIONES CUL; Townsend PP., 1988, HLTH DEPRIVATION INE; UK Department of communities and local government, 2011, ENGL IND DEPR 2010 G; *UN, 2006, TRENDS TOT MIGR STOC; UN-INSTRAW, 2012, CAD GLOB CUID 2007 2; United Nations, WORLD MIGR MAN MIGR; Villa M., 2001, MAPA MIGRATORIO INT; Wacquant Loic, 2001, PARIAS URBANOS MARGI; Wacquant Loic, 2000, CARCELES MISERIA; Yuan Y, 2014, HABITAT INT, V41, P142, DOI 10.1016/j.habitatint.2013.07.010	49	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146047	10.1371/journal.pone.0146047	http://dx.doi.org/10.1371/journal.pone.0146047			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CG	26756869	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800007
J	Cho, EJ; Choi, SH; Kim, JH; Kim, JE; Lee, MH; Chung, BY; Woo, HR; Kim, JH				Cho, Eun Ju; Choi, Seung Hee; Kim, Ji Hong; Kim, Ji Eun; Lee, Min Hee; Chung, Byung Yeoup; Woo, Hye Ryun; Kim, Jin-Hong			A Mutation in Plant-Specific SWI2/SNF2-Like Chromatin-Remodeling Proteins, DRD1 and DDM1, Delays Leaf Senescence in Arabidopsis thaliana	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; DNA METHYLATION; CHLOROPHYLL DEGRADATION; TRANSCRIPTION FACTOR; HISTONE METHYLATION; ENDOGENOUS TARGETS; PHOTOSYSTEM-II; GENE; IDENTIFICATION; GENOME	Leaf senescence is a finely regulated complex process; however, evidence for the involvement of epigenetic processes in the regulation of leaf senescence is still fragmentary. Therefore, we chose to examine the functions of DRD1, a SWI2/SNF2 chromatin remodeling protein, in epigenetic regulation of leaf senescence, particularly because drd1-6 mutants exhibited a delayed leaf senescence phenotype. Photosynthetic parameters such as Fv/Fm and ETRmax were decreased in WT leaves compared to leaves of drd1-6 mutants after dark treatment. The WT leaves remarkably lost more chlorophyll and protein content during dark-induced senescence (DIS) than the drd1-6 leaves did. The induction of senescenceassociated genes was noticeably inhibited in the drd1-6 mutant after 5-d of DIS. We compared changes in epigenetic regulation during DIS via quantitative expression analysis of 180-bp centromeric (CEN) and transcriptionally silent information (TSI) repeats. Their expression levels significantly increased in both the WT and the drd1-6 mutant, but did much less in the latter. Moreover, the delayed leaf senescence was observed in ddm1-2 mutants as well as the drd1-6, but not in drd1-p mutants. These data suggest that SWI2/SNF2 chromatin remodeling proteins such as DRD1 and DDM1 may influence leaf senescence possibly via epigenetic regulation.	[Cho, Eun Ju; Choi, Seung Hee; Kim, Ji Hong; Kim, Ji Eun; Lee, Min Hee; Chung, Byung Yeoup; Kim, Jin-Hong] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup Si 56212, Jeollabuk Do, South Korea; [Woo, Hye Ryun] DGIST, Dept New Biol, Daegu 42988, South Korea; [Kim, Jin-Hong] Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope Sci, Daejeon 34113, South Korea	Korea Atomic Energy Research Institute (KAERI); Daegu Gyeongbuk Institute of Science & Technology (DGIST); University of Science & Technology (UST)	Kim, JH (corresponding author), Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup Si 56212, Jeollabuk Do, South Korea.	jhongkim@kaeri.re.kr			Nuclear R & D Program of the Ministry of Education, Science and Technology (MEST), Republic of Korea	Nuclear R & D Program of the Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Nuclear R & D Program of the Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay N, 2014, J EXP BOT, V65, P3875, DOI 10.1093/jxb/eru132; Ay N, 2009, PLANT J, V58, P333, DOI [10.1111/j.0960-7412.2009.03782.x, 10.1111/j.1365-313X.2008.03782.x]; BATE NJ, 1991, J EXP BOT, V42, P801, DOI 10.1093/jxb/42.6.801; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Breeze E, 2008, PLANT BIOLOGY, V10, P99, DOI 10.1111/j.1438-8677.2008.00076.x; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Folly P, 1999, J BIOL CHEM, V274, P21811, DOI 10.1074/jbc.274.31.21811; Gentry M, 2014, EXP CELL RES, V321, P40, DOI 10.1016/j.yexcr.2013.11.010; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Guo Y, 2004, PLANT CELL ENVIRON, V27, P521, DOI 10.1111/j.1365-3040.2003.01158.x; Han SK, 2012, PLANT CELL, V24, P4892, DOI 10.1105/tpc.112.105114; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Hoch WA, 2003, PLANT PHYSIOL, V133, P1296, DOI 10.1104/pp.103.027631; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Kanno T, 2005, EMBO REP, V6, P649, DOI 10.1038/sj.embor.7400446; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kim JH, 2005, PLANT SCI, V168, P1115, DOI 10.1016/j.plantsci.2004.12.012; Kim JH, 2009, ENVIRON EXP BOT, V67, P363, DOI 10.1016/j.envexpbot.2009.07.001; Kruger N J, 1994, Methods Mol Biol, V32, P9; Kuriyama H, 2002, CURR OPIN PLANT BIOL, V5, P568, DOI 10.1016/S1369-5266(02)00305-9; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lim PO, 2005, CURR TOP DEV BIOL, V67, P49, DOI 10.1016/S0070-2153(05)67002-0; Lim PO, 2007, PLANT J, V52, P1140, DOI 10.1111/j.1365-313X.2007.03317.x; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; MAE T, 1984, PLANT CELL PHYSIOL, V25, P333; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Nooden LD, 1997, PHYSIOL PLANTARUM, V101, P746, DOI 10.1111/j.1399-3054.1997.tb01059.x; Obara K, 2001, PLANT PHYSIOL, V125, P615, DOI 10.1104/pp.125.2.615; Oh SA, 1997, PLANT J, V12, P527, DOI 10.1046/j.1365-313X.1997.00527.x; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Pontvianne F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001225; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; ROBERTS DR, 1987, PLANT MOL BIOL, V9, P343, DOI 10.1007/BF00014909; Sedivy JM, 2008, EXP CELL RES, V314, P1909, DOI 10.1016/j.yexcr.2008.02.023; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; SINGHAL RP, 1987, MECH AGEING DEV, V41, P199, DOI 10.1016/0047-6374(87)90040-6; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; Suorsa M, 2004, EUR J BIOCHEM, V271, P96, DOI 10.1046/j.1432-1033.2003.03906.x; Tsuchiya T, 2013, P NATL ACAD SCI USA, V110, pE3535, DOI 10.1073/pnas.1312545110; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wada S, 2009, PLANT PHYSIOL, V149, P885, DOI 10.1104/pp.108.130013; WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925; Zentgraf U, 2010, EUR J CELL BIOL, V89, P133, DOI 10.1016/j.ejcb.2009.10.014; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	58	23	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146826	10.1371/journal.pone.0146826	http://dx.doi.org/10.1371/journal.pone.0146826			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752684	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100158
J	Russell, KE; Chung, KF; Clarke, CJ; Durham, AL; Mallia, P; Footitt, J; Johnston, SL; Barnes, PJ; Hall, SR; Simpson, KD; Starkey, MR; Hansbro, PM; Adcock, IM; Wiegman, CH				Russell, Kirsty E.; Chung, Kian Fan; Clarke, Colin J.; Durham, Andrew L.; Mallia, Patrick; Footitt, Joseph; Johnston, Sebastian L.; Barnes, Peter J.; Hall, Simon R.; Simpson, Karen D.; Starkey, Malcolm R.; Hansbro, Philip M.; Adcock, Ian M.; Wiegman, Coen H.			The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; OBSTRUCTIVE PULMONARY-DISEASE; TAUTOMERASE ACTIVE-SITE; MOLECULAR-MECHANISMS; RHINOVIRUS INFECTION; HYPOXIA; ASTHMA; LIPOPOLYSACCHARIDE; HYPERSENSITIVITY; PATHOGENESIS	Introduction Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine associated with acute and chronic inflammatory disorders and corticosteroid insensitivity. Its expression in the airways of patients with chronic obstructive pulmonary disease (COPD), a relatively steroid insensitive inflammatory disease is unclear, however. Methods Sputum, bronchoalveolar lavage (BAL) macrophages and serum were obtained from nonsmokers, smokers and COPD patients. To mimic oxidative stress-induced COPD, mice were exposed to ozone for six-weeks and treated with ISO-1, a MIF inhibitor, and/or dexamethasone before each exposure. BAL fluid and lung tissue were collected after the final exposure. Airway hyperresponsiveness (AHR) and lung function were measured using whole body plethysmography. HIF-1 alpha binding to the Mif promoter was determined by Chromatin Immunoprecipitation assays. Results MIF levels in sputum and BAL macrophages from COPD patients were higher than those from non-smokers, with healthy smokers having intermediate levels. MIF expression correlated with that of HIF-1a in all patients groups and in ozone-exposed mice. BAL cell counts, cytokine mRNA and protein expression in lungs and BAL, including MIF, were elevated in ozone-exposed mice and had increased AHR. Dexamethasone had no effect on these parameters in the mouse but ISO-1 attenuated cell recruitment, cytokine release and AHR. Conclusion MIF and HIF-1 alpha levels are elevated in COPD BAL macrophages and inhibition of MIF function blocks corticosteroid-insensitive lung inflammation and AHR. Inhibition of MIF may provide a novel anti-inflammatory approach in COPD.	[Russell, Kirsty E.; Chung, Kian Fan; Clarke, Colin J.; Durham, Andrew L.; Barnes, Peter J.; Adcock, Ian M.; Wiegman, Coen H.] Royal Brompton NHS Fdn Trust, NIHR Resp Biomed Res Unit, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Russell, Kirsty E.; Chung, Kian Fan; Clarke, Colin J.; Durham, Andrew L.; Barnes, Peter J.; Adcock, Ian M.; Wiegman, Coen H.] Univ London Imperial Coll Sci Technol & Med, London, England; [Mallia, Patrick; Footitt, Joseph; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Infect Sect, London, England; [Hall, Simon R.; Simpson, Karen D.] GlaxoSmithKline, RRI DPU, Stevenage, Herts, England; [Starkey, Malcolm R.; Hansbro, Philip M.] Hunter Med Res Inst, Prior Res Ctr Resp Dis, Newcastle, NSW, Australia; [Starkey, Malcolm R.; Hansbro, Philip M.] Univ Newcastle, Newcastle, NSW 2300, Australia	Imperial College London; Royal Brompton Hospital; Imperial College London; Imperial College London; GlaxoSmithKline; Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Wiegman, CH (corresponding author), Royal Brompton NHS Fdn Trust, NIHR Resp Biomed Res Unit, Natl Heart & Lung Inst, Airway Dis Sect, London, England.	c.wiegman@imperial.ac.uk	Johnston, Sebastian Lennox/I-2423-2012; Adcock, Ian/L-3217-2019; Hansbro, Phil/G-7486-2013; Chung, Kian Fan/B-1872-2012	Johnston, Sebastian Lennox/0000-0003-3009-9200; Hansbro, Phil/0000-0002-4741-3035; Chung, Kian Fan/0000-0001-7101-1426; Wiegman, Coen/0000-0001-9161-0581; Adcock, Ian/0000-0003-2101-8843; Starkey, Malcolm/0000-0002-7359-7464; Barnes, Peter/0000-0002-5122-4018; Durham, Andrew/0000-0003-2372-4688	BBSRC CASE award; GSK; Medical Research Council Program [G0600879]; British Medical Association H. C. Roscoe Fellowships; British Lung Foundation/Severin Wunderman Family Foundation Lung Research Program [P00/2]; WellcomeTrust [083567/Z/07/Z]; National Institute for Health Research (NIHR) Biomedical Research Centre; NIHR respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation and Imperial College London; Wellcome Trust Programme [076472/2/05/Z]; MRC-ABPI COPDMAP consortia [G1001367/1]; Academy of Medical Sciences; Wellcome Trust Starter Grant award; MRC [G0600879] Funding Source: UKRI; Medical Research Council [G0600879] Funding Source: researchfish; National Institute for Health Research [CL-2008-21-014, NF-SI-0611-10148] Funding Source: researchfish; Asthma UK [CH11SJ] Funding Source: researchfish	BBSRC CASE award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GSK(GlaxoSmithKline); Medical Research Council Program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Medical Association H. C. Roscoe Fellowships; British Lung Foundation/Severin Wunderman Family Foundation Lung Research Program; WellcomeTrust(Wellcome Trust); National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation and Imperial College London; Wellcome Trust Programme(Wellcome Trust); MRC-ABPI COPDMAP consortia; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust Starter Grant award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	KR is the recipient of a BBSRC CASE award with GSK. This work was also supported in part by the Medical Research Council Program Grant G0600879 (KI, PJB, IMA and SLJ); British Medical Association H. C. Roscoe Fellowships (JF and PM); British Lung Foundation/Severin Wunderman Family Foundation Lung Research Program Grant P00/2 (SLJ); WellcomeTrust Grant 083567/Z/07/Z for the Centre for Respiratory Infection, Imperial College and the National Institute for Health Research (NIHR) Biomedical Research Centre funding scheme and by the NIHR respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation and Imperial College London. This work was also supported in part by a Wellcome Trust Programme Grant (076472/2/05/Z) to PJB and IMA. IMA and PJB are also supported through the MRC-ABPI COPDMAP consortia (G1001367/1). PM is supported by an Academy of Medical Sciences and Wellcome Trust Starter Grant award. PJB, SLJ and KFC are NIHR Senior Investigators. PH and MS are NIMRC Fellows. CHW was a RCUK Fellow. Authors SRH and KDS are employed by GSK. GSK provided support in the form of salaries for authors (SRH, KDS) and were included in the study design and data analysis and preparation of the manuscript (SRH, KDS). The specific roles of these authors are articulated in the "author contributions' section. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Beckett EL, 2013, J ALLERGY CLIN IMMUN, V131, P752, DOI 10.1016/j.jaci.2012.11.053; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brown V, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-24; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chen PF, 2010, MOL MED, V16, P400, DOI 10.2119/molmed.2009.00128; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Di Stefano A, 2004, CLIN EXP ALLERGY, V34, P1156, DOI 10.1111/j.1365-2222.2004.02030.x; Fallica J, 2014, AM J RESP CELL MOL B; Gaber T, 2011, J IMMUNOL, V186, P764, DOI 10.4049/jimmunol.0903421; ( GOLD) GIfCOLD, 2013, GLOBAL STRATEGY DIAG; Hansbro PM, 2014, J BIOL CHEM, V289, P18214, DOI 10.1074/jbc.M114.548594; Hirano S, 1996, AM J PHYSIOL-LUNG C, V270, pL836, DOI 10.1152/ajplung.1996.270.5.L836; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kobayashi M, 2006, EUR RESPIR J, V27, P726, DOI 10.1183/09031936.06.00107004; Korsgren M, 2000, MEDIAT INFLAMM, V9, P15, DOI 10.1080/09629350050024339; Le Hiress M, 2015, AM J RESP CRIT CARE; Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B; Leech M, 1998, ARTHRITIS RHEUM-US, V41, P910, DOI 10.1002/1529-0131(199805)41:5<910::AID-ART19>3.0.CO;2-E; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080782; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Magalhaes ES, 2007, EUR J IMMUNOL, V37, P1097, DOI 10.1002/eji.200635968; Makita H, 1998, AM J RESP CRIT CARE, V158, P573, DOI 10.1164/ajrccm.158.2.9707086; Mallia P, 2012, AM J RESP CRIT CARE, V186, P1117, DOI 10.1164/rccm.201205-0806OC; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Mroz RM, 2007, J PHYSIOL PHARMACOL, V58, P437; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Sauler M, 2014, AM J PHYSL LUNG CELL; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; She Wei-bin, 2012, Zhonghua Nei Ke Za Zhi, V51, P863; Triantaphyllopoulos K, 2011, AM J PHYSIOL-LUNG C, V300, pL691, DOI 10.1152/ajplung.00252.2010; Wiegman CH, 1979, CLIN SCI; Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418	40	35	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146102	10.1371/journal.pone.0146102	http://dx.doi.org/10.1371/journal.pone.0146102			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752192	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100041
J	Vallone, F; Lai, S; Spalletti, C; Panarese, A; Alia, C; Micera, S; Caleo, M; Di Garbo, A				Vallone, Fabio; Lai, Stefano; Spalletti, Cristina; Panarese, Alessandro; Alia, Claudia; Micera, Silvestro; Caleo, Matteo; Di Garbo, Angelo			Post-Stroke Longitudinal Alterations of InterHemispheric Correlation and Hemispheric Dominance in Mouse Pre-Motor Cortex	PLOS ONE			English	Article							FREELY MOVING MICE; SENSORIMOTOR CORTEX; ISCHEMIC-STROKE; FORELIMB AREAS; FUNCTIONAL RECOVERY; GRANGER CAUSALITY; PREMOTOR CORTEX; CORTICAL INJURY; CEREBRAL-CORTEX; BRAIN	Purpose Limited restoration of function is known to occur spontaneously after an ischemic injury to the primary motor cortex. Evidence suggests that Pre-Motor Areas (PMAs) may "take over" control of the disrupted functions. However, little is known about functional reorganizations in PMAs. Forelimb movements in mice can be driven by two cortical regions, Caudal and Rostral Forelimb Areas (CFA and RFA), generally accepted as primary motor and premotor cortex, respectively. Here, we examined longitudinal changes in functional coupling between the two RFAs following unilateral photothrombotic stroke in CFA (mm from Bregma: +0.5 anterior, +1.25 lateral). Methods Local field potentials (LFPs) were recorded from the RFAs of both hemispheres in freely moving injured and naive mice. Neural signals were acquired at 9, 16 and 23 days after surgery (sub-acute period in stroke animals) through one bipolar electrode per hemisphere placed in the center of RFA, with a ground screw over the occipital bone. LFPs were preprocessed through an efficient method of artifact removal and analysed through: spectral, cross-correlation, mutual information and Granger causality analysis. Results Spectral analysis demonstrated an early decrease (day 9) in the alpha band power in both the RFAs. In the late sub-acute period (days 16 and 23), inter-hemispheric functional coupling was reduced in ischemic animals, as shown by a decrease in the cross-correlation and mutual information measures. Within the gamma and delta bands, correlation measures were already reduced at day 9. Granger analysis, used as a measure of the symmetry of the inter-hemispheric causal connectivity, showed a less balanced activity in the two RFAs after stroke, with more frequent oscillations of hemispheric dominance. Conclusions These results indicate robust electrophysiological changes in PMAs after stroke. Specifically, we found alterations in transcallosal connectivity, with reduced inter-hemispheric functional coupling and a fluctuating dominance pattern. These reorganizations may underlie vicariation of lost functions following stroke.	[Vallone, Fabio; Di Garbo, Angelo] CNR, Inst Biophys, I-56100 Pisa, Italy; [Vallone, Fabio; Lai, Stefano; Panarese, Alessandro; Micera, Silvestro] Scuola Super Sant Anna, Translat Neural Engn Area, Biorobot Inst, Pisa, Italy; [Spalletti, Cristina; Caleo, Matteo] CNR, Neurosci Inst, I-56100 Pisa, Italy; [Spalletti, Cristina] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy; [Alia, Claudia] Scuola Normale Super Pisa, Pisa, Italy; [Micera, Silvestro] Ecole Polytech Fed Lausanne, Bertarelli Fdn Chair Translat Neuroengn, Ctr Neuroprosthet, Lausanne, Switzerland; [Micera, Silvestro] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Engn, Lausanne, Switzerland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Scuola Superiore Sant'Anna; Consiglio Nazionale delle Ricerche (CNR); Scuola Superiore Sant'Anna; Scuola Normale Superiore di Pisa; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Di Garbo, A (corresponding author), CNR, Inst Biophys, I-56100 Pisa, Italy.	angelo.digarbo@pi.ibf.cnr.it	Micera, Silvestro/AAD-6630-2021; Vallone, Fabio/AAA-5329-2019; Alia, Claudia/AAM-3555-2020; Spalletti, Cristina/GZK-3184-2022	Vallone, Fabio/0000-0001-8911-9611; Alia, Claudia/0000-0001-9440-5663; CALEO, MATTEO/0000-0002-4333-6378; PANARESE, Alessandro/0000-0002-4918-3069	Fondazione Pisa [158/2011]	Fondazione Pisa	The authors disclose receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Fondazione Pisa (GRANT: 158/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H., 1997, ANAL OBSERVED CHAOTI, V1997; Assenza G, 2015, CLIN NEUROPHYSIOL, V126, P1221, DOI 10.1016/j.clinph.2014.09.029; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Barry MD, 2014, EXP NEUROL, V261, P258, DOI 10.1016/j.expneurol.2014.05.023; BuchkremerRatzmann I, 1997, NEUROREPORT, V8, P519, DOI 10.1097/00001756-199701200-00028; Butefisch C, 2008, NEUROREHABIL NEURAL; Butz M, 2004, NEUROSCI LETT, V355, P93, DOI 10.1016/j.neulet.2003.10.065; Buzsaki G, 1988, NEUROSCI; Buzsaki G, 2011, RHYTHMS BRAIN; Buzsaki G, 2015, NAT NEUROSCI, V18, P484, DOI 10.1038/nn.3952; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chen JL, 2013, J NEUROSCI, V33, P17631, DOI 10.1523/JNEUROSCI.3255-13.2013; Chen XY, 2007, J NEUROPHYSIOL, V98, P878, DOI 10.1152/jn.00283.2007; Choi JH, 2010, J NEUROPHYSIOL, V104, P1825, DOI 10.1152/jn.00188.2010; Dancause N, 2006, NEUROSCIENTIST, V12, P489, DOI 10.1177/1073858406292782; Deffeyes JE, 2015, J NEUROPHYSIOL; Dijkhuizen RM, 2012, TRANSL STROKE RES, V3, P36, DOI 10.1007/s12975-011-0143-8; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guarino Irene, 2004, Neural Plasticity, V11, P241, DOI 10.1155/NP.2004.241; Guggenmos DJ, 2013, P NATL ACAD SCI USA, V110, P21177, DOI 10.1073/pnas.1316885110; Hira R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00055; James GA, 2009, TOP STROKE REHABIL, V16, P270, DOI 10.1310/tsr1604-270; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Joho RH, 1999, J NEUROPHYSIOL, V82, P1855, DOI 10.1152/jn.1999.82.4.1855; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Kantz H., 2004, NONLINEAR TIME SERIE; Keinath AT, 2014, HIPPOCAMPUS, V24, P1533, DOI 10.1002/hipo.22333; Kim YK, 2014, NEUROREHAB NEURAL RE, V28, P576, DOI 10.1177/1545968313520411; Kinsbourne M, 1974, CHILD DEV; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Lai S, 2015, NEUROREHAB NEURAL RE, V29, P382, DOI 10.1177/1545968314545174; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Liu Y, 1999, EXP BRAIN RES, V128, P149, DOI 10.1007/s002210050830; Magara F, 1998, NEUROSCIENCE, V87, P243, DOI 10.1016/S0306-4522(98)00161-4; Mainardi M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00001; Mansoori BK, 2014, EXP NEUROL, V254, P18, DOI 10.1016/j.expneurol.2014.01.010; Marshall AC, 2000, AM HEART J, V140, P303, DOI 10.1067/mhj.2000.108236; Marwan N, 2002, PHYS LETT A, V302, P299, DOI 10.1016/S0375-9601(02)01170-2; MATELLI M, 1991, J COMP NEUROL, V311, P445, DOI 10.1002/cne.903110402; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; ROOM P, 1989, J NEUROSCI METH, V27, P191, DOI 10.1016/0165-0270(89)90080-0; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Saiki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098662; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Schroeter M, 2002, J NEUROSCI METH, V117, P43, DOI 10.1016/S0165-0270(02)00072-9; Silasi G, 2014, NEURON, V83, P1354, DOI 10.1016/j.neuron.2014.08.052; Spalletti C, 2014, NEUROREHAB NEURAL RE, V28, P188, DOI 10.1177/1545968313506520; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Umeda T, 2011, EUR J NEUROSCI, V34, P1453, DOI 10.1111/j.1460-9568.2011.07866.x; van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124; Vanderwolf CH, 1975, HIPPOCAMPUS, V2, P101; Vannini E, 2015, BRAIN STRUCT FUNCT; Viaro R, 2014, J PHYSIOL-LONDON, V592, P2137, DOI 10.1113/jphysiol.2013.268821; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Westlake KP, 2012, EXP NEUROL, V237, P160, DOI 10.1016/j.expneurol.2012.06.020; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107; Wu WQ, 2011, CLIN NEUROPHYSIOL, V122, P21, DOI 10.1016/j.clinph.2010.06.003; Yu CL, 2015, J NEUROSCI METH, V239, P100, DOI 10.1016/j.jneumeth.2014.10.004; Zeiler SR, 2013, CURR OPIN NEUROL, V26, P609, DOI 10.1097/WCO.0000000000000025; Zilles K, 1996, ADV NEUROL, V70, P29	77	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146858	10.1371/journal.pone.0146858	http://dx.doi.org/10.1371/journal.pone.0146858			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752066	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100166
J	Wang, T; Wang, HJ; Wang, XX				Wang, Tao; Wang, Hongjue; Wang, Xiaoxia			CD-Based Indices for Link Prediction in Complex Network	PLOS ONE			English	Article							PROTEIN INTERACTIONS; MISSING LINKS	Lots of similarity-based algorithms have been designed to deal with the problem of link prediction in the past decade. In order to improve prediction accuracy, a novel cosine similarity index CD based on distance between nodes and cosine value between vectors is proposed in this paper. Firstly, node coordinate matrix can be obtained by node distances which are different from distance matrix and row vectors of the matrix are regarded as coordinates of nodes. Then, cosine value between node coordinates is used as their similarity index. A local community density index LD is also proposed. Then, a series of CD-based indices include CD-LD-k, CD*LD-k, CD-k and CDI are presented and applied in ten real networks. Experimental results demonstrate the effectiveness of CD-based indices. The effects of network clustering coefficient and assortative coefficient on prediction accuracy of indices are analyzed. CD-LD-k and CD*LD-k can improve prediction accuracy without considering the assortative coefficient of network is negative or positive. According to analysis of relative precision of each method on each network, CD-LD-k and CD*LD-k indices have excellent average performance and robustness. CD and CD-k indices perform better on positive assortative networks than on negative assortative networks. For negative assortative networks, we improve and refine CD index, referred as CDI index, combining the advantages of CD index and evolutionary mechanism of the network model BA. Experimental results reveal that CDI index can increase prediction accuracy of CD on negative assortative networks.	[Wang, Tao; Wang, Hongjue] North China Elect Power Univ, Sch Math & Phys, Baoding, Hebei Province, Peoples R China; [Wang, Xiaoxia] North China Elect Power Univ, Sch Control & Comp Engn, Baoding, Hebei Province, Peoples R China	North China Electric Power University; North China Electric Power University	Wang, T (corresponding author), North China Elect Power Univ, Sch Math & Phys, Baoding, Hebei Province, Peoples R China.	wtwxx@163.com			Fundamental Research Funds for the Central Universities [13MS108]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the Fundamental Research Funds for the Central Universities (Grant No. 13MS108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern KR, 2014, J FINANC, V69, P527, DOI 10.1111/jofi.12122; Al Hasan M, 2011, SOCIAL NETWORK DATA ANALYTICS, P243; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barzel B, 2013, NAT BIOTECHNOL, V31, P720, DOI 10.1038/nbt.2601; Boas PRV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026106; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cannistraci CV, 2013, BIOINFORMATICS, V29, P199, DOI 10.1093/bioinformatics/btt208; Cannistraci CV, 2013, SCI REP-UK, V3, DOI 10.1038/srep01613; Chen BL, 2014, APPL INTELL, V41, P694, DOI 10.1007/s10489-014-0558-5; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Crone SF, 2005, DMIN '05: PROCEEDINGS OF THE 2005 INTERNATIONAL CONFERENCE ON DATA MINING, P215; Cui AX, 2011, ACTA PHYS SIN-CH ED, V60, DOI 10.7498/aps.60.038901; Ding JY, 2015, PHYSICA A, V417, P76, DOI 10.1016/j.physa.2014.09.005; Dong LY, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/125123; Estrada E, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/03/P03008; Faqeeh A, 2012, PHYSICA A, V391, P2463, DOI 10.1016/j.physa.2011.12.017; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Garlaschelli D, 2010, SYMMETRY-BASEL, V2, P1683, DOI 10.3390/sym2031683; Gorni G, 2001, I MATH ACAD POLONAIS, V76, P113; Grabowski A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066110; Guha R., 2004, P 13 INT C WORLD WID, P403, DOI [10.1145/988672.988727, DOI 10.1145/988672.988727]; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2003, PHYS REV E, V68, P93; Hasan M Al, 2006, P SIAM DAT MIN WORKS; He YL, 2015, EXPERT SYST APPL, V42, P21, DOI 10.1016/j.eswa.2014.07.018; Hu T, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/6/060508; Kashima H, 2006, IEEE DATA MINING, P340; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Li FH, 2014, PROCEDIA COMPUT SCI, V29, P432, DOI 10.1016/j.procs.2014.05.039; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lichtenwalter R.N., 2010, P 16 ACM SIGKDD INT, P243; [刘宏鲲 LIU HongKun], 2011, [中国科学. 物理学, 力学, 天文学, Scientia Sinica Physica, Mechanica & Astronomica], V41, P816; Liu WP, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58007; Liu Z, 2015, CHAOS, V25, DOI 10.1063/1.4906371; Liu Z, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48007; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2015, P NATL ACAD SCI USA, V112, P2325, DOI 10.1073/pnas.1424644112; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; [吕琳媛 Lv Linyuan], 2010, [电子科技大学学报, Journal of University of Electronic Science and Technology of China], V39, P651; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Saito R, 2003, BIOINFORMATICS, V19, P756, DOI 10.1093/bioinformatics/btg070; Sarukkai RR, 2000, COMPUT NETW, V33, P377, DOI 10.1016/S1389-1286(00)00044-X; Sherkat E, 2015, PHYSICA A, V419, P80, DOI 10.1016/j.physa.2014.10.011; Tan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107056; Tang JL, 2015, WSDM'15: PROCEEDINGS OF THE EIGHTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P87, DOI 10.1145/2684822.2685295; Wang WQ, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/28004; [许小可 Xu Xiaoke], 2014, [复杂系统与复杂性科学, Complex Systems and Complexity Science], V11, P41; Yang Y., 2014, KNOWL INF SYST, P1; You ZH, 2010, BIOINFORMATICS, V26, P2744, DOI 10.1093/bioinformatics/btq510; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	53	3	4	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146727	10.1371/journal.pone.0146727	http://dx.doi.org/10.1371/journal.pone.0146727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752405	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100141
J	Zeng, XZ; Lu, ZF; Lv, XQ; Guo, YP; Cui, XG				Zeng, Xian-Zhang; Lu, Zhi-Fang; Lv, Xiang-Qi; Guo, Yue-Ping; Cui, Xiao-Guang			Epidural Co-Administration of Dexmedetomidine and Levobupivacaine Improves the Gastrointestinal Motility Function after Colonic Resection in Comparison to Co-Administration of Morphine and Levobupivacaine	PLOS ONE			English	Article							RAT SPINAL-CORD; BUPIVACAINE; CLONIDINE; SURGERY; ROPIVACAINE; ANESTHESIA; ANALGESIA; EFFICACY; TRANSIT	Gastrointestinal motility may be impaired after intestinal surgery. Epidural morphine is effective in controlling postoperative pain, but can further reduce gastrointestinal motility. Here, we aimed to investigate the effects of epidural dexmedetomidine on gastrointestinalmotility in patients undergoing colonic resection. Seventy-four patients undergoing colonic resection were enrolled in this clinical trial and allocated randomly to treatment with dexmedetomidine (D group) or morphine (M group). The D group received a loading dose epidural administration of 3 ml dexmedetomidine (0.5 mu g kg(-1)) and then a continuous epidural administration of 80 mu g dexmedetomidine in 150 ml levobupivacaine (0.125%) at 3 ml h(-1) for two days. The M group received a loading dose epidural administration of 3 ml morphine (0.03mg kg(-1)) and then a continuous epidural administration of 4.5 mg morphine in 150 ml levobupivacaine at 3ml h(-1) for two days. Verbal rating score (VRS), postoperative analgesic requirements, side effects related to analgesia, the time to postoperative first flatus (FFL) and first feces (FFE) were recorded. VRS and postoperative analgesic requirements were not significantly different between treatment groups. In contrast, the time to FFL and time to FFE were significant longer in M group in comparison to D group (P < 0.05). Moreover, patients in M group had a significantly higher incidence of nausea, vomiting, and pruritus (P < 0.05). No patients showed neurologic deficits in either group. In comparison to morphine, epidural dexmedetomidine is safe and beneficial for the recovery of gastrointestinalmotility after colonic resection when used as an adjunct with levobupivacaine for postoperative pain control.	[Zeng, Xian-Zhang; Lu, Zhi-Fang; Lv, Xiang-Qi; Guo, Yue-Ping; Cui, Xiao-Guang] Harbin Med Univ, Dept Anesthesiol, Hosp 2, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University	Cui, XG (corresponding author), Harbin Med Univ, Dept Anesthesiol, Hosp 2, 246 Xuefu Rd, Harbin 150001, Heilongjiang, Peoples R China.	cuixiaoguang1018@126.com						Asai T, 1997, BRIT J ANAESTH, V78, P301, DOI 10.1093/bja/78.3.301; Asano T, 2000, ANESTH ANALG, V90, P400, DOI 10.1097/00000539-200002000-00030; Aydin C, 2009, WORLD J GASTROENTERO, V15, P1620, DOI 10.3748/wjg.15.1620; Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016; El-Hennawy AM, 2009, BRIT J ANAESTH, V103, P268, DOI 10.1093/bja/aep159; Fairbanks CA, 2002, J PHARMACOL EXP THER, V300, P282, DOI 10.1124/jpet.300.1.282; Fukuda H, 2005, NEUROGASTROENT MOTIL, V17, P245, DOI 10.1111/j.1365-2982.2004.00602.x; Gupta R, 2011, INDIAN J ANAESTH, V55, P347, DOI 10.4103/0019-5049.84841; Holte K, 2000, BRIT J SURG, V87, P1480, DOI 10.1046/j.1365-2168.2000.01595.x; Iirola T, 2011, BRIT J ANAESTH, V106, P522, DOI 10.1093/bja/aer004; Ishii H, 2008, EUR J NEUROSCI, V27, P3182, DOI 10.1111/j.1460-9568.2008.06260.x; Kanazi GE, 2006, ACTA ANAESTH SCAND, V50, P222, DOI 10.1111/j.1399-6576.2006.00919.x; Konakci S, 2008, EUR J ANAESTH, V25, P403, DOI 10.1017/S0265021507003079; Memis D, 2006, EUR J ANAESTH, V23, P700, DOI 10.1017/S0265021506000512; Mohamed AA, 2012, PAIN PHYSICIAN, V15, P339; Rancourt MPM, 2012, ANESTH ANALG, V115, P958, DOI 10.1213/ANE.0b013e318265bab7; RAVINDRAN RS, 1982, ANESTH ANALG, V61, P279; RUFFOLO RR, 1993, ANNU REV PHARMACOL, V33, P243, DOI 10.1146/annurev.pharmtox.33.1.243; Salgado PFS, 2008, REV ASSOC MED BRAS, V54, P110, DOI 10.1590/S0104-42302008000200011; Solanki SL, 2013, ANAESTH INTENS CARE, V41, P51, DOI 10.1177/0310057X1304100110; Vieira Antônio Mauro, 2004, Rev. Bras. Anestesiol., V54, P473, DOI 10.1590/S0034-70942004000400003; Yoshitomi T, 2008, ANESTH ANALG, V107, P96, DOI 10.1213/ane.0b013e318176be73; Zeng XZ, 2014, ANAESTH INTENS CARE, V42, P185, DOI 10.1177/0310057X1404200204; Zhang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055556	24	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146215	10.1371/journal.pone.0146215	http://dx.doi.org/10.1371/journal.pone.0146215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751791	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100052
J	Littera, R; Chessa, L; Onali, S; Figorilli, F; Lai, S; Secci, L; La Nasa, G; Caocci, G; Arras, M; Melis, M; Cappellini, S; Balestrieri, C; Serra, G; Conti, M; Zolfino, T; Casale, M; Casu, S; Pasetto, MC; Barca, L; Salustro, C; Matta, L; Scioscia, R; Zamboni, F; Faa, G; Orru, S; Carcassi, C				Littera, Roberto; Chessa, Luchino; Onali, Simona; Figorilli, Francesco; Lai, Sara; Secci, Luca; La Nasa, Giorgio; Caocci, Giovanni; Arras, Marcella; Melis, Maurizio; Cappellini, Sara; Balestrieri, Cinzia; Serra, Giancarlo; Conti, Maria; Zolfino, Teresa; Casale, Michele; Casu, Stefania; Pasetto, Maria Cristina; Barca, Lucia; Salustro, Claudia; Matta, Laura; Scioscia, Rosetta; Zamboni, Fausto; Faa, Gavino; Orru, Sandro; Carcassi, Carlo			Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PRIMARY SCLEROSING CHOLANGITIS; PRIMARY BILIARY-CIRRHOSIS; T-CELLS; POSSIBLE ASSOCIATION; GENE KIR2DS1; NK CELLS; SUSCEPTIBILITY; DISEASE; KIRS	Background Natural killer cells are involved in the complex mechanisms underlying autoimmune diseases but few studies have investigated their role in autoimmune hepatitis. Killer immunoglobulin-like receptors are key regulators of natural killer cell-mediated immune responses. Methods and Findings KIR gene frequencies, KIR haplotypes, KIR ligands and combinations of KIRs and their HLA Class I ligands were investigated in 114 patients diagnosed with type 1 autoimmune hepatitis and compared with a group of 221 healthy controls. HLA Class I and Class II antigen frequencies were compared to those of 551 healthy unrelated families representative of the Sardinian population. In our cohort, type 1 autoimmune hepatitis was strongly associated with the HLA-B18, Cw5, DR3 haplotype. The KIR2DS1 activating KIR gene and the high affinity HLA-C2 ligands were significantly higher in patients compared to controls. Patients also had a reduced frequency of HLA-Bw4 ligands for KIR3DL1 and HLA-C1 ligands for KIR2DL3. Age at onset was significantly associated with the KIR2DS1 activating gene but not with HLA-C1 or HLA-C2 ligand groups. Conclusions The activating KIR gene KIR2DS1 resulted to have an important predictive potential for early onset of type 1 autoimmune hepatitis. Additionally, the low frequency of the KIR-ligand combinations KIR3DL1/HLA-Bw4 and KIR2DL3/HLA-C1 coupled to the high frequency of the HLA-C2 high affinity ligands for KIR2DS1 could contribute to unwanted NK cell autoreactivity in AIH-1.	[Littera, Roberto; Melis, Maurizio] R Binaghi Hosp, ASL 8, Reg Transplant Ctr, Cagliari, Italy; [Chessa, Luchino; Onali, Simona; Figorilli, Francesco; Secci, Luca; Casale, Michele; Casu, Stefania; Pasetto, Maria Cristina; Barca, Lucia; Salustro, Claudia; Matta, Laura; Scioscia, Rosetta] Univ Cagliari, Dept Med Sci M Aresu, Ctr Study Liver Dis, Cagliari, Italy; [Chessa, Luchino; Balestrieri, Cinzia; Serra, Giancarlo; Conti, Maria] Univ Hosp, Dept Internal Med, Cagliari, Italy; [Lai, Sara; Orru, Sandro; Carcassi, Carlo] R Binaghi Hosp, ASL 8, Med Genet, Cagliari, Italy; [La Nasa, Giorgio; Caocci, Giovanni; Arras, Marcella] R Binaghi Hosp, ASL 8, Bone Marrow Transplant Ctr, Cagliari, Italy; [La Nasa, Giorgio; Caocci, Giovanni] Univ Cagliari, Dept Med Sci M Aresu, Hematol Unit, Cagliari, Italy; [Cappellini, Sara; Zolfino, Teresa] G Brotzu Hosp, Dept Unit Liver Transplantat, Cagliari, Italy; [Zamboni, Fausto] G Brotzu Hosp, Dept Gen Surg, Div Liver & Pancreas Transplantat, Cagliari, Italy; [Faa, Gavino] Univ Cagliari, Dept Surg Sci, Div Pathol, Cagliari, Italy; [Orru, Sandro; Carcassi, Carlo] Univ Cagliari, Dept Med Sci M Aresu, Med Genet, Cagliari, Italy	University of Cagliari; University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari; University of Cagliari; University of Cagliari; University of Cagliari	Littera, R (corresponding author), R Binaghi Hosp, ASL 8, Reg Transplant Ctr, Cagliari, Italy.	roby.litter@gmail.com	Caocci, Giovanni/AAM-6674-2020; Chessa, Luchino/K-4255-2019; Littera, Roberto/N-9759-2016; LAI, SARA/GXV-2963-2022	Caocci, Giovanni/0000-0002-6585-5187; Chessa, Luchino/0000-0002-9474-0995; Littera, Roberto/0000-0003-3143-3792; Lai, Sara/0000-0002-8040-0631; Carcassi, Carlo/0000-0002-9533-1579; Melis, Maurizio/0000-0002-5857-781X; ORRU, SANDRO/0000-0001-5085-7975	Fondazione Banco di Sardegna [2014-1861]	Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	The research performed in this report falls within the institutional responsibilities of the investigators of the participating centers, all of which pertain to the Italian National Public Health Service. Grant funding (2014-1861) for part of the reagents was received from the "Fondazione Banco di Sardegna". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Bittencourt PL, 1999, AM J GASTROENTEROL, V94, P1906; Bjorkstrom NK, 2012, BLOOD, V120, P3455, DOI 10.1182/blood-2012-03-416867; Bogdanos DP, 2004, INT J IMMUNOPATH PH, V17, P83, DOI 10.1177/039463200401700112; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; CONTU L, 1992, TISSUE ANTIGENS, V40, P165, DOI 10.1111/j.1399-0039.1992.tb02041.x; Czaja AJ, 1997, HEPATOLOGY, V25, P317; Czaja AJ, 2005, ADV CLIN CHEM, V40, P127, DOI 10.1016/S0065-2423(05)40004-9; Czaja AJ, 2015, DIG DIS SCI; Czaja AJ, 2010, HEPATOLOGY, V52, P1177, DOI 10.1002/hep.23874; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; David G, 2013, J IMMUNOL, V191, P4778, DOI 10.4049/jimmunol.1301580; DONALDSON PT, 1991, HEPATOLOGY, V13, P701, DOI 10.1016/0270-9139(91)92567-R; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Liu PMF, 2013, WORLD J GASTROENTERO, V19, P4455, DOI 10.3748/wjg.v19.i28.4455; Ferri S, 2010, HEPATOLOGY, V52, P999, DOI 10.1002/hep.23792; Fogel LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4232; Folci M, 2014, INFLAMM CELL SIGNAL, V1, pe51, DOI DOI 10.14800/ICS.51; Fortes MD, 2007, LIVER INT, V27, P1409, DOI 10.1111/j.1478-3231.2007.01581.x; Gagne K, 2002, HUM IMMUNOL, V63, P271, DOI 10.1016/S0198-8859(02)00373-7; Guerini FR, 2011, J INFECT DIS, V203, P1235, DOI 10.1093/infdis/jir020; Heneghan MA, 2013, LANCET, V382, P1433, DOI 10.1016/S0140-6736(12)62163-1; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Hov JR, 2010, J HEPATOL, V52, P712, DOI 10.1016/j.jhep.2009.11.029; Invernizzi P, 2011, HEPATOLOGY, V54, P714, DOI 10.1002/hep.24414; Jiao YL, 2008, J CLIN IMMUNOL, V28, P343, DOI 10.1007/s10875-008-9183-6; Jobim M, 2008, TISSUE ANTIGENS, V72, P392, DOI 10.1111/j.1399-0039.2008.01096.x; Karlsen TH, 2007, J HEPATOL, V46, P899, DOI 10.1016/j.jhep.2007.01.032; Koh C, 2013, HEPATOLOGY, V58, P2142, DOI 10.1002/hep.26578; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lapierre P, 2007, TRANSL RES, V149, P107, DOI 10.1016/j.trsl.2006.11.010; LEWONTIN RC, 1964, GENETICS, V49, P49; Littera R, 2013, HUM IMMUNOL, V74, P1288, DOI 10.1016/j.humimm.2013.05.007; Lleo A, 2010, HEPATOLOGY, V52, P987, DOI 10.1002/hep.23783; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Marsh SGE, 2003, TISSUE ANTIGENS, V62, P79, DOI 10.1034/j.1399-0039.2003.00072.x; Mieli-Vergam G, 2008, WORLD J GASTROENTERO; Muratori P, 2005, WORLD J GASTROENTERO, V11, P1862, DOI 10.3748/wjg.v11.i12.1862; Nattermann J, 2011, J HEPATOL, V55, P265, DOI 10.1016/j.jhep.2011.01.005; Norris S, 1998, J HEPATOL, V28, P84, DOI 10.1016/S0168-8278(98)80206-7; Oo YH, 2010, HEPATOL INT, V4, P475, DOI 10.1007/s12072-010-9183-5; OTA M, 1992, IMMUNOGENETICS, V36, P49, DOI 10.1007/BF00209292; Pando M, 1999, HEPATOLOGY, V30, P1374, DOI 10.1002/hep.510300611; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Pellett F, 2007, TISSUE ANTIGENS, V69, P106, DOI 10.1111/j.1399-0039.2006.762_6.x; ROBINSON WP, 1991, GENETICS, V129, P925; Schramm C, 2014, J HEPATOL, V60, P478, DOI 10.1016/j.jhep.2013.11.025; Shimoda S, 2011, HEPATOLOGY, V53, P1270, DOI 10.1002/hep.24194; SLATKIN M, 1972, GENETICS, V72, P157; Strettell MDJ, 1997, GASTROENTEROLOGY, V112, P2028, DOI 10.1053/gast.1997.v112.pm9178696; Strettell MDJ, 1997, HEPATOLOGY, V26, P1023, DOI 10.1002/hep.510260434; THOMSON G, 1984, TISSUE ANTIGENS, V24, P250, DOI 10.1111/j.1399-0039.1984.tb02134.x; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Venstrom JM, 2012, NEW ENGL J MED, V367, P805, DOI 10.1056/NEJMoa1200503; Williams F, 2005, HUM IMMUNOL, V66, P836, DOI 10.1016/j.humimm.2005.04.005; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Zachou Kalliopi, 2004, J Autoimmune Dis, V1, P2, DOI 10.1186/1740-2557-1-2; Zhang WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092267	60	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146086	10.1371/journal.pone.0146086	http://dx.doi.org/10.1371/journal.pone.0146086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26744892	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600024
J	Martini, MC; Gonzalez, CA; Wiese, E				Martini, Molly C.; Gonzalez, Christian A.; Wiese, Eva			Seeing Minds in Others - Can Agents with Robotic Appearance Have Human-Like Preferences?	PLOS ONE			English	Article							ANTHROPOMORPHISM; PERCEPTION; ATTRIBUTION; ANIMACY; SELF; BIAS	Ascribing mental states to non-human agents has been shown to increase their likeability and lead to better joint-task performance in human-robot interaction (HRI). However, it is currently unclear what physical features non-human agents need to possess in order to trigger mind attribution and whether different aspects of having a mind (e.g., feeling pain, being able to move) need different levels of human-likeness before they are readily ascribed to non-human agents. The current study addresses this issue by modeling how increasing the degree of human-like appearance (on a spectrum from mechanistic to humanoid to human) changes the likelihood by which mind is attributed towards non-human agents. We also test whether different internal states (e.g., being hungry, being alive) need different degrees of humanness before they are ascribed to non-human agents. The results suggest that the relationship between physical appearance and the degree to which mind is attributed to non-human agents is best described as a two-linear model with no change in mind attribution on the spectrum from mechanistic to humanoid robot, but a significant increase in mind attribution as soon as human features are included in the image. There seems to be a qualitative difference in the perception of mindful versus mindless agents given that increasing human-like appearance alone does not increase mind attribution until a certain threshold is reached, that is: agents need to be classified as having a mind first before the addition of more human-like features significantly increases the degree to which mind is attributed to that agent.	[Martini, Molly C.; Gonzalez, Christian A.; Wiese, Eva] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	George Mason University	Martini, MC (corresponding author), George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA.	mmarti35@masonlive.gmu.edu						Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Ames DL, 2008, PSYCHOL SCI, V19, P642, DOI 10.1111/j.1467-9280.2008.02135.x; Arnhold E, 2014, EASYNLS EASY NONLINE; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Breazeal C, 2000, ADAPT BEHAV, V8, P49, DOI 10.1177/105971230000800104; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Cohen J., 2003, APPL MULTIPLE REGRES; Davis MH, 1996, J PERS SOC PSYCHOL, V70, P713, DOI 10.1037/0022-3514.70.4.713; Dennett Daniel C., 1987, INTENTIONAL STANCE; Epley N, 2008, SOC COGNITION, V26, P143, DOI 10.1521/soco.2008.26.2.143; Epley N, 2007, PSYCHOL REV, V114, P864, DOI 10.1037/0033-295X.114.4.864; Flykt A., 1998, THE KAROLINSKA DIREC; Fong T, 2003, ROBOT AUTON SYST, V42, P143, DOI 10.1016/S0921-8890(02)00372-X; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Hackel LM, 2014, J EXP SOC PSYCHOL, V52, P15, DOI 10.1016/j.jesp.2013.12.001; Kay AC, 2008, J PERS SOC PSYCHOL, V95, P18, DOI 10.1037/0022-3514.95.1.18; Kiesler S, 2008, SOC COGNITION, V26, P169, DOI 10.1521/soco.2008.26.2.169; Klein AM, 2009, Q J EXP PSYCHOL, V62, P1189, DOI 10.1080/17470210802384214; Looser CE, 2010, PSYCHOL SCI, V21, P1854, DOI 10.1177/0956797610388044; Morewedge CK, 2009, J EXP PSYCHOL GEN, V138, P535, DOI 10.1037/a0016796; Powers KE, 2014, PSYCHOL SCI, V25, P1943, DOI 10.1177/0956797614547706; Ristic J, 2005, COGNITION, V94, pB55, DOI 10.1016/j.cognition.2004.04.005; Rosset E, 2008, COGNITION, V108, P771, DOI 10.1016/j.cognition.2008.07.001; Scassellati B, 1998, 1628 MIT ART INT LAB; Simmel M, 1944, AM J PSYCHOL, P243, DOI 102307/1416950; Waytz A, 2010, TRENDS COGN SCI, V14, P383, DOI 10.1016/j.tics.2010.05.006; Waytz A, 2010, PERSPECT PSYCHOL SCI, V5, P219, DOI 10.1177/1745691610369336; Wiese E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045391; Wykowska A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094339	29	39	39	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146310	10.1371/journal.pone.0146310	http://dx.doi.org/10.1371/journal.pone.0146310			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA5AX	26745500	gold, Green Published, Green Submitted			2022-12-27	WOS:000367815600038
J	van der Stap, T; Coolen, JWP; Lindeboom, HJ				van der Stap, Tim; Coolen, Joop W. P.; Lindeboom, Han J.			Marine Fouling Assemblages on Offshore Gas Platforms in the Southern North Sea: Effects of Depth and Distance from Shore on Biodiversity	PLOS ONE			English	Article							RIGS-TO-REEFS; CORAL LOPHELIA-PERTUSA; LONG-TERM DYNAMICS; GULF-OF-MEXICO; OIL PLATFORMS; COMMUNITIES; GROWTH; INSTALLATIONS; DISTURBANCE; FOUNDATION	Offshore platforms are known to act as artificial reefs, though there is on-going debate on whether this effect is beneficial or harmful for the life in the surrounding marine environment. Knowing what species exist on and around the offshore platforms and what environmental variables influence this species assemblage is crucial for a better understanding of the impact of offshore platforms on marine life. Information on this is limited for offshore platforms in the southern North Sea. This study aims to fill this gap in our knowledge and to determine how the composition and the abundance of species assemblages changes with depth and along a distance-from-shore gradient. The species assemblages on five offshore gas platforms in the southern North Sea have been inventoried using Remotely Operated Vehicles inspection footage. A total of 30 taxa were identified. A Generalised Additive Model of the species richness showed a significant non-linear relation with water depth (p = 0.001): from a low richness in shallow waters it increases with depth until 15-20 m, after which richness decreases again. Using PERMANOVA, water depth (p <= 0.001), community age (p <= 0.001) and the interaction between distance from shore and community age (p <= 0.001) showed a significant effect on the species assemblages. Future research should focus on the effect additional environmental variables have on the species assemblages.	[van der Stap, Tim; Coolen, Joop W. P.; Lindeboom, Han J.] IMARES Wageningen UR, Inst Marine Resource & Ecosyst Studies, NL-1780 AB Den Helder, Netherlands; [van der Stap, Tim; Coolen, Joop W. P.; Lindeboom, Han J.] Wageningen UR, Chair Grp Aquat Ecol & Water Qual Management, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Coolen, JWP (corresponding author), IMARES Wageningen UR, Inst Marine Resource & Ecosyst Studies, POB 57, NL-1780 AB Den Helder, Netherlands.	joop.coolen@wur.nl	Coolen, Joop W.P./AAG-9704-2019; Cunningham, Susan/AAR-3915-2020	Coolen, Joop W.P./0000-0002-8127-6097; van der Stap, Tim/0000-0002-0053-0795; Cunningham, Susan/0000-0001-9934-2585	Wageningen University & Research centre [KB-14-007]; Nederlandse Aardolie Maatschappij BV; Wintershall Holding GmbH; EBN B.V.; JWPC	Wageningen University & Research centre; Nederlandse Aardolie Maatschappij BV; Wintershall Holding GmbH; EBN B.V.; JWPC	The work reported in this publication was funded by the Wageningen University & Research centre (http://www.wageningenur.nl) TripleP@Sea Innovation program (KB-14-007; received by TVDS, JWPC and HJL) and with financial support from the Nederlandse Aardolie Maatschappij BV (NAM; http://www.nam.nl), Wintershall Holding GmbH (http://www.wintershall.com) and EBN B.V. (http://www.ebn.nl), all received by JWPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], RICE U STUDIES; [Anonymous], 2014, R LANG ENV STAT COMP; Bergmark P, 2014, MAR ECOL PROG SER, V516, P275, DOI 10.3354/meps10997; Bouma Sietse, 2013, Nederlandse Faunistische Mededelingen, V41, P61; Bram JB, 2005, J EXP MAR BIOL ECOL, V317, P223, DOI 10.1016/j.jembe.2004.12.003; Butler AJ, 1999, MAR ECOL PROG SER, V182, P109, DOI 10.3354/meps182109; Butler AJ, 1996, BIOFOULING, V9, P187, DOI 10.1080/08927019609378303; Caselle JE, 2002, ICES J MAR SCI, V59, pS258, DOI 10.1006/jmsc.2002.1264; Claisse JT, 2014, P NATL ACAD SCI USA, V111, P15462, DOI 10.1073/pnas.1411477111; Cleveland W. S., 1985, ELEMENTS GRAPHING DA; Coolen Joop W. P., 2015, Marine Biodiversity Records, V8, pe140, DOI 10.1017/S1755267215001165; Coolen JWP, 2015, J SEA RES, V103, P84, DOI 10.1016/j.seares.2015.06.010; Cripps SJ, 2002, ICES J MAR SCI, V59, pS300, DOI 10.1006/jmsc.2002.1293; De Mesel I, 2015, HYDROBIOLOGIA, V756, P37, DOI 10.1007/s10750-014-2157-1; England PR, 2008, MAR FRESHWATER RES, V59, P515, DOI 10.1071/MF07224; EWEA, 2015, EUR OFFSH WIND IND K; FORTEATH GNR, 1982, MAR ECOL PROG SER, V8, P61, DOI 10.3354/meps008061; Fowler AM, 2014, OCEAN COAST MANAGE, V87, P20, DOI 10.1016/j.ocecoaman.2013.10.019; Fowler AM, 2015, P NATL ACAD SCI USA, V112, pE102, DOI 10.1073/pnas.1422274112; Gass SE, 2006, MAR POLLUT BULL, V52, P549, DOI 10.1016/j.marpolbul.2005.10.002; Goddard JHR, 2010, B MAR SCI, V86, P533; Guerin A. J., 2009, THESIS; HARDY FG, 1981, BOT MAR, V24, P173, DOI 10.1515/botm.1981.24.4.173; Helvey M, 2002, ICES J MAR SCI, V59, pS266, DOI 10.1006/jmsc.2002.1226; Jickells TD, 1998, SCIENCE, V281, P217, DOI 10.1126/science.281.5374.217; Jorgensen D, 2012, FRONT ECOL ENVIRON, V10, P178, DOI 10.1890/12.WB.012; Jorgensen D, 2012, OCEAN COAST MANAGE, V58, P57, DOI 10.1016/j.ocecoaman.2011.12.012; Jorgensen T, 2002, ICES J MAR SCI, V59, pS288, DOI 10.1006/jmsc.2001.1165; Judge ML, 1997, J EXP MAR BIOL ECOL, V210, P209, DOI 10.1016/S0022-0981(96)02691-3; Kaplan SW, 1984, MAR BIOL ASS, V79, P155, DOI [10.1016/0022-0981(84)90216, DOI 10.1016/0022-0981(84)90216-]; Kerckhof F, 2010, UNDERWATER TECHNOL, V29, P137, DOI 10.3723/ut.29.137; Krone R, 2013, MAR ENVIRON RES, V85, P1, DOI 10.1016/j.marenvres.2012.12.004; Langhamer O, 2009, P 28 INT C OC OFFSH; Langhamer O, 2009, ESTUAR COAST SHELF S, V82, P426, DOI 10.1016/j.ecss.2009.02.009; Leewis R, 2000, ARTIFICIAL REEFS IN EUROPEAN SEAS, P419; Lengkeek W., 2013, NED FAUN MEDED, V40, P49; LEWBEL GS, 1987, MAR ENVIRON RES, V21, P199, DOI 10.1016/0141-1136(87)90066-3; Lindeboom HJ, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035101; Lindeboom H, 2015, HYDROBIOLOGIA, V756, P169, DOI 10.1007/s10750-015-2267-4; Lokkeborg S, 2002, ICES J MAR SCI, V59, pS294, DOI 10.1006/jmsc.2002.1218; Macreadie PI, 2012, FRONT ECOL ENVIRON, V10, P179, DOI 10.1890/12.WB.013; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P177, DOI 10.1890/12.WB.011; MATHERS EM, 1992, MAR ECOL PROG SER, V86, P31, DOI 10.3354/meps086031; MOSS BL, 1981, BOT MAR, V24, P207, DOI 10.1515/botm.1981.24.4.207; Oksanen AJ, 2008, VEGAN PACKAGE COMMUN; Olsen O.T., 1883, PISCATORIAL ATLAS N; OLSGARD F, 1995, MAR ECOL PROG SER, V122, P277, DOI 10.3354/meps122277; OSPAR Commission, 2013, INV OFFSH INST; OTTO L, 1990, NETH J SEA RES, V26, P161, DOI 10.1016/0077-7579(90)90091-T; Page HM, 2006, MAR ECOL PROG SER, V325, P101, DOI 10.3354/meps325101; PAGE HM, 1987, J EXP MAR BIOL ECOL, V111, P159, DOI 10.1016/0022-0981(87)90053-0; Page HM, 1999, MAR ECOL PROG SER, V185, P47, DOI 10.3354/meps185047; Picken G, 2000, ARTIFICIAL REEFS IN EUROPEAN SEAS, P331; PICKEN GB, 1989, B MAR SCI, V44, P782; Ponti M, 2002, ICES J MAR SCI, V59, pS316, DOI 10.1006/jmsc.2002.1225; Rijkswaterstaat, 2014, WAT; Roberts JM, 2002, UNDERWATER TECHNOL, V25, P83, DOI 10.3723/175605402783219163; Russell DJF, 2014, CURR BIOL, V24, pR638, DOI 10.1016/j.cub.2014.06.033; Sammarco PW, 2014, ICES J MAR SCI, V71, P417, DOI 10.1093/icesjms/fst140; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Sarkar D, 2008, USE R, P1; Smyth K, 2014, RENEWABLES TO REEFS, DOI [10.1016/j.marpolbul.2014.10.045, DOI 10.1016/J.MARP0LBUL.2014.10.045]; Soldal AV, 2002, ICES J MAR SCI, V59, pS281, DOI 10.1006/jmsc.2002.1279; SOUTHGATE T, 1985, ESTUAR COAST SHELF S, V20, P651, DOI 10.1016/0272-7714(85)90023-X; Stachowitsch M, 2002, MAR POLLUT BULL, V44, P853, DOI 10.1016/S0025-326X(02)00085-1; Studio R, 2014, RSTUDIO INT DEV ENV; Svensson JR, 2007, ECOLOGY, V88, P830, DOI 10.1890/06-0976; TETT PB, 1993, PHILOS T ROY SOC A, V343, P493, DOI 10.1098/rsta.1993.0061; van der Stap T, 2015, DRYAD DIGIT REPOS, DOI [10.5061/dryad.6p566, DOI 10.5061/DRYAD.6P566]; VANBUUREN JT, 1984, MAR POLLUT BULL, V15, P305, DOI 10.1016/0025-326X(84)90200-5; VideoLAN, 2013, VLC MED PLAYER VERS; Whomersley P, 2003, J MAR BIOL ASSOC UK, V83, P897, DOI 10.1017/S0025315403008014h; Wilhelmsson D, 2006, ICES J MAR SCI, V63, P775, DOI 10.1016/j.icesjms.2006.02.001; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; WoRMS Editorial Board, 2015, WORLD REGISTER MARIN; Yan T, 2006, INT BIODETER BIODEGR, V58, P99, DOI 10.1016/j.ibiod.2006.07.007; Yan T, 2003, BIOFOULING, V19, P133, DOI 10.1080/0892701021000057927; Zintzen V, 2007, THESIS; Zintzen V, 2010, BELG J ZOOL, V140, P20; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	82	57	58	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146324	10.1371/journal.pone.0146324	http://dx.doi.org/10.1371/journal.pone.0146324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745870	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600042
J	Yuan, YX; Teng, Q; Zhong, RQ; Haghighat, M; Richardson, EA; Ye, ZH				Yuan, Youxi; Teng, Quincy; Zhong, Ruiqin; Haghighat, Marziyeh; Richardson, Elizabeth A.; Ye, Zheng-Hua			Mutations of Arabidopsis TBL32 and TBL33 Affect Xylan Acetylation and Secondary Wall Deposition	PLOS ONE			English	Article							PLANT-CELL WALLS; O-ACETYLATION; GLUCURONOXYLAN BIOSYNTHESIS; STRUCTURAL-CHARACTERIZATION; DUF231 DOMAIN; CORN STOVER; PROTEINS; POLYSACCHARIDE; ASPEN; HETEROXYLAN	Xylan is a major acetylated polymer in plant lignocellulosic biomass and it can be mono- and di-acetylated at O-2 and O-3 as well as mono-acetylated at O-3 of xylosyl residues that is substituted with glucuronic acid (GlcA) at O-2. Based on the finding that ESK1, an Arabidopsis thaliana DUF231 protein, specifically mediates xylan 2-O- and 3-O-monoacetylation, we previously proposed that different acetyltransferase activities are required for regiospecific acetyl substitutions of xylan. Here, we demonstrate the functional roles of TBL32 and TBL33, two ESK1 close homologs, in acetyl substitutions of xylan. Simultaneous mutations of TBL32 and TBL33 resulted in a significant reduction in xylan acetyl content and endoxylanase digestion of the mutant xylan released GlcA-substituted xylooligomers without acetyl groups. Structural analysis of xylan revealed that the tbl32 tbl33 mutant had a nearly complete loss of 3-O-acetylated, 2-O-GlcA-substituted xylosyl residues. A reduction in 3-O-monoacetylated and 2,3-di-O-acetylated xylosyl residues was also observed. Simultaneous mutations of TBL32, TBL33 and ESK1 resulted in a severe reduction in xylan acetyl level down to 15% of that of the wild type, and concomitantly, severely collapsed vessels and stunted plant growth. In particular, the S2 layer of secondary walls in xylem vessels of tbl33 esk1 and tbl32 tbl33 esk1 exhibited an altered structure, indicating abnormal assembly of secondary wall polymers. These results demonstrate that TBL32 and TBL33 play an important role in xylan acetylation and normal deposition of secondary walls.	[Yuan, Youxi; Zhong, Ruiqin; Haghighat, Marziyeh; Richardson, Elizabeth A.; Ye, Zheng-Hua] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Teng, Quincy] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ye, ZH (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	yh@uga.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-03ER15415]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by grants from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (http://science.energy.gov) under the grant number DE-FG02-03ER15415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; Brown DM, 2007, PLANT J, V52, P1154, DOI 10.1111/j.1365-313X.2007.03307.x; Burk DH, 2006, J INTEGR PLANT BIOL, V48, P85, DOI 10.1111/j.1744-7909.2006.00202.x; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Del Rio JC, 2007, J AGR FOOD CHEM, V55, P5461, DOI 10.1021/jf0705264; Evtuguin DV, 2003, CARBOHYD RES, V338, P597, DOI 10.1016/S0008-6215(02)00529-3; Gille S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00012; Gille S, 2011, PLANT CELL, V23, P4041, DOI 10.1105/tpc.111.091728; Goncalves VMF, 2008, CARBOHYD RES, V343, P256, DOI 10.1016/j.carres.2007.11.002; Gou JY, 2012, PLANT CELL, V24, P50, DOI 10.1105/tpc.111.092411; Grondahl M, 2003, CARBOHYD POLYM, V52, P359, DOI 10.1016/S0144-8617(03)00014-6; Helle S, 2003, ENZYME MICROB TECH, V33, P786, DOI 10.1016/S0141-0229(03)00214-X; HOEBLER C, 1989, J AGR FOOD CHEM, V37, P360, DOI 10.1021/jf00086a020; Ishii T, 1997, PLANT PHYSIOL, V113, P1265, DOI 10.1104/pp.113.4.1265; Janbon G, 2001, MOL MICROBIOL, V42, P453, DOI 10.1046/j.1365-2958.2001.02651.x; Jia ZH, 2005, CARBOHYD RES, V340, P1818, DOI 10.1016/j.carres.2005.04.015; Kabel MA, 2007, CARBOHYD POLYM, V69, P94, DOI 10.1016/j.carbpol.2006.09.006; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1659, DOI 10.1093/pcp/pcm155; Lee CH, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27797; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1204, DOI 10.1093/pcp/pcs064; Lee CH, 2011, PLANT CELL PHYSIOL, V52, P1289, DOI 10.1093/pcp/pcr075; Lee C, 2010, PLANT PHYSIOL, V153, P526, DOI 10.1104/pp.110.155309; Manabe Y, 2013, PLANT PHYSIOL, V163, P1107, DOI 10.1104/pp.113.225193; Marques G, 2010, CARBOHYD POLYM, V81, P517, DOI 10.1016/j.carbpol.2010.02.043; Naran R, 2009, CELLULOSE, V16, P661, DOI 10.1007/s10570-009-9324-y; Pawar PM, 2015, PLANT BIOTECHNOL J, DOI [10.1111/pbi.12393, DOI 10.1111/PBI.12393)]; Pawar PMA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00118; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Pogorelko G, 2013, PLANT PHYSIOL, V162, P9, DOI 10.1104/pp.113.214460; Prozil SO, 2012, CARBOHYD RES, V356, P252, DOI 10.1016/j.carres.2012.02.001; Ralet MC, 2005, PHYTOCHEMISTRY, V66, P1832, DOI 10.1016/j.phytochem.2005.06.003; Schultink A, 2015, PLANT PHYSIOL, V167, P1271, DOI 10.1104/pp.114.256479; Selig MJ, 2009, CELLULOSE, V16, P711, DOI 10.1007/s10570-009-9322-0; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Teleman A, 2000, CARBOHYD RES, V329, P807, DOI 10.1016/S0008-6215(00)00249-4; Teleman A, 2003, CARBOHYD RES, V338, P525, DOI 10.1016/S0008-6215(02)00491-3; Teleman A, 2002, CARBOHYD RES, V337, P373, DOI 10.1016/S0008-6215(01)00327-5; Teng Q, 2012, ANALYST, V137, P2226, DOI 10.1039/c2an16251b; Urbanowicz BR, 2014, PLANT J, V80, P197, DOI 10.1111/tpj.12643; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Xiong GY, 2013, MOL PLANT, V6, P1373, DOI 10.1093/mp/sst014; Ye ZH, 2002, INT REV CYTOL, V220, P225; YORK WS, 1988, CARBOHYD RES, V173, P113, DOI 10.1016/S0008-6215(00)90807-3; Yuan YX, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv172; Yuan YX, 2013, PLANT CELL PHYSIOL, V54, P1186, DOI 10.1093/pcp/pct070; Zhong RQ, 1997, PLANT CELL, V9, P2159, DOI 10.1105/tpc.9.12.2159; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27933; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140	52	47	48	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146460	10.1371/journal.pone.0146460	http://dx.doi.org/10.1371/journal.pone.0146460			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745802	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600051
J	Schiffner-Rohe, J; Witt, A; Hemmerling, J; von Eiff, C; Leverkus, FW				Schiffner-Rohe, Julia; Witt, Annika; Hemmerling, Jana; von Eiff, Christof; Leverkus, Friedrich-Wilhelm			Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk - A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; CIRCULATING IMMUNE-COMPLEXES; URINARY ANTIGEN TEST; POLYSACCHARIDE VACCINE; STREPTOCOCCUS-PNEUMONIAE; INFLUENZA VACCINE; CONJUGATE VACCINE; PNEUMOLYSIN; RECOMMENDATIONS; IMMUNIZATION	Background Pneumococcal community-acquired pneumonia (pCAP) is the most frequent form of pneumonia. The elderly and adults with underlying diseases are at an increased risk of developing pCAP. The 23-valent pneumococcal polysaccharide vaccine (PPV23) was licensed over 30 years ago and is recommended as the standard intervention in many countries across the globe, although its efficacy continues to be debated. We performed a meta-analysis of randomized controlled trials (RCTs) to investigate the effect of PPV23 for preventing pCAP in adults >= 60 years of age. Methods An existing Cochrane Review was updated to Oct 2014 using a systematic literature search to select appropriate RCTs. DerSimonian and Laird random-effects meta-analyses were performed and odd ratios (OR) with 95%-confidence intervals (CI) and p-values were calculated for the descriptive analyses. Reasons for heterogeneity were explored by subgroup analyses. Results Meta-analysis of PPV23 efficacy included four studies. Three of them did not demonstrate efficacy for PPV23. The body of evidence indicated statistically significant heterogeneity (I-2 = 78%, p = 0.004) that could be explained by subgroup analysis by "study setting". Further effect modifiers for pCAP were "continent of trial" (p<0.01), and "method of pneumococcal diagnostics" (p = 0.001). Subgroup analyses revealed that the only study showing efficacy for PPV23 was an outlier. Overall, the validity of the meta-analytic PPV23 efficacy assessment was confirmed by the meta-analysis of all-cause CAP including six studies. Discussion Inconsistencies in PPV23 treatment effects to prevent pCAP could solely be explained by one outlier study that was performed in nursing homes in Japan. The effect modifier "method of pneumococcal diagnostics" should be interpreted carefully, since methodological weaknesses are not restricted to one special method only, which would justify the exclusion of certain studies. Overall, we conclude from our meta-analysis that to date there is no proof that PPV23 can prevent pCAP in a general, community-dwelling elderly population.	[Schiffner-Rohe, Julia; Leverkus, Friedrich-Wilhelm] Pfizer Deutschland GmbH, D-10785 Berlin, Germany; [Witt, Annika; Hemmerling, Jana] AMS Adv Med Serv GmbH, D-80639 Munich, Germany; [von Eiff, Christof] Pfizer Pharma GmbH, D-10785 Berlin, Germany	Pfizer; Pfizer	Schiffner-Rohe, J (corresponding author), Pfizer Deutschland GmbH, Linkstr 10, D-10785 Berlin, Germany.	Julia.Schiffner-Rohe@pfizer.com			Pfizer Deutschland GmbH	Pfizer Deutschland GmbH	The study was funded by Pfizer Deutschland GmbH. The funder provided support in the form of employee salaries for authors JSR, FL, CvE. The specific roles of these authors are articulated in the 'Author Contributions' section. The contributions of Pfizer employee Daniel Desgrandchamps (DD), MD, was the valuable input in the study protocol development. Pfizer employees Heinz-Josef Schmitt, MD, and Jurgen Wilde provided valuable input in design and review of the manuscript.	Advisory Commitee on Immunization Practices (ACIP), 2014, SUMM REP AUG 13 2014; Alfageme I, 2006, THORAX, V61, P189, DOI 10.1136/thx.2005.043323; Andrews NJ, 2012, VACCINE, V30, P6802, DOI 10.1016/j.vaccine.2012.09.019; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Castiglia P, 2014, ADV THER, V31, P1011, DOI 10.1007/s12325-014-0157-1; Cilloniz C, 2013, CHEST, V144, P999, DOI 10.1378/chest.13-0062; Dowell SF, 2001, CLIN INFECT DIS, V32, P824, DOI 10.1086/319205; European Medicines Agency (EMA), 2011, EMEAHC001104110028; Furumoto A, 2008, VACCINE, V26, P4284, DOI 10.1016/j.vaccine.2008.05.037; Hamer DH, 2002, CLIN INFECT DIS, V34, P1025, DOI 10.1086/339446; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Honkanen PO, 1999, VACCINE, V17, P2493, DOI 10.1016/S0264-410X(99)00069-9; Horita N, 2013, RESPIROLOGY, V18, P1177, DOI 10.1111/resp.12163; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Institute for Quality and Efficiency in Health Care (IQWIG), 2015, GEN METH VERS 4 2; JALONEN E, 1989, J INFECTION, V19, P127, DOI 10.1016/S0163-4453(89)91864-1; Kawakami K, 2010, VACCINE, V28, P7063, DOI 10.1016/j.vaccine.2010.08.010; LEINONEN M, 1990, SERODIAG IMMUN INF D, V4, P451, DOI 10.1016/0888-0786(90)90058-V; Liapikou A, 2014, RESP CARE, V59, P1078, DOI 10.4187/respcare.02788; Maruyama T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1004; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Musher DM, 2001, CLIN INFECT DIS, V32, P534, DOI 10.1086/318709; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; Paton JCL R. A., 1991, PURIFICATION IMMUNOG, P2297; Robert Koch-Institut, 2014, EPIDEMIOLOGISCHES B; Rozenbaum MH, 2013, EUR J CLIN MICROBIOL, V32, P305, DOI 10.1007/s10096-012-1778-4; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Salisbury CB, 2011, JCVI ADVICE PNEUMOCO; Scott JAG, 2000, CLIN DIAGN LAB IMMUN, V7, P64, DOI 10.1128/CDLI.7.1.64-67.2000; Sicras-Mainar A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-283; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; Torres A, 2014, EUR J CLIN MICROBIOL, V33, P1065, DOI 10.1007/s10096-014-2067-1; van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502	34	55	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146338	10.1371/journal.pone.0146338	http://dx.doi.org/10.1371/journal.pone.0146338			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761816	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100031
J	Tan, JW; Andrade, AO; Li, H; Walter, S; Hrabal, D; Rukavina, S; Limbrecht-Ecklundt, K; Hoffman, H; Traue, HC				Tan, Jun-Wen; Andrade, Adriano O.; Li, Hang; Walter, Steffen; Hrabal, David; Rukavina, Stefanie; Limbrecht-Ecklundt, Kerstin; Hoffman, Holger; Traue, Harald C.			Recognition of Intensive Valence and Arousal Affective States via Facial Electromyographic Activity in Young and Senior Adults	PLOS ONE			English	Article							EMOTION RECOGNITION; AGE; RESPONSES; INDEXES; OLDER	Background Research suggests that interaction between humans and digital environments characterizes a form of companionship in addition to technical convenience. To this effect, humans have attempted to design computer systems able to demonstrably empathize with the human affective experience. Facial electromyography (EMG) is one such technique enabling machines to access to human affective states. Numerous studies have investigated the effects of valence emotions on facial EMG activity captured over the corrugator supercilii (frowning muscle) and zygomaticus major (smiling muscle). The arousal emotion, specifically, has not received much research attention, however. In the present study, we sought to identify intensive valence and arousal affective states via facial EMG activity. Methods Ten blocks of affective pictures were separated into five categories: neutral valence/low arousal (0VLA), positive valence/high arousal (PVHA), negative valence/high arousal (NVHA), positive valence/low arousal (PVLA), and negative valence/low arousal (NVLA), and the ability of each to elicit corresponding valence and arousal affective states was investigated at length. One hundred and thirteen participants were subjected to these stimuli and provided facial EMG. A set of 16 features based on the amplitude, frequency, predictability, and variability of signals was defined and classified using a support vector machine (SVM). Results We observed highly accurate classification rates based on the combined corrugator and zygomaticus EMG, ranging from 75.69% to 100.00% for the baseline and five affective states (0VLA, PVHA, PVLA, NVHA, and NVLA) in all individuals. There were significant differences in classification rate accuracy between senior and young adults, but there was no significant difference between female and male participants. Conclusion Our research provides robust evidences for recognition of intensive valence and arousal affective states in young and senior adults. These findings contribute to the successful future application of facial EMG for identifying user affective states in human machine interaction (HMI) or companion robotic systems (CRS).	[Tan, Jun-Wen; Li, Hang] Lishui Univ, Coll Teacher Educ, Lishui, Peoples R China; [Andrade, Adriano O.] Univ Fed Uberlandia, Fac Elect Engn, Biomed Engn Lab, BR-38400 Uberlandia, MG, Brazil; [Walter, Steffen; Hrabal, David; Rukavina, Stefanie; Limbrecht-Ecklundt, Kerstin; Hoffman, Holger; Traue, Harald C.] Univ Ulm, Emot Lab, Sect Med Psychol, D-89069 Ulm, Germany	Lishui University; Universidade Federal de Uberlandia; Ulm University	Tan, JW (corresponding author), Lishui Univ, Coll Teacher Educ, Lishui, Peoples R China.	junwen.tan@hotmail.com	Andrade, Adriano de Oliveira/D-9721-2012	Andrade, Adriano de Oliveira/0000-0002-5689-6606	Transregional Collaborative Research Center (DFG) - German Research Foundation (DFG) [SFB TRR62]; China Scholarship Council (CSC); Brazilian Government	Transregional Collaborative Research Center (DFG) - German Research Foundation (DFG); China Scholarship Council (CSC)(China Scholarship Council); Brazilian Government	This research was supported by grants from the Transregional Collaborative Research Center (DFG-Project SFB TRR62) "CompanionTechnology for Cognitive Technical System" funded by the German Research Foundation (DFG) and doctoral scholarships by the China Scholarship Council (CSC) for Jun-Wen Tan and Hang Li. The authors thank the Brazilian Government for the financial support. In particular the agencies FAPEMIG (Research Foundation of the state of Minas Gerais), CNPq (National Council of Technological and Scientific Development) and CAPES Foundation for the Coordination and Improvement of Higher Level or Education Personnel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan M.R., 2009, EUR J SCI RES, V33, P480; Andrade AO, 2014, BIOMED SIGNAL PROCES, V10, P65, DOI 10.1016/j.bspc.2013.12.009; Andrade OA, 2012, EMG DECOMPOSITION AR; Broekens Joost, 2009, Gerontechnology, V8, P94, DOI 10.4017/gt.2009.08.02.002.00; Burriss L, 2007, COGNITION EMOTION, V21, P182, DOI 10.1080/02699930600562235; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Cacioppo JT, 1997, ANN REV GERONTOLOGY; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Gross JJ, 2011, EMOT REV, V3, P8, DOI 10.1177/1754073910380974; Gruss S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140330; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Lang P.J., 2008, A8 U FLOR; Lang P. J., 1972, HDB PSYCHOPHYSIOLOGY, P623; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; LANZETTA JT, 1989, J PERS SOC PSYCHOL, V56, P543, DOI 10.1037/0022-3514.56.4.543; Larsen JT, 2009, PSYCHOPHYSIOLOGY, V46, P831, DOI 10.1111/j.1469-8986.2009.00820.x; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Larsen R.J., 1992, EMOTION, P25; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; MEHRABIAN A, 1995, GENET SOC GEN PSYCH, V121, P339; Neiss MB, 2009, NEUROBIOL AGING, V30, P1305, DOI 10.1016/j.neurobiolaging.2007.11.007; Picard R. W., 1997, AFFECTIVE COMPUTING; Reminger SL, 2000, AGING NEUROPSYCHOL C, V7, P156, DOI 10.1076/1382-5585(200009)7:3;1-Q;FT156; Ribeiro RL, 2007, PHYSIOL BEHAV, V91, P671, DOI 10.1016/j.physbeh.2007.03.031; Ritz T, 1999, J PSYCHOPHYSIOL, V13, P3, DOI 10.1027//0269-8803.13.1.3; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Russell, 1974, APPROACH ENV PSYCHOL; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Scheibe S, 2010, J GERONTOL B-PSYCHOL, V65, P135, DOI 10.1093/geronb/gbp132; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Smith DP, 2005, J GERONTOL B-PSYCHOL, V60, pP49, DOI 10.1093/geronb/60.1.P49; Tan JW, 2012, J AMB INTEL HUM COMP, V3, P3, DOI 10.1007/s12652-011-0084-9; Traue HC, 2014, COVERBAL SYNCHRONY IN HUMAN-MACHINE INTERACTION, P99; Tsai JL, 2000, PSYCHOL AGING, V15, P684, DOI 10.1037/0882-7974.15.4.684; Uchino BN, 2010, J GERONTOL B-PSYCHOL, V65, P154, DOI 10.1093/geronb/gbp127; van Boxtel A., 2010, P MEAS BEH 2010 EIND, P104, DOI DOI 10.1145/1931344.1931382; van Boxtel AV, 2009, OXFORD COMPANION EMO, P419; van Boxtel AV, 2009, OXFORD COMPANION EMO, P105; van Reekum CM, 2011, SOC COGN AFFECT NEUR, V6, P177, DOI 10.1093/scan/nsq031; Walter S, 2011, GMS PSYCHOSOC MED, V8, P1; Walter S, 2013, IEEE T SYST MAN CY-S, V43, P988, DOI 10.1109/TSMCA.2012.2216869; Walter S, 2011, LECT NOTES COMPUT SC, V6763, P603, DOI 10.1007/978-3-642-21616-9_68; Wendemuth Andreas, 2012, Cognitive Behavioural Systems (COST 2012). International Training School. Revised Selected Papers, P89, DOI 10.1007/978-3-642-34584-5_7; Wilks Y, 2010, KEY SOCIAL PSYCHOL E, P35; WITVLIET CV, 1995, PSYCHOPHYSIOLOGY, V32, P436; Zhang J, 2011, INT J PSYCHOPHYSIOL, V79, P378, DOI 10.1016/j.ijpsycho.2010.12.005	51	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146691	10.1371/journal.pone.0146691	http://dx.doi.org/10.1371/journal.pone.0146691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761427	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100038
J	Telleria, JL; Fernandez-Lopez, J; Fandos, G				Telleria, Jose L.; Fernandez-Lopez, Javier; Fandos, Guillermo			Effect of Climate Change on Mediterranean Winter Ranges of Two Migratory Passerines	PLOS ONE			English	Article							SPECIES RICHNESS; NORTH-AFRICA; ABUNDANCE; HABITAT; IMPACTS; BIRDS; DISTRIBUTIONS; AVAILABILITY; DETERMINANTS; PRODUCTIVITY	We studied the effect of climate change on the distribution of two insectivorous passerines (the meadow pipit Anthus pratensis and the chiffchaff Phylloscopus collybita) in wintering grounds of the Western Mediterranean basin. In this region, precipitation and temperature can affect the distribution of these birds through direct (thermoregulation costs) or indirect effects (primary productivity). Thus, it can be postulated that projected climate changes in the region will affect the extent and suitability of their wintering grounds. We studied pipit and chiffchaff abundance in several hundred localities along a belt crossing Spain and Morocco and assessed the effects of climate and other geographical and habitat predictors on bird distribution. Multivariate analyses reported a positive effect of temperature on the present distribution of the two species, with an additional effect of precipitation on the meadow pipit. These climate variables were used with Maxent to model the occurrence probabilities of species using ring recoveries as presence data. Abundance and occupancy of the two species in the study localities adjusted to the distribution models, with more birds in sectors of high climate suitability. After validation, these models were used to forecast the distribution of climate suitability according to climate projections for 2050-2070 (temperature increase and precipitation reduction). Results show an expansion of climatically suitable sectors into the highlands by the effect of warming on the two species, and a retreat of the meadow pipit from southern sectors related to rain reduction. The predicted patterns show a mean increase in climate suitability for the two species due to the warming of the large highland expanses typical of the western Mediterranean.	[Telleria, Jose L.; Fernandez-Lopez, Javier; Fandos, Guillermo] Univ Complutense, Dept Zool & Antropol Fis, Fac Ciencias Biol, E-28040 Madrid, Spain; [Fernandez-Lopez, Javier] CSIC, Real Jardin Bot Madrid, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Telleria, JL (corresponding author), Univ Complutense, Dept Zool & Antropol Fis, Fac Ciencias Biol, E-28040 Madrid, Spain.	telleria@bio.ucm.es	Fandos, Guillermo/O-9909-2014; Fernández-López, Javier/AAU-7282-2020; Tellería, José Luis/K-2944-2013; Tellería, José Luis/AAQ-3702-2020	Fandos, Guillermo/0000-0003-1579-9444; Fernández-López, Javier/0000-0003-4352-0252; Tellería, José Luis/0000-0001-6170-8860; Tellería, José Luis/0000-0001-6170-8860	Spanish Ministry of Economy and Competitiveness [CGL2011-22953/BOS]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This paper was funded by project CGL2011-22953/BOS (Conservation of migratory birds in Iberia and the Maghreb: present patterns and future changes) of the Spanish Ministry of Economy and Competitiveness. JFL and GF were supported by predoctoral grants from the Spanish Ministry of Economy and Competitiveness.	ALERSTAM T, 1979, OIKOS, V33, P228, DOI 10.2307/3543999; Barbet-Massin M, 2009, BIOL LETTERS, V5, P248, DOI 10.1098/rsbl.2008.0715; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busse Przemyslaw, 2001, Ring, V23, P3; Calder W.A., 1974, AVIAN BIOL, V4, P259; Carrascal LM, 2012, ECOL RES, V27, P293, DOI 10.1007/s11284-011-0900-x; Carrascal Luis M., 2012, P36; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Cramp S., 1992, BIRDS W PALEARCTIC, VVI; Cramp S., 1988, BIRDS W PALEARCTIC; Cuesta M, ATLAS AVES REPROD ES, P489; de la Hera I, 2012, J AVIAN BIOL, V43, P333, DOI 10.1111/j.1600-048X.2012.05804.x; Del Moral JC, 2013, ATLAS AVES INVIERNO; Doblas-Miranda E, 2009, PEDOBIOLOGIA, V52, P361, DOI 10.1016/j.pedobi.2008.11.006; Dunning Jr JB, 1992, CRC HDB AVIAN BODY M; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Evans KL, 2006, GLOBAL ECOL BIOGEOGR, V15, P372, DOI 10.1111/j.1466-822x.2006.00228.x; FERNANDEZ AR, 1993, J VEG SCI, V4, P313, DOI 10.2307/3235589; Garcia-Ruiz JM, 2011, EARTH-SCI REV, V105, P121, DOI 10.1016/j.earscirev.2011.01.006; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Guo Q, 2012, GLOBAL CHANGE BIOL, V18, P3624, DOI 10.1111/gcb.12010; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Harris RMB, 2014, WIRES CLIM CHANGE, V5, P621, DOI 10.1002/wcc.291; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutto R.L., 1985, P455; IPCC, 2014, CLIMATE CHANGE 2014, DOI 10.1016/S0022-0248(00)00575-3; Jackman SD, 2015, PSCL CLASSES METHODS; Khaliq I, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1097; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; Kotlarski S, 2012, CLIMATIC CHANGE, V112, P189, DOI 10.1007/s10584-011-0195-5; La Sorte F, 2012, PLOS ONE, V9; La Sorte FA, 2009, P ROY SOC B-BIOL SCI, V276, P3167, DOI 10.1098/rspb.2009.0162; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lennon JJ, 2000, J ANIM ECOL, V69, P581, DOI 10.1046/j.1365-2656.2000.00418.x; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Telleria JL, 2014, ARDEOLA, V61, P335, DOI 10.13157/arla.61.2.2014.335; Telleria JL, 2014, BIRD STUDY, V61, P527, DOI 10.1080/00063657.2014.953033; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; Meehan TD, 2004, ECOL LETT, V7, P532, DOI 10.1111/j.1461-0248.2004.00611.x; Melles SJ, 2011, GLOBAL CHANGE BIOL, V17, P17, DOI 10.1111/j.1365-2486.2010.02214.x; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Nahal I., 1981, MEDITERRANEAN TYPE S, P63; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pautasso M, 2012, ITAL J ZOOL, V79, P296, DOI 10.1080/11250003.2011.627381; Pearce-Higgins JW, 2015, J ANIM ECOL, V84, P943, DOI 10.1111/1365-2656.12364; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rangwala I, 2012, CLIMATIC CHANGE, V114, P527, DOI 10.1007/s10584-012-0419-3; Rappole JH, 2003, ECOL APPL, V13, P735, DOI 10.1890/1051-0761(2003)013[0735:WVBLFA]2.0.CO;2; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Cano LS, 2014, J AVIAN BIOL, V45, P514, DOI 10.1111/jav.00391; Schilling J, 2012, AGR ECOSYST ENVIRON, V156, P12, DOI 10.1016/j.agee.2012.04.021; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Seoane J, 2004, ECOL MODEL, V171, P209, DOI 10.1016/j.ecolmodel.2003.08.006; Seoane J, 2008, GLOBAL ECOL BIOGEOGR, V17, P111, DOI 10.1111/j.1466-8238.2007.00351.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stocker TF, 2013, 5 ASS REP INT PAN CL; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; Telleria J.L., 1999, AVES IBERICAS, VII; Telleria JL, 2009, J BIOGEOGR, V36, P220, DOI 10.1111/j.1365-2699.2008.01983.x; Thevenot M., 2003, THE BIRDS OF MOROCCO; Trivino M, 2013, BIOL CONSERV, V168, P192, DOI 10.1016/j.biocon.2013.10.005; Trivino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029373; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wisz MS, 2007, J BIOGEOGR, V34, P828, DOI 10.1111/j.1365-2699.2006.01661.x; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zink RM, 2011, BIOL J LINN SOC, V104, P237, DOI 10.1111/j.1095-8312.2011.01752.x; Zuur Alain F., 2009, P1	79	18	18	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146958	10.1371/journal.pone.0146958	http://dx.doi.org/10.1371/journal.pone.0146958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761791	Green Submitted, Green Published, gold			2022-12-27	WOS:000368033100058
J	Li, L; Yang, J; Chu, YK; Wu, WB; Xue, J; Liang, P; Chen, L				Li, Liang; Yang, Jian; Chu, Yakui; Wu, Wenbo; Xue, Jin; Liang, Ping; Chen, Lei			A Novel Augmented Reality Navigation System for Endoscopic Sinus and Skull Base Surgery: A Feasibility Study	PLOS ONE			English	Article							REGISTRATION	Objective To verify the reliability and clinical feasibility of a self-developed navigation system based on an augmented reality technique for endoscopic sinus and skull base surgery. Materials and Methods In this study we performed a head phantom and cadaver experiment to determine the display effect and accuracy of our navigational system. We compared cadaver head-based simulated operations, the target registration error, operation time, and National Aeronautics and Space Administration Task Load Index scores of our navigation system to conventional navigation systems. Results The navigation system developed in this study has a novel display mode capable of fusing endoscopic images to three-dimensional (3-D) virtual images. In the cadaver head experiment, the target registration error was 1.28 +/- 0.45 mm, which met the accepted standards of a navigation system used for nasal endoscopic surgery. Compared with conventional navigation systems, the new system was more effective in terms of operation time and the mental workload of surgeons, which is especially important for less experienced surgeons. Conclusion The self-developed augmented reality navigation system for endoscopic sinus and skull base surgery appears to have advantages that outweigh those of conventional navigation systems. We conclude that this navigational system will provide rhinologists with more intuitive and more detailed imaging information, thus reducing the judgment time and mental workload of surgeons when performing complex sinus and skull base surgeries. Ultimately, this new navigational system has potential to increase the quality of surgeries. In addition, the augmented reality navigational system could be of interest to junior doctors being trained in endoscopic techniques because it could speed up their learning. However, it should be noted that the navigation system serves as an adjunct to a surgeon's skills and knowledge, not as a substitute.	[Li, Liang; Chen, Lei] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100853, Peoples R China; [Yang, Jian; Chu, Yakui] Beijing Inst Technol, Sch Opt & Elect, Beijing Engn Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China; [Wu, Wenbo; Xue, Jin; Liang, Ping] Chinese Peoples Liberat Army Gen Hosp, Dept Intervent Ultrasound, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Beijing Institute of Technology; Chinese People's Liberation Army General Hospital	Chen, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100853, Peoples R China.	Chen301@aliyun.com			National science and technology Support Plan; Ministry of Science and Technology of the People's Republic of China [2013BAI01B01]	National science and technology Support Plan; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	The study was supported by the National science and technology Support Plan (Funding institution: Ministry of Science and Technology of the People's Republic of China, URLs: http://program.most.gov.cn/, Grant number: 2013BAI01B01, Grant author: PL.) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anon JB, 1998, LARYNGOSCOPE, V108, P949, DOI 10.1097/00005537-199807000-00001; Bastien S, 2002, ST HEAL T, V88, P153; Blackwell M, 1998, CLIN ORTHOP RELAT R, P111, DOI 10.1097/00003086-199809000-00014; Cao A, 2009, BEHAV RES METHODS, V41, P113, DOI 10.3758/BRM.41.1.113; Caversaccio M, 2008, RHINOLOGY, V46, P156; Chu Sau-Tung, 2006, J Chin Med Assoc, V69, P529; Citardi Martin J, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P23, DOI 10.1097/MOO.0b013e3280123130; Dixon BJ, 2014, LARYNGOSCOPE, V124, P853, DOI 10.1002/lary.24385; Edwards P J, 1995, J Image Guid Surg, V1, P172, DOI 10.1002/(SICI)1522-712X(1995)1:3<172::AID-IGS7>3.3.CO;2-U; Edwards PJE, 1999, ST HEAL T, V62, P102; Irugu DVK, 2014, INDIAN J OTOLARYNGOL, V66, pS307, DOI 10.1007/s12070-011-0380-x; Maurer CR, 1997, IEEE T MED IMAGING, V16, P447, DOI 10.1109/42.611354; Mischkowski RA, 2006, J CRANIO MAXILL SURG, V34, P478, DOI 10.1016/j.jcms.2006.07.862; Ramakrishnan VR, 2013, INT FORUM ALLERGY RH, V3, P236, DOI 10.1002/alr.21094; Snyderman C, 2004, OTOLARYNG HEAD NECK, V131, P145, DOI 10.1016/j.otohns.2004.03.002; Thoranaghatte R, 2009, INT J MED ROBOT COMP, V5, P415, DOI 10.1002/rcs.273; Weijian C, 2013, 6 INT C IM SIGN PROC, P932	17	27	29	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146996	10.1371/journal.pone.0146996	http://dx.doi.org/10.1371/journal.pone.0146996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757365	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888800041
J	Watanabe, KH; Mayo, M; Jensen, KM; Villeneuve, DL; Ankley, GT; Perkins, EJ				Watanabe, Karen H.; Mayo, Michael; Jensen, Kathleen M.; Villeneuve, Daniel L.; Ankley, Gerald T.; Perkins, Edward J.			Predicting Fecundity of Fathead Minnows (Pimephales promelas) Exposed to Endocrine-Disrupting Chemicals Using a MATLAB (R)-Based Model of Oocyte Growth Dynamics	PLOS ONE			English	Article							TERM REPRODUCTION ASSAY; PITUITARY-GONADAL AXIS; COMPUTATIONAL MODEL; INHIBITOR; 17-BETA-TRENBOLONE; STEROIDOGENESIS; ECOTOXICOLOGY; KETOCONAZOLE; VITELLOGENIN; POPULATION	Fish spawning is often used as an integrated measure of reproductive toxicity, and an indicator of aquatic ecosystem health in the context of forecasting potential population-level effects considered important for ecological risk assessment. Consequently, there is a need for flexible, widely-applicable, biologically-based models that can predict changes in fecundity in response to chemical exposures, based on readily measured biochemical endpoints, such as plasma vitellogenin (VTG) concentrations, as input parameters. Herein we describe a MATLAB1 version of an oocyte growth dynamics model for fathead minnows (Pimephales promelas) with a graphical user interface based upon a previously published model developed with MCSim software and evaluated with data from fathead minnows exposed to an androgenic chemical, 17 beta-trenbolone. We extended the evaluation of our new model to include six chemicals that inhibit enzymes involved in steroid biosynthesis: fadrozole, ketoconazole, propiconazole, prochloraz, fenarimol, and trilostane. In addition, for unexposed fathead minnows from group spawning design studies, and those exposed to the six chemicals, we evaluated whether the model is capable of predicting the average number of eggs per spawn and the average number of spawns per female, which was not evaluated previously. The new model is significantly improved in terms of ease of use, platform independence, and utility for providing output in a format that can be used as input into a population dynamics model. Model-predicted minimum and maximum cumulative fecundity over time encompassed the observed data for fadrozole and most propiconazole, prochloraz, fenarimol and trilostane treatments, but did not consistently replicate results fromketoconazole treatments. For average fecundity (eggs.female(-1).day(-1)), eggs per spawn, and the number of spawns per female, the range of model-predicted values generally encompassed the experimentally observed values. Overall, we found that the model predicts reproduction metrics robustly and its predictions capture the variability in the experimentally observed data.	[Watanabe, Karen H.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Portland, OR 97201 USA; [Watanabe, Karen H.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Mayo, Michael; Perkins, Edward J.] US Army Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS USA; [Jensen, Kathleen M.; Villeneuve, Daniel L.; Ankley, Gerald T.] US EPA, Midcontinent Ecol Div, Duluth, MN USA	Oregon Health & Science University; Oregon Health & Science University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); United States Environmental Protection Agency	Watanabe, KH (corresponding author), Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Portland, OR 97201 USA.	watanabk@ohsu.edu		Watanabe, Karen/0000-0002-3572-6667	US Army Environmental Quality and Installations 6.1 Basic Research Program	US Army Environmental Quality and Installations 6.1 Basic Research Program	US Army Environmental Quality and Installations 6.1 Basic Research Program funding to KHW, MM, and EJP. United States Army Corps of Engineers cooperative agreement to KHW (# W912HZ-11-2-0023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankley GT, 2007, ENVIRON TOXICOL CHEM, V26, P1214, DOI 10.1897/06-428R.1; Ankley GT, 2014, ENVIRON TOXICOL CHEM, V33, P2529, DOI 10.1002/etc.2708; Ankley GT, 2012, AQUAT TOXICOL, V114, P88, DOI 10.1016/j.aquatox.2012.02.012; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Ankley GT, 2005, TOXICOL SCI, V86, P300, DOI 10.1093/toxsci/kfi202; Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI [10.1897/1551-5028(2003)022&lt;1350:EOTAGP&gt;2.0.CO;2, 10.1002/etc.5620220623]; Ankley GT, 2002, TOXICOL SCI, V67, P121, DOI 10.1093/toxsci/67.1.121; Ankley GT, 2001, ENVIRON TOXICOL CHEM, V20, P1276, DOI 10.1002/etc.5620200616; Ankley GT, 2002, EPA600R01067 ORD NHE; Bois FY, 1997, J STAT SOFTW, V2, P1, DOI [10.18637/jss.v002.i09, DOI 10.18637/JSS.V002.I09]; Cheng W-Y, 2014, 53 ANN M SOC TOX, P114; Craft JA, 2004, MAR ENVIRON RES, V58, P419, DOI 10.1016/j.marenvres.2004.03.025; Durhan EJ, 2006, ENVIRON HEALTH PERSP, V114, P65, DOI 10.1289/ehp.8055; Jensen KM, 2006, ENVIRON SCI TECHNOL, V40, P3112, DOI 10.1021/es052174s; Jensen KM, 2004, AQUAT TOXICOL, V70, P99, DOI 10.1016/j.aquatox.2004.06.012; Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; KOMANICKY P, 1978, J CLIN ENDOCR METAB, V47, P1042, DOI 10.1210/jcem-47-5-1042; Leino RL, 2005, ENVIRON TOXICOL PHAR, V19, P85, DOI 10.1016/j.etap.2004.05.010; Li ZH, 2011, CAN J FISH AQUAT SCI, V68, P1528, DOI 10.1139/f2011-066; Li ZH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-63; Liu CS, 2011, ENVIRON SCI TECHNOL, V45, P769, DOI 10.1021/es102659p; Mayo M, 2012, SETAC N AM 33 ANN M, P362; Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1; Miller DH, 2004, ECOTOX ENVIRON SAFE, V59, P1, DOI 10.1016/j.ecoenv.2004.05.005; Murphy CA, 2005, REPROD TOXICOL, V19, P395, DOI 10.1016/j.reprotox.2004.09.006; OECD (Organisation for Economic Co-operation and Development), 2012, TEST 229 FISH SHORT; Sainsbury R, 2004, BRIT J CANCER, V90, P1733, DOI 10.1038/sj.bjc.6601731; Salameh S, 2008, ISR MED ASSOC J, V10, P804; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; Schmieder PK, 2004, ENVIRON SCI TECHNOL, V38, P6333, DOI 10.1021/es0495314; Skolness SY, 2013, TOXICOL SCI, V132, P284, DOI 10.1093/toxsci/kft010; Sohoni P, 2001, ENVIRON SCI TECHNOL, V35, P2917, DOI 10.1021/es000198n; Sun H, 2012, BMC BIOL, P1; Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584; U. S. Environmental Protection Agency, 2015, END DISR SCREEN RPOG; Villeneuve DL, 2008, TOXICOL SCI, V104, P113, DOI 10.1093/toxsci/kfn073; Villeneuve DL, 2011, ENVIRON TOXICOL CHEM, V30, P1, DOI 10.1002/etc.396	38	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146594	10.1371/journal.pone.0146594	http://dx.doi.org/10.1371/journal.pone.0146594			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756814	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800017
J	Lee, HJ; Kang, JO; Kim, SM; Ji, SM; Park, SY; Kim, ME; Jigden, B; Lim, JE; Hwang, SY; Lee, YH; Oh, B				Lee, Hyeon-Ju; Kang, Ji-One; Kim, Sung-Moon; Ji, Su-Min; Park, So-Yon; Kim, Marina E.; Jigden, Baigalmaa; Lim, Ji Eun; Hwang, Sue-Yun; Lee, Young-Ho; Oh, Bermseok			Gene Silencing and Haploinsufficiency of Csk Increase Blood Pressure	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SMOOTH-MUSCLE-CELLS; PROTEIN-TYROSINE KINASE; CONDUCTANCE K-CHANNEL; ANGIOTENSIN-II; COMMON VARIANTS; C-SRC; HYPERTENSION; LOCI; ACTIVATION	Objective Recent genome-wide association studies have identified 33 human genetic loci that influence blood pressure. The 15q24 locus is one such locus that has been confirmed in Asians and Europeans. There are 21 genes in the locus within a 1-Mb boundary, but a functional link of these genes to blood pressure has not been reported. We aimed to identify a causative gene for blood pressure change in the 15q24 locus. Methods and Results CSK and ULK3 were selected as candidate genes based on eQTL analysis studies that showed the association between gene transcript levels and the lead SNP (rs1378942). Injection of siRNAs for mouse homologs Csk, Ulk3, and Cyp1a2 (negative control) showed reduced target gene mRNA levels in vivo. However, Csk siRNA only increased blood pressure while Ulk3 and Cyp1a2 siRNA did not change it. Further, blood pressure in Csk(+/-) heterozygotes was higher than in wild-type, consistent with what we observed in Csk siRNAinjected mice. We confirmed that haploinsufficiency of Csk increased the active form of Src in Csk(+/-) mice aorta. We also showed that inhibition of Src by PP2, a Src inhibitor decreased high blood pressure in Csk(+/-) mice and the active Src in Csk(+/-) mice aorta and in Csk knockdown vascular smooth muscle cells, suggesting blood pressure regulation by Csk through Src. Conclusions Our study demonstrates that Csk is a causative gene in the 15q24 locus and regulates blood pressure through Src, and these findings provide a novel therapeutic target for the treatment of hypertension.	[Lee, Hyeon-Ju; Kang, Ji-One; Kim, Sung-Moon; Ji, Su-Min; Park, So-Yon; Kim, Marina E.; Jigden, Baigalmaa; Lim, Ji Eun; Oh, Bermseok] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Lee, Young-Ho] Yonsei Univ, Dept Phys, Coll Med, Seoul 120749, South Korea; [Hwang, Sue-Yun] HanKyong Natl Univ, Dept Chem Engn, Coll Engn, Ansung Si, Gyeonggi Do, South Korea	Kyung Hee University; Yonsei University; Yonsei University Health System; Hankyong National University	Oh, B (corresponding author), Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Seoul, South Korea.	ohbs@khu.ac.kr		Lee, Young-Ho/0000-0002-5749-1045	Basic Science Research Program through National Research Foundation of Korea (NRF) [2014005277, 2011-0030072]; Korean government (MSIP) [2014005277, 2011-0030072]	Basic Science Research Program through National Research Foundation of Korea (NRF); Korean government (MSIP)	This work has been supported by the Basic Science Research Program through National Research Foundation of Korea (NRF) grants (grand numbers: 2014005277 and 2011-0030072; http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Basic Science Research Program through a National Research Foundation of Korea (NRF) grant, funded by the Korean government (MSIP) (2014005277) and (MSIP) (2011-0030072).	Chen JC, 2012, MOL CELL BIOL, V32, P981, DOI 10.1128/MCB.06410-11; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Duan LJ, 2004, BLOOD, V103, P1370, DOI 10.1182/blood-2003-05-1701; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; GOTHAM SM, 1988, ANAL BIOCHEM, V173, P353, DOI 10.1016/0003-2697(88)90199-6; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Han Y, 2011, PFLUG ARCH EUR J PHY, V461, P437, DOI 10.1007/s00424-011-0932-7; Han YJ, 2008, AM J HYPERTENS, V21, P860, DOI 10.1038/ajh.2008.199; Hong KW, 2010, J HUM HYPERTENS, V24, P367, DOI 10.1038/jhh.2009.86; Ishida M, 1998, CIRC RES, V82, P7; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; Ji Su-Min, 2012, Genomics & Informatics, V10, P40, DOI 10.5808/GI.2012.10.1.40; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Park SY, 2014, HYPERTENS RES, V37, P811, DOI 10.1038/hr.2014.84; Robey RB, 2002, J MEMBRANE BIOL, V187, P135, DOI 10.1007/s00232-001-0157-3; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shin YB, 2013, J HYPERTENS, V31, P1575, DOI 10.1097/HJH.0b013e32836189e9; Tabara Y, 2010, HYPERTENSION, V56, P973, DOI 10.1161/HYPERTENSIONAHA.110.153429; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Touyz RM, 2002, HYPERTENSION, V39, P479, DOI 10.1161/hy02t2.102909; Touyz RM, 2001, J HYPERTENS, V19, P441, DOI 10.1097/00004872-200103000-00012; Wang WH, 2000, AM J PHYSIOL-RENAL, V278, pF165, DOI 10.1152/ajprenal.2000.278.1.F165; Wei Y, 2001, AM J PHYSIOL-RENAL, V281, pF206, DOI 10.1152/ajprenal.2001.281.2.F206; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; YAMAJI Y, 1995, P NATL ACAD SCI USA, V92, P6274, DOI 10.1073/pnas.92.14.6274; Yue P, 2011, KIDNEY INT, V79, P423, DOI 10.1038/ki.2010.380; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	43	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146841	10.1371/journal.pone.0146841	http://dx.doi.org/10.1371/journal.pone.0146841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751575	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100162
J	Somintara, S; Leardkamolkarn, V; Suttiarporn, P; Mahatheeranont, S				Somintara, Somsuda; Leardkamolkarn, Vijittra; Suttiarporn, Panawan; Mahatheeranont, Sugunya			Anti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous Leukemia	PLOS ONE			English	Article							INTERFERON-GAMMA; CANCER-RISK; CELL; RADIATION; INTERLEUKIN-12; INFLAMMATION; CHEMOTHERAPY; ACTIVATION; INDUCTION; APOPTOSIS	Background Acute myelogenous leukemia (AML) is a cancer of the blood that most commonly affects human adults. The specific cause of AML is unclear, but it induces abnormality of white blood cells that grow rapidly and accumulate in bone marrow interfering with the production and functions of the normal blood cells. AML patients face poor prognosis and low quality of life during chemotherapy or transplantation of hematopoietic stem cells due to the progressive impairment of their immune system. The goal of this study is to find natural products that have the potential to delay growth or eliminate the abnormal leukemic cells but cause less harmful effect to the body's immune system. Methods and Findings The unsaponified fraction of Riceberry rice bran (RBDS) and the main pure compound, gramisterol, were studied for cytotoxicity and biological activities in WEHI-3 cells and in the leukemic mouse model induced by transplantation of WEHI-3 cells intraperitoneally. In the in vitro assay, RBDS and gramisterol exerted sub-G1 phase cell cycle arrest with a potent induction of apoptosis. Both of them effectively decreased cell cycle controlling proteins (cyclin D1 and cyclin E), suppressed cellular DNA synthesis and mitotic division, and reduced anti-apoptosis Bcl-2 protein, but increased apoptotic proteins (p53 and Bax) and activated caspase-3 enzyme in the intrinsic cell death stimulation pathway. In leukemic mice, daily feeding of RBDS significantly increased the amount of immune function-related cells including CD3(+), CD19(+), and CD11b(+), and elevated the serum levels of IFN-gamma, TNF-alpha, IL-2, and IL-12 beta cytokines, but suppressed IL-10 level. At the tumor sites, CD11b(+) cells were polarized and became active phagocytotic cells. Treatment of mice normal immune cells with gramisterol alone or a combination of gramisterol with cytokines released from RBDS-treated leukemic mice splenocytes culture synergistically increased pSTAT1 transcriptional factor that up-regulated the genes controlling cell survival and function. Phosphorylation of STAT1 was absent in WEHI-3. Instead, similar treatments significantly decreased pSTAT3 signaling that regulates transcription of genes controlling tumor growth and proliferation. Conclusions Rice bran gramisterol possesses a promising anti-cancer effect against a tumor of white blood cells and induces the production of anti-cancer immune-related cytokines. Gramisterol induces cell cycle arrest and apoptosis via suppression of pSTAT3 signaling control of tumor cells' growth and progression. Gramisterol increased IFN-gamma production and prevented the dysfunctional immune system of leukemic mice by enhancing pSTAT1 transcription signal controlling proliferation and functions of hematopoietic cells in the spleen. Together with IFN-gamma, gramisterol efficiently facilitates leukemic mice immune system modulation leading to improvement of the AML condition. Administration of RBDS containing gramisterol potentiates immune recovery of leukemic mice and extends their survival. This finding encourages the medicinal application of rice bran gramisterol as a palliative treatment or an alternative agent for future drug development against AML.	[Somintara, Somsuda; Leardkamolkarn, Vijittra] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Suttiarporn, Panawan; Mahatheeranont, Sugunya] Chiang Mai Univ, Dept Chem, Fac Sci, Chiang Mai 50000, Thailand	Mahidol University; Chiang Mai University	Leardkamolkarn, V (corresponding author), Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand.	vijittra.lea@mahidol.ac.th	Mahatheeranont, Sugunya/S-2315-2018	Suttiarporn, Panawan/0000-0002-7581-0185; Mahatheeranont, Sugunya/0000-0003-2389-4935	Nation Research Council of Thailand (NRCT); National Research Universities (NRU) of Thailand	Nation Research Council of Thailand (NRCT); National Research Universities (NRU) of Thailand	This study was funded by the Nation Research Council of Thailand (NRCT) and the National Research Universities (NRU) of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Garcia C, 2007, FOOD CHEM, V102, P1228, DOI 10.1016/j.foodchem.2006.07.012; Ardiansyah, 2006, J AGR FOOD CHEM, V54, P1914, DOI 10.1021/jf052561l; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; CURTIS RE, 1992, NEW ENGL J MED, V326, P1745, DOI 10.1056/NEJM199206253262605; DiNardo CD, 2015, EXPERT OPIN PHARMACO, V16, P95, DOI 10.1517/14656566.2015.981527; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; GouilleuxGruart V, 1996, BLOOD, V87, P1692; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hansen MH, 2001, P NATL ACAD SCI USA, V98, P12659, DOI 10.1073/pnas.171460798; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hayes RB, 2001, AM J IND MED, V40, P117, DOI 10.1002/ajim.1078.abs; Ishigami S, 2000, CANCER LETT, V159, P103, DOI 10.1016/S0304-3835(00)00542-5; Jariwalla RJ, 2001, DRUG EXP CLIN RES, V27, P17; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kaufman DW, 2009, ANN HEMATOL, V88, P1079, DOI 10.1007/s00277-009-0731-9; Leardkamolkarn V, 2011, FOOD CHEM, V125, P978, DOI 10.1016/j.foodchem.2010.09.093; Lee CK, 2000, J IMMUNOL, V164, P1286, DOI 10.4049/jimmunol.164.3.1286; Lin HI, 2005, CANCER LETT, V230, P248, DOI 10.1016/j.canlet.2004.12.044; Linet MS, 2009, PEDIATR RADIOL, V39, pS4, DOI 10.1007/s00247-008-1026-3; Mertens-Talcott SU, 2005, CANCER LETT, V218, P141, DOI 10.1016/j.canlet.2004.06.007; Min B, 2011, J FOOD SCI, V76, pC117, DOI 10.1111/j.1750-3841.2010.01929.x; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pensa S, 2000, JAK STAT PATHWAY DIS, P100; Prangthip P, 2013, J FUNCT FOODS, V5, P195, DOI 10.1016/j.jff.2012.10.005; Ron E, 1998, RADIAT RES, V150, pS30, DOI 10.2307/3579806; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Savitz DA, 1997, AM J IND MED, V31, P287; Schechter T, 2015, BIOL BLOOD MARROW TR, V21, P172, DOI 10.1016/j.bbmt.2014.08.008; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sriseadka T, 2012, J AGR FOOD CHEM, V60, P11723, DOI 10.1021/jf303204s; Suttiarporn P, 2015, NUTRIENTS, V7, P1672, DOI 10.3390/nu7031672; Travis LB, 1999, NEW ENGL J MED, V340, P351, DOI 10.1056/NEJM199902043400504; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; WARNER NL, 1969, J NATL CANCER I, V43, P963; WeberNordt RM, 1996, BLOOD, V88, P2549, DOI 10.1182/blood.V88.7.2549.bloodjournal8872549; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang WD, 2003, IMMUNOLOGY, V108, P177, DOI 10.1046/j.1365-2567.2003.01489.x	41	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146869	10.1371/journal.pone.0146869	http://dx.doi.org/10.1371/journal.pone.0146869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752299	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100168
J	Warrick, JW; Timm, A; Swick, A; Yin, J				Warrick, Jay W.; Timm, Andrea; Swick, Adam; Yin, John			Tools for Single-Cell Kinetic Analysis of Virus-Host Interactions	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; MONOCLONAL-ANTIBODIES; MICROFLUIDIC DEVICE; GENE-EXPRESSION; IMAGE-ANALYSIS; M PROTEIN; TRACKING; INFECTION; RNA; HETEROGENEITY	Measures of cellular gene expression or behavior, when performed on individual cells, inevitably reveal a diversity of behaviors and outcomes that can correlate with normal or diseased states. For virus infections, the potential diversity of outcomes are pushed to an extreme, where measures of infection reflect features of the specific infecting virus particle, the individual host cell, as well as interactions between viral and cellular components. Single-cell measures, while revealing, still often rely on specialized fluid handling capabilities, employ end-point measures, and remain labor-intensive to perform. To address these limitations, we consider a new microwell-based device that uses simple pipette-based fluid handling to isolate individual cells. Our design allows different experimental conditions to be implemented in a single device, permitting easier and more standardized protocols. Further, we utilize a recently reported dual-color fluorescent reporter system that provides dynamic readouts of viral and cellular gene expression during single-cell infections by vesicular stomatitis virus. In addition, we develop and show how free, open-source software can enable streamlined data management and batch image analysis. Here we validate the integration of the device and software using the reporter system to demonstrate unique single-cell dynamic measures of cellular responses to viral infection.	[Warrick, Jay W.; Timm, Andrea; Swick, Adam; Yin, John] Univ Wisconsin, Dept Chem & Biol Engn, Wisconsin Inst Discovery, Syst Biol Theme, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Yin, J (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Wisconsin Inst Discovery, Syst Biol Theme, Madison, WI 53706 USA.	john.yin@wisc.edu		Yin, John/0000-0001-6146-0594; Timm, Andrea/0000-0002-0570-9217	National Institutes of Health [R01-AI091646, U19-AI0104317]; NIH [T32-AI078985]; NSF GRFP [DGE-1256259]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI104317, U19AI070503, R01AI091646, T32AI078985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (R01-AI091646, U19-AI0104317). J.W. and A.T. were NIH trainees (T32-AI078985), and A.S. was an NSF GRFP trainee (DGE-1256259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ahmed M, 1997, VIROLOGY, V237, P378, DOI 10.1006/viro.1997.8808; Akpinar F, 2016, J VIROL, V90, P1599, DOI 10.1128/JVI.02190-15; Allan C, 2012, NAT METHODS, V9, P245, DOI [10.1038/NMETH.1896, 10.1038/nmeth.1896]; [Anonymous], 2014, R LANG ENV STAT COMP; Barr JN, 1997, J VIROL, V71, P1794, DOI 10.1128/JVI.71.3.1794-1801.1997; BERTHOLD M.R., 2007, STUDIES CLASSIFICATI; Carey BL, 2008, J VIROL, V82, P12104, DOI 10.1128/JVI.01508-08; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Castellarnau M, 2015, SMALL, V11, P489, DOI 10.1002/smll.201401369; Choi J, 2011, ANAL CHEM, V83, P6890, DOI 10.1021/ac2013916; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f; Eaton J. W., 2009, GNU OCTAVE VERSION 3; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Flanagan EB, 2001, J VIROL, V75, P6107, DOI 10.1128/JVI.75.13.6107-6114.2001; Gong YA, 2010, LAB CHIP, V10, P2334, DOI 10.1039/c004847j; Haselgrubler T, 2013, ANAL BIOANAL CHEM; Hensel SC, 2009, B MATH BIOL, V71, P1671, DOI 10.1007/s11538-009-9419-5; Hornik K, 2003, RSERVE FAST WAY PROV; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kan A, 2011, J MICROSC-OXFORD, V244, P194, DOI 10.1111/j.1365-2818.2011.03529.x; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Lindstrom S, 2009, LAB CHIP, V9, P3465, DOI 10.1039/b912596e; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Love KR, 2013, TRENDS BIOTECHNOL, V31, P16, DOI 10.1016/j.tibtech.2013.03.001; Lyles D, 2007, FIELDS VIROLOGY, P1364; Lyles DS, 1997, VIROLOGY, V229, P77, DOI 10.1006/viro.1996.8415; Mali P, 2013, NAT METHODS, V10, P403, DOI [10.1038/nmeth.2407, 10.1038/NMETH.2407]; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; Maska M, 2014, BIOINFORMATICS, V30, P1609, DOI 10.1093/bioinformatics/btu080; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408; Nagai H, 2001, ANAL CHEM, V73, P1043, DOI 10.1021/ac000648u; Ogunniyi AO, 2009, NAT PROTOC, V4, P767, DOI 10.1038/nprot.2009.40; Ozawa T, 2009, LAB CHIP, V9, P158, DOI 10.1039/b810438g; Patil S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005728; Pelkmans L, 2012, SCIENCE, V336, P425, DOI 10.1126/science.1222161; Rand U, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku492; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Rettig JR, 2005, ANAL CHEM, V77, P5628, DOI 10.1021/ac0505977; Roach KL, 2009, BIOTECHNOL PROGR, V25, P1772, DOI 10.1002/btpr.289; Rueden C, IMAGEJ2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sen GC, 2007, CURR TOP MICROBIOL, V316, P233; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Sisan DR, 2012, P NATL ACAD SCI USA, V109, P19262, DOI 10.1073/pnas.1207544109; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Srivastava R, 2002, J THEOR BIOL, V218, P309, DOI 10.1006/jtbi.2002.3078; Swick A, 2014, BIOTECHNOL BIOENG, V111, P1200, DOI 10.1002/bit.25170; Timm A, 2012, VIROLOGY, V424, P11, DOI 10.1016/j.virol.2011.12.005; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Urbanek S., **DATA OBJECT**; Valero A, 2008, LAB CHIP, V8, P62, DOI 10.1039/b713420g; Warrick JW, JEXPERIMENT JEX; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Yamanaka YJ, 2012, ANAL CHEM, V84, P10531, DOI 10.1021/ac302264q; Yamanaka YJ, 2012, INTEGR BIOL-UK, V4, P1175, DOI [10.1039/c2ib20167d, 10.1039/c2ib200157d]; Zernicka-Goetz M, 2010, NAT REV GENET, V11, P743, DOI 10.1038/nrg2886; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249; Zhu Y, 2009, VIROLOGY, V385, P39, DOI 10.1016/j.virol.2008.10.031	67	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145081	10.1371/journal.pone.0145081	http://dx.doi.org/10.1371/journal.pone.0145081			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752057	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100012
J	Yamashita, M; Hirohashi, Y; Torigoe, T; Kusumoto, H; Murai, A; Imagawa, T; Sato, N				Yamashita, Masamichi; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Kusumoto, Hiroki; Murai, Aiko; Imagawa, Tomohiro; Sato, Noriyuki			Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response	PLOS ONE			English	Article							STEM-LIKE CELLS; SELF-RENEWAL; COLON-CANCER; GENOME; BMI-1; TUMORIGENICITY; AGGREGATION; INHIBITION; MICE	Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are defined by their abilities of tumor initiation, self-renewal and differentiation. In a previous study, we showed by gene knockdown using siRNA and gene overexpression experiments that Dnaj (Hsp40) homolog, subfamily B, member 8 (DNAJB8), a role in the maintenance, of renal cell carcinoma CSCs/CICs. In the present study, we established Dnajb8 knockout (KO) renal cell carcinoma (RCC) line cells (RenCa cells) and analyzed the cells to confirm the function of Dnajb8 in RCC CSCs/CICs. Dnajb8 KO cells showed reduced ratios of side population cells and reduced sphere forming ability. An in vivo single cell tumor initiation assay revealed that the numbers of CSCs/CICs were 3 in 4 wild-type RenCa cells and 1 in 4 Dnajb8 KO cells. Dnajb8 KO cells showed sensitivity to Docetaxel. On the other hand, Dnajb8 KO cells did not show any sensitivities to stresses including low pH, low glucose, heat shock and sensitivity to cisplatin. The results indicate that Dnajb8 has a role in tumor initiation, side population ratio and sphere formation but it is dispensable for stress responses.	[Yamashita, Masamichi; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Kusumoto, Hiroki; Murai, Aiko; Sato, Noriyuki] Sapporo Med Univ, Dept Pathol, Sch Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Yamashita, Masamichi; Imagawa, Tomohiro] Tottori Univ, Sch Vet Med, Dept Vet Diagnost Imaging, Fac Agr, Tottori 6808553, Japan	Sapporo Medical University; Tottori University	Hirohashi, Y (corresponding author), Sapporo Med Univ, Dept Pathol, Sch Med, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	hirohash@sapmed.ac.jp; torigoe@sapmed.ac.jp	Hirohashi, Yoshihiko/AFQ-4227-2022; Yamashita, Masamichi/AGR-3298-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Suharakinenzaidan Co., Ltd.; Kobayashi foundation for cancer research; Northern Advancement Center for Science & Technology of Hokkaido Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sagawa Foundation for Promotion of Cancer Research; Suharakinenzaidan Co., Ltd.; Kobayashi foundation for cancer research(Kobayashi Foundation for Cancer Research); Northern Advancement Center for Science & Technology of Hokkaido Japan	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to NS), program for developing the supporting system for upgrading education and research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to NS) and Takeda Science Foundation (to YH), Sagawa Foundation for Promotion of Cancer Research (to YH), Suharakinenzaidan Co., Ltd. (to Y.H.) and Kobayashi foundation for cancer research (to YH). This study was supported in part by Grants-in-Aid for Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan (to YH and TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chen YC, 2010, ORAL ONCOL, V46, P158, DOI 10.1016/j.oraloncology.2009.11.007; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morita R, 2014, CANCER SCI, V105, P389, DOI 10.1111/cas.12362; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nakatsugawa M, 2009, CANCER SCI, V100, P1485, DOI 10.1111/j.1349-7006.2009.01187.x; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yasuda K, 2014, LAB INVEST, V94, P1355, DOI 10.1038/labinvest.2014.122; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	31	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146501	10.1371/journal.pone.0146501	http://dx.doi.org/10.1371/journal.pone.0146501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751205	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100090
J	Yang, Y; Nguyen, TT; Jeong, MH; Crisan, F; Yu, YH; Ha, HH; Choi, KH; Jeong, HG; Jeong, TC; Lee, KY; Kim, KK; Hur, JS; Kim, H				Yang, Yi; Thanh Thi Nguyen; Jeong, Min-Hye; Crisan, Florin; Yu, Young Hyun; Ha, Hyung-Ho; Choi, Kyung Hee; Jeong, Hye Gwang; Jeong, Tae Cheon; Lee, Kwang Youl; Kim, Kyung Keun; Hur, Jae-Seoun; Kim, Hangun			Inhibitory Activity of (+)-Usnic Acid against Non-Small Cell Lung Cancer Cell Motility	PLOS ONE			English	Article							USNIC ACID; RHO-GTPASES; LICHEN; METASTASIS; P190RHOGEF; HALLMARKS; SIGNAL	Lichens are symbiotic organisms that produce various unique chemicals that can be used for pharmaceutical purposes. With the aim of screening new anti-cancer agents that inhibit cancer cell motility, we tested the inhibitory activity of seven lichen species collected from the Romanian Carpathian Mountains against migration and invasion of human lung cancer cells and further investigated the molecular mechanisms underlying their anti-metastatic activity. Among them, Alectoria samentosa, Flavocetraria nivalis, Alectoria ochroleuca, and Usnea florida showed significant inhibitory activity against motility of human lung cancer cells. HPLC results showed that usnic acid is the main compound in these lichens, and (+)-usnic acid showed similar inhibitory activity that crude extract have. Mechanistically, beta-catenin-mediated TOPFLASH activity and KITENIN-mediated AP-1 activity were decreased by (+)-usnic acid treatment in a dose-dependent manner. The quantitative real-time PCR data showed that (+)-usnic acid decreased the mRNA level of CD44, Cyclin D1 and c-myc, which are the downstream target genes of both beta-catenin/LEF and c-jun/AP-1. Also, Rac1 and RhoA activities were decreased by treatment with (+)-usnic acid. Interestingly, higher inhibitory activity for cell invasion was observed when cells were treated with (+)-usnic acid and cetuximab. These results implied that (+)-usnic acid might have potential activity in inhibition of cancer cell metastasis, and (+)-usnic acid could be used for anti-cancer therapy with a distinct mechanisms of action.	[Yang, Yi; Thanh Thi Nguyen; Jeong, Min-Hye; Hur, Jae-Seoun] Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon, South Korea; [Thanh Thi Nguyen] Tay Nguyen Univ, Fac Nat Sci & Technol, Buon Ma Thuot, Vietnam; [Crisan, Florin] Univ Babes Bolyai, Fac Biol & Geol, Dept Taxon & Ecol, R-3400 Cluj Napoca, Romania; [Yu, Young Hyun; Ha, Hyung-Ho; Choi, Kyung Hee] Sunchon Natl Univ, Coll Pharm, Sunchon, South Korea; [Yu, Young Hyun; Ha, Hyung-Ho; Choi, Kyung Hee] Sunchon Natl Univ, Res Inst Life & Pharmaceut Sci, Sunchon, South Korea; [Jeong, Hye Gwang] Chungnam Natl Univ, Coll Pharm, Daejeon, South Korea; [Jeong, Tae Cheon] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Lee, Kwang Youl] Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea; [Kim, Kyung Keun] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Gwangju, South Korea	Sunchon National University; Tay Nguyen University; Babes Bolyai University from Cluj; Sunchon National University; Sunchon National University; Chungnam National University; Yeungnam University; Chonnam National University; Chonnam National University	Hur, JS (corresponding author), Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon, South Korea.	jshur1@sunchon.ac.kr; hangunkim@sunchon.ac.kr	Crisan, Florin/V-1240-2017	Jeong, Hye Gwang/0000-0002-8020-8914	National Research Foundation of Korea [NRF-2013R1A1A2004677, NRF-2013R1A2A2A07067609, NRF-2015R1A4A1041219, MRC-2011-0030132]; Korea National Research Resource Center Program [NRF-2014M3A9B8002115]; Sunchon Research Center for Natural Medicine	National Research Foundation of Korea(National Research Foundation of Korea); Korea National Research Resource Center Program; Sunchon Research Center for Natural Medicine	This study was supported by the National Research Foundation of Korea (NRF-2013R1A1A2004677, NRF-2013R1A2A2A07067609, NRF-2015R1A4A1041219 and MRC-2011-0030132) and by the Korea National Research Resource Center Program (NRF-2014M3A9B8002115). This study also received support from a research grant funded by the Sunchon Research Center for Natural Medicine.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Araujo AAS, 2015, NAT PROD RES, V29, P2167, DOI 10.1080/14786419.2015.1007455; Bae JA, 2014, CLIN CANCER RES, V20, P4115, DOI 10.1158/1078-0432.CCR-13-2863; Bjerke JW, 2004, NEW ZEAL J BOT, V42, P647, DOI 10.1080/0028825X.2004.9512916; Bjerke JW, 2002, PHOTOCH PHOTOBIO SCI, V1, P678, DOI 10.1039/b203399b; Brodo I. M., 2001, LICHENS N AM; Cocchietto M, 2002, NATURWISSENSCHAFTEN, V89, P137, DOI 10.1007/s00114-002-0305-3; Coley PD, 1988, EFFECTS PLANT GROWTH; Culberson C.F., 1969, CHEM BOT GUIDE LICHE; Santos NPD, 2006, EUR J PHARM BIOPHARM, V64, P154, DOI 10.1016/j.ejpb.2006.05.018; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Durazo FA, 2004, AM J GASTROENTEROL, V99, P950, DOI 10.1111/j.1572-0241.2004.04165.x; Elix JA, 1984, RECENT PROGR CHEM LI; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Favreau JT, 2002, ANN INTERN MED, V136, P590, DOI 10.7326/0003-4819-136-8-200204160-00008; FIEDLER P, 1986, PHYTOCHEMISTRY, V25, P461, DOI 10.1016/S0031-9422(00)85501-6; FISCUS S A, 1972, Bryologist, V75, P299, DOI 10.2307/3241467; GOLLAPUDI SR, 1994, J NAT PROD, V57, P934, DOI 10.1021/np50109a009; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Han D, 2004, BIOCHEM PHARMACOL, V67, P439, DOI 10.1016/j.bcp.2003.09.032; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huneck S, 1999, NATURWISSENSCHAFTEN, V86, P559, DOI 10.1007/s001140050676; Huneck S, 1996, IDENTIFICATION LICHE; Ingolfsdottir K, 2002, PHYTOCHEMISTRY, V61, P729, DOI 10.1016/S0031-9422(02)00383-7; Kim H., 2015, RECENT ADV LICHENOLO, P201, DOI DOI 10.1007/978-81-322-2235-4_11; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim H, 2008, BIOCHEM BIOPH RES CO, V377, P636, DOI 10.1016/j.bbrc.2008.10.030; Kinoshita Y., 1997, J HATTORI BOT LAB, V83, P173; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Martins MCB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111102; Murali A, 2014, CELL MOL LIFE SCI, V71, P1703, DOI 10.1007/s00018-013-1519-6; Neff GW, 2004, J HEPATOL, V41, P1062, DOI 10.1016/j.jhep.2004.06.028; NGUYEN TAD, 2014, BIOSCI BIOTECHNOL RE, V11, P11; ORANGE A, 2001, MICROCHEMICAL METHOD; Savjani Ketan T, 2012, ISRN Pharm, V2012, P195727, DOI 10.5402/2012/195727; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Yui Y, 2010, CLIN EXP METASTAS, V27, P619, DOI 10.1007/s10585-010-9352-x; Zagoskina NV, 2013, MICROBIOLOGY+, V82, P445, DOI 10.1134/S0026261713030132	40	25	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146575	10.1371/journal.pone.0146575	http://dx.doi.org/10.1371/journal.pone.0146575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751081	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100103
J	Akasaka, T; Fujimoto, K; Yamamoto, T; Okada, T; Fushumi, Y; Yamamoto, A; Tanaka, T; Togashi, K				Akasaka, Thai; Fujimoto, Koji; Yamamoto, Takayuki; Okada, Tomohisa; Fushumi, Yasutaka; Yamamoto, Akira; Tanaka, Toshiyuki; Togashi, Kaori			Optimization of Regularization Parameters in Compressed Sensing of Magnetic Resonance Angiography: Can Statistical Image Metrics Mimic Radiologists' Perception?	PLOS ONE			English	Article							INTRACRANIAL ANEURYSMS; MR-ANGIOGRAPHY; RECONSTRUCTION; COIL	In Compressed Sensing (CS) of MRI, optimization of the regularization parameters is not a trivial task. We aimed to establish a method that could determine the optimal weights for regularization parameters in CS of time-of-flight MR angiography (TOF-MRA) by comparing various image metrics with radiologists' visual evaluation. TOF-MRA of a healthy volunteer was scanned using a 3T-MR system. Images were reconstructed by CS from retrospectively under-sampled data by varying the weights for the L1 norm of wavelet coefficients and that of total variation. The reconstructed images were evaluated both quantitatively by statistical image metrics including structural similarity (SSIM), scale invariant feature transform (SIFT) and contrast-to-noise ratio (CNR), and qualitatively by radiologists' scoring. The results of quantitative metrics and qualitative scorings were compared. SSIM and SIFT in conjunction with brain masks and CNR of artery-to-parenchyma correlated very well with radiologists' visual evaluation. By carefully selecting a region to measure, we have shown that statistical image metrics can reflect radiologists' visual evaluation, thus enabling an appropriate optimization of regularization parameters for CS.	[Akasaka, Thai; Fujimoto, Koji; Yamamoto, Takayuki; Okada, Tomohisa; Fushumi, Yasutaka; Yamamoto, Akira; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Tanaka, Toshiyuki] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan	Kyoto University; Kyoto University	Fujimoto, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan.	kfb@kuhp.kyoto-u.ac.jp	Okada, Tomohisa/C-5939-2008; Fushimi, Yasutaka/L-8922-2017; Tanaka, Toshiyuki/C-2749-2011	Fushimi, Yasutaka/0000-0002-1982-3168; Okada, Tomohisa/0000-0003-2312-5677; YAMAMOTO, Takayuki/0000-0003-0306-3691; Akasaka, Thai/0000-0002-6602-5732	MEXT [25120002, 25120008]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Initiative for High-Dimensional Data-Driven Science through Deepening of Sparse Modeling", MEXT grant numbers 25120002, 25120008. https://www.jsps.go.jp/english/e-grants/grants01.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar Y. A. Y., 2012, INT J SCI ENG RES, V3, P1; Almandoz JED, 2012, J NEUROSURG, V117, P309, DOI 10.3171/2012.4.JNS112306; Arganda-Carreras I., TRAINABLE WEKA SEGME, phttp; Cukur T, 2009, MAGN RESON MED, V61, P1122, DOI 10.1002/mrm.21907; Eckert MP, 1998, SIGNAL PROCESS, V70, P177, DOI 10.1016/S0165-1684(98)00124-8; HENDRICK R E, 1984, Magnetic Resonance Imaging, V2, P193, DOI 10.1016/0730-725X(84)90005-5; Hiratsuka Yoshiyasu, 2008, Magn Reson Med Sci, V7, P169; Huang JZ, 2011, MED IMAGE ANAL, V15, P670, DOI 10.1016/j.media.2011.06.001; Konar AS, 2014, IEEE ENG MED BIO, P2428, DOI 10.1109/EMBC.2014.6944112; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Milles J, 2010, P IEEE EMBS REG 8 IN, DOI [10.1109/ITAB.2010.5687775, DOI 10.1109/ITAB.2010.5687775]; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Sailer AMH, 2014, STROKE, V45, P119, DOI 10.1161/STROKEAHA.113.003133; Sharma SD, 2009, P 17 ANN M ISMRM HON, P2816; She HJ, 2014, MAGN RESON MED, V71, P645, DOI 10.1002/mrm.24716; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Vasanawala SS, 2010, RADIOLOGY, V256, P607, DOI 10.1148/radiol.10091218; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; White PM, 2001, RADIOLOGY, V219, P739, DOI 10.1148/radiology.219.3.r01ma16739; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Zhang CG, 2014, IEEE ENG MED BIO, P2416, DOI 10.1109/EMBC.2014.6944109; Zhang T, 2013, MAGN RESON MED, V69, P571, DOI 10.1002/mrm.24267; Zhu ZG, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/907501	25	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146548	10.1371/journal.pone.0146548	http://dx.doi.org/10.1371/journal.pone.0146548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26744843	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600064
J	Hu, XY; Huang, F; Szymusiak, M; Tian, XB; Liu, Y; Wang, ZJ				Hu, Xiaoyu; Huang, Fang; Szymusiak, Magdalena; Tian, Xuebi; Liu, Ying; Wang, Zaijie Jim			PLGA-Curcumin Attenuates Opioid-Induced Hyperalgesia and Inhibits Spinal CaMKII alpha	PLOS ONE			English	Article							PROTEIN-KINASE-II; MORPHINE ANTINOCICEPTIVE TOLERANCE; NF-KAPPA-B; NEUROPATHIC PAIN; HISTONE DEACETYLASE; MOUSE MODEL; DEPENDENCE; MICE; REVERSAL; EXPRESSION	Opioid-induced hyperalgesia (OIH) is one of the major problems associated with prolonged use of opioids for the treatment of chronic pain. Effective treatment for OIH is lacking. In this study, we examined the efficacy and preliminary mechanism of curcumin in attenuating OIH. We employed a newly developed PLGA-curcumin nanoformulation (PLGA-curcumin) in order to improve the solubility of curcumin, which has been a major obstacle in properly characterizing curcumin's mechanism of action and efficacy. We found that curcumin administered intrathecally or orally significantly attenuated hyperalgesia in mice with morphine-induced OIH. Furthermore, we demonstrated that the effects of curcumin on OIH correlated with the suppression of chronic morphine-induced CaMKIIa activation in the superficial laminae of the spinal dorsal horn. These data suggest that PLGA-curcumin may reverse OIH possibly by inhibiting CaMKIIa and its downstream signaling.	[Hu, Xiaoyu; Huang, Fang; Tian, Xuebi; Liu, Ying; Wang, Zaijie Jim] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60607 USA; [Hu, Xiaoyu; Huang, Fang; Tian, Xuebi; Liu, Ying; Wang, Zaijie Jim] Univ Illinois, Ctr Canc, Chicago, IL USA; [Szymusiak, Magdalena; Liu, Ying] Univ Illinois, Dept Chem Engn, Chicago, IL 60680 USA; [Tian, Xuebi] Huazhong Univ Sci & Technol, Dept Anesthesiol, Tongji Med Coll, Wuhan 430074, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Huazhong University of Science & Technology	Wang, ZJ (corresponding author), Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60607 USA.	zjwang@uic.edu	Hu, Xiaoyu/AAO-7197-2020		National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health (NIH) [K07 AT003647]; NSF Career Award (NSF-CMMI) [1350731]; NSFc [81328009]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K07AT003647] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098141] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NSF Career Award (NSF-CMMI); NSFc(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a grant (K07 AT003647) from the National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health (NIH http://www.nih.gov). Nanoparticle formation and characterization were supported by NSF Career Award (NSF-CMMI 1350731 http://www.nsf.gov). Mechanistic CaMKII study received funds from NSFc (81328009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Asher GN, 2013, ALTERN THER HEALTH M, V19, P20; Banafshe HR, 2014, EUR J PHARMACOL, V723, P202, DOI 10.1016/j.ejphar.2013.11.033; Bengmark S, 2006, JPEN-PARENTER ENTER, V30, P45, DOI 10.1177/014860710603000145; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Chen CQ, 2013, CARCINOGENESIS, V34, P1442, DOI 10.1093/carcin/bgt070; Chen Y, 2007, BASIC CLIN PHARMACOL, V101, P427, DOI 10.1111/j.1742-7843.2007.00142.x; Chen Y, 2010, J NEUROSCI, V30, P38, DOI 10.1523/JNEUROSCI.4346-09.2010; Chen Y, 2009, J PHARMACOL EXP THER, V330, P650, DOI 10.1124/jpet.109.152165; de Mos M, 2009, J PAIN, V10, P1161, DOI 10.1016/j.jpain.2009.04.012; He Y, 2012, J PAIN, V13, P598, DOI 10.1016/j.jpain.2012.03.011; Hu XY, 2015, J PHARMACOL EXP THER, V352, P420, DOI 10.1124/jpet.114.219303; Lee SJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-144; Lee Y, 2005, CURR PHARM DESIGN, V11, P1737, DOI 10.2174/1381612053764896; Liang DY, 2013, J PAIN, V14, P36, DOI 10.1016/j.jpain.2012.10.005; Liu HL, 2005, ACTA PHARMACOL SIN, V26, P603, DOI 10.1111/j.1745-7254.2005.00081.x; Luo F, 2008, J PHARMACOL EXP THER, V325, P267, DOI 10.1124/jpet.107.132167; Marchiani A, 2014, CURR MED CHEM, V21, P204; Mayadevi M, 2012, BIOORGAN MED CHEM, V20, P6040, DOI 10.1016/j.bmc.2012.08.029; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Sharma S, 2006, EUR J PHARMACOL, V536, P256, DOI 10.1016/j.ejphar.2006.03.006; Shen H, 2013, MOL PHARMACEUT, V10, P4546, DOI 10.1021/mp400358z; Shukla PK, 2006, NEUROSCI LETT, V404, P266, DOI 10.1016/j.neulet.2006.06.013; Tang L, 2006, J PHARMACOL EXP THER, V317, P901, DOI 10.1124/jpet.105.097733; Tang L, 2006, NEUROSCI LETT, V397, P1, DOI 10.1016/j.neulet.2005.11.050; Vanderah TW, 2001, PAIN, V92, P5, DOI 10.1016/S0304-3959(01)00311-6; Wang R, 2008, BRAIN RES, V1210, P84, DOI 10.1016/j.brainres.2008.01.104; Wang ZJJ, 2003, EUR J PHARMACOL, V465, P199, DOI 10.1016/S0014-2999(03)01484-5; Xu Y, 2009, NEUROPHARMACOLOGY, V57, P463, DOI 10.1016/j.neuropharm.2009.06.010; Yang C, 2011, J PHARMACOL EXP THER, V338, P164, DOI 10.1124/jpet.110.175539; Zhang L, 2012, BEHAV BRAIN RES, V235, P67, DOI 10.1016/j.bbr.2012.07.019; Zhao X, 2012, NEUROPHARMACOLOGY, V62, P843, DOI 10.1016/j.neuropharm.2011.08.050; Zhu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091303	34	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146393	10.1371/journal.pone.0146393	http://dx.doi.org/10.1371/journal.pone.0146393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26744842	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600044
J	Lin, CH; Wang, CH; Hsu, SL; Liao, LY; Lin, TA; Hsueh, CM				Lin, Chi-Hsin; Wang, Chen-Hsuan; Hsu, Shih-Lan; Liao, Li-Ya; Lin, Ting-An; Hsueh, Chi-Mei			Molecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic Brain	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; SPRAGUE-DAWLEY RAT; OXYGEN-SERUM DEPRIVATION; IN-VITRO ISCHEMIA; CORTICAL-NEURONS; GLUCOSE DEPRIVATION; SIGNALING PATHWAYS; PROTEIN-KINASE; CELL-DEATH; INJURY	The protective value of neuron-derived conditioned medium (NCM) in cerebral ischemia and the underlying mechanism(s) responsible for NCM-mediated brain protection against cerebral ischemia were investigated in the study. NCM was first collected from the neuronal culture growing under the in vitro ischemic condition (glucose-, oxygen-and serum-deprivation or GOSD) for 2, 4 or 6 h. Through the focal cerebral ischemia (bilateral CCAO/unilateral MCAO) animal model, we discovered that ischemia/reperfusion (I/R)-induced brain infarction was significantly reduced by NCM, given directly into the cistern magna at the end of 90 min of CCAO/MCAO. Immunoblocking and chemical blocking strategies were applied in the in vitro ischemic studies to show that NCM supplement could protect microglia, astrocytes and neurons from GOSD-induced cell death, in a growth factor (TGFa1, NT-3 and GDNF) and p-ERK dependent manner. Brain injection with TGFa1, NT3, GDNF and ERK agonist (DADS) alone or in combination, therefore also significantly decreased the infarct volume of ischemic brain. Moreover, NCM could inhibit ROS but stimulate IL-1a release from GOSD-treated microglia and limit the infiltration of IL-a-positive microglia into the core area of ischemic brain, revealing the anti-oxidant and anti-inflammatory activities of NCM. In overall, NCM-mediated brain protection against cerebral ischemia has been demonstrated for the first time in S. D. rats, due to its anti-apoptotic, anti-oxidant and potentially anti-glutamate activities (NCM-induced IL-1a can inhibit the glutamate-mediated neurotoxicity) and restriction upon the infiltration of inflammatory microglia into the core area of ischemic brain. The therapeutic potentials of NCM, TGFa1, GDNF, NT-3 and DADS in the control of cerebral ischemia in human therefore have been suggested and require further investigation.	[Lin, Chi-Hsin; Wang, Chen-Hsuan; Liao, Li-Ya; Lin, Ting-An; Hsueh, Chi-Mei] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lin, Chi-Hsin] Mackay Mem Hosp, Dept Med Res, New Taipei, Taiwan; [Wang, Chen-Hsuan] Natl Taiwan Sport Univ, Dept Adapted Phys Educ, Taoyuan, Taiwan; [Hsu, Shih-Lan] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Hsueh, Chi-Mei] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; Mackay Memorial Hospital; Taichung Veterans General Hospital; National Chung Hsing University	Hsueh, CM (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	cmhsueh@dragon.nchu.edu.tw		Hsueh, Chi-Mei/0000-0002-3837-2841; Wang, Chen-Hsuan/0000-0001-9355-1490	Mackay Memorial Hospital [MMH-10139];  [NSC-99-2320-B-005-006-MY3];  [TCVGH-984104D]	Mackay Memorial Hospital; ; 	This work was supported by grants NSC-99-2320-B-005-006-MY3, TCVGH-984104D and Mackay Memorial Hospital Grant MMH-10139, and ATU plan under the Ministry of Education, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2014, NEUROSCIENCE, V277, P755, DOI 10.1016/j.neuroscience.2014.07.064; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Brewer GJ, 1996, NEUROREPORT, V7, P1509, DOI 10.1097/00001756-199606170-00014; Chang YC, 2014, ANESTH ANALG, V118, P116, DOI 10.1213/ANE.0b013e3182a94479; Chao HJ, 2005, J NEUROIMMUNOL, V158, P159, DOI 10.1016/j.jneuroim.2004.09.008; Chu LF, 2008, BRAIN RES, V1239, P24, DOI 10.1016/j.brainres.2008.08.087; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hsu PC, 2013, THESIS, P1; Hsueh CM, 2003, NEUROSCI LETT, V349, P155, DOI 10.1016/S0304-3940(03)00831-0; Hsueh CM, 2002, J NEUROIMMUNOL, V123, P102, DOI 10.1016/S0165-5728(01)00488-X; Jing Z, 2014, J CEREBR BLOOD F MET, V34, P1613, DOI 10.1038/jcbfm.2014.119; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kitagawa H, 1998, STROKE, V29, P1417, DOI 10.1161/01.STR.29.7.1417; Krohn K, 1999, GLIA, V25, P332, DOI 10.1002/(SICI)1098-1136(19990215)25:4<332::AID-GLIA3>3.0.CO;2-1; Lee Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/297241; Lin CH, 2005, NEUROSCI LETT, V387, P22, DOI 10.1016/j.neulet.2005.06.070; Lin Chen, 2013, Theory and Applications of Models of Computation. 10th International Conference, TAMC 2013. Proceedings, P1, DOI 10.1007/978-3-642-38236-9_1; Lin CH, 2006, EXP NEUROL, V201, P225, DOI 10.1016/j.expneurol.2006.04.014; Liot G, 2004, EXP NEUROL, V187, P38, DOI 10.1016/j.expneurol.2004.01.002; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lu YZ, 2005, NEUROSCI LETT, V373, P159, DOI 10.1016/j.neulet.2004.10.004; Moustakas A, 2001, J CELL SCI, V114, P4359; Neff F, 2002, ANN NY ACAD SCI, V973, P70, DOI 10.1111/j.1749-6632.2002.tb04608.x; Neumar RW, 2000, ANN EMERG MED, V36, P483, DOI 10.1067/mem.2000.110995; Parmar J, 2015, INT J DEV NEUROSCI, V43, P35, DOI 10.1016/j.ijdevneu.2015.03.010; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Ramalingam M, 2014, J RECEPT SIG TRANSD, DOI [10.3109/10799893.2014.970276, DOI 10.3109/10799893.2014.970276]; Saeed SA, 2007, EXP BRAIN RES, V182, P1, DOI 10.1007/s00221-007-1050-9; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; Stoldt VR, 2006, FASEB J, V20, P965, DOI 10.1096/fj.04-3032fje; Tabakman R, 2004, J MOL NEUROSCI, V22, P237, DOI 10.1385/JMN:22:3:237; TYMIANSKI M, 1993, BRAIN RES, V607, P319, DOI 10.1016/0006-8993(93)91523-U; Wang CH, 2010, CURR NEUROVASC RES, V7, P223, DOI 10.2174/156720210792231859; Wang CH, 2009, BRAIN RES BULL, V79, P169, DOI 10.1016/j.brainresbull.2009.02.006; Wang XJ, 2008, NEUROCHEM RES, V33, P826, DOI 10.1007/s11064-007-9514-7; Wu DT, 2005, J AM SOC NEPHROL, V16, P3211, DOI 10.1681/ASN.2004121055; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; Zhu Y, 2004, NEUROSCIENCE, V123, P897, DOI 10.1016/j.neuroscience.2003.10.037; Zhu ZH, 2006, BRAIN RES, V1114, P1, DOI 10.1016/j.brainres.2006.07.070	43	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146692	10.1371/journal.pone.0146692	http://dx.doi.org/10.1371/journal.pone.0146692			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745377	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600077
J	Guttal, V; Raghavendra, S; Goel, N; Hoarau, Q				Guttal, Vishwesha; Raghavendra, Srinivas; Goel, Nikunj; Hoarau, Quentin			Lack of Critical Slowing Down Suggests that Financial Meltdowns Are Not Critical Transitions, yet Rising Variability Could Signal Systemic Risk	PLOS ONE			English	Article							EARLY WARNING SIGNAL; REGIME SHIFTS; TIPPING POINT; MARKET; VOLATILITY; DYNAMICS; BEHAVIOR; ECOLOGY; MODEL; TIME	Complex systems inspired analysis suggests a hypothesis that financial meltdowns are abrupt critical transitions that occur when the system reaches a tipping point. Theoretical and empirical studies on climatic and ecological dynamical systems have shown that approach to tipping points is preceded by a generic phenomenon called critical slowing down, i.e. an increasingly slow response of the system to perturbations. Therefore, it has been suggested that critical slowing down may be used as an early warning signal of imminent critical transitions. Whether financial markets exhibit critical slowing down prior to meltdowns remains unclear. Here, our analysis reveals that three major US (Dow Jones Index, S&P 500 and NASDAQ) and two European markets (DAX and FTSE) did not exhibit critical slowing down prior to major financial crashes over the last century. However, all markets showed strong trends of rising variability, quantified by time series variance and spectral function at low frequencies, prior to crashes. These results suggest that financial crashes are not critical transitions that occur in the vicinity of a tipping point. Using a simple model, we argue that financial crashes are likely to be stochastic transitions which can occur even when the system is far away from the tipping point. Specifically, we show that a gradually increasing strength of stochastic perturbations may have caused to abrupt transitions in the financial markets. Broadly, our results highlight the importance of stochastically driven abrupt transitions in real world scenarios. Our study offers rising variability as a precursor of financial meltdowns albeit with a limitation that they may signal false alarms.	[Guttal, Vishwesha; Goel, Nikunj; Hoarau, Quentin] Indian Inst Sci, Ctr Ecol Sci, Bengaluru 560012, Karnataka, India; [Raghavendra, Srinivas] Natl Univ Ireland, JE Cairnes Sch Business & Econ, Galway, Ireland; [Raghavendra, Srinivas] Indian Inst Sci, Ctr Contemporary Studies, Bengaluru 560012, Karnataka, India; [Hoarau, Quentin] Ecole Normale Super, F-94235 Cachan, France	Indian Institute of Science (IISC) - Bangalore; Ollscoil na Gaillimhe-University of Galway; Indian Institute of Science (IISC) - Bangalore; UDICE-French Research Universities; Universite Paris Saclay	Guttal, V (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bengaluru 560012, Karnataka, India.	guttal@ces.iisc.ernet.in	Goel, Nikunj/AAJ-3252-2021; Guttal, Vishwesha/A-3007-2008	Goel, Nikunj/0000-0002-5720-7761; Guttal, Vishwesha/0000-0002-2677-857X	DBT-IISc partnership program; DBT Ramalingaswamy fellowship; Whitaker Institute and J. E. Cairnes College of Business, Public Policy and Law, National University of Ireland, Galway	DBT-IISc partnership program; DBT Ramalingaswamy fellowship; Whitaker Institute and J. E. Cairnes College of Business, Public Policy and Law, National University of Ireland, Galway	This work was supported by DBT-IISc partnership program and a DBT Ramalingaswamy fellowship to VG. SR acknowledges support from Whitaker Institute and J. E. Cairnes College of Business, Public Policy and Law, National University of Ireland, Galway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by DBT-IISc partnership program and a DBT Ramalingaswamy fellowship to VG. SR acknowledges support from Whitaker Institute and J. E. Cairnes College of Business, Public Policy and Law, National University of Ireland, Galway. We acknowledge constructive comments from Marten Scheffer, William Brock, Vasilis Dakos and Karthik Azhagesan on the manuscript.	Alfarano S, 2007, MINIMAL NOISE TRADER, P345; BEJA A, 1980, J FINANC, V35, P235, DOI 10.2307/2327380; Bhaduri A, 2015, METROECONOMICA, V66, P158, DOI 10.1111/meca.12070; Bierut BK, 2013, GLOBAL LIQUIDITY EAR, P377; BOLLERSLEV T, 1992, J ECONOMETRICS, V52, P5, DOI 10.1016/0304-4076(92)90064-X; Brenner M., 1989, FINANC ANAL J, V45, P61, DOI DOI 10.2469/FAJ.V45.N4.61; Brock W.A., 1991, NONLINEAR DYNAMICS C; Brock WA, 1997, ECONOMETRICA, V65, P1059, DOI 10.2307/2171879; Bussiere M, 2006, J INT MONEY FINANC, V25, P953, DOI 10.1016/j.jimonfin.2006.07.007; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; DAY RH, 1990, J ECON BEHAV ORGAN, V14, P299, DOI 10.1016/0167-2681(90)90061-H; Diks C, 2012, EARLY WARMING SIGNAL; Drake JM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0686; Edison HJ, 2000, DO INDICATORS FINANC; Eross A, 2015, EARLY WARNING INDICA; Farmer JD, 2002, J ECON BEHAV ORGAN, V49, P149, DOI 10.1016/S0167-2681(02)00065-3; Farmer JD, 2002, IND CORP CHANGE, V11, P895, DOI 10.1093/icc/11.5.895; Gaunersdorfer A., 2007, LONG MEMORY EC, P265, DOI [10.1007/978-3-540-34625-8_9, DOI 10.1007/978-3-540-34625-8_9]; Gaunersdorfer A, 2001, BIFURCATION ROUTES V; Goldstein M., 2000, ASSESSING FINANCIAL; Goswami B, 2012, PHYSICA A, V391, P4364, DOI 10.1016/j.physa.2012.04.018; Guttal V, 2013, THEORETICAL ECOLOGY; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Guttal V, 2007, ECOL MODEL, V201, P420, DOI 10.1016/j.ecolmodel.2006.10.005; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Kefi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092097; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; Lebaron B, 2006, HANDB ECON, V13, P1187; Lenton TM, 2011, NAT CLIM CHANGE, V1, P201, DOI [10.1038/NCLIMATE1143, 10.1038/NCLIMATE143]; LEVY M, 1994, ECON LETT, V45, P103, DOI 10.1016/0165-1765(94)90065-5; Liu YH, 1999, PHYS REV E, V60, P1390, DOI 10.1103/PhysRevE.60.1390; LUX T, 1995, ECON J, V105, P881, DOI 10.2307/2235156; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Lux T., 2000, INT J THEOR APPL FIN, V3, P675, DOI DOI 10.1142/S0219024900000826; Ma S. K., 2000, MODERN THEORY CRITIC; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Meng H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03655; Oh KJ, 2006, EXPERT SYST, V23, P83, DOI 10.1111/j.1468-0394.2006.00326.x; Poon SH, 2003, J ECON LIT, V41, P478, DOI 10.1257/002205103765762743; Quax R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01898; Samanidou E, 2007, REP PROG PHYS, V70, P409, DOI 10.1088/0034-4885/70/3/R03; Sandoval L, 2012, PHYSICA A, V391, P187, DOI 10.1016/j.physa.2011.07.023; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; SCHWERT GW, 1990, REV FINANC STUD, V3, P77, DOI 10.1093/rfs/3.1.77; Sethna JP, 2007, STAT MECH ENTROPY OR; Song DM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026108; Sornette D, 2009, WHY STOCK MARKETS CR; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tan JPL, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-41038-1; Taylor S.J., 1994, MATH FINANC, V4, P183, DOI DOI 10.1111/J.1467-9965.1994.TB00057.X; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470; Zeeman EC., 1974, J MATH ECON, V1, P39, DOI DOI 10.1016/0304-4068(74)90034-2; Zheng ZY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00888	62	31	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0144198	10.1371/journal.pone.0144198	http://dx.doi.org/10.1371/journal.pone.0144198			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA8CX	26761792	Green Published, Green Accepted, gold			2022-12-27	WOS:000368033100004
J	Pezzoni, M; Mairesse, J; Stephan, P; Lane, J				Pezzoni, Michele; Mairesse, Jacques; Stephan, Paula; Lane, Julia			Gender and the Publication Output of Graduate Students: A Case Study	PLOS ONE			English	Article							WORK; PERFORMANCE; FACULTY; SCIENCE; PEERS; WOMEN	We examine gender differences among the six PhD student cohorts 2004-2009 at the California Institute of Technology using a new dataset that includes information on trainees and their advisors and enables us to construct detailed measures of teams at the advisor level. We focus on the relationship between graduate student publications and: (1) their gender; (2) the gender of the advisor, (3) the gender pairing between the advisor and the student and (4) the gender composition of the team. We find that female graduate students coauthor on average 8.5% fewer papers than men; that students writing with female advisors publish 7.7% more. Of particular note is that gender pairing matters: male students working with female advisors publish 10.0% more than male students working with male advisors; women students working with male advisors publish 8.5% less. There is no difference between the publishing patterns of male students working with male advisors and female students working with female advisors. The results persist and are magnified when we focus on the quality of the published articles, as measured by average Impact Factor, instead of number of articles. We find no evidence that the number of publications relates to the gender composition of the team. Although the gender effects are reasonably modest, past research on processes of positive feedback and cumulative advantage suggest that the difference will grow, not shrink, over the careers of these recent cohorts.	[Pezzoni, Michele] Univ Nice Sophia Antipolis, GREDEG, F-06189 Nice, France; [Pezzoni, Michele] Bocconi Univ, CRIOS, Milan, Italy; [Pezzoni, Michele] Coll Carlo Alberto, BRICK, Turin, Italy; [Mairesse, Jacques] CREST ENSAE, Paris, France; [Mairesse, Jacques; Stephan, Paula] NBER, Cambridge, MA 02138 USA; [Stephan, Paula] Georgia State Univ, Andrew Young Sch, Atlanta, GA 30303 USA; [Lane, Julia] NYU, New York, NY USA; [Lane, Julia] Univ Strasbourg, Strasbourg, France; [Lane, Julia] Univ Melbourne, Melbourne, Vic, Australia	UDICE-French Research Universities; Universite Cote d'Azur; Bocconi University; Collegio Carlo Alberto; Institut Polytechnique de Paris; National Bureau of Economic Research; University System of Georgia; Georgia State University; New York University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Melbourne	Stephan, P (corresponding author), NBER, Cambridge, MA 02138 USA.	pstephan@gsu.edu		Pezzoni, Michele/0000-0002-2255-8166; Lane, Julia/0000-0002-8139-2960	Alfred P. Sloan Foundation; NSF Education and Human Resources Award [1348691]; Direct For Education and Human Resources [1547507] Funding Source: National Science Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NSF Education and Human Resources Award; Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This work was supported by the Alfred P. Sloan Foundation; NSF Education and Human Resources Award 1348691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christina Jones and David Mayo for help with data issues. Megan McGarvey, Kaye Husbands Fealing and Cornelia Lawson made useful comments on earlier drafts of this paper. We acknowledge support from the Alfred P. Sloan Foundation and NSF Education and Human Resources Award 1348691.	Apesteguia J, 2012, MANAGE SCI, V58, P78, DOI 10.1287/mnsc.1110.1348; Azoulay P, 2010, Q J ECON, V125, P549, DOI 10.1162/qjec.2010.125.2.549; Bandiera O, 2009, ECONOMETRICA, V77, P1047, DOI 10.3982/ECTA6496; Black Grant C, 2010, EC U SCI ROLE FOREIG, P129; Blau F.D., 2010, CAN MENTORING HELP F; Booth AL, 2013, IZA DISCUSSION PAPER; Boschini A, 2007, J LABOR ECON, V25, P325, DOI 10.1086/510764; Ceci S. J., 2014, PSYCHOL SCI PUBLIC I; Conti A., 2015, RES POLICY; Conti A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133177; Dasgupta N, 2015, P NATL ACAD SCI USA, V112, P4988, DOI 10.1073/pnas.1422822112; David P. A., 1993, POSITIVE FEEDBACKS R; Fox M.F., 2006, HDB SOCIOLOGY GENDER, P441, DOI DOI 10.1007/0-387-36218-5_20; Fox MF, 2007, J HIGH EDUC, V78, P542, DOI 10.1353/jhe.2007.0032; Fox MF, 2003, EQUAL RITES, UNEQUAL OUTCOMES: WOMEN IN AMERICAN RESEARCH UNIVERSITIES, P91; Fox MF, 2006, INT J LEARN CHANG, P1; Freeman RB, 2014, NATL BUR EC RES WORK, V19905; Hilton NJ, 2015, ENHANCING EFFECTIVEN; Ichniowski C, 2014, NATL BUR EC RES WORK, V20478; Joshi A., 2014, ADM SCI Q; Joshi A, 2015, ACAD MANAGE J, V58, P59, DOI 10.5465/amj.2013.0718; Lane JI, 2015, RES POLICY, V44, P1659, DOI 10.1016/j.respol.2014.12.013; Levin SG, 1998, SEX ROLES, V38, P1049, DOI 10.1023/A:1018882711314; Lissoni F, 2011, IND CORP CHANGE, V20, P253, DOI 10.1093/icc/dtq073; Long JS, 1990, JSTOR, P1297; Mairesse J, 2015, REV ECON-FR, V66, P65, DOI 10.3917/reco.661.0065; Mas A, 2009, AM ECON REV, V99, P112, DOI 10.1257/aer.99.1.112; Merton RK, 1988, JSTOR, P606; Milkman K. L., 2015, J APPL PSYCHOL; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Reuters T., 2011, J CIT REPORTS; Sheltzer JM, 2014, P NATL ACAD SCI USA, V111, P10107, DOI 10.1073/pnas.1403334111; Stvilia B, 2011, J AM SOC INF SCI TEC, V62, P270, DOI 10.1002/asi.21464; Williams WM, 2015, P NATL ACAD SCI USA, V112, P5360, DOI 10.1073/pnas.1418878112; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	36	47	50	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145146	10.1371/journal.pone.0145146	http://dx.doi.org/10.1371/journal.pone.0145146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA8CX	26760776	Green Published, gold			2022-12-27	WOS:000368033100008
J	Tilsen, S; Spincemaille, P; Xu, B; Doerschuk, P; Luh, WM; Feldman, E; Wang, Y				Tilsen, Sam; Spincemaille, Pascal; Xu, Bo; Doerschuk, Peter; Luh, Wen-Ming; Feldman, Elana; Wang, Yi			Anticipatory Posturing of the Vocal Tract Reveals Dissociation of Speech Movement Plans from Linguistic Units	PLOS ONE			English	Article							COARTICULATION; KINEMATICS; MODEL	Models of speech production typically assume that control over the timing of speech movements is governed by the selection of higher-level linguistic units, such as segments or syllables. This study used real-time magnetic resonance imaging of the vocal tract to investigate the anticipatory movements speakers make prior to producing a vocal response. Two factors were varied: preparation (whether or not speakers had foreknowledge of the target response) and pre-response constraint (whether or not speakers were required to maintain a specific vocal tract posture prior to the response). In prepared responses, many speakers were observed to produce pre-response anticipatory movements with a variety of articulators, showing that that speech movements can be readily dissociated from higher-level linguistic units. Substantial variation was observed across speakers with regard to the articulators used for anticipatory posturing and the contexts in which anticipatory movements occurred. The findings of this study have important consequences for models of speech production and for our understanding of the normal range of variation in anticipatory speech behaviors.	[Tilsen, Sam; Feldman, Elana] Cornell Univ, Linguist, Ithaca, NY 14853 USA; [Spincemaille, Pascal; Wang, Yi] Cornell Weill Med Coll, Radiol, New York, NY 10022 USA; [Xu, Bo; Doerschuk, Peter; Wang, Yi] Cornell Univ, Biomed Engn, Ithaca, NY 15843 USA; [Luh, Wen-Ming] Cornell Univ, Human Ecol, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Tilsen, S (corresponding author), Cornell Univ, Linguist, 203 Morrill Hall, Ithaca, NY 14853 USA.	tilsen@cornell.edu	Tilsen, Sam/AAF-4876-2021; Wang, Yi/GRS-4287-2022	Tilsen, Sam/0000-0003-0865-5119; Spincemaille, Pascal/0000-0002-8821-1341; Xu, Bo/0000-0001-7715-6888	Cornell Institute for Social Sciences; National Institutes of Health [S10RR025145, R01CA181566]; NIH [S10RR025145, R01CA181566]; NATIONAL CANCER INSTITUTE [R01CA181566] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025145] Funding Source: NIH RePORTER	Cornell Institute for Social Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The Cornell Institute for Social Sciences provided funds for MRI scanner fees and participant compensation (http://socialsciences.cornell.edu/). National Institutes of Health S10RR025145 and R01CA181566 supported YW and the construction of the Cornell MRI facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Shri Narayanan, Michael Proctor, Vikram Ramanarayanan, and Zisis Skordilis for advice in processing MRI images. We thank Bruce McKee, Emily Qualls, Robin Karlin, and Hao Yi for help in testing the MRI protocol. We also thank Abby Cohn, Draga Zec, John Hale, and members of the Cornell Phonetics Lab for discussions of this research. This research was supported in part by NIH S10RR025145, NIH R01CA181566, and the Cornell University Institute of Social Sciences.	Beddor PS, 2002, J PHONETICS, V30, P591, DOI 10.1006/jpho.2002.0177; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birkholz P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060603; Bohland JW, 2010, J COGNITIVE NEUROSCI, V22, P1504, DOI 10.1162/jocn.2009.21306; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Farnetani E, 1999, COARTICULATION THEOR, P31; Frisch SA, 2002, J PHONETICS, V30, P139, DOI 10.1006/jpho.2002.0176; Gafos A. I., 1999, ARTICULATORY BASIS L; Gick B, 2004, PHONETICA, V61, P220, DOI 10.1159/000084159; Goldstein L, 2006, ACTION TO LANGUAGE VIA THE MIRROR NEURON SYSTEM, P215, DOI 10.1017/CBO9780511541599.008; Goldstein L, 2007, COGNITION, V103, P386, DOI 10.1016/j.cognition.2006.05.010; Gow DW, 2004, J MEM LANG, V51, P279, DOI 10.1016/j.jml.2004.05.004; Grosvald M, 2009, J PHONETICS, V37, P173, DOI 10.1016/j.wocn.2009.01.002; GUENTHER FH, 1995, PSYCHOL REV, V102, P594, DOI 10.1037/0033-295X.102.3.594; Hansson, 2010, CONSONANT HARMONY LO; Hardcastle W. J., 1999, COARTICULATION THEOR; Heinz J, 2010, LINGUIST INQ, V41, P623, DOI 10.1162/LING_a_00015; Jordan M. I., 1997, ADV PSYCHOL, V121, P471, DOI [10.1016/s0166-4115(97)80111-2, DOI 10.1016/S0166-4115(97)80111-2]; Kawamoto AH, 2008, J MEM LANG, V58, P347, DOI 10.1016/j.jml.2007.06.002; Kroger BJ, 2011, LECT NOTES COMPUT SC, V6800, P287, DOI 10.1007/978-3-642-25775-9_27; Kroger B. J., 2010, SPEECH MOTOR CONTROL, P23; Lammert A, 2013, INTERSPEECH, P959; Lammert AC, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P1572; Levelt W., 1993, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lofqvist A, 1997, J SPEECH LANG HEAR R, V40, P877, DOI 10.1044/jslhr.4004.877; LUBKER J, 1982, J ACOUST SOC AM, V71, P437, DOI 10.1121/1.387447; Mooshammer C, 2012, J PHONETICS, V40, P374, DOI 10.1016/j.wocn.2012.02.002; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; OHMAN SEG, 1967, J ACOUST SOC AM, V41, P310; Ostry DJ, 1996, J NEUROSCI, V16, P1570; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Ramanarayanan V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104168; Ramanarayanan V, 2013, J ACOUST SOC AM, V134, P510, DOI 10.1121/1.4807639; Rastle K, 2002, J EXP PSYCHOL HUMAN, V28, P307, DOI 10.1037//0096-1523.28.2.307; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; Saltzman E., 2008, P SPEECH PROSODY 200, P175; SUSSMAN HM, 1993, J ACOUST SOC AM, V94, P1256, DOI 10.1121/1.408178; Tilsen S., 2014, CORNELL WORKING PAPE, P24; Tilsen S, 2012, J PHONETICS, V40, P764, DOI 10.1016/j.wocn.2012.08.005; WHALEN DH, 1990, J PHONETICS, V18, P3, DOI 10.1016/S0095-4470(19)30356-0; Xu B, 2012, MAGN RESON MED	43	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146813	10.1371/journal.pone.0146813	http://dx.doi.org/10.1371/journal.pone.0146813			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DA8CX	26760511	Green Submitted, Green Published, gold			2022-12-27	WOS:000368033100043
J	Yang, CW; Chen, MF				Yang, Chu-Wen; Chen, Mei-Fang			Uncovering the Potential Pan Proteomes Encoded by Genomic Strand RNAs of Influenza A Viruses	PLOS ONE			English	Article							VIRULENCE DETERMINANTS; SEGMENT 3; PROTEIN; IDENTIFICATION; GENE; CONTAINS; PATTERN; REGION; NS	Influenza A virus genomes are composed of eight negative sense RNAs. In total, 16 proteins encoded by eight positive sense RNAs were identified. One putative protein coding sequence (PCS) encoded by genomic strand RNA of segment 8 has been previously proposed. In this study, 95,608, 123,965 and 35,699 genomic strand RNA sequences from influenza A viruses from avian, human and mammalian hosts, respectively, were used to identify PCSs encoded by the genomic strand RNAs. In total, 326,069 PCSs with lengths equal to or longer than 80 amino acids were identified and clustered into 270 PCS groups. Twenty of the 270 PCS groups which have greater than 10% proportion in influenza A viruses from avian, human or mammalian hosts were selected for detailed study. Maps of the 20 PCSGs in the influenza A virus genomes were constructed. The proportions of the 20 PCSGs in influenza A viruses from different hosts and serotypes were analyzed. One secretory and five membrane proteins predicted from the PCS groups encoded by genomic strand RNAs of segments 1, 2, 4, 6, 7 and 8 were identified. These results suggest the possibility of the ambisense nature of the influenza A virus genomic RNAs and a potential coding sequence reservoir encoding potential pan proteomes of influenza A viruses.	[Yang, Chu-Wen] Soochow Univ, Dept Microbiol, Taipei 111, Taiwan; [Chen, Mei-Fang] Taipei Vet Gen Hosp, Dept Med Res, Taipei 112, Taiwan	Soochow University; Taipei Veterans General Hospital	Yang, CW (corresponding author), Soochow Univ, Dept Microbiol, Taipei 111, Taiwan.	ycw6861@scu.edu.tw						Allen JE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-77; Alymova IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111603; BAEZ M, 1980, NUCLEIC ACIDS RES, V8, P5845, DOI 10.1093/nar/8.23.5845; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Bui VN, 2012, VIROLOGY, V423, P77, DOI 10.1016/j.virol.2011.11.019; Cenik C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r29; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Christman MC, 2011, INFECT GENET EVOL, V11, P803, DOI 10.1016/j.meegid.2011.02.021; Clifford M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-198; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Forbes NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031839; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Giria MT, 2012, J CLIN VIROL, V53, P140, DOI 10.1016/j.jcv.2011.11.002; Gutierrez RA, 2013, INFECT GENET EVOL, V15, P69, DOI 10.1016/j.meegid.2011.10.019; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Kainov DE, 2011, J BIOL CHEM, V286, P7239, DOI 10.1074/jbc.M110.203489; Kamal RP, 2015, J VIROL, V89, P5835, DOI 10.1128/JVI.03137-14; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee VJ, 2011, J CLIN VIROL, V50, P104, DOI 10.1016/j.jcv.2010.10.004; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-183; Lycett SJ, 2009, J VIROL, V83, P9901, DOI 10.1128/JVI.00608-09; Makkoch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051275; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Muramoto Y, 2013, J VIROL, V87, P2455, DOI 10.1128/JVI.02656-12; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Nguyen M, 2003, VIRUS RES, V93, P141, DOI 10.1016/S0168-1702(03)00094-7; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Schrauwen EJA, 2014, EUR J CLIN MICROBIOL, V33, P479, DOI 10.1007/s10096-013-1984-8; Shi M, 2012, J VIROL, V86, P12411, DOI 10.1128/JVI.01677-12; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamuri AU, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000564; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Vasin AV, 2014, VIRUS RES, V185, P53, DOI 10.1016/j.virusres.2014.03.015; Wise HM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002998; Wise HM, 2011, NUCLEIC ACIDS RES, V39, P7775, DOI 10.1093/nar/gkr487; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Zhang ZD, 2011, INFECT GENET EVOL, V11, P1790, DOI 10.1016/j.meegid.2011.07.025; Zhirnov OP, 2007, DOKL BIOCHEM BIOPHYS, V414, P127, DOI 10.1134/S1607672907030106	45	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146936	10.1371/journal.pone.0146936	http://dx.doi.org/10.1371/journal.pone.0146936			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761196	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100055
J	Euler, CW; Juncosa, B; Ryan, PA; Deutsch, DR; McShan, WM; Fischetti, VA				Euler, Chad W.; Juncosa, Barbara; Ryan, Patricia A.; Deutsch, Douglas R.; McShan, W. Michael; Fischetti, Vincent A.			Targeted Curing of All Lysogenic Bacteriophage from Streptococcus pyogenes Using a Novel Counter-selection Technique	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; COMPLETE GENOME SEQUENCE; RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; HUMAN PHARYNGEAL CELLS; TOXIC-SHOCK-SYNDROME; SEROTYPE M3 STRAIN; CHROMOSOMAL ISLANDS; M1T1 CLONE; PROPHAGE INDUCTION	Streptococcus pyogenes is a human commensal and a bacterial pathogen responsible for a wide variety of human diseases differing in symptoms, severity, and tissue tropism. The completed genome sequences of >37 strains of S. pyogenes, representing diverse disease-causing serotypes, have been published. The greatest genetic variation among these strains is attributed to numerous integrated prophage and prophage-like elements, encoding several virulence factors. A comparison of isogenic strains, differing in prophage content, would reveal the effects of these elements on streptococcal pathogenesis. However, curing strains of prophage is often difficult and sometimes unattainable. We have applied a novel counter-selection approach to identify rare S. pyogenes mutants spontaneously cured of select prophage. To accomplish this, we first inserted a two-gene cassette containing a gene for kanamycin resistance (Kan(R)) and the rpsL wild-type gene, responsible for dominant streptomycin sensitivity (Sm-S), into a targeted prophage on the chromosome of a streptomycin resistant (Sm-R) mutant of S. pyogenes strain SF370. We then applied antibiotic counter-selection for the re-establishment of the Kan(S)/Sm-R phenotype to select for isolates cured of targeted prophage. This methodology allowed for the precise selection of spontaneous phage loss and restoration of the natural phage attB attachment sites for all four prophage-like elements in this S. pyogenes chromosome. Overall, 15 mutants were constructed that encompassed every permutation of phage knockout as well as a mutant strain, named CEM1 Delta phi, completely cured of all bacteriophage elements (a similar to 10% loss of the genome); the only reported S. pyogenes strain free of prophage-like elements. We compared CEM1 Delta phi to the WT strain by analyzing differences in secreted DNase activity, as well as lytic and lysogenic potential. These mutant strains should allow for the direct examination of bacteriophage relationships within S. pyogenes and further elucidate how the presence of prophage may affect overall streptococcal survival, pathogenicity, and evolution.	[Euler, Chad W.; Juncosa, Barbara; Ryan, Patricia A.; Deutsch, Douglas R.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10065 USA; [Euler, Chad W.] CUNY Hunter Coll, Dept Med Lab Sci, New York, NY 10065 USA; [Euler, Chad W.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [McShan, W. Michael] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci & Microbiol & Immunol, Oklahoma City, OK 73117 USA	Rockefeller University; City University of New York (CUNY) System; Hunter College (CUNY); Cornell University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Euler, CW (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10065 USA.	ceuler@hunter.cuny.edu			U.S. Public Health Service grants [AI11822, AI057472]; Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR11-133]; NIH [R15A1072718]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057472, R37AI011822, R01AI011822] Funding Source: NIH RePORTER	U.S. Public Health Service grants(United States Department of Health & Human ServicesUnited States Public Health Service); Oklahoma Center for the Advancement of Science and Technology (OCAST); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. Public Health Service grants AI11822 and AI057472 to V.A.F and an Oklahoma Center for the Advancement of Science and Technology (OCAST) grant HR11-133 and by NIH Grant Number R15A1072718 to WMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Banks DJ, 2003, J INFECT DIS, V188, P1898, DOI 10.1086/379897; Banks DJ, 2003, INFECT IMMUN, V71, P7079, DOI 10.1128/IAI.71.12.7079-7086.2003; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Bao YJ, 2014, J BACTERIOL, V196, P4089, DOI 10.1128/JB.02131-14; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Bessen DE, 2015, INFECT GENET EVOL, V33, P393, DOI 10.1016/j.meegid.2014.10.011; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; Brenciani A, 2010, ANTIMICROB AGENTS CH, V54, P221, DOI 10.1128/AAC.00499-09; Broudy TB, 2002, INFECT IMMUN, V70, P2805, DOI 10.1128/IAI.70.6.2805-2811.2002; Broudy TB, 2001, INFECT IMMUN, V69, P1440, DOI 10.1128/IAI.69.3.1440-1443.2001; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Canchaya C, 2002, VIROLOGY, V302, P245, DOI 10.1006/viro.2002.1570; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DEMARINI DM, 1992, MUTAT RES, V267, P1, DOI 10.1016/0027-5107(92)90106-C; Desiere F, 2001, VIROLOGY, V288, P325, DOI 10.1006/viro.2001.1085; Euler CW, 2007, J BACTERIOL, V189, P1044, DOI 10.1128/JB.01411-06; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FINKEN M, 1993, MOL MICROBIOL, V9, P1239, DOI 10.1111/j.1365-2958.1993.tb01253.x; Fittipaldi N, 2012, EMERG INFECT DIS, V18, P650, DOI 10.3201/eid1804.111803; Fittipaldi N, 2012, AM J PATHOL, V180, P1522, DOI 10.1016/j.ajpath.2011.12.037; FUNATSU G, 1972, J MOL BIOL, V68, P547, DOI 10.1016/0022-2836(72)90108-8; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hendrickson C, 2015, PLOS ONE IN PRESS; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Iannelli F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00687; Kimoto H, 2003, BIOSCI BIOTECH BIOCH, V67, P2203, DOI 10.1271/bbb.67.2203; Knetsch MLW, 2001, EMBO J, V20, P1620, DOI 10.1093/emboj/20.7.1620; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; LEDERBERG J, 1951, J BACTERIOL, V61, P549, DOI 10.1128/JB.61.5.549-550.1951; Lindsay J, 2008, STAPHYLOCOCCUS MOL G; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Lizano S, 2007, J BACTERIOL, V189, P1426, DOI 10.1128/JB.01179-06; Loeffler JM, 2006, INFECT IMMUN, V74, P4486, DOI 10.1128/IAI.00020-06; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Martin-Galiano AJ, 2003, ANTIMICROB AGENTS CH, V47, P1257, DOI 10.1128/AAC.47.4.1257-1261.2003; Matos RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003539; McIver KS, 2002, MOL MICROBIOL, V43, P1591, DOI 10.1046/j.1365-2958.2002.02849.x; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; Mcshan WM, 1997, MOL MICROBIOL, V23, P719, DOI 10.1046/j.1365-2958.1997.2591616.x; Miyoshi-Akiyama T, 2012, J BACTERIOL, V194, P5466, DOI 10.1128/JB.01265-12; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Nguyen SV, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00109; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Nozawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019543; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Port GC, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00612-13; Port GC, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00725-15; Proft T, 2003, EMERG INFECT DIS, V9, P1211; Proft T, 1999, J EXP MED, V189, P89, DOI 10.1084/jem.189.1.89; Proft T, 2001, J IMMUNOL, V166, P6711, DOI 10.4049/jimmunol.166.11.6711; Rajakumar K, 1997, INFECT IMMUN, V65, P4606, DOI 10.1128/IAI.65.11.4606-4614.1997; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; Ryan PA, 2007, PLOS COMPUT BIOL, V3, P1177, DOI 10.1371/journal.pcbi.0030132; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Scott J, 2008, J BACTERIOL, V190, P6290, DOI 10.1128/JB.01569-07; Scott J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00317; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Sitkiewicz I, 2006, P NATL ACAD SCI USA, V103, P16009, DOI 10.1073/pnas.0607669103; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tse H, 2012, J INFECT DIS, V206, P341, DOI 10.1093/infdis/jis362; Uchiyama S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002736; Udo EE, 2001, J MED MICROBIOL, V50, P909, DOI 10.1099/0022-1317-50-10-909; Vlaminckx BJM, 2007, INFECT IMMUN, V75, P3673, DOI 10.1128/IAI.01695-06; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wiederholt KM, J DAIRY SCI, V76, P921; Zheng PX, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00149-12	82	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146408	10.1371/journal.pone.0146408	http://dx.doi.org/10.1371/journal.pone.0146408			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756207	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800012
J	Raman, F; Scribner, E; Saut, O; Wenger, C; Colin, T; Fathallah-Shaykh, HM				Raman, Fabio; Scribner, Elizabeth; Saut, Olivier; Wenger, Cornelia; Colin, Thierry; Fathallah-Shaykh, Hassan M.			Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme	PLOS ONE			English	Article							ANTIANGIOGENIC THERAPY; ISCHEMIC-STROKE; GLIOMA GROWTH; BRAIN; ANGIOGENESIS; INVASION; BEVACIZUMAB; CANCER; MODEL; VEGF	Glioblastoma multiforme is a malignant brain tumor with poor prognosis and high morbidity due to its invasiveness. Hypoxia-driven motility and concentration-driven motility are two mechanisms of glioblastoma multiforme invasion in the brain. The use of anti-angiogenic drugs has uncovered new progression patterns of glioblastoma multiforme associated with significant differences in overall survival. Here, we apply a mathematical model of glioblastoma multiforme growth and invasion in humans and design computational trials using agents that target angiogenesis, tumor replication rates, or motility. The findings link highly-dispersive, moderately-dispersive, and hypoxia-driven tumors to the patterns observed in glioblastoma multiforme treated by anti-angiogenesis, consisting of progression by Expanding FLAIR, Expanding FLAIR + Necrosis, and Expanding Necrosis, respectively. Furthermore, replication rate-reducing strategies (e.g. Tumor Treating Fields) appear to be effective in highly-dispersive and moderately-dispersive tumors but not in hypoxia-driven tumors. The latter may respond to motility-reducing agents. In a population computational trial, with all three phenotypes, a correlation was observed between the efficacy of the rate-reducing agent and the prolongation of overall survival times. This research highlights the potential applications of computational trials and supports new hypotheses on glioblastoma multiforme phenotypes and treatment options.	[Raman, Fabio; Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Scribner, Elizabeth; Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Math, Birmingham, AL 35294 USA; [Saut, Olivier; Colin, Thierry] Univ Bordeaux, Dept Math, Talence, France; [Wenger, Cornelia] Univ Lisbon, Fac Ciencias, Inst Biophys & Biomed Engn, Lisbon, Portugal; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; UDICE-French Research Universities; Universite de Bordeaux; Universidade de Lisboa; University of Alabama System; University of Alabama Birmingham	Fathallah-Shaykh, HM (corresponding author), Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.	hfathall@uab.edu		Fathallah-Shaykh, Hassan/0000-0002-2690-7685; Wenger, Cornelia/0000-0001-7889-9093; Raman, Fabio/0000-0003-2393-9937	Laboratory of Excellence TRAIL [ANR-10-LABX-57]; French State; French National Research Agency (ANR) in the frame of the "Investments for the future" Programme IdEx Bordeaux - CPU [ANR-10-IDEX-03-02]	Laboratory of Excellence TRAIL; French State; French National Research Agency (ANR) in the frame of the "Investments for the future" Programme IdEx Bordeaux - CPU(French National Research Agency (ANR))	TC and OS are supported by the Laboratory of Excellence TRAIL ANR-10-LABX-57 and with financial support from the French State, managed by the French National Research Agency (ANR) in the frame of the "Investments for the future" Programme IdEx Bordeaux - CPU (ANR-10-IDEX-03-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GJ, 2014, NEOPLASIA, V16, P543, DOI 10.1016/j.neo.2014.06.003; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Eikenberry SE, 2009, CELL PROLIFERAT, V42, P511, DOI 10.1111/j.1365-2184.2009.00613.x; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Hathout L, 2015, INT J ONCOL, V46, P825, DOI 10.3892/ijo.2014.2741; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kidwell CS, 2001, STROKE, V32, P1349, DOI 10.1161/01.STR.32.6.1349; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Konukoglu E, 2010, MED IMAGE ANAL, V14, P111, DOI 10.1016/j.media.2009.11.005; Konukoglu E, 2010, IEEE T MED IMAGING, V29, P77, DOI 10.1109/TMI.2009.2026413; Lin MI, 2004, CANCER CELL, V6, P529, DOI 10.1016/S1535-6108(04)00340-X; Miranda PC, 2014, PHYS MED BIOL, V59, P4137, DOI 10.1088/0031-9155/59/15/4137; Moreno L, 2013, EXPERT OPIN DRUG DIS, V8, P363, DOI 10.1517/17460441.2013.768984; Mrugala MM, 2014, SEMIN ONCOL, V41, pS4, DOI 10.1053/j.seminoncol.2014.09.010; Nowosielski M, 2014, NEUROLOGY, V82, P1684, DOI 10.1212/WNL.0000000000000402; Plasswilm L, 2000, PATHOBIOLOGY, V68, P99, DOI 10.1159/000055909; Saut O, 2014, B MATH BIOL, V76, P2306, DOI 10.1007/s11538-014-0007-y; Scribner E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115018; Shelton LM, 2010, J NEURO-ONCOL, V99, P165, DOI 10.1007/s11060-010-0115-y; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Swanson KR, 2003, MATH COMPUT MODEL, V37, P1177, DOI 10.1016/S0895-7177(03)00129-8; Swanson KR, 2008, MATH COMPUT MODEL, V47, P638, DOI 10.1016/j.mcm.2007.02.024; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Tang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075436; Weller M, 2013, NEURO-ONCOLOGY, V15, P971, DOI 10.1093/neuonc/not106; Wen PY, 2014, NEUROLOGY, V82, P1670, DOI 10.1212/WNL.0000000000000421; Wenger C, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou278.15; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8	39	17	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146617	10.1371/journal.pone.0146617	http://dx.doi.org/10.1371/journal.pone.0146617			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756205	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800022
J	Li, CY; Wang, YJ; Huang, SW; Cheng, CS; Wang, HC				Li, Chun-Yuan; Wang, Yi-Jan; Huang, Shiao-Wei; Cheng, Cheng-Shun; Wang, Han-Ching			Replication of the Shrimp Virus WSSV Depends on Glutamate-Driven Anaplerosis	PLOS ONE			English	Article							AEROBIC GLYCOLYSIS; METABOLISM; GLUCOSE; GLUTAMINOLYSIS; WSBV	Infection with the white spot syndrome virus (WSSV) induces a metabolic shift in shrimp that resembles the "Warburg effect" in mammalian cells. This effect is triggered via activation of the PI3K-Akt-mTOR pathway, and it is usually accompanied by the activation of other metabolic pathways that provide energy and direct the flow of carbon and nitrogen. Here we show that unlike the glutamine metabolism (glutaminolysis) seen in most cancer cells to double deaminate glutamine to produce glutamate and the TCA cycle intermediate alpha-ketoglutarate (alpha-KG), at the WSSV genome replication stage (12 hpi), although glutaminase (GLS) expression was upregulated, only glutamate was taken up by the hemocytes of WSSV-infected shrimp. At the same time, we observed an increase in the activity of the two enzymes that convert glutamate to alpha-KG, glutamate dehydrogenase (GDH) and aspartate aminotransferase (ASAT). alpha-ketoglutarate concentration was also increased. A series of inhibition experiments suggested that the up-regulation of GDH is regulated by mTORC2, and that the PI3K-mTORC1 pathway is not involved. Suppression of GDH and ASAT by dsRNA silencing showed that both of these enzymes are important for WSSV replication. In GDH-silenced shrimp, direct replenishment of alpha-KG rescued both ATP production and WSSV replication. From these results, we propose a model of glutamate-driven anaplerosis that fuels the TCA cycle via alpha-KG and ultimately supports WSSV replication.	[Li, Chun-Yuan; Wang, Yi-Jan; Cheng, Cheng-Shun; Wang, Han-Ching] Natl Cheng Kung Univ, Inst Biotechnol, Coll Biosci & Biotechnol, Tainan 701, Taiwan; [Huang, Shiao-Wei] Natl Taiwan Univ, Dept Life Sci, Coll Life Sci, Taipei 10764, Taiwan	National Cheng Kung University; National Taiwan University	Wang, HC (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Coll Biosci & Biotechnol, Tainan 701, Taiwan.	wanghc@mail.ncku.edu.tw	Wang, Han-Ching/AAT-6086-2021	Wang, Han-Ching/0000-0001-7283-4942	Ministry of Science and Technology [MOST 104-2321-B-006-027, MOST 104-2622-B-006-009 -CC1]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	HCW received the funding (MOST 104-2321-B-006-027; MOST 104-2622-B-006-009 -CC1) from the Ministry of Science and Technology (https://www.most.gov.tw/). This study was supported financially by these funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt AP, 2012, P NATL ACAD SCI USA, V109, P11818, DOI 10.1073/pnas.1205995109; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chambers JW, 2010, J VIROL, V84, P1867, DOI 10.1128/JVI.02123-09; Chen IT, 2011, J VIROL, V85, P12919, DOI 10.1128/JVI.05385-11; Courtnay R, 2015, MOL BIOL REP, V42, P841, DOI 10.1007/s11033-015-3858-x; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dhar AK, 2009, MOL IMMUNOL, V46, P1688, DOI 10.1016/j.molimm.2009.02.020; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Fontaine KA, 2014, J VIROL, V88, P4366, DOI 10.1128/JVI.03134-13; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsieh YC, 2015, DEV COMP IMMUNOL IN; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kimmich GA, 2002, AM J PHYSIOL-CELL PH, V282, pC1404, DOI 10.1152/ajpcell.00487.2001; Kudchodkar SB, 2006, P NATL ACAD SCI USA, V103, P14182, DOI 10.1073/pnas.0605825103; Lightner DV, 2011, J INVERTEBR PATHOL, V106, P110, DOI 10.1016/j.jip.2010.09.012; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Magistretti PJ, 2009, AM J CLIN NUTR, V90, p875S, DOI 10.3945/ajcn.2009.27462CC; Masui K, 2014, TRENDS ENDOCRIN MET, V25, P364, DOI 10.1016/j.tem.2014.04.002; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Noch E, 2012, MOL CANCER THER, V11, P14, DOI 10.1158/1535-7163.MCT-11-0517; Pavlides S, 2010, AGING-US, V2, P185, DOI 10.18632/aging.100134; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Read RD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000374; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Sanchez EL, 2015, VIROLOGY; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Smith TJ, 2008, TRENDS BIOCHEM SCI, V33, P557, DOI 10.1016/j.tibs.2008.07.007; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Su MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004196; Wang CH, 1995, DIS AQUAT ORGAN, V23, P239, DOI 10.3354/dao023239; Wang KCHC, 2010, FISH SHELLFISH IMMUN, V29, P94, DOI 10.1016/j.fsi.2010.02.020; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yu YJ, 2011, TRENDS MICROBIOL, V19, P360, DOI 10.1016/j.tim.2011.04.002; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	41	17	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146902	10.1371/journal.pone.0146902	http://dx.doi.org/10.1371/journal.pone.0146902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751681	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100177
J	Liu, NN; Ma, XW; Zhou, SH; Wang, P; Sun, Y; Li, XC; Hou, YX				Liu, Nana; Ma, Xiaowen; Zhou, Sihong; Wang, Ping; Sun, Yun; Li, Xiancai; Hou, Yuxia			Molecular and Functional Characterization of a Polygalacturonase-Inhibiting Protein from Cynanchum komarovii That Confers Fungal Resistance in Arabidopsis	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; SIGNAL-TRANSDUCTION PATHWAYS; BOTRYTIS-CINEREA; PHASEOLUS-VULGARIS; SALICYLIC-ACID; DEFENSE RESPONSES; TRANSGENIC PLANTS; ABIOTIC STRESS; CELL-WALLS; PEAR PGIP	Compliance with ethical standards: This study did not involve human participants and animals, and the plant of interest is not an endangered species. Polygalacturonase-inhibiting proteins (PGIPs) are leucine-rich repeat proteins that plants produce against polygalacturonase, a key virulence agent in pathogens. In this paper, we cloned and purified CkPGIP1, a gene product from Cynanchum komarovii that effectively inhibits polygalacturonases from Botrytis cinerea and Rhizoctonia solani. We found the expression of CkPGIP1 to be induced in response to salicylic acid, wounding, and infection with B. cinerea and R. solani. In addition, transgenic overexpression in Arabidopsis enhanced resistance against B. cinerea. Furthermore, CkPGIP1 obtained from transgenic Arabidopsis inhibited the activity of B. cinerea and R. solani polygalacturonases by 62.7-66.4% and 56.5-60.2%, respectively. Docking studies indicated that the protein interacts strongly with the B1-sheet at the N-terminus of the B. cinerea polygalacturonase, and with the C-terminus of the polygalacturonase from R. solani. This study highlights the significance of CkPGIP1 in plant disease resistance, and its possible application to manage fungal pathogens.	[Liu, Nana; Ma, Xiaowen; Zhou, Sihong; Wang, Ping; Sun, Yun; Li, Xiancai; Hou, Yuxia] China Agr Univ, Coll Sci, Beijing 100193, Peoples R China	China Agricultural University	Hou, YX (corresponding author), China Agr Univ, Coll Sci, Beijing 100193, Peoples R China.	houyuxia@cau.edu.cn		Liu, Nana/0000-0001-9745-8525	Program of National Nature Science Foundation of China [31071751]; Genetically Modified Organism Breeding Major Project [2015ZX08005-002]	Program of National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organism Breeding Major Project	This work was supported by the Program of National Nature Science Foundation of China (Grant no. 31071751) and the Genetically Modified Organism Breeding Major Project (Grant no. 2015ZX08005-002). And YXH received the funding.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; ABUGOUKH AA, 1983, PHYSIOL PLANT PATHOL, V23, P123, DOI 10.1016/0048-4059(83)90039-5; Afzal AJ, 2007, PROTEIN EXPRES PURIF, V53, P346, DOI 10.1016/j.pep.2006.12.017; Aguero CB, 2005, MOL PLANT PATHOL, V6, P43, DOI 10.1111/j.1364-3703.2004.00262.x; Ahsan N, 2005, PLANT SCI, V169, P1081, DOI 10.1016/j.plantsci.2005.07.006; Akagi A, 2010, EUR J PLANT PATHOL, V128, P423, DOI 10.1007/s10658-010-9684-z; Bennett A, 1996, U.S. Patent, Patent No. [5569830, No. 5,569,830]; Bezier A, 2002, EUR J PLANT PATHOL, V108, P111, DOI 10.1023/A:1015061108045; Centis S, 1997, MOL PLANT MICROBE IN, V10, P769, DOI 10.1094/MPMI.1997.10.6.769; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; D'Ovidio R, 2006, PLANTA, V224, P633, DOI 10.1007/s00425-006-0235-y; De Lorenzo G, 2001, ANNU REV PHYTOPATHOL, V39, P313, DOI 10.1146/annurev.phyto.39.1.313; Desiderio A, 1997, MOL PLANT MICROBE IN, V10, P852, DOI 10.1094/MPMI.1997.10.7.852; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; FAVARON F, 1994, PLANTA, V195, P80, DOI 10.1007/BF00206295; Ferrari S, 2003, PLANT CELL, V15, P93, DOI 10.1105/tpc.005165; Ferrari S, 2006, MOL PLANT MICROBE IN, V19, P931, DOI 10.1094/MPMI-19-0931; FREDIANI M, 1993, THEOR APPL GENET, V87, P369, DOI 10.1007/BF01184925; Gruner R, 2003, EUR J BIOCHEM, V270, P4876, DOI 10.1046/j.1432-1033.2003.03888.x; Isshiki A, 2001, MOL PLANT MICROBE IN, V14, P749, DOI 10.1094/MPMI.2001.14.6.749; Johnson C, 2003, PLANT CELL, V15, P1846, DOI 10.1105/tpc.012211; JOHNSTON DJ, 1993, J EXP BOT, V44, P971, DOI 10.1093/jxb/44.5.971; Jones DA, 1997, ADV BOT RES, V24, P89; Joubert DA, 2006, TRANSGENIC RES, V15, P687, DOI 10.1007/s11248-006-9019-1; KARR AL, 1970, PLANT PHYSIOL, V46, P69, DOI 10.1104/pp.46.1.69; Kars I, 2005, PLANT J, V43, P213, DOI 10.1111/j.1365-313X.2005.02436.x; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Komjanc M, 1999, PLANT MOL BIOL, V40, P945, DOI 10.1023/A:1006275924882; Leckie F, 1999, EMBO J, V18, P2352, DOI 10.1093/emboj/18.9.2352; Li RG, 2003, PLANTA, V217, P299, DOI 10.1007/s00425-003-0988-5; Lim JM, 2009, J PROTEOME RES, V8, P673, DOI 10.1021/pr800855f; Lu LX, 2012, PLANT CELL REP, V31, P1173, DOI 10.1007/s00299-012-1239-7; Manfredini C, 2005, PHYSIOL MOL PLANT P, V67, P108, DOI 10.1016/j.pmpp.2005.10.002; Mariotti L, 2008, PHYLLOPHILUM MYCOL R; Matsushima N, 2012, BIOMOLECULES, V2, P288, DOI 10.3390/biom2020288; Mattei B, 2001, BIOCHEMISTRY-US, V40, P569, DOI 10.1021/bi0017632; Maulik A, 2013, PROTEINS, V81, P852, DOI 10.1002/prot.24243; Maulik A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S19; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Misas-Villamil JC, 2008, CURR OPIN PLANT BIOL, V11, P380, DOI 10.1016/j.pbi.2008.04.007; Oeser B, 2002, FUNGAL GENET BIOL, V36, P176, DOI 10.1016/S1087-1845(02)00020-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietro AD, 1998, MOL PLANT MICROBE IN, V11, P91; Powell ALT, 2000, MOL PLANT MICROBE IN, V13, P942, DOI 10.1094/MPMI.2000.13.9.942; Prabhu SA, 2014, J EXP BOT, V65, P5033, DOI 10.1093/jxb/eru266; Ramanathan V, 1997, J EXP BOT, V48, P1185, DOI 10.1093/jxb/48.6.1185; Ramonell KM, 2002, CURR OPIN PLANT BIOL, V5, P291, DOI 10.1016/S1369-5266(02)00266-2; Sathiyaraj G, 2010, MOL BIOL REP, V37, P3445, DOI 10.1007/s11033-009-9936-1; SHARROCK KR, 1994, PHYSIOL MOL PLANT P, V45, P305, DOI 10.1016/S0885-5765(05)80061-X; Shieh MT, 1997, APPL ENVIRON MICROB, V63, P3548, DOI 10.1128/AEM.63.9.3548-3552.1997; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Sicilia F, 2005, PLANT PHYSIOL, V139, P1380, DOI 10.1104/pp.105.067546; Sun WX, 2009, GENESIS, V47, P535, DOI 10.1002/dvg.20530; SZECSI A, 1990, J PHYTOPATHOL, V130, P188, DOI 10.1111/j.1439-0434.1990.tb01167.x; TAYLOR RJ, 1988, PHYTOPATHOLOGY, V78, P1101, DOI 10.1094/Phyto-78-1101; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wang QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016930; Wang R, 2015, PLANT MOL BIOL, V87, P181, DOI 10.1007/s11103-014-0269-7; Wang XJ, 2013, PLANT MOL BIOL, V81, P379, DOI 10.1007/s11103-013-0007-6; Zhu YF, 2014, PLANT CELL, V26, P4149, DOI 10.1105/tpc.114.128611	61	17	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146959	10.1371/journal.pone.0146959	http://dx.doi.org/10.1371/journal.pone.0146959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752638	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100185
J	Liu, Y; Zhang, L; Zhou, JY; Pan, JS; Hu, W; Zhou, YH				Liu, Yong; Zhang, Le; Zhou, Jin-Yong; Pan, Jinshun; Hu, Wei; Zhou, Yi-Hua			Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs	PLOS ONE			English	Article							SURFACE-ANTIGEN; VIRUS INFECTION; HEPATOCELLULAR-CARCINOMA; ANTIBODIES; CARRIERS; MUTATIONS; VARIANTS; MUTANTS	Coexistence of hepatitis B surface antigen (HBsAg) and antibody against HBsAg (anti-HBs) comprises an atypical serological profile in patients with chronic hepatitis B virus (HBV) infection. In this study, in total 94 patients with coexisting HBsAg and anti-HBs and 94 ageand sex-matched patients with positive HBsAg were characterized by quantitatively measuring HBsAg and HBV DNA, sequencing large S genes, and observing clinical features. Compared with common hepatitis B patients, the patients with coexisting HBsAg and antiHBs had lower HBsAg and HBV DNA levels. These two groups had similar rate of pre-S deletion mutations. However, in patients with coexisting HBsAg and anti-HBs, more amino acid substitutions in the a determinant of S gene were observed in HBV genotype C, but not in genotype B. Fourteen patients with coexisting HBsAg and anti-HBs were followed up for an average of 15.5 months. There were no significant changes in the levels of HBsAg, antiHBs, HBV DNA and ALT over the follow-up period. Compared with the baseline sequences, amino acid substitutions in the MHR of HBsAg occurred in 14.3% (2/14) patients. In conclusion, coexistence of HBsAg and anti-HBs may be associated with higher frequency of mutations in the a determinant of HBV genotype C.	[Liu, Yong; Zhang, Le; Zhou, Jin-Yong; Pan, Jinshun; Hu, Wei; Zhou, Yi-Hua] Nanjing Univ, Nanjing Drum Tower Hosp, Dept Expt Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Yong; Zhang, Le; Zhou, Jin-Yong; Pan, Jinshun; Zhou, Yi-Hua] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yi-Hua] Nanjing Univ, Nanjing Drum Tower Hosp, Dept Infect Dis, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Zhou, YH (corresponding author), Nanjing Univ, Nanjing Drum Tower Hosp, Dept Expt Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.	zgr03summer@126.com		Pan, jinshun/0000-0002-6394-7010	Health Bureau of Nanjing City, China [YKK09114]	Health Bureau of Nanjing City, China	This work was supported by the Grant (YKK09114) for the Development of Medical Sciences from the Health Bureau of Nanjing City, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian SM, 2013, J CLIN VIROL, V57, P201, DOI 10.1016/j.jcv.2012.04.027; Brunetto MR, 2014, J HEPATOL, V60, P473, DOI 10.1016/j.jhep.2013.12.001; Chen Y, 2011, J CLIN VIROL, V52, P198, DOI 10.1016/j.jcv.2011.07.011; Colson P, 2007, VIROLOGY, V367, P30, DOI 10.1016/j.virol.2007.05.012; Ding F, 2015, J MED VIROL, V87, P2067, DOI 10.1002/jmv.24273; Frider B, 2007, LIVER INT, V27, P727, DOI 10.1111/j.1478-3231.2007.01480.x; Gerlich WH, 2007, CLIN INFECT DIS, V44, P1170, DOI 10.1086/513296; Han ZG, 2015, CLIN CHIM ACTA, V438, P266, DOI 10.1016/j.cca.2014.09.007; HEIJTINK RA, 1982, J MED VIROL, V10, P83, DOI 10.1002/jmv.1890100202; Huang XY, 2010, J MED VIROL, V82, P23, DOI 10.1002/jmv.21669; Jang JS, 2009, J MED VIROL, V81, P1531, DOI 10.1002/jmv.21577; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lee BS, 2013, J MED VIROL, V85, P1327, DOI 10.1002/jmv.23594; Liu WW, 2012, ARCH VIROL, V157, P627, DOI 10.1007/s00705-011-1215-5; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Ponde RAA, 2011, EUR J CLIN MICROBIOL, V30, P1325, DOI 10.1007/s10096-011-1240-z; Ponde RAA, 2013, EUR J CLIN MICROBIOL, V32, P461, DOI 10.1007/s10096-012-1781-9; Romano L, 2015, HUM VACC IMMUNOTHER, V11, P53, DOI 10.4161/hv.34306; Seo SI, 2014, J MED VIROL, V86, P124, DOI 10.1002/jmv.23779; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Tsai HT, 2008, INT REV IMMUNOL, V27, P427, DOI 10.1080/08830180802295757; Wang YM, 1999, J GASTROENTEROL, V34, P600, DOI 10.1007/s005350050379; Zhou YH, 2009, J CLIN VIROL, V46, P363, DOI 10.1016/j.jcv.2009.09.012	25	11	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146980	10.1371/journal.pone.0146980	http://dx.doi.org/10.1371/journal.pone.0146980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751075	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100187
J	Raggi, F; Russo, D; Urbani, C; Sardella, C; Manetti, L; Cappellani, D; Lupi, I; Tomisti, L; Martino, E; Marcocci, C; Bogazzi, F				Raggi, Francesco; Russo, Dania; Urbani, Claudio; Sardella, Chiara; Manetti, Luca; Cappellani, Daniele; Lupi, Isabella; Tomisti, Luca; Martino, Enio; Marcocci, Claudio; Bogazzi, Fausto			Divergent Effects of Dioxin- or Non-Dioxin-Like Polychlorinated Biphenyls on the Apoptosis of Primary Cell Culture from the Mouse Pituitary Gland	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; CISPLATIN-INDUCED APOPTOSIS; THYROID-HORMONE RECEPTOR; BREAST-CANCER CELLS; NF-KAPPA-B; GROWTH-HORMONE; OXIDATIVE STRESS; MITOCHONDRIAL PATHWAY; LIVER CARCINOGENESIS; MEDIATED APOPTOSIS	Polychlorinated biphenyls (PCBs) can disrupt the endocrine function, promote neoplasms and regulate apoptosis in some tissues; however, it is unknown whether PCBs can affect the apoptosis of pituitary cells. The study evaluated the effect of PCBs on the apoptosis of normal pituitary cells and the underlying mechanisms. Primary cell cultures obtained from mouse pituitary glands were exposed to Aroclor 1254 or selected dioxin-like (PCB 77, PCB 126) or non-dioxin-like (PCB 153, PCB 180) congeners. Apoptosis was evaluated by Annexin V staining, DNA fragmentation, and TUNEL assay. Both the expression and activity of caspases were analyzed. Selective thyroid hormone receptor (TR) or aryl-hydrocarbon receptor (AhR) or CYP1A1 antagonist were used to explore the mechanisms underlying PCBs action. Our results showed that Aroclor 1254 induced the apoptosis of pituitary cells as well as the final caspase-3 level and activity through the extrinsic pathway, as shown by the increased caspase-8 level and activity. On the other hand, the intrinsic pathway evaluated by measuring caspase-9 expression was silent. The selected nondioxin- like congeners either increased (PCB 180) or reduced (PCB 153) pituitary cell apoptosis, affecting the extrinsic pathway (PCB 180), or both the extrinsic and intrinsic pathways (PCB 153), respectively. In contrast, the dioxin-like congeners (PCB 77 and PCB 126) did not affect apoptosis. The anti-apoptotic phenotype of PCB 153 was counteracted by a TR or a CYP1A1 antagonist, whereas the pro-apoptotic effect of PCB 180 was counteracted by an AhR antagonist. The induced apoptosis of Aroclor 1254 or PCB 180 was associated with a reduction of cell proliferation, whereas the decreased apoptosis due to PCB 153 increased cell proliferation by 30%. In conclusion, our data suggest that non-dioxin-like PCBs may modulate apoptosis and the proliferation rate of pituitary cells that have either pro-or anti-apoptotic effects depending on the specific congeners. However, the impact of PCBs on the process of pituitary tumorigenesis remains to be elucidated.	[Raggi, Francesco; Russo, Dania; Urbani, Claudio; Sardella, Chiara; Manetti, Luca; Cappellani, Daniele; Lupi, Isabella; Tomisti, Luca; Martino, Enio; Marcocci, Claudio; Bogazzi, Fausto] Univ Pisa, Endocrinol Sect, Dept Clin & Expt Med, Pisa, Italy	University of Pisa	Bogazzi, F (corresponding author), Univ Pisa, Endocrinol Sect, Dept Clin & Expt Med, Pisa, Italy.	fausto.bogazzi@med.unipi.it	BOGAZZI, FAUSTO/I-2087-2012; Urbani, Claudio/K-8388-2016; Manetti, Luca/K-9022-2016; Cappellani, Daniele/P-5785-2019; Sardella, Chiara/K-9085-2016	BOGAZZI, FAUSTO/0000-0001-5975-4411; Urbani, Claudio/0000-0002-2207-4727; Manetti, Luca/0000-0001-9911-5366; Cappellani, Daniele/0000-0003-0703-3561; Sardella, Chiara/0000-0003-2497-5825	MIUR (Ministry of Instruction, University and Research), Italy; Research Project of National Interest (PRIN) [2010TYCL9B_008]	MIUR (Ministry of Instruction, University and Research), Italy(Ministry of Education, Universities and Research (MIUR)); Research Project of National Interest (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by grants from MIUR (Ministry of Instruction, University and Research), Italy, as a Research Project of National Interest (PRIN) 2012 number: 2010TYCL9B_008.	Abella V, 2015, TOXICOL LETT, V234, P13, DOI 10.1016/j.toxlet.2015.02.001; Andreu-Fernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056881; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Bell MR, 2014, CURR OPIN PHARMACOL, V19, P134, DOI 10.1016/j.coph.2014.09.020; Bogazzi F, 2005, J ENDOCRINOL INVEST, V28, P899, DOI 10.1007/BF03345321; Bogazzi F, 2004, ENDOCRINOLOGY, V145, P3353, DOI 10.1210/en.2004-0225; Bogazzi F, 2008, ENDOCRINOLOGY, V149, P5758, DOI 10.1210/en.2008-0346; Bogazzi F, 2013, ENDOCRINOLOGY, V154, P4226, DOI 10.1210/en.2013-1220; Bohnenberger S, 2001, CARCINOGENESIS, V22, P1601, DOI 10.1093/carcin/22.10.1601; Cannavo S, 2010, EUR J ENDOCRINOL, V163, P509, DOI 10.1530/EJE-10-0465; Carmazzi Y, 2012, CELL PROLIFERAT, V45, P545, DOI 10.1111/j.1365-2184.2012.00847.x; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Connor K, 1997, TOXICOL APPL PHARM, V145, P111, DOI 10.1006/taap.1997.8169; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dickerson SM, 2011, TOXICOL APPL PHARM, V252, P36, DOI 10.1016/j.taap.2011.01.012; Espandiari P, 2003, TOXICOL APPL PHARM, V186, P55, DOI 10.1016/S0041-008X(02)00018-2; Feng CZ, 2012, J BIOL CHEM, V287, P22730, DOI 10.1074/jbc.M111.338590; Feng SL, 2013, BBA-REV CANCER, V1836, P197, DOI 10.1016/j.bbcan.2013.05.001; Ghosh S, 2010, ENVIRON INT, V36, P893, DOI 10.1016/j.envint.2010.06.010; Giera S, 2011, ENDOCRINOLOGY, V152, P2909, DOI 10.1210/en.2010-1490; Giesy JP, 1998, CRIT REV TOXICOL, V28, P511, DOI 10.1080/10408449891344263; Gore AC, 2010, HORM-INT J ENDOCRINO, V9, P16, DOI 10.14310/horm.2002.1249; Guaiquil VH, 2001, J BIOL CHEM, V276, P40955, DOI 10.1074/jbc.M106878200; Hamers T, 2011, TOXICOL SCI, V121, P88, DOI 10.1093/toxsci/kfr043; Heimler I, 1998, ENDOCRINOLOGY, V139, P4373, DOI 10.1210/en.139.10.4373; Horiguchi K, 2010, J ENDOCRINOL, V204, P115, DOI 10.1677/JOE-09-0333; Hsu PC, 2007, TOXICOL APPL PHARM, V221, P68, DOI 10.1016/j.taap.2007.01.027; Ishizuya-Oka A, 2011, DEV GROWTH DIFFER, V53, P202, DOI 10.1111/j.1440-169X.2010.01222.x; Ito T, 2004, J BIOL CHEM, V279, P25204, DOI 10.1074/jbc.M402143200; Jiang M, 2009, AM J PHYSIOL-RENAL, V296, pF983, DOI 10.1152/ajprenal.90579.2008; Kim GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027799; Kim JJ, 2010, CELL DEATH DIFFER, V17, P1420, DOI 10.1038/cdd.2010.19; Knerr S, 2006, CRIT REV TOXICOL, V36, P663, DOI 10.1080/10408440600845304; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kurotani R, 2002, J ENDOCRINOL, V172, P477, DOI 10.1677/joe.0.1720477; Labi V, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.20; Lee SH, 2001, BIOL PHARM BULL, V24, P1380, DOI 10.1248/bpb.24.1380; Lema Carolina, 2011, Curr Cell Biochem, V1, P1; Lin WY, 2011, J BIOL CHEM, V286, P2665, DOI 10.1074/jbc.M110.168286; Liu CJ, 2014, TOXICOL APPL PHARM, V277, P270, DOI 10.1016/j.taap.2014.03.027; Lu Y, 2007, FREE RADICAL BIO MED, V43, P1061, DOI 10.1016/j.freeradbiomed.2007.06.021; Lu ZJ, 2004, TOXICOL SCI, V81, P35, DOI 10.1093/toxsci/kfh193; Lucchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020785; Ludewig G, 2013, CANCER LETT, V334, P46, DOI 10.1016/j.canlet.2012.11.041; MCKINNEY JD, 1994, ENVIRON HEALTH PERSP, V102, P290, DOI 10.1289/ehp.94102290; McLean LS, 2015, CHEM RES TOXICOL, V28, P855, DOI 10.1021/tx500485v; Melmed S, 2015, ENDOCRIN METAB CLIN, V44, P1, DOI 10.1016/j.ecl.2014.11.004; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Monje L, 2007, J ENDOCRINOL, V194, P201, DOI 10.1677/JOE-07-0014; Murati T, 2015, TOXICOL MECH METHOD, V25, P302, DOI 10.3109/15376516.2015.1028605; National Research Council, 2011, GUIDE CARE USE LAB A; Nunes LM, 2014, AAPS J, V16, P872, DOI 10.1208/s12248-014-9617-4; Pan JX, 2001, J CLIN ENDOCR METAB, V86, P4731, DOI 10.1210/jc.86.10.4731; Park KT, 2005, MOL PHARMACOL, V67, P612, DOI 10.1124/mol.104.005223; Ptak A, 2011, TOXICOL IND HEALTH, V27, P315, DOI 10.1177/0748233710387003; Ptak A, 2010, ENVIRON INT, V36, P935, DOI 10.1016/j.envint.2009.06.012; Robles-Escajeda E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073508; Rodriguez M, 2013, MOL CANCER RES, V11, P780, DOI 10.1158/1541-7786.MCR-12-0675; Sanchez-Alonso JA, 2004, TOXICOL LETT, V153, P311, DOI 10.1016/j.toxlet.2004.05.012; Stolpmann K, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.127; Su K., 2014, ULTRASTRUCT PATHOL, P1, DOI DOI 10.3109/01913123.2014.973130; Tharappel JC, 2002, TOXICOL APPL PHARM, V179, P172, DOI 10.1006/taap.2001.9360; Troyano A, 2003, CELL DEATH DIFFER, V10, P889, DOI 10.1038/sj.cdd.4401249; U.S. EPA, 2003, NO NCEA C 1340; Upadhyay G, 2004, HEPATOLOGY, V39, P1120, DOI 10.1002/hep.20085; Viluksela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104639; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wu YJ, 2005, J PHARMACOL EXP THER, V312, P424, DOI 10.1124/jpet.104.075119; Yamada-Okabe T, 2004, TOXICOL APPL PHARM, V194, P201, DOI 10.1016/j.taap.2003.09.010; Yamada-Okabe T, 2003, EUR J BIOCHEM, V270, P3064, DOI 10.1046/j.1432-1033.2003.03686.x; Yang Dongren, 2010, Curr Neurobiol, V1, P70; Zhong YF, 2015, J ENVIRON SCI HEAL A, V50, P806, DOI 10.1080/10934529.2015.1019797; Zhu YM, 2009, FREE RADICAL BIO MED, V47, P1762, DOI 10.1016/j.freeradbiomed.2009.09.024; Zoeller RT, 2000, ENDOCRINOLOGY, V141, P181, DOI 10.1210/en.141.1.181	76	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146729	10.1371/journal.pone.0146729	http://dx.doi.org/10.1371/journal.pone.0146729			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752525	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100142
J	Reyes-Zurita, FJ; Rufino-Palomares, EE; Garcia-Salguero, L; Peragon, J; Medina, PP; Parra, A; Cascante, M; Lupianez, JA				Reyes-Zurita, Fernando J.; Rufino-Palomares, Eva E.; Garcia-Salguero, Leticia; Peragon, Juan; Medina, Pedro P.; Parra, Andres; Cascante, Marta; Lupianez, Jose A.			Maslinic Acid, a Natural Triterpene, Induces a Death Receptor-Mediated Apoptotic Mechanism in Caco-2 p53-Deficient Colon Adenocarcinoma Cells	PLOS ONE			English	Article							PROTEIN-TURNOVER RATES; TUMOR-NECROSIS-FACTOR; CANCER CELLS; DEPENDENT APOPTOSIS; WHITE MUSCLE; GROWTH; MITOCHONDRIA; HT29; INHIBITION; PATHWAY	Maslinic acid (MA) is a natural triterpene present in high concentrations in the waxy skin of olives. We have previously reported that MA induces apoptotic cell death via the mitochondrial apoptotic pathway in HT29 colon cancer cells. Here, we show that MA induces apoptosis in Caco-2 colon cancer cells via the extrinsic apoptotic pathway in a dose-dependent manner. MA triggered a series of effects associated with apoptosis, including the cleavage of caspases -8 and -3, and increased the levels of t-Bid within a few hours of its addition to the culture medium. MA had no effect on the expression of the Bax protein, release of cytochrome-c or on the mitochondrial membrane potential. This suggests that MA triggered the extrinsic apoptotic pathway in this cell type, as opposed to the intrinsic pathway found in the HT29 colon-cancer cell line. Our results suggest that the apoptotic mechanism induced in Caco-2 may be different from that found in HT29 colon-cancer cells, and that in Caco-2 cells MA seems to work independently of p53. Natural antitumoral agents capable of activating both the extrinsic and intrinsic apoptotic pathways could be of great use in treating colon-cancer of whatever origin.	[Reyes-Zurita, Fernando J.; Rufino-Palomares, Eva E.; Garcia-Salguero, Leticia; Medina, Pedro P.; Lupianez, Jose A.] Univ Granada, Fac Sci, Dept Biochem & Mol Biol 1, E-18071 Granada, Spain; [Peragon, Juan] Univ Jaen, Biochem & Mol Biol Section, Dept Expt Biol, Jaen 23071, Spain; [Parra, Andres] Univ Granada, Fac Sci, Sect Nat Prod, Dept Organ Chem, E-18071 Granada, Spain; [Cascante, Marta] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain	University of Granada; Universidad de Jaen; University of Granada; University of Barcelona	Cascante, M (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain.	martacascante@ub.edu; jlcara@ugr.es	Parra-Sanchez, Andres/G-4864-2013; Palomares, Eva Rufino/B-4642-2013; CASCANTE, MARTA/AAG-4355-2022; CASCANTE, MARTA/AFK-5991-2022; Vico, Pedro Pablo Medina/D-1688-2013; Peragón, Juan/B-6397-2015; Reyes Zurita, Fernando Jesús/M-1244-2014; Lupianez, Jose Antonio/M-6664-2015	Parra-Sanchez, Andres/0000-0001-7485-8753; Palomares, Eva Rufino/0000-0002-9650-825X; CASCANTE, MARTA/0000-0002-2062-4633; CASCANTE, MARTA/0000-0002-2062-4633; Vico, Pedro Pablo Medina/0000-0002-7834-7093; Reyes Zurita, Fernando Jesús/0000-0003-3438-0753; Peragon Sanchez, Juan/0000-0002-7502-1119; Lupianez, Jose Antonio/0000-0001-9095-7145; Garcia Salguero, Encarnacion Leticia/0000-0002-5860-809X	Technology and Innovation Council of the Andalucian regional government [157]; Spanish government [AGL2006-12210-C03-02/ALI, SAF2005-01627, ISCIII-RTICC (RD06/0020/0046)]; European Union FEDER funds	Technology and Innovation Council of the Andalucian regional government; Spanish government(Spanish GovernmentEuropean Commission); European Union FEDER funds(European Commission)	This study was supported by grants Group BIO 157 from the Technology and Innovation Council of the Andalucian regional government and AGL2006-12210-C03-02/ALI, SAF2005-01627, ISCIII-RTICC (RD06/0020/0046) from the Spanish government and European Union FEDER funds.	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Bhushan S, 2007, APOPTOSIS, V12, P1911, DOI 10.1007/s10495-007-0105-5; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Djelloul S, 1997, FEBS LETT, V406, P234, DOI 10.1016/S0014-5793(97)00208-1; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Fernandez-Navarro M, 2010, MASLINIC ACID COMPON, P1415; Fernandez-Navarro M, 2008, COMP BIOCHEM PHYS C, V147, P158, DOI 10.1016/j.cbpc.2007.09.010; Fernandez-Navarro M, 2006, COMP BIOCHEM PHYS C, V144, P130, DOI 10.1016/j.cbpc.2006.07.006; Fukumitsu S, 2016, MOL NUTR FOOD RES, V60, P399, DOI 10.1002/mnfr.201500465; Fulda S, 2009, MOL NUTR FOOD RES, V53, P140, DOI 10.1002/mnfr.200700491; Garcia-Granados A, 1998, MOLECULES, V3, pM88, DOI 10.3390/M88; Garcia-Granados A, 1998, PCT Int. Appl., Patent No. [WO 9804331, 9804331]; Gupta S, 2002, J CLIN IMMUNOL, V22, P185, DOI 10.1023/A:1016089607548; Huang LF, 2011, EUR J PHARMACOL, V672, P169, DOI 10.1016/j.ejphar.2011.09.175; Hyer ML, 2008, CANCER RES, V68, P2927, DOI 10.1158/0008-5472.CAN-07-5759; Ikeda T, 2003, CANCER RES, V63, P5551; Ito Y, 2001, MOL PHARMACOL, V59, P1094, DOI 10.1124/mol.59.5.1094; Ito Y, 2000, CELL GROWTH DIFFER, V11, P261; Kim KB, 2002, MOL CANCER THER, V1, P177; Kim YJ, 2008, BIOL PHARM BULL, V31, P826, DOI 10.1248/bpb.31.826; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li YL, 2010, INT J CANCER, V127, P462, DOI 10.1002/ijc.25044; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mokhtari K, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/272457; Peragon J, 2015, INT J MOL SCI, V16, P21681, DOI 10.3390/ijms160921681; Rabi T, 2007, BREAST CANCER RES TR, V101, P27, DOI 10.1007/s10549-006-9275-z; Ray RM, 2001, AM J PHYSIOL-GASTR L, V281, pG37, DOI 10.1152/ajpgi.2001.281.1.G37; Reyes FJ, 2006, FEBS LETT, V580, P6302, DOI 10.1016/j.febslet.2006.10.038; Reyes-Zurita FJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-154; Reyes-Zurita FJ, 2009, CANCER LETT, V273, P44, DOI 10.1016/j.canlet.2008.07.033; Rufino-Palomares EE, 2012, AQUACULT NUTR, V18, P568, DOI 10.1111/j.1365-2095.2011.00933.x; Rufino-Palomares EE, 2012, AQUACULT NUTR, V18, P138, DOI 10.1111/j.1365-2095.2011.00882.x; Rufino-Palomares E, 2011, PROTEOMICS, V11, P3312, DOI 10.1002/pmic.201000271; Rufino-Palomares EE, 2015, CURR ORG CHEM, V19, P919, DOI 10.2174/1385272819666150119225952; Rufino-Palomares EE, 2013, AQUACULT NUTR, V19, P709, DOI 10.1111/anu.12018; Rufino-Palomares EE, 2013, J PROTEOMICS, V83, P15, DOI 10.1016/j.jprot.2013.02.031; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Saleem M, 2005, CARCINOGENESIS, V26, P1956, DOI 10.1093/carcin/bgi157; Sanchez-Tena S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059392; Sporn MB, 2000, CARCINOGENESIS, V21, P525, DOI 10.1093/carcin/21.3.525; Stadheim TA, 2002, J BIOL CHEM, V277, P16448, DOI 10.1074/jbc.M108974200; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Van Erk Marjan J, 2004, J Carcinog, V3, P8, DOI 10.1186/1477-3163-3-8; Wang XD, 2001, GENE DEV, V15, P2922; Yang L, 2007, CANCER LETT, V256, P267, DOI 10.1016/j.canlet.2007.06.018	50	35	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146178	10.1371/journal.pone.0146178	http://dx.doi.org/10.1371/journal.pone.0146178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751572	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100050
J	Ma, SY; Qing, L; Yang, XB; Liang, GQ; Zhang, LE; Li, Q; Xiong, F; Peng, SW; Ma, YF; Huang, XW; Zou, YF				Ma, Shuyan; Qing, Li; Yang, Xiaobo; Liang, Guiqiang; Zhang, Li'e; Li, Qin; Xiong, Feng; Peng, Suwan; Ma, Yifei; Huang, Xiaowei; Zou, Yunfeng			Expression Profiles of Long Noncoding RNAs and Messenger RNAs in Mn-Exposed Hippocampal Neurons of Sprague-Dawley Rats Ascertained by Microarray: Implications for Mn-Induced Neurotoxicity	PLOS ONE			English	Article							MANGANESE-INDUCED NEUROTOXICITY; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; COGNITIVE FUNCTION; NERVOUS-SYSTEM; GENE; BRAIN; APOPTOSIS; STRESS	Manganese (Mn) is an essential trace element, while excessive expose may induce neurotoxicity. Recently, lncRNAs have been extensively studied and it has been confirmed that lncRNAs participate in neural functions and aberrantly expressed lncRNAs are involved in neurological diseases. However, the pathological effects of lncRNAs on Mn-induced neurotoxicity remain unclear. In this study, the expression profiles of lncRNAs and messenger RNAs (mRNAs) were identified in Mn-treated hippocampal neurons and control neurons via microarray. Bioinformatic methods and intersection analysis were also employed. Results indicated that 566, 1161, and 1474 lncRNAsmeanwhile 1848, 3228, and 4022mRNAs were aberrantly expressed in low, intermediate, and high Mn-exposed groups compared with the control group, respectively. Go analysis determined that differentially expressedmRNAs were targeted to biological processes, cellular components, and molecular functions. Pathway analysis indicated that these mRNAs were enriched in insulin secretion, cell cycle, and DNA replication. Intersection analysis denominated that 135 lncRNAs and 373 mRNAs were consistently up-regulated while 150 lncRNAs and 560 mRNAs were consistently down-regulated. Meanwhile, lncRNA BC079195 was significantly up-regulated while lncRNAs uc. 229-and BC089928 were significantly down-regulated in three comparison groups. The relative expression levels of 3 lncRNAs and 4 mRNAs were validated through qRT-PCR. To the best of our knowledge, this study is the first to identify the expression patterns of lncRNAs and mRNAs in hippocampal neurons of Sprague-Dawley rats. The results may provide evidence on underlying mechanisms of Mn-induced neurotoxicity, and aberrantly expressed lncRNAs/ mRNAs may be useful in further investigations to detect early symptoms of Mn-induced neuropsychiatric disorders in the central nervous system.	[Ma, Shuyan; Qing, Li; Liang, Guiqiang; Zhang, Li'e; Li, Qin; Xiong, Feng; Peng, Suwan; Ma, Yifei; Huang, Xiaowei; Zou, Yunfeng] Guangxi Med Univ, Sch Publ Hlth, Teaching & Res Sect Hygien Toxicol, Nanning, Guangxi, Peoples R China; [Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Zou, YF (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Teaching & Res Sect Hygien Toxicol, Nanning, Guangxi, Peoples R China.	email_zyf@163.com	Yang, Xiaobo/G-3854-2016		National Natural Science Foundation of China [81160339, 21467003]; China Postdoctoral Science Foundation [2014M562500XB]; Guangxi Natural Science Foundation [2011GXNSFA018187]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was financially supported by the National Natural Science Foundation of China (Nos. 81160339 and 21467003), China Postdoctoral Science Foundation (No. 2014M562500XB), and Guangxi Natural Science Foundation (No. 2011GXNSFA018187).	Arisi I, 2011, J ALZHEIMERS DIS, V24, P721, DOI 10.3233/JAD-2011-101881; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bornhorst J, 2012, J BIOL CHEM, V287, P17140, DOI 10.1074/jbc.M112.344093; Bowler RM, 2003, INT J HYG ENVIR HEAL, V206, P517, DOI 10.1078/1438-4639-00249; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen P, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00265; Chen XD, 2014, J MOL NEUROSCI, V52, P403, DOI 10.1007/s12031-013-0166-6; Couper J., 1837, BR ANN MED PHARM, V1, P41, DOI DOI 10.1002/JCP.22692; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Croze E, 2013, PHARMACOGENOMICS J, V13, P443, DOI 10.1038/tpj.2012.27; Dieter HH, 2005, ACTA HYDROCH HYDROB, V33, P72, DOI 10.1002/aheh.200400556; Gerhardsson L, 2008, DEMENT GERIATR COGN, V25, P508, DOI 10.1159/000129365; Gouge A, 2001, MECH DEVELOP, V107, P203, DOI 10.1016/S0925-4773(01)00465-8; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Han J, 2014, WORLD J GASTROENTERO, V20, P8139, DOI 10.3748/wjg.v20.i25.8139; Hashimoto-Torii K, 2003, MECH DEVELOP, V120, P1097, DOI 10.1016/j.mod.2003.09.001; Hernandez RB, 2011, TOXICOL SCI, V124, P414, DOI 10.1093/toxsci/kfr234; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Holden T, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/579136; Hozumi I, 2011, J NEUROL SCI, V303, P95, DOI 10.1016/j.jns.2011.01.003; Hsu YC, 2014, STEM CELL TRANSL MED, V3, P713, DOI 10.5966/sctm.2013-0111; Hu J, 2013, P NATL ACAD SCI USA, V110, P14520, DOI 10.1073/pnas.1308610110; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Josephs KA, 2005, NEUROLOGY, V64, P2033, DOI 10.1212/01.WNL.0000167411.93483.A1; Karch Celeste M, 2015, Biol Psychiatry, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137432; Kruer MC, 2010, ANN NEUROL, V68, P611, DOI 10.1002/ana.22122; Kruse LS, 2011, J CHEM NEUROANAT, V42, P184, DOI 10.1016/j.jchemneu.2011.07.002; Kulangara K, 2014, BIOMATERIALS, V35, P5327, DOI 10.1016/j.biomaterials.2014.03.034; Kyratzi E, 2014, NEUROBIOL AGING, V35, P2053, DOI 10.1016/j.neurobiolaging.2014.03.019; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee Y, 2012, PSYCHIAT GENET, V22, P206, DOI 10.1097/YPG.0b013e328353ae3d; Levy BS, 2003, INT J OCCUP ENV HEAL, V9, P153, DOI 10.1179/oeh.2003.9.2.153; Li M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07380; Li W, 2012, GENES BRAIN BEHAV, V11, P87, DOI 10.1111/j.1601-183X.2011.00734.x; Li ZQ, 2014, NEURAL REGEN RES, V9, P978, DOI 10.4103/1673-5374.133151; Lipe GW, 1999, J ENVIRON SCI HEAL B, V34, P119, DOI 10.1080/03601239909373187; Lipovich L, 2012, GENETICS, V192, P1133, DOI 10.1534/genetics.112.145128; Massone S, 2011, NEUROBIOL DIS, V41, P308, DOI 10.1016/j.nbd.2010.09.019; Meyer NP, 2003, DEV BIOL, V257, P343, DOI 10.1016/S0012-1606(03)00065-4; Michalke B, 2007, J ENVIRON MONITOR, V9, P650, DOI 10.1039/b704173j; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Mohamadkhani A, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.18794; Montaron ME, 2004, NEUROTOX RES, V6, P571, DOI 10.1007/BF03033453; Montesinos Maria Luz, 2014, Adv Neurobiol, V8, P249; Morgen K, 2014, ALZHEIMERS DEMENT, V10, pS269, DOI 10.1016/j.jalz.2013.11.001; Mus E, 2007, P NATL ACAD SCI USA, V104, P10679, DOI 10.1073/pnas.0701532104; Myers JE, 2003, NEUROTOXICOLOGY, V24, P885, DOI 10.1016/S0161-813X(03)00081-0; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Papait R, 2013, J CARDIOVASC TRANSL, V6, P876, DOI 10.1007/s12265-013-9488-6; Parisiadou L, 2008, NEUROBIOL DIS, V30, P353, DOI 10.1016/j.nbd.2008.02.004; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Reaney SH, 2006, TOXICOL SCI, V93, P114, DOI 10.1093/toxsci/kfl028; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roberts TC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0507; Rodier J, 1955, BRIT J IND MED, V12, P21; Schroeter JD, 2011, TOXICOL SCI, V120, P481, DOI 10.1093/toxsci/kfq389; Sidoryk-Wegrzynowicz M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-23; Soreq L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003517; Spadaro Paola A., 2012, Frontiers in Genetics, V3, P132, DOI 10.3389/fgene.2012.00132; Stevens SJC, 2011, AM J MED GENET A, V155A, P2739, DOI 10.1002/ajmg.a.34274; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sun M, 2015, ENDOCR REV, V36, P25, DOI 10.1210/er.2014-1034; Tong YW, 2014, J ALZHEIMERS DIS, V42, P865, DOI 10.3233/JAD-140534; Tronel S, 2015, BRAIN STRUCT FUNCT, V220, P645, DOI 10.1007/s00429-014-0715-y; Wan CH, 2014, TOXICOL APPL PHARM, V281, P294, DOI 10.1016/j.taap.2014.10.013; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013662; Wang T, 2015, NEUROTOXICOLOGY, V48, P109, DOI 10.1016/j.neuro.2015.02.007; Wang YM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0137-y; Wenk M, 2012, J BIOL CHEM, V287, P43585, DOI 10.1074/jbc.M112.413070; Williams BB, 2010, J NEUROCHEM, V112, P227, DOI 10.1111/j.1471-4159.2009.06445.x; Wollmer MA, 2007, NEUROGENETICS, V8, P179, DOI 10.1007/s10048-007-0087-z; Xiang MQ, 2013, SCI CHINA LIFE SCI, V56, P985, DOI 10.1007/s11427-013-4543-8; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang J, 2009, P NATL ACAD SCI USA, V106, P15356, DOI 10.1073/pnas.0907213106; Zhang L, 2015, BRAIN RES, V1594, P61, DOI 10.1016/j.brainres.2014.10.060; Zhang LF, 2014, TOXICOLOGY, V323, P95, DOI 10.1016/j.tox.2014.06.011; Zou YF, 2014, OCCUP ENVIRON MED, V71, P189, DOI 10.1136/oemed-2013-101896	92	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145856	10.1371/journal.pone.0145856	http://dx.doi.org/10.1371/journal.pone.0145856			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745496	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600018
J	Nomade, S; Genty, D; Sasco, R; Scao, V; Feruglio, V; Baffier, D; Guillou, H; Bourdier, C; Valladas, H; Reigner, E; Debard, E; Pastre, JF; Geneste, JM				Nomade, Sebastien; Genty, Dominique; Sasco, Romain; Scao, Vincent; Feruglio, Valerie; Baffier, Dominique; Guillou, Herve; Bourdier, Camille; Valladas, Helene; Reigner, Edouard; Debard, Evelyne; Pastre, Jean-Francois; Geneste, Jean-Michel			A 36,000-Year-Old Volcanic Eruption Depicted in the Chauvet-Pont d'Arc Cave (Ardsche, France)?	PLOS ONE			English	Article							DECAY CONSTANTS; ARDECHE; GEOCHRONOLOGY; CHRONOLOGY; DATES	Among the paintings and engravings found in the Chauvet-Pont d'Arc cave (Ard che, France), several peculiar spray-shape signs have been previously described in the Megaloceros Gallery. Here we document the occurrence of strombolian volcanic activity located 35 km northwest of the cave, and visible from the hills above the cave entrance. The volcanic eruptions were dated, using Ar-40/Ar-39, between 29 +/- 10 ka and 35 +/- 8 ka (2 sigma), which overlaps with the C-14 AMS and thermoluminescence ages of the first Aurignacian occupations of the cave in the Megaloceros Gallery. Our work provides the first evidence of an intense volcanic activity between 40 and 30 ka in the Bas-Vivarais region, and it is very likely that Humans living in the Ardsche river area witnessed one or several eruptions. We propose that the spray-shape signs found in the Chauvet-Pont d'Arc cave could be the oldest known depiction of a volcanic eruption, predating by more than 34 ka the description by Pliny the Younger of the Vesuvius eruption (AD 79) and by 28 ka the Catalhoyuk mural discovered in central Turkey.	[Nomade, Sebastien; Genty, Dominique; Sasco, Romain; Scao, Vincent; Guillou, Herve; Valladas, Helene; Reigner, Edouard] Univ Paris Saclay, CEA CNRS UVSQ, Lab Sci Climat & Environm, UMR8212,LSCE IPSL, Gif Sur Yvette, France; [Feruglio, Valerie; Geneste, Jean-Michel] Univ Bordeaux, CNRS, Lab PACEA, UMR 5199, Pessac, France; [Baffier, Dominique] Univ Paris Ouest Nanterre, Lab ArScAn, UMR 7041, Nanterre, France; [Bourdier, Camille] Univ Toulouse Jean Jaures, Lab TRACES, UMR 5608, Toulouse, France; [Debard, Evelyne] Univ Lyon 1, Lab Geol Lyon, UMR CNRS 5276, F-69622 Villeurbanne, France; [Pastre, Jean-Francois] Univ Paris 01, Lab Geog Phys, UMR CNRS 8591, Meudon, France; [Pastre, Jean-Francois] Univ Paris 12, Lab Geog Phys, UMR CNRS 8591, Meudon, France; [Geneste, Jean-Michel] Minist Culture & Commun, Ctr Natl Prehist, Perigueux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Nomade, S (corresponding author), Univ Paris Saclay, CEA CNRS UVSQ, Lab Sci Climat & Environm, UMR8212,LSCE IPSL, Gif Sur Yvette, France.	sebastien.nomade@lsce.ipsl.fr		Bourdier, Camille/0000-0003-4432-1722; nomade, sebastien/0000-0001-7373-0571	Universite Paris-Sud XI (France) [20122014]	Universite Paris-Sud XI (France)	PHD funding for Romain Sasco (20122014) was provided by the ED "MIPEGE" from the Universite Paris-Sud XI (France).	BERGER E, 1975, CR ACAD SCI D NAT, V280, P419; CHAUVEL C, 1984, GEOCHIM COSMOCHIM AC, V48, P93, DOI 10.1016/0016-7037(84)90352-1; Clottes J, 2001, GROTTE CHAUVET ART O; DOWNES H, 1987, EARTH PLANET SC LETT, V82, P121, DOI 10.1016/0012-821X(87)90112-9; Faujas de Saint-Font B, 1778, RECHERCHES VOLCANS E; Feruglio V, 2005, BULL SOC PREHIST FR, V102, P149, DOI 10.3406/bspf.2005.13347; Genty D, 2004, CR PALEVOL, V3, P629, DOI 10.1016/j.crpv.2004.06.005; Guerin G, 2007, CR GEOSCI, V339, P40, DOI 10.1016/j.crte.2006.10.005; Guibert P, 2015, QUAT GEOCHRONOL, V29, P36, DOI 10.1016/j.quageo.2015.04.007; Guillou H, 2011, QUAT GEOCHRONOL, V6, P530, DOI 10.1016/j.quageo.2011.03.011; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Karakhanian A, 2002, J VOLCANOL GEOTH RES, V113, P319, DOI 10.1016/S0377-0273(01)00264-5; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Lee JY, 2006, GEOCHIM COSMOCHIM AC, V70, P4507, DOI 10.1016/j.gca.2006.06.1563; Mellaart J, 1964, ILLUSTRATED LONDON N; Nomade S, 2005, CHEM GEOL, V218, P315, DOI 10.1016/j.chemgeo.2005.01.005; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Poulett-Srope G, 1858, GEOLOGY EXTINCT VOLC; Quiles A, 2014, RADIOCARBON, V56, P833, DOI 10.2458/56.16940; Renne PR, 2011, GEOCHIM COSMOCHIM AC, V75, P5097, DOI 10.1016/j.gca.2011.06.021; ROCHETTE P, 1993, CR ACAD SCI II, V316, P913; Sasco R, 2015, THESIS, V11; Schmitt AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084711; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Valladas H, 2001, RADIOCARBON, V43, P977; Valladas H, 2005, BULL SOC PREHIST FR, V102, P109, DOI 10.3406/bspf.2005.13342	26	21	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146621	10.1371/journal.pone.0146621	http://dx.doi.org/10.1371/journal.pone.0146621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745626	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600069
J	Wang, JJ; Nie, BB; Duan, SF; Zhu, HT; Liu, H; Shan, BC				Wang, Jingjuan; Nie, Binbin; Duan, Shaofeng; Zhu, Haitao; Liu, Hua; Shan, Baoci			Functionally Brain Network Connected to the Retrosplenial Cortex of Rats Revealed by 7T fMRI	PLOS ONE			English	Article							RETICULAR-FORMATION; SMALL-WORLD; SCHIZOPHRENIA; ASYMMETRIES; NAVIGATION; LESIONS; HUBS	Functional networks are regarded as important mechanisms for increasing our understanding of brain function in healthy and diseased states, and increased interest has been focused on extending the study of functional networks to animal models because such models provide a functional understanding of disease progression, therapy and repair. In rodents, the retrosplenial cortex (RSC) is an important cortical region because it has a large size and presents transitional patterns of lamination between the neocortex and archicortex. In addition, a number of invasive studies have highlighted the importance of the RSC for many functions. However, the network based on the RSC in rodents remains unclear. Based on the critical importance of the RSC, we defined the bilateral RSCs as two regions of interest and estimated the network based on the RSC. The results showed that the related regions include the parietal association cortex, hippocampus, thalamus nucleus, midbrain structures, and hypothalamic mammillary bodies. Our findings indicate two possible major networks: a sensory-cognitive network that has a hub in the RSCs and processes sensory information, spatial learning, and episodic memory; and a second network that is involved in the regulation of visceral functions and arousal. In addition, functional asymmetry between the bilateral RSCs was observed.	[Wang, Jingjuan; Nie, Binbin; Duan, Shaofeng; Zhu, Haitao; Liu, Hua; Shan, Baoci] Chinese Acad Sci, Inst High Energy Phys, Div Nucl Technol & Applicat, Beijing, Peoples R China; [Wang, Jingjuan; Nie, Binbin; Duan, Shaofeng; Zhu, Haitao; Liu, Hua; Shan, Baoci] Beijing Engn Res Ctr Radiog Tech & Equipment, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Liu, H (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Div Nucl Technol & Applicat, Beijing, Peoples R China.	liuhua@ihep.ac.cn; shanbc@ihep.ac.cn	Zhu, Hai-Tao/GQH-5040-2022; zhu, HAITAO/GVL-0589-2022	Liu, Hua/0000-0002-0301-3144; wang, Jingjuan/0000-0002-2996-006X; Nie, Binbin/0000-0002-8038-7772; Shan, Baoci/0000-0001-7417-5063; Wang, Jingjuan/0000-0001-8844-0374; Duan, Shaofeng/0000-0002-2695-5898	National Natural Science Foundations of China [81201147, 91232713]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundations of China 81201147 (to BBN) who played a role in studying design, data collection; and National Natural Science Foundations of China 91232713 (to BCS) who played a role in analysis, decision to publish, and preparation of the manuscript.	Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; CROW TJ, 1990, SCHIZOPHRENIA BULL, V16, P433, DOI 10.1093/schbul/16.3.433; Di X, 2015, BRAIN STRUCT FUNCT, V220, P37, DOI 10.1007/s00429-013-0634-3; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Harker KT, 2004, HIPPOCAMPUS, V14, P224, DOI 10.1002/hipo.10159; Jones BE, 2005, TRENDS PHARM SCI; Keene CS, 2008, BEHAV NEUROSCI, V122, P89, DOI 10.1037/0735-7044.122.1.89; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liang ZF, 2012, NEUROIMAGE, V59, P1190, DOI 10.1016/j.neuroimage.2011.08.009; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Mac LP, 1949, PSYCHOSOM MED, V11, P338; Medaglia JD, 2015, J COGNITIVE NEUROSCI, V27, P1471, DOI 10.1162/jocn_a_00810; MORUZZI G, 1976, J PHYSIOLOGY PARIS, V70, P681; Nie B, 2013, HUM BRAIN MAPP, V34, P1306, DOI 10.1002/hbm.21511; Paxinos G., 2004, THE RAT BRAIN IN STE; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ROUTTENBERG A, 1968, PSYCHOL REV, V75, P51, DOI 10.1037/h0025303; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; St-Laurent M, 2009, HIPPOCAMPUS, V19, P612, DOI 10.1002/hipo.20539; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Whishaw IQ, 2001, BEHAV BRAIN RES, V118, P67, DOI 10.1016/S0166-4328(00)00312-0; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001; Zilles K, 1996, NEUROSCI BIOBEHAV R, V20, P593, DOI 10.1016/0149-7634(95)00072-0	28	12	12	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146535	10.1371/journal.pone.0146535	http://dx.doi.org/10.1371/journal.pone.0146535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745803	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600061
J	Zhang, XM; Wu, WL; Zhu, YC; Jiang, Y; Du, J; Chen, RC				Zhang, Xianming; Wu, Weiliang; Zhu, Yongcheng; Jiang, Ying; Du, Juan; Chen, Rongchang			Abdominal Muscle Activity during Mechanical Ventilation Increases Lung Injury in Severe Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							PRESSURE RELEASE VENTILATION; ANIMAL-MODELS; OXYGENATION	Objective It has proved that muscle paralysis was more protective for injured lung in severe acute respiratory distress syndrome (ARDS), but the precise mechanism is not clear. The purpose of this study was to test the hypothesis that abdominal muscle activity during mechanically ventilation increases lung injury in severe ARDS. Methods Eighteen male Beagles were studied under mechanical ventilation with anesthesia. Severe ARDS was induced by repetitive oleic acid infusion. After lung injury, Beagles were randomly assigned into spontaneous breathing group (BIPAPSB) and abdominal muscle paralysis group (BIPAP(AP)). All groups were ventilated with BIPAP model for 8h, and the high pressure titrated to reached a tidal volume of 6ml/kg, the low pressure was set at 10 cmH(2)O, with I:E ratio 1:1, and respiratory rate adjusted to a PaCO2 of 35-60mmHg. Six Beagles without ventilator support comprised the control group. Respiratory variables, end-expiratory volume (EELV) and gas exchange were assessed during mechanical ventilation. The levels of Interleukin (IL)-6, IL-8 in lung tissue and plasma were measured by qRT-PCR and ELISA respectively. Lung injury scores were determined at end of the experiment. Results For the comparable ventilator setting, as compared with BIPAPSB group, the BIPAPAP group presented higher EELV (427 +/- 47 vs. 366 +/- 38 ml) and oxygenation index (293 +/- 36 vs. 226 +/- 31 mmHg), lower levels of IL-6(216.6 +/- 48.0 vs. 297.5 +/- 71.2 pg/ml) and IL-8(246.8 +/- 78.2 vs. 357.5 +/- 69.3 pg/ml) in plasma, and lower express levels of IL-6 mRNA (15.0 +/- 3.8 vs. 21.2 +/- 3.7) and IL-8 mRNA (18.9 +/- 6.8 vs. 29.5 +/- 7.9) in lung tissues. In addition, less lung histopathology injury were revealed in the BIPAPAP group (22.5 +/- 2.0 vs. 25.2 +/- 2.1). Conclusion Abdominal muscle activity during mechanically ventilation is one of the injurious factors in severe ARDS, so abdominal muscle paralysis might be an effective strategy to minimize ventilator-induce lung injury.	[Zhang, Xianming; Du, Juan] Guangyang Med Univ, Affiliated Hosp 1, Guangyang, Guizhou, Peoples R China; [Wu, Weiliang; Zhu, Yongcheng; Jiang, Ying; Chen, Rongchang] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Resp Mech Lab,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Resp Mech Lab,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	chenrongchang8@163.com	zhang, xian/GYA-0290-2022		National Project 973 [2009CB522108]	National Project 973(National Basic Research Program of China)	This work was supported by National Project 973, 2009CB522108 (Study on the system for the prevention and control of lung injury).	BAYDUR A, 1982, AM REV RESPIR DIS, V126, P788; Caironi P, 2010, AM J RESP CRIT CARE, V181, P578, DOI 10.1164/rccm.200905-0787OC; Carvalho AR, 2009, ANESTH ANALG, V109, P856, DOI 10.1213/ane.0b013e3181aff245; Daoud EG, 2012, RESP CARE, V57, P282, DOI 10.4187/respcare.01238; de Abreu MG, 2012, CURR OPIN ANESTHESIO, V25, P148, DOI 10.1097/ACO.0b013e3283504bde; Dembinski R, 2007, CRIT CARE MED, V35, P2359, DOI 10.1097/01.CCM.0000281857.87354.A5; DOUGLAS WW, 1977, AM REV RESPIR DIS, V115, P559; DUGGAN JE, 1989, ANESTH ANALG, V69, P598; Esquer C, 2008, NEONATOLOGY, V94, P100, DOI 10.1159/000116634; Frawley P M, 2001, AACN Clin Issues, V12, P234, DOI 10.1097/00044067-200105000-00007; Hardman JG, 2003, ANESTH ANALG, V97, P1846, DOI 10.1213/01.ANE.0000090316.46604.89; Henzler D, 2010, INTENS CARE MED, V36, P1427, DOI 10.1007/s00134-010-1827-3; Malbrain MLNG, 2005, CURR OPIN CRIT CARE, V11, P156, DOI 10.1097/01.ccx.0000155355.86241.1b; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Patroniti N, 2004, INTENS CARE MED, V30, P282, DOI 10.1007/s00134-003-2109-0; Putensen C, 2006, CURR OPIN CRIT CARE, V12, P13, DOI 10.1097/01.ccx.0000198994.37319.60; Putensen C, 1999, AM J RESP CRIT CARE, V159, P1241, DOI 10.1164/ajrccm.159.4.9806077; Roy S, 2013, SHOCK, V39, P28, DOI 10.1097/SHK.0b013e31827b47bb; Schweiger JW, 2003, CRIT CARE MED, V31, P2364, DOI 10.1097/01.CCM.0000085187.36136.9B; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Suh GY, 1999, J KOREAN MED SCI, V14, P613, DOI 10.3346/jkms.1999.14.6.613; Wang HM, 2008, EUR SURG RES, V40, P305, DOI 10.1159/000121471; WARNER DO, 1991, J APPL PHYSIOL, V70, P539, DOI 10.1152/jappl.1991.70.2.539; Wrigge H, 2003, ANESTHESIOLOGY, V99, P376, DOI 10.1097/00000542-200308000-00019; Xia JG, 2014, ANESTHESIOLOGY, V120, P1441, DOI 10.1097/ALN.0000000000000259; Xia JG, 2011, CRIT CARE, V15, DOI 10.1186/cc10502; Yoshida T, 2013, CRIT CARE MED, V41, P536, DOI 10.1097/CCM.0b013e3182711972	28	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145694	10.1371/journal.pone.0145694	http://dx.doi.org/10.1371/journal.pone.0145694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745868	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600012
J	Alkharusi, A; Lesma, E; Ancona, S; Chiaramonte, E; Nystrom, T; Gorio, A; Norstedt, G				Alkharusi, Amira; Lesma, Elena; Ancona, Silvia; Chiaramonte, Eloisa; Nystrom, Thomas; Gorio, Alfredo; Norstedt, Gunnar			Role of Prolactin Receptors in Lymphangioleiomyomatosis	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; RAPAMYCIN ANALOG CCI-779; TARGET-OF-RAPAMYCIN; CELL-GROWTH; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; INTERFERON-GAMMA; KNOCKOUT MICE; TSC2; PROTEIN; MTOR	Pulmonary lymphangioleiomyomatosis (LAM) is a rare lung disease caused by mutations in the tumor suppressor genes encoding Tuberous Sclerosis Complex (TSC) 1 and TSC2. The protein product of the TSC2 gene is a well-known suppressor of the mTOR pathway. Emerging evidence suggests that the pituitary hormone prolactin (Prl) has both endocrine and paracrine modes of action. Here, we have investigated components of the Prl system in models for LAM. In a TSC2 (+/-) mouse sarcoma cell line, down-regulation of TSC2 using siRNA resulted in increased levels of the Prl receptor. In human LAM cells, the Prl receptor is detectable by immunohistochemistry, and the expression of Prl in these cells stimulates STAT3 and Erk phosphorylation, as well as proliferation. A high affinity Prl receptor antagonist consisting of Prl with four amino acid substitutions reduced phosphorylation of STAT3 and Erk. Antagonist treatment further reduced the proliferative and invasive properties of LAM cells. In histological sections from LAM patients, Prl receptor immuno reactivity was observed. We conclude that the Prl receptor is expressed in LAM, and that loss of TSC2 increases Prl receptor levels. It is proposed that Prl exerts growth-stimulatory effects on LAM cells, and that antagonizing the Prl receptor can block such effects.	[Alkharusi, Amira; Nystrom, Thomas] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Norstedt, Gunnar] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Norstedt, Gunnar] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Lesma, Elena; Ancona, Silvia; Chiaramonte, Eloisa; Gorio, Alfredo] Univ Milan, Labs Pharmacol, Dept Hlth Sci, Milan, Italy; [Alkharusi, Amira] Sultan Qaboos Univ, Coll Med & Hlth Sci, Muscat, Oman	Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska Institutet; University of Milan; Sultan Qaboos University	Norstedt, G (corresponding author), Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.	gunnar.norstedt@ki.se		Lesma, Elena/0000-0002-9096-713X	Swedish Heart and Lung Foundation; Sultan Qaboos University (SQU) in Oman; SQU; Sultan Qaboos University in Oman	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Sultan Qaboos University (SQU) in Oman; SQU; Sultan Qaboos University in Oman	This work was supported by grants from the Swedish Heart and Lung Foundation and from Sultan Qaboos University (SQU) in Oman. Amira Alkharusi received a full scholarship from SQU.; The authors would like to thank Dr. Vladana Vukojevic for her valuable contributions regarding the acquisition of confocal microscopy images of PrlR and GHR immuno reactivity. We would also like to thank Dr. Maha Al-Asmakh for her technical assistance. We are grateful to Novo Nordisk for the gift of recombinant PrlRA. This work was supported by grants from the Swedish Heart and Lung Foundation and from Sultan Qaboos University in Oman.	Barclay JL, 2009, INT J CANCER, V124, P1756, DOI 10.1002/ijc.24172; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; Bernichtein S, 2003, J BIOL CHEM, V278, P35988, DOI 10.1074/jbc.M305687200; Bishop JD, 2006, J ENDOCRINOL, V190, P307, DOI 10.1677/joe.1.06368; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Boudreau RTM, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730493; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCKLEY KM, 1995, AM FAM PHYSICIAN, V51, P831; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Christensen HR, 2013, ENDOCRINOLOGY, V154, P4777, DOI 10.1210/en.2013-1476; CORRIN B, 1975, AM J PATHOL, V79, P348; Ferraris J, 2013, NEUROENDOCRINOLOGY, V98, P171, DOI 10.1159/000354701; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; Goncharova EA, 2009, MOL PHARMACOL, V76, P766, DOI 10.1124/mol.109.057042; Horseman ND, 2014, J MOL ENDOCRINOL, V52, pR95, DOI 10.1530/JME-13-0220; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Johnson SR, 2006, EUR RESPIR J, V27, P1056, DOI 10.1183/09031936.06.00113303; Jomain JB, 2007, J BIOL CHEM, V282, P33118, DOI 10.1074/jbc.M704364200; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Lee L, 2006, GENE CHROMOSOME CANC, V45, P933, DOI 10.1002/gcc.20357; Lesma E, 2014, J CELL MOL MED, V18, P766, DOI 10.1111/jcmm.12237; Liu Y, 2011, PROTEIN ENG DES SEL, V24, P855, DOI 10.1093/protein/gzr047; Messina Michael P., 2007, BMC Pharmacology, V7, P14, DOI 10.1186/1471-2210-7-14; Moir LM, 2012, AM J PHYSIOL-LUNG C, V303, pL703, DOI 10.1152/ajplung.00414.2011; Moss AMTDJ, 2015, CLIN EPIDEMIOL, V7, P249, DOI 10.2147/CLEP.S50780; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Terasaki Y, 2010, AM J RESP CRIT CARE, V182, P531, DOI 10.1164/rccm.200911-1737OC; TRUONG AT, 1984, EMBO J, V3, P429, DOI 10.1002/j.1460-2075.1984.tb01824.x; Vesterlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025358; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146653	10.1371/journal.pone.0146653	http://dx.doi.org/10.1371/journal.pone.0146653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765535	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300031
J	Amarit, R; Kopwitthaya, A; Pongsoon, P; Jarujareet, U; Chaitavon, K; Porntheeraphat, S; Sumriddetchkajorn, S; Koanantakool, T				Amarit, Ratthasart; Kopwitthaya, Atcha; Pongsoon, Prasit; Jarujareet, Ungkarn; Chaitavon, Kosom; Porntheeraphat, Supanit; Sumriddetchkajorn, Sarun; Koanantakool, Thaweesak			High-Quality Large-Magnification Polymer Lens from Needle Moving Technique and Thermal Assisted Moldless Fabrication Process	PLOS ONE			English	Article								The need of mobile microscope is escalating as well as the demand of high quality optical components in low price. We report here a novel needle moving technique to fabricate milli-size lens together with thermal assist moldless method. Our proposed protocol is able to create a high tensile strength structure of the lens and its base which is beneficial for exploiting in convertinga smart phone to be a digital microscope. We observe that no bubble trapped in a lens when this technique is performed which can overcome a challenge problem found in a typical dropping technique. We demonstrate the symmetry, smoothness and micron-scale resolution of the fabricated structure. This proposed technique is promising to serve as high quality control mass production without any expensive equipment required.	[Amarit, Ratthasart; Kopwitthaya, Atcha; Pongsoon, Prasit; Jarujareet, Ungkarn; Chaitavon, Kosom; Porntheeraphat, Supanit; Sumriddetchkajorn, Sarun] Natl Elect & Comp Technol Ctr NECTEC, Pathum Thani, Thailand; [Koanantakool, Thaweesak] NSTDA, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Electronics & Computer Technology Center (NECTEC); National Science & Technology Development Agency - Thailand	Kopwitthaya, A (corresponding author), Natl Elect & Comp Technol Ctr NECTEC, Pathum Thani, Thailand.	atcha.kopwitthaya@nectec.or.th		Sumriddetchkajorn, Sarun/0000-0003-3173-0017; Porntheeraphat, Supanit/0000-0003-0986-473X	National Electronics and Computer Technology center [P1451286]	National Electronics and Computer Technology center	Support was provided by the National Electronics and Computer Technology center, grant number P1451286 [http://www.nectec.or.th]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MICRONANOREPLICATION; Beadie G, 2008, OPT EXPRESS, V16, P11847, DOI 10.1364/OE.16.011847; Brenner K. H., 2004, MICROOPTICS TECHNOLO; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Chen HS, 2013, OPT EXPRESS, V21, P18079, DOI 10.1364/OE.21.018079; Cox WR, 2001, OPT PHOTONICS NEWS, V12, P32, DOI 10.1364/OPN.12.6.000032; Cybulski JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098781; D'Ambrosio MV, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3480; Grzybowski B, 2000, SENSOR ACTUAT A-PHYS, V86, P81, DOI 10.1016/S0924-4247(00)00421-0; Karlen W, 2015, DEVICE CIRC SYST, P1; Kim H.-K., 2008, 12 INT C MIN SYST CH, P994; Lee WM, 2014, BIOMED OPT EXPRESS, V5, P1626, DOI 10.1364/BOE.5.001626; Mills A.F., 1992, HEAT TRANSF; Mudanyali O, 2010, LAB CHIP, V10, P1417, DOI 10.1039/c000453g; O'Neill FT, 2002, OPTIK, V113, P391, DOI 10.1078/0030-4026-00186; Rasooly A., 2009, LAB CHIP TECHNOLOGY; Shyu RF, 2007, MICROSYST TECHNOL, V13, P1601, DOI 10.1007/s00542-006-0265-1; Skandarajah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096906; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Sung YL, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.4.047005; Switz NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095330; Trespidi F, 2014, MICROELECTRON ENG, V126, P13, DOI 10.1016/j.mee.2014.03.043; Wang Y, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/9/095010; Wilbur JL, 1996, CHEM MATER, V8, P1380, DOI 10.1021/cm950579d	24	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146414	10.1371/journal.pone.0146414	http://dx.doi.org/10.1371/journal.pone.0146414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765524	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300018
J	Zahn, R; Grosso, A; Scheibe, A; Bekker, LG; Ketende, S; Dausab, F; Iipinge, S; Beyrer, C; Trapance, G; Baral, S				Zahn, Ryan; Grosso, Ashley; Scheibe, Andrew; Bekker, Linda-Gail; Ketende, Sosthenes; Dausab, Friedel; Iipinge, Scholastica; Beyrer, Chris; Trapance, Gift; Baral, Stefan			Human Rights Violations among Men Who Have Sex with Men in Southern Africa: Comparisons between Legal Contexts	PLOS ONE			English	Article							HIV-INFECTION; SELF-EFFICACY; TOWNSHIP MEN; CAPE-TOWN; STIGMA; DEPRESSION; PREVALENCE; BOTSWANA; MODEL; GAY	In 1994, South Africa approved a constitution providing freedom from discrimination based on sexual orientation. Other Southern African countries, including Botswana, Malawi, and Namibia, criminalize same-sex behavior. Men who have sex with men (MSM) have been shown to experience high levels of stigma and discrimination, increasing their vulnerability to negative health and other outcomes. This paper examines the relationship between criminalization of same-sex behavior and experiences of human rights abuses by MSM. It compares the extent to which MSM in peri-urban Cape Town experience human rights abuses with that of MSM in Gaborone, Botswana; Blantyre and Lilongwe, Malawi; and Windhoek, Namibia. In 2008, 737 MSM participated in a cross-sectional study using a structured survey collecting data regarding demographics, human rights, HIV status, and risk behavior. Participants accrued in each site were compared using bivariate and multivariate logistic regression. Encouragingly, the results indicate MSM in Cape Town were more likely to disclose their sexual orientation to family or healthcare workers and less likely to be blackmailed or feel afraid in their communities than MSM in Botswana, Malawi, or Namibia. However, South African MSM were not statistically significantly less likely experience a human rights abuse than their peers in cities in other study countries, showing that while legal protections may reduce experiences of certain abuses, legislative changes alone are insufficient for protecting MSM. A comprehensive approach with interventions at multiple levels in multiple sectors is needed to create the legal and social change necessary to address attitudes, discrimination, and violence affecting MSM.	[Zahn, Ryan; Grosso, Ashley; Ketende, Sosthenes; Beyrer, Chris; Baral, Stefan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Scheibe, Andrew; Bekker, Linda-Gail] Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Dausab, Friedel] Rainbow Project, Windhoek, Namibia; [Iipinge, Scholastica] Univ Namibia, Sch Nursing & Publ Hlth, Windhoek, Namibia; [Trapance, Gift] Ctr Dev People, Lilongwe, Malawi	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; University of Namibia	Zahn, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	rzahn2@jhu.edu	Grosso, Ashley/AAH-9924-2020; Bekker, Linda-Gail/AAZ-8929-2020; Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419; Scheibe, Andrew/0000-0002-3238-0699; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Grosso, Ashley/0000-0001-5759-7125	Sexual Health and Rights Project (SHARP) of the Open Society Institute; Open Society Initiative for Southern Africa (OSISA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Sexual Health and Rights Project (SHARP) of the Open Society Institute; Open Society Initiative for Southern Africa (OSISA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Sexual Health and Rights Project (SHARP) of the Open Society Institute (opensocietyfoundations.org) and the Open Society Initiative for Southern Africa (OSISA; http://www.osisa.org/). Thoko Budaza, Sisonke Msimang, and Vicci Tallis of the Open Society Initiative for Southern Africa provided significant administrative support to each of the community partners as well as input into the study design and the questionnaire. Benaifer Badha and Christina Alexander of the Sexual Health and Rights Project (SHARP) at OSI were responsible for duplicate data entry. Sue Simon and Heather Doyle of SHARP initiated this work and provided ongoing support to partners.	amfAR JHU, 2012, ACH AIDS FREE GEN GA; Amnesty International, 2013, MAK LOV CRIM CRIM SA; Anderson AM, 2015, AIDS CARE, V27, P63, DOI 10.1080/09540121.2014.951597; [Anonymous], 2003, HUMAN RIGHTS WATCH R; Arreola S, 2015, AIDS BEHAV, V19, P227, DOI 10.1007/s10461-014-0869-x; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Binswanger H., 2005, SEXUAL MINORITIES VI; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Cock J, 2003, WOMEN STUD INT FORUM, V26, P35, DOI 10.1016/S0277-5395(02)00353-9; Epprecht M, 2013, HUNGOCHANI: THE HISTORY OF A DISSIDENT SEXUALITY IN SOUTHERN AFRICA, 2ND EDITION, P1; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Human Rights Campaign Foundation, 2014, REP STAT HUM RIGHTS; Ilyayambwa Mwanawina, 2012, INT J HUMANITIES SOC, V2, P50; Itaborahy LP, 2013, STATE SPONSORED HOMO; Johnson CA, 2007, MAP HIV AIDS PROGRAM; Kasunda A., 2012, NATION MALAWI, V19; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Mason K, 2015, J HUM RIGHTS PRACT, V7, P139, DOI 10.1093/jhuman/huu026; Massoud Mark F., 2003, PEACE REV, V15, P301, DOI [10.1080/1040265032000130896, DOI 10.1080/1040265032000130896]; McAllister J, 2013, CULT HEALTH SEX, V15, P88, DOI 10.1080/13691058.2012.742929; Mwakasungula U., 2013, HUMAN RIGHTS SEXUAL; Nel JA, 2008, ACTA CRIMINOLOGICA, V21; Petros G, 2006, CULT HEALTH SEX, V8, P67, DOI 10.1080/13691050500391489; Pringle A., 2004, SEXUAL EXCLUSION HOM; Reid Graeme, 2002, URBAN FORUM, V13, P99, DOI DOI 10.1007/S12132-002-0010-5; Roberts B, 2008, HSRC REV, V6, P9; Senior K, 2010, LANCET INFECT DIS, V10, P448, DOI 10.1016/S1473-3099(10)70127-4; Spitzberg B H, 1999, Violence Vict, V14, P241; Spruill J., 2008, J HOMOSEXUAL, V46, P91; StataCorp, 2011, STAT STAT SOFTW REL; Thoreson R, 2011, NOWHERE TURN BLACKMA; Tucker A, 2014, AIDS CARE, V26, P882, DOI 10.1080/09540121.2013.859652; Tucker A, 2013, AIDS CARE, V25, P1227, DOI 10.1080/09540121.2013.764383; Tucker Andrew, 2009, QUEER VISIBILITIES S; van der Elst EM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18741; Wells H, 2006, 67 EMP WOM GEND EQ; World AIDS-Free, 2010, UNN CONN CREAT SOC C	38	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147156	10.1371/journal.pone.0147156	http://dx.doi.org/10.1371/journal.pone.0147156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB4CC	26764467	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300074
J	Chakravarthy, H; Beli, E; Navitskaya, S; O'Reilly, S; Wang, Q; Kady, N; Huang, C; Grant, MB; Busik, JV				Chakravarthy, Harshini; Beli, Eleni; Navitskaya, Svetlana; O'Reilly, Sandra; Wang, Qi; Kady, Nermin; Huang, Chao; Grant, Maria B.; Busik, Julia V.			Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; HEMATOPOIETIC STEM-CELLS; BLOOD-VESSEL FORMATION; DENDRITIC CELLS; MICROGLIAL RESPONSE; SDF-1/CXCR4 AXIS; MOUSE RETINA; MONOCYTES; DIFFERENTIATION; PATHOGENESIS	Diabetic retinopathy is a sight-threatening complication of diabetes, affecting 65% of patients after 10 years of the disease. Diabetic metabolic insult leads to chronic low-grade inflammation, retinal endothelial cell loss and inadequate vascular repair. This is partly due to bone marrow (BM) pathology leading to increased activity of BM-derived pro-inflammatory monocytes and impaired function of BM-derived reparative circulating angiogenic cells (CACs). We propose that diabetes has a significant long-term effect on the nature and proportion of BM-derived cells that circulate in the blood, localize to the retina and home back to their BM niche. Using a streptozotocin mouse model of diabetic retinopathy with GFP BM-transplantation, we have demonstrated that BM-derived circulating pro-inflammatory monocytes are increased in diabetes while reparative CACs are trapped in the BM and spleen, with impaired release into circulation. Diabetes also alters activation of splenocytes and BM-derived dendritic cells in response to LPS stimulation. A majority of the BM-derived GFP cells that migrate to the retina express microglial markers, while others express endothelial, pericyte and Muller cell markers. Diabetes significantly increases infiltration of BM-derived microglia in an activated state, while reducing infiltration of BM-derived endothelial progenitor cells in the retina. Further, control CACs injected into the vitreous are very efficient at migrating back to their BM niche, whereas diabetic CACs have lost this ability, indicating that the in vivo homing efficiency of diabetic CACs is dramatically decreased. Moreover, diabetes causes a significant reduction in expression of specific integrins regulating CAC migration. Collectively, these findings indicate that BM pathology in diabetes could play a role in both increased pro-inflammatory state and inadequate vascular repair contributing to diabetic retinopathy.	[Chakravarthy, Harshini; Navitskaya, Svetlana; O'Reilly, Sandra; Wang, Qi; Kady, Nermin; Huang, Chao; Busik, Julia V.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Beli, Eleni; Grant, Maria B.] Indiana Univ, Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA	Michigan State University; Indiana University System; Indiana University-Purdue University Indianapolis	Busik, JV (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	busik@msu.edu	Beli, Eleni/AGR-8255-2022; Busik, Julia V/A-2698-2010; Beli, Eleni/AAL-7433-2020	Busik, Julia V/0000-0003-3453-7124; Beli, Eleni/0000-0003-1889-640X	AgBioResearch [MICL02163]; National Institutes of Health [EY-01-6077, EY-07739, EY-12601, DK-09-0730]; NATIONAL EYE INSTITUTE [R01EY025383, R01EY007739, R01EY012601, R01EY016077, R29EY007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK090730] Funding Source: NIH RePORTER	AgBioResearch; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by AgBioResearch MICL02163 to JB [http://agbioresearch.msu.edu/] and the National Institutes of Health EY-01-6077 to JB, EY-07739 to MBG, EY-12601 to MBG, DK-09-0730 to JB and MBG [http://www.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer S. F., 2013, J CLIN CELLULAR I S1; Abcouwer Steven F, 2011, J Ocul Biol Dis Infor, V4, P25, DOI 10.1007/s12177-012-9086-x; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Antonetti D A, 1999, Semin Ophthalmol, V14, P240, DOI 10.3109/08820539909069543; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Boettcher C, 2008, BRIT J OPHTHALMOL, V92, P272, DOI 10.1136/bjo.2007.126318; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4; Calzi SL, 2008, DIABETES, V57, P2488, DOI 10.2337/db08-0381; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fox TE, 2006, DIABETES, V55, P3573, DOI 10.2337/db06-0539; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hazra S, 2013, DIABETOLOGIA, V56, P644, DOI 10.1007/s00125-012-2781-0; Hinze A, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-35; Hu P, 2013, AM J PATHOL, V183, P1608, DOI 10.1016/j.ajpath.2013.07.009; Jin H, 2006, J CLIN INVEST, V116, P652, DOI 10.1172/JCI24751; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kern TS, 2000, INVEST OPHTH VIS SCI, V41, P3972; Kerr EC, 2008, J AUTOIMMUN, V31, P354, DOI 10.1016/j.jaut.2008.08.006; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lehmann U, 2010, NEUROBIOL DIS, V40, P177, DOI 10.1016/j.nbd.2010.05.022; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Loomans CJM, 2009, MOL MED, V15, P152, DOI 10.2119/molmed.2009.00032; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Marchetti V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00076; Mazo IB, 2011, TRENDS IMMUNOL, V32, P493, DOI 10.1016/j.it.2011.06.011; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Mollah ZUA, 2008, J IMMUNOL, V180, P3166, DOI 10.4049/jimmunol.180.5.3166; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Opreanu M, 2011, DIABETES, V60, P2370, DOI 10.2337/db10-0550; Opreanu M, 2010, INVEST OPHTH VIS SCI, V51, P3253, DOI 10.1167/iovs.09-4731; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Plett PA, 2003, BLOOD, V102, P2285, DOI 10.1182/blood-2002-12-3742; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Saito H, 2012, AM J PHYSIOL-CELL PH, V302, pC892, DOI 10.1152/ajpcell.00380.2011; Santos AM, 2010, J COMP NEUROL, V518, P477, DOI 10.1002/cne.22227; SCHRODER S, 1991, AM J PATHOL, V139, P81; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Soulet D, 2008, CURR OPIN PHARMACOL, V8, P508, DOI 10.1016/j.coph.2008.04.002; Stitt Alan W., 2000, Molecular Cell Biology Research Communications, V3, P380, DOI 10.1006/mcbr.2000.0243; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Vagima Y, 2011, METHODS MOL BIOL, V750, P277, DOI 10.1007/978-1-61779-145-1_19; Wary KK, 2009, STEM CELLS, V27, P3112, DOI 10.1002/stem.241; Williams NL, 2011, FEMS IMMUNOL MED MIC, V61, P218, DOI 10.1111/j.1574-695X.2010.00767.x; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yang MX, 2012, INFLAMMATION, V35, P388, DOI 10.1007/s10753-011-9374-9; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhao XH, 2010, J RECEPT SIG TRANSD, V30, P246, DOI 10.3109/10799893.2010.488241	68	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146829	10.1371/journal.pone.0146829	http://dx.doi.org/10.1371/journal.pone.0146829			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760976	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100045
J	Shuai, FM; Li, XH; Li, YF; Li, J; Yang, JP; Lek, S				Shuai, Fangmin; Li, Xinhui; Li, Yuefei; Li, Jie; Yang, Jiping; Lek, Sovan			Temporal Patterns of Larval Fish Occurrence in a Large Subtropical River	PLOS ONE			English	Article							FRESH-WATER FISHES; REDUNDANCY ANALYSIS; STOCK ASSESSMENT; SOCKEYE-SALMON; TEMPERATURE; ICHTHYOPLANKTON; ESTUARY; ASSEMBLAGES; ENVIRONMENT; AUSTRALIA	Knowledge of temporal patterns of larval fish occurrence is limited in south China, despite its ecological importance. This research examines the annual and seasonal patterns of fish larval presence in the large subtropical Pearl River. Data is based on samples collected every two days, from 2006 to 2013. In total, 45 taxa representing 13 families and eight orders were sampled. The dominant larval family was Cyprinidae, accounting for 27 taxa. Squaliobarbus curriculus was the most abundant species, followed by Megalobrama terminalis, Xenocypris davidi, Cirrhinus molitorella, Hemiculter leuscisculus and Squalidus argentatus. Fish larvae abundances varied significantly throughout the seasons (multivariate analyses: Cluster, SIMPROF and ANOSIM). The greatest numbers occurred between May and September, peaking from June through August, which corresponds to the reproductive season. In this study, redundancy analysis was used to describe the relationship between fish larval abundance and associated environmental factors. Mean water temperature, river discharge, atmospheric pressure, maximum temperature and precipitation play important roles in larval occurrence patterns. According to seasonal variations, fish larvae occurrence is mainly affected by water temperature. It was also noted that the occurrence of Salanx reevesii and Cyprinus carpio larvae is associated with higher dissolved oxygen (DO) concentrations, higher atmospheric pressure and lower water temperatures which occur in the spring. On the other hand, M. terminalis, X. davidi, and C. molitorella are associated with high precipitation, high river discharge, low atmospheric pressure and low DO concentrations which featured during the summer months. S. curriculus also peaks in the summer and is associated with peak water temperatures and minimum NH3-N concentrations. Rhinogobius giurinus occur when higher atmospheric pressure, lower precipitation and lower river discharges occur in the autumn. Dominant fish species stagger their spawning period to avoid intraspecific competition for food resources during early life stages; a coexistence strategy to some extent. This research outlines the environmental requirements for successful spawning for different fish species. Understanding processes such as those outlined in this research paper is the basis of conservation of fish community diversity which is a critical resource to a successful sustainable fishery in the Pearl River.	[Shuai, Fangmin; Li, Xinhui; Li, Yuefei; Li, Jie; Yang, Jiping] CAFS, Pearl River Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China; [Shuai, Fangmin; Li, Xinhui; Li, Yuefei; Li, Jie; Yang, Jiping] Minist Agr, Expt Stn Sci Observat Fishery Resources & Environ, Guangzhou, Guangdong, Peoples R China; [Shuai, Fangmin; Li, Xinhui; Li, Yuefei; Li, Jie; Yang, Jiping] Key Lab Conservat & Ecol Restorat Fishery Resourc, Guangzhou, Guangdong, Peoples R China; [Shuai, Fangmin; Lek, Sovan] Univ Toulouse 3, F-31062 Toulouse, France	Chinese Academy of Fishery Sciences; Pearl River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Li, XH (corresponding author), CAFS, Pearl River Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China.	lxhui01@aliyun.com			National Natural Science Foundation of China [31400354]; Special Fund for Agro-scientific Research in the Public Interest [201303048]; Guangxi Natural Science Foundation of China [2013GXNSFEA053003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Guangxi Natural Science Foundation of China	This work was supported by 31400354 http://www.nsfc.gov.cn/ National Natural Science Foundation of China (FS), 201303048 http://www.moa.gov.cn/ Special Fund for Agro-scientific Research in the Public Interest (XL), and 2013GXNSFEA053003 http://kjxm.gxsti.net Guangxi Natural Science Foundation of China (XL).; We are grateful to the Zhaoqing Detachment of the Guangdong Fishing Administrative Brigade for their assistance in the field. We thank Peter Winterton for his assistance in writing this manuscript. We also grateful to the LOTUS Unlimited Erasmus Mundus that give the first author post-doc mobility. This research is funded by the Guangxi Natural Science Foundation of China (2013GXNSFEA053003), National Natural Science Foundation of China (31400354) and the Special Fund for Agro-scientific Research in the Public Interest (201303048).	Ahn C, 2009, ECOL ENG, V35, P1036, DOI 10.1016/j.ecoleng.2009.03.005; Akin S, 2005, ESTUAR COAST SHELF S, V64, P671, DOI 10.1016/j.ecss.2005.03.019; Anderson JT, 2001, CAN J FISH AQUAT SCI, V58, P1386, DOI 10.1139/cjfas-58-7-1386; Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; Anguis V, 2005, AQUACULTURE, V243, P133, DOI 10.1016/j.aquaculture.2004.09.026; Bice CM, 2011, ECOL ENG, V37, P1901, DOI 10.1016/j.ecoleng.2011.06.046; Boeing WJ, 2008, ECOL INDIC, V8, P292, DOI 10.1016/j.ecolind.2007.03.002; Booth AJ, 2000, ICES J MAR SCI, V57, P858, DOI 10.1006/jmsc.2000.0816; Busby MS, 2014, FISH OCEANOGR, V23, P270, DOI 10.1111/fog.12062; Cao W., 2007, FISH RESOURCES EARLY; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clarke KR, 1994, CHANGE MARINE COMMUN; Clarke R. K., 1993, MARINE ECOLOGY PROGR, V92, P205; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004140; Cushing DH, 1975, MARINE ECOLOGY FISHE; Davis ML, 2006, FISH B-NOAA, V104, P585; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Felix-Hackradt FC, 2013, ESTUAR COAST SHELF S, V129, P59, DOI 10.1016/j.ecss.2013.05.029; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Fincham JI, 2013, J SEA RES, V75, P69, DOI 10.1016/j.seares.2012.07.004; Gehrke PC, 2001, REGUL RIVER, V17, P369, DOI 10.1002/rrr.648.abs; Genner MJ, 2010, J PLANKTON RES, V32, P699, DOI 10.1093/plankt/fbp082; Gu JW, 2012, SCI TOTAL ENVIRON, V435, P541, DOI 10.1016/j.scitotenv.2012.07.040; Hereu B, 2006, MAR ECOL PROG SER, V325, P187, DOI 10.3354/meps325187; Hernandez-Miranda E, 2003, ESTUAR COAST SHELF S, V56, P1075, DOI 10.1016/S0272-7714(02)00308-6; Hickford MJH, 2003, MAR ECOL PROG SER, V252, P255, DOI 10.3354/meps252255; Hu WW, 2008, ECOL ENG, V33, P233, DOI 10.1016/j.ecoleng.2008.04.003; Huang LM, 2004, MAR POLLUT BULL, V49, P588, DOI 10.1016/j.marpolbul.2004.03.015; Humphries P, 1999, ENVIRON BIOL FISH, V56, P129, DOI 10.1023/A:1007536009916; Jobling M., 1995, ENVIRON BIOL FISH; Kerr KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097593; Kokita T, 2000, MAR ECOL PROG SER, V199, P263, DOI 10.3354/meps199263; Koslow JA, 2011, MAR ECOL PROG SER, V436, P207, DOI 10.3354/meps09270; Kurita Y, 2011, FISH B-NOAA, V109, P79; LAPRISE R, 1995, MAR ECOL PROG SER, V122, P73, DOI 10.3354/meps122073; Lasker R., 1981, MARINE FISH LARVAE M; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; LEIS JM, 1987, AUST J MAR FRESH RES, V38, P211; Li KZ, 2006, ESTUAR COAST SHELF S, V67, P543, DOI 10.1016/j.ecss.2005.12.008; Liang Z. S., 1985, REPORT FISHERY RESOU, V6, P255; Liao GZ, 1989, CAN J FISH AQUAT SCI, P561; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Makarenkov V, 2002, ECOLOGY, V83, P1146, DOI 10.1890/0012-9658(2002)083[1146:NRAACC]2.0.CO;2; Martin FD, 2008, HYDROBIOLOGIA, V598, P139, DOI 10.1007/s10750-007-9146-6; Martins EG, 2012, CAN J FISH AQUAT SCI, V69, P330, DOI 10.1139/F2011-154; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCasker N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109317; Moore WG, 1942, ECOLOGY, V23, P319, DOI 10.2307/1930671; Piller KR, 2004, T AM FISH SOC, V133, P1004, DOI 10.1577/T03-047.1; Pringle CM, 2000, BIOSCIENCE, V50, P807, DOI 10.1641/0006-3568(2000)050[0807:REOHAO]2.0.CO;2; Prista N, 2003, OCEANOL ACTA, V26, P525, DOI 10.1016/S0399-1784(03)00047-1; Rankin TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108871; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanchez W, 2011, ENVIRON INT, V37, P1342, DOI 10.1016/j.envint.2011.06.002; Sassa C, 2013, DEEP-SEA RES PT I, V81, P49, DOI 10.1016/j.dsr.2013.07.008; Shimizu Akio, 2006, Bulletin of Fisheries Research Agency, P1; Shuai FM, 2015, ECOL MODEL IN PRESS; Tan XC, 2010, ENVIRON BIOL FISH, V88, P217, DOI 10.1007/s10641-010-9632-y; TRICKLEBANK KA, 1992, ESTUAR COAST SHELF S, V34, P263, DOI 10.1016/S0272-7714(05)80083-6; Unfer G, 2011, ECOL FRESHW FISH, V20, P438, DOI 10.1111/j.1600-0633.2010.00456.x; Vilizzi L, 2012, FUND APPL LIMNOL, V181, P215, DOI 10.1127/1863-9135/2012/0394; WINEMILLER KO, 1989, OECOLOGIA, V81, P225, DOI 10.1007/BF00379810; Wong SNP, 2014, DEEP SEA RES; Xie G, 2000, AQUATIC SCI TECH INF, V27, P246; Yoshioka PM, 2008, MAR ECOL PROG SER, V368, P309, DOI 10.3354/meps07728; Yu Z. T., 1988, GEZHOUBA DAM 4 FAMOU; Zeng GZ, 2008, GUANGXI AGR SCI, V39, P97; Zhang G, 2012, ENVIRON BIOL FISH, V93, P439, DOI 10.1007/s10641-011-9934-8	73	19	21	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146441	10.1371/journal.pone.0146441	http://dx.doi.org/10.1371/journal.pone.0146441			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760762	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100035
J	Zermoglio, PF; Guralnick, RP; Wieczorek, JR				Zermoglio, Paula F.; Guralnick, Robert P.; Wieczorek, John R.			A Standardized Reference Data Set for Vertebrate Taxon Name Resolution	PLOS ONE			English	Article							BIODIVERSITY; INFORMATICS; BIG	Taxonomic names associated with digitized biocollections labels have flooded into repositories such as GBIF, iDigBio and VertNet. The names on these labels are often misspelled, out of date, or present other problems, as they were often captured only once during accessioning of specimens, or have a history of label changes without clear provenance. Before records are reliably usable in research, it is critical that these issues be addressed. However, still missing is an assessment of the scope of the problem, the effort needed to solve it, and a way to improve effectiveness of tools developed to aid the process. We present a carefully human-vetted analysis of 1000 verbatim scientific names taken at random from those published via the data aggregator VertNet, providing the first rigorously reviewed, reference validation data set. In addition to characterizing formatting problems, human vetting focused on detecting misspelling, synonymy, and the incorrect use of Darwin Core. Our results reveal a sobering view of the challenge ahead, as less than 47% of name strings were found to be currently valid. More optimistically, nearly 97% of name combinations could be resolved to a currently valid name, suggesting that computer-aided approaches may provide feasible means to improve digitized content. Finally, we associated names back to biocollections records and fit logistic models to test potential drivers of issues. A set of candidate variables (geographic region, year collected, higher-level clade, and the institutional digitally accessible data volume) and their 2-way interactions all predict the probability of records having taxon name issues, based on model selection approaches. We strongly encourage further experiments to use this reference data set as a means to compare automated or computer-aided taxon name tools for their ability to resolve and improve the existing wealth of legacy data.	[Zermoglio, Paula F.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst IEGEBA CONICET UBA, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Zermoglio, Paula F.] Univ Tours, Inst Rech Biol Insecte, UMR CNRS 7261, Tours, France; [Guralnick, Robert P.] Univ Florida, Univ Florida Museum Nat Hist, Gainesville, FL USA; [Wieczorek, John R.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of Buenos Aires; Universite de Tours; State University System of Florida; University of Florida; University of California System; University of California Berkeley	Zermoglio, PF (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst IEGEBA CONICET UBA, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina.	pzermoglio@gmail.com		Zermoglio, Paula Florencia/0000-0002-6056-5084	National Science Foundation, Division of Biological Infrastructure [1062193, 0960550, 1262600]; Div Of Biological Infrastructure [1535793, 1062193] Funding Source: National Science Foundation	National Science Foundation, Division of Biological Infrastructure(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation, Division of Biological Infrastructure, No. 1062193. http://www.nsf.gov/awardsearch/showAward?AWD_ID=1062193; National Science Foundation, Division of Biological Infrastructure, No. 0960550. http://nsf.gov/awardsearch/showAward?AWD_ID=0960550; and National Science Foundation, Division of Biological Infrastructure, No. 1262600. http://www.nsf.gov/awardsearch/showAward?AWD_ID=1262600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2002, P NATL ACAD SCI USA, V99, P3706, DOI 10.1073/pnas.062691099; AmphibiaWeb, 2015, INF AMPH BIOL CONS; [Anonymous], 2013, PLANT LIST VERSION 1; [Anonymous], 2015, WORLD SPID CAT VERS; [Anonymous], 2015, AVIBASE; Barton K., 2015, MUMIN MULTIMODEL INF; Beaujean AA, 2015, PACKAGE BAYLOR U ED; BERENDSOHN WG, 1995, TAXON, V44, P207, DOI 10.2307/1222443; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapman AD., 2005, PRINCIPLES METHODS D; Constable H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000309; Costello MJ, 2014, BIOL CONSERV, V173, P68, DOI 10.1016/j.biocon.2013.10.018; Costello MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051629; DAMERAU FJ, 1964, COMMUN ACM, V7, P171, DOI 10.1145/363958.363994; Deck J, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0014-0; Duarte M, 2014, BIOL CONSERV, V176, P236, DOI 10.1016/j.biocon.2014.05.028; Eschmeyer W. N., 2015, CATALOG FISHES GENER; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Froese R., 2021, FISHBASE; Gaiji S., 2013, BIODIVERS INFORM, V8, P94; GBIF, 2013, GBIF BACKB TAX; Gill FB, 2014, AUK, V131, P150, DOI 10.1642/AUK-13-206.1; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guralnick RP, 2007, ECOL LETT, V10, P663, DOI 10.1111/j.1461-0248.2007.01063.x; Hill AW, 2010, POSITION PAPER FUTUR; HJARDING A., 2012, ORYX; Index Fungorum, 2015, INDEX FUNGORUM; International Commission for Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Kennedy J, 2006, OMICS, V10, P220, DOI 10.1089/omi.2006.10.220; Kluyver TA, 2013, ECOL EVOL, V3, P1262, DOI 10.1002/ece3.529; Lepage D, 2014, ZOOKEYS, P117, DOI 10.3897/zookeys.420.7089; Leray M, 2015, PEERJ, V3, DOI 10.7717/peerj.1047; Maldonado C, 2015, GLOBAL ECOL BIOGEOGR, V24, P973, DOI 10.1111/geb.12326; Padial JM, 2006, SYST BIOL, V55, P859, DOI 10.1080/1063515060081588; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Patterson DJ, 2010, TRENDS ECOL EVOL, V25, P686, DOI 10.1016/j.tree.2010.09.004; Peng T, 2012, GSTF J COMPUTING JOC, V2, P55; R_Core_Team, 2015, R LANG ENV STAT COMP; Rees T., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0107510, DOI 10.1371/J0URNAL.P0NE.0107510]; Robertson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102623; Roskov Y A, 2015, SPECIES 2000 ITIS CA; Schuh RT, 2003, BOT REV, V69, P59, DOI 10.1663/0006-8101(2003)069[0059:TLSAIY]2.0.CO;2; Uetz P., 2015, REPTILE DATABASE; Vanden Berghe E, 2015, ECOL INFORM, V28, P29, DOI 10.1016/j.ecoinf.2015.05.004; Vieglais D., 2009, DARWIN CORE; Wieczorek J., 2015, VERTNET DARWIN CORE; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; Wilson DW, 2015, MAMMAL SPECIES WORLD; WoRMS Editorial Board, 2015, WORLD REGISTER MARIN	53	17	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146894	10.1371/journal.pone.0146894	http://dx.doi.org/10.1371/journal.pone.0146894			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760296	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100051
J	Matthews, N; Welch, L; Achtman, R; Fenton, R; FitzGerald, B				Matthews, Nestor; Welch, Leslie; Achtman, Rebecca; Fenton, Rachel; FitzGerald, Brynn			Simultaneity and Temporal Order Judgments Exhibit Distinct Reaction Times and Training Effects	PLOS ONE			English	Article							INFORMATION; STIMULI; MODEL; DISCRIMINATION; PERCEPTION; SYNCHRONY; TASK	A considerable body of sensory research has addressed the rules governing simultaneity judgments (SJs) and temporal order judgments (TOJs). In principle, neural events that register stimulus-arrival-time differences at an early sensory stage could set the limit on SJs and TOJs alike. Alternatively, distinct limits on SJs and TOJs could arise from task-specific neural events occurring after the stimulus-driven stage. To distinguish between these possibilities, we developed a novel reaction-time (RT) measure and tested it in a perceptuallearning procedure. The stimuli comprised dual-stream Rapid Serial Visual Presentation (RSVP) displays. Participants judged either the simultaneity or temporal order of red-letter and black-number targets presented in opposite lateral hemifield streams of black-letter distractors. Despite identical visual stimulation across-tasks, the SJ and TOJ tasks generated distinct RT patterns. SJs exhibited significantly faster RTs to synchronized targets than to subtly asynchronized targets; TOJs exhibited the opposite RT pattern. These task-specific RT patterns cannot be attributed to the early, stimulus-driven stage and instead match what one would predict if the limits on SJs and TOJs arose from task-specific decision spaces. That is, synchronized targets generate strong evidence for simultaneity, which hastens SJ RTs. By contrast, synchronized targets provide no information about temporal order, which slows TOJ RTs. Subtly asynchronizing the targets reverses this information pattern, and the corresponding RT patterns. In addition to investigating RT patterns, we also investigated training-transfer between the tasks. Training to improve SJ precision failed to improve TOJ precision, and vice versa, despite identical visual stimulation across tasks. This, too, argues against early, stimulus-driven limits on SJs and TOJs. Taken together, the present study offers novel evidence that distinct rules set the limits on SJs and TOJs.	[Matthews, Nestor; Achtman, Rebecca; Fenton, Rachel; FitzGerald, Brynn] Denison Univ, Dept Psychol, Granville, OH 43023 USA; [Welch, Leslie] Brown Univ, Cognit Linguist & Psychol Sci, Providence, RI 02912 USA	Denison University; Brown University	Matthews, N (corresponding author), Denison Univ, Dept Psychol, Granville, OH 43023 USA.	matthewsn@denison.edu			Denison University Brickman Teaching Excellence Award	Denison University Brickman Teaching Excellence Award	A 2014 Denison University Brickman Teaching Excellence Award to NM supported this research.	AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; ALLAN LG, 1975, PERCEPT PSYCHOPHYS, V18, P29, DOI 10.3758/BF03199363; AXELROD S, 1968, J GERONTOL, V23, P191, DOI 10.1093/geronj/23.2.191; Bernasconi F, 2010, NEUROIMAGE, V50, P1271, DOI 10.1016/j.neuroimage.2010.01.016; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Diederich A, 2015, PSYCHOL REV, V122, P232, DOI 10.1037/a0038696; FREIDES D, 1974, PSYCHOL BULL, V81, P284, DOI 10.1037/h0036331; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Garcia-Perez MA, 2015, ATTEN PERCEPT PSYCHO, V77, P1750, DOI 10.3758/s13414-015-0869-6; Garcia-Perez MA, 2012, PSYCHON B REV, V19, P820, DOI 10.3758/s13423-012-0278-y; Green DM, 1966, SIGNAL DETECTION THE; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; HIRSH IJ, 1959, J ACOUST SOC AM, V31, P759, DOI 10.1121/1.1907782; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; Love SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054798; Luce D., 1991, RESPONSE TIMES THEIR; Matthews N, 2013, J VISION, V13, DOI 10.1167/13.8.2; Matthews N, 2012, J VISION, V12, DOI 10.1167/12.2.1; Megevand P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071608; Miller J, 2004, PERCEPT PSYCHOPHYS, V66, P563, DOI 10.3758/BF03194901; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Saffell T, 2003, VISION RES, V43, P1365, DOI 10.1016/S0042-6989(03)00137-8; Sanders A.F., 1980, ATTENTION PERFORM, V8, P59; Schroter H, 2007, PSYCHON B REV, V14, P39, DOI 10.3758/BF03194025; Shannon C. E., 1949, MATH THEORY COMMUNIC; SHAW EAG, 1974, J ACOUST SOC AM, V56, P1848, DOI 10.1121/1.1903522; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Stevenson RA, 2013, EXP BRAIN RES, V225, P479, DOI 10.1007/s00221-012-3387-y; ULRICH R, 1987, PERCEPT PSYCHOPHYS, V42, P224, DOI 10.3758/BF03203074; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Verleger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057421; Weiss K, 2011, Q J EXP PSYCHOL, V64, P394, DOI 10.1080/17470218.2010.495783; Woodworth R.S., 1938, EXP PSYCHOL; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	40	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0145926	10.1371/journal.pone.0145926	http://dx.doi.org/10.1371/journal.pone.0145926			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CG	26756716	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800006
J	Zheng, W; Zong, JF; Huang, CB; Chen, JH; Wu, JX; Chen, CB; Lin, SJ; Pan, JJ				Zheng, Wei; Zong, Jingfeng; Huang, Chaobin; Chen, Juhui; Wu, Junxin; Chen, Chuanben; Lin, Shaojun; Pan, Jianji			Multimodality Treatment May Improve the Survival Rate of Patients with Metastatic Nasopharyngeal Carcinoma with Good Performance Status	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; PROGNOSTIC-FACTORS; CISPLATIN; BENEFIT	The aim of the present study was to evaluate the benefit of chemotherapy, combined with palliative radiotherapy (PRT) and other local treatments to the metastatic sites, for patients with metastatic nasopharyngeal carcinoma (NPC) who had a performance status 0-2. We conducted a retrospective review of available data from 197 biopsy-proven NPC patients who developed metastasis after their initial definitive treatment. These patients were grouped into three categories according to the different treatment paths that were followed: the best supportive care (64 patients), chemotherapy alone (55 patients), and multimodality treatment with chemotherapy combined with PRT and other local treatments to metastatic sites (78 patients). The 2-year metastatic survival rate of patients in the multimodality treatment group was 57.7%, which was significantly better than that of the patients in both the chemotherapy alone group and the best supportive care group (32.7% and 1.6%, respectively). The independent significant factors affecting survival were the disease-free interval prior to the detection of metastatic disease, the number of metastases, the number of chemotherapy cycles and the biological effective dose of PRT. In conclusion, multimodality treatment may improve survival of select patients with recurrent NPC with distant metastases.	[Zheng, Wei; Zong, Jingfeng; Huang, Chaobin; Chen, Juhui; Wu, Junxin; Chen, Chuanben; Lin, Shaojun; Pan, Jianji] Fujian Med Univ, Prov Clin Coll, Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou 350014, Fujian, Peoples R China; [Zheng, Wei; Zong, Jingfeng; Huang, Chaobin; Chen, Juhui; Wu, Junxin; Chen, Chuanben; Lin, Shaojun; Pan, Jianji] Fujian Med Univ, Union Hosp, Fujian Prov Canc Hosp, Fujian Prov Key Lab Translat Canc Med, Fuzhou 350014, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Pan, JJ (corresponding author), Fujian Med Univ, Prov Clin Coll, Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou 350014, Fujian, Peoples R China.	panjianji@126.com	, 宗井凤/AAH-1938-2020	Pan, Jianji/0000-0002-3211-7874	Medical Innovation Program of Fujian [2015-CX-6]; key Clinical Specialty Discipline Construction Program of Fujian, P.R.C.	Medical Innovation Program of Fujian; key Clinical Specialty Discipline Construction Program of Fujian, P.R.C.	This study was funded by Medical Innovation Program of Fujian (No: 2015-CX-6) and key Clinical Specialty Discipline Construction Program of Fujian, P.R.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensouda Y, 2011, EUR ANN OTORHINOLARY, V128, P79, DOI 10.1016/j.anorl.2010.10.003; Cao X, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-370; Cao X, 2011, ORAL ONCOL, V47, P747, DOI 10.1016/j.oraloncology.2011.05.010; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Chen MQ, 2014, J CHIN MED ASSOC, V77, P562, DOI 10.1016/j.jcma.2014.05.014; Fandi A, 2000, J CLIN ONCOL, V18, P1324, DOI 10.1200/JCO.2000.18.6.1324; Jin Y, 2012, J CANCER RES CLIN, V138, P1717, DOI 10.1007/s00432-012-1219-x; Khanfira A, 2007, CANCER RADIOTHER, V11, P461, DOI 10.1016/j.canrad.2007.06.006; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lee AWM, 2014, RADIOTHER ONCOL, V110, P377, DOI 10.1016/j.radonc.2014.02.003; Nieder C, 2005, INT J RADIAT ONCOL, V61, P851, DOI 10.1016/j.ijrobp.2004.06.016; Niibe Y, 2015, ANTICANCER RES, V35, P4903; O'Sullivan GJ, 2015, WORLD J RADIOL, V7, P202, DOI 10.4329/wjr.v7.i8.202; Ong YK, 2003, EUR J CANCER, V39, P1535, DOI 10.1016/S0959-8049(03)00310-1; Pan CC, 2011, INT J HYPERTHER, V27, P549, DOI 10.3109/02656736.2011.593019; Tang LQ, 2013, J CLIN ONCOL, V31, P2861, DOI 10.1200/JCO.2012.46.0816; Tian YM, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-272; Xue C, 2013, ANN ONCOL, V24, P1055, DOI 10.1093/annonc/mds581	18	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146771	10.1371/journal.pone.0146771	http://dx.doi.org/10.1371/journal.pone.0146771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757277	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800030
J	Chang, JW; Chen, HL; Su, HJ; Lee, CC				Chang, Jung-Wei; Chen, Hsiu-Ling; Su, Huey-Jen; Lee, Ching-Chang			Abdominal Obesity and Insulin Resistance in People Exposed to Moderate-to-High Levels of Dioxin	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; HOMEOSTASIS MODEL ASSESSMENT; CARDIOVASCULAR RISK-FACTORS; GLUCOSE-TOLERANCE TEST; METABOLIC SYNDROME; CONTAMINATED AREA; SENSITIVITY INDEXES; ENDOCRINE ORGAN; ADIPOSE-TISSUE; FAT	Obesity, a risk factor for developing metabolic complications, is a major public health problem. Abdominal obesity is strongly accompanied by a cluster of metabolic abnormalities characterized by insulin resistance. The link between persistent organic pollutants (POPs) and insulin resistance has been investigated in animal and epidemiological studies. We aimed to examine whether insulin resistance is greater in people with abdominal obesity (AO) and concomitant exposure to serum dioxins (PCDD/Fs). We conducted a cross-sectional descriptive study of 2876 participants living near a PCDD/Fs contaminated area. Seventeen 2,3,7,8-substituted PCDD/Fs congeners were measured, and then the associations between the main predictor variable, serum TEQDF-1998, abdominal obesity (AO), dependent variables, and insulin resistance were examined. Twelve of the 17 congeners, widely distributed among PCDDs, and PCDFs, had trends for associations with abdominal adiposity. In men, the highest quintiles of 1,2,3,7,8-PeCDF; 1,2,3,7,8-PeCDD; 2,3,7,8-TCDD; 2,3,7,8-TCDF; and 2,3,4,7,8-PeCDF had the top five adjusted odds ratios (AORs) + 95% confidence intervals (CIs):[4.2; 2.7-6.4], [3.6; 2.3-5.7], [3.2; 2.1-5.0], [3.0; 2.0-4.5], and [2.9; 1.9-4.7], respectively. In women, the highest quintiles of 1,2,3,4,7,8,9-HpCDF; 1,2,3,6,7,8-HxCDF; and 1,2,3,4,6,7,8-HpCDF had the top three AORs + 95% CIs:[3.0; 1.9-4.7], [2.0; 1.3-3.1], and [1.9; 1.3-2.9], respectively. After confounding factors had been adjusted for, men, but not women, with higher serum TEQ(DF-1998) levels or abdominal obesity had a significantly (P-trend < 0.001) greater risk for abnormal insulin resistance. The groups with the highest joint serum TEQ(DF-1998) and abdominal obesity levels were associated with elevated insulin resistance at 5.0 times the odds of the groups with the lowest joint levels (AOR 5.23; 95% CI: 3.53-7.77). We hypothesize that serum TEQ(DF-1998) and abdominal obesity affect the association with insulin resistance in general populations.	[Chang, Jung-Wei; Su, Huey-Jen; Lee, Ching-Chang] Natl Cheng Kung Univ, Res Ctr Environm Trace Tox Subst, Tainan 701, Taiwan; [Chen, Hsiu-Ling] Hung Kuang Univ, Dept Ind Safety & Hlth, Taichung, Taiwan; [Su, Huey-Jen; Lee, Ching-Chang] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan	National Cheng Kung University; Hungkuang University; National Cheng Kung University	Lee, CC (corresponding author), Natl Cheng Kung Univ, Res Ctr Environm Trace Tox Subst, Tainan 701, Taiwan.	cclee@mail.ncku.edu.tw			Department of Health, Tainan City government	Department of Health, Tainan City government	This study was supported by grants from the Department of Health, Tainan City government.	Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Ascaso Juan F, 2003, Eur J Intern Med, V14, P101, DOI 10.1016/S0953-6205(03)00022-0; Bastard JP, 2007, DIABETES METAB, V33, P261, DOI 10.1016/j.diabet.2007.02.004; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Branchi I, 2002, NEUROTOXICOLOGY, V23, P375, DOI 10.1016/S0161-813X(02)00078-5; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chang JW, 2010, CHEMOSPHERE, V81, P1027, DOI 10.1016/j.chemosphere.2010.08.050; Chang JW, 2013, EPIDEMIOLOGY, V24, P582, DOI 10.1097/EDE.0b013e318294ef68; Chang JW, 2010, EPIDEMIOLOGY, V21, P56, DOI 10.1097/EDE.0b013e3181c2fc6e; Daniel M, 1999, AM J CLIN NUTR, V69, P455; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DESPRES JP, 1993, NUTRITION, V9, P452; Dhooge W, 2010, ENVIRON INT, V36, P330, DOI 10.1016/j.envint.2010.01.005; Emoto M, 1999, DIABETES CARE, V22, P818, DOI 10.2337/diacare.22.5.818; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Greene ME, 2000, PROSTAG OTH LIPID M, V62, P45, DOI 10.1016/S0090-6980(00)00075-7; Groop L, 2000, BRIT J NUTR, V83, pS39; Hennig B, 2005, ENVIRON HEALTH PERSP, V113, P83, DOI 10.1289/ehp.7280; Ho SC, 2001, INT J OBESITY, V25, P1689, DOI 10.1038/sj.ijo.0801784; Hue O, 2007, CHEMOSPHERE, V67, P1463, DOI 10.1016/j.chemosphere.2006.10.033; Hutley L, 2005, AM J MED SCI, V330, P280, DOI 10.1097/00000441-200512000-00005; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim MJ, 2012, ENVIRON HEALTH PERSP, V120, P508, DOI 10.1289/ehp.1104282; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; KOHLI KK, 1979, CHEM-BIOL INTERACT, V25, P139, DOI 10.1016/0009-2797(79)90042-5; Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI [10.1016/j.numecd.2006.10.005, 10.1038/ki.2008.517]; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2012, ENVIRON INT, V40, P170, DOI 10.1016/j.envint.2011.07.010; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nathan DM, 2001, ENDOCRINOL METAB, P827; Naville D, 2013, FASEB J, V27, P3860, DOI 10.1096/fj.13-231670; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Remillard RBJ, 2002, ENVIRON HEALTH PERSP, V110, P853, DOI 10.1289/ehp.02110853; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Snehalatha C, 2000, DIABETIC MED, V17, P152, DOI 10.1046/j.1464-5491.2000.00239.x; STAHL BU, 1993, TOXICOLOGY, V79, P81, DOI 10.1016/0300-483X(93)90207-9; Stolar M, 2007, CLEV CLIN J MED, V74, P199, DOI 10.3949/ccjm.74.3.199; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Valsamakis G, 2004, DIABETIC MED, V21, P1339, DOI 10.1111/j.1464-5491.2004.01361.x; Yeckel CW, 2004, J CLIN ENDOCR METAB, V89, P1096, DOI 10.1210/jc.2003-031503	43	25	25	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145818	10.1371/journal.pone.0145818	http://dx.doi.org/10.1371/journal.pone.0145818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752053	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100026
J	Ejarque, M; Mir-Coll, J; Gomis, R; German, MS; Lynn, FC; Gasa, R				Ejarque, Miriam; Mir-Coll, Joan; Gomis, Ramon; German, Michael S.; Lynn, Francis C.; Gasa, Rosa			Generation of a Conditional Allele of the Transcription Factor Atonal Homolog 8 (Atoh8)	PLOS ONE			English	Article							CELL-DIFFERENTIATION; PANCREAS PROGENITORS; BETA-CELLS; MOUSE; GENE; EXPRESSION; MATH6; REGENERATION; NEUROGENIN3; REGULATOR	Atonal Homolog 8 (Atoh8) is a basic helix-loop-helix (bHLH) transcription factor that is highly conserved across species and expressed in multiple tissues during embryogenesis. In the developing pancreas, Atoh8 is expressed in endocrine progenitors but declines in hormone- positive cells, suggesting a role during early stages of the endocrine differentiation program. We previously generated a whole-body Atoh8 knockout but early lethality of null embryos precluded assessment of Atoh8 functions during organ development. Here we report the generation of a conditional Atoh8 knockout mouse strain by insertion of two loxP sites flanking exon 1 of the Atoh8 gene. Pancreas-specific Atoh8 knockout (Atoh8 Delta(panc)) mice were obtained by mating this strain with a Pdx1-Cre transgenic line. Atoh8 Delta(panc) mice were born at the expected mendelian ratio and showed normal appearance and fertility. Pancreas weight and gross pancreatic morphology were normal. All pancreatic cell lineages were present, although endocrine delta (somatostatin) cells were modestly augmented in Atoh8 Delta(panc) as compared to control neonates. This increase did not affect whole-body glucose tolerance in adult knockout animals. Gene expression analysis in embryonic pancreases at the time of the major endocrine differentiation wave revealed modest alterations in several early endocrine differentiation markers. Together, these data argue that Atoh8 modulates activation of the endocrine program but it is not essential for pancreas formation or endocrine differentiation in the mouse. Given the ubiquitous expression pattern of Atoh8, the availability of a mouse strain carrying a conditional allele for this gene warrants further studies using temporally regulated Cre transgenic lines to elucidate time or cell-autonomous functions of Atoh8 during development and in the adult.	[Ejarque, Miriam; Mir-Coll, Joan; Gomis, Ramon; Gasa, Rosa] IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain; [Ejarque, Miriam; Gomis, Ramon; Gasa, Rosa] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Ejarque, Miriam; Mir-Coll, Joan; Gomis, Ramon] Univ Barcelona, Barcelona, Spain; [German, Michael S.] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA USA; [Lynn, Francis C.] Child & Family Res Inst, Diabet Res Program, Vancouver, BC, Canada; [Lynn, Francis C.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; University of California System; University of California San Francisco; Child & Family Research Institute; University of British Columbia	Gasa, R (corresponding author), IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain.	rgasa@clinic.ub.es	Ejarque, Miriam/H-1503-2015	Ejarque, Miriam/0000-0003-0545-9817; Mir, Joan/0000-0003-0677-5977; Lynn, Francis/0000-0001-9318-1063	Spanish Ministerio de Ciencia e Innovacion [BFU2008-02299/BMC]; Ministerio de Economia y Competitividad/Instituto de Salud Carlos III [PI13/01500]; Generalitat de Catalunya [2014 SGR659]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad/Instituto de Salud Carlos III(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work has been supported by the Spanish Ministerio de Ciencia e Innovacion (BFU2008-02299/BMC to RGa), Ministerio de Economia y Competitividad/Instituto de Salud Carlos III (PI13/01500 to RGa) and Generalitat de Catalunya (2014 SGR659 to RGo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan-Renuka A, 2014, HISTOCHEM CELL BIOL, V141, P289, DOI 10.1007/s00418-013-1155-0; Braun M, 2014, VITAM HORM, V95, P165, DOI 10.1016/B978-0-12-800174-5.00007-7; Ejarque M, 2013, BBA-GENE REGUL MECH, V1829, P1175, DOI 10.1016/j.bbagrm.2013.08.003; Fang F, 2014, J CELL SCI, V127, P1428, DOI 10.1242/jcs.136358; Gasa R, 2008, DIFFERENTIATION, V76, P381, DOI 10.1111/j.1432-0436.2007.00228.x; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guttsches AK, 2015, HISTOCHEM CELL BIOL, V143, P443, DOI 10.1007/s00418-014-1299-6; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kordowich S, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-52; Kubo F, 2010, DEV DYNAM, V239, P2492, DOI 10.1002/dvdy.22381; Landsman L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001143; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lynn FC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002430; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Mastracci TL, 2011, DEV BIOL, V359, P1, DOI 10.1016/j.ydbio.2011.08.001; Pan FC, 2015, DEVELOPMENT, V142, P3637, DOI 10.1242/dev.126011; Pardo FN, 2012, DIABETOLOGIA, V55, P3331, DOI 10.1007/s00125-012-2696-9; Rawnsley DR, 2013, J BIOL CHEM, V288, P24429, DOI 10.1074/jbc.M113.463083; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Rukstalis JM, 2009, ISLETS, V1, P177, DOI 10.4161/isl.1.3.9877; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Serafimidis I, 2008, STEM CELLS, V26, P3, DOI 10.1634/stemcells.2007-0194; Song YY, 2015, GASTROENTEROLOGY, V149, P1068, DOI 10.1053/j.gastro.2015.06.010; TEITELMAN G, 1993, DEVELOPMENT, V118, P1031; Yao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010945; Zhang J, 2014, GENE DEV, V28, P829, DOI 10.1101/gad.235499.113	29	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146273	10.1371/journal.pone.0146273	http://dx.doi.org/10.1371/journal.pone.0146273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752640	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100059
J	Jegou, M; Gondret, F; Vincent, A; Trefeu, C; Gilbert, H; Louveau, I				Jegou, Maeva; Gondret, Florence; Vincent, Annie; Trefeu, Christine; Gilbert, Helene; Louveau, Isabelle			Whole Blood Transcriptomics Is Relevant to Identify Molecular Changes in Response to Genetic Selection for Feed Efficiency and Nutritional Status in the Pig	PLOS ONE			English	Article							MONONUCLEAR-CELLS; DIVERGENT SELECTION; LIPID-METABOLISM; GROWING PIGS; EXPRESSION; ENERGY; IDENTIFICATION; PATHWAYS; DIET	The molecular mechanisms underlying feed efficiency need to be better understood to improve animal efficiency, a research priority to support a competitive and sustainable livestock production. This study was undertaken to determine whether pig blood transcriptome was affected by differences in feed efficiency and by ingested nutrients. Growing pigs from two lines divergently selected for residual feed intake (RFI) and fed isoproteic and isocaloric diets contrasted in energy source and nutrients were considered. Between 74 and 132 days of age, pigs (n = 12 by diet and by line) received a regular diet rich in cereals and low in fat (LF) or a diet where cereals where partially substituted by lipids and fibers (HF). At the end of the feeding trial, the total number of white blood cells was not affected by the line or by the diet, whereas the red blood cell number was higher (P < 0.001) in low RFI than in high RFI pigs. Analysis of the whole blood transcriptome using a porcine microarray reveals a higher number of probes differentially expressed (DE) between RFI lines than between diets (2,154 versus 92 probes DE, P < 0.01). This corresponds to 528 overexpressed genes and 477 underexpressed genes in low RFI pigs compared with high RFI pigs, respectively. Overexpressed genes were predominantly associated with translational elongation. Underexpressed genes were mainly involved in the immune response, regulation of inflammatory response, anti-apoptosis process, and cell organization. These findings suggest that selection for RFI has affected the immune status and defense mechanisms of pigs. Genes DE between diets were mainly related to the immune system and lipid metabolism. Altogether, this study demonstrates the usefulness of the blood transcriptome to identify the main biological processes affected by genetic selection and feeding strategies.	[Jegou, Maeva; Gondret, Florence; Vincent, Annie; Trefeu, Christine; Louveau, Isabelle] INRA, Pegase UMR1348, St Gilles, France; [Jegou, Maeva; Gondret, Florence; Vincent, Annie; Trefeu, Christine; Louveau, Isabelle] Agrocampus Ouest, Pegase UMR1348, Rennes, France; [Gilbert, Helene] INRA, GenPhySE UMR1388, F-31326 Castanet Tolosan, France; [Gilbert, Helene] Univ Toulouse, INP, ENSAT, GenPhySE UMR1388, Castanet Tolosan, France; [Gilbert, Helene] Univ Toulouse, INP, ENVT, GenPhySE UMR1388, Toulouse, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Louveau, I (corresponding author), INRA, Pegase UMR1348, St Gilles, France.	isabelle.louveau@rennes.inra.fr		Gilbert, Helene/0000-0002-4385-3228; Gondret, Florence/0000-0001-7997-1560	INRA (France); Region Bretagne (France); French National Research Agency (Agence Nationale de la Recherche ANR) [ANR-11-BSV7-0004 FatInteger]	INRA (France); Region Bretagne (France)(Region Bretagne); French National Research Agency (Agence Nationale de la Recherche ANR)(French National Research Agency (ANR))	Maeva Jegou is supported by a PhD grant from INRA and Region Bretagne (France). This study was funded by the French National Research Agency (Agence Nationale de la Recherche ANR, ANR-11-BSV7-0004 FatInteger).	Animal Task Force, 2013, RES INN SUST LIV SEC; Arkfeld EK, 2015, J ANIM SCI, V93, P2530, DOI 10.2527/jas.2014-8546; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Caimari A, 2010, INT J OBESITY, V34, P831, DOI 10.1038/ijo.2010.17; Catalan V, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0460-8; Cruzen SM, 2013, J ANIM SCI, V91, P4007, DOI 10.2527/jas.2013-6413; Deans KJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-280; Demirci Hakan, 2013, J Ophthalmic Vis Res, V8, P303; Diaz-Rua R, 2015, J NUTR BIOCHEM, V26, P398, DOI 10.1016/j.jnutbio.2014.11.013; Dunkelberger JR, 2015, LIVEST SCI, V177, P132, DOI 10.1016/j.livsci.2015.04.014; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faure J, 2013, MEAT SCI, V93, P37, DOI 10.1016/j.meatsci.2012.07.006; Fu WJ, 2010, J NUTR BIOCHEM, V21, P561, DOI 10.1016/j.jnutbio.2009.11.007; Ghosh S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-56; Gilbert H, 2007, J ANIM SCI, V85, P3182, DOI 10.2527/jas.2006-590; Gondret F, 2014, J ANIM SCI, V92, P4865, DOI 10.2527/jas.2014-7995; Grubbs JK, 2014, J ANIM SCI, V92, P1995, DOI 10.2527/jas.2013-7391; Guo H, 2013, ENDOCRINOLOGY, V154, P3525, DOI 10.1210/en.2013-1289; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jegou M, 2016, EUR J NUTR, V55, P1189, DOI 10.1007/s00394-015-0932-z; Konieczna J, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0366-2; Labussiere E, 2015, ANIMAL, V9, P1653, DOI 10.1017/S1751731115000932; Le Naou T, 2012, J ANIM SCI, V90, P4771, DOI 10.2527/jas.2012-5226; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Mach N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-894; Mani V, 2013, J ANIM SCI, V91, P2141, DOI 10.2527/jas.2012-6053; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Montagne L, 2014, J ANIM SCI, V92, P1512, DOI 10.2527/jas.2013-6623; Mpetile Z, 2015, J ANIM SCI, V93, P892, DOI 10.2527/jas.2014-8132; Niemann H, 2011, J ANIM SCI, V89, P4344, DOI 10.2527/jas.2011-4235; Oliver P, 2013, PFLUG ARCH EUR J PHY, V465, P459, DOI 10.1007/s00424-013-1246-8; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prunier A, 2010, ANIMAL, V4, P886, DOI 10.1017/S175173111000008X; R Core Team, 2018, R LANG ENV STAT COMP; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; Sanchez J, 2012, J CLIN ENDOCR METAB, V97, pE648, DOI 10.1210/jc.2011-2209; Takahashi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037581; Telle-Hansen VH, 2013, GENES NUTR, V8, P425, DOI 10.1007/s12263-012-0329-z; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vincent A, 2015, J ANIM SCI, V93, P2745, DOI 10.2527/jas.2015-8928; Wu GY, 2014, DIABETES-METAB RES, V30, P447, DOI 10.1002/dmrr.2493	45	26	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146550	10.1371/journal.pone.0146550	http://dx.doi.org/10.1371/journal.pone.0146550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752050	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100096
J	Lai, A; Bozzi, G; Franzetti, M; Binda, F; Simonetti, FR; De Luca, A; Micheli, V; Meraviglia, P; Bagnarelli, P; Di Biagio, A; Monno, L; Saladini, F; Zazzi, M; Zehender, G; Ciccozzi, M; Balotta, C				Lai, Alessia; Bozzi, Giorgio; Franzetti, Marco; Binda, Francesca; Simonetti, Francesco R.; De Luca, Andrea; Micheli, Valeria; Meraviglia, Paola; Bagnarelli, Patrizia; Di Biagio, Antonio; Monno, Laura; Saladini, Francesco; Zazzi, Maurizio; Zehender, Gianguglielmo; Ciccozzi, Massimo; Balotta, Claudia			HIV-1 A1 Subtype Epidemic in Italy Originated from Africa and Eastern Europe and Shows a High Frequency of Transmission Chains Involving Intravenous Drug Users	PLOS ONE			English	Article							FORMER SOVIET-UNION; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; ST-PETERSBURG; WEST-AFRICA; TYPE-1; RECOMBINANT; INFECTIONS; RUSSIA; PREDOMINANCE	Background Subtype A accounts for only 12% of HIV-1 infections worldwide but predominates in Russia and Former Soviet Union countries of Eastern Europe. After an early propagation via heterosexual contacts, this variant spread explosively among intravenous drug users. A distinct A1 variant predominates in Greece and Albania, which penetrated directly from Africa. Clade A1 accounts for 12.5% of non-B subtypes in Italy, being the most frequent after F1 subtype. Aim Aim of this study was to investigate the circulation of A1 subtype in Italy and trace its origin and diffusion through phylogenetic and phylodynamic approaches. Results The phylogenetic analysis of 113 A1 pol sequences included in the Italian ARCA database, indicated that 71 patients (62.8%) clustered within 5 clades. A higher probability to be detected in clusters was found for patients from Eastern Europe and Italy (88.9% and 60.4%, respectively) compared to those from Africa (20%) (p < .001). Higher proportions of clustering sequences were found in intravenous drug users with respect to heterosexuals (85.7% vs. 59.3%, p = .056) and in women with respect to men (81.4% vs. 53.2%, p < .006). Subtype A1 dated phylogeny indicated an East African origin around 1961. Phylogeographical reconstruction highlighted 3 significant groups. One involved East European and some Italian variants, the second encompassed some Italian and African strains, the latter included the majority of viruses carried by African and Italian subjects and all viral sequences from Albania and Greece. Conclusions Subtype A1 originated in Central Africa and spread among East European countries in 1982. It entered Italy through three introduction events: directly from East Africa, from Albania and Greece, and from the area encompassing Moldavia and Ukraine. As in previously documented A1 epidemics of East European countries, HIV-1 A1 subtype spread in Italy in part through intravenous drug users. However, Eastern European women contributed to the penetration of such variant, probably through sex work.	[Lai, Alessia; Bozzi, Giorgio; Franzetti, Marco; Binda, Francesca; Simonetti, Francesco R.; Zehender, Gianguglielmo; Balotta, Claudia] Univ Milan, Dept Biomed & Clin Sci L Sacco, Infect Dis & Immunopathol Sect, L Sacco Hosp, Milan, Italy; [De Luca, Andrea] Siena Univ Hosp, Div Infect Dis, Siena, Italy; [Micheli, Valeria] L Sacco Hosp Vialba, Microbiol Lab, Milan, Italy; [Meraviglia, Paola] L Sacco Hosp Vialba, Div Infect Dis 2, Milan, Italy; [Bagnarelli, Patrizia] Univ Politecn Marche, Microbiol Sect, Virol Lab, Dept Biomed Sci, Ancona, Italy; [Di Biagio, Antonio] San Martino Hosp, Infect Dis Clin, Genoa, Italy; [Monno, Laura] Univ Bari, Div Infect Dis, Bari, Italy; [Saladini, Francesco; Zazzi, Maurizio] Univ Siena, Dept Med Biotechnol, I-53100 Siena, Italy; [Ciccozzi, Massimo] Italian Inst Hlth, Epidemiol Unit, Dept Infect Parasite & Immune Mediated Dis, Rome, Italy	University of Milan; Luigi Sacco Hospital; University of Siena; University Hospital of Siena; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; Marche Polytechnic University; University of Genoa; IRCCS AOU San Martino IST; Universita degli Studi di Bari Aldo Moro; University of Siena	Lai, A (corresponding author), Univ Milan, Dept Biomed & Clin Sci L Sacco, Infect Dis & Immunopathol Sect, L Sacco Hosp, Milan, Italy.	alessia.lai@unimi.it	Saladini, Francesco/D-5837-2015; De Luca, Andrea/G-8810-2011; Zazzi, Maurizio/K-3422-2018; Micheli, Valeria/G-4927-2018; Di Biagio, Antonio/J-4901-2019; Ciccozzi, Massimo/AAC-3271-2022; CICCOZZI, MASSIMO/C-6484-2016; LAI, ALESSIA/AAR-1300-2021; Bagnarelli, Patrizia/AAL-2750-2020; Balotta, Claudia/L-7295-2017	Saladini, Francesco/0000-0002-9934-377X; De Luca, Andrea/0000-0002-9561-9193; Zazzi, Maurizio/0000-0002-0344-6281; Micheli, Valeria/0000-0001-5629-3875; Di Biagio, Antonio/0000-0003-1436-5089; Ciccozzi, Massimo/0000-0003-3866-9239; CICCOZZI, MASSIMO/0000-0003-3866-9239; LAI, ALESSIA/0000-0002-3174-5721; Bagnarelli, Patrizia/0000-0001-5231-9660; Simonetti, Francesco Roberto/0000-0002-4165-660X; MONNO, Laura/0000-0002-2713-4258; meraviglia, paola/0000-0002-3356-7199; Balotta, Claudia/0000-0002-1107-9119				Andersson S, 1999, VIROLOGY, V262, P312, DOI 10.1006/viro.1999.9867; Antoniadou ZA, 2014, AIDS RES HUM RETROV, V30, P225, DOI [10.1089/AID.2013.0166, 10.1089/aid.2013.0166]; Ciccozzi M, 2005, J INFECT DIS, V192, P475, DOI 10.1086/431599; Dehne KL, 2000, AIDS, V14, pS75; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Galkin AN, 2012, AIDS RES HUM RETROV, V28, P939, DOI [10.1089/aid.2011.0302, 10.1089/AID.2011.0302]; Gao F, 2001, AIDS RES HUM RETROV, V17, P675, DOI 10.1089/088922201750236951; Grossman Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135061; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Laga V, 2015, CURR HIV RES, V13, P219, DOI 10.2174/1570162X13666150407142834; Lai A, 2010, HIV MED, V11, P593, DOI 10.1111/j.1468-1293.2010.00832.x; Lai A, 2014, J MED VIROL, V86, P729, DOI 10.1002/jmv.23891; Lai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042223; Liitsola K, 1998, AIDS, V12, P1907, DOI 10.1097/00002030-199814000-00023; Lukashov VV, 1999, AIDS RES HUM RETROV, V15, P1577, DOI 10.1089/088922299309874; Meloni ST, 2004, J VIROL, V78, P12438, DOI 10.1128/JVI.78.22.12438-12445.2004; Nabatov AA, 2002, AIDS RES HUM RETROV, V18, P891, DOI 10.1089/08892220260190380; Njai HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081848; Nyamache AK, 2013, AIDS RES HUM RETROV, V29, P400, DOI [10.1089/AID.2012.0213, 10.1089/aid.2012.0213]; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pandrea I, 2001, AIDS RES HUM RETROV, V17, P1297, DOI 10.1089/088922201750461375; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Phuphuakrat A, 2012, AIDS RES HUM RETROV, V28, P937, DOI [10.1089/aid.2011.0139, 10.1089/AID.2011.0139]; Salemi M, 2008, AIDS RES HUM RETROV, V24, P771, DOI 10.1089/aid.2007.0181; SLATKIN M, 1989, GENETICS, V123, P603; Smolskaya T, 2006, AIDS RES HUM RETROV, V22, P1074, DOI 10.1089/aid.2006.22.1074; Thomson MM, 2007, AIDS RES HUM RETROV, V23, P1599, DOI 10.1089/aid.2007.0166; Thomson MM, 2009, JAIDS-J ACQ IMM DEF, V51, P332, DOI 10.1097/QAI.0b013e31819c1757; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000	29	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146097	10.1371/journal.pone.0146097	http://dx.doi.org/10.1371/journal.pone.0146097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752062	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100040
J	Li, WT; Xiong, BL; Wang, SW; Deng, XP; Yin, LN; Li, HB				Li, Wenting; Xiong, Binglin; Wang, Shiwen; Deng, Xiping; Yin, Lina; Li, Hongbing			Regulation Effects of Water and Nitrogen on the Source-Sink Relationship in Potato during the Tuber Bulking Stage	PLOS ONE			English	Article							WHEAT TRITICUM-AESTIVUM; NET PHOTOSYNTHETIC RATE; GRAIN-YIELD; DRY-MATTER; N-FERTILIZATION; USE EFFICIENCY; FOOD SECURITY; MEDITERRANEAN ENVIRONMENT; CHLOROPHYLL FLUORESCENCE; GENETIC-IMPROVEMENT	The source-sink relationship determines crop yield, and it is largely regulated by water and nutrients in agricultural production. This has been widely investigated in cereals, but fewer studies have been conducted in root and tuber crops such as potato (Solanum tuberosum L.). The objective of this study was to investigate the source-sink relationship in potato and the regulation of water and nitrogen on the source-sink relationship during the tuber bulking stage. A pot experiment using virus-free plantlets of the Atlantic potato cultivar was conducted, using three water levels (50%, 70% and 90% of field capacity) and three nitrogen levels (0, 0.2, 0.4 g N.kg(-1) soil). The results showed that, under all water and nitrogen levels, plant source capacity were small at the end of the experiment, since photosynthetic activity in leaves were low and non-structural reserves in underground stems were completely remobilized. While at this time, there were very big differences in maximum and minimum tuber number and tuber weight, indicating that the sink tuber still had a large potential capacity to take in assimilates. These results suggest that the source-supplied assimilates were not sufficient enough to meet the demands of sink growth. Thus, we concluded that, unlike cereals, potato yield is more likely to be source-limited than sink-limited during the tuber bulking stage. Water and nitrogen are two key factors in potato production management. Our results showed that water level, nitrogen level and the interaction between water and nitrogen influence potato yield mainly through affecting source capacity via the net photosynthetic rate, total leaf area and leaf life span. Well-watered, sufficient nitrogen and well-watered combined with sufficient nitrogen increased yield mainly by enhancing the source capacity. Therefore, this suggests that increasing source capacity is more crucial to improve potato yield.	[Li, Wenting; Xiong, Binglin; Wang, Shiwen; Deng, Xiping; Yin, Lina; Li, Hongbing] Northwest A&F Univ, Stata Key Lab Soil Eros & Dryland Farming Loess P, Inst Soil & Water Conservat, Chinese Acad Sci, Yangling, Shaanxi, Peoples R China; [Li, Wenting; Xiong, Binglin; Wang, Shiwen; Deng, Xiping; Yin, Lina; Li, Hongbing] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, SW (corresponding author), Northwest A&F Univ, Stata Key Lab Soil Eros & Dryland Farming Loess P, Inst Soil & Water Conservat, Chinese Acad Sci, Yangling, Shaanxi, Peoples R China.	shiwenwang@nwsuaf.edu.cn	Wang, Shiwen/AAA-9751-2019; Yin, Lina/AAA-9723-2019	Wang, Shiwen/0000-0003-3195-5531; deng, xi ping/0000-0003-4577-9217	National Natural Science Foundation of China [31101597]; National Key Technology Support Program of China [2015BAD22B01]; Ministry of Science and Technology of the People's Republic of China; West Light Foundation of the Chinese Academy of Sciences; Youth Innovation Promotion Association of CAS, Chinese Academy of Sciences [2013307]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program of China(National Key Technology R&D Program); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of CAS, Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China, (31101597, http://www.nsfc.gov.cn/), National Natural Science Foundation of China to SWW, National Key Technology Support Program of China (2015BAD22B01, http://program.most.gov.cn), Ministry of Science and Technology of the People's Republic of China to SWW, and the West Light Foundation of the Chinese Academy of Sciences and Youth Innovation Promotion Association of CAS (2013307, http://www.cas.cn/), Chinese Academy of Sciences to SWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrizio R, 2010, FIELD CROP RES, V115, P179, DOI 10.1016/j.fcr.2009.11.003; Asseng S, 2003, PLANT SOIL, V256, P217, DOI 10.1023/A:1026231904221; Basu PS, 1998, PHOTOSYNTHETICA, V35, P13, DOI 10.1023/A:1006801311105; Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Belanger G, 2000, AM J POTATO RES, V77, P11, DOI 10.1007/BF02853657; Belanger G, 2001, AM J POTATO RES, V78, P109, DOI 10.1007/BF02874766; BENBI DK, 1993, FERT RES, V36, P63, DOI 10.1007/BF00749949; BENBI DK, 1990, J AGR SCI, V115, P7, DOI 10.1017/S0021859600073846; Bingham IJ, 2007, FIELD CROP RES, V101, P198, DOI 10.1016/j.fcr.2006.11.005; Birch PRJ, 2012, FOOD SECUR, V4, P477, DOI 10.1007/s12571-012-0220-1; Blankenau K, 2002, J AGRON CROP SCI, V188, P146, DOI 10.1046/j.1439-037X.2002.00548.x; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; Braun DM, 2014, J EXP BOT, V65, P1713, DOI 10.1093/jxb/ert416; CALDERINI DF, 1995, PLANT BREEDING, V114, P108, DOI 10.1111/j.1439-0523.1995.tb00772.x; CLEGG K. M., 1956, Journal of the Science of Food and Agriculture, V7, P40, DOI 10.1002/jsfa.2740070108; Costa L. dalla, 1997, Potato Research, V40, P19, DOI 10.1007/BF02407559; Craigon J, 2002, EUR J AGRON, V17, P273, DOI 10.1016/S1161-0301(02)00066-7; Deblonde PMK, 2001, EUR J AGRON, V14, P31, DOI 10.1016/S1161-0301(00)00081-2; Ehdaie B, 2008, FIELD CROP RES, V106, P34, DOI 10.1016/j.fcr.2007.10.012; ENGELS C, 1987, POTATO RES, V30, P177, DOI 10.1007/BF02357661; Errebhi M, 1999, AM J POTATO RES, V76, P143, DOI 10.1007/BF02853579; EVANS JR, 1983, PLANT PHYSIOL, V72, P297, DOI 10.1104/pp.72.2.297; Fabeiro C, 2001, AGR WATER MANAGE, V48, P255, DOI 10.1016/S0378-3774(00)00129-3; Fangmeier A, 2002, EUR J AGRON, V17, P353, DOI 10.1016/S1161-0301(02)00071-0; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Ferreira TC, 2007, AGR WATER MANAGE, V90, P45, DOI 10.1016/j.agwat.2007.02.012; Fischer RA, 2007, J AGR SCI-CAMBRIDGE, V145, P99, DOI 10.1017/S0021859607006843; Gheysari M, 2009, AGR WATER MANAGE, V96, P809, DOI 10.1016/j.agwat.2008.11.003; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goffart JP, 2008, POTATO RES, V51, P355, DOI 10.1007/s11540-008-9118-x; Gonzalez-Dugo V, 2010, AGRON SUSTAIN DEV, V30, P529, DOI 10.1051/agro/2009059; HAHN SK, 1982, EUPHYTICA, V31, P13, DOI 10.1007/BF00028301; Hogy P, 2009, EUR J AGRON, V30, P78, DOI 10.1016/j.eja.2008.07.007; Hopkins BG, 2008, CROP MANAGEMENT, V7; Ierna A, 2006, AGR WATER MANAGE, V82, P193, DOI 10.1016/j.agwat.2005.05.005; Ierna A, 2012, AGR WATER MANAGE, V115, P276, DOI 10.1016/j.agwat.2012.09.011; Ierna A, 2011, AGR WATER MANAGE, V101, P35, DOI 10.1016/j.agwat.2011.08.024; JAMIESON PD, 1995, NEW ZEAL J CROP HORT, V23, P55, DOI 10.1080/01140671.1995.9513868; JEFFERIES RA, 1993, ANN APPL BIOL, V122, P105, DOI 10.1111/j.1744-7348.1993.tb04018.x; KLEINKOPF GE, 1981, AGRON J, V73, P799; Li ZK, 1998, MOL BREEDING, V4, P419, DOI 10.1023/A:1009608128785; Liu FL, 2004, FIELD CROP RES, V86, P1, DOI 10.1016/S0378-4290(03)00165-5; Liu P, 2014, J EXP BOT, V65, P4747, DOI 10.1093/jxb/eru220; LYNCH DR, 1989, CROP SCI, V29, P1207, DOI 10.2135/cropsci1989.0011183X002900050024x; Madani A, 2010, ACTA SCI-AGRON, V32, P145, DOI 10.4025/actasciagron.v32i1.6273; Mauromicale G, 2006, PHOTOSYNTHETICA, V44, P76, DOI 10.1007/s11099-005-0161-4; Meyer RD, 1998, AGRON J, V90, P420, DOI 10.2134/agronj1998.00021962009000030017x; NELSON DW, 1973, AGRON J, V65, P109, DOI 10.2134/agronj1973.00021962006500010033x; Plaut Z, 2004, FIELD CROP RES, V86, P185, DOI 10.1016/j.fcr.2003.08.005; Prasad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117891; RADIN JW, 1982, PLANT PHYSIOL, V69, P771, DOI 10.1104/pp.69.4.771; Reynolds MP, 2005, ANN APPL BIOL, V146, P39, DOI 10.1111/j.1744-7348.2005.03100.x; Roitsch T, 1999, CURR OPIN PLANT BIOL, V2, P198, DOI 10.1016/S1369-5266(99)80036-3; Ruuska SA, 2006, FUNCT PLANT BIOL, V33, P799, DOI 10.1071/FP06062; SCHNYDER H, 1993, NEW PHYTOL, V123, P233, DOI 10.1111/j.1469-8137.1993.tb03731.x; Serrago RA, 2013, FIELD CROP RES, V150, P42, DOI 10.1016/j.fcr.2013.05.016; Shao HB, 2009, CRIT REV BIOTECHNOL, V29, P131, DOI 10.1080/07388550902869792; SINGH G, 1969, AM POTATO J, V46, P398, DOI 10.1007/BF02869560; SLAFER GA, 1991, EUPHYTICA, V58, P37, DOI 10.1007/BF00035338; Sun L, 2012, POTATO RES, V55, P303, DOI 10.1007/s11540-012-9220-y; Sweetlove LJ, 2000, PLANT CELL ENVIRON, V23, P523, DOI 10.1046/j.1365-3040.2000.00567.x; TANGUILIG VC, 1987, PLANT SOIL, V103, P155, DOI 10.1007/BF02370385; VANLOON CD, 1981, AM POTATO J, V58, P51, DOI 10.1007/BF02855380; Venkateswarlu B., 1987, INT RICE RES I, V125, P1; VOS J, 1992, ANN BOT-LONDON, V70, P27, DOI 10.1093/oxfordjournals.aob.a088435; Waddell JT, 1999, AGRON J, V91, P991, DOI 10.2134/agronj1999.916991x; Wang Z, 1997, BIOL PLANTARUM, V39, P379, DOI 10.1023/A:1001076125525; Warraich E. A., 2002, International Journal of Agriculture and Biology, V4, P300; Westermann DT, 2005, AM J POTATO RES, V82, P301, DOI 10.1007/BF02871960; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yao YL, 2000, SOIL SCI PLANT NUTR, V46, P825, DOI 10.1080/00380768.2000.10409148; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Zhang HP, 2010, CROP PASTURE SCI, V61, P852, DOI 10.1071/CP10161; Zheng X, 2009, PLANT PROD SCI, V12, P449, DOI 10.1626/pps.12.449	74	25	28	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146877	10.1371/journal.pone.0146877	http://dx.doi.org/10.1371/journal.pone.0146877			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752657	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100171
J	Mallela, SK; Almeida, R; Ejsing, CS; Conzelmann, A				Mallela, Shamroop K.; Almeida, Reinaldo; Ejsing, Christer S.; Conzelmann, Andreas			Functions of Ceramide Synthase Paralogs YPR114w and YJR116w of Saccharomyces cerevisiae	PLOS ONE			English	Article							ORBITRAP MASS-SPECTROMETRY; ALKALINE CERAMIDASE; OXIDATIVE STRESS; YEAST LONGEVITY; SPHINGOLIPIDS; APOPTOSIS; COPPER; GENE; MUTANTS; LAG1P	Ceramide is synthesized in yeast by two redundant acyl-CoA dependent synthases, Lag1 and Lac1. In lag1 Delta lac1 Delta cells, free fatty acids and sphingoid bases are elevated, and ceramides are produced through the redundant alkaline ceramidases Ypc1 and Ydc1, working backwards. Even with all four of these genes deleted, cells are surviving and continue to contain small amounts of complex sphingolipids. Here we show that these residual sphingolipids are not synthesized by YPR114w or YJR116w, proteins of unknown function showing a high degree of homology to Lag1 and Lac1. Indeed, the hextuple lag1 Delta lac1 Delta ypc1 Delta ydc1 Delta ypr114w Delta yjr116w Delta mutant still contains ceramides and complex sphingolipids. Yjr116w Delta exhibit an oxygen-dependent hypersensitivity to Cu2+ due to an increased mitochondrial production of reactive oxygen species (ROS) and a mitochondrially orchestrated programmed cell death in presence of copper, but also a general copper hypersensitivity that cannot be counteracted by the antioxidant N-acetyl-cysteine (NAC). Myriocin efficiently represses the synthesis of sphingoid bases of ypr114w Delta, but not its growth. Both yjr116w Delta and ypr114w Delta have fragmented vacuoles and produce less ROS than wild type, before and after diauxic shift. Ypr114w Delta/ypr114w Delta have an increased chronological life span. Thus, Yjr116w and Ypr114w are related, but not functionally redundant.	[Mallela, Shamroop K.; Conzelmann, Andreas] Univ Fribourg, Dept Biol, Div Biochem, CH-1700 Fribourg, Switzerland; [Almeida, Reinaldo; Ejsing, Christer S.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Fribourg; University of Southern Denmark	Conzelmann, A (corresponding author), Univ Fribourg, Dept Biol, Div Biochem, Chemin Musee 10, CH-1700 Fribourg, Switzerland.	andreas.conzelmann@unifr.ch	Mallela, Shamroop kumar/W-6982-2019; Ejsing, Christer S/R-5922-2016	Mallela, Shamroop kumar/0000-0002-4553-8504; Ejsing, Christer S./0000-0003-4963-0276	Swiss National Science Foundation [CRSI33_125232, 31003AB_131078]; Novartis Foundation; Lundbeckfonden [R44-A4342]; Danish Council for Independent Research/Natural Sciences [09-072484]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); Lundbeckfonden(Lundbeckfonden); Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by grants CRSI33_125232 and 31003AB_131078 from the Swiss National Science Foundation and a Grant from the Novartis Foundation to A.C., grants from the Lundbeckfonden (R44-A4342) and the Danish Council for Independent Research/Natural Sciences (09-072484) to C.S.E..	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P1933, DOI 10.1007/s00018-008-8129-8; Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Beeler TJ, 1997, MOL GEN GENET, V255, P570, DOI 10.1007/s004380050530; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Carcel-Trullols J, 2015, BIOCH BIOPHYS ACTA; Cerantola V, 2009, MOL MICROBIOL, V71, P1523, DOI 10.1111/j.1365-2958.2009.06628.x; Chung JH, 2003, J BIOL CHEM, V278, P28872, DOI 10.1074/jbc.M300943200; CULOTTA VC, 1994, J BIOL CHEM, V269, P25295; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Dickson RC, 2010, ADV EXP MED BIOL, V688, P217; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ejsing CS, 2006, J MASS SPECTROM, V41, P372, DOI 10.1002/jms.997; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Farrugia G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00064; Finnigan GC, 2011, GENETICS, V187, P771, DOI 10.1534/genetics.110.125567; Guerriero CJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1562, DOI 10.1152/ajpcell.00426.2006; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Huang XH, 2013, AGING CELL, V12, P652, DOI 10.1111/acel.12090; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Jiang JC, 2004, EXP GERONTOL, V39, P999, DOI 10.1016/j.exger.2004.03.026; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lemar KM, 2007, YEAST, V24, P695, DOI 10.1002/yea.1503; Liang QL, 2007, MOL BIOL CELL, V18, P4741, DOI 10.1091/mbc.E07-05-0431; Luttgeharm KD, 2015, ANAL BIOCHEM, V478, P96, DOI 10.1016/j.ab.2015.02.016; Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876; Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200; Niles BJ, 2014, CELL REP, V6, P541, DOI 10.1016/j.celrep.2013.12.040; Quaranta D, 2011, APPL ENVIRON MICROB, V77, P416, DOI 10.1128/AEM.01704-10; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rego A, 2014, FEMS YEAST RES, V14, P160, DOI 10.1111/1567-1364.12096; Rego A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048571; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Sokol E, 2013, ANAL BIOCHEM, V443, P88, DOI 10.1016/j.ab.2013.08.020; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Vionnet C, 2011, J BIOL CHEM, V286, P6769, DOI 10.1074/jbc.M110.176875; Voynova NS, 2014, FEMS YEAST RES, V14, P776, DOI 10.1111/1567-1364.12169; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0	45	1	1	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145831	10.1371/journal.pone.0145831	http://dx.doi.org/10.1371/journal.pone.0145831			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752183	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100027
J	Nishimura, T; Kaminuma, O; Saeki, M; Kitamura, N; Matsuoka, K; Yonekawa, H; Mori, A; Hiroi, T				Nishimura, Tomoe; Kaminuma, Osamu; Saeki, Mayumi; Kitamura, Noriko; Matsuoka, Kunie; Yonekawa, Hiromichi; Mori, Akio; Hiroi, Takachika			Essential Contribution of CD4(+) T Cells to Antigen-Induced Nasal Hyperresponsiveness in Experimental Allergic Rhinitis	PLOS ONE			English	Article							GRASS-POLLEN IMMUNOTHERAPY; MESSENGER-RNA EXPRESSION; TRANSGENIC RICE SEED; DOMAIN-CONTAINING 10; AIRWAY HYPERRESPONSIVENESS; SUBSTANCE-P; BRONCHIAL HYPERRESPONSIVENESS; EOSINOPHILIC INFLAMMATION; NONALLERGIC RHINITIS; GROWTH-FACTOR	Nasal hyperresponsiveness (NHR) is a characteristic feature of allergic rhinitis (AR); however, the pathogenesis of NHR is not fully understood. In this study, during the establishment of an experimental AR model using ovalbumin-immunized and -challenged mice, augmentation of the sneezing reaction in response to nonspecific proteins as well as a chemical stimulant was detected. Whether NHR is independent of mast cells and eosinophils was determined by using mast cell-and eosinophil-deficient mice. NHR was suppressed by treatment with anti-CD4 antibody, suggesting the pivotal contribution of CD4(+) T cells. Furthermore, antigen challenge to mice to which in vitro-differentiated Th1, Th2, and Th17 cells but not naive CD4(+) T cells had been adoptively transferred led to the development of equivalent NHR. Since antigen-specific IgE and IgG were not produced in these mice and since antigen-specific IgE-transgenic mice did not develop NHR even upon antigen challenge, humoral immunity would be dispensable for NHR. CD4+ T cells play a crucial role in the pathogenesis of AR via induction of NHR, independent of IgE-, mast cell-, and eosinophil-mediated responses.	[Nishimura, Tomoe; Kaminuma, Osamu; Saeki, Mayumi; Kitamura, Noriko; Hiroi, Takachika] Tokyo Metropolitan Inst Med Sci, Allergy & Immunol Project, Setagaya Ku, Tokyo 113, Japan; [Matsuoka, Kunie] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Setagaya Ku, Tokyo 113, Japan; [Yonekawa, Hiromichi] Tokyo Metropolitan Inst Med Sci, Basic Res Ctr, Setagaya Ku, Tokyo 113, Japan; [Mori, Akio] Sagamihara Natl Hosp, Natl Hosp Org, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science	Kaminuma, O (corresponding author), Tokyo Metropolitan Inst Med Sci, Allergy & Immunol Project, Setagaya Ku, Tokyo 113, Japan.	kaminuma-os@igakuken.or.jp			Japan Society for the Promotion of Science [15K07787]; Astellas Foundation for Research on Metabolic Disorders [1090]; Towa Foundation for Food Science and Research; Kieikai Research Foundation; Hoyu Science Foundation [22]; Smoking Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; Towa Foundation for Food Science and Research; Kieikai Research Foundation(Kieikai Research Foundation); Hoyu Science Foundation; Smoking Research Foundation	This work was supported by a 'Grant-in-Aid for Scientific Research' from Japan Society for the Promotion of Science (KAKENHI, Grant Number 15K07787), the Astellas Foundation for Research on Metabolic Disorders (No. 1090), the Towa Foundation for Food Science and Research, the Kieikai Research Foundation, the Hoyu Science Foundation (No. 22), and the Smoking Research Foundation to OK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniuk J N, 2001, Curr Allergy Asthma Rep, V1, P207, DOI 10.1007/s11882-001-0007-5; BAROODY FM, 1992, J ALLERGY CLIN IMMUN, V90, P373, DOI 10.1016/S0091-6749(05)80017-X; Blum A, 2008, INFECT IMMUN, V76, P3651, DOI 10.1128/IAI.00358-08; Bouley J, 2015, J ALLERGY CLIN IMMUN, V136, P1055, DOI 10.1016/j.jaci.2015.03.001; BRADDING P, 1995, AM J RESP CRIT CARE, V151, P1900, DOI 10.1164/ajrccm.151.6.7767538; Cameron L, 2000, J ALLERGY CLIN IMMUN, V106, P46; Cantalupo L, 2008, NEUROSCI LETT, V434, P191, DOI 10.1016/j.neulet.2008.01.053; Di Lorenzo G, 2009, INT J IMMUNOPATH PH, V22, P1077, DOI 10.1177/039463200902200424; Durham SR, 1996, J ALLERGY CLIN IMMUN, V97, P1356, DOI 10.1016/S0091-6749(96)70205-1; DURHAM SR, 1995, INT ARCH ALLERGY IMM, V107, P282, DOI 10.1159/000237003; Garcia G, 2013, EUR RESPIR REV, V22, P251, DOI 10.1183/09059180.00004013; Gelfand EW, 1998, ALLERGY ASTHMA PROC, V19, P365, DOI 10.2500/108854198778612744; Ghaffar O, 1997, AM J RESP CELL MOL, V17, P17, DOI 10.1165/ajrcmb.17.1.2696; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; HUGHES JM, 1993, CLIN EXP ALLERGY, V23, P251, DOI 10.1111/j.1365-2222.1993.tb00318.x; Kaminuma O, 2012, CLIN EXP ALLERGY, V42, P315, DOI 10.1111/j.1365-2222.2011.03847.x; Kanthawatana S, 1997, ASIAN PAC J ALLERGY, V15, P65; Karasuyama H, 2011, ALLERGY, V66, P1133, DOI 10.1111/j.1398-9995.2011.02613.x; Kato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103540; Katoh S, 2011, EUR J IMMUNOL, V41, P3198, DOI 10.1002/eji.201141521; Kay AB, 2005, TRENDS MOL MED, V11, P148, DOI 10.1016/j.molmed.2005.02.002; Koga H, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-8; KONNO A, 1981, ARCH OTO-RHINO-LARYN, V232, P253, DOI 10.1007/BF00457450; Kraneveld AD, 1997, INT J IMMUNOPHARMACO, V19, P517, DOI 10.1016/S0192-0561(97)00085-4; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; Long R, 2015, INFLAMM RES, V64, P213, DOI 10.1007/s00011-015-0800-6; Masuyama K, 1998, J ALLERGY CLIN IMMUN, V102, P610, DOI 10.1016/S0091-6749(98)70277-5; MASUYAMA K, 1994, IMMUNOLOGY, V82, P192; Mori A, 2007, INT IMMUNOL, V19, P913, DOI 10.1093/intimm/dxm049; Motoi Y, 2012, IMMUNOL LETT, V147, P80, DOI 10.1016/j.imlet.2012.07.001; Nabe T, 2009, CLIN EXP ALLERGY, V39, P138, DOI 10.1111/j.1365-2222.2008.03097.x; Nishimura T, 2014, ALLERGOL INT, V63, P29, DOI 10.2332/allergolint.13-OA-0635; Nishimura T, 2013, INT ARCH ALLERGY IMM, V161, P125, DOI 10.1159/000350565; Nouri-Aria KT, 2000, CLIN EXP ALLERGY, V30, P1709, DOI 10.1046/j.1365-2222.2000.00998.x; Ogawa K, 2002, CLIN EXP ALLERGY, V32, P140, DOI 10.1046/j.0022-0477.2001.01248.x; Ohtomo T, 2010, INT ARCH ALLERGY IMM, V152, P79, DOI 10.1159/000312130; Parikh SA, 2003, CURR ALLERGY ASTHM R, V3, P266, DOI 10.1007/s11882-003-0049-y; Ponikau JU, 2003, J ALLERGY CLIN IMMUN, V112, P877, DOI 10.1016/j.jaci.2003.08.009; Saeki M, 2014, ALLERGOL INT, V63, P59, DOI 10.2332/allergolint.13-LE-0634; Saito H, 2001, IMMUNOLOGY, V104, P226, DOI 10.1046/j.1365-2567.2001.01253.x; Sanico AM, 1999, INT ARCH ALLERGY IMM, V118, P154, DOI 10.1159/000024054; Shin JH, 2012, AM J RHINOL ALLERGY, V26, pE71, DOI 10.2500/ajra.2012.26.3743; Sin Betul, 2011, Proc Am Thorac Soc, V8, P106, DOI 10.1513/pats.201008-057RN; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Sugahara S, 2003, EUR J PHARMACOL, V476, P229, DOI 10.1016/S0014-2999(03)02185-X; Suzuki K, 2011, PLANT BIOTECHNOL J, V9, P982, DOI 10.1111/j.1467-7652.2011.00613.x; TVeld CD, 1996, CLIN EXP ALLERGY, V26, P903, DOI 10.1046/j.1365-2222.1996.d01-395.x; VANWIJK RG, 1987, CLIN ALLERGY, V17, P563; VARNEY VA, 1993, J CLIN INVEST, V92, P644, DOI 10.1172/JCI116633; Wakasa Y, 2013, PLANT BIOTECHNOL J, V11, P66, DOI 10.1111/pbi.12007; WALDEN SM, 1991, AM REV RESPIR DIS, V144, P642, DOI 10.1164/ajrccm/144.3_Pt_1.642; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Zhang QL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-61	53	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146686	10.1371/journal.pone.0146686	http://dx.doi.org/10.1371/journal.pone.0146686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752722	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100130
J	Panpradist, N; Beck, IA; Chung, MH; Kiarie, JN; Frenkel, LM; Lutz, BR				Panpradist, Nuttada; Beck, Ingrid A.; Chung, Michael H.; Kiarie, James N.; Frenkel, Lisa M.; Lutz, Barry R.			Simplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide Ligation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIROLOGICAL FAILURE; ASSAY; MUTATIONS; EFAVIRENZ; ADULTS; EMTRICITABINE; OPTIMIZATION; COMBINATION; DIDANOSINE	Human immunodeficiency virus (HIV) is a chronic infection that can be managed by antiretroviral treatment (ART). However, periods of suboptimal viral suppression during lifelong ART can select for HIV drug resistant (DR) variants. Transmission of drug resistant virus can lessen or abrogate ART efficacy. Therefore, testing of individuals for drug resistance prior to initiation of treatment is recommended to ensure effective ART. Sensitive and inexpensive HIV genotyping methods are needed in low-resource settings where most HIV infections occur. The oligonucleotide ligation assay (OLA) is a sensitive point mutation assay for detection of drug resistance mutations in HIV pol. The current OLA involves four main steps from sample to analysis: (1) lysis and/or nucleic acid extraction, (2) amplification of HIV RNA or DNA, (3) ligation of oligonucleotide probes designed to detect single nucleotide mutations that confer HIV drug resistance, and (4) analysis via oligonucleotide surface capture, denaturation, and detection (CDD). The relative complexity of these steps has limited its adoption in resource-limited laboratories. Here we describe a simplification of the 2.5-hour plate-format CDD to a 45-minute paper-format CDD that eliminates the need for a plate reader. Analysis of mutations at four HIV-1 DR codons (K103N, Y181C, M184V, and G190A) in 26 blood specimens showed a strong correlation of the ratios of mutant signal to total signal between the paper CDD and the plate CDD. The assay described makes the OLA easier to perform in low resource laboratories.	[Panpradist, Nuttada; Lutz, Barry R.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Beck, Ingrid A.] Seattle Childrens Res Inst, Seattle, WA USA; [Chung, Michael H.] Univ Washington, Dept Internal Med, Seattle, WA 98195 USA; [Chung, Michael H.; Frenkel, Lisa M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Kiarie, James N.] Univ Nairobi, Dept Obstet, Nairobi, Kenya; [Kiarie, James N.] Univ Nairobi, Dept Gynecol, Nairobi, Kenya; [Frenkel, Lisa M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Frenkel, Lisa M.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; University of Nairobi; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lutz, BR (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	blutz@u.washington.edu	Panpradist, Nuttada/AAZ-2189-2021; Panpradist, Nuttada/AAX-4821-2021	Lutz, Barry/0000-0003-4298-4901; Panpradist, Nuttada/0000-0002-2733-4110; kiarie, james/0000-0003-4180-7858	Coulter Translational Research Partnership and Global Women Adolescents and Children [75-5307 BRL, LMF 6/12-9/13]; Seattle Children's Research Institute Bridge Fund [24040015, LMF 11/13-4/14]; National Institute of Health/National Institute of Allergy and Infectious Diseases [R01-AI058723 LMF 5/14-4/19 (03/05-02/12), 1R01AI110375-01 LMF 5/14-4/19]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058723, R01AI110375] Funding Source: NIH RePORTER	Coulter Translational Research Partnership and Global Women Adolescents and Children; Seattle Children's Research Institute Bridge Fund; National Institute of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by: a joint grant from Coulter Translational Research Partnership and Global Women Adolescents and Children (75-5307 BRL & LMF 6/12-9/13), http://depts.washington.edu/gwach/; Seattle Children's Research Institute Bridge Fund (24040015, LMF 11/13-4/14), http://www.seattlechildrens.org/research/child-health-behavior-and-development/bridge-funding/; and National Institute of Health/National Institute of Allergy and Infectious Diseases (R01-AI058723 LMF 5/14-4/19 (03/05-02/12) and 1R01AI110375-01 LMF 5/14-4/19), http://www.nih.gov/, http://www.niaid.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altikatoglu M, 2011, PROTEIN J, V30, P84, DOI 10.1007/s10930-011-9306-4; Awano H, 1996, BER BUNSEN PHYS CHEM, V100, P1700, DOI 10.1002/bbpc.19961001006; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Beck IA, 2008, JAIDS-J ACQ IMM DEF, V48, P418, DOI 10.1097/QAI.0b013e31817ed7d7; Beck IA, 2014, J CLIN MICROBIOL, V52, P2320, DOI 10.1128/JCM.00306-14; Beek IA, 2002, J CLIN MICROBIOL, V40, P1413, DOI 10.1128/JCM.40.4.1413-1419.2002; Borroto-Esoda K, 2007, AIDS RES HUM RETROV, V23, P988, DOI 10.1089/aid.2006.0310; Chung MH, 2014, JAIDS-J ACQ IMM DEF, V67, P246, DOI 10.1097/QAI.0000000000000312; Dharmaraja S, 2013, PROC SPIE, V8615, DOI 10.1117/12.2006138; Edelstein RE, 1998, J CLIN MICROBIOL, V36, P569, DOI 10.1128/JCM.36.2.569-572.1998; Ellis GM, 2004, J CLIN MICROBIOL, V42, P3670, DOI [10.1128/JCM.42.8.3670-3674.2004, 10.1128/jcm.42.8.3670-3674.2004]; Fridley GE, 2013, MRS BULL, V38, P326, DOI 10.1557/mrs.2013.60; Fridley GE, 2012, LAB CHIP, V12, P4321, DOI 10.1039/c2lc40785j; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; HERZOG V, 1973, ANAL BIOCHEM, V55, P554, DOI 10.1016/0003-2697(73)90144-9; Josephygg PD, 1982, HORSERADISH PEROXIDA, P257; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Jourdain G, 2010, CLIN INFECT DIS, V50, P1397, DOI 10.1086/652148; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lutz B, 2013, LAB CHIP, V13, P2840, DOI 10.1039/c3lc50178g; Lutz BR, 2011, LAB CHIP, V11, P4274, DOI 10.1039/c1lc20758j; MONTOYA A, 1987, J IMMUNOL METHODS, V99, P13, DOI 10.1016/0022-1759(87)90026-3; Mutsvangwa J, 2014, J VIROL METHODS, V210, P36, DOI 10.1016/j.jviromet.2014.09.005; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Ramachandran S, 2012, 16 INT C MIN SYST CH; Ramachandran S, 2014, ANALYST, V139, P1456, DOI 10.1039/c3an02296j; Thompson MA, 2014, ANTIRETROVIRAL TREAT, P308; Toley BJ, 2013, ANAL CHEM, V85, P11545, DOI 10.1021/ac4030939; Toley BJ, 2012, 16 INT C MIN SYST CH, P305; UNAIDS, 2012, HIV AIDS FACT SHEET; Wagner TA, 2010, J CLIN MICROBIOL, V48, P1555, DOI 10.1128/JCM.02062-09; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307	37	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145962	10.1371/journal.pone.0145962	http://dx.doi.org/10.1371/journal.pone.0145962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751207	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100034
J	Field, S; Thompson, B				Field, Sterling; Thompson, Beth			Analysis of the Maize dicer-like1 Mutant, fuzzy tassel, Implicates MicroRNAs in Anther Maturation and Dehiscence	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILE; GENIC MALE-STERILITY; GAMYB-LIKE GENES; POLLEN DEVELOPMENT; ARABIDOPSIS-THALIANA; FLOWER DEVELOPMENT; PLANT MICRORNAS; ABIOTIC STRESS; WATER-DEFICIT; SMALL RNAS	Sexual reproduction in plants requires development of haploid gametophytes from somatic tissues. Pollen is the male gametophyte and develops within the stamen; defects in the somatic tissues of the stamen and in the male gametophyte itself can result in male sterility. The maize fuzzy tassel (fzt) mutant has a mutation in dicer-like1 (dcl1), which encodes a key enzyme required for microRNA (miRNA) biogenesis. Many miRNAs are reduced in fzt, and fzt mutants exhibit a broad range of developmental defects, including male sterility. To gain further insight into the roles of miRNAs in maize stamen development, we conducted a detailed analysis of the male sterility defects in fzt mutants. Early development was normal in fzt mutant anthers, however fzt anthers arrested in late stages of anther maturation and did not dehisce. A minority of locules in fzt anthers also exhibited anther wall defects. At maturity, very little pollen in fzt anthers was viable or able to germinate. Normal pollen is tricellular at maturity; pollen from fzt anthers included a mixture of unicellular, bicellular, and tricellular pollen. Pollen from normal anthers is loaded with starch before dehiscence, however pollen from fzt anthers failed to accumulate starch. Our results indicate an absolute requirement for miRNAs in the final stages of anther and pollen maturation in maize. Anther wall defects also suggest that miRNAs have key roles earlier in anther development. We discuss candidate miRNAs and pathways that might underlie fzt anther defects, and also note that male sterility in fzt resembles water deficit-induced male sterility, highlighting a possible link between development and stress responses in plants.	[Field, Sterling; Thompson, Beth] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Thompson, B (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	thompsonb@ecu.edu		Field, Sterling/0000-0001-6320-7648	National Science Foundation [IOS-1148971]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant IOS-1148971 to BT. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Arikit S, 2013, CURR OPIN PLANT BIOL, V16, P170, DOI 10.1016/j.pbi.2013.01.006; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BEDINGER P, 1992, PLANT CELL, V4, P879, DOI 10.1105/tpc.4.8.879; CHANG MT, 1989, GENOME, V32, P232, DOI 10.1139/g89-434; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938; Datta R, 2002, PLANT PHYSIOL, V130, P1645, DOI 10.1104/pp.006908; Datta R, 2001, SEX PLANT REPROD, V14, P127, DOI 10.1007/s00497-001-0105-5; DAWE RK, 1990, DEV BIOL, V142, P233, DOI 10.1016/0012-1606(90)90167-H; DAWE RK, 1992, DEVELOPMENT, V116, P1077; Dolferus R, 2011, PLANT SCI, V181, P331, DOI 10.1016/j.plantsci.2011.05.015; Duvick D. N., 1965, ADV GENET, V13, P51; Ferdous J, 2015, PLANT BIOTECHNOL J, V13, P293, DOI 10.1111/pbi.12318; HORNER HT, 1995, CROP SCI, V35, P1527, DOI 10.2135/cropsci1995.0011183X003500060002x; HSU SY, 1988, MAYDICA, V33, P77; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jin Y, 2013, MOL PLANT, V6, P1630, DOI 10.1093/mp/sst067; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kawanabe T, 2006, PLANT CELL PHYSIOL, V47, P784, DOI 10.1093/pcp/pcj039; Kelliher T, 2014, FRONT PLANT SCI, V5; Kelliher T, 2011, DEV BIOL, V350, P32, DOI 10.1016/j.ydbio.2010.11.005; LAUGHNAN JR, 1983, ANNU REV GENET, V17, P27, DOI 10.1146/annurev.ge.17.120183.000331; Lian H, 2013, J EXP BOT, V64, P3397, DOI 10.1093/jxb/ert178; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu L, 2013, PLANT MOL BIOL, V83, P165, DOI 10.1007/s11103-013-0085-5; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Nag A, 2010, CURR TOP DEV BIOL, V91, P349, DOI 10.1016/S0070-2153(10)91012-0; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Nogueira FTS, 2007, GENE DEV, V21, P750, DOI 10.1101/gad.1528607; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Peterson P, 1981, IOWA STATE J RES; Peterson R., 2010, International Journal of Plant Biology, V1, P66; PFAHLER PL, 1981, ENVIRON HEALTH PERSP, V37, P125, DOI 10.2307/3429260; REGAN SM, 1990, PLANT CELL, V2, P877, DOI 10.1105/tpc.2.9.877; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; SAINI HS, 1981, ANN BOT-LONDON, V48, P623, DOI 10.1093/oxfordjournals.aob.a086170; SAINI HS, 1984, AUST J PLANT PHYSIOL, V11, P243, DOI 10.1071/PP9840243; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Shi YL, 2009, J INTEGR PLANT BIOL, V51, P774, DOI 10.1111/j.1744-7909.2009.00849.x; Skibbe DS, 2005, MAYDICA, V50, P367; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Thompson BE, 2014, PLANT CELL, V26, P4702, DOI 10.1105/tpc.114.132670; Timofejeva L, 2013, G3-GENES GENOM GENET, V3, P231, DOI 10.1534/g3.112.004465; Vizcay-Barrena G, 2006, J EXP BOT, V57, P2709, DOI 10.1093/jxb/erl032; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Walbot V, 2013, MAIZE HDB; Wang CJR, 2012, DEVELOPMENT, V139, P2594, DOI 10.1242/dev.077891; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048445; Wang YH, 2011, PLANT SIGNAL BEHAV, V6, P494, DOI 10.4161/psb.6.4.14558; WARMKE HE, 1977, J HERED, V68, P213, DOI 10.1093/oxfordjournals.jhered.a108817; Wen LY, 1999, SEX PLANT REPROD, V11, P323, DOI 10.1007/s004970050159; Wilson ZA, 2009, J EXP BOT, V60, P1479, DOI 10.1093/jxb/erp095; Zhai JX, 2015, P NATL ACAD SCI USA, V112, P3146, DOI 10.1073/pnas.1418918112; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	61	11	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146534	10.1371/journal.pone.0146534	http://dx.doi.org/10.1371/journal.pone.0146534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745722	gold, Green Published, Green Submitted			2022-12-27	WOS:000367815600060
J	St John, EP; Simen, BB; Turenchalk, GS; Braverman, MS; Abbate, I; Aerssens, J; Bouchez, O; Gabriel, C; Izopet, J; Meixenberger, K; Di Giallonardo, F; Schlapbach, R; Paredes, R; Sakwa, J; Schmitz-Agheguian, GG; Thielen, A; Victor, M; Metzner, KJ; Daumer, MP				St John, Elizabeth P.; Simen, Birgitte B.; Turenchalk, Gregory S.; Braverman, Michael S.; Abbate, Isabella; Aerssens, Jeroen; Bouchez, Olivier; Gabriel, Christian; Izopet, Jacques; Meixenberger, Karolin; Di Giallonardo, Francesca; Schlapbach, Ralph; Paredes, Roger; Sakwa, James; Schmitz-Agheguian, Gudrun G.; Thielen, Alexander; Victor, Martin; Metzner, Karin J.; Daeumer, Martin P.		454 HIV-1 Alpha Study Grp	A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; MINORITY VARIANTS; MUTATIONS; PROTEASE; POPULATIONS; DIVERSITY; EMERGENCE; ACCURACY; FAILURE	Background Ultra deep sequencing is of increasing use not only in research but also in diagnostics. For implementation of ultra deep sequencing assays in clinical laboratories for routine diagnostics, intra-and inter-laboratory testing are of the utmost importance. Methods A multicenter study was conducted to validate an updated assay design for 454 Life Sciences' GS FLX Titanium system targeting protease/reverse transcriptase (RTP) and env (V3) regions to identify HIV-1 drug-resistance mutations and determine co-receptor use with high sensitivity. The study included 30 HIV-1 subtype B and 6 subtype non-B samples with viral titers (VT) of 3,940-447,400 copies/mL, two dilution series (52,129-1,340 and 25,130-734 copies/mL), and triplicate samples. Amplicons spanning PR codons 10-99, RT codons 1-251 and the entire V3 region were generated using barcoded primers. Analysis was performed using the GS Amplicon Variant Analyzer and geno2pheno for tropism. For comparison, population sequencing was performed using the ViroSeq HIV-1 genotyping system. Results The median sequencing depth across the 11 sites was 1,829 reads per position for RTP (IQR 592-3,488) and 2,410 for V3 (IQR 786-3,695). 10 preselected drug resistant variants were measured across sites and showed high inter-laboratory correlation across all sites with data (P < 0.001). The triplicate samples of a plasmid mixture confirmed the high interlaboratory consistency (mean% +/- stdev: 4.6 +/- 0.5, 4.8 +/- 0.4, 4.9 +/- 0.3) and revealed good intra-laboratory consistency (mean% range +/- stdev range: 4.2-5.2 +/- 0.04-0.65). In the two dilutions series, no variants >20% were missed, variants 2-10% were detected at most sites (even at low VT), and variants 1-2% were detected by some sites. All mutations detected by population sequencing were also detected by UDS. Conclusions This assay design results in an accurate and reproducible approach to analyze HIV-1 mutant spectra, even at variant frequencies well below those routinely detectable by population sequencing.	[St John, Elizabeth P.; Simen, Birgitte B.; Turenchalk, Gregory S.; Braverman, Michael S.] 454 Life Sci, Branford, CT USA; [Abbate, Isabella] Natl Inst Infect Dis L Spallanzani, Rome, Italy; [Aerssens, Jeroen] Janssen Infect Dis Diagnost Bvba, Beerse, Belgium; [Bouchez, Olivier] Lab Genet Cellulaire, Plateforme Genom Toulouse, Toulouse, France; [Gabriel, Christian] Blutzentrale Linz, Linz, Austria; [Izopet, Jacques] Fac Med Toulouse, INSERM, U563, F-31073 Toulouse, France; [Meixenberger, Karolin] Robert Koch Inst, Berlin, Germany; [Di Giallonardo, Francesca; Metzner, Karin J.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Schlapbach, Ralph] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Paredes, Roger] Inst Recerca SIDA IrsiCaixa, Badalona, Spain; [Sakwa, James] Technol Innovat Agcy Natl Genom Platform, Durban, South Africa; [Schmitz-Agheguian, Gudrun G.; Victor, Martin] Roche Appl Sci, Penzberg, Germany; [Thielen, Alexander; Daeumer, Martin P.] Inst Immunol & Genet, Kaiserslautern, Germany; [Metzner, Karin J.] Univ Zurich, Inst Med Virol, Zurich, Switzerland	IRCCS Lazzaro Spallanzani; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Robert Koch Institute; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Institut de Recerca de la Sida - IrsiCaixa; Roche Holding; University of Zurich	Metzner, KJ (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	Karin.Metzner@usz.ch	Schlapbach, Ralph/R-8234-2016; Bruselles, Alessandro/M-6012-2019; Metzner, Karin J/G-5319-2011; Giombini, Emanuela/AAB-6073-2020; Gabriel, Christian/A-1689-2014; Abbate, Isabella/K-6434-2016; Bruselles, Alessandro/M-7908-2017	Bruselles, Alessandro/0000-0002-1556-4998; Metzner, Karin J/0000-0003-4862-1503; Giombini, Emanuela/0000-0003-2237-9755; Gabriel, Christian/0000-0003-2043-9320; Bruselles, Alessandro/0000-0002-1556-4998; Schlapbach, Ralph/0000-0002-7488-4262; Bruggmann, Remy/0000-0001-5629-6363; Di Giallonardo, Francesca/0000-0002-8749-4095; Radonic, Aleksandar/0000-0001-6200-9607; Lengauer, Thomas/0000-0003-3801-2640; Aerssens, Jeroen/0000-0002-9254-4800; Nitsche, Andreas/0000-0001-8185-3176; IZOPET, JACQUES/0000-0002-8462-3234; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Rozera, Gabriella/0000-0002-3590-8268; Van Marck, Herwig/0000-0002-5198-5335; Gordon, Michelle/0000-0001-9945-1394; Simen, Birgitte/0000-0003-0503-0973	454 Life Sciences, a Roche Company; Roche Applied Sciences	454 Life Sciences, a Roche Company; Roche Applied Sciences	This study was financed by 454 Life Sciences, a Roche Company and Roche Applied Sciences. The funder had a main role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; Cozzi-Lepri A, 2015, J ANTIMICROB CHEMOTH, V70, P930, DOI 10.1093/jac/dku426; Di Giallonardo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074249; Dudley DM, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0122-8; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gorzer I, 2010, J VIROL METHODS, V169, P248, DOI 10.1016/j.jviromet.2010.07.040; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MCCULLOCH RK, 1995, PCR METH APPL, V4, P219; Metzner KJ, 2014, AIDS, V28, P2231, DOI 10.1097/QAD.0000000000000397; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Nicot F, 2012, J CLIN VIROL, V55, P107, DOI 10.1016/j.jcv.2012.06.018; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Quinones-Mateu ME, 2014, J CLIN VIROL, V61, P9, DOI 10.1016/j.jcv.2014.06.013; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Simen BB, 2014, J VIROL METHODS, V204, P31, DOI 10.1016/j.jviromet.2014.04.007; Stelzl E, 2011, J VIROL METHODS, V178, P94, DOI 10.1016/j.jviromet.2011.08.020; Stenman J, 2003, BIOTECHNIQUES, V34, P172, DOI 10.2144/03341dd05; Swenson LC, 2012, CURR OPIN HIV AIDS, V7, P478, DOI 10.1097/COH.0b013e328356e9da; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Team RC, 2012, R LANG ENV STAT COMP; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669	34	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146687	10.1371/journal.pone.0146687	http://dx.doi.org/10.1371/journal.pone.0146687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756901	Green Published, Green Accepted, gold			2022-12-27	WOS:000367888800027
J	Waugh, C; Khan, SA; Carver, S; Hanger, J; Loader, J; Polkinghorne, A; Beagley, K; Timms, P				Waugh, Courtney; Khan, Shahneaz Ali; Carver, Scott; Hanger, Jonathan; Loader, Joanne; Polkinghorne, Adam; Beagley, Kenneth; Timms, Peter			A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus)	PLOS ONE			English	Article							GENETIC DIVERSITY; IMMUNITY; POPULATION	Diseases associated with Chlamydia pecorum infection are a major cause of decline in koala populations in Australia. While koalas in care can generally be treated, a vaccine is considered the only option to effectively reduce the threat of infection and disease at the population level. In the current study, we vaccinated 30 free-ranging koalas with a prototype Chlamydia pecorum vaccine consisting of a recombinant chlamydial MOMP adjuvanted with an immune stimulating complex. An additional cohort of 30 animals did not receive any vaccine and acted as comparison controls. Animals accepted into this study were either uninfected (Chlamydia PCR negative) at time of initial vaccination, or infected (C. pecorum positive) at either urogenital (UGT) and/or ocular sites (Oc), but with no clinical signs of chlamydial disease. All koalas were vaccinated /sampled and then re-released into their natural habitat before re-capturing and re-sampling at 6 and 12 months. All vaccinated koalas produced a strong immune response to the vaccine, as indicated by high titres of specific plasma antibodies. The incidence of new infections in vaccinated koalas over the 12-month period post-vaccination was slightly less than koalas in the control group, however, this was not statistically significant. Importantly though, the vaccine was able to significantly reduce the infectious load in animals that were Chlamydia positive at the time of vaccination. This effect was evident at both the Oc and UGT sites and was stronger at 6 months than at 12 months post-vaccination. Finally, the vaccine was also able to reduce the number of animals that progressed to disease during the 12-month period. While the sample sizes were small (statistically speaking), results were nonetheless striking. This study highlights the potential for successful development of a Chlamydia vaccine for koalas in a wild setting.	[Waugh, Courtney; Polkinghorne, Adam; Timms, Peter] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld 4558, Australia; [Khan, Shahneaz Ali; Beagley, Kenneth; Timms, Peter] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Carver, Scott] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Hanger, Jonathan; Loader, Joanne] Endeavour Vet Ecol, Toorbul, Qld 4510, Australia	University of the Sunshine Coast; Queensland University of Technology (QUT); University of Tasmania	Timms, P (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, 90 Sippy Downs Dr, Sippy Downs, Qld 4558, Australia.	ptimms@usc.edu.au	Beagley, Kenneth/J-1129-2012; Carver, Scott/J-7654-2014	Beagley, Kenneth/0000-0003-3112-6557; Carver, Scott/0000-0002-3579-7588; Polkinghorne, Adam/0000-0002-6803-9222; Timms, Peter/0000-0002-1682-0025; Waugh, Courtney/0000-0001-5234-4137; Polkinghorne, Adam/0000-0002-6567-2962	Australian Research Council (ARC) [LP1202000051]; Queensland Government (Department of Transport and Main Roads); Moreton Bay Rail Link project team	Australian Research Council (ARC)(Australian Research Council); Queensland Government (Department of Transport and Main Roads); Moreton Bay Rail Link project team	This work was funded by an Australian Research Council (ARC) Linkage Grant (LP1202000051) awarded to PT, AP, and KB. This project was significantly supported by the Queensland Government (Department of Transport and Main Roads) and specifically the Moreton Bay Rail Link project team.	Carey AJ, 2010, AM J REPROD IMMUNOL, V63, P161, DOI 10.1111/j.1600-0897.2009.00776.x; Craig AP, 2014, VACCINE, V32, P4163, DOI 10.1016/j.vaccine.2014.05.049; Devereaux LN, 2003, SYST APPL MICROBIOL, V26, P245, DOI 10.1078/072320203322346092; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Govendir M, 2012, J VET PHARMACOL THER, V35, P147, DOI 10.1111/j.1365-2885.2011.01307.x; Hernandez-Sanchez J, 2015, VACCINE, V33, P4459, DOI 10.1016/j.vaccine.2015.07.029; Khan SA, 2014, VACCINE, V32, P5781, DOI 10.1016/j.vaccine.2014.08.037; Kollipara A, 2013, VET MICROBIOL, V167, P513, DOI 10.1016/j.vetmic.2013.08.009; Kollipara A, 2013, VACCINE, V31, P1217, DOI 10.1016/j.vaccine.2012.12.057; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Marsh J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-77; Puls RL, 2006, CLIN SCI, V110, P59, DOI 10.1042/CS20050157; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Wan C, 2011, AUST VET J, V89, P409, DOI 10.1111/j.1751-0813.2011.00827.x; Waugh CA, 2015, VACCINE, V33, P855, DOI 10.1016/j.vaccine.2014.12.052	15	28	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146934	10.1371/journal.pone.0146934	http://dx.doi.org/10.1371/journal.pone.0146934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756624	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800036
J	Krogmann, AO; Lusebrink, E; Steinmetz, M; Asdonk, T; Lahrmann, C; Lutjohann, D; Nickenig, G; Zimmer, S				Krogmann, Alexander O.; Luesebrink, Enzo; Steinmetz, Martin; Asdonk, Tobias; Lahrmann, Catharina; Luetjohann, Dieter; Nickenig, Georg; Zimmer, Sebastian			Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNITY; BACTERIAL-DNA; CARDIAC DYSFUNCTION; SYSTEMIC INFLAMMATION; ACTIVATION; OLIGODEOXYNUCLEOTIDE; TLR9; TOLL-LIKE-RECEPTOR-9; CHOLESTEROL	Background Toll-like receptors (TLR) of the innate immune system have been closely linked with the development of atherosclerotic lesions. TLR9 is activated by unmethylated CpG motifs within ssDNA, but also by CpG motifs in nucleic acids released during vascular apoptosis and necrosis. The role of TLR9 in vascular disease remains controversial and we sought to investigate the effects of a proinflammatory TLR9 stimulation in mice. Methods and Findings TLR9-stimulation with high dose CpG ODN at concentrations between 6.25nM to 30nM induced a significant proinflammatory cytokine response in mice. This was associated with impaired reendothelialization upon acute denudation of the carotid and increased numbers of circulating endothelial microparticles, as a marker for amplified endothelial damage. Chronic TLR9 agonism in apolipoprotein E-deficient (ApoE(-/-)) mice fed a cholesterol-rich diet increased aortic production of reactive oxygen species, the number of circulating endothelial microparticles, circulating sca-1/flk-1 positive cells, and most importantly augmented atherosclerotic plaque formation when compared to vehicle treated animals. Importantly, high concentrations of CpG ODN are required for these proatherogenic effects. Conclusions Systemic stimulation of TLR9 with high dose CpG ODN impaired reendothelialization upon acute vascular injury and increased atherosclerotic plaque development in ApoE(-/-) mice. Further studies are necessary to fully decipher the contradictory finding of TLR9 agonism in vascular biology.	[Krogmann, Alexander O.; Luesebrink, Enzo; Steinmetz, Martin; Asdonk, Tobias; Lahrmann, Catharina; Nickenig, Georg; Zimmer, Sebastian] Univ Klinikum Bonn, Med Klin & Poliklin 2, D-53105 Bonn, Germany; [Luetjohann, Dieter] Univ Bonn, Inst Klin Chem & Klin Pharmakol, D-53125 Bonn, Germany	University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn	Krogmann, AO (corresponding author), Univ Klinikum Bonn, Med Klin & Poliklin 2, D-53105 Bonn, Germany.	Alexander.Krogmann@ukb.uni-bonn.de		Steinmetz, Martin/0000-0002-5452-6687	Else-Kroner-Fresenius-Stiftung (Bad Homburg, Germany); medical faculty of the Rheinische Friedrich-Wilhelms University of Bonn (BONFOR) [Q-605.0312]	Else-Kroner-Fresenius-Stiftung (Bad Homburg, Germany); medical faculty of the Rheinische Friedrich-Wilhelms University of Bonn (BONFOR)	This work was funded by the Else-Kroner-Fresenius-Stiftung (Bad Homburg, Germany) and the medical faculty of the Rheinische Friedrich-Wilhelms University of Bonn (BONFOR), http://www.ekfs.de/de/start.html, Grant number for AK: Q-605.0312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baratono SR, 2015, EUR J IMMUNOL, V45, P1313, DOI 10.1002/eji.201445319; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Boehm O., 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/217297; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Calandrini CA, 2014, ORAL DIS, V20, pe128, DOI 10.1111/odi.12205; Cao ZJ, 2013, BBA-MOL BASIS DIS, V1832, P96, DOI 10.1016/j.bbadis.2012.08.008; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Cole JE, 2013, TRENDS PHARMACOL SCI, V34, P629, DOI 10.1016/j.tips.2013.09.008; Darwiche SS, 2013, J TRAUMA ACUTE CARE, V74, P1454, DOI 10.1097/TA.0b013e3182905ed2; Davis HL, 1998, J IMMUNOL, V160, P870; Fitzner N, 2011, INT IMMUNOPHARMACOL, V11, P1789, DOI 10.1016/j.intimp.2011.07.006; Gao M, 2013, J INFECT DIS, V207, P1471, DOI 10.1093/infdis/jit036; Gill R, 2011, SHOCK, V35, P164, DOI 10.1097/SHK.0b013e3181eddcab; Gray RC, 2007, J LEUKOCYTE BIOL, V81, P1075, DOI 10.1189/jlb.1006606; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henke PK, 2011, ARTERIOSCL THROM VAS, V31, P43, DOI 10.1161/ATVBAHA.110.216317; Hirata Y, 2013, ATHEROSCLEROSIS, V231, P227, DOI 10.1016/j.atherosclerosis.2013.09.010; Jackson SW, 2014, J IMMUNOL, V192, P4525, DOI 10.4049/jimmunol.1400098; Karper JC, 2012, ARTERIOSCLER THROMB, P1, DOI [10.1161/ATVBAHA.112.249391/-/DC1, DOI 10.1161/ATVBAHA.112.249391/-/DC1]; Kim SC, 2014, LIFE SCI, V119, P1, DOI 10.1016/j.lfs.2014.09.029; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; Koulis C, 2014, ARTERIOSCLER THROMB, P1, DOI [10.1161/ATVBAHA.113.302407/-/DC1, DOI 10.1161/ATVBAHA.113.302407/-/DC1]; Koulis C, 2014, ARTERIOSCL THROM VAS, V34, P516, DOI 10.1161/ATVBAHA.113.302407; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Lee JG, 2008, CELL SIGNAL, V20, P2266, DOI 10.1016/j.cellsig.2008.08.022; Mathur S, 2011, SHOCK, V36, P478, DOI 10.1097/SHK.0b013e31822d6442; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohm IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104407; Ohm IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104398; Renko J, 2013, EUR J DERMATOL, V23, P53, DOI 10.1684/ejd.2012.1908; Shintani Y, 2014, EMBO REP, V15, P438, DOI 10.1002/embr.201337945; Sorrentino R, 2010, J CELL PHYSIOL, V223, P158, DOI 10.1002/jcp.22022; Sparwasser T, 1999, J IMMUNOL, V162, P2368; Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Utaisincharoen P, 2002, CLIN EXP IMMUNOL, V128, P467, DOI 10.1046/j.1365-2249.2002.01866.x; Velten M, 2012, CARDIOVASC RES, V96, P422, DOI 10.1093/cvr/cvs280; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Vollmer J, 2006, INT REV IMMUNOL, V25, P155, DOI 10.1080/08830180600743107; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Whitmore MM, 2004, CANCER RES, V64, P5850, DOI 10.1158/0008-5472.CAN-04-0063; Zhang X, 2012, SHOCK, V38, P146, DOI 10.1097/SHK.0b013e31825ce0de; Zimmer S, 2015, CIRC RES, V116, P323, DOI 10.1161/CIRCRESAHA.116.301135; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	50	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146326	10.1371/journal.pone.0146326	http://dx.doi.org/10.1371/journal.pone.0146326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751387	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100063
J	Lynch, SM; Peek, MK; Mitra, N; Ravichandran, K; Branas, C; Spangler, E; Zhou, WT; Paskett, ED; Gehlert, S; DeGraffinreid, C; Rebbeck, TR; Riethman, H				Lynch, Shannon M.; Peek, M. K.; Mitra, Nandita; Ravichandran, Krithika; Branas, Charles; Spangler, Elaine; Zhou, Wenting; Paskett, Electra D.; Gehlert, Sarah; DeGraffinreid, Cecilia; Rebbeck, Timothy R.; Riethman, Harold			Race, Ethnicity, Psychosocial Factors, and Telomere Length in a Multicenter Setting	PLOS ONE			English	Article							POPULATION HEALTH; PERCEIVED STRESS; CANCER; ASSOCIATION; DISCRIMINATION; INSTABILITY; VARIANTS; WHITES; STATES; LOCUS	Background Leukocyte telomere length(LTL) has been associated with age, self-reported race/ethnicity, gender, education, and psychosocial factors, including perceived stress, and depression. However, inconsistencies in associations of LTL with disease and other phenotypes exist across studies. Population characteristics, including race/ethnicity, laboratory methods, and statistical approaches in LTL have not been comprehensively studied and could explain inconsistent LTL associations. Methods LTL was measured using Southern Blot in 1510 participants from a multi-ethnic, multi-center study combining data from 3 centers with different population characteristics and laboratory processing methods. Main associations between LTL and psychosocial factors and LTL and race/ethnicity were evaluated and then compared across generalized estimating equations(GEE) and linear regression models. Statistical models were adjusted for factors typically associated with LTL(age, gender, cancer status) and also accounted for factors related to center differences, including laboratory methods(i.e., DNA extraction). Associations between LTL and psychosocial factors were also evaluated within race/ethnicity subgroups (Non-hispanic Whites, African Americans, and Hispanics). Results Beyond adjustment for age, gender, and cancer status, additional adjustments for DNA extraction and clustering by center were needed given their effects on LTL measurements. In adjusted GEE models, longer LTL was associated with African American race (Beta(beta) (standard error(SE)) = 0.09(0.04), p-value = 0.04) and Hispanic ethnicity (beta(SE) = 0.06 (0.01), p-value = 0.02) compared to Non-Hispanic Whites. Longer LTL was also associated with less than a high school education compared to having greater than a high school education (a(SE) = 0.06(0.02), p-value = 0.04). LTL was inversely related to perceived stress (a (SE) = -0.02(0.003), p < 0.001). In subgroup analyses, there was a negative association with LTL in African Americans with a high school education versus those with greater than a high school education(beta(SE) = -0.11(0.03), p-value < 0.001). Conclusions Laboratory methods and population characteristics that differ by center can influence telomere length associations in multicenter settings, but these effects could be addressed through statistical adjustments. Proper evaluation of potential sources of bias can allow for combined multicenter analyses and may resolve some inconsistencies in reporting of LTL associations. Further, biologic effects on LTL may differ under certain psychosocial and racial/ethnic circumstances and could impact future health disparity studies.	[Lynch, Shannon M.; Mitra, Nandita; Branas, Charles; Spangler, Elaine; Zhou, Wenting; Rebbeck, Timothy R.] Univ Penn, Philadelphia, PA 19104 USA; [Lynch, Shannon M.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Peek, M. K.; Riethman, Harold] Univ Texas Med Branch, Galveston, TX 77555 USA; [Ravichandran, Krithika] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Paskett, Electra D.; DeGraffinreid, Cecilia] Ohio State Univ, Columbus, OH 43210 USA; [Gehlert, Sarah] Washington Univ, St Louis, MO USA; [Rebbeck, Timothy R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Rebbeck, Timothy R.] Harvard Univ, Boston, MA 02115 USA; [Riethman, Harold] Old Dominion Univ, Norfolk, VA USA	University of Pennsylvania; Fox Chase Cancer Center; University of Texas System; University of Texas Medical Branch Galveston; The Wistar Institute; University System of Ohio; Ohio State University; Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; Harvard University; Old Dominion University	Lynch, SM (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	shannon.lynch@fccc.edu	Rebbeck, Timothy/GLU-8348-2022	Rebbeck, Timothy/0000-0002-4799-1900	National Institutes of Health [P50-CA105641, P60-NM006900, R01-CA85074, F31-AG039986]; NATIONAL CANCER INSTITUTE [P50CA105641, P30CA010815, R01CA085074, P30CA006927, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG039986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health [P50-CA105641, P60-NM006900 and R01-CA85074; www.cancer.gov] to TRR and F31-AG039986 to SML[www.nia.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bleil ME, 2012, MENOPAUSE, V19, P1176, DOI 10.1097/gme.0b013e31825540d8; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Butt HZ, 2010, EUR J VASC ENDOVASC, V40, P17, DOI 10.1016/j.ejvs.2010.04.012; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cheung ALM, 2008, FRONT BIOSCI-LANDMRK, V13, P2075, DOI 10.2741/2825; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Cohen S., 1994, MIND GARDEN; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Crockett LJ, 2005, J CONSULT CLIN PSYCH, V73, P47, DOI 10.1037/0022-006X.73.1.47; Cunningham JM, 2013, CANCER EPIDEM BIOMAR, V22, P2047, DOI 10.1158/1055-9965.EPI-13-0409; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Eaton W. W., 2004, USE PSYCHOL TESTING, V3, P363, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Elbers CC, 2014, J GERONTOL A-BIOL, V69, P527, DOI 10.1093/gerona/glt121; Engelhardt M, 1997, BLOOD, V90, P182; Epel ES, 2010, BRAIN BEHAV IMMUN, V24, P531, DOI 10.1016/j.bbi.2009.11.018; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Flores E, 2008, HISPANIC J BEHAV SCI, V30, P401, DOI 10.1177/0739986308323056; Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864; Hofmann J, 2014, TELOMERE LENGT UNPUB; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Kimura M, 2010, NAT PROTOC, V5, P1596, DOI 10.1038/nprot.2010.124; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Londono-Vallejo JA, 2008, BIOCHIMIE, V90, P73, DOI 10.1016/j.biochi.2007.07.009; Lynch SM, 2013, INT J CANCER, V133, P2672, DOI 10.1002/ijc.28272; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; MARKIDES KS, 1986, PUBLIC HEALTH REP, V101, P253; Markides KS, 2011, INT HANDB POPUL, V2, P227, DOI 10.1007/978-90-481-9996-9_11; Maubaret CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083122; Munoz P, 2006, CELL CYCLE, V5, P718, DOI 10.4161/cc.5.7.2636; National Research Council (US) Panel on Race E and Health in Later Life, 2004, CRITICAL PERSPECTIVE; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donovan A, 2009, BRAIN BEHAV IMMUN, V23, P446, DOI 10.1016/j.bbi.2008.11.006; O'Donovan A, 2012, BRAIN BEHAV IMMUN; O'Donovan A, 2011, BIOL PSYCHIAT, V70, P465, DOI 10.1016/j.biopsych.2011.01.035; Palloni A, 2004, DEMOGRAPHY, V41, P385, DOI 10.1353/dem.2004.0024; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Paskett ED, 2010, PREV MED, V50, P74, DOI 10.1016/j.ypmed.2009.09.001; Peek MK, 2010, AM J PUBLIC HEALTH, V100, P940, DOI 10.2105/AJPH.2007.129312; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rebbeck TR, 2008, INT J CANCER, V123, P1385, DOI 10.1002/ijc.23687; Rode L, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv074; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Shalev I, 2013, PSYCHONEURO IN PRESS; Shell AM, 2013, SOC SCI MED, V99, P56, DOI 10.1016/j.socscimed.2013.10.006; Starkweather AR, 2014, NURS RES, V63, P36, DOI 10.1097/NNR.0000000000000009; Wang L, 2013, WOMEN HEALTH, V53, P20, DOI 10.1080/03630242.2012.732680; Warnecke RB, 2008, AM J PUBLIC HEALTH, V98, P1608, DOI 10.2105/AJPH.2006.102525; Weischer M, 2013, JNCI-J NATL CANCER I, V105, P459, DOI 10.1093/jnci/djt016; Weng NP, 2001, J LEUKOCYTE BIOL, V70, P861; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837	64	54	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146723	10.1371/journal.pone.0146723	http://dx.doi.org/10.1371/journal.pone.0146723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26752285	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100140
J	Couvy-Duchesne, B; Ebejer, JL; Gillespie, NA; Duffy, DL; Hickie, IB; Thompson, PM; Martin, NG; de Zubicaray, GI; McMahon, KL; Medland, SE; Wright, MJ				Couvy-Duchesne, Baptiste; Ebejer, Jane L.; Gillespie, Nathan A.; Duffy, David L.; Hickie, Ian B.; Thompson, Paul M.; Martin, Nicholas G.; de Zubicaray, Greig I.; McMahon, Katie L.; Medland, Sarah E.; Wright, Margaret J.			Head Motion and Inattention/Hyperactivity Share Common Genetic Influences: Implications for fMRI Studies of ADHD	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY MRI; STIMULUS-CORRELATED MOTION; ATTENTION PROBLEMS; BRAIN ACTIVATION; TWIN; NETWORK; SUBJECT; NOISE	Head motion (HM) is a well known confound in analyses of functional MRI (fMRI) data. Neuroimaging researchers therefore typically treat HM as a nuisance covariate in their analyses. Even so, it is possible that HM shares a common genetic influence with the trait of interest. Here we investigate the extent to which this relationship is due to shared genetic factors, using HM extracted from resting-state fMRI and maternal and self report measures of Inattention and Hyperactivity-Impulsivity from the Strengths and Weaknesses of ADHD Symptoms and Normal Behaviour (SWAN) scales. Our sample consisted of healthy young adult twins (N = 627 (63% females) including 95 MZ and 144 DZ twin pairs, mean age 22, who had mother-reported SWAN; N = 725 (58% females) including 101 MZ and 156 DZ pairs, mean age 25, with self reported SWAN). This design enabled us to distinguish genetic from environmental factors in the association between head movement and ADHD scales. HM was moderately correlated with maternal reports of Inattention (r = 0.17, p-value = 7.4E-5) and Hyperactivity-Impulsivity (r = 0.16, p-value = 2.9E-4), and these associations were mainly due to pleiotropic genetic factors with genetic correlations [95% CIs] of r(g) = 0.24 [0.02, 0.43] and r(g) = 0.23 [0.07, 0.39]. Correlations between self-reports and HM were not significant, due largely to increased measurement error. These results indicate that treating HM as a nuisance covariate in neuroimaging studies of ADHD will likely reduce power to detect between-group effects, as the implicit assumption of independence between HM and Inattention or Hyperactivity-Impulsivity is not warranted. The implications of this finding are problematic for fMRI studies of ADHD, as failing to apply HM correction is known to increase the likelihood of false positives. We discuss two ways to circumvent this problem: censoring the motion contaminated frames of the RS-fMRI scan or explicitly modeling the relationship between HM and Inattention or Hyperactivity-Impulsivity.	[Couvy-Duchesne, Baptiste; Duffy, David L.; Martin, Nicholas G.; Medland, Sarah E.; Wright, Margaret J.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Couvy-Duchesne, Baptiste; de Zubicaray, Greig I.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Couvy-Duchesne, Baptiste; McMahon, Katie L.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Couvy-Duchesne, Baptiste; Wright, Margaret J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Ebejer, Jane L.; Gillespie, Nathan A.] Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Hickie, Ian B.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Thompson, Paul M.] Univ So Calif, Keck Sch Med, Imaging Genet Ctr, Marina Del Rey, CA USA; [de Zubicaray, Greig I.] Queensland Inst Technol, Inst Hlth Biomed Innovat, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Queensland; Virginia Commonwealth University; University of Sydney; University of Southern California; Queensland University of Technology (QUT)	Couvy-Duchesne, B (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	baptiste.couvyduchesne@qimrberghofer.edu.au	Thompson, Paul M/C-4194-2018; McMahon, Katie L/C-6440-2009; Hickie, Ian B/K-8975-2015; Duffy, David L/B-7392-2013; Medland, Sarah/AAT-7595-2020; de Zubicaray, Greig/ABC-8955-2021; Medland, Sarah E/C-7630-2013; de Zubicaray, Greig I/B-1763-2008; Wright, Margaret Jane/A-4560-2016	Thompson, Paul M/0000-0002-4720-8867; McMahon, Katie L/0000-0002-6357-615X; Hickie, Ian B/0000-0001-8832-9895; Duffy, David L/0000-0001-7227-632X; Medland, Sarah/0000-0003-1382-380X; de Zubicaray, Greig/0000-0003-4506-0579; Medland, Sarah E/0000-0003-1382-380X; de Zubicaray, Greig I/0000-0003-4506-0579; Wright, Margaret Jane/0000-0001-7133-4970; Couvy-Duchesne, Baptiste/0000-0002-0719-9302	Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA [RO1HD050735]; National Health and Medical Research Council (NHMRC), Australia [496682]; Australian NHMRC Grant [1009839]; Australian Research Council (ARC) [A7960034, A79906588, A79801419, DP0212016]; Australian Research Council Future Fellowship [110100548]; NHMRC Senior Research Fellowship; ARC Future Fellowship [FT0991634]; University of Queensland (UQI PhD scholarship); NIH [U54 020403]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040060] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowship(Australian Research Council); University of Queensland (UQI PhD scholarship); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The imaging study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA (Grant RO1HD050735), and the National Health and Medical Research Council (NHMRC), Australia (Project Grant 496682). ADHD studies were supported in part by the Australian NHMRC Grant 1009839. Zygosity typing was funded by the Australian Research Council (ARC) (Grants A7960034, A79906588, A79801419, and DP0212016). SM is supported by an Australian Research Council Future Fellowship 110100548. DLD is supported by an NHMRC Senior Research Fellowship. GIdZ is supported by an ARC Future Fellowship (FT0991634). BCD is supported by the University of Queensland (UQI PhD scholarship). PMT is also supported by NIH grant U54 020403. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, NHMRC, or ARC. The authors are very grateful to the twins for their generosity of time and willingness to participate in our studies. The authors thank research nurses Marlene Grace and Ann Eldridge for twin recruitment, Richard Parker for data collection, research assistants Lachlan Strike, Kori Johnson, Aaron Quiggle, and Natalie Garden, and radiographers Matthew Meredith, Peter Hobden, Kate Borg, Aiman Al Najjar, and Anita Burns for data acquisition, David Butler, Daniel Park, David Smyth and Anthony Conciatore for IT support.	Arnett AB, 2013, J ATTEN DISORD, V17, P152, DOI 10.1177/1087054711427399; Ashburner J, 2014, SPM12 MANUAL 2014; Beall EB, 2014, NEUROIMAGE, V101, P21, DOI 10.1016/j.neuroimage.2014.06.038; Bebko G, 2015, PSYCHIAT RES-NEUROIM, V231, P77, DOI 10.1016/j.pscychresns.2014.10.015; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Blokland GAM, 2008, BIOL PSYCHOL, V79, P70, DOI 10.1016/j.biopsycho.2008.03.006; Blokland GAM, 2011, J NEUROSCI, V31, P10882, DOI 10.1523/JNEUROSCI.5334-10.2011; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Bright MG, 2015, NEUROIMAGE, V114, P158, DOI 10.1016/j.neuroimage.2015.03.070; Bright MG, 2014, NEUROIMAGE, V87, P287, DOI 10.1016/j.neuroimage.2013.10.055; Bright MG, 2013, NEUROIMAGE, V64, P526, DOI 10.1016/j.neuroimage.2012.09.043; Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Chang Z, 2013, JAMA PSYCHIAT, V70, P311, DOI 10.1001/jamapsychiatry.2013.287; Chiang MC, 2012, J NEUROSCI, V32, P8732, DOI 10.1523/JNEUROSCI.5993-11.2012; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Couvy-Duchesne B, 2014, NEUROIMAGE, DOI [10.1016/j.neuroimage.2014.08.010, DOI 10.1016/J.NEUR0IMAGE.2014.08.010]; Davis J, 2015, MOL PSYCHIATR, V20, P152, DOI 10.1038/mp.2014.139; de Zubicaray GI, 2008, BRAIN IMAGING BEHAV, V2, P258, DOI 10.1007/s11682-008-9029-0; Dohm MR, 2002, FUNCT ECOL, V16, P273; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; Eaves LJ, 1997, J CHILD PSYCHOL PSYC, V38, P965, DOI 10.1111/j.1469-7610.1997.tb01614.x; Ebejer JL, 2015, BEHAV GENET, V45, P35, DOI 10.1007/s10519-014-9670-x; Epstein JN, 2007, PSYCHIAT RES-NEUROIM, V155, P75, DOI 10.1016/j.pscychresns.2006.12.009; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Evans DM, 2002, BIOL PSYCHOL, V61, P33, DOI 10.1016/S0301-0511(02)00051-0; Friedman-Weieneth JL, 2009, J ATTEN DISORD, V13, P42, DOI 10.1177/1087054708322991; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 2006, STAT PARAMETRIC MAPP; Gershon J, 2002, J Atten Disord, V5, P143, DOI 10.1177/108705470200500302; Gillespie NA, 2013, TWIN RES HUM GENET, V16, P21, DOI 10.1017/thg.2012.111; GOODMAN R, 1989, J CHILD PSYCHOL PSYC, V30, P691, DOI 10.1111/j.1469-7610.1989.tb00782.x; GOODMAN R, 1989, J CHILD PSYCHOL PSYC, V30, P671, DOI 10.1111/j.1469-7610.1989.tb00781.x; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; HAJNAL JV, 1994, MAGNET RESON MED, V31, P283, DOI 10.1002/mrm.1910310307; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Hasson R, 2012, J ATTEN DISORD, V16, P190, DOI 10.1177/1087054711427398; Hay DA, 2007, BIOL PSYCHIAT, V61, P700, DOI 10.1016/j.biopsych.2006.04.040; Hayasaka S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00880; Ilott N, 2010, GENES BRAIN BEHAV, V9, P296, DOI 10.1111/j.1601-183X.2009.00560.x; Jahanshad N, 2013, P NATL ACAD SCI USA, V110, P4768, DOI 10.1073/pnas.1216206110; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 1999, FMRIB ANAL GROUP TEC; Jo HJ, 2013, J APPL MATH, DOI 10.1155/2013/935154; Jones TB, 2010, NEUROIMAGE, V49, P401, DOI 10.1016/j.neuroimage.2009.07.051; Kan KJ, 2013, J AM ACAD CHILD PSY, V52, P12, DOI 10.1016/j.jaac.2012.10.009; Kong XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104989; Larsson H, 2013, PSYCHOL MED, V43, P197, DOI 10.1017/S0033291712001067; Leask SJ, 2013, THER ADV PSYCHOPHARM, V3, P29, DOI 10.1177/2045125312464997; Li F, 2014, RADIOLOGY, V272, P514, DOI 10.1148/radiol.14131622; Lin P, 2014, BRAIN IMAGING BEHAV, V8, P558, DOI 10.1007/s11682-013-9279-3; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; Martin N, 2002, BRIT J PSYCHIAT, V180, P260, DOI 10.1192/bjp.180.3.260; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; Mayer AR, 2007, J INT NEUROPSYCH SOC, V13, P839, DOI 10.1017/S1355617707071081; Medland SE, 2009, NEUROPSYCHOLOGIA, V47, P330, DOI 10.1016/j.neuropsychologia.2008.09.005; Merwood A, 2013, PSYCHOL MED, V43, P1973, DOI 10.1017/S0033291712002978; Mowinckel AM, 2012, NEUROIMAGE, V63, P1364, DOI 10.1016/j.neuroimage.2012.08.004; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Neale MC, 1992, METHODOLOGY GENETIC; Phillips MD, 2008, NEUROLOGY, V70, P248, DOI 10.1212/01.wnl.0000302256.18915.25; Pinto R, 2012, BEHAV GENET, V42, P875, DOI 10.1007/s10519-012-9561-y; Polderman TJC, 2007, J CHILD PSYCHOL PSYC, V48, P1080, DOI 10.1111/j.1469-7610.2007.01783.x; Posner J, 2014, NEUROPSYCHOL REV, V24, P3, DOI 10.1007/s11065-014-9251-z; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramtekkar UP, 2010, J AM ACAD CHILD ADOL, V49; Redcay E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00573; Renteria ME, 2014, GENES BRAIN BEHAV, V13, P821, DOI 10.1111/gbb.12177; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Seto E, 2001, NEUROIMAGE, V14, P284, DOI 10.1006/nimg.2001.0829; Simonoff E, 1998, PSYCHOL MED, V28, P825, DOI 10.1017/S0033291798006886; Sinclair B, UNPUB; Siqueira AD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/380531; Sripada C, 2014, HUM BRAIN MAPP, V35, P4693, DOI 10.1002/hbm.22504; Swanson J, 2014, CATEGORICAL DIMENSIO; Tijssen RHN, 2009, HUM BRAIN MAPP, V30, P2641, DOI 10.1002/hbm.20695; Tong YJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00196; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Verweij Karin J H, 2012, Methods Mol Biol, V850, P151, DOI 10.1007/978-1-61779-555-8_9; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wickham H., 2012, STRINGR MAKE IT EASI; Wickham H., 2014, SCALES SCALE FUNCTIO; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wood AC, 2009, J AM ACAD CHILD PSY, V48, P1023, DOI 10.1097/CHI.0b013e3181b54612; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Wylie GR, 2014, HUM BRAIN MAPP, V35, P1, DOI 10.1002/hbm.22150; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yoo SS, 2005, NEUROSCI RES, V53, P84, DOI 10.1016/j.neures.2005.06.004; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng LL, 2014, P NATL ACAD SCI USA, V111, P6058, DOI 10.1073/pnas.1317424111	101	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146271	10.1371/journal.pone.0146271	http://dx.doi.org/10.1371/journal.pone.0146271			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745144	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600035
J	Grueneberg, J; Engelen, AH; Costa, R; Wichard, T				Grueneberg, Jan; Engelen, Aschwin H.; Costa, Rodrigo; Wichard, Thomas			Macroalgal Morphogenesis Induced by Waterborne Compounds and Bacteria in Coastal Seawater	PLOS ONE			English	Article							ULVA-MUTABILIS CHLOROPHYTA; GAMETE RELEASE; GREEN SEAWEED; RIA-FORMOSA; YELLOW SEA; SP-NOV.; GROWTH; LAGOON; DIFFERENTIATION; COMMUNITY	Axenic gametes of the marine green macroalga Ulva mutabilis Foyn (Ria Formosa, locus typicus) exhibit abnormal development into slow-growing callus-like colonies with aberrant cell walls. Under laboratory conditions, it was previously demonstrated that all defects in growth and thallus development can be completely abolished when axenic gametes are inoculated with a combination of two specific bacterial strains originally identified as Roseo-bacter sp. strain MS2 and Cytophaga sp. strain MS6. These bacteria release diffusible morphogenetic compounds (= morphogens), which act similar to cytokinin and auxin. To investigate the ecological relevance of the waterborne bacterial morphogens, seawater samples were collected in the Ria Formosa lagoon (Algarve, Southern Portugal) at 20 sampling sites and tidal pools to assess their morphogenetic effects on the axenic gametes of U. mutabilis. Specifically the survey revealed that sterile-filtered seawater samples can completely recover growth and morphogenesis of U. mutabilis under axenic conditions. Morphogenetic activities of free-living and epiphytic bacteria isolated from the locally very abundant Ulva species (i.e., U. rigida) were screened using a multiwell-based testing system. The most represented genera isolated from U. rigida were Alteromonas, Pseudoalteromonas and Sulfitobacter followed by Psychrobacter and Polaribacter. Several naturally occurring bacterial species could emulate MS2 activity (= induction of cell divisions) regardless of taxonomic affiliation, whereas the MS6 activity (= induction of cell differentiation and cell wall formation) was species-specific and is probably a feature of difficult-to-culture bacteria. Interestingly, isolated bacteroidetes such as Algoriphagus sp. and Polaribacter sp. could individually trigger complete Ulva morphogenesis and thus provide a novel mode of action for bacterial-induced algal development. This study also highlights that the accumulation of algal growth factors in a shallow water body separated from the open ocean by barrier islands might have strong implications to, for example, the wide usage of natural coastal seawater in algal (land based) aquacultures of Ulva.	[Grueneberg, Jan; Wichard, Thomas] Univ Jena, Jena Sch Microbial Commun, Inst Inorgan & Analyt Chem, Jena, Germany; [Engelen, Aschwin H.; Costa, Rodrigo] Univ Algarve, Ctr Marine Sci, Faro, Portugal	Friedrich Schiller University of Jena; Universidade do Algarve	Wichard, T (corresponding author), Univ Jena, Jena Sch Microbial Commun, Inst Inorgan & Analyt Chem, Jena, Germany.	Thomas.Wichard@uni-jena.de	Wichard, Thomas/C-2794-2009; Wichard, Thomas/L-9861-2019; Engelen, Aschwin H/M-3432-2013; da Silva Costa, Rodrigo/N-7274-2013	Wichard, Thomas/0000-0003-0061-4160; Wichard, Thomas/0000-0003-0061-4160; Engelen, Aschwin H/0000-0002-9579-9606; da Silva Costa, Rodrigo/0000-0002-5932-4101	Deutsche Forschungsgemeinschaft [CRC 1127 ChemBioSys]; Jena School for Microbial Communication; Fundacao para a Ciencia e a Tecnologia [SFRH /BPD /64990 /2009]; European Union [227799-ASSEMBLE]; Friedrich Schiller University Jena, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jena School for Microbial Communication; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union(European Commission); Friedrich Schiller University Jena, Germany	This work was supported by Deutsche Forschungsgemeinschaft to TW, JG (http://www.dfg.de/GRANT NUMBER: CRC 1127 ChemBioSys), Jena School for Microbial Communication to TW, JG (http://www.jsmc.uni-jena.de/), Fundacao para a Ciencia e a Tecnologia to AE (http://www.fct.pt/GRANT NUMBER: SFRH /BPD /64990 /2009), and the European Union Seventh Framework Programme to TW, JG (http://www.assemblemarine.org/GRANT NUMBER: 227799-ASSEMBLE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Prof. Dr. Georg Pohnert (Friedrich Schiller University Jena, Germany) is acknowledged for his great support and helpful discussion during the preparation of the manuscript. The underlying map of Fig 2 is a courtesy of Prof. Dr. Rui Santos (Centre of Marine Science, Portugal). We thank three reviewers for their very helpful comments and suggestions throughout the review process.	Aguas M., 1986, SISTEMAS LAGUNARES A, P78; Alsufyani T, 2014, CHEM PHYS LIPIDS, V183, P100, DOI 10.1016/j.chemphyslip.2014.05.008; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Biebl H, 2005, INT J SYST EVOL MICR, V55, P2377, DOI 10.1099/ijs.0.63832-0; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Burke C, 2009, APPL ENVIRON MICROB, V75, P252, DOI 10.1128/AEM.01630-08; Esteves AIS, 2013, FEMS MICROBIOL ECOL, V85, P519, DOI 10.1111/1574-6941.12140; FJELD A, 1971, HEREDITAS-GENETISK A, V69, P290; FJELD A, 1975, Norwegian Journal of Botany, V22, P77; FOYN BJORN, 1958, ARCH PROTISKENKUNDE, V102, P473; fOYN BJORN, 1959, ARCH PROTISTENK, V104, P236; Friedrich M.W., 2012, SEAWEED BIOL; FRIES L, 1978, Z PFLANZENPHYSIOL, V88, P383, DOI 10.1016/S0044-328X(78)80253-0; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Joint I, 2002, SCIENCE, V298, P1207, DOI 10.1126/science.1077075; Joint I, 2007, PHILOS T R SOC B, V362, P1223, DOI 10.1098/rstb.2007.2047; Keller-Costa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088429; Lachnit T, 2010, BIOFOULING, V26, P247, DOI 10.1080/08927010903474189; Lachnit T, 2009, AQUAT BIOL, V5, P181, DOI 10.3354/ab00149; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Liu DY, 2013, ESTUAR COAST SHELF S, V129, P2, DOI 10.1016/j.ecss.2013.05.021; Liu F, 2013, MAR ENVIRON RES, V83, P38, DOI 10.1016/j.marenvres.2012.10.007; Lovejoy C, 1998, APPL ENVIRON MICROB, V64, P2806; LOVLIE A, 1963, CR TRAV LAB CARLSB, V34, P77; Luo HW, 2014, MICROBIOL MOL BIOL R, V78, P573, DOI 10.1128/MMBR.00020-14; Marshall K, 2006, MICROB ECOL, V52, P302, DOI 10.1007/s00248-006-9060-x; Matsuo Y, 2005, SCIENCE, V307, P1598, DOI 10.1126/science.1105486; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; MONTEIRO C, 1987, OCEANOL ACTA, V10, P359; Mudge SM, 2008, ESTUAR COAST SHELF S, V77, P278, DOI 10.1016/j.ecss.2007.09.032; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; Newton A, 2006, J COASTAL RES, P1346; Nienhuis, 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; Oertel W, 2015, J PHYCOL, V51, P963, DOI 10.1111/jpy.12336; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; PROVASOLI L, 1958, ANNU REV MICROBIOL, V12, P279, DOI 10.1146/annurev.mi.12.100158.001431; PROVASOLI L, 1958, BIOL BULL, V114, P375, DOI 10.2307/1538992; PROVASOLI L, 1980, J PHYCOL, V16, P196, DOI 10.1111/j.1529-8817.1980.tb03019.x; Riedel T, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-17; Salles P, 2005, ESTUAR COAST SHELF S, V65, P475, DOI 10.1016/j.ecss.2005.06.018; SFRISO A, 1992, ESTUARIES, V15, P517, DOI 10.2307/1352394; Singh RP, 2011, AQUAT BIOL, V12, P13, DOI 10.3354/ab00312; Smetacek V, 2013, NATURE, V504, P84, DOI 10.1038/nature12860; Spoerner M, 2012, J PHYCOL, V48, P1433, DOI 10.1111/j.1529-8817.2012.01231.x; Stigter Tibor Y., 2013, V18, P153; Stratmann J, 1996, J PHYCOL, V32, P1009, DOI 10.1111/j.0022-3646.1996.01009.x; TATEWAKI M, 1983, J PHYCOL, V19, P409, DOI 10.1111/j.0022-3646.1983.00409.x; Vesty EF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00015; Weerawongwiwat V, 2013, INT J SYST EVOL MICR, V63, P2553, DOI 10.1099/ijs.0.039628-0; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wichard T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00072; Wichard T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00086; Wichard T, 2010, J PHYCOL, V46, P248, DOI 10.1111/j.1529-8817.2010.00816.x	57	49	50	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146307	10.1371/journal.pone.0146307	http://dx.doi.org/10.1371/journal.pone.0146307			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745366	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600037
J	Soldatovic, I; Vukovic, R; Culafic, D; Gajic, M; Dimitrijevic-Sreckovic, V				Soldatovic, Ivan; Vukovic, Rade; Culafic, Djordje; Gajic, Milan; Dimitrijevic-Sreckovic, Vesna			siMS Score: Simple Method for Quantifying Metabolic Syndrome	PLOS ONE			English	Article							CARDIOVASCULAR RISK; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; CHILDREN; ADOLESCENTS; VALIDITY; FITNESS; DISEASE	Objective To evaluate siMS score and siMS risk score, novel continuous metabolic syndrome scores as methods for quantification of metabolic status and risk. Materials and Methods Developed siMS score was calculated using formula: siMS score = 2*Waist/Height + Gly/5.6 + Tg/1.7 + TA(systolic)/130-HDL/1.02 or 1.28 (for male or female subjects, respectively). siMS risk score was calculated using formula: siMS risk score = siMS score * age/45 or 50 (for male or female subjects, respectively) * family history of cardio/cerebro-vascular events (event = 1.2, no event = 1). A sample of 528 obese and non-obese participants was used to validate siMS score and siMS risk score. Scores calculated as sum of z-scores (each component of metabolic syndrome regressed with age and gender) and sum of scores derived from principal component analysis (PCA) were used for evaluation of siMS score. Variants were made by replacing glucose with HOMA in calculations. Framingham score was used for evaluation of siMS risk score. Results Correlation between siMS score with sum of z-scores and weighted sum of factors of PCA was high (r = 0.866 and r = 0.822, respectively). Correlation between siMS risk score and log transformed Framingham score was medium to high for age groups 18+, 30+ and 35+ (0.835, 0.707 and 0.667, respectively). Conclusions siMS score and siMS risk score showed high correlation with more complex scores. Demonstrated accuracy together with superior simplicity and the ability to evaluate and follow-up individual patients makes siMS and siMS risk scores very convenient for use in clinical practice and research as well.	[Soldatovic, Ivan; Gajic, Milan] Inst Med Stat & Informat, Belgrade, Serbia; [Vukovic, Rade] Mother & Child Hlth Care Inst Serbia Dr Vukan Cup, Belgrade, Serbia; [Culafic, Djordje] Clin Ctr Serbia, Clin Gastroenterol & Hepatol, Belgrade, Serbia; [Dimitrijevic-Sreckovic, Vesna] Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Disorders, Belgrade, Serbia; [Soldatovic, Ivan; Culafic, Djordje; Gajic, Milan; Dimitrijevic-Sreckovic, Vesna] Univ Belgrade, Sch Med, Belgrade, Serbia	University of Belgrade; Clinical Centre of Serbia; Clinical Centre of Serbia; University of Belgrade	Dimitrijevic-Sreckovic, V (corresponding author), Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Disorders, Belgrade, Serbia.	vesna.dimitrijevic.sreckovic1@gmail.com	Vukovic, Rade/H-3344-2019	Vukovic, Rade/0000-0002-1592-4105; Soldatovic, Ivan/0000-0003-4893-1683	Ministry of Science and Technological Development, Serbia [III 41029]	Ministry of Science and Technological Development, Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Science and Technological Development, Serbia, No. III 41029 (IS).; All authors declare no conflict of interest. This study is supported by Ministry of Science and Technological Development, Serbia, No. III 41029.	ALBERTI K, 1999, DIABETES MED, V15, pS39; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Avogaro P, 1967, ACTA DIABETOLLAT, V4, P36; Batey LS, 1997, CIRCULATION, V96, P4319; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Eisenmann JC, 2005, INT J OBESITY, V29, P1077, DOI 10.1038/sj.ijo.0802995; Eisenmann JC, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-8; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; Ferrannini E, 1992, Curr Opin Nephrol Hypertens, V1, P291, DOI 10.1097/00041552-199212000-00015; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Huo D, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-61; Kahn R, 2007, CIRCULATION, V115, P1806, DOI 10.1161/CIRCULATIONAHA.106.658336; Kato I, 1998, J CLIN EPIDEMIOL, V51, P1271, DOI 10.1016/S0895-4356(98)00119-X; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; Li CY, 2007, DIABETES CARE, V30, P1556, DOI 10.2337/dc06-2481; Martinez-Vizcaino V, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-81; Martinez-Vizcaino V, 2010, DIABETES CARE, V33, P1370, DOI 10.2337/dc09-2049; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Pladevall M, 2006, DIABETES CARE, V29, P113, DOI 10.2337/diacare.29.1.113; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; Wijndaele K, 2006, DIABETES CARE, V29, P2329, DOI 10.2337/dc06-1341; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woolston A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034410; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	30	37	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146143	10.1371/journal.pone.0146143	http://dx.doi.org/10.1371/journal.pone.0146143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745635	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600029
J	Wang, P; Huang, R; Lu, S; Xia, WQ; Cai, RR; Sun, HX; Wang, SH				Wang, Pin; Huang, Rong; Lu, Sen; Xia, Wenqing; Cai, Rongrong; Sun, Haixia; Wang, Shaohua			RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; SOLUBLE FORM; SERUM-LEVELS; RECEPTOR; GLYCOSYLATION; COMPLICATIONS; DEMENTIA; EXPRESSION	Objective Receptor for advanced glycation end products (AGEs; RAGE) binds to both AGEs and amyloid-beta peptides. RAGE is involved in chronic complications of type 2 diabetes and Alzheimer's disease. We aimed to investigate the roles of RAGE, AGEs and the Gly82Ser polymorphism of RAGE in mild cognitive impairment (MCI) among type 2 diabetes patients. Methods Of the 167 hospitalized type 2 diabetes patients recruited, 82 satisfied the diagnostic criteria for MCI, and 85 matched control individuals were classified as non-MCI. Demographic data were collected, and the soluble RAGE (sRAGE) concentrations, serum AGE-peptide (AGE-P) levels, RAGE Gly82Ser genotype and neuropsychological test results were examined. Results The MCI group exhibited a decreased sRAGE level (0.87 +/- 0.35 vs. 1.05 +/- 0.52 ng/ml, p<0.01) and an increased serum AGE-P level (3.54 +/- 1.27 vs. 2.71 +/- 1.18 U/ml, p<0.01) compared with the control group. Logistic regression analysis indicated that each unit reduction in the sRAGE concentration increased the MCI risk by 54% (OR 0.46[95% CI 0.22-0.96], p = 0.04) and that each unit increase in the AGE-P level increased the MCI risk by 72% in the type 2 diabetes patients (OR 1.72[95% CI 1.31-2.28], p<0.01). The serum sRAGE level was negatively correlated with the score on the trail making test-B (TMT-B) (r = -0.344, p = 0.002), which indicates early cognitive deficits related to diabetes. Moreover, the AGE-P level was positively correlated with multiple cognitive domains (all p<0.05). No significant differences in the neuropsychological test results or serum RAGE concentrations between the different RAGE genotypes or in the RAGE genotype frequencies between the MCI and control groups were identified (all p>0.05). Conclusions The RAGE pathway partially mediates AGE-induced MCI in diabetic patients. The serum AGE-P level may serve as a serum biomarker of MCI in these individuals, and sRAGE represents a predictor and even a potential intervention target of early cognitive decline in type 2 diabetes patients.	[Wang, Pin; Huang, Rong; Xia, Wenqing; Cai, Rongrong; Sun, Haixia; Wang, Shaohua] Southeast Univ, Affiliated ZhongDa Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Lu, Sen] Sichuan Acad Med Sci, Dept,Intens Care Unit, Chengdu, Sichuan Provinc, Peoples R China; [Lu, Sen] Sichuan Prov Peoples Hosp, Chengdu, Sichuan Provinc, Peoples R China	Southeast University - China; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Wang, SH (corresponding author), Southeast Univ, Affiliated ZhongDa Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	gyjwsh@163.com		Wang, Shaohua/0000-0001-9567-6668	National Natural Science Foundation of China [81370921, 81570732]; Social Development Project of JiangSu Province [SBE201170735]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Project of JiangSu Province	This work was partially supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/ No. 81370921, Wang SH; and No. 81570732, Wang SH); the Social Development Project of JiangSu Province (http://www.jstd.gov.cn/ No. SBE201170735, Wang SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2005, J BIOL CHEM, V280, P30406, DOI 10.1074/jbc.M414686200; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Aye T, 2011, DIABETES CARE, V34, P1458, DOI 10.2337/dc10-2164; Bar KJ, 2003, NEUROBIOL AGING, V24, P333, DOI 10.1016/S0197-4580(02)00086-6; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CARUBELLI R, 1995, FREE RADICAL BIO MED, V18, P265, DOI 10.1016/0891-5849(94)E0134-5; Cervellati C, 2014, J NEUROL SCI, V337, P156, DOI 10.1016/j.jns.2013.11.041; Chen G, 2011, DIABETES CARE, V34, P2586, DOI 10.2337/dc11-0958; Crosby-Nwaobi RR, 2013, DIABETES CARE, V36, P3177, DOI 10.2337/dc12-2141; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Daborg J, 2010, J NEURAL TRANSM, V117, P861, DOI 10.1007/s00702-010-0437-0; Ghidoni R, 2008, J NEURAL TRANSM, V115, P1047, DOI 10.1007/s00702-008-0069-9; Gorska-Ciebiada M, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00209, 10.3389/fnagi.2015.00209]; Hayden KM, 2006, ALZ DIS ASSOC DIS, V20, P93, DOI 10.1097/01.wad.0000213814.43047.86; Hickok Gregory, 2015, Handb Clin Neurol, V129, P149, DOI 10.1016/B978-0-444-62630-1.00008-1; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087095; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 1998, DIABETES, V47, P1155, DOI 10.2337/diabetes.47.7.1155; Jakus V, 2004, PHYSIOL RES, V53, P131; Kankova K, 2005, NEPHROL DIAL TRANSPL, V20, P1093, DOI 10.1093/ndt/gfh711; Kuhla B, 2004, J NEURAL TRANSM, V111, P427, DOI 10.1007/s00702-003-0038-2; Last D, 2007, DIABETES CARE, V30, P1193, DOI 10.2337/dc06-2052; LEDESMA MD, 1995, J NEUROCHEM, V65, P1658; LI JJ, 1994, BRAIN RES, V641, P285, DOI 10.1016/0006-8993(94)90156-2; Li KS, 2010, J NEURAL TRANSM, V117, P97, DOI 10.1007/s00702-009-0334-6; Liu NF, 2000, ACTA PHARMACOL SIN, V21, P276; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; Miura J, 2003, J DIABETES COMPLICAT, V17, P16, DOI 10.1016/S1056-8727(02)00183-6; Muscat S, 2007, MOL NUTR FOOD RES, V51, P525, DOI 10.1002/mnfr.200600254; Naka Y, 2004, ARTERIOSCL THROM VAS, V24, P1342, DOI 10.1161/01.ATV.0000133191.71196.90; Nakamura K, 2007, DIABETES-METAB RES, V23, P368, DOI 10.1002/dmrr.690; Nowotny K, 2015, BIOMOLECULES, V5, P194, DOI 10.3390/biom5010194; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Portet F, 2006, J NEUROL NEUROSUR PS, V77, P714, DOI 10.1136/jnnp.2005.085332; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Shimoike T, 2000, METABOLISM, V49, P1030, DOI 10.1053/meta.2000.7738; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Stefanova E, 2012, J NEUROL SCI, V322, P166, DOI 10.1016/j.jns.2012.07.065; Stitt AW, 1997, ANN NY ACAD SCI, V811, P115, DOI 10.1111/j.1749-6632.1997.tb51994.x; Sun ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137756; Sun ZL, 2001, CLIN CHIM ACTA, V313, P69, DOI 10.1016/S0009-8981(01)00651-9; Suzuki D, 1999, J AM SOC NEPHROL, V10, P822; Takeuchi M, 2008, CURR PHARM DESIGN, V14, P973, DOI 10.2174/138161208784139693; VLASSARA H, 1983, DIABETES, V32, P670, DOI 10.2337/diabetes.32.7.670; Wrobel K, 1997, CLIN CHEM, V43, P1563; WU JT, 1993, J CLIN LAB ANAL, V7, P252, DOI 10.1002/jcla.1860070503; Xu WL, 2004, NEUROLOGY, V63, P1181, DOI 10.1212/01.WNL.0000140291.86406.D1; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yanagisawa K, 1998, METABOLISM, V47, P1348, DOI 10.1016/S0026-0495(98)90303-1	53	40	43	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145521	10.1371/journal.pone.0145521	http://dx.doi.org/10.1371/journal.pone.0145521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745632	gold, Green Submitted, Green Published			2022-12-27	WOS:000367815600009
J	Kim, SH; Choi, HS; Chun, HJ; Yoo, IK; Lee, JM; Kim, ES; Keum, B; Seo, YS; Jeen, YT; Lee, HS; Um, SH; Kim, CD				Kim, Seung Han; Choi, Hyuk Soon; Chun, Hoon Jai; Yoo, In Kyung; Lee, Jae Min; Kim, Eun Sun; Keum, Bora; Seo, Yeon Seok; Jeen, Yoon Tae; Lee, Hong Sik; Um, Soon Ho; Kim, Chang Duck			A Novel Fixation Method for Variable-Sized Endoscopic Submucosal Dissection Specimens: An In Vitro Animal Experiment	PLOS ONE			English	Article							EARLY GASTRIC-CANCER; LONG-TERM OUTCOMES; LYMPH-NODE METASTASIS; MUCOSAL RESECTION; SINGLE-CENTER; INVASION	Background Endoscopic submucosal dissection is considered a curative and minimally invasive treatment for early gastric cancer; however, precise pathologic assessment of resected specimens is required to develop further treatment plans. Human error during specimen handling can affect objective assessment of resected specimens. In this study, we investigated whether a novel tissue fixation device offered more objective and standardized pathologic evaluation than conventional manual tissue fixation. Methods We developed a novel tissue fixation device for endoscopic submucosal dissection specimens. Two circular tissue samples 2, 3, and 4 cm in diameter were obtained from the body of 45 porcine stomachs. One specimen sample was placed in a fixation device; the other was manually fixed on corkboard. We used a pressure indicator to ensure constant pressure in the resected specimens in the fixation device. We measured submucosal diameter and thickness after 24 hr. Results The diameters for 2, 3, and 4 cm resected tissue samples were 23.85, 32.30, and 45.0 mm and 21.0, 32.0, and 44.50 mm for the fixation device and manual pinning groups, respectively. The submucosal thicknesses in the fixation device group were 397.09, 381.43, and 415.51 mu m and 393.76, 529.69, and 603.82 mu m by manual pinning for 2, 3, and 4 cm tissue samples, respectively. Analysis of standard deviation revealed that the submucosal thickness in the manual fixation group was much more variable than in the fixation device group (p = 0.012, 0.042, and 0.001 for 2, 3, and 4 cm tissue specimens, respectively; Fligner-Killeen test of homogeneity of variances). Conclusions Among variously sized resected tissue specimens, submucosal thicknesses were more variable in the conventional fixation group, while the thicknesses were comparatively consistent in the fixation device group. After endoscopic submucosal dissection, pathologic preparation using this fixation device could offer more objective assessment of specimens.	[Kim, Seung Han; Choi, Hyuk Soon; Chun, Hoon Jai; Yoo, In Kyung; Lee, Jae Min; Kim, Eun Sun; Keum, Bora; Seo, Yeon Seok; Jeen, Yoon Tae; Lee, Hong Sik; Um, Soon Ho; Kim, Chang Duck] Korea Univ, Coll Med, Inst Gastrointestinal Med Instrument Res, Div Gastroenterol & Hepatol,Dept Internal Med, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Chun, HJ (corresponding author), Korea Univ, Coll Med, Inst Gastrointestinal Med Instrument Res, Div Gastroenterol & Hepatol,Dept Internal Med, Seoul 136705, South Korea.	drchunhj@chol.com		Kim, Eun Sun/0000-0003-1820-459X; Lee, Hong Sik/0000-0001-9726-5416	National Research Foundation of Korea (NRF) grant - Korean Government [NRF-2014R1A2A2A01006131]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health & Welfare, Republic of Korea [HI13C2181]	National Research Foundation of Korea (NRF) grant - Korean Government; Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2014R1A2A2A01006131) (HJC), and it was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI13C2181). (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none, http://www.mw.go.kr/front_new/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2015, GASTRIC CANCER, V18, P188, DOI 10.1007/s10120-014-0341-7; Abe S, 2013, ENDOSCOPY, V45, P703, DOI 10.1055/s-0033-1344396; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Axon A, 2005, ENDOSCOPY, V37, P570, DOI 10.1055/s-2005-861352; Cho JY, 2006, ENDOSCOPY, V38, P429, DOI 10.1055/s-2006-925160; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; Gotoda Takuji, 2005, Clin Gastroenterol Hepatol, V3, pS71, DOI 10.1016/S1542-3565(05)00251-X; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Kim JY, 2013, HUM PATHOL, V44, P2829, DOI 10.1016/j.humpath.2013.07.037; Kim Kyoung Mee, 2010, Korean J Gastroenterol, V56, P214; Kosaka T, 2014, DIGEST ENDOSC, V26, P183, DOI 10.1111/den.12099; Lauwers GY, 2004, MODERN PATHOL, V17, P2, DOI 10.1038/modpathol.3800012; Mori H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121798; Nakamura K, 2015, SCAND J GASTROENTERO, V50, P413, DOI 10.3109/00365521.2014.940377; Oya H, 2012, GASTRIC CANCER, V15, P221, DOI 10.1007/s10120-011-0111-8; Park S, 2008, GUT LIVER, V2, P199, DOI 10.5009/gnl.2008.2.3.199; Tanabe S, 2014, GASTRIC CANCER, V17, P130, DOI 10.1007/s10120-013-0241-2; Toyonaga T, 2013, SURG ENDOSC, V27, P1000, DOI 10.1007/s00464-012-2555-2	18	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146573	10.1371/journal.pone.0146573	http://dx.doi.org/10.1371/journal.pone.0146573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26742107	gold, Green Published, Green Submitted			2022-12-27	WOS:000367810600059
J	Singh, A; Gupta, R; Pandey, R				Singh, Akanksha; Gupta, Rupali; Pandey, Rakesh			Rice Seed Priming with Picomolar Rutin Enhances Rhizospheric Bacillus subtilis CIM Colonization and Plant Growth	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; BIOFILM FORMATION; SOIL BACTERIA; ACID; RESISTANCE; INDUCTION; BIOCONTROL; DISEASE; STRESS	The effect of rutin, a bioflavonoid on the growth and biofilm formation of Bacillus subtilis strain CIM was investigated. In addition to swimming, swarming, and twitching potentials of B. subtilis CIM (BS), one picomolar (1 pM) of rutin was also observed to boost the biofilm forming ability of the bacterium. Bio-priming of rice seeds with BS and rutin not only augmented root and shoot lengths but also the photosynthetic pigments like chlorophyll and carotenoid. Similarly, high accumulation of phenolic and flavonoid contents was observed in the leaves. Fluorescent microscopic images revealed that BS plus rutin enhanced callose deposition in the leaves. It was also established that the least formation of reactive oxygen species in BS plus rutin treated rice plants was due to higher free radicals scavenging activity and total antioxidant potential. The results highlight chemo attractant nature of BS towards rutin, which by enhancing biofilm formation and root colonization indirectly strengthened the plants' defensive state.	[Singh, Akanksha; Gupta, Rupali; Pandey, Rakesh] CSIR Cent Inst Med & Aromat Plants, Dept Microbial Technol & Nematol, Lucknow 226015, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Pandey, R (corresponding author), CSIR Cent Inst Med & Aromat Plants, Dept Microbial Technol & Nematol, PO CIMAP, Lucknow 226015, Uttar Pradesh, India.	r.pandey@cimap.res.in		Singh, Akanksha/0000-0001-7206-3965				Abu El-Soud W, 2013, PLANT PHYSIOL BIOCH, V71, P173, DOI 10.1016/j.plaphy.2013.07.007; Ahn SJ, 2008, INFECT IMMUN, V76, P4259, DOI 10.1128/IAI.00422-08; Al-Wakeel S. M., 2013, Acta Agronomica Hungarica, V61, P23, DOI 10.1556/AAgr.61.2013.1.3; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Beneloujaephajri E, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-160; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cazorla FM, 2007, J APPL MICROBIOL, V103, P1950, DOI 10.1111/j.1365-2672.2007.03433.x; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; DAKORA FD, 1993, PLANT PHYSIOL, V101, P819, DOI 10.1104/pp.101.3.819; Fokom R., 2010, Research Journal of Agriculture and Biological Sciences, V6, P1015; Gupta R, 2015, BIOCONTROL SCI TECHN, V25, P1165, DOI 10.1080/09583157.2015.1036728; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hartmut K, 1983, ANALYSIS, V4, P142; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kikuchi K, 2007, MYCORRHIZA, V17, P563, DOI 10.1007/s00572-007-0131-8; Lagrange H, 2001, NEW PHYTOL, V149, P349, DOI 10.1046/j.1469-8137.2001.00027.x; Li Q, 2011, J PLANT PHYSIOL, V168, P927, DOI 10.1016/j.jplph.2010.11.025; Macdonald C, 2014, BIOENGINEERED, V5, P5, DOI 10.4161/bioe.25320; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Raj SN, 2012, BIOL CONTROL, V60, P90, DOI 10.1016/j.biocontrol.2011.10.011; Reuber TL, 1998, PLANT J, V16, P473, DOI 10.1046/j.1365-313x.1998.00319.x; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Saleh AM, 2015, J PLANT GROWTH REGUL, V34, P233, DOI 10.1007/s00344-014-9459-4; Singh A, 2014, LWT-FOOD SCI TECHNOL, V56, P390, DOI 10.1016/j.lwt.2013.11.030; Singh PK, 2013, PHYSIOL MOL BIOL PLA, V19, P53, DOI 10.1007/s12298-012-0126-6; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Staechel SE, 1985, NATURE, V318, P624, DOI [10.1038/318624a0, DOI 10.1038/318624A0]; Zhang HM, 2008, PLANT J, V56, P264, DOI 10.1111/j.1365-313X.2008.03593.x; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n	35	57	60	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146013	10.1371/journal.pone.0146013	http://dx.doi.org/10.1371/journal.pone.0146013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26742102	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600017
J	Vital, RB; Hamamoto, PT; Luvizutto, GJ; Ducati, LG; Braga, GP; Nunes, HRD; Romero, FR; Ganem, EM; Zanini, MA; Bazan, R				Vital, Roberto Bezerra; Hamamoto Filho, Pedro Tadao; Luvizutto, Gustavo Jose; Ducati, Luis Gustavo; Braga, Gabriel Pereira; de Carvalho Nunes, Helio Rubens; Romero, Flavio Ramalho; Ganem, Eliana Marisa; Zanini, Marco Antonio; Bazan, Rodrigo			Decompressive Hemicraniectomy in a South American Population - Morbidity and Outcomes Analysis	PLOS ONE			English	Article							MIDDLE-CEREBRAL-ARTERY; MALIGNANT INFARCTION; SURGICAL DECOMPRESSION; INTENSIVE-CARE; STROKE; CRANIECTOMY; TRIAL; MULTICENTER; SURGERY; DETERIORATION	Background Malignant cerebral artery strokes have a poor prognosis, with nearly 80% of mortality in some series despite intensive care. After a large randomized trial, decompressive hemicraniectomy has been performed more often in stroke patients. Here, we describe patients in a tertiary teaching hospital in Brazil, emphasizing the impact of age on outcomes. Methods A retrospective cohort of patients, with malignant strokes which received a decompressive hemicraniectomy, from paper and electronic medical records, from January 2010 to December 2013 was divided into two groups according to age. Results The final analysis included 60 patients. The overall mortality was higher among patients older than 60 yrs (67% vs. 41%; p = 0.039), whose group also had a worse outcome (76% with mRS 5 or 6) at 90 days (OR 3.91 CI95% 1.30-11.74), whereas only 24% had mRS of 0-4 (p = 0.015). All patients who presented with sepsis died (p = 0.003). The incidence of pulmonary infection was very high in the elderly group (76%) with significant intergroup differences (p = 0.027, OR 8.32 CI95% 0.70-98.48). Conclusions Older patients present more commonly with infections, more disabilities and a higher mortality, highlighting very poor results in elderly population. These results should be proved with a South American trial, and if confirmed, it can impact on future decisions regarding decompressive craniectomy for acute ischemic stroke in our region.	[Vital, Roberto Bezerra; Hamamoto Filho, Pedro Tadao; Luvizutto, Gustavo Jose; Ducati, Luis Gustavo; Braga, Gabriel Pereira; Romero, Flavio Ramalho; Zanini, Marco Antonio; Bazan, Rodrigo] Univ Estadual Paulista, Botucatu Med Sch, Dept Neurol Psychol & Psychiat, Botucatu, SP, Brazil; [de Carvalho Nunes, Helio Rubens] Univ Estadual Paulista, Botucatu Med Sch, Dept Publ Hlth Med, Botucatu, SP, Brazil; [Ganem, Eliana Marisa] Univ Estadual Paulista, Botucatu Med Sch, Dept Anesthesiol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Vital, RB (corresponding author), Univ Estadual Paulista, Botucatu Med Sch, Dept Neurol Psychol & Psychiat, Botucatu, SP, Brazil.	roberto_vital@hotmail.com	Hamamoto Filho, Pedro Tadao/D-2800-2012; Zanini, Marco Antonio/M-4898-2019; Zanini, Marco Antonio/L-9691-2019; Bazan, Rodrigo/D-4185-2012; Luvizutto, Gustavo/F-3709-2019; Zanini, Marco A/A-1413-2008; Braga, Gabriel P/I-1751-2015; Romero, Flavio/W-4532-2019	Hamamoto Filho, Pedro Tadao/0000-0001-6436-9307; Zanini, Marco Antonio/0000-0002-5712-9783; Bazan, Rodrigo/0000-0003-3872-308X; Luvizutto, Gustavo/0000-0002-6914-7225; Zanini, Marco A/0000-0002-5712-9783; Romero, Flavio/0000-0003-3800-8975				Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Frank JI, 2014, STROKE, V45, P781, DOI 10.1161/STROKEAHA.113.003200; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; de Carvalho JJF, 2011, STROKE, V42, P3341, DOI 10.1161/STROKEAHA.111.626523; Geurts M, 2013, STROKE, V44, P2506, DOI 10.1161/STROKEAHA.113.002014; Hofmeijer J, 2003, CRIT CARE MED, V31, P617, DOI 10.1097/01.CCM.0000050446.16158.80; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2015, NEUROSURGERY; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2011, INT J STROKE, V6, P79, DOI 10.1111/j.1747-4949.2010.00544.x; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kirkman MA, 2014, INTENS CARE MED, V40, P640, DOI 10.1007/s00134-014-3266-z; Lewis S, 2008, J NEUROL NEUROSUR PS, V79, P397, DOI 10.1136/jnnp.2007.126045; Mattos JP, 2010, ARQ NEURO-PSIQUIAT, V68, P339, DOI 10.1590/S0004-282X2010000300002; Martins SCO, 2013, INT J STROKE, V8, P106, DOI 10.1111/ijs.12062; Ragoschke-Schumm A, 2015, CEREBROVASC DIS, V40, P286, DOI 10.1159/000441194; Rai VK, 2014, NEUROL INDIA, V62, P26, DOI 10.4103/0028-3886.128273; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schuss P, 2013, J NEUROL, V260, P2149, DOI 10.1007/s00415-013-6950-y; Schwab S, 1997, NEUROLOGY, V48, P1608, DOI 10.1212/WNL.48.6.1608; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Shao AW, 2013, J CRANIOFAC SURG, V24, P2085, DOI 10.1097/SCS.0b013e3182a2435a; Takeuchi S, 2012, CLIN NEUROL NEUROSUR, V114, P1312, DOI 10.1016/j.clineuro.2012.03.044; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	25	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146747	10.1371/journal.pone.0146747	http://dx.doi.org/10.1371/journal.pone.0146747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764485	gold, Green Published, Green Submitted			2022-12-27	WOS:000368459300038
J	Wu, WC; Ma, WY; Wei, JN; Yu, TY; Lin, MS; Shih, SR; Hua, CH; Liao, YJ; Chuang, LM; Li, HY				Wu, Wan-Chen; Ma, Wen-Ya; Wei, Jung-Nan; Yu, Tse-Ya; Lin, Mao-Shin; Shih, Shyang-Rong; Hua, Cyue-Huei; Liao, Ying-Jhu; Chuang, Lee-Ming; Li, Hung-Yuan			Serum Glycated Albumin to Guide the Diagnosis of Diabetes Mellitus	PLOS ONE			English	Article							IRON-DEFICIENCY; LATE PREGNANCY; HEMOGLOBIN; GLUCOSE; VALUES; PREDICTS; INDEX; A1C; FRUCTOSAMINE; PROTEIN-1	In the diagnosis of diabetes mellitus, hemoglobin A1c (HbA1c) is sometimes measured to determine the need of an oral glucose tolerance test (OGTT). However, HbA1c does not accurately reflect glycemic status in certain conditions. This study was performed to test the possibility that measurement of serum glycated albumin (GA) better assesses the need for OGTT. From 2006 to 2012, 1559 subjects not known to have diabetes or to use anti-diabetic medications were enrolled. Serum GA was measured, and a 75-g OGTT was then performed to diagnose diabetes. Serum GA correlated significantly to age (r = 0.27, p<0.001), serum albumin (r = -0.1179, age-adjusted p = 0.001), body mass index (r = -0.24, age-adjusted p<0.001), waist circumference (r = -0.16, age-adjusted p<0.001), and plasma GA (r = 0.999, p<0.001), but was unaffected by diet (p = 0.8). Using serum GA at 15% for diagnosis of diabetes, the sensitivity, specificity, and area under the receiver-operating characteristic curve were 74%, 85%, and 0.86, respectively. Applying a fasting plasma glucose (FPG) value of < 100 mg/dL to exclude diabetes and of >= 126 mg/dL to diagnose diabetes, 14.4% of the study population require an OGTT (OGTT%) with a sensitivity of 78.8% and a specificity of 100%. When serum GA value of 14% and 17% were used to exclude and diagnose diabetes, respectively, the sensitivity improved to 83.3%, with a slightly decrease in specificity (98.2%), but a significant increase in OGTT%(35%). Using combined FPG and serum GA cutoff values (FPG < 100 mg/dL plus serum GA < 15% to exclude diabetes and FPG >= 126 mg/dL or serum GA >= 17% to diagnose diabetes), the OGTT% was reduced to 22.5% and the sensitivity increased to 85.6% with no change in specificity (98.2%). In the diagnosis of diabetes, serum GA measurements can be used to determine the need of an OGTT.	[Wu, Wan-Chen; Shih, Shyang-Rong; Liao, Ying-Jhu; Chuang, Lee-Ming; Li, Hung-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol, Taipei 100, Taiwan; [Ma, Wen-Ya] Cardinal Tien Hosp, Dept Internal Med, Div Endocrinol, New Taipei, Taiwan; [Wei, Jung-Nan] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yu, Tse-Ya] Far Eastern Mem Hosp, Dept Hlth Management Ctr, New Taipei, Taiwan; [Lin, Mao-Shin] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Hua, Cyue-Huei] Natl Taiwan Univ Hosp, Yun Lin Branch, Div Clin Pathol, Yunlin, Taiwan	National Taiwan University; National Taiwan University Hospital; Chia Nan University of Pharmacy & Science; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Li, HY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol, Taipei 100, Taiwan.	larsli@ntuh.gov.tw	Chuang, Lee-Ming/AAF-3324-2019	Li, Hung-Yuan/0000-0001-9644-2855; SHIH, SHYANG-RONG/0000-0001-7424-1358; WU, WAN-CHEN/0000-0002-2731-5331; CHUANG, LEE-MING/0000-0003-0978-2662	National Taiwan University Hospital [NTUH 102-M2262]	National Taiwan University Hospital(National Taiwan University)	This work was funded by NTUH 102-M2262 from National Taiwan University Hospital to HY Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Anand SS, 2003, DIABETES CARE, V26, P290, DOI 10.2337/diacare.26.2.290; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Freedman BI, 2010, AM J NEPHROL, V31, P375, DOI 10.1159/000287561; Furusyo N, 2011, DIABETOLOGIA, V54, P3028, DOI 10.1007/s00125-011-2310-6; Furusyo N, 2013, BBA-GEN SUBJECTS, V1830, P5509, DOI 10.1016/j.bbagen.2013.05.010; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hashimoto K, 2008, DIABETES CARE, V31, P1945, DOI 10.2337/dc08-0352; Hashimoto K, 2010, DIABETES CARE, V33, P509, DOI 10.2337/dc09-1954; Hu YM, 2010, ACTA DIABETOL, V47, P231, DOI 10.1007/s00592-009-0143-2; Huh JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089478; IBERG N, 1986, J BIOL CHEM, V261, P3542; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Ko GTC, 1998, DIABETES CARE, V21, P1221, DOI 10.2337/diacare.21.8.1221; Koga M, 2009, DIABETES RES CLIN PR, V84, P163, DOI 10.1016/j.diabres.2009.01.013; Koga M, 2007, CLIN CHIM ACTA, V378, P48, DOI 10.1016/j.cca.2006.10.013; Koga M, 2006, ENDOCR J, V53, P387, DOI 10.1507/endocrj.K05-137; Koga M, 2015, CLIN CHIM ACTA, V438, P19, DOI 10.1016/j.cca.2014.07.035; Koga M, 2011, DIABETES RES CLIN PR, V94, pE12, DOI 10.1016/j.diabres.2011.06.022; Koga M, 2010, ENDOCR J, V57, P751, DOI 10.1507/endocrj.K10E-138; Kosecki SM, 2005, ANN PHARMACOTHER, V39, P1557, DOI 10.1345/aph.1G010; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Li HY, 2012, J DIABETES INVEST, V3, P259, DOI 10.1111/j.2040-1124.2011.00181.x; Li HY, 2009, CLIN CHIM ACTA, V404, P149, DOI 10.1016/j.cca.2009.03.041; Li ZX, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-30; Lin MS, 2008, CLIN BIOCHEM, V41, P1362, DOI 10.1016/j.clinbiochem.2008.06.019; Little Randie R, 2009, J Diabetes Sci Technol, V3, P446; Little RR, 2001, CLIN CHEM, V47, P1985; Ma WY, 2013, DIABETES CARE, V36, P1660, DOI 10.2337/dc12-1452; Ma XJ, 2010, CLIN EXP PHARMACOL P, V37, P974, DOI 10.1111/j.1440-1681.2010.05417.x; Murea M, 2012, AM J NEPHROL, V36, P488, DOI 10.1159/000343920; Nathan DM, 2014, DIABETES, V63, P282, DOI 10.2337/db13-0782; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Okada T, 2011, INTERNAL MED, V50, P23, DOI 10.2169/internalmedicine.50.4129; Okada T, 2009, INTERNAL MED, V48, P1495, DOI 10.2169/internalmedicine.48.2301; Okumura A, 2007, JPN J OPHTHALMOL, V51, P236, DOI 10.1007/s10384-007-0431-8; Organization WH., WORLDW PREV AN 1993; Organization WH, US GLYC HAEM HBA1C D; PANZER S, 1982, BLOOD, V59, P1348; Peacock TP, 2008, KIDNEY INT, V73, P1062, DOI 10.1038/ki.2008.25; Poon AK, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000002; Sany Dawlat, 2013, Saudi J Kidney Dis Transpl, V24, P260; Song SO, 2012, ATHEROSCLEROSIS, V225, P450, DOI 10.1016/j.atherosclerosis.2012.09.005; Sundarm RC, 2007, BIOMED PHARMACOTHER, V61, P682, DOI 10.1016/j.biopha.2007.06.013; The Diabetes Association of the Republic of China, DAROC CLIN PRACT GUI; Wang FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051098; Xue YZ, 2012, EUR J GASTROEN HEPAT, V24, P1092, DOI 10.1097/MEG.0b013e328355a487; Yang C, 2012, CLIN MED, V12, P568, DOI 10.7861/clinmedicine.12-6-568; Yoshiuchi K, 2008, ENDOCR J, V55, P503, DOI 10.1507/endocrj.K07E-089; Zheng CM, 2012, CLIN CHIM ACTA, V413, P1555, DOI 10.1016/j.cca.2012.04.025	50	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146780	10.1371/journal.pone.0146780	http://dx.doi.org/10.1371/journal.pone.0146780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765575	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300043
J	Keller, S; Bartolino, V; Hidalgo, M; Bitetto, I; Casciaro, L; Cuccu, D; Esteban, A; Garcia, C; Garofalo, G; Josephides, M; Jadaud, A; Lefkaditou, E; Maiorano, P; Manfredi, C; Marceta, B; Massut, E; Micallef, R; Peristeraki, P; Relini, G; Sartor, P; Spedicato, MT; Tserpes, G; Quetglas, A				Keller, Stefanie; Bartolino, Valerio; Hidalgo, Manuel; Bitetto, Isabella; Casciaro, Loredana; Cuccu, Danila; Esteban, Antonio; Garcia, Cristina; Garofalo, Germana; Josephides, Marios; Jadaud, Angelique; Lefkaditou, Evgenia; Maiorano, Porzia; Manfredi, Chiara; Marceta, Bojan; Massut, Enric; Micallef, Reno; Peristeraki, Panagiota; Relini, Giulio; Sartor, Paolo; Spedicato, Maria Teresa; Tserpes, George; Quetglas, Antoni			Large-Scale Spatio-Temporal Patterns of Mediterranean Cephalopod Diversity	PLOS ONE			English	Article							SPECIES-RICHNESS; CONTINENTAL-SHELF; SPATIAL-PATTERN; FISH DIVERSITY; SEA; ASSEMBLAGES; WESTERN; BIODIVERSITY; FLUCTUATIONS; OCEAN	Species diversity is widely recognized as an important trait of ecosystems' functioning and resilience. Understanding the causes of diversity patterns and their interaction with the environmental conditions is essential in order to effectively assess and preserve existing diversity. While diversity patterns of most recurrent groups such as fish are commonly studied, other important taxa such as cephalopods have received less attention. In this work we present spatio-temporal trends of cephalopod diversity across the entire Mediterranean Sea during the last 19 years, analysing data from the annual bottom trawl survey MEDITS conducted by 5 different Mediterranean countries using standardized gears and sampling protocols. The influence of local and regional environmental variability in different Mediterranean regions is analysed applying generalized additive models, using species richness and the Shannon Wiener index as diversity descriptors. While the western basin showed a high diversity, our analyses do not support a steady eastward decrease of diversity as proposed in some previous studies. Instead, high Shannon diversity was also found in the Adriatic and Aegean Seas, and high species richness in the eastern Ionian Sea. Overall diversity did not show any consistent trend over the last two decades. Except in the Adriatic Sea, diversity showed a hump-shaped trend with depth in all regions, being highest between 200-400 m depth. Our results indicate that high Chlorophyll a concentrations and warmer temperatures seem to enhance species diversity, and the influence of these parameters is stronger for richness than for Shannon diversity.	[Keller, Stefanie; Hidalgo, Manuel; Massut, Enric; Quetglas, Antoni] Inst Espanol Oceanog, Ctr Oceanog Baleares, Palma De Mallorca 07015, Spain; [Bartolino, Valerio] SLU Swedish Univ Agr Sci, Dept Aquat Resources, Lysekil, Sweden; [Bitetto, Isabella; Casciaro, Loredana; Spedicato, Maria Teresa] COISPA Tecnol & Ric, Stn Sperimentale Studio Risorse Mare, Bari, Italy; [Cuccu, Danila] Univ Cagliari, Dipartemento Sci Vita & Ambiente, IEO, Cagliari, Italy; [Esteban, Antonio] Ctr Oceanog Murcia, Murcia, Spain; [Garcia, Cristina] Ctr Oceanog Malaga, IEO, Malaga, Spain; [Garofalo, Germana] CNR, IAMC Coastal Marine Environm Inst, Mazara Del Vallo, TP, Italy; [Josephides, Marios] Minist Agr Rural Dev & Environm, DFMR, Nicosia, Cyprus; [Jadaud, Angelique] IFREMER, UMR Ecosyst Marins Exploites EME 212, Sete, France; [Lefkaditou, Evgenia] HCMR, Athens, Greece; [Maiorano, Porzia] Univ Bari Aldo Moro, Dept Biol, Bari, Italy; [Manfredi, Chiara] Univ Bologna, Lab Biol Marina & Pesca, Fano, PS, Italy; [Marceta, Bojan] Fishery Res Inst Slovenia, Ljubljana, Slovenia; [Micallef, Reno] Minist Sustainable Dev, Dept Fisheries & Aquaculture, Marsa, Malta; [Peristeraki, Panagiota; Tserpes, George] HCMR, Iraklion, Crete, Greece; [Relini, Giulio] SIBM, Genoa, Italy; [Relini, Giulio] Univ Genoa, DISTAV, Genoa, Italy; [Sartor, Paolo] CIBM Ctr Interuniv Biol Marina & Ecol Appl, Livorno, Italy	Spanish Institute of Oceanography; Swedish University of Agricultural Sciences; University of Cagliari; Spanish Institute of Oceanography; Spanish Institute of Oceanography; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Ifremer; Hellenic Centre for Marine Research; Universita degli Studi di Bari Aldo Moro; University of Bologna; Hellenic Centre for Marine Research; University of Genoa	Keller, S (corresponding author), Inst Espanol Oceanog, Ctr Oceanog Baleares, Muelle Poniente S-N,Apdo 291, Palma De Mallorca 07015, Spain.	stefanie.keller@ba.ieo.es	Tserpes, George/L-6201-2013; Keller, Stefanie/K-7724-2019; Quetglas, Antoni/K-9089-2014; Isajlovic, Igor/AAP-9861-2020; Massutí, Enric/AAG-5117-2021; Hidalgo, Manuel/B-8023-2015	Tserpes, George/0000-0001-9052-4091; Keller, Stefanie/0000-0003-4826-9511; Quetglas, Antoni/0000-0002-1303-8003; SARTOR, PAOLO/0000-0001-7239-8255; Spedicato, Maria Teresa/0000-0001-9939-9426; Hidalgo, Manuel/0000-0002-3494-9658; Lefkaditou, Evgenia/0000-0002-7868-5375; Bartolino, Valerio/0000-0002-4506-4329; Massuti, Enric/0000-0002-9524-5873	EU; European Community [289257]; IEO-FPI grant [2011/11]	EU(European Commission); European Community(European Commission); IEO-FPI grant	This study was performed under the Data Collection Framework (cofunded by the EU and the national governments involved in the study). Funding was also received from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement MYFISH no 289257. The article does not necessarily reflect the views of the commission. SK was financed by an IEO-FPI grant (2011/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre J, 2010, GLOBAL CHANGE BIOL, V16, P2866, DOI 10.1111/j.1365-2486.2010.02223.x; Bartolino V, 2008, ICES J MAR SCI, V65, P963, DOI 10.1093/icesjms/fsn079; Bello G, 2004, BIOGEOGRAPHIA, V33, P209; Bello Giambattista, 2008, Biologia Marina Mediterranea, V15, P318; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Colloca F, 2004, MAR BIOL, V145, P1129, DOI 10.1007/s00227-004-1405-8; Colloca F, 2003, ESTUAR COAST SHELF S, V56, P469, DOI 10.1016/S0272-7714(02)00196-8; Colloca F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119590; Colloca F, 2013, FISH FISH, V14, P89, DOI 10.1111/j.1467-2979.2011.00453.x; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; D'Onghia G., 1996, Oebalia, V22, P33; Danovaro Roberto, 2003, Chemistry and Ecology, V19, P15, DOI 10.1080/0275754031000081467; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Gaertner JC, 2007, MAR ECOL PROG SER, V341, P191, DOI 10.3354/meps341191; Gaertner JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066753; Garofalo G, 2007, HYDROBIOLOGIA, V580, P117, DOI 10.1007/s10750-006-0460-1; Golani D, 1998, ITAL J ZOOL, V65, P95, DOI 10.1080/11250009809386801; Gonzalez M, 2002, SCI MAR, V66, P199, DOI 10.3989/scimar.2002.66s2199; Gotelli Nicholas J., 2011, P39; Granger V, 2015, PROG OCEANOGR, V130, P65, DOI 10.1016/j.pocean.2014.10.002; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Ibanez CM, 2009, MAR BIOL RES, V5, P374, DOI 10.1080/17451000802534873; Johannesen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034924; Kendall VJ, 2006, DEEP-SEA RES PT I, V53, P506, DOI 10.1016/j.dsr.2005.12.005; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Lefkaditou E., 2003, Journal of Northwest Atlantic Fishery Science, V31, P431; Lefkaditou E, 1998, S AFR J MARINE SCI, V20, P453; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Lloret J, 2001, FISH OCEANOGR, V10, P33, DOI 10.1046/j.1365-2419.2001.00151.x; Longhurst AR, 1987, ECOLOGY TROPICAL OCE, P370; Macias DM, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00079; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; MACPHERSON E, 1994, ECOGRAPHY, V17, P242, DOI 10.1111/j.1600-0587.1994.tb00099.x; Mangold K., 1988, P315; Mann K. H., 1996, DYNAMICS MARINE ECOS, P394; McClatchie S, 1997, DEEP-SEA RES PT I, V44, P647, DOI 10.1016/S0967-0637(96)00096-9; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Moutin T, 2002, J MARINE SYST, V33, P273, DOI 10.1016/S0924-7963(02)00062-3; Pierce GJ, 2008, HYDROBIOLOGIA, V612, P49, DOI 10.1007/s10750-008-9489-7; Puerta P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133439; Puerta P, 2014, MAR ECOL PROG SER, V514, P105, DOI 10.3354/meps10972; Quetglas A, 2014, J MARINE SYST, V138, P150, DOI 10.1016/j.jmarsys.2013.11.015; Quetglas A, 2000, ESTUAR COAST SHELF S, V50, P739, DOI 10.1006/ecss.1999.0603; Quetglas A, 2011, ACTA OECOL, V37, P476, DOI 10.1016/j.actao.2011.06.002; Quignard J.P., 2000, Biologia Marina Mediterranea, V7, P1; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Rosa R, 2008, GLOBAL ECOL BIOGEOGR, V17, P600, DOI 10.1111/j.1466-8238.2008.00397.x; Rosa R, 2008, ECOLOGY, V89, P3449, DOI 10.1890/08-0638.1; Salman Alp, 2009, Bollettino Malacologico, V45, P47; Siddon EC, 2011, MAR ECOL PROG SER, V426, P225, DOI 10.3354/meps09009; Sifner SK, 2005, ISR J ZOOL, V51, P315; Spencer CC, 2007, EVOL ECOL RES, V9, P775; Taviani M., 2002, Biologia Marina Mediterranea, V9, P445; Tolimieri N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010653; Vasilakopoulos P, 2014, CURR BIOL, V24, P1643, DOI 10.1016/j.cub.2014.05.070; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	63	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146469	10.1371/journal.pone.0146469	http://dx.doi.org/10.1371/journal.pone.0146469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760965	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100036
J	Mesoudi, A; Magid, K; Hussain, D				Mesoudi, Alex; Magid, Kesson; Hussain, Delwar			How Do People Become WEIRD? Migration Reveals the Cultural Transmission Mechanisms Underlying Variation in Psychological Processes	PLOS ONE			English	Article							INDIVIDUALISM-COLLECTIVISM; SELF-ENHANCEMENT; COGNITION; HYPOTHESIS; AMERICAN; CHILDREN; CHINESE; NICHE; HEAD; MIND	Cultural psychologists have shown that people from Western, Educated, Industrialised, Rich, Democratic (WEIRD) countries often exhibit different psychological processing to people from less-WEIRD countries. The former exhibit more individualistic and less collectivistic social orientation, and more analytic and less holistic cognition, than non-Westerners. Yet the mechanisms responsible for maintaining this cultural variation are unclear. Immigration is an ideal 'natural experiment' for uncovering such mechanisms. We used a battery of psychological measures previously shown to vary cross-culturally to compare the social orientation and cognitive style of 286 residents of East London from three cultural backgrounds: (i) 1st-generation British Bangladeshi immigrants; (ii) 2nd-generation British Bangladeshis raised in the UK to Bangladeshi-raised parents; and (iii) non-migrants whose parents were born and raised in the UK. Model comparison revealed that individualism and dispositional attribution, typical of Western societies, are driven primarily by horizontal cultural transmission (e.g. via mass media), with parents and other family members having little or no effect, while collectivism, social closeness and situational attribution were driven by a mix of vertical/oblique cultural transmission (e.g. via family contact) and horizontal cultural transmission. These individual-level transmission dynamics can explain hitherto puzzling population-level phenomena, such as the partial acculturation of 2nd-generation immigrants on measures such as collectivism (due to the mix of vertical and horizontal cultural transmission), or the observation in several countries of increasing individualism (which is transmitted horizontally and therefore rapidly) despite little corresponding change in collectivism (which is transmitted partly vertically and therefore more slowly). Further consideration of cultural transmission mechanisms, in conjunction with the study of migrant communities and model comparison statistics, can shed light on the persistence of, and changes in, culturally- variable psychological processes.	[Mesoudi, Alex] Univ Exeter, Dept Biosci, Human Biol & Cultural Evolut Grp, Penryn, Cornwall, England; [Mesoudi, Alex; Magid, Kesson] Univ Durham, Dept Anthropol, Durham, England; [Hussain, Delwar] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh, Midlothian, Scotland	University of Exeter; Durham University; University of Edinburgh	Mesoudi, A (corresponding author), Univ Exeter, Dept Biosci, Human Biol & Cultural Evolut Grp, Cornwall Campus, Penryn, Cornwall, England.	a.mesoudi@exeter.ac.uk			Economic and Social Research Council (ESRC) [ES/J01916X/1]; Economic and Social Research Council [ES/J01916X/1, ES/J01916X/2] Funding Source: researchfish; ESRC [ES/J01916X/2, ES/J01916X/1] Funding Source: UKRI	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by an Economic and Social Research Council (ESRC) research grant ES/J01916X/1 to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, BANGL MUSL COMM ENGL; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Barton K., 2015, MUMIN MULTIMODEL INF; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Burnham K.P., 2010, MODEL SELECTION MULT; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Cheung BY, 2011, PSYCHOL SCI, V22, P147, DOI 10.1177/0956797610394661; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; CHIU LH, 1972, INT J PSYCHOL, V7, P235, DOI 10.1080/00207597208246604; Christensen RHB., 2015, ORDINAL REGRESSION M; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Derex M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9398; Greenfield PM, 2003, COGNITIVE DEV, V18, P455, DOI 10.1016/j.cogdev.2003.09.004; Hamamura T, 2012, PERS SOC PSYCHOL REV, V16, P3, DOI 10.1177/1088868311411587; HARRIS JR, 1995, PSYCHOL REV, V102, P458, DOI 10.1037/0033-295X.102.3.458; Heine S. J., 2011, CULTURAL PSYCHOL; Heine SJ, 1997, J PERS SOC PSYCHOL, V72, P1268, DOI 10.1037/0022-3514.72.6.1268; Heine SJ, 2007, PERS SOC PSYCHOL REV, V11, P4, DOI 10.1177/1088868306294587; Henrich J, 2016, SECRET OF OUR SUCCESS: HOW CULTURE IS DRIVING HUMAN EVOLUTION, DOMESTICATING OUR SPECIES, AND MAKING US SMARTER, P1; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hong YY, 2000, AM PSYCHOL, V55, P709, DOI 10.1037//0003-066X.55.7.709; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hussain D, 2007, J CREAT COMMUN, V2, P189, DOI 10.1177/097325860700200210; Kim HS, 2014, ANNU REV PSYCHOL, V65, P487, DOI 10.1146/annurev-psych-010213-115040; Kitayama S., 2010, HDB CULTURAL PSYCHOL; Kitayama S, 2011, ANNU REV PSYCHOL, V62, P419, DOI 10.1146/annurev-psych-120709-145357; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Masuda T, 2008, PERS SOC PSYCHOL B, V34, P1260, DOI 10.1177/0146167208320555; Mesoudi A, 2011, CULTURAL EVOLUTION; Mesoudi A, 2016, CURR OPIN PSYCHOL, V7, P17, DOI 10.1016/j.copsyc.2015.07.001; Mesoudi A, 2009, PSYCHOL REV, V116, P929, DOI 10.1037/a0017062; Morling B, 2008, PERS SOC PSYCHOL REV, V12, P199, DOI 10.1177/1088868308318260; MORRIS MW, 1994, J PERS SOC PSYCHOL, V67, P949, DOI 10.1037/0022-3514.67.6.949; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Norenzayan A, 2002, COGNITIVE SCI, V26, P653, DOI 10.1207/s15516709cog2605_4; Oishi S., 2000, CULTURE SUBJECTIVE W, P87; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; R Core Team, 2013, R LANG ENV STAT COMP; Ross L., 1977, ADV EXP SOC PSYCHOL, V10, P173, DOI [10.1016/S0065-2601(08)60357-3, DOI 10.1016/S0065-2601(08)60357-3]; Ryder AG, 2000, J PERS SOC PSYCHOL, V79, P49, DOI 10.1037//0022-3514.79.1.49; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Triandis HC, 1998, J PERS SOC PSYCHOL, V74, P118, DOI 10.1037/0022-3514.74.1.118; Varnum MEW, 2010, CURR DIR PSYCHOL SCI, V19, P9, DOI 10.1177/0963721409359301; Venables WN., 2002, MODERN APPL STAT S 4	48	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147162	10.1371/journal.pone.0147162	http://dx.doi.org/10.1371/journal.pone.0147162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA8CX	26760972	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000368033100072
J	Patrut, A; Patrut, RT; Danthu, P; Pock-Tsy, JML; Rakosy, L; Lowy, DA; von Reden, KF				Patrut, Adrian; Patrut, Roxana T.; Danthu, Pascal; Pock-Tsy, Jean-Michel Leong; Rakosy, Laszlo; Lowy, Daniel A.; von Reden, Karl F.			AMS Radiocarbon Dating of Large Za Baobabs (Adansonia za) of Madagascar	PLOS ONE			English	Article							PERFORMANCE; CARBON; AGE	The article reports the radiocarbon investigation of Anzapalivoro, the largest za baobab (Adansonia za) specimen of Madagascar and of another za, namely the Big cistern baobab. Several wood samples collected from the large inner cavity and from the outer part/exterior of the tree were investigated by AMS (accelerator mass spectrometry) radiocarbon dating. For samples collected from the cavity walls, the age values increase with the distance into the wood up to a point of maximum age, after which the values decrease toward the outer part. This anomaly of age sequences indicates that the inner cavity of Anzapalivoro is a false cavity, practically an empty space between several fused stems disposed in a ring-shaped structure. The radiocarbon date of the oldest sample was 780 +/- 30 BP, which corresponds to a calibrated age of around 735 yr. Dating results indicate that Anzapalivoro has a closed ring-shaped structure, which consists of 5 fused stems that close a false cavity. The oldest part of the biggest za baobab has a calculated age of 900 years. We also disclose results of the investigation of a second za baobab, the Big cistern baobab, which was hollowed out for water storage. This specimen, which consists of 4 fused stems, was found to be around 260 years old.	[Patrut, Adrian] Univ Babes Bolyai, Fac Chem, R-3400 Cluj Napoca, Romania; [Patrut, Roxana T.; Rakosy, Laszlo] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania; [Danthu, Pascal] UPR BSEF, Cirad, Montpellier, France; [Danthu, Pascal] Direct Reg CIRAD, Antananarivo, Madagascar; [Danthu, Pascal; Pock-Tsy, Jean-Michel Leong] DP Foret & Biodivers, Antananarivo, Madagascar; [Lowy, Daniel A.] Nova Univ, Alexandria, VA USA; [von Reden, Karl F.] Woods Hole Oceanog Inst, Dept Geol & Geophys, NOSAMS Facil, Woods Hole, MA 02543 USA	Babes Bolyai University from Cluj; Babes Bolyai University from Cluj; CIRAD; CIRAD; Woods Hole Oceanographic Institution	Patrut, A (corresponding author), Univ Babes Bolyai, Fac Chem, R-3400 Cluj Napoca, Romania.	apatrut@gmail.com	Lowy, Daniel A/C-3265-2016; Laszlo, Rakosy/J-3541-2016; Patrut, Adrian/C-3566-2012; Rakosy, Laszlo/K-8702-2013	Laszlo, Rakosy/0000-0002-1866-3422; Patrut, Adrian/0000-0002-9862-6735; Rakosy, Laszlo/0000-0002-7793-6996; Patrut, Roxana/0000-0002-8691-2160	Romanian Ministry of National Education CNCS-UEFISCDI [PN-II-ID-PCE-2013-76]	Romanian Ministry of National Education CNCS-UEFISCDI	The research was funded by the Romanian Ministry of National Education CNCS-UEFISCDI under grant PN-II-ID-PCE-2013-76. Website: http://uefiscdi.gov.ro/. AP received the full funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum D.A., 1996, Primate Report, V46, P311; BAUM DA, 1995, ANN MO BOT GARD, V82, P440, DOI 10.2307/2399893; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Marie CN, 2009, BIODIVERS CONSERV, V18, P2759, DOI 10.1007/s10531-009-9672-9; Olsson I.U., 1986, P273; Pakenham T., 2004, REMARKABLE BAOBAB; Patrut A, 2015, STUDIA UBB CHEMIA, V50, P7; Patrut A, 2007, TREE PHYSIOL, V27, P1569, DOI 10.1093/treephys/27.11.1569; Patrut A, 2015, NUCL INSTRUM METH B, V361, P591, DOI 10.1016/j.nimb.2015.04.044; Patrut A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121170; Patrut A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117193; Patrut A, 2013, NUCL INSTRUM METH B, V294, P622, DOI 10.1016/j.nimb.2012.04.025; Patrut A, 2011, ANN FOREST SCI, V68, P993, DOI 10.1007/s13595-011-0107-x; Patrut A, 2010, RADIOCARBON, V52, P727; Patrut A, 2010, NUCL INSTRUM METH B, V268, P910, DOI 10.1016/j.nimb.2009.10.062; Pettigrew JD, 2012, TAXON, V61, P1240, DOI 10.1002/tax.616006; Povinec PP, 2009, RADIOCARBON, V51, P45, DOI 10.1017/S0033822200033701; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Randriamanana T, 2012, S AFR J BOT, V81, P61, DOI 10.1016/j.sajb.2012.05.005; Roberts ML, 2010, RADIOCARBON, V52, P228, DOI 10.1017/S0033822200045252; Robertson I, 2006, APPL GEOCHEM, V21, P1674, DOI 10.1016/j.apgeochem.2006.07.005; SOFER Z, 1980, ANAL CHEM, V52, P1389, DOI 10.1021/ac50058a063; Stutchbury R., 2013, THE BAOBAB; Vieilledent G, 2013, BIOL CONSERV, V166, P11, DOI 10.1016/j.biocon.2013.06.007; VOGEL JS, 1984, NUCL INSTRUM METH B, V5, P289, DOI 10.1016/0168-583X(84)90529-9; Wickens G.E., 2008, BAOBABS PACHYCAULS A, DOI DOI 10.1007/978-1-4020-6431-9; Woodborne S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124202	27	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146977	10.1371/journal.pone.0146977	http://dx.doi.org/10.1371/journal.pone.0146977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760300	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100060
J	Papanikolaou, NE; Demiris, N; Milonas, PG; Preston, S; Kypraios, T				Papanikolaou, Nikos E.; Demiris, Nikos; Milonas, Panagiotis G.; Preston, Simon; Kypraios, Theodore			Does Mutual Interference Affect the Feeding Rate of Aphidophagous Coccinellids? A Modeling Perspective	PLOS ONE			English	Article							PREDATOR-PREY SYSTEMS; FUNCTIONAL-RESPONSES; COLEOPTERA-COCCINELLIDAE; AUGMENTATIVE RELEASES; ADALIA-BIPUNCTATA; APPLE ORCHARDS; POPULATION; COMPETITION; COMPLEXITY; PARASITES	Mutual interference involves direct interactions between individuals of the same species that may alter their foraging success. Larvae of aphidophagous coccinellids typically stay within a patch during their lifetime, displaying remarkable aggregation to their prey. Thus, as larvae are exposed to each other, frequent encounters may affect their foraging success. A study was initiated in order to determine the effect of mutual interference in the coccinellids' feeding rate. One to four 4th larval instars of the fourteen-spotted ladybird beetle Propylea quatuordecimpunctata were exposed for 6 hours into plastic containers with different densities of the black bean aphid, Aphis fabae, on potted Vicia faba plants. The data were used to fit a purely prey-dependent Holling type II model and its alternatives which account for interference competition and have thus far been underutilized, i.e. the Beddington-DeAngelis, the Crowley-Martin and a modified Hassell-Varley model. The Crowley-Martin mechanistic model appeared to be slightly better among the competing models. The results showed that although the feeding rate became approximately independent of predator density at high prey density, some predator dependence in the coccinellid's functional response was observed at the low prey-high predator density combination. It appears that at low prey densities, digestion breaks are negligible so that the predators do waste time interfering with each other, whereas at high prey densities time loss during digestion breaks may fully accommodate the cost of interference, so that the time cost may be negligible.	[Papanikolaou, Nikos E.; Milonas, Panagiotis G.] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Athens, Greece; [Demiris, Nikos] Athens Univ Econ & Business, Dept Stat, Athens, Greece; [Preston, Simon; Kypraios, Theodore] Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England	Athens University of Economics & Business; University of Nottingham	Papanikolaou, NE (corresponding author), Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Athens, Greece.	nepapanikolaou@yahoo.gr	Milonas, Panagiotis/AAV-3805-2020	Milonas, Panagiotis/0000-0001-5391-7750; Kypraios, Theodore/0000-0002-6190-4762				ABRAMS PA, 1989, EVOL ECOL, V3, P95, DOI 10.1007/BF02270915; Agarwala BK, 2003, ENTOMOL EXP APPL, V106, P219, DOI 10.1046/j.1570-7458.2003.00021.x; BEDDINGTON JR, 1975, J ANIM ECOL, V44, P331, DOI 10.2307/3866; Begon M., 1996, ECOLOGY; CROWLEY PH, 1989, J N AM BENTHOL SOC, V8, P211, DOI 10.2307/1467324; DAY WH, 1994, ENTOMOL NEWS, V105, P244; de Villemereuil PB, 2011, ECOL MODEL, V222, P419, DOI 10.1016/j.ecolmodel.2010.10.011; DEANGELIS DL, 1975, ECOLOGY, V56, P881, DOI 10.2307/1936298; Dixon A.F.G., 2000, INSECT PREDATOR PREY; Dostalkova I, 2002, J THEOR BIOL, V218, P323, DOI 10.1006/jtbi.2002.3080; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Fernandez C, 1998, BAYESIAN STAT, V6, P1; Ferran A, 1996, EUR J ENTOMOL, V93, P59; Gilks WR, 1996, MARKOV CHAIN MONTE C; HASSELL MP, 1969, NATURE, V223, P1133, DOI 10.1038/2231133a0; Hassell MP., 1978, DYNAMICS ARTHROPOD P; HATTINGH V, 1990, ECOL ENTOMOL, V15, P385, DOI 10.1111/j.1365-2311.1990.tb00821.x; Hodek I., 1996, ECOLOGY COCCINELLIDA; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Juliano S.A., 2001, DESIGN ANAL ECOLOGIC, P178, DOI DOI 10.1201/9781003059813; Kehrli P, 2001, ENTOMOL EXP APPL, V99, P245, DOI 10.1023/A:1018945117119; Kindlmann P, 2001, BASIC APPL ECOL, V2, P333, DOI 10.1078/1439-1791-00071; Kratina P, 2009, OECOLOGIA, V159, P425, DOI 10.1007/s00442-008-1225-5; Michaud J.P., 2012, P488; OATEN A, 1975, AM NAT, V109, P289, DOI 10.1086/282998; Obrycki JJ, 2009, BIOL CONTROL, V51, P244, DOI 10.1016/j.biocontrol.2009.05.009; Papanikolaou NE, BAYESIAN INFER UNPUB; Papanikolaou NE, 2014, ANN ENTOMOL SOC AM, V107, P468, DOI 10.1603/AN13088; Roberts G, 1997, ANN APPL PROBAB, P110; Schellhorn NA, 2005, POPUL ECOL, V47, P71, DOI 10.1007/s10144-004-0204-x; Sentis A, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00379.1; Sentis A, 2012, OECOLOGIA, V169, P1117, DOI 10.1007/s00442-012-2255-6; Skalski GT, 2001, ECOLOGY, V82, P3083; Solomon ME, 1949, J ANIM ECOL, V41, P369; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2008, ECOL MODEL, V219, P248, DOI 10.1016/j.ecolmodel.2008.08.009; SUTHERLAND WJ, 1983, J ANIM ECOL, V52, P821, DOI 10.2307/4456; van Gils JA, 2004, J ANIM ECOL, V73, P386, DOI 10.1111/j.0021-8790.2004.00812.x; Wyss E, 1999, ENTOMOL EXP APPL, V90, P167, DOI 10.1023/A:1003564714363	43	30	30	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146168	10.1371/journal.pone.0146168	http://dx.doi.org/10.1371/journal.pone.0146168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756980	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800008
J	Castellano, J; Puente, A; Echeazarra, I; Usabiaga, O; Casamichana, D				Castellano, Julen; Puente, Asier; Echeazarra, Ibon; Usabiaga, Oidui; Casamichana, David			Number of Players and Relative Pitch Area per Player: Comparing Their Influence on Heart Rate and Physical Demands in Under-12 and Under-13 Football Players	PLOS ONE			English	Article							YOUNG SOCCER PLAYERS; SMALL-SIDED GAMES; INTERMITTENT RECOVERY TEST; RATE RESPONSES; YOUTH SOCCER; PHYSIOLOGICAL-RESPONSES; TIME-MOTION; MATCH PERFORMANCE; 10 HZ; RELIABILITY	The aim of the present study is to analyse the influence of different large-sided games (LSGs) on the physical and physiological variables in under-12s (U12) and -13s (U13) soccer players. The effects of the combination of different number of players per team, 7, 9, and 11 (P7, P9, and P11, respectively) with three relative pitch areas, 100, 200, and 300 m(2) (A100, A200, and A300, respectively), were analysed in this study. The variables analysed were: 1) global indicator such as total distance (TD); work:rest ratio (W:R); player-load (PL) and maximal speed (V-max); 2) heart rate (HR) mean and time spent in different intensity zones of HR (<75%, 75-84%, 84-90% and >90%), and; 3) five absolute (<8, 8-13, 13-16 and >16 Km h(-1)) and three relative speed categories (<40%, 40-60% and >60% V-max). The results support the theory that a change in format (player number and pitch dimensions) affects no similarly in the two players categories. Although it can seem that U13 players are more demanded in this kind of LSG, when the work load is assessed from a relative point of view, great pitch dimensions and/or high number of player per team are involved in the training task to the U12 players. The results of this study could alert to the coaches to avoid some types of LSGs for the U12 players such as:P11 played in A100, A200 or A300, P9 played in A200 or A300 and P7 played in A300 due to that U13>U12 in several physical and physiological variables (W:R, time spent in 84-90% HRmax, distance in 8-13 and 13-16 Km h(-1) and time spent in 40-60% V-max). These results may help youth soccer coaches to plan the progressive introduction of LSGs so that task demands are adapted to the physiological and physical development of participants.	[Castellano, Julen; Puente, Asier; Echeazarra, Ibon; Usabiaga, Oidui] Univ Basque Country UPV EHU, Vitoria, Spain; [Casamichana, David] Univ Cantabria, Gimbernat Cantabria Univ Sch, E-39005 Santander, Spain	University of Basque Country; Universidad de Cantabria	Castellano, J (corresponding author), Univ Basque Country UPV EHU, Vitoria, Spain.	julen.castellano@ehu.eus	Castellano, Julen/D-6127-2011	Castellano, Julen/0000-0001-5167-5284; USABIAGA ARRUABARRENA, OIDUI/0000-0003-1935-8961; Echeazarra, Ibon/0000-0002-6220-4178	University of the Basque Country (UPV/EHU) project [EHU12/14, 13523]	University of the Basque Country (UPV/EHU) project	This work was supported by the University of the Basque Country (UPV/EHU) project EHU12/14 "Evaluacion del proceso de entrenamiento y la competicion en el futbol de formacion" during the period 2012-14 [Code 13523].	Alexandre D, 2012, J STRENGTH COND RES, V26, P2890, DOI 10.1519/JSC.0b013e3182429ac7; Arana J, 2013, QUAL QUANT, V47, P3473, DOI 10.1007/s11135-012-9734-z; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Barnett M L, 1973, Res Q, V44, P440; Boyd LJ, 2011, INT J SPORT PHYSIOL, V6, P311, DOI 10.1123/ijspp.6.3.311; Brandes M, 2012, J STRENGTH COND RES, V26, P1353, DOI 10.1519/JSC.0b013e318231ab99; Buchheit M, 2010, INT J SPORTS MED, V31, P818, DOI 10.1055/s-0030-1262838; Buchheit M, 2010, INT J SPORTS MED, V31, P709, DOI 10.1055/s-0030-1261897; Buchheit M, 2008, COACH SPORT SCI J, V3, P21; Buchheit M, 2012, INT J SPORT PHYSIOL, V7, P76, DOI 10.1123/ijspp.7.1.76; Casamichana D, 2012, J STRENGTH COND RES, V26, P837, DOI 10.1519/JSC.0b013e31822a61cf; Casamichana D, 2010, J SPORT SCI, V28, P1615, DOI 10.1080/02640414.2010.521168; Castagna C, 2010, J STRENGTH COND RES, V24, P3227, DOI 10.1519/JSC.0b013e3181e72709; Castagna C, 2009, J STRENGTH COND RES, V23, P1954, DOI 10.1519/JSC.0b013e3181b7f743; Castellano J, 2011, INT J SPORTS MED, V32, P415, DOI 10.1055/s-0031-1271771; Castellano J, 2013, SCI FOOTBALL, VVII, P311; Castellano J, 2013, J STRENGTH COND RES, V27, P1295, DOI 10.1519/JSC.0b013e318267a5d1; Castellano J, 2011, J SPORT SCI MED, V10, P233; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Dellal A, 2008, J STRENGTH COND RES, V22, P1449, DOI 10.1519/JSC.0b013e31817398c6; Drust B, 2005, CHRONOBIOL INT, V22, P21, DOI 10.1081/CBI-200041039; Folgado H, 2014, EUR J SPORT SCI, V14, pS487, DOI 10.1080/17461391.2012.730060; Frencken W, 2013, J SYST SCI COMPLEX, V26, P85, DOI 10.1007/s11424-013-2284-1; Goto H, 2013, J STRENGTH COND RES, V24, P3227; Harley JA, 2010, J SPORT SCI, V28, P1391, DOI 10.1080/02640414.2010.510142; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hill-Haas SV, 2009, J SPORT SCI, V27, P1, DOI [10.1080/02640410802206857, 10.1080/02640410902761199]; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Johnston RJ, 2014, J STRENGTH COND RES, V28, P1649, DOI 10.1519/JSC.0000000000000323; Jones S., 2007, KINESIOLOGY, V39, P150; Katis A, 2009, J SPORT SCI MED, V8, P374; Kelly DA, 2009, J SCI MED SPORT, V12, P475, DOI 10.1016/j.jsams.2008.01.010; Koklu Y, 2011, J STRENGTH COND RES, V25, P1522, DOI 10.1519/JSC.0b013e3181e06ee1; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Mendez-Villanueva A, 2013, INT J SPORTS MED, V34, P101, DOI 10.1055/s-0032-1306323; Mendez-Villanueva A, 2011, J STRENGTH COND RES, V25, P2634, DOI 10.1519/JSC.0b013e318201c281; Ouellette J., 2004, STRATEGIES J PHYS SP, V17, P3, DOI [10.1080/08924562.2004.10591082, DOI 10.1080/08924562.2004.10591082]; Owen A., 2004, INSIGHT, V7, P50; Owen AL, 2011, J STRENGTH COND RES, V25, P2104, DOI 10.1519/JSC.0b013e3181f0a8a3; Rampinini E, 2007, J SPORT SCI, V25, P659, DOI 10.1080/02640410600811858; Silva P, 2014, J SPORT SCI, V32, P1888, DOI 10.1080/02640414.2014.961950; Stratton G., 2004, YOUTH SOCCER SCI PER; Tessitore A, 2006, J SPORT MED PHYS FIT, V46, P36; Tessitore A, 2012, J STRENGTH COND RES, V26, P106, DOI 10.1519/JSC.0b013e31821854f2; Wein H., 2007, DEV YOUTH SOCCER PLA	45	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0127505	10.1371/journal.pone.0127505	http://dx.doi.org/10.1371/journal.pone.0127505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752422	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100001
J	Deng, S; Yue, D; Yang, LC; Fu, X; Feng, YZ				Deng, Song; Yue, Dong; Yang, Le-chan; Fu, Xiong; Feng, Ya-zhou			Distributed Function Mining for Gene Expression Programming Based on Fast Reduction	PLOS ONE			English	Article							PREDICTION; STRENGTH	For high-dimensional and massive data sets, traditional centralized gene expression programming (GEP) or improved algorithms lead to increased run-time and decreased prediction accuracy. To solve this problem, this paper proposes a new improved algorithm called distributed function mining for gene expression programming based on fast reduction (DFMGEP-FR). In DFMGEP-FR, fast attribution reduction in binary search algorithms (FAR-BSA) is proposed to quickly find the optimal attribution set, and the function consistency replacement algorithm is given to solve integration of the local function model. Thorough comparative experiments for DFMGEP-FR, centralized GEP and the parallel gene expression programming algorithm based on simulated annealing (parallel GEPSA) are included in this paper. For the waveform, mushroom, connect-4 and musk datasets, the comparative results show that the average time-consumption of DFMGEP-FR drops by 89.09%%, 88.85%, 85.79% and 93.06%, respectively, in contrast to centralized GEP and by 12.5%, 8.42%, 9.62% and 13.75%, respectively, compared with parallel GEPSA. Six well-studied UCI test data sets demonstrate the efficiency and capability of our proposed DFMGEP-FR algorithm for distributed function mining.	[Deng, Song; Yue, Dong; Feng, Ya-zhou] Nanjing Univ Posts & Telecommun, Inst Adv Technol, Nanjing 210023, Jiangsu, Peoples R China; [Yang, Le-chan] Nanjing Univ, Int Inst Earth Syst Sci, Nanjing 210093, Jiangsu, Peoples R China; [Fu, Xiong] Nanjing Univ Posts & Telecommun, Sch Comp, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University of Posts & Telecommunications; Nanjing University; Nanjing University of Posts & Telecommunications	Deng, S (corresponding author), Nanjing Univ Posts & Telecommun, Inst Adv Technol, Nanjing 210023, Jiangsu, Peoples R China.	ds16090311@163.com			National Natural Science Foundation of P.R. China [51507084, 61202354]; NUPTSF [NY214203]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); NUPTSF	This work was supported by the National Natural Science Foundation of P.R. China under grant Nos. 51507084 and 61202354, NUPTSF under grant No. NY214203.	Chen L, 2014, ENG APPL ARTIF INTEL, V34, P66, DOI 10.1016/j.engappai.2014.05.005; Ferreira C, 2006, GENE EXPRESSION PROG; Gullu H, 2014, ENG APPL ARTIF INTEL, V35, P143, DOI 10.1016/j.engappai.2014.06.020; Huo Li-min, 2008, Proceedings of the CSEE, V28, P103; K-s Li, 2012, J SYSTEM SIMULATION, V3; Khatib H, 2012, RIVER PUBL SER COMM, P1; Koza J., 1994, GENETIC PROGRAMMING; [卢毅 Lu Yi], 2011, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V11, P85; Minqiang L, 2002, BASIC THEORY APPL GE; Mousavi SM, 2014, COMPUT IND ENG, V74, P120, DOI 10.1016/j.cie.2014.05.010; Mousavi SM, 2012, ADV ENG SOFTW, V45, P105, DOI 10.1016/j.advengsoft.2011.09.014; PAWLAK Z, 1982, INT J COMPUT INF SCI, V11, P341, DOI 10.1007/BF01001956; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng YZ, 2014, NEUROCOMPUTING, V137, P293, DOI 10.1016/j.neucom.2013.05.062; Si-wei J., 2005, Acta Electronica Sinica, V33, P2017; Zeng HL, 2004, INTELLIGENCE COMPUTI; [曾清红 Zeng Qinghong], 2004, [工程图学学报, Journal of Engineering Graphics], V25, P84; Zhao XY, 2014, NEUROCOMPUTING, V145, P512, DOI 10.1016/j.neucom.2014.05.002; Zheng Jiao-Ling, 2011, Journal of Software, V22, P899, DOI 10.3724/SP.J.1001.2011.03768; [朱明放 Zhu Mingfang], 2010, [计算机研究与发展, Journal of Computer Research and Development], V47, P292	20	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146698	10.1371/journal.pone.0146698	http://dx.doi.org/10.1371/journal.pone.0146698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751200	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100132
J	Dreier, J; Sorensen, JA; Brewer, JR				Dreier, Jes; Sorensen, Jens A.; Brewer, Jonathan R.			Superresolution and Fluorescence Dynamics Evidence Reveal That Intact Liposomes Do Not Cross the Human Skin Barrier	PLOS ONE			English	Article							TRANSDERMAL DRUG-DELIVERY; LASER-SCANNING MICROSCOPY; IN-VITRO; CORRELATION SPECTROSCOPY; LIPID VESICLES; PENETRATION; CARRIERS; FORMULATIONS; STRATEGIES; MECHANISM	In this study we use the combination of super resolution optical microscopy and raster image correlation spectroscopy (RICS) to study the mechanism of action of liposomes as transdermal drug delivery systems in human skin. Two different compositions of liposomes were applied to newly excised human skin, a POPC liposome and a more flexible liposome containing the surfactant sodium cholate. Stimulated emission depletion microscopy (STED) images of intact skin and cryo-sections of skin treated with labeled liposomes were recorded displaying an optical resolution low enough to resolve the 100 nm liposomes in the skin. The images revealed that virtually none of the liposomes remained intact beneath the skin surface. RICS two color cross correlation diffusion measurements of double labeled liposomes confirmed these observations. Our results suggest that the liposomes do not act as carriers that transport their cargo directly through the skin barrier, but mainly burst and fuse with the outer lipid layers of the stratum corneum. It was also found that the flexible liposomes showed a greater delivery of the fluorophore into the stratum corneum, indicating that they functioned as chemical permeability enhancers.	[Dreier, Jes; Brewer, Jonathan R.] Univ Southern Denmark, Dept Biochem & Mol Biol, MEMPHYS Ctr Membrane Biophys, Adv Bioimaging Grp, Odense, Denmark; [Sorensen, Jens A.] Odense Univ Hosp, Dept Reconstruct Surg, DK-5000 Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Brewer, JR (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, MEMPHYS Ctr Membrane Biophys, Adv Bioimaging Grp, Odense, Denmark.	brewer@bmb.sdu.dk	Brewer, Jonathan/C-7079-2012	Brewer, Jonathan/0000-0002-3444-1715; Sorensen, Jens Ahm/0000-0003-4903-0094; Dreier, Jes/0000-0002-9596-5125	Villum Fondet [VKR23119]; Villum Fonden [00007268] Funding Source: researchfish	Villum Fondet; Villum Fonden(Villum Fonden)	This work was supported by Villum Fondet, http://villumfonden.dk, grant number: VKR23119. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Roman R, 2004, EUR J PHARM BIOPHARM, V58, P301, DOI 10.1016/j.ejpb.2004.03.027; Bahia APCO, 2010, EUR J PHARM SCI, V39, P90, DOI 10.1016/j.ejps.2009.10.016; Bloksgaard M, 2014, INT J COSMETIC SCI, V36, P39, DOI 10.1111/ics.12089; Bloksgaard M, 2013, EUR J PHARM SCI, V50, P586, DOI 10.1016/j.ejps.2013.04.010; Bloksgaard M, 2012, OTOL NEUROTOL, V33, P177, DOI 10.1097/MAO.0b013e318241be63; BOND JR, 1988, J INVEST DERMATOL, V90, P486, DOI 10.1111/1523-1747.ep12460958; Bouwstra JA, 2003, PROG LIPID RES, V42, P1, DOI 10.1016/S0163-7827(02)00028-0; Bouwstra JA, 2002, ADV DRUG DELIVER REV, V54, pS41, DOI 10.1016/S0169-409X(02)00114-X; Brewer J, 2013, J INVEST DERMATOL, V133, P1260, DOI 10.1038/jid.2012.461; BRONAUGH RL, 1982, TOXICOL APPL PHARM, V62, P481, DOI 10.1016/0041-008X(82)90149-1; Carrer DC, 2008, J CONTROL RELEASE, V132, P12, DOI 10.1016/j.jconrel.2008.08.006; Cevc G, 2003, CLIN PHARMACOKINET, V42, P461, DOI 10.2165/00003088-200342050-00004; Cevc G, 1998, BBA-BIOMEMBRANES, V1368, P201, DOI 10.1016/S0005-2736(97)00177-6; Cevc G, 2004, ADV DRUG DELIVER REV, V56, P675, DOI 10.1016/j.addr.2003.10.028; Cevc G, 2002, BBA-BIOMEMBRANES, V1564, P21, DOI 10.1016/S0005-2736(02)00401-7; CEVC G, 1995, J CONTROL RELEASE, V36, P3, DOI 10.1016/0168-3659(95)00056-E; Cevc G, 2010, J CONTROL RELEASE, V141, P277, DOI 10.1016/j.jconrel.2009.10.016; Choi CK, 2011, BIOPHYS J, V100, P583, DOI 10.1016/j.bpj.2010.12.3719; Digman MA, 2005, BIOPHYS J, V88, pL33, DOI 10.1529/biophysj.105.061788; El Maghraby GMM, 2006, J PHARM PHARMACOL, V58, P415, DOI 10.1211/jpp.58.4.0001; Elsayed MMA, 2006, INT J PHARMACEUT, V322, P60, DOI 10.1016/j.ijpharm.2006.05.027; Friedrich H, 2010, ANGEW CHEM INT EDIT, V49, P7850, DOI 10.1002/anie.201001493; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Guldbrand S, 2013, EUR J PHARM BIOPHARM, V84, P430, DOI 10.1016/j.ejpb.2012.10.001; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Herwadkar A, 2012, INT J PHARMACEUT, V423, P289, DOI 10.1016/j.ijpharm.2011.11.041; Honeywell-Nguyen PL, 2006, J LIPOSOME RES, V16, P273, DOI 10.1080/08982100600848595; Honeywell-Nguyen PL, 2004, J INVEST DERMATOL, V123, P902, DOI 10.1111/j.0022-202X.2004.23441.x; Honeywell-Nguyen PL, 2002, BBA-GEN SUBJECTS, V1573, P130; Iwai I, 2012, J INVEST DERMATOL, V132, P2215, DOI 10.1038/jid.2012.43; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prausnitz MR, 2004, NAT REV DRUG DISCOV, V3, P115, DOI 10.1038/nrd1304; Simonsson C, 2011, TOXICOL APPL PHARM, V252, P221, DOI 10.1016/j.taap.2011.02.010; Subongkot T, 2014, INT J NANOMED, V9, P3539, DOI 10.2147/IJN.S65287; Tanner T, 2008, SKIN RES TECHNOL, V14, P249, DOI 10.1111/j.1600-0846.2008.00316.x; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; van Kuijk-Meuwissen MEMJ, 1998, BBA-BIOMEMBRANES, V1371, P31, DOI 10.1016/S0005-2736(97)00273-3; Wang YP, 2005, EUR J PHARM BIOPHARM, V60, P179, DOI 10.1016/j.ejpb.2004.12.008; Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025	41	40	41	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146514	10.1371/journal.pone.0146514	http://dx.doi.org/10.1371/journal.pone.0146514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751684	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100093
J	Foltz, SJ; Modi, JN; Melick, GA; Abousaud, MI; Luan, JN; Fortunato, MJ; Beedle, AM				Foltz, Steven J.; Modi, Jill N.; Melick, Garrett A.; Abousaud, Marin I.; Luan, Junna; Fortunato, Marisa J.; Beedle, Aaron M.			Abnormal Skeletal Muscle Regeneration plus Mild Alterations in Mature Fiber Type Specification in Fktn-Deficient Dystroglycanopathy Muscular Dystrophy Mice	PLOS ONE			English	Article							GLYCOPROTEIN COMPLEX; ALPHA-DYSTROGLYCAN; EXTRACELLULAR-MATRIX; SOLEUS MUSCLE; NEUROMUSCULAR-JUNCTIONS; MYOTONIC-DYSTROPHY; GENE-EXPRESSION; PRECURSOR CELLS; SATELLITE CELLS; AGRIN RECEPTOR	Glycosylated alpha-dystroglycan provides an essential link between extracellular matrix proteins, like laminin, and the cellular cytoskeleton via the dystrophin-glycoprotein complex. In secondary dystroglycanopathy muscular dystrophy, glycosylation abnormalities disrupt a complex O-mannose glycan necessary for muscle structural integrity and signaling. Fktn-deficient dystroglycanopathy mice develop moderate to severe muscular dystrophy with skeletal muscle developmental and/or regeneration defects. To gain insight into the role of glycosylated a-dystroglycan in these processes, we performed muscle fiber typing in young (2, 4 and 8 week old) and regenerated muscle. In mice with Fktn disruption during skeletal muscle specification (Myf5/Fktn KO), newly regenerated fibers (embryonic myosin heavy chain positive) peaked at 4 weeks old, while total regenerated fibers (centrally nucleated) were highest at 8 weeks old in tibialis anterior (TA) and iliopsoas, indicating peak degeneration/ regeneration activity around 4 weeks of age. In contrast, mature fiber type specification at 2, 4 and 8 weeks old was relatively unchanged. Fourteen days after necrotic toxin-induced injury, there was a divergence in muscle fiber types between Myf5/Fktn KO (skeletal- muscle specific) and whole animal knockout induced with tamoxifen post-development (Tam/Fktn KO) despite equivalent time after gene deletion. Notably, Tam/Fktn KO retained higher levels of embryonic myosin heavy chain expression after injury, suggesting a delay or abnormality in differentiation programs. In mature fiber type specification post-injury, there were significant interactions between genotype and toxin parameters for type 1, 2a, and 2x fibers, and a difference between Myf5/Fktn and Tam/Fktn study groups in type 2b fibers. These data suggest that functionally glycosylated a-dystroglycan has a unique role in muscle regeneration and may influence fiber type specification post-injury.	[Foltz, Steven J.; Modi, Jill N.; Melick, Garrett A.; Abousaud, Marin I.; Luan, Junna; Fortunato, Marisa J.; Beedle, Aaron M.] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Beedle, AM (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	beedlea@uga.edu	Beedle, Aaron M/K-1902-2015; Beedle, Aaron/AAI-7014-2020	Beedle, Aaron M/0000-0002-1019-3235; 	University of Georgia College of Pharmacy; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R15AR065077]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR065077] Funding Source: NIH RePORTER	University of Georgia College of Pharmacy; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors received funding for this work, in part, from the University of Georgia College of Pharmacy (to AMB) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases under Award Number R15AR065077 (to AMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C, 2012, NEUROMUSCULAR DISORD, V22, pS214, DOI 10.1016/j.nmd.2012.10.010; Bassez G, 2008, J NEUROPATH EXP NEUR, V67, P319, DOI 10.1097/NEN.0b013e31816b4acc; Beedle AM, 2007, J BIOL CHEM, V282, P16713, DOI 10.1074/jbc.C700061200; Beedle AM, 2012, J CLIN INVEST, V122, P3330, DOI 10.1172/JCI63004; Blanco G, 2004, NEUROMUSCULAR DISORD, V14, P217, DOI 10.1016/j.nmd.2003.09.008; BUTLERBROWNE GS, 1984, DEV BIOL, V102, P324, DOI 10.1016/0012-1606(84)90197-0; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Constantin B, 2014, BBA-BIOMEMBRANES, V1838, P635, DOI 10.1016/j.bbamem.2013.08.023; Damiani E, 1996, NEUROMUSCULAR DISORD, V6, P33, DOI 10.1016/0960-8966(95)00016-X; Di Costanzo S, 2014, HUM MOL GENET, V23, P5781, DOI 10.1093/hmg/ddu296; DUSTERHOFT S, 1993, DIFFERENTIATION, V53, P25, DOI 10.1111/j.1432-0436.1993.tb00642.x; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Esser K, 1999, J BIOL CHEM, V274, P12095, DOI 10.1074/jbc.274.17.12095; Fan Z, 2014, NEUROMUSCULAR DISORD, V24, P178, DOI 10.1016/j.nmd.2013.10.005; FINK RHA, 1990, J PHYSIOL-LONDON, V420, P337, DOI 10.1113/jphysiol.1990.sp017916; Fortunato MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097567; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Goddeeris MM, 2013, NATURE, V503, P136, DOI 10.1038/nature12605; Gumerson JD, 2010, AM J PHYSIOL-CELL PH, V299, pC1430, DOI 10.1152/ajpcell.00192.2010; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; HANNON K, 1992, DEV BIOL, V151, P137, DOI 10.1016/0012-1606(92)90221-2; Heslop L, 2000, J CELL SCI, V113, P2299; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kabaeva Z, 2011, HUM MOL GENET, V20, P3346, DOI 10.1093/hmg/ddr240; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Kanagawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106721; Kanagawa M, 2013, HUM MOL GENET, V22, P3003, DOI 10.1093/hmg/ddt157; Lee WH, 2006, J MUSCLE RES CELL M, V27, P235, DOI 10.1007/s10974-006-9066-5; Live D, 2013, CHEMBIOCHEM, V14, P2392, DOI 10.1002/cbic.201300417; Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265; Luz MAM, 2002, BRAZ J MED BIOL RES, V35, P691, DOI 10.1590/S0100-879X2002000600009; Nigro V, 2014, BIOCH BIOPHYS ACTA; NONAKA I, 1982, MUSCLE NERVE, V5, P102, DOI 10.1002/mus.880050204; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; OTT MO, 1991, DEVELOPMENT, V111, P1097; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Reissner C, 2014, J BIOL CHEM, V289, P27585, DOI 10.1074/jbc.M114.595413; Rosenblatt JD, 1996, DIFFERENTIATION, V60, P39, DOI 10.1046/j.1432-0436.1996.6010039.x; Sancisi V, 2014, AM J PHYSIOL-REG I, V306, pR124, DOI 10.1152/ajpregu.00379.2013; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SEALOCK R, 1994, CELL, V77, P617, DOI 10.1016/0092-8674(94)90045-0; Smith IC, 2010, J MUSCLE RES CELL M, V31, P267, DOI 10.1007/s10974-010-9229-2; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Taniguchi M, 2006, HUM MOL GENET, V15, P1279, DOI 10.1093/hmg/ddl045; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; Wang JF, 1999, NEUROMUSCULAR DISORD, V9, P150, DOI 10.1016/S0960-8966(98)00114-X	48	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0147049	10.1371/journal.pone.0147049	http://dx.doi.org/10.1371/journal.pone.0147049			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751696	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888100191
J	Hall, ME; Brinkley, TE; Chughtai, H; Morgan, TM; Hamilton, CA; Jordan, JH; Stacey, RB; Soots, S; Hundley, WG				Hall, Michael E.; Brinkley, Tina E.; Chughtai, Haroon; Morgan, Timothy M.; Hamilton, Craig A.; Jordan, Jennifer H.; Stacey, R. Brandon; Soots, Sandra; Hundley, W. Gregory			Adiposity Is Associated with Gender-Specific Reductions in Left Ventricular Myocardial Perfusion during Dobutamine Stress	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CARDIOVASCULAR EVENTS; VISCERAL FAT; CHEST-PAIN; WOMEN; RISK; INDIVIDUALS; DYSFUNCTION; ISCHEMIA	Background Obesity and visceral adiposity are increasingly recognized risk factors for cardiovascular disease. Visceral fat may reduce myocardial perfusion by impairing vascular endothelial function. Women experience more anginal symptoms compared to men despite less severe coronary artery stenosis, as assessed by angiography. Women and men have different fat storage patterns which may account for the observed differences in cardiovascular disease. Therefore, our objective was to evaluate the relationship between visceral adipose tissue distributions and myocardial perfusion in men and women. Methods Visceral and subcutaneous fat distributions and myocardial perfusion were measured in 69 men and women without coronary artery disease using magnetic resonance imaging techniques. Myocardial perfusion index was quantified after first-pass perfusion with gadolinium contrast at peak dose dobutamine stress. Results We observed inverse relationships between female gender (r = -0.35, p = 0.003), pericardial fat (r = -0.36, p = 0.03), intraperitoneal fat (r = -0.37, p = 0.001), and retroperitoneal fat (r = -0.36, p = 0.002) and myocardial perfusion index. Visceral fat depots were not associated with reduced myocardial perfusion at peak dose dobutamine in men. However, in women, BMI (r = -0.33, p = 0.04), pericardial fat (r = -0.53, p = 0.02), subcutaneous fat (r = -0.39, p = 0.01) and intraperitoneal fat (r = -0.30, p = 0.05) were associated with reduced myocardial perfusion during dobutamine stress. Conclusions Higher visceral fat volumes are associated with reduced left ventricular myocardial perfusion at peak dose dobutamine stress in women but not in men. These findings suggest that visceral fat may contribute to abnormal microcirculatory coronary artery perfusion syndromes, explaining why some women exhibit more anginal symptoms despite typically lower grade epicardial coronary artery stenoses than men.	[Hall, Michael E.] Univ Mississippi, Med Ctr, Div Cardiol, Dept Med, Jackson, MS 39216 USA; [Brinkley, Tina E.] Wake Forest Sch Med, Sect Gerontol & Geriatr Med, Dept Med, Winston Salem, NC USA; [Chughtai, Haroon] Beloit Mem Hosp, Div Cardiol, Beloit, WI USA; [Morgan, Timothy M.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Hamilton, Craig A.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC USA; [Jordan, Jennifer H.; Stacey, R. Brandon; Soots, Sandra; Hundley, W. Gregory] Wake Forest Sch Med, Dept Med, Sect Cardiovasc Med, Winston Salem, NC USA	University of Mississippi; University of Mississippi Medical Center; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Hall, ME (corresponding author), Univ Mississippi, Med Ctr, Div Cardiol, Dept Med, Jackson, MS 39216 USA.	mehall@umc.edu	Brinkley, Tina/AAT-9256-2021		National Institutes of Health (NIH) [P30AG21332, R01HL076438, T32HL091824, K01AG033652]; American Heart Association [14SDG20490339]; NIH, National Institutes of Diabetes and Digestive and Kidney Diseases [1K08DK099415-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076438, T32HL091824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK099415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021332, K01AG033652] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH, National Institutes of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research supported in part by National Institutes of Health (NIH) grants P30AG21332 (WGH), R01HL076438 (WGH), and T32HL091824 (WGH) and K01AG033652 (TEB). MEH was funded by a grant from the American Heart Association (14SDG20490339) and is currently funded by grant support from the NIH, National Institutes of Diabetes and Digestive and Kidney Diseases (1K08DK099415-01A1).	Brinkley TE, 2014, INT J OBES LOND; Brinkley TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028410; Chughtai HL, 2011, OBESITY, V19, P1784, DOI 10.1038/oby.2011.188; Chughtai HL, 2010, HYPERTENSION, V56, P901, DOI 10.1161/HYPERTENSIONAHA.110.157370; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gorter PM, 2008, AM J CARDIOL, V102, P380, DOI 10.1016/j.amjcard.2008.04.002; Griffiths KA, 2003, J AM COLL CARDIOL, V42, P698, DOI 10.1016/S0735-1097(03)00776-9; Gulati M, 2012, CLIN CARDIOL, V35, P141, DOI 10.1002/clc.21966; Hamilton CA, 2001, J CARDIOV MAGN RESON, V3, P297, DOI 10.1081/JCMR-100108582; Hundley WG, 2002, CIRCULATION, V106, P2328, DOI 10.1161/01.CIR.0000036017.46437.02; Karastergiou K, 2010, ARTERIOSCL THROM VAS, V30, P1340, DOI 10.1161/ATVBAHA.110.204719; Kim HM, 2007, DIABETES CARE, V30, P701, DOI 10.2337/dc06-1400; Larghat AM, 2013, J MAGN RESON IMAGING, V37, P865, DOI 10.1002/jmri.23889; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Mahabadi AA, 2010, ATHEROSCLEROSIS, V211, P195, DOI 10.1016/j.atherosclerosis.2010.02.013; Metz CNB, 2006, J AM COLL CARDIOL, V47, p21S, DOI 10.1016/j.jacc.2004.12.084; Moreau KL, 2012, J CLIN ENDOCR METAB, V97, P4692, DOI 10.1210/jc.2012-2244; Parikh NI, 2009, OBESITY, V17, P2054, DOI 10.1038/oby.2009.60; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Peterson LR, 2008, JACC-CARDIOVASC IMAG, V1, P424, DOI 10.1016/j.jcmg.2008.05.004; Reis SE, 2001, AM HEART J, V141, P735, DOI 10.1067/mhj.2001.114198; Rider OJ, 2012, CIRCULATION, V125, P1511, DOI 10.1161/CIRCULATIONAHA.111.069518; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Romero-Corral A, 2010, J AM COLL CARDIOL, V56, P662, DOI 10.1016/j.jacc.2010.03.063; Sade LE, 2009, ATHEROSCLEROSIS, V204, P580, DOI 10.1016/j.atherosclerosis.2008.09.038; Sturm W, 2009, OBESITY, V17, P1783, DOI 10.1038/oby.2009.81; Tamis-Holland JE, 2013, J AM COLL CARDIOL, V61, P1767, DOI 10.1016/j.jacc.2013.01.062; Yamatani H, 2013, MENOPAUSE, V20, P437, DOI 10.1097/gme.0b013e318271a640	29	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146519	10.1371/journal.pone.0146519	http://dx.doi.org/10.1371/journal.pone.0146519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751789	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100094
J	Huang, CC; Liu, S; Li, RZ; Sun, FS; Zhou, Y; Yu, GH				Huang, Chichao; Liu, Sha; Li, Ruizhi; Sun, Fusheng; Zhou, Ying; Yu, Guanghui			Spectroscopic Evidence of the Improvement of Reactive Iron Mineral Content in Red Soil by Long-Term Application of Swine Manure	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; STRUCTURE NEXAFS SPECTROSCOPY; FERTILIZATION; MICROSCOPY; PARTICLES; INSIGHTS; INCREASE; COLLOIDS; AL(III); FORMS	Mineral elements in soil solutions are thought to be the precursor of the formation of reactive minerals, which play an important role in global carbon (C) cycling. However, information regarding the regulation of mineral elements release in soil is scarce. Here, we examined the long-term (i.e., 23 yrs) effects of fertilisation practices on Fe minerals in a red soil in Southern China. The results from chemical analysis and Fourier-transform infrared spectroscopy showed that long-term swine manure (M) treatment released greater amounts of minerals into soil solutions than chemical fertilisers (NPK) treatment, and Fe played a dominant role in the preservation of dissolved organic C. Furthermore, Fe K-edge X-ray absorption near-edge fine structure spectroscopy demonstrated that reactive Fe minerals were mainly composed of less crystalline ferrihydrite in the M-treated soil and more crystalline goethite in the NPK-treated soil. In conclusion, this study reported spectroscopic evidence of the improvement of reactive Femineral content in the M-treated soil colloids when compared to NPK-treated soil colloids.	[Huang, Chichao; Liu, Sha; Li, Ruizhi; Sun, Fusheng; Yu, Guanghui] Nanjing Agr Univ, Natl Engn Res Ctr Organ Based Fertilizers, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Jiangsu Prov Key Lab Organ Solid Waste Utilizat, Nanjing 210095, Jiangsu, Peoples R China; [Zhou, Ying] Shanghai Inst Measurement & Testing Technol, Shanghai 201203, Peoples R China	Nanjing Agricultural University	Sun, FS (corresponding author), Nanjing Agr Univ, Natl Engn Res Ctr Organ Based Fertilizers, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Jiangsu Prov Key Lab Organ Solid Waste Utilizat, Nanjing 210095, Jiangsu, Peoples R China.	henan223@163.com; yuguanghui@njau.edu.cn	Yu, Guanghui/H-4968-2013	Yu, Guanghui/0000-0002-5699-779X; Sun, Fusheng/0000-0003-0538-3445	National Natural Science Foundation of China [41371248, 41371299]; National Basic Research Program of China [2011CB100503]; Natural Science Foundation of Jiangsu Province of China [BK20131321]; Qing Lan Project; Innovative Research Team Development Plan of the Ministry of China [IRT1256]; 111 Project [B12009]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Research Project of Shanghai Municipal Bureau of Quality and Technical Supervision [I00RJ1414]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Qing Lan Project(Jiangsu Polytech Institute); Innovative Research Team Development Plan of the Ministry of China; 111 Project(Ministry of Education, China - 111 Project); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Research Project of Shanghai Municipal Bureau of Quality and Technical Supervision	This work was financially jointly supported by National Natural Science Foundation of China (41371248 and 41371299), National Basic Research Program of China (2011CB100503), Natural Science Foundation of Jiangsu Province of China (BK20131321), the Qing Lan Project, the Innovative Research Team Development Plan of the Ministry of China (IRT1256), the 111 Project (B12009), the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions, and Research Project of Shanghai Municipal Bureau of Quality and Technical Supervision (I00RJ1414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242; Baker LL, 2010, CLAY CLAY MINER, V58, P772, DOI 10.1346/CCMN.2010.0580605; Cai P, 2011, J HAZARD MATER, V185, P1032, DOI 10.1016/j.jhazmat.2010.10.010; Hawkings JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4929; Heymann K, 2011, ORG GEOCHEM, V42, P1055, DOI 10.1016/j.orggeochem.2011.06.021; Hu YF, 2008, GEOCHIM COSMOCHIM AC, V72, P1959, DOI 10.1016/j.gca.2008.02.002; Huang J, 2014, APPL ENVIRON MICROB, V80, P29, DOI 10.1128/AEM.02335-13; Keiluweit M, 2015, NAT CLIM CHANGE, V5, P588, DOI 10.1038/nclimate2580; Kleber M, 2005, EUR J SOIL SCI, V56, P717, DOI 10.1111/j.1365-2389.2005.00706.x; Klitzke S, 2008, EUR J SOIL SCI, V59, P265, DOI 10.1111/j.1365-2389.2007.00997.x; Kong XB, 2014, NATURE, V506, P7, DOI 10.1038/506007a; Kramer MG, 2012, GLOBAL CHANGE BIOL, V18, P2594, DOI 10.1111/j.1365-2486.2012.02681.x; Lalonde K, 2012, NATURE, V483, P198, DOI 10.1038/nature10855; Lehmann J, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002435; Lehmann J, 2008, NAT GEOSCI, V1, P238, DOI 10.1038/ngeo155; Li JW, 2012, GEODERMA, V173, P184, DOI 10.1016/j.geoderma.2011.12.021; Fdez-Gubieda ML, 2013, ACS NANO, V7, P3297, DOI 10.1021/nn3059983; Machmuller MB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7995; Maillard E, 2014, GLOBAL CHANGE BIOL, V20, P666, DOI 10.1111/gcb.12438; MCLAREN JW, 1995, MIKROCHIM ACTA, V119, P287, DOI 10.1007/BF01244008; Prietzel J, 2007, EUR J SOIL SCI, V58, P1027, DOI 10.1111/j.1365-2389.2006.00882.x; Rasmussen PE, 1998, SCIENCE, V282, P893, DOI 10.1126/science.282.5390.893; Ravel B, 2005, PHYS SCRIPTA, VT115, P1007; Riedel T, 2013, P NATL ACAD SCI USA, V110, P10101, DOI 10.1073/pnas.1221487110; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schumacher M, 2005, ENVIRON SCI TECHNOL, V39, P9094, DOI 10.1021/es050099f; Siebecker M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6003; Solomon D, 2009, SOIL SCI SOC AM J, V73, P1817, DOI 10.2136/sssaj2008.0228; TORRENT J, 1980, GEODERMA, V23, P191, DOI 10.1016/0016-7061(80)90002-6; Uroz S, 2014, SOIL BIOL BIOCHEM, V69, P265, DOI 10.1016/j.soilbio.2013.11.002; Urquhart SG, 1999, J ELECTRON SPECTROSC, V100, P119, DOI 10.1016/S0368-2048(99)00043-2; Wen YL, 2014, SOIL SCI SOC AM J, V78, P2083, DOI 10.2136/sssaj2014.04.0147; Wen YL, 2014, CHEMOSPHERE, V111, P441, DOI 10.1016/j.chemosphere.2014.03.078; Wiesner MR, 2011, ACS NANO, V5, P8466, DOI 10.1021/nn204118p; Wu JN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103823, 10.1371/journal.pone.0105567]; Xiao J, 2015, CHEMOSPHERE, V138, P225, DOI 10.1016/j.chemosphere.2015.05.089; Xu RK, 2010, GEOCHIM COSMOCHIM AC, V74, P6422, DOI 10.1016/j.gca.2010.07.029; Yu GH, 2012, ENVIRON SCI TECHNOL, V46, P6102, DOI 10.1021/es3002212; Yu GH, 2011, ENVIRON SCI TECHNOL, V45, P9224, DOI 10.1021/es201483f; ZASOSKI RJ, 1977, COMMUN SOIL SCI PLAN, V8, P425, DOI 10.1080/00103627709366735; Zhang HM, 2009, PEDOSPHERE, V19, P199, DOI 10.1016/S1002-0160(09)60109-0; Zhang JC, 2013, EUR J SOIL SCI, V64, P797, DOI 10.1111/ejss.12104	42	11	14	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146364	10.1371/journal.pone.0146364	http://dx.doi.org/10.1371/journal.pone.0146364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752419	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100071
J	Lin, YY				Lin, Yowyu			Processing of Scalar Inferences by Mandarin Learners of English: An Online Measure	PLOS ONE			English	Article							WORKING-MEMORY; LANGUAGE; ACQUISITION; VOCABULARY	Scalar inferences represent the condition when a speaker uses a weaker expression such as some in a pragmatic scale like <some, all>, and s/he has the intention to reject the stronger use of the other word like all in the utterance. Considerable disagreement has arisen concerning how interlocutors derive the inferences. The study presented here tries to address this issue by examining online scalar inferences among Mandarin learners of English. To date, Default Inference and Relevance Theory have made different predictions regarding how people process scalar inferences. Findings from recently emerging first language studies did not fully resolved the debate but led to even more heated debates. The current three online psycholinguistic experiments reported here tried to address the processing of scalar inferences from second language perspective. Results showed that Mandarin learners of English showed faster reaction times and a higher acceptance rate when interpreting some as some but not all and this was true even when subjects were under time pressure, which was manifested in Experiment 2. Overall, the results of the experiments supported Default Theory. In addition, Experiment 3 also found that working memory capacity plays a critical role during scalar inference processing. High span readers were faster in accepting the some but not all interpretation than low span readers. However, compared with low span readers, high span readers were more likely to accept the some and possibly all condition, possibly due to their working memory capacity to generate scenarios to fit the interpretation.	[Lin, Yowyu] Natl Taiwan Univ, Dept Foreign Languages & Literatures, Taipei 10764, Taiwan	National Taiwan University	Lin, YY (corresponding author), Natl Taiwan Univ, Dept Foreign Languages & Literatures, Taipei 10764, Taiwan.	brianlin@ntu.edu.tw			Ministry of Science and Technology, Taiwan [102-2410-H-002-219]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by Ministry of Science and Technology, Taiwan (102-2410-H-002-219).	Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bley-Vroman R, 2009, STUD SECOND LANG ACQ, V31, P175, DOI 10.1017/S0272263109090275; Bonnefon JF, 2009, COGNITION, V112, P249, DOI 10.1016/j.cognition.2009.05.005; Bouton L.F., 1992, PRAGMAT LANG LEARN, V3, P53; Bouton LF, 1988, WORLD ENGLISH, V7, P183; Bygate M., 2001, RES PEDAGOGIC TASKS, P23; Chee MWL, 1999, J NEUROSCI, V19, P3050; Chee MWL, 1999, NEURON, V23, P127, DOI 10.1016/S0896-6273(00)80759-X; Chierchia G, 2001, PROC ANN BUCLD, P157; Chierchia G., 2004, STRUCTURES, P39; Clahsen H, 2006, TRENDS COGN SCI, V10, P564, DOI 10.1016/j.tics.2006.10.002; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; Dekydtspotter L, 2005, SECOND LANG RES, V21, P291, DOI 10.1191/0267658305sr249oa; Eckman F., 1993, SECOND LANG RES, V9, P234, DOI DOI 10.1177/026765839300900302; Ellis N. C., 1996, STUDIES 2 LANGUAGE A, V18, P91, DOI [10.1017/S0272263100014698, DOI 10.1017/S0272263100014698]; Ellis NC, 1996, Q J EXP PSYCHOL-A, V49, P234, DOI 10.1080/027249896392883; Grice Paul., 1989, STUDIES WAY WORDS; Grodner DJ, 2010, COGNITION, V116, P42, DOI 10.1016/j.cognition.2010.03.014; Hawkins Roger., 2001, 2 LANGUAGE SYNTAX; Horn L., 1992, OHIO STATE U WORKING, V40, P163, DOI DOI 10.3765/SALT.V2I0.3039; Horn LR, 1976, SEMANTIC PROPERTIES; Huang YT, 2009, COGNITIVE PSYCHOL, V58, P376, DOI 10.1016/j.cogpsych.2008.09.001; Ionin T., 2004, LANG ACQUIS, V12, P3, DOI [DOI 10.1207/S15327817LA1201_, 10.1207/s15327817la1201_2, DOI 10.1207/S15327817LA1201_2]; Just MA, 1996, PSYCHOL REV, V103, P773, DOI 10.1037/0033-295X.103.4.773; KLEIN D, 1995, P NATL ACAD SCI USA, V92, P2899, DOI 10.1073/pnas.92.7.2899; Levinson S. C., 1983, PRAGMATICS; LEVINSON SC, 1989, J LINGUIST, V25, P455, DOI 10.1017/S0022226700014183; Marty PP, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00403; Masoura EV, 1999, INT J PSYCHOL, V34, P383, DOI 10.1080/002075999399738; Master P., 1997, SYSTEM, V30, P331, DOI DOI 10.1016/S0346-251X(97)00010-9; Osterhout L, 2012, CAMBRIDGE HDB PSYCHO, P365, DOI [10.1017/CBO9781139029377.025, DOI 10.1017/CBO9781139029377.025]; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Schwartz BD, 1998, LINGUA, V106, P133, DOI 10.1016/S0024-3841(98)00032-1; SERVICE E, 1995, APPL PSYCHOLINGUIST, V16, P155, DOI 10.1017/S0142716400007062; SERVICE E, 1992, Q J EXP PSYCHOL-A, V45, P21, DOI 10.1080/14640749208401314; SERVICE E, 1993, J MEM LANG, V32, P608, DOI 10.1006/jmla.1993.1031; Slabakova R, 2010, LINGUA, V120, P2444, DOI 10.1016/j.lingua.2009.06.005; Sperber D., 1985, RELEVANCE COMMUNICAT, VSecond; THOMAS M, 1989, APPL PSYCHOLINGUIST, V10, P335, DOI 10.1017/S0142716400008663; Trenkic D, 2004, LINGUA, V114, P1401, DOI 10.1016/j.lingua.2003.09.005; Wilson D, 2004, HDB PRAGMATICS	44	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145494	10.1371/journal.pone.0145494	http://dx.doi.org/10.1371/journal.pone.0145494			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DA6CA	26752294	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100014
J	Moon, JS; Lee, SH; Kim, EJ; Cho, H; Lee, W; Kim, GW; Park, HJ; Cho, SW; Lee, C; Oh, JW				Moon, Jae-Su; Lee, Seung-Hoon; Kim, Eun-Jung; Cho, Hee; Lee, Wooseong; Kim, Geon-Woo; Park, Hyun-Ji; Cho, Seung-Woo; Lee, Choongho; Oh, Jong-Won			Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; CAP-INDEPENDENT TRANSLATION; SIRNA DELIVERY; CELL-CULTURE; HCV IRES; REPLICATION; PROTEIN; GENOME; POLYMERASE; PHOSPHORYLATION	The hepatitis C virus (HCV) internal ribosome entry site (IRES) that directs cap-independent viral translation is a primary target for small interfering RNA (siRNA)-based HCV antiviral therapy. However, identification of potent siRNAs against HCV IRES by bioinformatics-based siRNA design is a challenging task given the complexity of HCV IRES secondary and tertiary structures and association with multiple proteins, which can also dynamically change the structure of this cis-acting RNA element. In this work, we utilized siRNA tiling approach whereby siRNAs were tiled with overlapping sequences that were shifted by one or two nucleotides over the HCV IRES stem-loop structures III and IV spanning nucleotides (nts) 277-343. Based on their antiviral activity, we mapped a druggable region (nts 313-343) where the targets of potent siRNAs were enriched. siIE22, which showed the greatest anti-HCV potency, targeted a highly conserved sequence across diverse HCV genotypes, locating within the IRES subdomain IIIf involved in pseudoknot formation. Stepwise target shifting toward the 50 or 30 direction by 1 or 2 nucleotides reduced the antiviral potency of siIE22, demonstrating the importance of siRNA accessibility to this highly structured and sequence-conserved region of HCV IRES for RNA interference. Nanoparticle-mediated systemic delivery of the stability-improved siIE22 derivative gs_PS1 siIE22, which contains a single phosphorothioate linkage on the guide strand, reduced the serum HCV genome titer by more than 4 log(10) in a xenograft mouse model for HCV replication without generation of resistant variants. Our results provide a strategy for identifying potent siRNA species against a highly structured RNA target and offer a potential pan-HCV genotypic siRNA therapy that might be beneficial for patients resistant to current treatment regimens.	[Moon, Jae-Su; Lee, Seung-Hoon; Kim, Eun-Jung; Cho, Hee; Lee, Wooseong; Kim, Geon-Woo; Park, Hyun-Ji; Cho, Seung-Woo; Oh, Jong-Won] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea; [Lee, Choongho] Dongguk Univ, Coll Pharm, Goyang 410820, South Korea	Yonsei University; Dongguk University	Oh, JW (corresponding author), Yonsei Univ, Dept Biotechnol, 50 Yonsei Ro, Seoul 120749, South Korea.	jwoh@yonsei.ac.kr	Lee, Choongho/AAZ-9876-2020; Park, Hyun-Ji/GRX-8325-2022; Kim, Geon-Woo/AAL-3260-2021; Cho, Seung-Woo/AAU-1214-2021; Park, Hyun-Ji/ABA-6694-2021	Park, Hyun-Ji/0000-0001-9688-4418; Cho, Seung-Woo/0000-0001-8058-332X; Park, Hyun-Ji/0000-0001-9688-4418; KIM, GEON-WOO/0000-0003-0432-8268	Technology Innovation Program - Ministry of Knowledge Economy (MKE, Korea) [MKE 10035159]; National Research Foundation of Korea - Korea government (MSIP) [NRF 2009-0092959, 2010-0025982, 2013-063182, 2014R1A2A2A01005522, COMPA 2014-11-1672]	Technology Innovation Program - Ministry of Knowledge Economy (MKE, Korea); National Research Foundation of Korea - Korea government (MSIP)	This work was supported by a grant from the Technology Innovation Program (MKE 10035159) funded by the Ministry of Knowledge Economy (MKE, Korea) and, in part, by grants from the National Research Foundation of Korea funded by the Korea government (MSIP) (NRF 2009-0092959, 2010-0025982, 2013-063182, 2014R1A2A2A01005522, and COMPA 2014-11-1672).	Ahn DG, 2011, J VIRAL HEPATITIS, V18, pE298, DOI 10.1111/j.1365-2893.2010.01416.x; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; Berry KE, 2011, STRUCTURE, V19, P1456, DOI 10.1016/j.str.2011.08.002; Chandra PK, 2012, MOL THER, V20, P1724, DOI 10.1038/mt.2012.107; Chevalier C, 2007, MOL THER, V15, P1452, DOI 10.1038/sj.mt.6300186; Conrad KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056272; Davis Darrell R., 2011, Antiviral Chemistry & Chemotherapy, V21, P117, DOI 10.3851/IMP1693; Deerberg A, 2013, P NATL ACAD SCI USA, V110, P17850, DOI 10.1073/pnas.1217838110; Dibrov SM, 2014, J MED CHEM, V57, P1694, DOI 10.1021/jm401312n; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Fuchs G, 2015, P NATL ACAD SCI USA, V112, P319, DOI 10.1073/pnas.1421328111; Gagnon KT, 2014, NUCLEIC ACID THER, V24, P428, DOI 10.1089/nat.2014.1502; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Izumi RE, 2004, J VIROL, V78, P3763, DOI 10.1128/JVI.78.7.3763-3776.2004; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kanda T, 2007, J VIROL, V81, P669, DOI 10.1128/JVI.01496-06; Kandeel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057140; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kim MG, 2012, BIOCHEM BIOPH RES CO, V421, P112, DOI 10.1016/j.bbrc.2012.03.126; Kim SJ, 2009, J VIRAL HEPATITIS, V16, P697, DOI 10.1111/j.1365-2893.2009.01108.x; Kim SJ, 2004, J BIOL CHEM, V279, P50031, DOI 10.1074/jbc.M408617200; Lee W, 2013, BIOMATERIALS, V34, P9700, DOI 10.1016/j.biomaterials.2013.08.067; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Mahon KP, 2010, BIOCONJUGATE CHEM, V21, P1448, DOI 10.1021/bc100041r; Martell M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh088; Masaki T, 2015, CELL HOST MICROBE, V17, P217, DOI 10.1016/j.chom.2014.12.014; Niepmann M, 2013, CURR TOP MICROBIOL, V369, P143, DOI 10.1007/978-3-642-27340-7_6; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Perard J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2611; Perron MP, 2011, METHODS MOL BIOL, V725, P121, DOI 10.1007/978-1-61779-046-1_9; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Reynolds JE, 1996, RNA, V2, P867; Sagan SM, 2015, VIRUS RES, V206, P90, DOI 10.1016/j.virusres.2014.12.029; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Sun JM, 2012, J ANTIMICROB CHEMOTH, V67, P49, DOI 10.1093/jac/dkr432; Thi EP, 2015, NATURE, V521, P362, DOI 10.1038/nature14442; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476, DOI 10.1128/JVI.66.3.1476-1483.1992; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WANG CY, 1993, J VIROL, V67, P3338, DOI 10.1128/JVI.67.6.3338-3344.1993; Wang TH, 2000, J VIROL, V74, P11347, DOI 10.1128/JVI.74.23.11347-11358.2000; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu Y, 2011, VIRUS RES, V155, P406, DOI 10.1016/j.virusres.2010.11.009; Xiao F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004128; Yuen M, 2014, AM ASS STUD LIV DIS; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022; Zhu HH, 2012, J INFECT DIS, V205, P656, DOI 10.1093/infdis/jir802; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	56	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146710	10.1371/journal.pone.0146710	http://dx.doi.org/10.1371/journal.pone.0146710			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751678	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100135
J	Ryu, JA; Bang, OY; Suh, GY; Yang, JH; Lee, D; Park, J; Cho, J; Chung, CR; Park, CM; Jeon, K				Ryu, Jeong-Am; Bang, Oh Young; Suh, Gee Young; Yang, Jeong Hoon; Lee, Daesang; Park, Jinkyeong; Cho, Joongbum; Chung, Chi Ryang; Park, Chi-Min; Jeon, Kyeongman			Ischemic Stroke in Critically Ill Patients with Malignancy	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CEREBRAL INFARCTION; CANCER-PATIENTS; CEREBROVASCULAR COMPLICATIONS; NEUROLOGIC COMPLICATIONS; RISK-FACTOR; CHEMOTHERAPY; ETIOLOGY; PATTERN	Background Cerebrovascular diseases are a frequent cause of neurological symptoms in patients with cancer. The clinical characteristics of ischemic stroke (IS) in patients with cancer have been reported in several studies; however, limited data are available regarding critically ill patients with cancer who develop IS during their stay in the intensive care unit (ICU). Methods All consecutive patients who underwent brain magnetic resonance imaging (MRI) for suspicion of IS with acute abnormal neurologic symptoms or who developed signs of IS while in the ICU were retrospectively evaluated. We compared the clinical characteristics and diffusion- weighted imaging (DWI) lesion patterns between patients finally diagnosed as having or not having IS. Results Over the study period, a total of 88 patients underwent brain MRI for suspicion of IS, with altered mental status in 55 (63%), hemiparesis in 28 (32%), and seizure in 20 (23%). A total of 43 (49%) patients were ultimately diagnosed with IS. Multiple DWI lesions (41%) were more common than single lesions (8%). The etiologies of IS were not determined in the majority of patients (n = 27, 63%). In the remaining 16 (37%) patients, the most common aetiology of IS was cardioembolism (n = 8), followed by large-vessel atherosclerosis (n = 3) and small-vessel occlusion (n = 2). However, brain metastases were newly diagnosed in only 7 (8%) patients. Univariate comparison of the baseline characteristics between patients with or without IS did not reveal any significant differences in sex, malignancy type, recent chemotherapy, vascular risk factors, or serum D-dimer levels at the time of suspicion of IS. Thrombotic events were more common in the IS group than in the non-IS group (P = 0.028). However, patients who were ultimately diagnosed with IS had more hemiparesis symptoms at the time of suspicion of IS (P = 0.001). This association was significant even after adjusting for potentially confounding factors (adjusted odds ratio 5.339; 95% confidence interval, 1.521-19.163). Conclusions IS developed during ICU stays in critically ill patients with cancer have particular features that may be associated with cancer-related mechanism.	[Ryu, Jeong-Am; Suh, Gee Young; Yang, Jeong Hoon; Lee, Daesang; Park, Jinkyeong; Cho, Joongbum; Chung, Chi Ryang; Park, Chi-Min; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Bang, Oh Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea; [Park, Chi-Min] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.	kjeon@skku.edu	Suh, Gee Young/O-3676-2019; Park, Jinkyeong/GLV-1649-2022; Park, Jinkyeong/AGB-3445-2022; Jeon, Kyeongman/F-5963-2019	Suh, Gee Young/0000-0001-5473-1712; Park, Jinkyeong/0000-0002-8833-9062; Jeon, Kyeongman/0000-0002-4822-1772	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C0743]; Samsung Medical Center	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Samsung Medical Center(Samsung)	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C0743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, Samsung Medical Center provided support in the form of salaries for all of authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Bang OY, 2011, J CLIN NEUROL, V7, P53, DOI 10.3988/jcn.2011.7.2.53; Barlas I, 2001, Curr Opin Crit Care, V7, P68, DOI 10.1097/00075198-200104000-00003; Benoit DD, 2006, INTENS CARE MED, V32, P93, DOI 10.1007/s00134-005-2836-5; BLECK TP, 1993, CRIT CARE MED, V21, P98, DOI 10.1097/00003246-199301000-00019; Cestari DM, 2004, NEUROLOGY, V62, P2025, DOI 10.1212/01.WNL.0000129912.56486.2B; CHATURVEDI S, 1994, STROKE, V25, P1215, DOI 10.1161/01.STR.25.6.1215; Chong JN, 1998, AM J NEURORADIOL, V19, P1733; Darmon M, 2005, CRIT CARE MED, V33, P2488, DOI 10.1097/01.CCM.0000181728.13354.0A; Doriath V, 2007, J NEURO-ONCOL, V83, P285, DOI 10.1007/s11060-006-9319-6; GRAUS F, 1985, MEDICINE, V64, P16, DOI 10.1097/00005792-198501000-00002; Isensee LM, J CRIT CARE, V4, P208; Kim SG, 2010, STROKE, V41, P798, DOI 10.1161/STROKEAHA.109.571356; Lee EJ, 2014, INT J STROKE, V9, P406, DOI 10.1111/ijs.12124; LEFKOVITZ NW, 1986, STROKE, V17, P555, DOI 10.1161/01.STR.17.3.555; Naik-Tolani S, 1999, CLIN CHEST MED, V20, P423, DOI 10.1016/S0272-5231(05)70150-7; ONEILL BP, 1987, CANCER, V60, P90, DOI 10.1002/1097-0142(19870701)60:1<90::AID-CNCR2820600116>3.0.CO;2-C; Osias J, 2014, CRIT CARE CLIN, V30, P785, DOI 10.1016/j.ccc.2014.06.008; Pilato F, 2009, MINERVA ANESTESIOL, V75, P245; Rogers LR, 2010, SEMIN NEUROL, V30, P311, DOI 10.1055/s-0030-1255224; Schwebel C, 2013, CRIT CARE MED, V41, P1919, DOI 10.1097/CCM.0b013e31828a3bbd; Song JU, 2012, INTENS CARE MED, V38, P1505, DOI 10.1007/s00134-012-2594-0; Stefan O, 2009, J NEURO-ONCOL, V94, P221, DOI 10.1007/s11060-009-9818-3; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Tuma R, 2000, ARCH NEUROL-CHICAGO, V57, P1727, DOI 10.1001/archneur.57.12.1727; Wilcox ME, 2013, CRIT CARE MED, V41, pS81, DOI 10.1097/CCM.0b013e3182a16946; Yoo H, 2013, CRIT CARE, V17, DOI 10.1186/cc12829; Zhang YY, 2006, ACTA NEUROL SCAND, V114, P378, DOI 10.1111/j.1600-0404.2006.00709.x; Zhang YY, 2007, CEREBROVASC DIS, V23, P181, DOI 10.1159/000097639	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146836	10.1371/journal.pone.0146836	http://dx.doi.org/10.1371/journal.pone.0146836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751213	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100160
J	Xing, P; Chen, X; Luo, Y; Nie, SP; Zhao, ZC; Huang, JB; Wang, SW				Xing, Pei; Chen, Xin; Luo, Yong; Nie, Suping; Zhao, Zongci; Huang, Jianbin; Wang, Shaowu			The Extratropical Northern Hemisphere Temperature Reconstruction during the Last Millennium Based on a Novel Method	PLOS ONE			English	Article							SUMMER TEMPERATURE; PAST MILLENNIUM; CLIMATE; VARIABILITY; PROXY; MODEL; DENDROCLIMATOLOGY; REGRESSION; RESOLUTION; EVOLUTION	Large-scale climate history of the past millennium reconstructed solely from tree-ring data is prone to underestimate the amplitude of low-frequency variability. In this paper, we aimed at solving this problem by utilizing a novel method termed "MDVM", which was a combination of the ensemble empirical mode decomposition (EEMD) and variance matching techniques. We compiled a set of 211 tree-ring records from the extratropical Northern Hemisphere (30-90 degrees N) in an effort to develop a new reconstruction of the annual mean temperature by the MDVM method. Among these dataset, a number of 126 records were screened out to reconstruct temperature variability longer than decadal scale for the period 850-2000 AD. The MDVM reconstruction depicted significant low-frequency variability in the past millennium with evident Medieval Warm Period (MWP) over the interval 950-1150 AD and pronounced Little Ice Age (LIA) cumulating in 1450-1850 AD. In the context of 1150-year reconstruction, the accelerating warming in 20th century was likely unprecedented, and the coldest decades appeared in the 1640s, 1600s and 1580s, whereas the warmest decades occurred in the 1990s, 1940s and 1930s. Additionally, the MDVM reconstruction covaried broadly with changes in natural radiative forcing, and especially showed distinct footprints of multiple volcanic eruptions in the last millennium. Comparisons of our results with previous reconstructions and model simulations showed the efficiency of the MDVM method on capturing low-frequency variability, particularly much colder signals of the LIA relative to the reference period. Our results demonstrated that the MDVM method has advantages in studying large-scale and low-frequency climate signals using pure tree-ring data.	[Xing, Pei; Chen, Xin; Luo, Yong; Zhao, Zongci; Huang, Jianbin] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Xing, Pei] Beijing Municipal Climate Ctr, Beijing, Peoples R China; [Nie, Suping] China Meteorol Adm, Natl Climate Ctr, Beijing, Peoples R China; [Wang, Shaowu] Peking Univ, Dept Atmospher Sci, Sch Phys, Beijing 100871, Peoples R China; [Chen, Xin; Luo, Yong; Zhao, Zongci; Huang, Jianbin] Joint Ctr Global Change Studies, Beijing, Peoples R China	Tsinghua University; China Meteorological Administration; Peking University	Luo, Y (corresponding author), Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China.	Yongluo@mail.tsinghua.edu.cn	Nie, Suping/AAE-4906-2021; Huang, Jianbin/AAP-5941-2020		National Natural Science Foundation of China [41175066, 41275076]; China Postdoctoral Science Foundation [2014M550711]; China Meteorological Administration Special Public Welfare Research Fund [GYHY201306019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Meteorological Administration Special Public Welfare Research Fund	This study is supported by National Natural Science Foundation of China (41175066), China Postdoctoral Science Foundation (2014M550711), National Natural Science Foundation of China (41275076), and China Meteorological Administration Special Public Welfare Research Fund (GYHY201306019). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchukaitis KJ, 2013, J CLIMATE, V26, P3001, DOI 10.1175/JCLI-D-11-00139.1; Anchukaitis KJ, 2012, NAT GEOSCI, V5, P836, DOI 10.1038/ngeo1645; Bao Q, 2013, ADV ATMOS SCI, V30, P561, DOI 10.1007/s00376-012-2113-9; Bjorklund JA, 2013, THEOR APPL CLIMATOL, V113, P697, DOI 10.1007/s00704-012-0787-7; Blaauw M, 2007, HOLOCENE, V17, P283, DOI 10.1177/0959683607075857; Briffa KR, 2013, QUATERNARY SCI REV, V72, P83, DOI 10.1016/j.quascirev.2013.04.008; BRIFFA KR, 1992, CLIM DYNAM, V7, P111, DOI 10.1007/BF00211153; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; Buntgen U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025133; Buntgen U, 2005, CLIM DYNAM, V25, P141, DOI 10.1007/s00382-005-0028-1; Christiansen B, 2012, CLIM PAST, V8, P765, DOI 10.5194/cp-8-765-2012; Christiansen B, 2011, J CLIMATE, V24, P6013, DOI 10.1175/2011JCLI4145.1; Christiansen B, 2009, J CLIMATE, V22, P951, DOI 10.1175/2008JCLI2301.1; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; COOK ER, 1994, INT J CLIMATOL, V14, P379, DOI 10.1002/joc.3370140404; Cook ER, 2004, QUATERNARY SCI REV, V23, P2063, DOI 10.1016/j.quascirev.2004.08.013; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Corona C, 2010, CLIM PAST, V6, P379, DOI 10.5194/cp-6-379-2010; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; D'Arrigo R, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006352; D'Arrigo R, 2013, J GEOPHYS RES-ATMOS, V118, P9000, DOI 10.1002/jgrd.50692; EDDY JA, 1976, SCIENCE, V192, P1189, DOI 10.1126/science.192.4245.1189; Esper J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021236; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Esper J, 2013, DENDROCHRONOLOGIA, V31, P216, DOI 10.1016/j.dendro.2012.11.002; Fang KY, 2012, GLOBAL PLANET CHANGE, V80-81, P190, DOI 10.1016/j.gloplacha.2011.10.009; FEYNMAN J, 1984, J GEOPHYS RES-SPACE, V89, P3023, DOI 10.1029/JA089iA05p03023; Fritts H.C, 1976, TREE RINGS CLIMATE; Gao RS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009358; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gray LJ, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000282; Guiot J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009972; Hegerl GC, 2007, J CLIMATE, V20, P650, DOI 10.1175/JCLI4011.1; Hourdin F, 2013, CLIM DYNAM, V40, P2193, DOI 10.1007/s00382-012-1343-y; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Ji F, 2014, NAT CLIM CHANGE, V4, P462, DOI [10.1038/nclimate2223, 10.1038/NCLIMATE2223]; Jones PD, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017139; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Jungclaus JH, 2010, CLIM PAST, V6, P723, DOI 10.5194/cp-6-723-2010; Krivova NA, 2007, ASTRON ASTROPHYS, V467, P335, DOI 10.1051/0004-6361:20066725; Lavigne F, 2013, P NATL ACAD SCI USA, V110, P16742, DOI 10.1073/pnas.1307520110; Ljungqvist FC, 2010, GEOGR ANN A, V92A, P339, DOI 10.1111/j.1468-0459.2010.00399.x; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008272; Mann ME, 2013, J GEOPHYS RES-ATMOS, V118, P7617, DOI 10.1002/jgrd.50609; Mann ME, 2012, NAT GEOSCI, V5, P202, DOI [10.1038/ngeo1394, 10.1038/NGEO1394]; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Melvin TM, 2008, DENDROCHRONOLOGIA, V26, P71, DOI 10.1016/j.dendro.2007.12.001; Metropolis N., 1987, LOS ALAMOS SCI, V15, P125, DOI DOI 10.1128/JCM.05092-11; MICHAELSEN J, 1987, J CLIM APPL METEOROL, V26, P1589, DOI 10.1175/1520-0450(1987)026<1589:CVISCF>2.0.CO;2; Miller GH, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050168; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Peristykh AN, 2003, J GEOPHYS RES-SPACE, V108, DOI [10.1029/2002JA009390, 10.1029/2002JAD09390]; Phipps SJ., 2010, 4 ANT CLIM EC CRC; Riedwyl N, 2009, CLIM DYNAM, V32, P381, DOI 10.1007/s00382-008-0395-5; Rigozo NR, 2008, J ATMOS SOL-TERR PHY, V70, P1025, DOI 10.1016/j.jastp.2008.02.002; Rigozo NR, 2008, J ATMOS SOL-TERR PHY, V70, P1012, DOI 10.1016/j.jastp.2008.01.002; Rutherford S, 2005, J CLIMATE, V18, P2308, DOI 10.1175/JCLI3351.1; Schrijver CJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046658; Schurer AP, 2014, NAT GEOSCI, V7, P104, DOI [10.1038/NGEO2040, 10.1038/ngeo2040]; Shi F, 2014, SCI REP-UK, V4, DOI 10.1038/srep06739; Shi F, 2013, CLIM RES, V56, P231, DOI 10.3354/cr01156; Shi F, 2012, THEOR APPL CLIMATOL, V109, P233, DOI 10.1007/s00704-011-0576-8; Steinhilber F, 2011, PAGES NEWS, V19, P5; Swingedouw D, 2011, CLIM DYNAM, V36, P1349, DOI 10.1007/s00382-010-0803-5; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Vecchio A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066101; Vieira LEA, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200913276; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wu TW, 2010, CLIM DYNAM, V34, P123, DOI 10.1007/s00382-008-0487-2; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Wu ZW, 2011, CLIM DYNAM, V37, P1661, DOI 10.1007/s00382-010-0938-4; Yang B, 2014, P NATL ACAD SCI USA, V111, P2903, DOI 10.1073/pnas.1319238111; Yang FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057638	77	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146776	10.1371/journal.pone.0146776	http://dx.doi.org/10.1371/journal.pone.0146776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751947	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100151
J	Yu, A; Woo, SM; Joo, J; Yang, HR; Lee, WJ; Park, SJ; Nam, BH				Yu, Ami; Woo, Sang Myung; Joo, Jungnam; Yang, Hye-Ryung; Lee, Woo Jin; Park, Sang-Jae; Nam, Byung-Ho			Development and Validation of a Prediction Model to Estimate Individual Risk of Pancreatic Cancer	PLOS ONE			English	Article							POOLED-ANALYSIS; COHORT; KOREA; METAANALYSIS; PROGRESSION	Introduction There is no reliable screening tool to identify people with high risk of developing pancreatic cancer even though pancreatic cancer represents the fifth-leading cause of cancer-related death in Korea. The goal of this study was to develop an individualized risk prediction model that can be used to screen for asymptomatic pancreatic cancer in Korean men and women. Materials and Methods Gender-specific risk prediction models for pancreatic cancer were developed using the Cox proportional hazards model based on an 8-year follow-up of a cohort study of 1,289,933 men and 557,701 women in Korea who had biennial examinations in 1996-1997. The performance of the models was evaluated with respect to their discrimination and calibration ability based on the C-statistic and Hosmer-Leme show type chi(2) statistic. Results A total of 1,634 (0.13%) men and 561 (0.10%) women were newly diagnosed with pancreatic cancer. Age, height, BMI, fasting glucose, urine glucose, smoking, and age at smoking initiation were included in the risk prediction model for men. Height, BMI, fasting glucose, urine glucose, smoking, and drinking habit were included in the risk prediction model for women. Smoking was the most significant risk factor for developing pancreatic cancer in both men and women. The risk prediction model exhibited good discrimination and calibration ability, and in external validation it had excellent prediction ability. Conclusion Gender-specific risk prediction models for pancreatic cancer were developed and validated for the first time. The prediction models will be a useful tool for detecting high-risk individuals who may benefit from increased surveillance for pancreatic cancer.	[Yu, Ami; Joo, Jungnam; Yang, Hye-Ryung; Nam, Byung-Ho] Res Inst & Hosp, Natl Canc Ctr, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang Si, Gyeonggi Do, South Korea; [Woo, Sang Myung; Lee, Woo Jin; Park, Sang-Jae] Res Inst & Hosp, Natl Canc Ctr, Ctr Liver Canc, Goyang Si, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Nam, BH (corresponding author), Res Inst & Hosp, Natl Canc Ctr, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang Si, Gyeonggi Do, South Korea.	byunghonam@ncc.re.kr			National Cancer Center [NCC-1110310-2]	National Cancer Center	This work was supported by a grant from the National Cancer Center (grant no. NCC-1110310-2).	Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Bhutani MS, 2013, CLIN GASTROENTEROL H, V11, P731, DOI 10.1016/j.cgh.2013.02.004; Brat DJ, 1998, AM J SURG PATHOL, V22, P163, DOI 10.1097/00000478-199802000-00003; Canto MI, 2004, CLIN GASTROENTEROL H, V2, P606, DOI 10.1016/S1542-3565(04)00244-7; Canto MI, 2012, GASTROENTEROLOGY, V142, P796, DOI 10.1053/j.gastro.2012.01.005; Chari ST, 2007, SEMIN ONCOL, V34, P284, DOI 10.1053/j.seminoncol.2007.05.005; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Eom BW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132613; Genkinger JM, 2009, CANCER EPIDEM BIOMAR, V18, P765, DOI 10.1158/1055-9965.EPI-08-0880; Han MA, 2012, PANCREAS, V41, P648, DOI 10.1097/MPA.0b013e3182374d65; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hippisley-Cox J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007825; Hippisley-Cox J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X616355; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Huang J, 2013, BRIT J CANCER, V109, P2917, DOI 10.1038/bjc.2013.689; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Iodice S, 2008, LANGENBECK ARCH SURG, V393, P535, DOI 10.1007/s00423-007-0266-2; Jung KW, 2010, J KOREAN MED SCI, V25, P1113, DOI 10.3346/jkms.2010.25.8.1113; Kim J, 2010, AM J CLIN NUTR, V91, P1289, DOI 10.3945/ajcn.2009.28732; Lowenfels AB, 1999, GASTROENTEROL CLIN N, V28, P673, DOI 10.1016/S0889-8553(05)70080-7; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; NAM BH, 2000, DISCRIMINATION CALIB; Organization WH, 1994, INT STAT CLASS DIS R; Park S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054823; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Risch HA, 2012, MOL CARCINOGEN, V51, P109, DOI 10.1002/mc.20826; Shin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088079; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang WY, 2007, J CLIN ONCOL, V25, P1417, DOI 10.1200/JCO.2006.09.2452; Zhao D, 2011, J BIOMED INFORM, V44, P859, DOI 10.1016/j.jbi.2011.05.004	31	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146473	10.1371/journal.pone.0146473	http://dx.doi.org/10.1371/journal.pone.0146473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752291	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100084
J	Zhang, S; Yang, LL; Chen, PH; Jin, H; Xie, XM; Yang, ML; Gao, T; Hu, C; Yu, XM				Zhang, Shan; Yang, Lili; Chen, Peihong; Jin, Hua; Xie, Xinmiao; Yang, Meili; Gao, Ting; Hu, Cheng; Yu, Xuemei			Circulating Adipocyte Fatty Acid Binding Protein (FABP4) Levels Are Associated with Irisin in the Middle-Aged General Chinese Population	PLOS ONE			English	Article							SKELETAL-MUSCLE; ADIPOSE-TISSUE; IN-VIVO; EXERCISE; FNDC5; SERUM; METABOLISM; EXPRESSION; OBESITY; PLASMA	Background Adipocyte fatty acid binding protein (FABP4) has been recently characterized as an adipokine that is closely associated with obesity and metabolic syndrome. Irisin, a novel myokine, activates thermogenesis by increasing the transformation of white adipocytes to brown, and it has improved glucose homeostasis in animal models. In this study, we aimed to explore the relationship between serum FABP4 and irisin in middle-aged Chinese subjects. Methods A total of 111 normal residents (56 men and 55 women) of Fengxian District who were 40 to 60 years of age were recruited. Circulating FABP4 and irisin were determined by enzyme-linked immunosorbent assay. Anthropometric parameters, oral glucose tolerance test results, hemoglobin A1C (HbA1C), blood lipids, homeostasis model assessment of insulin resistance, homeostasis model assessment-beta and body fat composition were also determined. Results All participants were categorized by FABP4 tertiles. There were significant differences in blood pressure, body fat percentage, 2-h plasma glucose, and skeletal muscle mass among the three groups (P<0.05). Furthermore, FABP4 levels in the women were significantly higher than in the men (P<0.05). However, there was no sexual dimorphism in serum irisin (P>0.05). To exclude the effect of sex difference, partial correlations analysis showed that FABP4 was positively correlated with diastolic blood pressure (P<0.05) and body fat percentage (P<0.05) negatively correlated with skeletal muscle mass (P<0.05) and irisin (P<0.05), while irisin was positively correlated with HbA1c (P<0.05) and negatively correlated with creatinine (P<0.05). Multivariate regression analysis demonstrated that serum FABP4 was independently associated with skeletal muscle mass (P<0.001), diastolic blood pressure (P<0.05) and irisin (P<0.05) after adjustment for age, body mass index, body fat percentage, total cholesterol and HbA1C. Conclusions Elevated FABP4 levels increase the risks of obesity-related metabolic disorders and hypertension. Serum irisin might exert antagonistic effects on FABP4 in the middle-aged Chinese population.	[Zhang, Shan; Yang, Lili; Chen, Peihong; Jin, Hua; Xie, Xinmiao; Yang, Meili; Gao, Ting; Yu, Xuemei] Fengxian Cent Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Zhang, Shan; Yu, Xuemei] Southern Med Univ, Clin Med Coll 3, Dept Endocrinol & Metab, Guangzhou, Guangdong, Peoples R China; [Yang, Lili] Zunyi Med Coll, Affiliated Hosp 5, Dept Endocrinol & Metab, Zhuhai, Peoples R China; [Hu, Cheng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Shanghai 200030, Peoples R China	Southern Medical University - China; Zunyi Medical University; Shanghai Jiao Tong University	Yu, XM (corresponding author), Fengxian Cent Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China.	xuemeiyu12@163.com	Hu, Cheng/C-3346-2008	Hu, Cheng/0000-0003-4314-2386	Shanghai Committee of Science and Technology, China [134119b2500]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	This work was funded by grants from the Shanghai Committee of Science and Technology (134119b2500), China. The URLs of the funder's website is that http://www.stcsm.gov.cn/gk/gkml/xxgkbzsm/335201.htm. The author received no specific funding for this work.	Al-Daghri NM, 2014, EUR J CLIN INVEST, V44, P119, DOI 10.1111/eci.12196; Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Baar RA, 2005, AM J PHYSIOL-ENDOC M, V288, pE187, DOI 10.1152/ajpendo.00256.2004; Bao YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019115; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Coe NR, 1999, J LIPID RES, V40, P967; Ebert T, 2014, EUR J ENDOCRINOL, V170, P501, DOI 10.1530/EJE-13-1053; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Liu TY, 2015, CLIN SCI, V129, P839, DOI 10.1042/CS20150009; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Moraes C, 2013, HORM METAB RES, V45, P900, DOI 10.1055/s-0033-1354402; Moreno M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124100; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Sanchis-Gomar F, 2014, ENDOCRINE, V46, P674, DOI 10.1007/s12020-014-0170-9; Scalzo RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090696; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Suh JB, 2014, SCAND J GASTROENTERO, V49, P979, DOI 10.3109/00365521.2013.836754; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Xie XM, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0019-2; Xiong XQ, 2015, BBA-MOL BASIS DIS, V1852, P1867, DOI 10.1016/j.bbadis.2015.06.017; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Zhang HJ, 2013, J HEPATOL, V59, P557, DOI 10.1016/j.jhep.2013.04.030	33	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146605	10.1371/journal.pone.0146605	http://dx.doi.org/10.1371/journal.pone.0146605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752184	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100111
J	Zhao, S; Zhang, Z; Long, QQ; Ma, Y; Lian, XQ; Yang, Y; Gao, W; Chen, Z; Wang, LS				Zhao, Shan; Zhang, Zhen; Long, Qingqing; Ma, Yao; Lian, Xiaoqing; Yang, Yang; Gao, Wei; Chen, Zhong; Wang, Liansheng			Association between Time of Day of Sports-Related Physical Activity and the Onset of Acute Myocardial Infarction in a Chinese Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INTENSITY AEROBIC EXERCISE; SUDDEN CARDIAC DEATH; CIRCADIAN VARIATION; ARTERY-DISEASE; ENDOTHELIAL FUNCTION; VARIANT ANGINA; BLOOD-PRESSURE; LEISURE-TIME; RISK	Objective To investigate the association between the time of day of sports-related physical activity and the onset of acute myocardial infarction (AMI) in a coronary artery disease (CAD) population in China. Methods Between February 2014 and March 2015, a total of 696 patients from Nanjing, China, who had CAD were studied and divided into two groups (Non-AMI and AMI groups). The workrelated activity and sports-related physical activity information were obtained from a self-reporting predesigned patient questionnaire. Results Sports-related physical activity was associated with a lower risk of the onset of AMI, after adjusting the established and potential confounders, with an adjusted odds ratio (OR) of 0.67 (95% CI, 0.47-0.94) compared with those who did not have any sports-related physical activity. A dose-response relationship was observed for intensity, duration, and frequency of sports-related physical activity. Further stratification analysis revealed that the protective effects of sports-related physical activity were significant in the morning and evening groups, and patients who exercised in the evening were at a lower risk of AMI than those doing sports-related physical activity in the morning. The adjusted ORs for doing sports-related physical activity in the morning and evening groups were 0.60(0.36-0.98) and 0.56 (0.37-0.87), respectively, compared with inactivity (all P < 0.05). On the occurrence of AMI, doing sports-related physical activity in the evening had an adjusted OR of 0.93 (95% CI, 0.54-1.64, P = 0.824) compared with in the morning group. Conclusions Sports-related physical activity is associated with a lower risk of onset of AMI than inactivity in Chinese people. For CAD patients, we suggest they participate in sports-related physical activity of high intensity, long duration, and high frequency. Doing sports-related physical activity in the evening and in the morning have similar benefits on the prevention of the onset of AMI.	[Zhao, Shan; Zhang, Zhen; Long, Qingqing; Ma, Yao; Lian, Xiaoqing; Yang, Yang; Gao, Wei; Wang, Liansheng] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Zhong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Cardiol, Shanghai 200233, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University	Chen, Z (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Cardiol, 600 Yishan Rd, Shanghai 200233, Peoples R China.	zhongchen7498@sina.com.cn; drlswang@njmu.edu.cn			National Natural Science Foundation of China [81270255]; Science and Technological Innovation Group of Jiangsu Higher Education Institution "Qing-Lan Project" [JX2161015030]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Pudong New Area Science and Technology Development Fund [PKJ2014-Y09]; Shanghai Municipal Commission of Health and Family Planning Research Project [201440309]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technological Innovation Group of Jiangsu Higher Education Institution "Qing-Lan Project"; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Pudong New Area Science and Technology Development Fund; Shanghai Municipal Commission of Health and Family Planning Research Project	The study was funded by grants from the National Natural Science Foundation of China (No 81270255), the Science and Technological Innovation Group of Jiangsu Higher Education Institution "Qing-Lan Project"(JX2161015030), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Pudong New Area Science and Technology Development Fund (PKJ2014-Y09 to Dr. Zhong Chen), and Shanghai Municipal Commission of Health and Family Planning Research Project (201440309 to Dr. Zhong Chen).	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Cannon CP, 2013, CIRCULATION, V127, P1052, DOI 10.1161/CIR.0b013e3182831a11; Cannon CP, 1997, AM J CARDIOL, V79, P253, DOI 10.1016/S0002-9149(97)00743-1; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Fagard RH, 2007, EUR J CARDIOV PREV R, V14, P12, DOI 10.1097/HJR.0b013e3280128bbb; Folsom AR, 1997, MED SCI SPORT EXER, V29, P901, DOI 10.1097/00005768-199707000-00009; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu G, 2007, EUR HEART J, V28, P492, DOI 10.1093/eurheartj/ehl475; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Jones H, 2006, HYPERTENSION, V47, P778, DOI 10.1161/01.HYP.0000206421.09642.b5; Jones H, 2008, EUR J APPL PHYSIOL, V104, P481, DOI 10.1007/s00421-008-0797-4; Jones H, 2009, MED SCI SPORT EXER, V41, P1188, DOI 10.1249/MSS.0b013e318195109c; Kanaley JA, 2001, J CLIN ENDOCR METAB, V86, P2881, DOI 10.1210/jc.86.6.2881; Kawano H, 2002, J AM COLL CARDIOL, V40, P266, DOI 10.1016/S0735-1097(02)01956-3; Kemi OJ, 2010, J CARDIOPULM REHABIL, V30, P2, DOI 10.1097/HCR.0b013e3181c56b89; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Lian XQ, 2014, PREV MED, V58, P64, DOI 10.1016/j.ypmed.2013.10.020; Morikawa Y, 2013, CORONARY ARTERY DIS, V24, P177, DOI 10.1097/MCA.0b013e32835cbef5; MULLER JE, 1987, CIRCULATION, V75, P131, DOI 10.1161/01.CIR.75.1.131; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; MURRAY PM, 1993, ARCH INTERN MED, V153, P833, DOI 10.1001/archinte.153.7.833; Oguma Y, 2004, AM J PREV MED, V26, P407, DOI 10.1016/j.amepre.2004.02.007; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; PEKKANEN J, 1987, LANCET, V1, P1473, DOI 10.1016/S0140-6736(87)92218-5; Pescatello LS, 2000, BRIT J SPORT MED, V34, P86, DOI 10.1136/bjsm.34.2.86; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; Rognmo O, 2012, CIRCULATION, V126, P1436, DOI 10.1161/CIRCULATIONAHA.112.123117; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; SISCOVICK DS, 1990, T ASSOC LIF, V73, P37; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Ussher MH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub4; Wannamethee SG, 2000, CIRCULATION, V102, P1358, DOI 10.1161/01.CIR.102.12.1358; Wannamethee SG, 2002, CIRCULATION, V105, P1785, DOI 10.1161/01.CIR.0000016346.14762.71; WATERS DD, 1984, AM J CARDIOL, V54, P61, DOI 10.1016/0002-9149(84)90304-7; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7; Wisloff U, 2009, EXERC SPORT SCI REV, V37, P139, DOI 10.1097/JES.0b013e3181aa65fc; YASUE H, 1979, CIRCULATION, V59, P938, DOI 10.1161/01.CIR.59.5.938; Yasue H, 2008, J CARDIOL, V51, P2, DOI 10.1016/j.jjcc.2008.01.001; Yu S, 2003, HEART, V89, P502, DOI 10.1136/heart.89.5.502; Zhao H, 2014, INT J SPORT NUTR EXE, V24, P139, DOI 10.1123/ijsnem.2012-0226	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146472	10.1371/journal.pone.0146472	http://dx.doi.org/10.1371/journal.pone.0146472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752185	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100083
J	Zhou, Y; Yang, P; Cui, FL; Zhang, FT; Luo, XD; Xie, JK				Zhou, Yi; Yang, Ping; Cui, Fenglei; Zhang, Fantao; Luo, Xiangdong; Xie, Jiankun			Transcriptome Analysis of Salt Stress Responsiveness in the Seedlings of Dongxiang Wild Rice (Oryza rufipogon Griff.)	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; QUANTITATIVE TRAIT LOCI; R2R3-TYPE MYB GENE; RNA-SEQ REVEALS; SATIVA L.; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; DROUGHT TOLERANCE; ABIOTIC STRESSES; MESSENGER-RNA	Dongxiang wild rice (Oryza rufipogon Griff.) is the progenitor of cultivated rice (Oryza sativa L.), and is well known for its superior level of tolerance against cold, drought and diseases. To date, however, little is known about the salt-tolerant character of Dongxiang wild rice. To elucidate the molecular genetic mechanisms of salt-stress tolerance in Dongxiang wild rice, the Illumina HiSeq 2000 platform was used to analyze the transcriptome profiles of the leaves and roots at the seedling stage under salt stress compared with those under normal conditions. The analysis results for the sequencing data showed that 6,867 transcripts were differentially expressed in the leaves (2,216 up-regulated and 4,651 down-regulated) and 4,988 transcripts in the roots (3,105 up-regulated and 1,883 down-regulated). Among these differentially expressed genes, the detection of many transcription factor genes demonstrated that multiple regulatory pathways were involved in salt stress tolerance. In addition, the differentially expressed genes were compared with the previous RNA-Seq analysis of salt-stress responses in cultivated rice Nipponbare, indicating the possible specific molecular mechanisms of salt-stress responses for Dongxiang wild rice. A large number of the salt-inducible genes identified in this study were co-localized onto fine-mapped salt-tolerance-related quantitative trait loci, providing candidates for gene cloning and elucidation of molecular mechanisms responsible for salt-stress tolerance in rice.	[Zhou, Yi; Yang, Ping; Cui, Fenglei; Zhang, Fantao; Luo, Xiangdong; Xie, Jiankun] Jiangxi Normal Univ, Coll Life Sci, Nanchang, Peoples R China; [Zhou, Yi] Jiangxi Normal Univ, Inst Adv Study, Nanchang, Peoples R China	Jiangxi Normal University; Jiangxi Normal University	Zhou, Y (corresponding author), Jiangxi Normal Univ, Coll Life Sci, Nanchang, Peoples R China.	zhouyi25@mail2.sysu.edu.cn; xiejiankun@yahoo.com			National Natural Science Foundation of China [31360327, 31500259]; Natural Science Foundation of Jiangxi Province, China [20142BAB214012, 20151BAB204006]; Key Projects of Jiangxi Education Department [KJLD12059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province, China(Natural Science Foundation of Jiangxi Province); Key Projects of Jiangxi Education Department	This study was supported by the grants from the National Natural Science Foundation of China (31360327 and 31500259), the Natural Science Foundation of Jiangxi Province, China (20142BAB214012 and 20151BAB204006), and the Key Projects of Jiangxi Education Department (KJLD12059). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Benjamini Y, 2001, ANN STAT, V29, P1165; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Cao YF, 2005, PHYSIOL MOL PLANT P, V67, P202, DOI 10.1016/j.pmpp.2006.01.004; Chen H, 2012, PLANT SCI, V193, P8, DOI 10.1016/j.plantsci.2012.05.003; Chen LJ, 2013, PLANT PHYSIOL, V163, P1752, DOI 10.1104/pp.113.224881; Chen SY, 2009, CURR ISSUES MOL BIOL, V11, P81; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cui MH, 2013, FEBS LETT, V587, P1773, DOI 10.1016/j.febslet.2013.04.028; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Ding ZJ, 2014, PLANT J, V79, P13, DOI 10.1111/tpj.12538; Duan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045117; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Ge LF, 2008, PLANTA, V228, P191, DOI 10.1007/s00425-008-0729-x; Ge XM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-114; Ghosh A, 2014, PLANT J, V80, P93, DOI 10.1111/tpj.12621; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Gong JM, 1999, CHINESE SCI BULL, V44, P68, DOI 10.1007/BF03182889; Han M, 2014, MOL CELLS, V37, P532, DOI 10.14348/molcells.2014.0128; Hashimoto M, 2004, PLANT CELL PHYSIOL, V45, P550, DOI 10.1093/pcp/pch063; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang DeRun, 2012, Acta Agronomica Sinica, V38, P210, DOI 10.1016/S1875-2780(11)60101-6; Huang J, 2007, BBA-GENE STRUCT EXPR, V1769, P220, DOI 10.1016/j.bbaexp.2007.02.006; Huang J, 2012, PLANT MOL BIOL, V80, P337, DOI 10.1007/s11103-012-9955-5; Huang SB, 2006, PLANT PHYSIOL, V142, P1718, DOI 10.1104/pp.106.088864; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huda KMK, 2013, PLANT J, V76, P997, DOI 10.1111/tpj.12352; International Rice Genome Sequencing Project, 2005, NATURE, V436, P793, DOI DOI 10.1038/NATURE03895; Jami SK, 2012, PLANT CELL REP, V31, P813, DOI 10.1007/s00299-011-1201-0; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Joo J, 2014, PLANT BIOTECHNOL REP, V8, P431, DOI 10.1007/s11816-014-0335-2; Kader MA, 2006, J EXP BOT, V57, P4257, DOI 10.1093/jxb/erl199; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim DY, 2013, GENE, V529, P208, DOI 10.1016/j.gene.2013.08.023; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Lee SY, 2006, MOL CELLS, V21, P192; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li F, 2010, PLANT CELL REP, V29, P977, DOI 10.1007/s00299-010-0883-z; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Li W, 2011, EUPHYTICA, V178, P427, DOI 10.1007/s10681-010-0327-4; Liang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083056; Liang JL, 2015, EUPHYTICA, V201, P441, DOI 10.1007/s10681-014-1236-8; Liao JL, 2015, BMC GENOMICS, V16, P1222; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Liu CT, 2014, PLANT MOL BIOL, V84, P19, DOI 10.1007/s11103-013-0115-3; Liu CT, 2012, PLANTA, V235, P1157, DOI 10.1007/s00425-011-1564-z; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Liu WW, 2014, NEW PHYTOL, V201, P1192, DOI 10.1111/nph.12607; Lu TT, 2008, DNA RES, V15, P285, DOI 10.1093/dnares/dsn018; Mallikarjuna G, 2011, BIOTECHNOL LETT, V33, P1689, DOI 10.1007/s10529-011-0620-x; Mao DH, 2015, THEOR APPL GENET, V128, P1359, DOI 10.1007/s00122-015-2511-3; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Mizuno H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-683; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukherjee K, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-18; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Oono Y, 2011, RICE, V4, P50, DOI 10.1007/s12284-011-9064-0; Park SJ, 2006, PLANTA, V223, P932, DOI 10.1007/s00425-005-0148-1; Park SH, 2015, PLANT BIOTECHNOL REP, V9, P89, DOI 10.1007/s11816-015-0346-7; Pratt LH, 2005, PLANT PHYSIOL, V139, P869, DOI 10.1104/pp.105.066134; Price AH, 2006, TRENDS PLANT SCI, V11, P213, DOI 10.1016/j.tplants.2006.03.006; Rai AN, 2013, MOL BIOL REP, V40, P6429, DOI 10.1007/s11033-013-2757-2; Schmidt R, 2013, PLANT CELL, V25, P2115, DOI 10.1105/tpc.113.113068; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shimizu H, 2005, PLANT CELL PHYSIOL, V46, P1623, DOI 10.1093/pcp/pci178; Singh A, 2015, PLOS ONE, V10; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sun SJ, 2010, J EXP BOT, V61, P2807, DOI 10.1093/jxb/erq120; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; TARCZYNSKI MC, 1993, SCIENCE, V259, P508, DOI 10.1126/science.259.5094.508; Thiemann A, 2010, THEOR APPL GENET, V120, P401, DOI 10.1007/s00122-009-1189-9; Tian F, 2006, THEOR APPL GENET, V112, P570, DOI 10.1007/s00122-005-0165-2; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang F, 2015, PLANT J, V83, P224, DOI 10.1111/tpj.12879; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang L, 2013, PLANT CELL ENVIRON, V36, P224, DOI 10.1111/j.1365-3040.2012.02569.x; Wang SW, 2014, PLANT PHYSIOL, V165, P1144, DOI 10.1104/pp.114.238899; Wang WS, 2011, J GENET GENOMICS, V38, P419, DOI 10.1016/j.jgg.2011.07.006; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu LJ, 2007, PLANTA, V226, P815, DOI 10.1007/s00425-007-0528-9; Xia H, 2009, THEOR APPL GENET, V119, P635, DOI 10.1007/s00122-009-1075-5; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xiao J, 2013, PLANT PHYSIOL, V163, P1868, DOI 10.1104/pp.113.226019; Xiao N, 2015, THEOR APPL GENET, V128, P173, DOI 10.1007/s00122-014-2420-x; Xie J, 2010, GENET RESOUR CROP EV, V57, P597, DOI 10.1007/s10722-009-9498-z; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Yang WZ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0425-5; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; You J, 2014, PLANT PHYSIOL, V166, P2100, DOI 10.1104/pp.114.251116; Zhang FT, 2014, EUPHYTICA, V200, P1, DOI 10.1007/s10681-014-1121-5; Zhang T, 2014, PLANT MOL BIOL, V84, P315, DOI 10.1007/s11103-013-0135-z; Zhang X, 2006, PLANT MOL BIOL, V62, P247, DOI 10.1007/s11103-006-9018-x; Zhang XW, 2013, GENE, V530, P185, DOI 10.1016/j.gene.2013.08.048; Zhang Y, 2009, BMB REP, V42, P486, DOI 10.5483/BMBRep.2009.42.8.486; Zhang ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052538; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhou HP, 2014, PLANT CELL, V26, P1166, DOI 10.1105/tpc.113.117069; Zhou J, 2009, J PLANT PHYSIOL, V166, P1296, DOI 10.1016/j.jplph.2009.02.007; Zhu N, 2015, PLANT SCI, V236, P146, DOI 10.1016/j.plantsci.2015.03.023; Zhu Q, 2010, GENE, V457, P1, DOI 10.1016/j.gene.2010.02.011; Zhuang JY, 2002, THEOR APPL GENET, V105, P1137, DOI 10.1007/s00122-002-0974-5	123	85	92	7	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146242	10.1371/journal.pone.0146242	http://dx.doi.org/10.1371/journal.pone.0146242			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752408	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100057
J	Chiu, HY; Hsieh, CF; Chiang, YT; Tsai, YW; Huang, WF; Li, CY; Wang, TS; Tsai, TF				Chiu, Hsien-Yi; Hsieh, Chi-Feng; Chiang, Yi-Ting; Tsai, Yi-Wen; Huang, Weng-Foung; Li, Cheng-Yuan; Wang, Ting-Shun; Tsai, Tsen-Fang			Concomitant Sleep Disorders Significantly Increase the Risk of Cardiovascular Disease in Patients with Psoriasis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; APNEA; EVENTS; COMORBIDITY; DISTURBANCE; ARTHRITIS; INSOMNIA; INTERLEUKIN-6	Background The increased rates of cardiovascular morbidity and mortality in patients with psoriasis are not adequately explained by traditional risk factors. Whether concomitant sleep disorders (SDs) modify the risk of cardiovascular disease (CVD) in patients with psoriasis remains unknown. Methods Using the Taiwan National Health Insurance Research Database (NHIRD), we conducted a cohort study to investigate the association between concomitant SDs and CVD risk in patients with psoriasis. Data from 99,628 adults who received a psoriasis diagnosis during the period from 2004 to 2010 were analyzed. Cox proportional hazards regression analysis models were used to compare the risks of ischemic heart disease (IHD) and stroke between patients with and without SDs. Results Psoriasis patients with a concomitant SD had significantly higher risks of IHD (adjusted hazard ratio [aHR], 1.25; 95% confidence interval [CI], 1.22-1.28) and stroke (aHR, 1.24; 95% CI, 1.16-1.33) as compared with psoriasis patients without SDs. All psoriasis patient subgroups, including those with mild and severe psoriasis and those with and without arthritis, had increased HRs for IHD and stroke. The increases in IHD and stroke risks conferred by SDs were proportional to the dose of hypnotics used. The effect of SDs on the risks of IHD and stroke was greater in young adults than in middle-aged and older adults. Conclusions The risks of IHD and stroke were higher for psoriasis patients with SDs than for those without SDs. Clinicians should carefully evaluate CVD risk, particularly in young patients with psoriasis.	[Chiu, Hsien-Yi] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Dermatol, Hsinchu, Taiwan; [Chiu, Hsien-Yi; Wang, Ting-Shun; Tsai, Tsen-Fang] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Hsieh, Chi-Feng; Chiang, Yi-Ting; Tsai, Yi-Wen; Huang, Weng-Foung] Natl Yang Ming Univ, Inst Hlth & Welf Policy, Taipei 112, Taiwan; [Li, Cheng-Yuan] Taipei Vet Gen Hosp, Dept Dermatol, Taoyuan Branch, Taoyuan, Taiwan; [Li, Cheng-Yuan] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wang, Ting-Shun] Natl Taiwan Univ Hosp, Div Dermatol, Yun Lin Branch, Dou Liou, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Tsai, TF (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.	tftsai@yahoo.com		TSAI, TSEN-FANG/0000-0002-1498-1474; Chiu, Hsien-Yi/0000-0002-0493-9707; Li, Cheng-Yuan/0000-0002-3185-4995	National Taiwan University Hospital, Hsin-Chu Branch [HCH104-022]	National Taiwan University Hospital, Hsin-Chu Branch	This work was supported by a grant from National Taiwan University Hospital, Hsin-Chu Branch (HCH104-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuabara K, 2010, BRIT J DERMATOL, V163, P586, DOI 10.1111/j.1365-2133.2010.09941.x; Ahlehoff O, 2011, J INTERN MED, V270, P147, DOI 10.1111/j.1365-2796.2010.02310.x; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Buslau M, 1999, ACTA DERM-VENEREOL, V79, P234; Canivet C, 2014, J PSYCHOSOM RES, V76, P292, DOI 10.1016/j.jpsychores.2014.02.001; Chen JC, 2008, STROKE, V39, P3185, DOI 10.1161/STROKEAHA.108.521773; Chen YJ, 2012, ARTHRITIS RHEUM-US, V64, P1879, DOI 10.1002/art.34335; Chiu HY, 2012, BRIT J DERMATOL, V166, P288, DOI 10.1111/j.1365-2133.2011.10688.x; Chiu HY, 2015, BRIT J DERMATOL, V173, P146, DOI 10.1111/bjd.13599; Chiu HY, 2012, DERMATOL SIN, V30, P136, DOI 10.1016/j.dsi.2012.08.002; Dauden E, 2013, J EUR ACAD DERMATOL, V27, P1387, DOI 10.1111/jdv.12024; Duffin KC, 2009, J AM ACAD DERMATOL, V60, P604, DOI 10.1016/j.jaad.2008.10.059; Eder L, 2013, ANN RHEUM DIS, V72, P715, DOI 10.1136/annrheumdis-2012-201497; Ernste FC, 2015, ARTHRIT CARE RES, V67, P1015, DOI 10.1002/acr.22536; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gelfand JM, 2009, J INVEST DERMATOL, V129, P2411, DOI 10.1038/jid.2009.112; Gowda S, 2010, J AM ACAD DERMATOL, V63, P114, DOI 10.1016/j.jaad.2009.07.003; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Hirotsu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051183; Huang WS, 2013, SLEEP MED, V14, P1341, DOI 10.1016/j.sleep.2013.07.017; Karaca S, 2013, SLEEP BREATH, V17, P275, DOI 10.1007/s11325-012-0686-2; Lan CCE, 2012, ACTA DERM-VENEREOL, V92, P349, DOI 10.2340/00015555-1283; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nilsson PM, 2001, J INTERN MED, V250, P521, DOI 10.1046/j.1365-2796.2001.00913.x; Papadavid E, 2013, J EUR ACAD DERMATOL, V27, P820, DOI 10.1111/j.1468-3083.2012.04580.x; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Shlyankevich J, 2014, AM J MED, V127, P1148, DOI 10.1016/j.amjmed.2014.08.008; Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Suarez EC, 2008, BRAIN BEHAV IMMUN, V22, P960, DOI 10.1016/j.bbi.2008.01.011; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vgontzas AN, 2002, METABOLISM, V51, P887, DOI 10.1053/meta.2002.33357; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Westerlund A, 2013, EUR J EPIDEMIOL, V28, P463, DOI 10.1007/s10654-013-9802-2; Wu MP, 2014, STROKE, V45, P1349, DOI 10.1161/STROKEAHA.113.003675; Wu Y, 2008, J DRUGS DERMATOL, V7, P373; Yang YW, 2011, BRIT J DERMATOL, V165, P1037, DOI 10.1111/j.1365-2133.2011.10494.x; Yang YW, 2012, SLEEP MED, V13, P285, DOI 10.1016/j.sleep.2011.07.018; Yosipovitch G, 2000, BRIT J DERMATOL, V143, P969, DOI 10.1046/j.1365-2133.2000.03829.x	43	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146462	10.1371/journal.pone.0146462	http://dx.doi.org/10.1371/journal.pone.0146462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745869	Green Submitted, gold, Green Published			2022-12-27	WOS:000367815600052
J	Herate, C; Ramdani, G; Grant, NJ; Marion, S; Gasman, S; Niedergang, F; Benichou, S; Bouchet, J				Herate, Cecile; Ramdani, Ghania; Grant, Nancy J.; Marion, Sabrina; Gasman, Stephane; Niedergang, Florence; Benichou, Serge; Bouchet, Jerome			Phospholipid Scramblase 1 Modulates FcR-Mediated Phagocytosis in Differentiated Macrophages	PLOS ONE			English	Article							PLASMA-MEMBRANE PHOSPHOLIPIDS; GROWTH-FACTOR RECEPTOR; TRANSBILAYER MOVEMENT; PROTEIN; EXPRESSION; CELLS; DOMAIN; IDENTIFICATION; ORIENTATIONS; LYMPHOCYTES	Phospholipid Scramblase 1 (PLSCR1) was initially characterized as a type II transmembrane protein involved in bilayer movements of phospholipids across the plasma membrane leading to the cell surface exposure of phosphatidylserine, but other cellular functions have been ascribed to this protein in signaling processes and in the nucleus. In the present study, expression and functions of PLSCR1 were explored in specialized phagocytic cells of the monocyte/macrophage lineage. The expression of PLSCR1 was found to be markedly increased in monocyte-derived macrophages compared to undifferentiated primary monocytes. Surprisingly, this 3-fold increase in PLSCR1 expression correlated with an apparent modification in the membrane topology of the protein at the cell surface of differentiated macrophages. While depletion of PLSCR1 in the monocytic THP-1 cell-line with specific shRNA did not inhibit the constitutive cell surface exposure of phosphatidylserine observed in differentiated macrophages, a net increase in the FcR-mediated phagocytic activity was measured in PLSCR1-depleted THP-1 cells and in bone marrow-derived macrophages from PLSCR1 knock-out mice. Reciprocally, phagocytosis was down-regulated in cells overexpressing PLSCR1. Since endogenous PLSCR1 was recruited both in phagocytic cups and in phagosomes, our results reveal a specific role for induced PLSCR1 expression in the modulation of the phagocytic process in differentiated macrophages.	[Herate, Cecile; Ramdani, Ghania; Marion, Sabrina; Niedergang, Florence; Benichou, Serge; Bouchet, Jerome] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Herate, Cecile; Ramdani, Ghania; Marion, Sabrina; Niedergang, Florence; Benichou, Serge; Bouchet, Jerome] CNRS, UMR8104, Paris, France; [Herate, Cecile; Ramdani, Ghania; Marion, Sabrina; Niedergang, Florence; Benichou, Serge; Bouchet, Jerome] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Grant, Nancy J.; Gasman, Stephane] CNRS, UPR3212, Inst Neurosci Cellulaires & Integrat, Strasbourg, France; [Grant, Nancy J.; Gasman, Stephane] Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Benichou, S (corresponding author), Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France.	serge.benichou@inserm.fr	stéphane, gasman/Q-1145-2019; Gasman, Stephane/D-5113-2017; bouchet, jerome/I-7716-2019; Marion, Sabrina/B-8694-2018	stéphane, gasman/0000-0001-8415-1276; Gasman, Stephane/0000-0001-8415-1276; bouchet, jerome/0000-0002-6611-4380; Benichou, Serge/0000-0003-3602-3530; Marion, Sabrina/0000-0001-7824-955X; Niedergang, Florence/0000-0002-7064-830X	Inserm; CNRS; Universite Paris-Descartes	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Descartes	This work was supported by Inserm, CNRS and Universite Paris-Descartes.	Amir-Moazami O, 2008, J BIOL CHEM, V283, P25514, DOI 10.1074/jbc.M705320200; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bouchet J, 2012, J VIROL, V86, P4856, DOI 10.1128/JVI.06329-11; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; Corrotte M, 2010, J IMMUNOL, V185, P2942, DOI 10.4049/jimmunol.0903138; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; DUNLOP J, 1995, EMBO J, V14, P3609, DOI 10.1002/j.1460-2075.1995.tb00030.x; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; Gong QL, 2011, FEBS LETT, V585, P2647, DOI 10.1016/j.febslet.2011.07.019; Greuber EK, 2012, J IMMUNOL, V189, P5382, DOI 10.4049/jimmunol.1200974; Guenzel CA, 2012, J VIROL, V86, P2533, DOI 10.1128/JVI.05163-11; Hazeki K, 2009, J BIOCHEM, V145, P87, DOI 10.1093/jb/mvn142; Li Y, 2010, ARCH IMMUNOL THER EX, V58, P355, DOI 10.1007/s00005-010-0093-y; Merregaert J, 2010, J BIOL CHEM, V285, P37823, DOI 10.1074/jbc.M110.136408; Mitchell DC, 2012, BBA-BIOMEMBRANES, V1818, P951, DOI 10.1016/j.bbamem.2011.12.029; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Niedergang F, 2000, P NATL ACAD SCI USA, V97, P14650, DOI 10.1073/pnas.97.26.14650; Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; Posada IMD, 2014, BBA-BIOMEMBRANES, V1838, P1785, DOI 10.1016/j.bbamem.2014.03.009; Posada IMD, 2014, BBA-BIOMEMBRANES, V1838, P388, DOI 10.1016/j.bbamem.2013.09.018; Py B, 2004, J IMMUNOL, V172, P4008, DOI 10.4049/jimmunol.172.7.4008; Py B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005006; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Steevels TAM, 2011, EUR J IMMUNOL, V41, P575, DOI 10.1002/eji.201041179; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Sun J, 2001, J BIOL CHEM, V276, P28984, DOI 10.1074/jbc.M102505200; Suzuki E, 2010, J RHEUMATOL, V37, P1639, DOI 10.3899/jrheum.091420; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zhou QS, 1998, BLOOD, V92, P1707, DOI 10.1182/blood.V92.5.1707; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zhu QS, 1999, J BIOL CHEM, V274, P27898, DOI 10.1074/jbc.274.39.27898; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	42	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145617	10.1371/journal.pone.0145617	http://dx.doi.org/10.1371/journal.pone.0145617			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745724	Green Published, gold			2022-12-27	WOS:000367815600010
J	Roads, B; Mozer, MC; Busey, TA				Roads, Brett; Mozer, Michael C.; Busey, Thomas A.			Using Highlighting to Train Attentional Expertise	PLOS ONE			English	Article							EYE-MOVEMENTS; IDENTIFICATION; RECOGNITION; COGNITION; PATTERNS; DISPLAYS; GUIDANCE; THOUGHT; MEMORY; TASKS	Acquiring expertise in complex visual tasks is time consuming. To facilitate the efficient training of novices on where to look in these tasks, we propose an attentional highlighting paradigm. Highlighting involves dynamically modulating the saliency of a visual image to guide attention along the fixation path of a domain expert who had previously viewed the same image. In Experiment 1, we trained naive subjects via attentional highlighting on a fingerprint-matching task. Before and after training, we asked subjects to freely inspect images containing pairs of prints and determine whether the prints matched. Fixation sequences were automatically scored for the degree of expertise exhibited using a Bayesian discriminative model of novice and expert gaze behavior. Highlighted training causes gaze behavior to become more expert-like not only on the trained images but also on transfer images, indicating generalization of learning. In Experiment 2, to control for the possibility that the increase in expertise is due to mere exposure, we trained subjects via highlighting of fixation sequences from novices, not experts, and observed no transition toward expertise. In Experiment 3, to determine the specificity of the training effect, we trained subjects with expert fixation sequences from images other than the one being viewed, which preserves coarse-scale statistics of expert gaze but provides no information about fine-grain features. Observing at least a partial transition toward expertise, we obtain only weak evidence that the highlighting procedure facilitates the learning of critical local features. We discuss possible improvements to the highlighting procedure.	[Roads, Brett; Mozer, Michael C.] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Roads, Brett; Mozer, Michael C.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Busey, Thomas A.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Indiana University System; Indiana University Bloomington	Roads, B (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.	brett.roads@colorado.edu			NSF [SBE-0542013, SMA-1041755, SES-1461535]; NIJ [2009-DN-BX-K226]; National Science Foundation, Directorate of Social, Behavioral and Economic Sciences [SBE-0542013]; National Science Foundation, Office of Multidisciplinary Activities [SMA-1041755]; National Science Foundation, Division of Social and Economic Sciences [SES-1461535]; National Institute of Justice [2009-DN-BX-K226]	NSF(National Science Foundation (NSF)); NIJ; National Science Foundation, Directorate of Social, Behavioral and Economic Sciences(National Science Foundation (NSF)); National Science Foundation, Office of Multidisciplinary Activities(National Science Foundation (NSF)); National Science Foundation, Division of Social and Economic Sciences(National Science Foundation (NSF)); National Institute of Justice(US National Institute of Justice)	This research was supported by NSF Awards SBE-0542013, SMA-1041755, and SES-1461535, and NIJ Grant #2009-DN-BX-K226. We thank Samuel Vine and Eyal Reingold for their constructive critiques of an earlier version of this paper, and John Lynch and the Center for Research on Consumer Financial Decision Making at the University of Colorado for sharing eye tracking hardware.; This work was supported by the National Science Foundation, Directorate of Social, Behavioral and Economic Sciences (SBE-0542013 to MCM); National Science Foundation, Office of Multidisciplinary Activities (SMA-1041755 to MCM); National Science Foundation, Division of Social and Economic Sciences (SES-1461535 to MCM); and the National Institute of Justice (Grant #2009-DN-BX-K226 to TAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilalic M, 2008, COGNITION, V108, P652, DOI 10.1016/j.cognition.2008.05.005; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Busey T., 2011, J FORENSIC IDENTIFIC, V61, P60; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; Busey T, 2013, COGNITIVE SCI, V37, P731, DOI 10.1111/cogs.12029; Busey TA, 2010, PSYCHON B REV, V17, P155, DOI 10.3758/PBR.17.2.155; CARMODY DP, 1980, PERCEPTION, V9, P339, DOI 10.1068/p090339; Causer J, 2011, MED SCI SPORT EXER, V43, P1042, DOI 10.1249/MSS.0b013e3182035de6; Chukoskie L, 2013, P NATL ACAD SCI USA, V110, P10438, DOI 10.1073/pnas.1301216110; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Cook SW, 2008, COGNITION, V106, P1047, DOI 10.1016/j.cognition.2007.04.010; Dosher BA, 2005, P NATL ACAD SCI USA, V102, P5286, DOI 10.1073/pnas.0500492102; Dror IE, 2011, FINGERPRINT SOURCEBO; Dror IE, 2011, FORENSIC SCI INT, V208, P10, DOI 10.1016/j.forsciint.2010.10.013; Dror IE, 2010, PSYCHON B REV, V17, P161, DOI 10.3758/PBR.17.2.161; Feldon DF, 2007, EDUC PSYCHOL REV, V19, P91, DOI 10.1007/s10648-006-9009-0; Foulsham T, 2012, J EYE MOVEMENT RES, V5; Foulsham T, 2013, J EXP PSYCHOL GEN, V142, P41, DOI 10.1037/a0028227; Grant ER, 2003, PSYCHOL SCI, V14, P462, DOI 10.1111/1467-9280.02454; HE PY, 1992, VISION RES, V32, P2151, DOI 10.1016/0042-6989(92)90076-U; KUNDEL HL, 1990, INVEST RADIOL, V25, P890, DOI 10.1097/00004424-199008000-00004; Litchfield D, 2010, J EXP PSYCHOL-APPL, V16, P251, DOI 10.1037/a0020082; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; Nalanagula D, 2006, INT J IND ERGONOM, V36, P289, DOI 10.1016/j.ergon.2005.11.008; National Academy of Sciences, 2009, STRENGTHENING FORENS; NOTON D, 1971, VISION RES, V11, P929, DOI 10.1016/0042-6989(71)90213-6; Peterson MF, 2014, VISION RES, V99, P57, DOI 10.1016/j.visres.2013.11.005; Peterson MF, 2012, P NATL ACAD SCI USA, V109, pE3314, DOI 10.1073/pnas.1214269109; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Reingold EM, 2011, OXFORD HDB EYE MOVEM, P528, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0029; SCHLINGENSIEPEN KH, 1986, VISION RES, V26, P1111, DOI 10.1016/0042-6989(86)90045-3; Seitz AR, 2009, VISION RES, V49, P2604, DOI 10.1016/j.visres.2009.08.003; Tangen JM, 2011, PSYCHOL SCI, V22, P995, DOI 10.1177/0956797611414729; Tatler BW, 2009, VIS COGN, V17, P1029, DOI 10.1080/13506280902764539; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Thomas LE, 2007, PSYCHON B REV, V14, P663, DOI 10.3758/BF03196818; Thompson MB, 2013, J FORENSIC SCI, V58, P1519, DOI 10.1111/1556-4029.12203; Tomlinson MT, 2009, LECT NOTES ARTIF INT, V5638, P668, DOI 10.1007/978-3-642-02812-0_76; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Turk-Browne NB, 2008, J EXP PSYCHOL LEARN, V34, P399, DOI 10.1037/0278-7393.34.2.399; Valuch C, 2013, J VISION, V13, DOI 10.1167/13.3.3; van Gog T, 2009, COMPUT HUM BEHAV, V25, P785, DOI 10.1016/j.chb.2009.02.007; Velichkovsky B.M., 1995, PRAGMAT COGN, V3, P199, DOI https://doi.org/10.1075/pc.3.2.02vel; Vine SJ, 2012, SURGERY, V152, P32, DOI 10.1016/j.surg.2012.02.002	46	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146266	10.1371/journal.pone.0146266	http://dx.doi.org/10.1371/journal.pone.0146266			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA5AX	26744839	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600034
J	Zugic, A; Jeremic, I; Isakovic, A; Arsic, I; Savic, S; Tadic, V				Zugic, Ana; Jeremic, Ivica; Isakovic, Aleksandra; Arsic, Ivana; Savic, Snezana; Tadic, Vanja			Evaluation of Anticancer and Antioxidant Activity of a Commercially Available CO2 Supercritical Extract of Old Man's Beard (Usnea barbata)	PLOS ONE			English	Article							USNIC ACID; (+)-USNIC ACID; CANCER-CELLS; IN-VITRO; LICHEN; AUTOPHAGY; PROLIFERATION; MECHANISMS; PHENOLICS; ASSAY	There is a worldwide ongoing investigation for novel natural constituents with cytotoxic and antioxidant properties. The aim of this study was to investigate chemical profile and stated biological activities of the supercritical CO2 extract (SCE) of old man's beard compared to the extracts obtained using the conventional techniques (Soxhlet extracts and macerate). The most abundant compound identified was usnic acid, which content was inversely proportional to the polarity of the solvent used and was the highest in the SCE, which was the sample revealing the highest cytotoxic activity in tested tumor cell lines (B16 mouse melanoma and C6 rat glioma), with lower IC50 values compared to pure usnic acid. Further investigations suggested both SCE and usnic acid to induce apoptosis and/ or autophagy in B16 and C6, indicating higher cytotoxicity of SCE to be related to the higher degree of ROS production. A good correlation of usnic acid content in the extracts and their antioxidant capacity was established, extricating SCE as the most active one. Presented results support further investigations of SCE of old man's beard as a prospective therapeutic agent with potential relevance in the treatment of cancer and/ or in oxidative stress-mediated conditions.	[Zugic, Ana; Tadic, Vanja] Inst Med Plant Res Dr Josif Pancic, Belgrade, Serbia; [Jeremic, Ivica] Univ Belgrade, Inst Rheumatol, Belgrade, Serbia; [Jeremic, Ivica; Isakovic, Aleksandra] Univ Belgrade, Inst Biochem, Sch Med, Belgrade, Serbia; [Arsic, Ivana] Univ Nis, Dept Pharm, Fac Med, Nish, Serbia; [Savic, Snezana] Univ Belgrade, Dept Pharmaceut Technol & Cosmetol, Fac Pharm, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Nis; University of Belgrade	Tadic, V (corresponding author), Inst Med Plant Res Dr Josif Pancic, Belgrade, Serbia.	vtadic@mocbilja.rs	Tadić, Vanja/B-2845-2018; Savic, Snezana/AAI-9218-2020	Jeremic, Ivica/0000-0002-0566-8224; Savic, Snezana/0000-0002-6236-9730	Serbian Ministry of education, science and technological development [III 45017, III 41025]	Serbian Ministry of education, science and technological development	Serbian Ministry of education, science and technological development (http://www.mpn.gov.rs/) supported this study through the Research Projects: "Functional and physiologically active plant materials with added value for usage in pharmaceutical and food industries" (Project No. III 45017) and "Modulation of intracellular energy balance controlling signaling pathways in therapy of cancer and neuro-immuno-endocrine disorders (Project No. III 41025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2010, PLANT CELL TISS ORG, V102, P129, DOI 10.1007/s11240-010-9712-x; Atalay F, 2011, TURK J CHEM, V35, P647, DOI 10.3906/kim-1008-847; Backorova M, 2012, TOXICOL IN VITRO, V26, P462, DOI 10.1016/j.tiv.2012.01.017; Backorova M, 2011, TOXICOL IN VITRO, V25, P37, DOI 10.1016/j.tiv.2010.09.004; Behera BC, 2012, PHARM BIOL, V50, P968, DOI 10.3109/13880209.2012.654396; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Bessadottir M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051296; Bezivin C, 2004, PLANTA MED, V70, P874, DOI 10.1055/s-2004-827240; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Brisdelli F, 2013, PHYTOTHER RES, V27, P431, DOI 10.1002/ptr.4739; Campanella L, 2002, BIOCHIMIE, V84, P329, DOI 10.1016/S0300-9084(02)01386-X; Cardarelli M, 1997, CELL MOL LIFE SCI, V53, P667, DOI 10.1007/s000180050086; Chen S, 2014, TOXICOL SCI, V142, P33, DOI 10.1093/toxsci/kfu154; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Einarsdottir E, 2010, PLANTA MED, V76, P969, DOI 10.1055/s-0029-1240851; EMMENDORFFER A, 1990, J IMMUNOL METHODS, V131, P269, DOI 10.1016/0022-1759(90)90198-5; Engel K, 2007, J PHOTOCH PHOTOBIO B, V89, P9, DOI 10.1016/j.jphotobiol.2007.08.002; Fimia GM, 2009, CELL DEATH DIFFER, V16, P933, DOI 10.1038/cdd.2009.47; Gruenwald J., 2000, PDR HERBAL MED, V2nd ed.; Han D, 2004, BIOCHEM PHARMACOL, V67, P439, DOI 10.1016/j.bcp.2003.09.032; Ingolfsdottir K, 2002, PHYTOCHEMISTRY, V61, P729, DOI 10.1016/S0031-9422(02)00383-7; Iqbal S, 2012, INT J MOL SCI, V13, P6651, DOI 10.3390/ijms13066651; Jin JQ, 2013, J SOLUTION CHEM, V42, P1018, DOI 10.1007/s10953-013-0010-1; Koparal AT, 2006, NAT PROD RES, V20, P1300, DOI 10.1080/14786410601101910; Kristmundsdottir T, 2002, J PHARM PHARMACOL, V54, P1447, DOI 10.1211/002235702225; KUPCHAN SM, 1975, EXPERIENTIA, V31, P625; Lopez P, 2011, PHYTOTHER RES, V25, P271, DOI 10.1002/ptr.3256; Madamombe IT, 2003, PHARM BIOL, V41, P199, DOI 10.1076/phbi.41.3.199.15089; Mijatovic S, 2005, CELL MOL LIFE SCI, V62, P589, DOI 10.1007/s00018-005-4425-8; Milutinovic MD, 2013, HEM IND, V67, P261, DOI 10.2298/HEMIND120410074M; Paglin S, 2001, CANCER RES, V61, P439; Pereira CG, 2010, FOOD BIOPROCESS TECH, V3, P340, DOI 10.1007/s11947-009-0263-2; Rankovic B, 2012, INT J MOL SCI, V13, P14707, DOI 10.3390/ijms131114707; Shrestha G, 2013, PHYTOCHEM REV, V12, P229, DOI 10.1007/s11101-013-9283-7; Spigno G, 2007, J FOOD ENG, V78, P793, DOI 10.1016/j.jfoodeng.2005.11.020; TAKAI M, 1979, J MED CHEM, V22, P1380, DOI 10.1021/jm00197a019; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; White PAS, 2014, MOLECULES, V19, P14496, DOI 10.3390/molecules190914496; Yang TT, 1996, ANAL BIOCHEM, V241, P103, DOI 10.1006/abio.1996.0383; Zizovic I, 2012, J SUPERCRIT FLUID, V72, P7, DOI 10.1016/j.supflu.2012.07.018; Zugic A, 2014, IND CROP PROD, V52, P519, DOI 10.1016/j.indcrop.2013.11.027	41	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146342	10.1371/journal.pone.0146342	http://dx.doi.org/10.1371/journal.pone.0146342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745885	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600043
J	Wang, Y; Ma, XL; Liu, Y; Gong, K; Henricakson, KC; Xu, MZ; Wang, YH				Wang, Yong; Ma, Xiaolei; Liu, Yong; Gong, Ke; Henricakson, Kristian C.; Xu, Maozeng; Wang, Yinhai			A Two-Stage Algorithm for Origin-Destination Matrices Estimation Considering Dynamic Dispersion Parameter for Route Choice	PLOS ONE			English	Article							STOCHASTIC USER EQUILIBRIUM; TRAFFIC ASSIGNMENT PROBLEM; GENERALIZED LEAST-SQUARES; CONGESTED NETWORKS; TRIP MATRICES; TIME-SERIES; COUNTS; MODEL; CONVERGENCE; DEMAND	This paper proposes a two-stage algorithm to simultaneously estimate origin-destination (OD) matrix, link choice proportion, and dispersion parameter using partial traffic counts in a congested network. A non-linear optimization model is developed which incorporates a dynamic dispersion parameter, followed by a two-stage algorithm in which Generalized Least Squares (GLS) estimation and a Stochastic User Equilibrium (SUE) assignment model are iteratively applied until the convergence is reached. To evaluate the performance of the algorithm, the proposed approach is implemented in a hypothetical network using input data with high error, and tested under a range of variation coefficients. The root mean squared error (RMSE) of the estimated OD demand and link flows are used to evaluate the model estimation results. The results indicate that the estimated dispersion parameter theta is insensitive to the choice of variation coefficients. The proposed approach is shown to outperform two established OD estimation methods and produce parameter estimates that are close to the ground truth. In addition, the proposed approach is applied to an empirical network in Seattle, WA to validate the robustness and practicality of this methodology. In summary, this study proposes and evaluates an innovative computational approach to accurately estimate OD matrices using link-level traffic flow data, and provides useful insight for optimal parameter selection in modeling travelers' route choice behavior.	[Wang, Yong; Liu, Yong; Gong, Ke; Xu, Maozeng] Chongqing Jiaotong Univ, Sch Management, Chongqing, Peoples R China; [Wang, Yong; Henricakson, Kristian C.; Wang, Yinhai] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Ma, Xiaolei] Beihang Univ, Sch Transportat Sci & Engn, Beijing Key Lab Cooperat Vehicle Infrastruct Syst, Beijing 100191, Peoples R China; [Ma, Xiaolei] Jiangsu Prov Collaborat Innovat Ctr Modern Urban, Nanjing, Jiangsu, Peoples R China	Chongqing Jiaotong University; University of Washington; University of Washington Seattle; Beihang University	Ma, XL (corresponding author), Beihang Univ, Sch Transportat Sci & Engn, Beijing Key Lab Cooperat Vehicle Infrastruct Syst, Beijing 100191, Peoples R China.	xiaolei@buaa.edu.cn; yinhai@uw.edu	Ma, Xiaolei/J-4069-2014; Wang, Yinhai/B-5396-2012	Ma, Xiaolei/0000-0002-3841-5792; Wang, Yinhai/0000-0002-4180-5628; XU, Maozeng/0000-0003-2231-4222; Gong, Ke/0000-0002-8486-8506	National Natural Science Foundation of China [71402011, 71471024, 51408019, 71301180, 51329801]; National Social Science Foundation of Chongqing of China [2013YBJJ035]; Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1400307]; Natural Science Foundation of Chongqing of China [cstc2015jcyjA30012]; National Key Technologies R&D Program of China [2014BAG01B03]; Science and Technology Project on Transportation Construction by the Ministry of Transport of China [2015318835200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of Chongqing of China; Scientific and Technological Research Program of Chongqing Municipal Education Commission; Natural Science Foundation of Chongqing of China(Natural Science Foundation of Chongqing); National Key Technologies R&D Program of China(National Key Technology R&D Program); Science and Technology Project on Transportation Construction by the Ministry of Transport of China	This research is supported by National Natural Science Foundation of China (Project No. 71402011, 71471024, 51408019, 71301180, 51329801), National Social Science Foundation of Chongqing of China (No. 2013YBJJ035), and the Scientific and Technological Research Program of Chongqing Municipal Education Commission (No. KJ1400307), and the Natural Science Foundation of Chongqing of China (No. cstc2015jcyjA30012), National Key Technologies R&D Program of China (2014BAG01B03), Science and Technology Project on Transportation Construction by the Ministry of Transport of China (2015318835200).; The helpful comments from the two anonymous reviewers are gratefully acknowledged. This research is supported by National Natural Science Foundation of China (Project No. 71402011, 71471024, 51408019, 71301180, 51329801), National Social Science Foundation of Chongqing of China (No. 2013YBJJ035), and the Scientific and Technological Research Program of Chongqing Municipal Education Commission (No. KJ1400307), and the Natural Science Foundation of Chongqing of China(No. cstc2015jcyjA30012), National Key Technologies R&D Program of China (2014BAG01B03), Science and Technology Project on Transportation Construction by the Ministry of Transport of China (2015318835200).	Akamatsu T, 2000, TRANSPORT RES B-METH, V34, P515, DOI 10.1016/S0191-2615(99)00036-3; Beckmann M.J., 1956, STUDIES EC TRANSPORT; BELL MGH, 1983, TRANSPORT SCI, V17, P198, DOI 10.1287/trsc.17.2.198; Bell MGH, 1995, TRANSPORT RES B-METH, V29, P287, DOI 10.1016/0191-2615(95)00005-X; BELL MGH, 1991, TRANSPORT RES B-METH, V25, P13, DOI 10.1016/0191-2615(91)90010-G; Boggs PT, 2000, J COMPUT APPL MATH, V124, P123, DOI 10.1016/S0377-0427(00)00429-5; Bureau of Public Roads, 1964, TRAFF ASS MAN; Caggiani L, 2013, TRANSPORT RES C-EMER, V28, P130, DOI 10.1016/j.trc.2010.12.005; Cantarella GE, 1997, TRANSPORT SCI, V31, P107, DOI 10.1287/trsc.31.2.107; Cascetta E, 1997, TRANSPORTATION, V24, P271, DOI 10.1023/A:1004968411792; Cascetta E, 2001, TRANSPORT SCI, V35, P134, DOI 10.1287/trsc.35.2.134.10138; CASCETTA E, 1984, TRANSPORT RES B-METH, V18, P289, DOI 10.1016/0191-2615(84)90012-2; CASCETTA E, 1988, TRANSPORT RES B-METH, V22, P437, DOI 10.1016/0191-2615(88)90024-0; Cheung WM, 2006, J ADV TRANSPORT, V40, P95, DOI 10.1002/atr.5670400106; Conti PL, 2010, COMPUT NETW, V54, P2626, DOI 10.1016/j.comnet.2010.04.012; Daganzo C. F., 1977, Transportation Science, V11, P253, DOI 10.1287/trsc.11.3.253; FISK CS, 1989, TRANSPORT RES B-METH, V23, P331, DOI 10.1016/0191-2615(89)90009-X; FISK CS, 1983, TRANSPORT RES B-METH, V17, P245, DOI 10.1016/0191-2615(83)90018-8; FISK CS, 1988, TRANSPORT RES B-METH, V22, P69, DOI 10.1016/0191-2615(88)90035-5; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Guo XL, 2010, EUR J OPER RES, V201, P463, DOI 10.1016/j.ejor.2009.03.023; Han S, 2007, TRANSPORT RES B-METH, V41, P1094, DOI 10.1016/j.trb.2007.05.001; Hazelton ML, 2003, TRANSPORT RES A-POL, V37, P811, DOI 10.1016/S0965-8564(03)00044-2; Inoue S, 2012, PROCD SOC BEHV, V43, P445, DOI 10.1016/j.sbspro.2012.04.118; Kumar A, 2015, TRANSPORT RES B-METH, V71, P213, DOI 10.1016/j.trb.2014.11.002; Lam WHK, 2006, TRANSPORT RES B-METH, V40, P368, DOI 10.1016/j.trb.2005.05.003; LAM WHK, 1992, TRANSPORT RES B-METH, V26, P275, DOI 10.1016/0191-2615(92)90038-X; Lam WHK, 2001, TRANSPORT RES B-METH, V35, P549, DOI 10.1016/S0191-2615(00)00010-2; Liu HX, 2009, NETW SPAT ECON, V9, P485, DOI 10.1007/s11067-007-9023-x; Liu SS, 1996, TRANSPORT RES A-POL, V30, P287; Lo HP, 2003, TRANSPORT RES A-POL, V37, P771, DOI 10.1016/S0965-8564(03)00048-X; Londono G, 2014, PROCEDIA SOCIAL BEHA, V162, P378; Lu CC, 2008, TRANSPORT RES C-EMER, V16, P371, DOI 10.1016/j.trc.2007.08.002; Lu ZB, 2015, J ADV TRANSPORT, V49, P210, DOI 10.1002/atr.1292; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Ma XL, 2011, TRANSPORT RES REC, P37, DOI 10.3141/2215-04; MAHER MJ, 1983, TRANSPORT RES B-METH, V17, P435, DOI 10.1016/0191-2615(83)90030-9; Manley E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127095; Meng Q, 2008, J ADV TRANSPORT, V42, P429, DOI 10.1002/atr.5670420403; Meng Q, 2012, TRANSPORTMETRICA, V8, P261, DOI 10.1080/18128601003736026; Rodenas RG, 2009, EUR J OPER RES, V197, P320; Shao H, 2014, TRANSPORT RES B-METH, V68, P52, DOI 10.1016/j.trb.2014.06.002; SHEFFI Y, 1982, NETWORKS, V12, P191, DOI 10.1002/net.3230120209; Sheu JB, 2006, PHYSICA A, V367, P461, DOI 10.1016/j.physa.2005.11.039; Simini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060069; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; SPIESS H, 1987, TRANSPORT RES B-METH, V21, P395, DOI 10.1016/0191-2615(87)90037-3; Tang JJ, 2014, PHYSICA A, V405, P303, DOI 10.1016/j.physa.2014.03.038; VANZUYLEN HJ, 1980, TRANSPORT RES B-METH, V14, P281, DOI 10.1016/0191-2615(80)90008-9; Wong SC, 1999, TRANSPORT RES B-METH, V33, P609, DOI 10.1016/S0191-2615(99)00015-6; Yan XY, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0834; Yang H, 2001, TRANSPORT SCI, V35, P107, DOI 10.1287/trsc.35.2.107.10133; YANG H, 1992, TRANSPORT RES B-METH, V26, P417, DOI 10.1016/0191-2615(92)90008-K; Zhang HL, 2013, TRANSPORT RES C-EMER, V27, P189	55	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146850	10.1371/journal.pone.0146850	http://dx.doi.org/10.1371/journal.pone.0146850			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761209	Green Published, gold			2022-12-27	WOS:000368033100046
J	Abongwa, M; Buxton, SK; Robertson, AP; Martin, RJ				Abongwa, Melanie; Buxton, Samuel K.; Robertson, Alan P.; Martin, Richard J.			Curiouser and Curiouser: The Macrocyclic Lactone, Abamectin, Is also a Potent Inhibitor of Pyrantel/Tribendimidine Nicotinic Acetylcholine Receptors of Gastro-Intestinal Worms	PLOS ONE			English	Article							OPEN-CHANNEL BLOCKER; ANTHELMINTIC RESISTANCE; ION CHANNELS; PYRANTEL; MODE; IVERMECTIN; LEVAMISOLE; DISCOVERY; TARGETS; AGONIST	Nematode parasites may be controlled with drugs, but their regular application has given rise to concerns about the development of resistance. Drug combinations may be more effective than single drugs and delay the onset of resistance. A combination of the nicotinic antagonist, derquantel, and the macrocyclic lactone, abamectin, has been found to have synergistic anthelmintic effects against gastro-intestinal nematode parasites. We have observed in previous contraction and electrophysiological experiments that derquantel is a potent selective antagonist of nematode parasite muscle nicotinic receptors; and that abamectin is an inhibitor of the same nicotinic receptors. To explore these inhibitory effects further, we expressed muscle nicotinic receptors of the nodular worm, Oesophagostomum dentatum (Ode-UNC-29:Ode-UNC-63:Ode-UNC-38), in Xenopus oocytes under voltage-clamp and tested effects of abamectin on pyrantel and acetylcholine responses. The receptors were antagonized by 0.03 mu M abamectin in a non-competitive manner (reduced R-max, no change in EC50). This antagonism increased when abamectin was increased to 0.1 mu M. However, when we increased the concentration of abamectin further to 0.3 mu M, 1 mu M or 10 mu M, we found that the antagonism decreased and was less than with 0.1 mu M abamectin. The bi-phasic effects of abamectin suggest that abamectin acts at two allosteric sites: one high affinity negative allosteric (NAM) site causing antagonism, and another lower affinity positive allosteric (PAM) site causing a reduction in antagonism. We also tested the effects of 0.1 mu M derquantel alone and in combination with 0.3 mu M abamectin. We found that derquantel on these receptors, like abamectin, acted as a non-competitive antagonist, and that the combination of derquantel and abamectin produced greater inhibition. These observations confirm the antagonistic effects of abamectin on nematode nicotinic receptors in addition to GluCl effects, and illustrate more complex effects of macrocyclic lactones that may be exploited in combinations with other anthelmintics.	[Abongwa, Melanie; Buxton, Samuel K.; Robertson, Alan P.; Martin, Richard J.] Iowa State Univ, Dept Biomed Sci, Coll Vet Med, Ames, IA 50011 USA	Iowa State University	Martin, RJ (corresponding author), Iowa State Univ, Dept Biomed Sci, Coll Vet Med, Ames, IA 50011 USA.	rjmartin@iastate.edu	/A-1783-2011	/0000-0003-2422-1847; Buxton, Samuel/0000-0001-8796-9284	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI047194, R21AI092185-01A1]; Schlumberger Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047194, R21AI092185] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Schlumberger Foundation(Schlumberger); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI047194 to RJM, R21AI092185-01A1 to APR and the Schlumberger Foundation to MA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beech RN, 2015, PARASITOLOGY, V142, P303, DOI 10.1017/S003118201400170X; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Buxton SK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003870; Greco WR, 1996, J NATL CANCER I, V88, P699, DOI 10.1093/jnci/88.11.699; Greenberg RM, 2014, CURR CLIN MICROBIOL, V1, P51, DOI 10.1007/s40588-014-0007-6; Guest M, 2007, INT J PARASITOL, V37, P1577, DOI 10.1016/j.ijpara.2007.05.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Jin T, 2010, SENSORS-BASEL, V10, P2438, DOI 10.3390/s100302438; Kotze AC, 2014, INT J PARASITOL-DRUG, V4, P164, DOI 10.1016/j.ijpddr.2014.07.007; LACEY E, 1990, PARASITOL TODAY, V6, P112, DOI 10.1016/0169-4758(90)90227-U; Leathwick DM, 2012, VET PARASITOL, V186, P93, DOI 10.1016/j.vetpar.2011.11.050; Lee Byung H., 2002, Current Topics in Medicinal Chemistry, V2, P779, DOI 10.2174/1568026023393705; Lloberas M, 2013, INT J PARASITOL-DRUG, V3, P20, DOI 10.1016/j.ijpddr.2012.11.001; Martin RJ, 2007, PARASITOLOGY, V134, P1093, DOI 10.1017/S0031182007000029; Martin RJ, 2012, EXP PARASITOL, V132, P40, DOI 10.1016/j.exppara.2011.08.012; MARTIN RJ, 1992, PARASITOLOGY, V104, P549, DOI 10.1017/S0031182000063812; Martin RJ, 1997, VET J, V154, P11, DOI 10.1016/S1090-0233(05)80005-X; POLDERMAN AM, 1991, AM J TROP MED HYG, V44, P336, DOI 10.4269/ajtmh.1991.44.336; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Puttachary S, 2013, MOL BIOCHEM PARASIT, V188, P79, DOI 10.1016/j.molbiopara.2013.02.004; Rayes D, 2001, NEUROPHARMACOLOGY, V41, P238, DOI 10.1016/S0028-3908(01)00057-0; Robertson AP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003495; ROBERTSON SJ, 1994, EUR J PHARMACOL, V271, P273, DOI 10.1016/0014-2999(94)90784-6; Rufener L, 2010, MOL PHARMACOL, V78, P895, DOI 10.1124/mol.110.066498; Saeger B, 2001, FASEB J, V15, P1332, DOI 10.1096/fj.00-0664fje; Williamson SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000517; Wolstenholme AJ, 2014, INT J PARASITOL-DRUG, V4, P218, DOI 10.1016/j.ijpddr.2014.10.001; Wolstenholme AJ, 2011, INT J PARASITOL-DRUG, V1, P2, DOI 10.1016/j.ijpddr.2011.09.003; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218	30	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146854	10.1371/journal.pone.0146854	http://dx.doi.org/10.1371/journal.pone.0146854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751958	gold, Green Published			2022-12-27	WOS:000367888100165
J	Chiu, YL; Kao, S; Lin, HC; Tsai, MC; Lee, CZ				Chiu, Yu-Lung; Kao, Senyong; Lin, Herng-Ching; Tsai, Ming-Chieh; Lee, Cha-Ze			Healthcare Service Utilization for Practicing Physicians: A Population-Based Study	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; DOCTORS; FAMILIES; BEHAVIOR; ILLNESS; TAIWAN	Background Physicians are considered to be the most informed consumers in the use of medical services since they have more information about diseases or medical technology. However, although plenty of researchers have suggested that different medical seeking behavior exists among physicians, very few empirical studies have been conducted to investigate differences in medical utilization between physicians and the general population. Objective We explored differences in the utilization of healthcare services between physicians and the general population using a population-based dataset. Design A cross-sectional study. Participants Data for this study were sourced from the Taiwan Longitudinal Health Insurance Database 2000. We included 1426 physicians and 1426 sex- and age-matched comparison subjects. Methods We used Wilcoxon-Mann-Whitney tests to explore differences in variables of healthcare resource utilization between physicians and comparison subjects. We further used Kruskal-Wallis tests to examine differences in variables of healthcare resource utilization between physician practice location and comparison subjects.	[Chiu, Yu-Lung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chiu, Yu-Lung; Kao, Senyong] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chiu, Yu-Lung; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Lin, Herng-Ching; Tsai, Ming-Chieh] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Lee, Cha-Ze] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Defense Medical Center; National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Cathay General Hospital; National Taiwan University; National Taiwan University Hospital	Lee, CZ (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	czl@ntu.edu.tw		Kao, Senyeong/0000-0002-0209-240X				Allibone A, 1981, J R Coll Gen Pract, V31, P728; Balch CM, 2009, ARCH SURG-CHICAGO, V144, P371, DOI 10.1001/archsurg.2008.575; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Christie V, 1996, SHAPING PROFESSION P; Davidson SK, 2003, MED J AUSTRALIA, V179, P302, DOI 10.5694/j.1326-5377.2003.tb05552.x; Domenighetti G, 1993, Int J Technol Assess Health Care, V9, P505; DUGOWSON CE, 1987, WESTERN J MED, V146, P494; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; ISAACS AJ, 1995, BRIT MED J, V311, P1399, DOI 10.1136/bmj.311.7017.1399; Kotb AA, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.164.3355; Lam ST, 2014, ACAD PSYCHIATR, V38, P632, DOI 10.1007/s40596-014-0138-3; Lin CM, 2008, HEALTH SERV RES, V43, P675, DOI 10.1111/j.1475-6773.2007.00776.x; McKevitt C, 1997, J ROY SOC MED, V90, P491, DOI 10.1177/014107689709000907; McNagny SE, 1997, ANN INTERN MED, V127, P1093, DOI 10.7326/0003-4819-127-12-199712150-00007; Rosvold EO, 2002, SCAND J PUBLIC HEALT, V30, P125, DOI 10.1080/14034940210133744; Schneck SA, 1998, JAMA-J AM MED ASSOC, V280, P2039, DOI 10.1001/jama.280.23.2039; Shimizu Takashi, 2005, Environmental Health and Preventive Medicine, V10, P227, DOI 10.1007/BF02897695; Slee DA, 2009, SLEES HLTH CARE TERM; SLOAN FA, 2012, HLTH EC; Steffen MW, 2014, OCCUP MED, V65, P45; Tomljenovic M, 2014, PSYCHIAT DANUB, V26, P450; Xirasagar S, 2006, INT J HEALTH PLAN M, V21, P117, DOI 10.1002/hpm.836	22	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0130690	10.1371/journal.pone.0130690	http://dx.doi.org/10.1371/journal.pone.0130690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26752592	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100002
J	Dalu, T; Sachikonye, MTB; Alexander, ME; Dube, T; Froneman, WP; Manungo, KI; Bepe, O; Wasserman, RJ				Dalu, Tatenda; Sachikonye, Mwazvita T. B.; Alexander, Mhairi E.; Dube, Timothy; Froneman, William P.; Manungo, Kwanele I.; Bepe, Onias; Wasserman, Ryan J.			Ecological Assessment of Two Species of Potamonautid Freshwater Crabs from the Eastern Highlands of Zimbabwe, with Implications for Their Conservation	PLOS ONE			English	Article							MACROINVERTEBRATE COMMUNITIES; RIVER-CRABS; DECAPODA; BRACHYURA; HEALTH; STREAM	The spatial ecology of freshwater crabs and their conservation status is largely understudied in Africa. An ecological assessment was conducted at 104 localities in 51 rivers and/or streams in the Eastern Highlands of Zimbabwe whereby the distribution and abundances of freshwater crab species were mapped and the possible drivers of the observed trends in population structure explored. In addition, information on crab utilisation as a food resource by local communities was assessed via face to face interviews across the region. Finally, the conservation status of each species was assessed using the IUCN Red List criteria. Only two crab species Potamonautes mutareensis and Potamonautes unispinus were recorded within the region of study. Potamonautes mutareensis was largely restricted to less impacted environments in the high mountainous river system, whereas P. unispinus was found in low laying areas. In stretches of river where both species were found to cooccur, the species were never sampled from the same site, with P. mutareensis occurring in shallower, faster flowing environments and P. unispinus in deeper, slow flowing sites. Interview results revealed that the local communities, particularly in the southern part of the Eastern Highlands around the Chipinge area, had a considerable level of utilisation (55% of households) on the harvesting of crabs for household consumption during the non-agricultural season (May to September). Results from the IUCN Red List assessment indicate that both species should be considered as "Least Concern". Threats to freshwater crabs in the Eastern Highlands, however, include widespread anthropogenic impacts such as habitat destruction associated with gold and diamond mining, inorganic and organic pollution and possibly exploitation for human consumption. The current study provides important information and insight towards the possible development of a freshwater crab conservation action plan within the region.	[Dalu, Tatenda; Froneman, William P.] Rhodes Univ, Zool & Entomol, ZA-6140 Grahamstown, Eastern Cape, South Africa; [Sachikonye, Mwazvita T. B.] Rhodes Univ, Environm Sci, ZA-6140 Grahamstown, Eastern Cape, South Africa; [Alexander, Mhairi E.] Univ West Scotland, Sch Sci & Sport, Inst Biomed & Environm Hlth Res, Paisley, Renfrew, Scotland; [Dube, Timothy] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Pietermaritzburg, Kwazulu Natal, South Africa; [Manungo, Kwanele I.] Chimanimani Natl Pk, Chimanimani, Manicaland, Zimbabwe; [Bepe, Onias] Nyanga Natl Pk, Nyanga, Manicaland, Zimbabwe; [Wasserman, Ryan J.] South Africa Inst Aquat Biodivers, Grahamstown, Eastern Cape, South Africa	Rhodes University; Rhodes University; University of West Scotland; University of Kwazulu Natal; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity	Dalu, T (corresponding author), Rhodes Univ, Zool & Entomol, ZA-6140 Grahamstown, Eastern Cape, South Africa.	dalutatenda@yahoo.co.uk	Dube, Timothy/O-5006-2019; Dalu, Tatenda/K-3089-2012; Froneman, William/C-9085-2012; Dalu, Mwazvita TB/J-2112-2019; Froneman, William/GLS-0460-2022	Dube, Timothy/0000-0003-3456-8991; Dalu, Tatenda/0000-0002-9019-7702; Dalu, Mwazvita TB/0000-0001-6757-316X; Froneman, William/0000-0003-0615-1355; Wasserman, Ryan/0000-0002-4162-1503	Ruffords Organisation [16137-1]; Idea Wild	Ruffords Organisation; Idea Wild	This research project was funded by Ruffords Organisation (16137-1) and Idea Wild support grant. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Bates D., 2009, LME4 LINEAR MIXED EF; Boyero L, 2001, HYDROBIOLOGIA, V464, P219, DOI 10.1023/A:1013922307096; Burgess ND, 2000, COASTAL FORESTS E AF, P443; Butler J, 1993, IUCN OTTER SPECIALIS, V8, P6; Butler JRA, 1996, J TROP ECOL, V12, P475, DOI 10.1017/S0266467400009718; Chakona A, 2008, HYDROBIOLOGIA, V607, P199, DOI 10.1007/s10750-008-9391-3; Chakona A, 2009, AQUAT ECOL, V43, P1095, DOI 10.1007/s10452-008-9222-7; Cumberlidge N., 1997, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V99, P571; Cumberlidge N, 2008, IUCN RED LIST THREAT; Cumberlidge N, 1999, FRESHWATER CRABS W A, V236; Cumberlidge N, 2008, AFR J ECOL, V46, P74, DOI 10.1111/j.1365-2028.2007.00815.x; Cumberlidge N, 2014, CRUSTACEANA MONOGR, V19, P71; Cumberlidge Neil, 2002, Zoosystema, V24, P41; Cumberlidge N, 2009, BIOL CONSERV, V142, P1665, DOI 10.1016/j.biocon.2009.02.038; Dallas Helen F., 2007, African Journal of Aquatic Science, V32, P165, DOI 10.2989/AJAS.2007.32.2.8.205; Daniels SR, 2014, ZOOL J LINN SOC-LOND, V171, P356, DOI 10.1111/zoj.12139; Daniels SR, 2011, MOL PHYLOGENET EVOL, V61, P534, DOI 10.1016/j.ympev.2011.07.015; Dobson M., 2004, FRESHW FORUM, V21, P3; Edenhofer O., 2014, CONTRIBUTION WORKING; ESRI, 2011, ARCGIS DESKT REL 10; Gouws G, 2001, WATER SA, V27, P85; Gratwicke B, 2004, AFR ZOOL, V39, P25; Grubaugh JW, 1996, CAN J FISH AQUAT SCI, V53, P896, DOI 10.1139/cjfas-53-4-896; Hill M. P., 1992, SO AFRICAN J AQUATIC, V18, P42, DOI DOI 10.1080/10183469.1992.9631323; Hopkins R., 2011, FROGLOG, V97, P23; Inc SPSS, 2007, SPSS REL 16 0 0 WIND; Kadye WT, 2013, HYDROBIOLOGIA, V720, P75, DOI 10.1007/s10750-013-1624-4; Kadye WT, 2008, HYDROBIOLOGIA, V614, P329, DOI 10.1007/s10750-008-9517-7; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Manicaland Correspondent, 2015, MAR VILL SAY GOVT PR; McGinley M., 2008, ENCY EARTH ENV INFOR; Ogola JS, 2002, ENVIRON GEOCHEM HLTH, V24, P141, DOI 10.1023/A:1014207832471; Phiri EE, 2013, INVERTEBR SYST, V27, P530, DOI 10.1071/IS13012; R Core Team, 2021, R LANGUAGE ENV STAT; Reed Sadie K., 2006, Zootaxa, V1262, P1; Scott JM, 1993, WILDLIFE MONOGR, V123, P57; Silvano D, 2005, AMPHIBIAN CONSERVATI; Tan HTW, 2007, NATURAL HERITAGE SIN; Tarras-Wahlberg NH, 2001, SCI TOTAL ENVIRON, V278, P239, DOI 10.1016/S0048-9697(01)00655-6; Timberlake J, 1994, PHYS FEATURES CHIRIN; Timberlake J, 1994, FOREST CONSERVATION; Tunhumaa NM, 2007, 8 WAT WARFSA GWP SA; TURNBULLKEMP PSJ, 1960, NATURE, V185, P481, DOI 10.1038/185481a0; van Straaten P, 2000, SCI TOTAL ENVIRON, V259, P105, DOI 10.1016/S0048-9697(00)00553-2; White F., 1978, Monographiae Biologicae, V31, P463; Wild H., 1968, VEGETATION MAP FLORA; WILLIAMS TR, 1968, T ROY SOC TROP MED H, V62, P29, DOI 10.1016/0035-9203(68)90027-8; WILLIAMS TR, 1964, ANN TROP MED PARASIT, V58, P159, DOI 10.1080/00034983.1964.11686226; Yeo DCJ, 2008, HYDROBIOLOGIA, V595, P275, DOI 10.1007/s10750-007-9023-3; Yeo DCJ, 2008, SINGAPORE RED DATA B; Zuur Alain F., 2009, P1	52	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145923	10.1371/journal.pone.0145923	http://dx.doi.org/10.1371/journal.pone.0145923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751064	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100033
J	Gomaa, N; Glogauer, M; Tenenbaum, H; Siddiqi, A; Quinonez, C				Gomaa, Noha; Glogauer, Michael; Tenenbaum, Howard; Siddiqi, Arjumand; Quinonez, Carlos			Social-Biological Interactions in Oral Disease: A 'Cells to Society' View	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; ALLOSTATIC LOAD; SOCIOECONOMIC-STATUS; PHYSIOLOGICAL DYSREGULATION; INFLAMMATORY DISEASE; HEALTH DISPARITIES; HEART-DISEASE; DENTAL-CARIES; RISK-FACTOR; STRESS	Oral diseases constitute a major worldwide public health problem, with their burden concentrating in socially disadvantaged and less affluent groups of the population, resulting in significant oral health inequalities. Biomedical and behavioural approaches have proven relatively ineffective in reducing these inequalities, and have potentially increased the health gap between social groups. Some suggest this stems from a lack of understanding of how the social and psychosocial contexts in which behavioural and biological changes occur influence oral disease. To unravel the pathways through which social factors affect oral health outcomes, a better understanding is thus needed of how the social 'gets under the skin,' or becomes embodied, to alter the biological. In this paper, we present the current knowledge on the interplay between social and biological factors in oral disease. We first provide an overview of the process of embodiment in chronic disease and then evaluate the evidence on embodiment in oral disease by reviewing published studies in this area. Results show that, in periodontal disease, income, education and perceived stress are correlated with elevated levels of stress hormones, disrupted immune biomarkers and increased allostatic load. Similarly, socioeconomic position and increased financial stress are related to increased stress hormones and cariogenic bacterial counts in dental caries. Based on these results, we propose a dynamic model depicting social-biological interactions that illustrates potential interdependencies between social and biological factors that lead to poor oral health. This work and the proposed model may aid in developing a better understanding of the causes of oral health inequalities and implicate the importance of addressing the social determinants of oral health in innovating public health interventions.	[Gomaa, Noha; Quinonez, Carlos] Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, Toronto, ON, Canada; [Gomaa, Noha; Quinonez, Carlos] Univ Toronto, Fac Dent, Discipline Dent Publ Hlth, Toronto, ON, Canada; [Glogauer, Michael; Tenenbaum, Howard] Univ Toronto, Fac Dent, Dept Periodontol, Toronto, ON, Canada; [Siddiqi, Arjumand] Univ Toronto, Dalla Lana Fac Publ Hlth, Discipline Social & Behav Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto	Gomaa, N (corresponding author), Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, Toronto, ON, Canada.	noha.gomaa@mail.utoronto.ca	Glogauer, Michael/D-2504-2011; Gomaa, Noha/ADU-3638-2022	Gomaa, Noha/0000-0002-7351-9036				Aboodi GM, 2011, J PERIODONTOL, V82, P726, DOI 10.1902/jop.2010.100508; Adler NE, 2003, CURR DIR PSYCHOL SCI, V12, P119, DOI 10.1111/1467-8721.01245; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Ahn AC, 2006, PLOS MED, V3, P956, DOI 10.1371/journal.pmed.0030209; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Arrow P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-245; Astrom A N, 2001, Clin Oral Investig, V5, P122; Bakri I, 2013, J CLIN PERIODONTOL, V40, P955, DOI 10.1111/jcpe.12142; Baum A, 2011, HDB STRESS SCI BIOL, P47; Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-200; Berkman LF., 2014, SOCIAL EPIDEMIOLOGY, V2nd ed.; BLANE D, 1985, SOCIOL HEALTH ILL, V7, P423, DOI 10.1111/1467-9566.ep10832355; Borrell LN, 2011, J EPIDEMIOL COMMUN H, V65, P144, DOI 10.1136/jech.2009.098269; Boscolo P, 2011, INT J IMMUNOPATH PH, V24, P51; Boyce WT, 2010, SOC SCI MED, V71, P1644, DOI 10.1016/j.socscimed.2010.07.045; Breivik T, 1996, EUR J ORAL SCI, V104, P327, DOI 10.1111/j.1600-0722.1996.tb00087.x; Brunner E, 1996, SOCIAL BIOL BASIS CA, P272; BRUNNER E, 1999, SOCIAL DETERMINANTS; Bublitz A, 1980, P EUROPEAN DIALYSIS, V18, P517; Buchwald S, 2013, J CLIN PERIODONTOL, V40, P203, DOI 10.1111/jcpe.12056; CHMS. Health Canada, 2010, HEALTH CANADA REPORT; Cohen S., 1995, MEASURING STRESS GUI, P3; Cornfield J, 2009, INT J EPIDEMIOL, V38, P1175, DOI 10.1093/ije/dyp289; Fidalgo TKD, 2014, J DENT, V42, P1372, DOI 10.1016/j.jdent.2014.07.011; Duffy SA, 2002, GEN HOSP PSYCHIAT, V24, P140, DOI 10.1016/S0163-8343(02)00180-9; Gersten O, 2008, SOC SCI MED, V66, P507, DOI 10.1016/j.socscimed.2007.09.004; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P145, DOI 10.1034/j.1600-051X.2003.300201.x; Gibson S, 2008, NUTR RES REV, V21, P134, DOI 10.1017/S0954422408110976; Glei DA, 2007, PSYCHOSOM MED, V69, P769, DOI 10.1097/PSY.0b013e318157cba6; Hawkley LC, 2011, PSYCHOPHYSIOLOGY, V48, P1134, DOI 10.1111/j.1469-8986.2011.01185.x; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hirschfeld J, 2015, INT J MED MICROBIOLO; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; INGLEHART M, 1995, PERIODONTOL 2000, V8, P15, DOI 10.1111/j.1600-0757.1995.tb00042.x; Ippoliti F, 2013, J NEUROIMMUNE PHARM, V8, P212, DOI 10.1007/s11481-012-9432-6; Ji S, 2007, J PERIODONTAL RES, V42, P503, DOI 10.1111/j.1600-0765.2007.00974.x; Johannsen A, 2007, J PERIODONTAL RES, V42, P546, DOI 10.1111/j.1600-0765.2007.00980.x; Johannsen A, 2006, J PERIODONTOL, V77, P1403, DOI 10.1902/jop.2006.050411; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Kay EJ, 1996, COMMUNITY DENT ORAL, V24, P231, DOI 10.1111/j.1600-0528.1996.tb00850.x; Kennedy AE, 2013, HUM IMMUNOL, V74, P35; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Lawrence HP, 2005, SPEC CARE DENT, V25, P242, DOI 10.1111/j.1754-4505.2005.tb01657.x; Lee JY, 2014, J DENT RES, V93, P224, DOI 10.1177/0022034513511821; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Logan JG, 2008, J CLIN NURS, V17, P201, DOI 10.1111/j.1365-2702.2008.02347.x; Lowe G D, 2001, Ann Periodontol, V6, P1, DOI 10.1902/annals.2001.6.1.1; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Masterson EE, 2015, AM J PUBLIC HEALTH, pe1; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McEwen BS, 2001, ANN NY ACAD SCI, V935, P42; MCLEOD JD, 1990, J HEALTH SOC BEHAV, V31, P162, DOI 10.2307/2137170; Mengel R, 2002, J CLIN PERIODONTOL, V29, P1012, DOI 10.1034/j.1600-051X.2002.291106.x; Miller GE, 2008, BIOL PSYCHIAT, V64, P266, DOI 10.1016/j.biopsych.2008.03.017; Moss ME, 1996, J PERIODONTOL, V67, P1060, DOI 10.1902/jop.1996.67.10s.1060; Nasstrom K, 1995, SCANNING MICROSCOPY, V10, P339; Nasstrom K, 1995, SCANNING MICROSCOPY, V10, P46; Ness RB, 2007, ANN EPIDEMIOL, V17, P564, DOI 10.1016/j.annepidem.2006.10.014; Newton JT, 2005, COMMUNITY DENT ORAL, V33, P25, DOI 10.1111/j.1600-0528.2004.00190.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Priyadarshini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043232; Quinn K, 2010, J URBAN HEALTH, V87, P688, DOI 10.1007/s11524-010-9465-1; Robertson T, 2015, BRAIN BEHAV IMMUN, V45, P41, DOI 10.1016/j.bbi.2014.10.005; Roux AVD, 2007, ANN EPIDEMIOL, V17, P569, DOI 10.1016/j.annepidem.2007.03.001; Roux AVD, 2012, ANNU REV PUBL HEALTH, V33, P41, DOI 10.1146/annurev-publhealth-031811-124534; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Sabbah W, 2008, J EPIDEMIOL COMMUN H, V62, P415, DOI 10.1136/jech.2007.064188; Sabbah W, 2009, SOC SCI MED, V68, P298, DOI 10.1016/j.socscimed.2008.10.030; Sapolsky R, 2005, SCI AM, V293, P92, DOI 10.1038/scientificamerican1205-92; Schou L, 1994, Community Dent Health, V11, P97; Schwartz AR, 2003, PSYCHOSOM MED, V65, P22, DOI 10.1097/01.PSY.0000046075.79922.61; Seeman TE, 2002, PSYCHOSOM MED, V64, P395, DOI 10.1097/00006842-200205000-00004; Seeman T, 2008, SOC SCI MED, V66, P72, DOI 10.1016/j.socscimed.2007.08.027; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Seplaki CL, 2006, DEMOGRAPHY, V43, P165, DOI 10.1353/dem.2006.0009; Sheiham A, 2000, COMMUNITY DENT ORAL, V28, P399, DOI 10.1034/j.1600-0528.2000.028006399.x; Sheiham A, 2000, PERIODONTOL, V2005, P118; Sisson KL, 2007, COMMUNITY DENT ORAL, V35, P81, DOI 10.1111/j.1600-0528.2007.00354.x; Slavich GM, 2015, BRAIN BEHAV IMMUN, V45, P13, DOI 10.1016/j.bbi.2014.10.012; Solar O, 2007, CONCEPTUAL FRAMEWORK; Steptoe A, 2002, EUR HEART J, V23, P1757, DOI 10.1053/euhj.2001.3233; Steptoe A, 1999, J HYPERTENS, V17, P193, DOI 10.1097/00004872-199917020-00003; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Szanton SL, 2005, BIOL RES NURS, V7, P7, DOI 10.1177/1099800405278216; Taubman MA, 2005, J PERIODONTOL, V76, P2033, DOI 10.1902/jop.2005.76.11-S.2033; Taylor G, 2014, CHIEF PUBLIC HLTH OF; Theall KP, 2012, AM J EPIDEMIOL, V176, pS164, DOI 10.1093/aje/kws185; Thomson WM, 2012, PERIODONTOL 2000, V60, P54, DOI 10.1111/j.1600-0757.2011.00405.x; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; Watt R, 2001, COMMUNITY DENT ORAL, V29, P161, DOI 10.1034/j.1600-0528.2001.290301.x; Watt RG, 2005, B WORLD HEALTH ORGAN, V83, P711; Watt RG, 2012, COMMUNITY DENT ORAL, V40, P44, DOI 10.1111/j.1600-0528.2012.00719.x; Wood LG, 2012, CHEST, V142, P86, DOI 10.1378/chest.11-1838; Ying G, 2010, PERIODONTAL DIS OVER	102	30	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146218	10.1371/journal.pone.0146218	http://dx.doi.org/10.1371/journal.pone.0146218			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751953	Green Published, gold			2022-12-27	WOS:000367888100053
J	Guo, Z; Zheng, L; Liao, XH; Geller, D				Guo, Zhong; Zheng, Liang; Liao, Xinghua; Geller, David			Up-Regulation of Human Inducible Nitric Oxide Synthase by p300 Transcriptional Complex	PLOS ONE			English	Article							NF-KAPPA-B; INOS GENE; HUMAN HEPATOCYTES; RESPONSE ELEMENT; PROMOTER; EXPRESSION; IDENTIFICATION; CYTOKINES; ENDOTOXIN; UPSTREAM	p300, a ubiquitous transcription coactivator, plays an important role in gene activation. Our previous work demonstrated that human inducible nitric oxide synthase (hiNOS) expression can be highly induced with the cytokine mixture (CM) of TNF-alpha + IL-1 beta + IFN-gamma. In this study, we investigated the functional role of p300 in the regulation of hiNOS gene expression. Our initial data showed that overexpression of p300 significantly increased the basal and cytokine-induced hiNOS promoter activities in A549 cells. Interestingly, p300 activated cytokine-induced hiNOS transcriptional activity was completely abrogated by deleting the upstream hiNOS enhancer at -5 kb to -6 kb in the promoter. Furthermore, p300 over-expression increased cytokine-induced transcriptional activity on a heterologous minimal TK promoter with the same hiNOS enhancer. Site-directed mutagenesis of the hiNOS AP-1 motifs revealed that an intact upstream (-5.3kb) AP-1 binding site was critical for p300 mediated cytokine-induced hiNOS transcription. Furthermore, our ChIP analysis demonstrated that p300 was binding to Jun D and Fra-2 proteins at -5.3 kb AP-1 binding site in vivo. Lastly, our 3C assay was able to detect a long DNA loop between the hiNOS enhancer and core promoter site, and ChIP loop assay confirmed that p300 binds to AP-1 and RNA pol II proteins. Overall, our results suggest that coactivator p300 mediates cytokine-induced hiNOS trans-activation by forming a distant DNA loop between its enhancer and core promoter region.	[Guo, Zhong; Zheng, Liang] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Liao, Xinghua; Geller, David] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Guo, Z (corresponding author), Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15261 USA.	zhg1@pitt.edu; gellerda@upmc.edu						Cao WS, 2003, P NATL ACAD SCI USA, V100, P7773, DOI 10.1073/pnas.1337185100; Chan HM, 2001, J CELL SCI, V114, P2363; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Chu SC, 1998, BIOCHEM BIOPH RES CO, V248, P871, DOI 10.1006/bbrc.1998.9062; Deng WG, 2003, J IMMUNOL, V171, P6581, DOI 10.4049/jimmunol.171.12.6581; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; Du QA, 2006, CANCER RES, V66, P7024, DOI 10.1158/0008-5472.CAN-05-4110; Feng XS, 2002, P NATL ACAD SCI USA, V99, P14212, DOI 10.1073/pnas.212306199; Ganster RW, 2005, J INTERF CYTOK RES, V25, P707, DOI 10.1089/jir.2005.25.707; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; GELLER DA, 1993, P NATL ACAD SCI USA, V90, P3491, DOI 10.1073/pnas.90.8.3491; GELLER DA, 1995, J IMMUNOL, V155, P4890; Goodman RH, 2000, GENE DEV, V14, P1553; Guo H, 2008, J BIOL CHEM, V283, P25209, DOI 10.1074/jbc.M804062200; Guo Z, 2003, FASEB J, V17, P1718, DOI 10.1096/fj.02-1172fje; Guo Z, 2007, FASEB J, V21, P535, DOI 10.1096/fj.06-6739com; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; Mellott JK, 2001, AM J PHYSIOL-LUNG C, V280, pL390, DOI 10.1152/ajplung.2001.280.3.L390; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; NUSSLER AK, 1992, J EXP MED, V176, P261, DOI 10.1084/jem.176.1.261; Park KS, 2009, J MOL BIOL, V390, P595, DOI 10.1016/j.jmb.2009.05.036; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Ratajczak-Wrona W, 2013, J IMMUNOTOXICOL, V10, P32, DOI 10.3109/1547691X.2012.686929; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Wong J M, 1995, Adv Pharmacol, V34, P155	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146640	10.1371/journal.pone.0146640	http://dx.doi.org/10.1371/journal.pone.0146640			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751080	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100117
J	Przygodzki, T; Talar, M; Blazejczyk, A; Kalchenko, V; Watala, C				Przygodzki, Tomasz; Talar, Marcin; Blazejczyk, Agnieszka; Kalchenko, Vyacheslav; Watala, Cezary			Quantification of the Blood Platelet Reactivity in the ADP-Induced Model of Non-Lethal Pulmonary Thromboembolism in Mice with the Use of Laser Doppler Flowmetry	PLOS ONE			English	Article							IN-VIVO; AGGREGATION	Introduction The paper describes an alternative method for quantification of in vivo ADP-induced thromboembolism. The aim of the studies was to develop a method of quantification which would not require either extravasation or labelling of platelets. Our proposed approach is based on the monitoring of changes of blood flow with the use of laser Doppler flowmetry. Materials and Methods Mice of C57Bl strain were used in the study. ADP was injected to the vena cava and blood flow was monitored with the use of a laser Doppler flowmeter in the mesentery. Measurements in platelet-depleted mice, mice pretreated with cangrelor, an ADP receptor antagonist, and eptifibatide, a blocker of fibrinogen binding to GPIIbIIIa, were conducted as the proof-of-concept in the performed experiments. Intravital microscopy and ex vivo imaging of organs was performed to identify the sites of aggregate formation resulting from ADP injection. Results The injection of ADP resulted in a dose-dependent reduction of the blood flow in the mesentery. These responses were fully attributable to blood platelet aggregation, as shown by the lack of the effect in platelet-depleted mice, and significantly reduced responses in mice pretreated with cangrelor and eptifibatide. No platelet aggregate formation in mesenteric vessels was revealed by intravital microscopy, while ex vivo imaging showed accumulation of fluorescent labelled platelets in the lung. Conclusions Injection of ADP to the venous system results in the formation of platelet aggregates predominantly in the lung. This results in reversible blood flow cessation in peripheral blood vessels. The measurement of this blood flow cessation in the mesentery allows indirect measurement of ADP-induced pulmonary thromboembolism. We suggest that this approach can be useful for in vivo screening for antiplatelet drug candidates.	[Przygodzki, Tomasz; Talar, Marcin; Watala, Cezary] Med Univ Lodz, Dept Haemostasis & Haemostat Disorders, Chair Biomed Sci, Lodz, Poland; [Blazejczyk, Agnieszka] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Kalchenko, Vyacheslav] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel	Medical University Lodz; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Weizmann Institute of Science	Przygodzki, T (corresponding author), Med Univ Lodz, Dept Haemostasis & Haemostat Disorders, Chair Biomed Sci, Lodz, Poland.	tomasz.przygodzki@umed.lodz.pl	Kalchenko, Vyacheslav/F-2924-2012; Watala, Cezary/ABF-4863-2020	Watala, Cezary/0000-0002-5627-7872; Kalchenko, Vyacheslav/0000-0002-3166-7049; Przygodzki, Tomasz/0000-0003-4937-8621	National Science Centre [DEC-2012/06/A/NZ5/00069]; European Regional Development Fund within the framework of the Innovative Economy Programme [POIG 01.01.02-00-069/09-00]; Medical University of Lodz [502-03/6-020-01/502-64-067]	National Science Centre(National Science Centre, Poland); European Regional Development Fund within the framework of the Innovative Economy Programme; Medical University of Lodz	The work was supported by National Science Centre (https://www.ncn.gov.pl/?language=en) by grant number DEC-2012/06/A/NZ5/00069 and by the project POIG 01.01.02-00-069/09-00 financed by the European Regional Development Fund within the framework of the Innovative Economy Programme 2007-2013 (http://www.ncbr.gov.pl/en/). Marcin Talar was supported by Medical University of Lodz from grant number 502-03/6-020-01/502-64-067.	Armstrong PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020062; Hu ZB, 2010, NEONATOLOGY, V98, P100, DOI 10.1159/000280413; Jayakumar T, 2013, J NUTR BIOCHEM, V24, P1086, DOI 10.1016/j.jnutbio.2012.08.007; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Mordon S, 2002, MICROVASC RES, V64, P316, DOI 10.1006/mvre.2002.2435; Paul W, 2007, BRIT J PHARMACOL, V150, P105, DOI 10.1038/sj.bjp.0706957; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Tymvios C, 2008, THROMB HAEMOSTASIS, V99, P435, DOI 10.1160/TH07-07-0479; Watala C, 2006, BLOOD COAGUL FIBRIN, V17, P113, DOI 10.1097/01.mbc.0000203862.85610.ac	9	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146346	10.1371/journal.pone.0146346	http://dx.doi.org/10.1371/journal.pone.0146346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751810	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100066
J	Ramasindrazana, B; Dellagi, K; Lagadec, E; Randrianarivelojosia, M; Goodman, SM; Tortosa, P				Ramasindrazana, Beza; Dellagi, Koussay; Lagadec, Erwan; Randrianarivelojosia, Milijaona; Goodman, Steven M.; Tortosa, Pablo			Diversity, Host Specialization, and Geographic Structure of Filarial Nematodes Infecting Malagasy Bats	PLOS ONE			English	Article							CHIROPTERA MINIOPTERIDAE; LITOMOSOIDES NEMATODA; POPULATION-STRUCTURE; SMALL MAMMALS; HABITAT USE; MADAGASCAR; ONCHOCERCIDAE; FILARIOIDEA; IDENTIFICATION; CONSERVATION	We investigated filarial infection in Malagasy bats to gain insights into the diversity of these parasites and explore the factors shaping their distribution. Samples were obtained from 947 individual bats collected from 52 sites on Madagascar and representing 31 of the 44 species currently recognized on the island. Samples were screened for the presence of micro-and macro-parasites through both molecular and morphological approaches. Phylogenetic analyses showed that filarial diversity in Malagasy bats formed three main groups, the most common represented by Litomosa spp. infecting Miniopterus spp. (Miniopteridae); a second group infecting Pipistrellus cf. hesperidus (Vespertilionidae) embedded within the Litomosoides cluster, which is recognized herein for the first time from Madagascar; and a third group composed of lineages with no clear genetic relationship to both previously described filarial nematodes and found in M. griveaudi, Myotis goudoti, Neoromicia matroka (Vespertilionidae), Otomops madagascariensis (Molossidae), and Paratriaenops furculus (Hipposideridae). We further analyzed the infection rates and distribution pattern of Litomosa spp., which was the most diverse and prevalent filarial taxon in our sample. Filarial infection was disproportionally more common in males than females in Miniopterus spp., which might be explained by some aspect of roosting behavior of these cave-dwelling bats. We also found marked geographic structure in the three Litomosa clades, mainly linked to bioclimatic conditions rather than host-parasite associations. While this study demonstrates distinct patterns of filarial nematode infection in Malagasy bats and highlights potential drivers of associated geographic distributions, future work should focus on their alpha taxonomy and characterize arthropod vectors.	[Ramasindrazana, Beza; Dellagi, Koussay; Lagadec, Erwan; Tortosa, Pablo] Ctr Rech & Veille Malad Emergentes Ocean Indien, Plateforme Rech CYROI, St Clotilde, Reunion, France; [Ramasindrazana, Beza; Dellagi, Koussay; Lagadec, Erwan; Tortosa, Pablo] Univ La Reunion, UMR PIMIT Proc Infect Milieu Insulaire Trop, CNRS 9192, INSERM,U1187,IRD 249 Plateforme Rech CYROI, F-97490 St Denis, Reunion, France; [Ramasindrazana, Beza; Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar; [Randrianarivelojosia, Milijaona] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Field Museum of Natural History (Chicago)	Ramasindrazana, B (corresponding author), Ctr Rech & Veille Malad Emergentes Ocean Indien, Plateforme Rech CYROI, St Clotilde, Reunion, France.	ramasindrazana@gmail.com	RAMASINDRAZANA, Beza/AGY-9255-2022	Randrianarivelojosia, Milijaona/0000-0003-2767-0349; Abid, sayda/0000-0003-2488-1431; Tortosa, Pablo/0000-0002-7928-7264; RAMASINDRAZANA, Beza/0000-0002-8838-949X	Volkswagen Foundation; Fonds Europeen de Developpement Regional FEDER POCT Reunion (pathogenes associes a la faune sauvage ocean Indien) [31189]; RunEmerge project by the European Frame work programme FP7 Capacities/Regpot; "Fonds de Cooperation Regionale" of the Prefecture de La Reunion; Dr. Ralph and Marian Falk Medical Research Trust	Volkswagen Foundation(Volkswagen); Fonds Europeen de Developpement Regional FEDER POCT Reunion (pathogenes associes a la faune sauvage ocean Indien); RunEmerge project by the European Frame work programme FP7 Capacities/Regpot; "Fonds de Cooperation Regionale" of the Prefecture de La Reunion; Dr. Ralph and Marian Falk Medical Research Trust	Financial support associated with fieldwork was graciously provided by The Volkswagen Foundation and Fonds Europeen de Developpement Regional FEDER POCT Reunion (pathogenes associes a la faune sauvage ocean Indien #31189). BR received postdoctoral fellowship from RunEmerge project funded by the European Frame work programme FP7 Capacities/Regpot, and post doctoral grants from "Fonds de Cooperation Regionale" of the Prefecture de La Reunion and from the Dr. Ralph and Marian Falk Medical Research Trust to The Field Museum of Natural History, Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bain O, 2008, PARASITE, V15, P342, DOI 10.1051/parasite/2008153342; BAIN O., 1967, Bulletin du Museum National d'Histoire Naturelle, V38, P928; Brant SV, 1997, J PARASITOL, V83, P700, DOI 10.2307/3284249; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Casiraghi M, 2004, INT J PARASITOL, V34, P191, DOI 10.1016/j.ijpara.2003.10.004; Casiraghi M, 2001, PARASITOLOGY, V122, P93, DOI 10.1017/S0031182000007149; Charleston MA, 2002, SYST BIOL, V51, P528, DOI 10.1080/10635150290069940; Christidis L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092440; Cornet A, 1974, ESSAI DE CARTOGRAPHI; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dietrich M, 2014, MOL ECOL, V23, P2783, DOI 10.1111/mec.12777; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Eger J., 2003, NATURAL HIST MADAGAS, P1287; Ferri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020843; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GARDNER SL, 1986, SYST PARASITOL, V8, P235, DOI 10.1007/BF00009892; Gondorf F, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004616; Goodman SM, 2007, J MAMMAL, V88, P1216, DOI 10.1644/06-MAMM-A-285R1.1; Goodman SM, 2010, J ZOOL SYST EVOL RES, V48, P75, DOI 10.1111/j.1439-0469.2009.00524.x; Goodman S. M., 2011, CHAUVES SOURIS MADAG; Goodman SM, 2005, ANIM CONSERV, V8, P153, DOI 10.1017/S136794300500199X; Goodman SM., 2013, ATLAS SELECTED LAND, P169; Goodman SM, 2015, ZOOL J LINN SOC-LOND, V173, P988, DOI 10.1111/zoj.12223; Goodman SM, 2012, ZOOTAXA, P1; Goodman Steven M., 2011, Zootaxa, V2880, P1; Goodman SM, 2009, AM MUS NOVIT, P1, DOI 10.1206/652.1; Goodman SM, 2009, ZOOL SCR, V38, P339, DOI 10.1111/j.1463-6409.2008.00377.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guerrero R, 2006, PARASITE, V13, P127, DOI 10.1051/parasite/2006132127; Guerrero R, 2011, PARASITE, V18, P151, DOI 10.1051/parasite/2011182151; Guerrero R, 2002, COMP PARASITOL, V69, P177, DOI 10.1654/1525-2647(2002)069[0177:NAKSOL]2.0.CO;2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugot JP, 2001, NEMATOLOGY, V3, P199, DOI 10.1163/156854101750413270; Junker K, 2008, ONDERSTEPOORT J VET, V75, P261; Junker K, 2009, PARASITE, V16, P43, DOI 10.1051/parasite/2009161043; Kofoky A, 2007, BIODIVERS CONSERV, V16, P1039, DOI 10.1007/s10531-006-9059-0; Lagadec E, 2012, EMERG INFECT DIS, V18, P1696, DOI 10.3201/eid1810.111898; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Martin C, 2006, PARASITE, V13, P3, DOI 10.1051/parasite/2006131003; Martin C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002565; Meszaros F, 1980, PARASITOL HUNG, V13, P56; Morand S, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P63, DOI 10.1007/978-4-431-36025-4_4; Notarnicola J, 2005, SYST PARASITOL, V62, P171, DOI 10.1007/s11230-005-5490-y; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; R Core Team, 2021, R LANGUAGE ENV STAT; Raharimanga V., 2003, Archives de l'Institut Pasteur de Madagascar, V69, P70; Rakotoarivelo AA, 2009, AFR J ECOL, V47, P283, DOI 10.1111/j.1365-2028.2008.00947.x; Ramasindrazana B, 2011, BIOL J LINN SOC, V104, P284, DOI 10.1111/j.1095-8312.2011.01740.x; Pereira MJR, 2009, J HERED, V100, P533, DOI 10.1093/jhered/esp032; Randrianandrianina F, 2006, ACTA CHIROPTEROL, V8, P429, DOI 10.3161/1733-5329(2006)8[429:HUACOB]2.0.CO;2; Robert V, 2014, MALAGASY NATURE, V8, P54; Rodrigues L, 2010, BEHAV ECOL SOCIOBIOL, V64, P835, DOI 10.1007/s00265-009-0900-9; Russell AL, 2007, MOL ECOL, V16, P839, DOI 10.1111/j.1365-294X.2007.03192.x; Russell AL, 2008, J BIOGEOGR, V35, P995, DOI 10.1111/j.1365-2699.2008.01891.x; SAWADA I, 1966, JPN J MED SCI BIOL, V19, P51, DOI 10.7883/yoken1952.19.51; Tibayrenc M, 1979, B MUSEUM HIST NATURE, V4, P183; Tortosa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075215; Traversa D, 2007, VET PARASITOL, V146, P263, DOI 10.1016/j.vetpar.2007.03.015; Weyeneth N, 2011, J BIOGEOGR, V38, P44, DOI 10.1111/j.1365-2699.2010.02393.x; Wilkinson DA, 2014, J VIROL, V88, P8268, DOI 10.1128/JVI.01211-14; Wilkinson DA, 2012, VIRUS RES, V170, P159, DOI 10.1016/j.virusres.2012.08.022; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	66	4	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145709	10.1371/journal.pone.0145709	http://dx.doi.org/10.1371/journal.pone.0145709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751792	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100024
J	Winiarski, KJ; McGarigal, K				Winiarski, Kristopher J.; McGarigal, Kevin			Effects of Photo and Genotype-Based Misidentification Error on Estimates of Survival, Detection and State Transition using Multistate Survival Models	PLOS ONE			English	Article							CAPTURE-RECAPTURE; MARK-RECAPTURE; COMPUTER-PROGRAM; POPULATION; ANIMALS; IDENTIFICATION; MULTIPLE	We simulated multistate capture histories (CHs) by varying state survival (phi), detection (p) and transition (psi), number of total capture occasions and releases per capture occasion and then modified these scenarios to mimic false rejection error (FRE), a common misidentification error, resulting from the failure to match samples of the same individual. We then fit a multistate model and estimated accuracy, bias and precision of state-specific phi, p and psi to better understand the effects of FRE on different simulation scenarios. As expected, phi, and p, decreased in accuracy with FRE, with lower accuracy when CHs were simulated under a shorter-term study and a lower number of releases per capture occasion (lower sample size). Accuracy of. estimates were robust to FRE except in those CH scenarios simulated using low sample size. The effect of FRE on bias was not consistent among parameters and differed by CH scenario. As expected, phi was negatively biased with increased FRE (except for the low. low p CH scenario simulated with a low sample size), but we found that the magnitude of bias differed by scenario (high p CH scenarios were more negatively biased). State transition was relatively unbiased, except for the low p CH scenarios simulated with a low sample size, which were positively biased with FRE, and high p CH scenarios simulated with a low sample size. The effect of FRE on precision was not consistent among parameters and differed by scenario and sample size. Precision of phi decreased with FRE and was lowest with the low phi low p CH scenarios. Precision of p estimates also decreased with FRE under all scenarios, except the low phi high p CH scenarios. However, precision of psi increased with FRE, except for those CH scenarios simulated with a low sample size. Our results demonstrate how FRE leads to loss of accuracy in parameter estimates in a multistate model with the exception of. when estimated using an adequate sample size.	[Winiarski, Kristopher J.; McGarigal, Kevin] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Winiarski, Kristopher J.] Univ Massachusetts, Northeast Climate Sci Ctr, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Winiarski, KJ (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	withakri@gmail.com			Northeast Climate Science Center	Northeast Climate Science Center	KW is a student fellow supported by the Northeast Climate Science Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres KL, 2004, MOL ECOL NOTES, V4, P315, DOI 10.1111/j.1471-8286.2004.00616.x; Bolger DT, 2012, METHODS ECOL EVOL, V3, P813, DOI 10.1111/j.2041-210X.2012.00212.x; Burghardt Tilo, 2008, THESIS; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Dreschsler A, 2015, ECOLOGY EVOLUTION, V5, P141, DOI [10.1002/ece3.1340, DOI 10.1002/ECE3.1340]; Gamble L, 2008, J APPL ECOL, V45, P170, DOI 10.1111/j.1365-2664.2007.01368.x; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Bonner S, 2013, BIOMETRICS, V69, P766, DOI 10.1111/biom.12045; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; LAAKE J.L, 2013, 201301 AFSC NOAA AL; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Link WA, 2010, BIOMETRICS, V66, P178, DOI 10.1111/j.1541-0420.2009.01244.x; Lukacs PM, 2009, ENVIRON ECOL STAT SE, V3, P711, DOI 10.1007/978-0-387-78151-8_32; Lukacs PM, 2005, MOL ECOL, V14, P3909, DOI 10.1111/j.1365-294X.2005.02717.x; Matthe Maximilian, 2008, Zeitschrift fuer Feldherpetologie, V15, P89; Mills L. S., 2013, CONSERVATION WILDLIF; Morrison TA, 2011, METHODS ECOL EVOL, V2, P454, DOI 10.1111/j.2041-210X.2011.00106.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; R: Development C. Team, 2009, R LANG ENV STAT COMP; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Sherley Richard B., 2010, Endangered Species Research, V11, P101, DOI 10.3354/esr00267; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilberg MJ, 2004, MOL ECOL NOTES, V4, P783, DOI 10.1111/j.1471-8286.2004.00797.x; Woods JG, 1999, WILDLIFE SOC B, V27, P616; Wright JA, 2009, BIOMETRICS, V65, P833, DOI 10.1111/j.1541-0420.2008.01165.x; Yoshizaki J., 2007, THESIS; Yoshizaki J, 2011, ENVIRON ECOL STAT, V18, P27, DOI 10.1007/s10651-009-0116-1; Yoshizaki J, 2009, ECOLOGY, V90, P3, DOI 10.1890/08-0304.1	36	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145640	10.1371/journal.pone.0145640	http://dx.doi.org/10.1371/journal.pone.0145640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751208	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100020
J	Al-Doghachi, FAJ; Islam, A; Zainal, Z; Saiman, MI; Embong, Z; Taufiq-Yap, YH				Al-Doghachi, Faris A. J.; Islam, Aminul; Zainal, Zulkarnain; Saiman, Mohd Izham; Embong, Zaidi; Taufiq-Yap, Yun Hin			High Coke-Resistance Pt/Mg1-xNixO Catalyst for Dry Reforming of Methane	PLOS ONE			English	Article							MGO SOLID-SOLUTION; WATER-GAS SHIFT; CARBON-DIOXIDE; EFFICIENT CONVERSION; PARTIAL OXIDATION; SYNGAS PRODUCTION; NOBLE-METALS; CO2; PERFORMANCE; NI	A highly active and stable nano structured Pt/Mg1-xNixO catalysts was developed by a simple co-precipitation method. The obtained Pt/Mg1-xNixO catalyst exhibited cubic structure nanocatalyst with a size of 50-80 nm and realized CH4 and CO2 conversions as high as 98% at 900 degrees C with excellent stability in the dry reforming of methane. The characterization of catalyst was performed using various kinds of analytical techniques including XRD, BET, XRF, TPR-H-2, TGA, TEM, FESEM, FT-IR, and XPS analyses. Characterization of spent catalyst further confirms that Pt/Mg1-xNixO catalyst has high coke-resistance for dry reforming. Thus, the catalyst demonstrated in this study, offers a promising catalyst for resolving the dilemma between dispersion and reducibility of supported metal, as well as activity and stability during high temperature reactions.	[Al-Doghachi, Faris A. J.; Islam, Aminul; Zainal, Zulkarnain; Saiman, Mohd Izham; Taufiq-Yap, Yun Hin] Univ Putra Malaysia, Fac Sci, Catalysis Sci & Technol Res Ctr, Serdang 43400, Selangor, Malaysia; [Al-Doghachi, Faris A. J.; Islam, Aminul; Zainal, Zulkarnain; Saiman, Mohd Izham; Taufiq-Yap, Yun Hin] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia; [Embong, Zaidi] Univ TunHussienOnn Malaysia UTHM, Fac Sci Technol & Human Dev, Dept Sci, Parit Raja 86400, Batu Pahat, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Taufiq-Yap, YH (corresponding author), Univ Putra Malaysia, Fac Sci, Catalysis Sci & Technol Res Ctr, Serdang 43400, Selangor, Malaysia.	yap@science.upm.edu.my	Embong, Zaidi/AAF-8380-2019; Yap, Yun Hin Taufiq/AAB-8959-2019; Al-doghachi, Faris/AAJ-8566-2021; Islam, Aminul/W-6383-2019	Embong, Zaidi/0000-0003-0841-7890; Yap, Yun Hin Taufiq/0000-0002-3994-6720; Al-doghachi, Faris/0000-0003-3226-0678; Islam, Aminul/0000-0001-9933-143X	University Putra Malaysia	University Putra Malaysia	This work was supported by the University Putra Malaysia.	Abatzoglou N., 2015, WIELY INTERDISCIPLIN; Aldbea F. W., 2012, SOL GEL SCI TECHNOL, V62; Appari S, 2014, APPL CATAL A-GEN, V471, P118, DOI 10.1016/j.apcata.2013.12.002; Chen P, 1998, APPL CATAL A-GEN, V166, P343, DOI 10.1016/S0926-860X(97)00291-3; Chen XY, 2014, CATAL TODAY, V233, P14, DOI 10.1016/j.cattod.2014.03.058; Chen XJ, 2014, RSC ADV, V4, P8703, DOI 10.1039/c3ra47018k; Choudhary VR, 2006, APPL ENERG, V83, P1024, DOI 10.1016/j.apenergy.2005.09.008; Choudhary VR, 2000, APPL ENERG, V66, P161, DOI 10.1016/S0306-2619(99)00039-2; Dias JAC, 2003, CATAL TODAY, V85, P59, DOI 10.1016/S0920-5861(03)00194-9; Djinovic P, 2011, CHEM ENG PROCESS, V50, P1054, DOI 10.1016/j.cep.2011.05.018; Ferreira-Aparicio P, 2000, J CATAL, V190, P296, DOI 10.1006/jcat.1999.2752; GRANGE P, 1980, CATAL REV, V21, P135, DOI 10.1080/03602458008068062; Hidalgo-Carrillo J, 2012, J COLLOID INTERF SCI, V382, P67, DOI 10.1016/j.jcis.2012.05.050; Hou ZY, 2006, INT J HYDROGEN ENERG, V31, P555, DOI 10.1016/j.ijhydene.2005.06.010; Hu YH, 1997, LANGMUIR, V13, P2055, DOI 10.1021/la960986j; Hu YH, 2009, CATAL TODAY, V148, P206, DOI 10.1016/j.cattod.2009.07.076; Jogalekar AY, 1998, J CHEM TECHNOL BIOT, V72, P368, DOI 10.1002/(SICI)1097-4660(199808)72:4<368::AID-JCTB2915>3.0.CO;2-C; Khobragade M, 2012, APPL ENERG, V94, P385, DOI 10.1016/j.apenergy.2012.02.002; Kim T, 2014, APPL ENERG, V113, P1692, DOI 10.1016/j.apenergy.2013.09.023; Li CL, 2013, APPL ENERG, V107, P297, DOI 10.1016/j.apenergy.2013.02.039; Liu DP, 2009, J CATAL, V266, P380, DOI 10.1016/j.jcat.2009.07.004; Maciel CG, 2013, APPL ENERG, V112, P52, DOI 10.1016/j.apenergy.2013.06.003; Maillard F, 2005, PHYS CHEM CHEM PHYS, V7, P385, DOI 10.1039/b411377b; Mei ZJ, 2015, CHEM ENG J, V259, P293, DOI 10.1016/j.cej.2014.07.125; Mojovic Z, 2004, MATER SCI FORUM, V453-454, P257, DOI 10.4028/www.scientific.net/MSF.453-454.257; NAKAMURA J, 1994, CATAL LETT, V25, P265, DOI 10.1007/BF00816306; Ocsachoque M, 2011, CATAL TODAY, V172, P226, DOI 10.1016/j.cattod.2011.02.057; Osaki T, 2001, J CATAL, V204, P89, DOI 10.1006/jcat.2001.3382; Qiao H., 2009, J NANOMATER, V239, P238; ROSTRUPNIELSEN JR, 1993, J CATAL, V144, P38, DOI 10.1006/jcat.1993.1312; Saha B, 2014, FUEL, V120, P202, DOI 10.1016/j.fuel.2013.12.016; Shih-Cheng L., 2015, APPL ENERGY; Sutthiumporn K, 2012, INT J HYDROGEN ENERG, V37, P11195, DOI 10.1016/j.ijhydene.2012.04.059; Tomishige K, 2000, IND ENG CHEM RES, V39, P1891, DOI 10.1021/ie990884z; Tomishige K, 2004, CATAL TODAY, V89, P405, DOI 10.1016/j.cattod.2004.01.003; Topalidis A, 2007, CATAL TODAY, V127, P238, DOI 10.1016/j.cattod.2007.04.015; Tsyganok AI, 2003, CATAL COMMUN, V4, P493, DOI 10.1016/S1566-7367(03)00130-4; Wang XC, 2012, GREEN CHEM, V14, P758, DOI 10.1039/c2gc15946e; Wu GW, 2013, ACS SUSTAIN CHEM ENG, V1, P1052, DOI 10.1021/sc400123f; Xu XH, 2013, APPL ENERG, V108, P202, DOI 10.1016/j.apenergy.2013.03.028	40	20	20	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145862	10.1371/journal.pone.0145862	http://dx.doi.org/10.1371/journal.pone.0145862			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745623	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600019
J	Kim, HJ; Lee, JH; Ahn, SE; Park, MJ; Lee, DH				Kim, Hyun-Jung; Lee, Jin-Hyuck; Ahn, Sung-Eun; Park, Min-Ji; Lee, Dae-Hee			Influence of Anterior Cruciate Ligament Tear on Thigh Muscle Strength and Hamstring-to-Quadriceps Ratio: A Meta-Analysis	PLOS ONE			English	Article							KNEE FUNCTION; RECONSTRUCTION; PROPRIOCEPTION; FEMORIS; BALANCE	Theoretical compensation after anterior cruciate ligament (ACL) tear could cause quadriceps weakness and hamstring activation, preventing anterior tibial subluxation and affecting the expected hamstring-to-quadriceps ratio. Although quadriceps weakness often occurs after ACL tears, it remains unclear whether hamstring strength and hamstring-to-quadriceps ratio increase in ACL deficient knees. This meta-analysis compared the isokinetic muscle strength of quadriceps and hamstring muscles, and the hamstring-to-quadriceps ratio, of the injured and injured limbs of patients with ACL tears. This meta-analysis included all studies comparing isokinetic thigh muscle strengths and hamstring-to-quadriceps ratio in the injured and uninjured legs of patients with ACL tear, without or before surgery. Thirteen studies were included in the meta-analysis. Quadriceps and hamstring strengths were 22.3 N.m (95% CI: 15.2 to 29.3 N.m; P<0.001) and 7.4 N.m (95% CI: 4.3 to 10.5 N.m; P<0.001) lower, respectively, on the injured than on the uninjured side. The mean hamstring-toquadriceps ratio was 4% greater in ACL deficient than in uninjured limbs (95% CI: 1.7% to 6.3%; P<0.001). Conclusively, Decreases were observed in both the quadriceps and hamstring muscles of patients with ACL tear, with the decrease in quadriceps strength being 3-fold greater. These uneven reductions slightly increase the hamstring-to-quadriceps ratio in ACL deficient knees.	[Kim, Hyun-Jung] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea; [Lee, Jin-Hyuck; Ahn, Sung-Eun; Park, Min-Ji] Korea Univ, Coll Med, Dept Sports Med Ctr, Seoul 136705, South Korea; [Lee, Dae-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea.	eoak22@empal.com	lee, dae hee/I-9390-2017					Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; Benjuya N, 2000, ISOKINET EXERC SCI, V8, P229, DOI 10.3233/IES-2000-0052; de Jong SN, 2007, ARTHROSCOPY, V23, P21, DOI 10.1016/j.arthro.2006.08.024; DVIR Z, 1989, CLIN BIOMECH, V4, P87, DOI 10.1016/0268-0033(89)90044-2; Eitzen I, 2010, J ORTHOP SPORT PHYS, V40, P705, DOI 10.2519/jospt.2010.3345; FRIDEN T, 1990, ACTA ORTHOP SCAND, V61, P131, DOI 10.3109/17453679009006504; Georgoulis AD, 2010, ORTHOP TRAUMATOL-SUR, V96, pS119, DOI 10.1016/j.otsr.2010.09.004; Gibson ASC, 2000, J ORTHOP SPORT PHYS, V30, P418, DOI 10.2519/jospt.2000.30.7.418; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hole CD, 2000, ERGONOMICS, V43, P1603, DOI 10.1080/001401300750004023; Hortobagyi T, 2005, CLIN BIOMECH, V20, P97, DOI 10.1016/j.clinbiomech.2004.08.004; JPT H., 2011, COCHRANE HDB SYSTEMA; KANNUS P, 1988, PHYS THER, V68, P961, DOI 10.1093/ptj/68.6.961; Keays SL, 2003, J ORTHOPAED RES, V21, P231, DOI 10.1016/S0736-0266(02)00160-2; Ko Min Soo, 2012, Knee Surg Relat Res, V24, P113, DOI 10.5792/ksrr.2012.24.2.113; Lee Dae-Hee, 2015, Knee Surg Relat Res, V27, P101, DOI 10.5792/ksrr.2015.27.2.101; Lee HM, 2009, KNEE, V16, P387, DOI 10.1016/j.knee.2009.01.006; Lee J, 2013, J ASIAN ARCHIT BUILD, V12, P25, DOI 10.3130/jaabe.12.25; LEPHART SM, 1992, J ORTHOP SPORT PHYS, V16, P174, DOI 10.2519/jospt.1992.16.4.174; Lewek M, 2002, CLIN BIOMECH, V17, P56, DOI 10.1016/S0268-0033(01)00097-3; Palmieri RM, 2005, KNEE SURG SPORT TR A, V13, P370, DOI 10.1007/s00167-004-0547-z; Palmieri-Smith RM, 2009, EXERC SPORT SCI REV, V37, P147, DOI 10.1097/JES.0b013e3181aa6669; Reider B, 2003, ARTHROSCOPY, V19, P2, DOI 10.1053/jars.2003.50006; Segawa H, 2002, ARTHROSCOPY, V18, P177, DOI 10.1053/jars.2002.29894; Sell TC, 2007, J ORTHOP RES, V25, P1589, DOI 10.1002/jor.20459; Tsepis E, 2004, KNEE SURG SPORT TR A, V12, P22, DOI 10.1007/s00167-003-0377-4; Urbach D, 2001, J BONE JOINT SURG BR, V83B, P1104, DOI 10.1302/0301-620X.83B8.11618; van Grinsven S, 2010, KNEE SURG SPORT TR A, V18, P1128, DOI 10.1007/s00167-009-1027-2; Wells G., 2013, NEWCASTLE OTTAWA SCA; Yoon JP, 2013, CLIN ORTHOP SURG, V5, P19, DOI 10.4055/cios.2013.5.1.19	30	33	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146234	10.1371/journal.pone.0146234	http://dx.doi.org/10.1371/journal.pone.0146234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745808	gold, Green Published			2022-12-27	WOS:000367815600031
J	Moro, T; Nakao, S; Sumiyoshi, H; Ishii, T; Miyazawa, M; Ishii, N; Sato, T; Iida, Y; Okada, Y; Tanaka, M; Hayashi, H; Ueha, S; Matsushima, K; Inagaki, Y				Moro, Tadashi; Nakao, Sachie; Sumiyoshi, Hideaki; Ishii, Takamasa; Miyazawa, Masaki; Ishii, Naoaki; Sato, Tadayuki; Iida, Yumi; Okada, Yoshinori; Tanaka, Masayuki; Hayashi, Hideki; Ueha, Satoshi; Matsushima, Kouji; Inagaki, Yutaka			A Combination of Mitochondrial Oxidative Stress and Excess Fat/Calorie Intake Accelerates Steatohepatitis by Enhancing Hepatic CC Chemokine Production in Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; COLLAGEN GENE-TRANSCRIPTION; NONALCOHOLIC STEATOHEPATITIS; STELLATE CELLS; FIBROSIS; SDHC; MUTATION	Mitochondrial oxidative stress is considered as a key accelerator of fibrosis in various organs including the liver. However, the production of oxidative stress and progression of liver fibrosis may merely represent the independent consequences of hepatocellular injury caused by the primary disease. Because of a lack of appropriate experimental models to evaluate the sole effects of oxidative stress, it is virtually unknown whether this stress is causatively linked to the progression of liver fibrosis. Here, we examined the direct effects of mitochondrial reactive oxygen species (ROS) on the progression of high fat/calorie diet-induced steatohepatitis using Tet-mev-1 mice, in which a mutated succinate dehydrogenase transgene impairs the mitochondrial electron transport and generates an excess amount of ROS in response to doxycycline administration. Wild type and Tet-mev-1 mice that had been continuously given doxycycline-containing water were subsequently fed either normal chow or a cholesterol-free high-fat/high-sucrose diet for 4 months at approximately 1 or 2 years of age. Histopathological examinations indicated that neither the mitochondrial ROS induced in Tet-mev-1 mice nor the feeding of wild type animals with high-fat/ high-sucrose diet alone caused significant liver fibrosis. Only when the Tet-mev-1 mice were fed a high-fat/high-sucrose diet, it induced lipid peroxidation in hepatocytes and enhanced hepatic CC chemokine expression. These events were accompanied by increased infiltration of CCR5-positive cells and activation of myofibroblasts, resulting in extensive liver fibrosis. Interestingly, this combinatorial effect of mitochondrial ROS and excess fat/calorie intake on liver fibrosis was observed only in 2-year-old Tet-mev-1 mice, not in the 1-year-old animals. Collectively, these results indicate that mitochondrial ROS in combination with excess fat/calorie intake accelerates liver fibrosis by enhancing CC chemokine production in aged animals. We have provided a good experimental model to explore how high fat/calorie intake increases the susceptibility to nonalcoholic steatohepatitis in aged individuals who have impaired mitochondrial adaptation.	[Moro, Tadashi; Nakao, Sachie; Sumiyoshi, Hideaki; Inagaki, Yutaka] Tokai Univ, Grad Sch Med, Ctr Matrix Biol & Med, Isehara, Kanagawa, Japan; [Moro, Tadashi; Nakao, Sachie; Sumiyoshi, Hideaki; Inagaki, Yutaka] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa 25911, Japan; [Ishii, Takamasa; Miyazawa, Masaki; Ishii, Naoaki] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Sato, Tadayuki; Iida, Yumi; Okada, Yoshinori; Tanaka, Masayuki; Hayashi, Hideki] Tokai Univ, Support Ctr Med Res & Educ, Res & Promot Div Isehara, Isehara, Kanagawa, Japan; [Ishii, Takamasa; Ishii, Naoaki; Inagaki, Yutaka] Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan; [Moro, Tadashi] Minophagen Pharmaceut Co Ltd, Res Lab, Zama, Kanagawa, Japan; [Ueha, Satoshi; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo, Japan; [Moro, Tadashi; Sumiyoshi, Hideaki; Ueha, Satoshi; Matsushima, Kouji; Inagaki, Yutaka] Japan Agcy Med Res & Dev, Japan Sci Technol, CREST, Chiyoda Ku, Tokyo, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; University of Tokyo; Japan Science & Technology Agency (JST)	Inagaki, Y (corresponding author), Tokai Univ, Grad Sch Med, Ctr Matrix Biol & Med, Isehara, Kanagawa, Japan.	yutakai@is.icc.u-tokai.ac.jp	Miyazawa, Masaki/AFS-6486-2022	Ueha, Satoshi/0000-0002-3871-9921; Tanaka, Masayuki/0000-0002-8682-8719	Grants-in-Aid for Scientific Research [25293179] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Chalasani N, 2004, AM J GASTROENTEROL, V99, P1497, DOI 10.1111/j.1572-0241.2004.30159.x; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Hino K, 2014, HEPATOL RES, V44, P123, DOI 10.1111/hepr.12247; Inagaki Y, 2003, HEPATOLOGY, V38, P890, DOI 10.1053/jhep.2003.50408; Inagaki Y, 2001, J BIOL CHEM, V276, P16573, DOI 10.1074/jbc.M010485200; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Ishii T, 2005, CANCER RES, V65, P203; Ishii T, 2011, MITOCHONDRION, V11, P155, DOI 10.1016/j.mito.2010.09.006; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Miyazawa M, 2009, J RADIAT RES, V50, P73, DOI 10.1269/jrr.08097; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Musso G, 2011, CURR OPIN LIPIDOL, V22, P489, DOI 10.1097/MOL.0b013e32834c37ee; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Orr WC, 2013, ANTIOXID REDOX SIGN, V19, P788, DOI 10.1089/ars.2012.5002; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Pasini B, 2008, EUR J HUM GENET, V16, P79, DOI 10.1038/sj.ejhg.5201904; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Puri P, 2006, ZAKIM BOYES HEPATOLO, p941 968; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sachdeva MM, 2014, EXP EYE RES, V119, P111, DOI 10.1016/j.exer.2013.10.024; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Sumida Y, 2003, J HEPATOL, V38, P32, DOI 10.1016/S0168-8278(02)00331-8; Tomita K, 2014, HEPATOLOGY, V59, P154, DOI 10.1002/hep.26604; Zamara E, 2004, J HEPATOL, V40, P60, DOI 10.1016/S0168-8278(03)00480-X; Zhu H, 2012, J DIGEST DIS, V13, P133, DOI 10.1111/j.1751-2980.2011.00569.x	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146592	10.1371/journal.pone.0146592	http://dx.doi.org/10.1371/journal.pone.0146592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745268	Green Submitted, gold, Green Published			2022-12-27	WOS:000367815600066
J	Popescu, V; Schoonheim, MM; Versteeg, A; Chaturvedi, N; Jonker, M; de Menezes, RX; Garre, FG; Uitdehaag, BMJ; Barkhof, F; Vrenken, H				Popescu, Veronica; Schoonheim, Menno M.; Versteeg, Adriaan; Chaturvedi, Nimisha; Jonker, Marianne; de Menezes, Renee Xavier; Garre, Francisca Gallindo; Uitdehaag, Bernard M. J.; Barkhof, Frederik; Vrenken, Hugo			Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; REGIONAL BRAIN ATROPHY; SURFACE-BASED ANALYSIS; COGNITIVE IMPAIRMENT; HIPPOCAMPAL VOLUME; CORTICAL ATROPHY; MS PATIENTS; GRAY; SEGMENTATION; QUANTIFICATION	Background Studies disagree on the location of grey matter (GM) atrophy in the multiple sclerosis (MS) brain. Aim To examine the consistency between FSL, FreeSurfer, SPM for GM atrophy measurement (for volumes, patient/control discrimination, and correlations with cognition). Materials and Methods 127 MS patients and 50 controls were included and cortical and deep grey matter (DGM) volumetrics were performed. Consistency of volumes was assessed with Intraclass Correlation Coefficient/ICC. Consistency of patients/controls discrimination was assessed with Cohen's d, t-tests, MANOVA and a penalized double-loop logistic classifier. Consistency of association with cognition was assessed with Pearson correlation coefficient and ANOVA. Voxel-based morphometry (SPM-VBM and FSL-VBM) and vertex-wise FreeSurfer were used for group-level comparisons. Results The highest volumetry ICC were between SPM and FreeSurfer for cortical regions, and the lowest between SPM and FreeSurfer for DGM. The caudate nucleus and temporal lobes had high consistency between all software, while amygdala had lowest volumetric consistency. Consistency of patients/controls discrimination was largest in the DGM for all software, especially for thalamus and pallidum. The penalized double-loop logistic classifier most often selected the thalamus, pallidum and amygdala for all software. FSL yielded the largest number of significant correlations. DGM yielded stronger correlations with cognition than cortical volumes. Bilateral putamen and left insula volumes correlated with cognition using all methods. Conclusion GM volumes from FreeSurfer, FSL and SPM are different, especially for cortical regions. While group-level separation between MS and controls is comparable, correlations between regional GM volumes and clinical/cognitive variables in MS should be cautiously interpreted.	[Popescu, Veronica; Versteeg, Adriaan; Barkhof, Frederik; Vrenken, Hugo] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Schoonheim, Menno M.] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [Chaturvedi, Nimisha; Jonker, Marianne; de Menezes, Renee Xavier; Garre, Francisca Gallindo] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Uitdehaag, Bernard M. J.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Vrenken, Hugo] Vrije Univ Amsterdam Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Vrenken, H (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Neurosci Campus Amsterdam NCA, Amsterdam, Netherlands.	h.vrenken@vumc.nl	Schoonheim, Menno/AAI-6853-2021; Schoonheim, Menno M/X-5398-2018; Jonker, Marianne A/Q-5180-2017; Chaturvedi, Nimisha/X-8618-2019; Barkhof, Frederik/AAJ-6226-2020; Chaturvedi, Nimisha/AAY-2199-2020	Schoonheim, Menno/0000-0002-2504-6959; Schoonheim, Menno M/0000-0002-2504-6959; Jonker, Marianne A/0000-0003-0134-8482; Barkhof, Frederik/0000-0003-3543-3706; Vrenken, Hugo/0000-0001-9106-1172; Popescu, Veronica/0000-0002-7156-5442; Uitdehaag, Bernard/0000-0002-9226-7364; Chaturvedi, Nimisha/0000-0002-3065-0202	Dutch MS Research Foundation [10-718]; Du Pre grant of the MS International Federation	Dutch MS Research Foundation; Du Pre grant of the MS International Federation	The study was supported by the Dutch MS Research Foundation grant 10-718 and the Du Pre grant 2013 of the MS International Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann DR, 2009, NEUROLOGY, V72, P595, DOI 10.1212/01.wnl.0000335765.55346.fc; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Audoin B, 2006, J NEUROL, V253, P1495, DOI 10.1007/s00415-006-0264-2; Audoin B, 2010, J NEUROL NEUROSUR PS, V81, P690, DOI 10.1136/jnnp.2009.188748; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Battaglini M, 2009, J NEUROL SCI, V282, P55, DOI 10.1016/j.jns.2009.02.322; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Bergsland N, 2012, AM J NEURORADIOL, V33, P1573, DOI 10.3174/ajnr.A3086; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Ceccarelli A, 2008, NEUROIMAGE, V42, P315, DOI 10.1016/j.neuroimage.2008.04.173; Chard DT, 2010, J MAGN RESON IMAGING, V32, P223, DOI 10.1002/jmri.22214; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Derakhshan M, 2010, NEUROIMAGE, V52, P1261, DOI 10.1016/j.neuroimage.2010.05.029; Doring TM, 2011, J MAGN RESON IMAGING, V33, P565, DOI 10.1002/jmri.22473; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Durand-Dubief F, 2012, AM J NEURORADIOL, V33, P1918, DOI 10.3174/ajnr.A3107; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Gelineau-Morel R, 2012, HUM BRAIN MAPP, V33, P2802, DOI 10.1002/hbm.21402; Henry RG, 2008, J NEUROL NEUROSUR PS, V79, P1236, DOI 10.1136/jnnp.2007.134825; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Hulst HE, 2013, NEUROLOGY, V80, P1025, DOI 10.1212/WNL.0b013e31828726cc; Jasperse B, 2007, NEUROIMAGE, V38, P529, DOI 10.1016/j.neuroimage.2007.07.056; Kiy G, 2011, MULT SCLER J, V17, P1088, DOI 10.1177/1352458511403530; Koenig KA, 2014, MAGN RESON IMAGING, V32, P354, DOI 10.1016/j.mri.2013.12.012; Lansley J, 2013, NEUROSCI BIOBEHAV R, V37, P819, DOI 10.1016/j.neubiorev.2013.03.006; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Modica CM, 2015, AM J NEURORADIOL, V36, P57, DOI 10.3174/ajnr.A3998; Morgen K, 2006, NEUROIMAGE, V30, P891, DOI 10.1016/j.neuroimage.2005.10.032; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Popescu V, 2014, NEUROIMAGE-CLIN, V4, P366, DOI 10.1016/j.nicl.2014.01.004; Rajagopalan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0274-8; Ramasamy DP, 2009, J NEUROL SCI, V282, P47, DOI 10.1016/j.jns.2008.12.034; Rocca MA, 2010, RADIOLOGY, V257, P463, DOI 10.1148/radiol.10100326; Roosendaal SD, 2011, MULT SCLER J, V17, P1098, DOI 10.1177/1352458511404916; Schoonheim MM, 2012, NEUROLOGY, V79, P1754, DOI 10.1212/WNL.0b013e3182703f46; Sepulcre J, 2006, ARCH NEUROL-CHICAGO, V63, P1175, DOI 10.1001/archneur.63.8.1175; Sicotte NL, 2008, BRAIN, V131, P1134, DOI 10.1093/brain/awn030; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Steenwijk MD, 2013, NEUROIMAGE-CLIN, V3, P462, DOI 10.1016/j.nicl.2013.10.003; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Wylezinska M, 2003, NEUROLOGY, V60, P1949, DOI 10.1212/01.WNL.0000069464.22267.95	45	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0143942	10.1371/journal.pone.0143942	http://dx.doi.org/10.1371/journal.pone.0143942			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745873	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600002
J	Li, Z; Ren, TH; Yan, BJ; Tan, FQ; Yang, MY; Ren, ZL				Li, Zhi; Ren, Tianheng; Yan, Benju; Tan, Feiquan; Yang, Manyu; Ren, Zhenglong			A Mutant with Expression Deletion of Gene Sec-1 in a 1RS.1BL Line and Its Effect on Production Quality of Wheat	PLOS ONE			English	Article							AGRONOMIC PERFORMANCE; RYE CHROMATIN; 1BL.1RS TRANSLOCATION; 1B/1R TRANSLOCATION; SHORT ARM; 1BL/1RS TRANSLOCATION; ALLELIC VARIATION; RESISTANCE GENES; HEXAPLOID WHEAT; FLOUR QUALITY	The chromosome arm 1RS of rye (Secale cereal L.) has been used worldwide as a source of genes for agronomic and resistant improvement. However, the 1RS arm in wheat has end-use quality defects that are partially attributable to the presence of omega-secalins, which are encoded by genes at the Sec-1 locus. Various attempts in removing the Sec-1 genes from the 1RS. 1BL translocation chromosome have been made. In the present study, two new primary 1RS. 1BL translocation lines, T917-26 and T917-15, were developed from a cross between wheat variety "A42912" and Chinese local rye "Weining." The lines T917-15 and T917-26 carried a pair of intact and homogeneous 1RS. 1BL chromosomes. The line T917-26 also harbored an expression deletion of some genes at the Sec-1 locus, which originated from a mutation that occurred simultaneously with wheat-rye chromosome translocations. These results suggest that the accompanying mutations of the evolutionarily significant translocations are remarkable resources for plant improvement. Comparison of translocation lines with its wheat parent showed improvements in the end-use quality parameters, which included protein content (PC), water absorption (WA), sodium dodecyl sulfate sedimentation (SDSS), wet gluten (WG), dry gluten (DG) and dough stickiness (DS), whereas significant reduction in gluten index (GI) and stability time (ST) were observed. These findings indicate that 1RS in wheat has produced a higher amount of protein, although these comprised worse compositions. However, in the T917-26 line that harbored an expression deletion mutation in the Sec-1 genes, the quality parameters were markedly improved relative to its sister line, T917-15, especially for GI and DS (P < 0.05). These results indicated that expression deletion of Sec-1 genes significantly improves the end-use quality of wheat cultivars harboring the 1RS. 1BL translocation. Strategies to remove the Sec-1 genes from the 1RS. 1BL translocation in wheat improvement are discussed.	[Li, Zhi; Ren, Tianheng; Yan, Benju; Tan, Feiquan; Yang, Manyu; Ren, Zhenglong] Sichuan Agr Univ, Agron Coll, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Ren, TH (corresponding author), Sichuan Agr Univ, Agron Coll, Chengdu, Sichuan, Peoples R China.	renth@sicau.edu.cn; renzllab@sicau.edu.cn		Ren, Tianheng/0000-0002-4962-9032	National Natural Science Foundation of China [31271722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (#31271722) (received by ZR) (http://www.nsfc.gov.cn/).; We gratefully acknowledge the financial support from the National Natural Science Foundation of China (#31271722). We also acknowledge excellent technical assistance provided by Mrs H.Q. Zhang.	Anugrahwati DR, 2008, GENOME, V51, P341, DOI 10.1139/G08-019; BAUM M, 1991, CHROMOSOMA, V101, P1, DOI 10.1007/BF00360680; BERZONSKY WA, 1991, THEOR APPL GENET, V81, P629, DOI 10.1007/BF00226729; Bonafede MD, 2015, J CEREAL SCI, V62, P143, DOI 10.1016/j.jcs.2015.02.001; Burnett CJ, 1995, EUPHYTICA, V86, P159; CARVER BF, 1995, CROP SCI, V35, P1316, DOI 10.2135/cropsci1995.0011183X003500050010x; Chai JF, 2005, CELL RES, V15, P658, DOI 10.1038/sj.cr.7290335; Clarke BC, 1999, PLANT SYST EVOL, V214, P1, DOI 10.1007/BF00985728; Clarke BC, 1996, CHROMOSOMA, V105, P269, DOI 10.1007/BF02524644; DEXTER JE, 1980, CAN J PLANT SCI, V60, P25, DOI 10.4141/cjps80-004; DHALIWAL AS, 1990, J CEREAL SCI, V12, P113, DOI 10.1016/S0733-5210(09)80093-3; Francki MG, 2001, GENOME, V44, P266, DOI 10.1139/gen-44-2-266; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070483; Gianibelli MC, 2001, CEREAL CHEM, V78, P635, DOI 10.1094/CCHEM.2001.78.6.635; Gil DH, 2011, FIELD CROP RES, V123, P1, DOI 10.1016/j.fcr.2011.04.001; Gobaa S, 2008, J CEREAL SCI, V48, P598, DOI 10.1016/j.jcs.2007.12.006; GRAYBOSCH RA, 1993, J CEREAL SCI, V17, P95, DOI 10.1006/jcrs.1993.1010; Graybosch RA, 2001, J CEREAL SCI, V33, P3, DOI 10.1006/jcrs.2000.0336; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; HOLLENHORST MM, 1983, CROP SCI, V23, P91, DOI 10.2135/cropsci1983.0011183X002300010026x; Howell T, 2014, THEOR APPL GENET, V127, P2695, DOI 10.1007/s00122-014-2408-6; HUSSAIN A, 1994, EUPHYTICA, V78, P109; JONES BL, 1982, CEREAL CHEM, V59, P181; Kim W, 2004, CROP SCI, V44, P1254, DOI 10.2135/cropsci2004.1254; Kumlay AM, 2003, CROP SCI, V43, P1643, DOI 10.2135/cropsci2003.1643; Lapitan NLV, 2007, CROP SCI, V47, P811, DOI 10.2135/cropsci2006.08.0529; Lelley T, 2004, J CEREAL SCI, V39, P313, DOI 10.1016/j.jcs.2003.11.003; Li HM, 2013, GENET MOL RES, V12, P1740, DOI 10.4238/2013.May.21.5; Lukaszewski AJ, 2001, CROP SCI, V41, P1062, DOI 10.2135/cropsci2001.4141062x; Mago R, 2005, THEOR APPL GENET, V112, P41, DOI 10.1007/s00122-005-0098-9; MARAIS GF, 1994, PLANT BREEDING, V113, P265, DOI 10.1111/j.1439-0523.1994.tb00735.x; MARTIN DJ, 1990, EUPHYTICA, V51, P77, DOI 10.1007/BF00022895; Martin P, 2001, CROP SCI, V41, P1080, DOI 10.2135/cropsci2001.4141080x; Mater Y, 2004, GENOME, V47, P292, DOI [10.1139/G03-101, 10.1139/g03-101]; McKendry AL, 1996, CROP SCI, V36, P844, DOI 10.2135/cropsci1996.0011183X003600040003x; Mettin D., 1973, Proceedings of the fourth international wheat genetics symposium. Alien genetic material., P179; Moiraghi M, 2013, J CEREAL SCI, V58, P424, DOI 10.1016/j.jcs.2013.08.007; MORENOSEVILLA B, 1995, CROP SCI, V35, P1607, DOI 10.2135/cropsci1995.0011183X003500060015x; PAYNE PI, 1982, THEOR APPL GENET, V63, P129, DOI 10.1007/BF00303695; Rabinovich SV, 1998, EUPHYTICA, V100, P323, DOI 10.1023/A:1018361819215; Ren TH, 2011, GENOME, V54, P316, DOI [10.1139/G10-121, 10.1139/g10-121]; Ren TH, 2012, EUPHYTICA, V183, P133, DOI 10.1007/s10681-011-0412-3; Ren TH, 2009, EUPHYTICA, V169, P207, DOI 10.1007/s10681-009-9924-5; Ren TianHeng, 2009, Journal of Triticeae Crops, V29, P419; Ren ZL, 1997, SCI CHINA SER C, V40, P323, DOI 10.1007/BF02879094; REN ZL, 1990, PLANT BREEDING, V105, P265, DOI 10.1111/j.1439-0523.1990.tb01284.x; REN ZL, 1990, PLANT BREEDING, V105, P257, DOI 10.1111/j.1439-0523.1990.tb01283.x; Schlegel R, 1997, PLANT BREEDING, V116, P537, DOI 10.1111/j.1439-0523.1997.tb02186.x; Sebesta EE, 1978, TRANSFER GREENBUG RE, P61; SHEWRY PR, 1986, CAN J GENET CYTOL, V28, P76, DOI 10.1139/g86-010; Singh M, 2005, J FOOD SCI TECH MYS, V42, P455; SINGH NK, 1990, THEOR APPL GENET, V80, P609, DOI 10.1007/BF00224219; Tang ZX, 2009, PLANT BREEDING, V128, P524, DOI 10.1111/j.1439-0523.2008.01598.x; Tang ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110282; TYLER JM, 1987, CROP SCI, V27, P526, DOI 10.2135/cropsci1987.0011183X002700030020x; Villareal RL, 1996, EUPHYTICA, V89, P363, DOI 10.1007/BF00022294; VILLAREAL RL, 1991, PLANT BREEDING, V106, P77, DOI 10.1111/j.1439-0523.1991.tb00482.x; WIESER H, 1994, J CEREAL SCI, V19, P149, DOI 10.1006/jcrs.1994.1020; Yang Z.J., 1997, J SICHUAN AGR U, V15, P452; Zeller F. J., 1973, Proceedings of the fourth international wheat genetics symposium. Alien genetic material., P209; ZELLER FJ, 1983, Z PFLANZENZUCHT, V90, P285; Zhao CH, 2012, FIELD CROP RES, V127, P79, DOI 10.1016/j.fcr.2011.11.008; Zhou JW, 2013, CROP PASTURE SCI, V64, P865, DOI 10.1071/CP13246; Zhou Yang, 2004, Acta Agronomica Sinica, V30, P531	64	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146943	10.1371/journal.pone.0146943	http://dx.doi.org/10.1371/journal.pone.0146943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765323	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300054
J	Bohnenstiehl, DR; Lillis, A; Eggleston, DB				Bohnenstiehl, DelWayne R.; Lillis, Ashlee; Eggleston, David B.			The Curious Acoustic Behavior of Estuarine Snapping Shrimp: Temporal Patterns of Snapping Shrimp Sound in Sub-Tidal Oyster Reef Habitat	PLOS ONE			English	Article							AMBIENT NOISE; CORAL-REEFS; LEVEL; RECRUITMENT; ENVIRONMENT; SYNALPHEUS; SIGNALS; ORIGIN; FISHES; LARVAE	Ocean soundscapes convey important sensory information to marine life. Like many mid-to- low latitude coastal areas worldwide, the high-frequency (>1.5 kHz) soundscape of oyster reef habitat within the West Bay Marine Reserve (36 degrees N, 76 degrees W) is dominated by the impulsive, short-duration signals generated by snapping shrimp. Between June 2011 and July 2012, a single hydrophone deployed within West Bay was programmed to record 60 or 30 seconds of acoustic data every 15 or 30 minutes. Envelope correlation and amplitude information were then used to count shrimp snaps within these recordings. The observed snap rates vary from 1500-2000 snaps per minute during summer to <100 snaps per minute during winter. Sound pressure levels are positively correlated with snap rate (r = 0.71-0.92) and vary seasonally by similar to 15 decibels in the 1.5-20 kHz range. Snap rates are positively correlated with water temperatures (r = 0.81-0.93), as well as potentially influenced by climate-driven changes in water quality. Light availability modulates snap rate on diurnal time scales, with most days exhibiting a significant preference for either nighttime or daytime snapping, and many showing additional crepuscular increases. During mid-summer, the number of snaps occurring at night is 5-10% more than predicted by a random model; however, this pattern is reversed between August and April, with an excess of up to 25% more snaps recorded during the day in the mid-winter. Diurnal variability in sound pressure levels is largest in the mid-winter, when the overall rate of snapping is at its lowest, and the percentage difference between daytime and nighttime activity is at its highest. This work highlights our lack of knowledge regarding the ecology and acoustic behavior of one of the most dominant soniforous invertebrate species in coastal systems. It also underscores the necessity of long-duration, high-temporal-resolution sampling in efforts to understand the bioacoustics of animal behaviors and associated changes within the marine soundscape.	[Bohnenstiehl, DelWayne R.; Lillis, Ashlee; Eggleston, David B.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Eggleston, David B.] N Carolina State Univ, Ctr Marine Sci & Technol, Morehead City, NC 28557 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Bohnenstiehl, DR (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, 2800 Faucette Dr, Raleigh, NC 27695 USA.	drbohnen@ncsu.edu		Eggleston, David/0000-0001-7840-2665; Lillis, Ashlee/0000-0001-5754-2861	NSF [OCE-1234688]; PADI Foundation [5145]; National Shellfisheries Association Student Research Grant	NSF(National Science Foundation (NSF)); PADI Foundation; National Shellfisheries Association Student Research Grant	Funding and support was provided by NSF (OCE-1234688) as well as the PADI Foundation (#5145) and a National Shellfisheries Association Student Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 1993, J TOKYO U FISH, P75; Au WWL, 1998, J ACOUST SOC AM, V103, P41, DOI 10.1121/1.423234; Bormpoudakis D, 2013, LANDSCAPE ECOL, V28, P495, DOI 10.1007/s10980-013-9849-1; Cato DH, 2005, PASSIVE ACOUSTICS KE, P411; Cato DH, 1992, MRLTR9123, P27; Chitre MA, 2006, IEEE J OCEANIC ENG, V31, P497, DOI 10.1109/JOE.2006.875272; Cochran ES, 2004, SCIENCE, V306, P1164, DOI 10.1126/science.1103961; Duffy E. J, 2002, BEHAV ECOL SOCIOBIOL, V51, P488, DOI DOI 10.1007/S00265-002-0455-5; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Etherington LL, 2000, MAR ECOL PROG SER, V204, P179, DOI 10.3354/meps204179; EVEREST FA, 1948, J ACOUST SOC AM, V20, P137, DOI 10.1121/1.1906355; Ferguson BG, 2001, J ACOUST SOC AM, V109, P3031, DOI 10.1121/1.1339823; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Hughes AR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0715; Hughes M, 1996, ANIM BEHAV, V52, P247, DOI 10.1006/anbe.1996.0170; Hulburt EO, 1943, J ACOUST SOC AM, V14, P173, DOI 10.1121/1.1916214; JOHNSON MW, 1947, BIOL BULL, V93, P122, DOI 10.2307/1538284; Jung SK, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.07GG09; KNOWLTON N, 1982, BEHAV ECOL SOCIOBIOL, V10, P289, DOI 10.1007/BF00302819; KNOWLTON RE, 1963, BIOL BULL, V125, P311, DOI 10.2307/1539406; Lammers MO, 2008, J ACOUST SOC AM, V123, P1720, DOI 10.1121/1.2836780; Legg M. W., 2007, OCEANS 2007 EUROPE, P1, DOI [10.1109/OCEANSE.2007.4302279, DOI 10.1109/OCEANSE.2007.4302279]; Lillis A, 2015, EFFECT NOISE AQUATIC; Lillis A, 2015, PEERJ, V3, DOI 10.7717/peerj.999; Lillis A, 2014, MAR ECOL PROG SER, V509, P57, DOI 10.3354/meps10917; Lillis A, 2014, MAR ECOL PROG SER, V505, P1, DOI 10.3354/meps10805; Lillis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079337; Luczkovich JJ, 2008, T AM FISH SOC, V137, P533, DOI 10.1577/T06-258.1; Luczkovich Joseph J., 2000, Bioacoustics, V10, P323; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; National Research Council, 2003, OC NOIS MAR MAMM; Nolan BA, FORMA FUNCTIO, V2, P289; Palomar NE, 2005, J ETHOL, V23, P173, DOI 10.1007/s10164-005-0149-3; Piercy JJB, 2014, MAR ECOL PROG SER, V516, P35, DOI 10.3354/meps10986; Pierson KJ, 2014, T AM FISH SOC, V143, P273, DOI 10.1080/00028487.2013.847863; Pietrafesa L.J., 1986, P341; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Puckett BJ, 2012, MAR COAST FISH, V4, P605, DOI 10.1080/19425120.2012.713892; Radford CA, 2014, MAR ECOL PROG SER, V505, P19, DOI 10.3354/meps10782; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Radford CA, 2007, B MAR SCI, V80, P369; Rindone RR, 2011, J EXP MAR BIOL ECOL, V407, P216, DOI 10.1016/j.jembe.2011.06.018; Schmitz B, 2002, CRUSTACEAN NERVOUS SYSTEM, P536; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Spence HR, 2008, SOUTHEAST NAT, V7, P207, DOI 10.1656/1528-7092(2008)7[207:MADDIT]2.0.CO;2; Staaterman E, 2014, MAR ECOL PROG SER, V508, P17, DOI 10.3354/meps10911; Stroup DF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030088; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Valdes-Weaver LM, 2006, LIMNOL OCEANOGR, V51, P1410, DOI 10.4319/lo.2006.51.3.1410; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; Watanabe M, 2002, WATER SCI TECHNOL, V46, P419, DOI 10.2166/wst.2002.0772; Williams A.B., 1984, SHRIMPS LOBSTERS CRA	52	66	67	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0143691	10.1371/journal.pone.0143691	http://dx.doi.org/10.1371/journal.pone.0143691			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761645	Green Submitted, Green Published, gold			2022-12-27	WOS:000368033100003
J	Davenport, LC; Goodenough, KS; Haugaasen, T				Davenport, Lisa C.; Goodenough, Katharine S.; Haugaasen, Torbjorn			Birds of Two Oceans? Trans-Andean and Divergent Migration of Black Skimmers (Rynchops niger cinerascens) from the Peruvian Amazon	PLOS ONE			English	Article							CONNECTIVITY; POPULATIONS; TRACKING	Seasonal flooding compels some birds that breed in aquatic habitats in Amazonia to undertake annual migrations, yet we know little about how the complex landscape of the Amazon region is used seasonally by these species. The possibility of trans-Andes migration for Amazonian breeding birds has largely been discounted given the high geographic barrier posed by the Andean Cordillera and the desert habitat along much of the Pacific Coast. Here we demonstrate a trans-Andes route for Black Skimmers (Rynchops niger cinerascens) breeding on the Manu River (in the lowlands of Manu National Park, Peru), as well as divergent movement patterns both regionally and across the continent. Of eight skimmers tracked with satellite telemetry, three provided data on their outbound migrations, with two crossing the high Peruvian Andes to the Pacific. A third traveled over 1800 km to the southeast before transmissions ended in eastern Paraguay. One of the two trans-Andean migrants demonstrated a full round-trip migration back to its tagging location after traveling down the Pacific Coast from latitude 9 degrees South to latitude 37 degrees S, spending the austral summer in the Gulf of Arauco, Chile. This is the first documentation of a trans-Andes migration observed for any bird breeding in lowland Amazonia. To our knowledge, this research also documents the first example of a tropical-breeding waterbird migrating out of the tropics to spend the non-breeding season in the temperate summer, this being the reverse pattern with respect to seasonality for austral migrants in general.	[Davenport, Lisa C.] Univ Florida, Florida Museum Nat Hist, Dept Nat Hist, Gainesville, FL 32611 USA; [Davenport, Lisa C.] Duke Univ, Ctr Trop Conservat, Durham, NC USA; [Goodenough, Katharine S.] Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA; [Haugaasen, Torbjorn] Norwegian Univ Life Sci, Dept Ecol, As, Norway	State University System of Florida; University of Florida; Duke University; University of Oklahoma System; University of Oklahoma - Norman; Norwegian University of Life Sciences	Davenport, LC (corresponding author), Univ Florida, Florida Museum Nat Hist, Dept Nat Hist, Gainesville, FL 32611 USA.	ldavenport@parkswatch.org	Haugaasen, Torbjørn/I-2663-2013	Haugaasen, Torbjørn/0000-0003-0901-5324; Davenport, Lisa/0000-0002-2573-1622; Goodenough, Katharine/0000-0002-6372-8627	Microwave Telemetry, Inc.	Microwave Telemetry, Inc.	Microwave Telemetry, Inc. provided an equipment grant to KSG through the Christiane Howey Award. The funder had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Amat JA, 2004, ANIM BEHAV, V67, P293, DOI 10.1016/j.anbehav.2003.06.014; Antas Paulo De Tarso Zuquim, 1994, Bird Conservation International, V4, P181; Boyd JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063051; Burger J., 1990, BLACK SKIMMER SOCIAL; Canepuccia AD, 2007, MAMM BIOL, V72, P163, DOI 10.1016/j.mambio.2006.07.003; Castellucci L, 2012, CENT ISS CONT ECON T, P1; Chesser RT, 2010, BIRD CONSERV INT, V4, P91; Clements JF, 2014, EBIRD CLEMENTS CHECK; CLS (Collecte Localisation Satellites), 2011, COLLECTE LOCALISATIO; COPPINGER MP, 1988, OSTRICH, V59, P85, DOI 10.1080/00306525.1988.9633707; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Cumming GS, 2012, J BIOGEOGR, V39, P1401, DOI 10.1111/j.1365-2699.2012.02711.x; Davenport L, 2015, DATA BIRDS 2 OCEANS; Davenport LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046886; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Duffy David Cameron, 2013, Marine Ornithology, V41, P155; ESRI, 2012, ARCGIS REL 10 1; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Fraser KC, 2012, P ROY SOC B-BIOL SCI, V279, P4901, DOI 10.1098/rspb.2012.2207; GAUNT AS, 1999, GUIDELINES USE WILD; GENTRY AH, 1990, 4 NEOTROPICAL RAINFO, P542; Goulding M., 1980, FISHES FOREST EXPLOR; Goulding M, 2003, SMITHSONIAN ATLAS AM; GROOM MJ, 1992, ECOLOGY, V73, P785, DOI 10.2307/1940157; GUDMUNDSSON GA, 1995, P ROY SOC B-BIOL SCI, V261, P73, DOI 10.1098/rspb.1995.0119; Haig SM, 1998, CONSERV BIOL, V12, P749, DOI 10.1046/j.1523-1739.1998.97102.x; Hamilton SK, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000306; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; Heckscher CM, 2011, AUK, V128, P531, DOI 10.1525/auk.2011.10280; Hockey PAR, 2000, EMU, V100, P401, DOI 10.1071/MU0006S; HUGHES RA, 1970, IBIS, V112, P229, DOI 10.1111/j.1474-919X.1970.tb00095.x; Jahn AE, 2013, AUK, V130, P223, DOI 10.1525/auk.2013.12077; Jahn AE, 2009, ORNITOL NEOTROP, V20, P275; JAKSIC FM, 1983, J MAMMAL, V64, P693, DOI 10.2307/1380529; Jaramillo A., 2003, BIRDS CHILE; Junk W.J., 2013, ECOL STUD, V126; Junk WJ, 2013, AQUAT SCI, V75, P113, DOI 10.1007/s00027-012-0253-8; Kranstauber B, 2011, ENVIRON MODELL SOFTW, V26, P834, DOI 10.1016/j.envsoft.2010.12.005; Lambertucci SA, 2014, BIOL CONSERV, V170, P145, DOI 10.1016/j.biocon.2013.12.041; Mariano-Jelicich R, 2014, WATERBIRDS, V37, P175, DOI 10.1675/063.037.0206; McKnight A, 2013, MAR ECOL PROG SER, V491, P253, DOI 10.3354/meps10469; Miller MR, 2005, CAN J ZOOL, V83, P1314, DOI 10.1139/Z05-125; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; MYERS JP, 1987, AM SCI, V75, P19; Nakazawa Y, 2004, AUK, V121, P610, DOI 10.1642/0004-8038(2004)121[0610:SNONMB]2.0.CO;2; Ocampo D, 2015, AUK, V132, P1, DOI 10.1642/AUK-14-71.1; Palm EC, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0029-6; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Pedler RD, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0547; Rappole J, 2013, THE AVIAN MIGRANT; ROBINSON SK, 1985, AUK, V102, P506, DOI 10.1093/auk/102.3.506; Schulenberg T.S., 2007, BIRDS PERU REVISED U, P18; Shuford WD, 2008, STUDIES W BIRDS 1 CA; Skewgar E, 2014, WATERBIRDS, V37, P203, DOI 10.1675/063.037.0208; Sundar K.S. Gopi, 2004, Forktail, V20, P89; Takekawa JY, 2015, OSTRICH, V86, P155, DOI 10.2989/00306525.2015.1033773; Terborgh John, 1989, HAVE ALL BIRDS GONE; Wall J., 2014, MOVEMENT ECOLOGY TOO; Watts BD, 2014, RAVEN, V85, P12; Webster Michael S., 2005, P199; WITHERS PC, 1977, J EXP BIOL, V70, P13	62	14	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0144994	10.1371/journal.pone.0144994	http://dx.doi.org/10.1371/journal.pone.0144994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760301	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100006
J	Meise, K; von Engelhardt, N; Forcada, J; Hoffman, JI				Meise, Kristine; von Engelhardt, Nikolaus; Forcada, Jaume; Hoffman, Joseph Ivan			Offspring Hormones Reflect the Maternal Prenatal Social Environment: Potential for Foetal Programming?	PLOS ONE			English	Article							ANTARCTIC FUR-SEAL; HAIR CORTISOL CONCENTRATION; MALE REPRODUCTIVE SUCCESS; PITUITARY-ADRENAL AXIS; ARCTOCEPHALUS-GAZELLA; MATING SYSTEMS; PUP MORTALITY; STRESS; BEHAVIOR; DENSITY	Females of many species adaptively program their offspring to predictable environmental conditions, a process that is often mediated by hormones. Laboratory studies have shown, for instance, that social density affects levels of maternal cortisol and testosterone, leading to fitness-relevant changes in offspring physiology and behaviour. However, the effects of social density remain poorly understood in natural populations due to the difficulty of disentangling confounding influences such as climatic variation and food availability. Colonially breeding marine mammals offer a unique opportunity to study maternal effects in response to variable colony densities under similar ecological conditions. We therefore quantified maternal and offspring hormone levels in 84 Antarctic fur seals (Arctocephalus gazella) from two closely neighbouring colonies of contrasting density. Hair samples were used as they integrate hormone levels over several weeks or months and therefore represent in utero conditions during foetal development. We found significantly higher levels of cortisol and testosterone (both P < 0.001) in mothers from the high density colony, reflecting a more stressful and competitive environment. In addition, offspring testosterone showed a significant positive correlation with maternal cortisol (P < 0.05). Although further work is needed to elucidate the potential consequences for offspring fitness, these findings raise the intriguing possibility that adaptive foetal programming might occur in fur seals in response to the maternal social environment. They also lend support to the idea that hormonally mediated maternal effects may depend more strongly on the maternal regulation of androgen rather than cortisol levels.	[Meise, Kristine; von Engelhardt, Nikolaus; Hoffman, Joseph Ivan] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany; [Forcada, Jaume] British Antarctic Survey, Cambridge CB3 0ET, England	University of Bielefeld; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Meise, K (corresponding author), Univ Bielefeld, Dept Anim Behav, Morgenbreede 45, D-33615 Bielefeld, Germany.	kristine.meise@googlemail.com	Hoffman, Joseph i/K-7725-2012; Forcada, Jaume/GYU-0677-2022; von Engelhardt, Nikolaus/B-6730-2008	Hoffman, Joseph i/0000-0001-5895-8949; von Engelhardt, Nikolaus/0000-0003-4971-6408	Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme [PCIG-GA-2011-303618]; Deutsche Forschungsgemeinschaft standard grant [HO 5122/3-1]; Career Bridge Doctorate - Bielefeld Young Researchers' Fund; Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University; Natural Environment Research Council [bas0100035] Funding Source: researchfish; NERC [bas0100035] Funding Source: UKRI	Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme; Deutsche Forschungsgemeinschaft standard grant; Career Bridge Doctorate - Bielefeld Young Researchers' Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This field work on Bird Island was supported by the Natural Environment Research Council. The laboratory work was supported by a Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme (grant number: PCIG-GA-2011-303618) and a Deutsche Forschungsgemeinschaft standard grant (grant number: HO 5122/3-1) awarded to J.I.H. K.M. was funded by the Career Bridge Doctorate - Postdoc stipend of the Bielefeld Young Researchers' Fund. The authors acknowledge support for the publication fee by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work contributes to the Ecosystems project of the British Antarctic Survey, Natural Environment Research Council, and part of the Polar Science for Planet Earth Programme. We acknowledge support for the publication fee by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University. We are also grateful to Mick Mackey and Jonathan Ashburner who helped with the fieldwork at Bird Island. Finally, we want to thank Kathrin Engel who helped with laboratory work and Luke Eberhart-Phillips for preparing the map of the two study colonies.	Andrews MH, 2004, J PHYSIOL-LONDON, V555, P659, DOI 10.1113/jphysiol.2003.056705; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Arthur B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120888; Atkinson S, 1997, Rev Reprod, V2, P175, DOI 10.1530/revreprod/2.3.175; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; BARTHOLOMEW GA, 1970, EVOLUTION, V24, P546, DOI 10.1111/j.1558-5646.1970.tb01790.x; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Boness D.J., 1991, P1; Bonin CA, 2014, BEHAV ECOL SOCIOBIOL, V68, P597, DOI 10.1007/s00265-013-1674-7; Boonekamp JJ, 2008, BIOL LETTERS, V4, P741, DOI 10.1098/rsbl.2008.0347; Boyd IL, 1996, J MAMMAL, V77, P124, DOI 10.2307/1382714; BOYD IL, 1989, BEHAV ECOL SOCIOBIOL, V24, P377, DOI 10.1007/BF00293265; Browne P, 2006, GEN COMP ENDOCR, V147, P175, DOI 10.1016/j.ygcen.2005.12.019; Bryan HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080537; Burton PJ, 1999, BIOL REPROD, V60, P234, DOI 10.1095/biolreprod60.2.234; Cassini MH, 1999, BEHAV ECOL, V10, P612, DOI 10.1093/beheco/10.5.612; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Comin A., 2008, Proceedings of the XVI Congress of the Mediterranean Federation for Health and Production of Ruminants, Zadar, Croatia, 26 April 2008, P221; Crawley M. J., 2008, R BOOK; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Del Giudice M, 2012, PSYCHONEUROENDOCRINO, V37, P1614, DOI 10.1016/j.psyneuen.2012.05.014; Dettmer AM, 2014, PSYCHONEUROENDOCRINO, V42, P59, DOI 10.1016/j.psyneuen.2014.01.002; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; Doidge D.W., 1986, P102; DOIDGE DW, 1984, J ZOOL, V202, P449, DOI 10.1111/j.1469-7998.1984.tb05095.x; DUCK CD, 1990, J ZOOL, V222, P103, DOI 10.1111/j.1469-7998.1990.tb04032.x; Fairbanks LA, 2011, PSYCHONEUROENDOCRINO, V36, P1201, DOI 10.1016/j.psyneuen.2011.02.013; Forcada J, 2008, ENCY MARINE MAMMALS, P1325; Forcada J, 2014, NATURE, V511, P462, DOI 10.1038/nature13542; Fowden AL, 2009, EXP PHYSIOL, V94, P607, DOI 10.1113/expphysiol.2008.046359; Gentry RL, 1982, EQUIPMENT TECHNIQUES, P1; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; Gleason ED, 2009, FRONT NEUROENDOCRIN, V30, P460, DOI 10.1016/j.yfrne.2009.04.009; Gluckman P. D., 2005, THE FETAL MATRIX; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Herman RA, 2000, HORM BEHAV, V38, P52, DOI 10.1006/hbeh.2000.1608; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Hoffman JI, 2006, MOL ECOL, V15, P3841, DOI 10.1111/j.1365-294X.2006.03053.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Hoffman JI, 2004, EVOLUTION, V58, P2087; Hoffman JI, 2012, MAMM BIOL, V77, P71, DOI 10.1016/j.mambio.2011.09.002; Hofmeyr GJG, 2007, S AFR J WILDL RES, V37, P1, DOI 10.3957/0379-4369-37.1.1; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kaiser S, 2003, BEHAV BRAIN RES, V144, P199, DOI 10.1016/S0166-4328(03)00077-9; Kaiser S, 2003, PSYCHONEUROENDOCRINO, V28, P67, DOI 10.1016/S0306-4530(02)00010-0; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; Kapoor A, 2014, PEDIATR RES, V75, P476, DOI 10.1038/pr.2014.1; Karlen J, 2013, PEDIATRICS, V132, pE1333, DOI 10.1542/peds.2013-1178; Katz H, 2013, AQUAT MAMM, V39, P290, DOI 10.1578/AM.39.3.2013.290; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Koren L, 2002, ANIM BEHAV, V63, P403, DOI 10.1006/anbe.2001.1907; Li CW, 2007, GEN COMP ENDOCR, V151, P202, DOI 10.1016/j.ygcen.2007.01.014; Lidgard DC, 2008, HORM BEHAV, V53, P241, DOI 10.1016/j.yhbeh.2007.10.003; Liggins GC, 2000, AM J OBSTET GYNECOL, V182, P475; LING JK, 1970, Q REV BIOL, V45, P16, DOI 10.1086/406361; Macbeth BJ, 2012, WILDLIFE SOC B, V36, P747, DOI 10.1002/wsb.219; Matthews SG, 2002, TRENDS ENDOCRIN MET, V13, P373, DOI 10.1016/S1043-2760(02)00690-2; Mazur A, 1997, EVOL HUM BEHAV, V18, P317, DOI 10.1016/S1090-5138(97)00013-5; McCann T.S., 1987, NOAA TECHNICAL REPOR, V51, P5; MCCANN TS, 1980, J ZOOL, V192, P295; Meylan S, 2012, PHILOS T R SOC B, V367, P1647, DOI 10.1098/rstb.2012.0020; Ortiz RM, 2001, AM J PHYSIOL-REG I, V280, pR790, DOI 10.1152/ajpregu.2001.280.3.R790; Pearson BL, 2015, AM J PRIMATOL, V77, P462, DOI 10.1002/ajp.22363; Powell LH, 2002, PSYCHOSOM MED, V64, P502, DOI 10.1097/00006842-200205000-00015; R Development Core Team, 2014, R LANG ENV STAT COMP; Reid K, 2005, CAN J ZOOL, V83, P604, DOI 10.1139/Z05-045; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Rogovin K, 2003, HORM BEHAV, V43, P132, DOI 10.1016/S0018-506X(02)00028-4; Sachser N, 2011, NEUROSCI BIOBEHAV R, V35, P1518, DOI 10.1016/j.neubiorev.2010.09.002; Sangiao-Alvarellos S, 2005, J EXP ZOOL PART A, V303A, P761, DOI 10.1002/jez.a.203; SAPOLSKY RM, 1982, HORM BEHAV, V16, P279, DOI 10.1016/0018-506X(82)90027-7; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Scheffer V.B., 1963, US FISH WILDLIFE SER; Sheriff MJ, 2013, ECOL LETT, V16, P271, DOI 10.1111/ele.12042; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Spitz J, 2015, COMP BIOCHEM PHYS A, V187, P214, DOI 10.1016/j.cbpa.2015.02.006; Staniland IJ, 2003, MAR MAMMAL SCI, V19, P331, DOI 10.1111/j.1748-7692.2003.tb01112.x; Stoffel MA, 2015, P NATL ACAD SCI USA, V112, pE5005, DOI 10.1073/pnas.1506076112; Terwissen CV, 2013, GEN COMP ENDOCR, V194, P162, DOI 10.1016/j.ygcen.2013.09.010; Tiira K, 2006, BEHAV ECOL SOCIOBIOL, V59, P657, DOI 10.1007/s00265-005-0094-8; Tiira K, 2003, MOL ECOL, V12, P2399, DOI 10.1046/j.1365-294X.2003.01925.x; TRILLMICH F, 1984, BIOL J LINN SOC, V21, P209; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Valimaki K, 2007, BEHAV ECOL SOCIOBIOL, V61, P997, DOI 10.1007/s00265-006-0332-8; Venables WN., 2002, MODERN APPL STAT S 4; von Engelhardt N, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 4: BIRDS, P91; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Welberg LAM, 2005, J ENDOCRINOL, V186, pR7, DOI 10.1677/joe.1.06374; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1994, J EXP ZOOL, V270, P372, DOI 10.1002/jez.1402700406; Zgaga L, 2013, EUR J ENDOCRINOL, V169, P59, DOI 10.1530/EJE-12-0916; Zuur Alain F., 2009, P1	97	22	22	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145352	10.1371/journal.pone.0145352	http://dx.doi.org/10.1371/journal.pone.0145352			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761814	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000368033100013
J	Priglinger, CS; Obermann, J; Szober, CM; Merl-Pham, J; Ohmayer, U; Behler, J; Gruhn, F; Kreutzer, TC; Wertheimer, C; Geerlof, A; Priglinger, SG; Hauck, SM				Priglinger, Claudia S.; Obermann, Jara; Szober, Christoph M.; Merl-Pham, Juliane; Ohmayer, Uli; Behler, Jennifer; Gruhn, Fabian; Kreutzer, Thomas C.; Wertheimer, Christian; Geerlof, Arie; Priglinger, Siegfried G.; Hauck, Stefanie M.			Epithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased beta 1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding	PLOS ONE			English	Article							EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY; THOMSEN-FRIEDENREICH ANTIGEN; GROWTH-FACTOR; HUMAN BREAST; N-GLYCANS; TGF-BETA; RETINAL-DETACHMENT; SIGNALING PATHWAY; TUMOR PROGRESSION; CLINICAL-TRIAL	Epithelial-to-mesenchymal transition (EMT) of retinal pigment epithelial cells is a crucial event in the onset of proliferative vitreoretinopathy (PVR), the most common reason for treatment failure in retinal detachment surgery. We studied alterations in the cell surface glycan expression profile upon EMT of RPE cells and focused on its relevance for the interaction with galectin-3 (Gal-3), a carbohydrate binding protein, which can inhibit attachment and spreading of human RPE cells in a dose- and carbohydrate-dependent manner, and thus bares the potential to counteract PVR-associated cellular events. Lectin blot analysis revealed that EMT of RPE cells in vitro confers a glycomic shift towards an abundance of Thomsen-Friedenreich antigen, poly-N-acetyllactosamine chains, and complex-type branched N-glycans. Using inhibitors of glycosylation we found that both, binding of Gal-3 to the RPE cell surface and Gal-3-mediated inhibition of RPE attachment and spreading, strongly depend on the interaction of Gal-3 with tri-or tetra-antennary complex type N-glycans and sialylation of glycans but not on complex-type O-glycans. Importantly, we found that beta 1,6 N-acetylglucosaminyltransferase V (Mgat5), the key enzyme catalyzing the synthesis of tetra-or tri-antennary complex type N-glycans, is increased upon EMT of RPE cells. Silencing of Mgat5 by siRNA and CRISPR-Cas9 genome editing resulted in reduced Gal-3 binding. We conclude from these data that binding of recombinant Gal-3 to the RPE cell surface and inhibitory effects on RPE attachment and spreading largely dependent on interaction with Mgat5 modified N-glycans, which are more abundant on dedifferentiated than on the healthy, native RPE cells. Based on these findings we hypothesize that EMT of RPE cells in vitro confers glycomic changes, which account for high affinity binding of recombinant Gal-3, particularly to the cell surface of myofibroblastic RPE. From a future perspective recombinant Gal-3 may disclose a therapeutic option allowing for selectively targeting RPE cells with pathogenic relevance for development of PVR.	[Priglinger, Claudia S.; Szober, Christoph M.; Kreutzer, Thomas C.; Wertheimer, Christian; Priglinger, Siegfried G.] Univ Munich, Dept Ophthalmol, Munich, Germany; [Obermann, Jara; Merl-Pham, Juliane; Ohmayer, Uli; Behler, Jennifer; Gruhn, Fabian; Hauck, Stefanie M.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munich, Res Unit Prot Sci, Munich, Germany; [Geerlof, Arie] German Res Ctr Environm Hlth GmbH, Prot Express & Purificat Facil, Inst Biol Struct, Helmholtz Zentrum Munich, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Priglinger, CS (corresponding author), Univ Munich, Dept Ophthalmol, Munich, Germany.	claudia.alge-priglinger@med.uni-muenchen.de	Merl-Pham, Juliane/N-7258-2014; Hauck, Stefanie/B-3300-2013	Merl-Pham, Juliane/0000-0002-3422-4083; Hauck, Stefanie/0000-0002-1630-6827; Wertheimer, Christian/0000-0002-7017-7560	Forschungsforderung der deutschen Forschungsgemeinschaft (DFG) [PR 1248/2-2, HA6014/2-2]; EyeNovative Forderpreis (Novartis pharmaceuticals)	Forschungsforderung der deutschen Forschungsgemeinschaft (DFG); EyeNovative Forderpreis (Novartis pharmaceuticals)	This work was funded by Forschungsforderung der deutschen Forschungsgemeinschaft (DFG), grant no PR 1248/2-2 to CSP and grant no HA6014/2-2 to SMH (http://www.dfg.de). This work was also funded by EyeNovative Forderpreis 2012 to CSP (Novartis pharmaceuticals, http://www.ophtha-foerderpreis.de). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	Alge CS, 2006, INVEST OPHTH VIS SCI, V47, P415, DOI 10.1167/iovs.05-0308; Alge CS, 2003, INVEST OPHTH VIS SCI, V44, P3629, DOI 10.1167/iovs.02-1225; Alge-Priglinger CS, 2011, BIOCHIMIE, V93, P477, DOI 10.1016/j.biochi.2010.10.021; Alge-Priglinger CS, 2009, MOL VIS, V15, P2162; Alge-Priglinger CS, 2009, INVEST OPHTH VIS SCI, V50, P5495, DOI 10.1167/iovs.08-3193; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Asaria RHY, 2001, OPHTHALMOLOGY, V108, P1179, DOI 10.1016/S0161-6420(01)00589-9; CAMPOCHIARO PA, 1993, EXP EYE RES, V57, P539, DOI 10.1006/exer.1993.1158; Cardillo JA, 2004, BRIT J OPHTHALMOL, V88, P1201, DOI 10.1136/bjo.2003.039917; Charteris DG, 2004, OPHTHALMOLOGY, V111, P2240, DOI 10.1016/j.ophtha.2004.05.036; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; de Melo FHM, 2007, J HISTOCHEM CYTOCHEM, V55, P1015, DOI 10.1369/jhc.7A7174.2007; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 2002, BBA-GEN SUBJECTS, V1573, P414, DOI 10.1016/S0304-4165(02)00411-7; Eibl KH, 2003, INVEST OPHTH VIS SCI, V44, P3556, DOI 10.1167/iovs.02-1172; Eibl KH, 2007, INVEST OPHTH VIS SCI, V48, P1305, DOI 10.1167/iovs.06-0591; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; FERNANDES B, 1991, CANCER RES, V51, P718; Glinsky VV, 2001, CANCER RES, V61, P4851; Glinsky VV, 2000, CANCER RES, V60, P2584; Goletz S, 1997, J CELL SCI, V110, P1585; Granovsky M, 2000, NAT MED, V6, P306; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Hughes RC, 2001, BIOCHIMIE, V83, P667; KAMPIK A, 1981, AM J OPHTHALMOL, V91, P573, DOI 10.1016/0002-9394(81)90055-6; Karmakar S, 2008, GLYCOBIOLOGY, V18, P770, DOI 10.1093/glycob/cwn066; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P401, DOI 10.1016/S0304-4165(02)00321-5; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Kon CH, 1998, BRIT J OPHTHALMOL, V82, P554, DOI 10.1136/bjo.82.5.554; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Lee JJ, 2002, INVEST OPHTH VIS SCI, V43, P3117; Lei HT, 2011, MOL CELL BIOL, V31, P1788, DOI 10.1128/MCB.01321-10; Lei H, 2010, AM J PATHOL, V177, P132, DOI 10.2353/ajpath.2010.090604; Li N, 2014, J CELL MOL MED, V18, P1975, DOI 10.1111/jcmm.12331; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; MACHEMER R, 1988, INVEST OPHTH VIS SCI, V29, P1771; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Mazurek N, 2005, CANCER RES, V65, P10767, DOI 10.1158/0008-5472.CAN-04-3333; Nakano T, 1996, ANTICANCER RES, V16, P3577; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Oshima Y, 2002, GENE THER, V9, P1214, DOI 10.1038/sj.gt.3301789; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pennock S, 2011, AM J PATHOL, V179, P2931, DOI 10.1016/j.ajpath.2011.08.043; Priglinger CS, 2013, OPHTHALMOLOGE, V110, P948, DOI 10.1007/s00347-013-2832-z; Priglinger CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070011; Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3; Saika S, 2005, LAB INVEST, V85, P838, DOI 10.1038/labinvest.3700294; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Saravanan C, 2010, GLYCOBIOLOGY, V20, P13, DOI 10.1093/glycob/cwp133; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Seelentag WKF, 1998, CANCER RES, V58, P5559; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shimura T, 2004, CANCER RES, V64, P6363, DOI 10.1158/0008-5472.CAN-04-1816; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki O, 2008, ONCOL REP, V19, P743; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Valenzuela HF, 2007, CANCER RES, V67, P6155, DOI 10.1158/0008-5472.CAN-05-4431; Velez G, 2013, INVEST OPHTH VIS SCI, V54, P1392, DOI 10.1167/iovs.12-10320; Wiedemann P, 1998, AM J OPHTHALMOL, V126, P550, DOI 10.1016/S0002-9394(98)00115-9; WIEDEMANN P, 1987, AM J OPHTHALMOL, V104, P10, DOI 10.1016/0002-9394(87)90286-8; Wu PC, 2008, J OCUL PHARMACOL TH, V24, P25, DOI 10.1089/jop.2007.0044; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zou J, 2005, CARCINOGENESIS, V26, P309, DOI 10.1093/carcin/bgh329	71	27	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146887	10.1371/journal.pone.0146887	http://dx.doi.org/10.1371/journal.pone.0146887			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760037	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100050
J	Andey, T; Patel, A; Marepally, S; Chougule, M; Spencer, SD; Rishi, AK; Singh, M				Andey, Terrick; Patel, Apurva; Marepally, Srujan; Chougule, Mahavir; Spencer, Shawn D.; Rishi, Arun K.; Singh, Mandip			Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine	PLOS ONE			English	Article							CELL LUNG-CANCER; MANNOSE RECEPTOR; DENDRITIC CELLS; DRUG-DELIVERY; TUMOR-GROWTH; MODEL; NANOPARTICLES; MACROPHAGES; COMBINATION; METASTASIS	Purpose To formulate hydroxypropyl methylcellulose-stabilized self-emulsifying solid dispersible carriers of noscapine to enhance oral bioavailability. Methods Formulation of noscapine (Nos) self-emulsifying solid dispersible microparticles (SESDs) was afforded by emulsification using an optimized formula of Labrafil M1944, Tween-80, and Labrasol followed by spray-drying with hydroxypropyl methylcellulose (HPMC), with and without mannosamine (Mann-Nos_SESDs and Nos_SESDs respectively); self-microemulsifying liquid dispersions (SMEDDs) with and without mannosamine (Mann-Nos_SMEDDs and Nos_SMEDDs respectively) were also prepared. SMEDDs and SESDs were characterized for size, polydispersity, surface charge, entrapment efficiency, in vitro permeability, in vitro release kinetics, and oral pharmacokinetics in Sprague-Dawley rats (10 mg/kg p.o). The antitumor efficacy of Mann-Nos_SESDs on the basis of chemosensitization to cisplatin (2.0 mg/kg, IV) was investigated in a chemorefractory lung tumor Nu/Nu mouse model up to a maximal oral dose of 300 mg/kg. Results The oil/surfactant/co-surfactant mixture of Labrafil M1944, Tween-80, and Labrasol optimized at weight ratios of 62.8: 9.30: 27.90% produced stable self-microemulsifying dispersions (SMEDDs) at a SMEDD to water ratio of 1-3: 7-9 parts by weight. SMEDDs had hydrodynamic diameters between 231 and 246 nm; surface charges ranged from -16.50 to -18.7 mV; and entrapment efficiencies were between 32 and 35%. SESDs ranged in size between 5.84 and 6.60 mu m with surface charges from -10.62 to -12.40 mV and entrapment efficiencies of 30.96 +/- 4.66 and 32.05 +/- 3.72%(Nos_SESDs and Mann-Nos_SESDs respectively). MannNos_SESDs exhibited saturating uptake across Caco-2 monolayers (Papp = 4.94 +/- 0.18 x 10(-6) cm/s), with controlled release of 50% of Nos in 6 hr at pH 6.8 following Higuchi kinetics. Mann-Nos_SESDs was 40% more bioavailable compared to Nos_SESDs; and was effective in sensitizing H1650 SP cells to Cisplatin in vitro and in an orthotopic lung tumor model of H1650 SP origin. Conclusions Mannosylated noscapine self-emulsifying solid dispersions (Mann-Nos_SESDs) are bioavailable and potentiate the antineoplastic effect of cisplatin-based chemotherapy in cisplatin-resistant NSCLC.	[Andey, Terrick] Massachusetts Coll Pharm & Allied Hlth Sci, Sch Pharm, Dept Pharmaceut Sci, Worcester, MA USA; [Andey, Terrick] Hlth Sci Univ, Worcester, MA USA; [Patel, Apurva; Spencer, Shawn D.; Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut, Tallahassee, FL 32307 USA; [Marepally, Srujan] Natl Ctr Biol Sci NCBS, Inst Stem Cell Biol & Regenerat Med inStem, Bangalore, Karnataka, India; [Chougule, Mahavir] Univ Hawaii, Daniel K Inouye Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA; [Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA	State University System of Florida; Florida A&M University; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Hawaii System; University Hawaii Hilo; Wayne State University	Singh, M (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut, 1520 South Martin Luther King Jr Blvd, Tallahassee, FL 32307 USA.	mandip.sachdeva@famu.edu	Terrick Andey, B.Pharm./AAZ-1306-2021		National Institute on Minority Health and Health Disparities (NIMHD) [P20MD006738]; National Institute on Minority Health and Health Disparities [P20MD006738] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was funded by a P20MD006738 grant from the National Institute on Minority Health and Health Disparities (NIMHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MO, 2011, J CONTROL RELEASE, V149, P314, DOI 10.1016/j.jconrel.2010.10.030; Alisaraie L, 2011, CHEM BIOL DRUG DES, V78, P535, DOI 10.1111/j.1747-0285.2011.01189.x; Andey T, 2014, J CONTROL RELEASE, V184, P67, DOI 10.1016/j.jconrel.2014.03.049; Andey T, 2013, EUR J PHARM SCI, V50, P227, DOI 10.1016/j.ejps.2013.07.007; Aneja R, 2007, CANCER CHEMOTH PHARM, V60, P831, DOI 10.1007/s00280-007-0430-y; Chougule M, 2011, LUNG CANCER, V71, P271, DOI 10.1016/j.lungcan.2010.06.002; Chougule MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027394; Chougule MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017733; Chougule MB, 2011, PLOS ONE, V6; DAHLSTROM B, 1982, EUR J CLIN PHARMACOL, V22, P535, DOI 10.1007/BF00609627; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; Fang ZZ, 2012, BRIT J PHARMACOL, V167, P1271, DOI 10.1111/j.1476-5381.2012.02067.x; Fleisher D, 1999, CLIN PHARMACOKINET, V36, P233, DOI 10.2165/00003088-199936030-00004; Gohel M C, 2000, AAPS PharmSciTech, V1, pE31; Guo YM, 2012, THERANOSTICS, V2, P1104, DOI 10.7150/thno.4525; Hattori Y, 2006, J PHARMACOL EXP THER, V318, P828, DOI 10.1124/jpet.106.105098; Jackson T, 2008, CANCER CHEMOTH PHARM, V63, P117, DOI 10.1007/s00280-008-0720-z; Jain A, 2010, J CONTROL RELEASE, V148, P359, DOI 10.1016/j.jconrel.2010.09.003; KARLSSON MO, 1990, EUR J CLIN PHARMACOL, V39, P275, DOI 10.1007/BF00315110; Khoo SM, 2001, J PHARM SCI, V90, P1599, DOI 10.1002/jps.1110; Lapthorne S, 2012, IMMUNOLOGY, V136, P312, DOI 10.1111/j.1365-2567.2012.03581.x; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Madan J, 2013, COLLOID SURFACE B, V107, P235, DOI 10.1016/j.colsurfb.2013.02.010; Madan J, 2010, CANCER CHEMOTH PHARM, V65, P537, DOI 10.1007/s00280-009-1060-3; Mahmood T, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-20; Patankar NA, 2013, CLIN CANCER RES, V19, P865, DOI 10.1158/1078-0432.CCR-12-2459; Sarkar S, 2012, INT J CANCER, V131, pE1088, DOI 10.1002/ijc.27615; Sebak S, 2010, INT J NANOMED, V5, P525; Siepmann F, 2005, J CONTROL RELEASE, V105, P226, DOI 10.1016/j.jconrel.2005.03.028; Singh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055982; Witoonsaridsilp W, 2012, AAPS PHARMSCITECH, V13, P699, DOI 10.1208/s12249-012-9788-1; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Yi T, 2008, EUR J PHARM SCI, V34, P274, DOI 10.1016/j.ejps.2008.04.010; Zucchetti M, 1995, CLIN CANCER RES, V1, P1517	34	12	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146804	10.1371/journal.pone.0146804	http://dx.doi.org/10.1371/journal.pone.0146804			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757437	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888800031
J	Crepaldi, G; Scire, CA; Carrara, G; Sakellariou, G; Caporali, R; Hmamouchi, I; Dougados, M; Montecucco, C				Crepaldi, Gloria; Scire, Carlo Alberto; Carrara, Greta; Sakellariou, Garifallia; Caporali, Roberto; Hmamouchi, Ihsane; Dougados, Maxime; Montecucco, Carlomaurizio			Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis	PLOS ONE			English	Article							LIPID PROFILE; DOUBLE-BLIND; INFLAMMATION; THERAPY; TARGET; ATORVASTATIN; BIOLOGICS; REMISSION; CACHEXIA; OBESITY	Objectives To explore the influence of comorbidities on clinical outcomes and disease activity in rheumatoid arthritis (RA). Methods In patients included in the cross-sectional observational multicenter international study COMORA, demographics, disease characteristics and comorbidities (hypertension, diabetes, hyperlipidemia, renal failure, ischemic heart disease, stroke, cancer, gastro-intestinal ulcers, hepatitis, depression, chronic pulmonary disease, obesity) were collected. Multivariable linear regression models explored the relationship between each comorbidity and disease activity measures: 28-swollen joint count (SJC), 28-tender joint count (TJC), erythrocyte sedimentation rate (ESR), patient's and physician's global assessment (PtGA, PhGA), patient reported fatigue and 28-Disease Activity Score (DAS28). Results are expressed as mean difference (MD) adjusted for the main confounders (age, gender, disease characteristics and treatment). Results A total of 3,920 patients were included: age (mean +/- SD) 56.27 +/- 13.03 yrs, female 81.65%, disease duration median 7.08 yrs (IQR 2.97-13.27), DAS28 (mean +/- SD) 3.74 +/- 1.55. Patients with diabetes had more swollen and tender joints and worse PtGA and PhGA (MD + 1.06, + 0.93, + 0.53 and + 0.54, respectively). Patients with hyperlipidemia had a lower number of swollen and tender joints, lower ESR and better PtGA and PhGA (MD -0.77, -0.56, -3.56, -0.31 and -0.35, respectively). Patients with history of ischemic heart disease and obese patients had more tender joints (MD + 1.27 and + 1.07) and higher ESR levels (MD +5.64 and +5.20). DAS28 is influenced exclusively by cardiovascular comorbidities, in particular diabetes, hyperlipidemia, ischemic heart disease and obesity. Conclusions Cardiovascular comorbidities relate more than others with disease activity in RA. Diabetes and hyperlipidemia in particular seem associated with higher and lower disease activity respectively influencing almost all considered outcomes, suggesting a special importance of this pattern of comorbidities in disease activity assessment and clinical management.	[Crepaldi, Gloria; Sakellariou, Garifallia; Caporali, Roberto; Montecucco, Carlomaurizio] IRCCS Policlin San Matteo Fdn, Dept Rheumatol, Pavia, Italy; [Scire, Carlo Alberto; Carrara, Greta] Italian Soc Rheumatol, Epidemiol Unit, Milan, Italy; [Hmamouchi, Ihsane] Mohammed V Souissi Univ, Fac Med, Lab Biostat Clin Res & Epidemiol LBRCE, Rabat, Morocco; [Dougados, Maxime] Paris Descartes Univ, Fac Med, Hosp Cochin, Rheumatol Dept B, Paris, France	IRCCS Fondazione San Matteo; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Caporali, R (corresponding author), IRCCS Policlin San Matteo Fdn, Dept Rheumatol, Pavia, Italy.	caporali@smatteo.pv.it	Montecucco, Carlomaurizio/K-5236-2018; Scirè, Carlo Alberto/E-5774-2013; Carrara, Greta/ABF-8075-2020; Sakellariou, Garifallia/E-5468-2011; caporali, roberto/AAB-1873-2019; Dougados, Maxime/P-5287-2016	Montecucco, Carlomaurizio/0000-0001-8263-3925; Scirè, Carlo Alberto/0000-0001-7451-0271; Sakellariou, Garifallia/0000-0002-1849-5123; caporali, roberto/0000-0001-9300-6169; Carrara, Greta/0000-0001-9752-2275; HMAMOUCHI, IHSANE/0000-0003-4402-5034	Roche Ltd.	Roche Ltd.	The COMORA study was conducted with the support of an unrestricted grant from Roche Ltd. The ancillary analysis described in this manuscript has been done without any type of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajeganova S, 2013, ARTHRIT CARE RES, V65, P78, DOI 10.1002/acr.21710; Akash MSH, 2012, J PHARM SCI-US, V101, P1647, DOI 10.1002/jps.23057; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arts E., 2014, ANN RHEUM DIS; Boers M, 2003, ANN RHEUM DIS, V62, P842, DOI 10.1136/ard.62.9.842; Brennan A, 2007, RHEUMATOLOGY, V46, P1345, DOI 10.1093/rheumatology/kem115; Burner TW, 2009, CURR OPIN RHEUMATOL, V21, P50, DOI 10.1097/BOR.0b013e32831bc0c4; Canoz M, 2008, CLIN INVEST MED, V31, pE373; Combe B, 2013, J RHEUMATOL, V40, P1650, DOI 10.3899/jrheum.121515; Daien CI, 2012, ANN RHEUM DIS, V71, P862, DOI 10.1136/annrheumdis-2011-201148; Del Rosso A, 2006, CURR DIABETES REV, V2, P455, DOI 10.2174/1573399810602040455; Dessein PH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/358949; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; El-Barbary AM, 2011, J RHEUMATOL, V38, P229, DOI 10.3899/jrheum.100582; Elkan AC, 2009, EUR J NUTR, V48, P315, DOI 10.1007/s00394-009-0017-y; Georgiadis AN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1952; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Koenen TB, 2011, DIABETES, V60, P517, DOI 10.2337/db10-0266; Krishnan E, 2005, ANN RHEUM DIS, V64, P1350, DOI 10.1136/ard.2005.037903; Kroot EJJA, 2001, J RHEUMATOL, V28, P1511; Kuriya B, 2012, J RHEUMATOL, V39, P1155, DOI 10.3899/jrheum.111341; Listing J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1933; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Michaud K, 2007, BEST PRACT RES CL RH, V21, P885, DOI 10.1016/j.berh.2007.06.002; Navarro-Millan I, 2013, ARTHRITIS RHEUM-US, V65, P1430, DOI 10.1002/art.37916; Park YB, 2002, AM J MED, V113, P188, DOI 10.1016/S0002-9343(02)01186-5; Pincus T, 2012, CLIN EXP RHEUMATOL, V30, pS10; Putrik P, 2016, ANN RHEUM DIS, V75, P715, DOI 10.1136/annrheumdis-2015-207738; Radner H, 2015, SEMIN ARTHRITIS RHEU; Radner H, 2011, RHEUMATOLOGY, V50, P381, DOI 10.1093/rheumatology/keq334; Ranganath VK, 2008, J RHEUMATOL, V35, P1966; Ranganath VK, 2013, RHEUMATOLOGY, V52, P1809, DOI 10.1093/rheumatology/ket224; Robertson J, 2013, NAT REV RHEUMATOL, V9, P513, DOI 10.1038/nrrheum.2013.91; Schoels M, 2010, ANN RHEUM DIS, V69, P638, DOI 10.1136/ard.2009.123976; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Studenic P, 2012, ARTHRITIS RHEUM-US, V64, P2814, DOI 10.1002/art.34543; Summers GD, 2010, NAT REV RHEUMATOL, V6, P445, DOI 10.1038/nrrheum.2010.105; Tiippana-Kinnunen T, 2013, SCAND J RHEUMATOL, V42, P451, DOI 10.3109/03009742.2013.790073; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Urruela MA, 2012, CURR RHEUMATOL REP, V14, P428, DOI 10.1007/s11926-012-0269-z; van Sijl AM, 2011, SEMIN ARTHRITIS RHEU, V41, P393, DOI 10.1016/j.semarthrit.2011.04.003; Westwell-Roper C, 2014, IMMUNOL CELL BIOL, V92, P314, DOI 10.1038/icb.2014.4; Wolfe F, 2009, J RHEUMATOL, V36, P27, DOI 10.3899/jrheum.080591	46	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146991	10.1371/journal.pone.0146991	http://dx.doi.org/10.1371/journal.pone.0146991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757209	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800040
J	Feng, YG; Cheng, DJ; Zhang, CF; Li, YC; Zhang, ZY; Wang, J; Shi, YZ				Feng, Yanguo; Cheng, Dejun; Zhang, Chaofeng; Li, Yuchun; Zhang, Zhiying; Wang, Juan; Shi, Yuzhong			Association of PDE4B Polymorphisms with Susceptibility to Schizophrenia: A Meta-Analysis of Case-Control Studies	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; GENETIC ASSOCIATION; DISC1; PHOSPHODIESTERASES; POPULATION; VARIANTS; GENOMICS; RISK; TWIN	Background The PDE4B single nucleotide polymorphisms (SNPs) have been reported to be associated with schizophrenia risk. However, current findings are ambiguous or even conflicting. To better facilitate the understanding the genetic role played by PDE4B in susceptibility to schizophrenia, we collected currently available data and conducted this meta-analysis. Methods A comprehensive electronic literature searching of PubMed, Embase, Web of Science and Cochrane Library was performed. The association between PDE4B SNPs and schizophrenia was evaluated by odds ratios (ORs) and 95% confidence intervals (CIs) under allelic, dominant and recessive genetic models. The random effects model was utilized when high between-study heterogeneity (I-2 > 50%) existed, otherwise the fixed effects model was used. Results Five studies comprising 2376 schizophrenia patients and 3093 controls were finally included for meta-analysis. The rs1040716 was statistically significantly associated with schizophrenia risk in Asian and Caucasian populations under dominant model (OR = 0.87, 95% CI: 0.76-0.99, P = 0.04). The rs2180335 was significantly related with schizophrenia risk in Asian populations under allelic (OR = 0.82, 95% CI: 0.72-0.93, P = 0.003) and dominant (OR = 0.75, 95% CI: 0.64-0.88, P < 0.001) models. A significant association was also observed between rs4320761 and schizophrenia in Asian populations under allelic model (OR = 0.87, 95% CI: 0.75-1.00, P = 0.048). In addition, a strong association tendency was found between rs6588190 and schizophrenia in Asian populations under allelic model (OR = 0.87, 95% CI: 0.76-1.00, P = 0.055). Conclusion This meta-analysis suggests that PDE4B SNPs are genetically associated with susceptibility to schizophrenia. However, due to limited sample size, more large-scale, multi-racial association studies are needed to further clarify the genetic association between various PDE4B variants and schizophrenia.	[Feng, Yanguo; Cheng, Dejun; Zhang, Chaofeng; Li, Yuchun; Zhang, Zhiying; Wang, Juan; Shi, Yuzhong] Xinxiang Med Univ, Affiliated Hosp 2, Henan Mental Hosp, Dept Psychiat, Xinxiang, Peoples R China	Xinxiang Medical University	Shi, YZ (corresponding author), Xinxiang Med Univ, Affiliated Hosp 2, Henan Mental Hosp, Dept Psychiat, Xinxiang, Peoples R China.	syzscience123@163.com	li, Yu/HCI-9086-2022; Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022					Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Bae JS, 2015, GEN PHYSIOL BIOPHYS, V34, P277, DOI 10.4149/gpb_2015004; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fatemi SH, 2008, SCHIZOPHR RES, V101, P36, DOI 10.1016/j.schres.2008.01.029; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Guan FL, 2012, HUM GENET, V131, P1047, DOI 10.1007/s00439-011-1120-8; Holliday EG, 2009, AM J PSYCHIAT, V166, P206, DOI 10.1176/appi.ajp.2008.08030442; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Kahler AK, 2010, AM J MED GENET B, V153B, P86, DOI 10.1002/ajmg.b.30958; KAIYA H, 1992, PROSTAG LEUKOTR ESS, V46, P33, DOI 10.1016/0952-3278(92)90056-O; Karam CS, 2010, TRENDS PHARMACOL SCI, V31, P381, DOI 10.1016/j.tips.2010.05.004; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; McCarthy SE, 2014, SCHIZOPHRENIA BULL, V40, P492, DOI 10.1093/schbul/sbu042; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Numata S, 2008, J PSYCHIATR RES, V43, P7, DOI 10.1016/j.jpsychires.2008.01.013; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Pickard BS, 2007, PSYCHIAT GENET, V17, P129, DOI 10.1097/YPG.0b013e328014492b; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Rastogi A, 2009, SCHIZOPHR RES, V114, P39, DOI 10.1016/j.schres.2009.06.019; Shi WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127995; Singh S, 2014, GENE, V535, P97, DOI 10.1016/j.gene.2013.09.110; Siuciak JA, 2008, CNS DRUGS, V22, P983, DOI 10.2165/0023210-200822120-00002; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; SZPIRER C, 1995, CYTOGENET CELL GENET, V69, P11, DOI 10.1159/000133927; Tomppo L, 2009, BIOL PSYCHIAT, V65, P1055, DOI 10.1016/j.biopsych.2009.01.014	32	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0147092	10.1371/journal.pone.0147092	http://dx.doi.org/10.1371/journal.pone.0147092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756575	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800045
J	Knight, R; Small, W; Carson, A; Shoveller, J				Knight, Rod; Small, Will; Carson, Anna; Shoveller, Jean			Complex and Conflicting Social Norms: Implications for Implementation of Future HIV Pre-Exposure Prophylaxis (PrEP) Interventions in Vancouver, Canada	PLOS ONE			English	Article							YOUNG MEN; ACCEPTABILITY; PREVENTION; SEX; EXPERIENCES	Background HIV Pre-Exposure Prophylaxis (PrEP) has been found to be efficacious in preventing HIV acquisition among seronegative individuals in a variety of risk groups, including men who have sex with men and people who inject drugs. To date, however, it remains unclear how socio-cultural norms (e.g., attitudes towards HIV; social understandings regarding HIV risk practices) may influence the scalability of future PrEP interventions. The objective of this study is to assess how socio-cultural norms may influence the implementation and scalability of future HIV PrEP interventions in Vancouver, Canada. Methods We conducted 50 interviews with young men (ages 18-24) with a variety of HIV risk behavioural profiles (e.g., young men who inject drugs; MSM). Interviews focused on participants' experiences and perceptions with various HIV interventions and policies, including PrEP. Results While awareness of PrEP was generally low, perceptions about the potential personal and public health gains associated with PrEP were interconnected with expressions of complex and sometimes conflicting social norms. Some accounts characterized PrEP as a convenient form of reliable protection against HIV, likening it to the female birth control pill. Other accounts cast PrEP as a means to facilitate 'socially unacceptable' behaviour (e.g., promiscuity). Stigmatizing rhetoric was used to position PrEP as a tool that could promote some groups' proclivities to take 'risks'. Conclusion Stigma regarding 'risky' behaviour and PrEP should not be underestimated as a serious implementation challenge. Pre-implementation strategies that concomitantly aim to improve knowledge about PrEP, while addressing associated social prejudices, may be key to effective implementation and scale-up.	[Knight, Rod; Small, Will] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Knight, Rod; Small, Will] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Knight, Rod; Carson, Anna; Shoveller, Jean] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia	Shoveller, J (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	jean.shoveller@ubc.ca		Knight, Rod/0000-0002-1464-1584; Carson, Anna/0000-0002-6848-2937	Canadian Institutes of Health Research [HHP-123778, EPP-122906]; US National Institutes of Health [R01DA033147, R01DA028532, U01DA038886]; Post-Doctoral Fellowship from CIHR; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033147, U01DA038886, R01DA028532] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Post-Doctoral Fellowship from CIHR; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Canadian Institutes of Health Research (HHP-123778 and EPP-122906) and the US National Institutes of Health (R01DA033147, R01DA028532, U01DA038886). Knight is supported by a Post-Doctoral Fellowship from CIHR and the Michael Smith Foundation for Health Research. Small is supported by a Career Scholar Award from the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Barry D, 2011, J Int AIDS Soc, V14 Suppl 2, pS2, DOI 10.1186/1758-2652-14-S2-S2; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Berg RC, 2013, SOC SCI MED, V78, P61, DOI 10.1016/j.socscimed.2012.11.033; British Columbia Center for Excellence in HIV/AIDS (BCCfE), 2015, GUID US PREEXP PROPH; British Columbia Centre for (BCCDC), 2015, BCCDC HIV ANN REP 20; British Columbia. Provincial Health Officer, 2014, HIV STIGM SOC TACKL; Calabrese SK, 2015, AM J PUBLIC HEALTH, V105, P1960, DOI 10.2105/AJPH.2015.302816; Canadian AIDS Treatment Information Exchange (CATIE), 2015, FACT SHEET PREEXP PR; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Escudero DJ, 2015, AIDS BEHAV, V19, P752, DOI 10.1007/s10461-014-0867-z; Galindo GR, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-116; Gilbert M, HLTH LITERACY SEXUAL; Glaser B.G., 1968, DISCOV GROUNDED THEO; Hightow-Weidman LB, 2012, AIDS CARE, V24, P910, DOI 10.1080/09540121.2011.647677; Holt M, 2015, CULT HEALTH SEX, V17, P428, DOI 10.1080/13691058.2014.960003; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Johnson W. D., 2008, COCHRANE DATABASE SY, V3; Kain T, 2013, P INT ASS PROV AIDS; Knight R., 2015, HEALTH; Knight R, 2013, CRIT PUBLIC HEALTH, V24, P283; Knight R, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-54; Knight R, 2013, HEALTH-LONDON, V17, P441, DOI 10.1177/1363459312464071; Knight R, 2012, SOCIOL HEALTH ILL, V34, P1246, DOI 10.1111/j.1467-9566.2012.01471.x; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Lopez LM, 2013, COCHRANE DATABASE SY, V10; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Moreno R, 2014, COCHRANE DATABASE SY, V7; Musschenga AW, 2005, J MED PHILOS, V30, P467, DOI 10.1080/03605310500253030; Ontario HIV Treatment Network (OHTN), 2013, RAP REV 75 GAY MENS; Rodger A, 2014, P 21 C RETR OPP INF; Saberi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050061; Sachdev DD, 2014, CLIN INFECT DIS, V58, P1786, DOI 10.1093/cid/ciu229; Shoveller JA, 2010, SOCIOL HEALTH ILL, V32, P57, DOI 10.1111/j.1467-9566.2009.01222.x; Wood E, 2006, HARM REDUCT J, V3, P18, DOI DOI 10.1186/1477-7517-3-18; Young I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005717; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Young I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064038	37	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146513	10.1371/journal.pone.0146513	http://dx.doi.org/10.1371/journal.pone.0146513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CG	26756474	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800014
J	Pollock, KM; Montamat-Sicotte, DJ; Grass, L; Cooke, GS; Kapembwa, MS; Kon, OM; Sampson, RD; Taylor, GP; Lalvani, A				Pollock, Katrina M.; Montamat-Sicotte, Damien J.; Grass, Lisa; Cooke, Graham S.; Kapembwa, Moses S.; Kon, Onn M.; Sampson, Robert D.; Taylor, Graham P.; Lalvani, Ajit			PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; CELL-BASED ASSAY; PROGRAMMED DEATH-1; ANTIRETROVIRAL THERAPY; LATENT TUBERCULOSIS; INFECTION; RESPONSES; DISEASE; CD4(+); COHORT	HIV co-infection is an important risk factor for tuberculosis (TB) providing a powerful model in which to dissect out defective, protective and dysfunctional Mycobacterium tuberculosis (MTB)-specific immune responses. To identify the changes induced by HIV co-infection we compared MTB-specific CD4+ responses in subjects with active TB and latent TB infection (LTBI), with and without HIV co-infection. CD4+ T-cell subsets producing interferon-gamma (IFN-gamma), interleukin-2 (IL-2) and tumour necrosis factor-alpha (TNF-alpha) and expressing CD279 (PD-1) were measured using polychromatic flow-cytometry. HIV-TB co-infection was consistently and independently associated with a reduced frequency of CD4+ IFN-gamma and IL-2-dual secreting T-cells and the proportion correlated inversely with HIV viral load (VL). The impact of HIV co-infection on this key MTB-specific T-cell subset identifies them as a potential correlate of mycobacterial immune containment. The percentage of MTB-specific IFN-gamma-secreting T-cell subsets that expressed PD-1 was increased in active TB with HIV co-infection and correlated with VL. This identifies a novel correlate of dysregulated immunity to MTB, which may in part explain the paucity of inflammatory response in the face of mycobacterial dissemination that characterizes active TB with HIV co-infection.	[Pollock, Katrina M.; Montamat-Sicotte, Damien J.; Grass, Lisa; Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, TB Res Ctr, Resp Infect Sect, Natl Heart & Lung Inst, London, England; [Cooke, Graham S.; Taylor, Graham P.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, London, England; [Kapembwa, Moses S.] North West London Hosp NHS Trust, Dept GU & HIV Med, London, England; [Kon, Onn M.] Imperial Coll Healthcare Trust, St Marys Hosp, TB Serv, London, England; [Sampson, Robert D.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, Flow Cytometry Facil, Natl Heart & Lung Inst, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Pollock, KM (corresponding author), Univ London Imperial Coll Sci Technol & Med, TB Res Ctr, Resp Infect Sect, Natl Heart & Lung Inst, London, England.	k.pollock@imperial.ac.uk		Pollock, Katrina/0000-0001-9513-5183; Sampson, Robert/0000-0003-1983-9589; Kon, Onn Min/0000-0003-2647-4688; Lalvani, Ajit/0000-0002-2396-246X	British Lung Foundation [TB0802]; NIHR Imperial Comprehensive Biomedical Research Centre; National Institute for Health Research [CL-2013-21-004, NF-SI-0513-10155] Funding Source: researchfish	British Lung Foundation; NIHR Imperial Comprehensive Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by a TB Funds grant from the British Lung Foundation (https://www.blf.org.uk/Home) TB0802. Ajit Lalvani is an NIHR Senior Investigator and Wellcome Trust Senior Research Fellow in Clinical Science. The research was supported by the NIHR Imperial Comprehensive Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Casey R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015619; Cockerham LR, 2014, AIDS, V28, P1749, DOI 10.1097/QAD.0000000000000314; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Day CL, 2013, AM J RESP CRIT CARE, V188, P492, DOI 10.1164/rccm.201208-1385OC; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Dosanjh DPS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028754; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Gooding Sarah, 2007, J Infect, V54, pe169, DOI 10.1016/j.jinf.2006.11.002; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Houben RMGJ, 2011, INT J TUBERC LUNG D, V15, P24; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Lalvani A, 2008, J INFECT DIS, V197, P941, DOI 10.1086/529049; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Leroux-Roels I, 2013, VACCINE, V31, P2196, DOI 10.1016/j.vaccine.2012.05.035; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Liu XQ, 2004, INFECT IMMUN, V72, P2574, DOI 10.1128/IAI.72.5.2574-2581.2004; Mahnke YD, 2012, BLOOD, V119, P3105, DOI 10.1182/blood-2011-09-380840; Matthews K, 2012, EUR J IMMUNOL, V42, P147, DOI 10.1002/eji.201141927; Mattila JT, 2011, J IMMUNOL, V186, P3527, DOI 10.4049/jimmunol.1003773; Millington KA, 2011, P NATL ACAD SCI USA, V108, P5730, DOI 10.1073/pnas.1015153108; Jurado JO, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17428; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Petrovas C, 2009, J IMMUNOL, V183, P1120, DOI 10.4049/jimmunol.0900182; Pollock KM, 2015, IMMUN INFLAMM DIS, V3, P141, DOI 10.1002/iid3.50; Pollock KM, 2013, J INFECT DIS, V208, P952, DOI 10.1093/infdis/jit265; Pollock KM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000762; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Saeidi A, 2015, CELL IMMUNOL, V297, P19, DOI 10.1016/j.cellimm.2015.05.005; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	49	19	20	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146905	10.1371/journal.pone.0146905	http://dx.doi.org/10.1371/journal.pone.0146905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756579	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800035
J	Pouly, D; Chenaux, S; Martin, V; Babis, M; Koch, R; Nagoshi, E; Katanaev, VL; Gachon, F; Staub, O				Pouly, Daniel; Chenaux, Sebastien; Martin, Virginie; Babis, Maja; Koch, Rafael; Nagoshi, Emi; Katanaev, Vladimir L.; Gachon, Frederic; Staub, Olivier			USP2-45 Is a Circadian Clock Output Effector Regulating Calcium Absorption at the Post-Translational Level	PLOS ONE			English	Article							UBIQUITIN-SPECIFIC PROTEASE; N-TERMINAL SEQUENCES; DEUBIQUITINATING ENZYME; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; DROSOPHILA CLOCK; TRANSCRIPTION; MOUSE; DEUBIQUITYLATION; METABOLISM	The mammalian circadian clock influences most aspects of physiology and behavior through the transcriptional control of a wide variety of genes, mostly in a tissue-specific manner. About 20 clock-controlled genes (CCGs) oscillate in virtually all mammalian tissues and are generally considered as core clock components. One of them is Ubiquitin-Specific Protease 2 (Usp2), whose status remains controversial, as it may be a cogwheel regulating the stability or activity of core cogwheels or an output effector. We report here that Usp2 is a clock output effector related to bodily Ca2+ homeostasis, a feature that is conserved across evolution. Drosophila with a whole-body knockdown of the orthologue of Usp2, CG14619 (dUsp2-kd), predominantly die during pupation but are rescued by dietary Ca2+ supplementation. Usp2-KO mice show hyperabsorption of dietary Ca2+ in small intestine, likely due to strong overexpression of the membrane scaffold protein NHERF4, a regulator of the Ca2+ channel TRPV6 mediating dietary Ca2+ uptake. In this tissue, USP2-45 is found in membrane fractions and negatively regulates NHERF4 protein abundance in a rhythmic manner at the protein level. In clock mutant animals (Cry1/Cry2-dKO), rhythmic USP2-45 expression is lost, as well as the one of NHERF4, confirming the inverse relationship between USP2-45 and NHERF4 protein levels. Finally, USP2-45 interacts in vitro with NHERF4 and endogenous Clathrin Heavy Chain. Taken together these data prompt us to define USP2-45 as the first clock output effector acting at the post-translational level at cell membranes and possibly regulating membrane permeability of Ca2+.	[Pouly, Daniel; Chenaux, Sebastien; Martin, Virginie; Babis, Maja; Katanaev, Vladimir L.; Gachon, Frederic; Staub, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Koch, Rafael; Nagoshi, Emi] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland; [Gachon, Frederic] Nestle Inst Hlth Sci, Dept Diabet & Circadian Rhythms, CH-1015 Lausanne, Switzerland; [Staub, Olivier] Natl Ctr Competence Res Kidney Ch, Zurich, Switzerland	University of Lausanne; University of Geneva; Nestle SA	Staub, O (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	olivier.staub@unil.ch	Katanaev, Vladimir/F-9480-2014; Gachon, Frédéric/H-3111-2019; POULY, Daniel/L-2612-2017	Katanaev, Vladimir/0000-0002-7909-5617; Gachon, Frédéric/0000-0002-9279-9707; POULY, Daniel/0000-0002-6345-2421; Koch, Rafael/0000-0001-6105-2638; Nagoshi, Emi/0000-0002-6365-4074	Swiss National Science Foundation [310030_141013/1, 31003A_138350, 31003A_130387]; NCCR Kidney; European Research Council [ERC-2010-StG-260988, ERC-StG-311194]; COST Action [ADMIRE BM1301]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Kidney; European Research Council(European Research Council (ERC)European Commission); COST Action(European Cooperation in Science and Technology (COST))	This work was supported by: Swiss National Science Foundation: www.snf.ch, Grant 310030_141013/1 to OS, Grant 31003A_138350 to VLK, Grant 31003A_130387 to EN; Grant NCCR Kidney.ch; the European Research Council: http://erc.europa.eu/, ERC-2010-StG-260988 to FG, ERC-StG-311194 to EN; and COST Action ADMIRE BM1301 to OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Baek SH, 1998, BIOCHEM J, V334, P677, DOI 10.1042/bj3340677; Bedard N, 2011, BIOL REPROD, V85, P594, DOI 10.1095/biolreprod.110.088542; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Brenza HL, 1998, P NATL ACAD SCI USA, V95, P1387, DOI 10.1073/pnas.95.4.1387; Bur IM, 2009, J BIOL CHEM, V284, P9066, DOI 10.1074/jbc.M808360200; Burkeen JF, 2011, J NEUROSCI, V31, P8432, DOI 10.1523/JNEUROSCI.6576-10.2011; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Enoki R, 2012, P NATL ACAD SCI USA, V109, P21498, DOI 10.1073/pnas.1214415110; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Faresse N, 2013, CELL PHYSIOL BIOCHEM, V31, P462, DOI 10.1159/000343382; Firsov D, 2010, KIDNEY INT, V78, P640, DOI 10.1038/ki.2010.227; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Halbritter J, 2015, J AM SOC NEPHROL, V26, P543, DOI 10.1681/ASN.2014040388; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Kim HJ, 2007, BIOCHEM BIOPH RES CO, V361, P433, DOI 10.1016/j.bbrc.2007.07.027; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lin HJ, 2000, MOL CELL BIOL, V20, P6568, DOI 10.1128/MCB.20.17.6568-6578.2000; Lin HJ, 2001, J BIOL CHEM, V276, P20357, DOI 10.1074/jbc.M008761200; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Liu Z, 2013, ONCOGENE, V32, P1660, DOI 10.1038/onc.2012.188; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; Luo WF, 2012, GENE DEV, V26, P2536, DOI 10.1101/gad.200584.112; Marpegan L, 2011, J NEUROSCI, V31, P8342, DOI 10.1523/JNEUROSCI.6537-10.2011; Miles RR, 2002, J CELL BIOCHEM, V85, P229, DOI 10.1002/jcb.10129; Moe OW, 2005, J AM SOC NEPHROL, V16, P729, DOI 10.1681/ASN.2004100888; Molusky MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047970; Molusky MM, 2012, DIABETES, V61, P1025, DOI 10.2337/db11-0970; Nijenhuis T, 2005, PFLUG ARCH EUR J PHY, V451, P181, DOI 10.1007/s00424-005-1430-6; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; PAK CYC, 1980, AM J MED, V69, P19, DOI 10.1016/0002-9343(80)90495-7; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PARFITT AM, 1974, BMJ-BRIT MED J, V1, P520, DOI 10.1136/bmj.1.5906.520; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Pike JW, 2011, MOL CELL ENDOCRINOL, V347, P3, DOI 10.1016/j.mce.2011.05.012; Pouly D, 2013, AM J PHYSIOL-RENAL, V305, pF21, DOI 10.1152/ajprenal.00012.2013; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Rougier JS, 2015, PFLUG ARCH EUR J PHY, V467, P1919, DOI 10.1007/s00424-014-1636-6; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Scoma HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025382; Shin YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027742; Stojkovic K, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00069; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tsou WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043112; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; WROBEL J, 1979, EXPERIENTIA, V35, P1581; WROBEL J, 1981, Acta Physiologica Polonica, V32, P407; WROBEL J, 1983, CALCIFIED TISSUE INT, V35, P352, DOI 10.1007/BF02405057; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang YM, 2014, J BIOL RHYTHM, V29, P243, DOI 10.1177/0748730414544741; Yang YM, 2012, BIOL OPEN, V1, P789, DOI 10.1242/bio.20121990; Young ME, 2014, J BIOL RHYTHM, V29, P257, DOI 10.1177/0748730414543141; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zierold C, 2001, P NATL ACAD SCI USA, V98, P13572, DOI 10.1073/pnas.241516798	74	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0145155	10.1371/journal.pone.0145155	http://dx.doi.org/10.1371/journal.pone.0145155			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756164	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800002
J	Arai, Y; Fukukawa, H; Atozi, T; Matsumoto, S; Hanazono, Y; Nagashima, H; Ohgane, J				Arai, Yoshikazu; Fukukawa, Hisho; Atozi, Takanori; Matsumoto, Shoma; Hanazono, Yutaka; Nagashima, Hiroshi; Ohgane, Jun			Ultra-Deep Bisulfite Sequencing to Detect Specific DNA Methylation Patterns of Minor Cell Types in Heterogeneous Cell Populations: An Example of the Pituitary Tissue	PLOS ONE			English	Article							HIGH-THROUGHPUT; STEM-CELLS; GENOME; GENE; IDENTIFICATION; PROFILES; PROTOCOL; DOMAIN; MOUSE	DNA methylation is an epigenetic modification important for cell fate determination and cell type-specific gene expression. Transcriptional regulatory regions of the mammalian genome contain a large number of tissue/cell type-dependent differentially methylated regions (T-DMRs) with DNA methylation patterns crucial for transcription of the corresponding genes. In general, tissues consist of multiple cell types in various proportions, making it difficult to detect T-DMRs of minor cell types in tissues. The present study attempts to detect T-DMRs of minor cell types in tissues by ultra-deep bisulfite sequencing of cell type-restricted genes and to assume proportions of minor cell types based on DNA methylation patterns of sequenced reads. For this purpose, we focused on transcriptionally active hypomethylated alleles (Hypo-alleles), which can be recognized by the high ratio of unmethylated CpGs in each sequenced read (allele). The pituitary gland contains multiple cell types including five hormone-expressing cell types and stem/progenitor cells, each of which is a minor cell type in the pituitary tissue. By ultra-deep sequencing of more than 100 reads for detection of Hypo-alleles in pituitary cell type-specific genes, we identified T-DMRs specific to hormone-expressing cells and stem/progenitor cells and used them to estimate the proportions of each cell type based on the Hypo-allele ratio in pituitary tissue. Therefore, introduction of the novel Hypo-allele concept enabled us to detect T-DMRs of minor cell types with estimation of their proportions in the tissue by ultra-deep bisulfite sequencing.	[Arai, Yoshikazu; Fukukawa, Hisho; Atozi, Takanori; Matsumoto, Shoma; Ohgane, Jun] Meiji Univ, Sch Agr, Dept Life Sci, Lab Genom Funct Engn, Kawasaki, Kanagawa, Japan; [Hanazono, Yutaka] Jichi Med Univ, Ctr Mol Med, Div Regenerat Med, Shimotsuke, Tochigi, Japan; [Hanazono, Yutaka] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Nagashima, Hiroshi] Meiji Univ, Sch Agr, Dept Life Sci, Lab Dev Engn, Kawasaki, Kanagawa, Japan; [Nagashima, Hiroshi] MUIIBR, Kawasaki, Kanagawa, Japan	Meiji University; Jichi Medical University; Japan Science & Technology Agency (JST); Meiji University	Ohgane, J (corresponding author), Meiji Univ, Sch Agr, Dept Life Sci, Lab Genom Funct Engn, Kawasaki, Kanagawa, Japan.	johgane@meiji.ac.jp	Ohgane, Jun/AAV-3548-2020	Matsumoto, Shoma/0000-0002-8662-4636; Nagashima, Hiroshi/0000-0001-9940-8783	Ministry of Education, Culture, Sports, Science and Technology of Japan [22710181]; MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan) [S1411021]; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency [15gm0210004h0115]; Meiji University International Institute for Bio-Resource Research (MUIIBR)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Meiji University International Institute for Bio-Resource Research (MUIIBR)	Financial support for this study was provided by a Grant-in Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22710181 to JO, https://www.jsps.go.jp/english/index.html), MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan)-Supported Program for the Strategic Research Foundation at Private Universities (S1411021 to JO, http://www.mext.go.jp/english/), Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (15gm0210004h0115 to YH and HN, http://www.jst.go.jp/kisoken/crest/en/index.html), and Meiji University International Institute for Bio-Resource Research (MUIIBR) (to HN, http://muiibr.com/english/index.html).	Arai Y, 2013, GENESIS, V51, P763, DOI 10.1002/dvg.22423; BENJONATHAN N, 1983, METHOD ENZYMOL, V103, P249; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; FEIL R, 1994, NUCLEIC ACIDS RES, V22, P695, DOI 10.1093/nar/22.4.695; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Ikegami K, 2009, INT J DEV BIOL, V53, P203, DOI 10.1387/ijdb.082741ki; Imamura T, 2001, GENOMICS, V76, P117, DOI 10.1006/geno.2001.6607; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Lieb JD, 2006, CYTOGENET GENOME RES, V114, P1, DOI 10.1159/000091922; Morrill BH, 2013, J REPROD DEVELOP, V59, P314, DOI 10.1262/jrd.2012-144; Ohgane J, 2008, PLACENTA, V29, pS29, DOI 10.1016/j.placenta.2007.09.011; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Sakamoto H, 2007, GENES CELLS, V12, P1123, DOI 10.1111/j.1365-2443.2007.01120.x; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Shiota K, 2004, CYTOGENET GENOME RES, V105, P325, DOI 10.1159/000078205; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Vankelecom H, 2010, GEN COMP ENDOCR, V166, P478, DOI 10.1016/j.ygcen.2009.11.007; Weng XL, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-31; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	26	5	5	0	382	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146498	10.1371/journal.pone.0146498	http://dx.doi.org/10.1371/journal.pone.0146498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752725	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100088
J	Gil-Santana, L; Almeida, JL; Oliveira, CAM; Hickson, LS; Daltro, C; Castro, S; Kornfeld, H; Netto, EM; Andrade, BB				Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Oliveira, Carolina A. M.; Hickson, Lucas S.; Daltro, Carla; Castro, Simone; Kornfeld, Hardy; Netto, Eduardo M.; Andrade, Bruno B.			Diabetes Is Associated with Worse Clinical Presentation in Tuberculosis Patients from Brazil: A Retrospective Cohort Study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MELLITUS; RISK; PREVALENCE; IMAGES	Background The rising prevalence of diabetes mellitus (DM) worldwide, especially in developing countries, and the persistence of tuberculosis (TB) as a major public health issue in these same regions, emphasize the importance of investigating this association. Here, we compared the clinical profile and disease outcomes of TB patients with or without coincident DM in a TB reference center in Brazil. Methods We performed a retrospective analysis of a TB patient cohort (treatment naive) of 408 individuals recruited at a TB primary care center in Brazil between 2004 and 2010. Data on diagnosis of TB and DM were used to define the groups. The study groups were compared with regard to TB disease presentation at diagnosis as well as to clinical outcomes such as cure and mortality rates upon anti-tuberculosis therapy (ATT) initiation. A composite score utilizing clinical, radiological and microbiological parameters was used to compare TB severity between the groups. Results DM patients were older than non-diabetic TB patients. In addition, diabetic individuals more frequently presented with cough, night sweats, hemoptysis and malaise than those without DM. The overall pattern of lung lesions assessed by chest radiographic examination was similar between the groups. Compared to non-diabetic patients, those with TB-diabetes exhibited positive acid-fast bacilli in sputum samples more frequently at diagnosis and at 30 days after ATT initiation. Notably, higher values of the TB severity score were significantly associated with TB-diabetes comorbidity after adjustment for confounding factors. Moreover, during ATT, diabetic patients required more frequent transfers to TB reference hospitals for complex clinical management. Nevertheless, overall mortality and cure rates were indistinguishable between the study groups. Conclusions These findings reinforce the idea that diabetes negatively impacts pulmonary TB severity. Our study argues for the systematic screening for DM in TB reference centers in endemic areas.	[Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Andrade, Bruno B.] Fundacao Oswaldo Cruz, Unidade Med Invest, Lab Integrad Microbiol & Imunorregulacao, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Andrade, Bruno B.] Fac Tecnol & Ciencias, Sch Med, Salvador, BA, Brazil; [Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Andrade, Bruno B.] Fundacao Jose Silveira, Multinat Org Network Sponsoring Translat & Epidem, Salvador, BA, Brazil; [Oliveira, Carolina A. M.; Hickson, Lucas S.; Castro, Simone; Netto, Eduardo M.; Andrade, Bruno B.] Fundacao Jose Silveira, Res Ctr, IBIT, Salvador, BA, Brazil; [Daltro, Carla; Netto, Eduardo M.] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil; [Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; University of Massachusetts System; University of Massachusetts Worcester	Andrade, BB (corresponding author), Fundacao Oswaldo Cruz, Unidade Med Invest, Lab Integrad Microbiol & Imunorregulacao, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.	bruno.andrade@bahia.fiocruz.br	Andrade, Bruno/AAI-2248-2020; Kornfeld, Hardy/AAS-2903-2021; Netto, Eduardo/D-1432-2013	Netto, Eduardo/0000-0003-1691-6761	Intramural Research Program of the Fundacao Oswaldo Cruz (FIOCRUZ); FIOCRUZ; Indo-US Vaccine Action program [USB1-31149-XX-13]	Intramural Research Program of the Fundacao Oswaldo Cruz (FIOCRUZ); FIOCRUZ; Indo-US Vaccine Action program	This study was supported by the Intramural Research Program of the Fundacao Oswaldo Cruz (FIOCRUZ). LG-S and JLA-S receive scientific initiation fellowships from FIOCRUZ. The work of HK was supported by a grant from the Indo-US Vaccine Action program (USB1-31149-XX-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; American Diabetes Society, 2015, DIAGN DIAB LEARN PRE; Andrade BB, 2014, CHEST, V145, P1244, DOI 10.1378/chest.13-1799; Baghaei P, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-58; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Bashar M, 2001, CHEST, V120, P1514, DOI 10.1378/chest.120.5.1514; Borekci S, 2015, RESPIRATION, V90, P191, DOI 10.1159/000434684; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; Chiang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121698; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Gray JM, 2013, SEMIN RESP CRIT CARE, V34, P32, DOI 10.1055/s-0032-1333469; Gupta Soham, 2011, J Infect Public Health, V4, P140, DOI 10.1016/j.jiph.2011.03.005; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129; MALERBI DA, 1992, DIABETES CARE, V15, P1509, DOI 10.2337/diacare.15.11.1509; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Ministerio da Saude Brasil, 2002, PROGR NAC CONTR TUB; Narayan Shyam, 2003, Indian Journal of Pediatrics, V70, P467, DOI 10.1007/BF02723134; Pedrozo C, 2009, INT J TUBERC LUNG D, V13, P413; Perez-Guzman C, 2000, AM J RESP CRIT CARE, V162, P1738, DOI 10.1164/ajrccm.162.5.2001040; Perez-Guzman C, 2001, INT J TUBERC LUNG D, V5, P455; Probst-Hensch NM, 2010, SWISS MED WKLY, V140, P26, DOI 10.4414/smw.2010.13072; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Reis-Santos B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100082; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Slatery E, 2014, NEGLECTED NONCOMPLIA; Suleiman SAS, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/645362; Uplekar MW, 2001, INT J TUBERC LUNG D, V5, P220; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2014, GLOB TUB REP; World Health Organization International Union against Tuberculosis and Lung Disease, 2011, COLL FRAM CAR CONTR	34	30	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146876	10.1371/journal.pone.0146876	http://dx.doi.org/10.1371/journal.pone.0146876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752596	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100170
J	Hardion, L; Leriche, A; Schwoertzig, E; Millon, A				Hardion, Laurent; Leriche, Agathe; Schwoertzig, Eugenie; Millon, Alexandre			Species Distribution 2.0: An Accurate Time- and Cost-Effective Method of Prospection Using Street View Imagery	PLOS ONE			English	Article							INVASIONS; POACEAE	Species occurrence data provide crucial information for biodiversity studies in the current context of global environmental changes. Such studies often rely on a limited number of occurrence data collected in the field and on pseudo-absences arbitrarily chosen within the study area, which reduces the value of these studies. To overcome this issue, we propose an alternative method of prospection using geo-located street view imagery (SVI). Following a standardised protocol of virtual prospection using both vertical (aerial photographs) and horizontal (SVI) perceptions, we have surveyed 1097 randomly selected cells across Spain (0.1x0.1 degree, i.e. 20% of Spain) for the presence of Arundo donax L. (Poaceae). In total we have detected A. donax in 345 cells, thus substantially expanding beyond the now twocenturies- old field-derived record, which described A. donax only 216 cells. Among the field occurrence cells, 81.1% were confirmed by SVI prospection to be consistent with species presence. In addition, we recorded, by SVI prospection, 752 absences, i.e. cells where A. donax was considered absent. We have also compared the outcomes of climatic niche modeling based on SVI data against those based on field data. Using generalized linear models fitted with bioclimatic predictors, we have found SVI data to provide far more compelling results in terms of niche modeling than does field data as classically used in SDM. This original, cost-and time-effective method provides the means to accurately locate highly visible taxa, reinforce absence data, and predict species distribution without long and expensive in situ prospection. At this time, the majority of available SVI data is restricted to human-disturbed environments that have road networks. However, SVI is becoming increasingly available in natural areas, which means the technique has considerable potential to become an important factor in future biodiversity studies.	[Hardion, Laurent; Leriche, Agathe; Millon, Alexandre] Avignon Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, CNRS, Aix Marseille Univ,IRD, F-13331 Marseille, France; [Hardion, Laurent; Schwoertzig, Eugenie] Univ Strasbourg, CNRS, LIVE, F-67000 Strasbourg, France	Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hardion, L (corresponding author), Avignon Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, CNRS, Aix Marseille Univ,IRD, F-13331 Marseille, France.	laurent.hardion@live-cnrs.unistra.fr; agathe.leriche@imbe.fr	Leriche, Agathe/C-3151-2008; Millon, Alexandre/R-6464-2017; Millon, Alexandre/AAF-8624-2020	Leriche, Agathe/0000-0001-9646-5344; Millon, Alexandre/0000-0002-9475-4123; Millon, Alexandre/0000-0002-9475-4123; Hardion, Laurent/0000-0002-4574-6354	Aix-Marseille university; French Ministry of Higher Education and Research	Aix-Marseille university; French Ministry of Higher Education and Research	LH was supported by a doctoral grant funded by Aix-Marseille university and the French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Beck J, 2014, ECOL INFORM, V19, P10, DOI 10.1016/j.ecoinf.2013.11.002; Christen D, 2006, CONSERV BIOL, V20, P385, DOI 10.1111/j.1523-1739.2006.00315.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Finnie TJR, 2007, J BIOGEOGR, V34, P1848, DOI 10.1111/j.1365-2699.2007.01750.x; Goodwin ZA, 2015, CURR BIOL, V25, pR1066, DOI 10.1016/j.cub.2015.10.002; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hardion L, 2014, ANN BOT-LONDON, V114, P455, DOI 10.1093/aob/mcu143; Hardion L, 2012, TAXON, V61, P1217, DOI 10.1002/tax.616004; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054861; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Olea PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054582; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Rousselet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074918; Serra Laliga L, 2007, THESIS; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Wijte AHBM, 2005, INT J PLANT SCI, V166, P507, DOI 10.1086/428915; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124	28	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146899	10.1371/journal.pone.0146899	http://dx.doi.org/10.1371/journal.pone.0146899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751565	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100176
J	Ishikawa, T; Abe, S; Hoshii, A; Yamada, Y; Iiduka, A; Nemoto, T; Takeda, K; Yoshida, T				Ishikawa, Toru; Abe, Satoshi; Hoshii, Asami; Yamada, Yumi; Iiduka, Akihiko; Nemoto, Takeo; Takeda, Keiko; Yoshida, Toshiaki			Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION	Background & Aims The amount of drug-loaded lipiodol in an HCC tumor post-transarterial chemoembolization (TACE) correlates with the risk of local tumor recurrence. Lipiodol enhancement of a tumor on conventional CT, measured in Hounsfield units (HU), can predict tumor response. Here we investigate whether cone-beam CT (CBCT) can also be used to predict tumor response, providing the benefit of being able to optimize the patient's treatment plan intra-procedurally. Methods A total of 82 HCC nodules (82 patients), <= 5 cm in diameter, were treated with balloon-occluded TACE using miriplatin between December 2013 and November 2014. For each patient, both CBCT and conventional CT images were obtained post-TACE. The degree of correlation between CBCT and conventional CT was determined by comparing identical regions of interest for each imaging modality using pixel values. Results The pixel values from conventional CT and CBCT were highly correlated, with a Pearson correlation coefficient of 0.912 (p< 0.001). The location of the nodules within the liver did not affect the results; the correlation coefficient was 0.891 (p< 0.001) for the left lobe and 0.926 (p< 0.001) for the right lobe. The mean pixel value for conventional CT was 439 +/- 279 HU, and the mean pixel value for CBCT was 416 +/- 311 HU. Conclusions CBCT may be used as a substitute for conventional CT to quantitatively evaluate the amount of drug-loaded lipiodol within an HCC nodule and, hence, the efficacy of TACE treatment. The major benefit of using CBCT is the ability to predict the likelihood of local recurrence intra-procedurally, enabling subsequent treatment optimization.	[Ishikawa, Toru; Abe, Satoshi; Yoshida, Toshiaki] Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata, Japan; [Hoshii, Asami; Yamada, Yumi; Iiduka, Akihiko] Saiseikai Niigata Daini Hosp, Dept Med Radiol, Niigata, Japan; [Nemoto, Takeo; Takeda, Keiko] Saiseikai Niigata Daini Hosp, Dept Radiol, Niigata, Japan		Ishikawa, T (corresponding author), Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata, Japan.	toruishi@ngt.saiseikai.or.jp						Imai N, 2012, JPN J CLIN ONCOL, V42, P175, DOI 10.1093/jjco/hyr189; Irie T, 2016, HEPATOL RES, V46, P209, DOI 10.1111/hepr.12564; Irie T, 2013, CARDIOVASC INTER RAD, V36, P706, DOI 10.1007/s00270-012-0476-z; Ishikawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083786; Iwazawa Jin, 2012, Cancer Manag Res, V4, P113, DOI 10.2147/CMAR.S30431; Kaneko S, 2012, HEPATOL RES, V42, P523, DOI 10.1111/j.1872-034X.2012.00981.x; Miyayama S, 2012, JPN J RADIOL, V30, P263, DOI 10.1007/s11604-011-0043-6; Miyayama S, 2011, JPN J RADIOL, V29, P371, DOI 10.1007/s11604-011-0568-8; Ogawa M, 2016, HEPATOL RES, V46, pE60, DOI 10.1111/hepr.12527; UCHIDA H, 1990, CARDIOVASC INTER RAD, V13, P140, DOI 10.1007/BF02575465; Wang ZJ, 2014, ACAD RADIOL, V21, P393, DOI 10.1016/j.acra.2013.11.006	11	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145546	10.1371/journal.pone.0145546	http://dx.doi.org/10.1371/journal.pone.0145546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752696	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100018
J	Joos, O; Amouzou, A; Silva, R; Banda, B; Park, L; Bryce, J; Kanyuka, M				Joos, Olga; Amouzou, Agbessi; Silva, Romesh; Banda, Benjamin; Park, Lois; Bryce, Jennifer; Kanyuka, Mercy		RMM Malawi Working Grp	Strengthening Community-Based Vital Events Reporting for Real-Time Monitoring of Under-Five Mortality: Lessons Learned from the Balaka and Salima Districts in Malawi	PLOS ONE			English	Article							HEALTH WORKERS; OPPORTUNITIES; REGISTRATION; SYSTEMS; CHILD	Background Malawi ratified a compulsory birth and death registration system in 2009. Until it captures complete coverage of vital events, Malawi relies on other data sources to calculate mortality estimates. We tested a community-based method to estimate annual under-five mortality rates (U5MR) through the Real-Time Monitoring of Under-Five Mortality (RMM) project in Malawi. We implemented RMM in two phases, and conducted an independent evaluation of phase one after 21 months of implementation. We present results of the phase two validation that covers the full project time span, and compare the results to those of the phase one validation. Methods and Findings We assessed the completeness of the counts of births and deaths and the accuracy of disaggregated U5MR from the community-based method against a retrospective full pregnancy history for rolling twelve-month periods after the independent evaluation. We used full pregnancy histories collected through household interviews carried out between November 2013 and January 2014 as the validation data source. Health Surveillance Agents (HSAs) across the 160 catchment areas submitted routine reports on pregnancies, births, and deaths consistently. However, for the 15-month implementation period post-evaluation, average completeness of birth event reporting was 76%, whereas average completeness of death event reporting was 67% relative to that expected from a comparable pregnancy history. HSAs underestimated the U5MR by an average of 21% relative to that estimated from a comparable pregnancy history. Conclusions On a medium scale, the community-based RMM method in Malawi produced substantial underestimates of annualized U5MR relative to those obtained from a full pregnancy history, despite the additional incentives and quality-control activities. We were not able to achieve an optimum level of incentive and support to make the system work while ensuring sustainability. Lessons learned from the implementation of RMM can inform programs supporting community-based interventions through HSAs in Malawi.	[Joos, Olga; Silva, Romesh; Park, Lois; Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD 21218 USA; [Amouzou, Agbessi] UNICEF, Div Policy & Practice, New York, NY USA; [Banda, Benjamin] World Food Program, Lilongwe, Malawi; [Kanyuka, Mercy] Malawi Natl Stat Off, Zomba, Malawi	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; UNICEF	Joos, O (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD 21218 USA.	ojoos1@jhu.edu		Joos, Olga/0000-0003-0335-4982; Hazel, Elizabeth A./0000-0002-9176-3278; Amouzou, Agbessi/0000-0002-6262-3866	Canadian Department of Foreign Affairs, Trade and Development; Institute for International Programs at Johns Hopkins Bloomberg School of Public Health; Malawi National Statistical Office of Malawi [7056791]	Canadian Department of Foreign Affairs, Trade and Development; Institute for International Programs at Johns Hopkins Bloomberg School of Public Health; Malawi National Statistical Office of Malawi	The RMM project was funded by Canadian Department of Foreign Affairs, Trade and Development, previously known as the Canadian International Development Agency. The Institute for International Programs at Johns Hopkins Bloomberg School of Public Health collaborated with the Malawi National Statistical Office of Malawi to conduct the work through the Real-Time Results Tracking grant (# 7056791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.international.gc.ca/international/index.aspx?lang=eng.	AbouZahr Carla, 2012, Pac Health Dialog, V18, P215; Allotey P, 2001, SOC SCI MED, V52, P1007, DOI 10.1016/S0277-9536(00)00207-0; Amouzou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088939; Amouzou A, 2013, TROP MED INT HEALTH, V18, P1231, DOI 10.1111/tmi.12167; Carter E, 2014, 63 ANN M AM SOC TROP; Crampin AC, 2012, INT J EPIDEMIOL, V41, P676, DOI 10.1093/ije/dys088; Gilroy KE, 2013, HEALTH POLICY PLANN, V28, P573, DOI 10.1093/heapol/czs095; Glenton C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010414.pub2; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; Jaskiewicz W, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-38; Kok MC, 2013, MALAWI MED J, V25, P5; Kubwalo K., 2012, MALAWI LAUNCH UNIVER; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; McCawBinns AM, 1996, INT J EPIDEMIOL, V25, P807, DOI 10.1093/ije/25.4.807; Ministry of Health Malawi, 2009, HLTH SURV ASS TRAIN; Mrisho M, 2008, T ROY SOC TROP MED H, V102, P669, DOI 10.1016/j.trstmh.2008.04.029; National Statistical Office Malawi, MAL POP CENS 2008; Ndawala J MV, 1994, AFR WORKSH STRAT ACC; NDONG I, 1994, INT J EPIDEMIOL, V23, P536, DOI 10.1093/ije/23.3.536; Singh P, 2013, ONE MILLION COMMUNIT; Smith S, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-24; UN DESA, 2010, STAT CIV REG VIT STA; UN Secretary General, GLOB STRAT WOM CHILD; WHO, 2011, KEEP PROM MEAS RES C; World Bank Group, 2014, CIV REG VIT STAT SCA; Zulu JM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-987	26	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0138406	10.1371/journal.pone.0138406	http://dx.doi.org/10.1371/journal.pone.0138406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752726	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100004
J	Nakajima, T; Vares, G; Wang, B; Nenoi, M				Nakajima, Tetsuo; Vares, Guillaume; Wang, Bing; Nenoi, Mitsuru			Chronic Intake of Japanese Sake Mediates Radiation-Induced Metabolic Alterations in Mouse Liver	PLOS ONE			English	Article							2ND MALIGNANT NEOPLASMS; GLUTATHIONE METABOLISM; CALORIE RESTRICTION; OXIDATIVE STRESS; X-IRRADIATION; RISK-FACTORS; BODY-WEIGHT; ALCOHOL; CANCER; SUPPLEMENTATION	Sake is a traditional Japanese alcoholic beverage that is gaining popularity worldwide. Although sake is reported to have beneficial health effects, it is not known whether chronic sake consumption modulates health risks due to radiation exposure or other factors. Here, the effects of chronic administration of sake on radiation-induced metabolic alterations in the livers of mice were evaluated. Sake (junmai-shu) was administered daily to female mice (C3H/He) for one month, and the mice were exposed to fractionated doses of X-rays (0.75 Gy/day) for the last four days of the sake administration period. For comparative analysis, a group of mice were administered 15% (v/v) ethanol in water instead of sake. Metabolites in the liver were analyzed by capillary electrophoresis-time-of-flight mass spectrometry one day following the last exposure to radiation. The metabolite profiles of mice chronically administered sake in combination with radiation showed marked changes in purine, pyrimidine, and glutathione (GSH) metabolism, which were only partially altered by radiation or sake administration alone. Notably, the changes in GSH metabolism were not observed in mice treated with radiation following chronic administration of 15% ethanol in water. Changes in several metabolites, including methionine and valine, were induced by radiation alone, but were not detected in the livers of mice who received chronic administration of sake. In addition, the chronic administration of sake increased the level of serum triglycerides, although radiation exposure suppressed this increase. Taken together, the present findings suggest that chronic sake consumption promotes GSH metabolism and anti-oxidative activities in the liver, and thereby may contribute to minimizing the adverse effects associated with radiation.	[Nakajima, Tetsuo; Vares, Guillaume; Wang, Bing; Nenoi, Mitsuru] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Nakajima, T (corresponding author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Chiba 260, Japan.	otetsu@nirs.go.jp	Vares, Guillaume/S-6530-2019	Vares, Guillaume/0000-0002-6191-9032; Nakajima, Tetsuo/0000-0001-6455-0122				Aguiar AS, 2004, BRAZ J MED BIOL RES, V37, P841, DOI 10.1590/S0100-879X2004000600009; Akahoshi M, 2003, HYPERTENS RES, V26, P965, DOI 10.1291/hypres.26.965; Akiba S, 2012, J RADIOL PROT, V32, P73, DOI 10.1088/0952-4746/32/1/73; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Arimoto-Kobayashi S, 1999, J AGR FOOD CHEM, V47, P221, DOI 10.1021/jf980685a; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Batra V, 2014, FOOD CHEM TOXICOL, V69, P46, DOI 10.1016/j.fct.2014.03.040; Christensen KE, 2010, J NUTR, V140, P1736, DOI 10.3945/jn.110.124917; Cruzat VF, 2014, NUTRITION, V30, P602, DOI 10.1016/j.nut.2013.10.019; Czeczot H, 2006, ACTA BIOCHIM POL, V53, P237; Deaciuc IV, 2005, HEPATOL RES, V31, P187, DOI 10.1016/j.hepres.2005.02.004; Donato F, 2002, AM J EPIDEMIOL, V155, P323, DOI 10.1093/aje/155.4.323; GHOSHAL AK, 1984, CARCINOGENESIS, V5, P1367, DOI 10.1093/carcin/5.10.1367; Goto T, 2015, J PROTEOME RES, V14, P1025, DOI 10.1021/pr501044k; Gu XS, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002110; Inoue M, 2005, BRIT J CANCER, V92, P182, DOI 10.1038/sj.bjc.6602277; Ishibashi Y, 2015, J BIOL CHEM; Iwasaki T, 2003, RADIAT RES, V159, P228, DOI 10.1667/0033-7587(2003)159[0228:SAOMON]2.0.CO;2; JOINER MC, 1986, INT J RADIAT BIOL, V49, P565; Kakazu E, 2007, J IMMUNOL, V179, P7137, DOI 10.4049/jimmunol.179.10.7137; Kakinuma S, 2012, MUTAT RES-FUND MOL M, V737, P43, DOI 10.1016/j.mrfmmm.2012.06.001; Khan N, 2010, CANCER LETT, V293, P133, DOI 10.1016/j.canlet.2009.12.013; Kharbanda KK, 2014, EXP MOL PATHOL, V97, P49, DOI 10.1016/j.yexmp.2014.05.006; Kim SR, 2014, J TOXICOL SCI, V39, P717, DOI 10.2131/jts.39.717; Lee HI, 2011, J FOOD SCI, V76, pT207, DOI 10.1111/j.1750-3841.2011.02385.x; Lee IJ, 2011, CANCER RES TREAT, V43, P24, DOI 10.4143/crt.2011.43.1.24; Lieber CS, 2003, ALCOHOL RES HEALTH, V27, P220; MARIJNEN YMT, 1989, ADV EXP MED BIOL, V253, P433; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; Masuo Y, 2009, ELECTROPHORESIS, V30, P1259, DOI 10.1002/elps.200900045; Mimura N, 2014, J BIOSCI BIOENG, V118, P406, DOI 10.1016/j.jbiosc.2014.04.006; Monobe M, 2002, J RADIAT RES, V43, P237, DOI 10.1269/jrr.43.237; Morganti AG, 2009, INT J RADIAT ONCOL, V74, P1501, DOI 10.1016/j.ijrobp.2008.10.089; Nakajima T, 2015, MED SCI MONITOR, V21, P1721, DOI 10.12659/MSM.893234; NCRP. (National council on radiation protection and measurements) Scientific Committee 1-17, 2011, NCRP REPORT; Nishikawa T, 2014, J HEPATOL, V60, P1203, DOI 10.1016/j.jhep.2014.02.014; Orman ES, 2013, J GASTROEN HEPATOL, V28, P77, DOI 10.1111/jgh.12030; PAUSCH J, 1972, BIOCHIM BIOPHYS ACTA, V258, P395, DOI 10.1016/0005-2744(72)90231-8; Phillips BJ, 2001, MUTAGENESIS, V16, P91, DOI 10.1093/mutage/16.2.91; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Puszyk WM, 2013, LAB INVEST, V93, P983, DOI 10.1038/labinvest.2013.94; Sayon-Orea C, 2011, NUTR REV, V69, P419, DOI 10.1111/j.1753-4887.2011.00403.x; SCHOTTENFELD D, 1979, CANCER, V43, P1962, DOI 10.1002/1097-0142(197905)43:5+<1962::AID-CNCR2820430703>3.0.CO;2-P; SCOTT MC, 1991, AGENTS ACTIONS, V32, P194, DOI 10.1007/BF01980873; Shang Y, 2014, INT J CANCER, V135, P1038, DOI 10.1002/ijc.28751; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091134; Takizawa Yukio, 2014, Radioisotopes, V63, P1; Travis LB, 2012, JNCI-J NATL CANCER I, V104, P357, DOI 10.1093/jnci/djr533; Vares G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106277; Weber G, 1976, Adv Enzyme Regul, V14, P3, DOI 10.1016/0065-2571(76)90005-4; Wood ME, 2012, J CLIN ONCOL, V30, P3734, DOI 10.1200/JCO.2012.41.8681; Wrenn DC, 2011, GYNECOL ONCOL, V122, P59, DOI 10.1016/j.ygyno.2011.03.007; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wynder E.L., 1978, CARCINOGENESIS COMPR, VVolume 2l, P59; Xiang JL, 2012, FOOD FUNCT, V3, P628, DOI 10.1039/c2fo10266h; Yamamoto H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-51; Yang L, 2012, LIFE SCI, V91, P389, DOI 10.1016/j.lfs.2012.08.003; Yoshida K, 1997, P NATL ACAD SCI USA, V94, P2615, DOI 10.1073/pnas.94.6.2615	58	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146730	10.1371/journal.pone.0146730	http://dx.doi.org/10.1371/journal.pone.0146730			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752639	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100143
J	Oinonen, S; Hyytiainen, K; Ahlvik, L; Laamanen, M; Lehtoranta, V; Salojarvi, J; Virtanen, J				Oinonen, Soile; Hyytiainen, Kari; Ahlvik, Lassi; Laamanen, Maria; Lehtoranta, Virpi; Salojarvi, Joona; Virtanen, Jarno			Cost-Effective Marine Protection - A Pragmatic Approach	PLOS ONE			English	Article							ATLANTIC SALMON FISHERY; BALTIC SEA; WATER-QUALITY; MANAGEMENT; FRAMEWORK; UNCERTAINTY; ECOSYSTEMS; KNOWLEDGE; NETWORKS; MODELS	This paper puts forward a framework for probabilistic and holistic cost-effectiveness analysis to provide support in selecting the least-cost set of measures to reach a multidimensional environmental objective. Following the principles of ecosystem-based management, the framework includes a flexible methodology for deriving and populating criteria for effectiveness and costs and analyzing complex ecological-economic trade-offs under uncertainty. The framework is applied in the development of the Finnish Programme of Measures (PoM) for reaching the targets of the EU Marine Strategy Framework Directive (MSFD). The numerical results demonstrate that substantial cost savings can be realized from careful consideration of the costs and multiple effects of management measures. If adopted, the proposed PoM would yield improvements in the state of the Baltic Sea, but the overall objective of the MSFD would not be reached by the target year of 2020; for various environmental and administrative reasons, it would take longer for most measures to take full effect.	[Oinonen, Soile; Lehtoranta, Virpi; Salojarvi, Joona] Finnish Environm Inst, Helsinki, Finland; [Hyytiainen, Kari] Univ Helsinki, Helsinki, Finland; [Oinonen, Soile; Ahlvik, Lassi; Virtanen, Jarno] Nat Resources Inst Finland, Helsinki, Finland; [Laamanen, Maria] Minist Environm, Helsinki, Finland	Finnish Environment Institute; University of Helsinki; Natural Resources Institute Finland (Luke)	Oinonen, S (corresponding author), Finnish Environm Inst, Helsinki, Finland.	Soile.M.Oinonen@ymparisto.fi		Hyytiainen, Kari/0000-0002-4366-0186; Ahlvik, Lassi/0000-0001-8357-6985	DEVOTES project (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status); European Union [308392]; ECA (Economics of Aquatic Foodwebs) project; Academy of Finland	DEVOTES project (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status); European Union(European Commission); ECA (Economics of Aquatic Foodwebs) project; Academy of Finland(Academy of Finland)	JS was supported by the DEVOTES project (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status), funded by the European Union under the 7th Framework Program 'The Ocean of Tomorrow' Theme (grant agreement no. 308392), and SO was supported by the ECA (Economics of Aquatic Foodwebs) project, funded by the Academy of Finland's Research Programme on Sustainable Governance of Aquatic Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlvik L, 2014, ENVIRON MODELL SOFTW, V55, P164, DOI 10.1016/j.envsoft.2014.01.027; Ahtiainen H., 2007, THESIS; Ahtiainen H., 2014, TEMANORD, V2014, P563, DOI [10.6027/TN2014-563, DOI 10.6027/TN2014-563]; Ahtiainen H, 2014, J ENVIRON ECON POLIC, V3, P278, DOI 10.1080/21606544.2014.901923; Ahtiainen H, 2013, MAR POLICY, V42, P20, DOI 10.1016/j.marpol.2013.01.011; Ahtiainen H, 2012, ECOL ECON, V83, P1, DOI 10.1016/j.ecolecon.2012.08.010; Atkins JP, 2011, MAR POLLUT BULL, V62, P215, DOI 10.1016/j.marpolbul.2010.12.012; Balana BB, 2011, ECOL ECON, V70, P1021, DOI 10.1016/j.ecolecon.2010.12.020; Berbel J, 2011, WATER RESOUR MANAG, V25, P623, DOI 10.1007/s11269-010-9717-6; Berg T, 2015, MAR POLLUT BULL, V96, P18, DOI 10.1016/j.marpolbul.2015.04.050; Borja A, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00072; Borja A, 2013, MAR POLLUT BULL, V76, P16, DOI 10.1016/j.marpolbul.2013.08.042; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Brouwer R, 2008, J ENVIRON PLANN MAN, V51, P597, DOI 10.1080/09640560802207860; Brouwer R, 2008, ENVIRON MODELL SOFTW, V23, P922, DOI 10.1016/j.envsoft.2007.10.006; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Elliott M, 2002, MAR POLLUT BULL, V44, pIII, DOI 10.1016/S0025-326X(02)00146-7; Elliott M, 2011, MAR POLLUT BULL, V62, P651, DOI 10.1016/j.marpolbul.2010.11.033; Haapasaari P, 2010, MAR POLICY, V34, P477, DOI 10.1016/j.marpol.2009.10.002; Hart R, 2003, ECOL ECON, V47, P79, DOI 10.1016/j.ecolecon.2002.09.002; Henrion M., 2013, ARXIV13042725; Hyytiainen K, 2013, ECOL ECON, V91, P69, DOI 10.1016/j.ecolecon.2013.04.001; Iho A, 2012, ECOL ECON, V77, P91, DOI 10.1016/j.ecolecon.2012.02.010; Jacobs S, 2015, ECOL MODEL, V295, P21, DOI 10.1016/j.ecolmodel.2014.08.024; Kelble CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070766; Kosenius AK, 2012, EC VALUATION E UNPUB; Kosenius AK, 2010, ECOL ECON, V69, P528, DOI 10.1016/j.ecolecon.2009.08.030; Kragt ME, 2013, WATER RESOUR ECON, V4, P1, DOI 10.1016/j.wre.2013.11.001; Kulmala S, 2007, FISH RES, V84, P368, DOI 10.1016/j.fishres.2006.11.029; Kulmala S, 2008, ECOL ECON, V64, P716, DOI 10.1016/j.ecolecon.2007.08.002; Kulmala S, 2013, STRATEG BEHAV ENVIRO, V3, P121, DOI 10.1561/102.00000026; Laurila-Pant M, 2015, ECOL INDIC, V55, P1, DOI 10.1016/j.ecolind.2015.02.034; Lehikoinen A., 2014, INT J MULTICRITERIA, V4, P114, DOI DOI 10.1504/IJMCDM.2014.060426; Levontin P, 2011, ICES J MAR SCI, V68, P632, DOI 10.1093/icesjms/fsr004; O'Hagan A, 2006, UNCERTAIN JUDGEMENTS; Ojaveer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019231; Rahikainen M, 2014, AMBIO, V43, P115, DOI 10.1007/s13280-013-0482-7; Gari SR, 2015, OCEAN COAST MANAGE, V103, P63, DOI 10.1016/j.ocecoaman.2014.11.013; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Stelzenmuller V, 2014, ICEJ MARINE SCI J; Uusitalo L, 2005, ICES J MAR SCI, V62, P708, DOI 10.1016/j.icesjms.2005.02.005; Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033; Uusitalo L, 2015, ENVIRON MODELL SOFTW, V63, P24, DOI 10.1016/j.envsoft.2014.09.017; van Engelen D, 2008, WATER POLICY, V10, P207, DOI 10.2166/wp.2008.041; Varis O, 1999, ECOL MODEL, V119, P177, DOI 10.1016/S0304-3800(99)00061-7	46	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0147085	10.1371/journal.pone.0147085	http://dx.doi.org/10.1371/journal.pone.0147085			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751965	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100193
J	Oltean, G; Ivanciu, LN				Oltean, Gabriel; Ivanciu, Laura-Nicoleta			Computational Intelligence and Wavelet Transform Based Metamodel for Efficient Generation of Not-Yet Simulated Waveforms	PLOS ONE			English	Article							APPROXIMATION; OPTIMIZATION	The design and verification of complex electronic systems, especially the analog and mixed-signal ones, prove to be extremely time consuming tasks, if only circuit-level simulations are involved. A significant amount of time can be saved if a cost effective solution is used for the extensive analysis of the system, under all conceivable conditions. This paper proposes a data-driven method to build fast to evaluate, but also accurate metamodels capable of generating not-yet simulated waveforms as a function of different combinations of the parameters of the system. The necessary data are obtained by early-stage simulation of an electronic control system from the automotive industry. The metamodel development is based on three key elements: a wavelet transform for waveform characterization, a genetic algorithm optimization to detect the optimal wavelet transform and to identify the most relevant decomposition coefficients, and an artificial neuronal network to derive the relevant coefficients of the wavelet transform for any new parameters combination. The resulted metamodels for three different waveform families are fully reliable. They satisfy the required key points: high accuracy (a maximum mean squared error of 7.1x10(-5) for the unity-based normalized waveforms), efficiency (fully affordable computational effort for metamodel build-up: maximum 18 minutes on a general purpose computer), and simplicity (less than 1 second for running the metamodel, the user only provides the parameters combination). The metamodels can be used for very efficient generation of new waveforms, for any possible combination of dependent parameters, offering the possibility to explore the entire design space. A wide range of possibilities becomes achievable for the user, such as: all design corners can be analyzed, possible worst-case situations can be investigated, extreme values of waveforms can be discovered, sensitivity analyses can be performed (the influence of each parameter on the output waveform).	[Oltean, Gabriel; Ivanciu, Laura-Nicoleta] Tech Univ Cluj Napoca, Dept Bases Elect, Cluj Napoca, Romania	Technical University of Cluj Napoca	Ivanciu, LN (corresponding author), Tech Univ Cluj Napoca, Dept Bases Elect, Cluj Napoca, Romania.	Laura.Ivanciu@bel.utcluj.ro	Ivanciu, Laura-Nicoleta/K-9029-2015; Oltean, Gabriel/B-3703-2013	Oltean, Gabriel/0000-0002-3493-4034				[Anonymous], DES EXP STAT MACH TL; COIFMAN R, 1995, 475 STANF U DEP STAT; Daubechies I., 1992, J ACOUST SOC AM, V6, P697, DOI [10.1063/1.4823127, DOI 10.1121/1.406784]; Duda R.O., 2006, PATTERN CLASSIFICATI; Eberhart R.C., 2007, COMPUTATIONAL INTELL; Eriksson L., 2008, DESIGN EXPT; Ferrari S, 2005, IEEE T NEURAL NETWOR, V16, P24, DOI 10.1109/TNN.2004.836233; Field SE, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031006; Garitselov O, 2012, IEEE T SEMICONDUCT M, V25, P26, DOI 10.1109/TSM.2011.2173957; Gyorodi RS, 2011, PATTERN RECOGNITION; Huang QC, 2015, ASIA S PACIF DES AUT, P460, DOI 10.1109/ASPDAC.2015.7059049; Jiuchao Li, 2010, 2010 International Conference on Microwave and Millimeter Wave Technology (ICMMT 2010), P1465, DOI 10.1109/ICMMT.2010.5524744; Kang SL, 2010, CHIN CONT DECIS CONF, P2481, DOI 10.1109/CCDC.2010.5498788; Khashei M, 2010, EXPERT SYST APPL, V37, P479, DOI 10.1016/j.eswa.2009.05.044; Kianifar MR, 2014, 2014 14TH UK WORKSHOP ON COMPUTATIONAL INTELLIGENCE (UKCI), P155; Konar A, 2006, COMPUTATIONAL INTELL; Moghbelli H, 2009, LECT NOTES COMPUT SC, V5551, P852, DOI 10.1007/978-3-642-01507-6_96; Mohanty S, 2012, ULTRAFAST DESIGN EXP; Mohanty SP, 2014, ANALOG INTEGR CIRC S, V79, P437, DOI 10.1007/s10470-014-0284-2; Montano JC, 2012, IEEE T IND ELECTRON, V59, P4032, DOI 10.1109/TIE.2011.2174532; Nason GP, 2008, USE R, P1; Nigam A, 2011, DATE 2011, P1; Oltean G, 2009, JAMRIS, V3, P63; Oros A, 2013, INT SYM DES TECH ELE, P171, DOI 10.1109/SIITME.2013.6743667; Principe JC, 2015, IEEE COMPUT INTELL M, V10, P68, DOI 10.1109/MCI.2015.2405352; Rafaila M, 2009, 12 WORKSH METH BESCH, P217; Rafaila M, 2010, IEEE INT SYMP DESIGN, P309, DOI 10.1109/DDECS.2010.5491760; Rutkowski L., 2008, COMPUTATIONAL INTELL, DOI DOI 10.1007/978-3-540-76288-1; Sang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110733; Shivraman SG, 2003, PROJECT REPORT SPEEC; Simpson TW, 2001, ENG COMPUT-GERMANY, V17, P129, DOI 10.1007/PL00007198; Suresh HN, 2013, IEEE INT ADV COMPUT, P12; Teixeira Júnior Luiz Albino, 2015, Pesqui. Oper., V35, P73, DOI 10.1590/0101-7438.2015.035.01.0073; Thames JL, 2011, PROCEEDINGS OF THE 49TH ANNUAL ASSOCIATION FOR COMPUTING MACHINERY SOUTHEAST CONFERENCE (ACMSE '11), P209; Whitley D, 2001, INFORM SOFTWARE TECH, V43, P817, DOI 10.1016/S0950-5849(01)00188-4; Ye H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075662; Zainuddin Zarita, 2008, WSEAS Transactions on Mathematics, V7, P333	37	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146602	10.1371/journal.pone.0146602	http://dx.doi.org/10.1371/journal.pone.0146602			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745370	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600067
J	Fischer, R; Helfrich-Forster, C; Peschel, N				Fischer, Robin; Helfrich-Foerster, Charlotte; Peschel, Nicolai			GSK-3 Beta Does Not Stabilize Cryptochrome in the Circadian Clock of Drosophila	PLOS ONE			English	Article							LIGHT-INPUT; TIMELESS; MELANOGASTER; NEURONS; PERIOD; BEHAVIOR; RHYTHM; PHOTORECEPTOR; GENE; PHOTOSENSITIVITY	Cryptochrome (CRY) is the primary photoreceptor of Drosophila's circadian clock. It resets the circadian clock by promoting light-induced degradation of the clock protein Timeless (TIM) in the proteasome. Under constant light, the clock stops because TIM is absent, and the flies become arrhythmic. In addition to TIM degradation, light also induces CRY degradation. This depends on the interaction of CRY with several proteins such as the E3 ubiquitin ligases Jetlag (JET) and Ramshackle (BRWD3). However, CRY can seemingly also be stabilized by interaction with the kinase Shaggy (SGG), the GSK-3 beta fly orthologue. Consequently, flies with SGG overexpression in certain dorsal clock neurons are reported to remain rhythmic under constant light. We were interested in the interaction between CRY, Ramshackle and SGG and started to perform protein interaction studies in S2 cells. To our surprise, we were not able to replicate the results, that SGG overexpression does stabilize CRY, neither in S2 cells nor in the relevant clock neurons. SGG rather does the contrary. Furthermore, flies with SGG overexpression in the dorsal clock neurons became arrhythmic as did wild-type flies. Nevertheless, we could reproduce the published interaction of SGG with TIM, since flies with SGG overexpression in the lateral clock neurons shortened their free-running period. We conclude that SGG does not directly interact with CRY but rather with TIM. Furthermore we could demonstrate, that an unspecific antibody explains the observed stabilization effects on CRY.	[Fischer, Robin; Helfrich-Foerster, Charlotte; Peschel, Nicolai] Univ Wurzburg, Bioctr, Neurobiol & Genet, D-97070 Wurzburg, Germany	University of Wurzburg	Peschel, N (corresponding author), Univ Wurzburg, Bioctr, Neurobiol & Genet, D-97070 Wurzburg, Germany.	nicolaipeschel@biozentrum.uni-wuerzburg.de		Helfrich-Forster, Charlotte/0000-0002-0859-9092	Deutsche Forschungsgemeinschaft [FKZ: Pe1798/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft FKZ: Pe1798/2-1 The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Beckwith EJ, 2015, J COMP NEUROL, V523, P982, DOI 10.1002/cne.23728; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Brandes C, 1996, NEURON, V16, P687, DOI 10.1016/S0896-6273(00)80088-4; Chen KF, 2011, CURR BIOL, V21, P719, DOI 10.1016/j.cub.2011.03.049; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Dubruille R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000787; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hermann C, 2012, J COMP NEUROL, V520, P970, DOI 10.1002/cne.22742; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Knowles A, 2009, J NEUROSCI, V29, P1152, DOI 10.1523/JNEUROSCI.0429-08.2009; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; KURKULOS M, 1991, P NATL ACAD SCI USA, V88, P3038, DOI 10.1073/pnas.88.8.3038; Lamba P, 2014, CELL REP, V7, P601, DOI 10.1016/j.celrep.2014.03.044; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Meissner RA, 2008, J NEUROSCI, V28, P9732, DOI 10.1523/JNEUROSCI.0840-08.2008; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Ozturk N, 2013, P NATL ACAD SCI USA, V110, P4980, DOI 10.1073/pnas.1303234110; Peschel N, 2006, P NATL ACAD SCI USA, V103, P17313, DOI 10.1073/pnas.0606675103; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rush BL, 2006, J BIOL RHYTHM, V21, P272, DOI 10.1177/0748730406290416; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; Schibler U, 2006, PROG BRAIN RES, V153, P271, DOI 10.1016/S0079-6123(06)53016-X; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	45	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146571	10.1371/journal.pone.0146571	http://dx.doi.org/10.1371/journal.pone.0146571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741981	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600058
J	Gessele, N; Garcia-Pino, E; Omerbasic, D; Park, TJ; Koch, U				Gessele, Nikodemus; Garcia-Pino, Elisabet; Omerbasic, Damir; Park, Thomas J.; Koch, Ursula			Structural Changes and Lack of HCN1 Channels in the Binaural Auditory Brainstem of the Naked Mole-Rat (Heterocephalus glaber)	PLOS ONE			English	Article							MEDIAL SUPERIOR OLIVE; ANTEROVENTRAL COCHLEAR NUCLEUS; HYPERPOLARIZATION-ACTIVATED CURRENT; VESICULAR GLUTAMATE TRANSPORTERS; COINCIDENCE-DETECTOR NEURONS; PRIMARY AXOSOMATIC ENDINGS; SOUND LOCALIZATION; LATERAL LEMNISCUS; TRAPEZOID BODY; VENTRAL NUCLEUS	Naked mole-rats (Heterocephalus glaber) live in large eu-social, underground colonies in narrow burrows and are exposed to a large repertoire of communication signals but negligible binaural sound localization cues, such as interaural time and intensity differences. We therefore asked whether monaural and binaural auditory brainstem nuclei in the naked mole-rat are differentially adjusted to this acoustic environment. Using antibody stainings against excitatory and inhibitory presynaptic structures, namely the vesicular glutamate transporter VGluT1 and the glycine transporter GlyT2 we identified all major auditory brainstem nuclei except the superior paraolivary nucleus in these animals. Naked mole-rats possess a well structured medial superior olive, with a similar synaptic arrangement to interaural-time-difference encoding animals. The neighboring lateral superior olive, which analyzes interaural intensity differences, is large and elongated, whereas the medial nucleus of the trapezoid body, which provides the contralateral inhibitory input to these binaural nuclei, is reduced in size. In contrast, the cochlear nucleus, the nuclei of the lateral lemniscus and the inferior colliculus are not considerably different when compared to other rodent species. Most interestingly, binaural auditory brainstem nuclei lack the membrane-bound hyperpolarization-activated channel HCN1, a voltage-gated ion channel that greatly contributes to the fast integration times in binaural nuclei of the superior olivary complex in other species. This suggests substantially lengthened membrane time constants and thus prolonged temporal integration of inputs in binaural auditory brainstem neurons and might be linked to the severely degenerated sound localization abilities in these animals.	[Gessele, Nikodemus; Garcia-Pino, Elisabet; Koch, Ursula] Free Univ Berlin, Inst Biol, Neurophysiol, Berlin, Germany; [Omerbasic, Damir] Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany; [Park, Thomas J.] Univ Illinois, Dept Biol Sci, Lab Integrat Neurosci, Chicago, IL 60680 USA	Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Koch, U (corresponding author), Free Univ Berlin, Inst Biol, Neurophysiol, Berlin, Germany.	ursula.koch@fu-berlin.de		Garcia-Pino, Elisabet/0000-0002-6207-5564; Omerbasic, Damir/0000-0003-1839-4856	German Excellence Initiative; Marie Curie Program of the European Commission - DRS postdoctoral fellowhip (EGP); DFG [SPP1608]; NeuroCure (UK); DFG (U.K.) [SPP1608]; NeuroCure (U.K.); Marie Curie Program of the European Commission-DRS postdoctoral fellowhip	German Excellence Initiative; Marie Curie Program of the European Commission - DRS postdoctoral fellowhip (EGP); DFG(German Research Foundation (DFG)); NeuroCure (UK); DFG (U.K.)(German Research Foundation (DFG)); NeuroCure (U.K.); Marie Curie Program of the European Commission-DRS postdoctoral fellowhip	Funded by German Excellence Initiative and the Marie Curie Program of the European Commission - DRS postdoctoral fellowhip (EGP). DFG - SPP1608, NeuroCure (UK).; We thank Gary Lewin for providing the naked mole-rats from his colony at the Max-Del-bruck-Center in Berlin-Buch. This work was supported by DFG grant SPP1608 (U.K.), NeuroCure (U.K.) and a German Excellence Initiative and the Marie Curie Program of the European Commission-DRS postdoctoral fellowhip (E.G.P).	Altieri SC, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00109; Baumann VJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00117; Benson CG, 1997, SYNAPSE, V25, P243; Benson CG, 2008, J COMP NEUROL, V510, P673, DOI 10.1002/cne.21820; Billups B, 2005, NEUROSCI LETT, V382, P66, DOI 10.1016/j.neulet.2005.02.071; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; Caminos E, 2007, J COMP NEUROL, V505, P363, DOI 10.1002/cne.21497; Couchman K, 2012, J NEUROPHYSIOL, V107, P1186, DOI 10.1152/jn.00586.2011; Couchman K, 2010, J NEUROSCI, V30, P17111, DOI 10.1523/JNEUROSCI.1760-10.2010; Credner S, 1997, J COMP PHYSIOL A, V180, P245, DOI 10.1007/s003590050045; Crish SD, 2006, ANAT REC PART A, V288A, P205, DOI 10.1002/ar.a.20288; Fang XD, 2014, CELL REP, V8, P1354, DOI 10.1016/j.celrep.2014.07.030; Felix RA, 2011, J NEUROSCI, V31, P12566, DOI 10.1523/JNEUROSCI.2450-11.2011; Ford MC, 2009, J COMP NEUROL, V514, P92, DOI 10.1002/cne.21998; Friauf E, 1999, J COMP NEUROL, V412, P17; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; GLENDENNING KK, 1991, J COMP NEUROL, V310, P377, DOI 10.1002/cne.903100308; GLENDENNING KK, 1981, J COMP NEUROL, V197, P673, DOI 10.1002/cne.901970409; Golding NL, 2012, J PHYSIOL-LONDON, V590, P5563, DOI 10.1113/jphysiol.2012.229328; Gomez-Nieto R, 2009, J COMP NEUROL, V516, P241, DOI 10.1002/cne.22139; Grothe B, 1997, J NEUROPHYSIOL, V77, P1553, DOI 10.1152/jn.1997.77.3.1553; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Hassfurth B, 2010, J NEUROSCI, V30, P9715, DOI 10.1523/JNEUROSCI.1552-10.2010; HEFFNER RS, 1993, J COMP NEUROL, V331, P418, DOI 10.1002/cne.903310311; HEFFNER RS, 1992, HEARING RES, V62, P206, DOI 10.1016/0378-5955(92)90188-S; Indig FE, 1997, BIOCHEM J, V327, P291, DOI 10.1042/bj3270291; Ito T, 2011, J COMP NEUROL, V519, P316, DOI 10.1002/cne.22521; Ito T, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00135; Jalabi W, 2013, J NEUROSCI, V33, P15044, DOI 10.1523/JNEUROSCI.2604-13.2013; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JORIS PX, 1995, J NEUROPHYSIOL, V73, P1043, DOI 10.1152/jn.1995.73.3.1043; Kadner A, 2008, NEUROSCIENCE, V151, P868, DOI 10.1016/j.neuroscience.2007.11.008; Kandler K, 2004, CURR OPIN NEUROBIOL, V14, P96, DOI 10.1016/j.conb.2004.01.017; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Kelly JB, 2009, J COMP NEUROL, V512, P573, DOI 10.1002/cne.21929; Khurana S, 2012, J NEUROSCI, V32, P2814, DOI 10.1523/JNEUROSCI.3882-11.2012; Koch U, 2004, EUR J NEUROSCI, V20, P79, DOI 10.1111/j.0953-816X.2004.03456.x; KUWABARA N, 1992, J COMP NEUROL, V324, P522, DOI 10.1002/cne.903240406; Lacey EA, 2000, LIFE UNDERGROUND BIO; Lange S, 2007, NATURWISSENSCHAFTEN, V94, P134, DOI 10.1007/s00114-006-0168-0; Leao KE, 2006, J PHYSIOL-LONDON, V576, P849, DOI 10.1113/jphysiol.2006.114702; Leao KE, 2011, EUR J NEUROSCI, V33, P1462, DOI 10.1111/j.1460-9568.2011.07627.x; Limb CJ, 2000, JARO-J ASSOC RES OTO, V1, P103, DOI 10.1007/s101620010032; Lohrke S, 2002, CELL TISSUE RES, V308, P19, DOI 10.1007/s00441-002-0533-z; Mahendrasingam S, 2000, BRAIN RES, V887, P477, DOI 10.1016/S0006-8993(00)03054-7; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Mathews PJ, 2010, NAT NEUROSCI, V13, P601, DOI 10.1038/nn.2530; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Muniak MA, 2013, J COMP NEUROL, V521, P1510, DOI 10.1002/cne.23238; Mylius J, 2013, J COMP NEUROL, V521, P1289, DOI 10.1002/cne.23232; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Oliver DL, 2000, MICROSC RES TECHNIQ, V51, P355, DOI 10.1002/1097-0029(20001115)51:4<355::AID-JEMT5>3.0.CO;2-J; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Park TJ, 1996, NATURWISSENSCHAFTEN, V83, P30, DOI 10.1007/BF01139307; Pollak GD, 2003, TRENDS NEUROSCI, V26, P33, DOI 10.1016/S0166-2236(02)00009-7; Preussner M, 2014, MOL CELL, V54, P651, DOI 10.1016/j.molcel.2014.04.015; Rautenberg PL, 2009, J COMP NEUROL, V517, P385, DOI 10.1002/cne.22166; Recio-Spinoso A, 2014, J NEUROPHYSIOL, V111, P817, DOI 10.1152/jn.00971.2011; RYUGO DK, 1982, J COMP NEUROL, V210, P239, DOI 10.1002/cne.902100304; Schofield BR, 1997, J COMP NEUROL, V379, P363, DOI 10.1002/(SICI)1096-9861(19970317)379:3<363::AID-CNE4>3.0.CO;2-1; Sherman P. W., 1991, BIOL NAKED MOLE RAT; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; Strenzke N, 2009, J NEUROSCI, V29, P7991, DOI 10.1523/JNEUROSCI.0632-09.2009; Trattner B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067351; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; WENTHOLD RJ, 1988, J COMP NEUROL, V276, P423, DOI 10.1002/cne.902760307; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Yamada R, 2005, J NEUROSCI, V25, P8867, DOI 10.1523/JNEUROSCI.2541-05.2005; Yosida S, 2007, ETHOLOGY, V113, P703, DOI 10.1111/j.1439-0310.2007.01371.x; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208	70	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146428	10.1371/journal.pone.0146428	http://dx.doi.org/10.1371/journal.pone.0146428			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760498	Green Published, gold, Green Accepted			2022-12-27	WOS:000368033100034
J	Kwak, YG; Moon, C; Kim, ES; Kim, BN				Kwak, Yee Gyung; Moon, Chisook; Kim, Eu Suk; Kim, Baek-Nam			Frequent Prescription of Antibiotics and High Burden of Antibiotic Resistance among Deceased Patients in General Medical Wards of Acute Care Hospitals in Korea	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; ANTIMICROBIAL USE; TERMINAL PATIENTS; DECISION-MAKING; ADVANCED CANCER; LIFE; END; THERAPY; AMERICA; ILL	Background Antibiotics are often administered to terminally ill patients until death, and antibiotic use contributes to the emergence of multidrug-resistant organisms (MDROs). We investigated antibiotic use and the isolation of MDROs among patients who died in general medical wards. Methods All adult patients who died in the general internal medicine wards at four acute care hospitals between January and June 2013 were enrolled. For comparison with these deceased patients, the same number of surviving, discharged patients was selected from the same divisions of internal medicine subspecialties during the same period. Results During the study period, 303 deceased patients were enrolled; among them, 265 (87.5%) had do-not-resuscitate (DNR) orders in their medical records. Antibiotic use was more common in patients who died than in those who survived (87.5% vs. 65.7%, P<0.001). Among deceased patients with DNR orders, antibiotic use was continued in 59.6% of patients after obtaining their DNR orders. Deceased patients received more antibiotic therapy courses (two [interquartile range (IQR) 1-3] vs. one [IQR 0-2], P<0.001). Antibiotics were used for longer durations in deceased patients than in surviving patients (13 [IQR 5-23] vs. seven days [IQR 0-18], P<0.001). MDROs were also more common in deceased patients than in surviving patients (25.7% vs. 10.6%, P<0.001). Conclusions Patients who died in the general medical wards of acute care hospitals were exposed to more antibiotics than patients who survived. In particular, antibiotic prescription was common even after obtaining DNR orders in patients who died. The isolation of MDROs during the hospital stay was more common in these patients who died. Strategies for judicious antibiotic use and appropriate infection control should be applied to these patient populations.	[Kwak, Yee Gyung] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Goyang, South Korea; [Moon, Chisook] Inje Univ, Busan Paik Hosp, Dept Internal Med, Busan, South Korea; [Kim, Eu Suk] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Kim, Baek-Nam] Inje Univ, Sanggye Paik Hosp, Dept Internal Med, Seoul, South Korea	Inje University; Inje University; Seoul National University (SNU); Inje University	Kim, BN (corresponding author), Inje Univ, Sanggye Paik Hosp, Dept Internal Med, Seoul, South Korea.	kimbn@paik.ac.kr	Kim, Baek-Nam/AGO-0326-2022	Kim, Baek-Nam/0000-0001-5551-2132				Albrecht JS, 2013, J PAIN SYMPTOM MANAG, V46, P483, DOI 10.1016/j.jpainsymman.2012.09.010; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; D'Agata E, 2008, ARCH INTERN MED, V168, P357, DOI 10.1001/archinternmed.2007.104; Daneman N, 2011, J ANTIMICROB CHEMOTH, V66, P2856, DOI 10.1093/jac/dkr395; Fins JJ, 1999, J PAIN SYMPTOM MANAG, V17, P6, DOI 10.1016/S0885-3924(98)00109-2; Ford PJ, 2005, BIOETHICS, V19, P379, DOI 10.1111/j.1467-8519.2005.00450.x; Heo DS, 2013, J KOREAN MED SCI, V28, P1, DOI 10.3346/jkms.2013.28.1.1; Ivo K, 2012, J MED ETHICS, V38, P310, DOI 10.1136/medethics-2011-100153; Kim DY, 2007, J PALLIAT MED, V10, P1153, DOI 10.1089/jpm.2006.0264; Levin PD, 2010, CHEST, V138, P588, DOI 10.1378/chest.09-2757; Marcus EL, 2001, CLIN INFECT DIS, V33, P1697, DOI 10.1086/323757; Nagy-Agren S, 2002, J PAIN SYMPTOM MANAG, V24, P64, DOI 10.1016/S0885-3924(02)00420-7; Oh DY, 2006, EUR J CANCER CARE, V15, P74, DOI 10.1111/j.1365-2354.2005.00603.x; Opal SM, 2009, JAMA-J AM MED ASSOC, V302, P2367, DOI 10.1001/jama.2009.1774; Phua J, 2015, JAMA INTERN MED, V175, P363, DOI 10.1001/jamainternmed.2014.7386; Polk RE, 2007, CLIN INFECT DIS, V44, P664, DOI 10.1086/511640; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Thompson AJ, 2012, AM J HOSP PALLIAT ME, V29, P599, DOI 10.1177/1049909111432625	19	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146852	10.1371/journal.pone.0146852	http://dx.doi.org/10.1371/journal.pone.0146852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761461	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100047
J	Shao, JJ; Xu, ZF; Peng, XM; Chen, M; Zhu, YR; Xu, L; Zhu, H; Yang, B; Luo, PH; He, QJ				Shao, Jinjin; Xu, Zhifei; Peng, Xueming; Chen, Min; Zhu, Yuanrun; Xu, Li; Zhu, Hong; Yang, Bo; Luo, Peihua; He, Qiaojun			Gefitinib Synergizes with Irinotecan to Suppress Hepatocellular Carcinoma via Antagonizing Rad51-Mediated DNA-Repair	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HOMOLOGOUS RECOMBINATION; RAD51 PROTEIN; CANCER-CELLS; PHASE-II; EXCHANGE MECHANISM; CAMPTOTHECIN; CYTOTOXICITY; INHIBITION; DRUG	Chemotherapy is the only choice for most of the advanced hepatocellular carcinoma (HCC) patients, while few agents were available, making it an urgent need to develop new chemotherapy strategies. A phase II clinical trial suggested that the efficacy of irinotecan in HCC was limited due to dose-dependent toxicities. Here, we found that gefitinib exhibited synergistic activity in combination with SN-38, an active metabolite of irinotecan, in HCC cell lines. And the enhanced apoptosis induced by gefitinib plus SN-38 was a result from caspase pathway activation. Mechanistically, gefitinib dramatically promoted the ubiquitin-proteasome-dependent degradation of Rad51 protein, suppressed the DNA repair, gave rise to more DNA damages, and ultimately resulted in the synergism of these two agents. In addition, the increased antitumor efficacy of gefitinib combined with irinotecan was further validated in a HepG2 xenograft mice model. Taken together, our data demonstrated for the first time that the combination of irinotecan and gefitinib showed potential benefit in HCC, which suggests that Rad51 is a promising target and provides a rationale for clinical trials investigating the efficacy of the combination of topoisomerase I inhibitors and gefitinib in HCC.	[Shao, Jinjin; Xu, Zhifei; Peng, Xueming; Chen, Min; Zhu, Yuanrun; Xu, Li; Zhu, Hong; Yang, Bo; Luo, Peihua; He, Qiaojun] Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Luo, PH (corresponding author), Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Zhejiang, Peoples R China.	peihualuo@zju.edu.cn; qiaojunhe@zju.edu.cn		Zhu, Hong/0000-0002-2575-4031	National Natural Science Foundation of China [81202605, 81473288]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China No. 81202605 (to PL) and No. 81473288 (to PL), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaudeau C, 1999, J MOL BIOL, V289, P1231, DOI 10.1006/jmbi.1999.2856; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Boige V, 2006, EUR J CANCER, V42, P456, DOI 10.1016/j.ejca.2005.09.034; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Chen JJ, 1999, CANCER RES, V59, p1752S; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Ciardiello F, 2001, CLIN CANCER RES, V7, P1459; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; FUKUOKA M, 1992, J CLIN ONCOL, V10, P16, DOI 10.1200/JCO.1992.10.1.16; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Horiike A, 2011, BRIT J CANCER, V105, P1131, DOI 10.1038/bjc.2011.375; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KASTAN MB, 1991, CANCER RES, V51, P6304; Kishida O, 2005, CANCER CHEMOTH PHARM, V55, P393, DOI 10.1007/s00280-004-0904-0; Ko JC, 2008, CARCINOGENESIS, V29, P1448, DOI 10.1093/carcin/bgn130; Ko JC, 2008, MOL CANCER THER, V7, P3632, DOI 10.1158/1535-7163.MCT-08-0578; Langenberg MHG, 2010, CLIN CANCER RES, V16, P2187, DOI 10.1158/1078-0432.CCR-09-2436; Liu XW, 2014, AUTOPHAGY, V10, P111, DOI 10.4161/auto.26838; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lu DSK, 2005, RADIOLOGY, V234, P954, DOI 10.1148/radiol.2343040153; MASUDA N, 1992, J CLIN ONCOL, V10, P1225, DOI 10.1200/JCO.1992.10.8.1225; Njei B, 2015, HEPATOLOGY, V61, P191, DOI 10.1002/hep.27388; O'Dwyer PJ, 2006, J CLIN ONCOL, V24, p213S; O'Reilly EM, 2001, CANCER-AM CANCER SOC, V91, P101, DOI 10.1002/1097-0142(20010101)91:1<101::AID-CNCR13>3.0.CO;2-K; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saltz LB, 2001, ONCOLOGIST, V6, P81, DOI 10.1634/theoncologist.6-1-81; Schneider S, 2006, PHARMACOGENET GENOM, V16, P555, DOI 10.1097/01.fpc.0000220563.44724.6d; Shihabi S, 2001, Clin Lung Cancer, V2, P275, DOI 10.3816/CLC.2001.n.010; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Tahara M, 2014, MOL CANCER THER, V13, P1170, DOI 10.1158/1535-7163.MCT-13-0683; Takenaka T, 2007, INT J CANCER, V121, P895, DOI 10.1002/ijc.22738; Tomicic MT, 2013, BBA-REV CANCER, V1835, P11, DOI 10.1016/j.bbcan.2012.09.002; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Wu MH, 2014, MOL PHARMACOL, V85, P866, DOI 10.1124/mol.113.090688; Yashiro M, 2011, BRIT J CANCER, V105, P1522, DOI 10.1038/bjc.2011.397	44	17	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146968	10.1371/journal.pone.0146968	http://dx.doi.org/10.1371/journal.pone.0146968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752698	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100186
J	Zhang, ZL; Gao, C; Lu, YX; Liu, YX; Liang, MX				Zhang, Zili; Gao, Chao; Lu, Yuxiao; Liu, Yuxin; Liang, Mingxin			Multi-Objective Ant Colony Optimization Based on the Physarum-Inspired Mathematical Model for Bi-Objective Traveling Salesman Problems	PLOS ONE			English	Article							EVOLUTIONARY ALGORITHMS; HYPERVOLUME INDICATOR	Bi-objective Traveling Salesman Problem (bTSP) is an important field in the operations research, its solutions can be widely applied in the real world. Many researches of Multiobjective Ant Colony Optimization (MOACOs) have been proposed to solve bTSPs. However, most of MOACOs suffer premature convergence. This paper proposes an optimization strategy for MOACOs by optimizing the initialization of pheromone matrix with the prior knowledge of Physarum-inspired Mathematical Model (PMM). PMM can find the shortest route between two nodes based on the positive feedback mechanism. The optimized algorithms, named as iPM-MOACOs, can enhance the pheromone in the short paths and promote the search ability of ants. A series of experiments are conducted and experimental results show that the proposed strategy can achieve a better compromise solution than the original MOACOs for solving bTSPs.	[Zhang, Zili; Gao, Chao; Lu, Yuxiao; Liu, Yuxin; Liang, Mingxin] Southwest Univ, Coll Comp & Informat Sci, Chongqing 400715, Peoples R China; [Zhang, Zili; Gao, Chao; Lu, Yuxiao; Liu, Yuxin; Liang, Mingxin] Southwest Univ, Coll Software, Chongqing 400715, Peoples R China; [Zhang, Zili] Deaken Univ, Sch Informat Technol, Geelong, Vic 3220, Australia; [Gao, Chao] Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130012, Peoples R China	Southwest University - China; Southwest University - China; Deakin University; Jilin University	Zhang, ZL (corresponding author), Southwest Univ, Coll Comp & Informat Sci, Chongqing 400715, Peoples R China.	zhangzl@swu.edu.cn; cgao@swu.edu.cn	liu, yuxin/GRY-3592-2022		National Natural Science Foundation of China [61403315, 61402379]; Natural Science Foundation of Chongqing [cstc2013jcyjA40022]; Fundamental Research Funds for the Central Universities [XDJK2016D020, XDJK2016A008]; open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University	This research was supported by the National Natural Science Foundation of China (61403315, 61402379), Natural Science Foundation of Chongqing (cstc2013jcyjA40022), the Fundamental Research Funds for the Central Universities (XDJK2016D020, XDJK2016A008) and the open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamatzky A, 2013, J BIONIC ENG, V10, P242, DOI 10.1016/S1672-6529(13)60220-6; Alaya I, 2007, PROC INT C TOOLS ART, P450, DOI 10.1109/ICTAI.2007.108; [Anonymous], AFR J MATH COMPUT SC; Bandyopadhyay S, 2015, IEEE T EVOLUT COMPUT, V19, P400, DOI 10.1109/TEVC.2014.2332878; Baran B., 2003, APPL INFORM, P97; Bringmann K, 2010, EVOL COMPUT, V18, P383, DOI 10.1162/EVCO_a_00012; Cao YT, 2015, J STAT PLAN INFER, V160, P60, DOI 10.1016/j.jspi.2014.12.004; Cheng JX, 2012, SOFT COMPUT, V16, P597, DOI 10.1007/s00500-011-0759-3; Chica M, 2010, INFORM SCIENCES, V180, P3465, DOI 10.1016/j.ins.2010.05.033; Doerner K, 2004, ANN OPER RES, V131, P79, DOI 10.1023/B:ANOR.0000039513.99038.c6; Evangelidis V, 2015, J ARCHAEOL SCI-REP, V2, P264, DOI 10.1016/j.jasrep.2015.02.005; Florios K, 2014, APPL MATH COMPUT, V237, P1, DOI 10.1016/j.amc.2014.03.110; Friedrich T, 2015, APPL SOFT COMPUT, V33, P223, DOI 10.1016/j.asoc.2015.04.043; Garcia-Martinez C, 2007, EUR J OPER RES, V180, P116, DOI 10.1016/j.ejor.2006.03.041; Hu MQ, 2014, APPL SOFT COMPUT, V25, P347, DOI 10.1016/j.asoc.2014.08.069; Iredi S, 2001, LECT NOTES COMPUT SC, V1993, P359; Jaszkiewicz A, 2002, EUR J OPER RES, V137, P50, DOI 10.1016/S0377-2217(01)00104-7; Li MQ, 2015, ARTIF INTELL, V228, P45, DOI 10.1016/j.artint.2015.06.007; Lopez-Ibanez M, 2010, P 12 ANN C GEN EV CO, P71, DOI 10.1145/1830483.1830494; Lopez-Ibanez M, 2012, IEEE T EVOLUT COMPUT, V16, P861, DOI 10.1109/TEVC.2011.2182651; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Rehmat A, 2007, PAK J STAT OPER RES, V3, P87, DOI 10.18187/pjsor.v3i2.62; Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015; Wang WJ, 2013, MACH LEARN, V92, P403, DOI 10.1007/s10994-013-5369-0; Wang Z, 2015, PHYS LIFE REV, V15, P1, DOI 10.1016/j.plrev.2015.07.006; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Zhang Yong-de, 2005, Control and Decision, V20, P170; Zhang ZL, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036006; Zhou AM, 2011, SWARM EVOL COMPUT, V1, P32, DOI 10.1016/j.swevo.2011.03.001; Zitzler E, 2003, IEEE T EVOLUT COMPUT, V7, P117, DOI 10.1109/TEVC.2003.810758; Zitzler E, 1998, LECT NOTES COMPUT SC, V1498, P292, DOI 10.1007/BFb0056872	31	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146709	10.1371/journal.pone.0146709	http://dx.doi.org/10.1371/journal.pone.0146709			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751562	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100134
J	Zhou, YD; Cao, XQ; Liu, ZH; Cao, YJ; Liu, CF; Zhang, YL; Xie, Y				Zhou, Yan-De; Cao, Xue-Qin; Liu, Zhi-Hua; Cao, Yong-Jun; Liu, Chun-Feng; Zhang, Yan-Lin; Xie, Ying			Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake in Human Umbilical Vein Endothelial Cells via mTOR/NF-kappa B/LOX-1 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; SMOOTH-MUSCLE-CELLS; LECTIN-LIKE; SIGNALING PATHWAY; RECEPTOR LOX-1; ATHEROSCLEROSIS; EXPRESSION; MTOR; SIROLIMUS; MICE	Background Lectin-like oxidized low-density lipoprotein-1 (LOX-1) is the major receptor for oxidized low density lipoprotein (ox-LDL) uptake in human umbilical vein endothelial cells (HUVECs). Previously, we found that rapamycin inhibited ox-LDL accumulation in HUVECs, and this effect was related to its role in increasing the activity of autophagy-lysosome pathway. In this study, we determined whether rapamycin could also reduce ox-LDL uptake in HUVECs and investigated the underlying signaling mechanisms. Results Flow cytometry and live cell imaging showed that rapamycin reduced Dil-ox-LDL accumulation in HUVECs. Furthermore, rapamycin reduced the ox-LDL-induced increase in LOX-1 mRNA and protein levels. Western blotting showed that rapamycin inhibited mechanistic target of rapamycin (mTOR), p70s6k and I kappa B alpha phosphorylation triggered by ox-LDL. Flow cytometry implied that mTOR, NF-kappa B knockdown and NF-kappa B inhibitors significantly reduced Dil-ox-LDL uptake. Moreover, immunofluorescent staining showed that rapamycin reduced the accumulation of p65 in the nucleus after ox-LDL treatment for 30 h. mTOR knockdown decreased LOX-1 protein production and I kappa B alpha phosphorylation induced by ox-LDL. NF-kappa B knockdown and NF-kappa B inhibitors reduced LOX-1 protein production, but did not inhibit mTOR phosphorylation stimulated by ox-LDL. Conclusions These findings demonstrate that rapamycin reduce mTOR phosphorylation and subsequently inhibit NF-kappa B activation and suppresses LOX-1, resulting in a reduction in ox-LDL uptake in HUVECs.	[Zhou, Yan-De; Cao, Xue-Qin; Liu, Zhi-Hua; Xie, Ying] Soochow Univ, Affiliated Hosp 2, Dept Endocrinol, Suzhou, Jiangsu, Peoples R China; [Cao, Yong-Jun; Liu, Chun-Feng; Zhang, Yan-Lin] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China; [Liu, Chun-Feng] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Zhang, YL (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Endocrinol, Suzhou, Jiangsu, Peoples R China.	zhangyanlin0012006@163.com; 13013883877@126.com		Liu, Chun-Feng/0000-0002-8364-0219	PhD Programs Foundation of the Ministry of Education of China [20113201120016]; Natural Science Foundation of Jiangsu Province [BK2012172]; National Natural Science Foundation of China [81200894, 81471195]; Suzhou Foundation of Science and Technology Development Plan [SYSD2012083, SDFEYGJ1106]; Suzhou Social Development project [SYS201548]; Soochow university [XKQ2015002]	PhD Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Foundation of Science and Technology Development Plan; Suzhou Social Development project; Soochow university	This work was supported by grants from the PhD Programs Foundation of the Ministry of Education of China (20113201120016), the Natural Science Foundation of Jiangsu Province (BK2012172), the National Natural Science Foundation of China (81200894, 81471195), the Suzhou Foundation of Science and Technology Development Plan (SYSD2012083, SDFEYGJ1106), the Suzhou Social Development project (SYS201548), and the second affiliated hospital of Soochow university preponderant clinic discipline group project (XKQ2015002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2006, PROG LIPID RES, V45, P379, DOI 10.1016/j.plipres.2006.03.002; Ahmed M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-101; Baetta R, 2009, J PHARMACOL EXP THER, V328, P419, DOI 10.1124/jpet.108.144147; BICKEL PE, 1992, J CLIN INVEST, V90, P1450, DOI 10.1172/JCI116012; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Chen WQ, 2009, BRIT J PHARMACOL, V156, P941, DOI 10.1111/j.1476-5381.2008.00102.x; Cilingiroglu Mehmet, 2005, Curr Atheroscler Rep, V7, P103, DOI 10.1007/s11883-005-0031-3; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Dhingra R, 2013, CIRC-HEART FAIL, V6, P335, DOI 10.1161/CIRCHEARTFAILURE.112.000061; Goueffic Y, 2007, ATHEROSCLEROSIS, V195, P23, DOI 10.1016/j.atherosclerosis.2006.11.023; Guo F, 2013, LEUKEMIA, V27, P2040, DOI 10.1038/leu.2013.93; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hou YC, 2012, AM J PHYSIOL-LUNG C, V302, pL174, DOI 10.1152/ajplung.00066.2011; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Itabe H, 2012, J CLIN BIOCHEM NUTR, V51, P1, DOI 10.3164/jcbn.11-00020R1; Kezic A, 2013, TRANSPL P, V45, P1708, DOI 10.1016/j.transproceed.2013.02.110; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kume N, 2004, CIRC RES, V94, P269, DOI 10.1161/01.RES.0000119804.92239.97; Li DY, 2002, J PHARMACOL EXP THER, V302, P601, DOI 10.1124/jpet.102.034959; Ling WH, 1997, J CLIN INVEST, V100, P244, DOI 10.1172/JCI119528; Liu P, 2012, J CELL PHYSIOL, V227, P867, DOI 10.1002/jcp.22993; Ma KL, 2007, AM J PHYSIOL-HEART C, V292, pH2721, DOI 10.1152/ajpheart.01174.2006; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Morrisett JD, 2002, J LIPID RES, V43, P1170, DOI 10.1194/jlr.M100392-JLR200; Mueller MA, 2008, ATHEROSCLEROSIS, V198, P39, DOI 10.1016/j.atherosclerosis.2007.09.019; Nagase M, 1998, J BIOL CHEM, V273, P33702, DOI 10.1074/jbc.273.50.33702; Parra V, 2014, DIABETES, V63, P75, DOI 10.2337/db13-0340; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Radhakrishnan P, 2013, CLIN CANCER RES, V19, P2025, DOI 10.1158/1078-0432.CCR-12-2909; Rafiee P, 2010, AM J PHYSIOL-GASTR L, V298, pG865, DOI 10.1152/ajpgi.00339.2009; Roebuck KA, 1999, INT J MOL MED, V4, P223; Sawamura T, 2012, CURR OPIN LIPIDOL, V23, P439, DOI 10.1097/MOL.0b013e32835688e4; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Vieira O, 2000, FASEB J, V14, P532, DOI 10.1096/fasebj.14.3.532; Waksman Ron, 2003, Cardiovasc Radiat Med, V4, P34, DOI 10.1016/S1522-1865(03)00121-5; White SJ, 2011, CARDIOVASC PATHOL, V20, P369, DOI 10.1016/j.carpath.2010.08.007; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu SW, 2013, CELL MOL LIFE SCI, V70, P2859, DOI 10.1007/s00018-012-1194-z; Yamada Y, 1998, CELL MOL LIFE SCI, V54, P628, DOI 10.1007/s000180050191; Zhang YL, 2010, BIOCHEM BIOPH RES CO, V394, P377, DOI 10.1016/j.bbrc.2010.03.026	41	22	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146777	10.1371/journal.pone.0146777	http://dx.doi.org/10.1371/journal.pone.0146777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752047	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100152
J	Duconge, J; Ramos, AS; Claudio-Campos, K; Rivera-Miranda, G; Bermudez-Bosch, L; Renta, JY; Cadilla, CL; Cruz, I; Feliu, JF; Vergara, C; Ruano, G				Duconge, Jorge; Ramos, Alga S.; Claudio-Campos, Karla; Rivera-Miranda, Giselle; Bermudez-Bosch, Luis; Renta, Jessicca Y.; Cadilla, Carmen L.; Cruz, Iadelisse; Feliu, Juan F.; Vergara, Cunegundo; Ruano, Gualberto			A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics	PLOS ONE			English	Article							VKORC1 GENOTYPES; DOSE REQUIREMENTS; GENETIC-FACTORS; CYP2C9; POLYMORPHISMS; ASSOCIATION; RISK; VARIANTS; COMPLICATIONS; PREDICTORS	Aim This study is aimed at developing a novel admixture-adjusted pharmacogenomic approach to individually refine warfarin dosing in Caribbean Hispanic patients. Patients & Methods A multiple linear regression analysis of effective warfarin doses versus relevant genotypes, admixture, clinical and demographic factors was performed in 255 patients and further validated externally in another cohort of 55 individuals. Results The admixture-adjusted, genotype-guided warfarin dosing refinement algorithm developed in Caribbean Hispanics showed better predictability (R-2 = 0.70, MAE = 0.72mg/day) than a clinical algorithm that excluded genotypes and admixture (R-2 = 0.60, MAE = 0.99mg/day), and outperformed two prior pharmacogenetic algorithms in predicting effective dose in this population. For patients at the highest risk of adverse events, 45.5% of the dose predictions using the developed pharmacogenetic model resulted in ideal dose as compared with only 29% when using the clinical non-genetic algorithm (p<0.001). The admixture-driven pharmacogenetic algorithm predicted 58% of warfarin dose variance when externally validated in 55 individuals from an independent validation cohort (MAE = 0.89 mg/day, 24% mean bias). Conclusions Results supported our rationale to incorporate individual's genotypes and unique admixture metrics into pharmacogenetic refinement models in order to increase predictability when expanding them to admixed populations like Caribbean Hispanics.	[Duconge, Jorge; Ramos, Alga S.; Bermudez-Bosch, Luis; Cruz, Iadelisse] UPR MSC, Sch Pharm, Dept Pharmaceut Sci, San Juan, PR 00921 USA; [Claudio-Campos, Karla] UPR MSC, Sch Med, Dept Pharmacol & Toxicol, San Juan, PR USA; [Rivera-Miranda, Giselle; Feliu, Juan F.] VA Caribbean Healthcare Syst VACHS, Serv Pharm, San Juan, PR USA; [Renta, Jessicca Y.; Cadilla, Carmen L.] UPR MSC, Sch Med, Dept Biochem, Mol Genet Lab, San Juan, PR USA; [Vergara, Cunegundo] Hartford Hosp, Brownstone Outpatient Clin, Hartford, CT 06115 USA; [Ruano, Gualberto] Genomas Inc, Hartford, CT USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Hartford Hospital	Duconge, J (corresponding author), UPR MSC, Sch Pharm, Dept Pharmaceut Sci, San Juan, PR 00921 USA.	Jorge.duconge@upr.edu	Feliu, Juan M./D-1890-2010	Feliu, Juan M./0000-0003-4751-3279; Duconge, Jorge/0000-0002-5955-3449	National Heart, Lung, and Blood Institute (NHLBI) [SC1 HL123911]; SCORE Program of the National Institute of General Medical Sciences (NIGMS); Research Center in Minority Institutions (RCMI) from the National Institute on Minority Health and Health Disparities (NIMHD) [8G12MD007600]; Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) at the University of Puerto Rico Medical Sciences Campus [R25 GM061838]; NIMHD of the National Institutes of Health (NIH) [8U54 MD007587]; Genomas Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL123911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587, G12MD007600] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); SCORE Program of the National Institute of General Medical Sciences (NIGMS); Research Center in Minority Institutions (RCMI) from the National Institute on Minority Health and Health Disparities (NIMHD); Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) at the University of Puerto Rico Medical Sciences Campus; NIMHD of the National Institutes of Health (NIH); Genomas Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This investigation was supported in part by the grant number SC1 HL123911 from the National Heart, Lung, and Blood Institute (NHLBI) and the SCORE Program of the National Institute of General Medical Sciences (NIGMS); by the Research Center in Minority Institutions (RCMI) award number 8G12MD007600 from the National Institute on Minority Health and Health Disparities (NIMHD); by the grant number R25 GM061838 from the Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) at the University of Puerto Rico Medical Sciences Campus; and by award number 8U54 MD007587 from NIMHD of the National Institutes of Health (NIH). Genomas Inc. provided support in the form of salaries for authors [GR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; [Anonymous], 2012, DECL MED US COSTS BE; [Anonymous], 2012, CHEST S2, P141; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Bartholow M., 2013, PHARM TIMES, V79, p[44, 42]; Bertoni B, 2003, HUM BIOL, V75, P1, DOI 10.1353/hub.2003.0016; Bress A, 2012, PHARMACOGENOMICS, V13, P1925, DOI [10.2217/PGS.12.164, 10.2217/pgs.12.164]; Bristol-Myers Squibb Company, 2011, COUM WARF SOD PACK I; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Caldwell MD, 2007, CLIN MED RES, V5, P8, DOI 10.3121/cmr.2007.724; Cavallari LH, 2010, CLIN PHARMACOL THER, V87, P459, DOI 10.1038/clpt.2009.223; Cavallari LH, 2013, PHARMACOGENET GENOM, V23, P228, DOI 10.1097/FPC.0b013e32835e95c7; Centers for Medicaid and Medicare Services, DEC MEM PHARM TEST W; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Claudio-Campos Karla, 2015, Drug Metabolism and Personalized Therapy, V30, P87, DOI 10.1515/dmdi-2014-0023; Dickmann LJ, 2001, MOL PHARMACOL, V60, P382, DOI 10.1124/mol.60.2.382; Drozda K, 2015, PHARMACOGENET GENOM, V25, P73, DOI 10.1097/FPC.0000000000000108; Duconge J, 2010, J PHARM PHARMACOPROT, V1, P1; Duconge J, 2014, PHARMACOGENOMICS PHA, V5, P5, DOI [http://dx.doi.org/10.4172/2153-0645.1000e141, DOI 10.4172/2153-0645.1000E141]; Duconge J, 2015, P R HEALTH SCI J, V34, P175; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Flockhart DA, 2008, GENET MED, V10, P139, DOI 10.1097/GIM.0b013e318163c35f; Goldstein JA, 2001, BRIT J CLIN PHARMACO, V52, P349, DOI 10.1046/j.0306-5251.2001.01499.x; GORDON J, 2006, PHARMACOGENOMICS PRO; Gulseth MP, 2009, AM J HEALTH-SYST PH, V66, P123, DOI 10.2146/ajhp080127; Guzzi PH, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-258; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Hillman MA, 2004, PHARMACOGENETICS, V14, P539, DOI 10.1097/01.fpc.0000114760.08559.dc; Horne BD, 2012, THROMB HAEMOSTASIS, V107, P232, DOI 10.1160/TH11-06-0388; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Limdi N, 2008, CLIN PHARMACOL THER, V83, P312, DOI 10.1038/sj.clpt.6100290; Lindh JD, 2008, J THROMB THROMBOLYS, V25, P151, DOI 10.1007/s11239-007-0048-2; Liu Y, 2012, CLIN PHARMACOL THER, V91, P660, DOI 10.1038/clpt.2011.269; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Martinez-Cruzado JC, 2005, AM J PHYS ANTHROPOL, V128, P131, DOI 10.1002/ajpa.20108; McClain MR, 2008, GENET MED, V10, P89, DOI 10.1097/GIM.0b013e31815bf924; Oliphant A, 2002, BIOTECHNIQUES, P56; Orengo-Mercado Carmelo, 2013, J Pharmacogenomics Pharmacoproteomics, V4; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Pritchard JK, 2000, GENETICS, V155, P945; Ramos AS, 2012, PHARMACOGENOMICS, V13, P1937, DOI [10.2217/PGS.12.171, 10.2217/pgs.12.171]; Reynolds KK, 2007, PERS MED, V4, P11, DOI 10.2217/17410541.4.1.11; Ruano G, 2008, PERS MED, V5, P225, DOI 10.2217/17410541.5.3.225; Ruano G, 2009, PHARMACOGENOMICS, V10, P565, DOI 10.2217/PGS.09.5; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Salari K, 2005, GENET EPIDEMIOL, V29, P76, DOI 10.1002/gepi.20079; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Scott SA, 2009, PHARMACOGENOMICS, V10, P1243, DOI [10.2217/pgs.09.71, 10.2217/PGS.09.71]; Sim SC, 2006, METHOD MOL BIOL, V320, P183, DOI DOI 10.1002/PBC.20074; Sissung TM, 2010, PHARMACOGENOMICS, V11, P89, DOI 10.2217/PGS.09.154; Suarez-Kurtz G, 2006, CURR DRUG TARGETS, V7, P1649, DOI 10.2174/138945006779025392; Suarez-Kurtz G, 2007, PHARMACOGENOMICS ADM; Takahashi H, 2006, PHARMACOGENET GENOM, V16, P101, DOI 10.1097/01.fpc.0000184955.08453.a8; Veenstra DL, 2005, PHARMACOGENET GENOM, V15, P687, DOI 10.1097/01.fpc.0000174789.77614.68; Via M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016513; Villagra D, 2010, CLIN CHIM ACTA, V411, P1306, DOI 10.1016/j.cca.2010.05.021; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; Wigle P, 2013, AM FAM PHYSICIAN, V87, P556; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Zineh I, 2013, NEW ENGL J MED, V369, P2273, DOI 10.1056/NEJMp1314529	66	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145480	10.1371/journal.pone.0145480	http://dx.doi.org/10.1371/journal.pone.0145480			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745506	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600008
J	Ebbing, J; Seibert, FS; Pagonas, N; Bauer, F; Miller, K; Kempkensteffen, C; Gunzel, K; Bachmann, A; Seifert, HH; Rentsch, CA; Ardelt, P; Wetterauer, C; Amico, P; Babel, N; Westhoff, TH				Ebbing, Jan; Seibert, Felix S.; Pagonas, Nikolaos; Bauer, Frederic; Miller, Kurt; Kempkensteffen, Carsten; Guenzel, Karsten; Bachmann, Alexander; Seifert, Hans H.; Rentsch, Cyrill A.; Ardelt, Peter; Wetterauer, Christian; Amico, Patrizia; Babel, Nina; Westhoff, Timm H.			Dynamics of Urinary Calprotectin after Renal Ischaemia	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE KIDNEY INJURY; BIOMARKER; NGAL; SURGERY; KIM-1	Background: Urinary calprotectin has been identified as a promising biomarker for acute kidney injury. To date, however, the time-dependent changes of this parameter during acute kidney injury remain elusive. The aim of the present work was to define the timecourse of urinary calprotectin secretion after ischaemia/reperfusion-induced kidney injury in comparison to neutrophil gelatinase-associated lipocalin, thereby monitoring the extent of tubular damage in nephron sparing surgery for kidney tumours. Methods: The study population consisted of 42 patients. Thirty-two patients underwent either open or endoscopic nephron sparing surgery for kidney tumours. During the surgery, the renal arterial pedicle was clamped with a median ischaemic time of 13 minutes (interquartile range, 4.5-20.3 minutes) in 26 patients. Ten retro-peritoneoscopic living donor nephrectomy patients and 6 nephron sparing surgery patients in whom the renal artery was not clamped served as controls. Urinary calprotectin and neutrophil gelatinase-associated lipocalin concentrations were repeatedly measured by enzyme-linked immunosorbent assay and assessed according to renal function parameters. Results: Urinary concentrations of calprotectin and neutrophil gelatinase-associated lipocalin increased significantly after ischaemia/reperfusion injury, whereas concentrations remained unchanged after nephron sparing surgery without ischaemia/reperfusion injury and after kidney donation. Calprotectin and neutrophil gelatinase-associated lipocalin levels were significantly increased 2 and 8 hours, respectively, post-ischaemia. Both proteins reached maximal concentrations after 48 hours, followed by a subsequent persistent decrease. Maximal neutrophil gelatinase-associated lipocalin and calprotectin concentrations were 9-fold and 69-fold higher than their respective baseline values. The glomerular filtration rate was only transiently impaired at the first post-operative day after ischaemia/reperfusion injury (p = 0.049). Conclusion: Calprotectin and neutrophil gelatinase-associated lipocalin can be used to monitor clinical and sub-clinical tubular damage after nephron sparing surgery for kidney tumours. Urinary calprotectin concentrations start rising within 2 hours after ischaemia/reperfusion-induced kidney injury.	[Ebbing, Jan; Bachmann, Alexander; Seifert, Hans H.; Rentsch, Cyrill A.; Ardelt, Peter; Wetterauer, Christian] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland; [Ebbing, Jan; Miller, Kurt; Kempkensteffen, Carsten; Guenzel, Karsten] Charite, Dept Urol, Berlin, Germany; [Seibert, Felix S.; Pagonas, Nikolaos; Bauer, Frederic; Babel, Nina; Westhoff, Timm H.] Ruhr Univ Bochum, Univ Hosp Marien Hosp Herne, Dept Med 1, Bochum, Germany; [Amico, Patrizia] Univ Basel Hosp, Dept Nephrol, CH-4031 Basel, Switzerland	University of Basel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum; St. Marien Hospital; University of Basel	Ebbing, J (corresponding author), Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.	Jan.Ebbing@usb.ch; Timm.Westhoff@marienhospital-herne.de	Babel, Nina/AAK-2034-2021; Pagonas, Nikolaos/V-2241-2019	Gunzel, Karsten/0000-0003-0504-3475; Rentsch, Cyrill/0000-0002-8085-6006; Babel, Nina/0000-0003-3673-712X; Westhoff, Timm H./0000-0001-5797-834X	German Research Foundation [FOR1368]	German Research Foundation(German Research Foundation (DFG))	The study was funded by the German Research Foundation (Research Unit FOR1368, http://www.dfg.de/en/research_funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi Z, 2013, J UROLOGY, V189, P1559, DOI 10.1016/j.juro.2012.10.029; Dessing MC, 2015, KIDNEY INT, V87, P85, DOI 10.1038/ki.2014.216; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Ebbing J, 2014, WORLD J UROL, V32, P1485, DOI 10.1007/s00345-013-1227-8; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fontanilla John, 2011, Expert Opin Med Diagn, V5, P161, DOI 10.1517/17530059.2011.552496; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Heller F, 2011, CLIN J AM SOC NEPHRO, V6, P2347, DOI 10.2215/CJN.02490311; Lane BR, 2013, UROL ONCOL-SEMIN ORI, V31, P682, DOI 10.1016/j.urolonc.2011.05.007; Langetepe J, 2014, EUR UROL SUPPL, V13, pe323; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Parekh DJ, 2013, J AM SOC NEPHROL, V24, P506, DOI 10.1681/ASN.2012080786; Pedersen KR, 2010, SCAND J CLIN LAB INV, V70, P374, DOI 10.3109/00365513.2010.486868; Schmid Marianne, 2015, World J Nephrol, V4, P160, DOI 10.5527/wjn.v4.i2.160; Schrier RW, 2004, J AM SOC NEPHROL, V15, P2756, DOI 10.1097/01.ASN.0000141324.49873.11; Seibert FS, 2013, ACTA PHYSIOL, V207, P700, DOI 10.1111/apha.12064; Silberstein JL, 2013, BJU INT, V112, P517, DOI 10.1111/bju.12066; Sprenkle PC, 2013, J UROLOGY, V190, P159, DOI 10.1016/j.juro.2013.01.101; Tepel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113006	24	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146395	10.1371/journal.pone.0146395	http://dx.doi.org/10.1371/journal.pone.0146395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745147	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600045
J	Fung, CM; White, JR; Brown, AS; Gong, HY; Weitkamp, JH; Frey, MR; McElroy, SJ				Fung, Camille M.; White, Jessica R.; Brown, Ashley S.; Gong, Huiyu; Weitkamp, Joern-Hendrik; Frey, Mark R.; McElroy, Steven J.			Intrauterine Growth Restriction Alters Mouse Intestinal Architecture during Development	PLOS ONE			English	Article							PANETH CELL-DIFFERENTIATION; NECROTIZING ENTEROCOLITIS; STEM-CELLS; NEUREGULIN-4; THROMBOXANE; EXPRESSION; MICROBIOTA; MORBIDITY; MORTALITY	Infants with intrauterine growth restriction (IUGR) are at increased risk for neonatal and lifelong morbidities affecting multiple organ systems including the intestinal tract. The underlying mechanisms for the risk to the intestine remain poorly understood. In this study, we tested the hypothesis that IUGR affects the development of goblet and Paneth cell lineages, thus compromising the innate immunity and barrier functions of the epithelium. Using a mouse model of maternal thromboxane A(2)-analog infusion to elicit maternal hypertension and resultant IUGR, we tested whether IUGR alters ileal maturation and specifically disrupts mucus-producing goblet and antimicrobial-secreting Paneth cell development. We measured body weights, ileal weights and ileal lengths from birth to postnatal day (P) 56. We also determined the abundance of goblet and Paneth cells and their mRNA products, localization of cellular tight junctions, cell proliferation, and apoptosis to interrogate cellular homeostasis. Comparison of the murine findings with human IUGR ileum allowed us to verify observed changes in the mouse were relevant to clinical IUGR. At P14 IUGR mice had decreased ileal lengths, fewer goblet and Paneth cells, reductions in Paneth cell specific mRNAs, and decreased cell proliferation. These findings positively correlated with severity of IUGR. Furthermore, the decrease in murine Paneth cells was also seen in human IUGR ileum. IUGR disrupts the normal trajectory of ileal development, particularly affecting the composition and secretory products of the epithelial surface of the intestine. We speculate that this abnormal intestinal development may constitute an inherent "first hit", rendering IUGR intestine susceptible to further injury, infection, or inflammation.	[Fung, Camille M.; Brown, Ashley S.] Univ Utah, Div Neonatol, Pediat, Salt Lake City, UT USA; [White, Jessica R.; Gong, Huiyu; McElroy, Steven J.] Univ Iowa, Div Neonatol, Pediat, Iowa City, IA 52242 USA; [Weitkamp, Joern-Hendrik] Vanderbilt Univ, Div Neonatol, Pediat, Nashville, TN 37235 USA; [Frey, Mark R.] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Frey, Mark R.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Frey, Mark R.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA	Utah System of Higher Education; University of Utah; University of Iowa; Vanderbilt University; University of Southern California; University of Southern California; Children's Hospital Los Angeles	McElroy, SJ (corresponding author), Univ Iowa, Div Neonatol, Pediat, Iowa City, IA 52242 USA.	steven-mcelroy@uiowa.edu	McElroy, Steven/AGR-6835-2022; Weitkamp, Joern-Hendrik/AAZ-8272-2020; Frey, Mark/M-1739-2019; McElroy, Steven/AAC-7204-2019	McElroy, Steven/0000-0002-4321-723X; Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Frey, Mark/0000-0002-2561-5402; McElroy, Steven/0000-0002-4321-723X	National Institute of Health [DK083677, DK097335, DK095004, HD061607, AI007343]; Children's Miracle Network; Divisions of Neonatology at The University of Utah; Vanderbilt University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD061607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095004, R03DK097335, K08DK083677] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Miracle Network; Divisions of Neonatology at The University of Utah; Vanderbilt University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institute of Health (www.NIH.gov) awards DK083677 (SJM), DK097335 (SJM), DK095004 (MRF), HD061607 (JHW), and AI007343 (JRW), the Children's Miracle Network (http://childrensmiraclenetworkhospitals.org/Hospital/UniversityofIowaChildrensHospital, JRW and SJM), and the Divisions of Neonatology at The University of Utah (http://medicine.utah.edu/pediatrics/neonatology/,CMF) and at Vanderbilt University (http://pediatrics.mc.vanderbilt.edu/interior.php?mid=4773, JHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Baserga M, 2004, EARLY HUM DEV, V79, P93, DOI 10.1016/j.earlhumdev.2004.04.015; Bernard JK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400846; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Bozzetti V, 2013, EARLY HUM DEV, V89, pS21, DOI 10.1016/j.earlhumdev.2013.07.006; Brown KS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/852378; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Clevers H, 2013, NATURE, V495, P53, DOI 10.1038/nature11958; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coutinho HB, 1998, J CLIN PATHOL, V51, P512, DOI 10.1136/jcp.51.7.512; Fung C, 2011, J DEV ORIG HLTH DIS, V2, P291, DOI 10.1017/S2040174411000535; Garite TJ, 2004, AM J OBSTET GYNECOL, V191, P481, DOI 10.1016/j.ajog.2004.01.036; Gilbert WM, 2003, AM J OBSTET GYNECOL, V188, P1596, DOI 10.1067/mob.2003.384; Gordon PV, 2014, J PERINATOL, V34, P732, DOI 10.1038/jp.2014.137; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Liu HS, 1998, INT J GYNECOL OBSTET, V63, P1, DOI 10.1016/S0020-7292(98)00101-5; March MI, 2015, J MATERN-FETAL NEO M, V28, P1285, DOI 10.3109/14767058.2014.951624; Martin R.J, 2020, FANAROFF MARTINS NEO, P1218; McElroy SJ, 2014, AM J PATHOL, V184, P2768, DOI 10.1016/j.ajpath.2014.06.015; McElroy SJ, 2013, NEONATOLOGY, V103, P10, DOI 10.1159/000342340; McElroy Steven J, 2011, Neoreviews, V12, pe517; McElroy SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG656, DOI 10.1152/ajpgi.00550.2010; Moore HM, 2012, CLIN CHIM ACTA, V413, P1305, DOI 10.1016/j.cca.2012.04.013; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Patel RM, 2015, PEDIATR RES, V78, P232, DOI 10.1038/pr.2015.97; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Regev RH, 2004, CLIN PERINATOL, V31, P453, DOI 10.1016/j.clp.2004.04.017; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Sanderson I.R., 1999, DEV GASTROINTESTINAL; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Weitkamp JH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099042, 10.1371/journal.pone.0105487]; Zhang CX, 2012, DIS MODEL MECH, V5, P522, DOI 10.1242/dmm.009001	37	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146542	10.1371/journal.pone.0146542	http://dx.doi.org/10.1371/journal.pone.0146542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745886	Green Submitted, gold, Green Published			2022-12-27	WOS:000367815600063
J	Qureshi-Baig, K; Ullmann, P; Rodriguez, F; Frasquilho, S; Nazarov, PV; Haan, S; Letellier, E				Qureshi-Baig, Komal; Ullmann, Pit; Rodriguez, Fabien; Frasquilho, Sonia; Nazarov, Petr V.; Haan, Serge; Letellier, Elisabeth			What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue	PLOS ONE			English	Article							TRANSFERASE ISOFORMS GSTP1-1; TUMOR-INITIATING CELLS; IN-VITRO PROPAGATION; STEM-CELLS; CD133 EXPRESSION; SELF-RENEWAL; IDENTIFICATION; POPULATIONS; GSTA4-4; GROWTH	Due to their self-renewal and tumorigenic properties, tumor-initiating cells (TICs) have been hypothesized to be important targets for colorectal cancer (CRC). However the study of TICs is hampered by the fact that the identification and culturing of TICs is still a subject of extensive debate. Floating three-dimensional spheroid cultures (SC) that grow in serumfree medium supplemented with growth factors are supposed to be enriched in TICs. We generated SC from fresh clinical tumor specimens and compared them to SC isolated from CRC cell-lines as well as to adherent differentiated counterparts. Patient-derived SC display self-renewal capacity and can induce serial transplantable tumors in immuno-deficient mice, which phenotypically resemble the tumor of origin. In addition, the original tumor tissue and established SC retain several similar CRC-relevant mutations. Primary SC express key stemness proteins such as SOX2, OCT4, NANOG and LGR5 and importantly show increased chemoresistance ability compared to their adherent differentiated counterparts and to cell line-derived SC. Strikingly, cells derived from spheroid or adherent differentiating culture conditions displayed similar self-renewal capacity and equally formed tumors in immune-deficient mice, suggesting that self-renewal and tumor-initiation capacity of TICs is not restricted to phenotypically immature spheroid cells, which we describe to be highly plastic and able to reacquire stem-cell traits even after long differentiation processes. Finally, we identified two genes among a sphere gene expression signature that predict disease relapse in CRC patients. Here we propose that SC derived from fresh patient tumor tissue present interesting phenotypic features that may have clinical relevance for chemoresistance and disease relapse and therefore represent a valuable tool to test for new CRC-therapies that overcome drug resistance.	[Qureshi-Baig, Komal; Ullmann, Pit; Rodriguez, Fabien; Haan, Serge; Letellier, Elisabeth] Univ Luxembourg, Life Sci Res Unit, Mol Dis Mech Grp, L-4367 Campus Belval, Luxembourg; [Frasquilho, Sonia] Integrated Biobank Luxembourg, L-1210 Luxembourg, Luxembourg; [Nazarov, Petr V.] Luxembourg Inst Hlth, Genom Res Unit, L-1526 Luxembourg, Luxembourg	University of Luxembourg; Luxembourg Institute of Health; Luxembourg Institute of Health	Letellier, E (corresponding author), Univ Luxembourg, Life Sci Res Unit, Mol Dis Mech Grp, 6 Ave Swing, L-4367 Campus Belval, Luxembourg.	elisabeth.letellier@uni.lu	Letellier, Elisabeth/I-9515-2016	Letellier, Elisabeth/0000-0001-8242-9393; Nazarov, Petr/0000-0003-3443-0298	Fondation Cancer [F1R-LSC-PAU-13HY2C]; Fonds National de la Recherche (FNR); Integrated Biobank of Luxembourg (IBBL); Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg	Fondation Cancer; Fonds National de la Recherche (FNR)(Luxembourg National Research Fund); Integrated Biobank of Luxembourg (IBBL); Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg	The authors would like to thank the Fondation Cancer (grant F1R-LSC-PAU-13HY2C) for funding this study and the Fonds National de la Recherche (FNR) for supporting KB and PU under the AFR grant scheme. We also thank the Integrated Biobank of Luxembourg (IBBL) for supporting this study. The authors are also grateful to the Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg for supporting KB and PU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2014, J NEUROPATH EXP NEUR, V73, P1062, DOI 10.1097/NEN.0000000000000130; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Calvet CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089644; Cammareri P, 2008, METHOD CELL BIOL, V86, P311, DOI 10.1016/S0091-679X(08)00014-9; Chen DT, 2012, J GASTROINTEST SURG, V16, P905, DOI 10.1007/s11605-011-1815-0; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; Collura A, 2013, CELL MOL LIFE SCI, V70, P729, DOI 10.1007/s00018-012-1160-9; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fan F, 2015, BRIT J CANCER, V112, P539, DOI 10.1038/bjc.2014.620; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Garcia-Gonzalez X, 2015, ONCOTARGET, V6, P6422, DOI 10.18632/oncotarget.3289; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Goswami Chirayu Pankaj, 2013, J Clin Bioinforma, V3, P22, DOI 10.1186/2043-9113-3-22; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; He NG, 1996, ARCH BIOCHEM BIOPHYS, V333, P214, DOI 10.1006/abbi.1996.0383; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirsch D, 2014, CARCINOGENESIS, V35, P849, DOI 10.1093/carcin/bgt377; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ieta K, 2008, ANN SURG ONCOL, V15, P638, DOI 10.1245/s10434-007-9605-3; Irene Miranda-Lorenzo, 2014, NAT METHODS, P11; Islam F, 2015, EXP CELL RES; Kai K, 2009, CANCER SCI, V100, P2275, DOI 10.1111/j.1349-7006.2009.01318.x; Kalinina EV, 2007, B EXP BIOL MED+, V143, P328, DOI 10.1007/s10517-007-0102-2; Kalinina EV, 2012, B EXP BIOL MED+, V154, P64, DOI 10.1007/s10517-012-1876-4; Kemper K, 2010, ONCOTARGET, V1, P387, DOI 10.18632/oncotarget.173; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee S-H, 2015, CANC LETT; Li L, 2012, ONCOGENE, V31, P3901, DOI 10.1038/onc.2011.541; Liu AF, 2013, CHIN J CANCER, V32, P483, DOI 10.5732/cjc.012.10282; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Muraro MG, 2012, STEM CELL TRANSL MED, V1, P592, DOI 10.5966/sctm.2012-0003; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Ohata H, 2012, CANCER RES, V72, P5101, DOI 10.1158/0008-5472.CAN-11-3812; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Qiu XF, 2012, CANCER LETT, V323, P161, DOI 10.1016/j.canlet.2012.04.004; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rodel C, 2012, LANCET ONCOL, V13, P679, DOI 10.1016/S1470-2045(12)70187-0; Sgambato A, 2010, J CELL PHYSIOL, V224, P234, DOI 10.1002/jcp.22124; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Weiswald LB, 2013, BRIT J CANCER, V108, P1720, DOI 10.1038/bjc.2013.132; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; Williams SA, 2013, LAB INVEST, V93, P970, DOI 10.1038/labinvest.2013.92; Wu H, 2014, CURR STEM CELL RES T, V9, P82, DOI 10.2174/1574888X09666131217114927; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Yang CG, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0619-6; Ye FG, 2015, CANCER RES, V75, P1504, DOI 10.1158/0008-5472.CAN-14-2341; Zhang G, 2012, MOL MED REP, V6, P519, DOI 10.3892/mmr.2012.939; Zhao RH, 2012, J THORAC CARDIOV SUR, V144, P1192, DOI 10.1016/j.jtcvs.2012.08.008	74	35	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146052	10.1371/journal.pone.0146052	http://dx.doi.org/10.1371/journal.pone.0146052			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745821	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600022
J	Sela, U; Park, CG; Park, A; Olds, P; Wang, S; Steinman, RM; Fischetti, VA				Sela, Uri; Park, Chae Gyu; Park, Andrew; Olds, Peter; Wang, Shu; Steinman, Ralph M.; Fischetti, Vincent A.			Dendritic Cells Induce a Subpopulation of IL-12R beta 2-Expressing Treg that Specifically Consumes IL-12 to Control Th1 Responses	PLOS ONE			English	Article							REGULATORY T-CELL; INTERFERON-GAMMA PRODUCTION; DIFFERENTIATION; INTERLEUKIN-12; PROLIFERATION; EXPRESSION; DIVERSITY; BET	Cytokines secreted from dendritic cells (DCs) play an important role in the regulation of T helper (Th) cell differentiation and activation into effector cells. Therefore, controlling cytokine secretion from DCs may potentially regulate Th differentiation/activation. DCs also induce de-novo generation of regulatory T cells (Treg) that modulate the immune response. In the current study we used the mixed leukocyte reaction (MLR) to investigate the effect of allospecific Treg on IL-12, TNF alpha and IL-6 secretion by DCs. Treg cells were found to markedly down-regulate IL-12 secretion from DCs following stimulation with TLR7/8 agonist. This down-regulation of IL-12 was neither due to a direct suppression of its production by the DCs nor a result of marked DC death. We found that IL-12 was rather actively consumed by Treg cells. IL-12 consumption was mediated by a subpopulation of IL-12R beta 2-expressing Treg cells and was dependent on MHC class-II expressed on dendritic cells. Furthermore, IL-12 consumption by Tregs increased their suppressive effect on T cell proliferation and Th1 activation. These results provide a new pathway of Th1 response regulation where IL-12 secreted by DCs is consumed by a sub-population of IL-12R beta 2-expressing Treg cells. Consumption of IL-12 by Tregs not only reduces the availability of IL-12 to Th effector cells but also enhances the Treg immunosuppressive effect. This DC-induced IL12R beta 2-expressing Treg subpopulation may have a therapeutic advantage in suppressing Th1 mediated autoimmunity.	[Sela, Uri; Park, Chae Gyu; Park, Andrew; Olds, Peter; Steinman, Ralph M.] Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, Lab Cellular Physiol & Immunol, New York, NY 10065 USA; [Sela, Uri; Wang, Shu; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10065 USA; [Park, Chae Gyu] Yonsei Univ, Severance Biomed Sci Inst, Brain Korea PLUS Project Med Sci 21, Lab Immunol,Coll Med, Seoul 03722, South Korea	Rockefeller University; Rockefeller University; Yonsei University; Yonsei University Health System	Sela, U (corresponding author), Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, Lab Cellular Physiol & Immunol, New York, NY 10065 USA.	usela@rockefeller.edu		Park, Chae Gyu/0000-0003-1906-1308; Olds, Peter/0000-0003-0373-2349	National Institute of Allergy and Infectious Diseases [AI051573]; National Research Foundation of Korea [NRF-2013R1A1A2058427, NRF-2014R1A4A1008625]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant support was provided by the National Institute of Allergy and Infectious Diseases (AI051573). RMS received the funding. CGP was supported by grants from the National Research Foundation of Korea (NRF-2013R1A1A2058427, NRF-2014R1A4A1008625).	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; BERTAGNOLLI MM, 1992, J IMMUNOL, V149, P3778; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coquerelle C, 2010, IMMUNOL REV, V234, P317, DOI 10.1111/j.0105-2896.2009.00887.x; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Koenecke C, 2012, J IMMUNOL, V189, P2890, DOI 10.4049/jimmunol.1200413; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; MURPHY EE, 1994, J EXP MED, V180, P223, DOI 10.1084/jem.180.1.223; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Sela U, 2011, J EXP MED, V208, P2489, DOI 10.1084/jem.20110466; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Verma ND, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00190; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	36	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146412	10.1371/journal.pone.0146412	http://dx.doi.org/10.1371/journal.pone.0146412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745371	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600047
J	Oliveira, AEMFM; Duarte, JL; Amado, JRR; Cruz, RAS; Rocha, CF; Souto, RNP; Ferreira, RMA; Santos, K; da Conceiao, EC; de Oliveira, LAR; Kelecom, A; Fernandes, CP; Carvalho, JCT				Oliveira, Anna E. M. F. M.; Duarte, Jonatas L.; Amado, Jesus R. R.; Cruz, Rodrigo A. S.; Rocha, Clarice F.; Souto, Raimundo N. P.; Ferreira, Ricardo M. A.; Santos, Karen; da Conceiao, Edemilson C.; de Oliveira, Leandra A. R.; Kelecom, Alphonse; Fernandes, Caio P.; Carvalho, Jose C. T.			Development of a Larvicidal Nanoemulsion with Pterodon emarginatus Vogel Oil	PLOS ONE			English	Article							AEDES-AEGYPTI; LEAF EXTRACTS; PHASE; OPTIMIZATION; DELIVERY; PESTICIDES; STABILITY; DESIGN; SEEDS	Pterodon emarginatus Vogel is a Brazilian species that belongs to the family Fabaceae, popularly known as sucupira. Its oil has several biological activities, including potent larvicidal property against Aedes aegypti. This insect is the vector of dengue, a tropical disease that has been considered a critical health problem in developing countries, such as Brazil. Most of dengue control methods involve larvicidal agents suspended or diluted in water and making active lipophilic natural products available is therefore considered a technological challenge. In this context, nanoemulsions appear as viable alternatives to solve this major problem. The present study describes the development of a novel nanoemulsion with larvicidal activity against A. aegypti along with the required Hydrophile Lipophile Balance determination of this oil. It was suggested that the mechanism of action might involve reversible inhibition of acetylcholinesterase and our results also suggest that the P. emarginatus nanoemulsion is not toxic for mammals. Thus, it contributes significantly to alternative integrative practices of dengue control, as well as to develop sucupira based nanoproducts for application in aqueous media.	[Oliveira, Anna E. M. F. M.; Duarte, Jonatas L.; Amado, Jesus R. R.; Cruz, Rodrigo A. S.; Rocha, Clarice F.; Fernandes, Caio P.; Carvalho, Jose C. T.] Univ Fed Amapa, Colegiado Farm, Lab Pesquisa Farm, BR-68902280 Macapa, AP, Brazil; [Oliveira, Anna E. M. F. M.; Duarte, Jonatas L.; Amado, Jesus R. R.; Cruz, Rodrigo A. S.; Fernandes, Caio P.; Carvalho, Jose C. T.] Univ Fed Amapa, Lab Nanobiotecnol Fitofarmaceut, Colegiado Farm, BR-68902280 Macapa, AP, Brazil; [Souto, Raimundo N. P.; Ferreira, Ricardo M. A.; Santos, Karen] Univ Fed Amapa, Lab Artropodes, Colegiado Ciencias Biol, BR-68902280 Macapa, AP, Brazil; [da Conceiao, Edemilson C.; de Oliveira, Leandra A. R.] Univ Fed Goias, Lab Pesquisa Desenvolvimento & Inovacao Bioprod, Fac Farm, BR-74605220 Goiania, Go, Brazil; [Kelecom, Alphonse] Univ Fed Fluminense, Lab Prod Nat Mar & Quim Bioorgan, BR-24001970 Niteroi, RJ, Brazil	Fundacao Universidade Federal do Amapa; Fundacao Universidade Federal do Amapa; Fundacao Universidade Federal do Amapa; Universidade Federal de Goias; Universidade Federal Fluminense	Fernandes, CP (corresponding author), Univ Fed Amapa, Colegiado Farm, Lab Pesquisa Farm, Campus Univ Marco Zero Equador, BR-68902280 Macapa, AP, Brazil.	caiofernandes@unifap.br	Oliveira, Anna/AAN-6694-2020; Cruz, Rodrigo/B-3224-2013; Amado, Jesus Rafael Rodriguez/Q-1739-2015; Carvalho, José Carlos Tavares/S-2427-2019; Duarte, Jonatas/M-4442-2017; Picanço Souto, Raimundo Nonato/GOV-5047-2022; Fernandes, Caio Pinho/A-1542-2015	Oliveira, Anna/0000-0001-9337-4519; Cruz, Rodrigo/0000-0003-1728-4145; Amado, Jesus Rafael Rodriguez/0000-0001-7574-6219; Carvalho, José Carlos Tavares/0000-0003-3662-9794; Duarte, Jonatas/0000-0002-7276-3686; Picanço Souto, Raimundo Nonato/0000-0002-8795-1217; Fernandes, Caio Pinho/0000-0002-6538-7360	CNPQ (Rede Amazonica de Pesquisa em Biofarmacos) [407768/2013-0]; FAPEAP (PRODETEC Araguari) [250.203.035/2013]	CNPQ (Rede Amazonica de Pesquisa em Biofarmacos)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPEAP (PRODETEC Araguari)(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP))	This study was supported by CNPQ (Rede Amazonica de Pesquisa em Biofarmacos - 407768/2013-0) and FAPEAP (PRODETEC Araguari - process no. 250.203.035/2013).	Alberti TB, 2014, J ETHNOPHARMACOL, V155, P485, DOI 10.1016/j.jep.2014.05.044; Angajala G, 2014, ACTA TROP, V135, P19, DOI 10.1016/j.actatropica.2014.03.012; Anjali CH, 2012, PEST MANAG SCI, V68, P158, DOI 10.1002/ps.2233; Baldissera MD, 2013, EXP PARASITOL, V134, P356, DOI 10.1016/j.exppara.2013.03.035; Barik TK, 2012, PARASITOL RES, V111, P1075, DOI 10.1007/s00436-012-2934-6; Brasil. Casos de Dengue, 1990, BRAS GRAND REG UN FE; Bruxel F, 2012, QUIM NOVA, V35, P1827, DOI 10.1590/S0100-40422012000900023; Caloni F, 2016, SCI TOTAL ENVIRON, V539, P331, DOI 10.1016/j.scitotenv.2015.09.005; Carvalho JCT, 1999, J ETHNOPHARMACOL, V64, P127, DOI 10.1016/S0378-8741(98)00116-0; Chang YH, 2014, J AGR FOOD CHEM, V62, P2306, DOI 10.1021/jf500160y; Cheong JN, 2008, J FOOD ENG, V89, P204, DOI 10.1016/j.jfoodeng.2008.04.018; Costa IC, 2014, LAT AM J PHARM, V33, P459; de Medeiros PM, 2015, J ETHNOPHARMACOL, V159, P43, DOI 10.1016/j.jep.2014.11.001; De Omena MC, 2006, VECTOR-BORNE ZOONOT, V6, P216, DOI 10.1089/vbz.2006.6.216; Dias DD, 2014, IND CROP PROD, V59, P154, DOI 10.1016/j.indcrop.2014.05.007; Duarte JL, 2015, REV BRAS FARMACOGN, V25, P189, DOI [10.1016/j.bjp.2015.02.010, 10.1016/j.bjp.2015.02.2010]; Dutra RC, 2012, REV BRAS FARMACOGN, V22, P971, DOI 10.1590/S0102-695X2012005000042; Dutra RC, 2009, REV BRAS FARMACOGN, V19, P429, DOI 10.1590/S0102-695X2009000300016; Dutra RC, 2009, J PHARM PHARMACOL, V61, P243, DOI [10.1211/jpp/61.02.0015, 10.1211/jpp.61.02.0015]; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fagg CW, 2015, J ETHNOPHARMACOL, V161, P18, DOI 10.1016/j.jep.2014.11.035; Fernandes CP, 2013, REV BRAS FARMACOGN, V23, P108, DOI 10.1590/S0102-695X2012005000127; Fernandes CP, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-22; Ferreira S.B., 2014, Rev. bras. plantas med., V16, P225, DOI 10.1590/S1516-05722014000200009; Forgiarini A, 2000, PROG COLL POL SCI S, V115, P36; Galceran Camila Benatti, 2011, Inflammopharmacology, V19, P139, DOI 10.1007/s10787-011-0081-9; Ghosh V, 2013, ASIAN J CHEM, V25, pS321; Grapentin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130674; Griffin W.C., 1949, J SOC COSMET CHEM, V1, P311; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hamdaoui M, 1995, TOXICOL LETT, V78, P38; Hovda LR, 2002, VET CLIN N AM-SMALL, V32, P455, DOI 10.1016/S0195-5616(01)00013-4; Kanis LA, 2012, PARASITOL RES, V110, P1173, DOI 10.1007/s00436-011-2610-2; Leong WF, 2011, FOOD CHEM, V129, P77, DOI 10.1016/j.foodchem.2011.04.027; LIMA R.B, 2015, LISTA ESPECIES FLORA; Lopez MD, 2010, IND CROP PROD, V31, P284, DOI 10.1016/j.indcrop.2009.11.005; MAHAJAN JR, 1973, J CHEM SOC PERK T 1, P520, DOI 10.1039/p19730000520; Mann RS, 2012, MINI-REV ORG CHEM, V9, P185; Martins MCB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111102; Montenegro Livya Holanda M., 2006, Rev. bras. farmacogn., V16, P611, DOI 10.1590/S0102-695X2006000500005; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Niwattisaiwong N, 2004, Drug Metabol Drug Interact, V20, P43; Nuchuchua O, 2009, AAPS PHARMSCITECH, V10, P1234, DOI 10.1208/s12249-009-9323-1; Orafidiya LO, 2002, INT J PHARMACEUT, V237, P241, DOI 10.1016/S0378-5173(02)00051-0; Ostertag F, 2012, J COLLOID INTERF SCI, V388, P95, DOI 10.1016/j.jcis.2012.07.089; Paula Fernanda B A, 2005, BMC Complement Altern Med, V5, P17, DOI 10.1186/1472-6882-5-17; Prophiro JS, 2012, PARASITOL RES, V110, P699, DOI 10.1007/s00436-011-2545-7; Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008; Rehman JU, 2014, FITOTERAPIA, V95, P65, DOI 10.1016/j.fitote.2014.03.002; Montefuscoli AR, 2014, PARASITOL RES, V113, P793, DOI 10.1007/s00436-013-3710-y; Rodrigues EDR, 2015, LAT AM J PHARM, V34, P338; Rodrigues EDR, 2014, REV BRAS FARMACOGN, V24, P699, DOI 10.1016/j.bjp.2014.10.013; Rodriguez-Rojo S, 2012, IND CROP PROD, V37, P137, DOI 10.1016/j.indcrop.2011.11.026; Seng CM, 2008, J VECTOR ECOL, V33, P139, DOI 10.3376/1081-1710(2008)33[139:CUOTLF]2.0.CO;2; Sevcikova P, 2012, COLLOID SURFACE A, V410, P130, DOI 10.1016/j.colsurfa.2012.06.031; Silva HD, 2011, J FOOD ENG, V102, P130, DOI 10.1016/j.jfoodeng.2010.08.005; Solans C, 2005, CURR OPIN COLLOID IN, V10, P102, DOI 10.1016/j.cocis.2005.06.004; Sole I, 2012, J COLLOID INTERF SCI, V376, P133, DOI 10.1016/j.jcis.2012.02.063; Soni N, 2014, SCI WORLD J, DOI 10.1155/2014/496362; Sugumar S, 2014, B ENTOMOL RES, V104, P393, DOI 10.1017/S0007485313000710; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023; Veerakumar K, 2014, PARASITOL RES, V113, P4085, DOI 10.1007/s00436-014-4077-4; Viegas C, 2003, QUIM NOVA, V26, P390, DOI 10.1590/S0100-40422003000300017; Wang LJ, 2009, J COLLOID INTERF SCI, V330, P443, DOI 10.1016/j.jcis.2008.10.077; WHO, 2005, GUID LAB FIELD TEST; WHO, 2011, GUID DRINK WAT QUAL	66	57	57	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145835	10.1371/journal.pone.0145835	http://dx.doi.org/10.1371/journal.pone.0145835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26742099	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600010
J	Valle, DL; Cabrera, EC; Puzon, JJM; Rivera, WL				Valle, Demetrio L., Jr.; Cabrera, Esperanza C.; Puzon, Juliana Janet M.; Rivera, Windell L.			Antimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug Resistance	PLOS ONE			English	Article							OUTER-MEMBRANE PERMEABILITY; KLEBSIELLA-PNEUMONIAE; SOUTHERN THAILAND; MEDICINAL-PLANTS; AIDS PATIENTS; ANTIBACTERIAL; ANTIOXIDANT; PROPERTY	Piper betle L. has traditionally been used in alternativemedicine in different countries for various therapeutic purposes, including as an anti-infective agent. However, studies reported in the literature are mainly on its activities on drug susceptible bacterial strains. This study determined the antimicrobial activities of its ethanol, methanol, and supercritical CO2 extracts on clinical isolates of multiple drug resistant bacteria which have been identified by the Infectious Disease Society of America as among the currently more challenging strains in clinical management. Assay methods included the standard disc diffusion method and the broth microdilution method for the determination of the minimum inhibitory concentration (MIC) and the minimum bactericidal concentrations (MBC) of the extracts for the testmicroorganisms. This study revealed the bactericidal activities of all the P. betle leaf crude extracts on methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), extended spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii, with minimum bactericidal concentrations that ranged from 19 mu g/ml to 1250 mu g/ml. The extracts proved to be more potent against the Gram positive MRSA and VRE than for the Gram negative test bacteria. VRE isolates were more susceptible to all the extracts than the MRSA isolates. Generally, the ethanol extracts proved to be more potent than the methanol extracts and supercritical CO2 extracts as shown by their lower MICs for both the Gram positive and Gram negative MDRs. MTT cytotoxicity assay showed that the highest concentration (100 mu g/ml) of P. betle ethanol extract tested was not toxic to normal human dermal fibroblasts (HDFn). Data from the study firmly established P. betle as an alternative source of anti-infectives against multiple drug resistant bacteria.	[Valle, Demetrio L., Jr.] Univ Philippines, Coll Sci, Inst Biol, Quezon City 1101, Philippines; [Cabrera, Esperanza C.] De La Salle Univ, Dept Biol, Manila 0922, Philippines; [Puzon, Juliana Janet M.; Rivera, Windell L.] Univ Philippines, Coll Sci, Inst Biol, Quezon City 1101, Philippines; [Puzon, Juliana Janet M.; Rivera, Windell L.] Univ Philippines, Coll Sci, Nat Sci Res Inst, Quezon City 1101, Philippines	University of the Philippines System; University of the Philippines Diliman; De La Salle University; University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Diliman	Cabrera, EC (corresponding author), De La Salle Univ, Dept Biol, Taft Ave, Manila 0922, Philippines.	esperanza.cabrera@dlsu.edu.ph			Philippine Council for Health Research and Development of the Department of Science and Technology, Philippines	Philippine Council for Health Research and Development of the Department of Science and Technology, Philippines	This work was supported by Philippine Council for Health Research and Development of the Department of Science and Technology, Philippines, to DLV. http://www.pchrd.dost.gov.ph/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basri D. F., 2005, Indian Journal of Pharmacology, V37, P26; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bratu S, 2005, ARCH INTERN MED, V165, P1430, DOI 10.1001/archinte.165.12.1430; Cetinkaya Y, 2000, CLIN MICROBIOL REV, V13, P686, DOI 10.1128/CMR.13.4.686-707.2000; Chakraborty D., 2011, INT J PHARM PHARM SC, V3, P192; Chaveerach A., 2006, Ethnobotany Research and Applications, V4, P223; Chicca A, 2008, BRIT J PHARMACOL, V153, P879, DOI 10.1038/sj.bjp.0707639; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Cortes-Maramba NP, 1993, GUIDEBOOK PROPER USE; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Guha P., 2006, Journal of Human Ecology, V19, P87; IROBI ON, 1994, J ETHNOPHARMACOL, V42, P39, DOI 10.1016/0378-8741(94)90021-3; Mula S, 2008, BIOORGAN MED CHEM, V16, P2932, DOI 10.1016/j.bmc.2007.12.052; Nalina T., 2007, American Journal of Biochemistry and Biotechnology, V3, P10; Nguyen HN, 2011, CHEM ENG PROCESS, V50, P1207, DOI 10.1016/j.cep.2011.08.006; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1988, J ANTIMICROB CHEMOTH, V22, P17, DOI 10.1093/jac/22.Supplement_A.17; Nouri L, 2014, IND CROP PROD, V62, P47, DOI 10.1016/j.indcrop.2014.08.015; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Quisumbing ET, 1978, MED PLANTS PHILIPI 1; Ramji N, 2002, J ETHNOPHARMACOL, V83, P149, DOI 10.1016/S0378-8741(02)00194-0; Row LCM, 2009, J CHIN CHEM SOC-TAIP, V56, P653, DOI 10.1002/jccs.200900097; Sawangjaroen N, 2005, PARASITOL RES, V95, P17, DOI 10.1007/s00436-004-1264-8; Sawangjaroen N, 2006, PARASITOL RES, V98, P588, DOI 10.1007/s00436-005-0119-2; Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025; Shitut S, 1999, Cent Eur J Public Health, V7, P137; Stapleton Paul D., 2002, Science Progress, V85, P57, DOI 10.3184/003685002783238870; Subashkumar R., 2013, International Journal of Research in Pharmaceutical and Biomedical Sciences, V4, P42; Tarun Agarwal, 2012, Advances in Applied Science Research, V3, P698; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P2255, DOI 10.1128/AAC.37.11.2255; Valle Demetrio L. Jr., 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P532, DOI 10.1016/j.apjtb.2015.04.005	32	22	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146349	10.1371/journal.pone.0146349	http://dx.doi.org/10.1371/journal.pone.0146349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741962	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600030
J	Dhand, A; Luke, DA; Carothers, BJ; Evanoff, BA				Dhand, Amar; Luke, Douglas A.; Carothers, Bobbi J.; Evanoff, Bradley A.			Academic Cross-Pollination: The Role of Disciplinary Affiliation in Research Collaboration	PLOS ONE			English	Article							SOCIAL NETWORK ANALYSIS; SCIENCE; CTSA; INTERDISCIPLINARITY; HEALTH	Academic collaboration is critical to knowledge production, especially as teams dominate scientific endeavors. Typical predictors of collaboration include individual characteristics such as academic rank or institution, and network characteristics such as a central position in a publication network. The role of disciplinary affiliation in the initiation of an academic collaboration between two investigators deserves more attention. Here, we examine the influence of disciplinary patterns on collaboration formation with control of known predictors using an inferential network model. The study group included all researchers in the Institute of Clinical and Translational Sciences (ICTS) at Washington University in St. Louis. Longitudinal data were collected on co-authorships in grants and publications before and after ICTS establishment. Exponential-family random graph models were used to build the network models. The results show that disciplinary affiliation independently predicted collaboration in grant and publication networks, particularly in the later years. Overall collaboration increased in the post-ICTS networks, with cross-discipline ties occurring more often than within-discipline ties in grants, but not publications. This research may inform better evaluation models of university-based collaboration, and offer a roadmap to improve cross-disciplinary collaboration with discipline-informed network interventions.	[Dhand, Amar] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Dhand, Amar; Luke, Douglas A.; Carothers, Bobbi J.] Washington Univ, George Warren Brown Sch Social Work, Ctr Publ Hlth Syst Sci, St Louis, MO 63130 USA; [Evanoff, Bradley A.] Washington Univ, Sch Med, Dept Internal Med, Div Gen Med Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dhand, A (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	dhanda@neuro.wustl.edu		Evanoff, Bradley A./0000-0003-0085-333X; Dhand, Amar/0000-0001-6470-7548; Carothers, Bobbi/0000-0001-6050-9712	Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1 TR000448]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092950] Funding Source: NIH RePORTER	Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.	Abramo G, 2012, J AM SOC INF SCI TEC, V63, P2206, DOI 10.1002/asi.22647; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Bian J, 2014, J BIOMED INFORM, V52, P130, DOI 10.1016/j.jbi.2014.01.015; Bian J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111928; Borner K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001399; Croyle RT, 2008, AM J PREV MED, V35, pS90, DOI 10.1016/j.amepre.2008.05.012; Cummings JN, 2005, SOC STUD SCI, V35, P703, DOI 10.1177/0306312705055535; Falk-Krzesinski HJ, 2011, RES EVALUAT, V20, P145, DOI 10.3152/095820211X12941371876580; Gewin Virginia, 2014, Nature, V511, P371; Goodreau SM, 2007, SOC NETWORKS, V29, P231, DOI 10.1016/j.socnet.2006.08.001; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Harris J.K., 2014, INTRO EXPONENTIAL RA; Hughes ME, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001580; Luke D. A., 2012, DISSEMINATION IMPLEM, P154, DOI DOI 10.1093/ACPR0F:0S0/9780199751877.001.0001; Luke DA, 2015, CTS-CLIN TRANSL SCI, V8, P143, DOI 10.1111/cts.12248; Masse LC, 2008, AM J PREV MED, V35, pS151, DOI 10.1016/j.amepre.2008.05.020; Morris Martina, 2008, J Stat Softw, V24, P1548; Nagarajan R, 2015, CTS-CLIN TRANSL SCI, V8, P150, DOI 10.1111/cts.12247; Nagarajan R, 2013, J BIOMED INFORM, V46, P40, DOI 10.1016/j.jbi.2012.08.002; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Norman CD, 2011, AM J EVAL, V32, P70, DOI 10.1177/1098214010379038; Qin J, 1997, J AM SOC INFORM SCI, V48, P893, DOI 10.1002/(SICI)1097-4571(199710)48:10<893::AID-ASI5>3.0.CO;2-X; ROSENFIELD PL, 1992, SOC SCI MED, V35, P1343, DOI 10.1016/0277-9536(92)90038-R; Schummer J, 2004, SCIENTOMETRICS, V59, P425, DOI 10.1023/B:SCIE.0000018542.71314.38; Stokols D, 2008, AM J PREV MED, V35, pS96, DOI 10.1016/j.amepre.2008.05.003; Stokols Daniel, 2003, Nicotine Tob Res, V5 Suppl 1, pS21; Vacca R, 2015, CTS-CLIN TRANSL SCI, V8, P281, DOI 10.1111/cts.12267; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	31	14	14	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145916	10.1371/journal.pone.0145916	http://dx.doi.org/10.1371/journal.pone.0145916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA8CX	26760302	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100024
J	Hagedoorn, P; Vandenheede, H; Willaert, D; Vanthomme, K; Gadeyne, S				Hagedoorn, Paulien; Vandenheede, Hadewijch; Willaert, Didier; Vanthomme, Katrien; Gadeyne, Sylvie			Regional Inequalities in Lung Cancer Mortality in Belgium at the Beginning of the 21st Century: The Contribution of Individual and Area-Level Socioeconomic Status and Industrial Exposure	PLOS ONE			English	Article							SMOKING; HEALTH; NEIGHBORHOOD; POSITION; RISK; EPIDEMIOLOGY; CONTEXT; TRENDS; COHORT; ASSOCIATIONS	Being a highly industrialized country with one of the highest male lung cancer mortality rates in Europe, Belgium is an interesting study area for lung cancer research. This study investigates geographical patterns in lung cancer mortality in Belgium. More specifically it probes into the contribution of individual as well as area-level characteristics to (sub-district patterns in) lung cancer mortality. Data from the 2001 census linked to register data from 2001-2011 are used, selecting all Belgian inhabitants aged 65+ at time of the census. Individual characteristics include education, housing status and home ownership. Urbanicity, unemployment rate, the percentage employed in mining and the percentage employed in other high-risk industries are included as sub-district characteristics. Regional variation in lung cancer mortality at sub-district level is estimated using directly age-standardized mortality rates. The association between lung cancer mortality and individual and area characteristics, and their impact on the variation of sub-district level is estimated using multilevel Poisson models. Significant sub-district variations in lung cancer mortality are observed. Individual characteristics explain a small share of this variation, while a large share is explained by sub-district characteristics. Individuals with a low socioeconomic status experience a higher lung cancer mortality risk. Among women, an association with lung cancer mortality is found for the sub-district characteristics urbanicity and unemployment rate, while for men lung cancer mortality was associated with the percentage employed in mining. Not just individual characteristics, but also area characteristics are thus important determinants of (regional differences in) lung cancer mortality.	[Hagedoorn, Paulien] Vrije Univ Brussel, Interface Demog, Dept Sociol, Fac Econ & Social Sci, Brussels, Belgium; Vrije Univ Brussel, Solvay Business Sch, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel	Hagedoorn, P (corresponding author), Vrije Univ Brussel, Interface Demog, Dept Sociol, Fac Econ & Social Sci, Brussels, Belgium.	Paulien.hagedoorn@vub.ac.be	Vanthomme, Katrien/ABE-3777-2021	Hagedoorn, Paulien/0000-0001-5566-0610	Research Foundation Flanders (FWO) [G025813N]	Research Foundation Flanders (FWO)(FWO)	This research was funded by the Research Foundation Flanders (FWO) (Grant G025813N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens W, 1998, Int J Occup Environ Health, V4, P236; Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Bayingana K, 2001, GEZONDHEIDSENQUETE M; Bentley R, 2008, CANCER CAUSE CONTROL, V19, P183, DOI 10.1007/s10552-007-9084-7; Boffetta P, 2006, MUTAT RES-GEN TOX EN, V608, P157, DOI 10.1016/j.mrgentox.2006.02.015; Bray F, 2004, EUR J CANCER, V40, P96, DOI 10.1016/j.ejca.2003.08.005; Bray FI, 2010, INT J CANCER, V126, P1454, DOI 10.1002/ijc.24855; Brown T, 2012, BRIT J CANCER, V107, pS56, DOI 10.1038/bjc.2012.119; Chaix B, 2006, INT J EPIDEMIOL, V35, P633, DOI 10.1093/ije/dyl009; Csavina J, 2012, SCI TOTAL ENVIRON, V433, P58, DOI 10.1016/j.scitotenv.2012.06.013; Deboosere P, 2004, CODEBOEK ALGEMENE SO; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Drieskens S., 1997, HLTH INTERVIEW SURVE; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; FANC, 2014, IS RAD FOUND; Fano V, 2004, OCCUP ENVIRON MED, V61, P757, DOI 10.1136/oem.2003.010728; Fay MP, 1997, STAT MED, V16, P791; Forey B, 2013, INT SMOKING STAT; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Gartner A, 2011, SOC SCI MED, V72, P1685, DOI 10.1016/j.socscimed.2011.03.017; Hastert TA, 2015, J EPIDEMIOL COMMUN H, V69, P168, DOI 10.1136/jech-2014-204417; Henau K, 2015, CANCER EPIDEMIOL, V39, P55, DOI 10.1016/j.canep.2014.10.009; Hendryx M, 2008, LUNG CANCER, V62, P1, DOI 10.1016/j.lungcan.2008.02.004; Hystad P, 2013, SOC SCI MED, V97, P95, DOI 10.1016/j.socscimed.2013.08.005; Idris BI, 2007, HEALTH PLACE, V13, P702, DOI 10.1016/j.healthplace.2006.11.001; International Agency for Research on Cancer, 1997, IARC MONOGRAPHS EVAL, V68; Janssen F, 2012, DEMOGR RES, V27, P233, DOI 10.4054/DemRes.2012.27.9; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; KUNST AE, 1993, SOC SCI MED, V37, P623, DOI 10.1016/0277-9536(93)90101-9; Lopez-Cima MF, 2013, INT J ENVIRON SCI TE, V10, P891, DOI 10.1007/s13762-013-0248-6; Luyten S, 2007, BELGISCHE STADSGEWES; Malvezzi M, 2013, LUNG CANCER, V80, P138, DOI 10.1016/j.lungcan.2013.01.020; Martikainen P, 2003, J EPIDEMIOL COMMUN H, V57, P210, DOI 10.1136/jech.57.3.210; Meijer M, 2012, SOC SCI MED, V74, P1204, DOI 10.1016/j.socscimed.2011.11.034; Nawrot T, 2006, LANCET ONCOL, V7, P119, DOI 10.1016/S1470-2045(06)70545-9; Nawrot TS, 2007, J EPIDEMIOL COMMUN H, V61, P146, DOI 10.1136/jech.2005.044263; OECD, 2007, OECD ENV PERF REV, DOI [10.1787/9789264031128-en, DOI 10.1787/9789264031128-EN]; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Robert SA, 1999, ANNU REV SOCIOL, V25, P489, DOI 10.1146/annurev.soc.25.1.489; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Sharp L, 2014, J URBAN HEALTH, V91, P510, DOI 10.1007/s11524-013-9846-3; Sharpe KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089513; Shohaimi S, 2003, J EPIDEMIOL COMMUN H, V57, P270, DOI 10.1136/jech.57.4.270; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; StataCorp, 2013, STAT STAT SOFTW REL; Steenland K, 2004, AM J EPIDEMIOL, V159, P1047, DOI 10.1093/aje/kwh129; Taeger D, 2015, SCAND J WORK ENV HEA, V41, P467, DOI 10.5271/sjweh.3513; Taylor MP, 2014, ENVIRON RES, V135, P296, DOI 10.1016/j.envres.2014.08.036; Tyczynski JE, 2003, LANCET ONCOL, V4, P45, DOI 10.1016/S1470-2045(03)00960-4; Van der Heydena JHA, 2009, LUNG CANCER, V63, P322, DOI 10.1016/j.lungcan.2008.06.006; VANLOON AJM, 1995, J EPIDEMIOL COMMUN H, V49, P65, DOI 10.1136/jech.49.1.65; vanLoon AJM, 1997, J EPIDEMIOL COMMUN H, V51, P24, DOI 10.1136/jech.51.1.24; Vigotti MA, 2014, INT J PUBLIC HEALTH, V59, P645, DOI 10.1007/s00038-014-0554-x; Woods LM, 2005, BRIT J CANCER, V92, P1279, DOI 10.1038/sj.bjc.6602506; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	56	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147099	10.1371/journal.pone.0147099	http://dx.doi.org/10.1371/journal.pone.0147099			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA8CX	26760040	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100068
J	Inskip, C; Carter, N; Riley, S; Roberts, T; MacMillan, D				Inskip, Chloe; Carter, Neil; Riley, Shawn; Roberts, Thomas; MacMillan, Douglas			Toward Human-Carnivore Coexistence: Understanding Tolerance for Tigers in Bangladesh	PLOS ONE			English	Article							ACCEPTANCE CAPACITY; ATTITUDES; CONSERVATION; PERCEPTION; CONFLICT; SUNDARBANS; RANCHERS; BELIEFS; RISKS; BEARS	Fostering local community tolerance for endangered carnivores, such as tigers (Panthera tigris), is a core component of many conservation strategies. Identification of antecedents of tolerance will facilitate the development of effective tolerance-building conservation action and secure local community support for, and involvement in, conservation initiatives. We use a stated preference approach for measuring tolerance, based on the 'Wildlife Stake-holder Acceptance Capacity' concept, to explore villagers' tolerance levels for tigers in the Bangladesh Sundarbans, an area where, at the time of the research, human-tiger conflict was severe. We apply structural equation modeling to test an a priori defined theoretical model of tolerance and identify the experiential and psychological basis of tolerance in this community. Our results indicate that beliefs about tigers and about the perceived current tiger population trend are predictors of tolerance for tigers. Positive beliefs about tigers and a belief that the tiger population is not currently increasing are both associated with greater stated tolerance for the species. Contrary to commonly-held notions, negative experiences with tigers do not directly affect tolerance levels; instead, their effect is mediated by villagers' beliefs about tigers and risk perceptions concerning human-tiger conflict incidents. These findings highlight a need to explore and understand the socio-psychological factors that encourage tolerance towards endangered species. Our research also demonstrates the applicability of this approach to tolerance research to a wide range of socio-economic and cultural contexts and reveals its capacity to enhance carnivore conservation efforts worldwide.	[Inskip, Chloe; Roberts, Thomas; MacMillan, Douglas] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England; [Carter, Neil] Boise State Univ, Human Environm Syst Ctr, Boise, ID 83725 USA; [Riley, Shawn] Michigan State Univ, E Lansing, MI 48824 USA	University of Kent; Idaho; Boise State University; Michigan State University	Inskip, C (corresponding author), Chester Zoo, Caughall Rd, Upton By Chester CH2 1LH, England.	chloeinskip@gmail.com		Carter, Neil/0000-0002-4399-6384	Economic and Social Research Council; Natural and Environmental Research Council [ES/F012179/1]; North of England Zoological Society (Chester Zoo); Michigan State University's Partnership for Ecosystem Research; Boise State University (NSF from the NSF Idaho EPSCoR Program) [IIA-1301792]; Boise State University (National Science Foundation); Michigan State University's Partnership for Ecosystem Research and Management; Office Of The Director [1301792] Funding Source: National Science Foundation	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural and Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); North of England Zoological Society (Chester Zoo); Michigan State University's Partnership for Ecosystem Research; Boise State University (NSF from the NSF Idaho EPSCoR Program); Boise State University (National Science Foundation); Michigan State University's Partnership for Ecosystem Research and Management; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	CI received funding for this research from the Economic and Social Research Council (http://www.esrc.ac.uk/), Natural and Environmental Research Council (http://www.nerc.ac.uk/; Grant Number: ES/F012179/1), and from The North of England Zoological Society (Chester Zoo; http://www.chesterzoo.org/conservation-and-research/field-conservation; no grant number). Funds to cover the publication fees for this paper were provided via SR by Michigan State University's Partnership for Ecosystem Research and via NC by Boise State University (NSF award number IIA-1301792 from the NSF Idaho EPSCoR Program and the National Science Foundation). The funders of the research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CI would like to thank her research team, particularly Zubair Fahad and Rowan Tully, as well as: M. Anwarul Islam, Samia Saif, Adam Barlow, Christina Greenwood Barlow and the rest of the staff at WildTeam; the VTRTs; Ben Baumberg for his statistical guidance; and the villagers who generously gave their time to answer our questions. The authors would also like to thank the two anonymous reviewers, whose comments improved the manuscript. Thanks also to Michigan State University's Partnership for Ecosystem Research and Management and Boise State University (NSF award number IIA-1301792 from the NSF Idaho EPSCoR Program and the National Science Foundation) who provided financial support for publication of this manuscript.	Ahmad I. U, 2009, BANGLADESH TIGER ACT; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2010, FRONT SOC PSYCHOL, P289; Alam MM, 2011, BANGLADESH SUNDARBAN; [Anonymous], 1996, USING MULTIVARIATE S; [Anonymous], 2013, PRINCIPLES PRIDE SCI; Arnoldi J., 2009, RISK; Aziz A, 2013, ORYX, V47, P510, DOI 10.1017/S0030605311001682; Barlow A, 2010, TIGER HUMAN CONFLICT; Bjerke T, 2000, PSYCHOL REP, V86, P37, DOI 10.2466/PR0.86.1.37-46; Bollen KA, 2012, HDB CAUSAL IN PRESS, P0; Browne-Nunez C., 2008, Human Dimensions of Wildlife, V13, P47, DOI 10.1080/10871200701812936; Bruskotter J. T., 2009, Human Dimensions of Wildlife, V14, P119, DOI 10.1080/10871200802712571; Bruskotter JT, 2015, HUM DIMENS WILDL, V20, P255, DOI 10.1080/10871209.2015.1016387; Bruskotter JT, 2014, CONSERV LETT, V7, P158, DOI 10.1111/conl.12072; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Carpenter Len H., 2000, Human Dimensions of Wildlife, V5, P5; Carter NH, 2012, ORYX, V46, P525, DOI 10.1017/S0030605312000245; DECKER DJ, 1988, WILDLIFE SOC B, V16, P53; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dressel S, 2015, CONSERV BIOL, V29, P565, DOI 10.1111/cobi.12420; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Garson GD, 2012, STRUCTURAL EQUATION; Goodrich JM, 2010, INTEGR ZOOL, V5, P300, DOI 10.1111/j.1749-4877.2010.00218.x; Gore ML, 2005, WILDLIFE SOC B, V33, P507, DOI 10.2193/0091-7648(2005)33[507:EORPOM]2.0.CO;2; Hogberg J, 2016, ENVIRON CONSERV, V43, P45, DOI 10.1017/S037689291500017X; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Inskip C, 2013, THESIS; Inskip C, 2014, BIOL CONSERV, V180, P42, DOI 10.1016/j.biocon.2014.09.028; Inskip C, 2013, HUM ECOL, V41, P169, DOI 10.1007/s10745-012-9556-6; Kansky R, 2014, BIOL CONSERV, V179, P93, DOI 10.1016/j.biocon.2014.09.008; Kansky R, 2014, CONSERV BIOL, V28, P924, DOI 10.1111/cobi.12275; Kellert SR, 1996, CONSERV BIOL, V10, P977, DOI 10.1046/j.1523-1739.1996.10040977.x; Kouabenan DR, 2009, SAFETY SCI, V47, P767, DOI 10.1016/j.ssci.2008.01.010; Kouabenan DR, 1998, RISK ANAL, V18, P243, DOI 10.1111/j.1539-6924.1998.tb01291.x; Lei P, 2007, INSTRUCTIONAL TOPICS; Lindsey PA, 2005, BIOL CONSERV, V125, P113, DOI 10.1016/j.biocon.2005.03.015; Lischka SA, 2008, J WILDLIFE MANAGE, V72, P502, DOI 10.2193/2007-117; Marchini S, 2012, BIOL CONSERV, V147, P213, DOI 10.1016/j.biocon.2012.01.002; McKenzie-Mohr D., 2011, FOSTERING SUSTAINABL, Vthird; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Naughton-Treves L, 2005, CONSERV BIOL SER, V9, P252; Newing H, 2011, CONDUCTING RESEARCH IN CONSERVATION: SOCIAL SCIENCE METHODS AND PRACTICE, P1; Oppenheim A. N., 1992, QUESTIONNAIRE DESIGN; Palmer A., 2008, MARKETING REV, V8, P255, DOI [10.1362/146934708x337672, DOI 10.1362/146934708X337672]; Rahman MA, 2012, BANGLADESH SUNDARBAN; Rastogi A, 2014, SOC NATUR RESOUR, V27, P1271, DOI 10.1080/08941920.2014.917753; Reisinger Y, 2008, J TRAVEL TOUR MARK, V21, P41, DOI [10.1300/J073v21n04, DOI 10.1300/J073V21N04]; Riley Shawn J., 2000, Human Dimensions of Wildlife, V5, P50; Riley SJ, 2000, WILDLIFE SOC B, V28, P931; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roskaft E, 2007, WILDLIFE BIOL, V13, P172, DOI 10.2981/0909-6396(2007)13[172:HATLCI]2.0.CO;2; Schusler Tania M., 2000, Human Dimensions of Wildlife, V5, P34; Siemer W. F., 2009, Human Dimensions of Wildlife, V14, P185, DOI 10.1080/10871200902856138; Sjoberg L, 2000, RISK ANAL, V20, P1, DOI 10.1111/0272-4332.00001; Sjoberg L, 1998, RISK ANAL, V18, P85, DOI 10.1111/j.1539-6924.1998.tb00918.x; Slagle K, 2013, J WILDLIFE MANAGE, V77, P863, DOI 10.1002/jwmg.515; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith K, 2000, WORLD DEV, V28, P1945, DOI 10.1016/S0305-750X(00)00053-X; Thirgood S, 2008, J APPL ECOL, V45, P1550, DOI 10.1111/j.1365-2664.2008.01519.x; Thornton C., 2010, Human Dimensions of Wildlife, V15, P359, DOI 10.1080/10871200903582626; Treves A, 2014, SCIENCE, V344, P475, DOI 10.1126/science.1252690; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; Verissimo D., 2013, CONSERV EVIDENCE, V10, P29; Williams CK, 2002, WILDLIFE SOC B, V30, P575; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1; Wu M.L, 2010, STRUCTURAL EQUATION; Young JC, 2010, BIODIVERS CONSERV, V19, P3973, DOI 10.1007/s10531-010-9941-7; Zajac RM, 2012, J WILDLIFE MANAGE, V76, P1331, DOI 10.1002/jwmg.398; Zimmermann A, 2005, ORYX, V39, P406, DOI 10.1017/S0030605305000992; Zinn HC, 2000, HUM DIMENS WILDL, V5, P37	71	43	43	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145913	10.1371/journal.pone.0145913	http://dx.doi.org/10.1371/journal.pone.0145913			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA8CX	26760035	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000368033100023
J	Joseph, LC; Barca, E; Subramanyam, P; Komrowski, M; Pajvani, U; Colecraft, HM; Hirano, M; Morrow, JP				Joseph, Leroy C.; Barca, Emanuele; Subramanyam, Prakash; Komrowski, Michael; Pajvani, Utpal; Colecraft, Henry M.; Hirano, Michio; Morrow, John P.			Inhibition of NAPDH Oxidase 2 (NOX2) Prevents Oxidative Stress and Mitochondrial Abnormalities Caused by Saturated Fat in Cardiomyocytes	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; (ROS)-INDUCED ROS RELEASE; ATRIAL-FIBRILLATION; HEART-FAILURE; MYOCARDIAL-INFARCTION; ELECTRON-TRANSPORT; INSULIN-RESISTANCE; NADPH OXIDASE; RISK; ACIDS	Obesity and high saturated fat intake increase the risk of heart failure and arrhythmias. The molecular mechanisms are poorly understood. We hypothesized that physiologic levels of saturated fat could increase mitochondrial reactive oxygen species (ROS) in cardiomyocytes, leading to abnormalities of calcium homeostasis and mitochondrial function. We investigated the effect of saturated fat on mitochondrial function and calcium homeostasis in isolated ventricular myocytes. The saturated fatty acid palmitate causes a decrease in mitochondrial respiration in cardiomyocytes. Palmitate, but not the monounsaturated fatty acid oleate, causes an increase in both total cellular ROS and mitochondrial ROS. Palmitate depolarizes the mitochondrial inner membrane and causes mitochondrial calcium overload by increasing sarcoplasmic reticulum calcium leak. Inhibitors of PKC or NOX2 prevent mitochondrial dysfunction and the increase in ROS, demonstrating that PKC-NOX2 activation is also required for amplification of palmitate induced-ROS. Cardiomyocytes from mice with genetic deletion of NOX2 do not have palmitate-induced ROS or mitochondrial dysfunction. We conclude that palmitate induces mitochondrial ROS that is amplified by NOX2, causing greater mitochondrial ROS generation and partial depolarization of the mitochondrial inner membrane. The abnormal sarcoplasmic reticulum calcium leak caused by palmitate could promote arrhythmia and heart failure. NOX2 inhibition is a potential therapy for heart disease caused by diabetes or obesity.	[Joseph, Leroy C.; Komrowski, Michael; Pajvani, Utpal; Morrow, John P.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA; [Barca, Emanuele; Hirano, Michio] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Subramanyam, Prakash; Colecraft, Henry M.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA	Columbia University; Columbia University; Columbia University	Morrow, JP (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA.	jpm46@columbia.edu			NIH [1K08HL105801, P30 CA013696]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD080642] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105801] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	JPM is supported by NIH grant 1K08HL105801. Some images were collected in the Confocal and Specialized Microscopy Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University, supported by NIH grant #P30 CA013696 (National Cancer Institute).	Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Biary N, 2011, J PHYSIOL-LONDON, V589, P5167, DOI 10.1113/jphysiol.2011.214239; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Bowser DN, 1998, BIOPHYS J, V75, P2004, DOI 10.1016/S0006-3495(98)77642-8; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Brynes AE, 2003, BRIT J NUTR, V89, P207, DOI 10.1079/BJN2002769; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Chiuve SE, 2012, AM J CLIN NUTR, V96, P498, DOI 10.3945/ajcn.112.040287; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; Dudley SC, 2005, CIRCULATION, V112, P1266, DOI 10.1161/CIRCULATIONAHA.105.538108; Dyntar D, 2001, DIABETES, V50, P2105, DOI 10.2337/diabetes.50.9.2105; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fessenden JD, 2006, J BIOL CHEM, V281, P21022, DOI 10.1074/jbc.M600670200; Filippi A, 2008, J CARDIOVASC MED, V9, P595, DOI 10.2459/JCM.0b013e3282f2c9d0; Harling L, 2011, HEART, V97, P1636, DOI 10.1136/heartjnl-2011-300245; Hayashi T, 2009, J CELL SCI, V122, P1005, DOI 10.1242/jcs.028175; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Hookana E, 2011, HEART RHYTHM, V8, P1570, DOI 10.1016/j.hrthm.2011.06.031; Jouven X, 2001, CIRCULATION, V104, P756, DOI 10.1161/hc3201.094151; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lemaitre RN, 2010, METABOLISM, V59, P1029, DOI 10.1016/j.metabol.2009.10.026; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu QH, 2009, CIRC RES, V105, P194, DOI 10.1161/CIRCRESAHA.109.195313; Luo M, 2013, J CLIN INVEST, V123, P1262, DOI 10.1172/JCI65268; Madamanchi NR, 2013, FREE RADICAL BIO MED, V61, P473, DOI 10.1016/j.freeradbiomed.2013.04.001; Marx SO, 2013, J MOL CELL CARDIOL, V58, P225, DOI 10.1016/j.yjmcc.2013.03.005; Micha R, 2010, LIPIDS, V45, P893, DOI 10.1007/s11745-010-3393-4; Morrow JP, 2011, CIRCULATION, V124, P2812, DOI 10.1161/CIRCULATIONAHA.111.056309; OLIVER MF, 1968, LANCET, V1, P710; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Rodrigo R, 2013, J AM COLL CARDIOL; Rodrigo R, 2013, J AM COLL CARDIOL, V62, P1457, DOI 10.1016/j.jacc.2013.07.014; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Schonfeld P, 2007, BBA-BIOENERGETICS, V1767, P1032, DOI 10.1016/j.bbabio.2007.04.005; Selvin E, 2014, CIRCULATION; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Steinberg SF, 2013, CIRC RES, V112, P393, DOI 10.1161/CIRCRESAHA.111.300496; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1, DOI 10.1152/ajpendo.00418.2011; WOITCZAK L, 1993, BIOCHIM BIOPHYS ACTA, V1183, P41, DOI 10.1016/0005-2728(93)90004-Y; Yang KC, 2013, CIRCULATION, V128, P1724, DOI 10.1161/CIRCULATIONAHA.113.005837; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	57	65	67	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0145750	10.1371/journal.pone.0145750	http://dx.doi.org/10.1371/journal.pone.0145750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756466	Green Published, gold			2022-12-27	WOS:000367888800004
J	Lee, NY; Park, HYL; Park, CK				Lee, Na Young; Park, Hae-Young Lopilly; Park, Chan Kee			Comparison of the Effects of Dorzolamide/Timolol Fixed Combination versus Latanoprost on Intraocular Pressure and Ocular Perfusion Pressure in Patients with Normal-Tension Glaucoma: A Randomized, Crossover Clinical Trial	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; TIMOLOL 0.5-PERCENT; BLOOD-PRESSURE; HEMODYNAMICS; COSOPT	Backgroud To assess the noninferiority of a dorzolamide-timolol fixed combination (DTFC) versus latanoprost in terms of intraocular pressure (IOP) and to compare blood pressure (BP), ocular perfusion pressure (OPP) and diastolic ocular perfusion pressure (DOPP) between the latanoprost and DTFC groups in patients with normal-tension glaucoma (NTG). Methods Prospective, interventional, randomized, single-blinded, crossover design study. Patients with newly diagnosed NTG that had not been treated with a glaucoma medication in the most recent 2 months were recruited. In total, 44 patients with NTG were randomly allocated to one of two groups. Patients in group A were treated with DTFC, lubricant, and latanoprost for 4 weeks each, whereas patients in group B were treated with latanoprost, lubricant, and DTFC for 4 weeks each. Patients were examined on day 1 (without medication), week 4 (under medication), week 8 (without medication), and week 12 (under medication). At weeks 4 and 12, diurnal IOP, systolic and diastolic BP, and OPP were measured at 8: 00 AM, 10: 00 AM, 12: 00 PM, 4: 00 PM, and 8: 00 PM. Results Baseline demographic characteristics showed no difference in terms of age, sex, central corneal thickness, spherical equivalent, or stage of glaucoma between the groups. The between-group difference was -0.19 +/- 0.18 mmHg (mean +/- SE, upper bound of one-sided 95% CI, 0.12). Diurnal IOP showed no difference between the groups with an average IOP reduction of 13.1% using latanoprost and 12.3% using DTFC. Diurnal systolic and diastolic BP were lower in the DTFC group than the latanoprost group; however, the difference between the groups was not statistically significant. Diurnal OPP and DOPP also showed no statistically significant difference between the groups. Conclusions IOP lowering efficacy of DTFC was noninferior to that of latanoprost in newly diagnosed NTG patients. There was no difference in BP, OPP, or DOPP between the latanoprost and DTFC groups. This prospective, randomized, single-blinded, crossover study demonstrated the noninferiority of DTFC versus latanoprost in terms of IOP in patients with NTG.	[Lee, Na Young] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Inchon, South Korea; [Park, Hae-Young Lopilly; Park, Chan Kee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	ckpark@catholic.ac.kr			Investigator Initiated Studies Program of Merck Sharp Dohme Corp.; Santen Pharmaceutical Co., LTD.	Investigator Initiated Studies Program of Merck Sharp Dohme Corp.; Santen Pharmaceutical Co., LTD.	This study was supported in part by a research grant from the Investigator Initiated Studies Program of Merck Sharp & Dohme Corp. and Santen Pharmaceutical Co., LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng JW, 2009, OPHTHALMOLOGY, V116, P1243, DOI 10.1016/j.ophtha.2009.01.036; Chow SC, 2005, J BIOPHARM STAT, V15, P575, DOI 10.1081/BIP-200062277; Coleman AL, 1999, LANCET, V354, P1803, DOI 10.1016/S0140-6736(99)04240-3; Costagliola C, 2008, GRAEF ARCH CLIN EXP, V246, P389, DOI 10.1007/s00417-007-0704-4; Crichton ACS, 2010, J OCUL PHARMACOL TH, V26, P503, DOI 10.1089/jop.2010.0032; Drance SM, 1998, AM J OPHTHALMOL, V125, P585, DOI 10.1016/S0002-9394(98)00019-1; Feke GT, 2013, J OCUL PHARMACOL TH, V29, P639, DOI 10.1089/jop.2012.0271; FRAUNFELDER FT, 1986, ARCH INTERN MED, V146, P1073, DOI 10.1001/archinte.146.6.1073; Galassi F, 2011, INVEST OPHTH VIS SCI, V52, P4467, DOI 10.1167/iovs.10-6710; Gass A, 1997, GRAEF ARCH CLIN EXP, V235, P634, DOI 10.1007/BF00946939; Harris A, 2003, EUR J OPHTHALMOL, V13, P24, DOI 10.1177/112067210301300104; Harris A, 2001, AM J OPHTHALMOL, V132, P490, DOI 10.1016/S0002-9394(01)01158-8; Harris A, 2000, OPHTHALMOLOGY, V107, P430, DOI 10.1016/S0161-6420(99)00093-7; Hayreh SS, 1999, AM J OPHTHALMOL, V128, P301, DOI 10.1016/S0002-9394(99)00160-9; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Henderer JD, 2005, J GLAUCOMA, V14, P267, DOI 10.1097/01.ijg.0000169389.09804.33; Igarashi R, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/720385; Ikeda Y, 2006, JPN J OPHTHALMOL, V50, P153, DOI 10.1007/s10384-005-0293-x; Januleviciene I, 2004, ACTA OPHTHALMOL SCAN, V82, P730, DOI 10.1111/j.1600-0420.2004.00358.x; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim TW, 2014, J GLAUCOMA, V23, P329, DOI 10.1097/IJG.0b013e3182741f4d; Ozyol E, 2014, J GLAUCOMA; Pajic B, 2003, CURR MED RES OPIN, V19, P95, DOI 10.1185/030079902125001434; Parmaksiz S, 2006, EUR J OPHTHALMOL, V16, P73, DOI 10.1177/112067210601600113; Quaranta L, 2006, INVEST OPHTH VIS SCI, V47, P2917, DOI 10.1167/iovs.05-1253; Shoji T, 2013, INVEST OPHTH VIS SCI, V54, P6242, DOI 10.1167/iovs.13-11942; Sugrue MF, 2000, PROG RETIN EYE RES, V19, P87, DOI 10.1016/S1350-9462(99)00006-3; Sung KR, 2008, GRAEFES ARCH CLIN EX, V246, P389; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429	29	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146680	10.1371/journal.pone.0146680	http://dx.doi.org/10.1371/journal.pone.0146680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756747	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888800026
J	Zhou, H; Wang, FZ; Liu, L; Zhang, M; Chen, XZ; Jin, SY				Zhou Huan; Wang Fuzhi; Liu Lu; Zhang Min; Chen Xingzhi; Jin Shiyang			Comparisons of Adherence to Antiretroviral Therapy in a High- Risk Population in China: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							INCOME COUNTRIES; MIDDLE-INCOME; BIAS	Background Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China. Methods We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge Infrastructure (Chinese), and Wanfang (Chinese) to identify studies published from January 1985 to May 2015. We used random-effects meta-analysis to calculate weighted mean estimates across studies and 95% CIs. Data were pooled with proportions transformed prior to pooling using the Freeman-Tukey double arcsine transformation and then back transformed to the original scale. We calculated the I-2 (and its 95% confidence intervals) and tau(2) to assess between-study heterogeneity. Results We identified 36 eligible articles, including 6885 HIV-positive individuals, reporting ART adherence. Pooled analysis produced an estimate of 77.61% (95% CI = 71.63-83.08) of patients with HIV with adequate adherence; however, high heterogeneity was observed between studies (I-2 = 96.60%, 95% CI = 96.00%-97.20%; tau(2) = 0.16). Three studies, which included 149 old HIV-infected patients, reported the highest ART adequate adherence rate (89.39%, 95% CI = 72.01-99.26) with high heterogeneity between the studies (I-2 = 86.20%, 95% CI = 60.00-95.20%; tau(2) = 0.13). While, only two studies, which included 143 heterosexual transmission group (HTG) patients, reported the lowest ART adequate adherence rate (51.55%, 95% CI = 41.33-61.71) with low heterogeneity between the studies (I-2 = 31.3%, tau(2) = 0.007). In the multivariable meta-regression model, high-risk populations was the main factor explaining heterogeneity (variance explained 28.14%). Conclusions ART adherence in some high-risk populations (e.g., heterosexual transmission group) is below the recommended levels for maintaining virologic suppression. It is crucial to develop comprehensive intervention strategies to promote ART adherence in high-risk populations and effectively prevent the spread of HIV/AIDS in China.	[Zhou Huan; Jin Shiyang] Bengbu Med Coll, Affiliated Hosp 1, Bengbu 233000, Anhui, Peoples R China; [Zhou Huan; Wang Fuzhi; Liu Lu; Zhang Min; Chen Xingzhi] Bengbu Med Coll, Dept Hlth Management, Bengbu 233000, Anhui, Peoples R China	Bengbu Medical College; Bengbu Medical College	Jin, SY (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Bengbu 233000, Anhui, Peoples R China.	jsybbmc@163.com						Ailika S, 2013, CHINESE J HLTH ED, P687; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Chang YL, 2010, XINJIANG MED J, V11, P78; Chen S.-C., 2013, INT J ANTENN PROPAG, V2013, P1, DOI DOI 10.1103/PHYSREVLETT.110.155003; Dai F, 2014, J QILU NURSING, V20, P77; Deng MH, 2012, CHINESE FOREIGN MED, V10, P70; Dong XB, 2014, MED INFORM, V27, P612; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feelemyer J, 2015, AIDS BEHAV, V19, P575, DOI 10.1007/s10461-014-0928-3; Gui XiuZhi, 2012, Maternal and Child Health Care of China, V27, P4683; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu HH, 2012, EFFECT PREVENTION MO; Kicinski M, 2015, STAT MED, V34, P2781, DOI 10.1002/sim.6525; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Lee SS, 2007, INT J STD AIDS, V18, P167, DOI 10.1258/095646207780132497; Li AiJie, 2012, Chinese Journal of Dermatovenereology, V26, P516; Li ZJ, 2015, MED INFORM, V28, P317; Liu AW, 2007, ANHUI J PREV MED, V20, P414; Liu J, 2013, CHIN J AIDS STD, V19, P2; Liu J.W., 2013, COMPUT MATH METHOD M, V2013, P10, DOI DOI 10.3724/SP.J.1146.2013.01820; Liu MR, 2014, MED PEOPLE, V27, P28; [刘霞 LIU Xia], 2011, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V34, P542; Lu J, 2008, CHIN J AIDS STD, V14, P569; Lu J, 2009, PROSPECTIVE COHORT S; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Mhaskar Rahul, 2013, Indian J Community Med, V38, P74, DOI 10.4103/0970-0218.112435; MILLER JJ, 1978, AM STAT, V32, P138, DOI 10.2307/2682942; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mittlbock M, 2006, STAT MED, V25, P4321, DOI 10.1002/sim.2692; Mountain E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105645; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Ortego C, 2011, GAC SANIT, V25, P282, DOI 10.1016/j.gaceta.2010.10.016; Pang J, 2009, YOUJIANG NATL MED J, V03, P432; Qiao JK, 2014, CHIN J AIDS STD, V20, P428; Qin YL, 2013, MOD HOSP, V13, P147; Rostom A, CELIAC DIS; Su FQ, 2011, GUANGXI MED J, V33, P1662; [王红红 WANG Honghong], 2008, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V17, P881; Wang LH, 2009, CHIN J AIDS STD, V15, P352; Wang Q., 2011, THESIS; Wang Q, 2013, CHIN J AIDS STD, V19, P393; Wang Yong-zhong, 2009, Zhonghua Yufang Yixue Zazhi, V43, P277, DOI 10.3760/cma.j.issn.0253-9624.2009.04.003; Wang YZ, 2008, CHINESE J MATERNAL C, V19, P407; Wei XB, 2012, CHINESE NURSING RES, V26, P842; Wu HongPing, 2013, Maternal and Child Health Care of China, V28, P1313; [杨成彬 Yang Chengbin], 2010, [中国全科医学, Chinese General Practice], V13, P3188; Ye HL, 2013, CHINESE NURSING RES, V27, P4055; Yu R., 2007, THESIS; Yuan Y., 2012, MODERN PREV MED, V39, P5954; Zeng H, 2016, SEX TRANSM INFECT, V92, P116, DOI 10.1136/sextrans-2014-051877; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhou, 2008, THESIS NE NORMAL U J; Zhou YF, 2012, CHIN J AIDS STD, V18, P746	55	3	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146659	10.1371/journal.pone.0146659	http://dx.doi.org/10.1371/journal.pone.0146659			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756336	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800023
J	Berm, EJJ; de Looff, M; Wilffert, B; Boersma, C; Annemans, L; Vegter, S; van Boven, JFM; Postma, MJ				Berm, Elizabeth J. J.; de Looff, Margot; Wilffert, Bob; Boersma, Cornelis; Annemans, Lieven; Vegter, Stefan; van Boven, Job F. M.; Postma, Maarten J.			Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; METASTATIC COLORECTAL-CANCER; POLYMERASE-CHAIN-REACTION; ACUTE CORONARY SYNDROME; HIV-INFECTED PATIENTS; CHRONIC HEPATITIS-C; BREAST-CANCER; PERSONALIZED MEDICINE; INHIBITOR THERAPY; PHARMACOECONOMIC ANALYSIS	Objective Due to extended application of pharmacogenetic and pharmacogenomic screening (PGx) tests it is important to assess whether they provide good value for money. This review provides an update of the literature. Methods A literature search was performed in PubMed and papers published between August 2010 and September 2014, investigating the cost-effectiveness of PGx screening tests, were included. Papers from 2000 until July 2010 were included via two previous systematic reviews. Studies' overall quality was assessed with the Quality of Health Economic Studies (QHES) instrument. Results We found 38 studies, which combined with the previous 42 studies resulted in a total of 80 included studies. An average QHES score of 76 was found. Since 2010, more studies were funded by pharmaceutical companies. Most recent studies performed cost-utility analysis, univariate and probabilistic sensitivity analyses, and discussed limitations of their economic evaluations. Most studies indicated favorable cost-effectiveness. Majority of evaluations did not provide information regarding the intrinsic value of the PGx test. There were considerable differences in the costs for PGx testing. Reporting of the direction and magnitude of bias on the cost-effectiveness estimates as well as motivation for the chosen economic model and perspective were frequently missing. Conclusions Application of PGx tests was mostly found to be a cost-effective or cost-saving strategy. We found that only the minority of recent pharmacoeconomic evaluations assessed the intrinsic value of the PGx tests. There was an increase in the number of studies and in the reporting of quality associated characteristics. To improve future evaluations, scenario analysis including a broad range of PGx tests costs and equal costs of comparator drugs to assess the intrinsic value of the PGx tests, are recommended. In addition, robust clinical evidence regarding PGx tests' efficacy remains of utmost importance.	[Berm, Elizabeth J. J.; Wilffert, Bob] Univ Groningen, Dept Pharm, Unit Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands; [de Looff, Margot; Boersma, Cornelis; Vegter, Stefan; van Boven, Job F. M.; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands; [Boersma, Cornelis; Vegter, Stefan] GSK, Zeist, Netherlands; [Wilffert, Bob] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Annemans, Lieven] Univ Ghent, Dept Publ Hlth, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Ageing & Hlth Care SHARE, Groningen, Netherlands	University of Groningen; University of Groningen; GlaxoSmithKline; University of Groningen; Ghent University; University of Groningen	Berm, EJJ (corresponding author), Univ Groningen, Dept Pharm, Unit Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands.	e.j.j.berm@rug.nl	van Boven, Job FM/K-7942-2019	van Boven, Job FM/0000-0003-2368-2262; Boersma, Cornelis/0000-0002-1190-2638; Postma, Maarten/0000-0002-6306-3653	GSK	GSK(GlaxoSmithKline)	The funder provided support in the form of salaries for authors CB, SV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. No funding was received for this study. GSK provided support in the form of salaries for authors CB, SV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Maarten J. Postma and Lieven Annemans have received grants, honoraria and speaking fees from several pharmaceutical companies. No other potential conflict of interest related to this study was reported.	Antonanzas F, 2012, EUR J HEALTH ECON, V13, P651, DOI 10.1007/s10198-011-0319-x; Assasi N, 2012, GENET TEST MOL BIOMA, V16, P1322, DOI 10.1089/gtmb.2012.0178; Bacchi CE, 2010, REV ASSOC MED BRAS, V56, P186, DOI 10.1590/S0104-42302010000200017; Beaulieu M, 2010, PHARMACOGENOMICS, V11, P1573, DOI [10.2217/pgs.10.145, 10.2217/PGS.10.145]; Behl AS, 2012, JNCI-J NATL CANCER I, V104, P1785, DOI 10.1093/jnci/djs433; Blank PR, 2011, CLIN CANCER RES, V17, P6338, DOI 10.1158/1078-0432.CCR-10-2267; Blank PR, 2010, BREAST CANCER RES TR, V124, P497, DOI 10.1007/s10549-010-0862-7; Carlson JJ, 2009, VALUE HEALTH, V12, P20, DOI 10.1111/j.1524-4733.2008.00415.x; Cascorbi I, 2013, EUR J CLIN PHARMACOL, V69, pS17, DOI 10.1007/s00228-013-1492-x; Chiou CF, 2003, MED CARE, V41, P32, DOI 10.1097/00005650-200301000-00007; Chou WH, 2000, J CLIN PSYCHOPHARM, V20, P246, DOI 10.1097/00004714-200004000-00019; Cosler LE, 2009, CANCER INVEST, V27, P953, DOI 10.3109/07357900903275217; Costa-Scharplatz M, 2007, PHARMACOGENET GENOM, V17, P359, DOI 10.1097/01.fpc.0000236336.34175.e8; Crespin DJ, 2011, VALUE HEALTH, V14, P483, DOI 10.1016/j.jval.2010.11.012; Daly TM, 2007, CLIN CHEM, V53, P1222, DOI 10.1373/clinchem.2007.086348; Dendukuri N, 2007, CAN MED ASSOC J, V176, P1429, DOI 10.1503/cmaj.061011; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Djalalov S, 2012, MOL DIAGN THER, V16, P389, DOI 10.1007/s40291-012-0010-7; Djalalov S, 2011, GENET MED, V13, P89, DOI 10.1097/GIM.0b013e3182003294; Dong D, 2012, NEUROLOGY, V79, P1259, DOI 10.1212/WNL.0b013e31826aac73; Donnan JR, 2011, PEDIATR BLOOD CANCER, V57, P231, DOI 10.1002/pbc.22936; Dubinsky MC, 2005, AM J GASTROENTEROL, V100, P2239, DOI 10.1111/j.1572-0241.2005.41900.x; Eckman MH, 2009, ANN INTERN MED, V150, P73, DOI 10.7326/0003-4819-150-2-200901200-00005; Egger M, 2003, Health Technol Assess, V7, P1; Elkin EB, 2004, J CLIN ONCOL, V22, P854, DOI 10.1200/JCO.2004.04.158; Frederix GWJ, 2013, VALUE HEALTH, V16, P1100, DOI 10.1016/j.jval.2013.06.012; Furuta T, 2007, CLIN PHARMACOL THER, V81, P521, DOI 10.1038/sj.clpt.6100043; Garrison LP, 2008, DRUG METAB REV, V40, P377, DOI 10.1080/03602530801952500 ; Gold HT, 2009, CANCER-AM CANCER SOC, V115, P3858, DOI 10.1002/cncr.24428; Goldstein JA, 2001, BRIT J CLIN PHARMACO, V52, P349, DOI 10.1046/j.0306-5251.2001.01499.x; Greeley SAW, 2011, DIABETES CARE, V34, P622, DOI 10.2337/dc10-1616; Hagaman JT, 2010, LUNG, V188, P125, DOI 10.1007/s00408-009-9217-8; Hall PS, 2012, JNCI-J NATL CANCER I, V104, P56, DOI 10.1093/jnci/djr484; Handorf EA, 2012, J ONCOL PRACT, V8, P267, DOI 10.1200/JOP.2011.000502; Hatz MHM, 2014, PHARMACOECONOMICS, V32, P443, DOI 10.1007/s40273-014-0143-0; Health Care Insurance Board, 2006, DUTCH PHARM GUID; Higashi MK, 2003, AM J MANAG CARE, V9, P493; Hughes DA, 2004, PHARMACOGENETICS, V14, P335, DOI 10.1097/00008571-200406000-00002; Husereau D, 2014, INT J TECHNOL ASSESS, V30, P179, DOI 10.1017/S0266462314000142; Johnson JA, 2012, CLIN PHARMACOL THER, V92, P437, DOI 10.1038/clpt.2012.125; Kauf TL, 2010, PHARMACOECONOMICS, V28, P1025, DOI 10.2165/11535540-000000000-00000; Kazi DS, 2014, ANN INTERN MED, V160, P221, DOI 10.7326/M13-1999; Kim SK, 2006, J RHEUMATOL, V33, P1266; Klang SH, 2010, VALUE HEALTH, V13, P381, DOI 10.1111/j.1524-4733.2010.00724.x; Lala A, 2013, J THROMB HAEMOST, V11, P81, DOI 10.1111/jth.12059; Lehmann DF, 2003, J CLIN PHARMACOL, V43, P1316, DOI 10.1177/0091270003259389; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lidgren M, 2008, ANN ONCOL, V19, P487, DOI 10.1093/annonc/mdm488; Lidgren M, 2008, ACTA ONCOL, V47, P1018, DOI 10.1080/02841860801901618; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Lopes GD, 2012, CANCER-AM CANCER SOC, V118, P1032, DOI 10.1002/cncr.26372; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Maitland-van der Zee AH, 2004, PHARMACOGENETICS, V14, P53, DOI 10.1097/00008571-200401000-00006; Marra CA, 2002, J RHEUMATOL, V29, P2507; Meckley LM, 2006, PHARMACOGENET GENOM, V16, P139, DOI 10.1097/01.fpc.0000189801.96220.82; Meckley LM, 2010, PHARMACOECONOMICS, V28, P61, DOI 10.2165/11318240-000000000-00000; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morelle M, 2006, INT J TECHNOL ASSESS, V22, P396, DOI 10.1017/S0266462306051300; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; Oh KT, 2004, RHEUMATOLOGY, V43, P156, DOI 10.1093/rheumatology/keh001; Olgiati P, 2012, PROG NEURO-PSYCHOPH, V36, P147, DOI 10.1016/j.pnpbp.2011.08.013; Panattoni L, 2012, PHARMACOECONOMICS, V30, P1067, DOI 10.2165/11595080-000000000-00000; Parthan A, 2013, PHARMACOECONOMICS, V31, P519, DOI 10.1007/s40273-013-0054-5; Patrick AR, 2009, CIRC-CARDIOVASC QUAL, V2, P429, DOI 10.1161/CIRCOUTCOMES.108.808592; Perlis RH, 2005, J CLIN PSYCHOPHARM, V25, P427, DOI 10.1097/01.jcp.0000177553.59455.24; Perlis RH, 2009, NEUROPSYCHOPHARMACOL, V34, P2227, DOI 10.1038/npp.2009.50; Phillips KA, 2014, GENET MED, V16, P251, DOI 10.1038/gim.2013.122; Pichereau S, 2010, J PHARM PHARM SCI, V13, P615; Pink J, 2014, CLIN PHARMACOL THER, V95, P199, DOI 10.1038/clpt.2013.190; Priest VL, 2006, PHARMACOECONOMICS, V24, P767, DOI 10.2165/00019053-200624080-00004; Rattanavipapong W, 2013, EPILEPSIA, V54, P1628, DOI 10.1111/epi.12325; Reed SD, 2011, J UROLOGY, V185, P841, DOI 10.1016/j.juro.2010.10.078; Reese ES, 2012, PHARMACOTHERAPY, V32, P323, DOI 10.1002/j.1875-9114.2012.01048; Ross S, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012001; Sax PE, 2005, CLIN INFECT DIS, V41, P1316, DOI 10.1086/496984; Schackman BR, 2008, AIDS, V22, P2025, DOI 10.1097/QAD.0b013e3283103ce6; Schackman BR, 2013, ANTIVIR THER, V18, P399, DOI 10.3851/IMP2500; Schalekamp T, 2006, CLIN PHARMACOL THER, V79, P511, DOI 10.1016/j.clpt.2006.03.008; Sendi P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000173; Serretti A, 2011, WORLD J BIOL PSYCHIA, V12, P501, DOI 10.3109/15622975.2011.572998; Shiffman D, 2012, CLIN THER, V34, P1387, DOI 10.1016/j.clinthera.2012.04.004; Shiroiwa T, 2010, MOL DIAGN THER, V14, P375, DOI 10.2165/11587610-000000000-00000; Siebert U, 2009, PHARMACOECONOMICS, V27, P341, DOI 10.2165/00019053-200927040-00006; Smith KJ, 2008, THROMB HAEMOSTASIS, V100, P447, DOI 10.1160/TH08-03-0149; Sorich MJ, 2013, PHARMACOGENOMICS, V14, P2013, DOI [10.2217/pgs.13.164, 10.2217/PGS.13.164]; Tavadia SMB, 2000, J AM ACAD DERMATOL, V42, P628, DOI 10.1016/S0190-9622(00)90176-2; Thompson AJ, 2014, VALUE HEALTH, V17, P22, DOI 10.1016/j.jval.2013.10.007; Tiamkao S, 2013, INT J CLIN PHARM-NET, V35, P608, DOI 10.1007/s11096-013-9777-9; van den Akker-van Marle ME, 2006, PHARMACOGENOMICS, V7, P783, DOI 10.2217/14622416.7.5.783; Vanderlaan BF, 2011, AM J MANAG CARE, V17, P455; Veenstra DL, 2007, GENET MED, V9, P695, DOI 10.1097/GIM.0b013e318156dd07; Vegter S, 2008, PHARMACOECONOMICS, V26, P569, DOI 10.2165/00019053-200826070-00005; Vegter S, 2010, DRUG DEVELOP RES, V71, P492, DOI 10.1002/ddr.20424; Vegter S, 2009, PHARMACOGENET GENOM, V19, P695, DOI 10.1097/FPC.0b013e3283307ca0; Verhoef TI, 2013, PHARMACOGENOMICS, V14, P869, DOI [10.2217/PGS.13.74, 10.2217/pgs.13.74]; Verhoef TI, 2012, PHARMACOGENOMICS, V13, P1405, DOI 10.2217/PGS.12.124; Vijayaraghavan A, 2012, INT J CANCER, V131, P438, DOI 10.1002/ijc.26400; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; Welton NJ, 2008, NICOTINE TOB RES, V10, P231, DOI 10.1080/14622200701767761; Winter J, 2004, ALIMENT PHARM THERAP, V20, P593, DOI 10.1111/j.1365-2036.2004.02124.x; Wong WB, 2010, PHARMACOECONOMICS, V28, P1001, DOI 10.2165/11537410-000000000-00000; You JHS, 2009, CLIN PHARMACOL THER, V86, P540, DOI 10.1038/clpt.2009.104; You JHS, 2004, THROMB HAEMOSTASIS, V92, P590, DOI 10.1160/TH04-03-0161; You JHS, 2014, PHARMACOGENET GENOM, V24, P6, DOI 10.1097/FPC.0000000000000014; You JHS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039640; Zhu J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-39	106	54	54	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146262	10.1371/journal.pone.0146262	http://dx.doi.org/10.1371/journal.pone.0146262			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752539	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100058
J	Rebeiro, PF; Gange, SJ; Horberg, MA; Abraham, AG; Napravnik, S; Samji, H; Yehia, BR; Althoff, KN; Moore, RD; Kitahata, MM; Sterling, TR; Curriero, FC				Rebeiro, Peter F.; Gange, Stephen J.; Horberg, Michael A.; Abraham, Alison G.; Napravnik, Sonia; Samji, Hasina; Yehia, Baligh R.; Althoff, Keri N.; Moore, Richard D.; Kitahata, Mari M.; Sterling, Timothy R.; Curriero, Frank C.		North Amer AIDS Cohort	Geographic Variations in Retention in Care among HIV-Infected Adults in the United States	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MEDICAL-CARE; ESTIMATING EQUATIONS; INFORMATION-SYSTEMS; CLINICAL COHORT; MISSED VISITS; CELL COUNTS; DISPARITIES; MORTALITY; HIV/AIDS	Objective To understand geographic variations in clinical retention, a central component of the HIV care continuum and key to improving individual-and population-level HIV outcomes. Design We evaluated retention by US region in a retrospective observational study. Methods Adults receiving care from 2000-2010 in 12 clinical cohorts of the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) contributed data. Individuals were assigned to Centers for Disease Control and Prevention (CDC)-defined regions by residential data (10 cohorts) and clinic location as proxy (2 cohorts). Retention was >= 2 primary HIV outpatient visits within a calendar year, >90 days apart. Trends and regional differences were analyzed using modified Poisson regression with clustering, adjusting for time in care, age, sex, race/ethnicity, and HIV risk, and stratified by baseline CD4+ count. Results Among 78,993 adults with 444,212 person-years of follow-up, median time in care was 7 years (Interquartile Range: 4-9). Retention increased from 2000 to 2010: from 73% (5,000/6,875) to 85% (7,189/8,462) in the Northeast, 75% (1,778/2,356) to 87% (1,630/1,880) in the Midwest, 68% (8,451/12,417) to 80% (9,892/12,304) in the South, and 68% (5,147/7,520) to 72% (6,401/8,895) in the West. In adjusted analyses, retention improved over time in all regions (p<0.01, trend), although the average percent retained lagged in the West and South vs. the Northeast (p<0.01). Conclusions In our population, retention improved, though regional differences persisted even after adjusting for demographic and HIV risk factors. These data demonstrate regional differences in the US which may affect patient care, despite national care recommendations.	[Rebeiro, Peter F.; Sterling, Timothy R.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Gange, Stephen J.; Abraham, Alison G.; Althoff, Keri N.; Moore, Richard D.; Curriero, Frank C.] Johns Hopkins Univ, Baltimore, MD USA; [Horberg, Michael A.] Kaiser Permanente Midatlantic States, Midatlantic Permanente Res Inst, Rockville, MD USA; [Napravnik, Sonia] Univ N Carolina, Chapel Hill, NC USA; [Samji, Hasina] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Yehia, Baligh R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kitahata, Mari M.] Univ Washington, Sch Med, Seattle, WA USA	Vanderbilt University; Johns Hopkins University; Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill; B.C. Centre for Excellence in HIV/AIDS; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle	Rebeiro, PF (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	p.rebeiro@vanderbilt.edu	Althoff, Keri N/HGC-5595-2022; Gange, Stephen/AGY-5004-2022	Gange, Stephen/0000-0001-7842-512X; Rebeiro, Peter/0000-0003-1951-9104; Althoff, Keri/0000-0002-5068-6595; Samji, Hasina/0000-0002-4555-7609	National Institutes of Health, USA [U01-AI069918, U01-AA013566, U24-AA020794, U01-AA020790, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01-AI35043, U01-AI37613, U01-AI37984, U01-AI38855]; Center's for Disease Control and Prevention, USA [CDC200-2006-18797]; Agency for Healthcare Research and Quality, USA [90047713]; Health Resources and Services Administration, USA [90051652]; Canadian Institutes of Health Research, Canada [TGF-96118, HCP-97105, CBR-86906, CBR-94036]; Ontario Ministry of Health and Long Term Care; Government of Alberta, Canada;  [K01-AI071754];  [K01-AI093197];  [K23 EY013707];  [K24-AI065298];  [K24-00432];  [MO1-RR-00052];  [N02-CP55504];  [P30-AI027763];  [P30-AI094189];  [P30-AI27757];  [P30-AI27767];  [P30-AI50410];  [P30-AI54999];  [P30-AI036219];  [P30-MH62246];  [R01-CA165937];  [R01-AA16893];  [R01-DA11602];  [U01-DA0356935];  [R01-DA04334];  [F31-DA035713];  [G12-MD007583];  [U01-AI38858];  [U01-AI42590];  [U01-AI68634];  [U01-AI68636];  [U01-AI69432];  [U01-AI69434];  [U01-HD32632];  [U10-EY08057];  [U10-EY08052];  [U10-EY08067];  [R01-DA12568];  [R24-AI067039];  [R56-AI102622];  [Z01-CP010214];  [Z01-CP010176];  [UL1-RR024131];  [UL1-TR000083];  [U54-MD007587]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA165937, Z01CP010176] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY008057, K23EY013707, U10EY008067, U10EY008052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI037613, R56AI102622, U01AI037984, U01AI035042, U01AI038858, U01AI069918, P30AI036219, P30AI050410, U01AI031834, U01AI038855, U01AI042590, U01AI034989, P30AI027757, U01AI035043, U01AI035041, U01AI069432, P30AI027763, K01AI071754, U01AI069434, P30AI054999, U01AI068634, U01AI034993, U01AI035039, K01AI093197, P30AI094189, U01AI068636, U01AI034994, U01AI035004, P30AI045008, K24AI065298, R24AI067039, P30AI110527, U01AI035040, P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013566, R01AA016893, U24AA020794, U01AA020790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA035713, R01DA004334, R01DA011602, R01DA012568] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583, U54MD007587] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center's for Disease Control and Prevention, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Agency for Healthcare Research and Quality, USA(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Health Resources and Services Administration, USA; Canadian Institutes of Health Research, Canada(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Government of Alberta, Canada; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants U01-AI069918, U01-AA013566, U24-AA020794, U01-AA020790, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01-AI35043, U01-AI37613, U01-AI37984, U01-AI38855, U01-AI38858, U01-AI42590, U01-AI68634, U01-AI68636, U01-AI69432, U01-AI69434, U01-HD32632, U10-EY08057, U10-EY08052, U10-EY08067, UL1-RR024131, UL1-TR000083, U54-MD007587, F31-DA035713, G12-MD007583, K01-AI071754, K01-AI093197, K23 EY013707, K24-AI065298, K24-00432, MO1-RR-00052, N02-CP55504, P30-AI027763, P30-AI094189, P30-AI27757, P30-AI27767, P30-AI50410, P30-AI54999, P30-AI036219, P30-MH62246, R01-CA165937, R01-AA16893, R01-DA11602, U01-DA0356935, R01-DA04334, R01-DA12568, R24-AI067039, R56-AI102622, Z01-CP010214, and Z01-CP010176 from the National Institutes of Health, USA; contract CDC200-2006-18797 from the Center's for Disease Control and Prevention, USA; contract 90047713 from the Agency for Healthcare Research and Quality, USA; contract 90051652 from the Health Resources and Services Administration, USA; grants TGF-96118, HCP-97105, CBR-86906, CBR-94036 from the Canadian Institutes of Health Research, Canada; Ontario Ministry of Health and Long Term Care; and the Government of Alberta, Canada.	Althoff KN, 2014, CLIN INFECT DIS, V58, P1185, DOI 10.1093/cid/ciu044; Althoff KN, 2012, ANN INTERN MED, V157, P325, DOI 10.7326/0003-4819-157-5-201209040-00005; An Qian, 2012, Morbidity and Mortality Weekly Report, V61, P805; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2011, CLIN INFECT DIS, DOI DOI 10.1093/cid/ciq043; [Anonymous], REGRESSION MODELLING, DOI DOI 10.1200/JCO.2017.76.1155; [Anonymous], 2013, ACCELERATING IMPROVE; [Anonymous], 2011, NAT HIST GEOGR INF S; Baum CF, 2008, STATA J, V8, P299, DOI 10.1177/1536867X0800800212; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Centers for Disease Control and Prevention, 2013, HIV SURV REP, V25; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Eberhart MG, 2013, JAIDS-J ACQ IMM DEF, V64, pS42, DOI 10.1097/QAI.0b013e3182a90112; Edison L, 2014, MMWR-MORBID MORTAL W, V63, P55; Ford MA, 2012, MONITORING HIV CARE; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; Gao S, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-8; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Geanuracos CG, 2007, AM J PUBLIC HEALTH, V97, P1974, DOI 10.2105/AJPH.2005.076851; Gill MJ, 2009, INT J STD AIDS, V20, P540, DOI 10.1258/ijsa.2008.008422; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Hanna DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078952; Hanna DB, 2013, CLIN INFECT DIS, V56, P1174, DOI 10.1093/cid/cit003; Hanna DB, 2012, AIDS, V26, P95, DOI 10.1097/QAD.0b013e32834dcf87; Hixson BA, 2011, J URBAN HEALTH, V88, P129, DOI 10.1007/s11524-010-9510-0; Holtgrave DR, 2012, AIDS BEHAV, V16, P1365, DOI 10.1007/s10461-012-0207-0; Houle B, 2009, AM J PUBLIC HEALTH, V99, P308, DOI 10.2105/AJPH.2008.138750; Howe CJ, 2010, AIDS RES HUM RETROV, V26, P875, DOI 10.1089/aid.2009.0282; Hsu LC, 2011, AIDS CARE, V23, P383, DOI 10.1080/09540121.2010.507740; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Improving Outcomes, IMPR OUTC ACC PROGR; Jones SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048036; Klassen AC, 2006, AM J PREV MED, V30, pS77, DOI 10.1016/j.amepre.2005.09.010; Klassen Ann Carroll, 2005, Int J Health Geogr, V4, P1, DOI 10.1186/1476-072X-4-1; Koch T, 2004, J GEOGR, V103, P76, DOI 10.1080/00221340408978578; Koch T., 2004, CARTOGRAPHICA, V39, P1, DOI DOI 10.3138/B123-8124-4390-5792; Kurth AE, 2012, JAIDS-J ACQ IMM DEF, V1; Lau B, 2007, AIDS RES HUM RETROV, V23, P769, DOI 10.1089/aid.2006.0171; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Morris TP, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-75; Mugavero MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P100, DOI 10.1097/QAI.0b013e31818d5c37; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Musal M, 2013, STAT MED, V32, P267, DOI 10.1002/sim.5457; Namosha E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069279; Niyonsenga T, 2013, AIDS BEHAV, V17, P700, DOI 10.1007/s10461-012-0236-8; Pan W, 2002, STAT SINICA, V12, P475; Papke L.E., 1993, ECONOMETRIC METHODS; Park WB, 2007, J INTERN MED, V261, P268, DOI 10.1111/j.1365-2796.2006.01762.x; Rebeiro P, 2013, JAIDS-J ACQ IMM DEF, V62, P356, DOI 10.1097/QAI.0b013e31827f578a; Rebeiro PF, 2015, AM J EPIDEMIOL, V182, P952, DOI 10.1093/aje/kwv181; Rebeiro PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111772; Reif S., 2011, HIV AIDS EPIDEMIC S; Richards TB, 1999, PUBLIC HEALTH REP, V114, P359, DOI 10.1093/phr/114.4.359; Shacham E, 2013, HIV MED, V14, P624, DOI 10.1111/hiv.12067; Stone VE, 2012, CURR INFECT DIS REP, V14, P53, DOI 10.1007/s11908-011-0226-4; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; The White House, 2021, NAT HIV AIDS STRAT U; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; Wallace RG, 2003, SOC SCI MED, V56, P1155, DOI 10.1016/S0277-9536(02)00121-1; Westergaard RP, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-10; Whiteside YO, 2014, MMWR-MORBID MORTAL W, V63, P85; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yehia Baligh, 2011, Am J Public Health, V101, pe4, DOI 10.2105/AJPH.2011.300259; Zou GY, 2013, STAT METHODS MED RES, V22, P661, DOI 10.1177/0962280211427759; [No title captured]	67	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146119	10.1371/journal.pone.0146119	http://dx.doi.org/10.1371/journal.pone.0146119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26752637	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100045
J	Wang, P; Ma, YC; Wang, XH; Jiang, H; Liu, H; Ran, W; Shen, QR				Wang, Ping; Ma, Yucui; Wang, Xihe; Jiang, Hong; Liu, Hua; Ran, Wei; Shen, Qirong			Spectral Exploration of Calcium Accumulation in Organic Matter in Gray Desert Soil from Northwest China	PLOS ONE			English	Article							CARBON; STABILIZATION; MECHANISMS; FE	Little attention has been paid to the accumulation of soil organic matter (SOM) in the fringes of the mid-latitude desert. In this paper, soil samples from a long-term field experiment conducted from 1990 to 2013 at a research station in Urumqi, China by different fertilizer treatments, were used to determine soil properties and soil dissolved organic matter (DOM) by chemical analysis, fluorescence excitation emission matrix (EEM) spectroscopy, and high resolution-transmission electron microscopy (HR-TEM). The binding features of DOM under the addition of Ca2+ were analyzed using a two-dimensional (2D) Fourier transform infrared (FTIR) spectrometer further to explore the response of the DOM to increasing concentrations of Ca2+. Long-term application of chemical fertilizers and goat manure increased soil organic carbon (SOC) by 1.34-and 1.86-fold, respectively, relative to the non-fertilized control (8.95g.kg(-1)). Compared with the control, application of chemical fertilizers and manure significantly increased the concentrations of Ca, Mg, Si, humic and fulvic acid-like substances in DOM but decreased the amounts of trivalent metals (Al and Fe) and protein-like substances. Although crystalline Al/Fe nanoparticles and amorphous or short-range- order Si/Al nanoparticles existed in all DOM samples, crystalline Ca/Si nanoparticles were predominant in the samples treated with goat manure. Although organic matter and Si-O-containing nanoparticles were involved in the binding of Ca2+ to DOM, application of chemical fertilizers weakened Ca2+ association with components of the amide II group (1510 cm(-1)) and Si-O linkage (1080 cm(-1)), whereas application of goat manure enhanced the affinity of Ca2+ for Si-O linkage. Our results suggested that the enrichment of Ca in gray desert soil possibly helps accumulate SOM by forming crystalline Ca/Si nanoparticles in addition to Ca2+ and organic matter complexes.	[Wang, Ping; Ma, Yucui; Jiang, Hong; Ran, Wei; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Xihe; Liu, Hua] Xinjiang Acad Agr Sci, Res Inst Soil & Fertilizer & Agr Water Conservat, Urumqi 830091, Peoples R China	Nanjing Agricultural University	Ran, W (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing 210095, Jiangsu, Peoples R China.	ranwei@njau.edu.cn	Shen, Qirong/AAB-6531-2020		National Natural Science Foundation of China [41371299, 41371248]; National Basic Research Program of China [2011CB100503, 2013CB127403]; Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2013BAD08B04-7]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	This work was supported by the National Natural Science Foundation of China (Grant No. 41371299 and 41371248), the National Basic Research Program of China (Grant no. 2011CB100503 and 2013CB127403) and the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (Grant No. 2013BAD08B04-7). The authors also thank the National Grey Desert Soil Fertility and Fertilizer Efficiency Monitoring Station for providing relevant data generated from these experiments.	Bashan Y, 2005, SOIL BIOL BIOCHEM, V37, P1795, DOI 10.1016/j.soilbio.2005.02.013; Clough A, 2000, AUST J SOIL RES, V38, P1005, DOI 10.1071/SR99102; Fialips CI, 2002, CLAY CLAY MINER, V50, P455, DOI 10.1346/000986002320514181; Hai L, 2010, SOIL BIOL BIOCHEM, V42, P253, DOI 10.1016/j.soilbio.2009.10.023; He XS, 2013, CHEMOSPHERE, V93, P2208, DOI 10.1016/j.chemosphere.2013.04.039; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lehmann J, 2008, NAT GEOSCI, V1, P238, DOI 10.1038/ngeo155; Li HY, 2013, ORG GEOCHEM, V58, P125, DOI 10.1016/j.orggeochem.2013.03.002; Lopez-Sangil L, 2013, SOIL BIOL BIOCHEM, V62, P57, DOI 10.1016/j.soilbio.2013.03.004; Meng F.Q., 2014, GEODERMA REG, V1, P19, DOI [10.1016/j.geodrs.2014.05.001, DOI 10.1016/J.GEODRS.2014.05.001]; Mikutta R, 2014, GEOCHIM COSMOCHIM AC, V144, P258, DOI 10.1016/j.gca.2014.08.026; Noda I, 2005, TWO DIMENSIONAL CORR; Oste LA, ENV SCI TECHNOLOGY, V36, P208; Pulido Moncada M, 2014, SOIL TILL RES, V140, P20, DOI 10.1016/j.still.2014.02.009; Ranjbar A, 2014, ADV POWDER TECHNOL, V25, P467, DOI 10.1016/j.apt.2013.07.011; Rodriguez-Blanco JD, 2011, NANOSCALE, V3, P265, DOI 10.1039/c0nr00589d; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; SCHNITZER M, 1991, SOIL SCI, V151, P41, DOI 10.1097/00010694-199101000-00008; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Six J, 2014, SOIL BIOL BIOCHEM, V68, pA4, DOI 10.1016/j.soilbio.2013.06.014; Sollins P, 1996, GEODERMA, V74, P65, DOI 10.1016/S0016-7061(96)00036-5; Sun BJ, 2008, POLYMER, V49, P2704, DOI 10.1016/j.polymer.2008.04.028; Trumbore SE, 1997, P NATL ACAD SCI USA, V94, P8284, DOI 10.1073/pnas.94.16.8284; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088279; Wen YL, 2014, CHEMOSPHERE, V111, P441, DOI 10.1016/j.chemosphere.2014.03.078; Wiesmeier M, 2014, GLOBAL CHANGE BIOL, V20, P653, DOI 10.1111/gcb.12384; Wu JN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103823, 10.1371/journal.pone.0105567]; Xu YM, 2014, J INTEGR AGR, V13, P554, DOI 10.1016/S2095-3119(13)60712-1; Yu GH, 2012, ENVIRON SCI TECHNOL; Zhang JC, 2013, EUR J SOIL SCI, V64, P797, DOI 10.1111/ejss.12104	30	10	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145054	10.1371/journal.pone.0145054	http://dx.doi.org/10.1371/journal.pone.0145054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751962	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100011
J	Zhang, SL; Liu, GQ; Duo, YF; Wang, JF; Li, JR; Li, CJ				Zhang, Shilin; Liu, Guoqing; Duo, Yongfu; Wang, Jianfeng; Li, Jierong; Li, Chunjing			Application of Ureteroscope in Emergency Treatment with Persistent Renal Colic Patients during Pregnancy	PLOS ONE			English	Article							URETERAL CALCULI; URINARY CALCULI; MANAGEMENT; KUB; HYDRONEPHROSIS; OBSTRUCTION	Background Although the application of ureteroscopy in the treatment of ureteral calculi during pregnancy has been on the rise, for persistent renal colic patients without ultrasound-detected ureteral calculi, it may represent a clinical dilemma due to the potential risks for both mother and fetus. Objective The aim of the present study is to present our experience with the application of the ureteroscope in the emergency treatment of persistent renal colic patients during pregnancy. Methods From March 2009 to September 2014, a total of 117 pregnant women who received ureteroscopy for persistent renal colic were retrospectively analyzed. Patients were divided into three groups according to duration of the persistent renal colic: Group A (within 12 hours; 24 cases); Group B (12 to 24 hours; 76 cases); and Group C (more than 24 hours; 17 cases). The stone-free rate, complications, and other qualitative data were analyzed. Results Of the 117 patients, 31 patients who were found not to have renal or ureteral calculi received ureteroscopic double-J (DJ) stent insertion, whereas 86 patients who were found with ureteral calculi received ureteroscopic lithotripsy (URSL) and DJ stent insertion. Among them, 24 patients (27.9%) were found with ureteral calculi by ureteroscopy rather than ultrasound. In addition, 73 patients (84.9%) had complete fragmentation of calculi; 12 patients (10.3%) had a threatened abortion (the rates of threatened abortion in Groups A, B and C were 8.3% vs. 6.5% vs. 29.4%; Group C compared with Groups A and B, p<0.05), and one patient (1.2%) had urosepsis (in Group C). However, these complications were cured with conservative treatment, without postpartum infant and maternal complications. Conclusion For pregnant patients with persistent renal colic/ureteral calculi and hydronephrosis, ureteroscopic DJ stent insertion and URSL are effective and safe options when conservative treatment fails, even if no urinary calculi were found by ultrasound. At the same time, for patients with persistent renal colic during pregnancy, early application of ureteroscopy may reduce the risk of preterm birth.	[Zhang, Shilin; Liu, Guoqing; Duo, Yongfu; Wang, Jianfeng; Li, Jierong; Li, Chunjing] Southern Med Univ, Foshan Maternal & Child Hlth Hosp, Dept Urol, Foshan 528000, Guangdong, Peoples R China	Southern Medical University - China	Zhang, SL (corresponding author), Southern Med Univ, Foshan Maternal & Child Hlth Hosp, Dept Urol, Peoples Rd 11, Foshan 528000, Guangdong, Peoples R China.	zhang_40_1@163.com			directive project of Department of Health of Gongdong Province [C2013014]; medical science fund of Foshan Municipal Technology Bureau [201308083]	directive project of Department of Health of Gongdong Province; medical science fund of Foshan Municipal Technology Bureau	The authors received funding of the directive project of Department of Health of Gongdong Province (C2013014) and the medical science fund of Foshan Municipal Technology Bureau (201308083) for this work.	Abdel-Gawad M, 2014, INT BRAZ J UROL, V40, P513, DOI [10.1590/S1677-5538.IBJU.2014.04.010, 10.1590/S1677-5538.IBJU.2014.04.10]; Abdel-Kader MS, 2013, UROL ANNALS, V5, P241, DOI 10.4103/0974-7796.120294; Atar M, 2012, INT J SURG, V10, P629, DOI 10.1016/j.ijsu.2012.10.006; Biyani CS, 2002, BJU INT, V89, P819, DOI 10.1046/j.1464-410X.2002.02773.x; DENSTEDT JD, 1992, J UROLOGY, V148, P1072, DOI 10.1016/S0022-5347(17)36821-0; DRAGO JR, 1982, UROLOGY, V20, P578, DOI 10.1016/0090-4295(82)90302-8; FINNEY RP, 1978, J UROLOGY, V120, P678, DOI 10.1016/S0022-5347(17)57326-7; Foell K, 2013, J ENDOUROL; Fregonesi A, 2013, UROL ANNALS, V5, P197, DOI 10.4103/0974-7796.115750; Georgescu D, 2014, CHIRURGIA-BUCHAREST, V109, P229; Hill CC, 2008, SURG CLIN N AM, V88, P391, DOI 10.1016/j.suc.2007.12.005; Hosking DH, 1999, J UROLOGY, V161, P48, DOI 10.1016/S0022-5347(01)62058-5; Ishii H, 2014, UROLITHIASIS, V42, P1, DOI 10.1007/s00240-013-0635-y; Korkes Fernando, 2014, J Bras Nefrol, V36, P389; Laing KA, 2012, UROL INT, V89, P380, DOI 10.1159/000343732; Lifshitz DA, 2002, J ENDOUROL, V16, P19, DOI 10.1089/089277902753483664; Moon TD, 2002, J UROLOGY, V167, P1984, DOI 10.1016/S0022-5347(05)65068-9; Nadeem M, 2012, INT J SURG, V10, P634, DOI 10.1016/j.ijsu.2012.10.007; Rosenberg E, 2011, WORLD J UROL, V29, P743, DOI 10.1007/s00345-011-0719-7; SCHWARZENBACH HR, 2012, SCHWEIZ RUNDSCH MED, V101, P1187; Semins MJ, 2009, J UROLOGY, V181, P139, DOI 10.1016/j.juro.2008.09.029; Spencer JA, 2004, J UROLOGY, V171, P256, DOI 10.1097/01.ju.0000102477.19999.b2; Teichman JMH, 2004, NEW ENGL J MED, V350, P684, DOI 10.1056/NEJMcp030813; Tokgoz O, 2013, ARCH GYNECOL OBSTET, V288, P1191, DOI 10.1007/s00404-013-2874-0; White WM, 2007, J ENDOUROL, V21, P1255, DOI 10.1089/end.2007.0017; Yen P, 2014, ACAD RADIOL, V21, P1035, DOI 10.1016/j.acra.2014.03.013; Zheng W, 2000, UROL CLIN N AM, V27, P301, DOI 10.1016/S0094-0143(05)70259-7	27	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146597	10.1371/journal.pone.0146597	http://dx.doi.org/10.1371/journal.pone.0146597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751955	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100109
J	An, RS; Grewal, PS				An, Ruisheng; Grewal, Parwinder S.			Comparative Analysis of Xenorhabdus koppenhoeferi Gene Expression during Symbiotic Persistence in the Host Nematode	PLOS ONE			English	Article							STEINERNEMA-CARPOCAPSAE; ESCHERICHIA-COLI; BIOFILM FORMATION; IN-VIVO; PHOTORHABDUS-LUMINESCENS; BACTERIAL RECEPTACLE; INTESTINAL VESICLE; SELECTIVE CAPTURE; REGULATOR CSRA; NEMATOPHILA	Species of Xenorhabdus and Photorhabdus bacteria form mutualistic associations with Steinernema and Heterorhabditis nematodes, respectively and serve as model systems for studying microbe-animal symbioses. Here, we profiled gene expression of Xenorhabdus koppenhoeferi during their symbiotic persistence in the newly formed infective juveniles of the host nematode Steinernema scarabaei through the selective capture of transcribed sequences (SCOTS). The obtained gene expression profile was then compared with other nematode-bacteria partnerships represented by Steinernema carpocapsae-Xenorhabdus nematophila and Heterorhabditis bacteriophora-Photorhabdus temperata. A total of 29 distinct genes were identified to be up-regulated and 53 were down-regulated in X. koppenhoeferi while in S. scarabaei infective juveniles. Of the identified genes, 8 of the up-regulated and 14 of the down-regulated genes were similarly expressed in X. nematophila during persistence in its host nematode S. carpocapsae. However, only one from each of these up-and down-regulated genes was common to the mutualistic partnership between the bacterium P. temperata and the nematode H. bacteriophora. Interactive network analysis of the shared genes between X. koppenhoeferi and X. nematophila demonstrated that the up-regulated genes were mainly involved in bacterial survival and the down-regulated genes were more related to bacterial virulence and active growth. Disruption of two selected genes pta (coding phosphotransacetylase) and acnB (coding aconitate hydratase) in X. nematophila with shared expression signature with X. koppenhoeferi confirmed that these genes are important for bacterial persistence in the nematode host. The results of our comparative analyses show that the two Xenorhabdus species share a little more than a quarter of the transcriptional mechanisms during persistence in their nematode hosts but these features are quite different from those used by P. temperata bacteria in their nematode host H. bacteriophora.	[An, Ruisheng; Grewal, Parwinder S.] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Grewal, PS (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, 2505 EJ Chapman Dr, Knoxville, TN 37996 USA.	pgrewal@utk.edu						Adams BJ, 2006, BIOL CONTROL, V37, P32, DOI 10.1016/j.biocontrol.2005.11.008; AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; An RS, 2011, MICROBIOL-SGM, V157, P2595, DOI 10.1099/mic.0.048959-0; An RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013154; An RS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-433; [Anonymous], 2012, HDB PROTEOLYTIC ENZY; Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Berg J, 2002, BIOCHEMISTRY MOSC; BIRD AF, 1983, INT J PARASITOL, V13, P599, DOI 10.1016/S0020-7519(83)80032-0; Boemare N, 2002, NEMATOLOGY, V4, P601, DOI 10.1163/15685410260438863; Broadbent JR, 2010, J BACTERIOL, V192, P2445, DOI 10.1128/JB.01618-09; Burton E, 2006, ANTIMICROB AGENTS CH, V50, P1835, DOI 10.1128/AAC.50.5.1835-1840.2006; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Cevikel MH, 2003, PANCREATOLOGY, V3, P329, DOI 10.1159/000071772; Chandra H, 2008, ENVIRON MICROBIOL, V10, P1285, DOI 10.1111/j.1462-2920.2007.01542.x; Chapuis E, 2012, P ROY SOC B-BIOL SCI, V279, P2672, DOI 10.1098/rspb.2012.0228; Chaston JM, 2013, CELL MICROBIOL, V15, P1545, DOI 10.1111/cmi.12134; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P1890, DOI 10.1128/AEM.69.4.1890-1897.2003; Cowles CE, 2004, MOL MICROBIOL, V54, P464, DOI 10.1111/j.1365-2958.2004.04271.x; Cowles CE, 2008, J BACTERIOL, V190, P4121, DOI 10.1128/JB.00123-08; CURRAN J, 1992, J NEMATOL, V24, P269; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Ensign SA, 2011, SCIENCE, V331, P294, DOI 10.1126/science.1201252; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; FERGUSON GP, 1995, MOL MICROBIOL, V17, P1025, DOI 10.1111/j.1365-2958.1995.mmi_17061025.x; Ferguson GP, 1997, J BACTERIOL, V179, P1007, DOI 10.1128/jb.179.4.1007-1012.1997; Ferguson GP, 2000, MOL MICROBIOL, V35, P113, DOI 10.1046/j.1365-2958.2000.01682.x; Ffrench-Constant R, 2003, FEMS MICROBIOL REV, V26, P433, DOI 10.1111/j.1574-6976.2003.tb00625.x; Flores-Lara Y, 2007, J INVERTEBR PATHOL, V95, P110, DOI 10.1016/j.jip.2007.01.006; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Gaugler R., 2002, ENTOMOPATHOGENIC NEM; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; Goetsch M, 2006, J BACTERIOL, V188, P2706, DOI 10.1128/JB.188.7.2706-2710.2006; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Grewal PS, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P157, DOI 10.1079/9781845936877.0157; Gury J, 2004, APPL ENVIRON MICROB, V70, P2146, DOI 10.1128/AEM.70.4.2146-2153.2004; Haydel SE, 2002, J BACTERIOL, V184, P2192, DOI 10.1128/JB.184.8.2192-2203.2002; Heungens K, 2002, MOL MICROBIOL, V45, P1337, DOI 10.1046/j.1365-2958.2002.03100.x; INABA K, 1994, BIOL PHARM BULL, V17, P395; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; Justice SS, 2005, J BACTERIOL, V187, P7680, DOI 10.1128/JB.187.22.7680-7686.2005; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kim SK, 2012, J INVERTEBR PATHOL, V110, P366, DOI 10.1016/j.jip.2012.04.011; Koppenhofer AM, 2009, BIOL CONTROL, V48, P63, DOI 10.1016/j.biocontrol.2008.09.005; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lango L, 2010, MOL MICROBIOL, V77, P1394, DOI 10.1111/j.1365-2958.2010.07300.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Martens EC, 2005, CELL MICROBIOL, V7, P1723, DOI 10.1111/j.1462-5822.2005.00585.x; Martens EC, 2005, MOL MICROBIOL, V58, P28, DOI 10.1111/j.1365-2958.2005.04742.x; Martens EC, 2003, J BACTERIOL, V185, P3678, DOI 10.1128/JB.185.12.3678-3682.2003; Mazzon RR, 2008, FEMS MICROBIOL LETT, V288, P178, DOI 10.1111/j.1574-6968.2008.01337.x; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Mitani DK, 2004, BIOL CONTROL, V29, P382, DOI 10.1016/j.biocontrol.2003.07.005; Morgan JAW, 2001, APPL ENVIRON MICROB, V67, P2062, DOI 10.1128/AEM.67.5.2062-2069.2001; Murayama N, 1996, J MOL BIOL, V256, P483, DOI 10.1006/jmbi.1996.0103; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pech M, 2011, P NATL ACAD SCI USA, V108, P3199, DOI 10.1073/pnas.1012994108; PINNER E, 1993, J BIOL CHEM, V268, P1729; POINAR GO, 1993, FUND APPL NEMATOL, V16, P333; POINER GO, 1966, PARASITOLOGY, V56, P385, DOI 10.1017/S0031182000070980; POPIEL I, 1991, J NEMATOL, V23, P432; Rediers H, 2005, MICROBIOL MOL BIOL R, V69, P217, DOI 10.1128/MMBR.69.2.217-261.2005; Richards GR, 2010, APPL ENVIRON MICROB, V76, P221, DOI 10.1128/AEM.01715-09; Rincon-Enriquez G, 2008, MOL MICROBIOL, V67, P1257, DOI 10.1111/j.1365-2958.2008.06118.x; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schellhorn HE, 1998, J BACTERIOL, V180, P6283; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Snyder H, 2007, APPL ENVIRON MICROB, V73, P5338, DOI 10.1128/AEM.02947-06; Somvanshi VS, 2012, SCIENCE, V337, P88, DOI 10.1126/science.1216641; Somvanshi VS, 2010, MOL MICROBIOL, V77, P1021, DOI 10.1111/j.1365-2958.2010.07270.x; Steffen MM, 2014, ISME J, V8, P2080, DOI 10.1038/ismej.2014.78; Stock SP, 2008, SYMBIOSIS, V46, P61; Studer SV, 2008, J BACTERIOL, V190, P5915, DOI 10.1128/JB.00148-08; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Vivas EI, 2001, J BACTERIOL, V183, P4687, DOI 10.1128/JB.183.16.4687-4693.2001; Wang CJ, 2003, J MED CHEM, V46, P5129, DOI 10.1021/jm030223a; Wang ZQ, 2007, J BIOL CHEM, V282, P2196, DOI 10.1074/jbc.M608206200; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wu Y, 2009, J BACTERIOL, V191, P1248, DOI 10.1128/JB.01086-08; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; Zhu XC, 2008, MICROBES INFECT, V10, P1274, DOI 10.1016/j.micinf.2008.07.025	90	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145739	10.1371/journal.pone.0145739	http://dx.doi.org/10.1371/journal.pone.0145739			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745883	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600013
J	Tian, PF; Lindorff-Larsen, K; Boomsma, W; Jensen, MH; Otzen, DE				Tian, Pengfei; Lindorff-Larsen, Kresten; Boomsma, Wouter; Jensen, Mogens Hogh; Otzen, Daniel Erik			A Monte Carlo Study of the Early Steps of Functional Amyloid Formation	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN AGGREGATION; FIBRIL ELONGATION; CURLI BIOGENESIS; BETA; OLIGOMERIZATION; POLYMERIZATION; ALGORITHMS; MECHANISMS; INHIBITOR	In addition to their well-known roles in neurodegenerative diseases and amyloidoses, amyloid structures also assume important functional roles in the cell. Although functional amyloid shares many physiochemical properties with its pathogenic counterpart, it is evolutionarily optimized to avoid cytotoxicity. This makes it an interesting study case for aggregation phenomenon in general. One of the most well-known examples of a functional amyloid, E. coli curli, is an essential component in the formation of bacterial biofilm, and is primarily formed by aggregates of the protein CsgA. Previous studies have shown that the minor sequence variations observed in the five different subrepeats (R1-R5), which comprise the CsgA primary sequence, have a substantial influence on their individual aggregation propensities. Using a recently described diffusion-optimized enhanced sampling approach for Monte Carlo simulations, we here investigate the equilibrium properties of the monomeric and dimeric states of these subrepeats, to probe whether structural properties observed in these early stage oligomers are decisive for the characteristics of the resulting aggregate. We show that the dimerization propensities of these peptides have strong correlations with their propensity for amyloid formation, and provide structural insights into the inter- and intramolecular contacts that appear to be essential in this process.	[Tian, Pengfei; Jensen, Mogens Hogh] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Tian, Pengfei; Lindorff-Larsen, Kresten; Boomsma, Wouter] Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr Prot Sci & Struct Biol, DK-2200 Copenhagen N, Denmark; [Tian, Pengfei; Lindorff-Larsen, Kresten; Boomsma, Wouter] Univ Copenhagen, NMR Lab, DK-2200 Copenhagen N, Denmark; [Otzen, Daniel Erik] Aarhus Univ, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark	University of Copenhagen; Niels Bohr Institute; University of Copenhagen; University of Copenhagen; Aarhus University	Boomsma, W (corresponding author), Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr Prot Sci & Struct Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	wb@bio.ku.dk; mhjensen@nbi.dk; dao@inano.au.dk	Jensen, Mogens H./U-5510-2017; Boomsma, Wouter/K-2903-2014; Tian, Pengfei/AGO-6921-2022; Lindorff-Larsen, Kresten/K-6469-2014	Jensen, Mogens H./0000-0001-8104-4299; Boomsma, Wouter/0000-0002-8257-3827; Lindorff-Larsen, Kresten/0000-0002-4750-6039; Tian, Pengfei/0000-0003-0255-8692	Lundbeck Foundation; Villum Foundation; Carlsberg Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF11OC1014446] Funding Source: researchfish; Villum Fonden [00007369] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Villum Foundation(Villum Fonden); Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation); Villum Fonden(Villum Fonden)	This work was supported by the Lundbeck Foundation, Villum Foundation, Carlsberg Foundation and Novo Nordisk Foundation.	Auer S, 2007, HFSP J, V1, P137, DOI 10.2976/1.2760023; Auer S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000458; Baftizadeh F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.168103; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; BERG BA, 1991, PHYS LETT B, V267, P249, DOI 10.1016/0370-2693(91)91256-U; Bille A, 2013, J PHYS CHEM B, V117, P9194, DOI 10.1021/jp404500b; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Boomsma W, 2014, P NATL ACAD SCI USA, V111, P13852, DOI 10.1073/pnas.1404948111; Boomsma W, 2013, J COMPUT CHEM, V34, P1697, DOI 10.1002/jcc.23292; Buchete NV, 2012, BIOPHYS J, V103, P1411, DOI 10.1016/j.bpj.2012.08.052; Buchete NV, 2005, J MOL BIOL, V353, P804, DOI 10.1016/j.jmb.2005.08.066; Cherny I, 2005, J MOL BIOL, V352, P245, DOI 10.1016/j.jmb.2005.07.028; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dueholm MS, 2015, J BIOL CHEM, V290, P20590, DOI 10.1074/jbc.M115.654780; Evans ML, 2015, MOL CELL, V57, P445, DOI 10.1016/j.molcel.2014.12.025; Evans ML, 2014, BBA-MOL CELL RES, V1843, P1551, DOI 10.1016/j.bbamcr.2013.09.010; Favrin G, 2001, J CHEM PHYS, V114, P8154, DOI 10.1063/1.1364637; Ferkinghoff-Borg J, 2002, EUR PHYS J B, V29, P481, DOI 10.1140/epjb/e2002-00328-1; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Han W, 2005, J AM CHEM SOC, V127, P15408, DOI 10.1021/ja051699h; Han W, 2014, J AM CHEM SOC, V136, P12450, DOI 10.1021/ja507002p; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Horvath I, 2012, J AM CHEM SOC, V134, P3439, DOI 10.1021/ja209829m; Hufnagel DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003740; Irback A, 2005, BIOPHYS J, V88, P1560, DOI 10.1529/biophysj.104.050427; Irback A, 2006, J COMPUT CHEM, V27, P1548, DOI 10.1002/jcc.20452; Irback Anders, 2009, PMC Biophys, V2, P2, DOI 10.1186/1757-5036-2-2; Irback A, 2008, PROTEINS, V71, P207, DOI 10.1002/prot.21682; Jiang P, 2013, J CHEM THEORY COMPUT, V9, P3816, DOI 10.1021/ct400312d; Jonsson SA, 2012, PROTEINS, V80, P2169, DOI 10.1002/prot.24107; Kim HY, 2007, CHEMBIOCHEM, V8, P1671, DOI 10.1002/cbic.200700366; Kim J, 2014, J BIOL CHEM, V289, P15094, DOI 10.1074/jbc.M113.542613; Landreh M, 2015, J BIOL CHEM, V290, P26430, DOI 10.1074/jbc.R115.653097; LEE J, 1993, PHYS REV LETT, V71, P211, DOI 10.1103/PhysRevLett.71.211; Lindorff-Larsen K., 2012, PLOS ONE, V7, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0032131, 10.1371/journal.pone.0032131]; Lipfert J, 2005, J MOL BIOL, V349, P648, DOI 10.1016/j.jmb.2005.03.083; Mitternacht S, 2011, J MOL BIOL, V410, P357, DOI 10.1016/j.jmb.2011.05.014; Mitternacht S, 2010, PROTEINS, V78, P2600, DOI 10.1002/prot.22775; Morriss-Andrews A, 2014, J PHYS CHEM LETT, V5, P1899, DOI 10.1021/jz5006847; Nadler W, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061905; Nagy-Smith K, 2015, P NATL ACAD SCI USA, V112, P9816, DOI 10.1073/pnas.1509313112; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; O'Malley TT, 2014, BIOCHEM J, V461, P413, DOI 10.1042/BJ20140219; Olsson S, 2014, J CHEM THEORY COMPUT, V10, P3484, DOI 10.1021/ct5001236; Otzen D, 2008, CELL MOL LIFE SCI, V65, P910, DOI 10.1007/s00018-007-7404-4; Roostaee A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-5; Roostaee A, 2009, J BIOL CHEM, V284, P30907, DOI 10.1074/jbc.M109.057950; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Tian PF, 2015, J AM CHEM SOC, V137, P22, DOI 10.1021/ja5093634; Trebst S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046701; Trusova Valeriya M., 2015, Biophysical Reviews and Letters, V10, P135, DOI 10.1142/S1793048015300029; Tukel C, 2009, CELL HOST MICROBE, V6, P45, DOI 10.1016/j.chom.2009.05.020; Urbanc B, 2004, BIOPHYS J, V87, P2310, DOI 10.1529/biophysj.104.040980; Valentin JB, 2014, PROTEINS, V82, P288, DOI 10.1002/prot.24386; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Wang X, 2010, P NATL ACAD SCI USA, V107, P163, DOI 10.1073/pnas.0908714107; Watson D, 2005, NEUROL RES, V27, P869, DOI 10.1179/016164105X49436; Wei GH, 2007, PRION, V1, P3, DOI 10.4161/pri.1.1.3969	70	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146096	10.1371/journal.pone.0146096	http://dx.doi.org/10.1371/journal.pone.0146096			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745180	gold, Green Published, Green Submitted			2022-12-27	WOS:000367815600025
J	Toro, TB; Pingali, S; Nguyen, TP; Garrett, DS; Dodson, KA; Nichols, KA; Haynes, RA; Payton-Stewart, F; Watt, TJ				Toro, Tasha B.; Pingali, Subramanya; Nguyen, Thao P.; Garrett, Destane S.; Dodson, Kyra A.; Nichols, Kyara A.; Haynes, Rashad A.; Payton-Stewart, Florastina; Watt, Terry J.			KDAC8 with High Basal Velocity Is Not Activated by N-Acetylthioureas	PLOS ONE			English	Article							HISTONE DEACETYLASE 8; SYNDROME SPECTRUM DISORDERS; HDAC8; SUBSTRATE; MECHANISM; INHIBITORS; SIRTUINS; RESVERATROL; DISEASES	Lysine deacetylases (KDACs) are enzymes that reverse the post-translational modification of lysine acetylation. Recently, a series of N-acetylthioureas were synthesized and reported to enhance the activity of KDAC8 with a fluorogenic substrate. To determine if the activation was general, we synthesized three of the most potent N-acetylthioureas and measured their effect with peptide substrates and the fluorogenic substrate under multiple reaction conditions and utilizing two enzyme purification approaches. No activation was observed for any of the three N-acetylthioureas under any assayed conditions. Further characterization of KDAC8 kinetics with the fluorogenic substrate yielded a k(cat)/K-M of 164 +/- 17 in the absence of any N-acetylthioureas. This catalytic efficiency is comparable to or higher than that previously reported when KDAC8 was activated by the N-acetylthioureas, suggesting that the previously reported activation effect may be due to use of an enzyme preparation that contains a large fraction of inactive enzyme. Further characterization with a less active preparation and additional substrates leads us to conclude that N-acetylthioureas are not true activators of KDAC8 and only increase activity if the enzyme preparation is below the maximal basal activity.	[Toro, Tasha B.; Pingali, Subramanya; Nguyen, Thao P.; Garrett, Destane S.; Dodson, Kyra A.; Nichols, Kyara A.; Haynes, Rashad A.; Payton-Stewart, Florastina; Watt, Terry J.] Xavier Univ, Dept Chem, New Orleans, LA 70125 USA	Xavier University of Louisiana	Watt, TJ (corresponding author), Xavier Univ, Dept Chem, 1 Drexel Dr, New Orleans, LA 70125 USA.	tjwatt@xula.edu	Nguyen, Thao/HCH-9537-2022		U. S. Army Research Laboratory; U.S. Army Research Office [W911NF1310129]; Louisiana Cancer Research Consortium; NIH-RCMI grant from the National Institute on Minority Health and Health Disparities [2G12MD007595-06]; National Institutes of Health [NIGMS 5T34GM007716-35, NIMHHD TL4GM118968]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [UL1GM118967, T34GM007716, RL5GM118966, TL4GM118968] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	U. S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office; Louisiana Cancer Research Consortium; NIH-RCMI grant from the National Institute on Minority Health and Health Disparities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This material is based upon work supported by, or in part by, the U.S. Army Research Laboratory and the U. S. Army Research Office under contract/grant number W911NF1310129 (TBT, TPN, DSG, KAN, TJW). This publication was made possible in part by funding from the Louisiana Cancer Research Consortium and the NIH-RCMI grant #2G12MD007595-06 from the National Institute on Minority Health and Health Disparities (SP, FP, TJW). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the Louisiana Cancer Research Consortium or the NIH. The authors also acknowledge NIGMS 5T34GM007716-35 (DSG) and NIMHHD TL4GM118968 (KAD, RAH, FP, TJW) from the National Institutes of Health. The Xavier University of Louisiana Center for Undergraduate Education (TPN) and UNCF Stem Scholars Program (KAN) also contributed to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aka Juliette Adjo, 2011, Handb Exp Pharmacol, V206, P1, DOI 10.1007/978-3-642-21631-2_1; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chen K, 2014, J AM CHEM SOC, V136, P11636, DOI 10.1021/ja501548p; Decroos C, 2015, BIOCHEMISTRY-US, V54, P6501, DOI 10.1021/acs.biochem.5b00881; Decroos C, 2014, ACS CHEM BIOL, V9, P2157, DOI 10.1021/cb5003762; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hubbard BP, 2014, TRENDS PHARMACOL SCI, V35, P146, DOI 10.1016/j.tips.2013.12.004; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Murugan K, 2015, DRUG DES DEV THER, V9, P2257, DOI 10.2147/DDDT.S78276; Olsen CA, 2014, CHEMMEDCHEM, V9, P434, DOI 10.1002/cmdc.201300421; Olson DE, 2014, ACS CHEM BIOL, V9, P2210, DOI 10.1021/cb500492r; Peng Lirong, 2011, Handb Exp Pharmacol, V206, P39, DOI 10.1007/978-3-642-21631-2_3; Riester D, 2007, BIOCHEM BIOPH RES CO, V357, P439, DOI 10.1016/j.bbrc.2007.03.158; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Singh RK, 2015, J BIOL CHEM, V290, P6607, DOI 10.1074/jbc.M114.600627; Singh RK, 2011, BIOORG MED CHEM LETT, V21, P5920, DOI 10.1016/j.bmcl.2011.07.080; Tang JH, 2013, CLIN SCI, V124, P651, DOI 10.1042/CS20120504; Toro TB, 2015, PROTEIN SCI, V24, P2020, DOI 10.1002/pro.2813; Vogelauer M, 2012, J BIOL CHEM, V287, P32006, DOI 10.1074/jbc.M112.362467; Wang XJ, 2014, KIDNEY INT, V86, P712, DOI 10.1038/ki.2014.111; Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135; Yao YL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/146493	27	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146900	10.1371/journal.pone.0146900	http://dx.doi.org/10.1371/journal.pone.0146900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745872	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600082
J	Liu, B; Govindan, R; Uzzi, B				Liu, Bin; Govindan, Ramesh; Uzzi, Brian			Do Emotions Expressed Online Correlate with Actual Changes in Decision-Making?: The Case of Stock Day Traders	PLOS ONE			English	Article							NEUROSCIENCE; NEGOTIATION; CIRCUMPLEX; BEHAVIOR; MARKETS; WORK; TIME	Emotions are increasingly inferred linguistically from online data with a goal of predicting off-line behavior. Yet, it is unknown whether emotions inferred linguistically from online communications correlate with actual changes in off-line activity. We analyzed all 886,000 trading decisions and 1,234,822 instant messages of 30 professional day traders over a continuous 2 year period. Linguistically inferring the traders' emotional states from instant messages, we find that emotions expressed in online communications reflect the same distributions of emotions found in controlled experiments done on traders. Further, we find that expressed online emotions predict the profitability of actual trading behavior. Relative to their baselines, traders who expressed little emotion or traders that expressed high levels of emotion made relatively unprofitable trades. Conversely, traders expressing moderate levels of emotional activation made relatively profitable trades.	[Liu, Bin] Google Inc, Mountain View, CA 94043 USA; [Govindan, Ramesh] Univ So Calif, Dept Comp Sci, Los Angeles, CA 90089 USA; [Uzzi, Brian] Northwestern Univ, Northwestern Inst Complex Syst NICO, Evanston, IL 60208 USA	Google Incorporated; University of Southern California; Northwestern University	Uzzi, B (corresponding author), Northwestern Univ, Northwestern Inst Complex Syst NICO, Evanston, IL 60208 USA.	uzzi@northwestern.edu			Army Research Laboratory [W911NF-09-2-0053]; Northwestern Institute on Complex Systems (NICO); Google; ARO [65674-NS-CF];  [DARPA BAA-11-64]	Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Northwestern Institute on Complex Systems (NICO); Google(Google Incorporated); ARO; 	This work received support from the Army Research Laboratory (under cooperative agreement W911NF-09-2-0053); DARPA BAA-11-64; Northwestern Institute on Complex Systems (NICO). The funder (Google) provided support in the form of salaries for author BL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Matthias Leiss, Christain Schultz, Chungwei Hang, Zhe Zhang, and Munindar Singh for their help with the research. Research was sponsored by the Northwestern Institute on Complex System (NICO), the Army Research Laboratory under cooperative agreement W911NF-09-2-0053 to RG and BU and ARO No. 65674-NS-CF to BU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Google) provided support in the form of salaries for author BL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1929, NY TIMES; Bradley M. M, 2007, D1 U FLOR; Butler JK, 1999, GROUP ORGAN MANAGE, V24, P217, DOI 10.1177/1059601199242005; Butts CT, 2008, SOCIOL METHODOL, V38, P155, DOI 10.1111/j.1467-9531.2008.00203.x; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; Damasio A.R., 2005, DESCARTES ERROR EMOT; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Fenton-O'Creevy M, J ORG BEHAV, V32, P1044; Garas A, 2002, NATURE SCI REPORTS, V2, P402; Gell-Mann M., 1996, Complexity, V2, P44, DOI 10.1002/(SICI)1099-0526(199609/10)2:1<44::AID-CPLX10>3.0.CO;2-X; Gilkey R, 2012, NEUROLEADERSHIP J, V4, P1; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Kahneman D., 2011, THINKING FAST SLOW; Kassam KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066032; Kring AM, 2003, PSYCHOL SCI, V14, P207, DOI 10.1111/1467-9280.02433; Lo AW, 2002, J COGNITIVE NEUROSCI, V14, P323, DOI 10.1162/089892902317361877; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Robertson D, 2007, NEUROPSYCHOLOGIA, V45, P755, DOI 10.1016/j.neuropsychologia.2006.08.014; ROSENTHAL R, 1988, NEGOTIATION J, V4, P267; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Saavedra S, 2011, PNAS; Saavedra S, 2013, P ROY SOC B, P1471; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Sanfey AG, 2007, CURR DIR PSYCHOL SCI, V16, P151, DOI 10.1111/j.1467-8721.2007.00494.x; Shiv B, 2005, PSYCHOL SCI, V16, P435; Steenbarger B, 2002, PSYCHOL TRADING TOOL; Verduyn P, 2009, EMOTION, V9, P83, DOI 10.1037/a0014610; WILCOX NT, 1993, ECON J, V103, P1397, DOI 10.2307/2234473	30	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0144945	10.1371/journal.pone.0144945	http://dx.doi.org/10.1371/journal.pone.0144945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB4CC	26765539	gold, Green Submitted, Green Published			2022-12-27	WOS:000368459300006
J	Lipner, MB; Marayati, R; Deng, YM; Wang, XX; Raftery, L; O'Neil, BH; Yeh, JJ				Lipner, Matthew B.; Marayati, Raoud; Deng, Yangmei; Wang, Xianxi; Raftery, Laura; O'Neil, Bert H.; Yeh, Jen Jen			Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts	PLOS ONE			English	Article							IN-VIVO; HEPATIC GLUCONEOGENESIS; MAMMALIAN TARGET; TUMOR XENOGRAFTS; CELL-GROWTH; MTOR; AMPK; RISK; APOPTOSIS; DECREASE	There is currently tremendous interest in developing anti-cancer therapeutics targeting cell signaling pathways important for both cancer cell metabolism and growth. Several epidemiological studies have shown that diabetic patients taking metformin have a decreased incidence of pancreatic cancer. This has prompted efforts to evaluate metformin, a drug with negligible toxicity, as a therapeutic modality in pancreatic cancer. Preclinical studies in cell line xenografts and one study in patient-derived xenograft (PDX) models were promising, while recently published clinical trials showed no benefit to adding metformin to combination therapy regimens for locally advanced and metastatic pancreatic cancer. PDX models in which patient tumors are directly engrafted into immunocompromised mice have been shown to be excellent preclinical models for biomarker discovery and therapeutic development. We evaluated the response of four PDX tumor lines to metformin treatment and found that all four of our PDX lines were resistant to metformin. We found that the mechanisms of resistance may occur through lack of sustained activation of adenosine monophosphate-activated protein kinase (AMPK) or downstream reactivation of the mammalian target of rapamycin (mTOR). Moreover, combined treatment with metformin and mTOR inhibitors failed to improve responses in cell lines, which further indicates that metformin alone or in combination with mTOR inhibitors will be ineffective in patients, and that resistance to metformin may occur through multiple pathways. Further studies are required to better understand these mechanisms of resistance and inform potential combination therapies with metformin and existing or novel therapeutics.	[Lipner, Matthew B.; Yeh, Jen Jen] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Lipner, Matthew B.; Marayati, Raoud; Deng, Yangmei; Wang, Xianxi; Yeh, Jen Jen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Raftery, Laura] ProHlth Care Reg Canc Ctr, Waukesha, WI USA; [O'Neil, Bert H.] Indiana Univ, Dept Med, Div Med Oncol, Indianapolis, IN USA; [Yeh, Jen Jen] Univ N Carolina, Dept Surg, Div Surg Oncol & Endocrinol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Indiana University System; Indiana University-Purdue University Indianapolis; University of North Carolina; University of North Carolina Chapel Hill	Yeh, JJ (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA.	jjyeh@med.unc.edu	, Animal Studies Core/ADK-4234-2022; , Pathology Services Core/CEZ-2246-2022; , Animal Studies Core/AAF-4432-2022		Lineberger Comprehensive Cancer Center; National Cancer Institute [CA140424, CA193650]; NATIONAL CANCER INSTITUTE [R01CA140424, R01CA193650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040] Funding Source: NIH RePORTER	Lineberger Comprehensive Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the Lineberger Comprehensive Cancer Center (B.H.O.) and CA140424 and CA193650 J.J.Y.) from the National Cancer Institute.	Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Braghiroli MI, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.563; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chaulagain CP, 2012, J PANCREAS, V13, P349, DOI 10.6092/1590-8577/935; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feng YH, 2011, J CELL MOL MED, V15, P825, DOI 10.1111/j.1582-4934.2010.01083.x; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Gotlieb WH, 2008, GYNECOL ONCOL, V110, P246, DOI 10.1016/j.ygyno.2008.04.008; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kawanami T, 2012, ONCOL REP, V27, P867, DOI 10.3892/or.2011.1597; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Kordes S, 2015, LANCET ONCOL, V16, P839, DOI 10.1016/S1470-2045(15)00027-3; Li WG, 2012, DIABETES RES CLIN PR, V96, P187, DOI 10.1016/j.diabres.2011.12.028; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lonardo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076518; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Neel NF, 2014, MOL CANCER THER, V13, P122, DOI 10.1158/1535-7163.MCT-12-1232; Pollak M, 2012, CLIN CANCER RES, V18, P2723, DOI 10.1158/1078-0432.CCR-12-0694; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Rubio-Viqueira B, 2009, CLIN PHARMACOL THER, V85, P217, DOI 10.1038/clpt.2008.200; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Torphy RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089474; Vakana E, 2012, J CELL BIOCHEM, V113, P404, DOI 10.1002/jcb.23369; Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499; Wang LW, 2008, WORLD J GASTROENTERO, V14, P7192, DOI 10.3748/wjg.14.7192; WILCOCK C, 1990, BIOCHEM PHARMACOL, V39, P1831, DOI 10.1016/0006-2952(90)90136-9; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500	45	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147113	10.1371/journal.pone.0147113	http://dx.doi.org/10.1371/journal.pone.0147113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760500	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100070
J	Montesinos, L; Bundo, M; Izquierdo, E; Campo, S; Badosa, E; Rossignol, M; Montesinos, E; Segundo, BS; Coca, M				Montesinos, Laura; Bundo, Mireia; Izquierdo, Esther; Campo, Sonia; Badosa, Esther; Rossignol, Michel; Montesinos, Emilio; Segundo, Blanca San; Coca, Mara			Production of Biologically Active Cecropin A Peptide in Rice Seed Oil Bodies	PLOS ONE			English	Article							ORYZA-SATIVA L.; ANTIMICROBIAL PEPTIDES; ORAL TOLERANCE; EXPRESSION; IMMOBILIZATION; VACCINE; PROTEIN; SURFACE; PLANTS; SPECIFICITY	Cecropin A is a natural antimicrobial peptide that exhibits fast and potent activity against a broad spectrum of pathogens and neoplastic cells, and that has important biotechnological applications. However, cecropin A exploitation, as for other antimicrobial peptides, is limited by their production and purification costs. Here, we report the efficient production of this bioactive peptide in rice bran using the rice oleosin 18 as a carrier protein. High cecropin A levels were reached in rice seeds driving the expression of the chimeric gene by the strong embryo-specific oleosin 18 own promoter, and targeting the peptide to the oil body organelle as an oleosin 18-cecropin A fusion protein. The accumulation of cecropin A in oil bodies had no deleterious effects on seed viability and seedling growth, as well as on seed yield. We also show that biologically active cecropin A can be easily purified from the transgenic rice seeds by homogenization and simple flotation centrifugation methods. Our results demonstrate that the oleosin fusion technology is suitable for the production of cecropin A in rice seeds, which can potentially be extended to other antimicrobial peptides to assist their exploitation.	[Montesinos, Laura; Badosa, Esther; Montesinos, Emilio] Univ Girona, Inst Food & Agr Technol CIDSAV XaRTA, Girona, Spain; [Bundo, Mireia; Campo, Sonia; Segundo, Blanca San; Coca, Mara] CSIC IRTA UAB UB, CRAG, Barcelona, Spain; [Izquierdo, Esther; Rossignol, Michel] SupAgro INRA CNRS UMII UMR 5004, Biochim & Physiol Mol Plantes, Mass Spectrometry Prote Platform, Montpellier, France	Universitat de Girona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Coca, M (corresponding author), CSIC IRTA UAB UB, CRAG, Edifici CRAG,Campus UAB, Barcelona, Spain.	maria.coca@cragenomica.es	Campo, Sonia/M-3521-2015; Coca, Maria A/P-6327-2014; San Segundo, Blanca/C-2417-2009; Romañó, Esther Badosa/H-3342-2015; Campo, Sonia/AAQ-1392-2020; MONTESINOS, EMILIO/H-5246-2015	Campo, Sonia/0000-0001-5477-3162; Coca, Maria A/0000-0002-5578-3175; San Segundo, Blanca/0000-0001-7409-3172; Romañó, Esther Badosa/0000-0001-7776-8286; Campo, Sonia/0000-0001-5477-3162; Bundo, Mireia/0000-0002-2765-1909; MONTESINOS, EMILIO/0000-0003-4455-8332	Spanish Ministry of Economy and Competitiveness [EUI2008-03769, EUI2008-03572, BIO2012-32838]; French Research Agency [ANR-08-KBBE-010]	Spanish Ministry of Economy and Competitiveness(Spanish Government); French Research Agency(French National Research Agency (ANR))	This work was supported by the Spanish Ministry of Economy and Competitiveness [Grants EUI2008-03769, EUI2008-03572 and BIO2012-32838], and by the French Research Agency [Grant ANR-08-KBBE-010]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Alfano R, 2014, BIOENGINEERED, V5, DOI 10.4161/bioe.28996; Badosa E, 2013, PLOS ONE, V8, P1, DOI [10.1371/journal.pone.0085515, DOI 10.1371/J0URNAL.P0NE.0085515]; Boothe J, 2010, PLANT BIOTECHNOL J, V8, P588, DOI 10.1111/j.1467-7652.2010.00511.x; Bundo M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-102; Candido ED, 2014, PEPTIDES, V55, P65, DOI 10.1016/j.peptides.2014.02.003; Cavallarin L, 1998, MOL PLANT MICROBE IN, V11, P218, DOI 10.1094/MPMI.1998.11.3.218; Chapman KD, 2012, J LIPID RES, V53, P215, DOI 10.1194/jlr.R021436; Chen JCF, 1999, PLANT CELL PHYSIOL, V40, P1079, DOI 10.1093/oxfordjournals.pcp.a029490; Chiang CJ, 2006, ENZYME MICROB TECH, V39, P1152, DOI 10.1016/j.enzmictec.2006.02.024; Chuang RLC, 1996, J BIOCHEM-TOKYO, V120, P74, DOI 10.1093/oxfordjournals.jbchem.a021396; Coca M, 2006, PLANTA, V223, P392, DOI 10.1007/s00425-005-0069-z; Davidson PM, 2013, ANNU REV FOOD SCI T, V4, P163, DOI 10.1146/annurev-food-030212-182535; Ferre R, 2006, APPL ENVIRON MICROB, V72, P3302, DOI 10.1128/AEM.72.5.3302-3308.2006; FLORACK D, 1995, TRANSGENIC RES, V4, P132, DOI 10.1007/BF01969415; Fujiwara Y, 2010, PROTEIN EXPRES PURIF, V72, P125, DOI 10.1016/j.pep.2010.02.008; Goyal RK, 2013, PLOS ONE, V8, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0077505, 10.1371/journal.pone.0077505]; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hashizume F, 2008, TRANSGENIC RES, V17, P1117, DOI 10.1007/s11248-008-9187-2; He Y, 2011, P NATL ACAD SCI USA, DOI [10.1073/pnas.1109736108/, DOI 10.1073/PNAS.1109736108/]; Hennegan K, 2005, TRANSGENIC RES, V14, P583, DOI 10.1007/s11248-004-6702-y; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; Hung YJ, 2008, BIORESOURCE TECHNOL, V99, P8662, DOI 10.1016/j.biortech.2008.04.017; Mulder KCL, 2013, CURR PROTEIN PEPT SC, V14, P556; Li YF, 2011, PROTEIN EXPRES PURIF, V80, P260, DOI 10.1016/j.pep.2011.08.001; Liu JH, 1997, MOL BREEDING, V3, P463, DOI 10.1023/A:1009604119618; Lopez-Garcia B, 2012, ACS SYM SER, V1095, P263; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Matsumoto Y, 2009, TRANSGENIC RES, V18, P185, DOI 10.1007/s11248-008-9205-4; MILLS D, 1994, PLANT SCI, V104, P17, DOI 10.1016/0168-9452(94)90186-4; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Montesinos E, 2012, ACS SYM SER, V1095, P235; Mulder KCL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00321; Nadal A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-159; Nandi S, 2005, TRANSGENIC RES, V14, P237, DOI 10.1007/s11248-004-8120-6; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; Nykiforuk CL, 2006, PLANT BIOTECHNOL J, V4, P77, DOI 10.1111/j.1467-7652.2005.00159.x; Nykiforuk CL, 2011, PLANT BIOTECHNOL J, V9, P250, DOI 10.1111/j.1467-7652.2010.00546.x; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Parmenter DL, 1995, PLANT MOL BIOL, V29, P1167, DOI 10.1007/BF00020460; Qu LQ, 2004, PLANT BIOTECHNOL J, V2, P113, DOI 10.1111/j.1467-7652.2004.00055.x; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Sardana R, 2007, TRANSGENIC RES, V16, P713, DOI 10.1007/s11248-006-9062-y; Schmidt MA, 2008, MOL PLANT, V1, P910, DOI 10.1093/mp/ssn049; Sharif MK, 2014, CRIT REV FOOD SCI, V54, P807, DOI 10.1080/10408398.2011.608586; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Stoger E, 2000, PLANT MOL BIOL, V42, P583, DOI 10.1023/A:1006301519427; Suzuki K, 2011, PLANT BIOTECHNOL J, V9, P982, DOI 10.1111/j.1467-7652.2011.00613.x; Takagi H, 2005, P NATL ACAD SCI USA, V102, P17525, DOI 10.1073/pnas.0503428102; Takagi H, 2005, PLANT BIOTECHNOL J, V3, P521, DOI 10.1111/j.1467-7652.2005.00143.x; Takagi H, 2008, VACCINE, V26, P6027, DOI 10.1016/j.vaccine.2008.09.019; Takagi H, 2010, PEPTIDES, V31, P1421, DOI 10.1016/j.peptides.2010.04.032; Tseng CW, 2014, J AGR FOOD CHEM, V62, P6771, DOI 10.1021/jf502022w; TZEN JTC, 1992, J CELL BIOL, V117, P327, DOI 10.1083/jcb.117.2.327; TZEN JTC, 1992, J BIOL CHEM, V267, P15626; Tzen JTC., 2012, ISRN BOT, V2012, P173954; Upton Mathew, 2012, Int J Microbiol, V2012, P326503, DOI 10.1155/2012/326503; VANROOIJEN GJH, 1995, BIO-TECHNOL, V13, P72, DOI 10.1038/nbt0195-72; Wakasa Y, 2013, BIOTECHNOL J, V8, P1133, DOI 10.1002/biot.201300065; Wakasa Y, 2011, PLANT BIOTECHNOL J, V9, P729, DOI 10.1111/j.1467-7652.2010.00576.x; Wang SY, 2013, PLANT CELL PHYSIOL, V54, P917, DOI 10.1093/pcp/pct043; Wu YY, 2010, PLANT PHYSIOL BIOCH, V48, P81, DOI 10.1016/j.plaphy.2009.12.004; Yang LT, 2005, PLANT CELL REP, V23, P759, DOI 10.1007/s00299-004-0881-0; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	67	17	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146919	10.1371/journal.pone.0146919	http://dx.doi.org/10.1371/journal.pone.0146919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760761	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100053
J	Abramson, DH; Daniels, AB; Marr, BP; Francis, JH; Brodie, SE; Dunkel, IJ; Gobin, YP				Abramson, David H.; Daniels, Anthony B.; Marr, Brian P.; Francis, Jasmine H.; Brodie, Scott E.; Dunkel, Ira J.; Gobin, Y. Pierre			Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma	PLOS ONE			English	Article							CHILDREN RECEIVING CARBOPLATIN; EXTERNAL-BEAM RADIOTHERAPY; INTRAOCULAR RETINOBLASTOMA; BILATERAL RETINOBLASTOMA; CHEMOREDUCTION; MANAGEMENT; OTOTOXICITY; MELPHALAN; OUTCOMES; SUCCESS	Purpose To report globe salvage rates, patient survival and adverse events of ophthalmic artery chemosurgery (OAC) for International Classification of Retinoblastoma (ICRB) group D retinoblastoma (naive and after prior failures). Methods Single institution retrospective review of all Group D eyes treated with OAC from 5/2006-12/2012. Patients were treated according to our previously-published techniques. Primary outcome was globe retention without need for external beam radiotherapy (EBRT). Demographics, prior treatments, OAC agents used, and adverse events were also recorded. Results 112 group D eyes (103 patients) that underwent OAC were included (average follow-up was 34 months, range: 2-110 months). 47 eyes were treatment-naive, 58 eyes received prior treatments elsewhere, and 7 young infants (7 eyes) underwent our published "bridge therapy" (single agent intravenous carboplatin) until old enough to undergo OAC. Median number of OAC sessions/eye was 3 (range 1-9). 110/112 eyes received intra-arterial melphalan, but only 31 eyes received melphalan alone. 43 eyes received carboplatin, and 78 eyes received topotecan (never as a single agent). 80/112 eyes received >1 drug over their treatment course, and 39 eyes received all three agents. 24 eyes (16 pretreated, 7 treatment-naive, 1 bridge) failed treatment and required enucleation during the study period. Enucleation and EBRT were avoided in 88/112 eyes (78.6%; including 40/47 [85.1%] treatment-naive eyes, 42/58 [72.4%] previously-treated eyes, and 6/7 eyes [85.7%] among bridge patients). By Kaplan-Meier survival analysis, globe salvage rate was 74% at 110 months among all patients, and 85% at 110 months in the treatment-naive subgroup. Transient grade 3/4 neutropenia was more common in patients receiving OAC bilaterally. No child died of metastatic disease. Conclusions OAC is effective for curing group D retinoblastoma, achieving rates of globe salvage many times higher than systemic chemotherapy (10-47%), even in eyes that previously failed other treatments. OAC can be performed multiple times, using multiple agents, on one or both eyes of patients.	[Abramson, David H.; Marr, Brian P.; Francis, Jasmine H.; Gobin, Y. Pierre] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA; [Daniels, Anthony B.] Vanderbilt Univ, Med Ctr, Dept Ophthalmol & Visual Sci, Nashville, TN 37203 USA; [Daniels, Anthony B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA; [Daniels, Anthony B.] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA; [Daniels, Anthony B.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Brodie, Scott E.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Dunkel, Ira J.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Gobin, Y. Pierre] Weill Cornell Med Coll, Neurosurg Intervent Radiol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Daniels, AB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Ophthalmol & Visual Sci, Nashville, TN 37203 USA.	anthony.b.daniels@vanderbilt.edu		Francis, Jasmine/0000-0002-7637-3108; Brodie, Scott/0000-0002-3303-4552; Dunkel, Ira/0000-0001-8091-6067	Fund for Ophthalmic Knowledge, Inc.; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Fund for Ophthalmic Knowledge, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Fund for Ophthalmic Knowledge, Inc. The sponsor or funding organization had no role in the design or conduct of this research (DHA).	Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2013, OPHTHALMOLOGY, V120, P560, DOI 10.1016/j.ophtha.2012.08.023; Abramson DH, 2012, BRIT J OPHTHALMOL, V96, P499, DOI 10.1136/bjophthalmol-2011-300498; Abramson DH, 2010, OPHTHALMOLOGY, V117, P1623, DOI 10.1016/j.ophtha.2009.12.030; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 1998, OPHTHALMOLOGY, V105, P573, DOI 10.1016/S0161-6420(98)94006-4; Bartuma K, 2014, ACTA OPHTHALMOL, V92, P404, DOI 10.1111/aos.12282; Berry JL, 2013, PEDIATR BLOOD CANCER, V60, P688, DOI 10.1002/pbc.24303; Chung SE, 2008, BRIT J OPHTHALMOL, V92, P1180, DOI 10.1136/bjo.2008.140046; Cohen VML, 2009, BRIT J OPHTHALMOL, V93, P887, DOI 10.1136/bjo.2008.142679; Francis JH, 2014, OPHTHALMOLOGY, V121, P1810, DOI 10.1016/j.ophtha.2014.03.028; Francis JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084247; Francis JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072441; Francis JH, 2013, INT J RADIAT ONCOL, V87, P517, DOI 10.1016/j.ijrobp.2013.06.2045; Francis JH, 2012, BRIT J OPHTHALMOL, V96, P1270, DOI 10.1136/bjophthalmol-2012-301686; Gao YJ, 2011, PEDIATR BLOOD CANCER, V57, P1113, DOI 10.1002/pbc.23002; Gobin YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044322; Gobin YP, 2012, ARCH OPHTHALMOL-CHIC, V130, P403, DOI 10.1001/archopthalmol.2011.2717; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Gombos DS, 2007, OPHTHALMOLOGY, V114, P1378, DOI 10.1016/j.ophtha.2007.03.074; Gunduz K, 2004, OPHTHALMOLOGY, V111, P1917, DOI 10.1016/j.ophtha.2004.04.016; Gunduz K, 2013, J PEDIAT OPHTH STRAB, V50, P296, DOI 10.3928/01913913-20130730-02; Jehanne M, 2009, PEDIATR BLOOD CANCER, V53, P1162, DOI 10.1002/pbc.22124; Jehanne M, 2009, PEDIATR BLOOD CANCER, V52, P637, DOI 10.1002/pbc.21898; Klufas MA, 2012, AM J NEURORADIOL, V33, P1608, DOI 10.3174/ajnr.A3019; Kunkele A, 2013, BRIT J OPHTHALMOL, V97, P1277, DOI 10.1136/bjophthalmol-2013-303452; Lee V, 2003, BRIT J OPHTHALMOL, V87, P1374, DOI 10.1136/bjo.87.11.1374; Lim FPM, 2013, J PEDIAT OPHTH STRAB, V50, P106, DOI 10.3928/01913913-20121211-01; Marr B, 2010, MIDDLE EAST AFR J OP, V17, P207, DOI 10.4103/0974-9233.65492; Marr BP, 2012, BRIT J OPHTHALMOL, V96, P1300, DOI 10.1136/bjophthalmol-2012-301925; Marr BP, 2012, ARCH OPHTHALMOL-CHIC, V130, P180, DOI 10.1001/archophthalmol.2011.386; Munier FL, 2012, BRIT J OPHTHALMOL, V96, P1078, DOI 10.1136/bjophthalmol-2011-301450; Munier FL, 2012, BRIT J OPHTHALMOL, V96, P1084, DOI 10.1136/bjophthalmol-2011-301016; Murphree AL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1348, DOI 10.1001/archopht.1996.01100140548005; Rizzuti AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P862, DOI 10.1001/archopht.126.6.862; Rodriguez-Galindo C, 2003, J CLIN ONCOL, V21, P2019, DOI 10.1200/JCO.2003.09.103; Shields CL, 2013, RETINA-J RET VIT DIS, V33, P2103, DOI 10.1097/IAE.0b013e318295f783; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1407, DOI 10.1001/archophthalmol.2011.151; Shields CL, 2006, OPHTHALMOLOGY, V113, P2276, DOI 10.1016/j.ophtha.2006.06.018; Shields CL, 2002, AM J OPHTHALMOL, V133, P657, DOI 10.1016/S0002-9394(02)01348-X; Shin Joo Young, 2010, Korean J Ophthalmol, V24, P219, DOI 10.3341/kjo.2010.24.4.219; Turaka K, 2012, PEDIATR BLOOD CANCER, V59, P121, DOI 10.1002/pbc.23278; Vajzovic LM, 2011, CLIN OPHTHALMOL, V5, P171, DOI 10.2147/OPTH.S12665; Wong FL, 1997, JAMA-J AM MED ASSOC, V278, P1262, DOI 10.1001/jama.278.15.1262; Zage PE, 2008, PEDIATR BLOOD CANCER, V50, P567, DOI 10.1002/pbc.21301	45	70	75	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146582	10.1371/journal.pone.0146582	http://dx.doi.org/10.1371/journal.pone.0146582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756643	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800016
J	Ferguson, GD; Delgado, M; Plantevin-Krenitsky, V; Jensen-Pergakes, K; Bates, RJ; Torres, S; Celeridad, M; Brown, H; Burnett, K; Nadolny, L; Tehrani, L; Packard, G; Pagarigan, B; Haelewyn, J; Nguyen, T; Xu, L; Tang, Y; Hickman, M; Baculi, F; Pierce, S; Miyazawa, K; Jackson, P; Chamberlain, P; LeBrun, L; Xie, WL; Bennett, B; Blease, K				Ferguson, Gregory D.; Delgado, Mercedes; Plantevin-Krenitsky, Veronique; Jensen-Pergakes, Kristen; Bates, R. J.; Torres, Sanaa; Celeridad, Maria; Brown, Heather; Burnett, Kelven; Nadolny, Lisa; Tehrani, Lida; Packard, Garrick; Pagarigan, Barbra; Haelewyn, Jason; Nguyen, Trish; Xu, Li; Tang, Yang; Hickman, Matthew; Baculi, Frans; Pierce, Steven; Miyazawa, Keiji; Jackson, Pilgrim; Chamberlain, Philip; LeBrun, Laurie; Xie, Weilin; Bennett, Brydon; Blease, Kate			A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; SYK INHIBITORS; PRECLINICAL CHARACTERIZATION; SELECTIVE-INHIBITION; ACTIVATES SYK; T-CELLS; RECEPTOR; NEUTROPHILS; EXPRESSION; MACROPHAGES	Autoantibodies and the immunoreceptors to which they bind can contribute to the pathogenesis of autoimmune diseases such as rheumatoid arthritis (RA). Spleen Tyrosine Kinase (Syk) is a non-receptor tyrosine kinase with a central role in immunoreceptor (FcR) signaling and immune cell functionality. Syk kinase inhibitors have activity in antibody-dependent immune cell activation assays, in preclinical models of arthritis, and have progressed into clinical trials for RA and other autoimmune diseases. Here we describe the characterization of a novel triazolopyridine-based Syk kinase inhibitor, CC-509. This compound is a potent inhibitor of purified Syk enzyme, FcR-dependent and FcR-independent signaling in primary immune cells, and basophil activation in human whole blood. CC-509 is moderately selective across the kinome and against other non-kinase enzymes or receptors. Importantly, CC-509 was optimized away from and has modest activity against cellular KDR and Jak2, kinases that when inhibited in a preclinical and clinical setting may promote hypertension and neutropenia, respectively. In addition, CC-509 is orally bioavailable and displays dose-dependent efficacy in two rodent models of immune-inflammatory disease. In passive cutaneous anaphylaxis (PCA), CC-509 significantly inhibited skin edema. Moreover, CC-509 significantly reduced paw swelling and the tissue levels of pro-inflammatory cytokines RANTES and MIP-1 alpha in the collagen-induced arthritis (CIA) model. In summary, CC-509 is a potent, moderately selective, and efficacious inhibitor of Syk that has a differentiated profile when compared to other Syk compounds that have progressed into the clinic for RA.	[Ferguson, Gregory D.; Bates, R. J.; Torres, Sanaa; Celeridad, Maria; Xu, Li; Xie, Weilin; Bennett, Brydon] Celgene Corp, Dept Inflammat Res, San Diego, CA 92121 USA; [Delgado, Mercedes; Plantevin-Krenitsky, Veronique; Nadolny, Lisa; Tehrani, Lida; Packard, Garrick] Celgene Corp, Dept Chem, San Diego, CA USA; [Brown, Heather; Burnett, Kelven; Tang, Yang; Blease, Kate] Celgene Corp, Dept Pharmacol, San Diego, CA USA; [Pagarigan, Barbra; Haelewyn, Jason; Nguyen, Trish; Hickman, Matthew; Baculi, Frans; Pierce, Steven; Jackson, Pilgrim; Chamberlain, Philip; LeBrun, Laurie] Celgene Corp, Dept Biochem, San Diego, CA USA; [Jensen-Pergakes, Kristen] Pfizer Corp, Dept Tumor Cell Biol, San Diego, CA USA; [Miyazawa, Keiji] Kissei Pharmaceut Co, Dept Corp Planning & Strategy, Matsumoto, Nagano, Japan	Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Celgene Corporation; Pfizer; Kissei Pharmaceutical Co Ltd	Ferguson, GD (corresponding author), Celgene Corp, Dept Inflammat Res, San Diego, CA 92121 USA.	gferguson66@yahoo.com	Hickman, Matthew/Y-2400-2019	Hickman, Matthew/0000-0001-9864-459X; JACKSON, PILGRIM/0000-0002-2796-5297	Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Drs. Henry Chan, Brian Cathers, and Lisa Morrison for helpful discussions and support during the preparation of this manuscript. Portions of this research were conducted at the Advanced Light Source a national user facility operated by Lawrence Berkeley National Laboratory, on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The Berkeley Center for Structural Biology is supported in part by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences.	AstraZeneca, 2013, ASTRAZENECA ANN TOP; Baluom M, 2013, BRIT J CLIN PHARMACO, V76, P78, DOI 10.1111/bcp.12048; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Brenner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-710; Browning JL, 2006, NAT REV DRUG DISCOV, V5, P564, DOI 10.1038/nrd2085; Cha HS, 2006, J PHARMACOL EXP THER, V317, P571, DOI 10.1124/jpet.105.097436; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Coffey G, 2012, J PHARMACOL EXP THER, V340, P350, DOI 10.1124/jpet.111.188441; Costello PS, 1996, ONCOGENE, V13, P2595; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Eberlein-Konig B, 2004, J INVEST ALLERG CLIN, V14, P10; Efremov DG, 2011, EXPERT OPIN INV DRUG, V20, P623, DOI 10.1517/13543784.2011.570329; Egerer K, 2009, DTSCH ARZTEBL INT, V106, P159, DOI 10.3238/arztebl.2009.0159; Elliott ER, 2011, J IMMUNOL, V187, P4319, DOI 10.4049/jimmunol.1100341; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Forsberg M, 2001, IMMUNOLOGY, V103, P465, DOI 10.1046/j.1365-2567.2001.01270.x; Fridman JS, 2010, J IMMUNOL, V184, P5298, DOI 10.4049/jimmunol.0902819; Gadina Massimo, 2013, J Investig Dermatol Symp Proc, V16, pS70, DOI 10.1038/jidsymp.2013.29; Geddis AE, 2002, CYTOKINE GROWTH F R, V13, P61, DOI 10.1016/S1359-6101(01)00030-2; Genetic Engineering and Biotechnology News, GENETIC ENG BIOTECHN; Graczyk PP, 2007, J MED CHEM, V50, P5773, DOI 10.1021/jm070562u; Grammatikos AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074550; Grandage VL, 2006, BRIT J HAEMATOL, V135, P303, DOI 10.1111/j.1365-2141.2006.06291.x; Hisamichi H, 2005, BIOORGAN MED CHEM, V13, P4936, DOI 10.1016/j.bmc.2005.05.033; HOLMDAHL R, 1989, CLIN EXPT RHEUMATO S, V3, pS51; Jakus Z, 2010, ARTHRITIS RHEUM-US, V62, P1899, DOI 10.1002/art.27438; KEYSTONE EC, 1977, ARTHRITIS RHEUM, V20, P1396, DOI 10.1002/art.1780200714; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; Kuno Y, 2001, BLOOD, V97, P1050, DOI 10.1182/blood.V97.4.1050; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Lauzurica P, 2000, BLOOD, V95, P2312, DOI 10.1182/blood.V95.7.2312.007k16_2312_2320; Liao C, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4329; LOKEN MR, 1990, CYTOMETRY, V11, P453, DOI 10.1002/cyto.990110402; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Miyazawa K, 1998, J BIOCHEM-TOKYO, V124, P1153, DOI 10.1093/oxfordjournals.jbchem.a022233; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Morgan AW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1847; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; National Institutes of Health, 2014, BIIB057 SUBJ RHEUM A; Nieto A, 2000, ARTHRITIS RHEUM, V43, P735, DOI 10.1002/1529-0131(200004)43:4<735::AID-ANR3>3.0.CO;2-Q; Nijjar JS, 2013, RHEUMATOLOGY, V52, P1556, DOI 10.1093/rheumatology/ket225; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Ozaki N, 2012, INT IMMUNOL, V24, P539, DOI 10.1093/intimm/dxs078; Pine PR, 2007, CLIN IMMUNOL, V124, P244, DOI 10.1016/j.clim.2007.03.543; Podolanczuk A, 2009, BLOOD, V113, P3154, DOI 10.1182/blood-2008-07-166439; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rigel Pharmaceuticals, 2013, RIG PROV PIP UPD; Salgado E, 2014, ANN RHEUM DIS, V73, P871, DOI 10.1136/annrheumdis-2012-203116; Singh R, 2012, J MED CHEM, V55, P3614, DOI 10.1021/jm201271b; Skinner M, 2014, BRIT J PHARMACOL, V171, P2308, DOI 10.1111/bph.12559; Steiner G, 2007, CLIN REV ALLERG IMMU, V32, P23, DOI 10.1007/BF02686079; Trubetskoy OV, 2005, J BIOMOL SCREEN, V10, P56, DOI 10.1177/1087057104269731; Tsubokawa M, 1997, EUR J BIOCHEM, V249, P792, DOI 10.1111/j.1432-1033.1997.t01-2-00792.x; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wong BR, 2004, EXPERT OPIN INV DRUG, V13, P743, DOI 10.1517/13543784.13.7.743; Zhu YH, 2007, TOXICOL APPL PHARM, V221, P268, DOI 10.1016/j.taap.2007.03.027	61	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0145705	10.1371/journal.pone.0145705	http://dx.doi.org/10.1371/journal.pone.0145705			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756335	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888800003
J	Brettner, F; Janitza, S; Prull, K; Weninger, E; Mansmann, U; Kuchenhoff, H; Jovanovic, A; Pollwein, B; Chappell, D; Zwissler, B; von Dossow, V				Brettner, Florian; Janitza, Silke; Pruell, Kathrin; Weninger, Ernst; Mansmann, Ulrich; Kuechenhoff, Helmut; Jovanovic, Alexander; Pollwein, Bernhard; Chappell, Daniel; Zwissler, Bernhard; von Dossow, Vera			Gender-Specific Differences in Low-Dose Haloperidol Response for Prevention of Postoperative Nausea and Vomiting: A Register-Based Cohort Study	PLOS ONE			English	Article							CLINICAL ANESTHESIA OUTCOMES; RISK-FACTORS; DOUBLE-BLIND; LAPAROSCOPIC SURGERY; PLUS ONDANSETRON; DEXAMETHASONE; PROPHYLAXIS; TRIAL; SCORE; MICE	Background Postoperative nausea and vomiting (PONV) is one of the most common and distressing complications after general anesthesia and surgery, with young non-smoking females receiving postoperative opioids being high-risk patients. This register-based study aims to evaluate the effect of low-dose haloperidol (0.5 mg intravenously) directly after induction of general anesthesia to reduce the incidence of PONV in the postoperative anesthesiological care unit (PACU). Methods Multivariable regression models were used to investigate the association between low-dose haloperidol and the occurrence of PONV using a patient registry containing 2,617 surgical procedures carried out at an university hospital. Results Haloperidol 0.5 mg is associated with a reduced risk of PONV in the total collective (adjusted odds ratio = 0.75, 95% confidence interval: [0.56, 0.99], p = 0.05). The results indicate that there is a reduced risk in male patients (adjusted odds ratio = 0.45, 95% confidence interval: [0.28, 0.73], p = 0.001) if a dose of 0.5 mg haloperidol was administered while there seems to be no effect in females (adjusted odds ratio = 1.02, 95% confidence interval: [0.71, 1.46], p = 0.93). Currently known risk factors for PONV such as female gender, duration of anesthesia and the use of opioids were confirmed in our analysis. Conclusion This study suggests that low-dose haloperidol has an antiemetic effect in male patients but has no effect in female patients. A confirmation of the gender-specific effects we have observed in this register-based cohort study might have major implications on clinical daily routine.	[Brettner, Florian; Weninger, Ernst; Jovanovic, Alexander; Pollwein, Bernhard; Chappell, Daniel; Zwissler, Bernhard; von Dossow, Vera] Univ Hosp Munich, Dept Anaesthesiol, Munich, Germany; [Janitza, Silke; Mansmann, Ulrich] Univ Munich, Dept Med Informat Biometry & Epidemiol, Munich, Germany; [Janitza, Silke; Kuechenhoff, Helmut] Univ Munich, Dept Stat, Stat Consulting Unit, Munich, Germany; [Pruell, Kathrin] Klinikum Dritter Orden, Anaesthesia & Intens Care Med Clin, Munich, Germany	University of Munich; University of Munich; University of Munich	Brettner, F (corresponding author), Univ Hosp Munich, Dept Anaesthesiol, Munich, Germany.	Florian.Brettner@med.uni-muenchen.de		Kuchenhoff, Helmut/0000-0002-6372-2487				Aouad MT, 2007, EUR J ANAESTH, V24, P171, DOI 10.1017/S0265021506001323; Apfel CC, 2012, BRIT J ANAESTH, V109, P742, DOI 10.1093/bja/aes276; Apfel CC, 2002, BRIT J ANAESTH, V88, P234, DOI 10.1093/bja/88.2.234; Apfel CC, 2005, ANASTH INTENSIV NOTF, V40, P497, DOI 10.1055/s-2005-861339; Apfel CC, 2004, ANAESTHESIA, V59, P1078, DOI 10.1111/j.1365-2044.2004.03875.x; Apfel CC, 1998, ANAESTHESIST, V47, P732, DOI 10.1007/s001010050620; Apfel CC, 2002, BRIT J ANAESTH, V88, P659, DOI 10.1093/bja/88.5.659; Arenas MC, 1999, PHARMACOL BIOCHEM BE, V62, P703, DOI 10.1016/S0091-3057(98)00207-X; ARENAS MC, 1995, PHARMACOL BIOCHEM BE, V51, P601, DOI 10.1016/0091-3057(94)00382-S; ARENAS MC, 1993, PHARMACOL BIOCHEM BE, V44, P233, DOI 10.1016/0091-3057(93)90303-B; Benevides ML, 2013, OBES SURG, V23, P1389, DOI 10.1007/s11695-013-0923-1; BREMNER WGM, 1993, BRIT J ANAESTH, V71, P296, DOI 10.1093/bja/71.2.296; Buttner M, 2004, ANESTHESIOLOGY, V101, P1454; Chaparro LE, 2010, EUR J ANAESTH, V27, P192, DOI 10.1097/EJA.0b013e32832fce15; Chu CC, 2008, ANESTH ANALG, V106, P1402, DOI 10.1213/ane.0b013e3181609424; Dagtekin O, 2009, PHARMACOLOGY, V83, P205, DOI 10.1159/000196812; DeBlieck C, 2013, ASSOC OPER ROOM NURS, V98, P370, DOI 10.1016/j.aorn.2012.12.021; Eberhart LHJ, 2000, ACTA ANAESTH SCAND, V44, P480, DOI 10.1034/j.1399-6576.2000.440422.x; Feng Ping-Hsun, 2009, Acta Anaesthesiol Taiwan, V47, P3, DOI 10.1016/S1875-4597(09)60013-8; Gan TJ, 2014, ANESTH ANALG, V118, P85, DOI 10.1213/ANE.0000000000000002; Grecu L, 2008, ANESTH ANALG, V106, P1410, DOI 10.1213/ane.0b013e31816091f0; Gupta A, 2003, ANESTHESIOLOGY, V99, P488; Joo J, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0081-1; Lee Y, 2007, CAN J ANAESTH, V54, P349, DOI 10.1007/BF03022656; Macario A, 1999, ANESTH ANALG, V89, P652, DOI 10.1097/00000539-199909000-00022; Macario A, 1999, ANESTH ANALG, V88, P1085, DOI 10.1097/00000539-199905000-00023; MAGLIOZZI JR, 1985, J CLIN PSYCHIAT, V46, P20; Myklejord Duane J, 2012, WMJ, V111, P207; Neuberger M, 2013, LANCET, V382, P394, DOI 10.1016/S0140-6736(13)61668-2; Peng SY, 2007, BRIT J ANAESTH, V98, P60, DOI 10.1093/bja/ael282; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosow CE, 2008, ANESTH ANALG, V106, P1407, DOI 10.1213/ane.0b013e3181609022; Rusch D, 2007, ANAESTHESIA, V62, P810, DOI 10.1111/j.1365-2044.2007.05136.x; Schumann R, 1999, ANESTH ANALG, V89, P796; Thomson D, 1998, EUR J ANAESTH, V15, P752, DOI 10.1097/00003643-199811000-00023; TORNETTA FJ, 1972, ANESTH ANAL CURR RES, V51, P964; Velickovic J, 2010, EUROPEAN J ANAESTHES, V27; Wang PK, 2012, WORLD J SURG, V36, P775, DOI 10.1007/s00268-012-1446-y; Wang TF, 2008, ACTA ANAESTH SCAND, V52, P280, DOI 10.1111/j.1399-6576.2007.01525.x; White PF, 2008, ANESTH ANALG, V107, P459, DOI 10.1213/ane.0b013e31817aa6e4; Wood S.N., 2001, R NEWS, V1, P20; Yang YL, 2008, CAN J ANAESTH, V55, P270, DOI 10.1007/BF03017203; Zhang-Wong JH, 1998, PSYCHIAT RES, V81, P333, DOI 10.1016/S0165-1781(98)00114-0	43	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146746	10.1371/journal.pone.0146746	http://dx.doi.org/10.1371/journal.pone.0146746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751066	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888100145
J	Chen, QM; Gao, HW; Hua, ZD; Yang, KM; Yan, J; Zhang, H; Ma, K; Zhang, S; Qi, L; Li, SJ				Chen, Qiuming; Gao, Huawei; Hua, Zhongdong; Yang, Keming; Yan, Jun; Zhang, Hao; Ma, Kai; Zhang, Sen; Qi, Lei; Li, Shoujun			Outcomes of Surgical Repair for Persistent Truncus Arteriosus from Neonates to Adults: A Single Center's Experience	PLOS ONE			English	Article							PULMONARY VASCULAR-RESISTANCE; VENTRICULAR SEPTAL-DEFECTS; TERM-FOLLOW-UP; PATCH CLOSURE; VALVE; MANAGEMENT; HOMOGRAFT; CHILDREN	Objective This study aimed to report our experiences with surgical repair in patients of all ages with persistent truncus arteriosus. Methods From July 2004 to July 2014, 50 consecutive patients with persistent truncus arteriosus who underwent anatomical repair were included in the retrospective review. Median follow-up time was 3.4 years (range, 3 months to 10 years). Results Fifty patients underwent anatomical repair at a median age of 19.6 months (range, 20 days to 19.1 years). Thirty patients (60%) were older than one year. The preoperative pulmonary vascular resistance and mean pulmonary artery pressure were 4.1 +/- 2.1 (range, 0.1 to 8.9) units. m(2) and 64.3 +/- 17.9 (range, 38 to 101) mmHg, respectively. Significant truncal valve regurgitation was presented in 14 (28%) patients. Hospital death occurred in 3 patients, two due to pulmonary hypertensive crisis and the other due to pneumonia. Three late deaths occurred at 3, 4 and 11 months after surgery. The actuarial survival rates were 87.7% and 87.7% at 1 year and 5 years, respectively. Multivariate analysis identified significant preoperative truncal valve regurgitation was a risk factor for overall mortality (odds ratio, 7.584; 95% CI: 1.335-43.092; p = 0.022). Two patients required reoperation of truncal valve replacement. One patient underwent reintervention for conduit replacement. Freedom from reoperation at 5 years was 92.9%. At latest examination, there was one patient with moderate-to-severe truncal valve regurgitation and four with moderate. Three patients had residual pulmonary artery hypertension. All survivors were in New York Heart Association class I-II. Conclusions Complete repair of persistent truncus arteriosus can be achieved with a relatively low mortality and acceptable early- and mid-term results, even in cases with late presentation. Significant preoperative truncal valve regurgitation remains a risk factor for overall mortality. The long-term outcomes warrant further follow-up.	[Li, Shoujun] Chinese Acad Med Sci, Peking Union Med Coll, Pediat Cardiac Surg Ctr, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; Chinese Acad Med Sci, Peking Union Med Coll, Fuwai Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Li, SJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Pediat Cardiac Surg Ctr, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	drlishoujun@yahoo.com		Zhang, Hao/0000-0002-0206-9066				Arslan AH, 2014, WORLD J PEDIATR CONG, V5, P211, DOI 10.1177/2150135113516370; Baskett RJ, 1996, J THORAC CARDIOV SUR, V112, P1170, DOI 10.1016/S0022-5223(96)70130-7; Boethig D, 2007, EUR J CARDIO-THORAC, V32, P133, DOI 10.1016/j.ejcts.2007.02.025; BOVE EL, 1989, ANN THORAC SURG, V47, P499, DOI 10.1016/0003-4975(89)90423-2; Brown JW, 2001, EUR J CARDIO-THORAC, V20, P221, DOI 10.1016/S1010-7940(01)00816-8; CALDER L, 1976, AM HEART J, V92, P23, DOI 10.1016/S0002-8703(76)80400-0; Chiaw Tang Hak, 2007, Congenit Heart Dis, V2, P433, DOI 10.1111/j.1747-0803.2007.00138.x; DIDONATO RM, 1985, J THORAC CARDIOV SUR, V89, P414; Fiore AC, 2010, EUR J CARDIO-THORAC, V38, P318, DOI 10.1016/j.ejcts.2010.01.063; Guenther F, 2009, EUR HEART J, V30, P1154, DOI 10.1093/eurheartj/ehp020; Henaine R, 2008, ANN THORAC SURG, V85, P172, DOI 10.1016/j.athoracsur.2007.07.039; Kharwar RB, 2014, J AM COLL CARDIOL, V63, P1807, DOI 10.1016/j.jacc.2013.12.054; McElhinney DB, 1998, ANN THORAC SURG, V65, P517, DOI 10.1016/S0003-4975(97)01064-3; MCGOON DC, 1968, J AMER MED ASSOC, V205, P69, DOI 10.1001/jama.205.2.69; Menon SC, 2007, CARDIOL YOUNG, V17, P333, DOI 10.1017/S1047951107000364; Myers PO, 2013, EUR J CARDIO-THORAC, V44, P813, DOI 10.1093/ejcts/ezt213; Novick WM, 2005, ANN THORAC SURG, V79, P21, DOI 10.1016/j.athoracsur.2004.06.107; Rajasinghe HA, 1997, J THORAC CARDIOV SUR, V113, P869, DOI 10.1016/S0022-5223(97)70259-9; Rajasinghe HA, 1997, J THORAC CARDIOVASC, V113, P878; Talwar S, 2012, INTERACT CARDIOV TH, V14, P699, DOI 10.1093/icvts/ivs044; Tlaskal T, 2010, EUR J CARDIO-THORAC, V37, P1278, DOI 10.1016/j.ejcts.2009.12.022; Viswanathan S, 2008, CATHETER CARDIO INTE, V71, P665, DOI 10.1002/ccd.21446; Vohra HA, 2010, J THORAC CARDIOV SUR, V140, P325, DOI 10.1016/j.jtcvs.2009.12.052; Williams JM, 1999, J AM COLL CARDIOL, V34, P545, DOI 10.1016/S0735-1097(99)00227-2; YOSHIZATO T, 1990, PEDIATR CARDIOL, V11, P36, DOI 10.1007/BF02239545	25	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146800	10.1371/journal.pone.0146800	http://dx.doi.org/10.1371/journal.pone.0146800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752522	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100156
J	Kim, JH; Pan, JH; Cho, HT; Kim, YJ				Kim, Jun Ho; Pan, Jeong Hoon; Cho, Hyung Taek; Kim, Young Jun			Black Ginseng Extract Counteracts Streptozotocin-Induced Diabetes in Mice	PLOS ONE			English	Article							PANAX-GINSENG; COMPOUND K; RATS; RED; GINSENOSIDES; WHITE; INFLAMMATION; RESPONSES; GLUCOSE; DAMAGE	Black ginseng, a new type of processed ginseng that has a unique ginsenoside profile, has been shown to display potent pharmacological activities in in vitro and in vivo models. Although red ginseng is considered beneficial for the prevention of diabetes, the relationship between black ginseng and diabetes is unknown. Therefore, this study was designed to evaluate the anti-diabetic potential of black ginseng extract (BGE) in streptozotocin (STZ)-induced insulin-deficient diabetic mice, in comparison with red ginseng extract (RGE). HPLC analyses showed that BGE has a different ginsenoside composition to RGE; BGE contains Rg5 and compound k as the major ginsenosides. BGE at 200 mg/kg reduced hyperglycemia, increased the insulin/glucose ratio and improved islet architecture and beta-cell function in STZ-treated mice. The inhibition of beta-cell apoptosis by BGE was associated with suppression of the cytokine-induced nuclear factor-kappa B-mediated signaling pathway in the pancreas. Moreover, these anti-diabetic effects of BGE were more potent than those of RGE. Collectively, our data indicate that BGE, in part by suppressing cytokine-induced apoptotic signaling, protects beta-cells from oxidative injury and counteracts diabetes in mice.	[Kim, Jun Ho; Pan, Jeong Hoon; Cho, Hyung Taek; Kim, Young Jun] Korea Univ, Dept Food & Biotechnol, Sejong, South Korea	Korea University	Kim, YJ (corresponding author), Korea Univ, Dept Food & Biotechnol, Sejong, South Korea.	yk46@korea.ac.kr			High Value-added Food Technology Development Program; iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries); Ministry of Agriculture, Food and Rural Affairs	High Value-added Food Technology Development Program; iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries); Ministry of Agriculture, Food and Rural Affairs	This research was supported by High Value-added Food Technology Development Program, funded by iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs (to JHK; [http://www.ipet.re.kr/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban YJ, 2010, J KOREAN SOC APPL BI, V53, P71, DOI 10.3839/jksabc.2010.012; Cho Youngho, 2012, [YAKHAK HOEJI, 약 학 회 지], V56, P145; Chu SH, 2014, INT IMMUNOPHARMACOL, V19, P317, DOI 10.1016/j.intimp.2014.01.018; Eleazu CO, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-60; Hong BN, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/593181; Hong YJ, 2012, J ETHNOPHARMACOL, V144, P225, DOI 10.1016/j.jep.2012.08.009; Hosseinzadeh H, 2005, J PHARM PHARM SCI, V8, P387; Jin Y, 2015, PLANT FOOD HUM NUTR, V70, P141, DOI 10.1007/s11130-015-0470-0; Joh EH, 2011, BIOCHEM PHARMACOL, V82, P278, DOI 10.1016/j.bcp.2011.05.003; Kim HJ, 2010, J GINSENG RES, V34, P104, DOI 10.5142/jgr.2010.34.2.104; Kim SJ, 2015, J GINSENG RES, V39, P125, DOI 10.1016/j.jgr.2014.09.003; Kim TW, 2012, INT IMMUNOPHARMACOL, V12, P110, DOI 10.1016/j.intimp.2011.10.023; Kim WY, 2000, J NAT PROD, V63, P1702, DOI 10.1021/np990152b; Lee MR, 2013, J GINSENG RES, V37, P308, DOI 10.5142/jgr.2013.37.308; Lee MR, 2012, J GINSENG RES, V36, P93, DOI 10.5142/jgr.2012.36.1.93; Lee MR, 2011, J GINSENG RES, V35, P421, DOI 10.5142/jgr.2011.35.4.421; Lee SM, 2014, PHYTOTHER RES, V28, P1893, DOI 10.1002/ptr.5203; Lee SR, 2009, TOXICOL IN VITRO, V23, P47, DOI 10.1016/j.tiv.2008.10.001; Leung K.W., 2010, CHINESE MED, V5, P20; Li W, 2012, FITOTERAPIA, V83, P192, DOI 10.1016/j.fitote.2011.10.011; Lim SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072685; Oh MR, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-237; Park HJ, 2011, KOREAN J PHYSIOL PHA, V15, P333, DOI 10.4196/kjpp.2011.15.6.333; SCHNEDL WJ, 1994, DIABETES, V43, P1326, DOI 10.2337/diabetes.43.11.1326; Sun BS, 2009, J PHARMACEUT BIOMED, V50, P15, DOI 10.1016/j.jpba.2009.03.025; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Vuguin P, 2001, J CLIN ENDOCR METAB, V86, P4618, DOI 10.1210/jc.86.10.4618; Vuksan V, 2008, NUTR METAB CARDIOVAS, V18, P46, DOI 10.1016/j.numecd.2006.04.003; Wang CZ, 2006, J AGR FOOD CHEM, V54, P9936, DOI 10.1021/jf062467k; Wu HX, 2014, IMMUNOPHARM IMMUNOT, V36, P124, DOI 10.3109/08923973.2014.880717	30	52	54	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146843	10.1371/journal.pone.0146843	http://dx.doi.org/10.1371/journal.pone.0146843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751692	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100163
J	Koppaka, V; Chen, Y; Mehta, G; Orlicky, DJ; Thompson, DC; Jester, JV; Vasiliou, V				Koppaka, Vindhya; Chen, Ying; Mehta, Gaurav; Orlicky, David J.; Thompson, David C.; Jester, James V.; Vasiliou, Vasilis			ALDH3A1 Plays a Functional Role in Maintenance of Corneal Epithelial Homeostasis	PLOS ONE			English	Article							DEHYDROGENASE 3A1 ALDH3A1; TUMOR-SUPPRESSOR PROTEIN; ALDEHYDE DEHYDROGENASES; REFRACTON HYPOTHESIS; CRYSTALLIN ALDH3A1; OXIDATIVE DAMAGE; P53 PROTEIN; STEM-CELLS; LOCALIZATION; EXPRESSION	Aldehyde dehydrogenase 1A1 (ALDH1A1) and ALDH3A1 are corneal crystallins. They protect inner ocular tissues from ultraviolet radiation (UVR)-induced oxidative damage through catalytic and non-catalytic mechanisms. Additionally, ALDH3A1 has been postulated to play a regulatory role in the corneal epithelium based on several studies that report an inverse association between ALDH3A1 expression and corneal cell proliferation. The underlying molecular mechanisms and the physiological significance of such association remain poorly understood. In the current study, we established Tet-On human corneal epithelial cell (hTCEpi) lines, which express tetracycline-inducible wild-type (wt) or catalytically- inactive (mu) ALDH3A1. Utilizing this cellular model system, we confirmed that human ALDH3A1 decreases corneal cell proliferation; importantly, this effect appears to be partially mediated by its enzymatic activity. Mechanistically, wt-ALDH3A1, but not mu-ALDH3A1, promotes sequestering of tumor suppressor p53 in the nucleus. In the mouse cornea, however, augmented cell proliferation is noted only in Aldh1a1(-/-)/3a1(-/-) double knockout (DKO) mice, indicating in vivo the anti-proliferation effect of ALDH3A1 can be rescued by the presence of ALDH1A1. Interestingly, the hyper-proliferative epithelium of the DKO corneas display nearly complete loss of p53 expression, implying that p53 may be involved in ALDH3A1/1A1-mediated effect. In hTCEpi cells grown in high calcium concentration, mRNA levels of a panel of corneal differentiation markers were altered by ALDH3A1 expression and modulated by its enzyme activity. In conclusion, we show for the first time that: (i) ALDH3A1 decreases corneal epithelial proliferation through both non-enzymatic and enzymatic properties; (ii) ALDH1A1 contributes to the regulation of corneal cellular proliferation in vivo; and (iii) ALDH3A1 modulates corneal epithelial differentiation. Collectively, our studies indicate a functional role of ALDH3A1 in the maintenance of corneal epithelial homeostasis by simultaneously modulating proliferation and differentiation through both enzymatic and non-enzymatic mechanisms.	[Koppaka, Vindhya; Chen, Ying; Mehta, Gaurav] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA; [Chen, Ying; Vasiliou, Vasilis] Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Aurora, CO USA; [Thompson, David C.] Univ Colorado, Dept Clin Pharmacol, Aurora, CO USA; [Jester, James V.] Univ Calif Irvine, Dept Ophthalmol, Gavin Herbert Eye Inst, Irvine, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine	Vasiliou, V (corresponding author), Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA.	vasilis.vasiliou@yale.edu		vasiliou, vasilis/0000-0003-2552-3118; Jester, James/0000-0002-9246-0981	National Eye Institute [EY17963, EY11490]; NIHS [EY17963, EY11490]; NATIONAL EYE INSTITUTE [R01EY011490, R01EY017963, R29EY011490] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute, EY17963 (VV) and EY11490 (VV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Surendra Singh and Bettina Miller, for input and advice and Dr. Philip Reigan for his helpful discussions. This work was supported in part by NIHS grants EY17963 and EY11490.	Chen Y, 2013, PROG RETIN EYE RES, V33, P28, DOI 10.1016/j.preteyeres.2012.10.001; Chen Y, 2012, EXP EYE RES, V102, P105, DOI 10.1016/j.exer.2011.04.008; Davis J, 2008, INVEST OPHTH VIS SCI, V49, P1814, DOI 10.1167/iovs.07-1057; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Estey T, 2007, J BIOL CHEM, V282, P4382, DOI 10.1074/jbc.M607546200; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Feng Y, 2004, MOL VIS, V10, P845; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Lassen N, 2007, J BIOL CHEM, V282, P25668, DOI 10.1074/jbc.M702076200; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; MAXWELL SA, 1994, CRIT REV ONCOGENESIS, V5, P23, DOI 10.1615/CritRevOncog.v5.i1.20; Nees DW, 2002, MOL CELL BIOL, V22, P849, DOI 10.1128/MCB.22.3.849-855.2002; Ou JX, 2010, INVEST OPHTH VIS SCI, V51, P1415, DOI 10.1167/iovs.09-4023; Pappa A, 2005, J BIOL CHEM, V280, P27998, DOI 10.1074/jbc.M503698200; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Pappa A, 2003, FREE RADICAL BIO MED, V34, P1178, DOI 10.1016/S0891-5849(03)00070-4; Piatigorsky J, 2000, J OCUL PHARMACOL TH, V16, P173, DOI 10.1089/jop.2000.16.173; Piatigorsky J, 1998, PROG RETIN EYE RES, V17, P145, DOI 10.1016/S1350-9462(97)00004-9; Piatigorsky J, 2001, CORNEA, V20, P853, DOI 10.1097/00003226-200111000-00015; Piatigorsky J, 2008, SEMIN CELL DEV BIOL, V19, P69, DOI 10.1016/j.semcdb.2007.10.010; Pokroy R, 2002, INVEST OPHTH VIS SCI, V43, P1736; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stagos D, 2010, BRAIN RES BULL, V81, P211, DOI 10.1016/j.brainresbull.2009.08.017; Tendler Y, 2006, EXP EYE RES, V82, P674, DOI 10.1016/j.exer.2005.09.005; Tendler Y, 2013, INT J MOL MED, V31, P540, DOI 10.3892/ijmm.2013.1247; Vasiliou V, 2013, CHEM-BIOL INTERACT, V202, P22, DOI 10.1016/j.cbi.2012.12.018; Vasiliou V, 2013, CHEM-BIOL INTERACT, V202, P2, DOI 10.1016/j.cbi.2012.10.026; Wang Y, 2013, INVEST OPHTH VIS SCI, V54, P3806, DOI 10.1167/iovs.13-12091; Wilson SE, 2003, AM J OPHTHALMOL, V136, P530, DOI 10.1016/S0002-9394(03)00085-0; Yamasaki K, 2009, INVEST OPHTH VIS SCI, V50, P604, DOI 10.1167/iovs.08-2239; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	33	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146433	10.1371/journal.pone.0146433	http://dx.doi.org/10.1371/journal.pone.0146433			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751691	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100079
J	Kuroda, Y; Maruyama, K; Fujii, H; Sugawara, I; Ko, SBH; Yasuda, H; Matsui, H; Matsuo, K				Kuroda, Yukiko; Maruyama, Kenta; Fujii, Hideki; Sugawara, Isamu; Ko, Shigeru B. H.; Yasuda, Hisataka; Matsui, Hidenori; Matsuo, Koichi			Osteoprotegerin Regulates Pancreatic beta-Cell Homeostasis upon Microbial Invasion	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; OSTEOCLASTOGENESIS-INHIBITORY FACTOR; MICE LACKING OSTEOPROTEGERIN; TUMOR-NECROSIS-FACTOR; KAPPA-B LIGAND; SALMONELLA-TYPHIMURIUM; POSTMENOPAUSAL WOMEN; INSULIN-RESISTANCE; BONE-RESORPTION; VIRUS-INFECTION	Osteoprotegerin (OPG), a decoy receptor for receptor activator of NF-kappa B ligand (RANKL), antagonizes RANKL's osteoclastogenic function in bone. We previously demonstrated that systemic administration of lipopolysaccharide (LPS) to mice elevates OPG levels and reduces RANKL levels in peripheral blood. Here, we show that mice infected with Salmonella, Staphylococcus, Mycobacteria or influenza virus also show elevated serum OPG levels. We then asked whether OPG upregulation following microbial invasion had an effect outside of bone. To do so, we treated mice with LPS and observed OPG production in pancreas, especially in beta-cells of pancreatic islets. Insulin release following LPS administration was enhanced in mice lacking OPG, suggesting that OPG inhibits insulin secretion under acute inflammatory conditions. Consistently, treatment of MIN6 pancreatic beta-cells with OPG decreased their insulin secretion following glucose stimulation in the presence of LPS. Finally, our findings suggest that LPS-induced OPG upregulation is mediated in part by activator protein (AP)-1 family transcription factors, particularly Fos proteins. Overall, we report that acute microbial infection elevates serum OPG, which maintains beta-cell homeostasis by restricting glucose-stimulated insulin secretion, possibly preventing microbe-induced exhaustion of beta-cell secretory capacity.	[Kuroda, Yukiko; Matsuo, Koichi] Keio Univ, Sch Med, Lab Cell & Tissue Biol, Tokyo, Japan; [Maruyama, Kenta] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Host Def Lab, Osaka, Japan; [Fujii, Hideki] Univ Ryukyus, Grad Sch Med, Dept Immunol, Okinawa, Japan; [Sugawara, Isamu] Japan AntiTB Assoc, Res Inst TB, Mycobacterial Reference Ctr, Tokyo, Japan; [Ko, Shigeru B. H.] Keio Univ, Sch Med, Sakaguchi Lab, Dept Syst Med, Tokyo, Japan; [Yasuda, Hisataka] Oriental Yeast Co, Nagahama Inst Biochem Sci, Nagahama, Shiga, Japan; [Matsui, Hidenori] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan; [Matsui, Hidenori] Kitasato Univ, Grad Sch Infect Control Sci, Tokyo, Japan	Keio University; Osaka University; University of the Ryukyus; Keio University; Oriental Yeast Co., Ltd.; Kitasato University; Kitasato University	Matsuo, K (corresponding author), Keio Univ, Sch Med, Lab Cell & Tissue Biol, Tokyo, Japan.	kmatsuo@keio.jp	Matsuo, Koichi/K-5695-2012; Kuroda, Yukiko/L-6332-2013	Matsuo, Koichi/0000-0002-1490-8955; Kuroda, Yukiko/0000-0002-5335-4238	Keio Gijuku Academic Development Funds; Ministry of Health, Labor and Welfare of Japan [201322003A]; Oriental Yeast Co.; Grants-in-Aid for Scientific Research [25460300] Funding Source: KAKEN	Keio Gijuku Academic Development Funds; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Oriental Yeast Co.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Keio Gijuku Academic Development Funds (YK), the Ministry of Health, Labor and Welfare of Japan 201322003A (KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Oriental Yeast Co. provided support in the form of a salary for author HY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the Author Contributions section.	AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; Bekker PJ, 2001, J BONE MINER RES, V16, P348, DOI 10.1359/jbmr.2001.16.2.348; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Bernardi S, 2014, MOL CELL ENDOCRINOL, V394, P13, DOI 10.1016/j.mce.2014.06.004; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Castellanos-Gonzalez A, 2008, J INFECT DIS, V197, P916, DOI 10.1086/528374; Chiang CY, 1999, INFECT IMMUN, V67, P4231, DOI 10.1128/IAI.67.8.4231-4236.1999; Decker C, 2013, J BIOL CHEM, V288, P33634, DOI 10.1074/jbc.M113.477281; Giboney PT, 2005, AM FAM PHYSICIAN, V71, P1105; GULIG PA, 1993, INFECT IMMUN, V61, P504, DOI 10.1128/IAI.61.2.504-511.1993; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Gulig PA, 1998, INFECT IMMUN, V66, P2471, DOI 10.1128/IAI.66.6.2471-2485.1998; Hanada R, 2011, J MOL MED, V89, P647, DOI 10.1007/s00109-011-0749-z; HANAKI H, 1995, ANTIMICROB AGENTS CH, V39, P1120, DOI 10.1128/AAC.39.5.1120; Heitmeier MR, 2001, J BIOL CHEM, V276, P11151, DOI 10.1074/jbc.M009159200; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Kajiya M., 2010, J ORAL MICROBIOL, V2, P5532, DOI DOI 10.3402/JOM.V2I0.5532; Kanzaki S, 2006, BONE, V39, P414, DOI 10.1016/j.bone.2006.01.155; Kanzaki S, 2009, J BONE MINER RES, V24, P43, DOI 10.1359/JBMR.080812; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kiechl S, 2013, NAT MED, V19, P358, DOI 10.1038/nm.3084; Kim J, 2013, J BONE MINER RES, V28, P2381, DOI 10.1002/jbmr.1973; Kondegowda NG, 2015, CELL METAB, V22, P77, DOI 10.1016/j.cmet.2015.05.021; Kondo T, 2004, J BONE MINER RES, V19, P1411, DOI 10.1359/JBMR.040604; Kuroda Y, 2012, WORLD J ORTHOP, V3, P167, DOI 10.5312/wjo.v3.i11.167; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; Maruyama K, 2006, J IMMUNOL, V177, P3799, DOI 10.4049/jimmunol.177.6.3799; Matsui H, 2000, MICROBIOL IMMUNOL, V44, P447, DOI 10.1111/j.1348-0421.2000.tb02519.x; Mian AH, 2008, J BONE MINER METAB, V26, P469, DOI 10.1007/s00774-007-0834-0; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Nanda KS, 2012, CYTOKINE, V60, P328, DOI 10.1016/j.cyto.2012.07.006; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Sano G, 2007, J BACTERIOL, V189, P8224, DOI 10.1128/JB.00898-07; Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689; Schrader J, 2007, DIABETOLOGIA, V50, P1243, DOI 10.1007/s00125-007-0672-6; Shimizu K, 2000, PANCREAS, V21, P134, DOI 10.1097/00006676-200008000-00005; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sugawara I, 1999, INFECT IMMUN, V67, P2585, DOI 10.1128/IAI.67.5.2585-2589.1999; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Toffoli B, 2011, MOL CELL ENDOCRINOL, V331, P136, DOI 10.1016/j.mce.2010.08.019; Ueland T, 2015, TRANSPLANTATION, V99, P100, DOI 10.1097/TP.0000000000000227; Vega D, 2007, J CLIN ENDOCR METAB, V92, P4514, DOI 10.1210/jc.2007-0646; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wei JW, 2015, CURR OSTEOPOROS REP, V13, P180, DOI 10.1007/s11914-015-0267-y; Yamato E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061211; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	54	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146544	10.1371/journal.pone.0146544	http://dx.doi.org/10.1371/journal.pone.0146544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751951	Green Published, gold			2022-12-27	WOS:000367888100095
J	Shilova, IN; Robidart, JC; DeLong, EF; Zehr, JP				Shilova, Irina N.; Robidart, Julie C.; DeLong, Edward F.; Zehr, Jonathan P.			Genetic Diversity Affects the Daily Transcriptional Oscillations of Marine Microbial Populations	PLOS ONE			English	Article							SINGLE-CELL GENOMICS; TIME-SERIES; OPEN-OCEAN; EXPRESSION; SYNECHOCOCCUS; PATTERNS; ATLANTIC; PROTEORHODOPSIN; BIOCONDUCTOR; ENVIRONMENT	Marine microbial communities are genetically diverse but have robust synchronized daily transcriptional patterns at the genus level that are similar across a wide variety of oceanic regions. We developed a microarray-inspired gene-centric approach to resolve transcription of closely-related but distinct strains/ecotypes in high-throughput sequence data. Applying this approach to the existing metatranscriptomics datasets collected from two different oceanic regions, we found unique and variable patterns of transcription by individual taxa within the abundant picocyanobacteria Prochlorococcus and Synechococcus, the alpha Proteobacterium Pelagibacter and the eukaryotic picophytoplankton Ostreococcus. The results demonstrate that marine microbial taxa respond differentially to variability in space and time in the ocean. These intra-genus individual transcriptional patterns underlie whole microbial community responses, and the approach developed here facilitates deeper insights into microbial population dynamics.	[Shilova, Irina N.; Robidart, Julie C.; Zehr, Jonathan P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [DeLong, Edward F.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Honolulu, HI USA	University of California System; University of California Santa Cruz; University of Hawaii System; University of Hawaii Manoa	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	Shilova, Irina/ABF-9218-2020	Shilova, Irina/0000-0002-6216-5842; Robidart, Julie/0000-0001-9805-3570	National Science Foundation Center for Microbial Oceanography: Research and Education [EF0424599]; Gordon and Betty Moore Foundation; Simons Collaboration on Ocean Processes and Ecology (SCOPE); National Science Foundation Dimensions in Biodiversity [1241221]; Division Of Ocean Sciences [1241093] Funding Source: National Science Foundation	National Science Foundation Center for Microbial Oceanography: Research and Education(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Simons Collaboration on Ocean Processes and Ecology (SCOPE); National Science Foundation Dimensions in Biodiversity; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by the National Science Foundation Center for Microbial Oceanography: Research and Education (http://cmore.soest.hawaii.edu/, EF0424599), the Gordon and Betty Moore Foundation (https://www.moore.org/, JZ and ED), the Simons Collaboration on Ocean Processes and Ecology (SCOPE, https://www.simonsfoundation.org/life-sciences/simons-collaboration-on-ocean-processes-and-ecology/) and National Science Foundation Dimensions in Biodiversity (1241221, JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren NA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00213; Aylward FO, 2015, P NATL ACAD SCI USA; Bombar D, 2015, J PLANKTON RES, V37, P727, DOI 10.1093/plankt/fbv049; Casciotti KL, 2001, APPL ENVIRON MICROB, V67, P2213, DOI 10.1128/AEM.67.5.2213-2221.2001; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chen F, 2004, AQUAT MICROB ECOL, V36, P153, DOI 10.3354/ame036153; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eren AM, 2015, ISME J, V9, P968, DOI 10.1038/ismej.2014.195; Eren AM, 2013, METHODS ECOL EVOL, V4, P1111, DOI 10.1111/2041-210X.12114; Futschik ME, 2008, BIOINFORMATICS, V24, P1063, DOI 10.1093/bioinformatics/btn072; Futschik ME, 2009, CYCLE SIGNIFICANCE P; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Hewson I, 2010, ENVIRON MICROBIOL, V12, P1940, DOI 10.1111/j.1462-2920.2010.02198.x; Hewson I, 2009, LIMNOL OCEANOGR, V54, P1981, DOI 10.4319/lo.2009.54.6.1981; Holtzendorff J, 2002, ENVIRON MICROBIOL, V4, P644, DOI 10.1046/j.1462-2920.2002.00347.x; John DE, 2012, HYDROBIOLOGIA, V679, P155, DOI 10.1007/s10750-011-0862-6; Karl DM, 2012, P NATL ACAD SCI USA, V109, P1842, DOI 10.1073/pnas.1120312109; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Konstantinidis KT, 2009, P NATL ACAD SCI USA, V106, P15909, DOI 10.1073/pnas.0902000106; Lami R, 2014, AQUAT MICROB ECOL, V73, P185, DOI 10.3354/ame01716; Lindell D, 2001, APPL ENVIRON MICROB, V67, P3340, DOI 10.1128/AEM.67.8.3340-3349.2001; Malmstrom RR, 2013, ISME J, V7, P184, DOI 10.1038/ismej.2012.89; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P1340, DOI 10.1111/j.1462-2920.2009.01860.x; Martiny AC, 2009, P NATL ACAD SCI USA, V106, P10787, DOI 10.1073/pnas.0902532106; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Ottesen EA, 2014, SCIENCE, V345, P207, DOI 10.1126/science.1252476; Ottesen EA, 2013, P NATL ACAD SCI USA, V110, pE488, DOI 10.1073/pnas.1222099110; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; Philippe N, 2007, BIOESSAYS, V29, P846, DOI 10.1002/bies.20629; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Robidart JC, 2014, ISME J, V8, P1175, DOI 10.1038/ismej.2013.244; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Satinsky BM, 2014, P NATL ACAD SCI USA, V111, P11085, DOI 10.1073/pnas.1402782111; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Shilova IN, 2014, ISME J, V8, P1476, DOI 10.1038/ismej.2014.1; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Steindler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019725; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Suzuki R, 2014, PVCLUST HIERARCHICAL; Varaljay VA, 2012, APPL ENVIRON MICROB, V78, P2775, DOI 10.1128/AEM.07559-11; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vergin KL, 2013, ISME J, V7, P1322, DOI 10.1038/ismej.2013.32; Vital M, 2015, ISME J, V9, P1130, DOI 10.1038/ismej.2014.204; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zehr JP, 2007, LIMNOL OCEANOGR, V52, P169, DOI 10.4319/lo.2007.52.1.0169; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819	53	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146706	10.1371/journal.pone.0146706	http://dx.doi.org/10.1371/journal.pone.0146706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751368	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000367888100133
J	Szoboszlay, M; White-Monsant, A; Moe, LA				Szoboszlay, Marton; White-Monsant, Alison; Moe, Luke A.			The Effect of Root Exudate 7,4 '-Dihydroxyflavone and Naringenin on Soil Bacterial Community Structure	PLOS ONE			English	Article							GENE-INDUCING FLAVONOIDS; SP NOV.; MICROBIAL COMMUNITY; PHENOLIC-ACIDS; SEQUENCE DATA; PLANT-GROWTH; RHIZOSPHERE; ACTINOBACTERIA; ACIDOBACTERIA; DIVERSITY	Our goal was to investigate how root exudate flavonoids influence the soil bacterial community structure and to identify members of the community that change their relative abundance in response to flavonoid exudation. Using a model system that approximates flavonoid exudation of Medicago sativa roots, we treated a soil with 7,4'-dihydroxyflavone and naringenin in two separate experiments using three different rates: medium (equivalent to the exudation rate of 7,4'-dihydroxyflavone from M. sativa seedlings), high (10x the medium rate), and low (0.1x the medium rate). Controls received no flavonoid. Soil samples were subjected to ATP assays and 16S rRNA gene amplicon sequencing. The flavonoid treatments caused no significant change in the soil ATP content. With the high 7,4'-dihydroxyflavone treatment rate, operational taxonomic units (OTUs) classified as Acidobacteria subdivision 4 increased in relative abundance compared with the control samples, whereas OTUs classified as Gaiellales, Nocardioidaceae, and Thermomonosporaceae were more prevalent in the control. The naringenin treatments did not cause significant changes in the soil bacterial community structure. Our results suggest that the root exudate flavonoid 7,4'-dihydroxyflavone can interact with a diverse range of soil bacteria and may have other functions in the rhizosphere in addition to nod gene induction in legume-rhizobia symbiosis.	[Szoboszlay, Marton; Moe, Luke A.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA; [White-Monsant, Alison] La Trobe Univ, Ctr AgriBiosci, Dept Anim Plant & Soil Sci, Melbourne, Vic, Australia	University of Kentucky; La Trobe University	Moe, LA (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	luke.moe@uky.edu		Szoboszlay, Marton/0000-0002-7264-3369; Moe, Luke/0000-0001-6864-4660	National Institute of Food and Agriculture of the United States Department of Agriculture [2011-67020-30195]	National Institute of Food and Agriculture of the United States Department of Agriculture	This work was supported by grant 2011-67020-30195 from the National Institute of Food and Agriculture of the United States Department of Agriculture to LAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Albuquerque L, 2011, SYST APPL MICROBIOL, V34, P595, DOI 10.1016/j.syapm.2011.07.001; Anderson CR, 2011, PEDOBIOLOGIA, V54, P309, DOI 10.1016/j.pedobi.2011.07.005; BAI QY, 1988, CHEMOSPHERE, V17, P2461, DOI 10.1016/0045-6535(88)90156-7; Blagodatskaya E, 2013, SOIL BIOL BIOCHEM, V67, P192, DOI 10.1016/j.soilbio.2013.08.024; Cesco S, 2012, BIOL FERT SOILS, V48, P123, DOI 10.1007/s00374-011-0653-2; Cesco S, 2010, PLANT SOIL, V329, P1, DOI 10.1007/s11104-009-0266-9; Chen F, 2013, CURR MICROBIOL, V67, P177, DOI 10.1007/s00284-013-0347-0; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Coombs JT, 2004, BIOL CONTROL, V29, P359, DOI 10.1016/j.biocontrol.2003.08.001; Coombs JT, 2003, APPL ENVIRON MICROB, V69, P5603, DOI 10.1128/AEM.69.9.5603-5608.2003; Cooper JE, 2004, ADV BOT RES, V41, P1; Crowe MA, 2014, INT J SYST EVOL MICR, V64, P220, DOI 10.1099/ijs.0.055079-0; da Rocha UN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082443; da Rocha UN, 2009, FEMS MICROBIOL ECOL, V69, P313, DOI 10.1111/j.1574-6941.2009.00702.x; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; DeNobili M, 1996, SOIL BIOL BIOCHEM, V28, P1099, DOI 10.1016/0038-0717(96)00074-0; DHARMATILAKE AJ, 1992, APPL ENVIRON MICROB, V58, P1153, DOI 10.1128/AEM.58.4.1153-1158.1992; DJORDJEVIC MA, 1987, EMBO J, V6, P1173, DOI 10.1002/j.1460-2075.1987.tb02351.x; Drake JE, 2013, BIOGEOSCIENCES, V10, P821, DOI 10.5194/bg-10-821-2013; Eren AM, 2015, ISME J, V9, P968, DOI 10.1038/ismej.2014.195; Fattorusso E, 2001, PHYTOCHEMISTRY, V57, P565, DOI 10.1016/S0031-9422(01)00039-5; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Foesel BU, 2013, SYST APPL MICROBIOL, V36, P82, DOI 10.1016/j.syapm.2012.11.002; Gremion F, 2003, ENVIRON MICROBIOL, V5, P896, DOI 10.1046/j.1462-2920.2003.00484.x; Griffiths BS, 1999, SOIL BIOL BIOCHEM, V31, P145, DOI 10.1016/S0038-0717(98)00117-5; HAMLEN RA, 1972, CAN J PLANT SCI, V52, P633, DOI 10.4141/cjps72-097; HARTWIG UA, 1991, PLANT PHYSIOL, V95, P797, DOI 10.1104/pp.95.3.797; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Hernandez M, 2015, APPL ENVIRON MICROB, V81, P2244, DOI 10.1128/AEM.03209-14; Huber KJ, 2014, INT J SYST EVOL MICR, V64, P1866, DOI 10.1099/ijs.0.060236-0; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Khamna S, 2009, WORLD J MICROB BIOT, V25, P649, DOI 10.1007/s11274-008-9933-x; Kim YE, 2014, J GEN APPL MICROBIOL, V60, P65, DOI 10.2323/jgam.60.65; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kroppenstedt RM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P682, DOI 10.1007/0-387-30743-5_27; Kuzyakov Y, 2007, PLANT SOIL, V290, P293, DOI 10.1007/s11104-006-9162-8; Landi L, 2006, SOIL BIOL BIOCHEM, V38, P509, DOI 10.1016/j.soilbio.2005.05.021; Lesuffleur F, 2007, PLANT SOIL, V294, P235, DOI 10.1007/s11104-007-9249-x; Lewis CE, 1998, J SCI FOOD AGR, V77, P58, DOI 10.1002/(SICI)1097-0010(199805)77:1&lt;58::AID-JSFA2&gt;3.0.CO;2-J; Lewis CE, 1998, J SCI FOOD AGR, V77, P45, DOI [10.1002/(SICI)1097-0010(199805)77:1&lt;45::AID-JSFA1&gt;3.0.CO;2-S, 10.1002/(SICI)1097-0010(199805)77:1<45::AID-JSFA1>3.0.CO;2-S]; LIPTON DS, 1987, PLANT PHYSIOL, V85, P315, DOI 10.1104/pp.85.2.315; Llugany M, 2013, J PLANT NUTR SOIL SC, V176, P851, DOI 10.1002/jpln.201300096; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mandalari G, 2007, J APPL MICROBIOL, V103, P2056, DOI 10.1111/j.1365-2672.2007.03456.x; Mandalari G, 2010, LETT APPL MICROBIOL, V51, P83, DOI 10.1111/j.1472-765X.2010.02862.x; MARTENS R, 1982, SOIL BIOL BIOCHEM, V14, P315, DOI 10.1016/0038-0717(82)90046-3; Martens R, 2001, SOIL BIOL BIOCHEM, V33, P973, DOI 10.1016/S0038-0717(01)00001-3; MAXWELL CA, 1990, PLANT PHYSIOL, V93, P1552, DOI 10.1104/pp.93.4.1552; MAXWELL CA, 1989, PLANT PHYSIOL, V91, P842, DOI 10.1104/pp.91.3.842; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; NANNIPIERI P, 1978, SOIL BIOL BIOCHEM, V10, P223, DOI 10.1016/0038-0717(78)90100-1; Nimnoi P, 2014, J PLANT NUTR, V37, P432, DOI 10.1080/01904167.2013.864308; Nimnoi P, 2010, WORLD J MICROB BIOT, V26, P193, DOI 10.1007/s11274-009-0159-3; ODHAM G, 1986, APPL ENVIRON MICROB, V52, P191, DOI 10.1128/AEM.52.1.191-196.1986; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Perez-Montano F, 2011, RES MICROBIOL, V162, P715, DOI 10.1016/j.resmic.2011.05.002; Probst TA, 2011, FORAGE GRAZINGLANDS, V9; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qawasmeh A, 2012, J AGR FOOD CHEM, V60, P3381, DOI 10.1021/jf204105k; Rauha JP, 2000, INT J FOOD MICROBIOL, V56, P3, DOI 10.1016/S0168-1605(00)00218-X; Rozanov AS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S12-S12; Ryu JY, 2005, J MICROBIOL BIOTECHN, V15, P1280; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaw LJ, 2008, SOIL BIOL BIOCHEM, V40, P528, DOI 10.1016/j.soilbio.2007.09.021; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P1867, DOI 10.1111/j.1462-2920.2006.01141.x; Shutsrirung A, 2013, SOIL SCI PLANT NUTR, V59, P322, DOI 10.1080/00380768.2013.776935; Sikora FJ, 2006, SOIL SCI SOC AM J, V70, P474, DOI 10.2136/sssaj2005.0164; Singh AK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-122; Soininen TH, 2014, PHYTOCHEM ANALYSIS, V25, P220, DOI 10.1002/pca.2495; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; T?th EM., 2014, PROKARYOTES ACTINOBA, DOI [10.1007/978-3-642-30138-4_193, DOI 10.1007/978-3-642-30138-4_193]; Tian XL, 2007, MICROB ECOL, V53, P700, DOI 10.1007/s00248-006-9163-4; Tomasi N, 2008, SOIL BIOL BIOCHEM, V40, P1971, DOI 10.1016/j.soilbio.2008.02.017; Valdes M, 2005, APPL ENVIRON MICROB, V71, P460, DOI 10.1128/AEM.71.1.460-466.2005; Van Der Boogaart KG, 2006, GEOLOGICAL SOC SPECI; Vandeputte OM, 2011, MICROBIOL-SGM, V157, P2120, DOI 10.1099/mic.0.049338-0; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Ziegler M, 2013, J MICROBIOL METH, V94, P30, DOI 10.1016/j.mimet.2013.04.003	80	34	35	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146555	10.1371/journal.pone.0146555	http://dx.doi.org/10.1371/journal.pone.0146555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752410	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100099
J	Binder, AK; Kosak, JP; Janhardhan, KS; Moser, G; Eling, TE; Korach, KS				Binder, April K.; Kosak, Justin P.; Janhardhan, Kyathanahalli S.; Moser, Glenda; Eling, Thomas E.; Korach, Kenneth S.			Expression of Human NSAID Activated Gene 1 in Mice Leads to Altered Mammary Gland Differentiation and Impaired Lactation	PLOS ONE			English	Article							TGF-BETA SUPERFAMILY; FAMILY-MEMBERS; BREAST-MILK; GROWTH; PROGESTERONE; SECRETION; EXPOSURES; CYTOKINE; REQUIRES; INSULIN	Transgenic mice expressing human non-steroidal anti-inflammatory drug activated gene 1 (NAG-1) have less adipose tissue, improved insulin sensitivity, lower insulin levels and are resistant to dietary induced obesity. The hNAG-1 expressing mice are more metabolically active with a higher energy expenditure. This study investigates female reproduction in the hNAG-1 transgenicmice and finds the femalemice are fertile but have reduced pup survival after birth. Examination of the mammary glands in these mice suggests that hNAG-1 expressing mice have altered mammary epithelial development during pregnancy, including reduced occupancy of the fat pad and increased apoptosis via TUNEL positive cells on lactation day 2. Pups nursing from hNAG-1 expressing dams have reduced milk spots compared to pups nursing from WT dams. When CD-1 pups were cross-fostered with hNAG-1 or WT dams; reduced milk volume was observed in pups nursing from hNAG-1 dams compared to pups nursing from WT dams in a lactation challenge study. Milk was isolated from WT and hNAG-1 dams, and the milk was found to have secreted NAG-1 protein (approximately 25 ng/mL) from hNAG-1 dams. The WT dams had no detectable hNAG-1 in the milk. A decrease in non-esterified free fatty acids in the milk of hNAG-1 dams was observed. Altered milk composition suggests that the pups were receiving inadequate nutrients during perinatal development. To examine this hypothesis serum was isolated from pups and clinical chemistry points were measured. Male and female pups nursing from hNAG-1 dams had reduced serum triglyceride concentrations. Microarray analysis revealed that genes involved in lipid metabolism are differentially expressed in hNAG-1 mammary glands. Furthermore, the expression of Cidea/CIDEA that has been shown to regulate milk lipid secretion in the mammary gland was reduced in hNAG-1 mammary glands. This study suggests that expression of hNAG-1 in mice leads to impaired lactation and reduces pup survival due to altered milk quality and quantity.	[Binder, April K.; Korach, Kenneth S.] NIEHS, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Kosak, Justin P.; Eling, Thomas E.] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Janhardhan, Kyathanahalli S.; Moser, Glenda] Integrated Lab Syst Inc, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Korach, KS (corresponding author), NIEHS, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	Korach@niehs.nih.gov		Binder, April/0000-0002-4095-4947; Korach, Kenneth/0000-0002-7765-418X	NIH, NIEHS Intramural Research Program [1ZIAES070065, Z01-ES010016-14]; Integrated Laboratory Systems Incorporated; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES010016, ZICES102445] Funding Source: NIH RePORTER	NIH, NIEHS Intramural Research Program; Integrated Laboratory Systems Incorporated; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding and support was provided by NIH, NIEHS Intramural Research Program: Projects 1ZIAES070065 (KSK) and Z01-ES010016-14 (TEE). Integrated Laboratory Systems Incorporated provided support in the form of salaries for authors KSJ and GM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baek SJ, 2006, GASTROENTEROLOGY, V131, P1553, DOI 10.1053/j.gastro.2006.09.015; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bierie B, 2009, J CELL PHYSIOL, V219, P57, DOI 10.1002/jcp.21646; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bottner M, 1999, CELL TISSUE RES, V297, P103, DOI 10.1007/s004410051337; Cases S, 2004, DEVELOPMENT, V131, P3047, DOI 10.1242/dev.01158; Chrysovergis K, 2014, INT J OBESITY, V38, P1555, DOI 10.1038/ijo.2014.27; DANIEL CW, 1987, CANCER RES, V47, P6052; Fenton SE, 2009, REPROD TOXICOL, V27, P365, DOI 10.1016/j.reprotox.2009.02.012; George JD, 1996, FUND APPL TOXICOL, V34, P56, DOI 10.1006/faat.1996.0175; Hewitt SC, 2002, CANCER RES, V62, P2798; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Horseman ND, 1999, J MAMMARY GLAND BIOL, V4, P79, DOI 10.1023/A:1018708704335; Hsieh CW, 2009, J NUTR, V139, P2257, DOI 10.3945/jn.109.113092; Humphreys RC, 1997, MOL ENDOCRINOL, V11, P801, DOI 10.1210/me.11.6.801; Humphreys RC, 1997, J MAMMARY GLAND BIOL, V2, P343, DOI 10.1023/A:1026343212187; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kim Joonseok, 2013, Case Rep Med, V2013, P131395, DOI 10.1155/2013/131395; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Moser GJ, 2010, SOC TOX 49 ANN M MAR; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Moura AS, 1997, RES COMMUN MOL PATH, V96, P179; Moura AS, 2002, BRAZ J MED BIOL RES, V35, P617, DOI 10.1590/S0100-879X2002000500016; Myers M, 2010, WIRES SYST BIOL MED, V2, P117, DOI 10.1002/wsbm.21; Richards Joanne S, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-02062-9_1; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Rigourd V, 2014, THER DRUG MONIT, V36, P590, DOI 10.1097/FTD.0000000000000058; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Sachs HC, 2013, PEDIATRICS, V132, pE796, DOI 10.1542/peds.2013-1985; Salisbury TB, 2009, MOL ENDOCRINOL, V23, P402, DOI 10.1210/me.2008-0370; TOPPER YJ, 1980, PHYSIOL REV, V60, P1049, DOI 10.1152/physrev.1980.60.4.1049; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; Wang WS, 2012, NAT MED, V18, P235, DOI 10.1038/nm.2614; Wang X, 2013, MATER RES LETT, V1, P19, DOI 10.1080/21663831.2012.686586; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Wang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020895; White SS, 2011, ENVIRON HEALTH PERSP, V119, P1070, DOI 10.1289/ehp.1002741; Winuthayanon W, 2009, ENVIRON HEALTH PERSP, V117, P1155, DOI 10.1289/ehp.0900613; Yamaguchi K, 2006, MOL CANCER THER, V5, P1352, DOI 10.1158/1535-7163.MCT-05-0528; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146518	10.1371/journal.pone.0146518	http://dx.doi.org/10.1371/journal.pone.0146518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745373	gold, Green Published, Green Submitted			2022-12-27	WOS:000367815600057
J	Danielson, KM; Estanislau, J; Tigges, J; Toxavidis, V; Camacho, V; Felton, EJ; Khoory, J; Kreimer, S; Ivanov, AR; Mantel, PY; Jones, J; Akuthota, P; Das, S; Ghiran, I				Danielson, Kirsty M.; Estanislau, Jessica; Tigges, John; Toxavidis, Vasilis; Camacho, Virginia; Felton, Edward J.; Khoory, Joseph; Kreimer, Simion; Ivanov, Alexander R.; Mantel, Pierre-Yves; Jones, Jennifer; Akuthota, Praveen; Das, Saumya; Ghiran, Ionita			Diurnal Variations of Circulating Extracellular Vesicles Measured by Nano Flow Cytometry	PLOS ONE			English	Article							MICROPARTICLES; EXERCISE	The identification of extracellular vesicles (EVs) as intercellular conveyors of biological information has recently emerged as a novel paradigm in signaling, leading to the exploitation of EVs and their contents as biomarkers of various diseases. However, whether there are diurnal variations in the size, number, and tissue of origin of blood EVs is currently not known, and could have significant implications when using EVs as biomarkers for disease progression. Currently available technologies for the measurement of EV size and number are either time consuming, require specialized equipment, or lack sufficient accuracy across a range of EV sizes. Flow cytometry represents an attractive alternative to these methods; however, traditional flow cytometers are only capable of measuring particles down to 500 nm, which is significantly larger than the average and median sizes of plasma EVs. Utilizing a Beckman Coulter MoFlo XDP flow cytometer with NanoView module, we employed nanoscale flow cytometry (termed nanoFCM) to examine the relative number and scatter distribution of plasma EVs at three different time points during the day in 6 healthy adults. Analysis of liposomes and plasma EVs proved that nanoFCM is capable of detecting biologically-relevant vesicles down to 100 nm in size. With this high resolution configuration, we observed variations in the relative size (FSC/SSC distributions) and concentration (proportions) of EVs in healthy adult plasma across the course of a day, suggesting that there are diurnal variations in the number and size distribution of circulating EV populations. The use of nanoFCM provides a valuable tool for the study of EVs in both health and disease; however, additional refinement of nanoscale flow cytometric methods is needed for use of these instruments for quantitative particle counting and sizing. Furthermore, larger scale studies are necessary to more clearly define the diurnal variations in circulating EVs, and thus further inform their use as biomarkers for disease.	[Danielson, Kirsty M.; Estanislau, Jessica; Tigges, John; Toxavidis, Vasilis; Camacho, Virginia; Felton, Edward J.; Khoory, Joseph; Mantel, Pierre-Yves; Akuthota, Praveen; Das, Saumya; Ghiran, Ionita] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Danielson, Kirsty M.; Estanislau, Jessica; Tigges, John; Toxavidis, Vasilis; Camacho, Virginia; Felton, Edward J.; Khoory, Joseph; Mantel, Pierre-Yves; Akuthota, Praveen; Das, Saumya; Ghiran, Ionita] Harvard Univ, Sch Med, Boston, MA USA; [Kreimer, Simion; Ivanov, Alexander R.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Kreimer, Simion; Ivanov, Alexander R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Jones, Jennifer] NCI, Mol Immunogenet & Vaccine Res Sect, Vaccine Branch, CCR, Bethesda, MD 20892 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Northeastern University; Northeastern University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ghiran, I (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	ighiran@bidmc.harvard.edu	Mantel, Pierre-Yves/N-3065-2015; Jones, Jennifer/C-8691-2015; Das, Saumya/R-7644-2019	Mantel, Pierre-Yves/0000-0001-9526-9309; Jones, Jennifer/0000-0002-9488-7719; Camacho, Virginia/0000-0002-6970-0932; Ivanov, Alexander R/0000-0002-4691-8488; Das, Saumya/0000-0002-4521-4606; Danielson, Kirsty/0000-0002-1667-2528	National Institutes of Health [R01 HL096795, 1U01HL126497-01, UH2TR000901]; Bill and Melinda Gates Foundation [OPP1032683]; NATIONAL CANCER INSTITUTE [ZIABC011502, ZIABC011503] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000901, UH3TR000901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122547, U01HL126497, R01HL096795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health R01 HL096795 (IG), 1U01HL126497-01 (IG), UH2TR000901 (SD) and Bill and Melinda Gates Foundation award OPP1032683 (IG).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Borges FT, 2013, BRAZ J MED BIOL RES, V46, P824, DOI 10.1590/1414-431X20132964; Chandler WL, 2011, J THROMB HAEMOST, V9, P1216, DOI 10.1111/j.1538-7836.2011.04283.x; Fruhbeis C, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28239; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Kogure Takayuki, 2013, Genes Cancer, V4, P261, DOI 10.1177/1947601913499020; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; Nolte-'t Hoen ENM, 2012, NANOMED-NANOTECHNOL, V8, P712, DOI 10.1016/j.nano.2011.09.006; Robert S, 2012, ARTERIOSCL THROM VAS, V32, P1054, DOI 10.1161/ATVBAHA.111.244616; Rousseau M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116812; Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Steen HB, 2004, CYTOM PART A, V57A, P94, DOI 10.1002/cyto.a.10115; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van der Pol E, 2012, J THROMB HAEMOST, V10, P919, DOI 10.1111/j.1538-7836.2012.04683.x; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	21	45	45	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0144678	10.1371/journal.pone.0144678	http://dx.doi.org/10.1371/journal.pone.0144678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745887	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600003
J	Quansah, E; Ohene, LA; Norman, L; Mireku, MO; Karikari, TK				Quansah, Emmanuel; Ohene, Lilian Akorfa; Norman, Linda; Mireku, Michael Osei; Karikari, Thomas K.			Social Factors Influencing Child Health in Ghana	PLOS ONE			English	Article							MATERNAL EDUCATION; INSURANCE SCHEME; MORTALITY DECLINE; DETERMINANTS; CARE; IMMUNIZATION; CONSEQUENCES; INEQUITIES; COUNTRIES; SERVICES	Objectives Social factors have profound effects on health. Children are especially vulnerable to social influences, particularly in their early years. Adverse social exposures in childhood can lead to chronic disorders later in life. Here, we sought to identify and evaluate the impact of social factors on child health in Ghana. As Ghana is unlikely to achieve the Millennium Development Goals' target of reducing child mortality by two-thirds between 1990 and 2015, we deemed it necessary to identify social determinants that might have contributed to the non-realisation of this goal. Methods ScienceDirect, PubMed, MEDLINE via EBSCO and Google Scholar were searched for published articles reporting on the influence of social factors on child health in Ghana. After screening the 98 articles identified, 34 of them that met our inclusion criteria were selected for qualitative review. Results Major social factors influencing child health in the country include maternal education, rural-urban disparities (place of residence), family income (wealth/poverty) and high dependency (multiparousity). These factors are associated with child mortality, nutritional status of children, completion of immunisation programmes, health-seeking behaviour and hygiene practices. Conclusions Several social factors influence child health outcomes in Ghana. Developing more effective responses to these social determinants would require sustainable efforts from all stakeholders including the Government, healthcare providers and families. We recommend the development of interventions that would support families through direct social support initiatives aimed at alleviating poverty and inequality, and indirect approaches targeted at eliminating the dependence of poor health outcomes on social factors. Importantly, the expansion of quality free education interventions to improve would-be-mother's health knowledge is emphasised.	[Quansah, Emmanuel] Univ Cape Coast, Sch Biol Sci, Dept Mol Biol & Biotechnol, Cape Coast, Ghana; [Quansah, Emmanuel; Ohene, Lilian Akorfa] De Montfort Univ, Fac Hlth & Life Sci, Leicester LE1 9BH, Leics, England; [Ohene, Lilian Akorfa] Univ Ghana, Sch Nursing, Dept Community Hlth, Accra, Ghana; [Norman, Linda] Univ Hlth & Allied Sci, Sch Nursing & Midwifery, Ho, Ghana; [Mireku, Michael Osei] Ecole Hautes Etud Santee Publ, Dept Methodes Quantitat Sante Publ METIS, Rennes, France; [Mireku, Michael Osei] Univ Paris 06, Ecole Doctorale Pierre Louis Santee Publ, Paris, France; [Mireku, Michael Osei] IRD, Meere & Enfant Face Infect Trop, Paris, France; [Karikari, Thomas K.] Univ Warwick, Sch Life Sci, Neurosci, Coventry CV4 7AL, W Midlands, England; [Karikari, Thomas K.] Univ Warwick, Midlands Integrat Biosci Training Partnership, Coventry CV4 7AL, W Midlands, England	University of Cape Coast; De Montfort University; University of Ghana; UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); University of Warwick; University of Warwick	Quansah, E (corresponding author), Univ Cape Coast, Sch Biol Sci, Dept Mol Biol & Biotechnol, Cape Coast, Ghana.	quansahmanuel@gmail.com; T.K.Karikari@warwick.ac.uk	Mireku, Michael/O-1714-2018; Karikari, Thomas/ABC-3367-2020	Mireku, Michael/0000-0002-2157-8456; Karikari, Thomas/0000-0003-1422-4358	Biotechnology and Biological Sciences Research Council (BBSRC) through the Midlands Integrative Biosciences Training Partnership [BB/J014532/1]; De Montfort University, Leicester, UK; Research Councils UK (RCUK) block grant at the University of Warwick	Biotechnology and Biological Sciences Research Council (BBSRC) through the Midlands Integrative Biosciences Training Partnership(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); De Montfort University, Leicester, UK; Research Councils UK (RCUK) block grant at the University of Warwick	TKK was funded by the Biotechnology and Biological Sciences Research Council (BBSRC; http://www.bbsrc.ac.uk) grant number BB/J014532/1 through the Midlands Integrative Biosciences Training Partnership. EQ was funded by a PhD studentship from De Montfort University, Leicester, UK. TKK acknowledges support from the Research Councils UK (RCUK) block grant at the University of Warwick for the payment of open access charges. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addai I, 2000, J BIOSOC SCI, V32, P1; Adongo PB, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-16; Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Akazili J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0637-7; Akyeampong K, 2007, ACCESS TO BASIC EDUC; Akyeampong K, 2009, COMP EDUC, V45, P175, DOI 10.1080/03050060902920534; Allotey P, 2001, SOC SCI MED, V52, P1007, DOI 10.1016/S0277-9536(00)00207-0; Ampaabeng SK, 2013, J HEALTH ECON, V32, P1013, DOI 10.1016/j.jhealeco.2013.08.001; Amugsi DA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005340; Andrzejewski CS, 2009, HEALTH PLACE, V15, P228, DOI 10.1016/j.healthplace.2008.05.002; Annim SK, 2015, J BIOSOC SCI, V47, P565, DOI 10.1017/S0021932014000340; Antoine P, 1988, Ann IFORD, V12, P9; Armar-Klemesu M, 2000, J NUTR, V130, P1597, DOI 10.1093/jn/130.6.1597; Asante Fa, 2007, Ghana Med J, V41, P110; Asenso-Okyere WK, 1997, AGR ECON, V17, P59, DOI 10.1016/S0169-5150(97)00011-X; Awoonor-Williams JK, 2016, INT J HEALTH PLAN M, V31, pE273, DOI 10.1002/hpm.2304; Baker EA, 2005, AM J PUBLIC HEALTH, V95, P553, DOI 10.2105/AJPH.2005.061812; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Bazzano AN, 2008, TROP MED INT HEALTH, V13, P123, DOI 10.1111/j.1365-3156.2007.01981.x; Benefo K, 1996, WORLD BANK ECON REV, V10, P123, DOI 10.1093/wber/10.1.123; BENEFO KD, 1995, DEMOGRAPHY, V32, P139, DOI 10.2307/2061737; BINKA FN, 1995, INT J EPIDEMIOL, V24, P127, DOI 10.1093/ije/24.1.127; Boyce WT, 1995, ANN BEHAV MED, V17, P315, DOI 10.1007/BF02888596; BRUGHA R, 1995, HEALTH POLICY PLANN, V10, P312, DOI 10.1093/heapol/10.3.312; Brugha RF, 1996, INT J EPIDEMIOL, V25, P840, DOI 10.1093/ije/25.4.840; CALDWELL J, 1982, HEALTH POLICY EDUC, V2, P251, DOI 10.1016/0165-2281(82)90012-1; CALDWELL JC, 1979, POP STUD-J DEMOG, V33, P395, DOI 10.2307/2173888; CALDWELL JC, 1983, POP STUD-J DEMOG, V37, P185, DOI 10.2307/2173981; Dako-Gyeke P, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-211; DAWSON G, 1994, DEV PSYCHOPATHOL, V6, P759, DOI 10.1017/S0954579400004776; de Melo EMDP, 2014, REV LAT-AM ENFERM, V22, P432, DOI 10.1590/0104-1169.3308.2434; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Duku SKO, 2015, J AGING SOC POLICY, V27, P331, DOI 10.1080/08959420.2015.1056650; Essuman A, 2013, INT J EDUC DEV, V33, P253, DOI 10.1016/j.ijedudev.2012.09.011; Fenny AP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1696-3; Forjuoh S N, 1995, Inj Prev, V1, P31, DOI 10.1136/ip.1.1.31; FOSU GB, 1992, SOCIOL FOCUS, V25, P329, DOI 10.1080/00380237.1992.10570989; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Garg A, 1998, J POPUL ECON, V11, P471, DOI 10.1007/s001480050080; Gawande Atul, 2010, NEW YORKER; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gram L, 2014, TROP MED INT HEALTH, V19, P802, DOI 10.1111/tmi.12324; Greenaway ES, 2012, J BIOSOC SCI, V44, P733, DOI 10.1017/S0021932012000041; Gyimah SO, 2007, J BIOSOC SCI, V39, P923, DOI 10.1017/S0021932007001927; Halfon Neal, 2010, Healthc Q, V14 Spec No 1, P8; Hong R, 2007, PUBLIC HEALTH NUTR, V10, P371, DOI 10.1017/S1368980007226035; Issaka AI, 2015, PUBLIC HEALTH NUTR, V18, P669, DOI 10.1017/S1368980014000834; ISSAKATINORGAH A, 1989, T ROY SOC TROP MED H, V83, P27, DOI 10.1016/0035-9203(89)90693-7; Janus M, 2007, THE EARLY DEVELOPMEN; Jehu-Appiah C, 2011, SOC SCI MED, V72, P157, DOI 10.1016/j.socscimed.2010.10.025; Johnson FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120556; Kanmiki EW, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-24; Kayode GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-165; Kimani-Murage EW, 2014, HEALTH PLACE, V29, P95, DOI 10.1016/j.healthplace.2014.06.003; Kusi A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0996-8; Lavy V, 1996, J HEALTH ECON, V15, P333, DOI 10.1016/0167-6296(95)00021-6; Marmot M, 2010, FAIR SOCIETY HEALTHY; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Matthews Z, 1997, J BIOSOC SCI, V29, P327, DOI 10.1017/S0021932097003271; Ministry of Health Ghana, 2014, GHANA NATIONAL NEWBO; Ministry of Health Ghana, UNDER 5 CHILD HEALTH; Ministry of Health Ghana, UNDER FIVES CHILD HE; Mireku MO, 2015, PEDIATRICS, V136, pE76, DOI 10.1542/peds.2015-0491; Mireku MO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003463; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moyer CA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-50; Nakamura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017774; O'Hare B, 2013, J ROY SOC MED, V106, P408, DOI 10.1177/0141076813489680; Okyere E, 2010, ANN TROP PAEDIATR, V30, P321, DOI 10.1179/146532810X12858955921311; Owusu-Addo E, 2016, HEALTH PROMOT INT, V31, P33, DOI 10.1093/heapro/dau069; Pharmacy Council Ghana Ministry of Health Ghana, 2009, ASSESSMENT OF HUMAN; Quansah E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/298409; Raphael D., 2009, SOCIAL DETERMINANTS; Ruel MT, 1999, WORLD DEV, V27, P1993, DOI 10.1016/S0305-750X(99)00097-2; Sakeah E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-90; Sakeah E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-340; Sarpong N, 2010, TROP MED INT HEALTH, V15, P191, DOI 10.1111/j.1365-3156.2009.02439.x; Sastry N, 1997, SOC SCI MED, V44, P989, DOI 10.1016/S0277-9536(96)00224-9; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Singh K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0762-y; Snow RC, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-13; Tolhurst R, 2008, SOC SCI MED, V66, P1106, DOI 10.1016/j.socscimed.2007.11.032; United Nations Development Programme Ghana National Development Pranning Commission/Gov-ernment of Ghana, 2010, 2010 GHANA MILLENNIU; Van de Poel Ellen, 2007, Int J Equity Health, V6, P21, DOI 10.1186/1475-9276-6-21; Vikram K, 2010, MATERNAL EDUCATION A; Wirth ME, 2006, B WORLD HEALTH ORGAN, V84, P519, DOI 10.2471/BLT.04.019984; World Health Organization, 2008, FINAL REPORT OF THE; Yarney L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-014-1332-7	88	24	25	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145401	10.1371/journal.pone.0145401	http://dx.doi.org/10.1371/journal.pone.0145401			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA5AX	26745277	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000367815600006
J	Thomsen, KL; Macnaughtan, J; Tritto, G; Mookerjee, RP; Jalan, R				Thomsen, Karen Louise; Macnaughtan, Jane; Tritto, Giovanni; Mookerjee, Rajeshwar P.; Jalan, Rajiv			Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; NERVOUS-SYSTEM; BACTERIAL-DNA; AMMONIA; IMMUNODEPRESSION; TRANSLOCATION; INFLAMMATION; PREDICTS; SURVIVAL; IMMUNE	Background and Aims EASL/AASLD hepatic encephalopathy (HE) guidelines proposed the alternative use of the term 'Covert HE' combining minimal HE (mHE) and Grade 1 HE into a single entity. However, longitudinal data to indicate that these are indeed a single entity are lacking. The aims of this study were to determine whether the occurrence of complications of cirrhosis requiring hospital admission and mortality were similar in these sub-groups of patients. Methods Clinically-stable cirrhotic patients (n = 106) with no previous history of 'Overt HE' were included over a 2-year period and classified as having no HE (n = 23), mHE (n = 39) or Grade 1 HE (n = 44). Standard biochemistry, venous ammonia, bacterial DNA and neutrophil function were measured at inclusion and the patients were followed for a mean of 230 +/- 95 days. Results Patients with Grade 1 HE had significantly more complications requiring hospitalisation (infection 9/18/34%; HE 4/8/18%; other 13/10/11%; P = 0.02) and significantly greater mortality (4/5/20%; P = 0.04) compared to patients with no HE or mHE respectively. Patients with mHE and grade 1 HE had similar ammonia levels, but higher than the no HE group (P<0.001). MELD score was similar between groups but Grade 1 HE patients had increased frequency of bacterial translocation (P = 0.06) and neutrophil spontaneous respiratory burst (P = 0.02) compared to patients with mHE. Conclusions The results of this study show for the first time that 'Covert HE' is a heterogeneous entity with significantly greater hospitalisations and mortality in the Grade 1 HE patients compared with mHE. Further prospective longer-term studies are required before EASL/AASLD guidance is fully implemented.	[Thomsen, Karen Louise; Macnaughtan, Jane; Tritto, Giovanni; Mookerjee, Rajeshwar P.; Jalan, Rajiv] UCL, Sch Med, Liver Failure Grp, UCL Inst Liver & Digest Hlth, London W1N 8AA, England	University of London; University College London; UCL Medical School	Jalan, R (corresponding author), UCL, Sch Med, Liver Failure Grp, UCL Inst Liver & Digest Hlth, Mortimer St, London W1N 8AA, England.	r.jalan@ucl.ac.uk		Mookerjee, Rajeshwar/0000-0002-6275-9384; Thomsen, Karen Louise/0000-0002-8118-4643	Vital Therapies; Gambro; Grifols	Vital Therapies; Gambro; Grifols	Rajiv Jalan received research funding from Vital Therapies, has served on Scientific Advisory Board for Conatus Pharma, and received lecture fees from Gambro and has on-going research collaboration with Gambro, Grifols and is the Principal Investigator of an Industry sponsored study (Sequana Medical). He is also inventor for a drug, L-ornithine phenyl acetate which UCL has licensed to Ocera Therapeutics. He is also the founder of UCL spin-out company Yaqrit ltd. and Cyberliver ltd. All other authors have nothing to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Amer Assoc Study Liver Dis, 2014, J HEPATOL, V61, P642, DOI 10.1016/j.jhep.2014.05.042; Bajaj JS, 2011, ALIMENT PHARM THER, V33, P739, DOI 10.1111/j.1365-2036.2011.04590.x; BOHMER RH, 1992, CYTOMETRY, V13, P525, DOI 10.1002/cyto.990130512; Bustamante J, 1999, J HEPATOL, V30, P890, DOI 10.1016/S0168-8278(99)80144-5; Cirera I, 2001, J HEPATOL, V34, P32, DOI 10.1016/S0168-8278(00)00013-1; Cordoba J, 2014, J HEPATOL, V60, P275, DOI 10.1016/j.jhep.2013.10.004; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; El Kebir D, 2008, ARCH IMMUNOL THER EX, V56, P41, DOI 10.1007/s00005-008-0008-3; Emsley Hedley C. A., 2010, Infectious Disorders - Drug Targets, V10, P91; ETHEREDGE EE, 1993, J SURG RES, V55, P261, DOI 10.1006/jsre.1993.1138; Hartmann IJC, 2000, AM J GASTROENTEROL, V95, P2029; Jepsen P, 2010, HEPATOLOGY, V51, P1675, DOI 10.1002/hep.23500; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kircheis G, 2002, HEPATOLOGY, V35, P357, DOI 10.1053/jhep.2002.30957; Lauridsen MM, 2015, METAB BRAIN DIS, V30, P1187, DOI 10.1007/s11011-015-9688-7; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Montagnese S, 2014, WORLD J GASTROENTERO, V20, P15756, DOI 10.3748/wjg.v20.i42.15756; Montagnese S, 2011, HEPATOLOGY, V53, P558, DOI 10.1002/hep.24043; Mookerjee RP, 2007, HEPATOLOGY, V46, P831, DOI 10.1002/hep.21737; Newton JL, 2008, HEPATOLOGY, V48, P541, DOI 10.1002/hep.22371; Ong JP, 2003, AM J MED, V114, P188, DOI 10.1016/S0002-9343(02)01477-8; Ortiz M, 2005, J HEPATOL, V42, pS45, DOI 10.1016/j.jhep.2004.11.028; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Romero-Gomez M, 2001, AM J GASTROENTEROL, V96, P2718, DOI 10.1016/S0002-9270(01)02692-2; Shawcross DL, 2011, J HEPATOL, V54, P640, DOI 10.1016/j.jhep.2010.07.045; Shawcross DI, 2008, HEPATOLOGY, V48, P1202, DOI 10.1002/hep.22474; Stewart CA, 2007, LIVER TRANSPLANT, V13, P1366, DOI 10.1002/lt.21129; Straub RH, 2006, GUT, V55, P1640, DOI 10.1136/gut.2006.091322; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Tranah TH, 2013, METAB BRAIN DIS, V28, P1, DOI 10.1007/s11011-012-9370-2; Tritto G, 2011, J HEPATOL, V55, P574, DOI 10.1016/j.jhep.2010.11.034; VANDERRIJT CCD, 1984, ELECTROEN CLIN NEURO, V57, P423, DOI 10.1016/0013-4694(84)90071-3; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Worlicek M, 2010, GUT, V59, P1127, DOI 10.1136/gut.2009.185413	37	33	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146076	10.1371/journal.pone.0146076	http://dx.doi.org/10.1371/journal.pone.0146076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745876	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600023
J	Wada, Y; Takami, Y; Tateishi, M; Ryu, T; Mikagi, K; Saitsu, H				Wada, Yoshiyuki; Takami, Yuko; Tateishi, Masaki; Ryu, Tomoki; Mikagi, Kazuhiro; Saitsu, Hideki			The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma	PLOS ONE			English	Article							1ST-LINE TREATMENT; ALPHA-FETOPROTEIN; DOSE-ESCALATION; REAL-WORLD; PHASE-II; SURVIVAL; TRIAL; CETUXIMAB; DESIGN; JAPAN	Background Whether radiologically detected progressive disease (PD) is an accurate metric for discontinuing sorafenib treatment in patients with hepatocellular carcinoma (HCC) is unclear. We investigated the efficacy of sorafenib treatment after radiologic confirmation of PD in patients with advanced HCC. Methods We retrospectively analyzed HCC patients treated with sorafenib at Kyushu Medical Center. Six of the 92 patients with radiologically confirmed PD were excluded because they were classified as Child-Pugh C or had an Eastern Cooperative Oncology Group (ECOG) performance status (PS) >= 3; 86 patients were ultimately enrolled. Results Among the 86 patients, 47 continued sorafenib treatment after radiologic confirmation of PD (the continuous group), whereas 39 did not (the discontinuous group). The median survival time (MST) in the continuous group after confirmation was 12.9 months compared with 4.5 months in the discontinuous group (p < 0.01). The time to progression in the continuous group after confirmation was 2.6 months compared with 1.4 months in the discontinuous group (p < 0.01); it was 4.2 months and 2.1 months in patients who had received sorafenib >4 months and <4 months, respectively, before confirmation (p = 0.03). In these subgroups, the post-PD MST was 16.7 months and 9.6 months, respectively (p < 0.01). Independent predictors of overall survival after radiologic detection of PD were (hazard ratio, confidence interval): ECOG PS <2 (0.290,0.107-0.880), Barcelona Clinical Liver Cancer stage B (0.146, 0.047-0.457), serum alpha-fetoprotein level >= 400 ng/mL (2.801, 1.355-5.691), and post-PD sorafenib administration (0.279, 0.150-0.510). Conclusion Continuing sorafenib treatment after radiologic confirmation of PD increased survival in patients with advanced HCC. Therefore, radiologically detected PD is not a metric for discontinuation of sorafenib treatment in such patients.	[Wada, Yoshiyuki; Takami, Yuko; Tateishi, Masaki; Ryu, Tomoki; Mikagi, Kazuhiro; Saitsu, Hideki] Natl Hosp Org Kyushu Med Ctr, Clin Res Inst, Dept Hepatobiliary Pancreat Surg, Fukuoka, Japan		Wada, Y (corresponding author), Natl Hosp Org Kyushu Med Ctr, Clin Res Inst, Dept Hepatobiliary Pancreat Surg, Fukuoka, Japan.	yoshiwada@kyumed.jp		Saitsu, Hirotomo/0000-0003-0723-0960				Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Arii S, 2010, HEPATOL RES, V40, P667, DOI 10.1111/j.1872-034X.2010.00673.x; Bettinger D, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25637; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; da Fonseca LG, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0264-5; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Estfan B, 2012, AM J CLIN ONCOL-CANC, DOI [10.1097/COC.0b013e3182468039, DOI 10.1097/C0C.0B013E3182468039]; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Iavarone M, 2011, HEPATOLOGY, V54, P2055, DOI 10.1002/hep.24644; Kim JE, 2012, ONCOLOGY-BASEL, V82, P119, DOI 10.1159/000336082; Kudo M, 2010, ONCOLOGY-BASEL, V78, P154, DOI 10.1159/000315245; Kuzuya T, 2011, ONCOLOGY-BASEL, V81, P251, DOI 10.1159/000334454; Lee IC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000688; Lencioni R, 2012, Int J Clin Pract, V66, P675, DOI 10.1111/j.1742-1241.2012.02940.x; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Marrero JA, 2011, HEPATOLOGY; Otsuka T, 2012, HEPATOL RES, V42, P879, DOI 10.1111/j.1872-034X.2012.00991.x; Reig M, 2013, HEPATOLOGY, V58, P2023, DOI 10.1002/hep.26586; Rimassa L, 2013, ONCOLOGIST, V18, P379, DOI 10.1634/theoncologist.2012-0221; Shao YY, 2010, CANCER-AM CANCER SOC, V116, P4590, DOI 10.1002/cncr.25257; Shingina A, 2013, CAN J GASTROENTEROL, V27, P393, DOI 10.1155/2013/170546; Tsuchiya K, 2014, CANCER-AM CANCER SOC, V120, P229, DOI 10.1002/cncr.28384; Ueshima K, 2011, DIGEST DIS, V29, P321, DOI 10.1159/000327570; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Vincenzi B, 2010, ONCOLOGIST, V15, P85, DOI 10.1634/theoncologist.2009-0143	30	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146456	10.1371/journal.pone.0146456	http://dx.doi.org/10.1371/journal.pone.0146456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745625	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600049
J	Chai, J; Qu, WN; Sun, XH; Zhang, K; Ge, Y				Chai, Jing; Qu, Weina; Sun, Xianghong; Zhang, Kan; Ge, Yan			Negativity Bias in Dangerous Drivers	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; EMOTIONAL STROOP TASK; INDIVIDUAL-DIFFERENCES; VISUAL-ATTENTION; DRIVING ANXIETY; ANGER; RISKY; P300; PERFORMANCE; BEHAVIOR	The behavioral and cognitive characteristics of dangerous drivers differ significantly from those of safe drivers. However, differences in emotional information processing have seldom been investigated. Previous studies have revealed that drivers with higher anger/anxiety trait scores are more likely to be involved in crashes and that individuals with higher anger traits exhibit stronger negativity biases when processing emotions compared with control groups. However, researchers have not explored the relationship between emotional information processing and driving behavior. In this study, we examined the emotional information processing differences between dangerous drivers and safe drivers. Thirty-eight non-professional drivers were divided into two groups according to the penalty points that they had accrued for traffic violations: 15 drivers with 6 or more points were included in the dangerous driver group, and 23 drivers with 3 or fewer points were included in the safe driver group. The emotional Stroop task was used to measure negativity biases, and both behavioral and electroencephalograph data were recorded. The behavioral results revealed stronger negativity biases in the dangerous drivers than in the safe drivers. The bias score was correlated with self-reported dangerous driving behavior. Drivers with strong negativity biases reported having been involved in mores crashes compared with the less-biased drivers. The event-related potentials (ERPs) revealed that the dangerous drivers exhibited reduced P3 components when responding to negative stimuli, suggesting decreased inhibitory control of information that is task-irrelevant but emotionally salient. The influence of negativity bias provides one possible explanation of the effects of individual differences on dangerous driving behavior and traffic crashes.	[Chai, Jing; Qu, Weina; Sun, Xianghong; Zhang, Kan; Ge, Yan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing, Peoples R China; [Chai, Jing] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Qu, WN (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing, Peoples R China.	quwn@psych.ac.cn; gey@psych.ac.cn			National Natural Science Foundation of China [31100750, 31400886]; Basic Project of National Science and Technology of China [2009FY110100]; Chinese Academy of Sciences Strategic Leading Science and Technology Special [XDA06030800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Project of National Science and Technology of China; Chinese Academy of Sciences Strategic Leading Science and Technology Special	This study was supported by grants from the National Natural Science Foundation of China (Grants No. 31100750 to Ge and 31400886 to Qu) (http://www.nsfc.gov.cn/), the Basic Project of National Science and Technology of China (No. 2009FY110100 to Zhang) (http://www.most.gov.cn/kjjh/gjkjjh/), and the Chinese Academy of Sciences Strategic Leading Science and Technology Special (No. XDA06030800 to Sun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by grants from the National Natural Science Foundation of China (Grants No. 31100750 and 31400886), the Basic Project of National Science and Technology of China (No. 2009FY110100), and the Chinese Academy of Sciences Strategic Leading Science and Technology Special (No. XDA06030800). The authors thank Jinyan Xia for data collection.	Abdu R, 2012, TRANSPORT RES F-TRAF, V15, P575, DOI 10.1016/j.trf.2012.05.007; [Anonymous], 2001, A5 U FLOR CTR RES PS; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Arnett JJ, 1997, ACCIDENT ANAL PREV, V29, P57, DOI 10.1016/S0001-4575(97)87007-8; ARTHUR W, 1994, J OCCUP ORGAN PSYCH, V67, P173, DOI 10.1111/j.2044-8325.1994.tb00559.x; AVOLIO BJ, 1985, HUM FACTORS, V27, P577, DOI 10.1177/001872088502700506; Baldwin CL, 2005, PSYCHOLOGIA, V48, P102, DOI 10.2117/psysoc.2005.102; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BELKIC K, 1992, PHYSIOL BEHAV, V52, P423, DOI 10.1016/0031-9384(92)90327-X; Bertsch K, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.028.2009; Bohner G, 2011, ANNU REV PSYCHOL, V62, P391, DOI 10.1146/annurev.psych.121208.131609; Bremner JD, 2004, BIOL PSYCHIAT, V55, P612, DOI 10.1016/j.biopsych.2003.10.001; Briggs GF, 2011, TRANSPORT RES F-TRAF, V14, P313, DOI 10.1016/j.trf.2011.02.004; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Chan M, 2013, ACCIDENT ANAL PREV, V50, P147, DOI 10.1016/j.aap.2012.04.004; Dahlen ER, 2005, ACCIDENT ANAL PREV, V37, P341, DOI 10.1016/j.aap.2004.10.006; Deffenbacher JL, 2003, BEHAV RES THER, V41, P701, DOI 10.1016/S0005-7967(02)00046-3; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Dula C, 2011, CURR PSYCHOL, V30, P324, DOI 10.1007/s12144-011-9120-3; Dula CS, 2010, ACCIDENT ANAL PREV, V42, P2050, DOI 10.1016/j.aap.2010.06.016; Dula CS, 2003, J SAFETY RES, V34, P559, DOI 10.1016/j.jsr.2003.03.004; Dula CS, 2003, J APPL SOC PSYCHOL, V33, P263, DOI 10.1111/j.1559-1816.2003.tb01896.x; Egloff B, 2001, PERS INDIV DIFFER, V31, P875, DOI 10.1016/S0191-8869(00)00188-4; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Feng CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029668; Goldstein A, 2002, PSYCHOPHYSIOLOGY, V39, P781, DOI 10.1017/S004857720201048X; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; Huang YX, 2006, NEUROSCI LETT, V398, P91, DOI 10.1016/j.neulet.2005.12.074; Iliescu D, 2013, ACCIDENT ANAL PREV, V51, P33, DOI 10.1016/j.aap.2012.10.014; Ito TA, 2005, COGNITION EMOTION, V19, P1, DOI 10.1080/02699930441000120; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Janelle CM, 1999, J SPORT EXERCISE PSY, V21, P70, DOI 10.1123/jsep.21.1.70; JIN HQ, 1991, INT J EPIDEMIOL, V20, P230, DOI 10.1093/ije/20.1.230; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kramer UM, 2007, NEUROIMAGE, V38, P203, DOI 10.1016/j.neuroimage.2007.07.029; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lu JY, 2013, J SAFETY RES, V45, P65, DOI 10.1016/j.jsr.2013.01.009; Machin MA, 2008, ACCIDENT ANAL PREV, V40, P541, DOI 10.1016/j.aap.2007.08.010; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Mesken J, 2007, TRANSPORT RES F-TRAF, V10, P458, DOI 10.1016/j.trf.2007.05.001; MIHAL WL, 1976, J APPL PSYCHOL, V61, P229, DOI 10.1037/0021-9010.61.2.229; Nesbit SM, 2007, AGGRESS VIOLENT BEH, V12, P156, DOI 10.1016/j.avb.2006.09.003; Olson MA, 2003, PSYCHOL SCI, V14, P636, DOI 10.1046/j.0956-7976.2003.psci_1477.x; Ou B, 2012, INT J IND ERGONOM, V42, P8, DOI 10.1016/j.ergon.2011.11.006; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Putman P, 2004, EMOTION, V4, P305, DOI 10.1037/1528-3542.4.3.305; Qu WN, 2014, ACCIDENT ANAL PREV, V64, P62, DOI 10.1016/j.aap.2013.11.004; Richer I, 2012, ACCIDENT ANAL PREV, V45, P620, DOI 10.1016/j.aap.2011.09.014; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Smart RG, 2002, CAN MED ASSOC J, V167, P761; Stephens AN, 2013, APPL COGNITIVE PSYCH, V27, P178, DOI 10.1002/acp.2894; Stephens AN, 2011, COGNITION EMOTION, V25, P1423, DOI 10.1080/02699931.2010.551184; Stephens AN, 2009, TRANSPORT RES F-TRAF, V12, P29, DOI 10.1016/j.trf.2008.06.005; Sullman MJM, 2014, ACCIDENT ANAL PREV, V71, P1, DOI 10.1016/j.aap.2014.04.019; Taylor J, 2008, NEW ZEAL J PSYCHOL, V37, P31; Taylor JE, 2011, AGE AGEING, V40, P62, DOI 10.1093/ageing/afq154; Thomas SJ, 2007, INT J PSYCHOPHYSIOL, V63, P221, DOI 10.1016/j.ijpsycho.2006.10.002; Ulleberg P, 2003, SAFETY SCI, V41, P427, DOI 10.1016/S0925-7535(01)00077-7; Underwood G., 1999, TRANSP RES F, V2, P55, DOI [10.1016/S1369-8478(99)00006-6, DOI 10.1016/S1369-8478(99)00006-6]; van Honk J, 2001, COGNITION EMOTION, V15, P279, DOI 10.1080/0269993004200222; Vassallo S, 2007, ACCIDENT ANAL PREV, V39, P444, DOI 10.1016/j.aap.2006.04.011; Wang JF, 2011, J RES PERS, V45, P441, DOI 10.1016/j.jrp.2011.05.004; Willemsen J, 2008, ACCIDENT ANAL PREV, V40, P798, DOI 10.1016/j.aap.2007.09.019; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Yuan JJ, 2007, NEUROPSYCHOLOGIA, V45, P2764, DOI 10.1016/j.neuropsychologia.2007.04.018; Yuan JJ, 2012, COGN AFFECT BEHAV NE, V12, P175, DOI 10.3758/s13415-011-0064-8; Yuan JJ, 2012, BIOL PSYCHOL, V89, P240, DOI 10.1016/j.biopsycho.2011.10.015; Zelinkova J, 2013, NEUROIMAGE, V83, P1024, DOI 10.1016/j.neuroimage.2013.07.063	71	20	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147083	10.1371/journal.pone.0147083	http://dx.doi.org/10.1371/journal.pone.0147083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB4CC	26765225	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300064
J	Moreno-Santillan, DD; Lacey, EA; Gendron, D; Ortega, J				Moreno-Santillan, Diana D.; Lacey, Eileen A.; Gendron, Diane; Ortega, Jorge			Genetic Variation at Exon 2 of the MHC Class II DQB Locus in Blue Whale (Balaenoptera musculus) from the Gulf of California	PLOS ONE			English	Article							EASTERN NORTH PACIFIC; SEQUENCE VARIATION; POLYMORPHISM; DUPLICATION; SELECTION; DIVERSITY; EVOLUTION; INFERENCE; BIRTH	The genes of the Major Histocompatibility Complex (MHC) play an important role in the vertebrate immune response and are among the most polymorphic genes known in vertebrates. In some marine mammals, MHC genes have been shown to be characterized by low levels of polymorphism compared to terrestrial taxa; this reduction in variation is often explained as a result of lower pathogen pressures in marine habitats. To determine if this same reduction in variation applies to the migratory population of blue whales (Balaenoptera musculus) that occurs in the Gulf of California, we genotyped a 172 bp fragment of exon 2 of the MHC Class II DQB locus for 80 members of this population. Twenty-two putatively functional DQB allotypes were identified, all of which were homologous with DQB sequences from other cetacean species. Up to 5 putative alleles per individual were identified, suggesting that gene duplication has occurred at this locus. Rates of non-synonymous to synonymous substitutions (omega) and maximum likelihood analyses of models of nucleotide variation provided potential evidence of ongoing positive selection at this exon. Phylogenetic analyses of DQB alleles from B. musculus and 16 other species of cetaceans revealed trans-specific conservation of MHC variants, suggesting that selection has acted on this locus over prolonged periods of time. Collectively our findings reveal that immunogenic variation in blue whales is comparable to that in terrestrial mammals, thereby providing no evidence that marine taxa are subject to reduced pathogen-induced selective pressures.	[Moreno-Santillan, Diana D.; Ortega, Jorge] Inst Politecn Nacl, Lab Bioconservac & Manejo, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Lacey, Eileen A.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Gendron, Diane] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Cetaceos & Quelonios, La Paz, Bcs, Mexico	Instituto Politecnico Nacional - Mexico; University of California System; University of California Berkeley; Instituto Politecnico Nacional - Mexico	Ortega, J (corresponding author), Inst Politecn Nacl, Lab Bioconservac & Manejo, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico.	artibeus2@aol.com		Moreno-Santillan, Diana D./0000-0003-2153-0732	Consejo Nacional de Ciencia y Tecnologia (CONACyT); Ciencia Basica CONACyT Project [156725]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ciencia Basica CONACyT Project	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT), Ciencia Basica CONACyT Project Number 156725 (http://www.conacyt.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axtner J, 2007, IMMUNOGENETICS, V59, P417, DOI 10.1007/s00251-007-0205-y; Baker CS, 2006, IMMUNOGENETICS, V58, P283, DOI 10.1007/s00251-006-0080-y; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J, 2009, MAR MAMMAL SCI, V25, P816, DOI 10.1111/j.1748-7692.2009.00298.x; Costa UP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058315, DOI 10.1371/J0URNAL.P0NE.0058315]; Cutrera AP, 2007, IMMUNOGENETICS, V59, P937, DOI 10.1007/s00251-007-0261-3; de Bellocq JG, 2010, IMMUNOGENETICS, V62, P59, DOI 10.1007/s00251-009-0411-x; Drummond A., 2011, GENEIOUS V5 5; Enriquez PL, 2005, THESIS; Flores-Ramirez S, 2000, J HERED, V91, P279, DOI 10.1093/jhered/91.4.279; Frias M, 2009, THESIS; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gendron D., 2012, Journal of Cetacean Research and Management, V12, P79; Gendron D., 2002, THESIS; Hayashi Kosuke, 2003, Mammal Study, V28, P89, DOI 10.3106/mammalstudy.28.89; Hoelzel AR, 1999, MOL BIOL EVOL, V16, P611, DOI 10.1093/oxfordjournals.molbev.a026143; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Johnson G, 2000, NUCLEIC ACIDS RES, V28, P214, DOI 10.1093/nar/28.1.214; Kennedy LJ, 2002, IMMUNOGENETICS, V54, P348, DOI 10.1007/s00251-002-0465-5; Klein J, 1998, SCAND J IMMUNOL, V47, P199; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Martinez A, 2005, REV INVEST CLIN, V57, P132; MacManes MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037562; MARELLO KL, 1995, ANIM GENET, V26, P345, DOI 10.1111/j.1365-2052.1995.tb02672.x; Miller HC, 2004, IMMUNOGENETICS, V56, P178, DOI 10.1007/s00251-004-0666-1; MURRAY BW, 1995, MOL BIOL EVOL, V12, P582; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nigenda-Morales S, 2008, J HERED, V99, P14, DOI 10.1093/jhered/esm087; Niranjan SK, 2010, VET IMMUNOL IMMUNOP, V138, P206, DOI 10.1016/j.vetimm.2010.07.014; Ortega D., 2009, THESIS; Otting N, 2002, IMMUNOGENETICS, V54, P230, DOI 10.1007/s00251-002-0461-9; Pan D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r158; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sears R, 1990, SCA88ID23; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Swarbrick PA, 1997, ANIM GENET, V28, P49, DOI 10.1111/j.1365-2052.1997.00063.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TROWSDALE J, 1989, IMMUNOGENETICS, V29, P19, DOI 10.1007/BF02341609; Xu SX, 2009, J MOL EVOL, V69, P260, DOI 10.1007/s00239-009-9272-z; Xu SX, 2010, J MOL EVOL, V71, P6, DOI 10.1007/s00239-010-9357-8; Yang G, 2005, J HERED, V96, P310, DOI 10.1093/jhered/esi055; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	51	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0141296	10.1371/journal.pone.0141296	http://dx.doi.org/10.1371/journal.pone.0141296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761201	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100001
J	Neira, V; Rabinowitz, P; Rendahl, A; Paccha, B; Gibbs, SG; Torremorell, M				Neira, Victor; Rabinowitz, Peter; Rendahl, Aaron; Paccha, Blanca; Gibbs, Shawn G.; Torremorell, Montserrat			Characterization of Viral Load, Viability and Persistence of Influenza A Virus in Air and on Surfaces of Swine Production Facilities	PLOS ONE			English	Article							ORAL FLUID SAMPLES; UNITED-STATES; TRANSMISSION; PIGS; INFECTION; SURVEILLANCE; POPULATIONS; OUTBREAK; WORKERS; HUMANS	Indirect transmission of influenza A virus (IAV) in swine is poorly understood and information is lacking on levels of environmental exposure encountered by swine and people during outbreaks of IAV in swine barns. We characterized viral load, viability and persistence of IAV in air and on surfaces during outbreaks in swine barns. IAV was detected in pigs, air and surfaces from five confirmed outbreaks with 48% (47/98) of oral fluid, 38% (32/84) of pen railing and 43% (35/82) of indoor air samples testing positive by IAV RT-PCR. IAV was isolated from air and oral fluids yielding a mixture of subtypes (H1N1, H1N2 and H3N2). Detection of IAV RNA from air was sustained during the outbreaks with maximum levels estimated between 7 and 11 days from reported onset. Our results indicate that during outbreaks of IAV in swine, aerosols and surfaces in barns contain significant levels of IAV potentially representing an exposure hazard to both swine and people.	[Neira, Victor; Rendahl, Aaron; Torremorell, Montserrat] Univ Minnesota, St Paul, MN 55108 USA; [Neira, Victor] Univ Chile, Santiago, Chile; [Rabinowitz, Peter] Univ Washington, Seattle, WA 98195 USA; [Paccha, Blanca] Yale Univ, New Haven, CT USA; [Gibbs, Shawn G.] Indiana Univ, Bloomington, IN USA	University of Minnesota System; University of Minnesota Twin Cities; Universidad de Chile; University of Washington; University of Washington Seattle; Yale University; Indiana University System; Indiana University Bloomington	Torremorell, M (corresponding author), Univ Minnesota, St Paul, MN 55108 USA.	torr0033@umn.edu	Ramirez, Victor Manuel Neira/M-8736-2013; Gibbs, Shawn G/S-1568-2019	Ramirez, Victor Manuel Neira/0000-0001-9062-9969; Gibbs, Shawn G/0000-0002-6041-5166; Rendahl, Aaron/0000-0001-5434-3592	National Pork Board	National Pork Board	Funding was provided by the National Pork Board. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067293; [Anonymous], 2007, MONITORAMENTOS SANIT; [Anonymous], 2008, R PROJECT STAT COMPU; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Choi MJ, 2015, CLIN INFECT DIS, V61, P1355, DOI 10.1093/cid/civ618; Corzo CA, 2014, TRANSBOUND EMERG DIS, V61, P28, DOI 10.1111/j.1865-1682.2012.01367.x; Corzo CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071444; Corzo CA, 2013, EMERG INFECT DIS, V19, P954, DOI 10.3201/eid1906.121637; Dee S, 2009, VET RES, V40, DOI 10.1051/vetres/2009022; Detmer S, 2013, CURR TOP MICROBIOL, V370, P85, DOI 10.1007/82_2012_220; Detmer SE, 2011, J VET DIAGN INVEST, V23, P241, DOI 10.1177/104063871102300207; Forgie SE, 2011, CLIN INFECT DIS, V52, P10, DOI 10.1093/cid/ciq030; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Irwin CK, 2011, APPL ENVIRON MICROB, V77, P1049, DOI 10.1128/AEM.02733-09; Jhung MA, 2013, CLIN INFECT DIS, V57, P1703, DOI 10.1093/cid/cit649; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; Loeffen WLA, 2011, VET MICROBIOL, V152, P304, DOI 10.1016/j.vetmic.2011.05.027; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Nelson MI, 2014, J VIROL, V88, P10110, DOI 10.1128/JVI.01080-14; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; Prickett J, 2008, J VET DIAGN INVEST, V20, P156, DOI 10.1177/104063870802000203; Romagosa A, 2012, INFLUENZA OTHER RESP, V6, P110, DOI 10.1111/j.1750-2659.2011.00276.x; SCHULMAN JL, 1967, J EXP MED, V125, P479, DOI 10.1084/jem.125.3.479; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Yee KS, 2009, AVIAN PATHOL, V38, P59, DOI 10.1080/03079450802632023; Zhang JQ, 2014, METHODS MOL BIOL, V1161, P277, DOI 10.1007/978-1-4939-0758-8_23; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	35	29	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146616	10.1371/journal.pone.0146616	http://dx.doi.org/10.1371/journal.pone.0146616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757362	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888800021
J	Sellens, E; Norris, JM; Dhand, NK; Heller, J; Hayes, L; Gidding, HF; Willaby, H; Wood, N; Bosward, KL				Sellens, Emily; Norris, Jacqueline M.; Dhand, Navneet K.; Heller, Jane; Hayes, Lynne; Gidding, Heather F.; Willaby, Harold; Wood, Nicholas; Bosward, Katrina L.			Q Fever Knowledge, Attitudes and Vaccination Status of Australia's Veterinary Workforce in 2014	PLOS ONE			English	Article							COXIELLA-BURNETII INFECTION; LONG-TERM PERSISTENCE; GOAT FARMS; DISEASE; HEALTH; CATS; SEROPREVALENCE; PREGNANCY; SAMPLES; RISKS	Q fever, caused by Coxiella burnetii, is a serious zoonotic disease in humans with a worldwide distribution. Many species of animals are capable of transmitting C. burnetii, and consequently all veterinary workers are at risk for this disease. An effective Q fever vaccine has been readily available and used in Australia for many years in at-risk groups, and the European Centre for Disease Prevention and Control has recently also called for the use of this vaccine among at-risk groups in Europe. Little is known about attitudes towards this vaccine and vaccine uptake in veterinary workers. This study aimed to determine the Q fever vaccination status of veterinarians and veterinary nurses in Australia and to assess and compare the knowledge and attitudes towards Q fever disease and vaccination of each cohort. An online cross-sectional survey performed in 2014 targeted all veterinarians and veterinary nurses in Australia. Responses from 890 veterinarians and 852 veterinary nurses were obtained. Binary, ordinal and multinomial logistic regression were used to make comparisons between the two cohorts. The results showed that 74% of veterinarians had sought vaccination compared to only 29% of veterinary nurses. Barriers to vaccination among those not vaccinated did not differ between cohorts, and included a lack of perceived risk, financial expense, time constraints, and difficulty in finding a vaccine provider. Poor knowledge and awareness of Q fever disease and vaccination were additional and notable barriers for the veterinary nursing cohort, suggesting veterinary clinics and veterinarians may not be meeting their legal responsibility to educate staff about risks and risk prevention. Further evaluation is needed to identify the drivers behind seeking and recommending vaccination so that recommendations can be made to improve vaccine uptake.	[Sellens, Emily; Norris, Jacqueline M.; Dhand, Navneet K.; Bosward, Katrina L.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Heller, Jane; Hayes, Lynne] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW 2678, Australia; [Gidding, Heather F.; Wood, Nicholas] Natl Ctr Immunisat Res & Surveillance, Westmead, NSW 2145, Australia; [Gidding, Heather F.] Univ New S Wales, UNSW Med, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; [Willaby, Harold] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Wood, Nicholas] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Sydney; Charles Sturt University; University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney	Sellens, E (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	esel3722@uni.sydney.edu.au; katrina.bosward@sydney.edu.au	Willaby, Harold W/Q-6530-2016; Heller, Jane/H-9596-2016; Dhand, Navneet K/H-5762-2019; Bosward, Katrina/ABF-5091-2020	Willaby, Harold W/0000-0003-3864-543X; Heller, Jane/0000-0003-3993-0160; Dhand, Navneet K/0000-0002-4362-3596; Bosward, Katrina/0000-0002-7561-2162; Hayes, Lynne/0000-0002-5172-0281; Norris, Jacqueline/0000-0002-0003-6930; Gidding, Heather/0000-0001-7595-9281	National Health and Medical Research Grant [1049558]; National Health and Medical Research early career research fellowship [1054350]	National Health and Medical Research Grant; National Health and Medical Research early career research fellowship	This study was fully funded by a National Health and Medical Research Grant (No: 1049558) 2012 (https://www.nhmrc.gov.au/). Heather Gidding is supported by a National Health and Medical Research early career research fellowship (No: 1054350) (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was fully funded by a National Health and Medical Research Grant (No: 1049558) 2012. Q fever: How common is it and how can we best prevent it? Research to inform Q fever vaccine policy in Australia and Internationally. Heather Gidding is supported by a National Health and Medical Research early career research fellowship.	Abe T, 2001, EUR J EPIDEMIOL, V17, P1029, DOI 10.1023/A:1020018907452; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; [Anonymous], 2011, GUID VET PERS BIOS; [Anonymous], 2012, AUSTR VET WORKF SURV; [Anonymous], 2014, ABS LAB FORC SURV VE; Armitage CJ, 2000, PSYCHOL HEALTH, V15, P173, DOI 10.1080/08870440008400299; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Australian Government Department of Health, 2013, AUSTR IMM HDB; Australian Veterinary Association, 2013, AUSTR VET WORKF SURV; Bosnjak E, 2010, CLIN MICROBIOL INFEC, V16, P1285, DOI 10.1111/j.1469-0691.2009.03062.x; Cairns K, 2007, J FELINE MED SURG, V9, P196, DOI 10.1016/j.jfms.2006.11.006; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Cooper A, 2011, AUST VET J, V89, P385, DOI 10.1111/j.1751-0813.2011.00819.x; de Rooij MMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032108; Denman J, 2009, INTERN MED J, V39, P479, DOI 10.1111/j.1445-5994.2009.01933.x; Dowd K, 2013, PREV VET MED, V111, P17, DOI 10.1016/j.prevetmed.2013.04.002; Fan WM, 2010, COMPUT HUM BEHAV, V26, P132, DOI 10.1016/j.chb.2009.10.015; Fenollar F, 2001, CLIN INFECT DIS, V33, P312, DOI 10.1086/321889; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Forland F, 2010, RISK ASSESSMENT Q FE; Gefenaite G, 2011, VACCINE, V29, P395, DOI 10.1016/j.vaccine.2010.11.008; Gibbons GC, 2014, ZOONOSES 2014; Gidding HF, 2009, VACCINE, V27, P2037, DOI 10.1016/j.vaccine.2009.02.007; Gikas A, 2010, EXPERT REV ANTI-INFE, V8, P529, DOI [10.1586/eri.10.29, 10.1586/ERI.10.29]; Guatteo R, 2006, VET RES, V37, P827, DOI 10.1051/vetres:2006038; Hofmann F, 2006, INFECTION, V34, P142, DOI 10.1007/s15010-006-5109-5; Hogerwerf L, 2012, APPL ENVIRON MICROB, V78, P5410, DOI 10.1128/AEM.00677-12; Hulur G, 2011, LEARN INDIVID DIFFER, V21, P742, DOI 10.1016/j.lindif.2011.09.006; Jeyaretnam J, 2000, AUST VET J, V78, P625, DOI 10.1111/j.1751-0813.2000.tb11939.x; Kersh GJ, 2013, APPL ENVIRON MICROB, V79, P1697, DOI 10.1128/AEM.03472-12; Komiya T, 2003, J VET MED SCI, V65, P1047, DOI 10.1292/jvms.65.1047; Komiya Tomoyoshi, 2003, Journal of Infection and Chemotherapy, V9, P151; Kopecny L, 2013, J FELINE MED SURG, V15, P1037, DOI 10.1177/1098612X13487360; KOSATSKY T, 1984, LANCET, V2, P1447; Landais C, 2007, EUR J CLIN MICROBIOL, V26, P341, DOI 10.1007/s10096-007-0285-5; Langley JM, 2003, AM J OBSTET GYNECOL, V189, P228, DOI 10.1067/mob.2003.448; Lipton BA, 2008, JAVMA-J AM VET MED A, V233, P1242, DOI 10.2460/javma.233.8.1242; Marmion B, 2007, MED J AUSTRALIA, V186, P164, DOI 10.5694/j.1326-5377.2007.tb00853.x; Marmion BP, 2005, QJM-INT J MED, V98, P7, DOI 10.1093/qjmed/hci009; Marrie TJ, 2010, INFECT DIS CLIN N AM, V24, P27, DOI 10.1016/j.idc.2009.10.004; MARRIE TJ, 1988, J INFECT DIS, V158, P101, DOI 10.1093/infdis/158.1.101; MARRIE TJ, 1989, EPIDEMIOL INFECT, V102, P119, DOI 10.1017/S0950268800029757; Massey PD, 2009, COMMUN DIS INTELL, V33, P41; Maywood P, 2011, Q FEVER SMALL ANIMAL, P4; MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981; Milazzo A, 2005, COMMUN DIS INTELL, V29, P400; Munckhof WJ, 2007, INTERN MED J, V37, P775, DOI 10.1111/j.1445-5994.2007.01489.x; Raoult D, 2002, ARCH INTERN MED, V162, P701, DOI 10.1001/archinte.162.6.701; Roest HIJ, 2013, EMERG INFECT DIS, V19, P834, DOI 10.3201/eid1905.121489; Dinelli MIS, 2009, AM J INFECT CONTROL, V37, P858, DOI 10.1016/j.ajic.2009.04.283; Shapiro AJ, 2015, VET MICROBIOL, V177, P154, DOI 10.1016/j.vetmic.2015.02.011; Shirangi A, 2007, AUST VET J, V85, P32, DOI 10.1111/j.1751-0813.2006.00077.x; Snow J., 2005, Northwest Public Health, V22, P22; SPELMAN DW, 1982, MED J AUSTRALIA, V1, P547, DOI 10.5694/j.1326-5377.1982.tb124169.x; St Leonards NSW, 2014, AUSTR VET WORKF SURV; Sukocheva OA, 2010, QJM-INT J MED, V103, P847, DOI 10.1093/qjmed/hcq113; Tozer SJ, 2014, ZOONOSES PUBLIC HLTH, V61, P105, DOI 10.1111/zph.12051; Tozer SJ, 2011, EUR J CLIN MICROBIOL, V30, P1287, DOI 10.1007/s10096-011-1225-y; Van Soest EM, 2004, AUST VET J, V82, P346, DOI 10.1111/j.1751-0813.2004.tb11101.x; WEBSTER JP, 1995, PARASITOLOGY, V110, P31, DOI 10.1017/S0031182000081014; WEINSTEIN ND, 1992, HEALTH PSYCHOL, V11, P170, DOI 10.1037/0278-6133.11.3.170; Whitney EAS, 2009, CLIN INFECT DIS, V48, P550, DOI 10.1086/596705; Wildman MJ, 2002, QJM-INT J MED, V95, P527, DOI 10.1093/qjmed/95.8.527; Willeberg P, 1937, AM J EPIDEMIOL, V111, P437; Wright JG, 2008, JAVMA-J AM VET MED A, V232, P1863, DOI 10.2460/javma.232.12.1863	65	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146819	10.1371/journal.pone.0146819	http://dx.doi.org/10.1371/journal.pone.0146819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CG	26756210	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888800032
J	Tseng, YH; Lin, YH; Tseng, YC; Lee, YC; Wu, YC; Hsu, WH; Yen, SH; Whang-Peng, J; Chen, YM				Tseng, Yen-Han; Lin, Yi-Hsuan; Tseng, Yen-Chiang; Lee, Yu-Chin; Wu, Yu-Chung; Hsu, Wen-Hu; Yen, Sang-Hue; Whang-Peng, Jacqueline; Chen, Yuh-Min			Adjuvant Therapy for Thymic Carcinoma - A Decade of Experience in a Taiwan National Teaching Hospital	PLOS ONE			English	Article							PHASE-II; CHEMOTHERAPY; CARBOPLATIN; OUTCOMES; VINCRISTINE; DOXORUBICIN; CISPLATIN; THYMOMA	Background Thymic carcinomas are rare tumors for which surgical resection is the first treatment of choice. The role of adjuvant treatment after surgery is unknown because of limited available data. The present study evaluated the efficacy of post-surgery adjuvant chemotherapy or radiotherapy in patients with thymic carcinoma. Methods To evaluate the role of adjuvant therapy in patients with thymic carcinoma, we retrospectively reviewed the records of patients with thymic carcinoma who were diagnosed and treated between 2004 and 2014. Results Among 78 patients with thymic carcinoma, 30 patients received surgical resection. Progression-free survival (PFS) and overall survival (OS) were significantly longer among these patients than among patients who received other treatments (PFS: 88.4 months vs 9.1 months, p<0.001; OS: 134.9 months vs 60.9 months; p = 0.003). Patients with stage III thymic carcinoma who received surgery had a longer OS than patients who did not receive surgery (70.1 months vs 23.9 months; p = 0.017, n = 11). Among 47 patients with stage IV carcinoma, 12 patients who received an extended thymothymectomy had a longer PFS than 35 patients who did not receive surgery (18.9 months vs 8.7 months; p = 0.029). Among 30 patients (with stage I-IV carcinoma) who received primary lesion surgery, 19 patients received an R0 resection and 9 patients of the 19 patients received adjuvant radiotherapy. These patients had longer PFS (50.3 months) than 2 patients who received adjuvant chemotherapy (5.9 months) or 4 patients who received concurrent chemoradiotherapy (7.5 months) after surgery (p = 0.003). Conclusions Surgical resection should be considered for patients with thymic carcinoma, even for patients with locally advanced or stage IV carcinoma. Adjuvant radiotherapy resulted in a better PFS after R0 resection.	[Tseng, Yen-Han; Chen, Yuh-Min] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Tseng, Yen-Han; Tseng, Yen-Chiang; Chen, Yuh-Min] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lin, Yi-Hsuan] Taipei Hosp, Minist Hlth & Welf, Dept Family Med, New Taipei, Taiwan; [Tseng, Yen-Chiang] Kaohsiung Vet Gen Hosp, Pingtung Branch, Dept Surg, Pingtung, Taiwan; [Lee, Yu-Chin] Sijhih Cathay Gen Hosp, New Taipei, Taiwan; [Wu, Yu-Chung; Hsu, Wen-Hu] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Yen, Sang-Hue] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Whang-Peng, Jacqueline; Chen, Yuh-Min] Taipei Med Univ, Taipei Canc Ctr, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; Cathay General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Medical University	Chen, YM (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.	ymchen@vghtpe.gov.tw						Agatsuma T, 2011, J THORAC ONCOL, V6, P2130, DOI 10.1097/JTO.0b013e31822e71c0; Ahmad U, 2015, J THORAC CARDIOV SUR, V149, P95, DOI 10.1016/j.jtcvs.2014.09.124; de Jong WK, 2008, EUR J CANCER, V44, P123, DOI 10.1016/j.ejca.2007.11.004; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ettinger DS, 2014, J NATL COMPR CANC NE, V12, P1738, DOI 10.6004/jnccn.2014.0176; Ettinger DS, 2013, J NATL COMPR CANC NE, V11, P562, DOI 10.6004/jnccn.2013.0072; Hirai F, 2015, ANN ONCOL, V26, P363, DOI 10.1093/annonc/mdu541; Inoue A, 2014, J THORAC ONCOL, V9, P1805, DOI 10.1097/JTO.0000000000000362; Kawasaki H, 2014, EJSO-EUR J SURG ONC, V40, P1151, DOI 10.1016/j.ejso.2014.03.006; Liu HC, 2002, ANN THORAC SURG, V73, P1076, DOI 10.1016/S0003-4975(01)03607-4; Okereke IC, 2012, ANN THORAC SURG, V93, P1668, DOI 10.1016/j.athoracsur.2012.01.014; Okuma Y, 2015, J CANCER RES CLIN, V141, P323, DOI 10.1007/s00432-014-1800-6; Sakai M, 2013, J THORAC DIS, V5, P161, DOI 10.3978/j.issn.2072-1439.2013.01.06; Song Z, 2014, EJSO-EUR J SURG ONC, V40, P1523, DOI 10.1016/j.ejso.2014.05.011; Venuta F, 2003, ANN THORAC SURG, V76, P1866, DOI 10.1016/S0003-4975(03)01020-8; Venuta F, 2012, GEN THORAC CARDIOVAS, V60, P1, DOI 10.1007/s11748-011-0814-0; Weksler B, 2013, ANN THORAC SURG, V95, P299, DOI 10.1016/j.athoracsur.2012.09.006; Yano M, 2008, J THORAC ONCOL, V3, P265, DOI 10.1097/JTO.0b013e3181653c71	18	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146609	10.1371/journal.pone.0146609	http://dx.doi.org/10.1371/journal.pone.0146609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757052	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800019
J	Wang, MY; Ruckstuhl, KE; Xu, WX; Blank, D; Yang, WK				Wang, Mu-Yang; Ruckstuhl, Kathreen E.; Xu, Wen-Xuan; Blank, David; Yang, Wei-Kang			Human Activity Dampens the Benefits of Group Size on Vigilance in Khulan (Equus hemionus) in Western China	PLOS ONE			English	Article							FLOCK SIZE; BEHAVIOR; PREDATION; DISTURBANCE; TOLERANCE; RESPONSES; XINJIANG; ECOLOGY; RISK	Animals receive anti-predator benefits from social behavior. As part of a group, individuals spend less time being vigilant, and vigilance decreases with increasing group size. This phenomenon, called "the many-eyes effect", together with the "encounter dilution effect", is considered among the most important factors determining individual vigilance behavior. However, in addition to group size, other social and environmental factors also influence the degree of vigilance, including disturbance from human activities. In our study, we examined vigilance behavior of Khulans (Equus hemionus) in the Xinjiang Province in western China to test whether and how human disturbance and group size affect vigilance. According to our results, Khulan showed a negative correlation between group size and the percentage time spent vigilant, although this negative correlation depended on the groups' disturbance level. Khulan in the more disturbed area had a dampened benefit from increases in group size, compared to those in the undisturbed core areas. Provision of continuous areas of high-quality habitat for Khulans will allow them to form larger undisturbed aggregations and to gain foraging benefits through reduced individual vigilance, as well as anti-predator benefits through increased probability of predator detection.	[Wang, Mu-Yang; Xu, Wen-Xuan; Blank, David; Yang, Wei-Kang] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresources Arid Land, Urumqi 830011, Xinjiang, Peoples R China; [Ruckstuhl, Kathreen E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Ruckstuhl, Kathreen E.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; University of Calgary; University of Cambridge	Yang, WK (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresources Arid Land, Urumqi 830011, Xinjiang, Peoples R China.	yangwk@ms.xjb.ac.cn	Ruckstuhl, Kathreen Eva/B-4469-2013	Ruckstuhl, Kathreen/0000-0002-2949-242X	National Natural Science Foundation of China [U1303301, 31401988]; West Light Foundation of the Chinese Academy of Sciences [XBBS201308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China under grant U1303301, 31401988; and the West Light Foundation of the Chinese Academy of Sciences under grant XBBS201308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Benhaiem S, 2008, ANIM BEHAV, V76, P611, DOI 10.1016/j.anbehav.2008.03.012; BURGER J, 1991, ENVIRON CONSERV, V18, P158, DOI 10.1017/S0376892900021743; Caro TM, 1999, BIOL CONSERV, V91, P91, DOI 10.1016/S0006-3207(99)00033-6; Chu H.J., 2009, BIODIVERS SCI, V17, P414; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; CRESSWELL W, 1994, ANIM BEHAV, V47, P433, DOI 10.1006/anbe.1994.1057; Dias RI, 2006, BEHAV PROCESS, V73, P248, DOI 10.1016/j.beproc.2006.06.002; Duchesne M, 2000, BIOL CONSERV, V96, P311, DOI 10.1016/S0006-3207(00)00082-3; Dyck MG, 2004, BIOL CONSERV, V116, P343, DOI 10.1016/S0006-3207(03)00204-0; Feh C, 2001, BIOL CONSERV, V101, P51, DOI 10.1016/S0006-3207(01)00051-9; Fernandez-Juricic E, 2003, APPL ANIM BEHAV SCI, V84, P219, DOI 10.1016/j.applanim.2003.08.004; Frid A, 2002, CONSERV ECOL, V6; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Jayakody S, 2008, WILDLIFE BIOL, V14, P81, DOI 10.2981/0909-6396(2008)14[81:RDCEVB]2.0.CO;2; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Manor R, 2003, ECOL APPL, V13, P1830, DOI 10.1890/01-5354; Moehlman PD, IUCN RED LIST THREAT; Papouchis CM, 2001, J WILDLIFE MANAGE, V65, P573, DOI 10.2307/3803110; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; Randler C, 2006, EUR J WILDLIFE RES, V52, P265, DOI 10.1007/s10344-006-0049-z; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; WALTHER FR, 1969, BEHAVIOUR, V34, P184, DOI 10.1163/156853969X00053; Wang Z, 2011, BIOL CONSERV, V144, P101, DOI 10.1016/j.biocon.2010.06.025; Xia CJ, 2014, BIOL CONSERV, V177, P142, DOI 10.1016/j.biocon.2014.06.021; Xia CJ, 2013, PAK J ZOOL, V45, P1241; Yasue M, 2005, J ETHOL, V23, P199, DOI 10.1007/s10164-005-0152-8; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132094	33	12	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146725	10.1371/journal.pone.0146725	http://dx.doi.org/10.1371/journal.pone.0146725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756993	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800028
J	Carrea, A; Diambra, L				Carrea, Alejandra; Diambra, Luis			Systems Biology Approach to Model the Life Cycle of Trypanosoma cruzi	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; CLUSTERING GENE-EXPRESSION; NETWORK INFERENCE; REGULATORY NETWORK; TRANS-SIALIDASE; CELL FATE; LANDSCAPES; INHIBITORS; STABILITY; MECHANISM	Due to recent advances in reprogramming cell phenotypes, many efforts have been dedicated to developing reverse engineering procedures for the identification of gene regulatory networks that emulate dynamical properties associated with the cell fates of a given biological system. In this work, we propose a systems biology approach for the reconstruction of the gene regulatory network underlying the dynamics of the Trypanosoma cruzi's life cycle. By means of an optimisation procedure, we embedded the steady state maintenance, and the known phenotypic transitions between these steady states in response to environmental cues, into the dynamics of a gene network model. In the resulting network architecture we identified a small subnetwork, formed by seven interconnected nodes, that controls the parasite's life cycle. The present approach could be useful for better understanding other single cell organisms with multiple developmental stages.	[Carrea, Alejandra; Diambra, Luis] Univ Nacl La Plata, Ctr Reg Estudios Genom, RA-1900 La Plata, Buenos Aires, Argentina	National University of La Plata	Diambra, L (corresponding author), Univ Nacl La Plata, Ctr Reg Estudios Genom, RA-1900 La Plata, Buenos Aires, Argentina.	ldiambra@gmail.com	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880				Akutsu T, 1999, PAC S BIOC, P17, DOI [10.1142/9789814447300_0003, DOI 10.1142/9789814447300_0003]; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; BISHOP CM, 1995, NEURAL COMPUT, V7, P108, DOI 10.1162/neco.1995.7.1.108; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Buschiazzo A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002474; Carvalho ST, 2010, GLYCOBIOLOGY, V20, P1034, DOI 10.1093/glycob/cwq065; Cruz MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051804; D'haeseleer P, 1999, Pac Symp Biocomput, P41; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Diambra L, 2008, PHYSICA A, V387, P2187, DOI 10.1016/j.physa.2007.12.006; Diambra L, 2011, PHYSICA A, V390, P2198, DOI 10.1016/j.physa.2011.02.021; Farkas I, 2003, PHYSICA A, V318, P601, DOI 10.1016/S0378-4371(02)01731-4; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Giordano R, 1999, J BIOL CHEM, V274, P3461, DOI 10.1074/jbc.274.6.3461; Good PI, 2008, COMMON ERRORS STAT A; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059434; Henry A, 2013, MOL BIOSYST, V9, P1726, DOI 10.1039/c3mb25562j; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Johnson CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040614; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Lang AH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003734; Li CH, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0787; Li CH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003165; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Mar JC, 2011, BIOINFORMATICS, V27, P1094, DOI 10.1093/bioinformatics/btr074; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2007, ANN NY ACAD SCI, V1115, P51, DOI 10.1196/annals.1407.019; Michailidis G, 2013, MATH BIOSCI, V246, P326, DOI 10.1016/j.mbs.2013.10.003; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Molinelli EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003290; Moody TN, 2000, FEBS LETT, V470, P305, DOI 10.1016/S0014-5793(00)01347-8; Nde PN, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00337; Nde PN, 2010, CHEM BIODIVERS, V7, P1051, DOI 10.1002/cbdv.200900320; Neres J, 2009, BIOORG MED CHEM LETT, V19, P589, DOI 10.1016/j.bmcl.2008.12.065; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, P NATL ACAD SCI USA, V107, P8195, DOI 10.1073/pnas.0910331107; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Zhou JX, 2011, TRENDS GENET, V27, P55, DOI 10.1016/j.tig.2010.11.002; Zhou JX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019798, 10.1371/journal.pone.0014752, 10.1371/journal.pone.0024340]; Zur RM, 2009, MED PHYS, V36, P4810, DOI 10.1118/1.3213517	49	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146947	10.1371/journal.pone.0146947	http://dx.doi.org/10.1371/journal.pone.0146947			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752404	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100183
J	Chaykovska, L; Heunisch, F; von Einem, G; Alter, ML; Hocher, CF; Tsuprykov, O; Dschietzig, T; Kretschmer, A; Hocher, B				Chaykovska, Lyubov; Heunisch, Fabian; von Einem, Gina; Alter, Markus L.; Hocher, Carl-Friedrich; Tsuprykov, Oleg; Dschietzig, Thomas; Kretschmer, Axel; Hocher, Berthold			Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; MOLECULE-1 KIM-1; EARLY-DIAGNOSIS; FAILURE	Background Vitamin-D-binding protein (VDBP) is a low molecular weight protein that is filtered through the glomerulus as a 25-(OH) vitamin D 3/VDBP complex. In the normal kidney VDBP is reabsorbed and catabolized by proximal tubule epithelial cells reducing the urinary excretion to trace amounts. Acute tubular injury is expected to result in urinary VDBP loss. The purpose of our study was to explore the potential role of urinary VDBP as a biomarker of an acute renal damage. Method We included 314 patients with diabetes mellitus or mild renal impairment undergoing coronary angiography and collected blood and urine before and 24 hours after the CM application. Patients were followed for 90 days for the composite endpoint major adverse renal events (MARE: need for dialysis, doubling of serum creatinine after 90 days, unplanned emergency rehospitalization or death). Results Increased urine VDBP concentration 24 hours after contrast media exposure was predictive for dialysis need (no dialysis: 113.06 +/- 299.61ng/ml, n = 303; need for dialysis: 613.07 +/- 700.45 ng/ml, n = 11, Mean +/- SD, p < 0.001), death (no death during follow-up: 121.41 +/- 324.45 ng/ml, n = 306; death during follow-up: 522.01 +/- 521.86 ng/ml, n = 8; Mean +/- SD, p < 0.003) and MARE (no MARE: 112.08 +/- 302.00ng/ml, n = 298; MARE: 506.16 +/- 624.61 ng/ml, n = 16, Mean +/- SD, p < 0.001) during the follow-up of 90 days after contrast media exposure. Correction of urine VDBP concentrations for creatinine excretion confirmed its predictive value and was consistent with increased levels of urinary Kidney Injury Molecule1 (KIM-1) and baseline plasma creatinine in patients with above mentioned complications. The impact of urinary VDBP and KIM-1 on MARE was independent of known CIN risk factors such as anemia, preexisting renal failure, preexisting heart failure, and diabetes. Conclusions Urinary VDBP is a promising novel biomarker of major contrast induced nephropathy-associated events 90 days after contrast media exposure.	[Chaykovska, Lyubov; Heunisch, Fabian; von Einem, Gina; Alter, Markus L.; Hocher, Carl-Friedrich; Tsuprykov, Oleg] Charite, Ctr Cardiovasc Res, D-13353 Berlin, Germany; [Chaykovska, Lyubov] Univ Zurich Hosp, Dept Vasc Surg, CH-8091 Zurich, Switzerland; [Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Dschietzig, Thomas] Immundiagnostik AG, Bensheim, Germany; [Dschietzig, Thomas] Charite, Dept Cardiol & Angiol, D-13353 Berlin, Germany; [Kretschmer, Axel] Bayer Pharma AG, Wuppertal, Germany; [Hocher, Berthold] IFLb Lab Med Berlin GmbH, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; University Zurich Hospital; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bayer AG; Bayer Healthcare Pharmaceuticals	Hocher, B (corresponding author), Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.	hocher@uni-potsdam.de	Hocher, Berthold/AAC-3510-2020	Dschietzig, Thomas Bernd/0000-0003-1186-8713; Hocher, Berthold/0000-0001-8143-0579; Chaykovska, Lyubov/0000-0002-6250-4007	Bayer Pharma AG, Wuppertal, Germany	Bayer Pharma AG, Wuppertal, Germany	Bayer Pharma AG, Wuppertal, Germany provided measurements of KIM-1 and VDBP in urine as well as salary for author [AK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these author is articulated in the Author Contributions section.	Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Doorenbos CRC, 2012, J STEROID BIOCHEM, V128, P56, DOI 10.1016/j.jsbmb.2011.09.002; Doorenbos CRC, 2009, NAT REV NEPHROL, V5, P691, DOI 10.1038/nrneph.2009.185; Han WK, 2008, KIDNEY INT, V73, P863, DOI 10.1038/sj.ki.5002715; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Kwon SH, 2013, CLIN EXP NEPHROL, V17, P359, DOI 10.1007/s10157-012-0707-2; Lattanzio MR, 2009, J AM OSTEOPATH ASSOC, V109, P13; Leaf DE, CLIN ENDOCRINOL OXF, V79, P491; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Little Brown and Company, 1994, NOM CRIT DIAGN DIS H, P253; Luo Q, 2013, CLIN NEPHROL, V79, P85, DOI 10.5414/CN106852; Mahadevappa R, 2013, AM J PHYSL RENAL PHY, V6; Malard V, 2009, BBA-PROTEINS PROTEOM, V1794, P882, DOI 10.1016/j.bbapap.2009.01.010; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Mehta RL, 2003, J AM SOC NEPHROL, V14, P2178, DOI 10.1097/01.ASN.0000079042.13465.1A; Mirkovic K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055887; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Parikh CR, 2013, CLIN J AM SOC NEPHRO, V8, P1079, DOI 10.2215/CJN.10971012; RACUSEN L C, 1986, Toxicologic Pathology, V14, P45; Thrailkill KM, 2011, J CLIN ENDOCR METAB, V96, P142, DOI 10.1210/jc.2010-0980; Tian XQ, 2014, EXP THER MED, V7, P411, DOI 10.3892/etm.2013.1426; Trummer O, 2013, CLIN CHEM, V59, P793, DOI 10.1373/clinchem.2012.193185; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; Wagener G, 2008, AM J NEPHROL, V28, P576, DOI 10.1159/000115973; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Wong PCY, 2012, INT J CARDIOL, V158, P186, DOI 10.1016/j.ijcard.2011.06.115	33	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145723	10.1371/journal.pone.0145723	http://dx.doi.org/10.1371/journal.pone.0145723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751954	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100025
J	Datta, D; Khatri, P; Banerjee, C; Singh, A; Meena, R; Saha, DR; Raman, R; Rajamani, P; Mitra, A; Mazumder, S				Datta, Debika; Khatri, Preeti; Banerjee, Chaitali; Singh, Ambika; Meena, Ramavatar; Saha, Dhira Rani; Raman, Rajagopal; Rajamani, Paulraj; Mitra, Abhijit; Mazumder, Shibnath			Calcium and Superoxide-Mediated Pathways Converge to Induce Nitric Oxide-Dependent Apoptosis in Mycobacterium fortuitum-Infected Fish Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-C; NF-KAPPA-B; SIGNALING PATHWAY; TNF-ALPHA; MURINE MACROPHAGES; PKC-ALPHA; TUBERCULOSIS; ACTIVATION; ERK1/2	Mycobacterium fortuitum causes 'mycobacteriosis' in wide range of hosts although the mechanisms remain largely unknown. Here we demonstrate the role of calcium (Ca+2)-signalling cascade on M. fortuitum-induced apoptosis in headkidney macrophages (HKM) of Clarias sp. M. fortuitum could trigger intracellular-Ca+2 influx leading to the activation of calmodulin (CaM), protein kinase C alpha (PKC alpha) and Calmodulin kinase II gamma (CaMKIIg). Gene silencing and inhibitor studies established the role of CaM in M. fortuitum pathogenesis. We noted that CaMKIIg activation is regulated by CaM as well as PKC alpha-dependent superoxide anions. This is altogether first report of oxidised CaMKIIg in mycobacterial infections. Our studies with targeted-siRNA and pharmacological inhibitors implicate CaMKIIg to be pro-apoptotic and critical for the activation of extra-cellular signal regulated kinase 1/2 (ERK1/2). Inhibiting the ERK1/2 pathway attenuated nitric oxide synthase 2 (NOS2)-induced nitric oxide (NO) production. Conversely, inhibiting the NOS2-NO axis by specific-siRNA and inhibitors down-regulated ERK1/2 activation suggesting the crosstalk between ERK1/2 and NO is essential for pathogenesis induced by the bacterium. Silencing the NOS2-NO axis enhanced intracellular bacterial survival and attenuated caspase-8 mediated activation of caspase-3 in the infected HKM. Our findings unveil hitherto unknown mechanism of M. fortuitum pathogenesis. We propose that M. fortuitum triggers intracellular Ca+2 elevations resulting in CaM activation and PKC alpha-mediated superoxide generation. The cascade converges in common pathway mediated by CaMKIIg resulting in the activation of ERK1/2-NOS2 axis. The crosstalk between ERK1/2 and NO shifts the balance in favour of caspase dependent apoptosis of M. fortuitum-infected HKM.	[Datta, Debika; Khatri, Preeti; Banerjee, Chaitali; Mazumder, Shibnath] Univ Delhi, Dept Zool, Immunobiol Lab, Delhi 110007, India; [Singh, Ambika; Raman, Rajagopal] Univ Delhi, Dept Zool, Gut Biol Lab, Delhi 110007, India; [Meena, Ramavatar; Rajamani, Paulraj] Jawaharlal Nehru Univ, Sch Environm Sci, Delhi, India; [Saha, Dhira Rani] Natl Inst Cholera & Enter Dis, Microscopy Lab, Kolkata, India; [Mitra, Abhijit] Indian Vet Res Inst, Anim Div, Genome Anal Lab, Izatnagar, Bareilly, India	University of Delhi; University of Delhi; Jawaharlal Nehru University, New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Mazumder, S (corresponding author), Univ Delhi, Dept Zool, Immunobiol Lab, Delhi 110007, India.	shibnath1@yahoo.co.in	Mitra, Abhijit/W-6278-2019	Mitra, Abhijit/0000-0003-4011-2579; MEENA, RAMOVATAR/0000-0002-3703-3274	National Funded for Basic, Strategic and Frontier Application Reseacrh in Agriculture /Indian Council of Agricultural Research Project Grant [RNAi-2014]; University of Delhi [(R)/RD/2012/917]; Indian Council of Agricultural Research Fellowship Govt of India; Council of Scientific and Industrial Research Fellowship; Department of Science and Technology-Innovation in Science Pursuit for Inspired Research Fellowship; University Grants Commission Fellowship; ICAR Fellowship (Govt of India); CSIR Fellowship (Govt of India); DST-INSPIRE Fellowship (Govt of India); UGC Fellowship (Govt of India)	National Funded for Basic, Strategic and Frontier Application Reseacrh in Agriculture /Indian Council of Agricultural Research Project Grant; University of Delhi(University of Delhi); Indian Council of Agricultural Research Fellowship Govt of India; Council of Scientific and Industrial Research Fellowship(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology-Innovation in Science Pursuit for Inspired Research Fellowship; University Grants Commission Fellowship(University Grants Commission, India); ICAR Fellowship (Govt of India); CSIR Fellowship (Govt of India)(Council of Scientific & Industrial Research (CSIR) - India); DST-INSPIRE Fellowship (Govt of India); UGC Fellowship (Govt of India)	This work was supported by National Funded for Basic, Strategic and Frontier Application Reseacrh in Agriculture /Indian Council of Agricultural Research Project Grant RNAi-2014 (SM, AM); University of Delhi Doctoral Research Programme, Dean (R)/R&D/2012/917 (SM); Indian Council of Agricultural Research Fellowship Govt of India (DD); Council of Scientific and Industrial Research Fellowship (PK); Department of Science and Technology-Innovation in Science Pursuit for Inspired Research Fellowship (CB); and University Grants Commission Fellowship (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors are grateful to S. Das, North Shore University Health system and T. Mazumder, Georgia Regents University for helpful discussions and critically analyzing the manuscript. The NOS2 antibody was kind gift from B. Ghosh, Institute of Genomics and Integrative Biology. We thank U. Rai, University of Delhi for the help in fluorescence microscopy, P. Arora for flowcytometry work and A. K. Pal for maintenance of fish. This work was supported by NFBSFARA/ICAR Project Grant (RNAi-2014) and University of Delhi Doctoral Research Programme, Dean (R)/R&D/2012/917. DD, PK, CB and AS were supported by ICAR Fellowship (Govt of India), CSIR Fellowship (Govt of India), DST-INSPIRE Fellowship (Govt of India), UGC Fellowship (Govt of India) respectively. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo JI, 2013, CELL MICROBIOL, V15, P1994, DOI 10.1111/cmi.12169; Arcila ML, 2007, CELL IMMUNOL, V249, P80, DOI 10.1016/j.cellimm.2007.11.006; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Banerjee C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004018; Banerjee C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05820; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Bhattacharyya A, 2002, FEMS IMMUNOL MED MIC, V34, P73, DOI 10.1111/j.1574-695X.2002.tb00605.x; Bohsali A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-237; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Cao JL, 2006, NEUROPHARMACOLOGY, V51, P315, DOI 10.1016/j.neuropharm.2006.03.028; Helguera-Repetto AC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/916521; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chaurasiya SK, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-271; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Choi JA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.489; Datta S, 2007, COMP BIOCHEM PHYS C, V145, P339, DOI 10.1016/j.cbpc.2007.01.005; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Du CG, 2006, AM J PHYSIOL-RENAL, V290, pF1044, DOI 10.1152/ajprenal.00341.2005; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Grayfer L, 2014, DEV COMP IMMUNOL, V43, P223, DOI 10.1016/j.dci.2013.08.003; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; Kashyap VK, 2012, J ANTIMICROB CHEMOTH, V67, P1188, DOI 10.1093/jac/dkr592; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lee SB, 2005, INFECT IMMUN, V73, P6499, DOI 10.1128/IAI.73.10.6499-6507.2005; Li L, 1997, J PHYSIOL-LONDON, V501, P17, DOI 10.1111/j.1469-7793.1997.017bo.x; Majumdar T, 2007, FISH SHELLFISH IMMUN, V23, P222, DOI 10.1016/j.fsi.2006.10.011; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Mendez-Samperio P, 2006, J INFECTION, V52, P147, DOI 10.1016/j.jinf.2005.02.027; Mendez-Samperio P, 2007, CELL IMMUNOL, V245, P111, DOI 10.1016/j.cellimm.2007.04.005; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Nhieu GT, 2004, BIOL CELL, V96, P93, DOI 10.1016/j.biocel.2003.10.006; O'Sullivan MP, 2007, INFECT IMMUN, V75, P1984, DOI 10.1128/IAI.01107-06; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Rojas M, 1997, J IMMUNOL, V159, P1352; Rojas M, 2000, J INFECT DIS, V182, P240, DOI 10.1086/315676; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Shukla S, 2013, FOLIA MICROBIOL, V58, P429, DOI 10.1007/s12223-013-0225-y; Smith MB, 2001, AM J CLIN PATHOL, V116, P225, DOI 10.1309/HF2V-E8WV-PX4Q-CHQH; Sorensen KK, 1997, J FISH DIS, V20, P93, DOI 10.1046/j.1365-2761.1997.d01-112.x; Spoida K, 2014, P NATL ACAD SCI USA, V111, P6479, DOI 10.1073/pnas.1321576111; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sun J, 2008, AM J PHYSIOL-CELL PH, V294, pC1586, DOI 10.1152/ajpcell.00129.2008; Sunagawa M, 2000, CARDIOVASC DRUG REV, V18, P211; Thamilselvan V, 2009, AM J PHYSIOL-RENAL, V297, pF1399, DOI 10.1152/ajprenal.00051.2009; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Yang CS, 2008, CELL MICROBIOL, V10, P741, DOI 10.1111/j.1462-5822.2007.01081.x; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	60	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146554	10.1371/journal.pone.0146554	http://dx.doi.org/10.1371/journal.pone.0146554			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752289	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100098
J	Griscom, BW; Ellis, PW; Baccini, A; Marthinus, D; Evans, JS; Ruslandi				Griscom, Bronson W.; Ellis, Peter W.; Baccini, Alessandro; Marthinus, Delon; Evans, Jeffrey S.; Ruslandi			Synthesizing Global and Local Datasets to Estimate Jurisdictional Forest Carbon Fluxes in Berau, Indonesia	PLOS ONE			English	Article							TROPICAL FORESTS; SOIL CARBON; EMISSIONS; BIOMASS; DEFORESTATION; IMPACT; STOCKS; MAP	Background Forest conservation efforts are increasingly being implemented at the scale of sub-national jurisdictions in order to mitigate global climate change and provide other ecosystem services. We see an urgent need for robust estimates of historic forest carbon emissions at this scale, as the basis for credible measures of climate and other benefits achieved. Despite the arrival of a new generation of global datasets on forest area change and biomass, confusion remains about how to produce credible jurisdictional estimates of forest emissions. We demonstrate a method for estimating the relevant historic forest carbon fluxes within the Regency of Berau in eastern Borneo, Indonesia. Our method integrates best available global and local datasets, and includes a comprehensive analysis of uncertainty at the regency scale. Principal Findings and Significance We find that Berau generated 8.91 +/- 1.99 million tonnes of net CO2 emissions per year during 2000-2010. Berau is an early frontier landscape where gross emissions are 12 times higher than gross sequestration. Yet most (85%) of Berau's original forests are still standing. The majority of net emissions were due to conversion of native forests to unspecified agriculture (43% of total), oil palm (28%), and fiber plantations (9%). Most of the remainder was due to legal commercial selective logging (17%). Our overall uncertainty estimate offers an independent basis for assessing three other estimates for Berau. Two other estimates were above the upper end of our uncertainty range. We emphasize the importance of including an uncertainty range for all parameters of the emissions equation to generate a comprehensive uncertainty estimate-which has not been done before. We believe comprehensive estimates of carbon flux uncertainty are increasingly important as national and international institutions are challenged with comparing alternative estimates and identifying a credible range of historic emissions values.	[Griscom, Bronson W.; Ellis, Peter W.] Nature Conservancy, Arlington, VA 22203 USA; [Griscom, Bronson W.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Baccini, Alessandro] Woods Hole Res Ctr, Falmouth, MA USA; [Marthinus, Delon] Nature Conservancy, Jakarta, Indonesia; [Evans, Jeffrey S.] Nature Conservancy, Ft Collins, CO USA; [Evans, Jeffrey S.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Ruslandi] Univ Florida, Gainesville, FL USA	Nature Conservancy; James Madison University; Woods Hole Research Center; The Nature Conservancy Indonesia; Nature Conservancy; University of Wyoming; State University System of Florida; University of Florida	Griscom, BW (corresponding author), Nature Conservancy, 4245 N Fairfax Dr, Arlington, VA 22203 USA.	bgriscom@tnc.org		Ruslandi, Ruslandi/0000-0002-8918-1893; Evans, Jeffrey/0000-0002-5533-7044; Ellis, Peter/0000-0001-7933-8298	United States Agency for International Development (USAID); Norwegian Agency for Development Cooperation (NORAD); Xerox Corporation; Boeing Corporation	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Norwegian Agency for Development Cooperation (NORAD)(CGIAR); Xerox Corporation; Boeing Corporation	This research was made possible by funding to The Nature Conservancy in support of the Berau Forest Carbon Program from the United States Agency for International Development (USAID), the Norwegian Agency for Development Cooperation (NORAD), Xerox Corporation, and Boeing Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper synthesizes a variety of analyses conducted by a large number of scientists at institutions including The Nature Conservancy (TNC), Woods Hole Research Center (WHRC), World Agroforestry Centre (ICRAF), Winrock International, University of Maryland, CCROM, Universitas Mulawarman, University of Florida, US Forest Service, and Daemeter Consulting. While we are responsible for judgments involved with this analysis, we are grateful to all individuals who have contributed scientific products and/or significant insights to this work including two anonymous reviewers and (in alphabetical order): Rizaldi Boer, Sandra Brown, Felipe Casarim, Lenny Christy, Sonya Dewi, Pascal Douard, Teuku Dharma, Andree Ekadinata, Muhammad Fajri, Greg Fishbein, David Ganz, Daniel Gilmor, Sean Grimland, Stephen Hagen, James Halperin, Lex Hovani, Jack Hurd, Matt Hansen, Hamilton Hardman, Herlina Hartanto, Nawa Irianto, Erin Madeira, Belinda Margono, Susan Mittenmier, Douglas Morton, Peter Navratil, Elis Nurhayati, Peter Potapov, Fran Price, Jack Putz, Saipul Rahman, Ali Sasmirul, Ade Soekadis, Fred Stolle, Umbar Sujoko, Alie Syopyan, Oscar Venter, Nicole Virgilio, Bambang Wahyudi, Iwied Wahyulianto, Sarah Walker, and Wahjudi Wardojo. There are many others not named here we are grateful to for providing critical support, particularly in the field components of this study. This research was made possible by funding to The Nature Conservancy in support of the Berau Forest Carbon Program from the United States Agency for International Development (USAID), the Norwegian Agency for Development Cooperation (NORAD), Xerox Corporation, and Boeing Corporation. The views expressed here are of the authors only, and do not necessarily reflect the views of The Nature Conservancy, The Woods Hole Research Institute, USAID, or any other institution. The authors declare that no competing interests exist.	Abood SA, 2015, CONSERV LETT, V8, P58, DOI 10.1111/conl.12103; [Anonymous], 2014, INDONESIA G OF FORES; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Ballantyne AP, 2015, BIOGEOSCIENCES, V12, P2565, DOI 10.5194/bg-12-2565-2015; Banin L, 2014, J ECOL, V102, P1025, DOI 10.1111/1365-2745.12263; Bonner MTL, 2013, FOREST ECOL MANAG, V291, P73, DOI 10.1016/j.foreco.2012.11.024; BRUIJNZEEL LA, 1995, ECOL STU AN, V110, P38; Bryant D., 1997, LAST FRONTIER FOREST; CNES, 2011, 10M SPOT RESOLUTION; Dewi S, 2011, ESTIMATION OF LULCF; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Fishbein G, 2015, EARLY LESSONS FROM J; Forest Carbon Partnership Facility (FCPF), 2013, FCPF CARBON FUND MET; Goetz Scott J, 2009, Carbon Balance Manag, V4, P2, DOI 10.1186/1750-0680-4-2; GOFC-GOLD, 2013, SOURC METH PROC MON; Grassi G, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/035005; Griscom B, 2014, GLOBAL CHANGE BIOL, V20, P923, DOI 10.1111/gcb.12386; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harja D, 2011, REDD ABACUS SP USER; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; Houghton RA, 2015, NAT CLIM CHANGE, V5, P1022, DOI 10.1038/nclimate2869; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; Ipcc, 2003, IPCC GOOD PRACTICE G, P23; IPCC, 2019, 2006 IPCC GUIDELINES, DOI DOI 10.35-10.49; Kim D, 2014, REMOTE SENSING OF EN; Lim M. T., 1986, Pertanika, V9, P81; LIM MT, 1988, J TROP ECOL, V4, P293, DOI 10.1017/S0266467400002856; MacKinnon K, 1997, THE ECOLOGY OF KALIM; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Morton Douglas C, 2011, Carbon Balance Manag, V6, P18, DOI 10.1186/1750-0680-6-18; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Navratil P, 2013, LAND COVER SITUATION; Palace M, 2012, TROPICAL FORESTS, P215; Pearson TRH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034017; Powers JS, 2011, P NATL ACAD SCI USA, V108, P6318, DOI 10.1073/pnas.1016774108; R Development Core team, 2014, R A LANGUAGE AND ENV; RePPProT, 1987, REGIONAL PHYSICAL PL; Reyes G, 1992, WOOD DENSITIES OF TR; Righi CA, 2009, FOREST ECOL MANAG, V258, P2535, DOI 10.1016/j.foreco.2009.09.010; Romijn E, 2013, ENVIRON SCI POLICY, V33, P246, DOI 10.1016/j.envsci.2013.06.002; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sidman G, 2014, WORLD BANK REDD DECI; Sist P, 2003, ANN FOREST SCI, V60, P803, DOI 10.1051/forest:2003075; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; SNI, 2010, SNI 7645; Song XP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126754; Thenkabail PS, 2004, INT J REMOTE SENS, V25, P5447, DOI 10.1080/01431160412331291279; Tyukavina A, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/7/074002; Tyukavina A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044039; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Wahyunto S, 2004, MAP OF PEATLAND DIST; WHITMORE T. C., 1984, TROPICAL RAINFORESTS; Winjum JK, 1998, FOREST SCI, V44, P272	58	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146357	10.1371/journal.pone.0146357	http://dx.doi.org/10.1371/journal.pone.0146357			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752298	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100070
J	Maruyama, EO; Aure, MH; Xie, XL; Myal, Y; Gan, L; Ovitt, CE				Maruyama, Eri O.; Aure, Marit H.; Xie, Xiaoling; Myal, Yvonne; Gan, Lin; Ovitt, Catherine E.			Cell-Specific Cre Strains For Genetic Manipulation in Salivary Glands	PLOS ONE			English	Article							PROLACTIN-INDUCIBLE PROTEIN; MOUSE SUBMANDIBULAR-GLAND; INTERCALATED DUCT CELLS; STEM-CELLS; TRANSCRIPTION FACTOR; BREAST CARCINOMAS; SELF-DUPLICATION; EXPRESSION; RAT; GCDFP-15	The secretory acinar cells of the salivary gland are essential for saliva secretion, but are also the cell type preferentially lost following radiation treatment for head and neck cancer. The source of replacement acinar cells is currently a matter of debate. There is evidence for the presence of adult stem cells located within specific ductal regions of the salivary glands, but our laboratory recently demonstrated that differentiated acinar cells are maintained without significant stem cell contribution. To enable further investigation of salivary gland cell lineages and their origins, we generated three cell-specific Cre driver mouse strains. For genetic manipulation in acinar cells, an inducible Cre recombinase (Cre-ER) was targeted to the prolactin-induced protein (Pip) gene locus. Targeting of the Dcpp1 gene, encoding demilune cell and parotid protein, labels intercalated duct cells, a putative site of salivary gland stem cells, and serous demilune cells of the sublingual gland. Duct cell-specific Cre expression was attempted by targeting the inducible Cre to the Tcfcp2l1 gene locus. Using the R26(Tomato) (Red) reporter mouse, we demonstrate that these strains direct inducible, cell-specific expression. Genetic tracing of acinar cells using Pip(GCE) supports the recent finding that differentiated acinar cells clonally expand. Moreover, tracing of intercalated duct cells expressing Dcpp(GCE) confirms evidence of duct cell proliferation, but further analysis is required to establish that renewal of secretory acinar cells is dependent on stem cells within these ducts.	[Maruyama, Eri O.; Aure, Marit H.; Ovitt, Catherine E.] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Maruyama, Eri O.; Aure, Marit H.; Xie, Xiaoling; Ovitt, Catherine E.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Xie, Xiaoling; Gan, Lin] Univ Rochester, Med Ctr, Dept Ophthalmol, Rochester, NY 14642 USA; [Xie, Xiaoling; Gan, Lin] Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; [Myal, Yvonne] Univ Manitoba, Dept Pathol, Fac Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Myal, Yvonne] Univ Manitoba, Fac Hlth Sci, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Manitoba; University of Manitoba	Ovitt, CE (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	Catherine_Ovitt@URMC.rochester.edu		Maruyama, Eri/0000-0003-3797-2754	National Institute of Dental and Craniofacial Research [R01 DE018896]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018896] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants R01 DE018896 and R01 DE018896 Supplement from National Institute of Dental and Craniofacial Research to C.E.O.	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Aure MH, 2015, J DENT RES, V94, P1502, DOI 10.1177/0022034515599770; Aure MH, 2015, DEV CELL, V33, P231, DOI 10.1016/j.devcel.2015.02.013; BALL WD, 1988, DEV BIOL, V129, P464, DOI 10.1016/0012-1606(88)90393-4; BALL WD, 1988, DEV BIOL, V125, P265, DOI 10.1016/0012-1606(88)90210-2; BEKHOR I, 1994, ARCH ORAL BIOL, V39, P1011, DOI 10.1016/0003-9969(94)90052-3; Blanchard A, 2009, CAN J PHYSIOL PHARM, V87, P859, DOI 10.1139/Y09-077; Denny PC, 1999, ANAT REC, V254, P408, DOI 10.1002/(SICI)1097-0185(19990301)254:3<408::AID-AR12>3.0.CO;2-G; Fox PC, 1998, ANN NY ACAD SCI, V842, P132, DOI 10.1111/j.1749-6632.1998.tb09641.x; Kwak M, 2015, STEM CELLS DEV, V24, P565, DOI 10.1089/scd.2014.0355; Lee B, 2003, MOL CELL ENDOCRINOL, V205, P33, DOI 10.1016/S0303-7207(03)00210-7; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Man YG, 2001, ANAT REC, V263, P202, DOI 10.1002/ar.1098; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; MAZOUJIAN G, 1983, AM J PATHOL, V110, P105; MAZOUJIAN G, 1989, CANCER, V63, P2156, DOI 10.1002/1097-0142(19890601)63:11<2156::AID-CNCR2820631115>3.0.CO;2-B; Mirels L, 1998, J HISTOCHEM CYTOCHEM, V46, P1061, DOI 10.1177/002215549804600910; Mugford JW, 2008, DEV BIOL, V319, P396, DOI 10.1016/j.ydbio.2008.03.044; Mullins JJ, 2006, PHYSIOL GENOMICS, V28, P129, DOI 10.1152/physiolgenomics.00153.2006; MURPHY LC, 1987, J BIOL CHEM, V262, P15236; MYAL Y, 1994, ENDOCRINOLOGY, V135, P1605, DOI 10.1210/en.135.4.1605; Nanduri LSY, 2013, RADIOTHER ONCOL, V108, P458, DOI 10.1016/j.radonc.2013.05.020; Pinkstaff C., 1993, BIOL SALIVARY GLANDS; Pringle S, 2013, STEM CELLS, V31, P613, DOI 10.1002/stem.1327; REDMAN RS, 1978, AM J ANAT, V153, P367, DOI 10.1002/aja.1001530304; Rodda S, 2001, J BIOL CHEM, V276, P3324, DOI 10.1074/jbc.M008167200; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SCHWARTZARAD D, 1988, J ANAT, V161, P143; Xiao N, 2014, J CLIN INVEST, V124, P3364, DOI 10.1172/JCI74096; Yamaguchi Y, 2006, DEVELOPMENT, V133, P4737, DOI 10.1242/dev.02658; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; ZAJICEK G, 1985, ANAT REC, V213, P150, DOI 10.1002/ar.1092130206	32	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146711	10.1371/journal.pone.0146711	http://dx.doi.org/10.1371/journal.pone.0146711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751783	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100136
J	Shi, WH; Qin, M; Chen, F; Xia, B				Shi, Weihua; Qin, Man; Chen, Feng; Xia, Bin			Supragingival Microbial Profiles of Permanent and Deciduous Teeth in Children with Mixed Dentition	PLOS ONE			English	Article							ORAL-CAVITY; FUSOBACTERIUM-NUCLEATUM; BACTERIAL INTERACTIONS; PLAQUE DEVELOPMENT; BIOFILM FORMATION; COMMUNITIES; HEALTH	Objectives The present study was designed to investigate the microbial profiles of teeth in different locations in mixed-dentition-stage children, and to compare the microbiomes of permanent and deciduous teeth in the same healthy oral cavity. Methods Supragingival plaque samples of teeth in various locations-the first permanent molars, deciduous molars, deciduous canines and incisors and permanent incisors-were collected from 20 healthy mixed-dentition-stage children with 10-12 permanent teeth erupted. Plaque DNA was extracted, and the V3-V4 hypervariable region of the bacterial 16S rRNA gene was amplified and subjected to sequencing. Results On average, 18,051 high-quality sequences per sample were generated. Permanent tooth sites tended to host more diverse bacterial communities than those of deciduous tooth sites. A total of 12 phyla, 21 classes, 38 orders, 66 families, 74 genera were detected ultimately. Five predominant phyla (Proteobacteria, Firmicutes, Bacteroidetes, Fusobacteria and Actinobacteria) were highly variable among sites. Of 26 genera with a mean relative abundance of > 0.1%, 16 showed significant differences in relative abundance among the groups. More than 20% of the total operational taxonomical units were detected only in permanent or deciduous teeth. The variation in the microbial community composition was due mainly to permanent teeth being enriched in Actinomyces and deciduous teeth in Treponema. The core microbiome of supragingival plaque in mixed dentition comprised 19 genera with complex correlationships. Conclusion Our results suggest differences in microbial diversity and composition between permanent and deciduous teeth sites in mixed dentition. Moreover, the core microbiome of these sites was determined. These findings enhance our understanding of the development of the native oral microbiota with age.	[Shi, Weihua; Qin, Man; Xia, Bin] Peking Univ, Sch Stomatol, Dept Pediat Dent, Beijing 100871, Peoples R China; [Chen, Feng] Peking Univ, Cent Lab, Sch Stomatol, Beijing 100871, Peoples R China	Peking University; Peking University	Xia, B (corresponding author), Peking Univ, Sch Stomatol, Dept Pediat Dent, Beijing 100871, Peoples R China.	summerinbeijing@vip.sina.com	qin, man/AAD-3710-2020		Capital Clinical Characteristics Applied Research Projects [Z141107002514058]; Beijing Municipal Science & Technology Commission; Construction Project of the National Key Discipline of Pediatric Dentistry by the Ministry of Health, P. R. of China [2014-2016]; Ministry of Health, the People's Republic of China	Capital Clinical Characteristics Applied Research Projects; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Construction Project of the National Key Discipline of Pediatric Dentistry by the Ministry of Health, P. R. of China; Ministry of Health, the People's Republic of China	The Capital Clinical Characteristics Applied Research Projects: grant numbers: Z141107002514058, funding institutions: Beijing Municipal Science & Technology Commission, the URLs: www.bjkw.gov.cn, Grant Recipient: BX; the Construction Project of the National Key Discipline of Pediatric Dentistry funded by the Ministry of Health, P. R. of China: grant numbers: 2014-2016, funding institutions: the Ministry of Health, the People's Republic of China, the URLs: http://www.nhfpc.gov.cn/, Grant Recipients: MQ, BX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Bath-Balogh M, 1997, SAUNDERS, V23, P44; Brailsford SR, 2005, CARIES RES, V39, P78, DOI 10.1159/000081661; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Guo LH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00328; Hojo K, 2009, J DENT RES, V88, P982, DOI 10.1177/0022034509346811; Oliveira MAHD, 2010, MICROSC RES TECHNIQ, V73, P572, DOI 10.1002/jemt.20796; Ismail AI, 2007, COMMUNITY DENT ORAL, V35, P170, DOI 10.1111/j.1600-0528.2007.00347.x; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P798, DOI 10.1099/00207713-45-4-798; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Li Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137030; Mahajan A, 2013, THESCIENTIFICWORLDJO, V2013, DOI 10.1155/2013/765434; Norskov-Lauritsen N, 2014, CLIN MICROBIOL REV, V27, P214, DOI 10.1128/CMR.00103-13; Okuda T, 2012, ANAEROBE, V18, P110, DOI 10.1016/j.anaerobe.2011.09.003; Papaioannou W, 2009, ORAL MICROBIOL IMMUN, V24, P183, DOI 10.1111/j.1399-302X.2008.00493.x; Qi X, 2008, REPORT 3 NATL ORAL H; Scheid RC., 2010, WOELFELS DENT ANATOM; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; Takahashi N, 1997, ORAL MICROBIOL IMMUN, V12, P323, DOI 10.1111/j.1399-302X.1997.tb00733.x; Takeshita T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08136; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Xu X, 2015, ENVIRON MICROBIOL, V17, P699, DOI 10.1111/1462-2920.12502; Yeh E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006141; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; ZHANG X, 2015, J BIOSCIENCES MED, V3, P23, DOI DOI 10.4236/JBM.2015.36004; Zimmerman JN, 2013, INT J MOL SCI, V14, P920, DOI 10.3390/ijms14010920	32	21	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146938	10.1371/journal.pone.0146938	http://dx.doi.org/10.1371/journal.pone.0146938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752284	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100182
J	Wang, L; Xu, WR; Cao, L; Tian, T; Yang, MF; Li, ZM; Ping, FF; Fan, WX				Wang, Lei; Xu, Wenrong; Cao, Lei; Tian, Tian; Yang, Mifang; Li, Zhongming; Ping, Fengfeng; Fan, Weixin			Differential Expression of Proteins Associated with the Hair Follicle Cycle - Proteomics and Bioinformatics Analyses	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; COMPREHENSIVE GUIDE; STEM-CELLS; IN-VITRO; GROWTH; MICE; VIMENTIN; CLASSIFICATION; TRANSFORMATION; MORPHOGENESIS	Hair follicle cycling can be divided into the following three stages: anagen, catagen, and telogen. The molecular signals that orchestrate the follicular transition between phases are still unknown. To better understand the detailed protein networks controlling this process, proteomics and bioinformatics analyses were performed to construct comparative protein profiles of mouse skin at specific time points (0, 8, and 20 days). Ninety - five differentially expressed protein spots were identified by MALDI-TOF/TOF as 44 proteins, which were found to change during hair follicle cycle transition. Proteomics analysis revealed that these changes in protein expression are involved in Ca2+-regulated biological processes, migration, and regulation of signal transduction, among other processes. Subsequently, three proteins were selected to validate the reliability of expression patterns using western blotting. Cluster analysis revealed three expression patterns, and each pattern correlated with specific cell processes that occur during the hair cycle. Furthermore, bioinformatics analysis indicated that the differentially expressed proteins impacted multiple biological networks, after which detailed functional analyses were performed. Taken together, the above data may provide insight into the three stages of mouse hair follicle morphogenesis and provide a solid basis for potential therapeutic molecular targets for this hair disease.	[Wang, Lei; Xu, Wenrong; Li, Zhongming] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Dermatol, Wuxi, Jiangsu, Peoples R China; [Cao, Lei] Nanjing Med Univ, Affiliated Wuxi Hosp 2, Dept Dermatol, Wuxi, Jiangsu, Peoples R China; [Tian, Tian] Nanjing Med Univ, Dept Neurobiol, Nanjing, Jiangsu, Peoples R China; [Yang, Mifang] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Ping, Fengfeng] Nanjing Med Univ, Dept Clin Lab Sci, Affiliated Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China; [Wang, Lei; Cao, Lei; Fan, Weixin] Nanjing Med Univ, Dept Dermatol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Fan, WX (corresponding author), Nanjing Med Univ, Dept Dermatol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	njmufanweixin@sina.com		ping, fengfeng/0000-0003-4444-4976	Science and Technology Development Foundation of Nanjing Medical University [2015NJMUZD069]; National Natural Science Foundation of China [81371754]	Science and Technology Development Foundation of Nanjing Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by the Science and Technology Development Foundation of Nanjing Medical University (2015NJMUZD069), National Natural Science Foundation of China (No. 81371754).	Al-Nuaimi Y, 2010, EXP DERMATOL, V19, P707, DOI 10.1111/j.1600-0625.2010.01114.x; Bizzarro V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045639; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Botchkarev VA, 2003, J INVEST DERM SYMP P, V8, P46, DOI 10.1046/j.1523-1747.2003.12171.x; Chen PH, 2011, J PROTEOMICS, V74, P2760, DOI 10.1016/j.jprot.2011.09.019; Curtis A, 2011, MOL IMAGING BIOL, V13, P1114, DOI 10.1007/s11307-010-0440-8; de Coupade C, 2000, HEPATOLOGY, V31, P371, DOI 10.1002/hep.510310217; Dong L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05432; Eckes B, 1998, J CELL SCI, V111, P1897; Elliott K, 1999, J INVEST DERMATOL, V113, P873, DOI 10.1046/j.1523-1747.1999.00797.x; Foitzik K, 2003, AM J PATHOL, V162, P1611, DOI 10.1016/S0002-9440(10)64295-2; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Hanif M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004114; Harada N, 2007, GROWTH HORM IGF RES, V17, P408, DOI 10.1016/j.ghir.2007.04.009; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hibino T, 2004, J DERMATOL SCI, V35, P9, DOI 10.1016/j.jdermsci.2003.12.003; Hu HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040124; Hunt DPJ, 2008, STEM CELLS, V26, P163, DOI 10.1634/stemcells.2007-0281; Ivaska Johanna, 2011, Small GTPases, V2, P51; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Junlatat J, 2014, PHYTOTHER RES, V28, P1030, DOI 10.1002/ptr.5100; Li YH, 2013, J INVEST DERMATOL, V133, P42, DOI 10.1038/jid.2012.235; Ma XY, 2015, INT J MOL MED, V35, P1246, DOI 10.3892/ijmm.2015.2135; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; Menko AS, 2014, MOL BIOL CELL, V25, P776, DOI 10.1091/mbc.E12-12-0900; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; PAPAIOANNOU VE, 1993, LAB ANIM SCI, V43, P189; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; ROBER RA, 1989, DEVELOPMENT, V105, P365; Rocken C, 2004, PATHOL RES PRACT, V200, P69, DOI 10.1016/j.prp.2004.03.002; Rushan X, 2007, J DERMATOL SCI, V48, P189, DOI 10.1016/j.jdermsci.2007.06.013; Sakaguchi M, 2007, J BIOL CHEM, V282, P35679, DOI 10.1074/jbc.M707538200; Santoni V, 2000, ELECTROPHORESIS, V21, P3329, DOI 10.1002/1522-2683(20001001)21:16<3329::AID-ELPS3329>3.0.CO;2-F; SLOMINSKI A, 1994, J INVEST DERMATOL, V102, P862, DOI 10.1111/1523-1747.ep12382606; Soma T, 1998, J INVEST DERMATOL, V111, P948, DOI 10.1046/j.1523-1747.1998.00408.x; Tani T, 2007, CLONING STEM CELLS, V9, P267, DOI 10.1089/clo.2006.0072; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281; Wang L, 2005, J MOL MED, V83, P812, DOI 10.1007/s00109-005-0676-y; Wang NL, 2009, PROTEOMICS, V9, P3425, DOI 10.1002/pmic.200800822; Won CH, 2012, BMB REP, V45, P253, DOI 10.5483/BMBRep.2012.45.4.253; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhou NH, 2009, ARCH DERMATOL RES, V301, P139, DOI 10.1007/s00403-008-0907-5; Zhu YF, 2006, J PROTEOME RES, V5, P2217, DOI 10.1021/pr0600733; Zhu Yi, 2013, J Trauma Manag Outcomes, V7, P7, DOI 10.1186/1752-2897-7-7	50	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146791	10.1371/journal.pone.0146791	http://dx.doi.org/10.1371/journal.pone.0146791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752403	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100155
J	Khatib, A; Arhab, Y; Bentebibel, A; Abousalham, A; Noiriel, A				Khatib, Abdallah; Arhab, Yani; Bentebibel, Assia; Abousalham, Abdelkarim; Noiriel, Alexandre			Reassessing the Potential Activities of Plant CGI-58 Protein	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; COMPARATIVE GENE IDENTIFICATION-58; CHANARIN-DORFMAN-SYNDROME; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; ARGININE KINASE; ARABIDOPSIS; CLONING; EXPRESSION	Comparative Gene Identification-58 (CGI-58) is a widespread protein found in animals and plants. This protein has been shown to participate in lipolysis in mice and humans by activating Adipose triglyceride lipase (ATGL), the initial enzyme responsible for the triacylglycerol (TAG) catabolism cascade. Human mutation of CGI-58 is the cause of Chanarin-Dorfman syndrome, an orphan disease characterized by a systemic accumulation of TAG which engenders tissue disorders. The CGI-58 protein has also been shown to participate in neutral lipid metabolism in plants and, in this case, a mutation again provokes TAG accumulation. Although its roles as an ATGL coactivator and in lipid metabolism are quite clear, the catalytic activity of CGI-58 is still in question. The acyltransferase activities of CGI-58 have been speculated about, reported or even dismissed and experimental evidence that CGI-58 expressed in E. coli possesses an unambiguous catalytic activity is still lacking. To address this problem, we developed a new set of plasmids and site-directed mutants to elucidate the in vivo effects of CGI-58 expression on lipid metabolism in E. coli. By analyzing the lipid composition in selected E. coli strains expressing CGI-58 proteins, and by reinvestigating enzymatic tests with adequate controls, we show here that recombinant plant CGI58 has none of the proposed activities previously described. Recombinant plant and mouse CGI-58 both lack acyltransferase activity towards either lysophosphatidylglycerol or lysophosphatidic acid to form phosphatidylglycerol or phosphatidic acid and recombinant plant CGI-58 does not catalyze TAG or phospholipid hydrolysis. However, expression of recombinant plant CGI-58, but not mouse CGI-58, led to a decrease in phosphatidylglycerol in all strains of E. coli tested, and a mutation of the putative catalytic residues restored a wild-type phenotype. The potential activities of plant CGI-58 are subsequently discussed.	[Khatib, Abdallah; Arhab, Yani; Bentebibel, Assia; Abousalham, Abdelkarim; Noiriel, Alexandre] Univ Lyon 1, CNRS, Inst Chim & Biochim Mol & Supramol, UMR 5246,Org & Dynam Membranes Biol, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Noiriel, A (corresponding author), Univ Lyon 1, CNRS, Inst Chim & Biochim Mol & Supramol, UMR 5246,Org & Dynam Membranes Biol, F-69622 Villeurbanne, France.	alexandre.noiriel@univ-lyon1.fr	Arhab, Yani/AAB-6135-2020; abousalham, abdelkarim/A-4363-2018; ABOUSALHAM, Abdelkarim/Q-4487-2019	Arhab, Yani/0000-0002-6165-3203; abousalham, abdelkarim/0000-0002-8020-4294; 	Lebanese Association for Scientific Research [2012-11]; LASER (Lebanese Association for Scientific Research)	Lebanese Association for Scientific Research; LASER (Lebanese Association for Scientific Research)	AK was supported by grant #2012-11 from the Lebanese Association for Scientific Research, www.laser-lb.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Sebastien Guiral for his advice on plasmid drawing and microbiology techniques, and Antoine Escudier for his technical help. The authors thank Baptiste Fourmaux (Functional Lipidomic Platform, IMBL-INSA Lyon, Villeurbanne, France) for the phospholipid analysis. We are grateful to Ligia Martins for providing the CotA clone. Prof. Dawn Brasaemle is gratefully acknowledged for providing the MmCGI-58 clone and for her advice on mouse CGI-58 purification. The English revision by Valerie James and Julie Carter is also appreciated. Abdallah Khatib was supported by a grant from LASER (Lebanese Association for Scientific Research).	AMES GF, 1968, J BACTERIOL, V95, P833, DOI 10.1128/JB.95.3.833-843.1968; Aygun-Sunar S, 2007, J BACTERIOL, V189, P8564, DOI 10.1128/JB.01121-07; Bayer A, 2004, BIOORGAN MED CHEM, V12, P2787, DOI 10.1016/j.bmc.2004.02.029; Beattie BK, 1996, BIOCHEMISTRY-US, V35, P9042, DOI 10.1021/bi960396k; Ben Ali Y, 2007, PROTEIN EXPRES PURIF, V51, P162, DOI 10.1016/j.pep.2006.07.018; Beneyton T, 2014, ANALYST, V139, P3314, DOI 10.1039/c4an00228h; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown AP, 2002, BIOCHEM J, V364, P795, DOI 10.1042/BJ20020071; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; COLEMAN J, 1990, J BIOL CHEM, V265, P17215; COLEMAN J, 1992, MOL GEN GENET, V232, P295, DOI 10.1007/BF00280009; Cullinane M, 2005, MICROBIOL-SGM, V151, P3071, DOI 10.1099/mic.0.27958-0; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; Dryden SC, 1996, J BACTERIOL, V178, P1030, DOI 10.1128/jb.178.4.1030-1038.1996; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; France RM, 1996, ARCH BIOCHEM BIOPHYS, V326, P93, DOI 10.1006/abbi.1996.0051; Ghosh AK, 2008, J BIOL CHEM, V283, P9768, DOI 10.1074/jbc.M708418200; Ghosh AK, 2009, PLANT PHYSIOL, V151, P869, DOI 10.1104/pp.109.144261; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; HOMMA H, 1982, J BIOCHEM, V91, P1103, DOI 10.1093/oxfordjournals.jbchem.a133792; James CN, 2010, P NATL ACAD SCI USA, V107, P17833, DOI 10.1073/pnas.0911359107; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; MA YZ, 1991, BIOCHEM J, V277, P207, DOI 10.1042/bj2770207; Matsui K, 2006, APPL MICROBIOL BIOT, V71, P75, DOI 10.1007/s00253-006-0328-3; McMahon D, 2014, J LIPID RES, V55, P1750, DOI 10.1194/jlr.M051151; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Morand LZ, 1998, BIOCHEM BIOPH RES CO, V244, P79, DOI 10.1006/bbrc.1998.8218; NANTEL G, 1978, CAN J BIOCHEM CELL B, V56, P324, DOI 10.1139/o78-050; NISHIJIMA M, 1981, J BACTERIOL, V145, P113, DOI 10.1128/JB.145.1.113-121.1981; NISHIJIMA M, 1979, J BIOL CHEM, V254, P7837; Oberer M, 2011, CURR OPIN LIPIDOL, V22, P149, DOI 10.1097/MOL.0b013e328346230e; Pan JC, 2004, PROTEIN SCI, V13, P1892, DOI 10.1110/ps.03464804; Park S, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27723; Park S, 2013, PLANT CELL, V25, P1726, DOI 10.1105/tpc.113.111898; RAETZ CRH, 1978, MICROBIOL REV, V42, P614, DOI 10.1128/MMBR.42.3.614-659.1978; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Serr J, 2011, J ANIM SCI, V89, P3490, DOI 10.2527/jas.2011-3897; Sutterlin HA, 2014, J BACTERIOL, V196, P3214, DOI 10.1128/JB.01876-14; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; Willis LM, 2013, P NATL ACAD SCI USA, V110, P7868, DOI 10.1073/pnas.1222317110; Xie M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005284; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Zhang J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.573857; Zierler KA, 2013, J BIOL CHEM, V288, P9892, DOI 10.1074/jbc.M112.420620; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	51	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145806	10.1371/journal.pone.0145806	http://dx.doi.org/10.1371/journal.pone.0145806			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745266	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600016
J	Park, HR; Lee, JM; Ehm, G; Yang, HJ; Song, IH; Lim, YH; Kim, MR; Kim, KR; Lee, WW; Kim, YE; Hwang, JH; Shin, CW; Park, H; Kim, JW; Kim, HJ; Kim, C; Kim, DG; Jeon, BS; Paek, SH				Park, Hye Ran; Lee, Jae Meen; Ehm, Gwanhee; Yang, Hui-Jun; Song, In Ho; Lim, Yong Hoon; Kim, Mi-Ryoung; Kim, Keyoung Ran; Lee, Woong-Woo; Kim, Young Eun; Hwang, Jae Ha; Shin, Chae Won; Park, Hyeyoung; Kim, Jin Wook; Kim, Han-Joon; Kim, Cheolyoung; Kim, Dong Gyu; Jeon, Beom Seok; Paek, Sun Ha			Long-Term Clinical Outcome of Internal Globus Pallidus Deep Brain Stimulation for Dystonia	PLOS ONE			English	Article							PRIMARY GENERALIZED DYSTONIA; HALLERVORDEN-SPATZ-SYNDROME; TARDIVE-DYSKINESIA; FOLLOW-UP; SEGMENTAL DYSTONIA; CERVICAL DYSTONIA; PALLIDOTOMY; NEUROSTIMULATION; PATIENT; BLEPHAROSPASM	Background GPi (Internal globus pallidus) DBS (deep brain stimulation) is recognized as a safe, reliable, reversible and adjustable treatment in patients with medically refractory dystonia. Objectives This report describes the long-term clinical outcome of 36 patients implanted with GPi DBS at the Neurosurgery Department of Seoul National University Hospital. Methods Nine patients with a known genetic cause, 12 patients with acquired dystonia, and 15 patients with isolated dystonia without a known genetic cause were included. When categorized by phenomenology, 29 patients had generalized, 5 patients had segmental, and 2 patients had multifocal dystonia. Patients were assessed preoperatively and at defined follow-up examinations postoperatively, using the Burke-Fahn-Marsden dystonia rating scale (BFMDRS) for movement and functional disability assessment. The mean follow-up duration was 47 months (range, 12-84) Results The mean movement scores significantly decreased from 44.88 points preoperatively to 26.45 points at 60-month follow up (N = 19, P = 0.006). The mean disability score was also decreased over time, from 11.54 points preoperatively to 8.26 points at 60-month follow up, despite no statistical significance (N = 19, P = 0.073). When analyzed the movement and disability improvement rates at 12-month follow up point, no significant difference was noted according to etiology, disease duration, age at surgery, age of onset, and phenomenology. However, the patients with DYT-1 dystonia and isolated dystonia without a known genetic cause showed marked improvement. Conclusions GPi DBS is a safe and efficient therapeutic method for treatment of dystonia patients to improve both movement and disability. However, this study has some limitations caused by the retrospective design with small sample size in a single-center.	[Park, Hye Ran; Lee, Jae Meen; Lim, Yong Hoon; Kim, Mi-Ryoung; Kim, Keyoung Ran; Kim, Jin Wook; Kim, Dong Gyu; Paek, Sun Ha] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea; [Ehm, Gwanhee] Myongji Hosp, Dept Neurol, Gyeonggi, South Korea; [Yang, Hui-Jun] Ulsan Univ Hosp, Dept Neurol, Ulsan, South Korea; [Song, In Ho] Osong Med Innovat Fdn, Med Device Dev Ctr, Chungcheong, South Korea; [Lee, Woong-Woo] Eulji Gen Hosp, Dept Neurol, Seoul, South Korea; [Kim, Young Eun] Hallym Univ, Dept Neurol, Sacred Heart Hosp, Gyeonggi, South Korea; [Hwang, Jae Ha] Daejeon Woori Hosp, Dept Neurosurg, Gyeonggi, South Korea; [Shin, Chae Won; Park, Hyeyoung; Kim, Han-Joon; Jeon, Beom Seok] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Kim, Cheolyoung] Med Imaging Lab, Seoul, South Korea; [Kim, Cheolyoung] CyberMed Inc, Seoul, South Korea; [Kim, Dong Gyu; Paek, Sun Ha] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Jeon, Beom Seok] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Myongji Hospital; University of Ulsan; Ulsan University Hospital; Osong Medical Innovation Foundation; Eulji University; Hallym University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Jeon, BS (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.	brain@snu.ac.kr; paeksh@snu.ac.kr	Cabrera, Mariel/GMX-2706-2022	Kim, Han-Joon/0000-0001-8219-9663; Shin, Chaewon/0000-0002-4157-492X	Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea [311011-05-3-SB020]; Korea Healthcare Technology RD Project [HI10C14110400, HI12C02050101, HI11C21100200]; Ministry of Health & Welfare, Republic of Korea; Technology Innovation Program [10050154]; Ministry of Trade, industry & Energy (MI, Korea); CyberMed, Inc	Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea; Korea Healthcare Technology RD Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Technology Innovation Program; Ministry of Trade, industry & Energy (MI, Korea); CyberMed, Inc	This study was supported by the Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea (311011-05-3-SB020), by the Korea Healthcare Technology R&D Project (HI10C14110400, HI12C02050101, HI11C21100200) funded by Ministry of Health & Welfare, Republic of Korea, by the Technology Innovation Program (10050154, Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) funded By the Ministry of Trade, industry & Energy (MI, Korea). CyberMed, Inc. provided support in the form of salaries for author CK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Alterman RL, 2007, NEUROLOGY, V69, P681, DOI 10.1212/01.wnl.0000267430.95106.ff; Bereznai B, 2002, MOVEMENT DISORD, V17, P138, DOI 10.1002/mds.1250; Bruggemann N, 2015, NEUROLOGY, V84, P895, DOI 10.1212/WNL.0000000000001312; BURKE RE, 1985, NEUROLOGY, V35, P73, DOI 10.1212/WNL.35.1.73; BURKE RE, 1982, NEUROLOGY, V32, P1335, DOI 10.1212/WNL.32.12.1335; Cif L, 2003, J Neurosurg Sci, V47, P52; Coubes P, 2004, J NEUROSURG, V101, P189, DOI 10.3171/jns.2004.101.2.0189; Coubes P, 2002, STEREOT FUNCT NEUROS, V78, P183, DOI 10.1159/000068962; Coubes P, 2000, LANCET, V355, P2220, DOI 10.1016/S0140-6736(00)02410-7; Damier P, 2007, ARCH GEN PSYCHIAT, V64, P170, DOI 10.1001/archpsyc.64.2.170; Eltahawy HA, 2004, MOVEMENT DISORD, V19, P969, DOI 10.1002/mds.20092; Fahn S, 1988, Adv Neurol, V50, P1; FitzGerald J, 2014, J NEUROL NEUROSURG P; Foote KD, 2005, NEUROSURGERY, V56, P415, DOI 10.1227/01.NEU.0000147978.67424.42; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; Jahanshahi M, 2014, J NEUROL, V261, P164, DOI 10.1007/s00415-013-7161-2; Johnsen M, 2002, J NEUROL, V249, P622, DOI 10.1007/s004150200073; Justesen CR, 1999, J NEUROSURG, V90, P551, DOI 10.3171/jns.1999.90.3.0551; Kefalopoulou Z, 2009, ACTA NEUROL SCAND, V119, P269, DOI 10.1111/j.1600-0404.2008.01115.x; Kosel M, 2007, J PSYCHIATR RES, V41, P801, DOI 10.1016/j.jpsychires.2006.07.010; Krause M, 2004, NEUROSURGERY, V55, P1361, DOI 10.1227/01.NEU.0000143331.86101.5E; Krauss JK, 2003, J NEUROL NEUROSUR PS, V74, P1598, DOI 10.1136/jnnp.74.11.1598; Krauss JK, 2003, J NEUROSURG, V98, P785, DOI 10.3171/jns.2003.98.4.0785; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Lee JYK, 2007, PARKINSONISM RELAT D, V13, P261, DOI 10.1016/j.parkreldis.2006.07.020; Lim BC, 2012, EUR J NEUROL, V19, P556, DOI 10.1111/j.1468-1331.2011.03589.x; Loher TJ, 2008, J NEUROL, V255, P881, DOI 10.1007/s00415-008-0798-6; Lozano AM, 1997, MOVEMENT DISORD, V12, P865, DOI 10.1002/mds.870120606; Muller J, 2002, NEUROLOGY, V59, P941, DOI 10.1212/01.WNL.0000026474.12594.0D; Muller J, 2002, J NEUROL, V249, P842, DOI 10.1007/s00415-002-0733-1; Ostrem JL, 2008, NEUROTHERAPEUTICS, V5, P320, DOI 10.1016/j.nurt.2008.01.002; Schrader C, 2004, MOVEMENT DISORD, V19, P583, DOI 10.1002/mds.10705; Speelman JD, 2010, EUR J NEUROL, V17, P102, DOI 10.1111/j.1468-1331.2010.03060.x; Starr PA, 2006, J NEUROSURG, V104, P488, DOI 10.3171/jns.2006.104.4.488; Stavrinou LC, 2012, J NEUROL SURG PART A, V73, P175, DOI 10.1055/s-0032-1313590; Tisch S, 2007, J NEUROL NEUROSUR PS, V78, P1314, DOI 10.1136/jnnp.2006.109694; Tisch S, 2007, IEEE T NEUR SYS REH, V15, P166, DOI 10.1109/TNSRE.2007.896994; Toda H, 2004, NEUROSURG FOCUS, V17, P9; Tronnier VM, 2000, J NEUROSURG, V92, P453, DOI 10.3171/jns.2000.92.3.0453; Trottenberg T, 2001, MOVEMENT DISORD, V16, P769, DOI 10.1002/mds.1119; Trottenberg T, 2001, J NEUROL NEUROSUR PS, V70, P557, DOI 10.1136/jnnp.70.4.557; Valldeoriola F, 2010, J NEUROL NEUROSUR PS, V81, P65, DOI 10.1136/jnnp.2009.174342; Vercueil L, 2001, J NEUROL, V248, P695, DOI 10.1007/s004150170116; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; Vidailhet M, 2012, J NEUROL NEUROSURG P, DOI 10.1136/jnnp-2011-301714; Vidailhet M, 2007, LANCET NEUROL, V6, P223, DOI 10.1016/S1474-4422(07)70035-2; Vitek JL, 1998, J NEUROSURG, V88, P1027, DOI 10.3171/jns.1998.88.6.1027; Volkmann J, 2012, LANCET NEUROL, V11, P1029, DOI 10.1016/S1474-4422(12)70257-0; Weetman J, 1997, J NEUROL NEUROSUR PS, V63, P554; Yianni J, 2003, MOVEMENT DISORD, V18, P436, DOI 10.1002/mds.10380; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	52	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146644	10.1371/journal.pone.0146644	http://dx.doi.org/10.1371/journal.pone.0146644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745717	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600070
J	Tomsic, J; Fultz, R; Liyanarachchi, S; He, HL; Senter, L; de la Chapelle, A				Tomsic, Jerneja; Fultz, Rebecca; Liyanarachchi, Sandya; He, Huiling; Senter, Leigha; de la Chapelle, Albert			HABP2 G534E Variant in Papillary Thyroid Carcinoma	PLOS ONE			English	Article							CANCER; GENE; MUTATION; FAMILY; RISK	The main nonmedullary form of thyroid cancer is papillary thyroid carcinoma (PTC) that accounts for 80-90% of all thyroid malignancies. Only 3-10% of PTC patients have a positive family history of PTC yet the familiality is one of the highest of all cancers as measured by case control studies. A handful of genes have been implicated accounting for a small fraction of this genetic predisposition. It was therefore of considerable interest that a mutation in the HABP2 gene was recently implicated in familial PTC. The present work was undertaken to examine the extent of HABP2 variant involvement in PTC. The HABP2 G534E variant (rs7080536) was genotyped in blood DNA from 179 PTC families (one affected individual per family), 1160 sporadic PTC cases and 1395 controls. RNA expression of HABP2 was tested by qPCR in RNA extracted from tumor and normal thyroid tissue from individuals that are homozygous wild-type or heterozygous for the variant. The variant was found to be present in 6.1% familial cases, 8.0% sporadic cases (2 individuals were homozygous for the variant) and 8.7% controls. The variant did not segregate with PTC in one large and 6 smaller families in which it occurred. In keeping with data from the literature and databases the expression of HABP2 was highest in the liver, much lower in 3 other tested tissues (breast, kidney, brain) but not found in thyroid. Given these results showing lack of any involvement we suggest that the putative role of variant HABP2 in PTC should be carefully scrutinized.	[Tomsic, Jerneja; Fultz, Rebecca; Liyanarachchi, Sandya; He, Huiling; de la Chapelle, Albert] Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Tomsic, Jerneja; Fultz, Rebecca; Liyanarachchi, Sandya; He, Huiling; Senter, Leigha; de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Senter, Leigha] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Tomsic, J (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	jerneja.tomsic@osumc.edu	Pinheiro, Maísa/E-7424-2012		National Cancer Institute (US) [P01CA124570, P30CA16058]; National Cancer Institute [P01CA124570, P30CA16058]; Ohio Supercomputer Center; NATIONAL CANCER INSTITUTE [P01CA124570, P30CA016058] Funding Source: NIH RePORTER	National Cancer Institute (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ohio Supercomputer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (US) grants P01CA124570 and P30CA16058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by National Cancer Institute Grants P01CA124570 and P30CA16058. The OSUCCC Genomics Shared Resource performed SNP genotyping. Genotyping of rs7080536 in Ohio samples was kindly performed by Dr. Julius Gudmundsson at deCODE Inc, Reykjavik, Iceland. This work was supported in part by an allocation of computing time from the Ohio Supercomputer Center. The Body Map data were kindly provided by the Gene Expression Applications research group at Illumina. Pedigrees shown were kindly drawn by Megan Knapke. The results published here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Albright F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-138; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Bonora E, 2010, J ONCOL, V2010, DOI 10.1155/2010/385206; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Fallah M, 2013, ENDOCR-RELAT CANCER, V20, P717, DOI 10.1530/ERC-13-0021; Gara SK, 2015, NEW ENGL J MED, V373, P448, DOI 10.1056/NEJMoa1502449; He HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061920; He HL, 2013, J CLIN ENDOCR METAB, V98, pE973, DOI 10.1210/jc.2012-3823; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Liyanarachchi S, 2013, THYROID, V23, P1532, DOI 10.1089/thy.2013.0102; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tomsic J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10566	14	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146315	10.1371/journal.pone.0146315	http://dx.doi.org/10.1371/journal.pone.0146315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745718	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600040
J	Odone, A; Calderon, R; Becerra, MC; Zhang, ZB; Contreras, CC; Yataco, R; Galea, J; Lecca, L; Bonds, MH; Mitnick, CD; Murray, MB				Odone, Anna; Calderon, Roger; Becerra, Mercedes C.; Zhang, Zibiao; Contreras, Carmen C.; Yataco, Rosa; Galea, Jerome; Lecca, Leonid; Bonds, Matthew H.; Mitnick, Carole D.; Murray, Megan B.			Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS; TRANSMISSION	Although risk factors for multi-drug resistant tuberculosis are known, few studies have differentiated between acquired and transmitted resistance. It is important to identify factors associated with these different mechanisms to optimize control measures. We conducted a prospective cohort study of index TB patients and their household contacts in Lima, Peru to identify risk factors associated with acquired and transmitted resistance, respectively. Patients with higher socioeconomic status (SES) had a 3-fold increased risk of transmitted resistance compared to those with lower SES when acquired resistance served as the baseline. Quality of housing mediated most of the impact of SES.	[Odone, Anna] Univ Parma, Dept Biomed Biotechnol & Translat Sci, Unit Publ Hlth, I-43100 Parma, Italy; [Calderon, Roger; Becerra, Mercedes C.; Contreras, Carmen C.; Yataco, Rosa; Galea, Jerome; Lecca, Leonid; Mitnick, Carole D.; Murray, Megan B.] Partners Hlth, Boston, MA 02114 USA; [Becerra, Mercedes C.; Bonds, Matthew H.; Mitnick, Carole D.; Murray, Megan B.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Zhang, Zibiao; Mitnick, Carole D.; Murray, Megan B.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Murray, Megan B.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Parma; Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Murray, MB (corresponding author), Partners Hlth, Boston, MA 02114 USA.	Megan_Murray@hms.harvard.edu	Mitnick, Carole/GRO-1991-2022; Galea, Jerome T./AAF-2172-2019; Galea, Jerome T/HGV-0203-2022; Odone, Anna/AAC-4715-2022	Mitnick, Carole/0000-0002-3455-658X; Galea, Jerome T./0000-0001-8732-6959; Galea, Jerome T/0000-0001-8732-6959; Calderon, Roger I./0000-0001-8932-0489; Odone, Anna/0000-0002-5657-9774; Lecca, Leonid/0000-0003-1363-3985	National Institutes of Health (NIH/NIAID) [U19 A1076217, U01 AI057786]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI057786] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the National Institutes of Health (NIH/NIAID grants U19 A1076217; U01 AI057786).	Andrews JR, 2014, J INFECT DIS, V210, P597, DOI 10.1093/infdis/jiu138; Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735; Cegielski JP, 2015, CLIN INFECT DIS; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Huang CC, 2014, CLIN INFECT DIS, V58, P765, DOI 10.1093/cid/cit948; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Murray M, 2002, AM J EPIDEMIOL, V155, P565, DOI 10.1093/aje/155.6.565; Odone A, 2015, EUR J PUBLIC HEALTH, V25, P506, DOI 10.1093/eurpub/cku208; Odone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112017; Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0; Odone A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077740; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Sloot R, 2013, J CLIN MICROBIOL, V51, P2427, DOI 10.1128/JCM.00489-13; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, WHOHTMTB201522; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	20	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146642	10.1371/journal.pone.0146642	http://dx.doi.org/10.1371/journal.pone.0146642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB4CC	26765328	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300030
J	Hernandez-Morera, P; Castano-Gonzalez, I; Travieso-Gonzalez, CM; Mompeo-Corredera, B; Ortega-Santana, F				Hernandez-Morera, Pablo; Castano-Gonzalez, Irene; Travieso-Gonzalez, Carlos M.; Mompeo-Corredera, Blanca; Ortega-Santana, Francisco			Quantification and Statistical Analysis Methods for Vessel Wall Components from Stained Images with Masson's Trichrome	PLOS ONE			English	Article							CHRONIC VENOUS INSUFFICIENCY; VARICOSE-VEINS; GENERAL-POPULATION; CONNECTIVE-TISSUE; COLLAGEN; ELASTIN; PATHOLOGY	Purpose To develop a digital image processing method to quantify structural components (smooth muscle fibers and extracellular matrix) in the vessel wall stained with Masson's trichrome, and a statistical method suitable for small sample sizes to analyze the results previously obtained. Methods The quantification method comprises two stages. The pre-processing stage improves tissue image appearance and the vessel wall area is delimited. In the feature extraction stage, the vessel wall components are segmented by grouping pixels with a similar color. The area of each component is calculated by normalizing the number of pixels of each group by the vessel wall area. Statistical analyses are implemented by permutation tests, based on resampling without replacement from the set of the observed data to obtain a sampling distribution of an estimator. The implementation can be parallelized on a multicore machine to reduce execution time. Results The methods have been tested on 48 vessel wall samples of the internal saphenous vein stained with Masson's trichrome. The results show that the segmented areas are consistent with the perception of a team of doctors and demonstrate good correlation between the expert judgments and the measured parameters for evaluating vessel wall changes. Conclusion The proposed methodology offers a powerful tool to quantify some components of the vessel wall. It is more objective, sensitive and accurate than the biochemical and qualitative methods traditionally used. The permutation tests are suitable statistical techniques to analyze the numerical measurements obtained when the underlying assumptions of the other statistical techniques are not met.	[Hernandez-Morera, Pablo] Univ Palmas Las Palmas de Gran Canar, IUMA Informat & Commun Syst, Las Palmas Gran Canaria, Spain; [Castano-Gonzalez, Irene] Doctor Negrin Univ Hosp Gran Canaria, Dept Dermatol, Las Palmas Gran Canaria, Spain; [Travieso-Gonzalez, Carlos M.] Univ Palmas Las Palmas de Gran Canar, Inst Technol Dev & Innovat Commun IDeTIC, Las Palmas Gran Canaria, Spain; [Mompeo-Corredera, Blanca; Ortega-Santana, Francisco] Univ Palmas Las Palmas de Gran Canar, Dept Morphol, Las Palmas Gran Canaria, Spain; [Ortega-Santana, Francisco] Clin Varices, CliniVar, Las Palmas Gran Canaria, Spain; [Hernandez-Morera, Pablo] Univ Palmas Las Palmas de Gran Canar, Dept Telemat Engn, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria	Hernandez-Morera, P (corresponding author), Univ Palmas Las Palmas de Gran Canar, IUMA Informat & Commun Syst, Campus Univ Tafira, Las Palmas Gran Canaria, Spain.	pablo.hernandez@ulpgc.es	Travieso-González, Carlos M./N-5967-2014	Travieso-González, Carlos M./0000-0002-4621-2768; Hernandez-Morera, Pablo/0000-0002-0907-4765; Ortega-Santana, Francisco/0000-0001-9041-153X				ANDREOTTI L, 1979, ANGIOLOGY, V30, P798, DOI 10.1177/000331977903001202; Belsare A., 2012, SIGNAL IMAGE PROCESS, P23, DOI DOI 10.5121/SIPIJ.2012.3403; CHELLO M, 1994, VASCULAR SURG, V28, P23, DOI 10.1177/153857449402800104; Elsharawy Mohamed A, 2007, Interact Cardiovasc Thorac Surg, V6, P219; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Evans CJ, 1999, J EPIDEMIOL COMMUN H, V53, P149, DOI 10.1136/jech.53.3.149; GANDHI RH, 1993, J VASC SURG, V18, P814, DOI 10.1016/0741-5214(93)90336-K; Garcia A, 1999, ANGIOLOGIA, V51, P197; Good PI, 2005, RESAMPLING METHODS P; Hesterberg T, 2010, INTRO PRACTICE STAT; Jantet G, 2002, ANGIOLOGY, V53, P245, DOI 10.1177/000331970205300301; Khan AA, 2000, PATHOLOGY, V32, P253; Laurinavicius A, 2012, ANAL CELL PATHOL, V35, P75, DOI [10.1155/2012/243416, 10.3233/ACP-2011-0033]; Lee AJ, 2015, J VASC SURG-VENOUS L, V3, P18, DOI 10.1016/j.jvsv.2014.09.008; MASHIAH A, 1991, ISRAEL J MED SCI, V27, P202; MAUREL E, 1990, CLIN CHIM ACTA, V193, P27, DOI 10.1016/0009-8981(90)90004-C; Ortega-Santana F, 2014, EUR J VASC ENDOVASC, V48, P452, DOI 10.1016/j.ejvs.2014.07.006; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pett M.A., 2015, NONPARAMETRIC STAT H; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; R-core, 2015, PACK PAR; Regadera J, 2014, CARDIOVASC RES, V103, DOI 10.1093/cvr/cvu098.137; ROSE SS, 1986, J CARDIOVASC SURG, V27, P534; SVEJCAR J, 1963, CLIN SCI, V24, P325; Travers JP, 1996, EUR J VASC ENDOVASC, V11, P230, DOI 10.1016/S1078-5884(96)80058-X; VANKUPPEVELT TH, 1995, INT J BIOCHEM CELL B, V27, P775, DOI 10.1016/1357-2725(95)00047-S; Venturi M, 1996, J SURG RES, V60, P245, DOI 10.1006/jsre.1996.0038; Wali MA, 2003, INT ANGIOL, V22, P188; Witten IH, 2011, MOR KAUF D, P1; Wollman R, 2007, J CELL SCI, V120, P3715, DOI 10.1242/jcs.013623	31	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146954	10.1371/journal.pone.0146954	http://dx.doi.org/10.1371/journal.pone.0146954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761643	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100057
J	Ziomkiewicz, A; Sancilio, A; Galbarczyk, A; Klimek, M; Jasienska, G; Bribiescas, RG				Ziomkiewicz, Anna; Sancilio, Amelia; Galbarczyk, Andrzej; Klimek, Magdalena; Jasienska, Grazyna; Bribiescas, Richard G.			Evidence for the Cost of Reproduction in Humans: High Lifetime Reproductive Effort Is Associated with Greater Oxidative Stress in Post-Menopausal Women	PLOS ONE			English	Article							FEMALE REPRODUCTION; OVARIAN-FUNCTION; TRADE-OFFS; MORTALITY; NUMBER; HISTORY; LONGEVITY; RISK; CHILDBEARING; PREGNANCIES	Life history theory predicts trade-offs between reproductive effort and maternal survivorship in energy-restricted environments. However, empirical evidence for the positive association between maternal mortality and reproductive effort from energetically challenged human populations are mixed and physiological mechanisms that may underlie this association are poorly understood. We hypothesized that increases in aerobic metabolism during repeated periods of pregnancy and lactation result in increased oxidative stress that may contribute to somatic deterioration, vulnerability to illness, and accelerated aging. We therefore predicted that lifetime gravidity and parity would be related to levels of biomarkers of oxidative stress, as well as antioxidative defence enzymes in post-menopausal women. Our hypothesis was supported by positive linear associations between levels of 8-OHdG, a biomarker of DNA oxidative damage (beta = 0.21, p<0.05), levels of antioxidative defence enzyme Cu-Zn SOD (beta = 0.25, p<0.05), and number of lifetime pregnancies. Furthermore, independent of age and health status, post-menopausal women with higher gravidity and parity (> = 4 pregnancies per lifetime) had 20% higher levels of 8-OHdG and 60% higher levels of Cu-Zn SOD compared to women with lower gravidity and parity (<4 pregnancies per lifetime). Our results present the first evidence for oxidative stress as a possible cost of reproductive effort in humans.	[Ziomkiewicz, Anna] Polish Acad Sci, Anthropol Unit Wroclaw, Wroclaw, Poland; [Ziomkiewicz, Anna; Sancilio, Amelia; Jasienska, Grazyna; Bribiescas, Richard G.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Galbarczyk, Andrzej; Klimek, Magdalena; Jasienska, Grazyna] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Environm Hlth, Krakow, Poland	Polish Academy of Sciences; Yale University; Jagiellonian University; Collegium Medicum Jagiellonian University	Ziomkiewicz, A (corresponding author), Polish Acad Sci, Anthropol Unit Wroclaw, Wroclaw, Poland.	aziomkiewicz-wichary@antropologia.pan.pl	Klimek, Magdalena/AAL-8318-2020; Galbarczyk, Andrzej/J-4657-2019; Ziomkiewicz, Anna/ABF-4923-2020; Jasienska, Grazyna/E-4901-2011; Ziomkiewicz, Anna/AAJ-1385-2021	Galbarczyk, Andrzej/0000-0002-7879-9735; Ziomkiewicz, Anna/0000-0002-1842-3314; Jasienska, Grazyna/0000-0001-8716-6342; 	Fulbright Commission; Polish National Science Centre [N N404 273440]; Polish Ministry of Sciences and Higher Education [IdP2011 000161]; Yale University; Salus Publica Foundation	Fulbright Commission; Polish National Science Centre; Polish Ministry of Sciences and Higher Education(Ministry of Science and Higher Education, Poland); Yale University; Salus Publica Foundation	This work was supported by Fulbright Commission (Senior Advanced Research Award to A. Ziomkiewicz): http://www.fulbright.edu.pl/en/home/, Polish National Science Centre (Grant no N N404 273440 to G. Jasienska): https://www.ncn.gov.pl/?language=en, Polish Ministry of Sciences and Higher Education (Grant no IdP2011 000161 to G. Jasienska): http://www.nauka.gov.pl/en/, Yale University, and Salus Publica Foundation: https://www.facebook.com/saluspublica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Albera E, 2011, REPROD DOMEST ANIM, V46, P763, DOI 10.1111/j.1439-0531.2010.01737.x; Albera E, 2010, REPROD DOMEST ANIM, V45, pe417, DOI 10.1111/j.1439-0531.2010.01592.x; Atsma F, 2008, MENOPAUSE, V15, P899, DOI 10.1097/gme.0b013e3181653d7d; Beeri MS, 2009, NEUROBIOL AGING, V30, P1184, DOI 10.1016/j.neurobiolaging.2007.11.011; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Brown L, 2010, MATERNAL FETAL NUTR; Butte NF, 2005, PUBLIC HEALTH NUTR, V8, P1010, DOI 10.1079/PHN2005793; Butte NF, 2000, AM J CLIN NUTR, V71, p1256S, DOI 10.1093/ajcn/71.5.1256s; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Doblhammer G, 2003, P ROY SOC B-BIOL SCI, V270, P1541, DOI 10.1098/rspb.2003.2400; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Dribe M, 2004, POP STUD-J DEMOG, V58, P297, DOI 10.1080/0032472042000272357; FAO/ WHO/ UNU Expert Consultation, 1985, TECH REP SER WHO, V724; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fisher G, 2011, J APPL PHYSIOL, V110, P730, DOI 10.1152/japplphysiol.00575.2010; Fletcher QE, 2013, EVOLUTION, V67, P1527, DOI 10.1111/evo.12014; Gagnon A, 2015, FERTIL STERIL, V103, P1109, DOI 10.1016/j.fertnstert.2015.03.030; Guan HB, 2013, CANCER EPIDEM BIOMAR, V22, P2345, DOI 10.1158/1055-9965.EPI-13-0759-T; Hank K, 2010, POP STUD-J DEMOG, V64, P275, DOI 10.1080/00324728.2010.506243; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Hung TH, 2010, REPROD SCI, V17, P401, DOI 10.1177/1933719109359704; Hurt LS, 2006, POP STUD-J DEMOG, V60, P55, DOI 10.1080/00324720500436011; Hurt LS, 2006, P ROY SOC B-BIOL SCI, V273, P149, DOI 10.1098/rspb.2005.3270; Idogun E, 2008, PAK J MED SCI Q, V24, P2; Idonije O. B., 2011, Research Journal of Obstetrics & Gynecology, V4, P28; Jasienska G, 2006, AM J HUM BIOL, V18, P422, DOI 10.1002/ajhb.20497; Jasienska G, 2004, AM J HUM BIOL, V16, P563, DOI 10.1002/ajhb.20063; Jasienska G, 1998, P ROY SOC B-BIOL SCI, V265, P1847, DOI 10.1098/rspb.1998.0511; Jasienska G., 2013, FRAGILE WISDOM EVOLU; Jasienska G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2395; Jasienska G, 2009, AM J HUM BIOL, V21, P524, DOI 10.1002/ajhb.20931; Karowicz-Bilinska A, 2008, REDOX REP, V13, P237, DOI 10.1179/135100008X308993; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Kontush A, 2003, ARTERIOSCL THROM VAS, V23, P1881, DOI 10.1161/01.ATV.0000091338.93223.E8; Lycett JE, 2000, P ROY SOC B-BIOL SCI, V267, P31, DOI 10.1098/rspb.2000.0962; Miller MW, 2014, MOL PSYCHIATR, V19, P1156, DOI 10.1038/mp.2014.111; Mobbs Charles V., 2007, V35, P39; Mutlu B, 2012, J MATERN-FETAL NEO M, V25, P802, DOI 10.3109/14767058.2011.594920; Naver KV, 2011, DIABETIC MED, V28, P43, DOI 10.1111/j.1464-5491.2010.03169.x; NESS RB, 1993, NEW ENGL J MED, V328, P1528, DOI 10.1056/NEJM199305273282104; PALMER JR, 1993, NEW ENGL J MED, V329, P1894; Pawlak K, 2005, CLIN BIOCHEM, V38, P700, DOI 10.1016/j.clinbiochem.2005.02.009; Sarban S, 2005, CLIN BIOCHEM, V38, P981, DOI 10.1016/j.clinbiochem.2005.08.003; Schottker B, 2015, J GERONTOL A-BIOL, V70, P518, DOI 10.1093/gerona/glu111; Seet RCS, 2011, FREE RADICAL BIO MED, V50, P1787, DOI 10.1016/j.freeradbiomed.2011.03.019; Semba RD, 2007, J AM GERIATR SOC, V55, P1421, DOI 10.1111/j.1532-5415.2007.01308.x; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37; Stuebe AM, 2009, AM J PERINAT, V26, P81, DOI 10.1055/s-0028-1103034; Tigas S, 2002, J CLIN ENDOCR METAB, V87, P302, DOI 10.1210/jc.87.1.302; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wactawski-Wende J, 2009, PAEDIATR PERINAT EP, V23, P171, DOI 10.1111/j.1365-3016.2008.00985.x	58	45	46	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145753	10.1371/journal.pone.0145753	http://dx.doi.org/10.1371/journal.pone.0145753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA8CX	26761206	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100019
J	Rose, PM; Kennard, MJ; Moffatt, DB; Sheldon, F; Butler, GL				Rose, Peter M.; Kennard, Mark J.; Moffatt, David B.; Sheldon, Fran; Butler, Gavin L.			Testing Three Species Distribution Modelling Strategies to Define Fish Assemblage Reference Conditions for Stream Bioassessment and Related Applications	PLOS ONE			English	Article							RUNNING-WATER SITES; CLIMATE-CHANGE; MULTIVARIATE-ANALYSIS; GREAT-PLAINS; RARE TAXA; PREDICTION; CATCHMENT; RIVERS; CLASSIFICATION; COMMUNITIES	Species distribution models are widely used for stream bioassessment, estimating changes in habitat suitability and identifying conservation priorities. We tested the accuracy of three modelling strategies (single species ensemble, multi-species response and community classification models) to predict fish assemblages at reference stream segments in coastal subtropical Australia. We aimed to evaluate each modelling strategy for consistency of predictor variable selection; determine which strategy is most suitable for stream bioassessment using fish indicators; and appraise which strategies best match other stream management applications. Five models, one single species ensemble, two multi-species response and two community classification models, were calibrated using fish species presence-absence data from 103 reference sites. Models were evaluated for generality and transferability through space and time using four external reference site datasets. Elevation and catchment slope were consistently identified as key correlates of fish assemblage composition among models. The community classification models had high omission error rates and contributed fewer taxa to the 'expected' component of the taxonomic completeness (O/E-50) index than the other strategies. This potentially decreases the model sensitivity for site impact assessment. The ensemble model accurately and precisely modelled O/E-50 for the training data, but produced biased predictions for the external datasets. The multi-species response models afforded relatively high accuracy and precision coupled with low bias across external datasets and had lower taxa omission rates than the community classification models. They inherently included rare, but predictable species while excluding species that were poorly modelled among all strategies. We suggest that themulti-species response modelling strategy ismost suited to bioassessment using freshwater fish assemblages in our study area. At the species level, the ensemble model exhibited high sensitivity without reductions in specificity, relative to the other models. We suggest that this strategy is well suited to other non-bioassessment stream management applications, e.g., identifying priority areas for species conservation.	[Rose, Peter M.; Kennard, Mark J.; Sheldon, Fran] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Moffatt, David B.] Ecosci Precinct, Dept Sci Informat Technol & Innovat, Brisbane, Qld, Australia; [Butler, Gavin L.] Grafton Fisheries Ctr, NSW Dept Primary Ind, Grafton, Australia	Griffith University; NSW Department of Primary Industries	Rose, PM (corresponding author), Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia.	peter.rose@griffithuni.edu.au	Sheldon, Fran/C-3730-2009; Kennard, Mark James/C-3425-2008	Sheldon, Fran/0000-0001-9944-6392; Kennard, Mark James/0000-0003-4383-4999; Butler, Gavin/0000-0003-4933-5306; Moffatt, David/0000-0003-1170-9464	Australian Postgraduate Award scholarship	Australian Postgraduate Award scholarship	PMR was funded by an Australian Postgraduate Award scholarship.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Baselga A, 2009, ECOGRAPHY, V32, P55, DOI 10.1111/j.1600-0587.2009.05856.x; Bond N, 2011, MAR FRESHWATER RES, V62, P1043, DOI 10.1071/MF10286; Bond NR, 2014, DIVERS DISTRIB, V20, P931, DOI 10.1111/ddi.12213; Bonthoux S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054179; Boulton AJ, 1999, FRESHWATER BIOL, V41, P469, DOI 10.1046/j.1365-2427.1999.00443.x; Bouska KL, 2015, HYDROBIOLOGIA, V747, P159, DOI 10.1007/s10750-014-2134-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2002, MANUAL SETTING USING; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Bunn SE, 2010, FRESHWATER BIOL, V55, P223, DOI 10.1111/j.1365-2427.2009.02375.x; Cao Y, 2001, J N AM BENTHOL SOC, V20, P144, DOI 10.2307/1468195; Capinha C, 2011, DIVERS DISTRIB, V17, P13, DOI 10.1111/j.1472-4642.2010.00727.x; Casatti L, 2006, NEOTROP ICHTHYOL, V4, P203, DOI 10.1590/S1679-62252006000200006; Chapman DS, 2011, J BIOGEOGR, V38, P1524, DOI 10.1111/j.1365-2699.2011.02517.x; Chessman BC, 2006, MAR FRESHWATER RES, V57, P601, DOI 10.1071/MF06091; Clarke RT, 2006, FRESHWATER BIOL, V51, P1924, DOI 10.1111/j.1365-2427.2006.01611.x; Department of Environment Climate Change and Water NSW, NO RIV REG BIOD MAN; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; EHMP, EC HLTH MON PROGR 20; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Esselman PC, 2010, ECOL FRESHW FISH, V19, P439, DOI 10.1111/j.1600-0633.2010.00430.x; Feio MJ, 2014, FRESHW SCI, V33, P1286, DOI 10.1086/678768; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Fischer JR, 2008, ECOL FRESHW FISH, V17, P597, DOI 10.1111/j.1600-0633.2008.00311.x; Frederico RG, 2014, FRESHWATER BIOL, V59, P2303, DOI 10.1111/fwb.12432; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gido KB, 2006, AM FISH S S, V48, P265; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Grinnell J., 1917, Auk Cambridge Mass, V34; Hallstan S, 2012, ECOL MODEL, V231, P11, DOI 10.1016/j.ecolmodel.2012.01.018; Hartley SB, NSW DPI FRESHWATER F; Hastie T, 2010, MDA MIXTURE FLEXIBLE; Herborg LM, 2007, CAN J FISH AQUAT SCI, V64, P1723, DOI 10.1139/F07-130; Hermoso V, 2011, FRESHWATER BIOL, V56, P57, DOI 10.1111/j.1365-2427.2009.02390.x; Hermoso V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059662; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/f00-239; Joy M., 2013, FRESHWATER FISH PRED; Joy MK, 2014, FRESHWATER BIOL, V49, P1036; Kennard MJ, 2006, HYDROBIOLOGIA, V572, P33, DOI 10.1007/s10750-005-0993-8; Kennard MJ, 2007, CAN J FISH AQUAT SCI, V64, P1346, DOI 10.1139/F07-108; Kennard MJ, 2010, FRESHWATER BIOL, V55, P171, DOI 10.1111/j.1365-2427.2009.02307.x; Kristensen EA, 2012, ENVIRON MONIT ASSESS, V184, P1435, DOI 10.1007/s10661-011-2052-4; Leathwick JR, 2008, J BIOGEOGR, V35, P1481, DOI 10.1111/j.1365-2699.2008.01887.x; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Linke S, 2005, FRESHWATER BIOL, V50, P147, DOI 10.1111/j.1365-2427.2004.01286.x; Marchant R, 2002, J N AM BENTHOL SOC, V21, P311, DOI 10.2307/1468417; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; MCINTOSH RP, 1995, BIOL REV, V70, P317, DOI 10.1111/j.1469-185X.1995.tb01069.x; Moss D, 1999, FRESHWATER BIOL, V41, P167, DOI 10.1046/j.1365-2427.1999.00376.x; MOSS D, 1987, FRESHWATER BIOL, V17, P41, DOI 10.1111/j.1365-2427.1987.tb01027.x; Mugodo J, 2006, HYDROBIOLOGIA, V572, P59, DOI 10.1007/s10750-006-0252-7; Oakes RM, 2005, ECOL FRESHW FISH, V14, P361, DOI 10.1111/j.1600-0633.2005.00110.x; Oberdorff T, 2001, FRESHWATER BIOL, V46, P399, DOI 10.1046/j.1365-2427.2001.00669.x; Olden JD, 2003, CONSERV BIOL, V17, P854, DOI 10.1046/j.1523-1739.2003.01280.x; Olden JD, 2002, FRESHWATER BIOL, V47, P1976, DOI 10.1046/j.1365-2427.2002.00945.x; Olden JD, 2006, ECOL APPL, V16, P1449, DOI 10.1890/1051-0761(2006)016[1449:RTSICP]2.0.CO;2; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; Poos MS., 2010, THESIS; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Rose P, 2015, MAR FRESHW RES; Smith MJ, 1999, FRESHWATER BIOL, V41, P269, DOI 10.1046/j.1365-2427.1999.00430.x; Stein JL, 2014, HYDROL EARTH SYST SC, V18, P1917, DOI 10.5194/hess-18-1917-2014; Stein JL, 2002, LANDSCAPE URBAN PLAN, V60, P1, DOI 10.1016/S0169-2046(02)00048-8; Stewart-Koster B, 2007, MAR FRESHWATER RES, V58, P675, DOI 10.1071/MF06183; Stewart-Koster B, 2013, ECOGRAPHY, V36, P342, DOI 10.1111/j.1600-0587.2012.07764.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; Van Sickle J., 2011, DISTRIBUTION R SCRIP; Van Sickle J, 2008, J N AM BENTHOL SOC, V27, P227, DOI 10.1899/07-111.1; Van Sickle J, 2007, J N AM BENTHOL SOC, V26, P319, DOI 10.1899/0887-3593(2007)26[319:EORTAP]2.0.CO;2; VanDerWal J, 2012, SDMTOOLS SPECIES DIS; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Venables WN., 2002, MODERN APPL STAT S, V4; Walsh CJ, 2006, MAR FRESHWATER RES, V57, P37, DOI 10.1071/MF05041; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Wilson CD, 2011, BIOL CONSERV, V144, P821, DOI 10.1016/j.biocon.2010.11.014; Zambrano L, 2006, CAN J FISH AQUAT SCI, V63, P1903, DOI 10.1139/F06-088	84	21	24	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146728	10.1371/journal.pone.0146728	http://dx.doi.org/10.1371/journal.pone.0146728			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757155	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800029
J	Akdogan, E; Tardu, M; Garipler, G; Baytek, G; Kavakli, IH; Dunn, CD				Akdogan, Emel; Tardu, Mehmet; Garipler, Gorkem; Baytek, Gulkiz; Kavakli, I. Halil; Dunn, Cory D.			Reduced Glucose Sensation Can Increase the Fitness of Saccharomyces cerevisiae Lacking Mitochondrial DNA	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; RNA-POLYMERASE-III; NUCLEAR-LOCALIZATION; PETITE MUTATION; YEAST-CELLS; HEAT-SHOCK; SUBCELLULAR-LOCALIZATION; KLUYVEROMYCES-LACTIS; CELLULAR-METABOLISM; MEMBRANE PROTEIN	Damage to the mitochondrial genome (mtDNA) can lead to diseases for which there are no clearly effective treatments. Since mitochondrial function and biogenesis are controlled by the nutrient environment of the cell, it is possible that perturbation of conserved, nutrient-sensing pathways may successfully treat mitochondrial disease. We found that restricting glucose or otherwise reducing the activity of the protein kinase A (PKA) pathway can lead to improved proliferation of Saccharomyces cerevisiae cells lacking mtDNA and that the transcriptional response to mtDNA loss is reduced in cells with diminished PKA activity. We have excluded many pathways and proteins from being individually responsible for the benefits provided to cells lacking mtDNA by PKA inhibition, and we found that robust import of mitochondrial polytopic membrane proteins may be required in order for cells without mtDNA to receive the full benefits of PKA reduction. Finally, we have discovered that the transcription of genes involved in arginine biosynthesis and aromatic amino acid catabolism is altered after mtDNA damage. Our results highlight the potential importance of nutrient detection and availability on the outcome of mitochondrial dysfunction.	[Akdogan, Emel; Garipler, Gorkem; Baytek, Gulkiz; Kavakli, I. Halil; Dunn, Cory D.] Koc Univ, Dept Mol Biol & Genet, TR-34450 Istanbul, Turkey; [Tardu, Mehmet; Kavakli, I. Halil] Koc Univ, Dept Chem & Biol Engn, TR-34450 Istanbul, Turkey	Koc University; Koc University	Dunn, CD (corresponding author), Koc Univ, Dept Mol Biol & Genet, TR-34450 Istanbul, Turkey.	cdunn@ku.edu.tr		Dunn, Cory/0000-0003-2393-5944; AKDOGAN, EMEL/0000-0002-0649-6436; Kavakli, Ibrahim/0000-0001-6624-3505	European Research Council [637649]; European Molecular Biology Organization Installation Grant; Istanbul Development Agency [ISTKA-TR/14/EVK/0039]; Koc University	European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization Installation Grant; Istanbul Development Agency(Turkiye Cumhuriyeti Kalkinma Bakanligi); Koc University(Koc University)	This study was supported by the European Research Council Starting Grant 637649, (http://erc.europa.eu) to CDD; European Molecular Biology Organization Installation Grant, (http://www.embo.org) to CDD; Istanbul Development Agency Grant ISTKA-TR/14/EVK/0039, (http://www.istka.org.tr) to IHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gulayse Ince Dunn, Abdurrahman Keskin, Arwa Bayrakdar, Funda Kar, Sara Nafisi, and Bengisu Seferoglu for comments on this manuscript, and we appreciate Xin Jie Chen's (State University of New York Upstate Medical School) communication of unpublished results. We thank Rob Jensen (Johns Hopkins School of Medicine) for providing antibodies to hexokinase and Maya Schuldiner (Weizmann Institute) for hsf1-DAmP and TOM70-GFP strains. This work was supported by a European Research Council Starting Grant (637649-RevMito) to CDD, by a European Molecular Biology Organization Installation Grant to CDD, by an Istanbul Development Agency grant (ISTKA-TR/14/EVK/0039) to IHK, and by Koc University.	Afgan E, 2011, NAT BIOTECHNOL, V29, P972, DOI 10.1038/nbt.2028; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baker N, 2015, P NATL ACAD SCI USA, V112, P9112, DOI 10.1073/pnas.1505411112; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; Brachmann CB, 1998, YEAST, V14, P115; Breker M, 2013, J CELL BIOL, V200, P839, DOI 10.1083/jcb.201301120; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; BULDER CJE, 1964, ANTON VAN LEE J M S, V30, P442, DOI 10.1007/BF02046758; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; Chen WW, 2014, CELL REP, V7, P27, DOI 10.1016/j.celrep.2014.02.046; Chen XJ, 2000, INT REV CYTOL, V194, P197; Chen XJ, 2004, GENETICS, V167, P607, DOI 10.1534/genetics.103.023655; Chen XJ, 1998, MOL GEN GENET, V259, P457, DOI 10.1007/s004380050836; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Demlow CM, 2003, GENETICS, V165, P961; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; Devauz F, 2001, EMBO REP, V2, P493, DOI 10.1093/embo-reports/kve114; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; DIETMEIER K, 1993, J BIOL CHEM, V268, P25958; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Dirick L, 2014, G3-GENES GENOM GENET, V4, P411, DOI 10.1534/g3.113.010108; Dunn CD, 2006, MOL BIOL CELL, V17, P213, DOI 10.1091/mbc.e05-06-0585; Dunn CD, 2003, GENETICS, V165, P35; Dunn CD, 2008, MOL BIOL CELL, V19, P5387, DOI 10.1091/mbc.E08-01-0103; DUPONT CH, 1985, BIOCHEM BIOPH RES CO, V132, P1116, DOI 10.1016/0006-291X(85)91922-9; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Ferguson SB, 2005, GENETICS, V169, P1203, DOI 10.1534/genetics.104.034256; FOURY F, 1989, J BIOL CHEM, V264, P20552; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Garipler G, 2014, P NATL ACAD SCI USA, V111, P1473, DOI 10.1073/pnas.1312399111; Garipler G, 2013, GENETICS, V194, P285, DOI 10.1534/genetics.113.149708; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; Gerbeth C, 2013, CELL METAB, V18, P578, DOI 10.1016/j.cmet.2013.09.006; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; GOLDRING ES, 1970, J MOL BIOL, V52, P323, DOI 10.1016/0022-2836(70)90033-1; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gray MW, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016097; Hallstrom TC, 2000, J BIOL CHEM, V275, P37347, DOI 10.1074/jbc.M007338200; Hanyu Y, 2009, GENES CELLS, V14, P539, DOI 10.1111/j.1365-2443.2009.01290.x; Hedbacker K, 2004, MOL CELL BIOL, V24, P1836, DOI 10.1128/MCB.24.5.1836-1843.2004; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Ieva R, 2014, MOL CELL, V56, P641, DOI 10.1016/j.molcel.2014.10.010; JAUNIAUX JC, 1978, J BACTERIOL, V133, P1096, DOI 10.1128/JB.133.3.1096-1107.1978; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Kabir MA, 2005, YEAST, V22, P219, DOI 10.1002/yea.1210; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kemppainen E, 2015, PLOS ONE IN PRESS; Kerscher O, 2000, MOL BIOL CELL, V11, P103, DOI 10.1091/mbc.11.1.103; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005; Kominsky DJ, 2002, GENETICS, V162, P1595; KOVACOVA V, 1968, BIOCHIM BIOPHYS ACTA, V162, P157, DOI 10.1016/0005-2728(68)90097-2; Leadsham JE, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-92; Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1; Lee K, 2013, MOL MICROBIOL, V88, P1120, DOI 10.1111/mmi.12246; Lee P, 2013, FEBS LETT, V587, P3648, DOI 10.1016/j.febslet.2013.10.004; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lippman SI, 2009, P NATL ACAD SCI USA, V106, P19928, DOI 10.1073/pnas.0907027106; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; MALESZKA R, 1989, CURR GENET, V16, P429, DOI 10.1007/BF00340722; Miceli Michael V., 2012, Frontiers in Genetics, V2, P102, DOI 10.3389/fgene.2011.00102; Mitchell SF, 2014, MOL CELL, V54, P547, DOI 10.1016/j.molcel.2014.04.033; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Orlova M, 2008, YEAST, V25, P745, DOI 10.1002/yea.1628; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Peng M, 2015, HUM MOL GENET, V24, P4829, DOI 10.1093/hmg/ddv207; PFANNER N, 1986, FEBS LETT, V209, P152, DOI 10.1016/0014-5793(86)81101-2; Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; RAHMAN MU, 1995, BIOCHEM BIOPH RES CO, V214, P188, DOI 10.1006/bbrc.1995.2273; Ramachandran V, 2011, MOL CELL, V43, P973, DOI 10.1016/j.molcel.2011.06.032; Rao S, 2012, MOL BIOL CELL, V23, P1618, DOI 10.1091/mbc.E11-11-0933; REID GA, 1982, J BIOL CHEM, V257, P3056; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; SIKORSKI RS, 1989, GENETICS, V122, P19; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Suomalainen A, 2011, SEMIN FETAL NEONAT M, V16, P236, DOI 10.1016/j.siny.2011.05.003; Swinnen E, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-3; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Teng X, 2013, MOL CELL, V52, P485, DOI 10.1016/j.molcel.2013.09.026; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; THORSNESS PE, 1993, MOL CELL BIOL, V13, P5418, DOI 10.1128/MCB.13.9.5418; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tudisca V, 2010, EUR J CELL BIOL, V89, P339, DOI 10.1016/j.ejcb.2009.08.005; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Updyke TV, 1999, US Patent Office, Patent No. [US 6162338 A, 6162338]; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Voet D., 2010, BIOCHEMISTRY; Wang XW, 2008, NAT CELL BIOL, V10, P1090, DOI 10.1038/ncb1769; Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Yakura M, 2006, BIOSCI BIOTECH BIOCH, V70, P1740, DOI 10.1271/bbb.60088; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; Yang YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003693; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	136	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146511	10.1371/journal.pone.0146511	http://dx.doi.org/10.1371/journal.pone.0146511			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751567	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888100092
J	Chen, ZR; Shao, XJ; Dou, XW; Zhang, XX; Wang, YQ; Zhu, CH; Hao, CL; Fan, MY; Ji, W; Yan, YD				Chen, Zhengrong; Shao, Xuejun; Dou, Xunwu; Zhang, Xinxing; Wang, Yuqing; Zhu, Canhong; Hao, Chuangli; Fan, Mingyue; Ji, Wei; Yan, Yongdong			Role of the Mycoplasma pneumoniae/Interleukin-8/Neutrophil Axis in the Pathogenesis of Pneumonia	PLOS ONE			English	Article							MYCOPLASMA-PNEUMONIAE; HOSPITALIZED CHILDREN; LUNG; INTERLEUKIN-8; INFLAMMATION; NEUTROPHILS; INFECTION; PROFILES	Neutrophil infiltration is the characteristic pathological feature of M. pneumoniae pneumonia (MPP). This study aimed to explore the associations among neutrophil activity, clinical presentation, and role of the M. pneumoniae/interleukin-8 (IL-8)/neutrophil axis in the pathogenesis of MPP. A total of 42 patients with MPP were prospectively enrolled in the study. Neutrophil activity, including matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO), and neutrophil elastase (NE), were measured. Clinical information was collected for all patients and control group. In vitro, IL-8 production was measured at different time points after M. pneumoniae infection of bronchial epithelial cells, and neutrophil activity was analyzed after IL-8 stimulation. The percentage of neutrophil in the bronchoalveolar lavage fluid was higher in the group of patients with high levels of M. pneumoniae DNA than in those with low levels of M. pneumoniae DNA (P < 0.05). IL-8, MMP-9, and NE in patients with MPP significantly increased compared with controls and decreased after treatment (P < 0.05). MPO and MMP-9 were associated with duration of fever (r = 0.332, P < 0.05) and length of stay (r = 0.342, P < 0.05), respectively. In vitro, M. pneumoniae induced IL-8 production by bronchial epithelial cells in a time dependent manner. MPO, MMP-9 and NE production by neutrophils significantly increased compared with medium controls after IL-8 stimulation. In summary, the M. pneumoniae/IL-8/neutrophil axis likely plays a vital role in the pathogenesis of MPP.	[Chen, Zhengrong; Zhang, Xinxing; Wang, Yuqing; Zhu, Canhong; Hao, Chuangli; Ji, Wei; Yan, Yongdong] Soochow Univ, Childrens Hosp, Dept Resp Dis, Suzhou, Peoples R China; [Shao, Xuejun] Soochow Univ, Childrens Hosp, Dept Clin Lab, Suzhou, Peoples R China; [Dou, Xunwu; Fan, Mingyue] Soochow Univ, Childrens Hosp, Dept Ophthalmol & Otorhinolaryngol, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Ji, W (corresponding author), Soochow Univ, Childrens Hosp, Dept Resp Dis, Suzhou, Peoples R China.	szdxjiwei@163.com; yyd3060@163.com	Wang, yuqing/HIR-1604-2022		National Natural Science Foundation of China [81401296, 81570016]; Science and Technology Projects for the youth of Suzhou [KJXW2012019]; Suzhou Science and Technology Projects [SYS201350, SYS201435]; Science and Technology Projects of Suzhou sanitary bureau [lczx201409]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Projects for the youth of Suzhou; Suzhou Science and Technology Projects; Science and Technology Projects of Suzhou sanitary bureau	This work was supported by the National Natural Science Foundation of China (Zhengrong Chen, grant number 81401296; Wei Ji, grant number 81570016), Science and Technology Projects for the youth of Suzhou (Zhengrong Chen, grant number KJXW2012019), and Suzhou Science and Technology Projects (Zhengrong Chen, grant number SYS201350; Yongdong Yan, grant number SYS201435), Science and Technology Projects of Suzhou sanitary bureau (Yongdong Yan, grant number lczx201409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnet S, 1997, INFECTION, V25, P95, DOI 10.1007/BF02113584; Bose S, 2014, MBIO, V5, DOI 10.1128/mBio.02186-14; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Chen ZR, 2014, J MED VIROL, V86, P2154, DOI 10.1002/jmv.23952; Chen ZR, 2013, DIAGN MICR INFEC DIS, V77, P362, DOI 10.1016/j.diagmicrobio.2013.09.006; Chmura K, 2008, AM J PHYSIOL-LUNG C, V295, pL220, DOI 10.1152/ajplung.90204.2008; Dalboni TM, 2013, CYTOKINE, V61, P716, DOI 10.1016/j.cyto.2013.01.016; Gasparoto TH, 2011, J ORAL REHABIL, V38, P41, DOI 10.1111/j.1365-2842.2010.02126.x; Hardy RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007562; Kurai D, 2013, INFLAMMATION, V36, P285, DOI 10.1007/s10753-012-9545-3; Lai JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014417; Looney MR, 2009, NAT MED, V15, P364, DOI 10.1038/nm0409-364; Muir MT, 2011, CHEST, V139, P305, DOI 10.1378/chest.10-1222; Narita M, 2000, CLIN DIAGN LAB IMMUN, V7, P909, DOI 10.1128/CDLI.7.6.909-914.2000; Pease James E, 2002, Am J Respir Med, V1, P19; Huong PLT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1304; Saraya T, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00410; Sohn MH, 2005, CHEST, V128, P322, DOI 10.1378/chest.128.1.322; Waites KB, 2003, PEDIATR PULM, V36, P267, DOI 10.1002/ppul.10346; Waitest KB, 2008, FUTURE MICROBIOL, V3, P635, DOI 10.2217/17460913.3.6.635; Wang MJ, 2014, INT J INFECT DIS, V29, P18, DOI 10.1016/j.ijid.2014.07.020; Wu Q, 2013, AM J PATHOL, V182, P819, DOI 10.1016/j.ajpath.2012.11.005; Xu D, 2011, EUR J PEDIATR, V170, P851, DOI 10.1007/s00431-010-1360-y; Yano T, 1991, Kansenshogaku Zasshi, V65, P365	24	32	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146377	10.1371/journal.pone.0146377	http://dx.doi.org/10.1371/journal.pone.0146377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752656	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100073
J	Choi, Y; Kang, MY; Lee, JH; Kang, WH; Hwang, J; Kwon, JK; Kang, BC				Choi, Yoomi; Kang, Min-Young; Lee, Joung-Ho; Kang, Won-Hee; Hwang, Jeena; Kwon, Jin-Kyung; Kang, Byoung-Cheorl			Isolation and Characterization of Pepper Genes Interacting with the CMV-P1 Helicase Domain	PLOS ONE			English	Article							CUCUMBER-MOSAIC-VIRUS; TO-CELL MOVEMENT; FORMATE DEHYDROGENASE; ARABIDOPSIS-THALIANA; PHOSPHOMANNOMUTASE PMM; REPLICATION COMPLEX; MOLECULAR-CLONING; OVER-EXPRESSION; HOST FACTORS; PROTEIN	Cucumber mosaic virus (CMV) is a destructive pathogen affecting Capsicum annuum (pepper) production. The pepper Cmr1 gene confers resistance to most CMV strains, but is overcome by CMV-P1 in a process dependent on the CMV-P1 RNA1 helicase domain (P1 helicase). Here, to identify host factors involved in CMV-P1 infection in pepper, a yeast two-hybrid library derived from a C. annuum 'Bukang' cDNA library was screened, producing a total of 76 potential clones interacting with the P1 helicase. Beta-galactosidase filter lift assay, PCR screening, and sequencing analysis narrowed the candidates to 10 genes putatively involved in virus infection. The candidate host genes were silenced in Nicotiana benthamiana plants that were then inoculated with CMV-P1 tagged with the green fluorescent protein (GFP). Plants silenced for seven of the genes showed development comparable to N. benthamiana wild type, whereas plants silenced for the other three genes showed developmental defects including stunting and severe distortion. Silencing formate dehydrogenase and calreticulin-3 precursor led to reduced virus accumulation. Formate dehydrogenase- silenced plants showed local infection in inoculated leaves, but not in upper (systemic) leaves. In the calreticulin-3 precursor-silenced plants, infection was not observed in either the inoculated or the upper leaves. Our results demonstrate that formate dehydrogenase and calreticulin-3 precursor are required for CMV-P1 infection.	[Kang, Byoung-Cheorl] Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul 151921, South Korea; Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kang, BC (corresponding author), Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul 151921, South Korea.	bk54@snu.ac.kr	Kang, Byoung-Cheorl/Q-6174-2019	Kang, Won-Hee/0000-0002-8029-9158	Next-Generation BioGreen 21 Program (The Agricultural Genome Center), Rural Development Administration [PJ011204]; Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of Korea	Next-Generation BioGreen 21 Program (The Agricultural Genome Center), Rural Development Administration; Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of Korea	This study was supported by a grant from the Next-Generation BioGreen 21 Program (The Agricultural Genome Center No. PJ011204), Rural Development Administration, and from the Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of Korea.	Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Ambard-Bretteville F, 2003, BIOCHEM BIOPH RES CO, V311, P966, DOI 10.1016/j.bbrc.2003.10.099; Canto T, 1997, VIROLOGY, V237, P237, DOI 10.1006/viro.1997.8804; Chen MH, 2005, PLANT PHYSIOL, V138, P1866, DOI 10.1104/pp.105.064386; Choi DS, 2014, PLANT PHYSIOL, V166, P1298, DOI 10.1104/pp.114.246736; Christensen A, 2008, PLANT CELL PHYSIOL, V49, P912, DOI 10.1093/pcp/pcn065; David P, 2010, THEOR APPL GENET, V121, P87, DOI 10.1007/s00122-010-1293-x; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; DING BA, 1995, VIROLOGY, V207, P345, DOI 10.1006/viro.1995.1093; Dong Y, 2007, PLANT PHYSIOL, V145, P1161, DOI 10.1104/pp.107.107391; Edwardson JR, 1991, CRC HDB VIRUSES INFE; Guo HS, 2002, EMBO J, V21, P398, DOI 10.1093/emboj/21.3.398; HAYES RJ, 1990, CELL, V63, P363, DOI 10.1016/0092-8674(90)90169-F; Herman PL, 2002, PLANT SCI, V163, P1137, DOI 10.1016/S0168-9452(02)00326-6; Hourton-Cabassa C, 1998, PLANT PHYSIOL, V116, P627, DOI 10.1104/pp.116.2.627; Huh SU, 2011, NEW PHYTOL, V191, P746, DOI 10.1111/j.1469-8137.2011.03717.x; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Jia XY, 2008, J EXP BOT, V59, P739, DOI 10.1093/jxb/erm369; Jia XY, 2009, PHYSIOL PLANTARUM, V136, P127, DOI [10.1111/j.1399-3054.2009.1223.x, 10.1111/j.1399-3054.2009.01223.x]; Jin ZL, 2005, TRANSGENIC RES, V14, P619, DOI 10.1007/s11248-005-5694-6; 이미연, 2006, The Plant Pathology Journal, V22, P265; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; Kang WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043136; Kang WH, 2010, THEOR APPL GENET, V120, P1587, DOI 10.1007/s00122-010-1278-9; Kim MJ, 2008, J VIROL, V82, P4823, DOI 10.1128/JVI.02518-07; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; Komatsu S, 2007, MOL GENET GENOMICS, V277, P713, DOI 10.1007/s00438-007-0220-6; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Lee WY, 2003, PHYSIOL PLANTARUM, V119, P573, DOI 10.1046/j.1399-3054.2003.00215.x; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Li QB, 2001, MOL PLANT MICROBE IN, V14, P378, DOI 10.1094/MPMI.2001.14.3.378; Li ZJ, 2000, EUR J BIOCHEM, V267, P737, DOI 10.1046/j.1432-1327.2000.01052.x; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Nardi MC, 2006, PLANTA, V223, P1263, DOI 10.1007/s00425-005-0175-y; Nelson DE, 1997, PLANT PHYSIOL, V114, P29, DOI 10.1104/pp.114.1.29; Olson BJSC, 2000, PLANT SCI, V159, P205, DOI 10.1016/S0168-9452(00)00337-X; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; Persson S, 2003, PLANT PHYSIOL, V133, P1385, DOI 10.1104/pp.103.024943; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Qian WQ, 2007, PLANT J, V49, P399, DOI 10.1111/j.1365-313X.2006.02967.x; Qiu YJ, 2012, PLANT J, V69, P489, DOI 10.1111/j.1365-313X.2011.04807.x; Reichel C, 2000, J VIROL, V74, P3330, DOI 10.1128/JVI.74.7.3330-3337.2000; Sekine KT, 2004, MOL PLANT MICROBE IN, V17, P623, DOI 10.1094/MPMI.2004.17.6.623; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; SINDELAR L, 1982, BIOL PLANTARUM, V24, P142, DOI 10.1007/BF02902861; Stapleford KA, 2010, VIRUSES-BASEL, V2, P1055, DOI 10.3390/v2051055; TESAR M, 1990, VIROLOGY, V174, P364, DOI 10.1016/0042-6822(90)90090-E; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; Valcu CM, 2009, J PROTEOME RES, V8, P4077, DOI 10.1021/pr900456c; Whitham SA, 2004, CURR OPIN PLANT BIOL, V7, P365, DOI 10.1016/j.pbi.2004.04.006; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Xu LS, 2010, PLANT PHYSIOL BIOCH, V48, P461, DOI 10.1016/j.plaphy.2010.03.002; Yang CL, 2007, MOL PLANT MICROBE IN, V20, P358, DOI 10.1094/MPMI-20-4-0358; Yeom SI, 2012, PLANT J, V69, P755, DOI 10.1111/j.1365-313X.2011.04828.x; Yu CM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-214; Zhou YC, 2011, J VIROL, V85, P11821, DOI 10.1128/JVI.00082-11	59	5	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146320	10.1371/journal.pone.0146320	http://dx.doi.org/10.1371/journal.pone.0146320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751216	Green Published, gold			2022-12-27	WOS:000367888100062
J	Frankowiak, K; Kret, S; Mazur, M; Meibom, A; Kitahara, MV; Stolarski, J				Frankowiak, Katarzyna; Kret, Slawomir; Mazur, Maciej; Meibom, Anders; Kitahara, Marcelo V.; Stolarski, Jaroslaw			Fine-Scale Skeletal Banding Can Distinguish Symbiotic from Asymbiotic Species among Modern and Fossil Scleractinian Corals	PLOS ONE			English	Article							SOLUBLE MINERALIZING MATRICES; PHOSPHATE-UPTAKE; GROWTH; CALCIFICATION; ZOOXANTHELLAE; BIOMINERALIZATION; PHOTOSYNTHESIS; MECHANISMS; DIAGENESIS; ARAGONITE	Understanding the evolution of scleractinian corals on geological timescales is key to predict how modern reef ecosystems will react to changing environmental conditions in the future. Important to such efforts has been the development of several skeleton-based criteria to distinguish between the two major ecological groups of scleractinians: zooxanthellates, which live in symbiosis with dinoflagellate algae, and azooxanthellates, which lack endosymbiotic dinoflagellates. Existing criteria are based on overall skeletal morphology and bio/geo-chemical indicators-none of them being particularly robust. Here we explore another skeletal feature, namely fine-scale growth banding, which differs between these two groups of corals. Using various ultra-structural imaging techniques (e.g., TEM, SEM, and NanoSIMS) we have characterized skeletal growth increments, composed of doublets of optically light and dark bands, in a broad selection of extant symbiotic and asymbiotic corals. Skeletons of zooxanthellate corals are characterized by regular growth banding, whereas in skeletons of azooxanthellate corals the growth banding is irregular. Importantly, the regularity of growth bands can be easily quantified with a coefficient of variation obtained by measuring bandwidths on SEM images of polished and etched skeletal surfaces of septa and/or walls. We find that this coefficient of variation (lower values indicate higher regularity) ranges from similar to 40 to similar to 90% in azooxanthellate corals and from similar to 5 to similar to 15% in symbiotic species. With more than 90% (28 out of 31) of the studied corals conforming to this microstructural criterion, it represents an easy and robust method to discriminate between zooxanthellate and azooxanthellate corals. This microstructural criterion has been applied to the exceptionally preserved skeleton of the Triassic (Norian, ca. 215 Ma) scleractinian Volzeia sp., which contains the first example of regular, fine-scale banding of thickening deposits in a fossil coral of this age. The regularity of its growth banding strongly suggests that the coral was symbiotic with zooxanthellates.	[Frankowiak, Katarzyna; Stolarski, Jaroslaw] Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland; [Kret, Slawomir] Polish Acad Sci, Inst Phys, PL-02668 Warsaw, Poland; [Mazur, Maciej] Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland; [Meibom, Anders] Ecole Polytech Fed Lausanne, Lab Biol Geochem, Sch Architecture Civil & Environm Engn, CH-1015 Lausanne, Switzerland; [Meibom, Anders] Univ Lausanne, Ctr Adv Surface Anal, Inst Earth Sci, CH-1015 Lausanne, Switzerland; [Kitahara, Marcelo V.] Univ Fed SaoPaulo, Dept Ciencias Mar, BR-11030400 Santos, Brazil	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; University of Warsaw; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Stolarski, J (corresponding author), Polish Acad Sci, Inst Paleobiol, Twarda 51-55, PL-00818 Warsaw, Poland.	stolacy@twarda.pan.pl	Frankowiak, Katarzyna/E-1281-2017; Stolarski, Jaroslaw/AAF-7331-2019; Stolarski, Jaroslaw/V-9586-2017; Kitahara, Marcelo Visentini/D-5560-2011; Kret, Slawomir/D-5585-2012	Frankowiak, Katarzyna/0000-0003-1378-3852; Stolarski, Jaroslaw/0000-0003-0994-6823; Stolarski, Jaroslaw/0000-0003-0994-6823; Kitahara, Marcelo Visentini/0000-0003-4011-016X; Kret, Slawomir/0000-0002-3532-5708; Mazur, Maciej/0000-0002-9197-5553; Meibom, Anders/0000-0002-4542-2819	European Union within the European Regional Development Fund, through the Innovative Economy Operational Program [POIG.02.02.00-00-025/09, POIG.02.01-00-14-032/08]; European Research Council (ERC) [246749]; National Science Centre (Poland) [DEC-2011/03/N/ST10/06470]	European Union within the European Regional Development Fund, through the Innovative Economy Operational Program; European Research Council (ERC)(European Research Council (ERC)); National Science Centre (Poland)	This work was partially supported by the European Union within the European Regional Development Fund, through the Innovative Economy Operational Program POIG.02.02.00-00-025/09 (NanoFun; cathodolumienscence microscopy) and POIG.02.01-00-14-032/08 (transmission electron microscopy), European Research Council (ERC) Advanced Grant 246749 BIOCARB (to AM), and the National Science Centre (Poland) research grant DEC-2011/03/N/ST10/06470 (to KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Barbeitos MS, 2010, P NATL ACAD SCI USA, V107, P11877, DOI 10.1073/pnas.0914380107; Benzerara K, 2011, ULTRAMICROSCOPY, V111, P1268, DOI 10.1016/j.ultramic.2011.03.023; Bertucci A, 2015, MOL ECOL, V24, P4489, DOI 10.1111/mec.13328; Bertucci A, 2013, BIOORGAN MED CHEM, V21, P1437, DOI 10.1016/j.bmc.2012.10.024; Bice KL, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000974; Brahmi C, 2012, CORAL REEFS, V31, P741, DOI 10.1007/s00338-012-0890-3; Budd AF, 2009, ACTA ZOOL-STOCKHOLM, V90, P142, DOI 10.1111/j.1463-6395.2008.00345.x; Cairns SD, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.227.3612; COATES AG, 1987, PALEOBIOLOGY, V13, P363; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; CUIF J, 1972, CR ACAD SCI D NAT, V275, P185; CUIF J-P, 1975, Geobios (Villeurbanne), V8, P157, DOI 10.1016/S0016-6995(75)80035-0; Cuif Jean-Pierre, 1998, Palaeontologische Zeitschrift, V72, P257; Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4; Cuif JP, 1999, INT J EARTH SCI, V88, P582, DOI 10.1007/s005310050286; Cuif JP, 1999, COMP BIOCHEM PHYS A, V123, P269, DOI 10.1016/S1095-6433(99)00059-8; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Domart-Coulon I, 2014, J STRUCT BIOL, V185, P79, DOI 10.1016/j.jsb.2013.10.012; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Finch AA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033543; Frankowiak K, 2013, PALAIOS, V28, P333, DOI 10.2110/palo.2012.p12-116r; FRICKE HW, 1987, OECOLOGIA, V73, P371, DOI 10.1007/BF00385253; Furla P, 2000, J EXP BIOL, V203, P3445; Gattuso JP, 1999, AM ZOOL, V39, P160; Gautret P, 1997, FACIES, V36, P189, DOI 10.1007/BF02536884; Godinot C, 2009, LIMNOL OCEANOGR, V54, P1627, DOI 10.4319/lo.2009.54.5.1627; Goffredo S, 2012, GEOCHIM COSMOCHIM AC, V85, P187, DOI 10.1016/j.gca.2012.02.014; GOREAU TF, 1959, BIOL BULL, V116, P59, DOI 10.2307/1539156; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hoeksema BW, 1989, ZOOLOGISCHE VERHANDE, V254, P1; Houlbreque F, 2004, MAR ECOL PROG SER, V282, P151, DOI 10.3354/meps282151; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; JACKSON AE, 1990, P ROY SOC B-BIOL SCI, V242, P201, DOI 10.1098/rspb.1990.0125; Kawaguti S., 1948, Bulletin of the Oceanographical Institute of Taiwan, VNo. 4, P65; Kopp C, 2013, MBIO, V4, DOI 10.1128/mBio.00052-13; Kopp C, 2015, MBIO, V6, DOI 10.1128/mBio.02299-14; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Marcelino LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061492; Meibom A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021313; Meibom A, 2008, GEOCHIM COSMOCHIM AC, V72, P1555, DOI 10.1016/j.gca.2008.01.009; Motai S, 2012, J STRUCT BIOL, V180, P389, DOI 10.1016/j.jsb.2012.09.009; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Ogilvie Maria M., 1896, Philosophical Transactions, Vclxxxvii, P83; Perrin C, 2007, CR PALEVOL, V6, P253, DOI 10.1016/j.crpv.2007.02.003; Perrin Christine, 2002, P587, DOI 10.2110/pec.02.72.0587; PETERS EC, 1988, P BIOL SOC WASH, V101, P234; Pokroy B, 2004, NAT MATER, V3, P900, DOI 10.1038/nmat1263; Przenioslo R, 2008, J STRUCT BIOL, V161, P74, DOI 10.1016/j.jsb.2007.09.020; RISK MJ, 1992, NATURE, V358, P572, DOI 10.1038/358572a0; Roniewicz E, 1989, DENKSCHR OSTERR AKAD, V126, P1; Rosen B.R., 1989, Memoir of the Association of Australasian Palaeontologists, V8, P355; Sandeman IM, 2008, REV BIOL TROP, V56, P1; Sandeman I. M, 2006, Rev. biol. trop, V54, P79; Sandeman IM, 2008, P 11 INT COR REEF S, V1, P69; SCHLICHTER D, 1990, NATURWISSENSCHAFTEN, V77, P447, DOI 10.1007/BF01135950; SCHLICHTER D, 1992, HELGOLANDER MEERESUN, V45, P423; SCHLICHTER D, 1986, MAR BIOL, V91, P403, DOI 10.1007/BF00428634; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P149, DOI 10.1016/j.palaeo.2005.03.054; SCHUHMACHER H, 1985, CORAL REEFS, V4, P1, DOI 10.1007/BF00302198; SIMKISS K, 1964, BIOL REV, V39, P487, DOI 10.1111/j.1469-185X.1964.tb01166.x; Sorek M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2942; STANLEY G D JR, 1988, Palaios, V3, P170; STANLEY GD, 1981, GEOLOGY, V9, P507, DOI 10.1130/0091-7613(1981)9<507:EHOSCA>2.0.CO;2; STANLEY GD, 1995, PALEOBIOLOGY, V21, P179, DOI 10.1017/S0094837300013191; Stolarski J, 2005, ACTA PALAEONTOL POL, V50, P847; Stolarski J, 2003, ACTA PALAEONTOL POL, V48, P497; SWART PK, 1983, EARTH-SCI REV, V19, P51, DOI 10.1016/0012-8252(83)90076-4; TRENCH RK, 1993, ENDOCYTOBIOSIS CELL, V9, P135; Webb GE, 2009, SEDIMENTOLOGY, V56, P1433, DOI 10.1111/j.1365-3091.2008.01041.x; Zibrowius H, 1980, MEMOIRES DE LINSTITU, V11, P198; Zolotoyabko E, 2007, CRYSTENGCOMM, V9, P1156, DOI 10.1039/b708704g	75	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0147066	10.1371/journal.pone.0147066	http://dx.doi.org/10.1371/journal.pone.0147066			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751803	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100192
J	Larsen, KS; Pottegard, A; Lindegaard, HM; Hallas, J				Larsen, Kasper Soltoft; Pottegard, Anton; Lindegaard, Hanne M.; Hallas, Jesper			Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control Study	PLOS ONE			English	Article							HIGH-DOSE ALLOPURINOL; XANTHINE-OXIDASE; SERUM URATE; GOUT; HYPERURICEMIA; REGISTRATION; FEBUXOSTAT; MANAGEMENT; INHIBITORS; REGISTERS	Background Gout gives rise to increased risk of cardiovascular events. Gout attacks can be effectively prevented with urate lowering drugs, and allopurinol potentially reduces cardiovascular risk. What target level of urate is required to reduce cardiovascular risk is not known. Objectives To investigate the effect of achieving target plasma urate with allopurinol on cardiovascular outcomes in a case-control study nested within long-term users of allopurinol. Methods We identified long-term users of allopurinol in Funen County, Denmark. Among these, we identified all cases of cardiovascular events and sampled 4 controls to each case from the same population. The cases and controls were compared with respect to whether they reached a urate target below 0.36 mmol/l on allopurinol. The derived odds ratios were controlled for potential confounders available from data on prescriptions, laboratory values and in-and outpatient contacts. Results No association between treatment-to-target urate level and cardiovascular events were found (adjusted odds ratio of 1.01, 95% confidence interval 0.79-1.28). No significant effect was seen in any subgroup defined by age, gender, renal function, allopurinol dose or the achieved urate level. Overall, the doses of allopurinol used in this study were low (mean approximate to 140 mg/day). Conclusion We were unable to demonstrate a link between achieved urate level in patients treated with allopurinol and risk of cardiovascular events. Possible explanations include that allopurinol doses higher than those used in this study are required to achieve cardiovascular risk reduction or that the cardiovascular effect of allopurinol is not mediated through low urate levels. It remains to be seen whether allopurinol has a dose-response relationship with cardiovascular events at higher doses.	[Larsen, Kasper Soltoft; Pottegard, Anton; Hallas, Jesper] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, DK-5000 Odense C, Denmark; [Hallas, Jesper] Odense Univ Hosp, Dept Clin Chem & Pharmacol, DK-5000 Odense C, Denmark; [Larsen, Kasper Soltoft; Lindegaard, Hanne M.] Odense Univ Hosp, Dept Rheumatol, DK-5000 Odense C, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Larsen, KS (corresponding author), Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, JB Winsloewvej 19-2, DK-5000 Odense C, Denmark.	kaslarsen@health.sdu.dk	Lindegaard, Hanne Merete/AAV-5437-2020	Lindegaard, Hanne Merete/0000-0002-5675-3859; Soltoft, Kasper/0000-0002-1111-8050; Pottegard, Anton/0000-0001-9314-5679	University of Southern Denmark	University of Southern Denmark	This paper presents independent research funded by the University of Southern Denmark.	Agarwal A, 2011, CRIT REV BIOTECHNOL, V31, P264, DOI 10.3109/07388551.2010.527823; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Chlopicki S, 2005, PHARMACOL REP, V57, P86; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Collaboration AT, 1994, BMJ-BRIT MED J, V8, P81; Dalbeth N, 2006, J RHEUMATOL, V33, P1646; de Abajo FJ, 2015, HEART, V101, P679, DOI 10.1136/heartjnl-2014-306670; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Gaist D, 1997, DAN MED BULL, V44, P445; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Kayyali US, 2003, TOXICOL APPL PHARM, V188, P59, DOI 10.1016/S0041-008X(02)00076-5; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kourliouros A, 2008, ANN THORAC SURG, V85, P1515, DOI 10.1016/j.athoracsur.2008.01.040; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Methodology WCC for DS, 2010, GUID ATC CLASS DDD A; National Kidney Foundation, 2002, KDOQI CLIN PRACT GUI; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Rajendra NS, 2011, J AM COLL CARDIOL, V58, P820, DOI 10.1016/j.jacc.2010.12.052; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; ROTHMAN KJ, EPIDEMIOLOGY INTRO; Samy Suissa, 2015, QUASICOHORT APPROACH; Sarawate CA, 2006, JCR-J CLIN RHEUMATOL, V12, P61, DOI 10.1097/01.rhu.0000209882.50228.9f; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Tausche AK, 2014, RHEUMATOL INT, V34, P101, DOI 10.1007/s00296-013-2857-2; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P8, DOI 10.1177/1403494811409654; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Tiong AY, 2005, AM HEART J, V150, P11, DOI 10.1016/j.ahj.2004.12.019; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wei L, 2011, BRIT J CLIN PHARMACO, V71, P600, DOI 10.1111/j.1365-2125.2010.03887.x; Wildenschild C, 2014, CLIN EPIDEMIOL, V6, P27, DOI 10.2147/CLEP.S50449; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146172	10.1371/journal.pone.0146172	http://dx.doi.org/10.1371/journal.pone.0146172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751377	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100049
J	Lopes, JFS; Brugger, MS; Menezes, RB; Camargo, RS; Forti, LC; Fourcassie, V				Lopes, Juliane F. S.; Brugger, Mariana S.; Menezes, Regys B.; Camargo, Roberto S.; Forti, Luiz Carlos; Fourcassie, Vincent			Spatio-Temporal Dynamics of Foraging Networks in the Grass-Cutting Ant Atta bisphaerica Forel, 1908 (Formicidae, Attini)	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; TRUNK TRAILS; PLASTICITY; STRATEGIES; EFFICIENCY; SELECTION; SYSTEM; GROWTH; PLANTS; LEVEL	Foraging networks are a key element for ant colonies because they facilitate the flow of resources from the environment to the nest and they allow the sharing of information among individuals. Here we report the results of an 8-month survey, extending from November 2009 to June 2010, of the foraging networks of four mature colonies of Atta bisphaerica, a species of grass-cutting ant which is considered as a pest in Brazil. We found that the distribution of foraging effort was strongly influenced by the landscape features around the nests, in particular by the permanently wet parts of the pasture in which the nests were located. The foraging networks consisted of underground tunnels which opened on average at 21.5m from the nests and of above-ground physical trails that reached on average 4.70m in length. The use of the foraging networks was highly dynamic, with few sections of the networks used for long periods of time. Three different phases, which could be linked to the seasonal change in the local rainfall regime, could be identified in the construction and use of the foraging networks. The first phase corresponded to the beginning of the rainy season and was characterized by a low foraging activity, as well as a low excavation and physical trail construction effort. The second phase, which began in February and extended up to the end of the humid season at the end of March, was characterized by an intense excavation and trail construction effort, resulting in an expansion of the foraging networks. Finally, in the third phase, which corresponded to the beginning of the dry season, the excavation and trail construction effort leveled off or decreased while foraging activity kept increasing. Our hypothesis is that ants could benefit from the underground tunnels and physical trails built during the humid season to maintain their foraging activity at a high level.	[Lopes, Juliane F. S.; Menezes, Regys B.] Univ Fed Juiz de Fora, Programa Pos Grad Ciencias Biol Comportamento & B, Juiz De Fora, MG, Brazil; [Lopes, Juliane F. S.] Univ Fed Juiz de Fora, Programa Pos Grad Ecol, Juiz De Fora, MG, Brazil; [Brugger, Mariana S.; Camargo, Roberto S.; Forti, Luiz Carlos] Univ Estadual Paulista, Dept Prod Vegetal, Fac Ciencias Agron, Botucatu, SP, Brazil; [Fourcassie, Vincent] Univ Fed Toulouse Midipyrenees, Univ Toulouse 3, Ctr Rech Cognit Anim, Toulouse 9, France; [Fourcassie, Vincent] CNRS, Ctr Rech Cognit Anim, UMR 5169, Toulouse 9, France	Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade Estadual Paulista; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Lopes, JFS (corresponding author), Univ Fed Juiz de Fora, Programa Pos Grad Ciencias Biol Comportamento & B, Campus Univ Martelos, Juiz De Fora, MG, Brazil.	julianeflopes@yahoo.com.br	lopes, juliane/C-6312-2013; Fourcassié, Vincent/AAJ-9016-2020; Carmargo, Roberto da Silva/B-5765-2011	lopes, juliane/0000-0001-7481-3109; Carmargo, Roberto da Silva/0000-0001-8772-421X; Camargo, Roberto/0000-0001-6723-5355	Capes (Coordenacao de Aperfercoamento de Pessoal de Nivel Superior)/Cofecub (Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil) [633/09]	Capes (Coordenacao de Aperfercoamento de Pessoal de Nivel Superior)/Cofecub (Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Capes (Coordenacao de Aperfercoamento de Pessoal de Nivel Superior)/Cofecub (Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil) project no633/09 "Characterisation of collective foraging activity in Neotropical ants and termites and study of its impact on the soils" to JFSL, LCF and VF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2001, INSECT SOC, V48, P291, DOI 10.1007/PL00001781; Araujo M. S., 2004, Revista Brasileira de Zoologia, V21, P33, DOI 10.1590/S0101-81752004000100006; BATES GH, 1950, J ANIM ECOL, V19, P21, DOI 10.2307/1568; Batschelet E, 1981, CIRCULAR STAT BIOL; Bouchebti S, 2015, INSECT SOC, V62, P97, DOI 10.1007/s00040-014-0378-y; BRENER AGF, 1993, REV BIOL TROP, V41, P891; Buhl J, 2009, BEHAV ECOL SOCIOBIOL, V63, P451, DOI 10.1007/s00265-008-0680-7; Castellani MA, 2009, SOCIOBIOLOGY, V54, P283; CHERRETT JM, 1972, J ANIM ECOL, V41, P647, DOI 10.2307/3200; Cuddington K, 2007, THEOR ECOL SER, P1; Silva PSD, 2013, ENTOMOL EXP APPL, V147, P110, DOI 10.1111/eea.12050; Delabie JH, 2011, FORMIGAS CORTADEIRAS, P80; DEVASCONCELOS HL, 1990, INSECT SOC, V37, P131, DOI 10.1007/BF02224026; Dussutour A, 2007, INSECT SOC, V54, P158, DOI 10.1007/s00040-007-0926-9; Farji-Brener AG, 1998, ECOSCIENCE, V5, P271, DOI 10.1080/11956860.1998.11682464; Forti LC, 1985, THESIS; Fourcassie V, 2010, J EXP BIOL, V213, P2357, DOI 10.1242/jeb.031237; Fowler H.G., 1986, P18; FOWLER HG, 1993, J APPL ENTOMOL, V116, P420, DOI 10.1111/j.1439-0418.1993.tb01216.x; FOWLER HG, 1990, WESTV STUD, P3; FRANKS NR, 1983, BEHAV ECOL SOCIOBIOL, V12, P261, DOI 10.1007/BF00302894; GOSS S, 1989, INSECT SOC, V36, P339, DOI 10.1007/BF02224885; HOLLDOBLER B, 1980, INSECT SOC, V27, P237, DOI 10.1007/BF02223667; HOLLDOBLER B, 1980, SCIENCE, V210, P732, DOI 10.1126/science.210.4471.732; Holldobler B., 1990, pi; Holldobler B., 2010, LEAF CUTTING ANTS CI; Howard JJ, 2001, BEHAV ECOL SOCIOBIOL, V49, P348, DOI 10.1007/s002650000314; HOWARD JJ, 1990, OECOLOGIA, V82, P394, DOI 10.1007/BF00317488; Kost C, 2005, J TROP ECOL, V21, P677, DOI 10.1017/S0266467405002592; Latty T, 2011, J R SOC INTERFACE, V8, P1298, DOI 10.1098/rsif.2010.0612; LOPEZ F, 1994, J ANIM ECOL, V63, P127, DOI 10.2307/5589; Lube LM, 2007, BIOLOGICO, V69, P301; MABELIS AA, 1979, NETH J ZOOL, V29, P451, DOI 10.1163/002829679X00016; Mariconi FAM, 1970, AS SAUVAS; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; Moreira AA, 2004, J APPL ENTOMOL, V128, P204, DOI 10.1111/j.1439-0418.2004.00839.x; Moreira Aldenise Alves, 2002, Acta Scientiarum Universidade Estadual de Maringa, V24, P369; Perna A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0334; Pielstrom S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095658; QUINET Y, 1991, BELG J ZOOL, V121, P55; ROCKWOOD LL, 1987, OECOLOGIA, V74, P55, DOI 10.1007/BF00377345; Rosengren R., 1987, Experientia Supplementum (Basel), V54, P117; Rosengren R., 1971, Acta Zoologica Fennica, V133, P1; SHEPHERD JD, 1982, BEHAV ECOL SOCIOBIOL, V11, P77, DOI 10.1007/BF00300095; Stager R., 1936, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V16, P679; TRANIELLO JFA, 1991, ETHOL ECOL EVOL, V3, P35, DOI 10.1080/08927014.1991.9525387; WALLER DA, 1982, OECOLOGIA, V52, P400, DOI 10.1007/BF00367966; Wirth R, 1997, J TROP ECOL, V13, P741, DOI 10.1017/S0266467400010907; Wirth R, 2003, ECOLOGICAL STUDIES S, V164; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur Alain F., 2009, P1	51	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146613	10.1371/journal.pone.0146613	http://dx.doi.org/10.1371/journal.pone.0146613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752413	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100113
J	Paulose, JK; Wright, JM; Patel, AG; Cassone, VM				Paulose, Jiffin K.; Wright, John M.; Patel, Akruti G.; Cassone, Vincent M.			Human Gut Bacteria Are Sensitive to Melatonin and Express Endogenous Circadian Rhythmicity	PLOS ONE			English	Article							COENZYME-A BIOSYNTHESIS; CLOCK GENE-EXPRESSION; GASTROINTESTINAL-TRACT; KAIC PHOSPHORYLATION; CYANOBACTERIAL; TIME; PURIFICATION; OSCILLATOR; MOTILITY	Circadian rhythms are fundamental properties of most eukaryotes, but evidence of biological clocks that drive these rhythms in prokaryotes has been restricted to Cyanobacteria. In vertebrates, the gastrointestinal system expresses circadian patterns of gene expression, motility and secretion in vivo and in vitro, and recent studies suggest that the enteric microbiome is regulated by the host's circadian clock. However, it is not clear how the host's clock regulates the microbiome. Here, we demonstrate at least one species of commensal bacterium from the human gastrointestinal system, Enterobacter aerogenes, is sensitive to the neurohormone melatonin, which is secreted into the gastrointestinal lumen, and expresses circadian patterns of swarming and motility. Melatonin specifically increases the magnitude of swarming in cultures of E. aerogenes, but not in Escherichia coli or Klebsiella pneumoniae. The swarming appears to occur daily, and transformation of E. aerogenes with a flagellar motor-protein driven lux plasmid confirms a temperature-compensated circadian rhythm of luciferase activity, which is synchronized in the presence of melatonin. Altogether, these data demonstrate a circadian clock in a non-cyanobacterial prokaryote and suggest the human circadian system may regulate its microbiome through the entrainment of bacterial clocks.	[Paulose, Jiffin K.; Wright, John M.; Patel, Akruti G.; Cassone, Vincent M.] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA	University of Kentucky	Cassone, VM (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.	Vincent.Cassone@uky.edu	Cassone, Vincent/AAD-5191-2022; Paulose, Jiffin/AAA-9296-2020	Paulose, Jiffin/0000-0002-0061-7786	National Institutes of Health [R01 AG045833-01]; United States Department of Agriculture [NIFA 2014-67012-21608]; Howard Hughes Medical Institute Science Education Grant; NATIONAL INSTITUTE ON AGING [R01AG045833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); Howard Hughes Medical Institute Science Education Grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Cassone (VMC) laboratory is supported by National Institutes of Health R01 AG045833-01, "Circadian rhythms and melatonin signaling in the aging gastrointestinal system"; United States Department of Agriculture NIFA 2014-67012-21608, "The role of the premammillary nucleus in the regulation of broodiness in the domestic turkey" (Mentor; Dr. Ashli Moore post-doctoral fellow); and Howard Hughes Medical Institute Science Education Grant, "Student Retention and Success in STEM through collaborative and multi-layered STEMCats Freshmen Program."	Acuna-Castroviejo D, 2014, CELL MOL LIFE SCI, V71, P2997, DOI 10.1007/s00018-014-1579-2; Aminov RI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00158; Axmann IM, 2014, MAR GENOM, V14, P3, DOI 10.1016/j.margen.2013.12.006; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brzozowski T, 2014, CURR PHARM DESIGN, V20, P4785; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; Bubenik GA, 1997, BIOL SIGNAL, V6, P40; Chen CQ, 2011, WORLD J GASTROENTERO, V17, P3888, DOI 10.3748/wjg.v17.i34.3888; Clerico EM, 2009, MICROBIOLOGY 2   MAR, P635, DOI [10.1099/mic.0.022343-0, DOI 10.1099/MIC.0.022343-0]; de Kivit S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00060; Deng Y, 2015, MOL NEUROBIOL, V51, P68, DOI 10.1007/s12035-014-8789-3; Difco Laboratories, 1984, DIFC MAN; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Egli M, 2012, BIOCHEMISTRY-US, V51, P1547, DOI 10.1021/bi201525n; Goodier RI, 2001, J BACTERIOL, V183, P2249, DOI 10.1128/JB.183.7.2249-2258.2001; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V298, pG143, DOI 10.1152/ajpgi.00402.2009; Hoogerwerf WA, 2008, GASTROENTEROLOGY, V135, P2019, DOI 10.1053/j.gastro.2008.08.048; Hosokawa N, 2011, P NATL ACAD SCI USA, V108, P15396, DOI 10.1073/pnas.1019612108; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Jones BV, 2010, GUT MICROBES, V1, P415, DOI 10.4161/gmic.1.6.14087; Kaval KG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00772; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Klewer DA, 2002, J BIOMOL NMR, V24, P77, DOI 10.1023/A:1020649703380; Kondo T, 2007, COLD SH Q B, V72, P47, DOI 10.1101/sqb.2007.72.029; Liang X, 2014, CELL, V159, P469, DOI 10.1016/j.cell.2014.10.020; Mackey SR, 2011, ADV GENET, V74, P13, DOI 10.1016/B978-0-12-387690-4.00002-7; Malloy JN, 2012, AM J PHYSIOL-GASTR L, V303, pG461, DOI 10.1152/ajpgi.00369.2011; MARTIN DP, 1993, BIOCHEM BIOPH RES CO, V192, P1155, DOI 10.1006/bbrc.1993.1537; Mishra PK, 2001, J BACTERIOL, V183, P2774, DOI 10.1128/JB.183.9.2774-2778.2001; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Partch CL, 2013, TRENDS CELL BIOL; Pearson MM, 2010, INFECT IMMUN, V78, P2834, DOI 10.1128/IAI.01222-09; Rasband W., 2006, IMAGEJ; Reiter RJ, 2011, J PHYSIOL PHARMACOL, V62, P269; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; WORRALL DM, 1983, BIOCHEM J, V215, P153, DOI 10.1042/bj2150153; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008	49	115	119	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146643	10.1371/journal.pone.0146643	http://dx.doi.org/10.1371/journal.pone.0146643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751389	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100119
J	Li, XQ; Coffield, JA				Li, Xiaqing; Coffield, Julie A.			Structural and Functional Interactions between Transient Receptor Potential Vanilloid Subfamily 1 and Botulinum Neurotoxin Serotype A	PLOS ONE			English	Article							CAPSAICIN RECEPTOR; SYNAPTIC PROTEIN; SENSORY NEURONS; TRPV1; TOXIN; PAIN; GANGLIOSIDES; EXOCYTOSIS; INJECTIONS; RELEASE	Background Botulinum neurotoxins are produced by Clostridium botulinum bacteria. There are eight serologically distinct botulinum neurotoxin isoforms (serotypes A-H). Currently, botulinum neurotoxin serotype A (BoNT/A) is commonly used for the treatment of many disorders, such as hyperactive musculoskeletal disorders, dystonia, and pain. However, the effectiveness of BoNT/A for pain alleviation and the mechanisms that mediate the analgesic effects of BoNT/A remain unclear. To define the antinociceptive mechanisms by which BoNT/A functions, the interactions between BoNT/A and the transient receptor potential vanilloid subfamily 1 (TRPV1) were investigated using immunofluorescence, co-immunoprecipitation, and western blot analysis in primary mouse embryonic dorsal root ganglion neuronal cultures. Results 1) Three-week-old cultured dorsal root ganglion neurons highly expressed transient TRPV1, synaptic vesicle 2A (SV2A) and synaptosomal-associated protein 25 (SNAP-25). SV2A and SNAP-25 are the binding receptor and target protein, respectively, of BoNT/A. 2) TRPV1 colocalized with both BoNT/A and cleaved SNAP-25 when BoNT/A was added to dorsal root ganglia neuronal cultures. 3) After 24 hours of BoNT/A treatment (1 nmol/l), both TRPV1 and BoNT/A positive bands were detected in western blots of immunoprecipitated pellets. 4) Blocking TRPV1 with a specific antibody decreased the cleavage of SNAP-25 by BoNT/A. Conclusion BoNT/A interacts with TRPV1 both structurally and functionally in cultured mouse embryonic dorsal root ganglion neurons. These results suggest that an alternative mechanism is used by BoNT/A to mediate pain relief.	[Li, Xiaqing] Shanxi Med Univ, Dept Pathophysiol, Taiyuan, Shanxi, Peoples R China; [Li, Xiaqing; Coffield, Julie A.] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA	Shanxi Medical University; University System of Georgia; University of Georgia	Li, XQ (corresponding author), Shanxi Med Univ, Dept Pathophysiol, Taiyuan, Shanxi, Peoples R China.	xqli2013@126.com			National Natural Scientific Foundation of China [81171178]; Natural Scientific Fund of Shanxi Province [2012011036-3]; Shanxi Scholarship Council of China [2012-047]; National Institute Health [R21-AI059705]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059705] Funding Source: NIH RePORTER	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Fund of Shanxi Province; Shanxi Scholarship Council of China; National Institute Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by National Natural Scientific Foundation of China (No. 81171178), Natural Scientific Fund of Shanxi Province (No. 2012011036-3) and Research Project Supported by Shanxi Scholarship Council of China (No. 2012-047), National Institute Health (No. R21-AI059705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia J, 2000, NEUROSCIENCE, V100, P685, DOI 10.1016/S0306-4522(00)00389-4; Allam N, 2005, CLIN J PAIN, V21, P182, DOI 10.1097/00002508-200503000-00010; Aoki KR, 2005, NEUROTOXICOLOGY, V26, P785, DOI 10.1016/j.neuro.2005.01.017; Apostolidis A, 2005, J UROLOGY, V174, P977, DOI 10.1097/01.ju.0000169481.42259.54; Binzen U, 2006, NEUROSCIENCE, V142, P527, DOI 10.1016/j.neuroscience.2006.06.020; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Carmichael NME, 2010, PAIN, V149, P316, DOI 10.1016/j.pain.2010.02.024; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Charrua Ana, 2011, Handb Exp Pharmacol, P345, DOI 10.1007/978-3-642-16499-6_17; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dattilio A, 2005, J UROLOGY, V173, P635, DOI 10.1097/01.ju.0000143191.55468.1d; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Everaerts W, 2011, CURR BIOL, V21, P316, DOI 10.1016/j.cub.2011.01.031; Gazerani P, 2010, PAIN, V151, P606, DOI 10.1016/j.pain.2010.07.029; Gibson HE, 2009, TRENDS NEUROSCI, V32, P215, DOI [10.1016/j.tins.2008.12.006, DOI 10.1016/J.TINS.2008.12.006]; Gong Y, 2002, BRAIN, V125, P2491, DOI 10.1093/brain/awf258; Goswami C, 2010, J CELL SCI, V123, P2044, DOI 10.1242/jcs.065144; Ha US, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.070; Lee WH, 2011, ANESTH ANALG, V112, P228, DOI 10.1213/ANE.0b013e3181ffa1d7; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; Lopshire JC, 1997, J NEUROPHYSIOL, V78, P3154, DOI 10.1152/jn.1997.78.6.3154; Lucioni A, 2008, BJU INT, V101, P366, DOI 10.1111/j.1464-410X.2007.07312.x; Luvisetto S, 2015, TOXICON, V94, P23, DOI 10.1016/j.toxicon.2014.12.007; Masuda K, 2004, GENES CELLS, V9, P821, DOI 10.1111/j.1365-2443.2004.00766.x; Meng JH, 2007, J CELL SCI, V120, P2864, DOI 10.1242/jcs.012211; Meng JH, 2009, J NEUROSCI, V29, P4981, DOI 10.1523/JNEUROSCI.5490-08.2009; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Nigam P K, 2010, Indian J Dermatol, V55, P8, DOI 10.4103/0019-5154.60343; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Santha P, 2010, PAIN, V150, P103, DOI 10.1016/j.pain.2010.04.006; Portela-Gomes GM, 2000, AM J PATHOL, V157, P1299, DOI 10.1016/S0002-9440(10)64645-7; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Santha P, 2003, NEUROSCIENCE, V116, P621, DOI 10.1016/S0306-4522(02)00701-7; Shimizu T, 2012, NEUROBIOL DIS, V48, P367, DOI 10.1016/j.nbd.2012.07.010; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; Szoke E, 2012, EUR J PHARMACOL, V628, P67; Thyagarajan B, 2009, J PHARMACOL EXP THER, V331, P361, DOI 10.1124/jpet.109.156901; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Vajn K, 2013, PLOS ONE, DOI [10.1371/journal.pone.0075720, DOI 10.1371/J0URNAL.P0NE.0075720]; Yiangou Yiangos, 2011, J Pain Res, V4, P347, DOI 10.2147/JPR.S25189; Zakir HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044023	42	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0143024	10.1371/journal.pone.0143024	http://dx.doi.org/10.1371/journal.pone.0143024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745805	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600001
J	Kremer, D; Cui, QL; Gottle, P; Kuhlmann, T; Hartung, HP; Antel, J; Kury, P				Kremer, David; Cui, Qiao-Ling; Goettle, Peter; Kuhlmann, Tanja; Hartung, Hans-Peter; Antel, Jack; Kuery, Patrick			CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; CHEMOKINE RECEPTORS; ADULT HUMAN; IN-VITRO; PROGENITOR CELLS; SCHWANN-CELLS; HUMAN BRAIN; DIFFERENTIATION	Differentiation of oligodendroglial precursor cells (OPCs), a crucial prerequisite for central nervous system (CNS) remyelination in diseases such as Multiple Sclerosis (MS), is modulated by a multitude of extrinsic and intrinsic factors. In a previous study we revealed that the chemokine CXCL12 stimulates rodent OPC differentiation via activation of its receptor CXCR7. We could now demonstrate that CXCR7 is also expressed on NogoA-and Nkx2.2-positive oligodendroglial cells in human MS brains and that stimulation of cultured primary fetal human OPCs with CXCL12 promotes their differentiation as measured by surface marker expression and morphologic complexity. Pharmacological inhibition of CXCR7 effectively blocks these CXCL12-dependent effects. Our findings therefore suggest that a specific activation of CXCR7 could provide a means to promote oligodendroglial differentiation facilitating endogenous remyelination activities.	[Kremer, David; Goettle, Peter; Hartung, Hans-Peter; Kuery, Patrick] Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany; [Cui, Qiao-Ling; Antel, Jack] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Kuhlmann, Tanja] Univ Hosp Munster, Inst Neuropathol, Munster, Germany	Heinrich Heine University Dusseldorf; McGill University; University of Munster	Kremer, D (corresponding author), Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany.	david.kremer81@gmail.com		antel, jack/0000-0002-5148-0636; Kury, Patrick/0000-0002-2654-1126	Walter and Ilse Rose Foundation; James and Elisabeth Cloppenburg, Peek & Cloppenburg Dusseldorf Stiftung	Walter and Ilse Rose Foundation; James and Elisabeth Cloppenburg, Peek & Cloppenburg Dusseldorf Stiftung	The MS Center at the Department of Neurology is supported in part by the Walter and Ilse Rose Foundation and the James and Elisabeth Cloppenburg, Peek & Cloppenburg Dusseldorf Stiftung.	Adler MW, 2005, J LEUKOCYTE BIOL, V78, P1204, DOI 10.1189/jlb.0405222; Ambrosini E, 2005, J NEUROPATH EXP NEUR, V64, P706, DOI 10.1097/01.jnen.0000173893.01929.fc; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Cui QL, 2010, J NEUROPATH EXP NEUR, V69, P930, DOI 10.1097/NEN.0b013e3181ef3be4; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Du YZ, 2006, J NEUROSCI RES, V84, P1692, DOI 10.1002/jnr.21080; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Gottle P, 2015, J NEUROSCI, V35, P906, DOI 10.1523/JNEUROSCI.1423-14.2015; Gottle P, 2010, ANN NEUROL, V68, P915, DOI 10.1002/ana.22214; Guo LL, 2010, J NEUROSCI RES, V88, P3233, DOI 10.1002/jnr.22486; Jadasz JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071814; Kadi L, 2006, J NEUROIMMUNOL, V174, P133, DOI 10.1016/j.jneuroim.2006.01.011; Kremer D, 2013, ANN NEUROL, V74, P721, DOI 10.1002/ana.23970; Kremer D, 2011, ANN NEUROL, V69, P602, DOI 10.1002/ana.22415; Kremer D, 2009, P NATL ACAD SCI USA, V106, P9087, DOI 10.1073/pnas.0900204106; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lipfert J, 2013, CELL MOL NEUROBIOL, V33, P111, DOI 10.1007/s10571-012-9876-5; Liu Yu-Qiang, 2014, J Anal Methods Chem, V2014, P617367, DOI 10.1155/2014/617367; Maysami S, 2006, NEUROREPORT, V17, P1187, DOI 10.1097/01.wnr.0000227985.92551.9a; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Odemis V, 2010, J CELL SCI, V123, P1081, DOI 10.1242/jcs.062810; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shimizu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020680; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Tang T, 2012, ASIAN PAC J CANCER P, V13, P5281, DOI 10.7314/APJCP.2012.13.10.5281; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; WARRINGTON AE, 1992, J NEUROSCI RES, V33, P338, DOI 10.1002/jnr.490330218; Wijtmans M, 2012, EUR J MED CHEM, V51, P184, DOI 10.1016/j.ejmech.2012.02.041; Williams JL, 2014, J EXP MED, V211, P791, DOI 10.1084/jem.20131224; Wolswijk G, 2002, BRAIN, V125, P338, DOI 10.1093/brain/awf031; Xiao JH, 2012, J NEUROCHEM, V122, P1167, DOI 10.1111/j.1471-4159.2012.07871.x; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	43	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146503	10.1371/journal.pone.0146503	http://dx.doi.org/10.1371/journal.pone.0146503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741980	gold, Green Submitted, Green Published			2022-12-27	WOS:000367810600051
J	Ito, H; Tanaka, S; Akiyama, Y; Shimada, S; Adikrisna, R; Matsumura, S; Aihara, A; Mitsunori, Y; Ban, D; Ochiai, T; Kudo, A; Arii, S; Yamaoka, S; Tanabe, M				Ito, Hiromitsu; Tanaka, Shinji; Akiyama, Yoshimitsu; Shimada, Shu; Adikrisna, Rama; Matsumura, Satoshi; Aihara, Arihiro; Mitsunori, Yusuke; Ban, Daisuke; Ochiai, Takanori; Kudo, Atsushi; Arii, Shigeki; Yamaoka, Shoji; Tanabe, Minoru			Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis	PLOS ONE			English	Article							DOUBLECORTIN-LIKE; HEPATOCELLULAR-CARCINOMA; LIVER METASTASIS; KINASE; IDENTIFICATION; PROMOTES; GROWTH; MODEL; SUBPOPULATION; INHIBITION	Patients with pancreatic cancer typically develop tumor invasion and metastasis in the early stage. These malignant behaviors might be originated from cancer stem cells (CSCs), but the responsible target is less known about invisible CSCs especially for invasion and metastasis. We previously examined the proteasome activity of CSCs and constructed a real-time visualization system for human pancreatic CSCs. In the present study, we found that CSCs were highly metastatic and dominantly localized at the invading tumor margins in a liver metastasis model. Microarray and siRNA screening assays showed that doublecortin-like kinase 1 (DCLK1) was predominantly expressed with histone modification in pancreatic CSCs with invasive and metastatic potential. Overexpression of DCLK1 led to amoeboid morphology, which promotes the migration of pancreatic cancer cells. Knockdown of DCLK1 profoundly suppressed in vivo liver metastasis of pancreatic CSCs. Clinically, DCLK1 was overexpressed in the metastatic tumors in patients with pancreatic cancer. Our studies revealed that DCLK1 is essential for the invasive and metastatic properties of CSCs and may be a promising epigenetic and therapeutic target in human pancreatic cancer.	[Ito, Hiromitsu; Tanaka, Shinji; Akiyama, Yoshimitsu; Shimada, Shu] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Oncol, Tokyo, Japan; [Ito, Hiromitsu; Tanaka, Shinji; Adikrisna, Rama; Matsumura, Satoshi; Aihara, Arihiro; Mitsunori, Yusuke; Ban, Daisuke; Ochiai, Takanori; Kudo, Atsushi; Arii, Shigeki; Tanabe, Minoru] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan; [Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Tanaka, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Oncol, Tokyo, Japan.	tanaka.monc@tmd.ac.jp	Kudo, Atsushi/AAO-7949-2021	Kudo, Atsushi/0000-0002-5301-3847; Ban, Daisuke/0000-0003-0868-8519	Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Ministry of Education, Culture, Sports, Science & Technology of Japan; Ministry of Health Labour & Welfare of Japan [22130005, 25253081, 15H01484, 15K15491]	Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Ministry of Education, Culture, Sports, Science & Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labour & Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), a Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Research (A), Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science & Technology of Japan, and a Health & Labour Sciences Research Grant from the Ministry of Health Labour & Welfare of Japan. Number: 22130005, 25253081, 15H01484, 15K15491. URL: https://kaken.nii.ac.jp/d/r/30253420.ja.html.	Adikrisna R, 2012, GASTROENTEROLOGY, V143, P234, DOI 10.1053/j.gastro.2012.03.054; Amano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008704; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ischenko I, 2014, P NATL ACAD SCI USA, V111, P3466, DOI 10.1073/pnas.1319911111; Kantara C, 2014, CANCER RES, V74, P2487, DOI 10.1158/0008-5472.CAN-13-3536; Kimura Y, 1996, INT J PANCREATOL, V20, P43; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Kramer N, 2013, MUTAT RES-REV MUTAT, V752, P10, DOI 10.1016/j.mrrev.2012.08.001; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin PT, 2000, J NEUROSCI, V20, P9152; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; Metildi CA, 2013, J SURG RES, V184, P290, DOI 10.1016/j.jss.2013.03.049; Murakami M, 2005, INT J CANCER, V117, P160, DOI 10.1002/ijc.21143; Muramatsu S, 2013, HEPATOLOGY, V58, P218, DOI 10.1002/hep.26345; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Nikolaou KC, 2015, EMBO J, V34, P430, DOI 10.15252/embj.201489279; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Ostapoff KT, 2014, CANCER RES, V74, P4996, DOI 10.1158/0008-5472.CAN-13-1807; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rheinbay E, 2013, CELL REP, V3, P1567, DOI 10.1016/j.celrep.2013.04.021; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sandstrom RS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05371; Sergeant G, 2009, NAT REV CLIN ONCOL, V6, P580, DOI 10.1038/nrclinonc.2009.127; Shin E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2443; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; Suemizu H, 2007, INT J ONCOL, V31, P741; Sureban SM, 2014, CANCER LETT, V351, P151, DOI 10.1016/j.canlet.2014.05.011; Sureban SM, 2011, CANCER RES, V71, P2328, DOI 10.1158/0008-5472.CAN-10-2738; Sureban SM, 2009, GASTROENTEROLOGY, V137, P649, DOI 10.1053/j.gastro.2009.05.004; Tanaka S., 2015, ANN SURG ONCOL, P1; Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Wang A, 2015, CELL STEM CELL, V16, P386, DOI 10.1016/j.stem.2015.02.013; Westcott JM, 2015, J CLIN INVEST, V125, P1927, DOI 10.1172/JCI77767; Westphalen CB, 2014, J CLIN INVEST, V124, P1283, DOI 10.1172/JCI73434; Weygant N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-103; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	56	48	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146564	10.1371/journal.pone.0146564	http://dx.doi.org/10.1371/journal.pone.0146564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764906	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300027
J	Silkens, MEWM; Arah, OA; Scherpbier, AJJA; Heineman, MJ; Lombarts, KMJMH				Silkens, Milou E. W. M.; Arah, Onyebuchi A.; Scherpbier, Albert J. J. A.; Heineman, Maas Jan; Lombarts, Kiki M. J. M. H.			Focus on Quality: Investigating Residents' Learning Climate Perceptions	PLOS ONE			English	Article							MEDICAL-EDUCATION; ENVIRONMENT; SYSTEM	Background A department's learning climate is known to contribute to the quality of postgraduate medical education and, as such, to the quality of patient care provided by residents. However, it is unclear how the learning climate is perceived over time. Objectives This study investigated whether the learning climate perceptions of residents changed over time. Methods The context for this study was residency training in the Netherlands. Between January 2012 and December 2014, residents from 223 training programs in 39 hospitals filled out the web-based Dutch Residency Educational Climate Test (D-RECT) to evaluate their clinical department's learning climate. Residents had to fill out 35 validated questions using a five point Likert-scale. We analyzed data using generalized linear mixed (growth) models. Results Overall, 3982 D-RECT evaluations were available to investigate our aim. The overall mean D-RECT score was 3.9 (SD = 0.3). The growth model showed an increase in D-RECT scores over time (b = 0.03; 95% CI: 0.01-0.06; p < 0.05). Conclusions The observed increase in D-RECT scores implied that residents perceived an improvement in the learning climate over time. Future research could focus on factors that facilitate or hinder learning climate improvement, and investigate the roles that hospital governing committees play in safeguarding and improving the learning climate.	[Silkens, Milou E. W. M.; Arah, Onyebuchi A.; Heineman, Maas Jan; Lombarts, Kiki M. J. M. H.] Univ Amsterdam, Acad Med Ctr, Ctr Evidence Based Educ, Profess Performance Res Grp, NL-1105 AZ Amsterdam, Netherlands; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Arah, Onyebuchi A.] UCLA Ctr Hlth Policy Res, Los Angeles, CA USA; [Scherpbier, Albert J. J. A.] Maastricht Univ, Dept Educ Dev & Res, NL-6200 MD Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Maastricht University	Silkens, MEWM (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Evidence Based Educ, Profess Performance Res Grp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.e.silkens@amc.uva.nl		Lombarts, Kiki/0000-0001-6167-0620; Arah, Onyebuchi/0000-0002-9067-1697	Dutch Ministry of Health and Welfare; Academic Medical Center; Maastricht University; Netherlands Organization for Scientific Research (NWO) [916.96.059]	Dutch Ministry of Health and Welfare; Academic Medical Center; Maastricht University; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research is part of the project "Quality of clinical teachers and residency training programs", which is financed by the Dutch Ministry of Health and Welfare and cofinanced by the Academic Medical Center and Maastricht University. OA is a recipient of a Veni grant (#916.96.059) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Bennett D, 2014, IRISH J MED SCI, V183, P611, DOI 10.1007/s11845-013-1060-5; Boerebach BCM, 2016, EVAL HEALTH PROF, V39, P21, DOI 10.1177/0163278714552520; Boerebach BCM, 2014, WORLD J SURG, V38, P2761, DOI 10.1007/s00268-014-2655-3; Boor K, 2011, MED TEACH, V33, P820, DOI 10.3109/0142159X.2010.541533; Brown J, 2007, MED EDUC, V41, P653, DOI 10.1016/j.1365-2923.2007.02785.x; Busari JO, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-51; Byrne JM, 2009, ACAD MED, V84, P199, DOI 10.1097/ACM.0b013e318193833b; Curry RH, 2008, ACAD MED, V83, P568, DOI 10.1097/ACM.0b013e3181722fca; Daugherty SR, 1998, JAMA-J AM MED ASSOC, V279, P1194, DOI 10.1001/jama.279.15.1194; Delva MD, 2004, ACAD MED, V79, P1120, DOI 10.1097/00001888-200411000-00025; Genn JM, 2001, MED TEACH, V23, P445, DOI 10.1080/01421590120075661; Heard JK, 2004, ACAD MED, V79, P858, DOI 10.1097/00001888-200409000-00011; Hobgood C, 2005, ACAD MED, V80, P758, DOI 10.1097/00001888-200508000-00012; Lombarts KMJMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086512; Lombarts M J M H Kiki, 2011, Ned Tijdschr Geneeskd, V155, pA3793; Mareiniss DP, 2004, ACAD MED, V79, P825, DOI 10.1097/00001888-200409000-00003; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; Piek J, 2015, INT J GYNECOL CANCER, V25, P180, DOI 10.1097/IGC.0000000000000323; Pinnock R, 2013, MED TEACH, V35, P699, DOI 10.3109/0142159X.2013.786175; Roff S, 2001, MED TEACH, V23, P333; Silkens MEWM, 2016, MED TEACH, V38, P476, DOI 10.3109/0142159X.2015.1060300; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Soemantri D, 2010, MED TEACH, V32, P947, DOI 10.3109/01421591003686229; Tsai JC, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-226; Wall D, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-210; WFME, 2003, POSTGR MED ED WFME G; Zyphur M, 2008, ADV HEALTH SCI EDUC, V13, P571, DOI 10.1007/s10459-007-9078-y	29	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147108	10.1371/journal.pone.0147108	http://dx.doi.org/10.1371/journal.pone.0147108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765742	gold, Green Published			2022-12-27	WOS:000368459300067
J	Yoon, A; Shin, JW; Kim, S; Kim, H; Chung, J				Yoon, Aerin; Shin, Jung Won; Kim, Soohyun; Kim, Hyori; Chung, Junho			Chicken scFvs with an Artificial Cysteine for Site-Directed Conjugation	PLOS ONE			English	Article							IN-VIVO; MONOCLONAL-ANTIBODIES; FC-RECEPTOR; THERAPY; BINDING; CANCER; CELLS; GENE; DRUG; TECHNOLOGY	For the site-directed conjugation of chemicals and radioisotopes to the chicken-derived single-chain variable fragment (scFv), we investigated amino acid residues replaceable with cysteine. By replacing each amino acid of the 157 chicken variable region framework residues (FR, 82 residues on V-H and 75 on V-L) with cysteine, 157 artificial cysteine mutants were generated and characterized. At least 27 residues on V-L and 37 on V-H could be replaced with cysteine while retaining the binding activity of the original scFv. We prepared three V-L (L5, L6 and L7) and two V-H (H13 and H16) mutants as scFv-C-kappa fusion proteins and showed that PEG-conjugation to the sulfhydryl group of the artificial cysteine was achievable in all five mutants. Because the charge around the cysteine residue affects the in vivo stability of thiol-maleimide conjugation, we prepared 16 charge-variant artificial cysteine mutants by replacing the flanking residues of H13 with charged amino acids and determined that the binding activity was not affected in any of the mutants except one. We prepared four charge-variant H13 artificial cysteine mutants (RCK, DCE, ECD and ECE) as scFv-C-kappa fusion proteins and confirmed that the reactivity of the sulfhydryl group on cysteine is active and their binding activity is retained after the conjugation process.	[Yoon, Aerin; Shin, Jung Won; Kim, Soohyun; Chung, Junho] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Yoon, Aerin; Shin, Jung Won; Kim, Soohyun; Kim, Hyori; Chung, Junho] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Chung, J (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.	jjhchung@snu.ac.kr		Kim, Soohyun/0000-0002-5584-5073	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2009-0093820]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2009-0093820) (www.msip.go.kr/) (HK and JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; Baldi L, 2005, BIOTECHNOL PROGR, V21, P148, DOI 10.1021/bp049830x; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Barrett DM, 2014, ANNU REV MED, V65, P333, DOI 10.1146/annurev-med-060512-150254; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Bodet-Milin C, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00177; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chaisemartin L, 2009, BIOCONJUGATE CHEM, V20, P847, DOI 10.1021/bc800272r; Chen XY, 2009, MABS-AUSTIN, V1, P563, DOI 10.4161/mabs.1.6.10058; Chowdhury PS, 1998, P NATL ACAD SCI USA, V95, P669, DOI 10.1073/pnas.95.2.669; Deckert PM, 2009, CURR DRUG TARGETS, V10, P158, DOI 10.2174/138945009787354502; Eccles SA, 1999, CURR OPIN MOL THER, V1, P737; Engert A, GHSG AFM13 OPEN LABE; Gill S, 2015, IMMUNOL REV, V263, P68, DOI 10.1111/imr.12243; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Jeffrey SC, 2013, BIOCONJUGATE CHEM, V24, P1256, DOI 10.1021/bc400217g; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Kampmeier F, 2009, BIOCONJUGATE CHEM, V20, P1010, DOI 10.1021/bc9000257; Kim H, 2014, BMB REP, V47, P130, DOI 10.5483/BMBRep.2014.47.3.006; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee Y, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.57; LYONS A, 1990, PROTEIN ENG, V3, P703, DOI 10.1093/protein/3.8.703; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Monnier PP, 2013, ANTIBODIES, V2, P193, DOI 10.3390/antib2020193; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; RODWELL JD, 1986, P NATL ACAD SCI USA, V83, P2632, DOI 10.1073/pnas.83.8.2632; Sharma SK, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0060-4; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Sheridan C, 2015, NAT BIOTECHNOL, V33, P219, DOI 10.1038/nbt0315-219; Shih HH, 2012, J BIOL CHEM, V287, P44425, DOI 10.1074/jbc.M112.415935; Stimmel JB, 2000, J BIOL CHEM, V275, P30445, DOI 10.1074/jbc.M001672200; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; Ueda M, 2015, MOL IMAGING BIOL, V17, P102, DOI 10.1007/s11307-014-0769-5; Voynov V, 2010, BIOCONJUGATE CHEM, V21, P385, DOI 10.1021/bc900509s; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466	41	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146907	10.1371/journal.pone.0146907	http://dx.doi.org/10.1371/journal.pone.0146907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764487	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300050
J	Zhang, CL; Liu, R; Yuan, JS; Cui, JG; Hu, FH; Yang, WX; Zhang, Y; Chen, YZ; Qiao, SB				Zhang, Changlin; Liu, Rong; Yuan, Jiansong; Cui, Jingang; Hu, Fenghuan; Yang, Weixian; Zhang, Yan; Chen, Youzhou; Qiao, Shubin			Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; ALCOHOL SEPTAL ABLATION; PROGNOSTIC VALUE; CLINICAL-SIGNIFICANCE; RECOMMENDATIONS; TOMOGRAPHY; EXPRESSION; BIOMARKERS; CARDIOLOGY	Background Both high-sensitivity cardiac troponin T and B-type natriuretic peptide are useful in detecting myocardial fibrosis, as determined by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR), in patients with non-obstructive hypertrophic cardiomyopathy. However, their values to predict myocardial fibrosis in hypertrophic obstructive cardiomyopathy (HOCM) remain unclear. We investigated the role of N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) and cardiac troponin I (cTnI) to identify LGE-CMR in patients with HOCM. Methods Peripheral concentrations of NT-proBNP and cTnI were determined in patients with HOCM (n = 163; age = 47.2 +/- 10.8 years; 38.7% females). Contrast-enhanced CMR was performed to identify and quantify myocardial fibrosis. Results LGE was detected in 120 of 163 patients (73.6%). Patients with LGE had significantly higher levels of NT-proBNP and cTnI than those without LGE (1386.2 [904.6-2340.8] vs. 866.6 [707.2-1875.2] pmol/L, P = 0.003; 0.024 [0.010-0.049] vs. 0.010 [0.005-0.021] ng/ml, P < 0.001, respectively). The extent of LGE was positively correlated with log cTnI (r = 0.371, P < 0.001) and log NT-proBNP (r = 0.211, P = 0.007). On multivariable analysis, both log cTnI and maximum wall thickness (MWT) were independent predictors of the presence of LGE (OR = 3.193, P = 0.033; OR = 1.410, P < 0.001, respectively), whereas log NT-proBNP was not. According to the ROC curve analysis, combined measurements of MWT >= 21 mm and/or cTnI >= 0.025ng/ml indicated good diagnostic performance for the presence of LGE, with specificity of 95% or sensitivity of 88%. Conclusions Serum cTnI is an independent predictor useful for identifying myocardial fibrosis, while plasma NT-proBNP is only associated with myocardial fibrosis on univariate analysis. Combined measurements of serum cTnI with MWT further improve its value in detecting myocardial fibrosis in patients with HOCM.	[Zhang, Changlin; Liu, Rong; Yuan, Jiansong; Cui, Jingang; Hu, Fenghuan; Yang, Weixian; Chen, Youzhou; Qiao, Shubin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Dept Cardiol,Fuwai Hosp, Beijing 100730, Peoples R China; [Zhang, Changlin; Liu, Rong; Yuan, Jiansong; Cui, Jingang; Hu, Fenghuan; Yang, Weixian; Zhang, Yan; Chen, Youzhou; Qiao, Shubin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Yan] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Dept Radiol,Fuwai Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Qiao, SB (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Dept Cardiol,Fuwai Hosp, Beijing 100730, Peoples R China.	qsbfw@sina.com						Arteaga E, 2005, AM HEART J, V150, P1228, DOI 10.1016/j.ahj.2005.02.045; Biagini E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001267; Bravo PE, 2013, CIRC-CARDIOVASC IMAG, V6, P210, DOI 10.1161/CIRCIMAGING.112.000110; Canga A, 2014, NEFROLOGIA, V34, P428, DOI 10.3265/Nefrologia.pre2014.Apr.12375; Chan RH, 2014, CIRCULATION, V130, P484, DOI 10.1161/CIRCULATIONAHA.113.007094; Coats CJ, 2013, EUR HEART J, V34, P2529, DOI 10.1093/eurheartj/eht070; Cramer G, 2014, AM J CARDIOL, V113, P1240, DOI 10.1016/j.amjcard.2013.12.033; D'Amato R, 2013, AM J CARDIOL, V112, P1190, DOI 10.1016/j.amjcard.2013.06.018; Dumont CA, 2007, REV ESP CARDIOL, V60, P15, DOI 10.1157/13097921; Ellims AH, 2014, EUR HEART J-CARD IMG, V15, P1108, DOI 10.1093/ehjci/jeu077; Ellims AH, 2014, CIRC-HEART FAIL, V7, P271, DOI 10.1161/CIRCHEARTFAILURE.113.000665; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Geske JB, 2013, J AM COLL CARDIOL, V61, P2456, DOI 10.1016/j.jacc.2013.04.004; Gommans F., 2013, J CARDIOVASC MAGN R, V15, pP144, DOI [10.1186/1532-429X-15-S1-P144, DOI 10.1186/1532-429X-15-S1-P144]; Hasegawa K, 1996, HYPERTENSION, V27, P259, DOI 10.1161/01.HYP.27.2.259; HASEGAWA K, 1993, CIRCULATION, V88, P372, DOI 10.1161/01.CIR.88.2.372; Hen Y, 2014, CIRC J, V78, P929, DOI 10.1253/circj.CJ-13-0979; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Ismail TF, 2014, HEART, V100, P1851, DOI 10.1136/heartjnl-2013-305471; Kawasaki T, 2013, AM J CARDIOL, V112, P867, DOI 10.1016/j.amjcard.2013.04.060; Kubo T, 2013, J AM COLL CARDIOL, V62, P1252, DOI 10.1016/j.jacc.2013.03.055; Kubo T, 2011, CIRC J, V75, P919, DOI 10.1253/circj.CJ-10-0782; Kuusisto J, 2012, HEART, V98, P1007, DOI 10.1136/heartjnl-2011-300960; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Maeder MT, 2010, HYPERTENSION, V56, P682, DOI 10.1161/HYPERTENSIONAHA.110.156547; Maron BJ, 2014, CIRCULATION, V130, P1617, DOI 10.1161/CIRCULATIONAHA.114.011580; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2004, CIRCULATION, V109, P984, DOI 10.1161/01.CIR.0000117098.75727.D8; Mewton N, 2011, EUR J RADIOL, V78, P87, DOI 10.1016/j.ejrad.2009.09.027; Moreno V, 2010, J CARD FAIL, V16, P950, DOI 10.1016/j.cardfail.2010.07.245; Murakami Y, 2002, CAN J CARDIOL, V18, P1294; Nagueh SF, 2011, J AM SOC ECHOCARDIOG, V24, P473, DOI 10.1016/j.echo.2011.03.006; Nakamura S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005968; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Park JR, 2012, INT J CARDIOVAS IMAG, V28, P763, DOI 10.1007/s10554-011-9876-4; Paya E, 2008, J CARD FAIL, V14, P414, DOI 10.1016/j.cardfail.2008.02.006; Petersen SE, 2007, CIRCULATION, V115, P2418, DOI 10.1161/CIRCULATIONAHA.106.657023; Roncarati R, 2014, J AM COLL CARDIOL, V63, P920, DOI 10.1016/j.jacc.2013.09.041; Rubinshtein R, 2010, CIRC-HEART FAIL, V3, P51, DOI 10.1161/CIRCHEARTFAILURE.109.854026; Steggerda RC, 2014, JACC-CARDIOVASC INTE, V7, P1227, DOI 10.1016/j.jcin.2014.05.023; Tsuruda T, 2002, CIRC RES, V91, P1127, DOI 10.1161/01.RES.0000046234.73401.70; Yan CW, 2013, CIRC-HEART FAIL, V6, P1013, DOI 10.1161/CIRCHEARTFAILURE.113.000414	43	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146572	10.1371/journal.pone.0146572	http://dx.doi.org/10.1371/journal.pone.0146572			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765106	gold, Green Published, Green Submitted			2022-12-27	WOS:000368459300028
J	Farnworth, B; Innes, J; Waas, JR				Farnworth, Bridgette; Innes, John; Waas, Joseph R.			Converting Predation Cues into Conservation Tools: The Effect of Light on Mouse Foraging Behaviour	PLOS ONE			English	Article							MICE MUS-MUSCULUS; HOUSE MOUSE; PATCH USE; RISK; POPULATION; RESPONSES; PREY; ILLUMINATION; AVOIDANCE; RATTUS	Prey face a conflict between acquiring energy and avoiding predators and use both direct and indirect cues to assess predation risk. Illumination, an indirect cue, influences nocturnal rodent foraging behaviour. New Zealand holds no native rodent species but has introduced mice (Mus musculus) that severely impair native biodiversity. We used Giving-Up Densities (GUDs) and observations of foraging frequency and duration to assess if artificial light induces risk avoidance behaviour in mice and could limit their activity. We found both captive (wild strain) mice in outdoor pens and wild mice within a pest fenced sanctuary (Maungatautari, New Zealand) displayed avoidance behaviour in response to illumination. In captivity, total foraging effort was similar across lit and unlit pens but mice displayed a strong preference for removing seeds from dark control areas (mean: 15.33 SD: +/-11.64 per 3.5 hours) over illuminated areas (2.00 +/-3.44). Wild mice also removed fewer seeds from illuminated areas (0.42 +/-1.00 per 12 hours) compared to controls (6.67 +/-9.20). Captive mice spent less than 1.0% of available time at illuminated areas, versus 11.3% at controls; visited the lit areas less than control areas (12.00 +/-9.77 versus 29.00 +/-21.58 visits respectively); and spent less time per visit at illuminated versus control areas (8.17 +/-7.83 versus 44.83 +/-87.52 seconds per visit respectively). Illumination could provide protection at ecologically sensitive sites, damaged exclusion fences awaiting repair, fence terminus zones of peninsula sanctuaries and shipping docks that service offshore islands. We promote the hypothesis that the tendency of mice to avoid illumination could be a useful conservation tool, and advance knowledge of risk assessment and foraging under perceived danger.	[Farnworth, Bridgette; Waas, Joseph R.] Univ Waikato, Hamilton, New Zealand; [Innes, John] Landcare Res Manaaki Whenua, Hamilton, New Zealand	University of Waikato	Farnworth, B (corresponding author), Univ Waikato, Hamilton, New Zealand.	bridgette.farnworth@outlook.com			Landcare Research Manaaki Whenua; University of Waikato; Tess Embling Memorial Trust; Brian Perry Trust	Landcare Research Manaaki Whenua; University of Waikato; Tess Embling Memorial Trust; Brian Perry Trust	This research was funded by Landcare Research Manaaki Whenua (BF and JI), University of Waikato (BF), Tess Embling Memorial Trust (BF) and Brian Perry Trust (BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Approval for the study at Maungatautari was given by Maungatautari Ecological Island Heritage Committee, with permission for private land access granted by Bill Garland and access to iwi land arranged by Tao Tauroa (Ngati Koroki Kahukura) and Robyn Nightingale (Raukawa Ki Wharepuhunga). We wish to acknowledge Bruce Patty for technical expertise in equipment and assistance in data collection as well as field support provided by Rod Millar, Bruce Scott, Richard Johnstone and other volunteers. This research was funded by Landcare Research Manaaki Whenua, University of Waikato, Tess Embling Memorial Trust and Brian Perry Trust. Research was approved by the University of Waikato Animal Ethics Committee (Protocol 919) and we thank all anonymous reviewers who improved the quality of this publication.	Angel A, 2009, BIOL INVASIONS, V11, P1743, DOI 10.1007/s10530-008-9401-4; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Bird BL, 2004, CONSERV BIOL, V18, P1435, DOI 10.1111/j.1523-1739.2004.00349.x; BOMFORD M, 1990, WILDLIFE SOC B, V18, P411; Bramley GN, 2000, J CHEM ECOL, V26, P705, DOI 10.1023/A:1005432322861; Bridgman LJ, 2013, ANIM BEHAV, V86, P257, DOI 10.1016/j.anbehav.2013.05.013; BRILLHART DB, 1991, J MAMMAL, V72, P764, DOI 10.2307/1381840; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Castellanos I, 2006, ANIM BEHAV, V72, P461, DOI 10.1016/j.anbehav.2006.02.005; Chivers DP, 1996, J CHEM ECOL, V22, P1709, DOI 10.1007/BF02272409; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Clarkson B., 2002, BOT WAIKATO, P82; Connolly TA, 2009, WILDLIFE RES, V36, P410, DOI 10.1071/WR09021; Cresswell W, 2011, J ORNITHOL, V152, P251, DOI 10.1007/s10336-010-0638-1; Cuthbert R, 2004, BIOL CONSERV, V117, P483, DOI 10.1016/j.biocon.2003.08.007; DICE LR, 1945, AM NAT, V79, P385, DOI 10.1086/281276; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; Edmunds, 1974, DEFENCE AMINALS; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; FITZGERALD BM, 1981, J ANIM ECOL, V50, P489, DOI 10.2307/4070; Flynn AM, 2010, J EXP MAR BIOL ECOL, V383, P32, DOI 10.1016/j.jembe.2009.10.017; Gillies C, 2008, USING TRACKING TUNNE; Grostal P, 1999, BEHAV ECOL, V10, P422, DOI 10.1093/beheco/10.4.422; Harper GA, 2010, BIOL INVASIONS, V12, P1449, DOI 10.1007/s10530-009-9560-y; Heithaus MR, 2008, J EXP MAR BIOL ECOL, V356, P43, DOI 10.1016/j.jembe.2007.12.013; Hughes AR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0715; INNES J, 1995, NEW ZEAL J ECOL, V19, P5; Innes J, 2014, IMPACTS MICE ALONE B; Innes J, 2012, NEW ZEAL J ECOL, V36, P232; King CM, 1996, NEW ZEAL J ECOL, V20, P253; King CM., 2005, HDB NZ MAMMALS; Koehler AE, 1990, 14 VERT PEST C U CAL; KOTLER BP, 1984, AM MIDL NAT, V111, P383, DOI 10.2307/2425333; Kramer KM, 2001, J MAMMAL, V82, P535, DOI 10.1644/1545-1542(2001)082<0535:EOLIOA>2.0.CO;2; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mackay Jamie W.B., 2007, P294; Maitland M., ISLAND INVASIVES ERA, P542; McCauley SJ, 2011, ECOLOGY, V92, P2043, DOI 10.1890/11-0455.1; MCNAMARA JM, 1987, ECOLOGY, V68, P1515, DOI 10.2307/1939235; METZGAR LH, 1967, J MAMMAL, V48, P387, DOI 10.2307/1377771; Miller A., 1999, ECOLOGICAL ENERGETIC; Molenaar J, 2003, ROAD ILLUMINATION NA, P72; Nersesian CL, 2012, BEHAV ECOL SOCIOBIOL, V66, P47, DOI 10.1007/s00265-011-1250-y; Pocock MJO, 2004, J ANIM ECOL, V73, P878, DOI 10.1111/j.0021-8790.2004.00863.x; Poot H, 2008, ECOL SOC, V13; Ristau C.A., 1991, P91; RUSCOE WA, 2005, HDB NZ MAMMALS, P204; Schmidt KA, 2006, OIKOS, V113, P82; Shapira I, 2013, NEW ZEAL J ECOL, V37, P33; SINCLAIR ARE, 1995, ECOLOGY, V76, P882, DOI 10.2307/1939353; Sone K., 2002, J FOR RES, V7, P17, DOI [10.1007/BF02762594, DOI 10.1007/BF02762594]; Speedy C, 2007, MANAG VERTEBR INVASI, P115; Stober Jonathan M., 2007, Human-Wildlife Conflicts, V1, P45; Thorson JM, 1998, BEHAV ECOL, V9, P151, DOI 10.1093/beheco/9.2.151; Wanless RM, 2007, BIOLOGY LETT, V3, P241, DOI 10.1098/rsbl.2007.0120; Young LC, 2013, BIOL INVASIONS, V15, P2627, DOI 10.1007/s10530-013-0479-y	58	16	16	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145432	10.1371/journal.pone.0145432	http://dx.doi.org/10.1371/journal.pone.0145432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760039	gold, Green Submitted, Green Published			2022-12-27	WOS:000368033100014
J	Somppi, S; Tornqvist, H; Kujala, MV; Hanninen, L; Krause, CM; Vainio, O				Somppi, Sanni; Tornqvist, Heini; Kujala, Miiamaaria V.; Hanninen, Laura; Krause, Christina M.; Vainio, Outi			Dogs Evaluate Threatening Facial Expressions by Their Biological Validity - Evidence from Gazing Patterns	PLOS ONE			English	Article							CANIS-FAMILIARIS; EMOTIONAL STIMULI; FACES; ATTENTION; CHIMPANZEES; MONKEYS; HUMANS; MEMORY; ANGRY; RECOGNITION	Appropriate response to companions' emotional signals is important for all social creatures. The emotional expressions of humans and non-human animals have analogies in their form and function, suggesting shared evolutionary roots, but very little is known about how animals other than primates view and process facial expressions. In primates, threat-related facial expressions evoke exceptional viewing patterns compared with neutral or positive stimuli. Here, we explore if domestic dogs (Canis familiaris) have such an attentional bias toward threatening social stimuli and whether observed emotional expressions affect dogs' gaze fixation distribution among the facial features (eyes, midface and mouth). We recorded the voluntary eye gaze of 31 domestic dogs during viewing of facial photographs of humans and dogs with three emotional expressions (threatening, pleasant and neutral). We found that dogs' gaze fixations spread systematically among facial features. The distribution of fixations was altered by the seen expression, but eyes were the most probable targets of the first fixations and gathered longer looking durations than mouth regardless of the viewed expression. The examination of the inner facial features as a whole revealed more pronounced scanning differences among expressions. This suggests that dogs do not base their perception of facial expressions on the viewing of single structures, but the interpretation of the composition formed by eyes, midface and mouth. Dogs evaluated social threat rapidly and this evaluation led to attentional bias, which was dependent on the depicted species: threatening conspecifics' faces evoked heightened attention but threatening human faces instead an avoidance response. We propose that threatening signals carrying differential biological validity are processed via distinctive neurocognitive pathways. Both of these mechanisms may have an adaptive significance for domestic dogs. The findings provide a novel perspective on understanding the processing of emotional expressions and sensitivity to social threat in non-primates.	[Somppi, Sanni; Kujala, Miiamaaria V.; Vainio, Outi] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland; [Tornqvist, Heini; Krause, Christina M.] Univ Helsinki, Fac Behav Sci, Cognit Sci, Helsinki, Finland; [Kujala, Miiamaaria V.] Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland; [Hanninen, Laura] Univ Helsinki, Fac Vet Med, Dept Prod Anim Med, Helsinki, Finland	University of Helsinki; University of Helsinki; Aalto University; University of Helsinki	Somppi, S (corresponding author), Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland.	sanni.somppi@helsinki.fi	Hänninen, Laura Talvikki/E-6683-2011	Hänninen, Laura Talvikki/0000-0001-5118-8451; Kujala, Miiamaaria/0000-0002-1377-2187; Vainio, Outi Maritta/0000-0003-3467-2246	Academy of Finland [137931]; Emil Aaltonen Foundation; Brain Research at Aalto University; University of Helsinki BRAHE consortium	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Brain Research at Aalto University; University of Helsinki BRAHE consortium	Academy of Finland (http://www.aka.fi) project #137931 to OV; Emil Aaltonen Foundation (http://www.emilaaltonen.fi/) to SS; The Brain Research at Aalto University and University of Helsinki BRAHE consortium (http://www.brain-mind.fi) to MVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong T, 2012, CLIN PSYCHOL REV, V32, P704, DOI 10.1016/j.cpr.2012.09.004; Beaudry O, 2014, COGNITION EMOTION, V28, P416, DOI 10.1080/02699931.2013.833500; Becker MW, 2009, Q J EXP PSYCHOL, V62, P1257, DOI 10.1080/17470210902725753; Belopolsky AV, 2011, VIS COGN, V19, P27, DOI 10.1080/13506285.2010.536186; Bethell EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044387; Bloom T, 2013, BEHAV PROCESS, V96, P1, DOI 10.1016/j.beproc.2013.02.010; Bolwig N., 1964, Behaviour, V22, P167; Brecht M, 2012, CURR OPIN NEUROBIOL, V22, P259, DOI 10.1016/j.conb.2011.12.003; Brosch T, 2005, EMOTION, V5, P360, DOI 10.1037/1528-3542.5.3.360; Buttelmann D, 2013, ANIM COGN, V16, P137, DOI 10.1007/s10071-012-0560-4; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Cangoz B, 2013, J EYE MOVEMENT RES, V6; Cao ZJ, 2014, NEUROIMAGE, V84, P901, DOI 10.1016/j.neuroimage.2013.09.064; Casey RA, 2014, APPL ANIM BEHAV SCI, V152, P52, DOI 10.1016/j.applanim.2013.12.003; Custance D, 2012, ANIM COGN, V15, P851, DOI 10.1007/s10071-012-0510-1; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Diogo R, 2009, J ANAT, V215, P300, DOI 10.1111/j.1469-7580.2009.01111.x; Duffy DL, 2008, APPL ANIM BEHAV SCI, V114, P441, DOI 10.1016/j.applanim.2008.04.006; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; Ekman P., 2002, MANUAL INVESTIGATORS; Ekman P., 1982, EMOTION HUMAN FACE; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; FOX MW, 1970, BEHAVIOUR, V36, P49, DOI 10.1163/156853970X00042; Gothard KM, 2004, ANIM COGN, V7, P25, DOI 10.1007/s10071-003-0179-6; Green MJ, 2003, COGNITION EMOTION, V17, P779, DOI 10.1080/02699930302282; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; Guo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042585; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Gyori B, 2010, APPL ANIM BEHAV SCI, V128, P69, DOI 10.1016/j.applanim.2010.10.005; Hirata S, 2010, ANIM COGN, V13, P679, DOI 10.1007/s10071-010-0316-y; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Hunnius S, 2011, COGNITION EMOTION, V25, P193, DOI 10.1080/15298861003771189; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kaminski J, 2013, LEARN MOTIV, V44, P294, DOI 10.1016/j.lmot.2013.05.001; Kano F, 2012, J COMP PSYCHOL, V126, P388, DOI 10.1037/a0029615; Kano F, 2010, J COMP PSYCHOL, V124, P287, DOI 10.1037/a0019146; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; King HM, 2012, PSYCHONEUROENDOCRINO, V37, P396, DOI 10.1016/j.psyneuen.2011.07.010; Kret ME, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00810; Lacreuse A, 2013, ANIM COGN, V16, P861, DOI 10.1007/s10071-013-0618-y; Matsumoto D., 2008, HDB EMOTIONS, V3, P211, DOI DOI 10.1016/J.BRAT.2006.05.004; Merola I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047653; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Mosher CP, 2011, BEHAV NEUROSCI, V125, P639, DOI 10.1037/a0024264; Muller CA, 2015, CURR BIOL, V25, P601, DOI 10.1016/j.cub.2014.12.055; Nagasawa M, 2013, BEHAV PROCESS, V98, P112, DOI 10.1016/j.beproc.2013.05.012; Nagasawa M, 2011, ANIM COGN, V14, P525, DOI 10.1007/s10071-011-0386-5; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Peterson MF, 2012, P NATL ACAD SCI USA, V109, pE3314, DOI 10.1073/pnas.1214269109; Racca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036076; Sakaki M, 2012, COGN AFFECT BEHAV NE, V12, P115, DOI 10.3758/s13415-011-0062-x; Scheller E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041792; Schirmer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074591; Somppi S, 2014, ANIM COGN, V17, P793, DOI 10.1007/s10071-013-0713-0; Somppi S, 2012, ANIM COGN, V15, P163, DOI 10.1007/s10071-011-0442-1; Tate AJ, 2006, PHILOS T R SOC B, V361, P2155, DOI 10.1098/rstb.2006.1937; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Terburg D, 2012, EMOTION, V12, P666, DOI 10.1037/a0027201; Vas J, 2005, APPL ANIM BEHAV SCI, V94, P99, DOI 10.1016/j.applanim.2005.02.001; Viranyi Z, 2014, SOCIAL DOG BEHAV COG, P35, DOI DOI 10.1016/B978-0-12-407818-5.00002-4; Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686; Waller BM, 2013, EMOT REV, V5, P54, DOI 10.1177/1754073912451503; Williams FJ, 2011, J NEUROSCI METH, V194, P259, DOI 10.1016/j.jneumeth.2010.10.022; Yang JJ, 2012, NEUROPSYCHOLOGIA, V50, P2566, DOI 10.1016/j.neuropsychologia.2012.07.001	69	33	33	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0143047	10.1371/journal.pone.0143047	http://dx.doi.org/10.1371/journal.pone.0143047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761433	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100002
J	Chang, J; Ryou, N; Jun, HJ; Hwang, SY; Song, JJ; Chae, SW				Chang, Jiwon; Ryou, Namhyung; Jun, Hyung Jin; Hwang, Soon Young; Song, Jae-Jun; Chae, Sung Won			Effect of Cigarette Smoking and Passive Smoking on Hearing Impairment: Data from a Population-Based Study	PLOS ONE			English	Article							PREVALENCE; ADULTS; RISK; EXPOSURE; HEALTH; AGE	Objectives In the present study, we aimed to determine the effect of both active and passive smoking on the prevalence of the hearing impairment and the hearing thresholds in different age groups through the analysis of data collected from the Korea National Health and Nutrition Examination Survey (KNHANES). Study Design Cross-sectional epidemiological study. Methods The KNHANES is an ongoing population study that started in 1998. We included a total of 12,935 participants aged >= 19 years in the KNHANES, from 2010 to 2012, in the present study. Pure-tone audiometric (PTA) testing was conducted and the frequencies tested were 0.5, 1, 2, 3, 4, and 6 kHz. Smoking status was categorized into three groups; current smoking group, passive smoking group and non-smoking group. Results In the current smoking group, the prevalence of speech-frequency bilateral hearing impairment was increased in ages of 40-69, and the rate of high frequency bilateral hearing impairment was elevated in ages of 30-79. When we investigated the impact of smoking on hearing thresholds, we found that the current smoking group had significantly increased hearing thresholds compared to the passive smoking group and non-smoking groups, across all ages in both speech-relevant and high frequencies. The passive smoking group did not have an elevated prevalence of either speech-frequency bilateral hearing impairment or high frequency bilateral hearing impairment, except in ages of 40s. However, the passive smoking group had higher hearing thresholds than the non-smoking group in the 30s and 40s age groups. Conclusion Current smoking was associated with hearing impairment in both speech-relevant frequency and high frequency across all ages. However, except in the ages of 40s, passive smoking was not related to hearing impairment in either speech-relevant or high frequencies.	[Chang, Jiwon] Hallym Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Chunchon, South Korea; [Ryou, Namhyung; Jun, Hyung Jin; Song, Jae-Jun; Chae, Sung Won] Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul 136705, South Korea; [Hwang, Soon Young] Korea Univ, Coll Med, Dept Med Stat, Seoul 136705, South Korea	Hallym University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Chae, SW (corresponding author), Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul 136705, South Korea.	schae@kumc.or.kr						Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; [Anonymous], 2015, FACT SHEET N300; Brant L J, 1996, J Am Acad Audiol, V7, P152; Cruickshanks KJ, 1998, JAMA-J AM MED ASSOC, V279, P1715, DOI 10.1001/jama.279.21.1715; Dawes P, 2014, JARO-J ASSOC RES OTO, V15, P663, DOI 10.1007/s10162-014-0461-0; Demeester K, 2009, INT J AUDIOL, V48, P222, DOI 10.1080/14992020802441799; Durante AS, 2013, INT J ENV RES PUB HE, V10, P5257, DOI 10.3390/ijerph10115257; Fabry DA, 2011, TOB CONTROL, V20, P82, DOI 10.1136/tc.2010.035832; Gopinath B, 2009, ARCH INTERN MED, V169, P415, DOI 10.1001/archinternmed.2008.597; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Itoh A, 2001, PUBLIC HEALTH, V115, P192; Jun HJ, 2015, LARYNGOSCOPE, V125, P690, DOI 10.1002/lary.24913; Karlsmose B, 2000, BRIT J AUDIOL, V34, P47, DOI 10.3109/03005364000000117; Mahomed F, 2013, EAR HEARING, V34, P745, DOI 10.1097/01.aud.0000436255.53747.a4; Martinez-Perez B, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2600; Nakanishi N, 2000, J OCCUP ENVIRON MED, V42, P1045, DOI 10.1097/00043764-200011000-00001; Nomura K, 2005, PREV MED, V40, P138, DOI 10.1016/j.ypmed.2004.05.011; Noorhassim I, 1998, AM J OTOLARYNG, V19, P240, DOI 10.1016/S0196-0709(98)90125-9; Ohgami N, 2011, TOXICOL IND HEALTH, V27, P143, DOI 10.1177/0748233710382539; ROSENHALL U, 1993, AUDIOLOGY, V32, P234; Sumit AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118960; Talaat HS, 2014, INT J PEDIATR OTORHI, V78, P46, DOI 10.1016/j.ijporl.2013.10.016; Turcot A, 2015, OCCUP MED-OXFORD, V65, P238, DOI 10.1093/occmed/kqu214; Uy J, 2013, ANN INTERN MED, V158, pITC41, DOI 10.7326/0003-4819-158-7-201304020-01004; Weitzman M, 2013, JAMA OTOLARYNGOL, V139, P669, DOI 10.1001/jamaoto.2013.3294	25	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146608	10.1371/journal.pone.0146608	http://dx.doi.org/10.1371/journal.pone.0146608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756932	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800018
J	Huang, Y; Wang, ZK; Zha, SF; Wang, Y; Jiang, W; Liao, YF; Song, ZY; Qi, ZR; Yin, YP				Huang, Yi; Wang, Zhongkang; Zha, Shenfang; Wang, Yu; Jiang, Wei; Liao, Yufeng; Song, Zhangyong; Qi, Zhaoran; Yin, Youping			De Novo Transcriptome and Expression Profile Analysis to Reveal Genes and Pathways Potentially Involved in Cantharidin Biosynthesis in the Blister Beetle Mylabris cichorii	PLOS ONE			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; RNA-SEQ; COLEOPTERA; MELOIDAE; TOOL; PRODUCT; LEADS	The dried body of Mylabris cichorii is well-known Chinese traditional medicine. The sesquiterpenoid cantharidin, which is secreted mostly by adult male beetles, has recently been used as an anti-cancer drug. However, little is known about the mechanisms of cantharidin biosynthesis. Furthermore, there is currently no genomic or transcriptomic information for M. cichorii. In this study, we performed de novo assembly transcriptome of M. cichorii using the Illumina Hiseq2000. A single run produced 9.19 Gb of clean nucleotides comprising 29,247 sequences, including 23,739 annotated sequences (about 81%). We also constructed two expression profile libraries (20-25 day-old adult males and 20-25 day-old adult females) and discovered 2,465 significantly differentially-expressed genes. Putative genes and pathways involved in the biosynthesis of cantharidin were then characterized. We also found that cantharidin biosynthesis in M. cichorii might only occur via the mevalonate (MVA) pathway, not via the methylerythritol 4-phosphate/deoxyxylulose 5-phosphate (MEP/DOXP) pathway or a mixture of these. Besides, we considered that cantharidin biosynthesis might be related to the juvenile hormone (JH) biosynthesis or degradation. The results of transcriptome and expression profiling analysis provide a comprehensive sequence resource for M. cichorii that could facilitate the in-depth study of candidate genes and pathways involved in cantharidin biosynthesis, and may thus help to improve our understanding of the mechanisms of cantharidin biosynthesis in blister beetles.	[Huang, Yi; Wang, Zhongkang; Zha, Shenfang; Wang, Yu; Jiang, Wei; Song, Zhangyong; Qi, Zhaoran; Yin, Youping] Chongqing Univ, Sch Life Sci, Key Lab Genet Funct & Regulat, Chongqing 400030, Peoples R China; [Wang, Yu] Panzhihua Univ, Panzhihua 617000, Peoples R China; [Liao, Yufeng] Tianjin Med Univ, Clin Med Coll, Tianjin 300270, Peoples R China	Chongqing University; Panzhihua University; Tianjin Medical University	Yin, YP (corresponding author), Chongqing Univ, Sch Life Sci, Key Lab Genet Funct & Regulat, Chongqing 400030, Peoples R China.	ypy128@sina.com		Huang, Yi/0000-0002-5734-650X				Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Bick JA, 2003, ARCH BIOCHEM BIOPHYS, V415, P146, DOI 10.1016/S0003-9861(03)00233-9; CARREL JE, 1974, SCIENCE, V183, P755, DOI 10.1126/science.183.4126.755; CARREL JE, 1993, EXPERIENTIA, V49, P171, DOI 10.1007/BF01989424; CARREL JE, 1986, EXPERIENTIA, V42, P853, DOI 10.1007/BF01941552; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Editorial Board of Pharmacopoeia of the People's Republic of China, 2005, PHARM PEOPL REP CH 1, P253; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GUENTHER H, 1969, J PHARM SCI, V58, P1274, DOI 10.1002/jps.2600581027; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Kamita SG, 2010, J PESTIC SCI, V35, P265, DOI 10.1584/jpestics.R10-09; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liao ZhiHua, 2006, Journal of Biological Sciences, V6, P209; Liu DW, 2009, ANTI-CANCER AGENT ME, V9, P392, DOI 10.2174/1871520610909040392; Manzano D, 2004, PLANTA, V219, P982, DOI 10.1007/s00425-004-1301-y; MATSUZAWA M, 1987, J AGR FOOD CHEM, V35, P823, DOI 10.1021/jf00077a045; McCormick J.P., 1987, P307; MCCORMICK JP, 1986, J AM CHEM SOC, V108, P8071, DOI 10.1021/ja00285a032; Moed L, 2001, ARCH DERMATOL, V137, P1357; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moshitzky P, 2003, INSECT BIOCHEM MOLEC, V33, P1299, DOI 10.1016/j.ibmb.2003.06.008; Nikbakhtzadeh MR, 2007, J INSECT PHYSIOL, V53, P890, DOI 10.1016/j.jinsphys.2007.02.012; PETER MG, 1977, HELV CHIM ACTA, V60, P2756, DOI 10.1002/hlca.19770600827; PETER MG, 1977, HELV CHIM ACTA, V60, P1262, DOI 10.1002/hlca.19770600416; SCHALLER H, 1995, PLANT PHYSIOL, V109, P761, DOI 10.1104/pp.109.3.761; SCHLATTE.C, 1968, EXPERIENTIA, V24, P994, DOI 10.1007/BF02138701; SIERRA JR, 1976, EXPERIENTIA, V32, P142, DOI 10.1007/BF01937729; Suzuki M, 2004, PLANT J, V37, P750, DOI 10.1111/j.1365-313X.2004.02003.x; Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45; Verma AK, 2013, J ETHNOPHARMACOL, V148, P869, DOI 10.1016/j.jep.2013.05.032; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Wang Hui-Rong, 2008, Acta Entomologica Sinica, V51, P264; Wang YN, 2014, J RES CONSUM, P14; Yang HY, 2007, ANTI-CANCER DRUG, V18, P1133, DOI 10.1097/CAD.0b013e3282eeb1c5; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin You-Ping, 2010, Acta Entomologica Sinica, V53, P1305; Zhang QR, 2005, INSECT BIOCHEM MOLEC, V35, P153, DOI 10.1016/j.ibmb.2004.10.010; Zhao YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125415	40	5	6	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146953	10.1371/journal.pone.0146953	http://dx.doi.org/10.1371/journal.pone.0146953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752526	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100184
J	Kabbara, A; Khalil, M; El-Falou, W; Eid, H; Hassan, M				Kabbara, Aya; Khalil, Mohamad; El-Falou, Wassim; Eid, Hassan; Hassan, Mahmoud			Functional Brain Connectivity as a New Feature for P300 Speller	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; MENTAL PROSTHESIS; NETWORKS; BAND	The brain is a large-scale complex network often referred to as the "connectome". Cognitive functions and information processing are mainly based on the interactions between distant brain regions. However, most of the 'feature extraction' methods used in the context of Brain Computer Interface (BCI) ignored the possible functional relationships between different signals recorded from distinct brain areas. In this paper, the functional connectivity quantified by the phase locking value (PLV) was introduced to characterize the evoked responses (ERPs) obtained in the case of target and non-targets visual stimuli. We also tested the possibility of using the functional connectivity in the context of 'P300 speller'. The proposed approach was compared to the well-known methods proposed in the state of the art of " P300 Speller", mainly the peak picking, the area, time/ frequency based features, the xDAWN spatial filtering and the stepwise linear discriminant analysis (SWLDA). The electroencephalographic (EEG) signals recorded from ten subjects were analyzed offline. The results indicated that phase synchrony offers relevant information for the classification in a P300 speller. High synchronization between the brain regions was clearly observed during target trials, although no significant synchronization was detected for a non-target trial. The results showed also that phase synchrony provides higher performance than some existing methods for letter classification in a P300 speller principally when large number of trials is available. Finally, we tested the possible combination of both approaches (classical features and phase synchrony). Our findings showed an overall improvement of the performance of the P300-speller when using Peak picking, the area and frequency based features. Similar performances were obtained compared to xDAWN and SWLDA when using large number of trials.	[Kabbara, Aya; Khalil, Mohamad; El-Falou, Wassim] ULFG1, Dept Elect & Comp Engn, Tripoli, Lebanon; [Kabbara, Aya; Khalil, Mohamad; El-Falou, Wassim] EDST, Azm Ctr Res Biotechnol & Its Applicat, Tripoli, Lebanon; [Eid, Hassan] Mazloum Hosp, Tripoli, Lebanon; [Hassan, Mahmoud] INSERM, U1099, F-35000 Rennes, France; [Hassan, Mahmoud] Univ Rennes 1, LTSI, F-35000 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Kabbara, A (corresponding author), ULFG1, Dept Elect & Comp Engn, Tripoli, Lebanon.	aya.kabbara7@gmail.com	Hassan, Mahmoud/AAF-4519-2019	Hassan, Mahmoud/0000-0003-0307-5086; Kahlil, Mohamad/0000-0002-9814-1949	Mazloum Hospital; Azm center for research in biotechnology and its applications, Tripoli, Lebanon	Mazloum Hospital; Azm center for research in biotechnology and its applications, Tripoli, Lebanon	This work was supported by Mazloum Hospital and Azm center for research in biotechnology and its applications, Tripoli, Lebanon.	[Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; Ansari-Asl K, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031916; Barachant A., 2014, ARXIV PREPRINT ARXIV; Bayliss JD, 2003, IEEE T NEUR SYS REH, V11, P113, DOI 10.1109/TNSRE.2003.814438; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Faes L, 2004, IEEE T BIO-MED ENG, V51, P1156, DOI 10.1109/TBME.2004.827271; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gysels E, 2005, SIGNAL PROCESS, V85, P2178, DOI 10.1016/j.sigpro.2005.07.008; Gysels E, 2004, IEEE T NEUR SYS REH, V12, P406, DOI 10.1109/TNSRE.2004.838443; Hamner B, 2011, ENG MED BIOL SOC EMB; Hassan M, 2015, CORTEX, V73, P276, DOI 10.1016/j.cortex.2015.08.019; Hoffmann U, 2005, I IEEE EMBS C NEUR E, P97; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Kabbara A, 2015, INT C BIOM ENG ICABM; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Lachaux J, 2002, PHASE SYNCHRONIZATIO; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lakerveld J, 2008, J NEUROL NEUROSUR PS, V79, P25, DOI 10.1136/jnnp.2007.116178; Lal T. N., 2005, P 22 INT C MACH LEAR; Laufs H, 2012, CURR OPIN NEUROL, V25, P194, DOI 10.1097/WCO.0b013e3283515db9; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; Meinicke P., 2002, NEURAL INFORM PROCES, P1107; Mheich A, 2015, J NEUROSCI METH, V242, P77, DOI 10.1016/j.jneumeth.2015.01.002; Morup M, 2006, NEUROIMAGE, V29, P938, DOI 10.1016/j.neuroimage.2005.08.005; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Rakotomarnonjy A, 2008, IEEE T BIO-MED ENG, V55, P1147, DOI 10.1109/TBME.2008.915728; Rivet B, 2009, IEEE T BIO-MED ENG, V56, P2035, DOI 10.1109/TBME.2009.2012869; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rosso OA, 2006, J NEUROSCI METH, V153, P163, DOI 10.1016/j.jneumeth.2005.10.009; Rottig D, 2006, J NEUROL, V253, P333, DOI 10.1007/s00415-005-0992-8; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; Sitaram R., 2007, COMPUTATIONAL INTELL; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Takano K, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00074; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Truccolo WA, 2002, CLIN NEUROPHYSIOL, V113, P206, DOI 10.1016/S1388-2457(01)00739-8; Varela FJ, 1994, BIOL RES, V28, P81; Wang Y, 2006, ENG MED BIOL SOC 200; Wei QG, 2007, J NEURAL ENG, V4, P120, DOI 10.1088/1741-2560/4/2/012; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	46	24	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146282	10.1371/journal.pone.0146282	http://dx.doi.org/10.1371/journal.pone.0146282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752711	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100060
J	Lin, J; Liu, J; Davies, ML; Chen, WQ				Lin, Jin; Liu, Jian; Davies, Michael L.; Chen, Weiqian			Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; D DEFICIENCY; 25-HYDROXYVITAMIN D; ANKYLOSING-SPONDYLITIS; IMMUNE-SYSTEM; HEALTH-STATUS; ASSOCIATION; RISK; SUPPLEMENTATION; AUTOIMMUNE	Background The evidence from epidemiological studies concerning the relationship between serum vitamin D concentrations and rheumatoid arthritis (RA) is inconsistent. This meta-analysis is aimed at determining the magnitude of the correlation between this common autoimmune disease and vitamin D, an important nutrient known to dampen adaptive immune responses. Methods Through multiple search strategies, relevant literature was identified and evaluated for quality before May 16 2015. Data extracted from eligible studies was synthesized to calculate pooled correlation coefficient (r), mean difference (MD) and odds ratio (OR). The Venice criteria were applied to assess the credibility of the evidence for each statistically significant association. Results A total of 24 reports involving 3489 patients were selected for analysis. RA patients had lower vitamin D levels than healthy controls (MD:-16.52 nmol/L, 95% confidence intervals [CI]:-18.85 to -14.19 nmol/L). There existed a negative relationship between serum 25-hydroxyvitamin D (25OHD) level and disease activity index, e.g. 25OHD vs. Disease Activity Score in 28 joints (DAS28): r = -0.13, 95% CI -0.16 to -0.09; 25OHD vs. C-reactive protein: r = -0.12, 95% CI -0.23 to -0.00. Additionally, latitude-stratified subgroup analysis yielded a relatively stronger negative correlation between 25OHD and DAS28 in low-latitude areas. This inverse relationship also appeared more significant in developing countries than in developed countries. No publication bias was detected. Conclusion RA patients had lower vitamin D values than healthy controls. There was a negative association between serum vitamin D and RA disease activity. However, more strictly controlled studies are needed to validate these findings.	[Lin, Jin; Liu, Jian; Chen, Weiqian] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Rheumatol, Hangzhou 310003, Zhejiang, Peoples R China; [Davies, Michael L.] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, Clin Immunol Lab, N Chicago, IL USA	Zhejiang University; Rosalind Franklin University Medical & Science	Chen, WQ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Rheumatol, Hangzhou 310003, Zhejiang, Peoples R China.	cwq678@126.com						Adorini L, 2005, CELL IMMUNOL, V233, P115, DOI 10.1016/j.cellimm.2005.04.013; Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; Arnson Y, 2007, ANN RHEUM DIS, V66, P1137, DOI 10.1136/ard.2007.069831; Atherton K, 2009, ANN RHEUM DIS, V68, P817, DOI 10.1136/ard.2008.090456; Attar SM, 2012, SAUDI MED J, V33, P520; Atwa MA, 2013, SAUDI MED J, V34, P806; Azzeh F. S., 2012, Pakistan Journal of Nutrition, V11, P293; Azzeh FS, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/260725; Baker JF, 2012, CLIN EXP RHEUMATOL, V30, P658; Baykal T, 2012, BRATISL MED J, V113, P610, DOI 10.4149/BLL_2012_137; Borenstein M., 2021, INTRO META ANAL; Brance ML, 2015, RHEUMATOL INT, V35, P499, DOI 10.1007/s00296-014-3071-6; Braun-Moscovici Y, 2011, RHEUMATOL INT, V31, P493, DOI 10.1007/s00296-009-1251-6; Cai GQ, 2015, CLIN CHIM ACTA, V438, P316, DOI 10.1016/j.cca.2014.08.040; Cantorna MT, 1998, J NUTR, V128, P68, DOI 10.1093/jn/128.1.68; Ceglia L, 2013, J CLIN ENDOCR METAB, V98, pE1927, DOI 10.1210/jc.2013-2820; Chalkidou A, 2012, EUR J CANCER, V48, P3499, DOI 10.1016/j.ejca.2012.05.001; Chen J, 2014, INT J RHEUM DIS, V17, P66, DOI 10.1111/1756-185X.12160; Craig SM, 2010, J RHEUMATOL, V37, P275, DOI 10.3899/jrheum.090705; Cutolo M, 2006, CLIN EXP RHEUMATOL, V24, P702; Cutolo M, 2007, AUTOIMMUN REV, V7, P59, DOI 10.1016/j.autrev.2007.07.001; Dehghan A, 2014, Z RHEUMATOL, V73, P461, DOI 10.1007/s00393-013-1297-4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edwards CJ, 2006, CLIN EXP IMMUNOL, V143, P1, DOI 10.1111/j.1365-2249.2005.02940.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fransen J, 2003, DEV VALIDATION DAS28; Gatenby P, 2013, CURR OPIN RHEUMATOL, V25, P184, DOI 10.1097/BOR.0b013e32835cfc16; Gheita TA, 2016, INT J RHEUM DIS, V19, P294, DOI 10.1111/1756-185X.12426; Gopinath K, 2011, INT J RHEUM DIS, V14, P332, DOI 10.1111/j.1756-185X.2011.01684.x; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; GW S, 1980, STAT METHODS, P185; Haque UJ, 2010, CLIN EXP RHEUMATOL, V28, P745; Hasan E, 2012, BIOL-TARGETS THER, V6, P31, DOI 10.2147/BTT.S27840; Heidari B, 2012, RHEUMATOL INT, V32, P991, DOI 10.1007/s00296-010-1736-3; Hewison M, 2012, RHEUM DIS CLIN N AM, V38, P125, DOI 10.1016/j.rdc.2012.03.012; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hiraki LT, 2014, RHEUMATOLOGY, V53, P2243, DOI 10.1093/rheumatology/keu276; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hong Q, 2014, RHEUMATOLOGY, V53, P1994, DOI 10.1093/rheumatology/keu173; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Kim TH, 2012, MED HYPOTHESES, V79, P757, DOI 10.1016/j.mehy.2012.08.022; Kostoglou-Athanassiou I, 2012, THER ADV ENDOCRINOL, V3, P181, DOI 10.1177/2042018812471070; Kriegel MA, 2011, SEMIN ARTHRITIS RHEU, V40, P512, DOI 10.1016/j.semarthrit.2010.07.009; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Maruotti N, 2010, J RHEUMATOL, V37, P491, DOI 10.3899/jrheum.090797; Matsumoto Y, 2015, MOD RHEUMATOL, V25, P246, DOI 10.3109/14397595.2014.952487; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Neve A, 2014, CLIN EXP MED, V14, P275, DOI 10.1007/s10238-013-0249-2; Ng T, 1997, Br J Hosp Med, V58, P521; Oelzner P, 1998, CALCIFIED TISSUE INT, V62, P193, DOI 10.1007/s002239900416; Oelzner P, 1999, RHEUMATOLOGY, V38, P841, DOI 10.1093/rheumatology/38.9.841; Oelzner P, 2006, RHEUMATOL INT, V26, P908, DOI 10.1007/s00296-005-0095-y; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Putrik P, 2016, ANN RHEUM DIS, V75, P715, DOI 10.1136/annrheumdis-2015-207738; Racovan M, 2012, RHEUMATOL INT, V32, P3823, DOI 10.1007/s00296-011-2268-1; Raczkiewicz A, 2015, JCR-J CLIN RHEUMATOL, V21, P126, DOI 10.1097/RHU.0000000000000233; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Rossini M, 2013, REUMATISMO, V65, P113, DOI 10.4081/reumatismo.2013.113; Rossini M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3195; Rostom A, 2004, CELIAC DIS AGENCY HE; Rupinski MT, 1996, EDUC PSYCHOL MEAS, V56, P419, DOI 10.1177/0013164496056003004; Sabbagh Z, 2013, NUTRIENTS, V5, P2268, DOI 10.3390/nu5072268; Sahebari M, 2014, CASP J INTERN MED, V5, P148; Sempos CT, 2012, SCAND J CLIN LAB INV, V72, P32, DOI 10.3109/00365513.2012.681935; Sharma Rajeev, 2014, J Assoc Physicians India, V62, P678; Skaaby T, 2015, ENDOCRINE, V50, P231, DOI 10.1007/s12020-015-0547-4; Song GG, 2012, CLIN RHEUMATOL, V31, P1733, DOI 10.1007/s10067-012-2080-7; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Szodoray P, 2008, SCAND J IMMUNOL, V68, P261, DOI 10.1111/j.1365-3083.2008.02127.x; Tizaoui K, 2015, IMMUNOBIOLOGY, V220, P807, DOI 10.1016/j.imbio.2014.12.013; Tsiligianni I, 2011, PRIM CARE RESP J, V20, P257, DOI 10.4104/pcrj.2011.00029; Turhanoglu AD, 2011, RHEUMATOL INT, V31, P911, DOI 10.1007/s00296-010-1393-6; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; van Riel PL, 2014, CLIN EXP RHEUMAT S85, V32, pS; Varenna M, 2012, CLIN EXP RHEUMATOL, V30, P714; Wells G.A., NEWCASTLE OTTAWA SCA; Welsh P, 2011, ANN RHEUM DIS, V70, P1165, DOI 10.1136/ard.2010.137265; Yazmalar L, 2013, AFR HEALTH SCI, V13, P47, DOI 10.4314/ahs.v13i1.7; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhao SZ, 2014, RHEUMATOLOGY, V53, P1595, DOI 10.1093/rheumatology/keu042; Zold E, 2011, VITAM HORM, V86, P261, DOI 10.1016/B978-0-12-386960-9.00011-3	83	98	104	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146351	10.1371/journal.pone.0146351	http://dx.doi.org/10.1371/journal.pone.0146351			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751969	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100067
J	Morabito, KM; Erez, N; Graham, BS; Ruckwardt, TJ				Morabito, Kaitlyn M.; Erez, Noam; Graham, Barney S.; Ruckwardt, Tracy J.			Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus K(d)M2(82-90) Epitope Is Transfer Dose-Dependent	PLOS ONE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; MOUSE MODEL; INFECTION; IMMUNOPATHOLOGY; IMMUNODOMINANCE; RESPONSES; COMPETITION; MICE	In this study, we compared two lines of transgenic CD8+ T cells specific for the same (KM282-90)-M-d epitope of respiratory syncytial virus in the CB6F1 hybrid mouse model. Here we found that these two transgenic lines had similar in vivo abilities to control viral load after respiratory syncytial virus infection using adoptive transfer. Transfer of the TRBV13-2 line resulted in higher levels of IL-6 and MIP1-alpha in the lung than TRBV13-1 transfer. Interestingly, when large numbers of cells were co-transferred, the lines formed a hierarchy, with TRBV13-2 being immunodominant over TRBV13-1 in the mediastinal lymph node despite no identifiable difference in proliferation or apoptosis between the lines. This hierarchy was not established when lower cell numbers were transferred. The phenotype and frequency of proliferating cells were also cell transfer dose-dependent with higher percentages of CD127(lo)CD62L(lo)KLRG1(lo) and proliferating cells present when lower numbers of cells were transferred. These results illustrate the importance of cell number in adoptive transfer experiments and its influence on the phenotype and hierarchy of the subsequent T cell response.	[Morabito, Kaitlyn M.; Erez, Noam; Graham, Barney S.; Ruckwardt, Tracy J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Morabito, Kaitlyn M.] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20007 USA; [Erez, Noam] Israel Inst Biol Res, Dept Infect Dis, Ness Ziona, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Georgetown University	Ruckwardt, TJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	truckwardt@mail.nih.gov	Graham, Barney S./AAC-5898-2019; Erez, Noam/AAW-4953-2021	Graham, Barney S./0000-0001-8112-0853; Erez, Noam/0000-0001-5241-8028; Morabito, Kaitlyn/0000-0002-4849-4690	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005027] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by intramural funding from the National Institute of Allergy and Infectious Diseases.	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bar-Haim E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099249; Billam P, 2011, J BIOL CHEM, V286, P4829, DOI 10.1074/jbc.M110.191437; Culley FJ, 2006, J VIROL, V80, P4521, DOI 10.1128/JVI.80.9.4521-4527.2006; Foulds KE, 2006, J IMMUNOL, V176, P3037, DOI 10.4049/jimmunol.176.5.3037; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Grufman P, 1999, EUR J IMMUNOL, V29, P2197, DOI 10.1002/(SICI)1521-4141(199907)29:07<2197::AID-IMMU2197>3.0.CO;2-B; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; OPENSHAW PJM, 1995, AM J RESP CRIT CARE, V152, pS59, DOI 10.1164/ajrccm/152.4_Pt_2.S59; Ostler T, 2002, EUR J IMMUNOL, V32, P2117, DOI 10.1002/1521-4141(200208)32:8<2117::AID-IMMU2117>3.0.CO;2-C; Roychowdhury S, 2004, CANCER RES, V64, P8062, DOI 10.1158/0008-5472.CAN-04-1860; Ruckwardt TJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002377; Ruckwardt TJ, 2010, J IMMUNOL, V185, P4673, DOI 10.4049/jimmunol.1001606; Rutigliano JA, 2007, VIROLOGY, V362, P314, DOI 10.1016/j.virol.2006.12.023; Varga SM, 2002, VIROLOGY, V295, P203, DOI 10.1006/viro.2002.1382; Vigano S., 2012, CLIN DEV IMMUNOL, V2012, DOI DOI 10.1155/2012/153863; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Wirth T, 2009, ADV EXP MED BIOL, V633, P71, DOI 10.1007/978-0-387-79311-5_7; Wirth TC, 2009, MOL IMMUNOL, V47, P71, DOI 10.1016/j.molimm.2008.12.018; Wolpert EZ, 1998, J IMMUNOL, V161, P4499; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146781	10.1371/journal.pone.0146781	http://dx.doi.org/10.1371/journal.pone.0146781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752171	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100153
J	Moyal, L; Feldbaum, N; Goldfeiz, N; Rephaeli, A; Nudelman, A; Weitman, M; Tarasenko, N; Gorovitz, B; Maron, L; Yehezkel, S; Amitay-Laish, I; Lubin, I; Hodak, E				Moyal, Lilach; Feldbaum, Nataly; Goldfeiz, Neta; Rephaeli, Ada; Nudelman, Abraham; Weitman, Michal; Tarasenko, Nataly; Gorovitz, Batia; Maron, Leah; Yehezkel, Shiran; Amitay-Laish, Iris; Lubin, Ido; Hodak, Emmilia			The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin	PLOS ONE			English	Article							T-CELL LYMPHOMA; DIETHYL PHOSPHATE AN-7; HDAC INHIBITORS; INTERFERON-GAMMA; SEZARY-SYNDROME; BUTYRIC-ACID; DNA-DAMAGE; COMBINATION; CANCER; VORINOSTAT	The 2 histone deacetylase inhibitors (HDACIs) approved for the treatment of cutaneous T-cell lymphoma (CTCL) including mycosis fungoides/sezary syndrome (MF/SS), suberoylanilide hydroxamic acid (SAHA) and romidepsin, are associated with low rates of overall response and high rates of adverse effects. Data regarding combination treatments with HDACIs is sparse. Butyroyloxymethyl diethylphosphate (AN-7) is a novel HDACI, which was found to have selective anticancer activity in several cell lines and animal models. The aim of this study was to compare the anticancer effects of AN-7 and SAHA, either alone or combined with doxorubicin, on MF/SS cell lines and peripheral blood lymphocytes (PBL) from patients with Sezary syndrome (SPBL). MyLa cells, Hut78 cells, SPBL, and PBL from healthy normal individuals (NPBL) were exposed to the test drugs, and the findings were analyzed by a viability assay, an apoptosis assay, and Western blot. AN-7 was more selectively toxic to MyLa cells, Hut78 cells, and SPBL (relative to NPBL) than SAHA and also acted more rapidly. Both drugs induced apoptosis in MF/SS cell lines, SAHA had a greater effect on MyLa cell line, while AN-7 induced greater apoptosis in SPBL; both caused an accumulation of acetylated histone H-3, but AN-7 was associated with earlier kinetics; and both caused a downregulation of the HDAC1 protein in MF/SS cell lines. AN-7 acted synergistically with doxorubicin in both MF/SS cell lines and SPBL, and antagonistically with doxorubicin in NPBL. By contrast, SAHA acted antagonistically with doxorubicin on MF/SS cell lines, SPBL, and NPBL, leaving <50% viable cells. In conclusion, AN-7 holds promise as a therapeutic agent in MF/SS and has several advantages over SAHA. Our data provide a rationale for combining AN-7, but not SAHA, with doxorubicin to induce the cell death in MF/SS.	[Moyal, Lilach; Feldbaum, Nataly; Goldfeiz, Neta; Gorovitz, Batia; Maron, Leah; Yehezkel, Shiran; Hodak, Emmilia] Felsenstein Med Res Ctr, Lab Mol Dermatol, Petah Tiqwa, Israel; [Moyal, Lilach; Feldbaum, Nataly; Goldfeiz, Neta; Rephaeli, Ada; Tarasenko, Nataly; Gorovitz, Batia; Maron, Leah; Yehezkel, Shiran; Amitay-Laish, Iris; Lubin, Ido; Hodak, Emmilia] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Moyal, Lilach; Amitay-Laish, Iris; Hodak, Emmilia] Rabin Med Ctr, Dept Dermatol, Petah Tiqwa, Israel; [Rephaeli, Ada; Tarasenko, Nataly] Felsenstein Med Res Ctr, Lab Pharmacol & Expt Oncol, Petah Tiqwa, Israel; [Nudelman, Abraham; Weitman, Michal] Bar Ilan Univ, Dept Chem, Div Med Chem, Ramat Gan, Israel; [Lubin, Ido] Felsenstein Med Res Ctr, Core Facil, Petah Tiqwa, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Bar Ilan University; Tel Aviv University	Moyal, L (corresponding author), Felsenstein Med Res Ctr, Lab Mol Dermatol, Petah Tiqwa, Israel.	lilachm@post.tau.ac.il			Israel Cancer Association [20130150]; Bar Ilan University and Rabin Medical Center Collaboration in Biomedical Research	Israel Cancer Association; Bar Ilan University and Rabin Medical Center Collaboration in Biomedical Research	LM and EH received a grant from the Israel Cancer Association (grant number- 20130150). LM EH AN AR received a grant from Bar Ilan University and Rabin Medical Center Collaboration in Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Akilov OE, 2012, BRIT J DERMATOL, V167, P194, DOI 10.1111/j.1365-2133.2012.10905.x; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Arrighetti Noemi, 2015, Critical Reviews in Oncogenesis, V20, P83; Bhatt S, 2013, J CLIN INVEST, V123, P2616, DOI 10.1172/JCI64503; Bolden JE, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.9; Bose P, 2014, PHARMACOL THERAPEUT, V143, P323, DOI 10.1016/j.pharmthera.2014.04.004; Bots M, 2009, CLIN CANCER RES, V15, P3970, DOI 10.1158/1078-0432.CCR-08-2786; Bradford PT, 2009, BLOOD, V113, P5064, DOI 10.1182/blood-2008-10-184168; Brodska B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/659254; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Contassot E, 2008, BLOOD, V111, P4780, DOI 10.1182/blood-2007-08-109074; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; Engel D, 2006, J CANCER RES CLIN, V132, P673, DOI 10.1007/s00432-006-0116-6; Gardner JM, 2009, J AM ACAD DERMATOL, V61, P112, DOI 10.1016/j.jaad.2008.11.889; Grant S, 2012, ADV CANCER RES, V116, P199, DOI 10.1016/B978-0-12-394387-3.00006-9; Guenova E, 2014, EXPERT OPIN INV DRUG, V23, P457, DOI 10.1517/13543784.2014.876407; Heinicke U, 2014, CANCER LETT, V351, P50, DOI 10.1016/j.canlet.2014.04.021; Hrabeta J, 2014, BIOMED PAP, V158, P161, DOI 10.5507/bp.2013.085; Jawed SI, 2014, J AM ACAD DERMATOL, V70, DOI 10.1016/j.jaad.2013.07.049; Kaliszczak M, 2013, BRIT J CANCER, V108, P342, DOI 10.1038/bjc.2012.576; KALTOFT K, 1984, BRIT J DERMATOL, V111, P303, DOI 10.1111/j.1365-2133.1984.tb04727.x; Kerl K, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-286; Kun L, 2014, SEMIN HEMATOL, V51, P35, DOI 10.1053/j.seminhematol.2013.11.004; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Li Janet Y, 2012, Cancer Manag Res, V4, P75, DOI 10.2147/CMAR.S9660; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; Matthews GM, 2012, ADV CANCER RES, V116, P165, DOI 10.1016/B978-0-12-394387-3.00005-7; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; Olsen EA, 2015, DERMATOL CLIN, V33, P643, DOI 10.1016/j.det.2015.06.001; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Rephaeli A, 2000, DRUG DEVELOP RES, V50, P379, DOI 10.1002/1098-2299(200007/08)50:3/4<379::AID-DDR20>3.0.CO;2-8; Rephaeli A, 2006, INVEST NEW DRUG, V24, P383, DOI 10.1007/s10637-006-6213-1; Rephaeli A, 2005, INT J CANCER, V116, P226, DOI 10.1002/ijc.21030; Robert C, 2012, ADV CANCER RES, V116, P87, DOI 10.1016/B978-0-12-394387-3.00003-3; Rosato RR, 2003, MOL CANCER THER, V2, P1273; Salazar-Mendiguchía Joel, 2014, Arch. Cardiol. Méx., V84, P218, DOI 10.1016/j.acmx.2013.08.006; Samimi S, 2013, J AM ACAD DERMATOL, V68, pE5, DOI 10.1016/j.jaad.2011.06.043; Sampson ER, 2011, J ORTHOP RES, V29, P623, DOI 10.1002/jor.21274; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Stutz N, 2012, J AM ACAD DERMATOL, V67, DOI 10.1016/j.jaad.2012.05.035; Sung JJ, 2014, J PHOTOCH PHOTOBIO B, V131, P104, DOI 10.1016/j.jphotobiol.2014.01.009; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tarasenko N, 2008, CLIN EXP METASTAS, V25, P703, DOI 10.1007/s10585-008-9179-x; Tarasenko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031393; Tarasenko N, 2012, INVEST NEW DRUG, V30, P130, DOI 10.1007/s10637-010-9542-z; Thurn KT, 2011, FUTURE ONCOL, V7, P263, DOI 10.2217/FON.11.2; Vigushin DM, 2004, CURR CANCER DRUG TAR, V4, P205, DOI 10.2174/1568009043481560; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zhang Y, 2007, RADIAT RES, V168, P115, DOI 10.1667/RR0811.1	53	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146115	10.1371/journal.pone.0146115	http://dx.doi.org/10.1371/journal.pone.0146115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752418	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100043
J	Natsume, Y; Toyota, T				Natsume, Yuno; Toyota, Taro			Asymmetrical Polyhedral Configuration of Giant Vesicles Induced by Orderly Array of Encapsulated Colloidal Particles	PLOS ONE			English	Article							EQUATION-OF-STATE; HARD-SPHERES; EMULSION	Giant vesicles (GVs) encapsulating colloidal particles by a specific volume fraction show a characteristic configuration under a hypertonic condition. Several flat faces were formed in GV membrane with orderly array of inner particles. GV shape changed from the spherical to the asymmetrical polyhedral configuration. This shape deformation was derived by entropic interaction between inner particles and GV membrane. Because a part of inner particles became to form an ordered phase in the region neighboring the GV membrane, free volume for the other part of particles increased. Giant vesicles encapsulating colloidal particles were useful for the model of "crowding effect" which is the entropic interaction in the cell.	[Natsume, Yuno] Japan Womens Univ, Fac Sci, Dept Math & Phys Sci, Tokyo 112, Japan; [Toyota, Taro] Univ Tokyo, Res Ctr Complex Syst Biol, Tokyo, Japan; [Toyota, Taro] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo, Japan	Japan Womens University; University of Tokyo; University of Tokyo	Toyota, T (corresponding author), Univ Tokyo, Res Ctr Complex Syst Biol, Tokyo, Japan.	cttoyota@mail.ecc.u-tokyo.ac.jp			Science Research Promotion Fund [23];  [24104004]	Science Research Promotion Fund; 	The Science Research Promotion Fund (YN, No. 23), Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Robotics" (TT, No. 24104004).	CARNAHAN NF, 1969, J CHEM PHYS, V51, P635, DOI 10.1063/1.1672048; Castellana ET, 2006, SURF SCI REP, V61, P429, DOI 10.1016/j.surfrep.2006.06.001; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Dinsmore AD, 1998, PHYS REV LETT, V80, P409, DOI 10.1103/PhysRevLett.80.409; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Fujiwara K, 2014, ACS SYNTH BIOL, V3, P870, DOI 10.1021/sb4001917; HALL KR, 1972, J CHEM PHYS, V57, P2252, DOI 10.1063/1.1678576; HOOVER WG, 1968, J CHEM PHYS, V49, P3609, DOI 10.1063/1.1670641; Kinoshita Masahiro, 2013, Biophys Rev, V5, P283, DOI 10.1007/s12551-013-0100-8; Miyoshi D, 2008, BIOCHIMIE, V90, P1040, DOI 10.1016/j.biochi.2008.02.009; Natsume Y, 2013, CHEM LETT, V42, P295, DOI 10.1246/cl.2013.295; Natsume Y, 2010, SOFT MATTER, V6, P5359, DOI 10.1039/c0sm00396d; Negishi M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061921; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v; Terasawa H, 2012, P NATL ACAD SCI USA, V109, P5942, DOI 10.1073/pnas.1120327109; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	18	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146683	10.1371/journal.pone.0146683	http://dx.doi.org/10.1371/journal.pone.0146683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752650	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100129
J	Albert, TK; Antrecht, C; Kremmer, E; Meisterernst, M				Albert, Thomas K.; Antrecht, Claudia; Kremmer, Elisabeth; Meisterernst, Michael			The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION; MEDIATOR COACTIVATOR; PHOSPHORYLATES P53; GENE-EXPRESSION; BINDING-SITE; PAF1 COMPLEX; DNA-DAMAGE; 7SK SNRNP; CHROMATIN	CDK9 is the catalytic subunit of positive elongation factor b (P-TEFb) that controls the transition of RNA polymerase II (RNAPII) into elongation. CDK9 inhibitors block mRNA synthesis and trigger activation of the stress-sensitive p53 protein. This in turn induces transcription of CDKN1A (p21) and other cell cycle control genes. It is presently unclear if and how p53 circumvents a general P-TEFb-requirement when it activates its target genes. Our investigations using a panel of specific inhibitors reason for a critical role of CDK9 also in the case of direct inhibition of the kinase. At the prototypic p21 gene, the activator p53 initially accumulates at the pre-bound upstream enhancer followed-with significant delay-by de novo binding to a secondary enhancer site within the first intron of p21. This is accompanied by recruitment of the RNAPII initiation machinery to both elements. ChIP and functional analyses reason for a prominent role of CDK9 itself and elongation factor complexes PAF1c and SEC involved in pause and elongation control. It appears that the strong activation potential of p53 facilitates gene activation in the situation of global repression of RNAPII transcription. The data further underline the fundamental importance of CDK9 for class II gene transcription.	[Albert, Thomas K.; Antrecht, Claudia; Meisterernst, Michael] Univ Munster, Fac Med, IMTB, D-48149 Munster, Germany; [Kremmer, Elisabeth] Helmholtz Res Ctr Environm & Hlth, IMI, D-81377 Munich, Germany	University of Munster	Meisterernst, M (corresponding author), Univ Munster, Fac Med, IMTB, D-48149 Munster, Germany.	meisterernst@uni-muenster.de		Albert, Thomas Karl/0000-0002-2488-0706	Deutsche Forschungsgemeinschaft [ME967/2-1, EXC 1003]; University of Muenster, IZKF-Interdisciplinary Center for Clinical Research [Mei2/017/12]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster, IZKF-Interdisciplinary Center for Clinical Research	MM was supported by Deutsche Forschungsgemeinschaft (ME967/2-1) www.dfg.de; Deutsche Forschungsgemeinschaft (EXC 1003 Cells in Motion) http://www.uni-muenster.de/Cells-inMotion; University of Muenster, IZKF-Interdisciplinary Center for Clinical Research (Mei2/017/12) http://www.campus.uni-muenster.de/izkf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866; Albert TK, 2014, BRIT J PHARMACOL, V171, P55, DOI 10.1111/bph.12408; Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Boeing S, 2010, J BIOL CHEM, V285, P188, DOI 10.1074/jbc.M109.046565; Bowman EA, 2013, DEVELOPMENT, V140, P3703, DOI 10.1242/dev.095778; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Claudio PP, 2006, J CELL PHYSIOL, V208, P602, DOI 10.1002/jcp.20698; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Deng LW, 2002, J BIOL CHEM, V277, P33922, DOI 10.1074/jbc.M111349200; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; FAN SJ, 1995, CANCER RES, V55, P1649; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kelso TWR, 2014, MOL CELL BIOL, V34, P3675, DOI 10.1128/MCB.00595-14; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Laitem C, 2015, NAT STRUCT MOL BIOL, V22, P396, DOI 10.1038/nsmb.3000; Leveille N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7520; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Ljungman M, 2007, CELL CYCLE, V6, P2252, DOI 10.4161/cc.6.18.4751; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Luse DS, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.27050; Malik S, 2007, P NATL ACAD SCI USA, V104, P6182, DOI 10.1073/pnas.0608717104; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; Schlereth K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003726; Shinobu N, 1999, J BIOL CHEM, V274, P17003, DOI 10.1074/jbc.274.24.17003; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Wang B, 2014, CELL DEATH DIFFER, V21, P521, DOI 10.1038/cdd.2013.132; Wier AD, 2013, P NATL ACAD SCI USA, V110, P17290, DOI 10.1073/pnas.1314754110; Wu LP, 2014, MOL CELL, V54, P920, DOI 10.1016/j.molcel.2014.04.013; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006	47	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146648	10.1371/journal.pone.0146648	http://dx.doi.org/10.1371/journal.pone.0146648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745862	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600072
J	Jawad, M; Choaie, E; Brose, L; Dogar, O; Grant, A; Jenkinson, E; McEwen, A; Millett, C; Shahab, L				Jawad, Mohammed; Choaie, Elham; Brose, Leonie; Dogar, Omara; Grant, Aimee; Jenkinson, Elizabeth; McEwen, Andy; Millett, Christopher; Shahab, Lion			Waterpipe Tobacco Use in the United Kingdom: A Cross-Sectional Study among University Students and Stop Smoking Practitioners	PLOS ONE			English	Article							COLLEGE-STUDENTS; HOOKAH USE; CIGARETTE-SMOKING; QUALITATIVE-ANALYSIS; CARCINOGEN EXPOSURE; PIPE NARGHILE; PREVALENCE; SMOKERS; INITIATION; ATTITUDES	Introduction Despite cigarette-like adverse health outcomes associated with waterpipe tobacco smoking and increase in its use among youth, it is a much underexplored research area. We aimed to measure the prevalence and patterns of waterpipe tobacco use and evaluate tobacco control policy with respect to waterpipe tobacco, in several universities across the UK. We also aimed to measure stop smoking practitioners' encounter of waterpipe tobacco smoking. Methods We distributed an online survey to six UK universities, asking detailed questions on waterpipe tobacco. Multivariable logistic regression models, adjusted for age, gender, ethnicity, graduate status, university and socioeconomic status (SES) assessed associations between waterpipe tobacco smoking (single use and dual use with cigarettes) and sociodemographic variables. SES was ascertained by average weekly self-spend on non-essentials. We also descriptively analysed data from a 2012 survey of stop smoking practitioners to assess the proportion of clients that used waterpipe regularly. Results f 2217 student responses, 66.0% (95% CI 63.9-68.0%) had tried waterpipe tobacco smoking; 14.3% (95% CI 12.8-15.8%) reported past-30 day use, and 8.7% (95% CI 7.6-9.9%) reported at least monthly users. Past-30 day waterpipe-only use was associated with being younger (AOR 0.95, 95% CI 0.91-0.99), male (AOR 1.44, 95% CI 1.08-1.94), higher SES (AOR 1.16, 95% CI 1.06-1.28) and belonging to non-white ethnicities (vs. white, AOR 2.24, 95% CI 1.66-3.04). Compared to less than monthly users, monthly users were significantly more likely to have urges to smoke waterpipe (28.1% vs. 3.1%, p<0.001) report difficulty in quitting (15.5% vs. 0.8%, p<0.001), report feeling guilty, and annoyed when criticised about waterpipe smoking (19.2% vs. 9.2%, p<0.001). Nearly a third (32.5%) of respondents who had tried waterpipe had violated the UK smokefree law and a quarter (24.5%) reporting seeing health warnings on waterpipe tobacco packaging or apparatuses. Of 1,282 smoking cessation practitioners, a quarter (23.4%, 95% CI 21.5-26.1%) reported having some clients who regularly use waterpipes, but 69.5% (95% CI 67.0-72.0%) never ask clients about waterpipe use. Three quarters (74.8%, 95% CI 72.4-77.1%) want more information about waterpipe tobacco smoking. Conclusions While two thirds of university students have ever tried waterpipe tobacco, at least monthly use is less common. Regular users display features of waterpipe tobacco dependence, and a substantial minority of SSS practitioners encounter clients who regularly use waterpipe. The lack of training on waterpipe for SSS practitioners and reported violations of smokefree laws for waterpipe highlight the need for regular surveillance of and a coordinated tobacco control strategy for waterpipe use.	[Jawad, Mohammed; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England; [Jawad, Mohammed] Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton SO16 6YD, Hants, England; [Choaie, Elham; McEwen, Andy; Shahab, Lion] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Brose, Leonie] Kings Coll London, Addict Dept, Inst Psychiat Psychol & Neurosci, London SE5 8BB, England; [Dogar, Omara] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Grant, Aimee] Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Cardiff CF14 4YS, S Glam, Wales; [Jenkinson, Elizabeth] Univ W England, Ctr Appearance Res, Bristol BS16 1QY, Avon, England	Imperial College London; University of Southampton; University of London; University College London; University of London; King's College London; University of York - UK; Cardiff University; University of West England	Jawad, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England.	mohammed.jawad06@imperial.ac.uk	Jawad, Mohammed/I-6919-2019; Shahab, Lion/B-5835-2009; Dogar, Omara F/J-2041-2019; Brose, Leonie S./H-6690-2019; Jenkinson, Elizabeth/AAQ-7591-2021	Jawad, Mohammed/0000-0002-1051-2136; Shahab, Lion/0000-0003-4033-442X; Jenkinson, Elizabeth/0000-0001-5686-5132; Millett, Christopher/0000-0002-0793-9884; Grant, Aimee/0000-0001-7205-5869; dogar, omara/0000-0002-7122-8403	NIHR Research Professorship award; National Institute for Health Research [ACF-2014-26-003] Funding Source: researchfish	NIHR Research Professorship award; National Institute for Health Research(National Institute for Health Research (NIHR))	CM was supported by an NIHR Research Professorship award.	Agaku IT, 2014, DRUG ALCOHOL DEPEN, V139, P60, DOI 10.1016/j.drugalcdep.2014.03.003; Akl EA, 2015, TOB CONTROL, V24, P13, DOI 10.1136/tobaccocontrol-2014-051906; Akl EA, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-12; Akl EA, 2010, INT J EPIDEMIOL, V39, P834, DOI 10.1093/ije/dyq002; Al Ali R, 2015, TOB CONTROL, V24, P125, DOI 10.1136/tobaccocontrol-2013-051206; Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Asfar T, 2014, ADDICT BEHAV, V39, P1066, DOI 10.1016/j.addbeh.2014.02.012; Baboor AS, 2014, SAUDI MED J, V35, P890; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boskabady MH, 2012, RESPIROLOGY, V17, P950, DOI 10.1111/j.1440-1843.2012.02194.x; Braun RE, 2012, J COMMUN HEALTH, V37, P294, DOI 10.1007/s10900-011-9444-9; Brose LS, 2015, BEHAV RES THER, V71, P34, DOI 10.1016/j.brat.2015.05.013; Cobb CO, 2015, NICOTINE TOB RES, V17, P667, DOI 10.1093/ntr/ntu196; Dogar O, 2014, NICOTINE TOB RES, V16, P682, DOI 10.1093/ntr/ntt211; Eissenberg T, 2008, J ADOLESCENT HEALTH, V42, P526, DOI 10.1016/j.jadohealth.2007.10.004; Fielder RL, 2012, ADDICT BEHAV, V37, P221, DOI 10.1016/j.addbeh.2011.10.001; Goodwin RD, 2014, DRUG ALCOHOL DEPEN, V141, P16, DOI 10.1016/j.drugalcdep.2014.04.024; Grant A, 2014, NICOTINE TOB RES, V16, P931, DOI 10.1093/ntr/ntu015; Heinz AJ, 2013, ADDICT BEHAV, V38, P2751, DOI 10.1016/j.addbeh.2013.07.009; Helen GS, 2014, CANCER EPIDEM BIOMAR, V23, P1055, DOI 10.1158/1055-9965.EPI-13-0939; Higher Education Statistics Agency, FREE ONL STAT STUD Q; Jaber R, 2015, INT J TUBERC LUNG D, V19, P481, DOI 10.5588/ijtld.14.0869; Jackson D, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-174; Jacob P, 2013, CANCER EPIDEM BIOMAR, V22, P765, DOI 10.1158/1055-9965.EPI-12-1422; Jarrett T, 2012, NICOTINE TOB RES, V14, P1145, DOI 10.1093/ntr/nts003; Jawad M, 2013, INT J TUBERC LUNG D, V17, P1364, DOI 10.5588/ijtld.12.0923; Jawad M, 2013, INT J TUBERC LUNG D, V17, P137, DOI 10.5588/ijtld.12.0175; Jawad M, 2016, NICOTINE TOB RES, V18, P395, DOI 10.1093/ntr/ntv101; Jawad Mohammed, 2015, Tob Control, V24 Suppl 1, pi60, DOI 10.1136/tobaccocontrol-2014-051911; Jawad M, 2014, NICOTINE TOB RES, V16, DOI 10.1093/ntr/ntu022; Jawad M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2698; Jawad M, 2013, NICOTINE TOB RES, V15, P2069, DOI 10.1093/ntr/ntt103; Jawad M, 2013, ADDICTION, V108, P1873, DOI 10.1111/add.12265; Khalil J, 2009, TOB CONTROL, V18, P420, DOI 10.1136/tc.2009.030148; Knishkowy B, 2005, PEDIATRICS, V116, pE113, DOI 10.1542/peds.2004-2173; Kumar SR, 2015, TOB CONTROL, V24, P54, DOI 10.1136/tobaccocontrol-2014-052038; Maziak W, 2005, PUBLIC HEALTH, V119, P400, DOI 10.1016/j.puhe.2004.08.002; Maziak W, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005549.pub2; Maziak W, 2015, TOB CONTROL, V24, P3, DOI 10.1136/tobaccocontrol-2014-051903; Maziak W, 2009, NICOTINE TOB RES, V11, P806, DOI 10.1093/ntr/ntp066; Mzayek F, 2012, NICOTINE TOB RES, V14, P448, DOI 10.1093/ntr/ntr234; Nakkash R, 2010, TOB CONTROL, V19, P235, DOI 10.1136/tc.2009.031773; Raad D, 2011, CHEST, V139, P764, DOI 10.1378/chest.10-0991; Radwan G, 2013, NICOTINE TOB RES, V15, P130, DOI 10.1093/ntr/nts099; Selim GM, 2013, ANATOL J CARDIOL, V13, P647, DOI 10.5152/akd.2013.191; Sepetdjian E, 2010, FOOD CHEM TOXICOL, V48, P3242, DOI 10.1016/j.fct.2010.08.033; Sibai AM, 2014, ATHEROSCLEROSIS, V234, P454, DOI 10.1016/j.atherosclerosis.2014.03.036; Soneji S, 2014, JAMA PEDIAT; Sutfin EL, 2014, ADDICT BEHAV, V39, P1191, DOI 10.1016/j.addbeh.2014.03.020; Nguyen T, 2013, J ENVIRON SCI HEAL B, V48, P1097, DOI 10.1080/03601234.2013.824300	50	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146799	10.1371/journal.pone.0146799	http://dx.doi.org/10.1371/journal.pone.0146799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745806	Green Published, gold, Green Accepted			2022-12-27	WOS:000367815600081
J	Zhou, JJ; Wang, WL; Xie, Y; Zhao, Y; Chen, X; Xu, WJ; Wang, Y; Guan, ZZ				Zhou, Jianjiang; Wang, Wenling; Xie, Yuan; Zhao, Yan; Chen, Xian; Xu, Wenjie; Wang, Yan; Guan, Zhizhong			Proteomics-Based Identification and Analysis of Proteins Associated with Helicobacter pylori in Gastric Cancer	PLOS ONE			English	Article							ABERRANT DNA METHYLATION; REAL-TIME PCR; EPIGENETIC MECHANISMS; INFECTION; EXPRESSION; CALMODULIN; GENES	Helicobacter pylori (H. pylori) is a spiral-shaped Gram-negative bacterium that causes the most common chronic infection in the human stomach. Approximately 1%-3% of infected individuals develop gastric cancer. However, the mechanisms by which H. pylori induces gastric cancer are not completely understood. The available evidence indicates a strong link between the virulence factor of H. pylori, cytotoxin-associated gene A (CagA), and gastric cancer. To further characterize H. pylori virulence, we established three cell lines by infecting the gastric cancer cell lines SGC-7901 and AGS with cagA(+) H. pylori and transfecting SGC-7901 with a vector carrying the full-length cagA gene. We detected 135 differently expressed proteins from the three cell lines using proteome technology, and 10 differential proteins common to the three cell lines were selected and identified by LC-MS/MS as well as verified by western blot: beta-actin, L-lactate dehydrogenase (LDH), dihydrolipoamide dehydrogenase (DLD), pre-mRNA-processing factor 19 homolog (PRPF19), ATP synthase, calmodulin (CaM), p64 CLCP, Ran-specific GTPase-activating protein (RanGAP), P43 and calreticulin. Detection of the expression of these proteins and genes encoding these proteins in human gastric cancer tissues by real-time PCR (RT-qPCR) and western blot revealed that the expression of beta-ACTIN, LDH, DLD, PRPF19 and CaM genes were up-regulated and RanGAP was down-regulated in gastric cancer tissues and/or metastatic lymph nodes compared to peri-cancerous tissues. High gene expression was observed for H. pylori infection in gastric cancer tissues. Furthermore, the LDH, DLD and CaM genes were demethylated at the promoter -2325, -1885 and -276 sites, respectively, and the RanGAP gene was highly methylated at the promoter -570 and -170 sites in H. pylori-infected and cagA-overexpressing cells. These results provide new insights into the molecular pathogenesis and treatment targets for gastric cancer with H. pylori infection.	[Zhou, Jianjiang; Xie, Yuan; Zhao, Yan; Chen, Xian; Xu, Wenjie; Wang, Yan; Guan, Zhizhong] Guizhou Med Univ, Mol Biol Key Lab, Guiyang, Guizhou, Peoples R China; [Zhou, Jianjiang] Guizhou Med Univ, Affiliated Hosp, Dept Clin Lab, Guiyang, Guizhou, Peoples R China; [Wang, Wenling] Guizhou Canc Hosp, Dept Oncol, Guiyang, Guizhou, Peoples R China	Guizhou Medical University; Guizhou Medical University	Zhou, JJ (corresponding author), Guizhou Med Univ, Mol Biol Key Lab, Guiyang, Guizhou, Peoples R China.	jianjiangzhou@sina.cn		Zhou, Jian/0000-0002-7650-7540	National Natural Science Foundation of China [81260303, 31560326]; Guizhou province foundation [[2014]06]; Key Project of Science and Technology of Guizhou Province [[2011] 3067, [2012]2039, (2011) 3067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guizhou province foundation; Key Project of Science and Technology of Guizhou Province	The work was supported by National Natural Science Foundation of China (81260303, 31560326), Guizhou province foundation (QianJiaoHe [2014]06) and Key Project of Science and Technology of Guizhou Province (QianKeHe SY [2011] 3067, QianKeHe J[2012]2039). In the original version, the work was supported by National Natural Science Foundation of China (81260303, 31560326) and Key Project of Science and Technology of Guizhou Province (QianKeHe SY(2011) 3067).	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Bauer B., 2011, ULCERS, V2011, DOI [DOI 10.1155/2011/340157, 10.1155/2011/340157]; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Cho SO, 2010, DIGEST DIS SCI, V55, P1550, DOI 10.1007/s10620-009-0908-z; Choi J, 2006, CIRC RES, V98, P1273, DOI 10.1161/01.RES.0000223059.19250.91; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Ding SZ, 2010, FUTURE ONCOL, V6, P851, DOI [10.2217/fon.10.37, 10.2217/FON.10.37]; Franco AT, 2009, MOL CELL PROTEOMICS, V8, P1947, DOI 10.1074/mcp.M900139-MCP200; Gigek CO, 2012, EPIGENOMICS-UK, V4, P279, DOI [10.2217/EPI.12.22, 10.2217/epi.12.22]; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Holland C, 2011, PROTEOMICS, V11, P2798, DOI 10.1002/pmic.201000793; Hunt TK, 2007, ANTIOXID REDOX SIGN, V9, P1115, DOI 10.1089/ars.2007.1674; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang GH, 2012, KOREAN J PATHOL, V46, P1, DOI 10.4132/KoreanJPathol.2012.46.1.1; Kim H, 2006, J BIOCHEM MOL BIOL, V39, P223, DOI 10.5483/BMBRep.2006.39.2.223; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li JJ, 2009, PROTEOM CLIN APPL, V3, P185, DOI 10.1002/prca.200800151; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Momynaliev KT, 2010, J PROTEOME RES, V9, P254, DOI 10.1021/pr900586w; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shin CM, 2010, CANCER SCI, V101, P1337, DOI 10.1111/j.1349-7006.2010.01535.x; Targosz A, 2012, INFLAMM RES, V61, P955, DOI 10.1007/s00011-012-0487-x; Venerito M, 2013, HELICOBACTER, V18, P39, DOI 10.1111/hel.12078; Wu AH, 2003, INT J CANCER, V103, P815, DOI 10.1002/ijc.10887; Wu MS, 2008, J GASTROEN HEPATOL, V23, P1657, DOI 10.1111/j.1440-1746.2008.05659.x; Yan HB, 2014, CARCINOGENESIS, V35, P867, DOI 10.1093/carcin/bgt398; Zhang J, 2008, BIOCHEM BIOPH RES CO, V375, P252, DOI 10.1016/j.bbrc.2008.08.012; Zhao L, 2008, J CELL BIOCHEM, V103, P471, DOI 10.1002/jcb.21409; Zhao Q, 2008, PLANT CELL, V20, P1639, DOI 10.1105/tpc.108.059220	37	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146521	10.1371/journal.pone.0146521	http://dx.doi.org/10.1371/journal.pone.0146521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745502	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600058
J	Chuang, MT; Liu, YS; Tsai, YS; Chen, YC; Wang, CK				Chuang, Ming-Tsung; Liu, Yi-Sheng; Tsai, Yi-Shan; Chen, Ying-Chen; Wang, Chien-Kuo			Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; IMAGE-GUIDED HISTOPATHOLOGY; INTRAAXIAL METASTATIC TUMOR; HIGH-GRADE GLIOMAS; STEREOTACTIC RADIOSURGERY; INITIAL-EXPERIENCE; SPECIAL ATTENTION; METABOLIC-CHANGES; INJURY; DIFFUSION	Purpose This meta-analysis examined roles of several metabolites in differentiating recurrent tumor from necrosis in patients with brain tumors using MR perfusion and spectroscopy. Methods Medline, Cochrane, EMBASE, and Google Scholar were searched for studies using perfusion MRI and/or MR spectroscopy published up to March 4, 2015 which differentiated between recurrent tumor vs. necrosis in patients with primary brain tumors or brain metastasis. Only two-armed, prospective or retrospective studies were included. A meta-analysis was performed on the difference in relative cerebral blood volume (rCBV), ratios of choline/creatine (Cho/Cr) and/or choline/N-acetyl aspartate (Cho/NAA) between participants undergoing MRI evaluation. A chi(2)-based test of homogeneity was performed using Cochran's Q statistic and I-2. Results Of 397 patients in 13 studies who were analyzed, the majority had tumor recurrence. As there was evidence of heterogeneity among 10 of the studies which used rCBV for evaluation (Q statistic = 31.634, I-2 = 97.11%, P < 0.0001) a random-effects analysis was applied. The pooled difference in means (2.18, 95% CI = 0.85 to 3.50) indicated that the average rCBV in a contrast-enhancing lesion was significantly higher in tumor recurrence compared with radiation injury (P = 0.001). Based on a fixed-effect model of analysis encompassing the six studies which used Cho/Cr ratios for evaluation (Q statistic = 8.388, I-2 = 40.39%, P = 0.137), the pooled difference in means (0.77, 95% CI = 0.57 to 0.98) of the average Cho/Cr ratio was significantly higher in tumor recurrence than in tumor necrosis (P = 0.001). There was significant difference in ratios of Cho to NAA between recurrent tumor and necrosis (1.02, 95% CI = 0.03 to 2.00, P = 0.044). Conclusions MR spectroscopy and MR perfusion using Cho/NAA and Cho/Cr ratios and rCBV may increase the accuracy of differentiating necrosis from recurrent tumor in patients with primary brain tumors or metastases.	[Chuang, Ming-Tsung; Liu, Yi-Sheng; Tsai, Yi-Shan; Chen, Ying-Chen; Wang, Chien-Kuo] Natl Cheng Kung Univ Hosp, Dept Diagnost Radiol, Tainan 70428, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital	Wang, CK (corresponding author), Natl Cheng Kung Univ Hosp, Dept Diagnost Radiol, Tainan 70428, Taiwan.	n625396@mail.hosp.ncku.edu.tw	liu, yi/GXE-9662-2022; Wang, Chien-Kuo/A-7196-2009; Wang, Chien-Kuo/V-8911-2019	Wang, Chien-Kuo/0000-0001-8887-2935; 				Alexiou GA, 2014, MAGN RESON IMAGING, V32, P854, DOI 10.1016/j.mri.2014.04.013; Amin A, 2012, J NEURO-ONCOL, V106, P579, DOI 10.1007/s11060-011-0694-2; Barajas RF, 2009, AM J NEURORADIOL, V30, P367, DOI 10.3174/ajnr.A1362; Bobek-Billewicz B, 2010, FOLIA NEUROPATHOL, V48, P81; Boxerman JL, 2014, AM J CLIN ONCOL; Chung WJ, 2013, RADIOLOGY, V269, P560, DOI 10.1148/radiol.13130016; D'Souza MM, 2014, CLIN NUCL MED, V39, P791, DOI 10.1097/RLU.0000000000000532; Di Costanzo A, 2006, J EXP CLIN CANC RES, V25, P383; Di Costanzo A, 2014, RADIOL MED, V119, P616, DOI 10.1007/s11547-013-0371-y; Elias AE, 2011, ACAD RADIOL, V18, P1101, DOI 10.1016/j.acra.2011.05.006; Enslow MS, 2012, CLIN NUCL MED, V37, P854, DOI 10.1097/RLU.0b013e318262c76a; Esteve F, 1998, INT J RADIAT ONCOL, V40, P279, DOI 10.1016/S0360-3016(97)00714-1; Guo J, 2012, ACTA NEUROCHIR, V154, P1361, DOI 10.1007/s00701-012-1418-x; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hu LS, 2012, NEURO-ONCOLOGY, V14, P919, DOI 10.1093/neuonc/nos112; Huang J, 2011, MAGN RESON IMAGING, V29, P993, DOI 10.1016/j.mri.2011.04.004; Ikehira H, 1995, Radiat Med, V13, P199; Kamada Kyousuke, 1997, Neurologia Medico-Chirurgica, V37, P250, DOI 10.2176/nmc.37.250; Kaminaga T, 2005, J COMPUT ASSIST TOMO, V29, P293, DOI 10.1097/01.rct.0000161422.95625.8a; Kim DY, 2014, AM J NEURORADIOL, V35, P2082, DOI 10.3174/ajnr.A3995; Krouwer HGJ, 1998, AM J NEURORADIOL, V19, P1695; Lai PH, 2002, AM J NEURORADIOL, V23, P1369; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Matsusue E, 2010, NEURORADIOLOGY, V52, P297, DOI 10.1007/s00234-009-0613-9; Mitsuya K, 2010, J NEURO-ONCOL, V99, P81, DOI 10.1007/s11060-009-0106-z; Nakajima T, 2009, NEUROL MED-CHIR, V49, P394, DOI 10.2176/nmc.49.394; Narang J, 2011, NEURO-ONCOLOGY, V13, P1037, DOI 10.1093/neuonc/nor075; Nelson SJ, 2011, NMR BIOMED, V24, P734, DOI 10.1002/nbm.1669; Plotkin M, 2004, J NEURO-ONCOL, V70, P49, DOI 10.1023/B:NEON.0000040810.77270.68; Prager AJ, 2015, AJNR AM J NEURORADIO; Rabinov JD, 2002, RADIOLOGY, V225, P871, DOI [10.1148/radiol.2253010997, 10.1148/radio1.225301-997]; Reddy K, 2013, J MED IMAG RADIAT ON, V57, P349, DOI 10.1111/j.1754-9485.2012.02472.x; Rock JP, 2004, NEUROSURGERY, V54, P1111, DOI 10.1227/01.NEU.0000119328.56431.A7; Rock JP, 2002, NEUROSURGERY, V51, P912, DOI 10.1097/00006123-200210000-00010; Ruzevick J, 2014, NEUROSURG REV, V37, P193, DOI 10.1007/s10143-013-0504-8; Schlemmer HP, 2002, NEURORADIOLOGY, V44, P216, DOI 10.1007/s002340100703; Schlemmer HP, 2001, AM J NEURORADIOL, V22, P1316; Shah R, 2012, RADIOGRAPHICS, V32, P1343, DOI 10.1148/rg.325125002; Shin KE, 2014, CLIN RADIOL, V69, pE264, DOI 10.1016/j.crad.2014.01.016; Smith EA, 2009, AM J ROENTGENOL, V192, pW45, DOI 10.2214/AJR.07.3934; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sundgren PC, 2009, AM J NEURORADIOL, V30, P1469, DOI 10.3174/ajnr.A1580; Taylor JS, 1996, INT J RADIAT ONCOL, V36, P1251, DOI 10.1016/S0360-3016(96)00376-8; Thompson G, 2011, BRIT J RADIOL, V84, pS127, DOI 10.1259/bjr/66316279; Tran Diem Kieu Thi, 2013, Surg Neurol Int, V4, pS129, DOI 10.4103/2152-7806.110661; Verma N, 2013, NEURO-ONCOLOGY, V15, P515, DOI 10.1093/neuonc/nos307; Wells G.A., NEWCASTLE OTTAWA SCA; Weybright P, 2005, AM J ROENTGENOL, V185, P1471, DOI 10.2214/AJR.04.0933; Xu JL, 2011, J MED IMAG RADIAT ON, V55, P587, DOI 10.1111/j.1754-9485.2011.02315.x; Zeng QS, 2007, INT J RADIAT ONCOL, V68, P151, DOI 10.1016/j.ijrobp.2006.12.001	50	73	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0141438	10.1371/journal.pone.0141438	http://dx.doi.org/10.1371/journal.pone.0141438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741961	Green Submitted, gold, Green Published			2022-12-27	WOS:000367810600002
J	Malick, MJ; Cox, SP				Malick, Michael J.; Cox, Sean P.			Regional-Scale Declines in Productivity of Pink and Chum Salmon Stocks in Western North America	PLOS ONE			English	Article							SOCKEYE-SALMON; SURVIVAL RATES; PACIFIC SALMON; ONCORHYNCHUS-NERKA; SPATIAL COVARIATION; HISTORICAL TRENDS; CHINOOK SALMON; KALMAN FILTER; COMMON TRENDS; PUGET-SOUND	Sockeye salmon (Oncorhynchus nerka) stocks throughout the southern part of their North American range have experienced declines in productivity over the past two decades. In this study, we tested the hypothesis that pink (O. gorbuscha) and chum (O. keta) salmon stocks have also experienced recent declines in productivity by investigating temporal and spatial trends in productivity of 99 wild North American pink and chum salmon stocks. We used a combination of population dynamics and time series models to quantify individual stock trends as well as common temporal trends in pink and chum salmon productivity across local, regional, and continental spatial scales. Our results indicated widespread declines in productivity of wild chum salmon stocks throughout Washington (WA) and British Columbia (BC) with 81% of stocks showing recent declines in productivity, although the exact form of the trends varied among regions. For pink salmon, the majority of stocks in WA and BC (65%) did not have strong temporal trends in productivity; however, all stocks that did have trends in productivity showed declining productivity since at least brood year 1996. We found weaker evidence of widespread declines in productivity for Alaska pink and chum salmon, with some regions and stocks showing declines in productivity (e.g., Kodiak chum salmon stocks) and others showing increases (e.g., Alaska Peninsula pink salmon stocks). We also found strong positive covariation between stock productivity series at the regional spatial scale for both pink and chum salmon, along with evidence that this regional-scale positive covariation has become stronger since the early 1990s in WA and BC. In general, our results suggest that common processes operating at the regional or multi-regional spatial scales drive productivity of pink and chum salmon stocks in western North America and that the effects of these process on productivity may change over time.	[Malick, Michael J.; Cox, Sean P.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Malick, MJ (corresponding author), Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada.	mmalick@sfu.ca		Malick, Michael/0000-0002-8376-5476	Simon Fraser University	Simon Fraser University	MJM was supported by a Graduate Fellowship from Simon Fraser University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison MD, 1996, FISH OCEANOGR, V5, P137, DOI 10.1111/j.1365-2419.1996.tb00113.x; Bartz KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124415; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chatfield C., 2004, ANAL TIME SERIES INT; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Dorner B, 2008, CAN J FISH AQUAT SCI, V65, P1842, DOI 10.1139/F08-094; Duffy EJ, 2005, ESTUAR COAST SHELF S, V64, P94, DOI 10.1016/j.ecss.2005.02.009; Duffy EJ, 2010, T AM FISH SOC, V139, P803, DOI 10.1577/T08-244.1; Farley EV, 2007, FISH B-NOAA, V105, P121; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Harvey A. C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; HENNEMUTH R C, 1980, Journal of Northwest Atlantic Fishery Science, V1, P101; Holmes EE, 2012, R J, V4, P11; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Johnson SP, 2009, ECOL RES, V24, P855, DOI 10.1007/s11284-008-0559-0; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kilduff DP, 2015, P NATL ACAD SCI USA, V112, P10962, DOI 10.1073/pnas.1503190112; Kilduff DP, 2014, ICES J MAR SCI, V71, P1671, DOI 10.1093/icesjms/fsu031; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Malick MJ, 2015, CAN J FISH AQUAT SCI, V72, P697, DOI 10.1139/cjfas-2014-0298; Mantua N, 2010, CLIMATIC CHANGE, V102, P187, DOI 10.1007/s10584-010-9845-2; McGurk MD, 1996, FISH B-NOAA, V94, P77; Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901; Minto C, 2014, CAN J FISH AQUAT SCI, V71, P203, DOI 10.1139/cjfas-2013-0161; Moss JH, 2005, T AM FISH SOC, V134, P1313, DOI 10.1577/T05-054.1; Mueter FJ, 2002, CAN J FISH AQUAT SCI, V59, P456, DOI 10.1139/f02-020; Mueter FJ, 2002, FISH OCEANOGR, V11, P205, DOI 10.1046/j.1365-2419.2002.00192.x; Mueter FJ, 2007, CAN J FISH AQUAT SCI, V64, P911, DOI 10.1139/F07-069; Myers Katherine W., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P159; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; Myers RA, 1997, CAN J FISH AQUAT SCI, V54, P1400, DOI 10.1139/cjfas-54-6-1400; Pearson WH, 2012, REV FISH BIOL FISHER, V22, P95, DOI 10.1007/s11160-011-9225-7; Peterman RM, 2012, CAN J FISH AQUAT SCI, V69, P1255, DOI 10.1139/F2012-063; PETERMAN RM, 1981, CAN J FISH AQUAT SCI, V38, P1113, DOI 10.1139/f81-151; Peterman RM, 2003, CAN J FISH AQUAT SCI, V60, P809, DOI 10.1139/F03-069; Peterman RM, 1998, CAN J FISH AQUAT SCI, V55, P2503, DOI 10.1139/cjfas-55-11-2503; Peterman RM, 2000, CAN J FISH AQUAT SCI, V57, P181, DOI 10.1139/cjfas-57-1-181; Price DM, 2010, N AM J FISH MANAGE, V30, P1110, DOI 10.1577/M10-004.1; Pyper BJ, 2005, T AM FISH SOC, V134, P86, DOI 10.1577/T04-034.1; Pyper BJ, 2002, T AM FISH SOC, V131, P343, DOI 10.1577/1548-8659(2002)131&lt;0343:SCISRO&gt;2.0.CO;2; Pyper BJ, 2001, CAN J FISH AQUAT SCI, V58, P1501, DOI 10.1139/cjfas-58-8-1501; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; R Core Team, 2013, R LANG ENV STAT COMP; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Ruggerone GT, 2015, CAN J FISH AQUAT SCI, V72, P818, DOI 10.1139/cjfas-2014-0134; Ruggerone GT, 2010, MAR COAST FISH, V2, P306, DOI 10.1577/C09-054.1; Shelton PA, 2006, CAN J FISH AQUAT SCI, V63, P235, DOI 10.1139/F05-253; Sobocinski KL, 2010, ESTUAR COAST, V33, P699, DOI 10.1007/s12237-009-9262-9; Stachura MM, 2014, CAN J FISH AQUAT SCI, V71, P226, DOI 10.1139/cjfas-2013-0367; Takasuka A, 2007, CAN J FISH AQUAT SCI, V64, P768, DOI 10.1139/F07-052; Teo SLH, 2009, DEEP-SEA RES PT II, V56, P2570, DOI 10.1016/j.dsr2.2009.03.007; Toft JD, 2013, ECOL ENG, V57, P97, DOI 10.1016/j.ecoleng.2013.04.022; Vert-pre KA, 2013, P NATL ACAD SCI USA, V110, P1779, DOI 10.1073/pnas.1214879110; VISSER H, 1988, BIOMETRICS, V44, P929, DOI 10.2307/2531724; WALTERS CJ, 1987, CAN J FISH AQUAT SCI, V44, P156, DOI 10.1139/f87-319; Zuur AF, 2003, CAN J FISH AQUAT SCI, V60, P542, DOI 10.1139/F03-030; Zuur AF, 2003, ENVIRONMETRICS, V14, P665, DOI 10.1002/env.611	59	27	28	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146009	10.1371/journal.pone.0146009	http://dx.doi.org/10.1371/journal.pone.0146009			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760510	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100025
J	Sorrentino, FS; Bonifazzi, C; Parmeggiani, F; Perri, P				Sorrentino, Francesco Saverio; Bonifazzi, Claudio; Parmeggiani, Francesco; Perri, Paolo			A Pilot Study to Propose a "Harm Scale", a New Method to Predict Risk of Harm to the Corneal Endothelium Caused by Longitudinal Phacoemulsification, and the Subsequent Effect of Endothelial Damage on Post Operative Visual Acuity	PLOS ONE			English	Article							CELL LOSS; CATARACT REMOVAL; PHACO; MICROSCOPY; THICKNESS; SURGERY	Purpose To study the effect of longitudinal phacoemulsification energy on corneal endothelium and to evaluate the relationship between changes of endothelial cells and postoperative visual acuity. Methods This prospective clinical observational cohort study included 50 patients with cataract who underwent longitudinal phacoemulsification. Sequential quantitative and qualitative morphometric endothelial cell analyses of the cornea were performed 4 weeks preoperatively and 6 weeks postoperatively using noncontact specular microscopy. Results There was a relationship between ECL percentage (ECL%) and the 5-score harm scale, well-described by a linear model (one-way ANOVA, R-2 = 73.3%). Analyzing the distribution of ECL% Mean with Tukey post-hoc pairwise comparison test (P < 0.001), the value of ECL = 20% has been regarded as cut-off to discriminate patients who obtained an excellent postoperative best-corrected visual acuity (BCVA > 85 letters) from those who just had a good visual outcome (BCVA <= 85 letters). There was a significant correlation among the 5-score harm scale, phaco energy intraoperatively delivered, and average cell area postoperatively. Conclusions The 5-score harm scale, a new method that enables to pigeonhole cataracts taking into account nucleus hardness and phaco times, allows to predict the harm on corneal endothelium after longitudinal phacoemulsification. Assessment of ECL% permits to discriminate between patients with excellent BCVA and with just good BCVA, postoperatively.	[Sorrentino, Francesco Saverio] Osped Maggiore Bologna, Unit Ophthalmol, Dept Surg Sci, Bologna, Italy; [Bonifazzi, Claudio] Univ Ferrara, Sect Human Physiol, Dept Biomed & Surg Sci, I-44100 Ferrara, Italy; [Parmeggiani, Francesco] Univ Ferrara, Div Ophthalmol, Dept Biomed & Surg Sci, I-44100 Ferrara, Italy	AUSL di Bologna; University of Ferrara; University of Ferrara	Sorrentino, FS (corresponding author), Osped Maggiore Bologna, Unit Ophthalmol, Dept Surg Sci, Bologna, Italy.	dr.fsorrentino@gmail.com						Aribaba OT, 2015, CLIN OPHTHALMOL, V9, P151, DOI 10.2147/OPTH.S75580; Atas M, 2014, INT J OPHTHALMOL-CHI, V7, P822, DOI 10.3980/j.issn.2222-3959.2014.05.15; Benetz B, 2011, CORNEA FUNDAMENTALS, P85; Bourne RRA, 2004, OPHTHALMOLOGY, V111, P679, DOI 10.1016/j.ophtha.2003.07.015; Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; CHENG H, 1988, ARCH OPHTHALMOL-CHIC, V106, P920, DOI 10.1001/archopht.1988.01060140066026; CHYLACK LT, 1989, ARCH OPHTHALMOL-CHIC, V107, P991, DOI 10.1001/archopht.1989.01070020053028; Devgan Uday, 2006, Ophthalmol Clin North Am, V19, P457; Devgan U, 2007, CURR OPIN OPHTHALMOL, V18, P19, DOI 10.1097/ICU.0b013e328011f9e1; Dick HB, 1996, J CATARACT REFR SURG, V22, P63; Doors M, 2013, JAMA OPHTHALMOL, V131, P1443, DOI 10.1001/jamaophthalmol.2013.5009; EIFERMAN RA, 1981, AM J OPHTHALMOL, V92, P328, DOI 10.1016/0002-9394(81)90520-1; Ganekal S, 2014, MIDDLE EAST AFR J OP, V21, P56, DOI 10.4103/0974-9233.124098; GIMBEL HV, 1991, J CATARACT REFR SURG, V17, P281, DOI 10.1016/S0886-3350(13)80824-3; Hengerer FH, 2011, J CATARACT REFR SURG, V37, P2095, DOI 10.1016/j.jcrs.2011.07.026; Hull D S, 1990, Trans Am Ophthalmol Soc, V88, P463; Jalbert I, 2003, BRIT J OPHTHALMOL, V87, P225, DOI 10.1136/bjo.87.2.225; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 2002, INVEST OPHTH VIS SCI, V43, P2152; KELMAN CD, 1967, AM J OPHTHALMOL, V64, P23, DOI 10.1016/0002-9394(67)93340-5; Kohlhaas M, 1998, OPHTHALMIC SURG LAS, V29, P890; Maurice D.M., 1984, EYE, V3rd, P85; McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da; Packer M, 2005, J CATARACT REFR SURG, V31, P424, DOI 10.1016/j.jcrs.2004.11.027; Ravalico G, 1997, J CATARACT REFR SURG, V23, P433, DOI 10.1016/S0886-3350(97)80190-3; Rosado-Adames N, 2012, CURR OPIN OPHTHALMOL, V23, P3, DOI 10.1097/ICU.0b013e32834e4b5f; Saito K, 1999, EXP EYE RES, V68, P431, DOI 10.1006/exer.1998.0626; Salvetat ML, 2011, CORNEA, V30, P754, DOI 10.1097/ICO.0b013e3182000c5d; Storr-Paulsen A, 2007, EUR J OPHTHALMOL, V17, P315; Szalai E, 2011, CORNEA, V30, P567, DOI 10.1097/ICO.0b013e3182000807; Walkow T, 2000, J CATARACT REFR SURG, V26, P727, DOI 10.1016/S0886-3350(99)00462-9; Wong T, 2000, J CATARACT REFR SURG, V26, P1374, DOI 10.1016/S0886-3350(00)00538-1; YEE RW, 1985, CURR EYE RES, V4, P671, DOI 10.3109/02713688509017661	34	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146580	10.1371/journal.pone.0146580	http://dx.doi.org/10.1371/journal.pone.0146580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761198	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100037
J	Wang, DS; Li, Y; Liu, Y; He, Y; Shi, GX				Wang, Dashan; Li, Yan; Liu, Yuan; He, Yan; Shi, Guixiu			Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity	PLOS ONE			English	Article							IL-17; INTERLEUKIN-17; GENETICS; PROMOTES; DISTINCT; LINEAGE; TISSUE; JOINT	Rheumatoid arthritis (RA) is a chronic, systematic autoimmune disease that mainly affects joints and bones. Although the precise etiology is still unknown, Th17 cell is being recognized as an important mediator in pathogenesis of RA. VSTM1-v2 is a novel cytokine which has recently been reported to promote the differentiation of Th17 cells. This study is performed to study whether VSTM1-v2 can be recognized as a biomarker of RA, and is correlated to IL-17 expression. We obtained peripheral blood mononuclear cells (PBMCs) from 40 patients with RA and 40 age-and sex-matched healthy controls by standard Ficoll-Paque Plus density centrifugation. The mRNA expression levels of VSTM1-v2 and IL-17A in PBMCs were detected by real time-PCR. Disease activity parameters of RA were measured by routine methods. Our results showed that VSTM1-v2 mRNA expression in PBMCs from RA patients was significantly increased in comparison of that in healthy individuals. The VSTM1-v2 mRNA expression level was positively correlated with IL-17A mRNA expression level, DAS28, CRP and ESR, but was not correlated to RF, Anti-CCP or ANA. VSTM1-v2 might be a biomarker of RA and a novel factor in the pathogenesis of RA.	[Wang, Dashan] Shandong Med Coll, Mol Biol Res Ctr, Key Med Hlth Lab Lab Med Shandong Prov, Dept Lab Med, Linyi 276000, Shandong, Peoples R China; [Li, Yan; Liu, Yuan; He, Yan; Shi, Guixiu] Xiamen Univ, Affiliated Hosp 1, Dept Rheumatol & Clin Immunol, Xiamen 361003, Fujian, Peoples R China	Xiamen University	Shi, GX (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Rheumatol & Clin Immunol, Xiamen 361003, Fujian, Peoples R China.	gshi@xmu.edu.cn		shi, guixiu/0000-0003-4044-3394	Natural Science Foundation of China (NSFC) [81273285, 30830094]; NSFC [81302565]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	The work was supported by Natural Science Foundation of China (NSFC) grants 81273285 and 30830094 to Dr. Guixiu Shi; NSFC grant 81302565 to Yan Li.	Alunno A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/751793; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bang SY, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0447-7; Benedetti G, 2014, EUR J IMMUNOL, V44, P339, DOI 10.1002/eji.201344184; Brusic Vladimir, 2003, J Bioinform Comput Biol, V1, P179, DOI 10.1142/S0219720003000034; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Doolan DL, 2011, INT J PARASITOL, V41, P3, DOI 10.1016/j.ijpara.2010.08.002; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Fu Xiao-jin, 2013, Yaoxue Xuebao, V48, P1651; Guo XH, 2012, CELL IMMUNOL, V278, P136, DOI 10.1016/j.cellimm.2012.07.009; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hickman-Brecks CL, 2011, J AUTOIMMUN, V36, P65, DOI 10.1016/j.jaut.2010.10.007; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Klareskog L, 2006, CURR OPIN IMMUNOL, V18, P650, DOI 10.1016/j.coi.2006.06.004; Klysik J, 2001, ACTA BIOTHEOR, V49, P191, DOI 10.1023/A:1011901410166; Kurko J, 2013, CLIN REV ALLERG IMMU, V45, P170, DOI 10.1007/s12016-012-8346-7; Li N, 2013, INT J CLIN EXP PATHO, V6, P1375; Liu HH, 2016, J BIOSCI BIOENG, V121, P133, DOI 10.1016/j.jbiosc.2015.05.016; Lubberts E, 2002, INFLAMM RES, V51, P102, DOI 10.1007/BF02684010; Lubberts E, 2005, J IMMUNOL, V175, P3360, DOI 10.4049/jimmunol.175.5.3360; Maecker B., 2001, Current Molecular Medicine (Hilversum), V1, P609, DOI 10.2174/1566524013363447; Maillefert JF, 2003, ANN RHEUM DIS, V62, P764, DOI 10.1136/ard.62.8.764; Metawi SA, 2011, CLIN RHEUMATOL, V30, P1201, DOI 10.1007/s10067-011-1737-y; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Raychaudhuri S, 2010, CURR OPIN RHEUMATOL, V22, P109, DOI 10.1097/BOR.0b013e328336474d; Teiten M-H, 2012, Cell Death Dis, V3, pe267, DOI 10.1038/cddis.2012.7; Zandbelt MM, 2001, ANN RHEUM DIS, V60, P841; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	29	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146805	10.1371/journal.pone.0146805	http://dx.doi.org/10.1371/journal.pone.0146805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760041	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100041
J	Zhang, RS; Liu, ZL; Zhang, H; Zhang, Y; Lin, D				Zhang, Ruoshuang; Liu, Zheli; Zhang, Han; Zhang, Yi; Lin, Dong			The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis	PLOS ONE			English	Article							CYCLOOXYGENASE-2 GENE-EXPRESSION; PLATELET-ACTIVATING-FACTOR; ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; UP-REGULATION; ANIMAL-MODEL; COX-2; RANIBIZUMAB; MACROPHAGE; LOCALIZATION	Choroidal neovascularization (CNV) is an important pathologic component of neovascular age-related macular degeneration (AMD), and CNV lesions later develop into fibrous scars, which contribute to the loss of central vision. Nowadays, the precise molecular and cellular mechanisms underlying CNV and subretinal fibrosis have yet to be fully elucidated. Cyclooxygenase-2 (COX-2) has previously been implicated in angiogenesis and fibrosis. However, the role of COX-2 in the pathogenesis of CNV and subretinal fibrosis is poorly understood. The present study reveals several important findings concerning the relationship of COX-2 signaling with CNV and subretinal fibrosis. Experimental CNV lesions were attenuated by the administration of NS-398, a COX-2-selective antagonist. NS-398-induced CNV suppression was found to be mediated by the attenuation of macrophage infiltration and down-regulation of VEGF in the retinal pigment epithelium-choroid complex. Additionally, NS-398 attenuated subretinal fibrosis, in an experimental model of subretinal scarring observed in neovascular AMD, by down-regulation of TGF-beta(2) in the retinal pigment epithelium-choroid complex. Moreover, we cultured mouse RPE cells and found that NS-398 decreased the secretion of VEGF and TGF-beta(2) in mouse RPE cells. The results of the present study provide new findings regarding the molecular basis of CNV and subretinal fibrosis, and provide a proof-of-concept approach for the efficacy of COX-2 inhibition in treating subretinal fibrosis.	[Zhang, Ruoshuang; Liu, Zheli; Zhang, Han; Zhang, Yi; Lin, Dong] China Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Shenyang 110001, Liaoning Provin, Peoples R China	China Medical University	Liu, ZL (corresponding author), China Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Shenyang 110001, Liaoning Provin, Peoples R China.	zheli_liu@163.com	LIU, zhe/HGD-6875-2022	Zhang, Han/0000-0002-9338-0051	Liaoning Science and Technology Project [2013225303]; Fund for Scientific Research of The First Hospital Of China Medical University [2014-04]	Liaoning Science and Technology Project; Fund for Scientific Research of The First Hospital Of China Medical University	This work was supported by Liaoning Science and Technology Project (No. 2013225303, H. Z.) and Fund for Scientific Research of The First Hospital Of China Medical University (No. 2014-04, H. Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2010, AM J OPHTHALMOL, V150, P315, DOI 10.1016/j.ajo.2010.04.011; AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178; Bakri SJ, 2014, OPHTHALMOLOGY, V121, P1102, DOI 10.1016/j.ophtha.2013.11.029; Barton D E, 1988, Oncogene Res, V3, P323; Bazan HEP, 1997, INVEST OPHTH VIS SCI, V38, P2492; Bloch SB, 2013, ACTA OPHTHALMOL, V91, P42, DOI 10.1111/j.1755-3768.2011.02268.x; Botting R, 2003, THROMB RES, V110, P269, DOI 10.1016/S0049-3848(03)00411-0; Catanuto P, 2009, EXP EYE RES, V88, P99, DOI 10.1016/j.exer.2008.10.013; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Chin MS, 2001, INVEST OPHTH VIS SCI, V42, P2338; Cianchi F, 2001, GASTROENTEROLOGY, V121, P1339, DOI 10.1053/gast.2001.29691; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Dias JRD, 2011, BRIT J OPHTHALMOL, V95, P1631, DOI 10.1136/bjo.2010.186361; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Fang IM, 2007, EXP EYE RES, V85, P667, DOI 10.1016/j.exer.2007.07.021; Fernandez-Morata JC, 2000, CLIN EXP ALLERGY, V30, P1275; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Folk JC, 2010, NEW ENGL J MED, V363, P1648, DOI 10.1056/NEJMct1000495; FUJII D, 1986, SOMAT CELL MOLEC GEN, V12, P281, DOI 10.1007/BF01570787; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Grossniklaus HE, 2002, MOL VIS, V8, P119; HLA T, 1993, ANN NY ACAD SCI, V696, P197; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Hu WZ, 2005, RETINA-J RET VIT DIS, V25, P1054, DOI 10.1097/00006982-200512000-00015; Huang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021411; Huff R, 1995, INFLAMM RES S2, V44, P145; Hwang JC, 2011, OPHTHAL SURG LAS IM, V42, DOI 10.3928/15428877-20100924-01; Jo YJ, 2011, INVEST OPHTH VIS SCI, V52, P6089, DOI 10.1167/iovs.10-5189; Kliffen M, 1997, BRIT J OPHTHALMOL, V81, P154, DOI 10.1136/bjo.81.2.154; Kubicka-Trzaska Agnieszka, 2014, Klin Oczna, V116, P277; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Lassus P, 2000, PEDIATR RES, V47, P602, DOI 10.1203/00006450-200005000-00008; Lipsky PE, 2000, ARCH INTERN MED, V160, P913, DOI 10.1001/archinte.160.7.913; Maloney SC, 2009, RETINA-J RET VIT DIS, V29, P176, DOI 10.1097/IAE.0b013e3181884fa6; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Maslinska D, 1999, FOLIA NEUROPATHOL, V37, P75; Meyer-Siegler K, 2001, MOL MED, V7, P850, DOI 10.1007/BF03401977; Nagineni CN, 2007, J CELL PHYSIOL, V210, P192, DOI 10.1002/jcp.20839; Ogata N, 1997, CURR EYE RES, V16, P9, DOI 10.1076/ceyr.16.1.9.5121; Petkova DK, 1999, CLIN EXP ALLERGY, V29, P965; Pfeffer BA, 1994, EXPT EYE RES, V59, P249; Reding T, 2006, GUT, V55, P1165, DOI 10.1136/gut.2005.077925; Rezaei KA, 2011, INVEST OPHTH VIS SCI, V52, P701, DOI 10.1167/iovs.10-6319; Rosenfeld PJ, 2011, OPHTHALMOLOGY, V118, P523, DOI 10.1016/j.ophtha.2010.07.011; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Schmidt-Erfurth U, 2011, OPHTHALMOLOGY, V118, P831, DOI 10.1016/j.ophtha.2010.09.004; Shio MT, 2004, EXP CELL RES, V298, P296, DOI 10.1016/j.yexcr.2004.04.027; Sydorova M, 2005, OPHTHALMIC RES, V37, P188, DOI 10.1159/000086594; Takahashi H, 2004, BIOCHEM BIOPH RES CO, V325, P461, DOI 10.1016/j.bbrc.2004.10.054; THIVIERGE M, 1995, J IMMUNOL, V154, P6593; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vecchio AJ, 2011, J STRUCT BIOL, V176, P254, DOI 10.1016/j.jsb.2011.07.019; Wang LS, 2002, SCAND J GASTROENTERO, V37, P467, DOI 10.1080/003655202317316114; Woods JM, 2003, EXP MOL PATHOL, V74, P282, DOI 10.1016/S0014-4800(03)00019-4; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068173; Zhu YM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-218	56	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146808	10.1371/journal.pone.0146808	http://dx.doi.org/10.1371/journal.pone.0146808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760305	Green Submitted, gold, Green Published			2022-12-27	WOS:000368033100042
J	Brown, LR; Gunnell, SM; Cassella, AN; Keller, LE; Scherkenbach, LA; Mann, B; Brown, MW; Hill, R; Fitzkee, NC; Rosch, JW; Tuomanen, EI; Thornton, JA				Brown, Lindsey R.; Gunnell, Steven M.; Cassella, Adam N.; Keller, Lance E.; Scherkenbach, Lisa A.; Mann, Beth; Brown, Matthew W.; Hill, Rebecca; Fitzkee, Nicholas C.; Rosch, Jason W.; Tuomanen, Elaine I.; Thornton, Justin A.			AdcAII of Streptococcus pneumoniae Affects Pneumococcal Invasiveness	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; LAMININ-BINDING PROTEIN; CIRCULAR-DICHROISM; EPITHELIAL-CELLS; ZINC; VIRULENCE; FAMILY; ADHESINS; PYOGENES; PSAA	Across bacterial species, metal binding proteins can serve functions in pathogenesis in addition to regulating metal homeostasis. We have compared and contrasted the activities of zinc (Zn2+)-binding lipoproteins AdcA and AdcAII in the Streptococcus pneumoniae TIGR4 background. Exposure to Zn2+-limiting conditions resulted in delayed growth in a strain lacking AdcAII (Delta AdcAII) when compared to wild type bacteria or a mutant lacking AdcA (Delta AdcA). AdcAII failed to interact with the extracellular matrix protein laminin despite homology to laminin-binding proteins of related streptococci. Deletion of AdcA or AdcAII led to significantly increased invasion of A549 human lung epithelial cells and a trend toward increased invasion in vivo. Loss of AdcAII, but not AdcA, was shown to negatively impact early colonization of the nasopharynx. Our findings suggest that expression of AdcAII affects invasiveness of S. pneumoniae in response to available Zn2+ concentrations.	[Brown, Lindsey R.; Gunnell, Steven M.; Cassella, Adam N.; Brown, Matthew W.; Thornton, Justin A.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; [Hill, Rebecca; Fitzkee, Nicholas C.] Mississippi State Univ, Dept Chem, Mississippi State, MS 39762 USA; [Keller, Lance E.] Univ Mississippi, Dept Microbiol, Med Ctr, Jackson, MS 39216 USA; [Scherkenbach, Lisa A.; Mann, Beth; Rosch, Jason W.; Tuomanen, Elaine I.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	Mississippi State University; Mississippi State University; University of Mississippi; University of Mississippi Medical Center; St Jude Children's Research Hospital	Thornton, JA (corresponding author), Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA.	thornton@biology.msstate.edu	Keller, Lance/AAY-8626-2020; Tuomanen, Elaine I/N-3081-2018; Rosch, Jason W/N-8106-2018	Tuomanen, Elaine I/0000-0003-0349-8716; Rosch, Jason W/0000-0002-1798-1760; Brown, Matthew/0000-0002-1254-0608; Hill, Blake/0000-0001-6228-3905; Burcham, Lindsey/0000-0002-5182-796X	National Institutes of Health [R03AI103294, R01AI27913]; American Lebanese Syrian Associated Charities; National Institute for General Medical Sciences [P20GM103646]; NIH [R15GM113152]; NATIONAL CANCER INSTITUTE [R25CA023944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027913, R03AI103294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476, R15GM113152, P20GM103646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grant number R03AI103294 (JAT), National Institutes of Health grant number R01AI27913 (EIT), and the American Lebanese Syrian Associated Charities (www.nih.gov). The lab of JAT was supported by grant #P20GM103646 (Center for Biomedical Research Excellence in Pathogen Host Interactions) from the National Institute for General Medical Sciences. NCF is supported by NIH grant R15GM113152.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Carter JE, 2002, BIOCHEM BIOPH RES CO, V297, P1062, DOI 10.1016/S0006-291X(02)02292-1; Dintilhac A, 1997, RES MICROBIOL, V148, P119, DOI 10.1016/S0923-2508(97)87643-7; Elsner A, 2002, INFECT IMMUN, V70, P4859, DOI 10.1128/IAI.70.9.4859-4869.2002; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Honsa ES, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00092; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khan MN, 2012, VACCINE, V30, P2900, DOI 10.1016/j.vaccine.2012.02.023; Kloosterman TG, 2007, MOL MICROBIOL, V65, P1049, DOI 10.1111/j.1365-2958.2007.05849.x; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; Nguyen AI, 2009, J AM CHEM SOC, V131, P3307, DOI 10.1021/ja808542j; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Plumptre CD, 2014, MOL MICROBIOL, V91, P834, DOI 10.1111/mmi.12504; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Romero-Steiner S, 2003, CLIN DIAGN LAB IMMUN, V10, P246, DOI 10.1128/CDLI.10.2.246-251.2003; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; RUSSELL H, 1990, J CLIN MICROBIOL, V28, P2191, DOI 10.1128/JCM.28.10.2191-2195.1990; SAMPSON JS, 1994, INFECT IMMUN, V62, P319, DOI 10.1128/IAI.62.1.319-324.1994; Shafeeq S, 2011, METALLOMICS, V3, P609, DOI 10.1039/c1mt00030f; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Strand TA, 2003, INFECT IMMUN, V71, P2009, DOI 10.1128/IAI.71.4.2009-2013.2003; Strand TA, 2001, BRIT J NUTR, V86, P301, DOI 10.1079/BJN2001399; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Terao Y, 2002, INFECT IMMUN, V70, P993; van Opijnen T, 2012, GENOME RES, V22, P2541, DOI 10.1101/gr.137430.112; VERSIECK J, 1985, CRC CR REV CL LAB SC, V22, P97, DOI 10.3109/10408368509165788; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08	36	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146785	10.1371/journal.pone.0146785	http://dx.doi.org/10.1371/journal.pone.0146785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752283	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100154
J	Guan, F; Ding, YM; Zhang, YM; Zhou, Y; Li, MX; Wang, CH				Guan, Feng; Ding, Youming; Zhang, Yemin; Zhou, Yu; Li, Mingxin; Wang, Changhua			Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; PI3K/AKT SIGNALING PATHWAY; INHIBITOR MK-2206; APOPTOSIS; AMPK; INVASION; ACTIVATION; INDUCTION; PROTEIN; GROWTH	Previous studies have evidenced that the anticancer potential of curcumin (diferuloylmethane), a main yellow bioactive compound from plant turmeric was mediated by interfering with PI3K/Akt signaling. However, the underlying molecular mechanism is still poorly understood. This study experimentally revealed that curcumin treatment reduced Akt protein expression in a dose- and time-dependent manner in MDA-MB-231 breast cancer cells, along with an activation of autophagy and suppression of ubiquitin-proteasome system (UPS) function. The curcumin-reduced Akt expression, cell proliferation, and migration were prevented by genetic and pharmacological inhibition of autophagy but not by UPS inhibition. Additionally, inactivation of AMPK by its specific inhibitor compound C or by target shRNA-mediated silencing attenuated curcumin-activated autophagy. Thus, these results indicate that curcumin-stimulated AMPK activity induces activation of the autophagy-lysosomal protein degradation pathway leading to Akt degradation and the subsequent suppression of proliferation and migration in breast cancer cell.	[Guan, Feng; Zhang, Yemin; Li, Mingxin; Wang, Changhua] Wuhan Univ, Sch Basic Med Sci, Dept Pathophysiol, Wuhan 430071, Peoples R China; [Ding, Youming; Zhou, Yu] Wuhan Univ, Renmin Hosp, Dept Hepatobiliary & Laparascop Surg, Wuhan 430060, Peoples R China	Wuhan University; Wuhan University	Wang, CH (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Pathophysiol, Wuhan 430071, Peoples R China.	chwang0525@whu.edu.cn			National Natural Science Foundation of China [81170790]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81170790) to Dr. Changhua Wang.	Alamdari N, 2009, NUTRITION, V25, P125, DOI 10.1016/j.nut.2008.09.002; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chen WC, 2013, J AGR FOOD CHEM, V61, P11817, DOI 10.1021/jf404092f; Chin YR, 2014, CANCER RES, V74, P964, DOI 10.1158/0008-5472.CAN-13-2175; Clark AR, 2014, BIOCHEM SOC T, V42, P1349, DOI 10.1042/BST20140160; Devassy JG, 2015, NUTR REV, V73, P155, DOI 10.1093/nutrit/nuu064; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Fan YN, 2008, APOPTOSIS, V13, P1401, DOI 10.1007/s10495-008-0272-z; Hasima N, 2014, CURR MED CHEM, V21, P1583, DOI 10.2174/09298673113206660135; Hudis C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3577; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Jana NR, 2004, J BIOL CHEM, V279, P11680, DOI 10.1074/jbc.M310369200; Jimenez-Flores LM, 2014, MOLECULES, V19, P8289, DOI 10.3390/molecules19068289; Juenemann K, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00001; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lee YK, 2009, ANN NY ACAD SCI, V1171, P489, DOI 10.1111/j.1749-6632.2009.04699.x; Liu DW, 2013, J BREAST CANCER, V16, P133, DOI 10.4048/jbc.2013.16.2.133; Mann KK, 2008, MOL CANCER THER, V7, P1680, DOI 10.1158/1535-7163.MCT-07-2164; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Naujokat C, 2007, IMMUNOLOGY, V120, P120, DOI 10.1111/j.1365-2567.2006.02487.x; Ramachandran C, 2005, ANTICANCER RES, V25, P3293; Saini KS, 2013, CANCER TREAT REV, V39, P935, DOI 10.1016/j.ctrv.2013.03.009; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; Seo BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095588; Shehzad A, 2013, BIOFACTORS, V39, P27, DOI 10.1002/biof.1065; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Squires MS, 2003, BIOCHEM PHARMACOL, V65, P361, DOI 10.1016/S0006-2952(02)01517-4; Xiao K, 2013, J PHARMACOL SCI, V123, P102, DOI 10.1254/jphs.13085FP; Xu XB, 2014, GENE, V546, P226, DOI 10.1016/j.gene.2014.06.006; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang W, 2011, CELL SIGNAL, V23, P19, DOI 10.1016/j.cellsig.2010.07.016; Zhu S, 2013, ASIAN PAC J CANCER P, V14, P5687, DOI 10.7314/APJCP.2013.14.10.5687	39	87	94	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146553	10.1371/journal.pone.0146553	http://dx.doi.org/10.1371/journal.pone.0146553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752181	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100097
J	Halidi, EM; Nativel, E; Akel, M; Kenouche, S; Coillot, C; Alibert, E; Jabakhanji, B; Schimpf, R; Zanca, M; Stein, P; Goze-Bac, C				Halidi, El Mohamed; Nativel, Eric; Akel, Mohamad; Kenouche, Samir; Coillot, Christophe; Alibert, Eric; Jabakhanji, Bilal; Schimpf, Remy; Zanca, Michel; Stein, Paul; Goze-Bac, Christophe			Evanescent Waves Nuclear Magnetic Resonance	PLOS ONE			English	Article							ANTENNA	Nuclear Magnetic Resonance spectroscopy and imaging can be classified as inductive techniques working in the near-to far-field regimes. We investigate an alternative capacitive detection with the use of micrometer sized probes positioned at sub wavelength distances of the sample in order to characterize and model evanescent electromagnetic fields originating from NMR phenomenon. We report that in this experimental configuration the available NMR signal is one order of magnitude larger and follows an exponential decay inversely proportional to the size of the emitters. Those investigations open a new road to a better understanding of the evanescent waves component in NMR with the opportunity to perform localized spectroscopy and imaging.	[Halidi, El Mohamed; Akel, Mohamad; Kenouche, Samir; Coillot, Christophe; Alibert, Eric; Jabakhanji, Bilal; Zanca, Michel; Goze-Bac, Christophe] Univ Montpellier, CNRS, UMR5221, BioNanoNMRI Lab Charles Coulomb, F-34090 Montpellier, France; [Nativel, Eric] Univ Montpellier, CNRS, UMR5214, IES Inst Elect, F-34090 Montpellier, France; [Schimpf, Remy] RS2D, F-67450 Mundolsheim, France; [Stein, Paul] Univ So Denmark, Inst Phys Chem & Pharm, DK-5230 Odense, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Montpellier; University of Southern Denmark	Goze-Bac, C (corresponding author), Univ Montpellier, CNRS, UMR5221, BioNanoNMRI Lab Charles Coulomb, F-34090 Montpellier, France.	christophe.goze@umontpellier.fr	Stein, Paul C./M-9044-2015; Kenouche, Samir/ABC-7715-2021	Stein, Paul C./0000-0002-7723-1419; Jabakhanji, Bilal/0000-0002-4009-3876; Kenouche, Samir/0000-0002-1682-7606				BLOCH F, 1946, PHYS REV, V70, P474, DOI 10.1103/PhysRev.70.474; Brunner DO, 2009, NATURE, V457, P994, DOI 10.1038/nature07752; Courjon D., 2003, NEAR FIELD MICROSCOP; Griffiths J.R., 2012, PROTEOMICS; HAHN EL, 1950, PHYS REV, V77, P297, DOI 10.1103/PhysRev.77.297.2; Hoult DI, 2001, J MAGN RESON, V148, P182, DOI 10.1006/jmre.2000.2229; Kramer A, 1996, MICRON, V27, P413, DOI 10.1016/S0968-4328(96)00047-9; KUMAR A, 1975, J MAGN RESON, V18, P69, DOI 10.1016/0022-2364(75)90224-3; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; Nativel E, 2004, MICROW OPT TECHN LET, V43, P209, DOI [10.1002/mop.20096, DOI 10.1002/MOP.20096]; Ocali O, 1997, MAGNET RESON MED, V37, P112, DOI 10.1002/mrm.1910370116; Prance RJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2762276; PURCELL EM, 1946, PHYS REV, V69, P37, DOI 10.1103/PhysRev.69.37; VIGOUREUX JM, 1992, APPL OPTICS, V31, P3170, DOI 10.1364/AO.31.003170	14	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0144483	10.1371/journal.pone.0144483	http://dx.doi.org/10.1371/journal.pone.0144483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751800	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100010
J	Kou, RQ; Lam, H; Duan, HR; Ye, L; Jongkam, N; Chen, WZ; Zhang, SF; Li, SH				Kou, Ruqin; Lam, Ham; Duan, Hairong; Ye, Li; Jongkam, Narisra; Chen, Weizhi; Zhang, Shifang; Li, Shihong			Benefits and Challenges with Applying Unique Molecular Identifiers in Next Generation Sequencing to Detect Low Frequency Mutations	PLOS ONE			English	Article							DNA-SYNTHESIS; HIV	Indexing individual template molecules with a unique identifier (UID) before PCR and deep sequencing is promising for detecting low frequency mutations, as true mutations could be distinguished from PCR errors or sequencing errors based on consensus among reads sharing same index. In an effort to develop a robust assay to detect from urine low-abundant bladder cancer cells carrying well-documented mutations, we have tested the idea first on a set of mock templates, with wild type and known mutants mixed at defined ratios. We have measured the combined error rate for PCR and Illumina sequencing at each nucleotide position of three exons, and demonstrated the power of a UID in distinguishing and correcting errors. In addition, we have demonstrated that PCR sampling bias, rather than PCR errors, challenges the UID-deep sequencing method in faithfully detecting low frequency mutation.	[Kou, Ruqin; Lam, Ham; Jongkam, Narisra; Zhang, Shifang; Li, Shihong] GENEWIZ LLC, Dept Dev, South Plainfield, NJ 07080 USA; [Duan, Hairong; Ye, Li; Chen, Weizhi] GENEWIZ CN, Dept Bioinformat, Suzhou 215123, Jiangsu, Peoples R China		Li, SH (corresponding author), GENEWIZ LLC, Dept Dev, 115 Corp Blvd, South Plainfield, NJ 07080 USA.	shihong.li@genewiz.com						Bejar R, 2014, J CLIN ONCOL, V32, P2691, DOI 10.1200/JCO.2013.52.3381; Brodin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119123; Bronte G, 2010, CANCER TREAT REV, V36, pS21, DOI 10.1016/S0305-7372(10)70016-5; Fu GK, 2011, P NATL ACAD SCI USA, V108, P9026, DOI 10.1073/pnas.1017621108; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; Liang RH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku355; Meldrum Cliff, 2011, Clin Biochem Rev, V32, P177; Menzo S, 2009, J INFECT DIS, V200, P1798, DOI 10.1086/647991; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shafikhani S, 1997, BIOTECHNIQUES, V23, P304, DOI 10.2144/97232rr01; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655	22	52	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146638	10.1371/journal.pone.0146638	http://dx.doi.org/10.1371/journal.pone.0146638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752634	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100115
J	Ramaekers, MG; Luning, PA; Lakemond, CMM; van Boekel, MAJS; Gort, G; Boesveldt, S				Ramaekers, Marielle G.; Luning, Pieternel A.; Lakemond, Catriona M. M.; van Boekel, Martinus A. J. S.; Gort, Gerrit; Boesveldt, Sanne			Food Preference and Appetite after Switching between Sweet and Savoury Odours in Women	PLOS ONE			English	Article							CEPHALIC PHASE RESPONSES; SENSORY-SPECIFIC SATIETY; FACIAL EXPRESSIONS; CUE EXPOSURE; HUMANS; LIKING; CONSUMPTION; OVERWEIGHT; BEHAVIOR; HUNGER	Background Exposure to food odours increases the appetite for congruent foods and decreases the appetite for incongruent foods. However, the effect of exposure to a variety of food odours, as often occurs in daily life, is unknown. Objective Investigate how switching between sweet and savoury odours affects the appetite for sweet and savoury products. Design Thirty women (age: 18-45y; BMI: 18.5-25kg/m(2)) intensely smelled the contents of cups filled with banana, meat or water (no-odour) in a within-subject design with four combinations: no-odour/banana, no-odour/meat, meat/banana and banana/meat. Participants received one combination per test day. In each combination, two cups with different fillings were smelled for five minutes after each other. Treatment order was balanced as much as possible. The effects of previous exposure and current odour on the appetite for (in) congruent sweet and savoury products, and odour pleasantness were analysed. A change from meat to banana odour or banana to meat odour was referred to as switch, whereas a change from no-odour to meat odour or no-odour to banana odour was no-switch. Results The current odour (P<0.001), as opposed to the previous exposure (P = 0.71), determined the appetite for (in) congruent sweet and savoury products, already one minute after a switch between sweet and savoury odours. The pleasantness of the odour decreased during odour exposure (P = 0.005). Conclusions After a switch, the appetite for specific products quickly adjusted to the new odour and followed the typical pattern as found during odour exposure in previous studies. Interestingly, the appetite for the smelled food remained elevated during odour exposure, known as sensory-specific appetite, whereas the pleasantness of the odour decreased over time, previously termed olfactory sensory-specific satiety. This seeming contradiction may result from different mechanisms underlying the odour-induced anticipation of food intake versus the decrease in hedonic value during prolonged sensory stimulation.	[Ramaekers, Marielle G.; Luning, Pieternel A.; Lakemond, Catriona M. M.; van Boekel, Martinus A. J. S.] Wageningen Univ, Food Qual & Design, NL-6700 AA Wageningen, Netherlands; [Gort, Gerrit] Univ Wageningen & Res Ctr, Biometris, NL-6700 AC Wageningen, Netherlands; [Boesveldt, Sanne] Wageningen Univ, Div Human Nutr, NL-6700 EV Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Boesveldt, S (corresponding author), Wageningen Univ, Div Human Nutr, POB 8129, NL-6700 EV Wageningen, Netherlands.	sanne.boesveldt@wur.nl	van Boekel, Martinus A.J.S./F-2959-2017	van Boekel, Martinus A.J.S./0000-0001-8145-8715				[Anonymous], 2006, SAS MIXED MODELS; Blundell J, 2010, OBES REV, V11, P251, DOI 10.1111/j.1467-789X.2010.00714.x; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chambaron S, 2015, APPETITE, V95, P74, DOI 10.1016/j.appet.2015.06.012; De Wijk R.A., 2012, FLAVOUR, V1, P24, DOI [10.1186/2044-7248-1-24, DOI 10.1186/2044-7248-1-24]; Fedoroff I, 2003, APPETITE, V41, P7, DOI 10.1016/S0195-6663(03)00026-6; Ferriday D, 2011, INT J OBESITY, V35, P142, DOI 10.1038/ijo.2010.117; Ferriday D, 2008, BRIT J NUTR, V100, P1325, DOI 10.1017/S0007114508978296; Finlayson G, 2008, APPETITE, V50, P120, DOI 10.1016/j.appet.2007.06.007; Finlayson G, 2007, PHYSIOL BEHAV, V90, P36, DOI 10.1016/j.physbeh.2006.08.020; Gaillet M, 2013, FOOD QUAL PREFER, V30, P274, DOI 10.1016/j.foodqual.2013.06.008; Gaillet-Torrent M, 2014, APPETITE; Griffioen-Roose S, 2012, AM J CLIN NUTR, V95, P32, DOI 10.3945/ajcn.111.020503; Gutjar S, 2015, FOOD RES INT, V76, P216, DOI 10.1016/j.foodres.2014.12.022; Hankey GJ, 2012, LANCET NEUROL, V11, P66, DOI 10.1016/S1474-4422(11)70265-4; He W, 2016, FOOD QUAL PREFER, V48, P130, DOI 10.1016/j.foodqual.2015.09.003; He W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00110; Just DR, 2009, CHOICES, P24; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Koster EP, 2002, OLFACTION, TASTE, AND COGNITION, P27, DOI 10.1017/CBO9780511546389.007; Mattes RD, 1997, J AM DIET ASSOC, V97, P406, DOI 10.1016/S0002-8223(97)00101-6; Morewedge CK, 2010, SCIENCE, V330, P1530, DOI 10.1126/science.1195701; Nederkoorn C, 2000, APPETITE, V35, P45, DOI 10.1006/appe.2000.0328; Oakes ME, 2000, CURR PSYCHOL, V19, P137, DOI 10.1007/s12144-000-1010-z; Pinel JPJ, 2000, AM PSYCHOL, V55, P1105, DOI 10.1037//0003-066X.55.10.1105; Power ML, 2008, APPETITE, V50, P194, DOI 10.1016/j.appet.2007.10.006; Ramaekers MG, 2014, INT J OBESITY, V38, P650, DOI 10.1038/ijo.2013.143; Ramaekers MG, 2014, J NUTR IN PRESS; ROGERS PJ, 1989, ADDICT BEHAV, V14, P387, DOI 10.1016/0306-4603(89)90026-9; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; ROLLS BJ, 1986, NUTR REV, V44, P93, DOI 10.1111/j.1753-4887.1986.tb07593.x; Rolls ET, 1997, PHYSIOL BEHAV, V61, P461, DOI 10.1016/S0031-9384(96)00464-7; Sclafani A, 1997, APPETITE, V29, P153, DOI 10.1006/appe.1997.0120; Smeets MAM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00096; Smeets PAM, 2011, NEUROIMAGE, V54, P1367, DOI 10.1016/j.neuroimage.2010.08.054; Smeets PAM, 2010, NUTR REV, V68, P643, DOI 10.1111/j.1753-4887.2010.00334.x; van Dongen MV, 2012, BRIT J NUTR, V108, P140, DOI 10.1017/S0007114511005277; Walla P, 2002, COGNITIVE BRAIN RES, V14, P309, DOI 10.1016/S0926-6410(02)00121-0; Walla P, 2010, J PSYCHOPHYSIOL, V24, P25, DOI 10.1027/0269-8803/a000003; Yeomans MR, 2006, PHYSIOL BEHAV, V89, P10, DOI [10.1016/j.physbeh.2006.04.010, 10.1016/j.physbeh.2006.01.029]; Yeomans MR, 2010, CHEMOSENS PERCEPT, V3, P34, DOI 10.1007/s12078-009-9052-6; Zoon HFA, 2014, PHYSIOL BEHAV, V133, P190, DOI 10.1016/j.physbeh.2014.05.026	43	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146652	10.1371/journal.pone.0146652	http://dx.doi.org/10.1371/journal.pone.0146652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751975	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100123
J	de Oliveira, SFV; Ganzinelli, M; Chila, R; Serino, L; Maciel, ME; Urban, CD; de Lima, RS; Cavalli, IJ; Generali, D; Broggini, M; Damia, G; Ribeiro, EMDF				Vieira de Oliveira, Sarah Franco; Ganzinelli, Monica; Chila, Rosaria; Serino, Leandro; Maciel, Marcos Euzebio; Urban, Cicero de Andrade; de Lima, Rubens Silveira; Cavalli, Iglenir Joao; Generali, Daniele; Broggini, Massimo; Damia, Giovanna; de Souza Fonseca Ribeiro, Enilze Maria			Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines	PLOS ONE			English	Article							METHYLTHIOADENOSINE PHOSPHORYLASE MTAP; HOMOZYGOUS DELETION; DOWN-REGULATION; CONCORDANT LOSS; 6-THIOGUANINE; DEFICIENT; CARCINOMA; TUMORS	MTAP is a ubiquitously expressed gene important for adenine and methionine salvage. The gene is located at 9p21, a chromosome region often deleted in breast carcinomas, similar to CDKN2A, a recognized tumor suppressor gene. Several research groups have shown that MTAP acts as a tumor suppressor, and some therapeutic approaches were proposed based on a tumors 'MTAP status. We analyzed MTAP and CDKN2A gene (RT-qPCR) and protein (western-blotting) expression in seven breast cancer cell lines and evaluated their promoter methylation patterns to better characterize the contribution of these genes to breast cancer. Cytotoxicity assays with inhibitors of de novo adenine synthesis (5-FU, AZA and MTX) after MTAP gene knockdown showed an increased sensitivity, mainly to 5-FU. MTAP expression was also evaluated in two groups of samples from breast cancer patients, fresh tumors and paired normal breast tissue, and from formalin-fixed paraffin embedded (FFPE) core breast cancer samples diagnosed as Luminal-A tumors and triple negative breast tumors (TNBC). The difference of MTAP expression between fresh tumors and normal tissues was not statistically significant. However, MTAP expression was significantly higher in Luminal-A breast tumors than in TNBC, suggesting the lack of expression in more aggressive breast tumors and the possibility of using the new approaches based on MTAP status in TNBC.	[Vieira de Oliveira, Sarah Franco; Serino, Leandro; Maciel, Marcos Euzebio; Cavalli, Iglenir Joao; de Souza Fonseca Ribeiro, Enilze Maria] Univ Fed Parana, Dept Genet, BR-80060000 Curitiba, Parana, Brazil; [Ganzinelli, Monica; Chila, Rosaria; Broggini, Massimo; Damia, Giovanna] Ist Ric Farmacol Mario Negri, Dept Oncol, Mol Pharmacol Lab, Milan, Lombardia, Italy; [Urban, Cicero de Andrade; de Lima, Rubens Silveira] Hosp Nossa Senhora Gracas, Dept Mastol, Breast Unit, Curitiba, Parana, Brazil; [Generali, Daniele] AO Ist Ospitalieri Cremona, UO Multidisciplinare Patol Mammaria, Lab Oncol Mol Senol, Cremona, Lombardia, Italy	Universidade Federal do Parana; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Ribeiro, EMDF (corresponding author), Univ Fed Parana, Dept Genet, BR-80060000 Curitiba, Parana, Brazil.	eribeiro@ufpr.br	Urban, Cicero A/D-1578-2011; damia, giovanna/AAB-1428-2020; broggini, massimo/AAA-6460-2020; Ribeiro, Enilze MSF/K-7319-2012; Ganzinelli, Monica/K-4548-2016	Urban, Cicero A/0000-0001-8964-9487; damia, giovanna/0000-0001-9749-434X; Ganzinelli, Monica/0000-0002-0526-0835; GENERALI, DANIELE/0000-0003-2480-3855; BROGGINI, MASSIMO/0000-0002-8138-9358	Programa de Apoio a Nucleos de Excelencia (PRONEX); Conselho Nacional de Ensino e Pesquisa, CNPq. Brazil [2465]; convenio [251/2013]	Programa de Apoio a Nucleos de Excelencia (PRONEX); Conselho Nacional de Ensino e Pesquisa, CNPq. Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); convenio	This work was supported by Programa de Apoio a Nucleos de Excelencia (PRONEX), and Conselho Nacional de Ensino e Pesquisa, CNPq. Brazil. Protocolo 24652; convenio 251/2013. Authors: EMSFR IJC.	Alhebshi HM, 2008, ASIAN PAC J CANCER P, V9, P291; Bertino JR, 2011, CANCER BIOL THER, V11, P627, DOI 10.4161/cbt.11.7.14948; Bisogna M, 2001, CANCER GENET CYTOGEN, V125, P131, DOI 10.1016/S0165-4608(00)00367-8; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Chen ZH, 1997, MOL PHARMACOL, V52, P903, DOI 10.1124/mol.52.5.903; Christopher SA, 2002, CANCER RES, V62, P6639; Conde L, 2012, HISTOPATHOLOGY, V61, P1082, DOI 10.1111/j.1365-2559.2012.04353.x; Crespo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046088; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dou Jian-Xin, 2009, Ai Zheng, V28, P390; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hellerbrand C, 2006, CARCINOGENESIS, V27, P64, DOI 10.1093/carcin/bgi201; Hustinx SR, 2005, MODERN PATHOL, V18, P959, DOI 10.1038/modpathol.3800377; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2014, COORD PREV VIG EST 2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kadariya Y, 2011, J BIOMOL SCREEN, V16, P44, DOI 10.1177/1087057110386371; KAMATANI N, 1981, P NATL ACAD SCI-BIOL, V78, P1219, DOI 10.1073/pnas.78.2.1219; Kim J, 2011, GENE CHROMOSOME CANC, V50, P421, DOI 10.1002/gcc.20867; Kindler H, 2009, INVEST NEW DRUG, V27, P75, DOI 10.1007/s10637-008-9160-1; Kirovski G, 2011, AM J PATHOL, V178, P1145, DOI 10.1016/j.ajpath.2010.11.059; Lin C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-192; Lubin M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005735; M'soka TJ, 2000, LEUKEMIA, V14, P935, DOI 10.1038/sj.leu.2401771; Miyazaki S, 2007, INT J ONCOL, V31, P1069; Schmid M, 1998, ONCOGENE, V17, P2669, DOI 10.1038/sj.onc.1202205; Su CY, 2014, EJSO-EUR J SURG ONC, V40, P1143, DOI 10.1016/j.ejso.2014.04.017; Tang BQ, 2015, G3-GENES GENOM GENET, V5, P35, DOI 10.1534/g3.114.014555; Tang BQ, 2012, CANCER BIOL THER, V13, P1082, DOI 10.4161/cbt.21115; Tedeschi PM, 2015, CANCER CHEMOTH PHARM, V75, P1247, DOI 10.1007/s00280-015-2747-2; TISDALE MJ, 1983, BIOCHEM PHARMACOL, V32, P2915, DOI 10.1016/0006-2952(83)90396-9; de Oliveira SFV, 2010, CANCER GENET CYTOGEN, V200, P23, DOI 10.1016/j.cancergencyto.2010.03.002; Zimling ZG, 2012, HISTOPATHOLOGY, V60, pE96, DOI 10.1111/j.1365-2559.2012.04196.x	33	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145647	10.1371/journal.pone.0145647	http://dx.doi.org/10.1371/journal.pone.0145647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751376	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100021
J	Gao, L; Xin, Z; Yuan, MX; Cao, X; Feng, JP; Shi, J; Zhu, XR; Yang, JK				Gao, Lu; Xin, Zhong; Yuan, Ming-Xia; Cao, Xi; Feng, Jian-Ping; Shi, Jing; Zhu, Xiao-Rong; Yang, Jin-Kui			High Prevalence of Diabetic Retinopathy in Diabetic Patients Concomitant with Metabolic Syndrome	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; RISK-FACTORS; MELLITUS; OBESITY; COMPLICATIONS; INFLAMMATION; ASSOCIATION; DEFINITION; COHORT	Objective To evaluate the relationship between metabolic syndrome (MetS) and the prevalence of diabetic retinopathy (DR). Research Design and Methods We conducted a case-controlled study, with data obtained from 2,551 Chinese participants between 18-79 years of age (representing a population of 1,660,500 in a district of Beijing). 74 cases of DR were found following data assessment by two 45 degrees digital retinal images. Subjects without DR (NDR group) selected from the remaining 2,477 subjects were matched 1:1 to the DR group by HbA1c. MetS was defined by incorporating diagnostic criteria of the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) and the International Diabetes Federation (IDF). Results There were no statistical differences between the DR group and NDR group in a number of biological or laboratory tests. However, the percentage of patients with DR increased vs. patients without DR with the number of MetS components from 1 to 5 (14.3% vs. 85.7%, 38.9% vs. 61.1%, 49.1% vs. 50.9%, 61.4% vs. 38.6% and 83.3% vs. 16.7%, respectively) (Pearson chi(2) = 9.938, P = 0.037). The trend to develop DR with MetS was significantly higher than that without MetS (NMetS) (chi(2) = 5.540, P = 0.019). MetS was an independent statistical indicator of the presence of DR after adjusting for age and sex [odds ratio (95% CI): 2.701 (1.248-5.849), P = 0.012], which is still the case with an additional adjustment for WC, SBP, TC, HbA1c and duration of diabetes [odds ratio (95% CI): 2.948(1.134-7.664), P = 0.027]. Conclusion DR is one of the diabetic microvascular complications. Apart from poor glycemic control, the concomitance of other metabolic factors can also influence DR. MetS, defined as a cluster of metabolic risk factors, is a strong and independent indicator of DR, even to the same extent as glycemic control.	[Gao, Lu; Xin, Zhong; Yuan, Ming-Xia; Feng, Jian-Ping; Zhu, Xiao-Rong; Yang, Jin-Kui] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China; [Gao, Lu] Capital Med Univ, Beijing Tongren Hosp, Dept Geriatr, Beijing, Peoples R China; [Cao, Xi; Shi, Jing; Yang, Jin-Kui] Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Yang, JK (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China.	jinkui.yang@foxmail.com	Xin, Zhongbao/G-5404-2010	Yang, Jin-Kui/0000-0002-5430-2149	Capital Medical Development Foundation [2009-Z-SQ03]; Expert Promotion Program of Beijing Health Systems [2009-3-34]	Capital Medical Development Foundation; Expert Promotion Program of Beijing Health Systems	This work was supported by the Capital Medical Development Foundation (No. 2009-Z-SQ03) and Expert Promotion Program of Beijing Health Systems (No. 2009-3-34) to Professor Jin-Kui Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Bonadonna RC, 2006, DIABETES CARE, V29, P2701, DOI 10.2337/dc06-0942; Buysschaert M, 2011, MED CLIN N AM, V95, P289, DOI 10.1016/j.mcna.2010.11.002; Chew EY, 2014, OPHTHALMOLOGY, V121, P2443, DOI 10.1016/j.ophtha.2014.07.019; de Jongh RT, 2004, CIRCULATION, V109, P2529, DOI 10.1161/01.CIR.0000129772.26647.6F; Engelgau MM, 1997, DIABETES CARE, V20, P785, DOI 10.2337/diacare.20.5.785; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Iwasaki T, 2008, DIABETES RES CLIN PR, V79, P427, DOI [10.1016/j.diabres.2007.10.035, 10.1016/j.diabres.2007.06.014]; Lamparter J, 2014, J DIABETES COMPLICAT, V28, P482, DOI 10.1016/j.jdiacomp.2014.02.008; Madan Ritu, 2010, J Assoc Physicians India, V58, P481; MOSS SE, 1994, OPHTHALMOLOGY, V101, P1061; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Nguyen TT, 2006, TRENDS ENDOCRIN MET, V17, P262, DOI 10.1016/j.tem.2006.07.006; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tomic M, 2013, COLLEGIUM ANTROPOL, V37, P51; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Tyrberg M, 2008, DIABETES OBES METAB, V10, P646, DOI 10.1111/j.1463-1326.2007.00759.x; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; van Leiden HA, 2003, ARCH OPHTHALMOL-CHIC, V121, P245, DOI 10.1001/archopht.121.2.245; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	28	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145293	10.1371/journal.pone.0145293	http://dx.doi.org/10.1371/journal.pone.0145293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745177	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600005
J	Kelly, RF; Hamman, SM; Morgan, KL; Nkongho, EF; Ngwa, VN; Tanya, V; Andu, WN; Sander, M; Ndip, L; Handel, IG; Mazeri, S; Muwonge, A; Bronsvoort, BMD				Kelly, Robert F.; Hamman, Saidou M.; Morgan, Kenton L.; Nkongho, Egbe F.; Ngwa, Victor Ngu; Tanya, Vincent; Andu, Walters N.; Sander, Melissa; Ndip, Lucy; Handel, Ian G.; Mazeri, Stella; Muwonge, Adrian; Bronsvoort, Barend M. de. C.			Knowledge of Bovine Tuberculosis, Cattle Husbandry and Dairy Practices amongst Pastoralists and Small-Scale Dairy Farmers in Cameroon	PLOS ONE			English	Article							LIVESTOCK/WILDLIFE INTERFACE AREAS; MYCOBACTERIUM-BOVIS; RISK-FACTORS; ZOONOTIC ASPECTS; MOUTH-DISEASE; PREVALENCE; INFECTION; AFRICA; TRANSMISSION; PATHOGENESIS	Background Control of bovine tuberculosis (bTB) and zoonotic tuberculosis (zTB) has relied upon surveillance and slaughter of infected cattle, milk pasteurisation and public health education. In Cameroon, like many other sub-Saharan African countries, there is limited understanding of current cattle husbandry or milk processing practices or livestock keepers awareness of bTB. This paper describes husbandry and milk processing practices within different Cameroonian cattle keeping communities and bTB awareness in comparison to other infectious diseases. Study design A population based cross-sectional sample of herdsmen and a questionnaire were used to gather data from pastoralists and dairy farmers in the North West Region and Vina Division of Cameroon. Results Pastoralists were predominately male Fulanis who had kept cattle for over a decade. Dairy farmers were non-Fulani and nearly half were female. Pastoralists went on transhumance with their cattle and came into contact with other herds and potential wildlife reservoirs of bTB. Dairy farmers housed their cattle and had little contact with other herds or wildlife. Pastoralists were aware of bTB and other infectious diseases such as foot-and-mouth disease and fasciolosis. These pastoralists were also able to identify clinical signs of these diseases. A similar proportion of dairy farmers were aware of bTB but fewer were aware of foot-and-mouth and fasciolosis. In general, dairy farmers were unable to identify any clinical signs for any of these diseases. Importantly most pastoralists and dairy farmers were unaware that bTB could be transmitted to people by consuming milk. Conclusions Current cattle husbandry practices make the control of bTB in cattle challenging especially in mobile pastoralist herds. Routine test and slaughter control in dairy herds would be tractable but would have profound impact on dairy farmer livelihoods. Prevention of transmission in milk offers the best approach for human risk mitigation in Cameroon but requires strategies that improved risk awareness amongst producers and consumers.	[Kelly, Robert F.; Mazeri, Stella; Muwonge, Adrian; Bronsvoort, Barend M. de. C.] Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Kelly, Robert F.] Univ Glasgow, Sch Vet Med, Farm Anim Clin Sci, Glasgow, Lanark, Scotland; [Hamman, Saidou M.] Inst Agr Res Dev, Reg Ctr Wakwa, Ngaoundere, Cameroon; [Morgan, Kenton L.] Univ Liverpool, Inst Ageing & Chron Dis, Wirral L64 7TE, Merseyside, England; [Morgan, Kenton L.] Univ Liverpool, Sch Vet Sci, Wirral L64 7TE, Merseyside, England; [Nkongho, Egbe F.] Univ Calabar, Fac Allied Med Sci, Microbiol & Parasitol Unit, Calabar, Nigeria; [Ngwa, Victor Ngu] Univ Ngaoundere, Sch Vet Med & Sci, Ngaoundere, Cameroon; [Tanya, Vincent] Cameroon Acad Sci, Yaounde, Cameroon; [Andu, Walters N.] Minist Livestock Fisheries & Anim Ind, NWR Reg Delegat, Bamenda, Cameroon; [Nkongho, Egbe F.; Sander, Melissa] Hosp Roundabout, TB Reference Lab Bamenda, Bamenda, Cameroon; [Ndip, Lucy] Univ Buea, Lab Emerging Infect Dis, Buea, Cameroon; [Handel, Ian G.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Glasgow; University of Liverpool; University of Liverpool; University of Calabar; University of Edinburgh	Kelly, RF (corresponding author), Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland.	rob.kelly@glasgow.ac.uk	guillermo, andres/AAW-4702-2021; Mazeri, Stella/AAH-7611-2020; Egbe Franklyn, Nkongho/L-1262-2018	Mazeri, Stella/0000-0002-4591-8267; NGU NGWA, VICTOR/0000-0001-9473-3309; ADRIAN, MUWONGE/0000-0002-8579-0384; Bronsvoort, Mark/0000-0002-3271-8485; Egbe Franklyn, Nkongho/0000-0002-9547-4609	Wellcome Trust [WT094945]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231760, BBS/E/D/05191133, BB/J004006/1, BBS/E/D/20211554] Funding Source: researchfish; BBSRC [BB/J004006/1, BBS/E/D/20231760, BBS/E/D/20211554, BBS/E/D/05191133] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust (WT094945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; [Anonymous], 2014, R LANG ENV STAT COMP; Awah Ndukum J, 2010, Vet Med Int, V2010, P495015, DOI 10.4061/2010/495015; Awah-Ndukum J, 2012, Vet Med Int, V2012, P798502, DOI 10.1155/2012/798502; Awah-Ndukum J, 2012, VET MED-CZECH, V57, P59, DOI 10.17221/5252-VETMED; Awah-Ndukum J., 2006, CAMEROON J EXP BIOL, V1, P116, DOI [10.4314/cajeb.v1i2.37938, DOI 10.4314/CAJEB.V1I2.37938]; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Bayemi PH, 2005, LIVEST RES RURAL DEV, V17; Bellet C, 2012, ACTA TROP, V123, P31, DOI 10.1016/j.actatropica.2012.03.010; Bessell PR., 2012, BMC VET RES, V51, P1, DOI [10.1186/1746-6148-8-51, DOI 10.1186/1746-6148-8-51]; Brian R., 1974, 5 PEOPLING CAMEROON, P19; Bronsvoort BM d C, 2003, EPIDEMIOLOGY FOOT MO; Bronsvoort BMD, 2003, TROP ANIM HEALTH PRO, V35, P491, DOI 10.1023/A:1027302525301; Burnham P., 1996, POLITICS CULTURAL DI, V1st, P96; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Collins JD, 2006, VET MICROBIOL, V112, P369, DOI 10.1016/j.vetmic.2005.11.041; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Curry J, 1996, HUM ECOL, V24, P161, DOI 10.1007/BF02169125; De Garine-Wichatitsky M, 2013, EPIDEMIOL INFECT, V141, P1342, DOI 10.1017/S0950268813000708; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075570; Department CNS, 2012, CAM CULT STAT; Dohoo IR, 2009, VET EPIDEMIOLOGIC RE, P395; FAO, 1990, M26 FAO; Frantz C, 1981, CHANGE DEV NOMADIC P, P89; GRANGE JM, 1994, VET MICROBIOL, V40, P137, DOI 10.1016/0378-1135(94)90052-3; GRANGE JM, 1994, EUR RESPIR J, V7, P1564, DOI 10.1183/09031936.94.07091564; Hlokwe TM, 2014, PREV VET MED, V115, P10, DOI 10.1016/j.prevetmed.2014.03.011; Holsinger VH, 1997, REV SCI TECH OIE, V16, P441, DOI 10.20506/rst.16.2.1037; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; Inangolet FO, 2008, TROP ANIM HEALTH PRO, V40, P501, DOI 10.1007/s11250-007-9126-x; Kangumba JGK, 1997, J S AFR VET ASSOC, V68, P130; Kankya C., 2010, BMC PUBLIC HEALTH, V10, P1; Knips V, 2005, 30 PPLPI; Koro FK, 2013, 1 INSIGHT CURRENT PR; Laval G, 2004, REV MED VET-TOULOUSE, V155, P494; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Maddock ECG, 1933, J HYG-CAMBRIDGE, V33, P103, DOI 10.1017/S002217240001843X; Manu IN, 2014, SCH J AGR SCI, V4, P11; Marcotty T, 2009, ANN TROP MED PARASIT, V103, P401, DOI 10.1179/136485909X451771; Mariam SH, 2009, APPL ENVIRON MICROB, V75, P1790, DOI 10.1128/AEM.01943-08; MARTRENCHAR A, 1993, PREV VET MED, V15, P221, DOI 10.1016/0167-5877(93)90115-A; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; Mbah EM, 2009, AFR J CONFL RESOLUT, V9, P11, DOI 10.4314/ajcr.v9i3.52177; Michel AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129926; Morgan KL, 2014, EMERG INFECT DIS, V20, P2048, DOI 10.3201/eid2012.140931; Moritz M, 2012, J ROY ANTHROPOL INST, V18, P418, DOI 10.1111/j.1467-9655.2012.01750.x; Moritz M, 2010, HUM ORGAN, V69, P138, DOI 10.17730/humo.69.2.aq85k02453w83363; Munyeme M, 2009, TROP ANIM HEALTH PRO, V41, P345, DOI 10.1007/s11250-008-9195-5; Munyeme M, 2008, PREV VET MED, V85, P317, DOI 10.1016/j.prevetmed.2008.03.006; Munyeme M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-21; Mwacalimba KK, 2013, PREV VET MED, V110, P274, DOI 10.1016/j.prevetmed.2012.10.020; Neill SD, 2001, TUBERCULOSIS, V81, P79, DOI 10.1054/tube.2000.0279; Njew R.M., 2002, CONTRIBUTIONS HEIFER; Olsen S, 2010, VET CLIN N AM-FOOD A, V26, P15, DOI 10.1016/j.cvfa.2009.10.006; Palmer MV, 2006, VET MICROBIOL, V112, P181, DOI 10.1016/j.vetmic.2005.11.028; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Radostits OM, 2000, DIS CAUSED BACTERIA, P909; RICHARDS WD, 1979, J FOOD PROTECT, V42, P55, DOI 10.4315/0362-028X-42.1.55; Scholte P, 2014, AFR J ECOL, V52, P370, DOI 10.1111/aje.12106; Sergeant E.S.G, 2015, EPITOOLS EPIDEMIOLOG; Sitima ACM, 1997, VIABILITY MYCOBACTER; Sone PM, 2012, AFR J CONFL RESOLUT, V12, P83; Taylor FW, 1995, FULANI ENGLISH DICT; Team QD, 2009, QGIS GEOGR INF SYST; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Tschopp R, 2010, VET REC, V167, P250, DOI 10.1136/vr.c3381; United Nations Statistics Division, 2014, UN DAT CAM; WHO, 2008, REPORT NO WHO HTM TB; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood PR, 2001, TUBERCULOSIS, V81, P147, DOI 10.1054/tube.2000.0272; World Bank, 2012, INT LIV PROD SYST N; World Bank, 2009, GEND LIV GEND AGR SO, P601	74	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146538	10.1371/journal.pone.0146538	http://dx.doi.org/10.1371/journal.pone.0146538			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745871	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000367815600062
J	Oliveira, MC; Tavares, LP; Vago, JP; Batista, NV; Queiroz-Junior, CM; Vieira, AT; Menezes, GB; Sousa, LP; van de Loo, FAJ; Teixeira, MM; Amaral, FA; Ferreira, AVM				Oliveira, Marina C.; Tavares, Luciana P.; Vago, Juliana P.; Batista, Nathalia V.; Queiroz-Junior, Celso M.; Vieira, Angelica T.; Menezes, Gustavo B.; Sousa, Lirlandia P.; van de Loo, Fons A. J.; Teixeira, Mauro M.; Amaral, Flavio A.; Ferreira, Adaliene V. M.			Tumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental Arthritis	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; ANTIGEN-INDUCED ARTHRITIS; LONG PENTRAXIN PTX3; INSULIN-RESISTANCE; TNF-ALPHA; ADIPOSE-TISSUE; LIPID PROFILE; INCREASED MORTALITY; INFLAMMATION; MICE	Metabolic alterations are associated with arthritis apart from obesity. However, it is still unclear which is the underlying process behind these metabolic changes. Here, we investigate the role of tumor necrosis factor (TNF) in this process in an acute model of antigeninduced arthritis (AIA). Immunized male BALB/c mice received an intra-articular injection of PBS (control) or methylated bovine serum albumin (mBSA) into their knees, and were also pre-treated with different drugs: Etanercept, an anti-TNF drug, DF2156A, a CXCR1/2 receptor antagonist, or a monoclonal antibody RB6-8C5 to deplete neutrophils. Local challenge with mBSA evoked an acute neutrophil influx into the knee joint, and enhanced the joint nociception, along with a transient systemic metabolic alteration (higher levels of glucose and lipids, and altered adipocytokines). Pre-treatment with the conventional biological Etanercept, an inhibitor of TNF action, ameliorated the nociception and the acute joint inflammation dominated by neutrophils, and markedly improved many of the altered systemic metabolites (glucose and lipids), adipocytokines and PTX3. However, the lessening of metabolic changes was not due to diminished accumulation of neutrophils in the joint by Etanercept. Reduction of neutrophil recruitment by pre-treating AIA mice with DF2156A, or even the depletion of these cells by using RB6-8C5 reduced all of the inflammatory parameters and hypernociception developed after AIA challenge, but could not prevent the metabolic changes. Therefore, the induction of joint inflammation provoked acute metabolic alterations which were involved with TNF. We suggest that the role of TNF in arthritis-associated metabolic changes is not due to local neutrophils, which are the major cells present in this model, but rather due to cytokines.	[Oliveira, Marina C.; Ferreira, Adaliene V. M.] Univ Fed Minas Gerais, Sch Nursing, Dept Nutr, Belo Horizonte, MG, Brazil; [Oliveira, Marina C.; Tavares, Luciana P.; Vago, Juliana P.; Batista, Nathalia V.; Vieira, Angelica T.; Menezes, Gustavo B.; Teixeira, Mauro M.; Amaral, Flavio A.; Ferreira, Adaliene V. M.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Immunopharmacol, Belo Horizonte, MG, Brazil; [Vago, Juliana P.; Sousa, Lirlandia P.] Univ Fed Minas Gerais, Fac Pharm, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil; [Queiroz-Junior, Celso M.] Univ Fed Minas Gerais, Fac Odontol, Dept Clin Pathol & Odontol Surg, Belo Horizonte, MG, Brazil; [Menezes, Gustavo B.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil; [van de Loo, Fons A. J.] Radboud Univ Nijmegen, Med Ctr, Expt Rheumatol, Nijmegen, Netherlands	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Radboud University Nijmegen	Ferreira, AVM (corresponding author), Univ Fed Minas Gerais, Sch Nursing, Dept Nutr, Belo Horizonte, MG, Brazil.	adaliene@gmail.com	Ferreira, Adaliene VM/G-8523-2011; Menezes, Gustavo B/B-3350-2013; Amaral, Flávio Almeida/C-3768-2018; Teixeira, Mauro M/A-4587-2008; DA SILVA, JULIANA PRISCILA VAGO/F-7386-2019; van de Loo, Fons AJ/A-3425-2014; Queiroz-Junior, Celso/L-5438-2013; Oliveira, Marina C./E-7895-2018; Vieira, Angelica T/A-6227-2015	Ferreira, Adaliene VM/0000-0003-2256-8652; Amaral, Flávio Almeida/0000-0002-1695-0612; Teixeira, Mauro M/0000-0002-6944-3008; DA SILVA, JULIANA PRISCILA VAGO/0000-0001-8188-3738; van de Loo, Fons AJ/0000-0002-5851-099X; Queiroz-Junior, Celso/0000-0002-7884-7709; Oliveira, Marina C./0000-0002-7423-9802; Vieira, Angelica T/0000-0002-4556-7671; Padua Tavares, Luciana/0000-0002-5319-0210; Sousa, Lirlandia/0000-0002-1042-9762	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes).	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Campbell RCJ, 2012, CLIN RHEUMATOL, V31, P717, DOI 10.1007/s10067-011-1887-y; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Coelho FM, 2008, ARTHRITIS RHEUM-US, V58, P2329, DOI 10.1002/art.23622; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Daien CI, 2012, ANN RHEUM DIS, V71, P862, DOI 10.1136/annrheumdis-2011-201148; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Dominical VM, 2011, SCAND J IMMUNOL, V73, P309, DOI 10.1111/j.1365-3083.2011.02503.x; Feng LJ, 2014, INFLAMM RES, V63, P335, DOI 10.1007/s00011-013-0705-1; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Frommer KW, 2010, ARTHRITIS RHEUM-US, V62, P2886, DOI 10.1002/art.27616; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Georgiadis AN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1952; Graziewicz MA, 2008, MOL THER, V16, P1316, DOI 10.1038/mt.2008.85; Greisen J, 2001, ANESTHESIOLOGY, V95, P578, DOI 10.1097/00000542-200109000-00007; Guerrero ATG, 2006, PHARMACOL BIOCHEM BE, V84, P244, DOI 10.1016/j.pbb.2006.05.008; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kyrou I, 2006, ANN NY ACAD SCI, V1083, P77, DOI 10.1196/annals.1367.008; Lopes F, 2011, ARTHRITIS RHEUM-US, V63, P2651, DOI 10.1002/art.30448; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; Marques PE, 2012, HEPATOLOGY, V56, P1971, DOI 10.1002/hep.25801; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Moreland LW, 2001, J RHEUMATOL, V28, P1238; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Olama SM, 2012, RHEUMATOL INT, V32, P683, DOI 10.1007/s00296-010-1698-5; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Plant MJ, 2000, ARTHRITIS RHEUM, V43, P1473, DOI 10.1002/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N; Porter MH, 2002, J LAB CLIN MED, V139, P140, DOI 10.1067/mlc.2002.121552; Queiroz CM, 2011, J IMMUNOL, V187, P3821, DOI 10.4049/jimmunol.1101195; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Ricart-Jane D, 2002, METABOLISM, V51, P925, DOI 10.1053/meta.2002.33353; Sachs D, 2011, BRIT J PHARMACOL, V162, P72, DOI 10.1111/j.1476-5381.2010.00895.x; Souza DG, 2002, AM J PATHOL, V160, P1755, DOI 10.1016/S0002-9440(10)61122-4; Stagakis I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3874; SVENSON KLG, 1988, METABOLISM, V37, P125, DOI 10.1016/S0026-0495(98)90005-1; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tam LS, 2007, CLIN RHEUMATOL, V26, P1495, DOI 10.1007/s10067-007-0539-8; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; van Halm VP, 2007, ANN RHEUM DIS, V66, P184, DOI 10.1136/ard.2006.051672; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Ye JP, 2010, AGING-US, V2, P361, DOI 10.18632/aging.100155; Zhang J. L., 2012, WORLD SURVEY RES, V25, P11, DOI DOI 10.1371/J0URNAL.P0NE.0034965; Zhang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078151	50	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146403	10.1371/journal.pone.0146403	http://dx.doi.org/10.1371/journal.pone.0146403			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26742100	gold, Green Submitted, Green Published			2022-12-27	WOS:000367810600038
J	Abraham, A; Kim, YS; Zhao, HF; Humphries, K; Persons, DA				Abraham, Allistair; Kim, Yoon-Sang; Zhao, Huifen; Humphries, Keith; Persons, Derek A.			Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/ SCID/IL2r gamma(null) Mice by Lentiviral Expression of NUP98-HOXA10HD	PLOS ONE			English	Article							EX-VIVO EXPANSION; UMBILICAL-CORD BLOOD; STEM-CELLS; ENVELOPE PROTEINS; CD34(+) CELLS; DIFFERENTIATION; TRANSPLANTATION; VECTORS; FUSIONS; HOXB4	Techniques to expand human hematopoietic stem cells ex-vivo could be beneficial to the fields of clinical hematopoietic stem cell transplantation and gene therapy targeted at hematopoietic stem cells. NUP98-HOXA10HD is a relatively newly discovered fusion gene that in mouse transplant experiments has been shown to increase numbers of hematopoietic stem cells. We evaluated whether this fusion gene could be used to expand engrafting human primitive CD34+ cells in an immunodeficient mouse model. Gene transfer was achieved using a lentiviral based vector. The engraftment of mobilized peripheral blood human CD34+ cells grown in culture for one week after gene transfer was evaluated 3-4 months after transplant and found to be 2-3 fold higher in the NUP98-HOXA10HD groups as compared to controls. These data suggest an expansive effect at least at the short term human repopulating cell level. Further evaluation in long term repopulating models and investment in a NUP98-HOXA10HD protein seems worthy of consideration. Additionally, the results here provide strong impetus to utilize NUP98-HOXA10HD as a tool to search for underlying genes and pathways involved in hematopoietic stem cell expansion that can be enhanced and have an even more potent expansive effect.	[Abraham, Allistair; Kim, Yoon-Sang; Zhao, Huifen; Persons, Derek A.] St Jude Childrens Res Hosp, Div Expt Hematol, Memphis, TN 38105 USA; [Humphries, Keith] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	St Jude Children's Research Hospital; British Columbia Cancer Agency	Abraham, A (corresponding author), Childrens Natl Med Ctr, Div Blood & Marrow Transplantat, Washington, DC 20010 USA.	aabraham@childrensnational.org		Kim, Yoon-Sang/0000-0002-2590-8096; Humphries, Richard/0000-0003-0540-7005; Abraham, Allistair/0000-0003-2019-0887	National Cancer Institute [T32 CA 070089]; American Lebanese Syrian Associated Charities; National Heart, Lung and Blood Institute [PO1HL053749]; NATIONAL CANCER INSTITUTE [T32CA070089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053749] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Cancer Institute, T32 CA 070089 (AA), the American Lebanese Syrian Associated Charities (DP) and the National Heart, Lung and Blood Institute, PO1HL053749 (DP).	Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Even Y, 2011, CELL TRANSPLANT, V20, P1099, DOI 10.3727/096368910X545068; Fares I, 2015, CURR OPIN HEMATOL, V22, P309, DOI 10.1097/MOH.0000000000000151; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Hai-Jiang W, 2008, AM J HEMATOL, V83, P922, DOI 10.1002/ajh.21262; Hanawa H, 2005, J VIROL, V79, P8410, DOI 10.1128/JVI.79.13.8410-8421.2005; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Horwitz ME, 2015, CYTOTHERAPY, V17, P730, DOI 10.1016/j.jcyt.2015.02.004; Kim YS, 2010, MOL THER, V18, P1310, DOI 10.1038/mt.2010.48; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; McNiece I, 2004, CYTOTHERAPY, V6, P311, DOI 10.1080/14653240410004871; McNiece I, 2000, EXP HEMATOL, V28, P1181, DOI 10.1016/S0301-472X(00)00520-8; McNiece IK, 2002, EXP HEMATOL, V30, P612, DOI 10.1016/S0301-472X(02)00805-6; Ohta H, 2007, EXP HEMATOL, V35, P817, DOI 10.1016/j.exphem.2007.02.012; Palmqvist L, 2006, BLOOD, V108, P1030, DOI 10.1182/blood-2005-12-007005; Peled T, 2004, EXP HEMATOL, V32, P547, DOI 10.1016/j.exphem.2004.03.002; Peled T, 2012, EXP HEMATOL, V40, P342, DOI 10.1016/j.exphem.2011.12.005; Pineault N, 2005, LEUKEMIA, V19, P636, DOI 10.1038/sj.leu.2403696; Pineault N, 2004, MOL CELL BIOL, V24, P1907, DOI 10.1128/MCB.24.5.1907-1917.2004; Robinson SN, 2012, EXP HEMATOL, V40, P445, DOI 10.1016/j.exphem.2012.01.015; Schiedlmeier B, 2003, BLOOD, V101, P1759, DOI 10.1182/blood-2002-03-0767; Siena S, 2000, J CLIN ONCOL, V18, P1360, DOI 10.1200/JCO.2000.18.6.1360; Slape C, 2004, LEUKEMIA LYMPHOMA, V45, P1341, DOI 10.1080/10428190310001659325; Tung SS, 2010, BEST PRACT RES CL HA, V23, P245, DOI 10.1016/j.beha.2010.06.004; Zhang XB, 2006, PLOS MED, V3, P687, DOI 10.1371/journal.pmed.0030173	30	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147059	10.1371/journal.pone.0147059	http://dx.doi.org/10.1371/journal.pone.0147059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761813	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100067
J	Rico-Uribe, LA; Caballero, FF; Olaya, B; Tobiasz-Adamczyk, B; Koskinen, S; Leonardi, M; Haro, JM; Chatterji, S; Ayuso-Mateos, JL; Miret, M				Alejandra Rico-Uribe, Laura; Felix Caballero, Francisco; Olaya, Beatriz; Tobiasz-Adamczyk, Beata; Koskinen, Seppo; Leonardi, Matilde; Maria Haro, Josep; Chatterji, Somnath; Luis Ayuso-Mateos, Jose; Miret, Marta			Loneliness, Social Networks, and Health: A Cross-Sectional Study in Three Countries	PLOS ONE			English	Article							OLDER-PEOPLE; COLLABORATIVE RESEARCH; DEPRESSIVE SYMPTOMS; AGING POPULATION; MENTAL-HEALTH; SUPPORT; ASSOCIATION; MORTALITY; RISK; LIFE	Objective It is widely recognized that social networks and loneliness have effects on health. The present study assesses the differential association that the components of the social network and the subjective perception of loneliness have with health, and analyzes whether this association is different across different countries. Methods A total of 10 800 adults were interviewed in Finland, Poland and Spain. Loneliness was assessed by means of the 3-item UCLA Loneliness Scale. Individuals' social networks were measured by asking about the number of members in the network, how often they had contacts with these members, and whether they had a close relationship. The differential association of loneliness and the components of the social network with health was assessed by means of hierarchical linear regression models, controlling for relevant covariates. Results In all three countries, loneliness was the variable most strongly correlated with health after controlling for depression, age, and other covariates. Loneliness contributed more strongly to health than any component of the social network. The relationship between loneliness and health was stronger in Finland (vertical bar beta vertical bar = 0.25) than in Poland (vertical bar beta vertical bar = 0.16) and Spain (vertical bar beta vertical bar = 0.18). Frequency of contact was the only component of the social network that was moderately correlated with health. Conclusions Loneliness has a stronger association with health than the components of the social network. This association is similar in three different European countries with different socioeconomic and health characteristics and welfare systems. The importance of evaluating and screening feelings of loneliness in individuals with health problems should be taken into account. Further studies are needed in order to be able to confirm the associations found in the present study and infer causality.	[Alejandra Rico-Uribe, Laura; Felix Caballero, Francisco; Luis Ayuso-Mateos, Jose; Miret, Marta] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Alejandra Rico-Uribe, Laura; Felix Caballero, Francisco; Olaya, Beatriz; Maria Haro, Josep; Luis Ayuso-Mateos, Jose; Miret, Marta] Inst Salud Carlos III, CIBERSAM, Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Felix Caballero, Francisco; Luis Ayuso-Mateos, Jose; Miret, Marta] Hosp Univ La Princesa, Dept Psychiat, Inst Invest Sanitaria Princesa IP, Madrid, Spain; [Olaya, Beatriz; Maria Haro, Josep] Parc Sanitari St Joan de Deu, Barcelona, Spain; [Tobiasz-Adamczyk, Beata] Jagiellonian Univ, Coll Med, Dept Med Sociol, Krakow, Poland; [Koskinen, Seppo] Natl Inst Hlth & Welf, Helsinki, Finland; [Leonardi, Matilde] Fdn IRCCS, Neurol Inst Carlo Besta, Milan, Italy; [Maria Haro, Josep] Univ Barcelona, Barcelona, Spain; [Chatterji, Somnath] World Hlth Org, Dept Hlth Stat & Informat Syst, Geneva, Switzerland	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Jagiellonian University; Collegium Medicum Jagiellonian University; Finland National Institute for Health & Welfare; IRCCS Istituto Neurologico Besta; University of Barcelona; World Health Organization	Miret, M (corresponding author), Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain.	marta.miret@uam.es	Haro, Josep Maria/D-1423-2011; leonardi, matilde/J-9997-2018; Miret, Marta/C-6103-2019; Olaya, Beatriz/AAB-1952-2020; CHATTERJI, Somnath/ABE-6832-2020; rico-uribe, laura-alejandra/M-5717-2014	Haro, Josep Maria/0000-0002-3984-277X; leonardi, matilde/0000-0003-0552-8923; Miret, Marta/0000-0003-3252-854X; Olaya, Beatriz/0000-0003-2046-3929; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X; rico-uribe, laura-alejandra/0000-0003-1530-6638	European Community (COURAGE in Europe) [223071]; European Commission Horizon (ATHLOS) [635316]; Instituto de Salud Carlos III-FIS research grant [PS09/00295, PS09/01845, PI12/01490, PI13/00059]; Spanish Ministry of Science and Innovation ACI-Promociona [ACI2009-1010]; European Union European Regional Development Fund (ERDF) "A Way to Build Europe" [PI12/01490, PI13/00059]; programme "Contratos predoctorales para Formacion de Personal Investigador, FPI-UAM", Universidad Autonoma de Madrid, Spain; Spanish Ministry of Economy and Competitiveness [FPDI-2013-15793]; Instituto de Salud Carlos III, Spain [CD12/00429]; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III	European Community (COURAGE in Europe); European Commission Horizon (ATHLOS); Instituto de Salud Carlos III-FIS research grant; Spanish Ministry of Science and Innovation ACI-Promociona(Spanish Government); European Union European Regional Development Fund (ERDF) "A Way to Build Europe"; programme "Contratos predoctorales para Formacion de Personal Investigador, FPI-UAM", Universidad Autonoma de Madrid, Spain; Spanish Ministry of Economy and Competitiveness(Spanish Government); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III(Instituto de Salud Carlos III)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 223071 (COURAGE in Europe), from the European Commission Horizon 2020 under grant number 635316 (ATHLOS), from the Instituto de Salud Carlos III-FIS research grant numbers PS09/00295, PS09/01845, PI12/01490 and PI13/00059, and from the Spanish Ministry of Science and Innovation ACI-Promociona (ACI2009-1010). Projects PI12/01490 and PI13/00059 have been co-funded by the European Union European Regional Development Fund (ERDF) "A Way to Build Europe". Laura Rico is supported by the programme "Contratos predoctorales para Formacion de Personal Investigador, FPI-UAM", Universidad Autonoma de Madrid, Spain. Marta Miret is grateful to the Spanish Ministry of Economy and Competitiveness for the postdoctoral fellowship (FPDI-2013-15793). Beatriz Olaya is part of the Sara Borrell postdoctoral programme (reference no. CD12/00429) supported by the Instituto de Salud Carlos III, Spain. The study was supported by the Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLIND I, 1992, SOC SCI MED, V34, P405, DOI 10.1016/0277-9536(92)90300-F; Alonso J, 2011, MOL PSYCHIATR, V16, P1234, DOI 10.1038/mp.2010.101; Alpass FM, 2003, AGING MENT HEALTH, V7, P212, DOI 10.1080/1360786031000101193; [Anonymous], 2013, REP EUR TASK FORC; Bekhet AK, 2012, ARCH PSYCHIAT NURS, V26, P214, DOI 10.1016/j.apnu.2011.09.007; Berkman LF, 2000, LANCET, V355, P1291, DOI 10.1016/S0140-6736(00)02107-3; Berkman LF, 2004, AM J EPIDEMIOL, V159, P167, DOI 10.1093/aje/kwh020; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Borsch-Supan Axel, 2005, Eur J Ageing, V2, P245, DOI 10.1007/s10433-005-0014-9; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Cacioppo JT, 2014, SOC PERSONAL PSYCHOL, V8, P58, DOI 10.1111/spc3.12087; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Cacioppo JT, 2002, PSYCHOSOM MED, V64, P407, DOI 10.1097/00006842-200205000-00005; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Carstensen LL, 2006, SCIENCE, P312; Cherry KE, 2013, J APPL GERONTOL, V32, P51, DOI 10.1177/0733464811409034; Cieza A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-218; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Draugalis JR, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj720111; Dykstra PA, 2009, EUR J AGEING, V6, P91, DOI 10.1007/s10433-009-0110-3; Eikemo TA, 2008, SOCIOL HEALTH ILL, V30, P565, DOI 10.1111/j.1467-9566.2007.01073.x; Fernandez-Ballesteros R, 2002, J SOC ISSUES, V58, P645, DOI 10.1111/1540-4560.00282; Fokkema T, 2012, J PSYCHOL, V146, P201, DOI 10.1080/00223980.2011.631612; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Golden J, 2009, INT J GERIATR PSYCH, V24, P694, DOI 10.1002/gps.2181; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Heikkinen RL, 2004, ARCH GERONTOL GERIAT, V38, P239, DOI 10.1016/j.archger.2003.10.004; Hohwu L, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2595; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; IMSERSO, 2014, PERS MAYOR ESP DAT E; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; Jylha M, 2004, CAN J AGING, V23, P157, DOI 10.1353/cja.2004.0023; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Lauder William, 2006, Psychol Health Med, V11, P233, DOI 10.1080/13548500500266607; Leonardi M, 2014, CLIN PSYCHOL PSYCHOT, V21, P193, DOI 10.1002/cpp.1856; Litwin H, 2000, J AGING STUD, V14, P213, DOI 10.1016/S0890-4065(00)80012-2; Litwin H, 2013, SOCIAL NETWORKS OLDE, P177; Luanaigh CO, 2008, INT J GERIATR PSYCH, V23, P1213, DOI 10.1002/gps.2054; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Marmot M, 2002, HLTH WEALTH LIFESTYL; Miller G, 2011, SCIENCE, V331, P138, DOI 10.1126/science.331.6014.138; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nolen-Hoeksema S, 2002, PSYCHOL AGING, V17, P116, DOI 10.1037//0882-7974.17.1.116; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Peerenboom L, 2015, J AFFECT DISORDERS, V182, P26, DOI 10.1016/j.jad.2015.04.033; Pikhartova J, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-106; Pinquart M, 2001, BASIC APPL SOC PSYCH, V23, P245, DOI 10.1207/S15324834BASP2304_2; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; Prince MJ, 1997, PSYCHOL MED, V27, P323, DOI 10.1017/S0033291796004485; Ramlagan S, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-100; Ryan AK, 2007, J AGING HEALTH, V19, P907, DOI 10.1177/0898264307308340; Salomon J.A., 2003, HLTH SYSTEMS PERFORM, P301; Schinka KC, 2012, J PSYCHOL, V146, P105, DOI 10.1080/00223980.2011.584084; Shankar A, 2015, PSYCHOL HEALTH, V30, P686, DOI 10.1080/08870446.2014.979823; Smyth N, 2015, SOC PSYCH PSYCH EPID, V50, P1111, DOI 10.1007/s00127-014-0943-8; Sokal RR, 1969, BIOMETRY FREEMAN CO; Stephens C, 2011, J AGING HEALTH, V23, P887, DOI 10.1177/0898264311400189; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; ?stun TB., 2005, HOUSEHOLD SAMPLE SUR; Sundstrom G, 2009, EUR J AGEING, V6, P267, DOI 10.1007/s10433-009-0134-8; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Tilvis Reijo S, 2011, J Aging Res, V2011, P534781, DOI 10.4061/2011/534781; United Nations, 2013, COMP MACR REG GEOGR; Vikstrom J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-78; Whelan BJ, 2013, J AM GERIATR SOC, V61, pS265, DOI 10.1111/jgs.12199; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234; Wolter K. M., 1985, INTRO VARIANCE ESTIM; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.; Zawisza K, 2014, CLIN PSYCHOL PSYCHOT, V21, P227, DOI 10.1002/cpp.1860	71	100	101	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145264	10.1371/journal.pone.0145264	http://dx.doi.org/10.1371/journal.pone.0145264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA8CX	26761205	Green Submitted, Green Published, gold			2022-12-27	WOS:000368033100010
J	Lampi, MC; Faber, CJ; Huynh, J; Bordeleau, F; Zanotelli, MR; Reinhart-King, CA				Lampi, Marsha C.; Faber, Courtney J.; Huynh, John; Bordeleau, Francois; Zanotelli, Matthew R.; Reinhart-King, Cynthia A.			Simvastatin Ameliorates Matrix Stiffness-Mediated Endothelial Monolayer Disruption	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; A REDUCTASE INHIBITORS; LIGHT-CHAIN KINASE; ARTERIAL STIFFNESS; SHEAR-STRESS; VASCULAR ENDOTHELIUM; SUBSTRATE STIFFNESS; RANDOMIZED-TRIAL; FOCAL ADHESIONS; GTPASE ACTIVITY	Arterial stiffening accompanies both aging and atherosclerosis, and age-related stiffening of the arterial intima increases RhoA activity and cell contractility contributing to increased endothelium permeability. Notably, statins are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors whose pleiotropic effects include disrupting small GTPase activity; therefore, we hypothesized the statin simvastatin could be used to attenuate RhoA activity and inhibit the deleterious effects of increased age-related matrix stiffness on endothelial barrier function. Using polyacrylamide gels with stiffnesses of 2.5, 5, and 10 kPa to mimic the physiological stiffness of young and aged arteries, endothelial cells were grown to confluence and treated with simvastatin. Our data indicate that RhoA and phosphorylated myosin light chain activity increase with matrix stiffness but are attenuated when treated with the statin. Increases in cell contractility, cell-cell junction size, and indirect measurements of intercellular tension that increase with matrix stiffness, and are correlated with matrix stiffness-dependent increases in monolayer permeability, also decrease with statin treatment. Furthermore, we report that simvastatin increases activated Rac1 levels that contribute to endothelial barrier enhancing cytoskeletal reorganization. Simvastatin, which is prescribed clinically due to its ability to lower cholesterol, alters the endothelial cell response to increased matrix stiffness to restore endothelial monolayer barrier function, and therefore, presents a possible therapeutic intervention to prevent atherogenesis initiated by age-related arterial stiffening.	[Lampi, Marsha C.; Faber, Courtney J.; Huynh, John; Bordeleau, Francois; Zanotelli, Matthew R.; Reinhart-King, Cynthia A.] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA	Cornell University	Reinhart-King, CA (corresponding author), Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.	cak57@cornell.edu	; Reinhart-King, Cynthia/A-9264-2016	Faber, Courtney/0000-0001-9156-7616; Zanotelli, Matthew/0000-0001-8547-6451; Reinhart-King, Cynthia/0000-0001-6959-3914	National Heart, Lung and Blood Institute [097296, 127499]; National Science Foundation (NSF) [1435755]; NSF	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was funded by the National Heart, Lung and Blood Institute (award numbers 097296 and 127499) and the National Science Foundation (NSF) (1435755) to CAR as well as a NSF Graduate Research Fellowship to MCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Ali F, 2009, J BIOL CHEM, V284, P18882, DOI 10.1074/jbc.M109.009886; Amerongen GPV, 2000, CIRCULATION, V102, P2803; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; ARNETT DK, 1994, AM J EPIDEMIOL, V140, P669, DOI 10.1093/oxfordjournals.aje.a117315; Aronson D, 2003, J HYPERTENS, V21, P3, DOI 10.1097/00004872-200301000-00002; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Califano JP, 2009, IEEE ENG MED BIO, P3343, DOI 10.1109/IEMBS.2009.5333194; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; COOPER JA, 1987, J APPL PHYSIOL, V62, P1076, DOI 10.1152/jappl.1987.62.3.1076; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Daneshjou N, 2015, J CELL BIOL, V208, P23, DOI 10.1083/jcb.201409108; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dong M, 2010, DRUG DISCOV TODAY, V15, P622, DOI 10.1016/j.drudis.2010.06.011; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GERSON RJ, 1989, AM J MED, V87, pS28, DOI 10.1016/S0002-9343(89)80596-0; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Huveneers S, 2015, CIRC RES, V116, P895, DOI 10.1161/CIRCRESAHA.116.305720; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Kohn JC, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00112; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Krishnan R, 2011, AM J PHYSIOL-CELL PH, V300, pC146, DOI 10.1152/ajpcell.00195.2010; Laufs U, 2000, CIRCULATION, V102, P3104; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lee K, 2005, CIRC RES, V97, P450, DOI 10.1161/01.RES.0000181026.94390.c9; Levinson S.S., 2008, J CLIN LIGAND ASSAY, V31, P25; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Nohria A, 2006, CIRC RES, V99, P1426, DOI 10.1161/01.RES.0000251668.39526.c7; O'Rourke MF, 2007, VASC MED, V12, P329, DOI 10.1177/1358863x07083392; Oberoi S, 2013, AM J ROENTGENOL, V200, P798, DOI 10.2214/AJR.12.8653; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; PEDERSEN TR, 1994, LANCET, V344, P1383; Peloquin J, 2011, J BIOMECH, V44, P815, DOI 10.1016/j.jbiomech.2010.12.018; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sadeghi NM, 2000, J IMMUNOL, V165, P2712, DOI 10.4049/jimmunol.165.5.2712; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Stroka KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061377; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Szulcek R, 2013, CARDIOVASC RES, V99, P471, DOI 10.1093/cvr/cvt075; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; TODD PA, 1990, DRUGS, V40, P583, DOI 10.2165/00003495-199040040-00007; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Weed SA, 1998, J CELL SCI, V111, P2433; Weisbrod RM, 2013, HYPERTENSION, V62, P1105, DOI 10.1161/HYPERTENSIONAHA.113.01744; Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135; Xiao HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059233	75	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147033	10.1371/journal.pone.0147033	http://dx.doi.org/10.1371/journal.pone.0147033			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761203	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100064
J	Xu, JX; Zheng, YF; He, YH; Wu, RJ; Mai, BR; Kang, HQ				Xu, Jingxin; Zheng, Youfei; He, Yuhong; Wu, Rongjun; Mai, Boru; Kang, Hanqing			The Effect of Elevated Ozone Concentrations with Varying Shading on Dry Matter Loss in a Winter Wheat-Producing Region in China	PLOS ONE			English	Article							FLUX-RESPONSE RELATIONSHIPS; CMAQ MODELING SYSTEM; INDUCED YIELD LOSS; AIR-QUALITY; PERFORMANCE EVALUATION; TRITICUM-AESTIVUM; EUROPEAN WHEAT; SURFACE OZONE; STOMATAL FLUX; EXPOSURE	Surface-level ozone pollution causes crop production loss by directly reducing healthy green leaf area available for carbon fixation. Ozone and its precursors also affect crop photosynthesis indirectly by decreasing solar irradiance. Pollutants are reported to have become even more severe in Eastern China over the last ten years. In this study, we investigated the effect of a combination of elevated ozone concentrations and reduced solar irradiance on a popular winter wheat Yangmai13 (Triticum aestivum L.) at field and regional levels in China. Winter wheat was grown in artificial shading and open-top-chamber environments. Treatment 1 (T1, i.e., 60% shading with an enhanced ozone of 100 +/- 9 ppb), Treatment 2 (T2, i.e., 20% shading with an enhanced ozone of 100 +/- 9 ppb), and Control Check Treatment (CK, i.e., no shading with an enhanced ozone of 100 +/- 9 ppb), with two plots under each, were established to investigate the response of winter wheat under elevated ozone concentrations and varying solar irradiance. At the field level, linear temporal relationships between dry matter loss and cumulative stomatal ozone uptake were first established through a parameterized stomatal-flux model. At the regional level, ozone concentrations and meteorological variables, including solar irradiance, were simulated using the WRF-CMAQ model (i.e., a meteorology and air quality modeling system). These variables were then used to estimate cumulative stomatal ozone uptake for the four major winter wheat-growing provinces. The regional-level cumulative ozone uptake was then used as the independent variable in field data-based regression models to predict dry matter loss over space and time. Field-level results showed that over 85%(T1: R-2 = 0.85 & T2: R-2 = 0.89) of variation in dry matter loss was explained by cumulative ozone uptake. Dry matter was reduced by 3.8% in T1 and 2.2% in T2 for each mmol O-3 . m(-2) of cumulative ozone uptake. At the regional level, dry matter loss in winter wheat would reach 50% under elevated ozone concentrations and reduced solar irradiance as determined in T1, and 30% under conditions as determined in T2. Results from this study suggest that a combination of elevated ozone concentrations and reduced solar irradiance could result in substantial dry matter loss in the Chinese wheat-growing regions.	[Xu, Jingxin; Zheng, Youfei; Wu, Rongjun; Mai, Boru; Kang, Hanqing] Nanjing Univ Informat Sci & Technol, China Meteorol Adm, Key Lab Aerosol Cloud Precipitat, Nan Jing, Jiang Su, Peoples R China; [Xu, Jingxin; He, Yuhong] Univ Toronto, Dept Geog, Mississauga, ON L5L 1C6, Canada	China Meteorological Administration; University of Toronto; University Toronto Mississauga	Zheng, YF (corresponding author), Nanjing Univ Informat Sci & Technol, China Meteorol Adm, Key Lab Aerosol Cloud Precipitat, Nan Jing, Jiang Su, Peoples R China.	zhengyf@nuist.edu.cn	He, Yuhong/AAA-9909-2020		Natural Science Foundation of Jiangsu Higher Education Institutions [20123228220003]; National Natural Science Fund project [41075114]; Jiangsu Province Ordinary University Graduate Student Research Innovation project [KYLX_0837]	Natural Science Foundation of Jiangsu Higher Education Institutions; National Natural Science Fund project(National Natural Science Foundation of China (NSFC)); Jiangsu Province Ordinary University Graduate Student Research Innovation project	This work was supported by the Natural Science Foundation of Jiangsu Higher Education Institutions (No. 20123228220003) to Youfei Zheng, the National Natural Science Fund project (No. 41075114) to Youfei Zheng, and Jiangsu Province Ordinary University Graduate Student Research Innovation project (No. KYLX_0837) to Jingxin Xu.	[Anonymous], 2015, NCAR COMMAND LANGUAG; Appel KW, 2007, ATMOS ENVIRON, V41, P9603, DOI 10.1016/j.atmosenv.2007.08.044; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Cavagnaro JB, 2007, J ARID ENVIRON, V68, P337, DOI 10.1016/j.jaridenv.2006.06.004; Che HZ, 2007, THEOR APPL CLIMATOL, V89, P83, DOI 10.1007/s00704-006-0258-0; Che HZ, 2009, THEOR APPL CLIMATOL, V97, P235, DOI 10.1007/s00704-008-0059-8; Dai F, 2009, PLANT PHYSIOL BIOCH, V45, P915; Danielsson H, 2003, ATMOS ENVIRON, V37, P475, DOI 10.1016/S1352-2310(02)00924-X; Ding AJ, 2008, ATMOS CHEM PHYS, V8, P1, DOI 10.5194/acp-8-1-2008; Eder B, 2006, ATMOS ENVIRON, V40, P4811, DOI 10.1016/j.atmosenv.2005.08.045; Elvira S, 2007, ENVIRON POLLUT, V146, P617, DOI 10.1016/j.envpol.2006.08.008; Emberson LD, 2000, ENVIRON POLLUT, V109, P403, DOI 10.1016/S0269-7491(00)00043-9; Ewert F, 2000, GLOBAL CHANGE BIOL, V6, P735, DOI 10.1046/j.1365-2486.2000.00351.x; Feng ZZ, 2014, ENVIRON POLLUT, V193, P296, DOI 10.1016/j.envpol.2014.06.004; Feng ZZ, 2012, ENVIRON POLLUT, V164, P16, DOI 10.1016/j.envpol.2012.01.014; Feng ZZ, 2009, ATMOS ENVIRON, V43, P1510, DOI 10.1016/j.atmosenv.2008.11.033; Foley KM, 2010, GEOSCI MODEL DEV, V3, P205, DOI 10.5194/gmd-3-205-2010; Fu JS, 2012, ATMOS CHEM PHYS, V12, P3837, DOI 10.5194/acp-12-3837-2012; Fuhrer J., 1994, CRITICAL LEVELS OZON, P42; Garcia-Plazaola JI, 2004, NEW PHYTOL, V163, P87, DOI 10.1111/j.1469-8137.2004.01096.x; Gego E, 2006, ATMOS ENVIRON, V40, P4920, DOI 10.1016/j.atmosenv.2005.12.045; Grunhage L, 2012, ENVIRON POLLUT, V165, P147, DOI 10.1016/j.envpol.2012.02.026; GRUTERS U, 1995, ENVIRON POLLUT, V87, P141, DOI 10.1016/0269-7491(94)P2600-E; He ZH, 2001, HIST WHEAT BEEDING C; Kreslavski VD, 2007, BIOCHEM MOSC SUPPL S, V1, P185, DOI 10.1134/S1990747807030014; Kurpius MR, 2002, ATMOS ENVIRON, V36, P4503, DOI 10.1016/S1352-2310(02)00423-5; Li YongGeng, 2005, Acta Phytoecologica Sinica, V29, P807; [刘建栋 Liu Jiandong], 2004, [大气科学, Chinese Journal of Atmospheric Sciences], V28, P59; LIVINGSTON NJ, 1987, CAN J FOREST RES, V17, P1273, DOI 10.1139/x87-197; LRTAP Convention, 2010, MAN METH CRIT MOD MA; Luo C, 2000, J GEOPHYS RES-ATMOS, V105, P1889, DOI 10.1029/1999JD900970; Martin MJ, 2001, ENVIRON POLLUT, V115, P425, DOI 10.1016/S0269-7491(01)00232-9; Mills G, 2000, ENVIRON POLLUT, V109, P533, DOI 10.1016/S0269-7491(00)00057-9; Mills G, 2011, GLOBAL CHANGE BIOL, V17, P592, DOI 10.1111/j.1365-2486.2010.02217.x; Nussbaum S, 2003, ENVIRON INT, V29, P385, DOI 10.1016/S0160-4120(02)00174-5; Odman MT, 2007, J APPL METEOROL CLIM, V46, P1731; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pleijel H, 2007, ATMOS ENVIRON, V41, P3022, DOI 10.1016/j.atmosenv.2006.12.002; Pleijel H, 2004, ATMOS ENVIRON, V38, P2259, DOI 10.1016/j.atmosenv.2003.09.076; Pleijel H, 2002, EUR J AGRON, V17, P303, DOI 10.1016/S1161-0301(02)00068-0; Shen J, 2011, SCI CHINA CHEM, V54, P1789, DOI 10.1007/s11426-011-4390-z; Shi CN, 2009, SCI TOTAL ENVIRON, V407, P5128, DOI 10.1016/j.scitotenv.2009.05.046; Smyth SC, 2009, ATMOS ENVIRON, V43, P1059, DOI 10.1016/j.atmosenv.2008.11.027; Sofo A, 2010, ANTIOXIDANTS OXIDATI, P329; Straub C, 2011, REMOTE SENS-BASEL, V3, P929, DOI 10.3390/rs3050929; Tang HY, 2013, GLOBAL CHANGE BIOL, V19, P2739, DOI 10.1111/gcb.12252; [佟磊 Tong Lei], 2011, [农业环境科学学报, Journal of Agro-Environment Science], V30, P1930; Unal A, 2005, ATMOS ENVIRON, V39, P5787, DOI 10.1016/j.atmosenv.2005.05.051; Vandermeiren M, 2012, ATMOS ENVIRON, V47, P76, DOI 10.1016/j.atmosenv.2011.11.035; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Wang C. Y., 2007, STUDY CHANGES OZONE; [吴荣军 Wu Rongjun], 2010, [生态学报, Acta Ecologica Sinica], V30, P2799; Xu J, 2008, SCI TOTAL ENVIRON, V399, P147, DOI 10.1016/j.scitotenv.2008.02.013; Yao Fang-Fang, 2007, Yingyong Shengtai Xuebao, V18, P2586; Yarwood G., 2005, RT040067 US EPA; Yu SC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007715; Yu-long Wang, 2008, Yingyong Shengtai Xuebao, V19, P901; Zhang MG, 2006, ATMOS ENVIRON, V40, P4874, DOI 10.1016/j.atmosenv.2005.06.063; Zhang Q, 2009, ATMOS CHEM PHYS, V9, P5131, DOI 10.5194/acp-9-5131-2009; [郑昌玲 Zheng Changling], 2005, [气象学报, Acta Meteorologica Sinica], V63, P184; Zheng Y, 2011, PHOTOSYNTHETICA, V49, P426, DOI 10.1007/s11099-011-0055-6; Zhou XingYuan, 2006, Journal of Nanjing Forestry University (Natural Sciences Edition), V30, P32; Zhu XK, 2011, GLOBAL CHANGE BIOL, V17, P2697, DOI 10.1111/j.1365-2486.2011.02400.x	63	1	1	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145446	10.1371/journal.pone.0145446	http://dx.doi.org/10.1371/journal.pone.0145446			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760509	gold, Green Published, Green Submitted			2022-12-27	WOS:000368033100016
J	Moro, L; Bardaji, A; Macete, E; Barrios, D; Morales-Prieto, DM; Espana, C; Mandomando, I; Sigauque, B; Dobano, C; Markert, UR; Benitez-Ribas, D; Alonso, PL; Menendez, C; Mayor, A				Moro, Laura; Bardaji, Azucena; Macete, Eusebio; Barrios, Diana; Morales-Prieto, Diana M.; Espana, Carolina; Mandomando, Inacio; Sigauque, Betuel; Dobano, Carlota; Markert, Udo R.; Benitez-Ribas, Daniel; Alonso, Pedro L.; Menendez, Clara; Mayor, Alfredo			Placental Microparticles and MicroRNAs in Pregnant Women with Plasmodium falciparum or HIV Infection	PLOS ONE			English	Article							CELL-DERIVED MICROPARTICLES; MATERNAL PLASMA; DENDRITIC CELLS; CIRCULATING LEVELS; APOPTOTIC BODIES; CEREBRAL MALARIA; MICROVESICLES; EXPRESSION; IDENTIFICATION; PREECLAMPSIA	Background During pregnancy, syncytiotrophoblast vesicles contribute to maternal tolerance towards the fetus, but also to pathologies such as pre-eclampsia. The aim of the study was to address whether Plasmodium falciparum and HIV infections in pregnancy affect the secretion, microRNA content and function of trophoblast microparticles. Methods Microparticles were isolated and characterized from 122 peripheral plasmas of Mozambican pregnant women, malaria-and/or HIV-infected and non-infected. Expression of placenta-related microRNAs in microparticles was analysed by qPCR and the effect of circulating microparticles on dendritic cells assessed by phenotype analysis and cytokine/chemokine measurement. Results Concentrations of total and trophoblast microparticles detected by flow cytometry were higher in HIV-positive (P = 0.005 and P = 0.030, respectively) compared to non-infected mothers, as well as in women delivering low birthweight newborns (P = 0.032 and P = 0.021, respectively). miR-517c was overexpressed in mothers with placental malaria (P = 0.034), compared to non-infected. Microparticles from HIV-positive induced a higher expression of MHCII (P = 0.021) and lower production of MCP1 (P = 0.008) than microparticles from non-infected women. Conclusions In summary, alterations in total and trophoblast microparticles associated with malaria and HIV in pregnant women may have an immunopathogenic role. The potential for placental-derived vesicles and microRNAs as biomarkers of adverse outcomes during pregnancy and malaria infection should be confirmed in future studies.	[Moro, Laura; Bardaji, Azucena; Barrios, Diana; Dobano, Carlota; Alonso, Pedro L.; Menendez, Clara; Mayor, Alfredo] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Bardaji, Azucena; Macete, Eusebio; Mandomando, Inacio; Sigauque, Betuel; Dobano, Carlota; Alonso, Pedro L.; Menendez, Clara; Mayor, Alfredo] Ctr Invest Saude Manhica, Manhica, Mozambique; [Moro, Laura; Morales-Prieto, Diana M.; Markert, Udo R.] Univ Hosp Jena, Dept Obstet, Placenta Lab, Jena, Germany; [Espana, Carolina; Benitez-Ribas, Daniel] Hosp Clin Barcelona, Dept Gastroenterol, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; Friedrich Schiller University of Jena; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona	Mayor, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	alfredo.mayor@isglobal.org	Mandomando, Inacio/ABD-8007-2020; MARKERT, UDO Rudolf/AAP-1663-2021; Bardají, Azucena/AAE-9145-2019; Mayor, Alfredo/H-7488-2017; Menéndez, Clara/Q-3446-2016; Barrios-Rodríguez, Diana/D-3910-2018; Alonso, Azucena Bardají/V-5978-2018; Alonso, Pedro L/AAZ-3645-2020; Prieto, Diana Maria Morales/AAU-6418-2020; Dobaño, Carlota/N-4119-2014	Mandomando, Inacio/0000-0002-1078-2187; MARKERT, UDO Rudolf/0000-0001-5299-595X; Mayor, Alfredo/0000-0003-3890-2897; Menéndez, Clara/0000-0002-2641-6907; Barrios-Rodríguez, Diana/0000-0001-9929-5707; Alonso, Azucena Bardají/0000-0002-5135-0540; Alonso, Pedro L/0000-0003-3292-3443; Prieto, Diana Maria Morales/0000-0002-7348-059X; Dobaño, Carlota/0000-0002-6751-4060; Moro, Laura/0000-0002-5648-0280	Instituto de Salud Carlos III [PI13/01478, CES10/021-I3SNS]; Banco de Bilbao, Vizcaya; Argentaria Foundation [BBVA02-0]; Ministerio de Ciencia e Innovacion [RYC-2008-02631]; Institut d'Investigacions Biomediques August Pi i Sunyer; Departament d'Universitats i Recerca de la Generalitat de Catalunya [Agencia de Gestion de Ayudas Universitarias y de Investigacion (AGAUR)] [2014SGR263]; Spanish Agency for International Cooperation	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Banco de Bilbao, Vizcaya; Argentaria Foundation; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Institut d'Investigacions Biomediques August Pi i Sunyer; Departament d'Universitats i Recerca de la Generalitat de Catalunya [Agencia de Gestion de Ayudas Universitarias y de Investigacion (AGAUR)]; Spanish Agency for International Cooperation(Spanish Government)	This work was supported by the Instituto de Salud Carlos III (PI13/01478, CES10/021-I3SNS to AM); the Banco de Bilbao, Vizcaya, Argentaria Foundation (BBVA02-0); the Ministerio de Ciencia e Innovacion (RYC-2008-02631 to CD); the Institut d'Investigacions Biomediques August Pi i Sunyer (to LM) and the Departament d'Universitats i Recerca de la Generalitat de Catalunya [Agencia de Gestion de Ayudas Universitarias y de Investigacion (AGAUR); grant 2014SGR263]. The Manhica Health Research Centre receives core support from the Spanish Agency for International Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree MH, 2012, J REPROD IMMUNOL, V94, P131, DOI 10.1016/j.jri.2012.03.488; Aharon A, 2011, THROMB RES, V127, pS67, DOI 10.1016/S0049-3848(11)70019-6; Alijotas-Reig J, 2013, FERTIL STERIL, V99, P441, DOI 10.1016/j.fertnstert.2012.10.009; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; ANDERSON VM, 1994, TROPH RES, V8, P47; Baker JV, 2013, JAIDS-J ACQ IMM DEF, V63, P367, DOI 10.1097/QAI.0b013e3182910121; Baron M, 2012, J CELL MOL MED, V16, P1365, DOI 10.1111/j.1582-4934.2011.01486.x; Bastos-Amador P, 2012, J LEUKOCYTE BIOL, V91, P751, DOI 10.1189/jlb.0111054; Bullerdiek J, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-27; Camolotto S, 2010, PLACENTA, V31, P312, DOI 10.1016/j.placenta.2010.01.004; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Combes V, 2006, INT J PARASITOL, V36, P541, DOI 10.1016/j.ijpara.2006.02.005; Combes V, 2010, PROG NEUROBIOL, V91, P140, DOI 10.1016/j.pneurobio.2010.01.007; Delabranche X, 2012, MED MALADIES INFECT, V42, P335, DOI 10.1016/j.medmal.2012.05.011; Dong FL, 2014, REPRODUCTION, V148, P33, DOI 10.1530/REP-14-0095; Faille D, 2009, FASEB J, V23, P3449, DOI 10.1096/fj.09-135822; Frleta D, 2012, J CLIN INVEST, V122, P4685, DOI 10.1172/JCI64439; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Guller S, 2011, PLACENTA, V32, P63, DOI 10.1016/j.placenta.2010.10.011; HARBOE M, 1959, SCAND J CLIN LAB INV, V11, P66, DOI 10.3109/00365515909060410; Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Laskarin G, 2007, AM J REPROD IMMUNOL, V58, P255, DOI 10.1111/j.1600-0897.2007.00511.x; Lok CAR, 2008, HYPERTENS PREGNANCY, V27, P344, DOI 10.1080/10641950801955733; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Mantel PY, 2014, CELL MICROBIOL, V16, P344, DOI 10.1111/cmi.12259; Markson LE, 1996, J ACQ IMMUN DEF SYND, V13, P227, DOI 10.1097/00042560-199611010-00004; Martin-Jaular L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026588; Mayne E, 2012, JAIDS-J ACQ IMM DEF, V59, P340, DOI 10.1097/QAI.0b013e3182439355; Mayor A, 2012, CLIN INFECT DIS, V54, P1561, DOI 10.1093/cid/cis236; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Mfonkeu JBP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013415; Miura K, 2014, PLACENTA, V35, P848, DOI 10.1016/j.placenta.2014.06.002; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Morales-Prieto DM, 2014, PLACENTA, V35, pS39, DOI 10.1016/j.placenta.2013.11.017; Naniche D, 2012, J INFECT DIS, V205, P568, DOI 10.1093/infdis/jir815; Nantakomol D, 2011, J INFECT DIS, V203, P700, DOI 10.1093/infdis/jiq104; Nomura S, 2012, PLATELETS, V23, P81, DOI 10.3109/09537104.2011.595850; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Prieto DMM, 2011, J REPROD IMMUNOL, V88, P106, DOI 10.1016/j.jri.2011.01.004; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Sahu U, 2013, HUM IMMUNOL, V74, P713, DOI 10.1016/j.humimm.2013.02.006; Schwartz DA, 2000, J INFECT DIS, V182, P1652, DOI 10.1086/317634; Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245; Tannetta D, 2014, CELL MOL IMMUNOL, P1; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Toth B, 2010, J REPROD IMMUNOL, V85, P25, DOI 10.1016/j.jri.2009.12.006; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596	57	24	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146361	10.1371/journal.pone.0146361	http://dx.doi.org/10.1371/journal.pone.0146361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757431	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888800011
J	Sarfraz, M; Hamid, S				Sarfraz, Mariyam; Hamid, Saima			Exploring Managers' Perspectives on MNCH Program in Pakistan: A Qualitative Study	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; CHALLENGES; CARE	Background Pakistan's Maternal, Newborn and Child Health (MNCH) Program is faced with multiple challenges in service delivery, financial and logistic management, training and deployment of human resources, and integration within the existing health system. There is a lack of evidence on managerial aspects of the MNCH program management and implementation. Methods and Findings This study used qualitative methods to explore the challenges national, provincial and district program managers have faced in implementing a community midwifery program in province of Punjab while also exploring future directions for the program under a devolved health system. While the program had been designed in earnest, the planning lacked critical elements of involving relevant stakeholders in design and implementation, socio-demographic context and capacity of the existing health system. Financial limitations, weak leadership and lack of a political commitment to the problem of maternal health have also had an impact on program implementation. Conclusions Our study results suggest that there is a need to re-structure the program while ensuring sustainability and collaboration within the health sector to increase uptake of skilled birth attendance and improve maternal health care in Pakistan.	[Sarfraz, Mariyam; Hamid, Saima] Hlth Serv Acad, Islamabad, Pakistan	Health Services Academy	Sarfraz, M (corresponding author), Hlth Serv Acad, Islamabad, Pakistan.	Sarfraz.mariyam@gmail.com		Sarfraz, Mariyam/0000-0002-0817-4879	UK Department for International Development (DFID); Australian Agency for International Development (AusAID)	UK Department for International Development (DFID); Australian Agency for International Development (AusAID)(Australian Aid (AusAID))	This document is an output from a project funded by the UK Department for International Development (DFID) and Australian Agency for International Development (AusAID) for the benefit of developing countries. Funders sponsored the field research and development of associated materials only.; We thank the individuals who participated in the study. We are grateful to our research team for their assistance in development of field guide and data collection. This document is an output from a project funded by the UK Department for International Development (DFID) and Australian Agency for International Development (AusAID) for the benefit of developing countries. However, the views expressed and information contained in this document are not necessarily those of, or endorsed by DFID, AusAID or the Maternal and Newborn Health Program Research and Advocacy Fund ( RAF), which accept no responsibility or liability for such views, completeness or accuracy of the information or for any reliance placed on them.	Abdullah MT, 2007, INT J HEALTH PLAN M, V22, P45, DOI 10.1002/hpm.855; Ali N., 2012, Pakistan Journal of Public Health, V2, P62; Bhutta ZA, 2013, LANCET, V381, P2207, DOI 10.1016/S0140-6736(12)61999-0; Dobson S, 2011, ARE COMMUNITY MIDWIV; Faisel A., 2012, ARE CMWS ACCESSIBLE; Glenton C, 2013, BARRIERS FACILITATOR; Hafeez A, 2011, J PAK MED ASSOC, V61, P210; Hall JJ, 2003, MED J AUSTRALIA, V178, P17, DOI 10.5694/j.1326-5377.2003.tb05033.x; Khan AA, 2014, JCPSP-J COLL PHYSICI, V24, P295, DOI 04.2014/JCPSP.295295; Liu A, 2011, MT SINAI J MED, V78, P419, DOI 10.1002/msj.20260; Malik AU., 2012, DEVOLUTION PAKISTAN; Management OP, 2009, LAD HLTH WORK PROGR; Mazhar Arslan, 2012, Healthc Policy, V8, P24; Mumtaz Z, 2014, BJOG INT J OBSTET GY; National Maternal NaCHP, 2007, PROGR PC 1; Neelofar Sami, 2012, Pakistan Journal of Public Health, V2, P46; Nishtar S, 2013, LANCET, V381, P2193, DOI 10.1016/S0140-6736(13)60019-7; Patton M. Q., 2005, QUALITATIVE RES; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Program NM, 2010, MAT NEON CHILD HLTH; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Saeed A., 2012, MAKING SENSE POLICY; Sarfraz M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-59; Statistics PBo, 2014, PAK NAT HLTH ACC 201; Tuckett Anthony G, 2005, Nurse Res, V13, P29; Tuturu, 2020, COMM CONS HLTH ED; Wajid A., 2010, INITIAL ASSESSMENT C; Walt G, 1990, COMMUNITY HLTH WORKE	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146665	10.1371/journal.pone.0146665	http://dx.doi.org/10.1371/journal.pone.0146665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756587	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800025
J	Jiang, XL; Chen, W; Liu, X; Wang, ZH; Liu, YP; Felder, RA; Gildea, JJ; Jose, PA; Qin, C; Yang, ZW				Jiang, Xiaoliang; Chen, Wei; Liu, Xing; Wang, Zihao; Liu, Yunpeng; Felder, Robin A.; Gildea, John J.; Jose, Pedro A.; Qin, Chuan; Yang, Zhiwei			The Synergistic Roles of Cholecystokinin B and Dopamine D-5 Receptors on the Regulation of Renal Sodium Excretion	PLOS ONE			English	Article							PROXIMAL TUBULE CELLS; NA+-H+ EXCHANGE; URINARY SODIUM; POTASSIUM EXCRETION; BLOOD-PRESSURE; II TYPE-1; K+-ATPASE; GASTRIN; HYPERTENSION; MECHANISMS	Renal dopamine D1-like receptors (D1R and D5R) and the gastrin receptor (CCKBR) are involved in the maintenance of sodium homeostasis. The D1R has been found to interact synergistically with CCKBR in renal proximal tubule (RPT) cells to promote natriuresis and diuresis. D5R, which has a higher affinity for dopamine than D1R, has some constitutive activity. Hence, we sought to investigate the interaction between D5R and CCKBR in the regulation of renal sodium excretion. In present study, we found D5R and CCKBR increase each other's expression in a concentration-and time-dependent manner in the HK-2 cell, the specificity of which was verified in HEK293 cells heterologously expressing both human D5R and CCKBR and in RPT cells from a male normotensive human. The specificity of D5R in the D5R and CCKBR interaction was verified further using a selective D5R antagonist, LE-PM436. Also, D5R and CCKBR colocalize and co-immunoprecipitate in BALB/c mouse RPTs and human RPT cells. CCKBR protein expression in plasma membrane-enriched fractions of renal cortex (PMFs) is greater in D5R-/- mice than D5R+/+ littermates and D5R protein expression in PMFs is also greater in CCKBR-/- mice than CCKBR+/+ littermates. High salt diet, relative to normal salt diet, increased the expression of CCKBR and D5R proteins in PMFs. Disruption of CCKBR in mice caused hypertension and decreased sodium excretion. The natriuresis in salt-loaded BALB/c mice was decreased by YF476, a CCKBR antagonist and Sch23390, a D1R/D5R antagonist. Furthermore, the natriuresis caused by gastrin was blocked by Sch23390 while the natriuresis caused by fenoldopam, a D1R/D5R agonist, was blocked by YF476. Taken together, our findings indicate that CCKBR and D5R synergistically interact in the kidney, which may contribute to the maintenance of normal sodium balance following an increase in sodium intake.	[Jiang, Xiaoliang; Chen, Wei; Liu, Xing; Wang, Zihao; Liu, Yunpeng; Qin, Chuan; Yang, Zhiwei] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Jiang, Xiaoliang; Chen, Wei; Liu, Xing; Wang, Zihao; Liu, Yunpeng; Qin, Chuan; Yang, Zhiwei] PUMC, Comparat Med Ctr, Beijing, Peoples R China; [Felder, Robin A.; Gildea, John J.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Jose, Pedro A.] Univ Maryland, Sch Med, Div Nephrol, Dept Med, Baltimore, MD 21201 USA; [Jose, Pedro A.] Univ Maryland, Sch Med, Div Nephrol, Dept Physiol, Baltimore, MD 21201 USA; [Yang, Zhiwei] CollaborativeInnovat Ctr Cardiovasc Disorders, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Virginia; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Jose, PA (corresponding author), Univ Maryland, Sch Med, Div Nephrol, Dept Med, Baltimore, MD 21201 USA.	pjose@medicine.umaryland.edu; qinchuan@pumc.edu.cn; yangzhiwei@cnilas.pumc.edu.cn			National Natural Science Foundation (China) [81370358]; National Institutes of Health (USA) [R01DK39308]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039308] Funding Source: NIH RePORTER	National Natural Science Foundation (China)(National Natural Science Foundation of China (NSFC)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by grants from National Natural Science Foundation (China) (81370358, ZWY) and National Institutes of Health (USA) (R01DK39308, PAJ).	Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Aperia A, 2012, J AM SOC NEPHROL, V23, P1283, DOI 10.1681/ASN.2012010102; Asico L, 2011, J AM SOC NEPHROL, V22, P82, DOI 10.1681/ASN.2010050533; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; BASTIE MJ, 1988, AM J PHYSIOL, V254, pG25, DOI 10.1152/ajpgi.1988.254.1.G25; Bavithra S, 2012, NEUROTOX RES, V21, P149, DOI 10.1007/s12640-011-9253-z; Beyer Cornelis, 1993, Clinical Chemistry, V39, P1613; Brown DA, 2003, AM J PHYSIOL-GASTR L, V285, pG804, DOI 10.1152/ajpgi.00150.2003; CAREY RM, 1978, CIRC RES, V43, P19, DOI 10.1161/01.RES.43.1.19; Chen Y, 2013, HYPERTENSION, V62, P927, DOI 10.1161/HYPERTENSIONAHA.113.01094; Crowley SD, 2014, J CLIN INVEST, V124, P2341, DOI 10.1172/JCI72274; DAHL LK, 1972, P SOC EXP BIOL MED, V140, P852; de Weerth A, 1998, EUR J CLIN INVEST, V28, P592; DELVAUX M, 1990, AM J PHYSIOL, V259, pG842, DOI 10.1152/ajpgi.1990.259.5.G842; Ericsson P, 2010, REGUL PEPTIDES, V161, P22, DOI 10.1016/j.regpep.2010.01.004; EWART HS, 1995, AM J PHYSIOL-CELL PH, V269, pC295, DOI 10.1152/ajpcell.1995.269.2.C295; Forman JP, 2012, CIRCULATION, V125, P3108, DOI 10.1161/CIRCULATIONAHA.112.096115; GARLICKI J, 1990, AM J PHYSIOL, V258, pE40, DOI 10.1152/ajpendo.1990.258.1.E40; Gildea JJ, 2008, HYPERTENSION, V51, P360, DOI 10.1161/HYPERTENSIONAHA.107.100099; Gildea JJ, 2014, KIDNEY INT, V86, P118, DOI 10.1038/ki.2014.5; Gildea JJ, 2012, HYPERTENSION, V60, P396, DOI 10.1161/HYPERTENSIONAHA.112.194175; Gildea JJ, 2010, HYPERTENSION, V56, P505, DOI 10.1161/HYPERTENSIONAHA.110.152256; Goetze JP, 2013, SCAND J GASTROENTERO, V48, P688, DOI 10.3109/00365521.2013.783101; Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628; Hall JE, 2012, COMPR PHYSIOL, V2, P2393, DOI 10.1002/cphy.c110058; Hamlyn JM, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00199; Herrera M, 2012, CURR OPIN NEPHROL HY, V21, P171, DOI 10.1097/MNH.0b013e3283503068; Hollon TR, 2002, J NEUROSCI, V22, P10801, DOI 10.1523/jneurosci.22-24-10801.2002; Hussain T, 2003, EXP BIOL MED, V228, P134, DOI 10.1177/153537020322800202; Jiang XL, 2013, CLIN EXP HYPERTENS, V35, P74, DOI 10.3109/10641963.2012.690474; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; Larsen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069689; Li HW, 2008, J CLIN INVEST, V118, P2180, DOI 10.1172/JCI33637; Liang MY, 2013, SEMIN NEPHROL, V33, P392, DOI [10.1016/j.semnephro1.2013.05.011, 10.1016/j.semnephrol.2013.05.011]; Liu TB, 2013, ENDOCRINOLOGY, V154, P865, DOI 10.1210/en.2012-1813; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064170; McQuarrie EP, 2014, HYPERTENSION, V64, P111, DOI 10.1161/HYPERTENSIONAHA.113.03093; Melis M, 2007, NUCL MED BIOL, V34, P633, DOI 10.1016/j.nucmedbio.2007.05.002; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Michell AR, 2008, ANNU REV PHYSIOL, V70, P379, DOI 10.1146/annurev.physiol.69.040705.141330; Mizuta K, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-89; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Periyasamy SM, 2005, KIDNEY INT, V67, P1868, DOI 10.1111/j.1523-1755.2005.00285.x; Pisegna JR, 1996, GASTROENTEROLOGY, V110, pA1106; RUSK IN, 1989, PHARMACOL BIOCHEM BE, V34, P17, DOI 10.1016/0091-3057(89)90346-8; Salomone LJ, 2007, HYPERTENSION, V49, P155, DOI 10.1161/01.HYP.0000251881.89610.ee; Sanada H, 1999, HYPERTENSION, V33, P1036, DOI 10.1161/01.HYP.33.4.1036; Sanada H, 2011, CURR HYPERTENS REP, V13, P55, DOI 10.1007/s11906-010-0167-6; SHARON P, 1981, PROSTAGLANDINS, V21, P81, DOI 10.1016/0090-6980(81)90122-2; Sordal O, 2013, HELICOBACTER, V18, P397, DOI 10.1111/hel.12066; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; Takinami Y, 1997, ALIMENT PHARM THERAP, V11, P113, DOI 10.1046/j.1365-2036.1997.110281000.x; TIBERI M, 1994, J BIOL CHEM, V269, P27925; Trivedi M, 2004, HYPERTENSION, V43, P376, DOI 10.1161/01.HYP.0000111587.51185.fe; von Schrenck T, 2000, KIDNEY INT, V58, P995, DOI 10.1046/j.1523-1755.2000.00257.x; Wang XY, 2010, HYPERTENSION, V55, P1431, DOI 10.1161/HYPERTENSIONAHA.109.148643; WANK SA, 1992, P NATL ACAD SCI USA, V89, P3125, DOI 10.1073/pnas.89.7.3125; WANK SA, 1992, P NATL ACAD SCI USA, V89, P8691, DOI 10.1073/pnas.89.18.8691; Weder AB, 2009, J CLIN HYPERTENS, V11, P707, DOI 10.1111/j.1751-7176.2009.00197.x; Yang ZW, 2006, AM J PHYSIOL-REG I, V290, pR96, DOI 10.1152/ajpregu.00434.2005; Yang ZW, 2005, AM J PHYSIOL-HEART C, V288, pH55, DOI 10.1152/ajpheart.00627.2004; Zeng CY, 2008, AM J PHYSIOL-HEART C, V294, pH551, DOI 10.1152/ajpheart.01036.2007; Zeng CY, 2005, HYPERTENSION, V45, P804, DOI 10.1161/01.HYP.0000155212.33212.99; Zhang LA, 2010, CLIN EXP HYPERTENS, V32, P464, DOI 10.3109/10641963.2010.496516; Zhang MZ, 2015, CURR OPIN NEPHROL HY, V24, P117, DOI 10.1097/MNH.0000000000000104; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324; Zhang YR, 2010, CLIN EXP PHARMACOL P, V37, P613, DOI 10.1111/j.1440-1681.2010.05364.x; Zhang YR, 2010, J COMP PHYSIOL B, V180, P117, DOI 10.1007/s00360-009-0391-z; Zhuo JL, 2013, COMPR PHYSIOL, V3, P1079, DOI 10.1002/cphy.c110061	71	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146641	10.1371/journal.pone.0146641	http://dx.doi.org/10.1371/journal.pone.0146641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751218	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100118
J	Jothi, DJ; Dhanraj, M; Solaiappan, S; Sivanesan, S; Kron, M; Dhanasekaran, A				Jothi, Jeeva D.; Dhanraj, Muthu; Solaiappan, Shanmugam; Sivanesan, Sanjana; Kron, Michael; Dhanasekaran, Anuradha			Brugia malayi Asparaginyl - tRNA Synthetase Stimulates Endothelial Cell Proliferation, Vasodilation and Angiogenesis	PLOS ONE			English	Article							LYMPHATIC FILARIASIS; RECEPTORS; IDENTIFICATION; SURVIVAL; PROTEIN; CXCR1	A hallmark of chronic infection with lymphatic filarial parasites is the development of lymphatic disease which often results in permanent vasodilation and lymphedema, but all of the mechanisms by which filarial parasites induce pathology are not known. Prior work showed that the asparaginyl-tRNA synthetase (BmAsnRS) of Brugia malayi, an etiological agent of lymphatic filariasis, acts as a physiocrine that binds specifically to interleukin-8 (IL-8) chemokine receptors. Endothelial cells are one of the many cell types that express IL-8 receptors. IL-8 also has been reported previously to induce angiogenesis and vasodilation, however, the effect of BmAsnRS on endothelial cells has not been reported. Therefore, we tested the hypothesis that BmAsnRS might produce physiological changes in endothelial by studying the in vitro effects of BmAsnRS using a human umbilical vein cell line EA.hy926 and six different endothelial cell assays. Our results demonstrated that BmAsnRS produces consistent and statistically significant effects on endothelial cells that are identical to the effects of VEGF, vascular endothelial growth factor. This study supports the idea that new drugs or immunotherapies that counteract the adverse effects of parasite-derived physiocrines may prevent or ameliorate the vascular pathology observed in patients with lymphatic filariasis.	[Jothi, Jeeva D.; Dhanraj, Muthu; Solaiappan, Shanmugam; Dhanasekaran, Anuradha] Anna Univ, Ctr Biotechnol, Madras 25, Tamil Nadu, India; [Sivanesan, Sanjana] Sri Ramachandra Med Coll, Chennai, Tamil Nadu, India; [Kron, Michael] Med Coll Wisconsin, Dept Med, Div Infect Dis, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	Anna University; Anna University Chennai; Sri Ramachandra Institute of Higher Education & Research; Medical College of Wisconsin	Dhanasekaran, A (corresponding author), Anna Univ, Ctr Biotechnol, Madras 25, Tamil Nadu, India.	anu@annauniv.edu	Dhanasekaran, Anuradha/AAF-3160-2022; Dhanasekaran, Anuradha/AFH-8265-2022	Dhanasekaran, Anuradha/0000-0002-0195-9681	UGC-BSR fellowship; University Grants Commission, New Delhi, India; U.S. National Institutes of Health, US National Institutes of Allergy and Infectious Diseases, National Institutes of Health [R21AI105472, UO1053877]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105472] Funding Source: NIH RePORTER	UGC-BSR fellowship; University Grants Commission, New Delhi, India(University Grants Commission, India); U.S. National Institutes of Health, US National Institutes of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Jeeva Jothi acknowledges the financial support provided through the UGC-BSR fellowship sponsored by the University Grants Commission, New Delhi, India. This research was supported in part by two grants to MK from the U.S. National Institutes of Health, US National Institutes of Allergy and Infectious Diseases, National Institutes of Health, R21AI105472 and UO1053877. The authors greatly acknowledge Dr. Michael Kron for providing the construct.	Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Crepin T, 2011, J MOL BIOL, V405, P1056, DOI 10.1016/j.jmb.2010.11.049; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; Danel Franck, 2011, Curr Drug Discov Technol, V8, P66, DOI 10.2174/157016311794519947; Daniel TO, 2000, ANNU REV PHYSIOL, V62, P649, DOI 10.1146/annurev.physiol.62.1.649; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Hirakata M, 1999, J IMMUNOL, V162, P2315; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Ibba M, 2001, EMBO REP, V2, P382; KAZURA JW, 1992, J INFECT DIS, V166, P1453, DOI 10.1093/infdis/166.6.1453; Kron M, 2003, MOL BIOCHEM PARASIT, V129, P33, DOI 10.1016/S0166-6851(03)00080-X; KRON M, 1995, FEBS LETT, V374, P122, DOI 10.1016/0014-5793(95)01092-S; Kron MA, 2005, MED HYPOTHESES, V65, P1124, DOI 10.1016/j.mehy.2005.06.016; Kron MA, 2012, CLIN VACCINE IMMUNOL, P276; Kron M, 2007, J CHROMATOGR B, V856, P234, DOI 10.1016/j.jchromb.2007.06.014; Kron MA, 2012, MOL BIOCHEM PARASIT, V185, P66, DOI 10.1016/j.molbiopara.2012.06.003; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Mahler M, 2014, AUTOIMMUN REV, V13, P367, DOI 10.1016/j.autrev.2014.01.022; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Matsuda J, 1997, BRIT J HAEMATOL, V97, P227, DOI 10.1046/j.1365-2141.1997.d01-2147.x; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; OTTESEN EA, 1992, PARASITOLOGY, V104, pS71, DOI 10.1017/S0031182000075259; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Patan S, 2004, CANC TREAT, V117, P3; Perrine KG, 1998, MOL BIOCHEM PARASIT, V30, P97; Ramirez BL, 2006, J INFECT DIS, V193, P1164, DOI 10.1086/501369; RUBANYI GM, 1993, J CARDIOVASC PHARM, V22, pS1, DOI 10.1097/00005344-199304000-00002; Russo RC, 2010, CURR OPIN DRUG DISC, V13, P414; Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; Weiner AM, 1999, CURR BIOL, V9, pR842, DOI 10.1016/S0960-9822(00)80041-X; Xing DQ, 2012, CIRCULATION, V125, P1533, DOI 10.1161/CIRCULATIONAHA.111.078436	39	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146132	10.1371/journal.pone.0146132	http://dx.doi.org/10.1371/journal.pone.0146132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751209	Green Published, gold			2022-12-27	WOS:000367888100048
J	Missailidis, C; Hallqvist, J; Qureshi, AR; Barany, P; Heimburger, O; Lindholm, B; Stenvinkel, P; Bergman, P				Missailidis, Catharina; Hallqvist, Jenny; Qureshi, Abdel Rashid; Barany, Peter; Heimburger, Olof; Lindholm, Bengt; Stenvinkel, Peter; Bergman, Peter			Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; HEMODIALYSIS-PATIENTS; ATHEROSCLEROSIS; ASSOCIATIONS; MORTALITY; PHOSPHATIDYLCHOLINE; METABOLISM; FAILURE; MALNUTRITION; DIALYSIS	Background The microbial metabolite Trimethylamine-N-oxide (TMAO) has been linked to adverse cardiovascular outcome and mortality in the general population. Objective To assess the contribution of TMAO to inflammation and mortality in chronic kidney disease (CKD) patients ranging from mild-moderate to end-stage disease and 1) associations with glomerular filtration rate (GFR) 2) effect of dialysis and renal transplantation (Rtx) 3) association with inflammatory biomarkers and 4) its predictive value for all-cause mortality. Methods Levels of metabolites were quantified by a novel liquid chromatography/tandem mass spectrometry-based method in fasting plasma samples from 80 controls and 179 CKD 3-5 patients. Comorbidities, nutritional status, biomarkers of inflammation and GFR were assessed. Results GFR was the dominant variable affecting TMAO (beta = -0.41; p<0.001), choline (beta = -0.38; p<0.001), and betaine (beta = 0.45; p<0.001) levels. A longitudinal study of 74 CKD 5 patients starting renal replacement therapy demonstrated that whereas dialysis treatment did not affect TMAO, Rtx reduced levels of TMAO to that of controls (p<0.001). Following Rtx choline and betaine levels continued to increase. In CKD 3-5, TMAO levels were associated with IL-6 (Rho = 0.42; p<0.0001), fibrinogen (Rho = 0.43; p<0.0001) and hsCRP (Rho = 0.17; p = 0.022). Higher TMAO levels were associated with an increased risk for all-cause mortality that remained significant after multivariate adjustment (HR 4.32, 95% CI 1.32-14.2; p = 0.016). Conclusion Elevated TMAO levels are strongly associated with degree of renal function in CKD and normalize after renal transplantation. TMAO levels correlates with increased systemic inflammation and is an independent predictor of mortality in CKD 3-5 patients.	[Missailidis, Catharina; Bergman, Peter] Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden; [Hallqvist, Jenny] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Swedish Metabol Ctr, S-90183 Umea, Sweden; [Qureshi, Abdel Rashid; Barany, Peter; Heimburger, Olof; Lindholm, Bengt; Stenvinkel, Peter] Karolinska Univ, Huddinge Hosp, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Swedish University of Agricultural Sciences; Karolinska Institutet; Karolinska University Hospital	Missailidis, C (corresponding author), Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden.	catharina.missailidis@ki.se	Qureshi, Abdul Rashid Tony/G-1358-2010; Lindholm, Bengt/P-1334-2017	Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Barany, Peter/0000-0001-6501-8293; Bergman, Peter/0000-0003-3306-3713; Lindholm, Bengt/0000-0003-4269-4293; Stenvinkel, Peter/0000-0002-8785-4820; Heimburger, Olof/0000-0003-0901-4145	Stockholms lans landsting [20130317]; Vetenskapsradet	Stockholms lans landsting; Vetenskapsradet(Swedish Research Council)	This study was funded by Stockholms lans landsting 20130317 and Vetenskapsradet 2013-2709. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Bain MA, 2006, NEPHROL DIAL TRANSPL, V21, P1300, DOI 10.1093/ndt/gfk056; BELL JD, 1991, BIOCHIM BIOPHYS ACTA, V1096, P101, DOI 10.1016/0925-4439(91)90046-C; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Bossola M, 2009, CLIN J AM SOC NEPHRO, V4, P379, DOI 10.2215/CJN.03490708; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Ghanavatian S, 2014, ANGIOLOGY, V65, P443, DOI 10.1177/0003319713483000; Grubb A, 2014, CLIN CHEM, V60, P974, DOI 10.1373/clinchem.2013.220707; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; Kaysen GA, 2015, J RENAL NUTR, V25, P351, DOI 10.1053/j.jrn.2015.02.006; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185; Miller CA, 2014, AM J CLIN NUTR, V100, P778, DOI 10.3945/ajcn.114.087692; Neovius M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004251; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Raj DSC, 2009, AM J KIDNEY DIS, V54, P1072, DOI 10.1053/j.ajkd.2009.06.022; Ramezani A, 2014, J AM SOC NEPHROL, V25, P657, DOI 10.1681/ASN.2013080905; Rhee EP, 2013, J AM SOC NEPHROL, V24, P1330, DOI 10.1681/ASN.2012101006; Srinivasa S, 2015, AIDS, V29, P443, DOI 10.1097/QAD.0000000000000565; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stubbs JR, 2016, J AM SOC NEPHROL, V27, P305, DOI 10.1681/ASN.2014111063; Tang WHW, 2015, J CARD FAIL, V21, P91, DOI 10.1016/j.cardfail.2014.11.006; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Therrien M, 2015, J RENAL NUTR, V25, P329, DOI 10.1053/j.jrn.2014.11.001; Troseid M, 2015, J INTERN MED, V277, P717, DOI 10.1111/joim.12328; VAZIRI ND, 1985, AM J GASTROENTEROL, V80, P608; Vaziri ND, 2013, AM J NEPHROL, V38, P99, DOI 10.1159/000353764; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wetmore JB, 2008, NEPHROLOGY, V13, P593, DOI 10.1111/j.1440-1797.2008.01021.x; Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010; Zhang AQ, 1999, FOOD CHEM TOXICOL, V37, P515, DOI 10.1016/S0278-6915(99)00028-9	33	193	204	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0141738	10.1371/journal.pone.0141738	http://dx.doi.org/10.1371/journal.pone.0141738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751065	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100005
J	Yeda, R; Ingasia, LA; Cheruiyot, AC; Okudo, C; Chebon, LJ; Cheruiyot, J; Akala, HM; Kamau, E				Yeda, Redemptah; Ingasia, Luicer A.; Cheruiyot, Agnes C.; Okudo, Charles; Chebon, Lorna J.; Cheruiyot, Jelagat; Akala, Hoseah M.; Kamau, Edwin			The Genotypic and Phenotypic Stability of Plasmodium falciparum Field Isolates in Continuous In Vitro Culture	PLOS ONE			English	Article							DRUG-SENSITIVITY; MICROSATELLITE MARKERS; CHLOROQUINE RESISTANCE; MALARIA; ASSAY; TRANSMISSION; PARASITES; PROFILES; CAMBODIA	The Plasmodium falciparum in vitro culture system is critical for genotypic and phenotypic analyses of the parasites. For genotypic analysis, the genomic DNA can be obtained directly from the patient blood sample or from culture adapted parasites whereas for phenotypic analysis, immediate ex vivo or in vitro culture adapted parasites are used. However, parasite biology studies have not investigated whether culture adaptation process affects genotypic and/or phenotypic characteristics of the parasites in short- or long-term cultures. Here, we set out to study the dynamics and stability of parasite genetic and phenotypic profiles as field isolate parasites were adapted in continuous cultures. Parasites collected from three different patients presenting with uncomplicated malaria were adapted and maintained in drug-free continuous cultures. Aliquots from the continuous cultures were collected every 24-48 hours for analyses. Each aliquot was treated as a separate parasite sample. For genetic analysis, microsatellite (MS) typing and single nucleotide polymorphism (SNP) analyses of 23 drug resistance markers were done. The 50% inhibitory concentrations (IC50) for some of the samples were also established for four antimalarial drugs. Samples from each patient (parasite-line) were compared as they were passed through the continuous culture. Data revealed genotypic and phenotypic profiles for the three parasite-lines fluctuated from one generation to the next with no specific pattern or periodicity. With few exceptions, multilocus analysis revealed samples from each parasite-line had high genetic diversity with unique haplotypes. Interestingly, changes in MS and SNP profiles occurred simultaneously. The difference in the IC(50)s of samples in each parasite-line reached statistical significance. However, phenotypic changes did not correspond or correlate to genotypic changes. Our study revealed parasite genetic and phenotypic characteristics fluctuates in short-and long-term cultures, which indicates parasite genetic information obtained even in short cultures is likely to be different from the natural infection parasites.	[Yeda, Redemptah; Ingasia, Luicer A.; Cheruiyot, Agnes C.; Okudo, Charles; Chebon, Lorna J.; Cheruiyot, Jelagat; Akala, Hoseah M.; Kamau, Edwin] USAMRD K, Dept Emerging Infect Dis, Global Emerging Infect Surveillance & Response Sy, Kenya Med Res Inst KEMRI,Walter Reed Project, Kisumu, Kenya; [Chebon, Lorna J.] Jomo Kenyatta Univ Agr & Technol, Coll Hlth Sci, Inst Trop Med & Infect Dis, Nairobi, Kenya	Kenya Medical Research Institute; Jomo Kenyatta University of Agriculture & Technology	Kamau, E (corresponding author), USAMRD K, Dept Emerging Infect Dis, Global Emerging Infect Surveillance & Response Sy, Kenya Med Res Inst KEMRI,Walter Reed Project, Kisumu, Kenya.	edwin.kamau.mil@mail.mil		Olubayo, Luicer Anne Ingasia/0000-0002-7370-7272; Chebon, Lorna/0000-0001-7236-8750; Akala, Hoseah/0000-0001-8584-2706	Global Emerging Infections Surveillance and Response System (GEIS) Program	Global Emerging Infections Surveillance and Response System (GEIS) Program	The study was funded by the Global Emerging Infections Surveillance and Response System (GEIS) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akala HM, 2014, J MULTIDISCIP HEALTH, V7, P515, DOI 10.2147/JMDH.S67252; Akala HM, 2011, AM J TROP MED HYG, V85, P34, DOI 10.4269/ajtmh.2011.10-0674; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Babiker HA, 1997, AM J TROP MED HYG, V56, P141, DOI 10.4269/ajtmh.1997.56.141; Babiker HA, 1998, AM J TROP MED HYG, V59, P582, DOI 10.4269/ajtmh.1998.59.582; Bacon DJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-120; Basco LK., 2007, FIELD APPL IN VITRO; Co EMA, 2009, ANTIMICROB AGENTS CH, V53, P2557, DOI 10.1128/AAC.01370-08; Eyase FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064299; Farnert A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-241; Felger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045542; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaur D, 2003, INFECT IMMUN, V71, P6742, DOI 10.1128/IAI.71.12.6742-6746.2003; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Ofosu-Okyere A, 2001, PARASITOLOGY, V123, P113, DOI 10.1017/S0031182001008162; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Smith T, 1999, T ROY SOC TROP MED H, V93, pS35, DOI 10.1016/S0035-9203(99)90325-5; Trager W, 1997, INT J PARASITOL, V27, P989, DOI 10.1016/S0020-7519(97)00080-5; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tyner SD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-198; van Schalkwyk DA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-320; WHO, 2020, REP ANT DRUG EFF RES; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4	30	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0143565	10.1371/journal.pone.0143565	http://dx.doi.org/10.1371/journal.pone.0143565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751382	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100007
J	Zhou, CM; Jiang, WL; Yuan, L; Lu, W; He, JG; Zhao, Q; Xu, BA				Zhou, Changming; Jiang, Weili; Yuan, Li; Lu, Wei; He, Jinge; Zhao, Qi; Xu, Biao			Access to Bacteriologic-Based Diagnosis in Smear Positive Retreatment Tuberculosis Patients in Rural China: A Cross-Sectional Study in Three Geographic Varied Provinces	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT; HEALTH SYSTEM; TB DIAGNOSIS; PROGRAM; EPIDEMIOLOGY; TRANSMISSION; MANAGEMENT; MIGRANTS; BARRIERS	Objective To determine factors influencing the utilization and accessibility to bacteriologic-based tuberculosis (TB) diagnosis among sputum smear positive (SS+) retreatment TB patients, and to develop strategies for improving the case detection rate of MDR-TB in rural China. Study Design and Setting A cross-sectional study of SS+ TB retreatment patients was conducted in eight counties from three provinces with different implementation period and strategy of MDR-TB program in China. Demographic and socioeconomic parameters were collected by self-reporting questionnaires. Sputum samples were collected and cultured by the laboratory of county-designated TB clinics and delivered to prefectural Centers for Disease Prevention and Control (CDC) labs for DST with 4 first-line anti-TB drugs. Results Among the 196 SS+ retreatment patients, 61.22% received culture tests during current treatment. Patients from more developed regions (OR = 24.0 and 3.6, 95% CI: 8.6-67.3 and 1.1-11.6), with better socio-economic status (OR = 3. 8, 95% CI: 1.3-10.7), who had multiple previous anti-TB treatments (OR = 5.0, 95% CI: 1.6-15.9), and who failed in the most recent anti-TB treatment (OR = 2.6, 95% CI: 1.0-6.4) were more likely to receive culture tests. The percentage of isolates resistant to any of first-line anti-TB drugs and MDR-TB were 50.0% (95% CI: 39.8%-60.2%) and 30.4%(95% CI: 21.0%-39.8%) respectively. Conclusions Retreatment SS+ TB patients, high risk MDR-TB population, had poor utilization of access to bacteriologic-based TB diagnosis, which is far from optimal. The next step of anti-TB strategy should be focused on how to make bacteriological-based diagnosis cheaper, safer and more maneuverable, and how to assure the DST-guided treatment for these high-risk TB patients.	[Zhou, Changming; Jiang, Weili; Yuan, Li; Zhao, Qi; Xu, Biao] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Zhou, Changming; Jiang, Weili; Yuan, Li; Zhao, Qi; Xu, Biao] Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China; [Lu, Wei] Jiangsu Prov Ctr Dis Control, Nanjing, Jiangsu, Peoples R China; [He, Jinge] Sichuan Prov Ctr Dis Control, Chengdu, Peoples R China; [Zhao, Qi; Xu, Biao] Karolinska Inst, Ctr Global Hlth, Stockholm, Sweden	Fudan University; Karolinska Institutet	Zhao, Q (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	zhaoqi@shmu.edu.cn			Western Pacific TB Operational Research [WP-11-STB-006210]; Key Discipline Development of Public Health of Shanghai [12GWZX0101]; National Nature Science Foundation of China [81202256]; VR-NSFC Joint Program of the National Science Foundation of China [81361138019]	Western Pacific TB Operational Research; Key Discipline Development of Public Health of Shanghai; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); VR-NSFC Joint Program of the National Science Foundation of China	This study was supported by Western Pacific TB Operational Research (Grant No. WP-11-STB-006210), the Key Discipline Development of Public Health of Shanghai (Grant No. 12GWZX0101), National Nature Science Foundation of China (Grand No. 81202256) and the VR-NSFC Joint Program of the National Science Foundation of China (Grant No. 81361138019).	CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Comber AJ, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-44; Gler MT, 2012, INT J TUBERC LUNG D, V16, P955, DOI 10.5588/ijtld.11.0502; Gunther G, 2014, CLIN MED, V14, P279, DOI 10.7861/clinmedicine.14-3-279; He GX, 2011, CLIN INFECT DIS, V52, pE153, DOI 10.1093/cid/cir075; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Li RZ, 2015, LANCET GLOB HEALTH, V3, pE217, DOI 10.1016/S2214-109X(15)70021-5; Li WB, 2015, FACTORS ASSOCIATED W, P14; Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018; Lin S, 2008, MODERN PREVENTIVE ME, V35, P1456; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; MacPherson DW, 2006, PUBLIC HEALTH, V120, P712, DOI 10.1016/j.puhe.2006.05.002; Marks SM, 2014, EMERG INFECT DIS, V20, P812, DOI 10.3201/eid2005.131037; Mehra M, 2013, INT J TUBERC LUNG D, V17, P1186, DOI 10.5588/ijtld.12.0959; Naidoo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103328; Oren E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-227; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Schaaf HS, 2009, CLIN CHEST MED, V30, P667, DOI 10.1016/j.ccm.2009.08.019; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; Tang SL, 2005, HEALTH POLICY, V72, P93, DOI 10.1016/j.healthpol.2004.06.009; Wang L, 2014, TUBERCULOSIS PREVALE, P2057; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Wang X, 2008, J CHINESE ANTITUBERC, V30, P159; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2014, GLOB TUB REP 2014; WHO, 2011, WHO GLOBAL TUBERCULO; Xie HB, 2011, CHINESE J ANTITUBERC, V33, P12; Xu B, 2006, HEALTH POLICY PLANN, V21, P365, DOI 10.1093/heapol/czl019; Xu B, 2005, INT J TUBERC LUNG D, V9, P784; Yao H, 2008, EVALUATING EFFECTS P, P1166; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370; Zhao QH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057333, 10.1371/journal.pone.0061140]; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	34	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146340	10.1371/journal.pone.0146340	http://dx.doi.org/10.1371/journal.pone.0146340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751583	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100064
J	Huang, B; Ren, XL; Wu, L; Zhu, LX; Xu, B; Li, YF; Ai, JH; Jin, L				Huang, Bo; Ren, Xinling; Wu, Li; Zhu, Lixia; Xu, Bei; Li, Yufeng; Ai, Jihui; Jin, Lei			Elevated Progesterone Levels on the Day of Oocyte Maturation May Affect Top Quality Embryo IVF Cycles	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; LIVE BIRTH-RATES; DEVELOPMENTAL COMPETENCE; PREGNANCY RATES; OVARIAN STIMULATION; BLASTOCYST TRANSFER; RISE; METAANALYSIS; WOMEN	In contrast to the impact of elevated progesterone on endometrial receptivity, the data on whether increased progesterone levels affects the quality of embryos is still limited. This study retrospectively enrolled 4,236 fresh in vitro fertilization (IVF) cycles and sought to determine whether increased progesterone is associated with adverse outcomes with regard to top quality embryos (TQE). The results showed that the TQE rate significantly correlated with progesterone levels on the day of human chorionic gonadotropin (hCG) trigger (P = 0.009). Multivariate linear regression analysis of factors related to the TQE rate, in conventional IVF cycles, showed that the TQE rate was negatively associated with progesterone concentration on the day of hCG (OR was -1.658, 95% CI: -2.806 to -0.510, P = 0.005). When the serum progesterone level was within the interval 2.0-2.5 ng/ml, the TQE rate was significantly lower (P < 0.05) than when the progesterone level was < 1.0 ng/ml; similar results were obtained for serum progesterone levels >2.5 ng/ml. Then, we choose a progesterone level at 1.5ng/ml, 2.0 ng/ml and 2.5 ng/ml as cut-off points to verify this result. We found that the TQE rate was significantly different (P < 0.05) between serum progesterone levels <2.0 ng/ml and >2.0 ng/ml. In conclusion, the results of this study clearly demonstrated a negative effect of elevated progesterone levels on the day of hCG trigger, on TQE rate, regardless of the basal FSH, the total gonadotropin, the age of the woman, or the time of ovarian stimulation. These data demonstrate that elevated progesterone levels (>2.0 ng/ml) before oocyte maturation were consistently detrimental to the oocyte.	[Huang, Bo; Ren, Xinling; Wu, Li; Zhu, Lixia; Xu, Bei; Li, Yufeng; Ai, Jihui; Jin, Lei] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Reprod Med Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Jin, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Reprod Med Ctr, Wuhan 430074, Peoples R China.	jinleirepro@yahoo.com	吴, 黎/GRX-6898-2022	Li, Yufeng/0000-0003-3906-8144	Young Teachers Foundation of Huazhong University of Science and Technology [2014QN096]	Young Teachers Foundation of Huazhong University of Science and Technology	This work was supported by the Young Teachers Foundation of Huazhong University of Science and Technology (grant no. 2014QN096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azemi M, 2012, REPROD BIOMED ONLINE, V24, P381, DOI 10.1016/j.rbmo.2012.01.010; Andersen AN, 2006, HUM REPROD, V21, P3217, DOI 10.1093/humrep/del284; Andersen CY, 2011, REPROD BIOMED ONLINE, V23, P187, DOI 10.1016/j.rbmo.2011.04.003; Bosch E, 2010, HUM REPROD, V25, P2092, DOI 10.1093/humrep/deq125; De Neubourg D, 2004, HUM REPROD, V19, P1476, DOI 10.1093/humrep/deh283; Dominko T, 1997, THERIOGENOLOGY, V47, P1041, DOI 10.1016/S0093-691X(97)00061-7; EDELSTEIN MC, 1990, FERTIL STERIL, V54, P853; Fair T, 2012, REPROD DOMEST ANIM, V47, P142, DOI 10.1111/j.1439-0531.2012.02068.x; Griesinger G, 2013, FERTIL STERIL, V100, P1622, DOI 10.1016/j.fertnstert.2013.08.045; Hill MJ, 2015, FERTIL STERIL, V103, P1477, DOI 10.1016/j.fertnstert.2015.02.038; HOFMANN GE, 1993, FERTIL STERIL, V60, P675; Huang B, 2015, FERTIL STERIL, V103, P1432, DOI 10.1016/j.fertnstert.2015.02.026; Huang B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-13; Kilicdag EB, 2010, ARCH GYNECOL OBSTET, V281, P747, DOI 10.1007/s00404-009-1248-0; Kolibianakis EM, 2012, CURR PHARM BIOTECHNO, V13, P464; Labarta E, 2011, OBSTET GYNECOL SURV, V66, P763, DOI 10.1097/OGX.0b013e3182402567; Lahoud R, 2012, ARCH GYNECOL OBSTET, V285, P535, DOI 10.1007/s00404-011-2045-0; Lee FK, 2009, FERTIL STERIL, V92, P1284, DOI 10.1016/j.fertnstert.2008.08.024; Liu L, 2013, EUR J OBSTET GYN R B, V171, P78, DOI 10.1016/j.ejogrb.2013.08.025; O'Shea LC, 2012, SYST BIOL REPROD MED, V58, P88, DOI 10.3109/19396368.2012.656217; Ochsenkun R, 2012, FERTIL STERIL, V98, P347, DOI 10.1016/j.fertnstert.2012.04.041; Papanikolaou EG, 2005, HUM REPROD, V20, P3198, DOI 10.1093/humrep/dei217; Papanikolaou EG, 2009, FERTIL STERIL, V91, P949, DOI 10.1016/j.fertnstert.2006.12.064; Saleh HA, 2009, J ASSIST REPROD GEN, V26, P239, DOI 10.1007/s10815-009-9309-7; SILVERBERG KM, 1994, FERTIL STERIL, V61, P508; Urrego R, 2015, THERIOGENOLOGY, V83, P1179, DOI 10.1016/j.theriogenology.2014.12.024; Veleva Z, 2012, HUMAN REPROD, V27; Venetis CA, 2007, HUM REPROD UPDATE, V13, P343, DOI 10.1093/humupd/dmm007	28	86	90	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145895	10.1371/journal.pone.0145895	http://dx.doi.org/10.1371/journal.pone.0145895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745711	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600020
J	Otsuka, S; Tsuzaki, M; Sonoda, J; Tanaka, S; Furukawa, S				Otsuka, Sho; Tsuzaki, Minoru; Sonoda, Junko; Tanaka, Satomi; Furukawa, Shigeto			A Role of Medial Olivocochlear Reflex as a Protection Mechanism from Noise-Induced Hearing Loss Revealed in Short-Practicing Violinists	PLOS ONE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; SYMPHONY-ORCHESTRA MUSICIANS; ACOUSTIC TRAUMA; SOUND EXPOSURE; GUINEA-PIG; PLASTICITY; HUMANS; SYSTEM; SUSCEPTIBILITY; EFFERENTS	Previous studies have indicated that extended exposure to a high level of sound might increase the risk of hearing loss among professional symphony orchestra musicians. One of the major problems associated with musicians' hearing loss is difficulty in estimating its risk simply on the basis of the physical amount of exposure, i.e. the exposure level and duration. The aim of this study was to examine whether the measurement of the medial olivocochlear reflex (MOCR), which is assumed to protect the cochlear from acoustic damage, could enable us to assess the risk of hearing loss among musicians. To test this, we compared the MOCR strength and the hearing deterioration caused by one-hour instrument practice. The participants in the study were music university students who are majoring in the violin, whose left ear is exposed to intense violin sounds (broadband sounds containing a significant number of high-frequency components) during their regular instrument practice. Audiogram and click-evoked otoacoustic emissions (CEOAEs) were measured before and after a one-hour violin practice. There was a larger exposure to the left ear than to the right ear, and we observed a left-ear specific temporary threshold shift (TTS) after the violin practice. Left-ear CEOAEs decreased proportionally to the TTS. The exposure level, however, could not entirely explain the inter-individual variation in the TTS and the decrease in CEOAE. On the other hand, the MOCR strength could predict the size of the TTS and CEOAE decrease. Our findings imply that, among other factors, the MOCR is a promising measure for assessing the risk of hearing loss among musicians.	[Otsuka, Sho; Furukawa, Shigeto] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa 2430198, Japan; [Tsuzaki, Minoru; Sonoda, Junko; Tanaka, Satomi] Kyoto City Univ Arts, Nishikyo Ku, Kyoto 6101197, Japan	Nippon Telegraph & Telephone Corporation	Otsuka, S (corresponding author), NTT Corp, NTT Commun Sci Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	otsuka.s@lab.ntt.co.jp		Furukawa, Shigeto/0000-0002-5833-7891	NTT Corporation;  [24243070]	NTT Corporation; 	Authors M.T., S.T. and J.S. were supported by Grant-in-Aid for Scientific Research (A) Grant No. 24243070 (https://www.jsps.go.jp/j-grantsinaid/index.html). NTT Corporation provided support in the form of salaries and research materials for S.F. and S.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; BERLIN CI, 1995, HEARING RES, V87, P96, DOI 10.1016/0378-5955(95)00082-F; Brashears Shanda M, 2003, J Am Acad Audiol, V14, P314; Brown MC, 1998, J NEUROPHYSIOL, V79, P3088, DOI 10.1152/jn.1998.79.6.3088; CODY AR, 1983, HEARING RES, V9, P55, DOI 10.1016/0378-5955(83)90134-X; COLLET L, 1990, HEARING RES, V43, P251, DOI 10.1016/0378-5955(90)90232-E; COLLET L, 1991, ACTA OTO-LARYNGOL, V111, P231, DOI 10.3109/00016489109137380; de Boer J, 2008, J NEUROSCI, V28, P4929, DOI 10.1523/JNEUROSCI.0902-08.2008; Emmerich E, 2008, EUR ARCH OTO-RHINO-L, V265, P753, DOI 10.1007/s00405-007-0538-z; Engdahl B, 1996, HEARING RES, V93, P72, DOI 10.1016/0378-5955(95)00197-2; Francis NA, 2010, HEARING RES, V267, P36, DOI 10.1016/j.heares.2010.04.009; Fuente A., 2015, FRONT SYST NEUROSCI, P9; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Hannah K, 2014, NOISE HEALTH, V16, P108, DOI 10.4103/1463-1741.132094; HENDERSON D, 1993, EAR HEARING, V14, P152, DOI 10.1097/00003446-199306000-00002; Illing RB, 2000, MICROSC RES TECHNIQ, V51, P364, DOI 10.1002/1097-0029(20001115)51:4<364::AID-JEMT6>3.0.CO;2-E; Jansen EJM, 2009, INT ARCH OCC ENV HEA, V82, P153, DOI 10.1007/s00420-008-0317-1; Kahari KR, 2001, SCAND AUDIOL, V30, P141, DOI 10.1080/010503901316914511; Kahari KR, 2001, SCAND AUDIOL, V30, P13, DOI 10.1080/010503901750069536; Kujawa SG, 1997, J NEUROPHYSIOL, V78, P3095, DOI 10.1152/jn.1997.78.6.3095; Kujawa SG, 1999, J NEUROPHYSIOL, V82, P863, DOI 10.1152/jn.1999.82.2.863; Liberman MC, 1996, J ACOUST SOC AM, V99, P3572, DOI 10.1121/1.414956; Lindgren F, 1981, ACTA OTO-LARYNGOL, V91, P1; Maison SF, 2000, J NEUROSCI, V20, P4701, DOI 10.1523/JNEUROSCI.20-12-04701.2000; Marshall L, 2009, J ACOUST SOC AM, V125, P995, DOI 10.1121/1.3050304; Muller J, 2010, J ACOUST SOC AM, V128, P1853, DOI 10.1121/1.3479535; Muller J, 2008, HEARING RES, V246, P9, DOI 10.1016/j.heares.2008.09.005; O'Brien I, 2008, J ACOUST SOC AM, V124, P926, DOI 10.1121/1.2940589; Obeling L., 1999, NOISE HEALTH, V1, P43; OSTRI B, 1989, SCAND AUDIOL, V18, P243, DOI 10.3109/01050398909042202; Perrot X, 1999, NEUROSCI LETT, V262, P167, DOI 10.1016/S0304-3940(99)00044-0; Perrot X, 2014, HEARING RES, V308, P27, DOI 10.1016/j.heares.2013.08.010; RAJAN R, 1988, BRAIN RES, V459, P241, DOI 10.1016/0006-8993(88)90640-3; Rajan R, 2000, J NEUROSCI, V20, P6684, DOI 10.1523/JNEUROSCI.20-17-06684.2000; ROYSTER JD, 1991, J ACOUST SOC AM, V89, P2793, DOI 10.1121/1.400719; SALVI RJ, 1990, HEARING RES, V50, P245, DOI 10.1016/0378-5955(90)90049-U; Schmidt JH, 2014, EAR HEARING, V35, P448, DOI 10.1097/AUD.0000000000000029; Schmidt JH, 2011, ANN OCCUP HYG, V55, P893, DOI 10.1093/annhyg/mer055; Smith DW, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00012; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Toppila E, 2011, NOISE HEALTH, V13, P45, DOI 10.4103/1463-1741.74001; Veuillet E, 2001, ACTA OTO-LARYNGOL, V121, P278; Wagner W, 2005, LARYNGOSCOPE, V115, P2021, DOI 10.1097/01.MLG.0000181463.16591.A7; Ward W D, 1965, J Occup Med, V7, P595, DOI 10.1097/00043764-196512000-00001; WILLOTT JF, 1982, SCIENCE, V216, P1331, DOI 10.1126/science.7079767; Wolpert S, 2014, AUDIOL NEURO-OTOL, V19, P31, DOI 10.1159/000354913	46	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146751	10.1371/journal.pone.0146751	http://dx.doi.org/10.1371/journal.pone.0146751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745634	gold, Green Submitted, Green Published			2022-12-27	WOS:000367815600079
J	Yu, YF; Qin, GY; Cnattingius, S; Gissler, M; Olsen, J; Zhao, NQ; Li, J				Yu, Yongfu; Qin, Guoyou; Cnattingius, Sven; Gissler, Mika; Olsen, Jorn; Zhao, Naiqing; Li, Jiong			Mortality in Children Aged 0-9 Years: A Nationwide Cohort Study from Three Nordic Countries	PLOS ONE			English	Article							HIGH-INCOME COUNTRIES; BACTERIAL-MENINGITIS; ADOLESCENT MORTALITY; SEX-DIFFERENCES; PRETERM BIRTH; YOUNG-PEOPLE; CHILDHOOD; TRENDS; EPIDEMIOLOGY; PATTERNS	Background Mortality in children under five years has been widely studied, whereas mortality at 5-9 years has received little attention. Using unique data from national registers in three Nordic countries, we aimed to characterize mortality directionality in children aged 0 to 9 years. Methods and Findings The cohort study included all children born in Denmark from 1973 to 2008 (n = 2,433,758), Sweden from 1973 to 2006 (n = 3,400,212), and a random sample of 89.3% of children born in Finland from 1987 to 2007 (n = 1,272,083). Children were followed from 0 to 9 years, and cumulative mortality and mortality rates were compared by age, gender, cause of death, and calendar periods. Among the 7,105,962 children, there were 48,299 deaths during study period. From 1981-1985 to 2001-2005, all-cause mortality rates were reduced by between 34% and 62% at different ages. Overall mortality rate ratio between boys and girls decreased from 1.25 to 1.21 with the most prominent reduction in children aged 5-9 years (from 1.59 to 1.19). Neoplasms, diseases of the nervous system and transport accidents were the most frequent cause of death after the first year of life. These three leading causes of death declined by 42% (from 6.2 to 3.6 per 100,000 person years), 43% (from 3.7 to 2.1) and 62% (from 3.9 to 1.5) in boys, and 25% (from 4.1 to 3.1 per 100000 person years), 42% (from 3.4 to 1.9) and 63% (from 3.0 to 1.1) in girls, respectively. Mortality from neoplasms was the highest in each age except infants when comparing cause-specific mortality, and half of deaths from diseases of the nervous system occurred in infancy. Mortality rate due to transport accidents increased with age and was highest in boys aged 5-9 years. Conclusions Mortality rate in children aged 0-9 years has been decreasing with diminished difference between genders over the past decades. Our results suggest the importance of further research on mortality by causes of neoplasms, and causes of transport accidents-especially in children aged 5-9 years.	[Yu, Yongfu] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Qin, Guoyou; Zhao, Naiqing] Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai 200433, Peoples R China; [Cnattingius, Sven] Karolinska Inst, Karolinska Univ Hosp, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Gissler, Mika] THL Natl Inst Hlth & Welf, Dept Informat, Helsinki, Finland; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Olsen, Jorn; Li, Jiong] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	Aarhus University; Fudan University; Karolinska Institutet; Karolinska University Hospital; Finland National Institute for Health & Welfare; University of California System; University of California Los Angeles; Aarhus University	Yu, YF (corresponding author), Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark.	yoyu@ph.au.dk	li, jiong/L-6534-2014; Yu, Yongfu/W-7557-2019; Yu, Yongfu/GLR-9881-2022	li, jiong/0000-0002-1716-8067; Yu, Yongfu/0000-0003-4208-9480; Gissler, Mika/0000-0001-8254-7525; li, jiong/0000-0003-1125-026X	European Commission's Seventh Framework Programme/European Research Council [ERC-2010-StG-260242-PROGEURO]; Danish Medical Research Council [09-072986]; Swedish Council for Working Life and Social Research [20100092]; Nordic Cancer Union [2013-78760]	European Commission's Seventh Framework Programme/European Research Council; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Nordic Cancer Union	This study was supported by a grant from the European Commission's Seventh Framework Programme/European Research Council (ERC-2010-StG-260242-PROGEURO to JL) http://ec.europa.eu/research/fp7/index_en.cfm. Data recruitment was supported by grants from the Danish Medical Research Council (project no. 09-072986 to JL) http://ufm.dk/site/english/councils-commissionscommittees/scientific-research-councils/the-danishmedical-research-council, the Swedish Council for Working Life and Social Research (Grant no. 20100092 to SC) http://www.forte.se/en/, the Nordic Cancer Union (2013-78760 to JL) http://www.ncu.nu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, CANC FACTS FIG 2014; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; DaCoTA, 2012, CHILDR ROAD TRAFF DE; Davies SM, 2007, PEDIATR BLOOD CANCER, V48, P727, DOI 10.1002/pbc.21113; Davis FG, 1998, J NEUROSURG, V88, P1, DOI 10.3171/jns.1998.88.1.0001; Garpenholt O, 1996, SCAND J INFECT DIS, V28, P165, DOI 10.3109/00365549609049069; Gissler M, 1999, ACTA PAEDIATR, V88, P310, DOI 10.1080/08035259950170088; Gissler M, 2012, J EPIDEMIOL COMMUN H, V66, P57, DOI 10.1136/jech.2009.093153; Gissler M, 2009, SCAND J PUBLIC HEALT, V37, P340, DOI 10.1177/1403494809103905; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gustafsson G, 2000, LEUKEMIA, V14, P2267, DOI 10.1038/sj.leu.2401961; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Hjalgrim LL, 2003, J NATL CANCER I, V95, P1539, DOI 10.1093/jnci/djg064; Holt DE, 2001, ARCH DIS CHILD-FETAL, V84, pF85, DOI 10.1136/fn.84.2.F85; Howitz M, 2008, SCAND J INFECT DIS, V40, P881, DOI 10.1080/00365540802325914; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Janssen F, 2004, B WORLD HEALTH ORGAN, V82, P904; Kalben BB, 2000, N AM ACTUAR J, V4, P83; Lantto M, 2008, ACTA PAEDIATR, V97, P1024, DOI 10.1111/j.1651-2227.2008.00856.x; Lantto M, 2015, ACTA PAEDIATR, V104, P466, DOI 10.1111/apa.12853; Li J, 2011, INT J EPIDEMIOL, V40, P1161, DOI 10.1093/ije/dyq127; Lie SO, 2005, LEUKEMIA, V19, P2090, DOI 10.1038/sj.leu.2403962; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mage DT, 2006, J WOMENS HEALTH, V15, P786, DOI 10.1089/jwh.2006.15.786; O'Shea TM, 1998, PEDIATRICS, V101, P642, DOI 10.1542/peds.101.4.642; Parkkari J, 2000, INT J EPIDEMIOL, V29, P516, DOI 10.1093/ije/29.3.516; Pearson J, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-26; PELTOLA H, 1992, LANCET, V340, P592, DOI 10.1016/0140-6736(92)92117-X; Rautava L, 2007, PEDIATRICS, V119, pE257, DOI 10.1542/peds.2006-1964; Richardson DK, 1998, PEDIATRICS, V102, P893, DOI 10.1542/peds.102.4.893; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Sidebotham P, 2014, LANCET, V384, P904, DOI 10.1016/S0140-6736(13)61090-9; Sidebotham P, 2014, LANCET, V384, P915, DOI 10.1016/S0140-6736(14)60581-X; Silfverdal SA, 2009, VACCINE, V27, P1601, DOI 10.1016/j.vaccine.2008.12.033; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Tsai CJ, 2008, CLIN INFECT DIS, V46, P1664, DOI 10.1086/587897; UNICEF, 2017, LEVELS TRENDS CHILD; UNICEF, 2011, STAT WORLDS CHILDR 2; UNICEF, 2015, COMMITTING CHILD SUR; Viner RM, 2014, LANCET, V384, P880, DOI 10.1016/S0140-6736(14)60485-2; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Wen SW, 2000, TERATOLOGY, V61, P342, DOI 10.1002/(SICI)1096-9926(200005)61:5<342::AID-TERA5>3.0.CO;2-7	45	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146669	10.1371/journal.pone.0146669	http://dx.doi.org/10.1371/journal.pone.0146669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26744840	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600074
J	Zhou, W; Koptyug, N; Ye, ST; Jia, YF; Lu, XL				Zhou, Wen; Koptyug, Nikita; Ye, Shutao; Jia, Yifan; Lu, Xiaolong			An Extended N-Player Network Game and Simulation of Four Investment Strategies on a Complex Innovation Network	PLOS ONE			English	Article							COLLABORATION NETWORKS; COOPERATION; EVOLUTION	As computer science and complex network theory develop, non-cooperative games and their formation and application on complex networks have been important research topics. In the inter-firm innovation network, it is a typical game behavior for firms to invest in their alliance partners. Accounting for the possibility that firms can be resource constrained, this paper analyzes a coordination game using the Nash bargaining solution as allocation rules between firms in an inter-firm innovation network. We build an extended inter-firm n-player game based on nonidealized conditions, describe four investment strategies and simulate the strategies on an inter-firm innovation network in order to compare their performance. By analyzing the results of our experiments, we find that our proposed greedy strategy is the best-performing in most situations. We hope this study provides a theoretical insight into how firms make investment decisions.	[Zhou, Wen; Ye, Shutao; Jia, Yifan; Lu, Xiaolong] Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China; [Zhou, Wen] Northwestern Univ, Kellogg Sch Management, Northwestern Inst Complex Syst NICO, Evanston, IL USA; [Koptyug, Nikita] Res Inst Ind Econ IFN, Stockholm, Sweden	Shanghai University; Northwestern University; Research Institute of Industrial Economics (IFN)	Zhou, W (corresponding author), Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China.	zhouwen@shu.edu.cn			National Natural Science Foundation of China [71203135]; Marianne and Marcus Wallenberg Foundation [2011.0023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Marianne and Marcus Wallenberg Foundation	This work was supported by: 1. National Natural Science Foundation of China, Grant No. 71203135, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list, WZ; 2. the Marianne and Marcus Wallenberg Foundation, grant number 2011.0023, https://www.wallenberg.com/mmw/en, NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by the National Science Foundation of China (Grant No. 71203135). Nikita Koptyug gratefully acknowledges financial support from the Marianne and Marcus Wallenberg Foundation. We would like to thank PJ Lamberson for helpful discussions.	AXELROD R, 1988, SCIENCE, V242, P1385, DOI 10.1126/science.242.4884.1385; Borgatti SP, 2011, ORGAN SCI, V22, P1168, DOI 10.1287/orsc.1100.0641; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Carayol N., 2005, European Journal of Economic and Social Systems, V18, P307; Chatterjee B., 2009, P IEEE INT C METH MO, P1, DOI DOI 10.1109/ICM2CS.2009.5397970; Chen ZQ, 2015, ENTROPY-SWITZ, V17, P3710, DOI 10.3390/e17063710; Contreras J, 2004, IEEE T POWER SYST, V19, P195, DOI 10.1109/TPWRS.2003.820692; Dehmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094985; Ehrenmann A., 2004, EQUILIBRIUM PROBLEMS; FREEMAN C, 1991, RES POLICY, V20, P499, DOI 10.1016/0048-7333(91)90072-X; Galeotti A, 2011, INT J ECON THEORY, V7, P77, DOI 10.1111/j.1742-7363.2010.00149.x; Galeotti A, 2010, REV ECON STUD, V77, P218, DOI 10.1111/j.1467-937X.2009.00570.x; Jackson MO, 1996, J ECON THEORY, V71, P44, DOI 10.1006/jeth.1996.0108; Jackson MO, 2002, GAME ECON BEHAV, V41, P265, DOI 10.1016/S0899-8256(02)00504-3; Lovejoy WS, 2010, MANAGE SCI, V56, P1127, DOI 10.1287/mnsc.1100.1168; McKelvey R.D., 1996, HDB COMPUTATIONAL EC, V1, P87, DOI DOI 10.1016/S1574-0021(96)01004-0; Nabetani K, 2011, COMPUT OPTIM APPL, V48, P423, DOI 10.1007/s10589-009-9256-3; Nakai Y, 2008, JASSS-J ARTIF SOC S, V11; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Oxley J, 2009, MANAGE SCI, V55, P635, DOI 10.1287/mnsc.1080.0968; Phelps CC, 2010, ACAD MANAGE J, V53, P890, DOI 10.5465/AMJ.2010.52814627; Roberts G, 1998, NATURE, V394, P175, DOI 10.1038/28160; Rolon M, 2012, COMPUT IND ENG, V63, P901, DOI 10.1016/j.cie.2012.06.004; Schilling MA, 2007, MANAGE SCI, V53, P1113, DOI 10.1287/mnsc.1060.0624; Schilling MA, 2009, STRATEGIC MANAGE J, V30, P233, DOI 10.1002/smj.731; Schnettler S, 2009, SOC NETWORKS, V31, P179, DOI 10.1016/j.socnet.2008.12.005; Stengel B. V., 2002, HDB GAME THEORY, V3, P1723, DOI DOI 10.1016/S1574-0005(02)03008-4; Tirole J, 2010, THEORY CORPORATE FIN; Van Zandt T, 2012, FIRMS PRICES MARKETS; Verspagen B, 2004, TECHNOVATION, V24, P563, DOI 10.1016/S0166-4972(02)00123-2; von Heusinger A, 2012, MATH PROGRAM, V132, P99, DOI 10.1007/s10107-010-0386-2; Wang CL, 2014, ACAD MANAGE J, V57, P484, DOI 10.5465/amj.2011.0917; Wen Z, 2010, INT CONF COMPUT AUTO, P442, DOI 10.1109/ICCAE.2010.5451635; Whittington KB, 2009, ADMIN SCI QUART, V54, P90, DOI 10.2189/asqu.2009.54.1.90; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; Zhou Wen, 2013, 2013 IEEE International Conference on Big Data, P48, DOI 10.1109/BigData.2013.6691687	39	3	3	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145407	10.1371/journal.pone.0145407	http://dx.doi.org/10.1371/journal.pone.0145407			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745375	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600007
J	Jalili, RB; Zhang, Y; Hosseini-Tabatabaei, A; Kilani, RT; Maharlooei, MK; Li, YY; Elizei, SS; Warnock, GL; Ghahary, A				Jalili, Reza B.; Zhang, Yun; Hosseini-Tabatabaei, Azadeh; Kilani, Ruhangiz T.; Maharlooei, Mohsen Khosravi; Li, Yunyuan; Elizei, Sanam Salimi; Warnock, Garth L.; Ghahary, Aziz			Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes	PLOS ONE			English	Article							INDOLEAMINE 2,3 DIOXYGENASE; ANTIGEN-PRESENTING CELLS; MESENCHYMAL STEM-CELLS; DENDRITIC CELLS; ALLOIMMUNE RESPONSES; LOCAL EXPRESSION; T-CELLS; REVERSAL; REGENERATION; PATHWAY	Type 1 diabetes (T1D) results from autoimmune destruction of insulin producing beta cells of the pancreatic islets. Curbing autoimmunity at the initiation of T1D can result in recovery of residual beta cells and consequently remission of diabetes. Here we report a cell-based therapy for autoimmune diabetes in non-obese diabetic (NOD) mice using dermal fibroblasts. This was achieved by a single injection of fibroblasts, expressing the immunoregulatory molecule indoleamine 2,3 dioxygenase (IDO), into peritoneal cavity of NOD mice shortly after the onset of overt hyperglycemia. Mice were then monitored for reversal of hyperglycemia and changes in inflammatory / regulatory T cell profiles. Blood glucose levels dropped into the normal range in 82% of NOD mice after receiving IDO-expressing fibroblasts while all control mice remained diabetic. We found significantly reduced islet inflammation, increased regulatory T cells, and decreased T helper 17 cells and beta cell specific autoreactive CD8+ T cells following IDO cell therapy. We further showed that some of intraperitoneal injected fibroblasts migrated to local lymph nodes and expressed co-inhibitory molecules. These findings suggest that IDO fibroblasts therapy can reinstate self-tolerance and alleviate beta cell autoreactivity in NOD mice, resulting in remission of autoimmune diabetes.	[Jalili, Reza B.; Zhang, Yun; Hosseini-Tabatabaei, Azadeh; Kilani, Ruhangiz T.; Maharlooei, Mohsen Khosravi; Li, Yunyuan; Elizei, Sanam Salimi; Warnock, Garth L.; Ghahary, Aziz] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia	Ghahary, A (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada.	aghahary@mail.ubc.ca	Maharlooei, Mohsen Khosravi/D-7464-2016; Maharlooei, Mohsen Khosravi/O-5588-2019	Maharlooei, Mohsen Khosravi/0000-0002-1394-9245; Maharlooei, Mohsen Khosravi/0000-0002-1394-9245	Canadian Institute of Health Research (CIHR); Juvenile Diabetes Research Foundation; Michael Smith Foundation for Health Research; International Collaboration On Repair Discoveries (ICORD)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); International Collaboration On Repair Discoveries (ICORD)	This project was funded by an operating grant received by AG from the Canadian Institute of Health Research (CIHR). RBJ received financial support from Juvenile Diabetes Research Foundation, Michael Smith Foundation for Health Research, and International Collaboration On Repair Discoveries (ICORD).	Ablamunits V, 2007, ANN NY ACAD SCI, V1103, P19, DOI 10.1196/annals.1394.006; Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; Tabarrozzi AEB, 2013, CLIN EXP IMMUNOL, V171, P135, DOI 10.1111/cei.12019; Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; BOOTS AMH, 1994, IMMUNOLOGY, V82, P268; Bouffi C, 2011, ANN RHEUM DIS, V70, P1671, DOI 10.1136/ard.2010.143297; Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Clemente-Casares X, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007773; Curran TA, 2014, IMMUNOBIOLOGY, V219, P17, DOI 10.1016/j.imbio.2013.06.008; Fallarino F, 2006, TRANSPL IMMUNOL, V17, P58, DOI 10.1016/j.trim.2006.09.017; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino F, 2009, J EXP MED, V206, P2511, DOI 10.1084/jem.20090134; Fife BT, 2011, ANN NY ACAD SCI, V1217, P45, DOI 10.1111/j.1749-6632.2010.05919.x; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forouzandeh F, 2010, WOUND REPAIR REGEN, V18, P614, DOI 10.1111/j.1524-475X.2010.00635.x; Godfrey KJ, 2012, DIABETIC MED, V29, P14, DOI 10.1111/j.1464-5491.2011.03433.x; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Haller MJ, 2011, DIABETES CARE, V34, P2567, DOI 10.2337/dc11-1406; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Herold KC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002981; Hosseini-Tabatabaei A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037747; Jalili RB, 2011, J CELL PHYSIOL, V226, P1813, DOI 10.1002/jcp.22515; Jalili RB, 2010, DIABETES, V59, P2219, DOI 10.2337/db09-1560; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; Lee CN, 2013, IMMUNOTHERAPY-UK, V5, P591, DOI [10.2217/IMT.13.48, 10.2217/imt.13.48]; Liew A, 2014, CURRENT DIABETES REP, V14, P1; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Marin-Gallen S, 2010, CLIN EXP IMMUNOL, V160, P207, DOI 10.1111/j.1365-2249.2009.04082.x; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Munn DH, 2004, TRENDS MOL MED, V10, P15, DOI 10.1016/j.molmed.2003.11.003; Orabona C, 2011, METHODS MOL BIOL, V677, P269, DOI 10.1007/978-1-60761-869-0_19; Pinchuk IV, 2011, GASTROENTEROLOGY, V140, P2019, DOI 10.1053/j.gastro.2011.02.059; Rezakhanlou AM, 2010, BIOL PROCED ONLINE, V12, P107, DOI 10.1007/s12575-010-9028-6; Saada JI, 2006, J IMMUNOL, V177, P5968, DOI 10.4049/jimmunol.177.9.5968; Sandner SE, 2005, J IMMUNOL, V174, P3408, DOI 10.4049/jimmunol.174.6.3408; Shimabukuro Y, 1996, J PERIODONTAL RES, V31, P217, DOI 10.1111/j.1600-0765.1996.tb00486.x; SPRENT J, 1995, CURR BIOL, V5, P1095, DOI 10.1016/S0960-9822(95)00219-3; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Veld PI, 2015, CURR OPIN ENDOCRINOL, V22, P86, DOI 10.1097/MED.0000000000000135; Wassenaar A, 1997, CLIN EXP IMMUNOL, V110, P277; Zhao Y, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-3	54	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146970	10.1371/journal.pone.0146970	http://dx.doi.org/10.1371/journal.pone.0146970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765526	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300055
J	Zell, P; Stinnesbeck, W				Zell, Patrick; Stinnesbeck, Wolfgang			Paleobiology of the Latest Tithonian (Late Jurassic) Ammonite Salinites grossicostatum Inferred from Internal and External Shell Parameters	PLOS ONE			English	Article							NORTHEASTERN MEXICO; SOUTHERN COAHUILA; LIFE; AMMONOIDS; PATTERNS; ONTOGENY	Based on material from the uppermost Tithonian La Caja Formation at Puerto Pinones, northeastern Mexico, the complete ontogenetic development (protoconch to adult) of the ammonite Salinites grossicostatum is outlined by a detailed morphometrical shell analysis. The embryonic stage, consisting of a small ellipsoid protoconch and ammonitella, ends at about 0.6 mm. Four major morphological changes are differentiated throughout ontogeny based on internal features such as reduced septal spacing and siphuncle position. Sexual dimorphism is reflected by shell size, siphuncular diameter, differences in the morphology of the apophysis, and by two distinct general trends in septal spacing. In addition, macroconchs are characterized by septal crowding at different stages, followed by the return to normal septum distances. Our analysis indicates a change in the mode of life after the neanic stage. A change in habitat preference is inferred for adult individuals. While microconchs persisted at Puerto Pinones, large mature macroconchs temporarily migrated to other areas, possibly for egg deposition. Salinites grossicostatum is endemic to the ancient Gulf of Mexico and is there restricted to outer continental shelf environments.	[Zell, Patrick; Stinnesbeck, Wolfgang] Heidelberg Univ, Inst Geowissensch, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Zell, P (corresponding author), Heidelberg Univ, Inst Geowissensch, Heidelberg, Germany.	Patrick.Zell@geow.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [DFG STI 128-17, STI 128-31]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research (including all scientific analyses) was funded by the Deutsche Forschungsgemeinschaft to WS (DFG STI 128-17 and STI 128-31). The DFG had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adatte T., 1994, GEOBIOS-LYON, V17, P37, DOI [10.1016/s0016-6995(94)80124-x, DOI 10.1016/S0016-6995(94)80124-X]; Arai K, 2012, J PALEONTOL, V86, P258, DOI 10.1666/11-068.1; Arkell W.J., 1957, TREATISE INVERTEBR L, P1; Bayer U., 1977, Neues Jb Geol Paleont Abh, V155, P162; Boletzky S. v., 1983, P31; Bucher H, 1996, AMMONOID PALEOBIOLOG, V13, P407, DOI [10.1007/978-1-4757-9153-2_12, DOI 10.1007/978-1-4757-9153-2_12]; Callomon J. H., 1963, Transactions of the Leicester Literary and Philosophical Society, V57, P21; Cantu-Chapa A, 2006, J PALEONTOL, V80, P294, DOI 10.1666/0022-3360(2006)080[0294:NUTJAF]2.0.CO;2; Cantu-Chapa A, 1976, SOC GEOL MEX BOL, V37, P60; Cantu-Chapa A., 1968, ASOCIACION PRONICERA, V2, P19; Crick R.E., 1978, U KANSAS PALEONTOLOG, V88, P1; Dauphin Y, 1978, SCI TERRE, V68, P1; Davis Richard Arnold, 1996, Topics in Geobiology, V13, P463; De Baets K, 2013, PALAEONTOGR ABT A, V299, P1; De Baets K, 2013, PALEOBIOLOGY, V39, P75, DOI 10.1666/0094-8373-39.1.75; DOGUZHAEVA L, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V195, P1; Drushchits V.V., 1970, PALEONTOL J+, V4, P26; Ebbighausen V, 2007, NEUES JAHRB GEOL P-A, V244, P9, DOI 10.1127/0077-7749/2007/0244-0009; HEWITT RA, 1988, LETHAIA, V21, P383, DOI 10.1111/j.1502-3931.1988.tb01767.x; Imlay R. W., 1939, Bulletin of the Geological Society of America, V50, P1; Imlay R. W., 1984, JURASSIC GULF RIM, P149; Imlay RW, 1942, BULL GEOL SOC AM, V53, P1417; Judoley C.M., 1968, PUBLICACION ESPECIAL, P1; Keupp H, 2000, AMMONITEN PALAOBIOLO; Keupp Helmut, 1995, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V16, P663; Klug C, 2007, PALAEONTOLOGY, V50, P1463, DOI 10.1111/j.1475-4983.2007.00722.x; Klug Christian, 2004, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V88, P63; Klug C, 2015, TOP GEOBIOL, V43, P253, DOI 10.1007/978-94-017-9630-9_7; Klug C, 2008, LETHAIA, V41, P477, DOI 10.1111/j.1502-3931.2008.00100.x; Korn Dieter, 2006, Fossil Record, V9, P198, DOI 10.1002/mmng.200600008; Korn D, 2010, FOSS REC, V13, P35, DOI 10.1002/mmng.200900010; Kraft S, 2008, NEUES JAHRB GEOL P-A, V250, P31, DOI 10.1127/0077-7749/2008/0250-0031; KULICKI C, 1974, Acta Palaeontologica Polonica, V19, P201; Kulicki C, 1996, AMMONOID PALEOBIOLOG, P65; Landman NH, 2012, GEOBIOS-LYON, V45, P87, DOI 10.1016/j.geobios.2011.11.006; LANDMAN NH, 1987, B AM MUS NAT HIST, V185, P117; LANDMAN NH, 1993, B AM MUS NAT HIST, P1; Lehmann U., 1975, Mitteilungen geol-palaont Inst Univ Hamburg, V44, P195; Lukeneder A, 2010, EARTH PLANET SC LETT, V296, P103, DOI 10.1016/j.epsl.2010.04.053; Makowski H., 1962, PALAEONTOLOGIA POLON, V12, P1; Mapes RH, 2009, LETHAIA, V42, P341, DOI 10.1111/j.1502-3931.2008.00141.x; Mignot Y., 1993, Documents des Laboratoires de Geologie Lyon, V124, P1; Miller AK, 1954, J PALEONTOL, V17, P1; Myczynski R., 1989, Annales Societatis Geologorum Poloniae, V59, P43; Myczynski R., 1990, FOSSILI EVOLUZIONE A, P405; Neige P, 1997, ECLOGAE GEOL HELV, V90, P605; Rouget I, 2001, PALAEONTOLOGY, V44, P53, DOI 10.1111/1475-4983.00169; Shimanskiy VN, 1948, MOSKOVSKOE GOSUDARST, V52, P78; Stridsberg S., 1985, Fossils and Strata, P1; Tajika A, 2015, PEERJ, V3, DOI 10.7717/peerj.1306; Tajika A, 2011, LETHAIA, V44, P287, DOI 10.1111/j.1502-3931.2010.00242.x; TANABE K, 1985, PALEOBIOLOGY, V11, P310, DOI 10.1017/S0094837300011611; TANABE K, 1979, Bulletin of the National Science Museum Series C (Geology and Paleontology), V5, P153; Teichert C, 1964, TREATISE INVERTEBR K, P12; Thompson SA, 2012, PROG OCEANOGR, V101, P106, DOI 10.1016/j.pocean.2012.02.001; USGS-The National Map Viewer, NAT MAP VIEW TOP MAP; VERMA H M, 1973, Bulletins of American Paleontology, V63, P107; Voorthuysen JH, 1940, BEITRAG KENNTNIS INN; Ward P. D., 1987, NATURAL HIST NAUTILU; WARD PD, 1985, PALEOBIOLOGY, V11, P438, DOI 10.1017/S0094837300011726; WARD PD, 1986, VELIGER, V28, P356; Westermann GEG, 1971, LIFE SCI CONTRIB R O, V78, P1, DOI [10.5962/bhl.title.52081, DOI 10.5962/BHL.TITLE.52081]; Wright C.W., 1996, TREATISE INVERTEBR L, P1; Zakharov YD, 1977, PALEONTOL J, V4, P445; Zell P, 2015, J S AM EARTH SCI, V60, P92, DOI 10.1016/j.jsames.2015.03.004; Zell P, 2015, REV MEX CIENC GEOL, V32, P11; Zell P, 2014, J S AM EARTH SCI, V56, P91, DOI 10.1016/j.jsames.2014.08.009; Zell P, 2013, NEUES JAHRB GEOL P-A, V270, P325, DOI 10.1127/0077-7749/2013/0374	68	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145865	10.1371/journal.pone.0145865	http://dx.doi.org/10.1371/journal.pone.0145865			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761441	Green Submitted, gold, Green Published			2022-12-27	WOS:000368033100020
J	Bracht, AJ; O'Hearn, ES; Fabian, AW; Barrette, RW; Sayed, A				Bracht, Alexa J.; O'Hearn, Emily S.; Fabian, Andrew W.; Barrette, Roger W.; Sayed, Abu			Real-Time Reverse Transcription PCR Assay for Detection of Senecavirus A in Swine Vesicular Diagnostic Specimens	PLOS ONE			English	Article							ONCOLYTIC PICORNAVIRUS; VALLEY-VIRUS; DISEASE; LESIONS; ASSOCIATION; PIGS	Senecavirus A (SV-A), formerly, Seneca Valley virus (SVV), has been detected in swine with vesicular lesions and is thought to be associated with swine idiopathic vesicular disease (SIVD), a vesicular disease syndrome that lacks a defined causative agent. The clinical presentation of SIVD resembles that of other more contagious and economically devastating vesicular diseases, such as foot-and-mouth disease (FMD), swine vesicular disease (SVD), and vesicular stomatitis (VS), that typically require immediate rule out diagnostics to lift restrictions on animal quarantine, movement, and trade. This study presents the development of a sensitive, SYBR Green RT-qPCR assay suitable for detection of SV-A in diagnostic swine specimens. After testing 50 pigs with clinical signs consistent with vesicular disease, 44 (88%) were found to be positive for SV-A by RT-qPCR as compared to none from a negative cohort of 35 animals without vesicular disease, indicating that the assay is able to successfully detect the virus in an endemic population. SV-A RNA was also detectable at a low level in sera from a subset of pigs that presented with (18%) or without (6%) vesicular signs. In 2015, there has been an increase in the occurrence of SV-A in the US, and over 200 specimens submitted to our laboratory for vesicular investigation have tested positive for the virus using this method. SV-A RNA was detectable in all common types of vesicular specimens including swabs and tissue from hoof lesions, oral and snout epithelium, oral swabs, scabs, and internal organ tissues such as liver and lymph node. Genome sequencing analysis from recent virus isolates was performed to confirm target amplicon specificity and was aligned to previous isolates.	[Bracht, Alexa J.; O'Hearn, Emily S.; Fabian, Andrew W.; Barrette, Roger W.] US Anim & Plant Hlth Inspect Serv, USDA, Foreign Anim Dis Diagnost Lab, Plum Isl Anim Dis Ctr, Orient, NY 11957 USA; [Sayed, Abu] US Anim & Plant Hlth Inspect Serv, USDA, Agr Select Agent Serv, Natl Import Export Serv, Riverdale, MD USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Bracht, AJ (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Foreign Anim Dis Diagnost Lab, Plum Isl Anim Dis Ctr, Orient, NY 11957 USA.	Alexa.J.Bracht@aphis.usda.gov						Adams MJ, 2015, ARCH VIROL, V160, P1837, DOI 10.1007/s00705-015-2425-z; Amass SF, 2004, J SWINE HEALTH PROD, V12, P192; Cameron R, 2006, DIS SKIN DIS SWINE; DE CASTRO M. P., 1964, ARQ INST BIOL [SAO PAULO], V31, P63; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Hales LM, 2008, J GEN VIROL, V89, P1265, DOI 10.1099/vir.0.83570-0; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harvey R B, 1990, J Vet Diagn Invest, V2, P227; KASZA L, 1972, RES VET SCI, V13, P46; KNOWLES NJ, 1988, VET REC, V122, P441, DOI 10.1136/vr.122.18.441; Knowles NJ, 2005, EUROPIC 2005 13 M EU; KRESSE JI, 1985, VET MICROBIOL, V10, P525, DOI 10.1016/0378-1135(85)90061-6; LAGER KM, 1994, J VET DIAGN INVEST, V6, P357, DOI 10.1177/104063879400600313; Li H., 2013, ARXIV 13033997; MONTGOMERY JF, 1987, NEW ZEAL VET J, V35, P21, DOI 10.1080/00480169.1987.35369; MUNDAY BL, 1982, AUST VET J, V59, P193, DOI 10.1111/j.1751-0813.1982.tb16008.x; Pasma T, 2008, CAN VET J, V49, P84; Reddy PS, 2007, J NATL CANCER I, V99, P1623, DOI 10.1093/jnci/djm198; Singh K., 2012, Journal of Veterinary Science and Technology, V3, P123; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Whitaker H K, 1990, J Vet Diagn Invest, V2, P244; Willcocks MM, 2011, J VIROL, V85, P4452, DOI 10.1128/JVI.01107-10; Yang M, 2012, J VET DIAGN INVEST, V24, P42, DOI 10.1177/1040638711426323	23	57	79	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146211	10.1371/journal.pone.0146211	http://dx.doi.org/10.1371/journal.pone.0146211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757142	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888800009
J	Chatterjee, A; Ghosh, A; Chakrabarti, BK				Chatterjee, Arnab; Ghosh, Asim; Chakrabarti, Bikas K.			Universality of Citation Distributions for Academic Institutions and Journals	PLOS ONE			English	Article							SCIENTIFIC IMPACT; BEHAVIOR; LAWS; STATISTICS; NETWORKS; SCIENCE; GROWTH	Citations measure the importance of a publication, and may serve as a proxy for its popularity and quality of its contents. Here we study the distributions of citations to publications from individual academic institutions for a single year. The average number of citations have large variations between different institutions across the world, but the probability distributions of citations for individual institutions can be rescaled to a common form by scaling the citations by the average number of citations for that institution. We find this feature seems to be universal for a broad selection of institutions irrespective of the average number of citations per article. A similar analysis for citations to publications in a particular journal in a single year reveals similar results. We find high absolute inequality for both these sets, Gini coefficients being around 0.66 and 0.58 for institutions and journals respectively. We also find that the top 25% of the articles hold about 75% of the total citations for institutions and the top 29% of the articles hold about 71% of the total citations for journals.	[Chatterjee, Arnab; Ghosh, Asim; Chakrabarti, Bikas K.] Saha Inst Nucl Phys, Condensed Matter Phys Div, Kolkata 700064, India; [Ghosh, Asim] Aalto Univ, Dept Comp Sci, Sch Sci, FI-00076 Aalto, Finland; [Chakrabarti, Bikas K.] Indian Stat Inst, Econ Res Unit, Kolkata 700108, India	Saha Institute of Nuclear Physics; Aalto University; Indian Statistical Institute; Indian Statistical Institute Kolkata	Chatterjee, A (corresponding author), Saha Inst Nucl Phys, Condensed Matter Phys Div, 1-AF Bidhannagar, Kolkata 700064, India.	arnabchat@gmail.com	Chatterjee, Arnab/C-1928-2009	Chatterjee, Arnab/0000-0001-8639-0115	BKC's J. C. Bose Fellowship Research Grant	BKC's J. C. Bose Fellowship Research Grant	AC and BKC acknowledge support from BKC's J. C. Bose Fellowship Research Grant.	Albarran P, 2015, J ASSOC INF SCI TECH, V66, P512, DOI 10.1002/asi.23219; Albarran P, 2011, SCIENTOMETRICS, V88, P385, DOI 10.1007/s11192-011-0407-9; Albarran P, 2011, J AM SOC INF SCI TEC, V62, P40, DOI 10.1002/asi.21448; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Burrell QL, 2002, SCIENTOMETRICS, V53, P309, DOI 10.1023/A:1014816911511; Caldarelli G., 2007, SCALE FREE NETWORKS; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chakravarty S. R., 2013, ECONOPHYSICS INCOME; Chatterjee A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01049; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Egghe L, 2000, SCIENTOMETRICS, V48, P345, DOI 10.1023/A:1005688404778; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Ghosh A, 2014, PHYSICA A, V410, P30, DOI 10.1016/j.physa.2014.05.026; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Inoue J, 2015, PHYSICA A, V429, P184, DOI 10.1016/j.physa.2015.01.082; Kaur J, 2013, J INFORMETR, V7, P924, DOI 10.1016/j.joi.2013.09.002; Khaleque A, 2014, ARXIV14031745; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Li YR, 2013, J INFORMETR, V7, P746, DOI 10.1016/j.joi.2013.06.001; Mansilla R, 2007, J INFORMETR, V1, P155, DOI 10.1016/j.joi.2007.01.001; MANTEGNA RN, 2000, INTRO ECONOPHYSICS C; Mantovani MC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48001; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Perianes-Rodriguez A, 2015, J ASS INFORM SC TECH; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00313; Petersen AM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00181; Peterson GJ, 2010, P NATL ACAD SCI USA, V107, P16023, DOI 10.1073/pnas.1010757107; Popescu I., 2003, GLOTTOMETRICS, V6, P83; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; PRICE DJD, 1965, SCIENCE, V149, P510; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033833; Radicchi F, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046116; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; ROUSSEAU R, 1994, SCIENTOMETRICS, V30, P213, DOI 10.1007/BF02017224; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Sen P., 2013, SOCIOPHYSICS INTRO; SHOCKLEY W, 1957, P IRE, V45, P279, DOI 10.1109/JRPROC.1957.278364; Stanley H.E., 1971, INTRO PHASE TRANSITI; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P72, DOI 10.1002/asi.21671; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825	44	18	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146762	10.1371/journal.pone.0146762	http://dx.doi.org/10.1371/journal.pone.0146762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751563	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100148
J	Matikainen, N; Bjornson, E; Soderlund, S; Boren, C; Eliasson, B; Pietillaien, KH; Bogl, LH; Hakkarainen, A; Lundbom, N; Rivellese, A; Riccardi, G; Despres, JP; Almeras, N; Holst, JJ; Deacon, CF; Boren, J; Taskinen, MR				Matikainen, Niina; Bjornson, Elias; Soderlund, Sanni; Boren, Christofer; Eliasson, Bjorn; Pietillaien, Kirsi H.; Bogl, Leonie H.; Hakkarainen, Antti; Lundbom, Nina; Rivellese, Angela; Riccardi, Gabriele; Despres, Jean-Pierre; Almeras, Natalie; Holst, Jens Juul; Deacon, Carolyn F.; Boren, Jan; Taskinen, Marja-Riitta			Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-2; INTESTINAL LIPOPROTEIN PRODUCTION; INCRETIN HORMONES GIP; ORAL GLUCOSE; CHYLOMICRON PRODUCTION; INSULIN RESPONSES; LIPID ABSORPTION; FAT; SECRETION; RELEASE	Context Glucose and lipids stimulate the gut-hormones glucagon-like peptide (GLP)-1, GLP-2 and glucose-dependent insulinotropic polypeptide (GIP) but the effect of these on human postprandial lipid metabolism is not fully clarified. Objective To explore the responses of GLP-1, GLP-2 and GIP after a fat-rich meal compared to the same responses after an oral glucose tolerance test (OGTT) and to investigate possible relationships between incretin response and triglyceride-rich lipoprotein (TRL) response to a fat-rich meal. Design Glucose, insulin, GLP-1, GLP-2 and GIP were measured after an OGTT and after a fat-rich meal in 65 healthy obese (BMI 26.5-40.2 kg/m(2)) male subjects. Triglycerides (TG), apoB48 and apoB100 in TG-rich lipoproteins (chylomicrons, VLDL1 and VLDL2) were measured after the fat-rich meal. Main Outcome Measures Postprandial responses (area under the curve, AUC) for glucose, insulin, GLP-1, GLP-2, GIP in plasma, and TG, apoB48 and apoB100 in plasma and TG-rich lipoproteins. Results The GLP-1, GLP-2 and GIP responses after the fat-rich meal and after the OGTT correlated strongly (r = 0.73, p < 0.0001; r = 0.46, p < 0.001 and r = 0.69, p < 0.001, respectively). Glucose and insulin AUCs were lower, but the AUCs for GLP-1, GLP-2 and GIP were significantly higher after the fat-rich meal than after the OGTT. The peak value for all hormones appeared at 120 minutes after the fat-rich meal, compared to 30 minutes after the OGTT. After the fat-rich meal, the AUCs for GLP-1, GLP-2 and GIP correlated significantly with plasma TG- and apoB48 AUCs but the contribution was very modest. Conclusions In obese males, GLP-1, GLP-2 and GIP responses to a fat-rich meal are greater than following an OGTT. However, the most important explanatory variable for postprandial TG excursion was fasting triglycerides. The contribution of endogenous GLP-1, GLP-2 and GIP to explaining the variance in postprandial TG excursion was minor.	[Matikainen, Niina; Soderlund, Sanni; Pietillaien, Kirsi H.; Bogl, Leonie H.; Taskinen, Marja-Riitta] Univ Helsinki, Res Programs Unit, Diabet & Obes, Helsinki, Finland; [Matikainen, Niina; Soderlund, Sanni; Pietillaien, Kirsi H.; Bogl, Leonie H.; Taskinen, Marja-Riitta] Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland; [Matikainen, Niina; Pietillaien, Kirsi H.] Helsinki Univ Hosp, Abdominal Ctr, Endocrinol, Helsinki, Finland; [Bjornson, Elias; Boren, Christofer; Eliasson, Bjorn; Boren, Jan] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Bjornson, Elias; Boren, Christofer; Eliasson, Bjorn; Boren, Jan] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Hakkarainen, Antti; Lundbom, Nina] Univ Helsinki, Cent Hosp, Dept Radiol, HUS Med Imaging Ctr, Helsinki, Finland; [Rivellese, Angela; Riccardi, Gabriele] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Despres, Jean-Pierre; Almeras, Natalie] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Holst, Jens Juul; Deacon, Carolyn F.] Univ Copenhagen, NNF Ctr Basic Metab Res, Copenhagen, Denmark; [Holst, Jens Juul; Deacon, Carolyn F.] Univ Copenhagen, Dept Biomed Sci, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Gothenburg; Sahlgrenska University Hospital; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; University of Naples Federico II; University of Copenhagen; University of Copenhagen	Boren, J (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden.	jan.boren@wlab.gu.se	Holst, Jens/AAA-8022-2022; Taskinen, Marja-Riitta/AAN-5432-2020; Hakkarainen, Antti/AAF-5928-2020; Eliasson, Bjorn/H-5783-2016	Taskinen, Marja-Riitta/0000-0002-6229-3588; Hakkarainen, Antti/0000-0002-7367-2532; Holst, Jens Juul/0000-0001-6853-3805; Bjornson, Elias/0000-0002-0003-6463; Deacon, Carolyn/0000-0003-2611-5642; Pietilainen, Kirsi/0000-0002-8522-1288; Bogl, Leonie-Helen/0000-0003-4316-2619; Matikainen, Niina/0000-0003-0041-1240; Eliasson, Bjorn/0000-0003-2569-4160	Helsinki University Central Hospital EVO-funds; Finnish Diabetes Research Foundation; Academy of Finland [266286, 272376]; European Foundation for the Study of Diabetes; Sigrid Juselius Foundation; Foundation Leducq France; Swedish Research Council; Swedish Heart Lung Foundation; Diabetes Research Wellness Foundation; Sahlgrenska University Hospital ALF grant; Swedish Diabetes Foundation; NovoNordisk Foundation; EU project RESOLVE; NNF Center for Basic Metabolic Research [Holst Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF10OC1013354] Funding Source: researchfish	Helsinki University Central Hospital EVO-funds; Finnish Diabetes Research Foundation; Academy of Finland(Academy of Finland); European Foundation for the Study of Diabetes; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Foundation Leducq France; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Diabetes Research Wellness Foundation; Sahlgrenska University Hospital ALF grant; Swedish Diabetes Foundation; NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); EU project RESOLVE; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	This paper was supported by grants from Helsinki University Central Hospital EVO-funds, Finnish Diabetes Research Foundation, Academy of Finland (grants 266286 and 272376), European Foundation for the Study of Diabetes, Sigrid Juselius Foundation, Foundation Leducq France, Swedish Research Council, Swedish Heart Lung Foundation, Diabetes Research Wellness Foundation, Sahlgrenska University Hospital ALF grant, Swedish Diabetes Foundation, the NovoNordisk Foundation and the EU project RESOLVE.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Boren J, 2014, CLIN CHIM ACTA, V431, P131, DOI 10.1016/j.cca.2014.01.015; Bunck MC, 2010, ATHEROSCLEROSIS, V212, P223, DOI 10.1016/j.atherosclerosis.2010.04.024; Carr RD, 2008, AM J PHYSIOL-ENDOC M, V295, pE779, DOI 10.1152/ajpendo.90233.2008; Chavez-Jauregui RN, 2010, GASTROENTEROLOGY, V139, P1538, DOI 10.1053/j.gastro.2010.05.002; Dash S, 2014, GASTROENTEROLOGY, V147, P1275, DOI 10.1053/j.gastro.2014.08.037; Dash S, 2013, DIABETES, V62, pA76; Deacon CF, 2009, BEST PRACT RES CL EN, V23, P425, DOI 10.1016/j.beem.2009.03.006; Demignot S, 2014, BIOCHIMIE, V96, P48, DOI 10.1016/j.biochi.2013.07.009; Drucker DJ, 2015, DIABETES, V64, P317, DOI 10.2337/db14-1514; Drucker DJ, 2014, ANNU REV PHYSIOL, V76, P561, DOI 10.1146/annurev-physiol-021113-170317; Duca FA, 2013, J NUTR BIOCHEM, V24, P1663, DOI 10.1016/j.jnutbio.2013.05.005; Duez H, 2006, ARTERIOSCL THROM VAS, V26, P1357, DOI 10.1161/01.ATV.0000222015.76038.14; ELRICK H, 1964, J CLIN ENDOCR METAB, V24, P1076, DOI 10.1210/jcem-24-10-1076; Hartmann B, 2000, PEPTIDES, V21, P73, DOI 10.1016/S0196-9781(99)00176-X; Hein GJ, 2013, DIABETES, V62, P373, DOI 10.2337/db12-0202; Hsieh J, 2010, DIABETOLOGIA, V53, P552, DOI 10.1007/s00125-009-1611-5; Hsieh J, 2015, ENDOCRINOLOGY, V156, P3538, DOI 10.1210/EN.2015-1110; Hsieh J, 2009, GASTROENTEROLOGY, V137, P997, DOI 10.1053/j.gastro.2009.05.051; Janssen P, 2013, ALIMENT PHARM THER, V37, P18, DOI 10.1111/apt.12092; Lindeman R., 1980, INTRO BIVARIATE MULT; Lindgren O, 2011, DIABETES OBES METAB, V13, P863, DOI 10.1111/j.1463-1326.2011.01420.x; Lindgren O, 2011, J CLIN ENDOCR METAB, V96, P2519, DOI 10.1210/jc.2011-0266; Malmstrom R, 1997, DIABETOLOGIA, V40, P454, DOI 10.1007/s001250050700; Matikainen N, 2006, DIABETOLOGIA, V49, P2049, DOI 10.1007/s00125-006-0340-2; Matikainen N, 2007, J CLIN ENDOCR METAB, V92, P3052, DOI 10.1210/jc.2007-0187; Matikainen N, 2014, DIABETES CARE, V37, P242, DOI 10.2337/dc13-1283; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGill HC, 1998, AM J CARDIOL, V82, p30T; Meier JJ, 2006, DIABETOLOGIA, V49, P452, DOI 10.1007/s00125-005-0126-y; Meier JJ, 2006, GASTROENTEROLOGY, V130, P44, DOI 10.1053/j.gastro.2005.10.004; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Mells JE, 2013, SEMIN LIVER DIS, V33, P343, DOI 10.1055/s-0033-1358527; Nauck MA, 2004, REGUL PEPTIDES, V122, P209, DOI 10.1016/j.regpep.2004.06.020; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535; PERLEY MJ, 1967, J CLIN INVEST, V46, P1954, DOI 10.1172/JCI105685; Robertson MD, 2003, GUT, V52, P834, DOI 10.1136/gut.52.6.834; SCHMIDT WE, 1985, DIABETOLOGIA, V28, P704, DOI 10.1007/BF00291980; Tavares W, 2000, AM J PHYSIOL-ENDOC M, V278, pE134, DOI 10.1152/ajpendo.2000.278.1.E134; Tremblay AJ, 2014, DIABETES OBES METAB, V16, P1223, DOI 10.1111/dom.12359; Vaag AA, 1996, EUR J ENDOCRINOL, V135, P425, DOI 10.1530/eje.0.1350425; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Xiao CT, 2015, DIABETES, V64, P2310, DOI 10.2337/db14-1706; Xiao CT, 2014, DIABETES, V63, P2394, DOI 10.2337/db13-1654; Xiao CT, 2014, ATHEROSCLEROSIS, V233, P608, DOI 10.1016/j.atherosclerosis.2013.12.047; Xiao CT, 2012, ARTERIOSCL THROM VAS, V32, P1513, DOI 10.1161/ATVBAHA.112.246207; Yusta B, 2000, GASTROENTEROLOGY, V119, P744, DOI 10.1053/gast.2000.16489	48	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145890	10.1371/journal.pone.0145890	http://dx.doi.org/10.1371/journal.pone.0145890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752550	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100030
J	Yue, W; Wang, AX; Zhu, RX; Yan, ZR; Zheng, SH; Wang, JW; Huo, J; Liu, YL; Li, X; Ji, Y				Yue, Wei; Wang, Anxin; Zhu, Runxiu; Yan, Zhongrui; Zheng, Shouhuan; Wang, Jingwei; Huo, Jia; Liu, Yunlin; Li, Xin; Ji, Yong			Association between Carotid Artery Stenosis and Cognitive Impairment in Stroke Patients: A Cross-Sectional Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; MIDDLE-AGED ADULTS; ALZHEIMERS-DISEASE; FOLLOW-UP; NEUROPSYCHOLOGICAL IMPROVEMENT; CARDIOVASCULAR-DISEASE; WHITEHALL-II; RISK-FACTORS; ENDARTERECTOMY; ATHEROSCLEROSIS	To investigate potential associations between carotid artery stenosis and cognitive impairment among patients with acute ischemic stroke and to provide important clinical implications. We measured the degree of carotid artery stenosis and recorded the Mini-Mental State Examination score (MMSE) at admission in 3116 acute ischemic stroke patients. The association between carotid stenosis and cognitive impairment assessed by MMSE was tested using multivariate regression analysis. Other clinical variables of interest were also studied. After adjusting for age, gender, education level, marriage, alcohol use, tobacco use, physical activity, hypertension, diabetes, hypercholesterolemia, atrial fibrillation, myocardial infarction and NIHSS (National Institutes of Health Stroke Scale) score, we found that participants with high-grade stenosis of the carotid artery had a higher likelihood of cognitive impairment compared to those without carotid artery stenosis (OR = 1.49, 95% CI: 1.05-2.11, p < 0.001). Left common carotid artery stenosis was associated with cognitive impairment in the univariate analysis, although this effect did not persist after adjustment for the NIHSS score. Cognitive impairment was associated with high-grade stenosis of the right carotid artery.	[Yue, Wei; Li, Xin] Tianjin Med Univ, Dept Neurol, Hosp 2, Tianjin, Peoples R China; [Yue, Wei; Ji, Yong] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Wang, Anxin] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Anxin] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Wang, Anxin] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Wang, Anxin] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Wang, Anxin] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Zhu, Runxiu] Inner Mongolia Peoples Hosp, Dept Neurol, Inner Mongolia, Hohhot, Peoples R China; [Yan, Zhongrui] Jining 1 Peoples Hosp, Dept Neurol, Jining, Shandong, Peoples R China; [Zheng, Shouhuan] Yanbian Univ Hosp, Dept Neurol, Yanji, Jilin Province, Peoples R China; [Wang, Jingwei] Harbin 2 Hosp, Dept Neurol, Harbin, Heilongjiang, Peoples R China; [Huo, Jia] Yili Friendship Hosp, Dept Neurol, Yili, Xinjiang Provin, Peoples R China; [Liu, Yunlin] Taian City Cent Hosp, Dept Neurol, Tai An, Shandong, Peoples R China	Tianjin Medical University; Capital Medical University; Capital Medical University; Yanbian University	Li, X (corresponding author), Tianjin Med Univ, Dept Neurol, Hosp 2, Tianjin, Peoples R China.	hhyw2014@163.com; jiyongusa@126.com	Wang, Anxin/AAD-4073-2021		Stroke Screening and Prevention Engineering Office of the National Health and Family Planning Commission	Stroke Screening and Prevention Engineering Office of the National Health and Family Planning Commission	The study was sponsored by the Stroke Screening and Prevention Engineering Office of the National Health and Family Planning Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hazzouri AZ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.004978; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; CASEY JE, 1989, J CLIN EXP NEUROPSYC, V11, P461, DOI 10.1080/01688638908400906; Cerhan JR, 1998, GERONTOLOGY, V44, P95, DOI 10.1159/000021991; Cohen RA, 2009, J CLIN EXP NEUROPSYC, V31, P96, DOI 10.1080/13803390802014594; Consoli A, 2012, AGING CLIN EXP RES, V24, P113; Federation ID., IDF DIABETES ATLAS, V10th; FISHER M, 1951, CAN MED ASSOC J, V65, P1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GREIFFENSTEIN MF, 1988, CORTEX, V24, P223, DOI 10.1016/S0010-9452(88)80031-5; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Haley AP, 2007, INT J CARDIOL, V121, P148, DOI 10.1016/j.ijcard.2006.10.032; HEMMINGSEN R, 1982, ACTA NEUROL SCAND, V66, P145, DOI 10.1111/j.1600-0404.1982.tb04512.x; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; JACOBS LA, 1983, SURGERY, V93, P683; Johnston SC, 2004, ANN INTERN MED, V140, P237, DOI 10.7326/0003-4819-140-4-200402170-00005; Kaffashian S, 2013, ALZHEIMERS DEMENT, V9, P572, DOI 10.1016/j.jalz.2012.07.001; KELLY MP, 1980, ARCH NEUROL-CHICAGO, V37, P743, DOI 10.1001/archneur.1980.00500610023002; KING GD, 1977, J CLIN PSYCHOL, V33, P215, DOI 10.1002/1097-4679(197701)33:1+<215::AID-JCLP2270330149>3.0.CO;2-D; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Komulainen P, 2007, NEUROEPIDEMIOLOGY, V28, P207, DOI 10.1159/000108112; LI RL, 1994, STROKE, V25, P2377, DOI 10.1161/01.STR.25.12.2377; Mathiesen EB, 2004, NEUROLOGY, V62, P695, DOI 10.1212/01.WNL.0000113759.80877.1F; PARKER JC, 1983, J CLIN NEUROPSYCHOL, V5, P345, DOI 10.1080/01688638308401182; Pettigrew LC, 2000, NEUROLOGY, V55, P30, DOI 10.1212/WNL.55.1.30; Piccinin AM, 2013, J GERONTOL B-PSYCHOL, V68, P374, DOI 10.1093/geronb/gbs077; Riley WA, 1991, J NEUROIMAGING, V1, P168, DOI DOI 10.1111/JON199114168; Sander K, 2010, INT J GERIATR PSYCH, V25, P389, DOI 10.1002/gps.2351; Silvestrini M, 2011, J ALZHEIMERS DIS, V25, P719, DOI 10.3233/JAD-2011-101968; Silvestrini M, 2009, NEUROBIOL AGING, V30, P1177, DOI 10.1016/j.neurobiolaging.2007.11.008; Singh-Manoux A, 2008, ATHEROSCLEROSIS, V197, P541, DOI 10.1016/j.atherosclerosis.2007.08.010; SIRKKA A, 1992, ACTA NEUROL SCAND, V85, P58; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Smith PJ, 2007, PSYCHOSOM MED, V69, P578, DOI 10.1097/PSY.0b013e31812f7b8e; Talelli P, 2004, J NEUROL SCI, V223, P129, DOI 10.1016/j.jns.2004.05.013; VANDENBURG W, 1985, PSYCHOL MED, V15, P341, DOI 10.1017/S003329170002362X; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wang AX, 2014, J HYPERTENS, V32, P1600, DOI 10.1097/HJH.0000000000000230; Wang J, 2014, ATHEROSCLEROSIS, V237, P661, DOI 10.1016/j.atherosclerosis.2014.10.083; Wendell CR, 2009, STROKE, V40, P3180, DOI 10.1161/STROKEAHA.109.557280; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Zhong WJ, 2012, ATHEROSCLEROSIS, V224, P506, DOI 10.1016/j.atherosclerosis.2012.07.024; Zhong WJ, 2011, ATHEROSCLEROSIS, V219, P330, DOI 10.1016/j.atherosclerosis.2011.07.013	44	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146890	10.1371/journal.pone.0146890	http://dx.doi.org/10.1371/journal.pone.0146890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751070	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100173
J	Morabito, R; Romano, O; La Spada, G; Marino, A				Morabito, Rossana; Romano, Orazio; La Spada, Giuseppa; Marino, Angela			H2O2-Induced Oxidative Stress Affects SO4 = Transport in Human Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; HYDROGEN-PEROXIDE; DIETARY ANTIOXIDANTS; PELAGIA-NOCTILUCA; MEMBRANE-PROTEINS; ANION-EXCHANGE; BAND-3 PROTEIN; CROSS-LINKING; CRUDE VENOM; CURCUMIN	The aim of the present investigation was to verify the effect of H2O2-induced oxidative stress on SO4 = uptake through Band 3 protein, responsible for Cl-/HCO3- as well as for cell membrane deformability, due to its cross link with cytoskeletal proteins. The role of cytoplasmic proteins binding to Band 3 protein has been also considered by assaying H2O2 effects on hemoglobin-free resealed ghosts of erythrocytes. Oxidative conditions were induced by 30 min exposure of human erythrocytes to different H2O2 concentrations (10 to 300 mu M), with or without GSH (glutathione, 2 mM) or curcumin (10 mu M), compounds with proved antioxidant properties. Since SO4 = influx through Band 3 protein is slower and better controllable than Cl-or HCO3- exchange, the rate constant for SO4 = uptake was measured to prove anion transport efficiency, while MDA (malondialdehyde) levels and -SH groups were estimated to quantify the effect of oxidative stress. H2O2 induced a significant decrease in rate constant for SO4 = uptake at both 100 and 300 mu M H2O2. This reduction, observed in erythrocytes but not in resealed ghosts and associated to increase in neither MDA levels nor in SH groups, was impaired by both curcumin and GSH, whereas only curcumin effectively restored H2O2-induced changes in erythrocytes shape. Our results show that: i) 30 min exposure to 300 mu M H2O2 reduced SO4 = uptake in human erythrocytes; ii) oxidative damage was revealed by the reduction in rate constant for SO4 = uptake, but not by MDA or -SH groups levels; iii) the damage was produced via cytoplasmic components which cross link with Band 3 protein; iv) the natural antioxidant curcumin may be useful in protecting erythrocytes from oxidative injury; v) SO4= uptake through Band 3 protein may be reasonably suggested as a tool to monitor erythrocytes function under oxidative conditions possibly deriving from alcohol consumption, use of drugs, radiographic contrast media administration, hyperglicemia or neurodegenerative diseases.	[Morabito, Rossana] Univ Messina, Dept Human & Social Sci, Messina, Italy; [Romano, Orazio] BromaTech Srl, Giarre, Italy; [La Spada, Giuseppa; Marino, Angela] Univ Messina, Dept Biol & Environm Sci, Messina, Italy	University of Messina; University of Messina	Marino, A (corresponding author), Univ Messina, Dept Biol & Environm Sci, Messina, Italy.	marinoa@unime.it	Morabito, Rossana/AFP-6914-2022					Alenghat FJ, 2013, CURR TOP MEMBR, V72, P89, DOI 10.1016/B978-0-12-417027-8.00003-9; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Arashiki N, 2013, BIOCHEMISTRY-US, V52, P5760, DOI 10.1021/bi400405p; Arora A, 2000, ARCH BIOCHEM BIOPHYS, V373, P102, DOI 10.1006/abbi.1999.1525; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Chaudhuri S, 2007, INT J BIOL MACROMOL, V41, P42, DOI 10.1016/j.ijbiomac.2006.12.003; Davies K. J., 1987, BIOL CHEM, V262, P9895; De Luca G, 2004, CELL BIOCHEM FUNCT, V22, P179, DOI 10.1002/cbf.1081; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Franke RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089512; Glauert HP, 2010, MOL NUTR FOOD RES, V54, P875, DOI 10.1002/mnfr.200900482; GUILLET R, 1991, CLIN HEMORHEOL, V11, P55; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; IHLER GM, 1983, PHARMACOL THERAPEUT, V20, P151, DOI 10.1016/0163-7258(83)90037-2; Ivanov IT, 1999, BBA-BIOMEMBRANES, V1415, P349, DOI 10.1016/S0005-2736(98)00202-8; JAIN SK, 1990, METABOLISM, V39, P971, DOI 10.1016/0026-0495(90)90310-9; Jennings ML, 2005, BIOPHYS J, V88, P2681, DOI 10.1529/biophysj.104.056812; JENNINGS ML, 1976, J MEMBRANE BIOL, V28, P187, DOI 10.1007/BF01869697; JESSEN F, 1986, J MEMBRANE BIOL, V92, P195, DOI 10.1007/BF01869388; Jung F, 2003, CLIN HEMORHEOL MICRO, V29, P53; Kelkel M, 2010, MOLECULES, V15, P7035, DOI 10.3390/molecules15107035; Kossler S, 2012, TOXICOLOGY, V292, P123, DOI 10.1016/j.tox.2011.12.002; Li D, 2014, GENET MOL RES, V13, P7304, DOI 10.4238/2014.February.21.9; Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011; Lutz HU, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00387; Marino A, 2007, CELL MOL BIOL, V53, pOL994, DOI 10.1170/113; Marino A, 2009, COMP BIOCHEM PHYS A, V152, P418, DOI 10.1016/j.cbpa.2008.11.016; Mendanha SA, 2012, BRAZ J MED BIOL RES, V45, P473, DOI 10.1590/S0100-879X2012007500050; Morabito R, 2015, CELL PHYSIOL BIOCHEM, V36, P345, DOI 10.1159/000430256; Morabito R, 2013, CELL PHYSIOL BIOCHEM, V32, P86, DOI 10.1159/000356630; Mueller S, 1997, ANAL BIOCHEM, V245, P55, DOI 10.1006/abio.1996.9939; Mulquiney PJ, 1997, EUR J BIOCHEM, V245, P71, DOI 10.1111/j.1432-1033.1997.00071.x; Ritter SC, 2011, BIOMED OPT EXPRESS, V2, P2012, DOI 10.1364/BOE.2.002012; ROMANO L, 1984, AM J PHYSIOL, V246, pC330, DOI 10.1152/ajpcell.1984.246.3.C330; Roy SS, 2005, ARCH BIOCHEM BIOPHYS, V436, P121, DOI 10.1016/j.abb.2005.01.015; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; SALHANY JM, 1990, J BIOL CHEM, V265, P17688; SNYDER LM, 1985, J CLIN INVEST, V76, P1971, DOI 10.1172/JCI112196; Soszynski M, 1997, FREE RADICAL BIO MED, V23, P463, DOI 10.1016/S0891-5849(97)00117-2; SRIVASTAVA SK, 1969, BIOCHEM J, V114, P833, DOI 10.1042/bj1140833; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; Stefanovic M, 2007, P NATL ACAD SCI USA, V104, P13972, DOI 10.1073/pnas.0706266104; Teti D, 2005, CELL PHYSIOL BIOCHEM, V16, P77, DOI 10.1159/000087734; Vigliarolo T, 2015, J BIOL CHEM; Xiong YL, 2013, CAN J PHYSIOL PHARM, V91, P1127, DOI 10.1139/cjpp-2013-0145; Yang W, 2015, CELL PHYSIOL BIOCHEM, V35, P789, DOI 10.1159/000369738; Yu C, 2014, ENVIRON TOXICOL PHAR, V37, P729, DOI 10.1016/j.etap.2014.02.011	49	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146485	10.1371/journal.pone.0146485	http://dx.doi.org/10.1371/journal.pone.0146485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745155	Green Submitted, Green Published, gold			2022-12-27	WOS:000367815600055
J	Riepl, K; Mussel, P; Osinsky, R; Hewig, J				Riepl, Korbinian; Mussel, Patrick; Osinsky, Roman; Hewig, Johannes			Influences of State and Trait Affect on Behavior, Feedback-Related Negativity, and P3b in the Ultimatum Game	PLOS ONE			English	Article							DECISION-MAKING; FACIAL EXPRESSION; NEURAL SYSTEM; FAIRNESS; RESPONSES; REWARD; POTENTIALS; UNFAIRNESS; DEPRESSION; MAGNITUDE	The present study investigates how different emotions can alter social bargaining behavior. An important paradigm to study social bargaining is the Ultimatum Game. There, a proposer gets a pot of money and has to offer part of it to a responder. If the responder accepts, both players get the money as proposed by the proposer. If he rejects, none of the players gets anything. Rational choice models would predict that responders accept all offers above 0. However, evidence shows that responders typically reject a large proportion of all unfair offers. We analyzed participants' behavior when they played the Ultimatum Game as responders and simultaneously collected electroencephalogram data in order to quantify the feedback-related negativity and P3b components. We induced state affect (momentarily emotions unrelated to the task) via short movie clips and measured trait affect (longer-lasting emotional dispositions) via questionnaires. State happiness led to increased acceptance rates of very unfair offers. Regarding neurophysiology, we found that unfair offers elicited larger feedback-related negativity amplitudes than fair offers. Additionally, an interaction of state and trait affect occurred: high trait negative affect (subsuming a variety of aversive mood states) led to increased feedback-related negativity amplitudes when participants were in an angry mood, but not if they currently experienced fear or happiness. We discuss that increased rumination might be responsible for this result, which might not occur, however, when people experience happiness or fear. Apart from that, we found that fair offers elicited larger P3b components than unfair offers, which might reflect increased pleasure in response to fair offers. Moreover, high trait negative affect was associated with decreased P3b amplitudes, potentially reflecting decreased motivation to engage in activities. We discuss implications of our results in the light of theories and research on depression and anxiety.	[Riepl, Korbinian; Mussel, Patrick; Osinsky, Roman; Hewig, Johannes] Univ Wurzburg, Dept Psychol 1, D-97070 Wurzburg, Germany	University of Wurzburg	Riepl, K (corresponding author), Univ Wurzburg, Dept Psychol 1, D-97070 Wurzburg, Germany.	korbinian.riepl@stud-mail.uni-wuerzburg.de	Mussel, Patrick/AAG-4166-2019; Mussel, Patrick/ABI-1413-2020; Hewig, Johannes/H-8840-2018	Mussel, Patrick/0000-0001-5010-5677; Hewig, Johannes/0000-0002-8400-189X	Schumpeter-Fellowship by the VolkswagenStiftung [85650, II/86486]	Schumpeter-Fellowship by the VolkswagenStiftung	This research was supported by a Schumpeter-Fellowship by the VolkswagenStiftung (85650; II/86486; https://www.volkswagenstiftung.de/en/funding/completed-initiatives/schumpeter-fellowships.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade EB, 2009, ORGAN BEHAV HUM DEC, V109, P1, DOI 10.1016/j.obhdp.2009.02.003; Barlow D. H., 2002, ANXIETY AND ITS DISO; Boksem MAS, 2010, SOC NEUROSCI-UK, V5, P118, DOI 10.1080/17470910903202666; Branas-Garza P, 2006, EXP ECON, V9, P253, DOI 10.1007/s10683-006-9126-0; Branas-Garza P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06025; Bruder GE, 2009, PSYCHIAT RES, V170, P218, DOI 10.1016/j.psychres.2008.10.023; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Crockett MJ, 2013, J NEUROSCI, V33, P3505, DOI 10.1523/JNEUROSCI.2761-12.2013; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Dunn BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015095; Espin AM, 2013, SHORT AND LONG RUN G; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Flykt A., 1998, KAROLINSKA DIRECTED, P91, DOI [10.1017/S0048577299971664, DOI 10.1017/S0048577299971664, 10.1037/t27732-000]; Forgas JP, 2013, SOC COGNITION, V31, P504; Foti D, 2009, BIOL PSYCHOL, V81, P1, DOI 10.1016/j.biopsycho.2008.12.004; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Harle KM, 2010, COGNITION EMOTION, V24, P1456, DOI 10.1080/02699930903510220; Harle KM, 2010, J ABNORM PSYCHOL, V119, P440, DOI 10.1037/a0018612; Hewig J, 2005, COGNITION EMOTION, V19, P1095, DOI 10.1080/02699930541000084; Hewig J, 2011, PSYCHOPHYSIOLOGY, V48, P507, DOI 10.1111/j.1469-8986.2010.01081.x; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Kreussel L, 2012, PSYCHOPHYSIOLOGY, V49, P207, DOI 10.1111/j.1469-8986.2011.01291.x; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Ma QG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00077; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moretti L, 2010, EMOTION, V10, P169, DOI 10.1037/a0017826; Moser JS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00466; Mussel P, 2014, PSYCHOPHYSIOLOGY, V51, P358, DOI 10.1111/psyp.12184; Mussel P, 2013, JUDGM DECIS MAK, V8, P381; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nitschke JB, 2001, COGNITIVE THER RES, V25, P1, DOI 10.1023/A:1026485530405; Osinsky R, 2014, SOC COGN AFFECT NEUR, V9, P731, DOI 10.1093/scan/nst051; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; ROTH AE, 1983, SCIENCE, V220, P687, DOI 10.1126/science.220.4598.687; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Staffiero G, 2013, ECON LETT, V121, P236, DOI 10.1016/j.econlet.2013.08.021; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Thomsen DK, 2006, COGNITION EMOTION, V20, P1216, DOI 10.1080/02699930500473533; TOMARKEN AJ, 1990, J PERS SOC PSYCHOL, V59, P791, DOI 10.1037/0022-3514.59.4.791; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; von Neumann J., 1953, THEORY GAMES EC BEHA; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yamagishi T, 2012, P NATL ACAD SCI USA, V109, P20364, DOI 10.1073/pnas.1212126109; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	55	27	27	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146358	10.1371/journal.pone.0146358	http://dx.doi.org/10.1371/journal.pone.0146358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26742103	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600031
J	Shrestha, BK; Karki, HS; Groth, DE; Jungkhun, N; Ham, JH				Shrestha, Bishnu K.; Karki, Hari Sharan; Groth, Donald E.; Jungkhun, Nootjarin; Ham, Jong Hyun			Biological Control Activities of Rice-Associated Bacillus sp Strains against Sheath Blight and Bacterial Panicle Blight of Rice	PLOS ONE			English	Article							INDUCED SYSTEMIC RESISTANCE; PLANT-GROWTH; ROOT-ROT; AMYLOLIQUEFACIENS; BIOCONTROL; DIVERSITY; DISEASE; PSEUDOMONAS; SUBTILIS; GENES	Potential biological control agents for two major rice diseases, sheath blight and bacterial panicle blight, were isolated from rice plants in this study. Rice-associated bacteria (RABs) isolated from rice plants grown in the field were tested for their antagonistic activities against the rice pathogens, Rhizoctonia solani and Burkholderia glumae, which cause sheath blight and bacterial panicle blight, respectively. Twenty-nine RABs were initially screened based on their antagonistic activities against both R. solani and B. glumae. In follow-up retests, 26 RABs of the 29 RABs were confirmed to have antimicrobial activities, but the rest three RABs did not reproduce any observable antagonistic activity against R. solani or B. glumae. According to16S rDNA sequence identity, 12 of the 26 antagonistic RABs were closest to Bacillus amyloliquefaciens, while seven RABs were to B. methylotrophicus and B, subtilis, respectively. The 16S rDNA sequences of the three non-antagonistic RABs were closest to Lysinibacillus sphaericus (RAB1 and RAB12) and Lysinibacillus macroides (RAB5). The five selected RABs showing highest antimicrobial activities (RAB6, RAB9, RAB16, RAB17S, and RAB18) were closest to B. amyloliquefaciens in DNA sequence of 16S rDNA and gyrB, but to B. subtilis in that of recA. These RABs were observed to inhibit the sclerotial germination of R. solani on potato dextrose agar and the lesion development on detached rice leaves by artificial inoculation of R. solani. These antagonistic RABs also significantly suppressed the disease development of sheath blight and bacterial panicle blight in a field condition, suggesting that they can be potential biological control agents for these rice diseases. However, these antagonistic RABs showed diminished disease suppression activities in the repeated field trial conducted in the following year probably due to their reduced antagonistic activities to the pathogens during the long-term storage in -70C, suggesting that development of proper storage methods to maintain antagonistic activity is as crucial as identification of new biological control agents.	[Shrestha, Bishnu K.; Karki, Hari Sharan; Ham, Jong Hyun] Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA; [Groth, Donald E.] Louisiana State Univ, Ctr Agr, Rice Res Stn, Rayne, LA 70578 USA; [Jungkhun, Nootjarin] Bur Rice Res & Dev, Chiang Rai Rice Res Ctr, Rice Dept, Phan 57120, Chiang Rai, Thailand	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Ham, JH (corresponding author), Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA.	jham@agcenter.lsu.edu	Karki, Hari Sharan/AAB-5819-2020		USDA NIFA (Hatch Project) [LAB93918, LAB94203]; Louisiana State University Agricultural Center; Louisiana Board of Regents (the Research and Development Program) [LEQSF(2008-11)-RD-A-02]; Agricultural Research Development Agency of Thailand	USDA NIFA (Hatch Project); Louisiana State University Agricultural Center; Louisiana Board of Regents (the Research and Development Program); Agricultural Research Development Agency of Thailand	This study was supported by the USDA NIFA (Hatch Project #: LAB93918 and LAB94203), the Louisiana State University Agricultural Center, the Louisiana Board of Regents (the Research and Development Program: LEQSF(2008-11)-RD-A-02), and the Agricultural Research Development Agency of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad V, 2014, ANAEROBE, V27, P87, DOI 10.1016/j.anaerobe.2014.04.001; [Anonymous], J STATE U AGR MECH C; ARAKI F, 1993, J PESTIC SCI, V18, pS69; Arias AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083037; Bashar M. A., 2010, Bangladesh Journal of Scientific and Industrial Research, V45, P225, DOI 10.3329/bjsir.v45i3.6529; BASHI E, 1977, T BRIT MYCOL SOC, V68, P17, DOI 10.1016/S0007-1536(77)80146-0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen XH, 2009, J BIOTECHNOL, V140, P38, DOI 10.1016/j.jbiotec.2008.10.015; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; Chithrashree, 2011, BIOL CONTROL, V59, P114, DOI 10.1016/j.biocontrol.2011.06.010; Chowdhury SP, 2015, MOL PLANT MICROBE IN, V28, P984, DOI 10.1094/MPMI-03-15-0066-R; Chowdhury SP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00780; Allievi MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111114; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; DATNOFF LE, 1995, BIOL CONTROL, V5, P427, DOI 10.1006/bcon.1995.1051; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DUFFY BK, 1995, PLANT DIS, V79, P907, DOI 10.1094/PD-79-0907; Dunlap CA, 2015, INT J SYST EVOL MICR, V65, P2104, DOI 10.1099/ijs.0.000226; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GOTO T, 1987, Annals of the Phytopathological Society of Japan, V53, P141, DOI 10.3186/jjphytopath.53.141; Groth DE, 2007, J PLANT REGIST, V1, P63, DOI 10.3198/jpr2006.10.0677crg; Groth DE, 2005, PLANT DIS, V89, P1171, DOI 10.1094/PD-89-1171; Guleria S, 2007, J PHYTOPATHOL, V155, P654, DOI 10.1111/j.1439-0434.2007.01291.x; Gupta P, 2014, BIORESOURCE TECHNOL, V173, P207, DOI 10.1016/j.biortech.2014.09.101; Hikichi Yasufumi, 1993, Annals of the Phytopathological Society of Japan, V59, P441, DOI 10.3186/jjphytopath.59.441; Hikichi Yasufumi, 2001, Journal of General Plant Pathology, V67, P58, DOI 10.1007/PL00012988; Huang TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042124; Jacobsen BJ, 2004, PHYTOPATHOLOGY, V94, P1272, DOI 10.1094/PHYTO.2004.94.11.1272; Kabir L, 2013, J MICROBIOL BIOTECHN, V23, P897, DOI 10.4014/jmb.1209.09069; Kanjanamaneesathian M, 1998, AUSTRALAS PLANT PATH, V27, P198, DOI 10.1071/AP98022; Karki HS, 2012, MOL PLANT PATHOL, V13, P785, DOI 10.1111/j.1364-3703.2012.00787.x; Kazempour M. N., 2004, Plant Pathology Journal, V3, P88; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Kumar KVK, 2009, PLANT GROWTH PROMOTI; LEE FN, 1983, PLANT DIS, V67, P829, DOI 10.1094/PD-67-829; Lee Hwang A, 2012, Prev Nutr Food Sci, V17, P64, DOI 10.3746/pnf.2012.17.1.064; Li Y, 2013, PLANT PATHOLOGY J, V29, P168, DOI 10.5423/PPJ.SI.08.2012.0125; Liu QL, 2012, RES MICROBIOL, V163, P470, DOI 10.1016/j.resmic.2012.05.009; Luo WJ, 2014, NAT PROD COMMUN, V9, P107; Ma L, 2013, ANTON LEEUW INT J G, V103, P299, DOI 10.1007/s10482-012-9810-3; Madhaiyan M, 2010, INT J SYST EVOL MICR, V60, P2490, DOI 10.1099/ijs.0.015487-0; MIAH SA, 1994, BANGLADESH J BOTANY, V23, P239; Moussa TAA, 2013, ANN APPL BIOL, V163, P72, DOI 10.1111/aab.12034; Nandakumar R, 2009, PLANT DIS, V93, P896, DOI 10.1094/PDIS-93-9-0896; Ongena M, 2007, ENVIRON MICROBIOL, V9, P1084, DOI 10.1111/j.1462-2920.2006.01202.x; Paulitz TC, 1992, BIOL CONTROL, V2, P226, DOI 10.1016/1049-9644(92)90063-J; Peng D, 2014, PEST MANAG SCI, V70, P258, DOI 10.1002/ps.3551; Peng J, 2013, J MICROBIOL BIOTECHN, V23, P437, DOI 10.4014/jmb.1208.08010; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Pinson SRM, 2010, CROP SCI, V50, P1287, DOI 10.2135/cropsci2008.07.0447; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Raj SN, 2006, PGPR: BIOCONTROL AND BIOFERTILIZATION, P197; Rice INfGEo Institute IRR, 1996, STAND EV SYST RIC IN; RYU EIHYO, 1940, KILASATO ARCH EXP MED, V17, P58; Sarosh BR, 2009, PLANT MOL BIOL, V70, P31, DOI 10.1007/s11103-009-9455-4; SATO Z, 1989, Annals of the Phytopathological Society of Japan, V55, P353, DOI 10.3186/jjphytopath.55.353; Schneider K, 2007, J NAT PROD, V70, P1417, DOI 10.1021/np070070k; Scholz R, 2014, J BACTERIOL, V196, P1842, DOI 10.1128/JB.01474-14; Sha X, 2006, CROP SCI, V46, P1811, DOI 10.2135/cropsci2005.10-0393; Shahjahan A., 2000, RICE J, V15, P26; Souza SA, 2013, GENET MOL BIOL, V36, P252, DOI [10.1590/S1415-47572013000200016, 10.1590/s1415-47572013000200016]; STAUB T, 1991, ANNU REV PHYTOPATHOL, V29, P421, DOI 10.1146/annurev.py.29.090191.002225; Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004; SUSLOW TV, 1982, PHYTOPATHOLOGY, V72, P917, DOI 10.1094/Phyto-72-917; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan SY, 2013, PEST MANAG SCI, V69, P1245, DOI 10.1002/ps.3491; Trivedi P, 2011, MICROB ECOL, V62, P324, DOI 10.1007/s00248-011-9822-y; Trung HM, 1993, INT RICE RES NOTES, V18; Tsushima S, 1996, JARQ-JPN AGR RES Q, V30, P85; Vendan RT, 2010, J MICROBIOL, V48, P559, DOI 10.1007/s12275-010-0082-1; Wang SA, 2009, J MICROBIOL BIOTECHN, V19, P1250, DOI 10.4014/jmb.0901.008; Wang X, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/465435; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WILLIAMSON MA, 1985, NETH J PLANT PATHOL, V91, P265, DOI 10.1007/BF02000012; Wirth MC, 2014, J INVERTEBR PATHOL, V115, P62, DOI 10.1016/j.jip.2013.10.003; Wu YC, 2014, J MICROBIOL BIOTECHN, V24, P1327, DOI 10.4014/jmb.1402.02061; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; Yamamoto S, 2015, PEST MANAG SCI, V71, P722, DOI 10.1002/ps.3837; Zhao YC, 2013, WORLD J MICROB BIOT, V29, P411, DOI 10.1007/s11274-012-1193-0	80	44	53	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146764	10.1371/journal.pone.0146764	http://dx.doi.org/10.1371/journal.pone.0146764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765124	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300040
J	Jiang, Z; Li, P; Jiang, DW; Dai, XY; Zhang, R; Wang, YH; Wang, YX				Jiang, Zhou; Li, Ping; Jiang, Dawei; Dai, Xinyue; Zhang, Rui; Wang, Yanhong; Wang, Yanxin			Microbial Community Structure and Arsenic Biogeochemistry in an Acid Vapor-Formed Spring in Tengchong Geothermal Area, China	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; HOT-SPRINGS; INNER-MONGOLIA; YUNNAN PROVINCE; HETAO BASIN; SP NOV.; DIVERSITY; WATER; SEQUENCES; OXIDATION	Arsenic biogeochemistry has been studied extensively in acid sulfate-chloride hot springs, but not in acid sulfate hot springs with low chloride. In this study, Zhenzhuquan in Tengchong geothermal area, a representative acid sulfate hot spring with low chloride, was chosen to study arsenic geochemistry and microbial community structure using Illumina MiSeq sequencing. Over 0.3 million 16S rRNA sequence reads were obtained from 6-paired parallel water and sediment samples along its outflow channel. Arsenic oxidation occurred in the Zhenxhuquan pool, with distinctly high ratios of arsenate to total dissolved arsenic (0.73-0.86). Coupled with iron and sulfur oxidation along the outflow channel, arsenic accumulated in downstream sediments with concentrations up to 16.44 g/kg and appeared to significantly constrain their microbial community diversity. These oxidations might be correlated with the appearance of some putative functional microbial populations, such as Aquificae and Pseudomonas (arsenic oxidation), Sulfolobus (sulfur and iron oxidation), Metallosphaera and Acidicaldus (iron oxidation). Temperature, total organic carbon and dissolved oxygen significantly shaped the microbial community structure of upstream and downstream samples. In the upstream outflow channel region, most microbial populations were microaerophilic/anaerobic thermophiles and hyperthermophiles, such as Sulfolobus, Nocardia, Fervidicoccus, Delftia, and Ralstonia. In the downstream region, aerobic heterotrophic mesophiles and thermophiles were identified, including Ktedonobacteria, Acidicaldus, Chthonomonas and Sphingobacteria. A total of 72.41-95.91% unassigned-genus sequences were derived from the downstream high arsenic sediments 16S rRNA clone libraries. This study could enable us to achieve an integrated understanding on arsenic biogeochemistry in acid hot springs.	[Jiang, Zhou; Li, Ping; Jiang, Dawei; Dai, Xinyue; Zhang, Rui; Wang, Yanhong; Wang, Yanxin] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Jiang, Zhou; Dai, Xinyue; Wang, Yanxin] China Univ Geosci, Sch Environm Studies, Wuhan 430074, Peoples R China	China University of Geosciences; China University of Geosciences	Li, P (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China.	pli@cug.edu.cn; yx.wang@cug.edu.cn	wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022	Jiang, Zhou/0000-0002-1716-113X	National Natural Science Foundation of China [41120124003, 41521001, 41372348]; Fundamental Research Funds for the Central Universities [CUG140505]; State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences [GBL11505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences	This research was financially supported by National Natural Science Foundation of China (grant no. 41120124003, 41521001, 41372348), the Fundamental Research Funds for the Central Universities (no. CUG140505) and State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences (no. GBL11505).	Aminin ALN, 2008, INT J INTEGRATIVE BI, V2, P145; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Birkle P, 2010, WATER RES, V44, P5605, DOI 10.1016/j.watres.2010.05.046; Briggs BR, 2014, ENVIRON MICROBIOL, V16, P1579, DOI 10.1111/1462-2920.12311; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cavalca L, 2013, FUTURE MICROBIOL, V8, P753, DOI [10.2217/FMB.13.38, 10.2217/fmb.13.38]; Clingenpeel SR, 2009, APPL ENVIRON MICROB, V75, P3362, DOI 10.1128/AEM.00336-09; D'Imperio S, 2008, APPL ENVIRON MICROB, V74, P5802, DOI 10.1128/AEM.00852-08; D'Imperio S, 2007, APPL ENVIRON MICROB, V73, P7067, DOI 10.1128/AEM.01161-07; Deng YM, 2011, ENVIRON EARTH SCI, V64, P2001, DOI 10.1007/s12665-011-1020-1; Donahoe-Christiansen J, 2004, APPL ENVIRON MICROB, V70, P1865, DOI 10.1128/AEM.70.3.1865-1868.2004; Drahota P, 2009, ENVIRON INT, V35, P1243, DOI 10.1016/j.envint.2009.07.004; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ford RG, 2002, ENVIRON SCI TECHNOL, V36, P2459, DOI 10.1021/es015768d; Garrity G.M., 2001, BERGEYS MANUAL SYSTE, P169; Guo QH, 2014, B VOLCANOL, V76, DOI 10.1007/s00445-014-0868-9; Guo QH, 2012, APPL GEOCHEM, V27, P1887, DOI 10.1016/j.apgeochem.2012.07.006; Guo QH, 2012, J VOLCANOL GEOTH RES, V215, P61, DOI 10.1016/j.jvolgeores.2011.12.003; Hedlund BP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00157; Hedlund BP, 2012, GEOSCI FRONT, V3, P273, DOI 10.1016/j.gsf.2011.12.006; Hou WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053350; Hug K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00569; Ilgen AG, 2011, CHEM GEOL, V288, P115, DOI 10.1016/j.chemgeo.2011.07.010; Inskeep WP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00095; Inskeep WP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00067; Inskeep WP, 2004, GEOCHIM COSMOCHIM AC, V68, P3141, DOI 10.1016/j.gca.2003.09.020; Jackson CR, 2001, ENVIRON MICROBIOL, V3, P532, DOI 10.1046/j.1462-2920.2001.00221.x; Jay ZJ, 2014, APPL ENVIRON MICROB, V80, P294, DOI 10.1128/AEM.02860-13; Jiang Z, 2014, EXTREMOPHILES, V18, P161, DOI 10.1007/s00792-013-0608-7; Johnson DB, 2006, ARCH MICROBIOL, V185, P212, DOI 10.1007/s00203-006-0087-7; King CE, 2014, INT J SYST EVOL MICR, V64, P1244, DOI 10.1099/ijs.0.059675-0; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Kozubal M, 2008, APPL ENVIRON MICROB, V74, P942, DOI 10.1128/AEM.01200-07; Kozubal MA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00109; Langner HW, 2001, ENVIRON SCI TECHNOL, V35, P3302, DOI 10.1021/es0105562; Le XC, 2000, ENVIRON SCI TECHNOL, V34, P2342, DOI 10.1021/es991203u; Lee KCY, 2011, INT J SYST EVOL MICR, V61, P2482, DOI 10.1099/ijs.0.027235-0; Li P, 2013, GEOMICROBIOL J, V30, P897, DOI 10.1080/01490451.2013.791354; Lieutaud A, 2010, J BIOL CHEM, V285, P20433, DOI 10.1074/jbc.M110.113761; Lopez DL, 2012, SCI TOTAL ENVIRON, V429, P57, DOI 10.1016/j.scitotenv.2011.08.043; Macur RE, 2004, GEOBIOLOGY, V2, P163, DOI 10.1111/j.1472-4677.2004.00032.x; Macur RE, 2013, GEOBIOLOGY, V11, P86, DOI 10.1111/gbi.12015; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; McCleskey RB, 2004, APPL GEOCHEM, V19, P995, DOI 10.1016/j.apgeochem.2004.01.003; Ogawa Y, 2012, GEOCHIM COSMOCHIM AC, V86, P367, DOI 10.1016/j.gca.2012.03.009; Pascua C, 2005, MINERAL MAG, V69, P897, DOI 10.1180/0026461056950297; Pascua C, 2006, ACTA GEOL SIN-ENGL, V80, P230; Perevalova AA, 2010, INT J SYST EVOL MICR, V60, P2082, DOI 10.1099/ijs.0.019042-0; Song J, 2015, J HAZARD MATER, V294, P70, DOI 10.1016/j.jhazmat.2015.03.048; Song ZQ, 2013, ENVIRON MICROBIOL, V15, P1160, DOI 10.1111/1462-2920.12025; Song ZQ, 2009, GEOMICROBIOL J, V26, P256, DOI 10.1080/01490450902892373; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07479; Wang YH, 2014, GEOMICROBIOL J, V31, P338, DOI 10.1080/01490451.2013.835886; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Xiang XY, 2003, EXTREMOPHILES, V7, P493, DOI 10.1007/s00792-003-0355-2	59	24	28	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146331	10.1371/journal.pone.0146331	http://dx.doi.org/10.1371/journal.pone.0146331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761709	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100030
J	Liang, CC; Liu, HL; Chang, SD; Chen, SH; Lee, TH				Liang, Ching-Chung; Liu, Ho-Ling; Chang, Shuenn-Dhy; Chen, Sheng-Hsien; Lee, Tsong-Hai			The Protective Effect of Human Umbilical Cord Blood CD34+Cells and Estradiol against Focal Cerebral Ischemia in Female Ovariectomized Rat: Cerebral MR Imaging and Immunohistochemical Study	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; BEHAVIORAL DEFICITS; DIFFUSION-PERFUSION; HIPPOCAMPAL CA1; CORTICAL AREAS; CD34(+) CELLS; EXPRESSION; STROKE; HYPERPERFUSION	Human umbilical cord blood derived CD34(+) stem cells are reported to mediate therapeutic effects in stroke animal models. Estrogen was known to protect against ischemic injury. The present study wished to investigate whether the protective effect of CD34(+) cells against ischemic injury can be reinforced with complemental estradiol treatment in female ovariectomized rat and its possible mechanism. Experiment 1 was to determine the best optimal timing of CD34(+) cell treatment for the neuroprotective effect after 60-min middle cerebral artery occlusion (MCAO). Experiment 2 was to evaluate the adjuvant effect of 17 beta-estradiol on CD34(+) cell neuroprotection after MCAO. Experiment 1 showed intravenous infusion with CD34(+) cells before MCAO (pre-treatment) caused less infarction size than those infused after MCAO (post-treatment) on 7T magnetic resonance T2-weighted images. Experiment 2 revealed infarction size was most significantly reduced after CD34(+) + estradiol pre-treatment. When compared with no treatment group, CD34(+) + estradiol pre-treatment showed significantly less ADC reduction at 2 h and 2 d, less CBF reduction at 2 h and less hyperperfusion at 2 d. The immunoreactivity of c-Fos, c-Jun and GFAP was attenuated, and BDNF showed significant recovery from 2 h to 2 d after MCAO, especially after CD34(+) + estradiol pre-treatment. The present study suggests pre-treatment with CD34(+) cells with complemental estradiol can be most protective against ischemic injury, which may act through stabilization of cerebral hemodynamics and normalization of the expressions of immediate early genes and BDNF.	[Liang, Ching-Chung; Chang, Shuenn-Dhy] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Female Urol Sect, Taoyuan, Taiwan; [Liang, Ching-Chung; Chang, Shuenn-Dhy; Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Liu, Ho-Ling] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Chen, Sheng-Hsien] Southern Taiwan Univ Sci & Technol, Inst Biotechnol, Tainan, Taiwan; [Lee, Tsong-Hai] Chang Gung Mem Hosp, Linkou Med Ctr, Stroke Sect, Dept Neurol, Taoyuan, Taiwan; [Lee, Tsong-Hai] Chang Gung Mem Hosp, Linkou Med Ctr, Stroke Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; University of Texas System; UTMD Anderson Cancer Center; Southern Taiwan University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lee, TH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	thlee@adm.cgmh.org.tw			National Science Council [NSC 99-2314-B-182A-043-MY3]; Chang Gung Memorial Hospital [CMRPG3C1201]; MOST [103-2314-B-182A-030-MY2, CMRPG3D0991-3]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); MOST	This work was funded by National Science Council grant NSC 99-2314-B-182A-043-MY3 (C.C.L.), Chang Gung Memorial Hospital grant CMRPG3C1201 (C.C.L.), and MOST 103-2314-B-182A-030-MY2 (T.H.L.), CMRPG3D0991-3 (T.H.L.).; We thank the assistance from the Molecular Imaging Center, Chang Gung Memorial Hospital Linkou Medical center, and technical support of CD34<SUP>+</SUP> purification from Research and Development Department, HealthBanks Biotech Co., Ltd. This work was supported by National Science Council grant NSC 99-2314-B-182A-043-MY3 (C.C.L.), Chang Gung Memorial Hospital grant CMRPG3C1201 (C.C.L.) and MOST 103-2314-B-182A-030-MY2 (T.H.L.), CMRPG3D0991-3 (T.H.L.).	Baird AE, 1998, J CEREBR BLOOD F MET, V18, P583, DOI 10.1097/00004647-199806000-00001; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen SH, 2007, SHOCK, V27, P663, DOI 10.1097/01.shk.0000248593.71388.40; Chi NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114909; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Hao HN, 2003, J HEMATOTH STEM CELL, V12, P23, DOI 10.1089/152581603321210109; HSU CY, 1993, STROKE, V24, pI78; Kidwell CS, 2001, NEUROLOGY, V57, P2015, DOI 10.1212/WNL.57.11.2015; Kiprianova I, 1999, J NEUROSCI RES, V56, P21, DOI 10.1002/(SICI)1097-4547(19990401)56:1<21::AID-JNR3>3.3.CO;2-H; Lee TH, 1996, BRAIN RES, V713, P199, DOI 10.1016/0006-8993(95)01510-8; Lee TH, 2004, J NEUROSCI RES, V76, P705, DOI 10.1002/jnr.20097; Lee TH, 1998, STROKE, V29, P1687, DOI 10.1161/01.STR.29.8.1687; Lee TH, 2006, BRAIN RES, V1116, P31, DOI 10.1016/j.brainres.2006.07.117; Lee TH, 2011, EXP NEUROL, V227, P314, DOI 10.1016/j.expneurol.2010.12.003; Lin TN, 2002, STROKE, V33, P2985, DOI 10.1161/01.STR.0000037675.97888.9D; Liu R, 2007, NEUROSCI LETT, V415, P237, DOI 10.1016/j.neulet.2007.01.074; Ma YL, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-118; MACFARLANE R, 1991, J NEUROSURG, V75, P845, DOI 10.3171/jns.1991.75.6.0845; Marchal G, 1996, BRAIN, V119, P409, DOI 10.1093/brain/119.2.409; Nystedt J, 2006, ACTA NEUROBIOL EXP, V66, P293; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Rau SW, 2003, J NEUROSCI, V23, P10487; SHIMOHAMA S, 1993, NEUROSCI LETT, V164, P55, DOI 10.1016/0304-3940(93)90856-G; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Valentim LM, 1999, NEUROSCIENCE, V91, P1291, DOI 10.1016/S0306-4522(98)00707-6; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Zhang QG, 2014, MOL CELL ENDOCRINOL, V389, P84, DOI 10.1016/j.mce.2013.12.019	30	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147133	10.1371/journal.pone.0147133	http://dx.doi.org/10.1371/journal.pone.0147133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760774	Green Submitted, gold, Green Published			2022-12-27	WOS:000368033100071
J	Vessieres, E; Dib, A; Bourreau, J; Lelievre, E; Custaud, MA; Lelievre-Pegorier, M; Loufrani, L; Henrion, D; Fassot, C				Vessieres, Emilie; Dib, Abdallah; Bourreau, Jennifer; Lelievre, Eric; Custaud, Marc-Antoine; Lelievre-Pegorier, Martine; Loufrani, Laurent; Henrion, Daniel; Fassot, Celine			Long Lasting Microvascular Tone Alteration in Rat Offspring Exposed In Utero to Maternal Hyperglycaemia	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; MICE LACKING; PROSTACYCLIN RECEPTOR; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; MECHANICAL-PROPERTIES; RENAL-FUNCTION; MYOGENIC TONE; NITRIC-OXIDE	Epidemiologic studies have demonstrated that cardiovascular risk is not only determined by conventional risk factors in adulthood, but also by early life events which may reprogram vascular function. To evaluate the effect of maternal diabetes on fetal programming of vascular tone in offspring and its evolution during adulthood, we investigated vascular reactivity of third order mesenteric arteries from diabetic mother offspring (DMO) and control mother offspring (CMO) aged 3 and 18 months. In arteries isolated from DMO the relaxation induced by prostacyclin analogues was reduced in both 3-and 18-month old animals although endothelium (acetylcholine)-mediated relaxation was reduced in 18-month old DMO only. Endothelium-independent (sodium nitroprusside) relaxation was not affected. Pressure-induced myogenic tone, which controls local blood flow, was reduced in 18-month old CMO compared to 3-month old CMO. Interestingly, myogenic tone was maintained at a high level in 18-month old DMO even though agonist-induced vasoconstriction was not altered. These perturbations, in 18-months old DMO rats, were associated with an increased pMLC/MLC, pPKA/PKA ratio and an activated RhoA protein. Thus, we highlighted perturbations in the reactivity of resistance mesenteric arteries in DMO, at as early as 3 months of age, followed by the maintenance of high myogenic tone in older rats. These modifications are in favour of excessive vasoconstrictor tone. These results evidenced a fetal programming of vascular functions of resistance arteries in adult rats exposed in utero to maternal diabetes, which could explain a re-setting of vascular functions and, at least in part, the occurrence of hypertension later in life.	[Vessieres, Emilie; Dib, Abdallah; Bourreau, Jennifer; Lelievre, Eric; Custaud, Marc-Antoine; Loufrani, Laurent; Henrion, Daniel; Fassot, Celine] Univ Angers, INSERM, U1083, CNRS,UMR 6214, Angers, France; [Vessieres, Emilie; Fassot, Celine] Cardiovasc Funct Vitro CARFI Platform, Angers, France; [Custaud, Marc-Antoine; Loufrani, Laurent; Henrion, Daniel] Univ Hosp CHU Angers, Angers, France; [Lelievre-Pegorier, Martine] Univ Paris 06, Cordeliers Res Ctr, INSERM, U872, Paris, France; [Lelievre-Pegorier, Martine] Univ Paris 05, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fassot, C (corresponding author), Univ Angers, INSERM, U1083, CNRS,UMR 6214, Angers, France.	celine.fassot@inserm.fr	Henrion, Daniel/J-8141-2015; Henrion, Daniel/N-7023-2015; Lelievre, Eric/M-2878-2015; Henrion, Daniel/AAK-1995-2021; Fassot, Celine/K-1494-2015	Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; lelievre, eric/0000-0002-4132-4023	SFD (Francophone Society of Diabetes); Fondation de France [2008002726]; Region des Pays de La Loire ART [2011-12354]	SFD (Francophone Society of Diabetes); Fondation de France(Fondation de France); Region des Pays de La Loire ART(Region Pays de la Loire)	This work was supported by research grants from SFD (Francophone Society of Diabetes), the "Fondation de France" (no. 2008002726) and "Region des Pays de La Loire ART no. 2011-12354".	Amri R, 1999, DIABETES, V48, P2240, DOI 10.2337/diabetes.48.11.2240; Arehart E, 2008, CIRC RES, V102, P986, DOI 10.1161/CIRCRESAHA.107.165936; Barker DJP, 2005, J AM SOC NEPHROL, V16, P2537, DOI 10.1681/ASN.2005020160; Kang KB, 2007, N-S ARCH PHARMACOL, V375, P273, DOI 10.1007/s00210-007-0153-y; Bonacasa B, 2011, MICROCIRCULATION, V18, P270, DOI 10.1111/j.1549-8719.2011.00088.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Chinnathambi V, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111542; Chinnathambi V, 2013, HYPERTENSION, V61, P647, DOI 10.1161/HYPERTENSIONAHA.111.00486; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; de Chantemele EJB, 2008, ARTERIOSCL THROM VAS, V28, P2216, DOI 10.1161/ATVBAHA.108.171751; Dubroca C, 2005, HYPERTENSION, V45, P974, DOI 10.1161/01.HYP.0000164582.63421.2d; Fassot C, 2008, J HYPERTENS, V26, P747, DOI 10.1097/HJH.0b013e3282f4b3d0; Franco MDP, 2002, CARDIOVASC RES, V56, P145, DOI 10.1016/S0008-6363(02)00508-4; Francois H, 2005, CELL METAB, V2, P201, DOI 10.1016/j.cmet.2005.08.005; Fujino T, 2004, J CLIN INVEST, V114, P805, DOI 10.1172/JCI200421382; Ghulmiyyah LM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.015; Giles TD, 2012, J CLIN HYPERTENS, V14, P198, DOI 10.1111/j.1751-7176.2012.00606.x; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gomes GN, 2011, BRAZ J MED BIOL RES, V44, P899, DOI 10.1590/S0100-879X2011000900011; Gros R, 2002, AM J PHYSIOL-HEART C, V282, pH380, DOI 10.1152/ajpheart.2002.282.1.H380; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Hoefer J, 2010, CIRC RES, V107, P923, DOI 10.1161/CIRCRESAHA.110.226464; Holemans K, 1999, BRIT J NUTR, V81, P73, DOI 10.1017/S0007114599000173; Hu J, 1998, J MATERN-FETAL INVES, V8, P185; HUANG A, 1993, HYPERTENSION, V22, P913, DOI 10.1161/01.HYP.22.6.913; Hughes JA, 2002, EXP PHYSIOL, V87, P527, DOI 10.1113/eph8702399; Ibrahim S, 2010, ARTERIOSCL THROM VAS, V30, P1802, DOI 10.1161/ATVBAHA.110.208900; Ingelfinger JR, 2007, NEW ENGL J MED, V356, P2093, DOI 10.1056/NEJMe078071; Jones JE, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/584831; Lamireau D, 2002, STROKE, V33, P2992, DOI 10.1161/01.STR.0000039340.62995.F2; Loufrani L, 2002, CIRC RES, V91, P1183, DOI 10.1161/01.RES.0000047505.11002.81; Loufrani L, 2001, CIRCULATION, V103, P864, DOI 10.1161/01.CIR.103.6.864; Massett MP, 2002, AM J PHYSIOL-HEART C, V283, pH2282, DOI 10.1152/ajpheart.00544.2002; Moustafa-Bayoumi M, 2007, J BIOL CHEM, V282, P37632, DOI 10.1074/jbc.M703227200; Muller-Delp J, 2002, AM J PHYSIOL-HEART C, V282, pH1843, DOI 10.1152/ajpheart.00666.2001; MULVANY MJ, 1990, PHYSIOL REV, V70, P921, DOI 10.1152/physrev.1990.70.4.921; Nehiri T, 2008, DIABETES, V57, P2167, DOI 10.2337/db07-0780; Painter RC, 2007, J HYPERTENS, V25, P533, DOI 10.1097/HJH.0b013e328012135b; Retailleau K, 2013, ARTERIOSCL THROM VAS, V33, P339, DOI 10.1161/ATVBAHA.112.300708; Rocha SO, 2005, PEDIATR RES, V58, P1274, DOI 10.1203/01.pdr.0000188698.58021.ff; Rodford JL, 2008, J PHYSIOL-LONDON, V586, P4709, DOI 10.1113/jphysiol.2008.156976; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Sathishkumar K, 2011, EARLY HUM DEV, V87, P407, DOI 10.1016/j.earlhumdev.2011.03.001; Schubert R, 1999, AM J PHYSIOL-HEART C, V277, pH1145, DOI 10.1152/ajpheart.1999.277.3.H1145; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Stitham J, 2007, GENE, V396, P180, DOI 10.1016/j.gene.2007.03.016; Tang EHC, 2008, PHYSIOL GENOMICS, V32, P409, DOI 10.1152/physiolgenomics.00136.2007; Tarry-Adkins JL, 2011, AM J CLIN NUTR, V94, p1765S, DOI 10.3945/ajcn.110.000620; Torrens C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050671; Van Huyen JPD, 2010, DIABETES, V59, P2597, DOI 10.2337/db10-0311; Wang PL, 1998, AM J PHYSIOL-GASTR L, V275, pG1454, DOI 10.1152/ajpgi.1998.275.6.G1454; Watanabe H, 2005, CIRC J, V69, P124, DOI 10.1253/circj.69.124; Yokoyama C, 2002, CIRCULATION, V106, P2397, DOI 10.1161/01.CIR.0000034733.93020.BC	56	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146830	10.1371/journal.pone.0146830	http://dx.doi.org/10.1371/journal.pone.0146830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756337	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800033
J	Daku, RM; Rabbi, F; Buttigieg, J; Coulson, IM; Horne, D; Martens, G; Ashton, NW; Suh, DY				Daku, Rhys M.; Rabbi, Fazle; Buttigieg, Josef; Coulson, Ian M.; Horne, Derrick; Martens, Garnet; Ashton, Neil W.; Suh, Dae-Yeon			PpASCL, the Physcomitrella patens Anther-Specific Chalcone Synthase-Like Enzyme Implicated in Sporopollenin Biosynthesis, Is Needed for Integrity of the Moss Spore Wall and Spore Viability	PLOS ONE			English	Article							POLLEN EXINE DEVELOPMENT; FUNCTIONAL-ANALYSIS; ANCESTRAL ROLES; KNOX GENES; LAND; ACID; EXPRESSION; SIMILARITY; MUTANTS; REVEALS	Sporopollenin is the main constituent of the exine layer of spore and pollen walls. The anther-specific chalcone synthase-like (ASCL) enzyme of Physcomitrella patens, PpASCL, has previously been implicated in the biosynthesis of sporopollenin, the main constituent of exine and perine, the two outermost layers of the moss spore cell wall. We made targeted knockouts of the corresponding gene, PpASCL, and phenotypically characterized ascl sporophytes and spores at different developmental stages. Ascl plants developed normally until late in sporophytic development, when the spores produced were structurally aberrant and inviable. The development of the ascl spore cell wall appeared to be arrested early in microspore development, resulting in small, collapsed spores with altered surface morphology. The typical stratification of the spore cell wall was absent with only an abnormal perine recognisable above an amorphous layer possibly representing remnants of compromised intine and/or exine. Equivalent resistance of the spore walls of ascl mutants and the control strain to acetolysis suggests the presence of chemically inert, defective sporopollenin in the mutants. Anatomical abnormalities of late-stage ascl sporophytes include a persistent large columella and an air space incompletely filled with spores. Our results indicate that the evolutionarily conserved PpASCL gene is needed for proper construction of the spore wall and for normal maturation and viability of moss spores.	[Daku, Rhys M.; Rabbi, Fazle; Suh, Dae-Yeon] Univ Regina, Dept Chem & Biochem, Regina, SK S4S 0A2, Canada; [Buttigieg, Josef; Ashton, Neil W.] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [Coulson, Ian M.] Univ Regina, Dept Geol, Regina, SK S4S 0A2, Canada; [Horne, Derrick; Martens, Garnet] Univ British Columbia, BioImaging Facil, Vancouver, BC, Canada	University of Regina; University of Regina; University of Regina; University of British Columbia	Ashton, NW (corresponding author), Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada.	Neil.Ashton@uregina.ca; suhdaey@uregina.ca	Suh, Dae-Yeon/AFU-3630-2022	Suh, Dae-Yeon/0000-0003-4094-5132	Natural Sciences and Engineering Research Council of Canada [262038-2013, 2982-2008]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (262038-2013, www.nserc-crsng.gc.ca, to DYS) and Natural Sciences and Engineering Research Council of Canada (2982-2008, www.nserc-crsng.gc.ca, to NWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; ASHTON NW, 1985, PLANTA, V164, P142, DOI 10.1007/BF00391040; Ashton NW, 2000, NEW PHYTOL, V146, P391, DOI 10.1046/j.1469-8137.2000.00671.x; Aya K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1552; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Boyd PJ, 1988, METHODS BRYOLOGY, P47; Chen WW, 2011, PLANT PHYSIOL, V157, P842, DOI 10.1104/pp.111.181693; Colpitts CC, 2011, NEW PHYTOL, V192, P855, DOI 10.1111/j.1469-8137.2011.03858.x; COURTICE GRM, 1978, J BRYOL, V10, P191, DOI 10.1179/jbr.1978.10.2.191; Dobritsa AA, 2010, PLANT PHYSIOL, V153, P937, DOI 10.1104/pp.110.157446; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Dominguez E, 1999, SEX PLANT REPROD, V12, P171, DOI 10.1007/s004970050189; ENGEL PP, 1968, AM J BOT, V55, P438, DOI 10.2307/2440573; Fraser WT, 2012, NEW PHYTOL, V196, P397, DOI 10.1111/j.1469-8137.2012.04301.x; Grienenberger E, 2010, PLANT CELL, V22, P4067, DOI 10.1105/tpc.110.080036; GRIMSLEY NH, 1977, MOL GEN GENET, V154, P97, DOI 10.1007/BF00265582; Hiss M, 2014, PLANT J, V79, P530, DOI 10.1111/tpj.12572; Hohe A, 2004, CURR GENET, V44, P339, DOI 10.1007/s00294-003-0458-4; Jepson C, 2014, FEBS J, V281, P3855, DOI 10.1111/febs.12920; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kim SS, 2013, J PLANT BIOL, V56, P1, DOI 10.1007/s12374-012-0385-3; Kim SS, 2010, PLANT CELL, V22, P4045, DOI 10.1105/tpc.110.080028; Lang D, 2008, TRENDS PLANT SCI, V13, P542, DOI 10.1016/j.tplants.2008.07.002; Morant M, 2007, PLANT CELL, V19, P1473, DOI 10.1105/tpc.106.045948; O'Donoghue MT, 2013, J EXP BOT, V64, P3567, DOI 10.1093/jxb/ert190; Peterson R., 2010, International Journal of Plant Biology, V1, P66; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Renzaglia KS, 2007, BRYOLOGIST, V110, P179, DOI 10.1639/0007-2745(2007)110[179:BPATMA]2.0.CO;2; Rozema J, 2001, J PHOTOCH PHOTOBIO B, V62, P108, DOI 10.1016/S1011-1344(01)00155-5; Sakakibara K, 2008, EVOL DEV, V10, P555, DOI 10.1111/j.1525-142X.2008.00271.x; Schuette S, 2009, ANN BOT-LONDON, V103, P749, DOI 10.1093/aob/mcn268; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; Singer SD, 2007, PLANT CELL REP, V26, P1155, DOI 10.1007/s00299-007-0312-0; Souza CD, 2009, PLANT CELL, V21, P507, DOI 10.1105/tpc.108.062513; Tang LK, 2009, NEW PHYTOL, V181, P576, DOI 10.1111/j.1469-8137.2008.02692.x; Wallace S, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr027; Wallace S, 2015, NEW PHYTOL, V205, P390, DOI 10.1111/nph.13012; Wang YB, 2013, PHYSIOL PLANTARUM, V149, P13, DOI 10.1111/ppl.12018; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884	43	21	21	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146817	10.1371/journal.pone.0146817	http://dx.doi.org/10.1371/journal.pone.0146817			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752629	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100157
J	Ding, SG; Wang, XW; Chen, W; Fang, Y; Liu, BY; Liu, Y; Fei, GH; Wang, LD				Ding, Shenggang; Wang, Xiaowu; Chen, Wei; Fang, Yuan; Liu, Boyu; Liu, Yan; Fei, Guanghe; Wang, Linding			Decreased Interleukin-10 Responses in Children with Severe Mycoplasma pneumoniae Pneumonia	PLOS ONE			English	Article							PULMONARY-DISEASE; EPITHELIAL-CELLS; GENE-EXPRESSION; RISK-FACTORS; INFECTION; MICE; LYSATE; IL-8	Several cytokines may play roles in the immunological pathogenesis of mycoplasmal pneumonia caused by Mycoplasma pneumoniae. In this study, we investigated serum cytokine profiles in children with mycoplasmal pneumonia. The serum levels of interleukin (IL)-8, IL-10, and IL-18 were examined using ELISA kits in 34 patients with M. pneumoniae infection (Group 1, 11 with severe mycoplasmal pneumonia; Group 2, 13 with mild mycoplasmal pneumonia; Group 3, 10 with asthma) and 32 age-matched, non-infected controls. The serum levels of IL-8, IL-10, and IL-18 increased significantly in patients with mycoplasmal pneumonia compared with those in controls (P < 0.01). The serum levels of IL-10 decreased significantly in Group 1 compared with those in Group 2 (P < 0.01). The serum levels of IL-18 increased significantly in Group 1 compared with those in Group 2 (P < 0.01). The serum levels of IL-10 and IL-18 decreased significantly in 10 M. pneumoniae-infected patients with asthma compared with those in 24 M. pneumoniae-infected patients without asthma (P < 0.01). We examined the level of interleukins (IL-8, IL-10 and IL-18) after the patients started therapy. The data showed that IL-18 were lower after therapy (P < 0.01). Collectively, our data suggested that these cytokines may be involved in the pathogenesis of mycoplasmal pneumonia.	[Ding, Shenggang] Anhui Med Univ, Affiliated Hosp 1, Dept Pediat, Hefei, Anhui, Peoples R China; [Wang, Xiaowu; Chen, Wei; Fang, Yuan; Liu, Boyu; Liu, Yan; Wang, Linding] Anhui Med Univ, Dept Microbiol, Hefei, Anhui, Peoples R China; [Fei, Guanghe] Anhui Med Univ, Affiliated Hosp 1, Dept Resp Med, Hefei, Anhui, Peoples R China; [Wang, Xiaowu] Fuyang Second Peoples Hosp, Dept Clin Lab, Fuyang, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Fei, GH (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Resp Med, Hefei, Anhui, Peoples R China.	guanghefei@126.com; wanglinding@ahmu.edu.cn	ding, shenggang/ABC-7274-2021		National Science Foundation of China [81271837, 81571963]; Natural Science Foundation Key project of Anhui Education Department [KJ2012A161, KJ2015A020]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Key project of Anhui Education Department	This work was supported by National Science Foundation of China (Grant No. 81271837, 81571963) and Natural Science Foundation Key project of Anhui Education Department (KJ2012A161, KJ2015A020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arae K, 2011, MICROBIOL IMMUNOL, V55, P748, DOI 10.1111/j.1348-0421.2011.00375.x; Chen ZR, 2013, DIAGN MICR INFEC DIS, V77, P362, DOI 10.1016/j.diagmicrobio.2013.09.006; Chmura K, 2008, AM J PHYSIOL-LUNG C, V295, pL220, DOI 10.1152/ajplung.90204.2008; Chung HL, 2011, CYTOKINE, V54, P218, DOI 10.1016/j.cyto.2011.02.008; CLYDE WA, 1993, CLIN INFECT DIS, V17, pS32; Esposito S, 2002, PEDIATR PULM, V34, P122, DOI 10.1002/ppul.10139; Glehen O, 2003, HEPATO-GASTROENTEROL, V50, P670; Hassan J, 2008, HUM IMMUNOL, V69, P851, DOI 10.1016/j.humimm.2008.09.003; Hayakawa M, 2002, CLIN DIAGN LAB IMMUN, V9, P669, DOI 10.1128/CDLI.9.3.669-676.2002; Huijskens EG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-276; Izumikawa K, 2014, J INFECT CHEMOTHER, V20, P181, DOI 10.1016/j.jiac.2013.09.009; Key NK, 2009, PEDIATR PULM, V44, P249, DOI 10.1002/ppul.20988; Lee KE, 2013, J CLIN IMMUNOL, V33, P1117, DOI 10.1007/s10875-013-9909-y; Mathisen Maria, 2010, Pediatr Infect Dis J, V29, pe1, DOI 10.1097/INF.0b013e3181c2a1b9; Mizukane R, 2002, RESPIRATION, V69, P87, DOI 10.1159/000049377; Narita M, 2000, CLIN DIAGN LAB IMMUN, V7, P909, DOI 10.1128/CDLI.7.6.909-914.2000; Narita M, 2001, CLIN DIAGN LAB IMMUN, V8, P1028, DOI 10.1128/CDLI.8.5.1028-1030.2001; Oishi T, 2011, J INFECT CHEMOTHER, V17, P803, DOI 10.1007/s10156-011-0265-7; Othman N, 2008, PEDIATR INT, V50, P662, DOI 10.1111/j.1442-200X.2008.02644.x; Pang Huan-Xiang, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P808; PIETSCH K, 1994, MICROBIOL-UK, V140, P2043, DOI 10.1099/13500872-140-8-2043; Salvatore CM, 2008, INFECT IMMUN, V76, P732, DOI 10.1128/IAI.00878-07; Seo Young Ho, 2014, Korean J Pediatr, V57, P186, DOI 10.3345/kjp.2014.57.4.186; Sohn MH, 2005, CHEST, V128, P322, DOI 10.1378/chest.128.1.322; Tanaka H, 2002, CHEST, V121, P1493, DOI 10.1378/chest.121.5.1493	25	21	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146397	10.1371/journal.pone.0146397	http://dx.doi.org/10.1371/journal.pone.0146397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751073	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100075
J	Gungor, B; Adiguzel, E; Gursel, I; Yilmaz, B; Gursel, M				Gungor, Bilgi; Adiguzel, Emre; Gursel, Ihsan; Yilmaz, Bilge; Gursel, Mayda			Intestinal Microbiota in Patients with Spinal Cord Injury	PLOS ONE			English	Article							COMMENSAL BACTERIA; BOWEL DYSFUNCTION; GUT MICROBIOTA; ACTIVATION; MICROGLIA; BUTYRATE; BRAIN; MOTOR	Human intestinal flora comprises thousands of bacterial species. Growth and composition of intestinal microbiota is dependent on various parameters, including immune mechanisms, dietary factors and intestinal motility. Patients with spinal cord injury (SCI) frequently display neurogenic bowel dysfunction due to the absence of central nervous system control over the gastrointestinal system. Considering the bowel dysfunction and altered colonic transit time in patients with SCI, we hypothesized the presence of a significant change in the composition of their gut microbiome. The objective of this study was to characterize the gut microbiota in adult SCI patients with different types of bowel dysfunction. We tested our hypothesis on 30 SCI patients (15 upper motor neuron [UMN] bowel syndrome, 15 lower motor neuron [LMN] bowel syndrome) and 10 healthy controls using the 16S rRNA sequencing. Gut microbial patterns were sampled from feces. Independent of study groups, gut microbiota of the participants were dominated by Blautia, Bifidobacterium, Faecalibacterium and Ruminococcus. When we compared all study groups, Roseburia, Pseudobutyrivibrio, Dialister, Marvinbryantia and Megamonas appeared as the genera that were statistically different between groups. In comparison to the healthy group, total bacterial counts of Pseudobutyrivibrio, Dialister and Megamonas genera were significantly lower in UMN bowel dysfunction group. The total bacterial count of Marvinbryantia genus was significantly lower in UMN bowel dysfunction group when compared to the LMN group. Total bacterial counts of Roseburia, Pseudobutyrivibrio and Megamonas genera were significantly lower in LMN bowel dysfunction group when compared to healthy groups. Our results demonstrate for the first time that butyrate-producing members are specifically reduced in SCI patients when compared to healthy subjects. The results of this study would be of interest since to our knowledge, microbiome-associated studies targeting SCI patients are non-existent and the results might help explain possible implications of gut microbiome in SCI.	[Gungor, Bilgi; Gursel, Mayda] Middle E Tech Univ, Dept Mol Biol & Genet, TR-06531 Ankara, Turkey; [Adiguzel, Emre; Yilmaz, Bilge] Gulhane Mil Med Acad, Dept PMR, Turkish Armed Forces Rehabil Ctr, Ankara, Turkey; [Gursel, Ihsan] Bilkent Univ, Dept Mol Biol & Genet, THORLAB, Ankara, Turkey	Middle East Technical University; Gaziler Physical Therapy & Research Hospital; Gulhane Military Medical Academy; Turkish Armed Forces Rehabilitation & Maintenance Center; Ihsan Dogramaci Bilkent University	Yilmaz, B (corresponding author), Gulhane Mil Med Acad, Dept PMR, Turkish Armed Forces Rehabil Ctr, Ankara, Turkey.	biyilmaz@gata.edu.tr; mgursel@metu.edu.tr	Gursel, M/H-1812-2012; YILMAZ, Bilge/A-7428-2013; Adiguzel, Emre/G-9138-2015; YILMAZ, Bilge/W-6481-2019; Gursel, Ihsan/AAT-7168-2021	Gursel, M/0000-0003-0044-9054; YILMAZ, Bilge/0000-0003-1173-9399; Adiguzel, Emre/0000-0002-2447-5065; YILMAZ, Bilge/0000-0003-1173-9399; Gursel, Ihsan/0000-0003-3761-1166	METU-GATA collaborative grant [BAP-08-11-2013-005]; Agency, Middle East Technical University; Agency, Gulhane Askeri Tip Akademisi	METU-GATA collaborative grant(Middle East Technical University); Agency, Middle East Technical University(Middle East Technical University); Agency, Gulhane Askeri Tip Akademisi	This project was supported by a METU-GATA collaborative grant to MG and BY (BAP-08-11-2013-005). Supporting Agencies, Middle East Technical University, and Gulhane Askeri Tip Akademisi.	[Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Collins S, 2009, DIGEST DIS, V27, P85, DOI 10.1159/000268126; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dantzer R, 2000, AUTON NEUROSCI-BASIC, V85, P60, DOI 10.1016/S1566-0702(00)00220-4; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Forsythe P, 2013, CELL MOL LIFE SCI, V70, P55, DOI 10.1007/s00018-012-1028-z; Fynne L, 2012, ACTA NEUROL SCAND, V125, P123, DOI 10.1111/j.1600-0404.2011.01508.x; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; LONGO WE, 1989, DIS COLON RECTUM, V32, P261, DOI 10.1007/BF02554543; Paillard D, 2007, ANTON LEEUW INT J G, V91, P417, DOI 10.1007/s10482-006-9121-7; Park JS, 2005, J NEUROIMMUNOL, V168, P56, DOI 10.1016/j.jneuroim.2005.07.003; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Roediger W E, 1989, Acta Vet Scand Suppl, V86, P116; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Singal A K, 2006, Adv Med Sci, V51, P15; Stiens SA, 1997, ARCH PHYS MED REHAB, V78, pS86, DOI 10.1016/S0003-9993(97)90416-0; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Valles M, 2009, DIS COLON RECTUM, V52, P1589, DOI 10.1007/DCR.0b013e3181a873f3; Vitkovic L, 2000, MOL PSYCHIATR, V5, P604, DOI 10.1038/sj.mp.4000813; Watkins LR, 2001, PAIN, V93, P201, DOI 10.1016/S0304-3959(01)00359-1; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3	31	80	90	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145878	10.1371/journal.pone.0145878	http://dx.doi.org/10.1371/journal.pone.0145878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752409	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100029
J	Guo, YY; Huang, LQ; Liu, ZJ; Wang, XQ				Guo, Yan-Yan; Huang, Lai-Qiang; Liu, Zhong-Jian; Wang, Xiao-Quan			Promise and Challenge of DNA Barcoding in Venus Slipper (Paphiopedilum)	PLOS ONE			English	Article							LAND PLANTS; UNIVERSAL BARCODE; IDENTIFICATION; L.; ORCHIDACEAE; LOCI; DISCRIMINATE; EVOLUTION; TAXONOMY; REGIONS	Orchidaceae are one of the largest families of flowering plants, with over 27,000 species described and all orchids are listed in CITES. Moreover, the seedlings of orchid species from the same genus are similar. The objective of DNA barcoding is rapid, accurate, and automated species identification, which may be used to identify illegally traded endangered species from vegetative specimens of Paphiopedilum (Venus slipper), a flagship group for plant conservation with high ornamental and commercial values. Here, we selected eight chloroplast barcodes and nrITS to evaluate their suitability in Venus slippers. The results indicate that all tested barcodes had no barcoding gap and the core plant barcodes showed low resolution for the identification of Venus slippers (18.86%). Of the single-locus barcodes, nrITS is the most efficient for the species identification of the genus (52.27%), whereas matK + atpF-atpH is the most efficient multi-locus combination (28.97%). Therefore, we recommend the combination of matK + atpF-atpH + ITS as a barcode for Venus slippers. Furthermore, there is an upper limit of resolution of the candidate barcodes, and only half of the taxa with multiple samples were identified successfully. The low efficiency of these candidate barcodes in Venus slippers may be caused by relatively recent speciation, the upper limit of the barcodes, and/or the sampling density. Although the discriminatory power is relatively low, DNA barcoding may be a promising tool to identify species involved in illegal trade, which has broad applications and is valuable for orchid conservation.	[Guo, Yan-Yan; Liu, Zhong-Jian] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Guo, Yan-Yan; Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Guo, Yan-Yan; Huang, Lai-Qiang] Tsinghua Univ, Grad Sch Shenzhen, Ctr Biotechnol & BioMed, Shenzhen 518057, Peoples R China; [Guo, Yan-Yan; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chinese Academy of Sciences; Institute of Botany, CAS	Liu, ZJ (corresponding author), Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China.	liuzj@sinicaorchid.org; xiaoq_wang@ibcas.ac.cn			National Natural Science Foundation of China [30730010, 31300179]; Chinese Academy of Sciences (the 100-Talent Project); China Postdoctoral Science Foundation [2014M550712]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (the 100-Talent Project); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the National Natural Science Foundation of China (Grant No. 30730010, 31300179), the Chinese Academy of Sciences (the 100-Talent Project), and the General Financial Grant from the China Postdoctoral Science Foundation (Grant No. 2014M550712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Alves TLS, 2014, MOL ECOL RESOUR, V14, P324, DOI 10.1111/1755-0998.12182; Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Averyanov L.V., 2003, SLIPPER ORCHIDS VIET; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chochai A, 2012, BOT J LINN SOC, V170, P176, DOI 10.1111/j.1095-8339.2012.01293.x; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Cribb P., 1998, GENUS PAPHIOPEDILUM; Cribb P.J., 2003, ORCHID CONSERVATION, P1; Cribb Phillip, 2005, Curtis's Botanical Magazine, V22, P12, DOI 10.1111/j.1355-4905.2005.00455.x; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Farrington L, 2009, AUST J BOT, V57, P276, DOI 10.1071/BT08138; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Federici S, 2013, BOT J LINN SOC, V171, P687, DOI 10.1111/boj.12034; Feng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071710; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Gu J, 2011, J SYST EVOL, V49, P213, DOI 10.1111/j.1759-6831.2011.00136.x; Guo YY, 2015, MOL ECOL, V24, P2838, DOI 10.1111/mec.13189; Guo YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038788; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Kim HM, 2014, MOL ECOL RESOUR, V14, P499, DOI 10.1111/1755-0998.12207; Koopowitz H, 2008, TROPICAL SLIPPER ORC; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li FW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026597; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Little DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081008; Liu ZJ, 2009, GENUS PAPHIOPEDILUM; Maia VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029877; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Morrison Cheryl L., 2005, Selbyana, V26, P196; Mort ME, 2010, TAXON, V59, P581, DOI 10.1002/tax.592022; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Palmer J. D., 1992, MOL SYSTEMATICS PLAN, P36, DOI DOI 10.1007/978-1-4615-3276-7; Parveen I, 2012, MOL ECOL RESOUR, V12, P82, DOI 10.1111/j.1755-0998.2011.03071.x; Pecnikar ZF, 2014, J APPL GENET, V55, P43, DOI 10.1007/s13353-013-0180-y; Percy DM, 2014, MOL ECOL, V23, P4737, DOI 10.1111/mec.12837; Quan X, 2011, J SYST EVOL, V49, P138, DOI 10.1111/j.1759-6831.2010.00112.x; Ran JH, 2010, J INTEGR PLANT BIOL, V52, P1109, DOI 10.1111/j.1744-7909.2010.00995.x; Ravikanth G, 2011, CURR SCI INDIA, V101, P269; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Ren H, 2011, J SYST EVOL, V49, P411, DOI 10.1111/j.1759-6831.2011.00152.x; Roberts DL, 2008, CURR BIOL, V18, pR325, DOI 10.1016/j.cub.2008.02.026; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Simeone MC, 2013, BOT J LINN SOC, V172, P478, DOI 10.1111/boj.12059; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Sun XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032057; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai CC, 2012, SCI HORTIC-AMSTERDAM, V142, P84, DOI 10.1016/j.scienta.2012.05.004; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; Xiang XG, 2011, J SYST EVOL, V49, P252, DOI 10.1111/j.1759-6831.2011.00116.x; Xu SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115168; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Yuan QJ, 2015, MOL ECOL RESOUR, V15, P358, DOI 10.1111/1755-0998.12296; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zuo YJ, 2011, PLANTA MED, V77, P182, DOI 10.1055/s-0030-1250166	75	20	20	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146880	10.1371/journal.pone.0146880	http://dx.doi.org/10.1371/journal.pone.0146880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752741	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888100172
J	Ke, CC; Lai, HC; Lin, CH; Hung, CJ; Chen, DY; Sheu, WHH; Lui, PW				Ke, Chi-Chen; Lai, Hui-Chin; Lin, Ching-Heng; Hung, Chih-Jen; Chen, Der-Yuan; Sheu, Wayne H-H.; Lui, Ping-Wing			Increased Risk of Herpes Zoster in Diabetic Patients Comorbid with Coronary Artery Disease and Microvascular Disorders: A Population-Based Study in Taiwan	PLOS ONE			English	Article							CARDIOVASCULAR RISK; VIRUS; COHORT; PATHOGENESIS; MELLITUS; US	We investigated the association between the risk of herpes zoster (HZ) and diabetes-related macrovascular comorbidities and microvascular disorders in diabetic patients. This retrospective study included 25,345 patients with newly identified HZ and age-and gender-matched controls retrieved from the National Health Insurance Research Database in Taiwan during the period of 2005 to 2011. Multivariate logistic regression analyses were used to calculate the odds ratios (OR) and to assess the risk factors for HZ in diabetic patients with associated macrovascular or microvascular disorders. Risk factors for HZ were significantly increased in cases of diabetes mellitus (DM) compared with those in cases of non-DM controls (20.2% vs. 17.0%, OR = 1.24, p < 0.001). Results of age-and gender-adjusted analyses demonstrated a significantly higher risk of HZ in DM patients with accompanying coronary artery disease (CAD) (adjusted OR = 1.21, p < 0.001) and microvascular disorders (aOR = 1.32, p < 0.001) than in DM patients with other comorbidities but no microvascular disorders. Patients who took thiazolidinedione, alpha-glucosidase inhibitors and insulin had a higher HZ risk than those taking metformin or sulphonylureas alone (aOR = 1.11, 1.14 and 1.18, p < 0.001, respectively). Patients who took insulin alone or in combination with other antidiabetic agents had a significantly higher risk of HZ (aOR = 1.25, p < 0.001) than those who received monotherapy. Diabetic patients comorbid with coronary artery disease and associated microvascular disorders had an increased risk of HZ occurrence.	[Ke, Chi-Chen; Lai, Hui-Chin; Hung, Chih-Jen; Lui, Ping-Wing] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Lin, Ching-Heng; Lui, Ping-Wing] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Taichung, Taiwan; [Sheu, Wayne H-H.] Taichung Vet Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Taichung, Taiwan; [Lui, Ping-Wing] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Lui, PW (corresponding author), Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan.	superanesthesia@gmail.com						Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Asia Pacific Cohort Collaboration, 2007, DIABETOLOGIA, V50, P2289, DOI 10.1007/s00125-007-0801-2; Backteman K, 2014, T CELLS NK CELLS COR, P1409; Breuer J, 2014, NEUROLOGY, V82, P206, DOI 10.1212/WNL.0000000000000038; Giubilato S, 2011, EUR HEART J, V32, P1214, DOI 10.1093/eurheartj/ehq499; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Guignard AP, 2014, INFECTION, V42, P729, DOI 10.1007/s15010-014-0645-x; Heymann AD, 2008, INFECTION, V36, P226, DOI 10.1007/s15010-007-6347-x; Jacob H S, 1992, Trans Am Clin Climatol Assoc, V103, P95; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Joesoef RM, 2012, MAYO CLIN PROC, V87, P961, DOI 10.1016/j.mayocp.2012.05.021; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; Legein B, 2013, CELL MOL LIFE SCI, V70, P3847, DOI 10.1007/s00018-013-1289-1; LUNGU O, 1995, P NATL ACAD SCI USA, V92, P10980, DOI 10.1073/pnas.92.24.10980; Nagasako Elna M., 2003, Journal of Medical Virology, V70, pS20, DOI 10.1002/jmv.10315; Nagel MA, 2014, J NEUROVIROL, V20, P157, DOI 10.1007/s13365-013-0183-9; Park HB, 2004, J RHEUMATOL, V31, P2151; Pedicino D, 2012, PATHOPHYSIOLOGY COMP, P45, DOI [10.5772/50611, DOI 10.5772/50611]; Pedicino D, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/184258; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; PYORALA K, 1987, Diabetes Metabolism Reviews, V3, P463; Scheen AJ, 2015, DIABETES METAB; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Struijs JN, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-84; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Vossen MTM, 2004, J INFECT DIS, V190, P72, DOI 10.1086/421277; Xiu F, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/486403	28	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146750	10.1371/journal.pone.0146750	http://dx.doi.org/10.1371/journal.pone.0146750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751202	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100146
J	Yeh, JK; Hsiao, YC; Jian, CR; Wang, CH; Wen, MS; Kuo, CT; Tsai, FC; Wu, VCC; Chen, TH				Yeh, Jih-Kai; Hsiao, Yuan-Chuan; Jian, Cian-Ruei; Wang, Chao-Hung; Wen, Ming-Shien; Kuo, Chi-Tai; Tsai, Feng-Chun; Wu, Victor Chien-Chia; Chen, Tien-Hsing			Comparison of Baseline versus Posttreatment Left Ventricular Ejection Fraction in Patients with Acute Decompensated Heart Failure for Predicting Cardiovascular Outcome: Implications from Single-Center Systolic Heart Failure Cohort	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; IMPROVEMENT; SURVIVAL; REHOSPITALIZATION; DETERMINANTS; PROGNOSIS; MORTALITY	Aims The prognostic values of left ventricular ejection fraction (LVEF) during heart failure (HF) with acute decompensation or after optimal treatment have not been extensively studied. We hypothesized that posttreatment LVEF has superior predictive value for long-term prognosis than LVEF at admission does. Methods and Results In Protocol 1, 428 acute decompensated HF (ADHF) patients with LVEF <= 35% in a tertiary medical center were enrolled and followed for a mean period of 34.7 +/- 10.8 months. The primary and secondary end points were all-cause mortality and HF readmission, respectively. In total, 86 deaths and 240 HF readmissions were recorded. The predictive values of baseline LVEF at admission and LVEF 6 months posttreatment were analyzed and compared. The posttreatment LVEFs were predictive for future events (P = 0.01 for all-cause mortality, P < 0.001 for HF readmission), but the baseline LVEFs were not. In Protocol 2, the outcomes of patients with improved LVEF (change of LVEF: >=+10%), unchanged LVEF (change of LVEF: -10% to +10%), and reduced LVEF (change of LVEF: <=-10%) were analyzed and compared. Improved LVEF occurred in 171 patients and was associated with a superior long-term prognosis among all groups (P = 0.02 for all-cause mortality, P < 0.001 for HF readmission). In Protocol 3, independent predictors of improved LVEF were analyzed, and baseline LV end-diastolic dimension (LVEDD) was identified as a powerful predictor in ADHF patients (P < 0.001). Conclusions In patients with ADHF, posttreatment LVEF but not baseline LVEF had prognostic power. Improved LVEF was associated with superior long-term prognosis, and baseline LVEDD identified patients who were more likely to have improved LVEF. Therefore, baseline LVEF should not be considered a relevant prognosis factor in clinical practice for patients with ADHF.	[Yeh, Jih-Kai; Wen, Ming-Shien; Kuo, Chi-Tai; Wu, Victor Chien-Chia; Chen, Tien-Hsing] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Cardiol, Taoyuan, Taiwan; [Hsiao, Yuan-Chuan; Jian, Cian-Ruei] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wang, Chao-Hung] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Heart Failure Ctr, Keelung, Taiwan; [Tsai, Feng-Chun] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Cardiothorac & Vasc Surg, Taoyuan, Taiwan; [Chen, Tien-Hsing] Chang Gung Hosp, Dept Cardiol, Xiamen, Peoples R China	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Wu, VCC (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Cardiol, Taoyuan, Taiwan.	victorcwu@hotmail.com	Wu, Victor Chien-Chia/GXF-4623-2022; Wang, Chao/GXF-8353-2022; Wu, Victor Chien-Chia/ABB-6872-2021	Wu, Victor Chien-Chia/0000-0002-9918-4369; Wu, Victor Chien-Chia/0000-0002-9918-4369				Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Bax JJ, 1999, J AM COLL CARDIOL, V34, P163, DOI 10.1016/S0735-1097(99)00157-6; Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60; Binkley PF, 2008, AM HEART J, V155, P69, DOI 10.1016/j.ahj.2007.08.010; Blechman I, 2014, CLIN CARDIOL, V37, P687, DOI 10.1002/clc.22331; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Funaro S, 2009, EUR HEART J, V30, P566, DOI 10.1093/eurheartj/ehn529; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Greene SJ, 2015, NAT REV CARDIOL, V12, P220, DOI 10.1038/nrcardio.2015.14; Jong P, 2002, ARCH INTERN MED, V162, P1689, DOI 10.1001/archinte.162.15.1689; Kubanek M, 2013, J AM COLL CARDIOL, V61, P54, DOI 10.1016/j.jacc.2012.07.072; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Matsumura Y, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0009-4; McDermott MM, 1997, AM HEART J, V134, P728, DOI 10.1016/S0002-8703(97)70057-7; McNamara DM, 2011, J AM COLL CARDIOL, V58, P1112, DOI 10.1016/j.jacc.2011.05.033; Merlo M, 2011, J AM COLL CARDIOL, V57, P1468, DOI 10.1016/j.jacc.2010.11.030; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; O'Connor CM, 2010, AM HEART J, V159, P841, DOI 10.1016/j.ahj.2010.02.023; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Sutton MS, 1997, CIRCULATION, V96, P3294; Tsuyuki RT, 2001, ARCH INTERN MED, V161, P2337, DOI 10.1001/archinte.161.19.2337; Uriel N, 2005, EUR J HEART FAIL, V7, P815, DOI 10.1016/j.ejheart.2004.10.013; Wilcox JE, 2012, AM HEART J, V163, P49, DOI 10.1016/j.ahj.2011.10.001; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145514	10.1371/journal.pone.0145514	http://dx.doi.org/10.1371/journal.pone.0145514			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752417	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100015
J	Toh, ZYC; Aung-Htut, MT; Pinniger, G; Adams, AM; Krishnaswarmy, S; Wong, BL; Fletcher, S; Wilton, SD				Toh, Zhi Yon Charles; Aung-Htut, May Thandar; Pinniger, Gavin; Adams, Abbie M.; Krishnaswarmy, Sudarsan; Wong, Brenda L.; Fletcher, Sue; Wilton, Steve D.			Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MESSENGER-RNA; GENE; MUTATIONS; DOMAIN; MODEL; TRANSLATION; EXPRESSION; DATABASE; CLUSTER	Duchenne and Becker muscular dystrophy severity depends upon the nature and location of the DMD gene lesion and generally correlates with the dystrophin open reading frame. However, there are striking exceptions where an in-frame genomic deletion leads to severe pathology or protein-truncating mutations (nonsense or frame-shifting indels) manifest as mild disease. Exceptions to the dystrophin reading frame rule are usually resolved after molecular diagnosis on muscle RNA. We report a moderate/severe Becker muscular dystrophy patient with an in-frame genomic deletion of DMD exon 5. This mutation has been reported by others as resulting in Duchenne or Intermediate muscular dystrophy, and the loss of this in-frame exon in one patient led to multiple splicing events, including omission of exon 6, that disrupts the open reading frame and is consistent with a severe phenotype. The patient described has a deletion of dystrophin exon 5 that does not compromise recognition of exon 6, and although the deletion does not disrupt the reading frame, his clinical presentation is more severe than would be expected for classical Becker muscular dystrophy. We suggest that the dystrophin isoform lacking the actin-binding sequence encoded by exon 5 is compromised, reflected by the phenotype resulting from induction of this dystrophin isoform in mouse muscle in vivo. Hence, exon skipping to address DMD-causing mutations within DMD exon 5 may not yield an isoform that confers marked clinical benefit. Additional studies will be required to determine whether multi-exon skipping strategies could yield more functional dystrophin isoforms, since some BMD patients with larger inframe deletions in this region have been reported with mild phenotypes.	[Toh, Zhi Yon Charles; Adams, Abbie M.; Fletcher, Sue; Wilton, Steve D.] Western Australian Neurosci Res Inst, Perth, WA, Australia; [Toh, Zhi Yon Charles; Adams, Abbie M.; Krishnaswarmy, Sudarsan; Fletcher, Sue; Wilton, Steve D.] Univ Western Australia, Perth, WA 6009, Australia; [Aung-Htut, May Thandar; Adams, Abbie M.; Fletcher, Sue; Wilton, Steve D.] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Pinniger, Gavin] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Wong, Brenda L.] Cincinnati Childrens Hosp Med Ctr, Dept Neurol, Dept Paediat, Cincinnati, OH 45229 USA	University of Western Australia; Murdoch University; University of Western Australia; Cincinnati Children's Hospital Medical Center	Wilton, SD (corresponding author), Western Australian Neurosci Res Inst, Perth, WA, Australia.	swilton@ccg.murdoch.edu.au	Pinniger, Gavin/F-1421-2013; Aung-Htut, May/AAF-6826-2019	Pinniger, Gavin/0000-0002-4400-0817; Aung-Htut, May/0000-0002-6379-2303; Adams, Abbie/0000-0003-3445-7052; Fletcher, Sue/0000-0002-8632-641X; Wilton, Steve/0000-0002-9400-893X	Muscular Dystrophy Association USA [272200]; National Health and Medical Research Council [1043758, 1055319, 1086311]; Duchenne Ireland; Muscular Dystrophy Western Australia	Muscular Dystrophy Association USA(Muscular Dystrophy Association); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Duchenne Ireland; Muscular Dystrophy Western Australia(Muscular Dystrophy Association)	This study was supported by the Muscular Dystrophy Association USA (272200), the National Health and Medical Research Council (1043758, 1055319, 1086311), Duchenne Ireland and Muscular Dystrophy Western Australia. DI and MDWA are special interest groups supporting muscular dystrophy research. Additionally, Sarepta Therapeutics provide the phosphorodiamidate morpholinos targeting mouse dystrophin exon 5. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; DUBOWITZ V, 1989, J CHILD NEUROL, V4, P240, DOI 10.1177/088307388900400402; Ervasti JM, 1997, SOC GEN PHY, V52, P31; Flanigan KM, 2011, HUM MUTAT, V32, P299, DOI 10.1002/humu.21426; Flanigan KM, 2003, AM J HUM GENET, V72, P931, DOI 10.1086/374176; Fletcher S, 2007, MOL THER, V15, P1587, DOI 10.1038/sj.mt.6300245; Fletcher S, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.40; Fragall CT, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-141; Futamura Naonobu, 2006, Rinsho Shinkeigaku, V46, P62; GANGOPADHYAY SB, 1992, AM J HUM GENET, V51, P562; Greer K, 2015, MOL GENET GENOM MED, V3, P320, DOI 10.1002/mgg3.144; Greer KL, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.8; Gualandi F, 2006, GENE, V370, P26, DOI 10.1016/j.gene.2005.11.002; Gualandi F, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e100; Gurvich OL, 2009, HUM MUTAT, V30, P633, DOI 10.1002/humu.20913; Harding PL, 2007, MOL THER, V15, P157, DOI 10.1038/sj.mt.6300006; HEALD A, 1994, NEUROLOGY, V44, P2388, DOI 10.1212/WNL.44.12.2388; Jearawiriyapaisarn N, 2008, MOL THER, V16, P1624, DOI 10.1038/mt.2008.120; Lattanzi L, 1998, J CLIN INVEST, V101, P2119, DOI 10.1172/JCI1505; Magri F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-37; Magri F, 2011, J NEUROL, V258, P1610, DOI 10.1007/s00415-011-5979-z; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Matsumura K, 1991, Rinsho Shinkeigaku, V31, P286; MCNAUGHTON JC, 1993, J MOL BIOL, V232, P314, DOI 10.1006/jmbi.1993.1389; Moulton HM, 2007, BIOCHEM SOC T, V35, P826, DOI 10.1042/BST0350826; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nevo Y, 2003, ISRAEL MED ASSOC J, V5, P94; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; PUCHTLER H, 1973, BEITR PATHOL, V150, P174, DOI 10.1016/S0005-8165(73)80016-2; ROBERTS RG, 1991, AM J HUM GENET, V49, P298; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; Takeshima Y, 2010, J HUM GENET, V55, P379, DOI 10.1038/jhg.2010.49; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Wein N, 2014, NAT MED, V20, P992, DOI 10.1038/nm.3628; Wilton SD, 2015, TRENDS MOL MED, V21, P417, DOI 10.1016/j.molmed.2015.04.006; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; WINNARD AV, 1993, HUM MOL GENET, V2, P737, DOI 10.1093/hmg/2.6.737; Witting N, 2013, NEUROMUSCULAR DISORD, V23, P25, DOI 10.1016/j.nmd.2012.07.004; WORTON RG, 1988, ANNU REV GENET, V22, P601, DOI 10.1146/annurev.ge.22.120188.003125	44	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145620	10.1371/journal.pone.0145620	http://dx.doi.org/10.1371/journal.pone.0145620			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745801	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600011
J	Wang, Q; Waterhouse, N; Feyijinmi, O; Dominguez, MJ; Martinez, LM; Sharp, Z; Service, R; Bothe, JR; Stollar, EJ				Wang, Qiang; Waterhouse, Nicklas; Feyijinmi, Olusegun; Dominguez, Matthew J.; Martinez, Lisa M.; Sharp, Zoey; Service, Rachel; Bothe, Jameson R.; Stollar, Elliott J.			Development and Application of a High Throughput Protein Unfolding Kinetic Assay	PLOS ONE			English	Article							SH3 DOMAIN; PULSE PROTEOLYSIS; TRANSITION-STATE; FUSION PROTEIN; STABILITY; BINDING; THERMODYNAMICS	The kinetics of folding and unfolding underlie protein stability and quantification of these rates provides important insights into the folding process. Here, we present a simple high throughput protein unfolding kinetic assay using a plate reader that is applicable to the studies of the majority of 2-state folding proteins. We validate the assay by measuring kinetic unfolding data for the SH3 (Src Homology 3) domain from Actin Binding Protein 1 (AbpSH3) and its stabilized mutants. The results of our approach are in excellent agreement with published values. We further combine our kinetic assay with a plate reader equilibrium assay, to obtain indirect estimates of folding rates and use these approaches to characterize an AbpSH3-peptide hybrid. Our high throughput protein unfolding kinetic assays allow accurate screening of libraries of mutants by providing both kinetic and equilibrium measurements and provide a means for in-depth phi-value analyses.	[Wang, Qiang; Waterhouse, Nicklas; Feyijinmi, Olusegun; Dominguez, Matthew J.; Martinez, Lisa M.; Sharp, Zoey; Service, Rachel; Stollar, Elliott J.] Eastern New Mexico Univ, Dept Phys Sci, Portales, NM 88130 USA; [Bothe, Jameson R.] Univ Wisconsin, NMRFAM, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Stollar, EJ (corresponding author), Eastern New Mexico Univ, Dept Phys Sci, Portales, NM 88130 USA.	elliott.stollar@enmu.edu		Bothe, Jameson/0000-0002-1753-0994	National Institute of General Medical Sciences of the National Institutes of Health [8P20GM103451]; Eastern New Mexico University; US Department of Education HSI-STEM grant; NIH [P41GM103399]; NIH shared instrumentation grant [S10RR027000]; University of Wisconsin-Madison; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, P20GM103451] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Eastern New Mexico University; US Department of Education HSI-STEM grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH shared instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by a grant from the National Institute of General Medical Sciences (8P20GM103451) of the National Institutes of Health (EJS), internal research grants from Eastern New Mexico University (EJS), a US Department of Education HSI-STEM grant (EJS, NW, ZS, LMM and MJD). This study made use of the National Magnetic Resonance Facility at Madison, which is supported by NIH grant P41GM103399 (NIGMS). SAXS studies were supported by funds from NIH shared instrumentation grant S10RR027000 and the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by a grant from the National Institute of General Medical Sciences (8P20GM103451) of the National Institutes of Health (EJS), internal research grants from Eastern New Mexico University (EJS), a US Department of Education HSI-STEM grant (EJS, NW, ZS, MMand MD). This study made use of the National Magnetic Resonance Facility at Madison, which is supported by NIH grant P41GM103399 (NIGMS). SAXS studies were supported by funds from NIH shared instrumentation grant S10RR027000 and the University of Wisconsin-Madison. We thank Alan Davidson for providing the AbpSH3 mutant plasmids and Jordan E Burke for help with the SAXS data collection. We also thank the reviewers, as well as Ben Luisi (University of Cambridge), Julie Forman-Kay (University of Toronto) and Barbara Lyons (New Mexico State University) for helpful suggestions that significantly improved the manuscript.	Arnold U, 2005, BIOCATAL BIOTRANSFOR, V23, P159, DOI 10.1080/10242420500183287; Arnold U, 1997, BIOCHEMISTRY-US, V36, P2166, DOI 10.1021/bi962723u; Aucamp JP, 2005, BIOTECHNOL BIOENG, V89, P599, DOI 10.1002/bit.20397; Biggar KK, 2012, BIOTECHNIQUES, V53, P231, DOI 10.2144/0000113922; Bogatyreva NS, 2009, NUCLEIC ACIDS RES, V37, pD342, DOI 10.1093/nar/gkn696; Candel AM, 2008, J MOL BIOL, V377, P117, DOI 10.1016/j.jmb.2007.11.060; Chichili VPR, 2013, PROTEIN SCI, V22, P153, DOI 10.1002/pro.2206; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gmeiner WH, 2001, CELL BIOCHEM BIOPHYS, V35, P115, DOI 10.1385/CBB:35:2:115; Haynes J, 2007, GENETICS, V176, P193, DOI 10.1534/genetics.106.070300; IMOTO T, 1986, J MOL BIOL, V190, P647, DOI 10.1016/0022-2836(86)90250-0; Laederach A, 2003, J MOL BIOL, V329, P1011, DOI 10.1016/S0022-2836(03)00531-X; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Maxwell KL, 2005, PROTEIN SCI, V14, P602, DOI 10.1110/ps.041205405; McGraw J, 2014, PROTEIN EXPRES PURIF, V96, P48, DOI 10.1016/j.pep.2014.01.014; Na YR, 2009, PROTEIN SCI, V18, P268, DOI 10.1002/pro.29; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pace C N, 1986, Methods Enzymol, V131, P266; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rath A, 2000, PROTEIN SCI, V9, P2457, DOI 10.1110/ps.9.12.2457; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P5929, DOI 10.1073/pnas.95.11.5929; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Srividhya J, 2006, COMPUT BIOL CHEM, V30, P209, DOI 10.1016/j.compbiolchem.2006.03.003; Stollar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051282; Stollar EJ, 2009, J BIOL CHEM, V284, P26918, DOI 10.1074/jbc.M109.028431; Walters J, 2009, METHOD ENZYMOL, V455, P1, DOI 10.1016/S0076-6879(08)04201-8; YAMADA H, 1993, J BIOCHEM-TOKYO, V114, P398, DOI 10.1093/oxfordjournals.jbchem.a124188	29	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146232	10.1371/journal.pone.0146232	http://dx.doi.org/10.1371/journal.pone.0146232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745729	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600030
J	LeMonte, JJ; Jolley, VD; Summerhays, JS; Terry, RE; Hopkins, BG				LeMonte, Joshua J.; Jolley, Von D.; Summerhays, Jeffrey S.; Terry, Richard E.; Hopkins, Bryan G.			Polymer Coated Urea in Turfgrass Maintains Vigor and Mitigates Nitrogen's Environmental Impacts	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; CONTROLLED-RELEASE NITROGEN; AMMONIA VOLATILIZATION; N2O EMISSIONS; FERTILIZERS; NITRATE; IRRIGATION; EFFICIENCY; DRAINAGE; TILLAGE	Polymer coated urea (PCU) is a N fertilizer which, when added to moist soil, uses temperature-controlled diffusion to regulate N release in matching plant demand and mitigate environmental losses. Uncoated urea and PCU were compared for their effects on gaseous (N2O and NH3) and aqueous (NO3-) N environmental losses in cool season turfgrass over the entire PCU N-release period. Field studies were conducted on established turfgrass sites with mixtures of Kentucky bluegrass (Poa pratensis L.) and perennial ryegrass (Lolium perenne L.) in sand and loam soils. Each study compared 0 kg N ha(-1) (control) to 200 kg N ha(-1) applied as either urea or PCU (Duration 45CR (R)). Application of urea resulted in 127-476% more evolution of measured N2O into the atmosphere, whereas PCU was similar to background emission levels from the control. Compared to urea, PCU reduced NH3 emissions by 41-49% and N2O emissions by 45-73%, while improving growth and verdure compared to the control. Differences in leachate NO3- among urea, PCU and control were inconclusive. This improvement in N management to ameliorate atmospheric losses of N using PCU will contribute to conserving natural resources and mitigating environmental impacts of N fertilization in turfgrass.	[LeMonte, Joshua J.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Jolley, Von D.; Summerhays, Jeffrey S.; Terry, Richard E.; Hopkins, Bryan G.] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA	University of Delaware; Brigham Young University	Hopkins, BG (corresponding author), Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA.	hopkins@byu.edu	Hopkins, Bryan G./F-3670-2011; LeMonte, Joshua/AAC-2075-2021	Hopkins, Bryan G./0000-0001-7313-055X; LeMonte, Joshua/0000-0002-1100-028X	Brigham Young University	Brigham Young University	Funding was supplied by an internal research grant provided by Brigham Young University.	[Anonymous], 2007, CONTRIBUTION WORKING; Bergstrom DW, 2001, COMMUN SOIL SCI PLAN, V32, P553, DOI 10.1081/CSS-100103028; Blaylock AD, 2004, ABSTR PAP AM CHEM S, V228, pU107; Blythe EK, 2002, J PLANT NUTR, V25, P1049, DOI 10.1081/PLN-120003938; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001811; Cahill S, 2010, AGRON J, V102, P1226, DOI 10.2134/agronj2010.0095; Cao B, 2006, PEDOSPHERE, V16, P390, DOI 10.1016/S1002-0160(06)60067-2; Cheng WG, 2006, NUTR CYCL AGROECOSYS, V74, P147, DOI 10.1007/s10705-005-5965-x; Christians N, 2007, FUNDAMENTALS TURFGRA; Delgado JA, 1996, J ENVIRON QUAL, V25, P1105, DOI 10.2134/jeq1996.00472425002500050025x; Du CW, 2006, J POLYM ENVIRON, V14, P223, DOI 10.1007/s10924-006-0025-4; Easton ZM, 2004, J ENVIRON QUAL, V33, P645, DOI 10.2134/jeq2004.0645; ENDELMAN FJ, 1974, J ENVIRON QUAL, V3, P295, DOI 10.2134/jeq1974.00472425000300030024x; Erisman JW, 2004, ENVIRON POLLUT, V129, P159, DOI 10.1016/j.envpol.2003.08.042; FANGMEIER A, 1994, ENVIRON POLLUT, V86, P43, DOI 10.1016/0269-7491(94)90008-6; Fenn ME, 1998, ECOL APPL, V8, P706, DOI 10.1890/1051-0761(1998)008[0706:NEINAE]2.0.CO;2; Food and Agriculture Organization of the United Nations, 2008, CURRENT WORLD FERTIL; Greenhouse Gas Working Group, 2010, AGR ROL GREENH GAS E; Guillard K, 2004, J ENVIRON QUAL, V33, P1822, DOI 10.2134/jeq2004.1822; Halvorson AD, 2008, J ENVIRON QUAL, V37, P1337, DOI 10.2134/jeq2007.0268; Halvorson AD, 2010, J ENVIRON QUAL, V39, P1554, DOI 10.2134/jeq2010.0041; Halvorson AD, 2010, SOIL SCI SOC AM J, V74, P436, DOI 10.2136/sssaj2009.0072; Hirsch AI, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002443; Hutchinson C, 2003, J PLANT NUTR, V26, P1709, DOI 10.1081/PLN-120023277; Hyatt CR, 2010, SOIL SCI SOC AM J, V74, P419, DOI 10.2136/sssaj2009.0126; Jassal RS, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000764; Jones J.B., 1996, PLANT ANAL HDB 2 PRA; Knight EC, 2007, CROP SCI, V47, P1628, DOI 10.2135/cropsci2006.09.0608; Maggiotto SR, 2000, J ENVIRON QUAL, V29, P621, DOI 10.2134/jeq2000.00472425002900020033x; Maharjan B, 2013, SOIL BIOL BIOCHEM, V66, P229, DOI 10.1016/j.soilbio.2013.07.015; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Miltner ED, 2004, HORTSCIENCE, V39, P1745, DOI 10.21273/HORTSCI.39.7.1745; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; Mulvaney RL, 1996, SSSA BOOK SER, V5; Nelson KA, 2009, AGRON J, V101, P681, DOI 10.2134/agronj2008.0201; Olson BM, 2009, J ENVIRON QUAL, V38, P2218, DOI 10.2134/jeq2008.0519; Pack JE, 2006, J PLANT NUTR, V29, P1301, DOI 10.1080/01904160600767633; Pack Jeffery, 2003, Hortscience, V38, P719; Parkin TB, 2014, AGRON J, V106, P694, DOI 10.2134/agronj2013.0219; Patil MD, 2010, PADDY WATER ENVIRON, V8, P189, DOI 10.1007/s10333-010-0197-3; Pereira HS, 2009, REV BRAS CIENC SOLO, V33, P1685, DOI 10.1590/S0100-06832009000600017; Rochette P, 2009, J ENVIRON QUAL, V38, P1383, DOI 10.2134/jeq2008.0295; SCHLESINGER WH, 1992, BIOGEOCHEMISTRY, V15, P191; Snyder C.S., 2007, GREENHOUSE GAS EMISS; Sutton MA, 2008, ENVIRON POLLUT, V156, P583, DOI 10.1016/j.envpol.2008.03.013; *USEPA, 2007, 430R07002 USEPA; Venterea RT, 2009, SOIL SCI SOC AM J, V73, P1087, DOI 10.2136/sssaj2008.0307; Wilson ML, 2010, J ENVIRON QUAL, V39, P492, DOI 10.2134/jeq2009.0265; Worthington CM, 2007, AM J POTATO RES, V84, P403, DOI 10.1007/BF02987186; [No title captured], DOI DOI 10.1094/CM-2008-0317-01-RV	51	22	23	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146761	10.1371/journal.pone.0146761	http://dx.doi.org/10.1371/journal.pone.0146761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764908	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300039
J	Lecocq, M; Felix, MS; Linares, JM; Chaves-Jacob, J; Decherchi, P; Dousset, E				Lecocq, Mathieu; Felix, Marie-Solenne; Linares, Jean-Marc; Chaves-Jacob, Julien; Decherchi, Patrick; Dousset, Erick			Titanium Implant Impairment and Surrounding Muscle Cell Death Following High-Salt Diet: An In Vivo Study	PLOS ONE			English	Article							BONE-RESORPTION; STAINLESS-STEELS; COCRMO ALLOYS; CORROSION; SODIUM; DISSOLUTION; CALCIUM	Aim of the study High-salt consumption has been widely described as a risk factor for cardiovascular, renal and bone functions. In the present study, the extent to which high-salt diet could influence Ti6Al4V implant surface characteristic, its adhesion to rat tibial crest, and could modify muscle cell viability of two surrounding muscles, was investigated in vivo. These parameters have also been assessed following a NMES (neuro-myoelectrostimulation) program similar to that currently used in human care following arthroplasty. Results After a three-week diet, a harmful effect on titanium implant surface and muscle cell viability was noted. This is probably due to salt corrosive effect on metal and then release of toxic substance around biologic tissue. Moreover, if the use of NMES with high-salt diet induced muscles damages, the latter were higher when implant was added. Unexpectedly, higher implant-to-bone adhesion was found for implanted animals receiving salt supplementation. Conclusion Our in vivo study highlights the potential dangerous effect of high-salt diet in arthroplasty based on titanium prosthesis. This effect appears to be more important when high-salt diet is combined with NMES.	[Lecocq, Mathieu; Felix, Marie-Solenne; Decherchi, Patrick; Dousset, Erick] Aix Marseille Univ, CNRS, Inst Sci Mouvement Etienne Jules MAREY UMR 7287, Equipe Plastic Syst Nerveux & Musculaire PSNM,Fac, F-13288 Marseille 09, France; [Linares, Jean-Marc; Chaves-Jacob, Julien] Aix Marseille Univ, CNRS, Inst Sci Mouvement Etienne Jules MAREY UMR 7286, Equipe Concept Bioinspiree CBI,IUT Aix Marseille, F-13625 Aix En Provence, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Dousset, E (corresponding author), Aix Marseille Univ, CNRS, Inst Sci Mouvement Etienne Jules MAREY UMR 7287, Equipe Plastic Syst Nerveux & Musculaire PSNM,Fac, 163,Ave Luminy, F-13288 Marseille 09, France.	erick.dousset@univ-amu.fr	DECHERCHI, Patrick/AAE-7756-2019	DECHERCHI, Patrick/0000-0001-5639-852X; chaves-jacob, Julien/0000-0002-4798-4276; FELIX, Marie-Solenne/0000-0003-3271-3964	Aix-Marseille Universite (AMU); Centre National de la Recherche Scientifique (CNRS)	Aix-Marseille Universite (AMU); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by public grants of Aix-Marseille Universite (AMU) and Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by public grants of Aix-Marseille Universite (AMU) and Centre National de la Recherche Scientifique (CNRS).	Audran M, 2000, JOINT BONE SPINE, V67, P509, DOI 10.1016/S1297-319X(00)00207-4; Broderick BJ, 2011, MED ENG PHYS, V33, P56, DOI 10.1016/j.medengphy.2010.09.003; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Buehlmeier J, 2012, J CLIN ENDOCR METAB, V97, P4789, DOI 10.1210/jc.2012-2857; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Chandra A, 2009, CIRP ANN-MANUF TECHN, V58, P499, DOI 10.1016/j.cirp.2009.03.114; Choi MG, 2005, P NATL ACAD SCI USA, V102, P4578, DOI 10.1073/pnas.0500693102; Cooper HJ, 2013, J BONE JOINT SURG AM, V95A, P865, DOI 10.2106/JBJS.L.01042; Creedon A, 2000, BRIT J NUTR, V84, P49; Dixon T, 2004, ANN RHEUM DIS, V63, P825, DOI 10.1136/ard.2003.012724; Franco V, 2006, J AM COLL NUTR, V25, p247S, DOI 10.1080/07315724.2006.10719574; Frassetto L, 2001, EUR J NUTR, V40, P200, DOI 10.1007/s394-001-8347-4; Frassetto LA, 2008, J NUTR, V138, p419S, DOI 10.1093/jn/138.2.419S; Frings-Meuthen P, 2008, J BONE MINER RES, V23, P517, DOI [10.1359/jbmr.071118, 10.1359/JBMR.071118]; Frings-Meuthen P, 2011, J APPL PHYSIOL, V111, P537, DOI 10.1152/japplphysiol.00454.2011; Gittens RA, 2011, J DENT RES, V90, P1389, DOI 10.1177/0022034511408428; Haidopoulos L., 2005, ETUDE EXPT OPTIMISAT; Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182; Hanawa T, 2002, SCI TECHNOL ADV MAT, V3, P289, DOI 10.1016/S1468-6996(02)00028-1; Heaney RP, 2006, J AM COLL NUTR, V25, p271S, DOI 10.1080/07315724.2006.10719577; Hedberg Y, 2014, J BIOMED MATER RES B, V102, P693, DOI 10.1002/jbm.b.33048; Helle F, 2012, ACTA PHYSL OXF, V207, P577; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Munoz AI, 2011, J MATER SCI-MATER M, V22, P437, DOI 10.1007/s10856-010-4224-0; Lecocq M, 2014, J BIOMED MAT RES B; Lewis AC, 2005, J BIOMED MATER RES A, V73A, P456, DOI 10.1002/jbm.a.30368; Massey LK, 1996, J BONE MINER RES, V11, P731; Muralidharan VS, 2003, CORROS REV, V21, P327; Mutlu-Sagesen L, 2011, DENT MATER J, V30, P598, DOI 10.4012/dmj.2011-031; Oloyo AK, 2012, CAN J PHYSIOL PHARM, V90, P1647, DOI 10.1139/y2012-132; Papakyriacou M, 2000, INT J FATIGUE, V22, P873, DOI 10.1016/S0142-1123(00)00057-8; Petersen MC, 2008, MICROCIRCULATION, V15, P405, DOI 10.1080/10739680701809093; Qiu JH, 2002, SURF INTERFACE ANAL, V33, P830, DOI 10.1002/sia.1460; Sarkis Karin Sedo, 2012, Endocrinol Nutr, V59, P207, DOI 10.1016/j.endonu.2011.10.010; Sarmugam R, 2014, NUTRIENTS, V6, P5534, DOI 10.3390/nu6125534; Suter T, 1997, ELECTROCHIM ACTA, V42, P3275, DOI 10.1016/S0013-4686(70)01783-8; Takemoto S, 2013, DENT MATER J, V32, P19, DOI 10.4012/dmj.2012-194; WHO, 2003, WHO TECHN REP SER, V916, P54	38	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146873	10.1371/journal.pone.0146873	http://dx.doi.org/10.1371/journal.pone.0146873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761710	Green Submitted, gold, Green Published			2022-12-27	WOS:000368033100048
J	Mitsui, T; Araki, A; Miyashita, C; Ito, S; Ikeno, T; Sasaki, S; Kitta, T; Moriya, K; Cho, K; Morioka, K; Kishi, R; Shinohara, N; Takeda, M; Nonomura, K				Mitsui, Takahiko; Araki, Atsuko; Miyashita, Chihiro; Ito, Sachiko; Ikeno, Tamiko; Sasaki, Seiko; Kitta, Takeya; Moriya, Kimihiko; Cho, Kazutoshi; Morioka, Keita; Kishi, Reiko; Shinohara, Nobuo; Takeda, Masayuki; Nonomura, Katsuya			The Relationship between the Second-to-Fourth Digit Ratio and Behavioral Sexual Dimorphism in School-Aged Children	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; GENDER-ROLE BEHAVIOR; TYPED BEHAVIOR; PRENATAL EXPOSURE; COHORT PROFILE; TESTOSTERONE; ENVIRONMENT; HYPOTHESIS; SUBSEQUENT; ESTROGEN	Sexually dimorphic brain development and behavior are known to be influenced by sex hormones exposure in prenatal periods. On the other hand, second-to forth digit ratio (2D/4D) has been used as an indirect method to investigate the putative effects of prenatal exposure to androgen. In the present study, we herein investigated the relationship between genderrole play behavior and the second-to-fourth digit ratio (2D/4D), which has been used as an indirect method to investigate the putative effects of prenatal exposure to androgens, in school-aged children. Among 4981 children who became 8 years old by November 2014 and were contactable for this survey by The Hokkaido Study of Environment and Children's Health, 1631 (32.7%), who had data for 2D/4D and Pre-school Activities Inventory (PSAI) as well as data for the survey at baseline, were available for analysis. Parents sent reports of PSAI on the sex-typical characteristics, preferred toys, and play activities of children, and black and white photocopies of the left and right hand palms via mail. PSAI consisted of 12 masculine items and 12 feminine items, and a composite score was created by subtracting the feminine score from the masculine score, with higher scores representing masculine-typical behavior. While composite scores in PSAI were significantly higher in boys than in girls, 2D/4D was significantly lower in boys than in girls. Although the presence or absence of brothers or sisters affected the composite, masculine, and feminine scored of PSAI, a multivariate regression model revealed that 2D/4D negatively correlated with the composite scores of PSAI in boys, whereas no correlation was found in girls. Although 2D/4D negatively correlated with the masculine score in boys and girls, no correlation was observed between 2D/4D and the feminine score. In conclusion, although social factors, such as the existence of brother or sisters, affect dimorphic brain development and behavior in childhood, the present study revealed that the prenatal hormonal environment was an important factor influencing masculine-typical dimorphic brain development and behavior in schoolaged children.	[Mitsui, Takahiko; Takeda, Masayuki] Univ Yamanashi, Grad Sch Med Sci, Dept Urol, Chuo City, Japan; [Mitsui, Takahiko; Kitta, Takeya; Moriya, Kimihiko; Shinohara, Nobuo; Nonomura, Katsuya] Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan; [Araki, Atsuko; Miyashita, Chihiro; Ito, Sachiko; Ikeno, Tamiko; Kishi, Reiko] Hokkaido Univ, Ctr Environm & Hlth Sci, Sapporo, Hokkaido, Japan; [Sasaki, Seiko] Hokkaido Univ, Dept Publ Hlth, Grad Sch Med, Sapporo, Hokkaido, Japan; [Cho, Kazutoshi; Morioka, Keita] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan; [Nonomura, Katsuya] Kushiro Rosai Hosp, Dept Urol, Kushiro, Hokkaido, Japan	University of Yamanashi; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Mitsui, T (corresponding author), Univ Yamanashi, Grad Sch Med Sci, Dept Urol, Chuo City, Japan.	tmitsui@yamanashi.ac.jp	Ikeda-Araki, Atsuko/A-4105-2012; , Takahiko/H-6660-2019	Ikeda-Araki, Atsuko/0000-0002-3065-262X; 	Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants; Japan Society for the Promotion of Science; Environment Research and Technology Development Fund from the Ministry of the Environment, Japan [5C-1252]; Grants-in-Aid for Scientific Research [26670321] Funding Source: KAKEN	Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Environment Research and Technology Development Fund from the Ministry of the Environment, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported in part by the Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, and the Environment Research and Technology Development Fund (5C-1252) from the Ministry of the Environment, Japan.	Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Becker M, 2015, CLIN ENDOCRINOL OXF; BenHur H, 1997, CALCIFIED TISSUE INT, V60, P520, DOI 10.1007/s002239900274; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Cohen-Bendahan CCC, 2005, NEUROSCI BIOBEHAV R, V29, P353, DOI 10.1016/j.neubiorev.2004.11.004; EHRHARDT AA, 1977, PSYCHONEUROENDOCRINO, V2, P391, DOI 10.1016/0306-4530(77)90010-5; EHRHARDT AA, 1984, ARCH SEX BEHAV, V13, P457, DOI 10.1007/BF01541430; Frisen L, 2009, J CLIN ENDOCR METAB, V94, P3432, DOI 10.1210/jc.2009-0636; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; Goldberg AE, 2012, SEX ROLES, V67, P503, DOI 10.1007/s11199-012-0198-3; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; GOLOMBOK S, 1993, J CHILD PSYCHOL PSYC, V34, P805, DOI 10.1111/j.1469-7610.1993.tb01072.x; Golombok S., 1993, PSYCHOL ASSESSMENT, V5, P131, DOI [https://doi.org/10.1037/1040-3590.5.2.131, DOI 10.1037/1040-3590.5.2.131, 10.1037/1040-3590.5.2.131]; Hines M, 2003, ARCH SEX BEHAV, V32, P93, DOI 10.1023/A:1022492106974; Jurgensen M, 2007, HORM BEHAV, V51, P443, DOI 10.1016/j.yhbeh.2007.01.001; Kishi R, 2013, ENVIRON HEALTH PREV, V18, P429, DOI 10.1007/s12199-013-0357-3; Kishi R, 2011, INT J EPIDEMIOL, V40, P611, DOI 10.1093/ije/dyq071; Knickmeyer RC, 2011, HORM BEHAV, V60, P256, DOI 10.1016/j.yhbeh.2011.05.009; Lamminmaki A, 2012, HORM BEHAV, V61, P611, DOI 10.1016/j.yhbeh.2012.02.013; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2003, ANN HUM BIOL, V30, P579, DOI 10.1080/0301446032000112689; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Mathews GA, 2009, HORM BEHAV, V55, P285, DOI 10.1016/j.yhbeh.2008.11.007; Meyer Bahlburg HF, 1977, PSYCHONEUROENDOCRINO, V2, P383; Mitsui T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120636; Okten A, 2002, EARLY HUM DEV, V70, P47, DOI 10.1016/S0378-3782(02)00073-7; Olvera-Hernandez S, 2015, PHYSIOL BEHAV, V139, P403, DOI 10.1016/j.physbeh.2014.11.060; Olvera-Hernandez Sandra, 2015, Adv Neurobiol, V10, P381, DOI 10.1007/978-1-4939-1372-5_18; Pasterski V, 2011, HORM BEHAV, V59, P549, DOI 10.1016/j.yhbeh.2011.02.007; REYES FI, 1973, J CLIN ENDOCR METAB, V37, P74, DOI 10.1210/jcem-37-1-74; Sasaki S., 2006, STUD SOCIOL PSYCHOL, V62, P174; Wong WI, 2013, ARCH SEX BEHAV, V42, P381, DOI 10.1007/s10508-012-9997-4	33	21	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146849	10.1371/journal.pone.0146849	http://dx.doi.org/10.1371/journal.pone.0146849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756472	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800034
J	Bronsart, LL; Stokes, C; Contag, CH				Bronsart, Laura L.; Stokes, Christian; Contag, Christopher H.			Chemiluminescence Imaging of Superoxide Anion Detects Beta-Cell Function and Mass	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; REACTIVE OXYGEN; INSULIN-SECRETION; PANCREATIC-ISLETS; COELENTERAZINE ANALOGS; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; NITRIC-OXIDE; EXPRESSION; LUCIGENIN	Superoxide anion is produced during normal cellular respiration and plays key roles in cellular physiology with its dysregulation being associated with a variety of diseases. Superoxide anion is a short-lived molecule and, therefore, its homeostatic regulation and role in biology and disease requires dynamic quantification with fine temporal resolution. Here we validated coelenterazine as a reporter of intracellular superoxide anion concentration and used it as a dynamic measure both in vitro and in vivo. Chemiluminescence was dependent upon superoxide anion levels, including those produced during cellular respiration, and concentrations varied both kinetically and temporally in response to physiologically relevant fluctuations in glucose levels. In vivo imaging with coelenterazine revealed that beta cells of the pancreas have increased levels of superoxide anion, which acted as a measure of beta-cell function and mass and could predict the susceptibility of mice to diabetes mellitus. Glucose response and regulation are key elements of cellular physiology and organismal biology, and superoxide anion appears to play a fundamental and dynamic role in both of these processes.	[Bronsart, Laura L.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Bronsart, Laura L.; Stokes, Christian; Contag, Christopher H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Dept Microbiol, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Dept Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Contag, CH (corresponding author), Stanford Univ, Dept Pediat, 318 Campus Dr, Stanford, CA 94305 USA.	ccontag@stanford.edu		Contag, Christopher/0000-0002-1011-8278	Chambers Family Foundation; March of Dimes; National Institutes of Health [1R24DK096465-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK096465] Funding Source: NIH RePORTER	Chambers Family Foundation; March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was generously supported, in part, by an unrestricted gift from the Chambers Family Foundation (to C.H.C.), the March of Dimes (to C.H.C.) and by a grant from the National Institutes of Health (1R24DK096465-01) (to C.H.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari Bharti, 2007, Recent Pat Cardiovasc Drug Discov, V2, P35, DOI 10.2174/157489007779606095; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cai Hua, 2007, V139, P293; Caldefie-Chezet F, 2002, CLIN CHIM ACTA, V319, P9, DOI 10.1016/S0009-8981(02)00015-3; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chung IS, 2013, ANESTH ANALG, V116, P327, DOI 10.1213/ANE.0b013e31827aec06; Cosentino F, 1997, CIRCULATION, V96, P25; Daiber A, 2004, FREE RADICAL BIO MED, V36, P101, DOI 10.1016/j.freeradbiomed.2003.10.012; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Edinger Matthias, 1999, Neoplasia (New York), V1, P303, DOI 10.1038/sj.neo.7900048; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fischer R, 2015, INTERRELATION OXIDAT, V2015, P1, DOI DOI 10.1155/2015/610813; Fisher AB, 2009, ANTIOXID REDOX SIGN, V11, P1349, DOI [10.1089/ars.2008.2378, 10.1089/ARS.2008.2378]; Graier WF, 1999, DIABETES RES CLIN PR, V45, P153, DOI 10.1016/S0168-8227(99)00045-5; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Griendling KK, 2000, REGUL PEPTIDES, V91, P21, DOI 10.1016/S0167-0115(00)00136-1; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Hooper DC, 1998, P NATL ACAD SCI USA, V95, P675, DOI 10.1073/pnas.95.2.675; Indo HP, 2015, J CLIN BIOCHEM NUTR, V56, P1, DOI 10.3164/jcbn.14-42; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Kervinen M, 2004, ANAL BIOCHEM, V324, P45, DOI 10.1016/j.ab.2003.09.004; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Klinke DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001374; Lee HB, 2003, J AM SOC NEPHROL, V14, pS241, DOI 10.1097/01.ASN.0000077410.66390.0F; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Liochev SI, 1997, ARCH BIOCHEM BIOPHYS, V337, P115, DOI 10.1006/abbi.1997.9766; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; LUCAS M, 1992, ANAL BIOCHEM, V206, P273, DOI 10.1016/0003-2697(92)90366-F; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Nazarewicz RR, 2013, J BIOMOL SCREEN, V18, P498, DOI 10.1177/1087057112468765; Negrin RS, 2006, NAT REV IMMUNOL, V6, P484, DOI 10.1038/nri1879; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rees JF, 1998, J EXP BIOL, V201, P1211; Ritzel RA, 2006, DIABETES CARE, V29, P717, DOI 10.2337/diacare.29.03.06.dc05-1538; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Shimomura O, 1997, BIOCHEM J, V326, P297, DOI 10.1042/bj3260297; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; Tarpey MM, 1999, CIRC RES, V84, P1203, DOI 10.1161/01.RES.84.10.1203; Teranishi K, 1997, ANAL BIOCHEM, V249, P37, DOI 10.1006/abio.1997.2150; Tseng JC, 2012, CHEM BIOL, V19, P1199, DOI 10.1016/j.chembiol.2012.08.007; Ungvari Z, 2007, INCREASED MITOCHONDR, P37; Vento M, 2003, J PEDIATR-US, V142, P240, DOI 10.1067/mpd.2003.91; Venugopal SK, 2002, DIABETES, V51, P3049, DOI 10.2337/diabetes.51.10.3049; Virostko J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057784; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; WELSH N, 1995, MOL MED, V1, P806, DOI 10.1007/BF03401895; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu K. K., 2008, CURR PROTOC PHARM, V5, P1; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao Hui, 2004, Mol Imaging, V3, P43, DOI 10.1162/153535004773861714	64	20	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146601	10.1371/journal.pone.0146601	http://dx.doi.org/10.1371/journal.pone.0146601			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752052	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100110
J	Hodge, SE; Hager, VR; Greenberg, DA				Hodge, Susan E.; Hager, Valerie R.; Greenberg, David A.			Using Linkage Analysis to Detect Gene-Gene Interactions. 2. Improved Reliability and Extension to More-Complex Models	PLOS ONE			English	Article							LOD SCORES; I ERROR; DISEASES; POWER; HETEROGENEITY; SIMULATION	Detecting gene-gene interaction in complex diseases has become an important priority for common disease genetics, but most current approaches to detecting interaction start with disease-marker associations. These approaches are based on population allele frequency correlations, not genetic inheritance, and therefore cannot exploit the rich information about inheritance contained within families. They are also hampered by issues of rigorous phenotype definition, multiple test correction, and allelic and locus heterogeneity. We recently developed, tested, and published a powerful gene-gene interaction detection strategy based on conditioning family data on a known disease-causing allele or a disease-associated marker allele(4). We successfully applied the method to disease data and used computer simulation to exhaustively test the method for some epistatic models. We knew that the statistic we developed to indicate interaction was less reliable when applied to more-complex interaction models. Here, we improve the statistic and expand the testing procedure. We computer-simulated multipoint linkage data for a disease caused by two interacting loci. We examined epistatic as well as additive models and compared them with heterogeneity models. In all our models, the at-risk genotypes are "major" in the sense that among affected individuals, a substantial proportion has a disease-related genotype. One of the loci (A) has a known disease-related allele (as would have been determined from a previous analysis). We removed (pruned) family members who did not carry this allele; the resultant dataset is referred to as "stratified." This elimination step has the effect of raising the "penetrance" and detectability at the second locus (B). We used the lod scores for the stratified and unstratified data sets to calculate a statistic that either indicated the presence of interaction or indicated that no interaction was detectable. We show that the new method is robust and reliable for a wide range of parameters. Our statistic performs well both with the epistatic models (false negative rates, i.e., failing to detect interaction, ranging from 0 to 2.5%) and with the heterogeneity models (false positive rates, i.e., falsely detecting interaction, <= 1%). It works well with the additive model except when allele frequencies at the two loci differ widely. We explore those features of the additive model that make detecting interaction more difficult. All testing of this method suggests that it provides a reliable approach to detecting gene-gene interaction.	[Hodge, Susan E.; Hager, Valerie R.; Greenberg, David A.] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43215 USA; [Hodge, Susan E.; Greenberg, David A.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43215 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Hodge, SE (corresponding author), Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43215 USA.	Susan.Hodge@nationwidechildrens.org	Greenberg, David/E-2148-2014		Nationwide Children's Hospital; Research Institute of Nationwide Children's Hospital, Columbus, Ohio	Nationwide Children's Hospital(Ohio State University); Research Institute of Nationwide Children's Hospital, Columbus, Ohio	This work was supported by Nationwide Children's Hospital, SEH VRH DAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The Research Institute of Nationwide Children's Hospital, Columbus, Ohio. We thank Ms. Junying Zhang for her work in programming the simulator. We also thank the two reviewers for their thoughtful comments, which have improved the paper considerably.	Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Abreu PC, 2002, GENET EPIDEMIOL, V22, P156, DOI 10.1002/gepi.0155; Beam AL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0368-0; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Corso B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093398; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Greenberg DA, 2011, HUM HERED, V72, P247, DOI 10.1159/000330633; Hodge SE, 1997, AM J HUM GENET, V60, P217; Holzinger ER, 2015, BIOCOMPUT-PAC SYM, P195; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124967; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; Ott J., 1999, ANAL HUMAN GENETIC L; Rodriguez-Murillo L, 2010, J HEART LUNG TRANSPL, V29, P174, DOI 10.1016/j.healun.2009.08.022; Tomer Y, 1998, AM J HUM GENET, V63, P1749, DOI 10.1086/302146; Tomer Y, 2007, J AUTOIMMUN, V29, P69, DOI 10.1016/j.jaut.2007.05.006	19	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146240	10.1371/journal.pone.0146240	http://dx.doi.org/10.1371/journal.pone.0146240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752287	Green Published, gold			2022-12-27	WOS:000367888100056
J	Roth, JM; Kohler, D; Schneider, M; Granja, TF; Rosenberger, P				Roth, Judith Marlene; Koehler, David; Schneider, Mariella; Granja, Tiago Folgosa; Rosenberger, Peter			Semaphorin 7A Aggravates Pulmonary Inflammation during Lung Injury	PLOS ONE			English	Article							PLEXIN C1; HYPOXIA; CHEMOKINES	The extent of pulmonary inflammation during lung injury ultimately determines patient outcome. Pulmonary inflammation is initiated by the migration of neutrophils into the alveolar space. Recent work has demonstrated that the guidance protein semaphorin 7A (SEMA7A) influences the migration of neutrophils into hypoxic tissue sites, yet, its role during lung injury is not well understood. Here, we report that the expression of SEMA7A is induced in vitro through pro-inflammatory cytokines. SEMA7A itself induces the production of proinflammatory cytokines in endothelial and epithelial cells, enhancing pulmonary inflammation. The induction of SEMA7A facilitates the transendothelial migration of neutrophils. In vivo, animals with deletion of SEMA7A expression showed reduced signs of pulmonary inflammatory changes following lipopolysaccharide challenge. We define here the role of SEMA7A in the development of lung injury and identify a potential pathway to interfere with these detrimental changes. Future anti-inflammatory strategies for the treatment of lung injury might be based on this finding.	[Roth, Judith Marlene; Koehler, David; Schneider, Mariella; Granja, Tiago Folgosa; Rosenberger, Peter] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Rosenberger, P (corresponding author), Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	peter.rosenberger@medizin.uni-tuebingen.de	Granja, Tiago/D-8426-2014; Granja, Tiago/O-2597-2019	Granja, Tiago/0000-0002-8137-1449; Granja, Tiago/0000-0002-8137-1449	DFG [DFG-MO 2252/1, DFG-RO 3671/6-1]; IZKF Promotionskolleg der Universitat Tubingen	DFG(German Research Foundation (DFG)); IZKF Promotionskolleg der Universitat Tubingen	This work was supported by DFG: DFG-MO 2252/1 (to DK), DFG-RO 3671/6-1 (to PR), IZKF Promotionskolleg der Universitat Tubingen (to JR), IZKF Promotionskolleg der Universitat Tubingen (to MS).	Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Granja T, 2014, MUCOSAL IMMUNOL, V7, P879, DOI 10.1038/mi.2013.104; Henes J, 2009, FASEB J, V23, P4244, DOI 10.1096/fj.09-138693; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Koenig K, 2014, EUR J IMMUNOL, V44, P2648, DOI 10.1002/eji.201343968; Lazova R, 2009, AM J DERMATOPATH, V31, P177, DOI 10.1097/DAD.0b013e318196672d; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Morote-Garcia JC, 2012, P NATL ACAD SCI USA, V109, P14146, DOI 10.1073/pnas.1202165109; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schaible B, 2010, RESP PHYSIOL NEUROBI, V174, P235, DOI 10.1016/j.resp.2010.08.006; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Taylor CT, 2009, ANN NY ACAD SCI, V1177, P178, DOI 10.1111/j.1749-6632.2009.05024.x; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Zhang ML, 2014, INT J MOL SCI, V15, P19650, DOI 10.3390/ijms151119650	21	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146930	10.1371/journal.pone.0146930	http://dx.doi.org/10.1371/journal.pone.0146930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752048	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100180
J	Yamada, H; Tsutsumi, K; Nakazawa, Y; Shibagaki, Y; Hattori, S; Ohta, Y				Yamada, Hazuki; Tsutsumi, Koji; Nakazawa, Yuki; Shibagaki, Yoshio; Hattori, Seisuke; Ohta, Yasutaka			Src Family Tyrosine Kinase Signaling Regulates FilGAP through Association with RBM10	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; FILAMIN-A; RHO GTPASES; RAC; BINDING; RNA; CROSSTALK; MOTIF; GAP; FYN	FilGAP is a Rac-specific GTPase-activating protein (GAP) that suppresses lamellae formation. In this study, we have identified RBM10 (RNA Binding Motif domain protein 10) as a FilGAP-interacting protein. Although RBM10 is mostly localized in the nuclei in human melanoma A7 cells, forced expression of Src family tyrosine kinase Fyn induced translocation of RBM10 from nucleus into cell peripheries where RBM10 and FilGAP are co-localized. The translocation of RBM10 from nucleus appears to require catalytic activity of Fyn since kinase-negative Fyn mutant failed to induce translocation of RBM10 in A7 cells. When human breast carcinoma MDA-MB-231 cells are spreading on collagen-coated coverslips, endogenous FilGAP and RBM10 were localized at the cell periphery with tyrosine-phosphorylated proteins. RBM10 appears to be responsible for targeting FilGAP at the cell periphery because depletion of RBM10 by siRNA abrogated peripheral localization of FilGAP during cell spreading. Association of RBM10 with FilGAP may stimulate RacGAP activity of FilGAP. First, forced expression of RBM10 suppressed FilGAP-mediated cell spreading on collagen. Conversely, depletion of endogenous RBM10 by siRNA abolished FilGAP-mediated suppression of cell spreading on collagen. Second, FilGAP suppressed formation of membrane ruffles induced by Fyn and instead produced spiky cell protrusions at the cell periphery. This protrusive structure was also induced by depletion of Rac, suggesting that the formation of protrusions may be due to suppression of Rac by FilGAP. We found that depletion of RBM10 markedly reduced the formation of protrusions in cells transfected with Fyn and FilGAP. Finally, depletion of RBM10 blocked FilGAP-mediated suppression of ruffle formation induced by EGF. Taken together, these results suggest that Src family tyrosine kinase signaling may regulate FilGAP through association with RBM10.	[Yamada, Hazuki; Tsutsumi, Koji; Nakazawa, Yuki; Ohta, Yasutaka] Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol, Sagamihara, Kanagawa 2520373, Japan; [Shibagaki, Yoshio; Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Tokyo 1088641, Japan	Kitasato University; Kitasato University	Ohta, Y (corresponding author), Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol, Sagamihara, Kanagawa 2520373, Japan.	yohta@kitasato-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant for All Kitasato Project Study, Kitasato University Research; Uehara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant for All Kitasato Project Study, Kitasato University Research; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant for All Kitasato Project Study, Kitasato University Research Grant for Young Researchers, and Grants from The Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2008, J PROTEOME RES, V7, P3900, DOI 10.1021/pr800198w; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Humphries JD, 2015, TRENDS CELL BIOL, V25, P388, DOI 10.1016/j.tcb.2015.02.008; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inoue A, 2014, FEBS LETT, V588, P942, DOI 10.1016/j.febslet.2014.01.052; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Johnston JJ, 2010, AM J HUM GENET, V86, P743, DOI 10.1016/j.ajhg.2010.04.007; Kawaguchi K, 2014, J BIOL CHEM, V289, P9675, DOI 10.1074/jbc.M113.546051; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Lavelin I, 2005, J BIOL CHEM, V280, P7178, DOI 10.1074/jbc.M411990200; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Lewis RA, 2007, DIFFERENTIATION, V75, P507, DOI 10.1111/j.1432-0436.2007.00159.x; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakahara S, 2015, J CELL SCI, V128, P2047, DOI 10.1242/jcs.160192; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; Nieves B, 2010, J CELL SCI, V123, P1216, DOI 10.1242/jcs.056549; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Wang YB, 2013, EMBO MOL MED, V5, P1431, DOI 10.1002/emmm.201302663; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Xi SC, 2003, J BIOL CHEM, V278, P31574, DOI 10.1074/jbc.M303499200	46	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146593	10.1371/journal.pone.0146593	http://dx.doi.org/10.1371/journal.pone.0146593			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751795	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100108
J	Lee, EJ; Lee, SJ; Kim, JH; Kim, KJ; Yang, SH; Jeong, KY; Seong, J				Lee, Eun-Jung; Lee, Seo Jin; Kim, Ji-Hye; Kim, Kyoung-Jin; Yang, Seung-Hyun; Jeong, Keun-Yeong; Seong, Jinsil			Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic Cells	PLOS ONE			English	Article							MOUSE BONE-MARROW; NF-KAPPA-B; T-CELL; RECEPTOR; CANCER; IL-12; STAT3; IMMUNOTHERAPY; RADIOTHERAPY; MACROPHAGES	Radiotherapy (RT) is a potent anti-tumor modality. However, unwanted effects including increased recurrence and metastasis that involve factors such as cytokines, which induce complex molecular mechanisms, have also been reported. In a previous study, we showed that interleukin (IL)-12 and radiotherapy combination treatment suppressed tumor growth and metastasis in a hepatoma mouse model. In this study, we investigated the mechanism underlying the IL-12 anti-tumor effect during radiotherapy. In tumor-bearing mice, irradiation decreased IL-12 expression in the tumors and spleens. However, a number of dendritic cells infiltrated into the tumors in which IL-12 expression did not decrease. To further study the underlying detailed mechanism for this decrease in IL-12, LPS-stimulated bone marrow-derived dendritic cells (BMDCs) were irradiated, and then IL-12- and IL-6-associated molecules were examined in irradiated tumors and BMDCs. Irradiation resulted in IL-12 suppression and IL-6 increase. IL-6 and signal transducer and activator of transcription 3 (STAT3) inhibitors restored the irradiation-induced IL-12 decrease via suppression of C-Rel activation. Taken together, our study suggests that irradiation-induced IL-6 can decrease IL-12 production through the inhibition of C-Rel phosphorylation by the IL-6/STAT3 signaling pathway.	[Lee, Eun-Jung; Lee, Seo Jin; Kim, Ji-Hye; Kim, Kyoung-Jin; Yang, Seung-Hyun; Jeong, Keun-Yeong; Seong, Jinsil] Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr, Coll Med, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System	Seong, J (corresponding author), Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr, Coll Med, Seoul 120752, South Korea.	jsseong@yuhs.ac	Jeong, Keun-Yeong/B-8845-2015	Jeong, Keun-Yeong/0000-0002-4933-3493; Yang, Seung-Hyun/0000-0002-0909-7828	National Nuclear RD Program [NRF-2010-0018544]; National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2014R1A2A1A11054463]	National Nuclear RD Program; National Research Foundation of Korea - Ministry of Science, ICT & Future Planning	This work was supported by the National Nuclear R&D Program (NRF-2010-0018544) and the Mid-career Researcher Program (NRF-2014R1A2A1A11054463) through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Carreno BM, 2013, J CLIN INVEST, V123, P3383, DOI 10.1172/JCI68395; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Demaria S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00095; Friedman EJ, 2002, CURR PHARM DESIGN, V8, P1765, DOI 10.2174/1381612023394089; Gameiro SR, 2014, ONCOTARGET, V5, P403, DOI 10.18632/oncotarget.1719; Golden EB, 2015, SEMIN RADIAT ONCOL, V25, P11, DOI 10.1016/j.semradonc.2014.07.005; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Henry CJ, 2008, J IMMUNOL, V181, P8576, DOI 10.4049/jimmunol.181.12.8576; Hoentjen F, 2005, BLOOD, V105, P689, DOI 10.1182/blood-2004-04-1309; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; Irie M, 2004, INT J CANCER, V111, P238, DOI 10.1002/ijc.20247; Jeong KY, 2015, INT J CANCER, V137, P721, DOI 10.1002/ijc.29428; Kim KW, 2006, MOL CANCER THER, V5, P2659, DOI 10.1158/1535-7163.MCT-06-0261; Kim W, 2011, J RADIAT RES, V52, P646, DOI 10.1269/jrr.10185; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106423; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Merrick A, 2005, BRIT J CANCER, V92, P1450, DOI 10.1038/sj.bjc.6602518; Middleton K, 2014, CRIT REV ONCOL HEMAT, V89, P129, DOI 10.1016/j.critrevonc.2013.08.004; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Muller K, 2007, EXP HEMATOL, V35, P96, DOI 10.1016/j.exphem.2007.01.017; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Ogawa M, 1999, CANCER RES, V59, P1531; Park HJ, 2012, CELL IMMUNOL, V278, P76, DOI 10.1016/j.cellimm.2012.07.001; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; SCHEICHER C, 1992, J IMMUNOL METHODS, V154, P253, DOI 10.1016/0022-1759(92)90199-4; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; VanderMeeren A, 1997, MEDIAT INFLAMM, V6, P185, DOI 10.1080/09629359791677; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P287; Weiss JM, 2007, EXPERT OPIN BIOL TH, V7, P1705, DOI 10.1517/14712598.7.11.1705; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu YC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01675	39	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146463	10.1371/journal.pone.0146463	http://dx.doi.org/10.1371/journal.pone.0146463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745884	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600053
J	Carvajal, A; Arias, LHM; Sainz, M; Escudero, A; Fierro, I; Sauzet, O; Cornelius, VR; Molokhia, M				Carvajal, Alfonso; Martin Arias, Luis H.; Sainz, Maria; Escudero, Antonio; Fierro, Inmaculada; Sauzet, Odile; Cornelius, Victoria R.; Molokhia, Mariam			Carpal Tunnel Syndrome Associated with Oral Bisphosphonates. A Population-Based Cohort Study	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; RISK-FACTORS; IN-VITRO; OSTEOPOROSIS; WOMEN; INTERLEUKIN-6; ACID	Background Bisphosphonates are widely used to prevent osteoporotic fractures. Some severe musculoskeletal reactions have been described with this medication; among them, some cases of carpal tunnel syndrome. Thus, the aim of this study was to explore whether bisphosphonates may be associated with this syndrome. Methods A cohort study was conducted to compare exposed to unexposed women; the exposed group was that composed of women having received at least one prescription of an oral bisphosphonate. For the purpose, we used information from The Health Improvement Network (THIN) database. The outcome of interest was defined as those women diagnosed with carpal tunnel syndrome. A survival analysis was performed; the Cox proportional hazard model was used to calculate hazard ratios and 95% confidence intervals, and to adjust for identified confounding variables. Results Out of a sample of 59,475 women older than 51 years, 19,825 were treated with bisphosphonates during the period studied. No differences in age distribution or mean follow-up time were observed between the two groups in comparison. Overall, there were 572 women diagnosed with carpal tunnel syndrome, 242 (1.2%) in the group exposed to bisphosphonates, and 330 (0.8%) in the unexposed. An adjusted hazard ratio of developing carpal tunnel syndrome of 1.38 (95% CI, 1.15-1.64) was found for women exposed to bisphosphonates; no significant changes in the hazard ratios were found when considering different levels of bisphosphonate exposure. Conclusions An increased risk of carpal tunnel syndrome is associated with the use of bisphosphonates in postmenopausal women.	[Carvajal, Alfonso; Martin Arias, Luis H.; Sainz, Maria; Escudero, Antonio; Fierro, Inmaculada] Univ Valladolid, Ctr Estudios Seguridad Medicamentos, Valladolid, Spain; [Sauzet, Odile] Univ Bielefeld, AG Epidemiol & Int Publ Hlth, D-33615 Bielefeld, Germany; [Cornelius, Victoria R.; Molokhia, Mariam] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	Universidad de Valladolid; University of Bielefeld; University of London; King's College London	Carvajal, A (corresponding author), Univ Valladolid, Ctr Estudios Seguridad Medicamentos, Valladolid, Spain.	carvajal@ife.uva.es	Sainz-Gil, María/V-5390-2017; MARTIN ARIAS, LUIS/H-6438-2015; Fierro, Inmaculada/D-7938-2019; Fierro, Inma/AAI-1745-2021	Sainz-Gil, María/0000-0002-4353-055X; MARTIN ARIAS, LUIS/0000-0002-3815-8781; Fierro, Inmaculada/0000-0003-4423-4493; Cornelius, Victoria/0000-0002-0080-1065	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; National Institute for Health Research [PDA/02/06/056] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author (s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcenilla A, 2012, RHEUMATOLOGY, V51, P250, DOI 10.1093/rheumatology/ker108; Blak B, 2006, 9 ANN C UK FED PRIM; Bland JDP, 2007, BMJ-BRIT MED J, V335, P343, DOI 10.1136/bmj.39282.623553.AD; Bourke Alison, 2004, Inform Prim Care, V12, P171; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; DEAHL MP, 1988, BRIT J PSYCHIAT, V153, P250, DOI 10.1192/bjp.153.2.250; EMA, 2012, SUMM PROD CHAR; FDA, 2015, FULL PRESCR INF; FDA, 2008, SEV PAIN OST DRUGS; Ferry S, 2000, AM J EPIDEMIOL, V151, P566, DOI 10.1093/oxfordjournals.aje.a010244; Frederiksen Louise, 2007, Ugeskr Laeger, V169, P1583; Hakim AJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P275, DOI 10.1002/art.10395; Harris-Adamson C, 2013, OCCUP ENVIRON MED, V70, P529, DOI 10.1136/oemed-2013-101365; Jones DPG, 2008, J RHEUMATOL, V35, P537; Jones DG, 2005, BRIT MED J, V330, P74, DOI 10.1136/bmj.330.7482.74; KASTING GB, 1992, J BONE MINER RES, V7, P513; Katz JN, 2002, NEW ENGL J MED, V346, P1807, DOI 10.1056/NEJMcp013018; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lim MJ, 2010, J KOREAN MED SCI, V25, P1277, DOI 10.3346/jkms.2010.25.9.1277; Mieog JSD, 2012, LANCET ONCOL, V13, P420, DOI 10.1016/S1470-2045(11)70328-X; Nathan PA, 2005, J HAND SURG-BRIT EUR, V30B, P593, DOI 10.1016/j.jhsb.2005.06.019; Reid IR, 2010, J CLIN ENDOCR METAB, V95, P4380, DOI 10.1210/jc.2010-0597; Sauty A, 1996, BONE, V18, P133, DOI 10.1016/8756-3282(95)00448-3; SCHWEITZER DH, 1995, J BONE MINER RES, V10, P956; Sibley PA, 2012, ORTHOPEDICS, V35, pE1286, DOI 10.3928/01477447-20120725-37; Solomon DH, 2009, CURR OPIN RHEUMATOL, V21, P363, DOI 10.1097/BOR.0b013e32832ca433; Sun K, 2013, OSTEOPOROSIS INT, V24, P279, DOI 10.1007/s00198-012-2158-8; Thiebaud D, 1997, CALCIFIED TISSUE INT, V61, P386, DOI 10.1007/s002239900353; Tseng CH, 2012, EUR J NEUROL, V19, P91, DOI 10.1111/j.1468-1331.2011.03440.x; Watson J, 2007, EUR J CLIN PHARMACOL, V63, P843, DOI 10.1007/s00228-007-0320-6; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; Wysowski DK, 2005, ARCH INTERN MED, V165, P346, DOI 10.1001/archinte.165.3.346-b	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146772	10.1371/journal.pone.0146772	http://dx.doi.org/10.1371/journal.pone.0146772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765346	gold, Green Published, Green Submitted			2022-12-27	WOS:000368459300042
J	Chang, CLT; Chung, CY; Kuo, CH; Kuo, TF; Yang, CW; Yang, WC				Chang, Cicero L. T.; Chung, Chih-Yao; Kuo, Chih-Horng; Kuo, Tien-Fen; Yang, Chu-Wen; Yang, Wen-Chin			Beneficial Effect of Bidens pilosa on Body Weight Gain, Food Conversion Ratio, Gut Bacteria and Coccidiosis in Chickens	PLOS ONE			English	Article							BROILER-CHICKENS; BUTANOL FRACTION; GROWTH PROMOTERS; INTESTINAL FLORA; PLANT-EXTRACT; PERFORMANCE; EIMERIA; INFECTION; POULTRY; MICROFLORA	In the interests of food safety and public health, plants and their compounds are now re-emerging as an alternative approach to treat gastrointestinal diseases in chickens. Here, we studied the impact of the edible medicinal plant, B. pilosa, on growth performance, gut bacteria and coccidiosis in chickens. First, we found that B. pilosa significantly elevated body weight gain and lowered feed conversion ratio in chickens. Next, we showed that B. pilosa reduced cecal damage as evidenced by increased hemorrhage, villus destruction and decreased villus-to-crypt ratio in chicken ceca. We also performed pyrosequencing of the PCR ampilcons based on the 16S rRNA genes of gut bacteria in chickens. Metagenomic analysis indicated that the chicken gut bacteria belonged to 6 phyla, 6 classes, 6 orders, 9 families, and 8 genera. More importantly, we found that B. pilosa affected the composition of bacteria. This change in bacteria composition was correlated with body weight gain, feed conversion ratio and gut pathology in chickens. Collectively, this work suggests that B. pilosa has beneficial effects on growth performance and protozoan infection in chickens probably via modulation of gut bacteria.	[Chang, Cicero L. T.; Chung, Chih-Yao] Natl Chung Hsing Univ, Coll Vet Med, Dept Vet Med, Taichung 402, Taiwan; [Kuo, Chih-Horng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Kuo, Tien-Fen; Yang, Wen-Chin] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Yang, Chu-Wen] Soochow Univ, Dept Microbiol, Taipei 11102, Taiwan; [Yang, Wen-Chin] Natl Ocean Univ, Dept Aquaculture, Keelung Chung, Taiwan; [Yang, Wen-Chin] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Yang, Wen-Chin] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan	National Chung Hsing University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Soochow University; National Yang Ming Chiao Tung University; National Chung Hsing University	Yang, CW (corresponding author), Soochow Univ, Dept Microbiol, Taipei 11102, Taiwan.	cwyang@mail.scu.edu.tw; wcyang@gate.sinica.edu.tw	Yang, Wen-Chin/D-3441-2015; Kuo, Chih-Horng/E-2045-2013; Chung, Chih-Yao/AEY-3140-2022	Yang, Wen-Chin/0000-0001-6410-2581; Kuo, Chih-Horng/0000-0002-2857-0529; Chung, Chih-Yao/0000-0002-2263-4181	Innovative Translational Agriculture Research (ITAR) grant of Academia Sinica, Taiwan	Innovative Translational Agriculture Research (ITAR) grant of Academia Sinica, Taiwan	This work was supported by the Innovative Translational Agriculture Research (ITAR) grant of Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adil S, 2012, J ANIM VET ADV, V11, P873, DOI 10.3923/javaa.2012.873.877; Angelakis E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010463; BARNES EM, 1972, AM J CLIN NUTR, V25, P1475; BARNES EM, 1972, BRIT POULTRY SCI, V13, P311, DOI 10.1080/00071667208415953; BARNES EM, 1977, AM J CLIN NUTR, V30, P1793, DOI 10.1093/ajcn/30.11.1793; Barrow P, 1992, PROBIOTICS CHICKENS; Bartolome AP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/340215; Belova A. V., 2012, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V60, P15; Bittar F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07174; Bublitz DC, 2015, AM J PRIMATOL, V77, P330, DOI 10.1002/ajp.22348; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Chang CLT, 2007, J IMMUNOL, V178, P6984, DOI 10.4049/jimmunol.178.11.6984; Chang CLT, 2005, J BIOMED SCI, V12, P79, DOI 10.1007/s11373-004-8172-x; Chang SL, 2007, TOXICOL APPL PHARM, V219, P54, DOI 10.1016/j.taap.2006.11.026; Chang SL, 2004, PLANTA MED, V70, P1045, DOI 10.1055/s-2004-832645; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Giannenas I, 2014, AVIAN PATHOL, V43, P209, DOI 10.1080/03079457.2014.899430; Kemper N, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-7; Luo YH, 2013, POULTRY SCI, V92, P2358, DOI 10.3382/ps.2012-02935; Mwale M, 2009, TROP ANIM HEALTH PRO, V41, P1685, DOI 10.1007/s11250-009-9366-z; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Orengo J, 2012, VET PARASITOL, V185, P158, DOI 10.1016/j.vetpar.2011.09.024; RANTALA M, 1973, BRIT POULTRY SCI, V14, P627, DOI 10.1080/00071667308416073; Ritzi MM, 2014, POULTRY SCI, V93, P2772, DOI 10.3382/ps.2014-04207; Schilling AK, 2012, APPL ENVIRON MICROB, V78, P3785, DOI 10.1128/AEM.07802-11; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Serratosa J, 2006, REV SCI TECH OIE, V25, P637, DOI 10.20506/rst.25.2.1687; Sharman PA, 2010, PARASITE IMMUNOL, V32, P590, DOI 10.1111/j.1365-3024.2010.01209.x; Sugiharto S., 2016, Journal of the Saudi Society of Agricultural Sciences, V15, P99, DOI 10.1016/j.jssas.2014.06.001; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; van der Wielen PWJJ, 2002, MICROBIAL ECOL, V44, P286, DOI 10.1007/s00248-002-2015-y; Vispo C, 1997, INTERACTION AVIAN GU; Warwick Clifford, 2013, JRSM Short Rep, V4, p2042533313490287, DOI 10.1177/2042533313490287; Weese JS, 2007, CLIN INFECT DIS, V45, P10, DOI 10.1086/518572; Williams RB, 2002, AVIAN PATHOL, V31, P253, DOI 10.1080/03079450220136567a; Williams RB, 1998, INT J PARASITOL, V28, P1089, DOI 10.1016/S0020-7519(98)00066-6; Yang WC, 2015, RES VET SCI, V98, P74, DOI 10.1016/j.rvsc.2014.11.002; Zambrano LD, 2014, T ROY SOC TROP MED H, V108, P313, DOI 10.1093/trstmh/tru056	39	36	37	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146141	10.1371/journal.pone.0146141	http://dx.doi.org/10.1371/journal.pone.0146141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765226	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300016
J	Iannilli, E; Gasparotti, R; Hummel, T; Zoni, S; Benedetti, C; Fedrighi, C; Tang, CY; Van Thriel, C; Lucchini, RG				Iannilli, Emilia; Gasparotti, Roberto; Hummel, Thomas; Zoni, Silvia; Benedetti, Chiara; Fedrighi, Chiara; Tang, Cheuk Ying; Van Thriel, Christoph; Lucchini, Roberto G.			Effects of Manganese Exposure on Olfactory Functions in Teenagers: A Pilot Study	PLOS ONE			English	Article							ASSESSING POTENTIAL RISK; ENVIRONMENTAL EXPOSURE; CHILDREN; VEGETABLES; SOILS; MOTOR	Long-term exposure to environmental manganese (Mn) affects not only attention and neuromotor functions but also olfactory functions of a pre-adolescent local population who have spent their whole life span in contaminated areas. In order to investigate the effect of such exposure at the level of the central nervous system we set up a pilot fMRI experiment pointing at differences of brain activities between a non-exposed population (nine subjects) and an exposed one (three subjects). We also measured the volume of the olfactory bulb as well as the identification of standard olfactory stimuli. Our results suggest that young subjects exposed to Mn exhibit a reduction of BOLD signal, subjective odor sensitivity and olfactory bulb volume. Moreover a region of interest SPM analysis showed a specifically reduced response of the limbic system in relation to Mn exposure, suggesting an alteration of the brain network dealing with emotional responses.	[Iannilli, Emilia; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell & Taste, Dresden, Germany; [Gasparotti, Roberto] Univ Brescia, Neuroradiol Unit, Brescia, Italy; [Zoni, Silvia; Benedetti, Chiara; Fedrighi, Chiara; Lucchini, Roberto G.] Univ Brescia, Occupat Med, Brescia, Italy; [Tang, Cheuk Ying] Icahn Sch Med Mt Sinai, Radiol & Psychiat, New York, NY 10029 USA; [Van Thriel, Christoph] TU Dortmund IfADo, Leibniz Res Ctr Working Environm & Human Factors, Neurotoxicol & Chemosensat, Dortmund, Germany; [Lucchini, Roberto G.] Icahn Sch Med Mt Sinai, Prevent Med, New York, NY 10029 USA	Technische Universitat Dresden; University of Brescia; University of Brescia; Icahn School of Medicine at Mount Sinai; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Icahn School of Medicine at Mount Sinai	Iannilli, E (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell & Taste, Dresden, Germany.	emilia.iannilli@googlemail.com	van Thriel, Christoph/AAF-4167-2021; Iannilli, Emilia/H-6776-2019; Gasparotti, Roberto/K-5165-2018	Iannilli, Emilia/0000-0001-6871-3769; Gasparotti, Roberto/0000-0002-2591-2415; Lucchini, Roberto/0000-0002-9723-0237; van Thriel, Christoph/0000-0003-3215-9262; Tang, Cheuk Ying/0000-0002-9828-0092	European Union through Sixth Framework Program for RTD [FOODCT- 2006-016253]; National Institute of Environmental Health Sciences (NIEHS) [R01ES019222]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019222] Funding Source: NIH RePORTER	European Union through Sixth Framework Program for RTD; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by funding from the European Union through its Sixth Framework Program for RTD (contract no FOODCT- 2006-016253). The project was supported also by Award Number R01ES019222 from the National Institute of Environmental Health Sciences (NIEHS).; This study was supported by funding from the European Union through its Sixth Framework Program for RTD (contract no FOODCT- 2006-016253). It reflects only the authors' views, and the European Commission is not liable for any use that may be made of the information contained therein. The project was supported also by Award Number R01ES019222 from the National Institute of Environmental Health Sciences (NIEHS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIEHS or the National Institutes of Health.	Arshamian A, 2013, NEUROPSYCHOLOGIA, V51, P123, DOI 10.1016/j.neuropsychologia.2012.10.023; Ferri R, 2015, SCI TOTAL ENVIRON, V518, P507, DOI 10.1016/j.scitotenv.2015.02.072; Guarneros M, 2013, CHEM SENSES, V38, P783, DOI 10.1093/chemse/bjt045; Harris AR, 2005, ENVIRON SCI TECHNOL, V39, P7410, DOI 10.1021/es050642s; Hough RL, 2004, ENVIRON HEALTH PERSP, V112, P215, DOI 10.1289/ehp.5589; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; HUTTENLOCHER PR, 1984, AM J MENT DEF, V88, P488; Khan K, 2012, NEUROTOXICOLOGY, V33, P91, DOI 10.1016/j.neuro.2011.12.002; Landrigan PJ, 1999, ENVIRON HEALTH PERSP, V107, P423, DOI 10.2307/3434621; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Oulhote Y, 2014, ENVIRON HEALTH PERSP, V122, P1343, DOI 10.1289/ehp.1307918; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Sommer JU, 2012, J NEUROSCI METH, V209, P189, DOI 10.1016/j.jneumeth.2012.05.026; Wang ZX, 2010, J ENVIRON QUAL, V39, P1616, DOI 10.2134/jeq2010.0007; Willander J, 2007, MEM COGNITION, V35, P1659, DOI 10.3758/BF03193499; Yousem DM, 1997, ACAD RADIOL, V4, P264, DOI 10.1016/S1076-6332(97)80027-X; Zoni S, 2012, J TRACE ELEM MED BIO, V26, P179, DOI 10.1016/j.jtemb.2012.04.023	18	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0144783	10.1371/journal.pone.0144783	http://dx.doi.org/10.1371/journal.pone.0144783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765332	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300005
J	Fullen, DJ; Noulin, N; Catchpole, A; Fathi, H; Murray, EJ; Mann, A; Eze, K; Balaratnam, G; Borley, DW; Gilbert, A; Lambkin-Williams, R				Fullen, Daniel J.; Noulin, Nicolas; Catchpole, Andrew; Fathi, Hosnieh; Murray, Edward J.; Mann, Alex; Eze, Kingsley; Balaratnam, Ganesh; Borley, Daryl W.; Gilbert, Anthony; Lambkin-Williams, Rob			Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INTRAVENOUS ZANAMIVIR; DOUBLE-BLIND; INFECTION; PREVENTION; RESPONSES; EFFICACY; DISEASE; SAFETY; OSELTAMIVIR	Background Influenza and its associated diseases are a major cause of morbidity and mortality. The United States Advisory Committee on Immunization Practices recommends influenza vaccination for everyone over 6 months of age. The failure of the flu vaccine in 2014-2015 demonstrates the need for a model that allows the rapid development of novel antivirals, universal/intra-seasonal vaccines, immunomodulators, monoclonal antibodies and other novel treatments. To this end we manufactured a new H3N2 influenza virus in compliance with Good Manufacturing Practice for use in the Human Viral Challenge Model. Methods and Strain Selection We chose an H3N2 influenza subtype, rather than H1N1, given that this strain has the most substantial impact in terms of morbidity or mortality annually as described by the Centre for Disease Control. We first subjected the virus batch to rigorous adventitious agent testing, confirmed the virus to be wild-type by Sanger sequencing and determined the virus titres appropriate for human use via the established ferret model. We built on our previous experience with other H3N2 and H1N1 viruses to develop this unique model. Human Challenge and Conclusions We conducted an initial safety and characterisation study in healthy adult volunteers, utilising our unique clinical quarantine facility in London, UK. In this study we demonstrated this new influenza (H3N2) challenge virus to be both safe and pathogenic with an appropriate level of disease in volunteers. Furthermore, by inoculating volunteers with a range of different inoculum titres, we established the minimum infectious titre required to achieve reproducible disease whilst ensuring a sensitive model that can be translated to design of subsequent field based studies.	[Fullen, Daniel J.; Noulin, Nicolas; Catchpole, Andrew; Fathi, Hosnieh; Murray, Edward J.; Mann, Alex; Eze, Kingsley; Balaratnam, Ganesh; Borley, Daryl W.; Gilbert, Anthony; Lambkin-Williams, Rob] hVIVO Serv Ltd, Queen Mary BioEnterprises Innovat Ctr, London E1 2AX, England		Fullen, DJ (corresponding author), hVIVO Serv Ltd, Queen Mary BioEnterprises Innovat Ctr, 42 New Rd, London E1 2AX, England.	d.fullen@hvivo.com	Lambkin-Williams, Rob/L-2397-2019	Lambkin-Williams, Rob/0000-0003-2107-0174; Gilbert, Anthony Saul/0000-0002-6582-3820; Mann, Alexander/0000-0002-3744-4604; Fullen, Daniel/0000-0002-8562-7157	hVIVO Services Limited	hVIVO Services Limited	The study was funded by hVIVO Services Limited. hVIVO Services Limited provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; All authors interpreted the data, reviewed the draft and approved the final version for publication. The study was entirely funded by hVIVO Services Limited there were no external competing interests.	Bagga B, 2013, ANTIVIR THER, V18, P785, DOI 10.3851/IMP2629; Bartlett John M S, 2003, Methods Mol Biol, V226, P3; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Borroso L, 2005, ANTIVIR THER, V10, P901; Calfee DP, 1999, ANTIMICROB AGENTS CH, V43, P1616, DOI 10.1128/AAC.43.7.1616; Calfee DP, 1999, ANTIVIR THER, V4, P143; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Grohskopf LA, 2014, MMWR-MORBID MORTAL W, V63, P691; Hayden FG, 2000, ANTIVIR THER, V5, P205; HAYDEN FG, 1994, ANTIMICROB AGENTS CH, V38, P1178, DOI 10.1128/AAC.38.5.1178; Hayden FG, 1996, JAMA-J AM MED ASSOC, V275, P295, DOI 10.1001/jama.275.4.295; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hayden FG, 2012, ANTIVIR THER, V17, P133, DOI 10.3851/IMP2062; Huang KYA, 2014, J INFECT DIS, V209, P1354, DOI 10.1093/infdis/jit650; Jenner E, 1923, INQUIRY CAUSES EFFEC, P84; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Kaji M, 2003, RESPIROLOGY, V8, P231, DOI 10.1046/j.1440-1843.2003.00457.x; Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701; Lambkin R, 2004, VACCINE, V22, P4390, DOI 10.1016/j.vaccine.2003.10.054; Lambkin R, 1996, VACCINE, V14, P212, DOI 10.1016/0264-410X(95)00183-2; Mann AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093761; Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; McClain MT, 2013, J CLIN VIROL, V58, P689, DOI 10.1016/j.jcv.2013.09.015; Memoli MJ, 2015, CLIN INFECT DIS, V60, P693, DOI 10.1093/cid/ciu924; Ovsyannikova IG, 2014, VIRAL IMMUNOL, V27, P174, DOI 10.1089/vim.2013.0111; Roberts KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043303; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Templeton N S, 1992, Diagn Mol Pathol, V1, P58, DOI 10.1097/00019606-199203000-00008; Tyrrell DA, 2002, COLD WARS FIGHT COMM; van den Brand JMA, 2012, VET PATHOL, V49, P562, DOI 10.1177/0300985811429812; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P231, DOI 10.1111/irv.12068; VONMAGNUS P, 1951, ACTA PATHOL MIC SC, V28, P278; Walker JB, 1997, J INFECT DIS, V176, P1417, DOI 10.1086/514136; Watson JM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0240-5; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198; Yap J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-12; YOUNGNER JS, 1994, J CLIN MICROBIOL, V32, P750, DOI 10.1128/JCM.32.3.750-754.1994; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	44	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145902	10.1371/journal.pone.0145902	http://dx.doi.org/10.1371/journal.pone.0145902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761707	Green Published, gold			2022-12-27	WOS:000368033100021
J	Han, SJ; Li, YY; Chan, BP				Han, Sejin; Li, Yuk Yin; Chan, Barbara Pui			Extracellular Protease Inhibition Alters the Phenotype of Chondrogenically Differentiating Human Mesenchymal Stem Cells (MSCs) in 3D Collagen Microspheres	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; IN-VITRO; HYDROGELS; CARTILAGE; FIBROCARTILAGE; MENISCUS; TISSUE; ASSAY	Matrix remodeling of cells is highly regulated by proteases and their inhibitors. Nevertheless, how would the chondrogenesis of mesenchymal stem cells (MSCs) be affected, when the balance of the matrix remodeling is disturbed by inhibiting matrix proteases, is incompletely known. Using a previously developed collagen microencapsulation platform, we investigated whether exposing chondrogenically differentiating MSCs to intracellular and extracellular protease inhibitors will affect the extracellular matrix remodeling and hence the outcomes of chondrogenesis. Results showed that inhibition of matrix proteases particularly the extracellular ones favors the phenotype of fibrocartilage rather than hyaline cartilage in chondrogenically differentiating hMSCs by upregulating type I collagen protein deposition and type II collagen gene expression without significantly altering the hypertrophic markers at gene level. This study suggests the potential of manipulating extracellular proteases to alter the outcomes of hMSC chondrogenesis, contributing to future development of differentiation protocols for fibrocartilage tissues for intervertebral disc and meniscus tissue engineering.	[Han, Sejin; Li, Yuk Yin; Chan, Barbara Pui] Univ Hong Kong, Tissue Engn Lab, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan, BP (corresponding author), Univ Hong Kong, Tissue Engn Lab, Dept Mech Engn, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	bpchan@hku.hk	Chan, Barbara Pui/AAM-7767-2020	Chan, BP/0000-0001-5419-2472	University of Hong Kong [201109176132]; Hong Kong Research Grants Council General Research Fund award [17100714]; Hong Kong Innovation and Technology Commission Grant [ITS/081/14FP]	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council General Research Fund award; Hong Kong Innovation and Technology Commission Grant	This work was supported by a grant from The University of Hong Kong Small Project Funding (201109176132), a Hong Kong Research Grants Council General Research Fund award (17100714) and a Hong Kong Innovation and Technology Commission Grant (ITS/081/14FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; BENJAMIN M, 1990, J ANAT, V171, P1; Bertram H, 2009, STEM CELLS DEV, V18, P881, DOI 10.1089/scd.2008.0306; Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001; Jin EJ, 2007, DEV BIOL, V308, P474, DOI 10.1016/j.ydbio.2007.06.003; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Li CH, 2011, TISSUE ENG PT A, V17, P777, DOI [10.1089/ten.tea.2010.0078, 10.1089/ten.TEA.2010.0078]; Li J, 2004, BRIT J HAEMATOL, V127, P326, DOI 10.1111/j.1365-2141.2004.05200.x; Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; Mhanna R, 2014, TISSUE ENG PT A, V20, P1165, DOI [10.1089/ten.tea.2013.0519, 10.1089/ten.TEA.2013.0519]; Mwale F, 2006, J ORTHOP RES, V24, P1791, DOI 10.1002/jor.20200; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raghothaman D, 2014, BIOMATERIALS, V35, P2607, DOI 10.1016/j.biomaterials.2013.12.008; Ravanti L, 2000, INT J MOL MED, V6, P391; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Singh P, 2012, J CELL SCI, V125, P3703, DOI 10.1242/jcs.095786; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Wang WJ, 2015, CLIN CHIM ACTA, V448, P238, DOI 10.1016/j.cca.2015.06.023	27	7	7	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146928	10.1371/journal.pone.0146928	http://dx.doi.org/10.1371/journal.pone.0146928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760956	Green Submitted, gold, Green Published			2022-12-27	WOS:000368033100054
J	Mekkaoui, C; Metellus, P; Kostis, WJ; Martuzzi, R; Pereira, FR; Beregi, JP; Reese, TG; Constable, TR; Jackowski, MP				Mekkaoui, Choukri; Metellus, Philippe; Kostis, William J.; Martuzzi, Roberto; Pereira, Fabricio R.; Beregi, Jean-Paul; Reese, Timothy G.; Constable, Todd R.; Jackowski, Marcel P.			Diffusion Tensor Imaging in Patients with Glioblastoma Multiforme Using the Supertoroidal Model	PLOS ONE			English	Article							WATER DIFFUSION; SCHEMES; TISSUES; GLIOMAS	Purpose Diffusion Tensor Imaging (DTI) is a powerful imaging technique that has led to improvements in the diagnosis and prognosis of cerebral lesions and neurosurgical guidance for tumor resection. Traditional tensor modeling, however, has difficulties in differentiating tumor-infiltrated regions and peritumoral edema. Here, we describe the supertoroidal model, which incorporates an increase in surface genus and a continuum of toroidal shapes to improve upon the characterization of Glioblastoma multiforme (GBM). Materials and Methods DTI brain datasets of 18 individuals with GBM and 18 normal subjects were acquired using a 3T scanner. A supertoroidal model of the diffusion tensor and two new diffusion tensor invariants, one to evaluate diffusivity, the toroidal volume (TV), and one to evaluate anisotropy, the toroidal curvature (TC), were applied and evaluated in the characterization of GBM brain tumors. TV and TC were compared with the mean diffusivity (MD) and fractional anisotropy (FA) indices inside the tumor, surrounding edema, as well as contralateral to the lesions, in the white matter (WM) and gray matter (GM). Results The supertoroidal model enhanced the borders between tumors and surrounding structures, refined the boundaries between WM and GM, and revealed the heterogeneity inherent to tumor-infiltrated tissue. Both MD and TV demonstrated high intensities in the tumor, with lower values in the surrounding edema, which in turn were higher than those of unaffected brain parenchyma. Both TC and FA were effective in revealing the structural degradation of WM tracts. Conclusions Our findings indicate that the supertoroidal model enables effective tensor visualization as well as quantitative scalar maps that improve the understanding of the underlying tissue structure properties. Hence, this approach has the potential to enhance diagnosis, preoperative planning, and intraoperative image guidance during surgical management of brain lesions.	[Mekkaoui, Choukri; Kostis, William J.; Reese, Timothy G.] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp,Athinoula Martinos Ctr Bio, Boston, MA 02115 USA; [Metellus, Philippe] Hop Timone Adultes Marseille, Dept Neurosurg, Marseille, Bouches Du Rhon, France; [Kostis, William J.] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Martuzzi, Roberto] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland; [Pereira, Fabricio R.; Beregi, Jean-Paul] Univ Hosp Ctr Nimes, Dept Radiol, Nimes, Gard, France; [Pereira, Fabricio R.; Beregi, Jean-Paul] Res Team EA 2415, Nimes, Gard, France; [Constable, Todd R.] Yale Univ, Sch Med, Dept Diagnost Radiol, Magnet Resonance Res Ctr, New Haven, CT 06510 USA; [Jackowski, Marcel P.] Univ Sao Paulo, Dept Comp Sci, Inst Math & Stat, Sao Paulo, Brazil	Harvard University; Harvard Medical School; Massachusetts General Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Rutgers State University New Brunswick; Rutgers State University Medical Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universite de Montpellier; CHU de Nimes; Yale University; Universidade de Sao Paulo	Mekkaoui, C (corresponding author), Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp,Athinoula Martinos Ctr Bio, Boston, MA 02115 USA.	mekkaoui@nmr.mgh.harvard.edu	BEREGI, Jean-Paul/C-2777-2012; Pereira, Fabricio/L-6572-2013; Constable, R. Todd/ABE-8038-2021	Pereira, Fabricio/0000-0003-3317-8756; Constable, R. Todd/0000-0001-5661-9521; Kostis, William/0000-0002-0543-9798	Sao Paulo Research Foundation (FAPESP) [2015/01587-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We thank the Sao Paulo Research Foundation (FAPESP grant #2015/01587-0).	Archip N, 2008, NEUROSURGERY, V63, P209, DOI [10.1227/01.NEU.0000297081.51540.45, 10.1227/01.neu.0000317395.08466.e6]; Bahn MM, 1999, J MAGN RESON, V139, P1, DOI 10.1006/jmre.1999.1752; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1997, ANN NY ACAD SCI, V820, P123, DOI 10.1111/j.1749-6632.1997.tb46192.x; Bauer AH, 2015, NEURORADIOLOGY, V57, P697, DOI 10.1007/s00234-015-1524-6; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Chen DQ, 2011, NEUROSURGERY, V68, P1077, DOI 10.1227/NEU.0b013e31820c6cbe; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Ennis DB, 2005, MAGNET RESON MED, V53, P169, DOI 10.1002/mrm.20318; Gerstner ER, 2011, SEMIN RADIAT ONCOL, V21, P141, DOI 10.1016/j.semradonc.2010.10.005; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Jones D., 2011, DIFFUSION MRI THEORY; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones TL, 2014, NEURO-ONCOLOGY, DOI [10.1093/neuonc/nou159, DOI 10.1093/NEU0NC/N0U159]; Kindlmann G, 2004, P IEEE TVC EG S VIS; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P155, DOI 10.1002/cmr.a.20050; Lazar M, 2005, MAGN RESON MED, V54, P860, DOI 10.1002/mrm.20653; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; Makris N, 1997, ANN NEUROL, V42, P951, DOI 10.1002/ana.410420617; Mekkaoui C, 2007, P ANN M BMES LOS ANG; Mekkaoui C, 2009, P 17 ANN M ISMRM HON; Mekkaoui C, 2008, J CARDIOV MAGN RE S1, V10, pA206, DOI 10.; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Price SJ, 2004, EUR RADIOL, V14, P1909, DOI 10.1007/s00330-004-2381-6; Price SJ, 2007, EUR RADIOL, V17, P1675, DOI 10.1007/s00330-006-0561-2; Roldan-Valadez E, 2014, RADIOL ONCOL, V48, P127, DOI 10.2478/raon-2014-0004; Schultz T, 2010, IEEE T VIS COMPUT GR, V16, P1595, DOI 10.1109/TVCG.2010.199; Tropine A, 2004, J MAGN RESON IMAGING, V20, P905, DOI 10.1002/jmri.20217; Westin C.F., 1997, P 5 ANN M ISMRM VANC; Wieshmann UC, 2000, J NEUROL NEUROSUR PS, V68, P501, DOI 10.1136/jnnp.68.4.501; Witwer BP, 2002, J NEUROSURG, V97, P568, DOI 10.3171/jns.2002.97.3.0568; Woodworth DC, 2014, J NEURO-ONCOL, V116, P551, DOI 10.1007/s11060-013-1320-2; Wu JS, 2007, NEUROSURGERY, V61, P935, DOI 10.1227/01.neu.0000303189.80049.ab	37	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146693	10.1371/journal.pone.0146693	http://dx.doi.org/10.1371/journal.pone.0146693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761637	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100039
J	Nalwoga, H; Ahmed, L; Arnes, JB; Wabinga, H; Akslen, LA				Nalwoga, Hawa; Ahmed, Lavina; Arnes, Jarle B.; Wabinga, Henry; Akslen, Lars A.			Strong Expression of Hypoxia-Inducible Factor-1 alpha (HIF-1 alpha) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; BASAL-LIKE PHENOTYPE; EPITHELIAL-MESENCHYMAL TRANSITION; FACTOR 1-ALPHA; ALDEHYDE DEHYDROGENASE; C-KIT; ANGIOGENESIS; METASTASIS; CARCINOMA; SURVIVAL	Purpose Inhibition of hypoxia-inducible factor (HIF) and Axl receptor tyrosine kinase is being evaluated for targeted therapy in solid tumors. Both HIF-1 alpha and Axl influence tumor growth and metastatic potential, and they have been linked to treatment failure in many cancers. However, there is a lack of reports on HIF-1 alpha expression in African breast cancer, which has a poor prognosis, and novel treatment targets must therefore be established. Here, we aimed to evaluate HIF-1 alpha in relation to Axl expression, angiogenesis markers, and other tumor characteristics in a series of African breast cancer. Methods Using immunohistochemistry, we examined 261 invasive breast cancers on tissue microarrays for HIF-1 alpha and Axl as well as several other markers, and a subset of 185 cases had information on VEGF (vascular endothelial growth factor) expression, microvessel density (MVD), proliferating microvessel density (pMVD) and vascular proliferation index (VPI) for important comparisons. Results Strong HIF-1 alpha expression was associated with increased Axl (p = 0.007), VEGF (p<0.0005), and p53 (p = 0.032) expression, as well as high tumor cell proliferation by Ki-67 (p = 0.006), and high tumor grade (p = 0.003). Tumors with strong HIF-1 alpha expression had significantly higher MVD (p = 0.019) and higher pMVD (p = 0.027) than tumors with weak expression. Conclusions High HIF-1 alpha expression is significantly associated with Axl and VEGF expression, and with markers of poor prognosis in this series of breast cancer, suggesting HIF-1 alpha and Axl as potential therapeutic targets in African breast cancer.	[Nalwoga, Hawa; Ahmed, Lavina; Akslen, Lars A.] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Haukeland Univ Hosp, Bergen, Norway; [Ahmed, Lavina] BerGenBio AS, Bergen, Norway; [Arnes, Jarle B.; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Nalwoga, Hawa; Wabinga, Henry] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Pathol, Kampala, Uganda	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Makerere University	Akslen, LA (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Haukeland Univ Hosp, Bergen, Norway.	lars.akslen@uib.no	Akslen, Lars A/C-1202-2017; Akslen, Lars A./AAG-6097-2021	Akslen, Lars A/0000-0003-2710-9543; Akslen, Lars A./0000-0003-2710-9543; , Hawa/0000-0002-2965-9445	Norwegian Programme for Development, Research and Education (NUFU) [64/2003]; University of Bergen; Norwegian Cancer Society [419328112691]; Research Council of Norway [191778, 223250]; Helse Vest Research Fund [911873]; Helse Vest RHF; Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen	Norwegian Programme for Development, Research and Education (NUFU); University of Bergen; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Helse Vest Research Fund; Helse Vest RHF; Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen	This work was partly supported by The Research Council of Norway through its Centres of Excellence funding scheme, project number 223250, (http://www.forskningsradet.no/en/Centre_schemes/1188910295281). HN was supported by the Norwegian Programme for Development, Research and Education (NUFU, Project No. 64/2003) and a postdoctoral grant from the University of Bergen. LAA was supported by other grants from the Norwegian Cancer Society (Grant No. 419328112691), the Research Council of Norway (Grant No. 191778) and Helse Vest Research Fund (Grant No. 911873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Department of Pathology at MakCHS for allowing us to use the archival tissue, the Kampala Cancer Registry for providing us with the data and Centre for Disease Control and Prevention (CDC) for computerizing the data base at the Pathology Department (MakCHS). In addition, we appreciate the excellent technical support offered by Sarah Nambooze, Ruth Nakigudde, Dorothy Lynn Nabbale, Gerd Lillian Hallseth and Bendik Nordanger. We likewise extend our thanks to all the staff of the Gades Laboratory for Pathology and Centre for Cancer Biomarkers (CCBIO) for their support during the study. This work was partly supported by the Research Council of Norway through its Centers of Excellence funding scheme, project number 223250. The study was also supported by the Norwegian Cancer Society, Helse Vest RHF, and the Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen.	Ahmed L, 2015, APMIS, V123, P688, DOI 10.1111/apm.12403; Alameddine RS, 2013, CURR OPIN ONCOL, V25, P313, DOI 10.1097/CCO.0b013e32835ff362; Amadori D, 2014, BREAST CANCER RES TR, V145, P177, DOI 10.1007/s10549-014-2903-0; Arnes JB, 2008, HISTOPATHOLOGY, V52, P370, DOI 10.1111/j.1365-2559.2007.02957.x; Bao B, 2012, BBA-REV CANCER, V1826, P272, DOI 10.1016/j.bbcan.2012.04.008; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Bos R, 2004, BREAST CANCER RES, V6, pR450, DOI 10.1186/bcr813; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Choi J, 2013, PATHOBIOLOGY, V80, P41, DOI 10.1159/000339513; Choo Jennifer R, 2010, Cancers (Basel), V2, P1040, DOI 10.3390/cancers2021040; Chuangsuwanich T, 2014, ASIAN PAC J CANCER P, V15, P1187, DOI 10.7314/APJCP.2014.15.3.1187; El Guerrab A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025080; Ellis IO, 2003, WHO CLASSIFICATION T, V5, P13; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Falchook GS, 2014, ONCOTARGET, V5, P10280, DOI 10.18632/oncotarget.2163; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gatza ML, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2899; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goonewardene TI, 2002, MICROSC RES TECHNIQ, V59, P41, DOI 10.1002/jemt.10175; Gruber G, 2004, BREAST CANCER RES, V6, pR191, DOI 10.1186/bcr775; Han ML, 2012, CANCER SCI, V103, P1058, DOI 10.1111/j.1349-7006.2012.02281.x; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Jeong W, 2014, INVEST NEW DRUG, V32, P340, DOI 10.1007/s10637-013-0048-3; Jeong W, 2014, CANCER CHEMOTH PHARM, V73, P343, DOI 10.1007/s00280-013-2362-z; Kronblad A, 2006, INT J CANCER, V118, P2609, DOI 10.1002/ijc.21676; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Linderholm BK, 2009, ANN ONCOL, V20, P1639, DOI 10.1093/annonc/mdp062; Lindner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071915; Litz J, 2006, MOL CANCER THER, V5, P1415, DOI 10.1158/1535-7163.MCT-05-0503; Liu Y, 2011, BREAST CANCER RES TR, V129, P175, DOI 10.1007/s10549-011-1432-3; Liu ZJ, 2015, J ZHEJIANG UNIV-SC B, V16, P32, DOI 10.1631/jzus.B1400221; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Mishra A, 2012, MOL CANCER RES, V10, P703, DOI 10.1158/1541-7786.MCR-11-0569; Mizukami Y, 2007, CLIN CANCER RES, V13, P5670, DOI 10.1158/1078-0432.CCR-07-0111; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; Nalwoga H, 2010, BRIT J CANCER, V102, P369, DOI 10.1038/sj.bjc.6605488; Nalwoga H, 2008, APMIS, V116, P515, DOI 10.1111/j.1600-0463.2008.01024.x; Nalwoga H, 2007, APMIS, V115, P1391, DOI 10.1111/j.1600-0463.2007.00862.x; Nalwoga H, 2011, BREAST CANCER RES TR, V130, P1063, DOI 10.1007/s10549-011-1740-7; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Ravi R, 2000, GENE DEV, V14, P34; Redig AJ, 2013, J INTERN MED, V274, P113, DOI 10.1111/joim.12084; Ribeiro-Silva A, 2006, AM J CLIN PATHOL, V125, P512, DOI 10.1309/D744C4NM15J3B00D; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Ryu K, 2011, BIOCHEM BIOPH RES CO, V407, P831, DOI 10.1016/j.bbrc.2011.03.119; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schnitt SJ, 2014, WORLD CANC REPORT 20, P362; Sheridan C, 2013, NAT BIOTECHNOL, V31, P775, DOI 10.1038/nbt0913-775a; Skobe M, 1997, NAT MED, V3, P1222, DOI 10.1038/nm1197-1222; Sousa B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-734; Stefansson IM, 2006, CANCER RES, V66, P3303, DOI 10.1158/0008-5472.CAN-05-1163; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; Tiezzi DG, 2013, CLINICS, V68, P592, DOI 10.6061/clinics/2013(05)03; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yehia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129356; Zhang WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129603; Zhong H, 1999, CANCER RES, V59, P5830	69	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146823	10.1371/journal.pone.0146823	http://dx.doi.org/10.1371/journal.pone.0146823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760782	Green Published, gold, Green Submitted			2022-12-27	WOS:000368033100044
J	Rubino, A; Bensi, M; Hainbucher, D; Zanchettin, D; Mapelli, F; Ogrinc, N; Marchetto, D; Borin, S; Cardin, V; Fajon, V; Horvat, M; Taricco, C; Baldi, F				Rubino, Angelo; Bensi, Manuel; Hainbucher, Dagmar; Zanchettin, Davide; Mapelli, Francesca; Ogrinc, Nives; Marchetto, Davide; Borin, Sara; Cardin, Vanessa; Fajon, Vesna; Horvat, Milena; Taricco, Carla; Baldi, Franco			Biogeochemical, Isotopic and Bacterial Distributions Trace Oceanic Abyssal Circulation	PLOS ONE			English	Article							SEDIMENTS; WATER; SEA; VARIABILITY; COMMUNITIES	We explore the possibility of tracing routes of dense waters toward and within the ocean abyss by the use of an extended set of observed physical and biochemical parameters. To this purpose, we employ mercury, isotopic oxygen, biopolymeric carbon and its constituents, together with indicators of microbial activity and bacterial diversity found in bottom waters of the Eastern Mediterranean. In this basin, which has been considered as a miniature global ocean, two competing sources of bottom water (one in the Adriatic and one in the Aegean seas) contribute to the ventilation of the local abyss. However, due to a recent substantial reduction of the differences in the physical characteristics of these two water masses it has become increasingly complex a water classification using the traditional approach with temperature, salinity and dissolved oxygen alone. Here, we show that an extended set of observed physical and biochemical parameters allows recognizing the existence of two different abyssal routes from the Adriatic source and one abyssal route from the Aegean source despite temperature and salinity of such two competing sources of abyssal water being virtually indistinguishable. Moreover, as the near-bottom development of exogenous bacterial communities transported by convectively-generated water masses in the abyss can provide a persistent trace of episodic events, intermittent flows like those generating abyssal waters in the Eastern Mediterranean basin may become detectable beyond the availability of concomitant measurements.	[Rubino, Angelo; Zanchettin, Davide] Univ Ca Foscari di Venezia, Dipartimento Sci Ambientali Informat & Stat, I-30172 Venice, VE, Italy; [Bensi, Manuel; Cardin, Vanessa] OGS, Ist Nazl Oceanog & Geofis Sperimentale, Trieste, Italy; [Hainbucher, Dagmar] Univ Hamburg, Inst Meereskunde, CEN, D-20146 Hamburg, Germany; [Mapelli, Francesca; Borin, Sara] Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, Milan, Italy; [Ogrinc, Nives; Fajon, Vesna; Horvat, Milena] Jozef Stefan Inst, Dept Environm Sci, Ljubljana 1000, Slovenia; [Marchetto, Davide; Baldi, Franco] Univ Ca Foscari di Venezia, Dipartimento Sci Mol & Nanosistemi, I-30172 Venice, VE, Italy; [Taricco, Carla] Univ Turin, Dipartimento Fis, Turin, Italy; [Taricco, Carla] INAF, Osservatorio Astrofis Torino, Pino Torinese, Italy	Universita Ca Foscari Venezia; Istituto Nazionale di Oceanografia e di Geofisica Sperimentale; University of Hamburg; University of Milan; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Universita Ca Foscari Venezia; University of Turin; Istituto Nazionale Astrofisica (INAF)	Rubino, A (corresponding author), Univ Ca Foscari di Venezia, Dipartimento Sci Ambientali Informat & Stat, Via Torino 155, I-30172 Venice, VE, Italy.	rubino@unive.it	Baldi, Fernando/E-5492-2012; Bensi, Manuel/AAV-2101-2020	Baldi, Fernando/0000-0003-4094-2011; Bensi, Manuel/0000-0002-0548-7351; Cardin, Vanessa/0000-0002-4710-6844; Borin, Sara/0000-0001-7479-8199; Taricco, Carla/0000-0002-0129-5539; Mapelli, Francesca/0000-0002-2928-6538	German Research Foundation (DFG) within the core program METEOR/MERIAN; University of Hamburg	German Research Foundation (DFG) within the core program METEOR/MERIAN(German Research Foundation (DFG)); University of Hamburg	The authors want to thank the captains and crews on the research vessels RV Maria Sibylla Merian and RV Poseidon for the excellent cooperation during the campaigns. Thanks go to all scientists/technicians involved in the field campaigns. The ship time of RV Maria Sibylla Merian and the financial support for the journey of scientists and transport of equipment was provided by the German Research Foundation (DFG) within the core program METEOR/MERIAN. The Poseidon cruise 414 was supported by funding from the University of Hamburg.; The authors thank the captains and crews on the research vessels RV Maria Sibylla Merian and RV Poseidon for the excellent cooperation during the campaigns. Thanks go to all scientists/technicians involved in the field campaigns. The ship time of RV Maria Sibylla Merian and the financial support for the journey of scientists and transport of equipment was provided by the German Research Foundation (DFG) within the core program METEOR/MERIAN. The Poseidon cruise 414 was supported by funding from the University of Hamburg. The data considered in the present investigation can be required directly to the authors. The authors are grateful to two anonymous reviewers, whose critical comments helped improving the overall quality of the manuscript.	Alford MH, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048075; Baldi F, 2010, CONT SHELF RES, V30, P1614, DOI 10.1016/j.csr.2010.06.009; Bensi M, 2013, J GEOPHYS RES-OCEANS, V118, P931, DOI 10.1029/2012JC008178; Bigg GR, 2000, J GEOPHYS RES-OCEANS, V105, P8527, DOI 10.1029/2000JC900005; Borin S, 2009, RES MICROBIOL, V160, P307, DOI 10.1016/j.resmic.2009.04.005; Cardin V, 2011, CONT SHELF RES, V31, P951, DOI 10.1016/j.csr.2011.03.002; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; CARPENTER JAMES H., 1965, LIMNOL OCEANOGR, V10, P135; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; FERRARA R, 1992, MAR CHEM, V38, P237, DOI 10.1016/0304-4203(92)90036-A; Gacic M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043216; Hainbucher D, 2014, OCEAN SCI, V10, P669, DOI 10.5194/os-10-669-2014; Hainbucher D, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025318; Horvat M, 2003, ATMOS ENVIRON, V37, pS93, DOI 10.1016/S1352-2310(03)00249-8; Korlevic M, 2015, APPL ENVIRON MICROB, V81, P1715, DOI 10.1128/AEM.03410-14; KOSTA L, 1978, J RADIOANAL CHEM, V44, P317, DOI 10.1007/BF02519624; Mapelli F, 2013, OCEAN SCI, V9, P585, DOI 10.5194/os-9-585-2013; Marshall J, 1999, REV GEOPHYS, V37, P1, DOI 10.1029/98RG02739; Olsen SM, 2008, NATURE, V455, P519, DOI 10.1038/nature07302; Rubino A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031737; Schroeder K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035146; Zagar D, 2006, SCI TOTAL ENVIRON, V368, P149, DOI 10.1016/j.scitotenv.2005.09.068; Zanchettin D, 2008, CLIMATIC CHANGE, V89, P411, DOI 10.1007/s10584-008-9395-z	23	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145299	10.1371/journal.pone.0145299	http://dx.doi.org/10.1371/journal.pone.0145299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761666	Green Submitted, Green Published, gold			2022-12-27	WOS:000368033100012
J	Bollich, KL; Hill, PL; Harms, PD; Jackson, JJ				Bollich, Kathryn L.; Hill, Patrick L.; Harms, Peter D.; Jackson, Joshua J.			When Friends' and Society's Expectations Collide: A Longitudinal Study of Moral Decision-Making and Personality across College	PLOS ONE			English	Article							BRIGGS TYPE INDICATOR; REASONING DEVELOPMENT; TRAIT DEVELOPMENT; ROLE-CONFLICT; LIFE EVENTS; MEAN-LEVEL; STABILITY; JUDGMENT; MODEL; AGE	Early adulthood is a developmentally important time period, with many novel life events needing to be traversed for the first time. Despite this important transition period, few studies examine the development of moral decision-making processes during this critical life stage. In the present study, college students completed moral decision-making measures during their freshman and senior years of college. Results indicate that, across four years, moral decision-making demonstrates considerable rank-order stability as well as change, such that people become more likely to help a friend relative to following societal rules. To help understand the mechanisms driving changes in moral decision-making processes, we examined their joint development with personality traits, a known correlate that changes during early adulthood in the direction of greater maturity. We found little evidence that personality and moral decision-making developmental processes are related. In sum, findings indicate that while moral decision-making processes are relatively stable across a four-year period, changes do occur which are likely independent of developmental processes driving personality trait change.	[Bollich, Kathryn L.; Jackson, Joshua J.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Hill, Patrick L.] Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada; [Harms, Peter D.] Univ Nebraska, Dept Management, Lincoln, NE USA	Washington University (WUSTL); Carleton University; University of Nebraska System; University of Nebraska Lincoln	Bollich, KL (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	kbollich@wustl.edu						Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; ATCHLEY RC, 1968, AM SOCIOL REV, V33, P774, DOI 10.2307/2092887; Bleidorn W, 2015, BRIT J PSYCHOL, V106, P700, DOI 10.1111/bjop.12117; Bleidorn W, 2012, PERS SOC PSYCHOL B, V38, P1594, DOI 10.1177/0146167212456707; Bollich KL, 2016, J RES PERS, V61, P15, DOI 10.1016/j.jrp.2015.12.003; BROWNFAIN JJ, 1952, J ABNORM SOC PSYCH, V47, P597, DOI 10.1037/h0058421; Carstensen LL, 2006, SCIENCE, V312, P1913, DOI 10.1126/science.1127488; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Chalmers RP, 2012, J STAT SOFTW, V48, P1; COTTINGHAM J, 1983, PHILOS STUD, V43, P83, DOI 10.1007/BF01112524; Derryberry WP, 2005, J ADV ACAD, V17, P6, DOI 10.4219/jsge-2005-392; Dollinger SJ, 1998, J SOC BEHAV PERS, V13, P349; Doris John, 2002, LACK CHARACTER PERSO, DOI DOI 10.1017/CBO9781139878364; Foster JD, 1999, J PSYCHOL THEOL, V27, P52, DOI 10.1177/009164719902700105; Furnham A, 1996, PERS INDIV DIFFER, V21, P303, DOI 10.1016/0191-8869(96)00033-5; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graziano W. G., 2009, HDB INDIVIDUAL DIFFE, P46, DOI DOI 10.1037/0022-3514.50.1.212; Harms PD, 2006, PERS SOC PSYCHOL B, V32, P851, DOI 10.1177/0146167206287720; Heist P, 1957, MANUAL OMNIBUS PERSO; Hill PL, 2010, CURR DIR PSYCHOL SCI, V19, P380, DOI 10.1177/0963721410389168; Hogan R, 2004, J CAREER ASSESSMENT, V12, P207, DOI 10.1177/1069072703255882; Hogan R, 2000, PERSON-ENVIRONMENT PSYCHOLOGY, SECOND EDITION, P1; Hogan R., 1996, 5 FACTOR MODEL PERSO, P163; Jackson JJ, 2014, EUR J PERSONALITY, V28, P300, DOI 10.1002/per.1964; Jackson JJ, 2012, PSYCHOL SCI, V23, P270, DOI 10.1177/0956797611423545; Jackson JJ, 2010, J RES PERS, V44, P501, DOI 10.1016/j.jrp.2010.06.005; Jackson JJ, 2009, J PERS SOC PSYCHOL, V96, P446, DOI 10.1037/a0014156; Jaffee S, 2000, PSYCHOL BULL, V126, P703, DOI 10.1037//0033-2909.126.5.703; Jensen-Campbell LA, 2001, J PERS, V69, P323, DOI 10.1111/1467-6494.00148; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Kalshoven K, 2011, J BUS ETHICS, V100, P349, DOI 10.1007/s10551-010-0685-9; Karim NSA, 2009, COMPUT EDUC, V53, P86, DOI 10.1016/j.compedu.2009.01.001; King SH., 1973, 5 LIVES HARVARD PERS; KITCHENER KS, 1984, J YOUTH ADOLESCENCE, V13, P197, DOI 10.1007/BF02089059; Kohlberg, 1984, PSYCHOL MORAL DEV NA; Kohlberg L., 1977, THEOR PRACT, V16, P53, DOI [https://doi.org/10.1080/00405847709542675, DOI 10.1080/00405847709542675, 10.2307/1475172]; Kohlberg Lawrence, 1983, CONTRIBUTIONS HUMAN, V10, P174; Lapsley D.K., 2001, IDENTITY, V1, P345, DOI [10.1207/S1532706XID0104_03, DOI 10.1207/S1532706XID0104_]; Lapsley DK, 2009, PERSONALITY, IDENTITY, AND CHARACTER: EXPLORATIONS IN MORAL PSYCHOLOGY, P185, DOI 10.1017/CBO9780511627125.009; Lodi-Smith J, 2007, PERS SOC PSYCHOL REV, V11, P68, DOI 10.1177/1088868306294590; Matsuba MK, 2004, J PERS, V72, P413, DOI 10.1111/j.0022-3506.2004.00267.x; Mayhew MJ, 2012, RES HIGH EDUC, V53, P26, DOI 10.1007/s11162-011-9226-3; Mayhew MJ, 2010, REV HIGH EDUC, V33, P357, DOI 10.1353/rhe.0.0153; McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612; MCCRAE RR, 1989, J PERS, V57, P17, DOI 10.1111/j.1467-6494.1989.tb00759.x; Mike A., 2015, INT ENCY SOCIAL BEHA, P658; Mund M, 2015, J PERS          0715; Myers I. B., 1985, MANUAL GUIDE DEV USE; Myers IsabelBriggs., 1962, MYERS BRIGGS TYPE IN; Myyry L, 2013, EUR J DEV PSYCHOL, V10, P269, DOI 10.1080/17405629.2012.757217; REST JR, 1985, DEV PSYCHOL, V21, P709, DOI 10.1037/0012-1649.21.4.709; Rest JR, 1999, J EDUC PSYCHOL, V91, P644, DOI 10.1037/0022-0663.91.4.644; Roberts B. W., 2008, HDB PERSONALITY THEO, V3, P375; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Roberts BW, 2005, J RES PERS, V39, P166, DOI 10.1016/j.jrp.2004.08.002; Roberts BW, 2004, J PERS SOC PSYCHOL, V87, P541, DOI 10.1037/0022-3514.87.4.541; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; SHAVER DG, 1987, J COLL STUDENT DEV, V28, P211; SHAVER DG, 1985, J COLL STUDENT DEV, V26, P400; Smith KD, 2007, J CROSS CULT PSYCHOL, V38, P333, DOI 10.1177/0022022107300279; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Stams GJ, 2006, J ABNORM CHILD PSYCH, V34, P697, DOI 10.1007/s10802-006-9056-5; Stouffer SA, 1951, AM J SOCIOL, V56, P395, DOI 10.1086/220785; Vazire S, 2010, J PERS SOC PSYCHOL, V98, P281, DOI 10.1037/a0017908; Walker LJ, 2007, J PERS SOC PSYCHOL, V93, P845, DOI 10.1037/0022-3514.93.5.845; Walker LJ, 2010, J PERS, V78, P907, DOI 10.1111/j.1467-6494.2010.00637.x; Walker LJ, 1998, DEV PSYCHOL, V34, P403, DOI 10.1037/0012-1649.34.3.403; Walker LJ, 2004, J PERS SOC PSYCHOL, V86, P629, DOI 10.1037/0022-3514.86.4.629; Walker LJ, 1999, J MORAL EDUC, V28, P145, DOI 10.1080/030572499103188; WHEELER S, 1961, AM SOCIOL REV, V26, P697, DOI 10.2307/2090199; Williams KM, 2010, J EXP PSYCHOL-APPL, V16, P293, DOI 10.1037/a0020773; Wrzus C, 2013, PSYCHOL BULL, V139, P53, DOI 10.1037/a0028601; Zhong CB, 2010, PSYCHOL SCI, V21, P311, DOI 10.1177/0956797609360754; ZURCHER LA, 1965, AM SOCIOL REV, V30, P539, DOI 10.2307/2091343	75	4	4	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146716	10.1371/journal.pone.0146716	http://dx.doi.org/10.1371/journal.pone.0146716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751944	Green Published, gold			2022-12-27	WOS:000367888100137
J	Jin, Q; Jiao, CY; Sun, SW; Song, C; Cai, YP; Lin, Y; Fan, HH; Zhu, YF				Jin, Qing; Jiao, Chunyan; Sun, Shiwei; Song, Cheng; Cai, Yongping; Lin, Yi; Fan, Honghong; Zhu, Yanfang			Metabolic Analysis of Medicinal Dendrobium officinale and Dendrobium huoshanense during Different Growth Years	PLOS ONE			English	Article							FLIGHT-MASS-SPECTROMETRY; PATTERN-RECOGNITION; QUALITY ASSESSMENT; DISCRIMINATION; GINSENG	Metabolomics technology has enabled an important method for the identification and quality control of Traditional Chinese Medical materials. In this study, we isolated metabolites from cultivated Dendrobium officinale and Dendrobium huoshanense stems of different growth years in the methanol/water phase and identified them using gas chromatography coupled with mass spectrometry (GC-MS). First, a metabolomics technology platform for Dendrobium was constructed. The metabolites in the Dendrobium methanol/water phase were mainly sugars and glycosides, amino acids, organic acids, alcohols. D. officinale and D. huoshanense and their growth years were distinguished by cluster analysis in combination with multivariate statistical analysis, including principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA). Eleven metabolites that contributed significantly to this differentiation were subjected to t-tests (P<0.05) to identify biomarkers that discriminate between D. officinale and D. huoshanense, including sucrose, glucose, galactose, succinate, fructose, hexadecanoate, oleanitrile, myo-inositol, and glycerol. Metabolic profiling of the chemical compositions of Dendrobium species revealed that the polysaccharide content of D. huoshanense was higher than that of D. officinale, indicating that the D. huoshanense was of higher quality. Based on the accumulation of Dendrobium metabolites, the optimal harvest time for Dendrobium was in the third year. This initial metabolic profiling platform for Dendrobium provides an important foundation for the further study of secondary metabolites (pharmaceutical active ingredients) and metabolic pathways.	[Jin, Qing; Jiao, Chunyan; Sun, Shiwei; Song, Cheng; Cai, Yongping; Lin, Yi; Fan, Honghong; Zhu, Yanfang] Anhui Agr Univ, Dept Life Sci, Hefei 230036, Peoples R China	Anhui Agricultural University	Cai, YP (corresponding author), Anhui Agr Univ, Dept Life Sci, Hefei 230036, Peoples R China.	ypcaiah@163.com; linyi1957@126.com	Song, Cheng/AAD-5614-2022	Song, Cheng/0000-0001-6274-330X	Discipline Backbone Cultivated Foundation in Anhui Agricultural University [2014XKPY-41]; Twelfth Five-Year Plan for Science & Technology Support of Anhui Province [1301032139]; Collaborative Innovation Center of Agri-forestry Industry in Dabieshan Area in Anhui Agricultural University	Discipline Backbone Cultivated Foundation in Anhui Agricultural University; Twelfth Five-Year Plan for Science & Technology Support of Anhui Province; Collaborative Innovation Center of Agri-forestry Industry in Dabieshan Area in Anhui Agricultural University	The study was supported by Discipline Backbone Cultivated Foundation in Anhui Agricultural University (Grant No. 2014XKPY-41, www.ahau.edu.cn), Twelfth Five-Year Plan for Science & Technology Support of Anhui Province (Grant No. 1301032139, www.ahkjt.gov.cn/technologi/index.htm), and Collaborative Innovation Center of Agri-forestry Industry in Dabieshan Area in Anhui Agricultural University (dbs.w1.ahau.edu.cn).; We would like to thank American Journal Experts (AJE) for editing our manuscript. Thanks for the GC-MS analysis platform provided by Zhongliang Zhu from University Of Science And Technology Of China. The study was supported by Discipline Backbone Cultivated Foundation in Anhui Agricultural University (Grant No. 2014XKPY-41), Twelfth Five-Year Plan for Science & Technology Support of Anhui Province ( Grant No. 1301032139), and Collaborative innovation Center of Agri-forestry Industry in Dabieshan Area in Anhui Agricultural University.	Chen XM, 2012, SCI CHINA LIFE SCI, V55, P1092, DOI 10.1007/s11427-012-4419-3; Duan LX, 2012, MOL PLANT, V5, P376, DOI 10.1093/mp/ssr093; Feng SG, 2015, GENE, V567, P182, DOI 10.1016/j.gene.2015.04.076; Jin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062352; Jumtee K, 2009, J SEP SCI, V32, P2296, DOI 10.1002/jssc.200900096; Kim N, 2011, J AGR FOOD CHEM, V59, P10435, DOI 10.1021/jf201718r; Lee DK, 2013, FOOD CHEM, V141, P3931, DOI 10.1016/j.foodchem.2013.06.064; Lee EJ, 2009, J AGR FOOD CHEM, V57, P7513, DOI 10.1021/jf901675y; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lu S, 2006, CHIN TRADIT HERB DRU, V37, P790; Lv Gui-Yuan, 2013, Zhongguo Zhong Yao Za Zhi, V38, P489; Ng TB, 2012, APPL MICROBIOL BIOT, V93, P1795, DOI 10.1007/s00253-011-3829-7; Noutsos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124501; Gutierrez RMP, 2010, J MED PLANTS RES, V4, P592; Sun H, 2012, ANALYST, V137, P170, DOI 10.1039/c1an15833c; Tan HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124794; Tianniam S, 2008, J BIOSCI BIOENG, V105, P655, DOI 10.1263/jbb.105.655; Toh DF, 2010, J PHARMACEUT BIOMED, V52, P43, DOI 10.1016/j.jpba.2009.12.005; Virjamo V, 2014, TREES-STRUCT FUNCT, V28, P427, DOI 10.1007/s00468-013-0960-3; Wang HY, 2015, AER ADV ENG RES, V9, P245; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Xiang XG, 2013, MOL PHYLOGENET EVOL, V69, P950, DOI 10.1016/j.ympev.2013.06.009; Xu J, 2013, PHYTOCHEM REV, V12, P341, DOI 10.1007/s11101-013-9310-8; Yaping D, 1998, CHIN PHARM J, V08; Yuan He, 2011, Zhongguo Zhong Yao Za Zhi, V36, P2465; Zhang JJ, 2011, J EXP BOT, V62, P1103, DOI 10.1093/jxb/erq343	26	50	56	7	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146607	10.1371/journal.pone.0146607	http://dx.doi.org/10.1371/journal.pone.0146607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752292	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100112
J	Parikh, RV; Ma, YF; Scherzer, R; Heringer, AS; Macgregor, JS; Martin, JN; Deeks, SG; Ganz, P; Hsue, PY				Parikh, Rushi V.; Ma, Yifei; Scherzer, Rebecca; Heringer, Amanda S.; Macgregor, John S.; Martin, Jeffrey N.; Deeks, Steven G.; Ganz, Peter; Hsue, Priscilla Y.			Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; DOPPLER-ECHOCARDIOGRAPHY; AMBRISENTAN THERAPY; PROGNOSTIC-FACTORS; PLASMA-LEVELS; BOSENTAN; DISEASE; ERA; PATHOGENESIS; INDIVIDUALS	Background HIV infection is an independent risk factor for PAH, but the underlying pathogenesis remains unclear. ET-1 is a robust vasoconstrictor and key mediator of pulmonary vascular homeostasis. Higher levels of ET-1 predict disease severity and mortality in other forms of PAH, and endothelin receptor antagonists are central to treatment, including in HIV-associated PAH. The direct relationship between ET-1 and PAH in HIV-infected individuals is not well described. Methods We measured ET-1 and estimated pulmonary artery systolic pressure (PASP) with transthoracic echocardiography (TTE) in 106 HIV-infected individuals. Participants with a PASP >= 30 mmHg (n = 65) underwent right heart catheterization (RHC) to definitively diagnose PAH. We conducted multivariable analysis to identify factors associated with PAH. Results Among 106 HIV-infected participants, 80% were male, the median age was 52 years and 77% were on antiretroviral therapy. ET-1 was significantly associated with higher values of PASP [14% per 0.1 pg/mL increase in ET-1, p = 0.05] and PASP >= 30 mmHg [PR (prevalence ratio) = 1.24, p = 0.012] on TTE after multivariable adjustment for PAH risk factors. Similarly, among the 65 individuals who underwent RHC, ET-1 was significantly associated with higher values of mean pulmonary artery pressure and PAH (34%, p = 0.003 and PR = 2.43, p = 0.032, respectively) in the multivariable analyses. Conclusions Higher levels of ET-1 are independently associated with HIV-associated PAH as hemodynamically assessed by RHC. Our findings suggest that excessive ET-1 production in the setting of HIV infection impairs pulmonary endothelial function and contributes to the development of PAH.	[Parikh, Rushi V.] Stanford Univ, Dept Cardiovasc Med, Stanford, CA 94305 USA; [Ma, Yifei] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Scherzer, Rebecca] San Francisco VA Med Ctr, Div Endocrinol & Metab, San Francisco, CA USA; [Heringer, Amanda S.; Macgregor, John S.; Ganz, Peter; Hsue, Priscilla Y.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94117 USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Posit Hlth Program, San Francisco, CA USA	Stanford University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Hsue, PY (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94117 USA.	priscilla.hsue@ucsf.edu			National Institutes of Health [R01HL095130, R01HL095126, K24AI112393]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095126, R01HL095130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K24AI112393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study received National Institutes of Health grant support from R01HL095130 (PYH), R01HL095126 (PYH), K24AI112393 (PYH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almodovar S, 2012, AIDS RES HUM RETROV, V28, P607, DOI [10.1089/aid.2011.0021, 10.1089/AID.2011.0021]; Almodovar Sharilyn, 2011, Proc Am Thorac Soc, V8, P308, DOI 10.1513/pats.201006-046WR; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Barbaro G, 2006, HEART, V92, P1164, DOI 10.1136/hrt.2005.076794; BERGER M, 1985, J AM COLL CARDIOL, V6, P359, DOI 10.1016/S0735-1097(85)80172-8; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Channick RN, 2004, J AM COLL CARDIOL, V43, p62S, DOI 10.1016/j.jacc.2004.02.042; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Chester Adrian H, 2014, Glob Cardiol Sci Pract, V2014, P62, DOI 10.5339/gcsp.2014.29; Degano B, 2009, EUR RESPIR J, V33, P92, DOI 10.1183/09031936.00094808; Degano B, 2010, AIDS, V24, P67, DOI 10.1097/QAD.0b013e328331c65e; EHRENREICH H, 1993, J IMMUNOL, V150, P4601; Feijoo MQ, 2014, AIDS, V28, P2693, DOI 10.1097/QAD.0000000000000470; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Galie N, 2005, J AM COLL CARDIOL, V46, P529, DOI 10.1016/j.jacc.2005.04.050; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Hsue PY, 2008, AIDS, V22, P825, DOI 10.1097/QAD.0b013e3282f7cd42; Iglesias D, 2015, CLIN BIOCHEM, V48, P1059, DOI 10.1016/j.clinbiochem.2015.06.007; Kanmogne GD, 2005, BIOCHEM BIOPH RES CO, V333, P1107, DOI 10.1016/j.bbrc.2005.05.198; KIRCHER BJ, 1990, AM J CARDIOL, V66, P493, DOI 10.1016/0002-9149(90)90711-9; Leyva F, 1997, METABOLISM, V46, P1137, DOI 10.1016/S0026-0495(97)90205-5; Lumley T, 2006, UW BIOSTATISTICS WOR; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; NOOTENS M, 1995, J AM COLL CARDIOL, V26, P1581, DOI 10.1016/0735-1097(95)00399-1; Nunes H, 2003, AM J RESP CRIT CARE, V167, P1433, DOI 10.1164/rccm.200204-330OC; Opravil M, 1997, AM J RESP CRIT CARE, V155, P990, DOI 10.1164/ajrccm.155.3.9117037; Opravil M, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327514.60879.47; Oudiz RJ, 2009, J AM COLL CARDIOL, V54, P1971, DOI 10.1016/j.jacc.2009.07.033; Parikh RV, 2014, AIDS, V28, P511, DOI 10.1097/QAD.0000000000000124; Parikh RV, 2013, ATHEROSCLEROSIS, V229, P246, DOI 10.1016/j.atherosclerosis.2013.04.025; Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269; Rubens C, 2001, CHEST, V120, P1562, DOI 10.1378/chest.120.5.1562; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Selby VN, 2012, AIDS, V26, P1967, DOI 10.1097/QAD.0b013e3283579653; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Shapiro S, 2012, CHEST, V141, P363, DOI 10.1378/chest.10-3114; Sitbon O, 2004, AM J RESP CRIT CARE, V170, P1212, DOI 10.1164/rccm.200404-445OC; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; YOSHIBAYASHI M, 1991, CIRCULATION, V84, P2280, DOI 10.1161/01.CIR.84.6.2280; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	43	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146355	10.1371/journal.pone.0146355	http://dx.doi.org/10.1371/journal.pone.0146355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752193	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100069
J	Wasiak, I; Kulikowska, A; Janczewska, M; Michalak, M; Cymerman, IA; Nagalski, A; Kallinger, P; Szymanski, WW; Ciach, T				Wasiak, Iga; Kulikowska, Aleksandra; Janczewska, Magdalena; Michalak, Magdalena; Cymerman, Iwona A.; Nagalski, Andrzej; Kallinger, Peter; Szymanski, Wladyslaw W.; Ciach, Tomasz			Dextran Nanoparticle Synthesis and Properties	PLOS ONE			English	Article							PROTEIN COMPLEXES; DRUG-RELEASE; DOXORUBICIN; DELIVERY; VIRUSES	Dextran is widely exploited in medical products and as a component of drug-delivering nanoparticles (NPs). Here, we tested whether dextran can serve as the main substrate of NPs and form a stable backbone. We tested dextrans with several molecular masses under several synthesis conditions to optimize NP stability. The analysis of the obtained nanoparticles showed that dextran NPs that were synthesized from 70 kDa dextran with a 5% degree of oxidation of the polysaccharide chain and 50% substitution with dodecylamine formed a NP backbone composed of modified dextran subunits, the mean diameter of which in an aqueous environment was around 100 nm. Dextran NPs could be stored in a dry state and reassembled in water. Moreover, we found that different chemical moieties (e.g., drugs such as doxorubicin) can be attached to the dextran NPs via a pH-dependent bond that allows release of the drug with lowering pH. We conclude that dextran NPs are a promising nano drug carrier.	[Wasiak, Iga; Kulikowska, Aleksandra; Janczewska, Magdalena; Michalak, Magdalena; Ciach, Tomasz] Warsaw Univ Technol, Fac Chem Engn, PL-00645 Warsaw, Poland; [Wasiak, Iga; Kulikowska, Aleksandra; Janczewska, Magdalena; Michalak, Magdalena; Cymerman, Iwona A.; Nagalski, Andrzej; Ciach, Tomasz] NanoVelos Sp Zoo, PL-00645 Warsaw, Poland; [Cymerman, Iwona A.] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Kallinger, Peter; Szymanski, Wladyslaw W.] Univ Vienna, Fac Phys, A-1090 Vienna, Austria	Warsaw University of Technology; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Vienna	Ciach, T (corresponding author), Warsaw Univ Technol, Fac Chem Engn, Warynskiego 1, PL-00645 Warsaw, Poland.	t.ciach@ichip.pw.edu.pl	Nagalski, Andrzej/AAH-3366-2019; Nagalski, Andrzej/O-3173-2015	Nagalski, Andrzej/0000-0002-4864-5604; Nagalski, Andrzej/0000-0002-4864-5604; Kallinger, Peter/0000-0002-4636-0859; Ciach, Tomasz/0000-0002-8726-8944; Szymanski, Wladyslaw/0000-0002-4760-5328	EuroNanoMed grant FonDiag; NanoVelos company	EuroNanoMed grant FonDiag; NanoVelos company	This work was partially supported by EuroNanoMed grant FonDiag. IW, MJ, AK, MM, IAC, AN, and TC are financially supported by the NanoVelos company (NanoVelos commercializes the technology originated from the research conducted at Warsaw University of Technology). The funder provided support in the form of salaries for authors IW, MJ, AK, MM, IAC, AN, and TC. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahed W, 2006, ADV DRUG DELIVER REV, V58, P1688, DOI 10.1016/j.addr.2006.09.017; Alhareth K, 2012, EUR J PHARM BIOPHARM, V81, P453, DOI 10.1016/j.ejpb.2012.03.009; Allmaier G, 2008, J AM SOC MASS SPECTR, V19, P1062, DOI 10.1016/j.jasms.2008.05.017; Anitha A, 2011, CARBOHYD POLYM, V84, P1158, DOI 10.1016/j.carbpol.2011.01.005; Bacher G, 2001, J MASS SPECTROM, V36, P1038, DOI 10.1002/jms.208; Casadei MA, 2006, INT J PHARMACEUT, V325, P140, DOI 10.1016/j.ijpharm.2006.06.012; Ciach T, 2003, OPTIMIZATION OF AEROSOL DRUG DELIVERY, P189; Dobrovolskaia M.A., 2013, HDB IMMUNOLOGICAL PR; Fuentes M, 2004, PROTEOMICS, V4, P2602, DOI 10.1002/pmic.200300766; Heindel ND, 1990, BIOCONJUGATE CHEM, V1, P77, DOI 10.1021/bc00001a010; Klemm D, 2006, ADV POLYM SCI, V205, P49, DOI 10.1007/12_097; Li BG, 2013, CARBOHYD POLYM, V93, P430, DOI 10.1016/j.carbpol.2012.12.051; Li YL, 2009, ANGEW CHEM INT EDIT, V48, P9914, DOI 10.1002/anie.200904260; Lisman A, 2014, J BIOMATER APPL, V28, P1386, DOI 10.1177/0885328213509676; Maisser A, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-012-1318-2; Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3; Muangsiri W, 2006, INT J PHARMACEUT, V315, P30, DOI 10.1016/j.ijpharm.2006.02.016; PASTEUR L, 1861, B SOC CHIM FR, P30; Pasut G, 2014, POLYMERS-BASEL, V6, P160, DOI 10.3390/polym6010160; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923; Wu F, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-197; Yeo Y, 2004, ARCH PHARM RES, V27, P1, DOI 10.1007/BF02980037; Yuan WE, 2009, INT J PHARMACEUT, V366, P154, DOI 10.1016/j.ijpharm.2008.09.007	23	49	53	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146237	10.1371/journal.pone.0146237	http://dx.doi.org/10.1371/journal.pone.0146237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752182	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100055
J	Wu, R; Nijland, M; Rutgers, B; Veenstra, R; Langendonk, M; van der Meeren, LE; Kluin, PM; Li, GW; Diepstra, A; Chiu, JF; van den Berg, A; Visser, L				Wu, Rui; Nijland, Marcel; Rutgers, Bea; Veenstra, Rianne; Langendonk, Myra; van der Meeren, Lotte E.; Kluin, Philip M.; Li, Guanwu; Diepstra, Arjan; Chiu, Jen-Fu; van den Berg, Anke; Visser, Lydia			Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas	PLOS ONE			English	Article							CYCLOPHILIN-A; MASS-SPECTROMETRY; CLASS-I; PROGRESSION; DATABASE; CANCER; CLASSIFICATION; CYCLOSPORINE; MIGRATION; SUBTYPES	Follicular lymphoma and diffuse large B cell lymphomas comprise the main entities of adult B cell malignancies. Although multiple disease driving gene aberrations have been identified by gene expression and genomic studies, only a few studies focused at the protein level. We applied 2 dimensional gel electrophoresis to compare seven GC B cell non Hodgkin lymphoma (NHL) cell lines with a lymphoblastoid cell line (LCL). An average of 130 spots were at least two folds different in intensity between NHL cell lines and the LCL. We selected approximately 38 protein spots per NHL cell line and linked them to 145 unique spots based on the location in the gel. 34 spots that were found altered in at least three NHL cell lines when compared to LCL, were submitted for LC-MS/MS. This resulted in 28 unique proteins, a substantial proportion of these proteins were involved in cell motility and cell metabolism. Loss of expression of B2M, and gain of expression of PRDX1 and PPIA was confirmed in the cell lines and primary lymphoma tissue. Moreover, inhibition of PPIA with cyclosporine A blocked cell growth of the cell lines, the effect size was associated with the PPIA expression levels. In conclusion, we identified multiple differentially expressed proteins by 2-D proteomics, and showed that some of these proteins might play a role in the pathogenesis of NHL.	[Wu, Rui; Rutgers, Bea; Veenstra, Rianne; Langendonk, Myra; van der Meeren, Lotte E.; Kluin, Philip M.; Diepstra, Arjan; van den Berg, Anke; Visser, Lydia] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Wu, Rui; Li, Guanwu; Chiu, Jen-Fu] Shantou Univ, Coll Med, Open Lab Tumor Mol Biol, Dept Biochem, Shantou, Peoples R China; [Nijland, Marcel] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Groningen; Shantou University; University of Groningen	Visser, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	l.visser@umcg.nl	van den Berg, Anke/H-1718-2011; Wu, Rui/AFL-7610-2022	van den Berg, Anke/0000-0002-8894-2638; Langendonk, Myra/0000-0002-1967-6997; van der Meeren, Lotte Elisabeth/0000-0002-4537-5645; Diepstra, Arjan/0000-0001-9239-1050	Abel Tasman Talent scholarship from the University of Groningen; de Cock Foundation; Dutch Cancer Society fellowship	Abel Tasman Talent scholarship from the University of Groningen; de Cock Foundation; Dutch Cancer Society fellowship(KWF Kankerbestrijding)	RW is funded by a Abel Tasman Talent scholarship from the University of Groningen, and received funding from the "de Cock Foundation" for this study. LEM is funded by a Dutch Cancer Society fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani R, 2007, LEUKEMIA LYMPHOMA, V48, P521, DOI 10.1080/10428190601137658; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anderson JR, 1998, ANN ONCOL, V9, P717, DOI 10.1023/A:1008265532487; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bennaceur-Griscelli A, 2004, CLIN CANCER RES, V10, P3029, DOI 10.1158/1078-0432.CCR-03-0554; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Campa MJ, 2003, CANCER RES, V63, P1652; Caron M, 2002, J CHROMATOGR B, V771, P197, DOI 10.1016/S1570-0232(02)00040-5; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Chan WC, 1997, BLOOD, V89, P3909; Deeb SJ, 2012, MOL CELL PROTEOMICS, V11, P77, DOI 10.1074/mcp.M111.015362; Demasi APD, 2013, VIRCHOWS ARCH, V463, P47, DOI 10.1007/s00428-013-1433-1; Fan Y, 2014, NAT CELL BIOL, V16, P445, DOI 10.1038/ncb2954; Freedman AS, 2014, AM J HEMATOL, V89, P429, DOI 10.1002/ajh.23674; Fujii K, 2005, PROTEOMICS, V5, P4274, DOI 10.1002/pmic.200401286; Fujii K, 2006, PROTEOMICS, V6, P4856, DOI 10.1002/pmic.200600097; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Howard BA, 2005, CANCER RES, V65, P8853, DOI 10.1158/0008-5472.CAN-05-1219; Jordanova ES, 2003, INT J CANCER, V103, P393, DOI 10.1002/ijc.10824; Joubert-Caron R, 2000, ELECTROPHORESIS, V21, P2566, DOI 10.1002/1522-2683(20000701)21:12<2566::AID-ELPS2566>3.0.CO;2-F; Kawahara T, 2015, ONCOTARGET, V6, P1582, DOI 10.18632/oncotarget.2750; Kinoshita T, 2012, INT J ONCOL, V40, P1770, DOI 10.3892/ijo.2012.1390; Lee YJ, 2013, INT J ONCOL, V42, P1569, DOI 10.3892/ijo.2013.1867; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ouyang J, 2011, BLOOD, V117, P4315, DOI 10.1182/blood-2010-11-320481; Payeli SK, 2008, ATHEROSCLEROSIS, V197, P564, DOI 10.1016/j.atherosclerosis.2007.08.025; Rafferty P, 2012, J IMMUNOTOXICOL, V9, P43, DOI 10.3109/1547691X.2011.614646; Riemersma SA, 2005, J PATHOL, V206, P328, DOI 10.1002/path.1783; Rodig SJ, 2008, CLIN CANCER RES, V14, P3338, DOI 10.1158/1078-0432.CCR-07-4709; Romesser PB, 2009, AM J PATHOL, V175, P25, DOI 10.2353/ajpath.2009.080707; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Sun S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096211; Swerdlow SH, 2008, WHO CLASSIFICATION T; Vaughn CP, 2006, PROTEOMICS, V6, P3223, DOI 10.1002/pmic.200500539; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Yang HR, 2007, BIOCHEM BIOPH RES CO, V361, P763, DOI 10.1016/j.bbrc.2007.07.085; Zheng JM, 2008, CANCER RES, V68, P7769, DOI 10.1158/0008-5472.CAN-08-0639	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146624	10.1371/journal.pone.0146624	http://dx.doi.org/10.1371/journal.pone.0146624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752561	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888100114
J	Yamashita, A; Fujimoto, M; Katayama, K; Yamaoka, S; Tsutsumi, N; Arimura, S				Yamashita, Akihiro; Fujimoto, Masaru; Katayama, Kenta; Yamaoka, Shohei; Tsutsumi, Nobuhiro; Arimura, Shin-ichi			Formation of Mitochondrial Outer Membrane Derived Protrusions and Vesicles in Arabidopsis thaliana	PLOS ONE			English	Article							PROTEINS DRP3A; SENESCENCE; ADL2B; CHLOROPLASTS; TRAFFICKING; FISSION; GTPASE; ROLES; ACTIN	Mitochondria are dynamic organelles that have inner and outer membranes. In plants, the inner membrane has been well studied but relatively little is known about the outer membrane. Here we report that Arabidopsis cells have mitochondrial outer membrane-derived structures, some of which protrude from the main body of mitochondria (mitochondrial outer-membrane protrusions; MOPs), while others form vesicle-like structures without a matrix marker. The latter vesicle-like structures are similar to some mammalian MDVs (mitochondrial-derived vesicles). Live imaging demonstrated that a plant MDV budded off from the tip of a MOP. MDVs were also observed in the drp3a drp3b double mutant, indicating that they could be formed without the mitochondrial fission factors DRP3A and DRP3B. Double staining studies showed that the MDVs were not peroxisomes, endosomes, Golgi apparatus or trans-Golgi network (TGN). The numbers of MDVs and MOPs increased in senescent leaves and after dark treatment. Together, these results suggest that MDVs and MOPs are related to leaf senescence.	[Yamashita, Akihiro; Fujimoto, Masaru; Katayama, Kenta; Tsutsumi, Nobuhiro; Arimura, Shin-ichi] Univ Tokyo, Grad Sch Agr & Life Sci, Plant Mol Genet Lab, Tokyo, Japan; [Yamaoka, Shohei] Kyoto Univ, Grad Sch Biostudies, Plant Mol Biol Lab, Kyoto, Japan; [Arimura, Shin-ichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST)	Arimura, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Plant Mol Genet Lab, Tokyo, Japan.	arimura@mail.ecc.u-tokyo.ac.jp	Arimura, Shinichi/AAA-2848-2020; Katayama, Kenta/AAE-8793-2019; Tsutsumi, Nobuhiro/C-6051-2016	Katayama, Kenta/0000-0003-3897-2609; Tsutsumi, Nobuhiro/0000-0002-2610-6837; Arimura, Shin-ichi/0000-0002-9537-1626	Japanese Science and Technology Agency (PRESTO); Japan Society for the Promotion of Science [24248001, 24380814, 25840108, 25120715]	Japanese Science and Technology Agency (PRESTO); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by grants partly from Japanese Science and Technology Agency (http://www.jst.go.jp/EN/index.html, PRESTO to S.A.) and partly from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html, Grant Numbers: 24248001 to N.T., 24380814 to S.A., 25840108 and 25120715 to S.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura S, 2004, PLANT CELL PHYSIOL, V45, P236, DOI 10.1093/pcp/pch024; Arimura S, 2002, P NATL ACAD SCI USA, V99, P5727, DOI 10.1073/pnas.082663299; Arimura S, 2008, PLANT CELL, V20, P1555, DOI 10.1105/tpc.108.058578; Aung K, 2012, J INTEGR PLANT BIOL, V54, P921, DOI 10.1111/j.1744-7909.2012.01174.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Doniwa Y, 2007, PLANT BIOTECHNOL-NAR, V24, P441, DOI 10.5511/plantbiotechnology.24.441; Duncan O, 2013, TRENDS PLANT SCI, V18, P207, DOI 10.1016/j.tplants.2012.12.004; Ebine K, 2011, NAT CELL BIOL, V13, P853, DOI 10.1038/ncb2270; Elgass K., 2013, BIOCHIM BIOPHYS ACTA, V1833, P150, DOI [10.1016/j.bbamcr.2012.05.002, DOI 10.1016/J.BBAMCR.2012.05.002]; Fujimoto M, 2010, P NATL ACAD SCI USA, V107, P6094, DOI 10.1073/pnas.0913562107; Fujimoto M, 2009, PLANT J, V58, P388, DOI 10.1111/j.1365-313X.2009.03786.x; Gross J, 2009, NAT REV GENET, V10, P657, DOI 10.1038/nrg2649; Izumi M, 2010, PLANT PHYSIOL, V154, P1196, DOI 10.1104/pp.110.158519; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Keech O, 2007, PLANT CELL ENVIRON, V30, P1523, DOI 10.1111/j.1365-3040.2007.01724.x; Li FQ, 2014, PLANT CELL, V26, P788, DOI 10.1105/tpc.113.120014; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Logan DC, 2000, J EXP BOT, V51, P865, DOI 10.1093/jexbot/51.346.865; Logan DC, 2004, J EXP BOT, V55, P783, DOI 10.1093/jxb/erh073; Mano S, 2004, PLANT J, V38, P487, DOI 10.1111/j.1365-313X.2004.02063.x; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Murcha MW, 2014, BBA-GEN SUBJECTS, V1840, P1233, DOI 10.1016/j.bbagen.2013.09.026; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Niu YH, 2012, J INTEGR PLANT BIOL, V54, P516, DOI 10.1111/j.1744-7909.2012.01140.x; Ruberti C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102012; Segui-Simarro JM, 2008, PLANT PHYSIOL, V148, P1380, DOI 10.1104/pp.108.126953; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Uemura T, 2014, PLANT CELL PHYSIOL, V55, P694, DOI 10.1093/pcp/pcu010; Van Gestel K, 2002, J EXP BOT, V53, P659, DOI 10.1093/jexbot/53.369.659; Weaver LM, 2001, PLANT PHYSIOL, V127, P876, DOI 10.1104/pp.010312; Yamaoka S, 2008, PLANT CELL, V20, P589, DOI 10.1105/tpc.107.055756; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011	35	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146717	10.1371/journal.pone.0146717	http://dx.doi.org/10.1371/journal.pone.0146717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752045	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100138
J	Zhou, LH; Li, YL; Hussain, N; Li, ZL; Wu, DZ; Jiang, LX				Zhou, Longhua; Li, Yuanlong; Hussain, Nazim; Li, Zhilan; Wu, Dezhi; Jiang, Lixi			Allelic Variation of BnaC.TT2.a and Its Association with Seed Coat Color and Fatty Acids in Rapeseed (Brassica napus L.)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; OIL CONTENT; OILSEED RAPE; PROANTHOCYANIDIN BIOSYNTHESIS; LINKAGE DISEQUILIBRIUM; INTERSPECIFIC CROSSES; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; PLANT DEVELOPMENT	Efficient molecular markers for the selection of rapeseed genetic materials with high seed oil content and ideal fatty acid (FA) composition are preferred by rapeseed breeders. Recently, we reported the molecular mechanism of TRANSPARENT TESTA 2 (TT2) in inhibiting seed FA biosynthesis in Arabidopsis. However, evidence showing the association of rapeseed TT2 homologs and seed FA production are still insufficient. In this study, we collected 83 rapeseed (Brassica napus L.) landraces from different geographical backgrounds to conduct association mapping of BnaC.TT2.a in relation to seed coat color and FA biosynthesis. Population background was corrected by 84 pairs of SSR markers that were uniformly distributed among the linkage groups of the Tapidor-Ningyou-7 DH population. A single copy of BnaC.TT2.a for single nucleotide polymorphism (SNP) assay was cloned by a pair of previously reported specific primers. From the analysis of BnaC.TT2.a allelic variations using GLM+Q model, four SNPs on intron 1 of BnaC.TT2.a that were associated with seed FA were discovered. Moreover, an InDel at position 738 on exon 3 of BnaC.TT2.a indicated a change of protein function that was significantly associated with seed coat color, linoleic acid (C18:2), and total FA content. These findings revealed the role of BnaC.TT2.a in regulating the seed color formation and seed FA biosynthesis in rapeseed, thereby suggesting effective molecular markers for rapeseed breeding.	[Zhou, Longhua; Li, Yuanlong; Hussain, Nazim; Li, Zhilan; Wu, Dezhi; Jiang, Lixi] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Hussain, N (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China.	hussain138@yahoo.com; jianglx@zju.edu.cn	Jiang, Lixi/N-3855-2014; Wu, Dezhi/AAO-9316-2020	Wu, Dezhi/0000-0002-7900-0542; Labar, Dr. Nazim Hussain/0000-0001-9209-3790	National Key Basic Research Project (973 project) [2015CB150205]; Natural Science Foundation of China (NSFC) [31371542]; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP)	National Key Basic Research Project (973 project)(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP)	The work of the authors' lab was sponsored by the National Key Basic Research Project (abbreviated as 973 project, Code No. 2015CB150205), Natural Science Foundation of China (abbreviated as NSFC, Code No. 31371542), and Jiangsu Collaborative Innovation Center for Modern Crop Production (abbreviated as JCIC-MCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bus A, 2011, THEOR APPL GENET, V123, P1413, DOI 10.1007/s00122-011-1676-7; Chai YR, 2009, MOL GENET GENOMICS, V281, P109, DOI 10.1007/s00438-008-0399-1; Chen MX, 2014, PLANT PHYSIOL, V165, P905, DOI 10.1104/pp.114.235507; Collins Andrew R, 2007, Methods Mol Biol, V376, P1; Cowling WA, 2010, GENOME, V53, P1024, DOI 10.1139/G10-087; DARVASI A, 1993, GENETICS, V134, P943; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Delourme R, 2006, THEOR APPL GENET, V113, P1331, DOI 10.1007/s00122-006-0386-z; Deng W, 2012, PLANT PHYSIOL, V160, P978, DOI 10.1104/pp.112.198713; Durstewitz G, 2010, GENOME, V53, P948, DOI 10.1139/G10-079; Ecke W, 2010, THEOR APPL GENET, V120, P921, DOI 10.1007/s00122-009-1221-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fritsche S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00129; Fu FY, 2007, GENOME, V50, P840, DOI 10.1139/G07-068; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Hall D, 2010, BRIEF FUNCT GENOMICS, V9, P157, DOI 10.1093/bfgp/elp048; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044145; Lu J, 2009, GENES GENOM, V31, P129, DOI 10.1007/BF03191146; Marles MAS, 2004, J SCI FOOD AGR, V84, P251, DOI 10.1002/jsfa.1621; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Nesi N, 2008, CR BIOL, V331, P763, DOI 10.1016/j.crvi.2008.07.018; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Padmaja KL, 2005, THEOR APPL GENET, V111, P8, DOI 10.1007/s00122-005-1933-8; Pritchard JK, 2000, GENETICS, V155, P945; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Rahman MH, 2001, PLANT BREEDING, V120, P463, DOI 10.1046/j.1439-0523.2001.00640.x; Rahman MH, 2001, PLANT BREEDING, V120, P473, DOI 10.1046/j.1439-0523.2001.00639.x; RASHID A, 1994, PLANT BREEDING, V112, P127, DOI 10.1111/j.1439-0523.1994.tb00660.x; Shen Y, 2009, J CEREAL SCI, V49, P106, DOI 10.1016/j.jcs.2008.07.010; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Theodoridou K, 2013, J SCI FOOD AGR, V93, P1986, DOI 10.1002/jsfa.6004; VANOOIJEN JW, 1992, THEOR APPL GENET, V84, P803, DOI 10.1007/BF00227388; Wang NA, 2011, J EXP BOT, V62, P5641, DOI 10.1093/jxb/err249; Wang Z, 2014, PLANT J, V77, P757, DOI 10.1111/tpj.12426; Wei YL, 2007, MOL BIOL REP, V34, P105, DOI 10.1007/s11033-006-9024-8; Westermeier P, 2009, THEOR APPL GENET, V119, P1301, DOI 10.1007/s00122-009-1135-x; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Yamamoto E, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-50; Yan XY, 2009, EUPHYTICA, V170, P355, DOI 10.1007/s10681-009-0006-5; Yang RQ, 2014, BRIEF BIOINFORM, V15, P814, DOI 10.1093/bib/bbt061; Yu CY, 2013, J APPL GENET, V54, P135, DOI 10.1007/s13353-012-0132-y; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhao JY, 2008, MOL BREEDING, V21, P115, DOI 10.1007/s11032-007-9113-y; Zhao JY, 2006, THEOR APPL GENET, V113, P33, DOI 10.1007/s00122-006-0267-5; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zhu YN, 2012, THEOR APPL GENET, V124, P515, DOI 10.1007/s00122-011-1725-2; Zou JT, 1997, PLANT CELL, V9, P909, DOI 10.1105/tpc.9.6.909	52	15	19	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146661	10.1371/journal.pone.0146661	http://dx.doi.org/10.1371/journal.pone.0146661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752200	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100125
J	Silva-Martin, N; Dauden, MI; Glatt, S; Hoffmann, NA; Kastritis, P; Bork, P; Beck, M; Muller, CW				Silva-Martin, Noella; Dauden, Maria I.; Glatt, Sebastian; Hoffmann, Niklas A.; Kastritis, Panagiotis; Bork, Peer; Beck, Martin; Mueller, Christoph W.			The Combination of X-Ray Crystallography and Cryo-Electron Microscopy Provides Insight into the Overall Architecture of the Dodecameric Rvb1/Rvb2 Complex	PLOS ONE			English	Article							STRUCTURAL BASIS; YEAST RVB1; ELECTRON; VISUALIZATION; RESOLUTION; SYSTEM; GENOME; AAA(+); STATES	The Rvb1/Rvb2 complex is an essential component of many cellular pathways. The Rvb-1/Rvb2 complex forms a dodecameric assembly where six copies of each subunit form two heterohexameric rings. However, due to conformational variability, the way the two rings pack together is still not fully understood. Here, we present the crystal structure and two cryo-electron microscopy reconstructions of the dodecameric, full-length Rvb1/Rvb2 complex, all showing that the interaction between the two heterohexameric rings is mediated through the Rvb1/Rvb2-specific domain II. Two conformations of the Rvb1/Rvb2 dodecamer are present in solution: a stretched conformation also present in the crystal, and a compact conformation. Novel asymmetric features observed in the reconstruction of the compact conformation provide additional insight into the plasticity of the Rvb1/Rvb2 complex.	[Silva-Martin, Noella; Dauden, Maria I.; Glatt, Sebastian; Hoffmann, Niklas A.; Kastritis, Panagiotis; Bork, Peer; Beck, Martin; Mueller, Christoph W.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Muller, CW (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	christoph.mueller@embl.de	Müller, Christoph W/I-7420-2012; Beck, Martin/B-5589-2011; Kastritis, Panagiotis L/F-2498-2010; Dauden, Maria I./AAA-4248-2021; Bork, Peer/F-1813-2013; Kastritis, Panagiotis/AAL-7029-2021; Glatt, Sebastian/AAS-1230-2020	Müller, Christoph W/0000-0003-2176-8337; Beck, Martin/0000-0002-7397-1321; Kastritis, Panagiotis L/0000-0002-1463-8422; Dauden, Maria I./0000-0003-2129-3941; Bork, Peer/0000-0002-2627-833X; Kastritis, Panagiotis/0000-0002-1463-8422; Glatt, Sebastian/0000-0003-2815-7133; Hoffmann, Niklas Alexander/0000-0002-0891-0581	EMBL Interdisciplinary Postdoc programm under EU; DFG	EMBL Interdisciplinary Postdoc programm under EU; DFG(German Research Foundation (DFG))	This work was funded by EMBL Interdisciplinary Postdoc programm under EU FP7 Marie-Curie Actions COFUND to NSM and Cell Networks (DFG-funded Excellence Initiative of the University of Heidelberg) to MID, PB, MB, CWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afanasyeva A, 2014, STRUCTURE, V22, P549, DOI 10.1016/j.str.2014.02.002; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Bock T, 2014, NUCLEIC ACIDS RES, V42, P13525, DOI 10.1093/nar/gku1147; Bricogne G BE, 2011, BUSTER VERSION XYZ; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheung KLY, 2010, J MOL BIOL, V404, P478, DOI 10.1016/j.jmb.2010.10.003; Cheung KLY, 2010, BIOCHEM CELL BIOL, V88, P77, DOI [10.1139/O09-159, 10.1139/o09-159]; Cuesta I, 2010, J MOL BIOL, V397, P1276, DOI 10.1016/j.jmb.2010.02.042; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gorynia S, 2011, J STRUCT BIOL, V176, P279, DOI 10.1016/j.jsb.2011.09.001; Gribun A, 2008, J MOL BIOL, V376, P1320, DOI 10.1016/j.jmb.2007.12.049; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Jeganathan A, 2015, J MOL BIOL, V427, P1875, DOI 10.1016/j.jmb.2015.01.010; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lakomek K, 2015, STRUCTURE, V23, P483, DOI 10.1016/j.str.2014.12.015; Li NN, 2015, NATURE, V524, P186, DOI 10.1038/nature14685; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lopez-Perrote A, 2012, NUCLEIC ACIDS RES, V40, P11086, DOI 10.1093/nar/gks871; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Monecke T, 2013, P NATL ACAD SCI USA, V110, P960, DOI 10.1073/pnas.1215214110; Neuwald AF, 1999, GENOME RES, V9, P27; Nguyen VQ, 2013, CELL, V154, P1220, DOI 10.1016/j.cell.2013.08.018; Niewiarowski A, 2010, BIOCHEM J, V429, P113, DOI 10.1042/BJ20100489; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petukhov M, 2012, STRUCTURE, V20, P1321, DOI 10.1016/j.str.2012.05.012; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Queval R, 2014, J BIOL CHEM, V289, P33999, DOI 10.1074/jbc.M114.576785; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Theobald DL, 2012, BIOINFORMATICS, V28, P1972, DOI 10.1093/bioinformatics/bts243; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146457	10.1371/journal.pone.0146457	http://dx.doi.org/10.1371/journal.pone.0146457			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745716	Green Submitted, gold, Green Published			2022-12-27	WOS:000367815600050
J	Liu, HY; Wang, K; Xiao, LL; Wang, SL; Du, LP; Cao, XY; Zhang, XX; Zhou, Y; Yan, YM; Ye, XG				Liu, Huiyun; Wang, Ke; Xiao, Lele; Wang, Shunli; Du, Lipu; Cao, Xinyou; Zhang, Xiaoxiang; Zhou, Yang; Yan, Yueming; Ye, Xingguo			Comprehensive Identification and Bread-Making Quality Evaluation of Common Wheat Somatic Variation Line AS208 on Glutenin Composition	PLOS ONE			English	Article							MOLECULAR-WEIGHT SUBUNITS; GENERATED DNA MARKERS; NEAR-ISOGENIC LINES; STORAGE PROTEINS; HEXAPLOID WHEAT; IMMATURE EMBRYOS; FUNCTIONAL-PROPERTIES; DOUGH FUNCTIONALITY; DEVELOPING GRAINS; GENETIC-VARIATION	High molecular weight glutenin subunits (HMW-GSs) are important seed storage proteins in wheat (Triticum aestivum) that determine wheat dough elasticity and processing quality. Clarification of the defined effectiveness of HMW-GSs is very important to breeding efforts aimed at improving wheat quality. To date, there have no report on the expression silencing and quality effects of 1Bx20 and 1By20 at the Glu-B1 locus in wheat. A wheat somatic variation line, AS208, in which both 1Bx20 and 1By20 at Glu-B1 locus were silenced, was developed recently in our laboratory. Evaluation of agronomic traits and seed storage proteins by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and reversed-phase high performance liquid chromatography (RP-HPLC) indicated that AS208 was highly similar to its parental cultivar Lunxuan987 (LX987), with the exception that the composition and expression of HMW-GSs was altered. The 1Bx20 and 1By20 in AS208 were further identified to be missing by polymerase chain reaction (PCR) and quantitative real-time RT-PCR (qRT-PCR) assays. Based on the PCR results for HMW-GS genes and their promoters in AS208 compared with LX987, 1Bx20 and 1By20 were speculated to be deleted in AS208 during in vitro culture. Quality analysis of this line with Mixograph, Farinograph, and Extensograph instruments, as well as analysis of bread-making quality traits, demonstrated that the lack of the genes encoding 1Bx20 and 1By20 caused various negative effects on dough processing and bread-making quality traits, including falling number, dough stability time, mixing tolerance index, crude protein values, wet gluten content, bread size, and internal cell structure. AS208 can potentially be used in the functional dissection of other HMW-GSs as a plant material with desirable genetic background, and in biscuit making industry as a high-quality weak gluten wheat source.	[Liu, Huiyun; Wang, Ke; Du, Lipu; Zhou, Yang; Ye, Xingguo] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Xiao, Lele; Yan, Yueming] Capital Normal Univ, Coll Life Sci, Key Lab Genet & Biotechnol, Beijing 100048, Peoples R China; [Wang, Shunli] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China; [Cao, Xinyou] Shandong Acad Agr Sci, Crop Res Inst, Jinan 250100, Shandong, Peoples R China; [Zhang, Xiaoxiang] Inst Agr Sci Lixiahe Dist, Yangzhou 225007, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Capital Normal University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Shandong Academy of Agricultural Sciences	Yan, YM (corresponding author), Capital Normal Univ, Coll Life Sci, Key Lab Genet & Biotechnol, Beijing 100048, Peoples R China.	yanym@cnu.edu.cn; yexingguo@caas.cn	Wang, Ke/AHB-2859-2022	Wang, Ke/0000-0001-6776-4935	National Natural Science Foundation of China [31371621, 31401380]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn, 31371621, YXG) and National Natural Science Foundation of China (http://www.nsfc.gov.cn, 31401380, WK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC, 1995, APPR METH AM ASS CER; Ahmad M, 2000, THEOR APPL GENET, V101, P892, DOI 10.1007/s001220051558; Altpeter F, 2004, PLANT MOL BIOL, V54, P783, DOI 10.1007/s11103-004-0122-5; Anderson O. D., 1996, P 6 INT GLUT WORKSH, P195; Arbeitsgemeinschaft Getreideforschung, 1994, STAND METH FUER GETR; Barro F, 2003, MOL BREEDING, V12, P223, DOI 10.1023/A:1026367214120; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bekes F, 2001, AUST J AGR RES, V52, P1325, DOI 10.1071/AR01041; Beshkova N, 1998, BIOTECHNOL BIOTEC EQ, V12, P53, DOI 10.1080/13102818.1998.10818988; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BRANLARD G, 1985, J CEREAL SCI, V3, P345, DOI 10.1016/S0733-5210(85)80007-2; BURNOUF T, 1984, J CHROMATOGR, V299, P185, DOI 10.1016/S0021-9673(01)97831-8; Butow BJ, 2003, THEOR APPL GENET, V107, P1524, DOI 10.1007/s00122-003-1396-8; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; Deng ZY, 2005, PLANT BREEDING, V124, P428, DOI 10.1111/j.1439-0523.2005.01158.x; Dowd C, 2002, PROTEIN EXPRES PURIF, V25, P97, DOI 10.1006/prep.2001.1614; FLAVELL RB, 1989, BIO-TECHNOL, V7, P1281; Gao LY, 2010, J AGR FOOD CHEM, V58, P2777, DOI 10.1021/jf903363z; Gupta RB, 1996, J EXP BOT, V47, P1377, DOI 10.1093/jxb/47.9.1377; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; He GY, 1999, MOL BREEDING, V5, P377, DOI 10.1023/A:1009681321708; He ZH, 2005, CEREAL CHEM, V82, P345, DOI 10.1094/CC-82-0345; Ishida Y, 2015, METHODS MOL BIOL, V1223, P189, DOI 10.1007/978-1-4939-1695-5_15; Jin H, 2011, CROP PASTURE SCI, V62, P746, DOI 10.1071/CP11134; Juhaasz A, 2003, THEOR APPL GENET, V107, P697, DOI 10.1007/s00122-003-1292-2; LAWRENCE GJ, 1988, J CEREAL SCI, V7, P109, DOI [10.1016/S0733-5210(88)80012-2, 10.1006/jcrs.1997.0158]; Lei ZS, 2006, J CEREAL SCI, V43, P94, DOI 10.1016/j.jcs.2005.08.003; Li W, 2004, THEOR APPL GENET, V109, P1093, DOI 10.1007/s00122-004-1726-5; Li YW, 2015, MOL PLANT, V8, P332, DOI 10.1016/j.molp.2014.10.002; Liu SX, 2008, THEOR APPL GENET, V118, P177, DOI 10.1007/s00122-008-0886-0; Liu W, 2012, J SCI FOOD AGR, V92, P106, DOI 10.1002/jsfa.4548; Ma W, 2005, THEOR APPL GENET, V111, P410, DOI 10.1007/s00122-005-2001-0; Ma W, 2003, EUPHYTICA, V134, P51, DOI 10.1023/A:1026191918704; Mackie AM, 1996, J CEREAL SCI, V23, P213, DOI 10.1006/jcrs.1996.0022; Majoul T, 2004, PROTEOMICS, V4, P505, DOI 10.1002/pmic.200300570; METAKOVSKY EV, 1984, THEOR APPL GENET, V69, P31, DOI 10.1007/BF00262533; Pang BS, 2008, J INTEGR PLANT BIOL, V50, P329, DOI 10.1111/j.1744-7909.2007.00573.x; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1988, J CEREAL SCI, V7, P229, DOI [10.1016/S0733-5210(88)80004-3, 10.1006/jcrs.1998.0194]; PAYNE PI, 1979, PLANTA, V145, P83, DOI 10.1007/BF00379931; PAYNE PI, 1984, PHILOS T R SOC B, V304, P359, DOI 10.1098/rstb.1984.0031; Pirozi MR, 2008, J CEREAL SCI, V48, P117, DOI 10.1016/j.jcs.2007.08.011; Ragupathy R, 2008, THEOR APPL GENET, V116, P283, DOI 10.1007/s00122-007-0666-2; Rasheed A, 2014, J CEREAL SCI, V60, P11, DOI 10.1016/j.jcs.2014.01.020; Richardson T, 2014, PLANT CELL TISS ORG, V119, P647, DOI 10.1007/s11240-014-0564-7; Schwarz G, 2004, THEOR APPL GENET, V109, P1064, DOI 10.1007/s00122-004-1718-5; Schwarz G, 2003, J AGR FOOD CHEM, V51, P4263, DOI 10.1021/jf0261304; Shen XiaoYong, 2010, Acta Agronomica Sinica, V36, P1037, DOI 10.3724/SP.J.1006.2010.01037; Shewry PR, 2003, THEOR APPL GENET, V106, P744, DOI 10.1007/s00122-002-1135-6; SHEWRY PR, 1992, J CEREAL SCI, V15, P105, DOI 10.1016/S0733-5210(09)80062-3; SMITH RL, 1994, CROP SCI, V34, P1373, DOI 10.2135/cropsci1994.0011183X003400050042x; Tamas L, 2002, J CEREAL SCI, V36, P313, DOI 10.1006/jcrs.2001.0457; Tao LL, 2011, AGR SCI CHINA, V10, P317, DOI 10.1016/S1671-2927(11)60010-2; TATHAM AS, 1985, CEREAL CHEM, V62, P405; UPELNIEK VP, 1995, THEOR APPL GENET, V90, P372, DOI 10.1007/BF00221979; Wang Shufang, 2013, Biomed Res Int, V2013, P690491, DOI 10.1155/2013/690491; Weegels PL, 1996, J CEREAL SCI, V23, P103, DOI 10.1006/jcrs.1996.0010; Wrigley CW, 1996, NATURE, V381, P738, DOI 10.1038/381738a0; Yan Y, 2003, THEOR APPL GENET, V107, P1321, DOI 10.1007/s00122-003-1315-z; Yan YM, 2009, J CEREAL SCI, V50, P398, DOI 10.1016/j.jcs.2009.08.004; Yang YS, 2014, THEOR APPL GENET, V127, P359, DOI 10.1007/s00122-013-2224-4; Ye XG, 2015, J INTEGR AGR, V14, P411, DOI 10.1016/S2095-3119(14)60945-X; Yin GX, 2011, AGR SCI CHINA, V10, P9, DOI 10.1016/S1671-2927(11)60302-7; Zhang XF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-243; Zhao XC, 1996, J CEREAL SCI, V23, P191, DOI 10.1006/jcrs.1996.0019	66	9	11	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146933	10.1371/journal.pone.0146933	http://dx.doi.org/10.1371/journal.pone.0146933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765256	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300053
J	Mellon, D				Mellon, DeForest, Jr.			Electrophysiological Evidence for Intrinsic Pacemaker Currents in Crayfish Parasol Cells	PLOS ONE			English	Article							TRANSIENT POTASSIUM CURRENT; CENTRAL OLFACTORY PATHWAY; CARDIAC GANGLION NEURONS; ACTIVATED INWARD CURRENT; HIGHER-LEVEL NEURONS; I-H; STOMATOGASTRIC GANGLION; MOTOR-NEURON; DEPOLARIZING RESPONSES; SYNAPTIC-TRANSMISSION	I used sharp intracellular electrodes to record from parasol cells in the semi-isolated crayfish brain to investigate pacemaker currents. Evidence for the presence of the hyperpolarization-activated inward rectifier potassium current was obtained in about half of the parasol cells examined, where strong, prolonged hyperpolarizing currents generated a slowly-rising voltage sag, and a post-hyperpolarization rebound. The amplitudes of both the sag voltage and the depolarizing rebound were dependent upon the strength of the hyperpolarizing current. The voltage sag showed a definite threshold and was non-inactivating. The voltage sag and rebound depolarization evoked by hyperpolarization were blocked by the presence of 5-10 mM Cs2+ ions, 10 mM tetraethyl ammonium chloride, and 10 mM cobalt chloride in the bathing medium, but not by the drug ZD 7288. Cs+ ions in normal saline in some cells caused a slight increase in mean resting potential and a reduction in spontaneous burst frequency. Many of the neurons expressing the hyperpolarization-activated inward potassium current also provided evidence for the presence of the transient potassium current I-A, which was inferred from experimental observations of an increased latency of post-hyperpolarization response to a depolarizing step, compared to the response latency to the depolarization alone. The latency increase was reduced in the presence of 4-aminopyridine (4-AP), a specific blocker of I-A. The presence of 4-AP in normal saline also induced spontaneous bursting in parasol cells. It is conjectured that, under normal physiological conditions, these two potassium currents help to regulate burst generation in parasol cells, respectively, by helping to maintain the resting membrane potential near a threshold level for burst generation, and by regulating the rate of rise of membrane depolarizing events leading to burst generation. The presence of post-burst hyperpolarization may depend upon I-A channels in parasol cells.	[Mellon, DeForest, Jr.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	University of Virginia	Mellon, D (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	dm6d@virginia.edu			US National Science Foundation [IBN-9727753]; University of Virginia; National Science Foundation [IBN-9727753]	US National Science Foundation(National Science Foundation (NSF)); University of Virginia; National Science Foundation(National Science Foundation (NSF))	This work was supported by the US National Science Foundation (www.NSF.gov), IBN-9727753, and the University of Virginia (www.virginia.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported in part by research grant IBN-9727753 from the National Science Foundation and by an in-house grant from the University of Virginia.	ANGSTADT JD, 1989, J NEUROSCI, V9, P2846; ANGSTADT JD, 1991, J NEUROSCI, V11, P746; Baro DJ, 2001, NEUROSCIENCE, V106, P419, DOI 10.1016/S0306-4522(01)00261-5; Beaumont V, 2002, NEURON, V33, P601, DOI 10.1016/S0896-6273(02)00581-0; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; BROWN H, 1979, J EXP BIOL, V81, P175; Calabrese RL, 1998, CURR OPIN NEUROBIOL, V8, P710, DOI 10.1016/S0959-4388(98)80112-8; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; GETTING PA, 1983, J NEUROPHYSIOL, V49, P1036, DOI 10.1152/jn.1983.49.4.1036; Goeritz ML, 2011, J NEUROPHYSIOL, V106, P44, DOI 10.1152/jn.00897.2010; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; HARRISWARRICK RM, 1987, BRAIN RES, V416, P381, DOI 10.1016/0006-8993(87)90923-1; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; Hartline Daniel K., 1992, P31; HARTLINE DK, 1979, BIOL CYBERN, V33, P223, DOI 10.1007/BF00337411; Kiehn O, 2000, BRAIN RES BULL, V53, P649, DOI 10.1016/S0361-9230(00)00398-1; KIEHN O, 1992, J NEUROPHYSIOL, V68, P496, DOI 10.1152/jn.1992.68.2.496; KIEHN O, 1992, J NEUROPHYSIOL, V68, P485, DOI 10.1152/jn.1992.68.2.485; Kloppenburg P, 1999, J NEUROPHYSIOL, V81, P29, DOI 10.1152/jn.1999.81.1.29; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; McKinzie ME, 2003, J COMP NEUROL, V84, P3043; MELLON D, 1992, J EXP BIOL, V167, P15; Mellon D, 1999, J NEUROPHYSIOL, V81, P1231, DOI 10.1152/jn.1999.81.3.1231; Mellon D, 2000, J NEUROPHYSIOL, V84, P3043, DOI 10.1152/jn.2000.84.6.3043; Mellon D, 2003, J NEUROPHYSIOL, V90, P2465, DOI 10.1152/jn.00310.2003; Mellon D, 2003, MICROSC RES TECHNIQ, V60, P278, DOI 10.1002/jemt.10267; Mellon DF, 1997, J COMP PHYSIOL A, V181, P205, DOI 10.1007/s003590050107; Mellon DF, 2005, J EXP BIOL, V208, P3711, DOI 10.1242/jeb.01827; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Peck JH, 2001, J NEUROPHYSIOL, V86, P2957, DOI 10.1152/jn.2001.86.6.2957; Prinz AA, 2003, J NEUROSCI, V23, P943; Raymond V, 1999, NEUROSCIENCE, V93, P1207, DOI 10.1016/S0306-4522(99)00218-3; Sullivan JM, 2001, J COMP NEUROL, V441, P9, DOI 10.1002/cne.1394; TAZAKI K, 1979, J NEUROPHYSIOL, V42, P1000, DOI 10.1152/jn.1979.42.4.1000; TAZAKI K, 1979, J NEUROPHYSIOL, V42, P1022, DOI 10.1152/jn.1979.42.4.1022; Thoby-Brisson M, 2000, J NEUROSCI, V20, P2994; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; TRAVAGLI RA, 1994, J NEUROPHYSIOL, V71, P1308, DOI 10.1152/jn.1994.71.4.1308; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; WALLIN BG, 1967, ACTA PHYSIOL SCAND, V70, P419, DOI 10.1111/j.1748-1716.1967.tb03640.x	45	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146091	10.1371/journal.pone.0146091	http://dx.doi.org/10.1371/journal.pone.0146091			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764465	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300014
J	Whittington, HJ; McAndrew, DJ; Cross, RL; Neubauer, S; Lygate, CA				Whittington, Hannah J.; McAndrew, Debra J.; Cross, Rebecca L.; Neubauer, Stefan; Lygate, Craig A.			Protective Effect of Creatine Elevation against Ischaemia Reperfusion Injury Is Retained in the Presence of Co-Morbidities and during Cardioplegia	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; INCREASED SUSCEPTIBILITY; MYOCARDIAL PROTECTION; RISK-FACTORS; IN-VIVO; HEART; CARDIOPROTECTION; HYPERTROPHY; ENERGY; METABOLISM	Ischaemic heart disease is most prevalent in the ageing population and often exists with other comorbidities; however the majority of laboratory research uses young, healthy animal models. Several recent workshops and focus meetings have highlighted the importance of using clinically relevant models to help aid translation to realistic patient populations. We have previously shown that mice over-expressing the creatine transporter (CrT-OE) have elevated intracellular creatine levels and are protected against ischaemia-reperfusion injury. Here we test whether elevating intracellular creatine levels retains a cardioprotective effect in the presence of common comorbidities and whether it is additive to protection afforded by hypothermic cardioplegia.	[Whittington, Hannah J.; McAndrew, Debra J.; Cross, Rebecca L.; Neubauer, Stefan; Lygate, Craig A.] Univ Oxford, Wellcome Trust Ctr Human Genet, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics	Lygate, CA (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England.	clygate@well.ox.ac.uk	Lygate, Craig/AAO-4731-2020	Lygate, Craig/0000-0001-6079-0284; Neubauer, Stefan/0000-0001-9017-5645	British Heart Foundation (BHF) - BHF Centre of Research Excellence, Oxford [RG/13/8/30266]; Wellcome Trust Core Award [090532/Z/09/Z]; MRC [G0800778] Funding Source: UKRI; British Heart Foundation [RG/13/8/30266] Funding Source: researchfish; Medical Research Council [G0800778] Funding Source: researchfish	British Heart Foundation (BHF) - BHF Centre of Research Excellence, Oxford; Wellcome Trust Core Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the British Heart Foundation (BHF) Programme Grant RG/13/8/30266, supported by the BHF Centre of Research Excellence, Oxford, and benefitted from a Wellcome Trust Core Award (090532/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akki A, 2012, AM J PHYSIOL-HEART C, V303, pH844, DOI 10.1152/ajpheart.00268.2012; Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Bache RJ, 1999, CARDIOVASC RES, V42, P616, DOI 10.1016/S0008-6363(98)00332-0; Boehm E, 2003, AM J PHYSIOL-ENDOC M, V284, pE399, DOI 10.1152/ajpendo.00259.2002; Boengler K, 2009, CARDIOVASC RES, V83, P247, DOI 10.1093/cvr/cvp033; BREISCH EA, 1984, LAB INVEST, V51, P333; Chambers DJ, 2010, PHARMACOL THERAPEUT, V127, P41, DOI 10.1016/j.pharmthera.2010.04.001; Cisowski M, 1996, J Cardiovasc Surg (Torino), V37, P75; ELLIOTT AC, 1992, J PHYSIOL-LONDON, V454, P467, DOI 10.1113/jphysiol.1992.sp019274; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Frohlich GM, 2013, EUR HEART J, V34, P1714, DOI 10.1093/eurheartj/eht090; Hausenloy DJ, 2010, BASIC RES CARDIOL, V105, P677, DOI 10.1007/s00395-010-0121-4; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; Ito WD, 1997, J MOL CELL CARDIOL, V29, P2169, DOI 10.1006/jmcc.1997.0456; Jahania MS, 1999, ANN THORAC SURG, V68, P1983, DOI 10.1016/S0003-4975(99)01028-0; Juhaszova M, 2005, CARDIOVASC RES, V66, P233, DOI 10.1016/j.cardiores.2004.12.020; KAPLINSKY E, 1994, CARDIOVASC DRUG THER, V8, P549, DOI 10.1007/BF00877223; Kates AM, 2003, J AM COLL CARDIOL, V41, P293, DOI 10.1016/S0735-1097(02)02714-6; Lecour S, 2014, CARDIOVASC RES, V104, P399, DOI 10.1093/cvr/cvu225; Lygate C, 2006, DRUG DISCOV TODAY DI, V3, P283, DOI 10.1016/j.ddmod.2006.10.002; Lygate CA, 2012, CARDIOVASC RES, V96, P466, DOI 10.1093/cvr/cvs272; NEUBAUER S, 1995, J CLIN INVEST, V95, P1092, DOI 10.1172/JCI117756; Przyklenk K, 2008, J AM COLL CARDIOL, V51, P1393, DOI 10.1016/j.jacc.2007.11.070; ROBINSON LA, 1987, J THORAC CARDIOV SUR, V93, P415; Spindler M, 2004, AM J PHYSIOL-HEART C, V287, pH1039, DOI 10.1152/ajpheart.01016.2003; Suleiman MS, 2008, BRIT J PHARMACOL, V153, P21, DOI 10.1038/sj.bjp.0707526; Sutherland FJ, 2003, CLIN EXP PHARMACOL P, V30, P867, DOI 10.1046/j.1440-1681.2003.03925.x; Tachikawa M, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-13; ten Hove M, 2005, CIRCULATION, V111, P2477, DOI 10.1161/01.CIR.0000165147.99592.01; The Jackson Laboratory, 2015, LIF SPAN BIOM; THELIN S, 1987, THORAC CARDIOV SURG, V35, P137, DOI 10.1055/s-2007-1020217; Tokarska-Schlattner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043178; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; Wallis J, 2005, CIRCULATION, V112, P3131, DOI 10.1161/CIRCULATIONAHA.105.572990; Whittington HJ, 2013, CARDIOVASC RES, V99, P694, DOI 10.1093/cvr/cvt140; Willems Laura, 2005, J Mol Cell Cardiol, V38, P245, DOI 10.1016/j.yjmcc.2004.09.014; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zervou S, 2016, MINI-REV MED CHEM, V16, P19, DOI 10.2174/1389557515666150722102151	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146429	10.1371/journal.pone.0146429	http://dx.doi.org/10.1371/journal.pone.0146429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765737	Green Published, gold			2022-12-27	WOS:000368459300019
J	Thagaard, IN; Krebs, L; Lausten-Thomsen, U; Larsen, SO; Holm, JC; Christiansen, M; Larsen, T				Thagaard, Ida Naslund; Krebs, Lone; Lausten-Thomsen, Ulrik; Larsen, Severin Olesen; Holm, Jens-Christian; Christiansen, Michael; Larsen, Torben			Dating of Pregnancy in First versus Second Trimester in Relation to Post-Term Birth Rate: A Cohort Study	PLOS ONE			English	Article							LAST MENSTRUAL PERIOD; ULTRASOUND EXAMINATIONS; ESTIMATED DATE; DELIVERY DATE; PREDICTION; POPULATION; ADVANTAGES; GESTATION; FETAL; SCAN	Objectives To evaluate in a national standardised setting whether the performance of ultrasound dating during the first rather than the second trimester of pregnancy had consequences regarding the definition of pre- and post-term birth rates. Methods A cohort study of 8,551 singleton pregnancies with spontaneous delivery was performed from 2006 to 2012 at Copenhagen University Hospital, Holbaek, Denmark. We determined the duration of pregnancy calculated by last menstrual period, crown rump length (CRL), biparietal diameter (1st trimester), BPD (2nd trimester), and head circumference and compared mean and median durations, the mean differences, the systematic discrepancies, and the percentages of pre-term and post-term pregnancies in relation to each method. The primary outcomes were post-term and pre-term birth rates defined by different dating methods. Results The change from use of second to first trimester measurements for dating was associated with a significant increase in the rate of post-term deliveries from 2.1-2.9% and a significant decrease in the rate of pre-term deliveries from 5.4-4.6% caused by systematic discrepancies. Thereby 25.1% would pass 41 weeks when GA is defined by CRL and 17.3% when BPD (2nd trimester) is used. Calibration for these discrepancies resulted in a lower post-term birth rate, from 3.1-1.4%, when first compared to second trimester dating was used. Conclusions Systematic discrepancies were identified when biometric formulas were used to determine duration of pregnancy. This should be corrected in clinical practice to avoid an overestimation of post-term birth and unnecessary inductions when first trimester formulas are used.	[Thagaard, Ida Naslund; Krebs, Lone; Larsen, Torben] Copenhagen Univ Hosp, Dept Obstet & Gynaecol, Holbaek, Denmark; [Larsen, Severin Olesen; Christiansen, Michael] State Serum Inst, Dept Clin Biochem, Copenhagen, Denmark; [Lausten-Thomsen, Ulrik; Holm, Jens-Christian] Copenhagen Univ Hosp, Dept Paediat, Childrens Obes Clin, Holbaek, Denmark	University of Copenhagen; Statens Serum Institut; University of Copenhagen	Thagaard, IN (corresponding author), Copenhagen Univ Hosp, Dept Obstet & Gynaecol, Holbaek, Denmark.	idanaeslund@gmail.com	Krebs, Lone/AAD-8273-2021; Holm, Jens-Christian/T-4594-2017	Krebs, Lone/0000-0001-5433-4776; Holm, Jens-Christian/0000-0003-4653-342X; Lausten-Thomsen, Ulrik/0000-0003-1136-4347; Thagaard, Ida Naslund/0000-0002-9749-9279	Region Zealand Health Sciences Research Foundation [15-000342]	Region Zealand Health Sciences Research Foundation	This work was supported by a grant from The Region Zealand Health Sciences Research Foundation, grant number: 15-000342 (http://www.regionsjaelland.dk/Sundhed/forskning/ forskningsfinansiering/Sider/oekonomi.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1997, ULTRASOUND OBST GYN, V10, P174, DOI 10.1046/j.1469-0705.1997.10030174.x; Chalouhi GE, 2011, J MATERN-FETAL NEO M, V24, P51, DOI 10.3109/14767051003728229; Chitty AS, 1994, BRIT J OBSTET GYNAEC, P35; Ekelund CK, 2015, ACTA OBSTET GYN SCAN, V94, P577, DOI 10.1111/aogs.12581; Harrington DJ, 2006, BJOG-INT J OBSTET GY, V113, P171, DOI 10.1111/j.1471-0528.2005.00833.x; Kallen K, 2002, ULTRASOUND OBST GYN, V20, P558, DOI 10.1046/j.1469-0705.2002.00855.x; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; Myklestad K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-33; Nguyen TH, 1999, ULTRASOUND OBST GYN, V14, P23, DOI 10.1046/j.1469-0705.1999.14010023.x; Okland I, 2012, ULTRASOUND OBST GYN, V39, P563, DOI 10.1002/uog.10081; Okland I, 2011, ULTRASOUND OBST GYN, V37, P207, DOI 10.1002/uog.7728; Okland I, 2010, ULTRASOUND OBST GYN, V36, P728, DOI 10.1002/uog.7707; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Salomon LJ, 2010, J MATERN-FETAL NEO M, V23, P1, DOI 10.3109/14767050903078672; Saltvedt S, 2004, ULTRASOUND OBST GYN, V24, P42, DOI 10.1002/uog.1047; Taipale P, 2001, OBSTET GYNECOL, V97, P189, DOI 10.1016/S0029-7844(00)01131-5; Tunon K, 1996, ULTRASOUND OBST GYN, V8, P178, DOI 10.1046/j.1469-0705.1996.08030178.x; Tunon K, 1998, ULTRASOUND OBST GYN, V11, P99, DOI 10.1046/j.1469-0705.1998.11020099.x; Zeitlin J, 2007, BJOG-INT J OBSTET GY, V114, P1097, DOI 10.1111/j.1471-0528.2007.01328.x	19	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147109	10.1371/journal.pone.0147109	http://dx.doi.org/10.1371/journal.pone.0147109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760299	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100069
J	Zhang, MJ; Wang, CC; Yang, CY; Meng, H; Agbagwa, IO; Wang, LX; Wang, YZ; Yan, S; Ren, SC; Sun, YH; Pei, G; Liu, X; Liu, J; Jin, L; Li, H; Sun, YL				Zhang, Minjie; Wang, Chuan-Chao; Yang, Caiyun; Meng, Hao; Agbagwa, Ikechukwu O.; Wang, Ling-Xiang; Wang, Yingzhi; Yan, Shi; Ren, Shancheng; Sun, Yinghao; Pei, Gang; Liu, Xin; Liu, Jiang; Jin, Li; Li, Hui; Sun, Yingli			Epigenetic Pattern on the Human Y Chromosome Is Evolutionarily Conserved	PLOS ONE			English	Article							DNA METHYLATION LANDSCAPE; SISTER-CHROMATID COHESION; RECENT COMMON ANCESTRY; IN-SITU HYBRIDIZATION; EMPEROR CAO CAO; MAMMALIAN DEVELOPMENT; RETT-SYNDROME; EARLY EMBRYOS; MOSAIC LOSS; CANCER	DNA methylation plays an important role for mammalian development. However, it is unclear whether the DNA methylation pattern is evolutionarily conserved. The Y chromosome serves as a powerful tool for the study of human evolution because it is transferred between males. In this study, based on deep-rooted pedigrees and the latest Y chromosome phylogenetic tree, we performed epigenetic pattern analysis of the Y chromosome from 72 donors. By comparing their respective DNA methylation level, we found that the DNA methylation pattern on the Y chromosome was stable among family members and haplogroups. Interestingly, two haplogroup-specific methylation sites were found, which were both genotype-dependent. Moreover, the African and Asian samples also had similar DNA methylation pattern with a remote divergence time. Our findings indicated that the DNA methylation pattern on the Y chromosome was conservative during human male history.	[Zhang, Minjie; Yang, Caiyun; Meng, Hao; Liu, Xin; Sun, Yingli] Chinese Acad Sci, Beijing Inst Genom, China Gastrointestinal Canc Res Ctr, Key Lab Genom & Precis Med, Beijing 100101, Peoples R China; [Zhang, Minjie; Meng, Hao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Chuan-Chao; Wang, Ling-Xiang; Wang, Yingzhi; Yan, Shi; Jin, Li; Li, Hui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Chuan-Chao; Wang, Ling-Xiang; Wang, Yingzhi; Yan, Shi; Jin, Li; Li, Hui] Fudan Univ, Sch Life Sci, MOE, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Agbagwa, Ikechukwu O.] Univ Port Harcourt, Dept Plant Sci & Biotechnol, Port Harcourt, Nigeria; [Sun, Yinghao] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol,Grad Sch, Shanghai 200031, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China; [Liu, Jiang] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; Fudan University; University of Port Harcourt; Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Jin, L (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	lijin.fudan@gmail.com; lihui.fudan@gmail.com; sunyl@big.ac.cn	Yan, Shi/GYR-3441-2022; Jin, Li/C-1468-2009; Wang, Chuan-Chao/AGY-2940-2022; Zhang, Minjie/AFT-6708-2022; Wang, Chuan-Chao/B-2975-2011; Jin, Li/M-5063-2019	Yan, Shi/0000-0001-8304-8445; Jin, Li/0000-0002-4546-2415; Wang, Chuan-Chao/0000-0003-4630-5232; Zhang, Minjie/0000-0001-8561-0729; Wang, Chuan-Chao/0000-0001-9628-0307; 	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01040407]; National Natural Science Foundation of China [91019024, 31100558, 91131002]; National Basic Research Program of China (973 Program) [2012CB518302, 2013CB911001]; National Excellent Youth Science Foundation of China [31222030]; Shanghai Rising-Star Program [12QA1400300]; China Ministry of Education Scientific Research Major Project [311016, 113022A]; MOE University Doctoral Research Supervisor's Funds [20120071110021]; Shanghai Professional Development Funding [2010001]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Excellent Youth Science Foundation of China; Shanghai Rising-Star Program; China Ministry of Education Scientific Research Major Project; MOE University Doctoral Research Supervisor's Funds; Shanghai Professional Development Funding	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XDA01040407), National Natural Science Foundation of China (grant no. 91019024, grant no. 31100558, and grant no. 91131002), National Basic Research Program of China (973 Program, grant no. 2012CB518302, and grant no. 2013CB911001), National Excellent Youth Science Foundation of China (grant no. 31222030), Shanghai Rising-Star Program (grant no. 12QA1400300), China Ministry of Education Scientific Research Major Project (grant no. 311016 and 113022A), MOE University Doctoral Research Supervisor's Funds (grant no. 20120071110021), and Shanghai Professional Development Funding (grant no. 2010001).	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Balaresque P, 2015, EUR J HUM GENET, V23, P1413, DOI 10.1038/ejhg.2014.285; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Dumanski JP, 2015, SCIENCE, V347, P81, DOI 10.1126/science.1262092; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gokhman D, 2014, SCIENCE, V344, P523, DOI 10.1126/science.1250368; Graves JAM, 2004, REPROD FERT DEVELOP, V16, P527, DOI 10.1071/RD03096; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Inagaki Sachiyo, 2002, Leg Med (Tokyo), V4, P202, DOI 10.1016/S1344-6223(02)00032-9; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; JIN YS, 1993, CANCER RES, V53, P2140; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Piccolo FM, 2014, TRENDS CELL BIOL, V24, P136, DOI 10.1016/j.tcb.2013.09.001; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; SEARS DD, 1995, GENETICS, V139, P1159; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stahl PR, 2012, PROSTATE, V72, P898, DOI 10.1002/pros.21492; Takahashi S, 1996, CLIN CANCER RES, V2, P137; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tricoli JV, 1999, CANCER GENET CYTOGEN, V111, P1, DOI 10.1016/S0165-4608(98)00212-X; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; van Heemst D, 2000, CHROMOSOMA, V109, P10, DOI 10.1007/s004120050408; Vijayakumar S, 2005, GENE CHROMOSOME CANC, V44, P365, DOI 10.1002/gcc.20250; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wang CC, 2013, J HUM GENET, V58, P238, DOI 10.1038/jhg.2013.5; Wang CC, 2012, J HUM GENET, V57, P216, DOI 10.1038/jhg.2011.147; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; Yan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105691; Yan S, 2011, EUR J HUM GENET, V19, P1013, DOI 10.1038/ejhg.2011.64; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	56	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146402	10.1371/journal.pone.0146402	http://dx.doi.org/10.1371/journal.pone.0146402			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760298	gold, Green Submitted, Green Published			2022-12-27	WOS:000368033100033
J	Nielsen, CH; Bornsen, L; Sellebjerg, F; Brimnes, MK				Nielsen, Claus H.; Bornsen, Lars; Sellebjerg, Finn; Brimnes, Marie K.			Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-alpha and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELL; IL-6-DEFICIENT MICE; OLIGODENDROCYTE GLYCOPROTEIN; HEALTHY-INDIVIDUALS; CYTOKINE RESPONSES; GLATIRAMER ACETATE; DENDRITIC CELLS; SELF-ANTIGEN; DISEASE	B cells are involved in driving relapsing-remitting multiple sclerosis (RRMS), as demonstrated by the positive effect of therapeutic B-cell depletion. Aside from producing antibodies, B cells are efficient antigen-presenting and cytokine-secreting cells. Diverse polyclonal stimuli have been used to study cytokine production by B cells, but here we used the physiologically relevant self-antigen myelin basic protein (MBP) to stimulate B cells from untreated patients with RRMS and healthy donors. Moreover, we took advantage of the unique ability of the monoclonal antibody MK16 to recognize the immunodominant peptide MBP85-99 presented on HLA-DR15, and used it as a probe to directly study B-cell presentation of self-antigenic peptide. The proportions of B cells producing TNF-alpha or IL-6 after stimulation with MBP were higher in RRMS patients than in healthy donors, indicating a pro-inflammatory profile for self-reactive patient B cells. In contrast, polyclonal stimulation with PMA + ionomycin and MBP revealed no difference in cytokine profile between B cells from RRMS patients and healthy donors. Expanded disability status scale (EDSS) as well as multiple sclerosis severity score (MSSS) correlated with reduced ability of B cells to produce IL-10 after stimulation with MBP, indicative of diminished B-cell immune regulatory function in patients with the most severe disease. Moreover, EDSS correlated positively with the frequencies of TNF-alpha, IL-6 and IL-10 producing B cells after polyclonal stimulation. Patientderived, IL-10-producing B cells presented MBP85-99 poorly, as did IL-6-producing B cells, particulary in the healthy donor group. B cells from MS patients thus present antigen to T cells in a pro-inflammatory context. These findings contribute to understanding the therapeutic effects of B-cell depletion in human autoimmune diseases, including MS.	[Nielsen, Claus H.; Brimnes, Marie K.] Rigshosp, Copenhagen Univ Hosp, Ctr Rheumatol & Spine Dis, Inst Inflammat Res, DK-2100 Copenhagen, Denmark; [Bornsen, Lars; Sellebjerg, Finn] Rigshosp, Copenhagen Univ Hosp, Dept Neurol, Danish Multiple Sclerosis Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nielsen, CH (corresponding author), Rigshosp, Copenhagen Univ Hosp, Ctr Rheumatol & Spine Dis, Inst Inflammat Res, DK-2100 Copenhagen, Denmark.	claus.henrik.nielsen@regionh.dk		Nielsen, Claus Henrik/0000-0001-7543-9016; Sellebjerg, Finn/0000-0002-1333-9623	Aase og Einar Danielsens foundation	Aase og Einar Danielsens foundation	This study was supported by Aase og Einar Danielsens foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audo R, 2014, ARTHRITIS RHEUMATOL, V66, pS168, DOI 10.1002/art.38666; Bao Y, 2014, J AUTOIMMUN, V55, P10, DOI 10.1016/j.jaut.2014.04.001; Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Barr TA, 2010, J IMMUNOL, V185, P2783, DOI 10.4049/jimmunol.1001431; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Brimnes MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113388; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Hedegaard CJ, 2009, IMMUNOLOGY, V128, pe451, DOI 10.1111/j.1365-2567.2008.02999.x; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; Ireland SJ, 2014, JAMA NEUROL, V71, P1421, DOI 10.1001/jamaneurol.2014.1472; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kristensen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127949; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Langkjaer A, 2012, CLIN IMMUNOL, V145, P1, DOI 10.1016/j.clim.2012.07.004; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mendel I, 1998, EUR J IMMUNOL, V28, P1727, DOI 10.1002/(SICI)1521-4141(199805)28:05<1727::AID-IMMU1727>3.0.CO;2-#; Naismith RT, 2010, NEUROLOGY, V74, P1860, DOI 10.1212/WNL.0b013e3181e24373; Nielsen CH, 2001, EUR J IMMUNOL, V31, P2660, DOI 10.1002/1521-4141(200109)31:9<2660::AID-IMMU2660>3.0.CO;2-E; O'Connor KC, 2010, J NEUROIMMUNOL, V223, P92, DOI 10.1016/j.jneuroim.2010.02.019; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Palanichamy A, 2014, J IMMUNOL, V193, P580, DOI 10.4049/jimmunol.1400118; Petereit HF, 2008, ACTA NEUROL SCAND, V117, P399, DOI 10.1111/j.1600-0404.2007.00958.x; Pierson ER, 2014, J IMMUNOL, V192, P929, DOI 10.4049/jimmunol.1302171; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Seamons A, 2006, J IMMUNOL, V177, P2097, DOI 10.4049/jimmunol.177.4.2097; Sellebjerg F, 2013, MULT SCLER J, V19, P179, DOI 10.1177/1352458512450353; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Shen P, 2015, INT IMMUNOL, V27, P513, DOI 10.1093/intimm/dxv037; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Zha BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049835; Zhong GM, 1997, J EXP MED, V186, P673, DOI 10.1084/jem.186.5.673	50	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146971	10.1371/journal.pone.0146971	http://dx.doi.org/10.1371/journal.pone.0146971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756931	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888800038
J	Fernandez-Nino, JA; Astudillo-Garcia, CI; Bojorquez-Chapela, I; Morales-Carmona, E; Montoya-Rodriguez, AA; Palacio-Mejia, LS				Alfredo Fernandez-Nino, Julian; Iveth Astudillo-Garcia, Claudia; Bojorquez-Chapela, Ietza; Morales-Carmona, Evangelina; Alejandra Montoya-Rodriguez, Airain; Sofia Palacio-Mejia, Lina			The Mexican Cycle of Suicide: A National Analysis of Seasonality, 2000-2013	PLOS ONE			English	Article							DEPENDENT SPECTRAL-ANALYSIS; TIME-SERIES; SPATIAL HIERARCHIES; DENGUE EPIDEMICS; SAO-PAULO; RATES; MORTALITY; REGRESSION; HOLIDAYS; GENDER	Introduction Suicide is a complex and multifactorial phenomenon with growing importance to public health. An increase in its occurrence has been observed in Mexico over the past 10 years. The present article analyzes the secular trend in suicide at the national level between the years 2000 and 2013. Materials and Methods All suicides during the study period (n = 64,298, of which 82.11% were men) were characterized using a spectral decomposition of the time series and a wavelet analysis to evaluate the effect of seasonal changes, type of area (urban versus rural) and sex. Results A seasonal pattern was observed with statistically significant cycles every 12 months, where peaks were identified in May but only for men in urban zones as of the year 2007. In addition, specific days of the year were found to have a higher frequency of suicides, which coincided with holidays (New Year, Mother's Day, Mexican Independence Day and Christmas). Conclusion A wavelet analysis can be used to decompose complex time series. To the best of our knowledge, this is the first application of this technique to the study of suicides in developing countries. This analysis enabled identifying a seasonal pattern among urban men in Mexico. The identification of seasonal patterns can help to create primary prevention strategies, increase the dissemination of crisis intervention strategies and promote mental health. These strategies could be emphasized during specific periods of the year and directed towards profiles with a higher risk.	[Alfredo Fernandez-Nino, Julian; Morales-Carmona, Evangelina; Sofia Palacio-Mejia, Lina] Natl Inst Publ Hlth Mexico, Informat Ctr Decis Publ Hlth CENIDSP, Cuernavaca, Morelos, Mexico; [Iveth Astudillo-Garcia, Claudia] Mexico Sch Publ Hlth, Cuernavaca, Morelos, Mexico; [Bojorquez-Chapela, Ietza] Colegio Frontera Norte, Dept Populat Studies, Tijuana, Mexico; [Alejandra Montoya-Rodriguez, Airain] Natl Inst Publ Hlth Mexico, Dept Reprod Hlth, Populat Hlth Res Ctr, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica; Colegio Frontera Norte; Instituto Nacional de Salud Publica	Astudillo-Garcia, CI (corresponding author), Mexico Sch Publ Hlth, Cuernavaca, Morelos, Mexico.	claudia.astudillo@espm.insp.mx	Palacio Mejía, Lina Sofia/C-8725-2014; Astudillo-García, Claudia Iveth/J-2243-2019; Fernández-Niño, Julián Alfredo/AHE-6038-2022	Palacio Mejía, Lina Sofia/0000-0003-3203-9420; Astudillo-García, Claudia Iveth/0000-0002-0895-5747; Fernández-Niño, Julián Alfredo/0000-0002-8948-8481; Morales-Carmona, Evangelina/0000-0002-5186-4605				Adak S, 1998, J AM STAT ASSOC, V93, P1488, DOI 10.2307/2670062; Ahn MH, 2012, J AFFECT DISORDERS, V142, P161, DOI 10.1016/j.jad.2012.05.008; Ajdacic-Gross V, 2003, SOC SCI MED, V57, P1173, DOI 10.1016/S0277-9536(02)00493-8; Ajdacic-Gross V, 2008, B WORLD HEALTH ORGAN, V86, P726, DOI 10.2471/BLT.07.043489; Ajdacic-Gross V, 2007, AM J EPIDEMIOL, V165, P561, DOI 10.1093/aje/kwk034; Ajdacic-Gross V, 2010, SOC SCI MED, V71, P657, DOI 10.1016/j.socscimed.2010.05.030; [Anonymous], 2012, PUBLIC HLTH ACTION P; [Anonymous], 2003, SINT MET EST VIT; [Anonymous], 2015, PROBL RUR URB; [Anonymous], 2015, EST OC EMPL; [Anonymous], 2011, STAT REL 12 STAT SOF; [Anonymous], 2012, PROYECC PROBL MUN ME; Bando DH, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-127; Bando DH, 2012, REV BRAS PSIQUIATR, V34, P286, DOI 10.1016/j.rbp.2012.02.001; Barker E, 2014, AUSTRALAS PSYCHIATRY, V22, P122, DOI 10.1177/1039856213519293; Barzilay S, 2014, ARCH SUICIDE RES, V18, P295, DOI 10.1080/13811118.2013.824825; Beauchamp GA, 2014, J EMERG MED, V46, P776, DOI 10.1016/j.jemermed.2013.09.023; Benedito-Silva AA, 2007, CHRONOBIOL INT, V24, P727, DOI 10.1080/07420520701535795; Borges G RH, 1996, SALUD PUBLICA MEXICO, V38; Branas CC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005619; Burrows S, 2013, PUBLIC HEALTH REP, V128, P443, DOI 10.1177/003335491312800604; Burrows S, 2010, INT J INJ CONTROL SA, V17, P23, DOI 10.1080/17457300903309231; Canetto SS, 1998, SUICIDE LIFE-THREAT, V28, P1; Casey P, 2012, J AFFECT DISORDERS, V136, P862, DOI 10.1016/j.jad.2011.09.020; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Cazelles B, 2006, PLOS MED, V3, P1212, DOI 10.1371/journal.pmed.0030328; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chang SS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5239; CHEW KSY, 1995, SOC SCI MED, V40, P223, DOI 10.1016/0277-9536(94)E0070-9; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Corcoran P, 2004, SUICIDE LIFE-THREAT, V34, P429, DOI 10.1521/suli.34.4.429.53735; De Leo D, 2013, CRISIS, V34, P1, DOI [10.1027/0227-5910/a000193, 10.1027/0227-5910/a000204]; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Dome P, 2010, BIOL PSYCHIAT, V68, P148, DOI 10.1016/j.biopsych.2010.03.005; Durkheim E., 1951, SUICIDE STUDY SOCIOL, DOI 10.2307/2088294; Faria Neice Müller Xavier, 2006, Cad. Saúde Pública, V22, P2611, DOI 10.1590/S0102-311X2006001200011; GABENNESCH H, 1988, SOC FORCES, V67, P129, DOI 10.2307/2579103; Gaxiola-Robles R, 2013, SALUD MENT, V36, P421, DOI 10.17711/SM.0185-3325.2013.053; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Hakko H, 2002, SUICIDE LIFE-THREAT, V32, P191, DOI 10.1521/suli.32.2.191.24403; HANNAN EJ, 1957, BIOMETRIKA, V44, P57, DOI 10.2307/2333240; Hernandez-Bringas HH, 2011, PAPELES POBLAC, V17, P69; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Gonzalez-Perez GJ, 2012, CIENC SAUDE COLETIVA, V17, P3195, DOI 10.1590/S1413-81232012001200005; KEVAN SM, 1980, SOC SCI MED-MED GEOG, V14, P369, DOI 10.1016/0160-8002(80)90005-2; Koskinen O, 2002, J AFFECT DISORDERS, V70, P197, DOI 10.1016/S0165-0327(01)00307-X; Levi F, 2003, ACTA PSYCHIAT SCAND, V108, P341, DOI 10.1034/j.1600-0447.2003.00147.x; Machado DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124934; Morselli EA., 1883, SUICIDE ESSAY COMP M; Nader IW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017413; Norstrom T, 2015, J EPIDEMIOL COMMUN H, V69, P110, DOI 10.1136/jech-2014-204602; Oravecz R, 2007, J AFFECT DISORDERS, V104, P211, DOI 10.1016/j.jad.2007.03.009; Pan American Health Organization (PAHO), 2014, SUIC MORT AM REG REP; Parker G, 2001, PSYCHOL MED, V31, P549, DOI 10.1017/S0033291701003294; Partonen T, 2004, J AFFECT DISORDERS, V81, P133, DOI 10.1016/S0165-0327(03)00137-X; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Petridou E, 2002, EPIDEMIOLOGY, V13, P106, DOI 10.1097/00001648-200201000-00017; Phillips MR, 2012, LANCET, V379, P2318, DOI 10.1016/S0140-6736(12)60913-1; Preti A, 2007, J AFFECT DISORDERS, V102, P19, DOI 10.1016/j.jad.2006.12.003; Razvodovsky Y, 2009, PUBLIC HEALTH, V123, P27, DOI 10.1016/j.puhe.2008.10.003; Retamal P, 1998, REV SAUDE PUBL, V32, P408, DOI 10.1590/S0034-89101998000500002; Reutfors J, 2009, J AFFECT DISORDERS, V119, P59, DOI 10.1016/j.jad.2009.02.020; Rocchi MBL, 2007, J AFFECT DISORDERS, V100, P129, DOI 10.1016/j.jad.2006.10.003; Roehner BM, 2015, PHYSICA A, V424, P350, DOI 10.1016/j.physa.2015.01.017; Rouyer T, 2008, MAR ECOL PROG SER, V359, P11, DOI 10.3354/meps07330; Rueda-Gandarilla T, 2010, CRONICAS SUICIDIO BA, P77; SPEECHLEY M, 1991, CAN J PUBLIC HEALTH, V82, P38; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P145; Timonen M, 2004, PSYCHIAT RES, V126, P167, DOI 10.1016/j.psychres.2004.02.005; Tsai JF, 2011, PSYCHIAT RES, V186, P147, DOI 10.1016/j.psychres.2010.07.043; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Vijayakumar L, 2005, CRISIS, V26, P104, DOI 10.1027/0227-5910.26.3.104; Vyssoki B, 2012, COMPR PSYCHIAT, V53, P535, DOI 10.1016/j.comppsych.2011.06.003; WALLIS KF, 1972, ECONOMETRICA, V40, P617, DOI 10.2307/1912957; Wilches-Gutierrez JL, 2012, SOC SCI MED, V74, P775, DOI 10.1016/j.socscimed.2011.11.018; Willeit M, 2008, NEUROPSYCHOPHARMACOL, V33, P1503, DOI 10.1038/sj.npp.1301560; World Health Organization, 2014, PREV SUIC PREV SUIC; Yip PSF, 2000, BRIT J PSYCHIAT, V177, P366, DOI 10.1192/bjp.177.4.366	78	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146495	10.1371/journal.pone.0146495	http://dx.doi.org/10.1371/journal.pone.0146495			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26752641	gold, Green Published			2022-12-27	WOS:000367888100087
J	Garavelli, L; Colas, F; Verley, P; Kaplan, DM; Yannicelli, B; Lett, C				Garavelli, Lysel; Colas, Franois; Verley, Philippe; Kaplan, David Michael; Yannicelli, Beatriz; Lett, Christophe			Influence of Biological Factors on Connectivity Patterns for Concholepas concholepas (loco) in Chile	PLOS ONE			English	Article							MARINE PROTECTED AREAS; LARVAL DISPERSAL; BENTHIC INVERTEBRATES; TRANSPORT; MORTALITY; BEHAVIOR; MODEL; TEMPERATURE; RECRUITMENT; SETTLEMENT	In marine benthic ecosystems, larval connectivity is a major process influencing the maintenance and distribution of invertebrate populations. Larval connectivity is a complex process to study as it is determined by several interacting factors. Here we use an individual-based, biophysical model, to disentangle the effects of such factors, namely larval vertical migration, larval growth, larval mortality, adults fecundity, and habitat availability, for the marine gastropod Concholepas concholepas (loco) in Chile. Lower transport success and higher dispersal distances are observed including larval vertical migration in the model. We find an overall decrease in larval transport success to settlement areas from northern to southern Chile. This spatial gradient results from the combination of current direction and intensity, seawater temperature, and available habitat. From our simulated connectivity patterns we then identify subpopulations of loco along the Chilean coast, which could serve as a basis for spatial management of this resource in the future.	[Garavelli, Lysel; Lett, Christophe] Ctr Rech Halieut Mediterraneenne & Trop, UMI UPMC UMMISCO 209, IRD, Sete, France; [Colas, Franois] UPMC, LOCEAN IPSL, IRD, Paris, France; [Verley, Philippe] Ctr Rech Halieut Mediterraneenne & Trop, UMR MARBEC, IRD, Sete, France; [Kaplan, David Michael] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Yannicelli, Beatriz] Univ Catolica Norte, Fac Ciencias Mar, CEAZA, Coquimbo, Chile; [Yannicelli, Beatriz] Univ Republica, Ctr Univ Reg Este, Montevideo, Uruguay	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; William & Mary; Virginia Institute of Marine Science; Universidad Catolica del Norte; Universidad de la Republica, Uruguay	Garavelli, L (corresponding author), Florida Atlantic Univ, Harbor Branch Oceanog Inst, Ft Pierce, FL 34946 USA.	lgaravelli@fau.edu	Kaplan, David/G-5230-2010; Garavelli, Lysel/HCJ-0702-2022; Lett, Christophe/A-2144-2010; Colas, Francois/B-4920-2012	Kaplan, David/0000-0001-6087-359X; Garavelli, Lysel/0000-0003-2919-6855; Lett, Christophe/0000-0001-5809-2452; Colas, Francois/0000-0002-5859-6586	"Programme Doctoral International Modelisation des Systemes Complexes" (PDIMSC); MOLOCO project through the grant from ECOS-Sud/CONICYT [C11B02]; Conseil General de l'Herault; IVth region of Chile	"Programme Doctoral International Modelisation des Systemes Complexes" (PDIMSC); MOLOCO project through the grant from ECOS-Sud/CONICYT; Conseil General de l'Herault(Region Occitanie); IVth region of Chile	This study was supported by the "Programme Doctoral International Modelisation des Systemes Complexes" (PDIMSC; http://www.ummisco.ird.fr/pdi/), the MOLOCO project through the grant noC11B02 from ECOS-Sud/CONICYT (http://www.univ-paris13.fr/cofecub-ecos/) and the cooperation program between "Conseil General de l'Herault" and IVth region of Chile operated by Agropolis International.	Aiken CM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001731; Aiken CM, 2007, MAR ECOL PROG SER, V339, P13, DOI 10.3354/meps339013; Bakun A., 1996, OCEAN PROCESSES MARI; Ban NC, 2011, J EXP MAR BIOL ECOL, V408, P21, DOI 10.1016/j.jembe.2011.07.023; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Brochier T, 2009, PROG OCEANOGR, V83, P261, DOI 10.1016/j.pocean.2009.07.044; Brochier T, 2008, PROG OCEANOGR, V79, P313, DOI 10.1016/j.pocean.2008.10.004; Butler MJ, 2011, MAR ECOL PROG SER, V422, P223, DOI 10.3354/meps08878; Capet XJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020123; Carr SD, 2008, FISH OCEANOGR, V17, P1, DOI 10.1111/j.1365-2419.2007.00447.x; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Castro LR, 2000, MAR ECOL PROG SER, V197, P247, DOI 10.3354/meps197247; Colas F, 2012, CLIM DYN; Colas F, 2013, J PHYS OCEANOGR, V43, P1073, DOI 10.1175/JPO-D-11-0241.1; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cushing DH, 1990, ADV MAR BIOL, V9, P295; da Silva A.M., 1994, ATLAS SURFACE MARINE, V6; DISALVO LH, 1994, J SHELLFISH RES, V13, P57; DISALVO LH, 1988, VELIGER, V30, P358; Domingues CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035794; Ellien C, 2004, J PLANKTON RES, V26, P117, DOI 10.1093/plankt/fbh018; Fernandez M, 2000, REV CHIL HIST NAT, V73, P797; Fernandez M, 2007, MAR ECOL PROG SER, V348, P229, DOI 10.3354/meps07032; Gallardo Fernandez G. L., 2008, SEASCAPES EXTINCTION; Garavelli L, 2014, PROG OCEANOGR, V124, P42, DOI 10.1016/j.pocean.2014.03.011; Gaymer CF, 2010, MAR FRESHWATER RES, V61, P1185, DOI 10.1071/MF09268; Gonzalez J, 2005, 200216 FIP; Green A, 2009, ORYX, V43, P488, DOI 10.1017/S0030605309990342; Guizien K, 2006, MAR ECOL PROG SER, V311, P47, DOI 10.3354/meps311047; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Incze LS, 2000, FISH OCEANOGR, V9, P99, DOI 10.1046/j.1365-2419.2000.00125.x; Jacobi MN, 2012, ECOGRAPHY, V35, P1004, DOI 10.1111/j.1600-0587.2012.07281.x; Kaplan DM, 2003, ESTUAR COAST SHELF S, V57, P385, DOI 10.1016/S0272-7714(02)00363-3; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE, V3rd, P491, DOI [10.1017/CBO9780511805400, DOI 10.1017/CBO9780511805400]; Leiva GE, 2002, REV FISH BIOL FISHER, V11, P283; Letelier J, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005171; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Manriquez PH, 2011, MAR ECOL PROG SER, V430, P207, DOI 10.3354/meps09153; Manriquez PH, 2004, J MAR BIOL ASSOC UK, V84, P651, DOI 10.1017/S0025315404009695h; Marchesiello P, 2003, J PHYS OCEANOGR, V33, P753, DOI 10.1175/1520-0485(2003)33<753:ESADOT>2.0.CO;2; Mason E, 2010, OCEAN MODEL, V35, P1, DOI 10.1016/j.ocemod.2010.05.007; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Molinet C, 2005, REV CHIL HIST NAT, V78, P409; Molinet C, 2008, MAR BIOL, V153, P779, DOI 10.1007/s00227-007-0847-1; Morales CE, 2007, PROG OCEANOGR, V75, P452, DOI 10.1016/j.pocean.2007.08.026; Morales CE, 2010, PROG OCEANOGR, V84, P158, DOI 10.1016/j.pocean.2009.12.001; MORENO CA, 1993, REV CHIL HIST NAT, V66, P93; Navarrete SA, 2005, NATL ACAD SCI US, V102; Nickols KJ, 2015, AM NAT, V185, P196, DOI 10.1086/679503; Nolasco R, 2013, MAR ECOL PROG SER, V485, P123, DOI 10.3354/meps10324; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Parada C, 2008, AFR J MAR SCI, V30, P437, DOI 10.2989/AJMS.2008.30.3.1.635; PECHENIK JA, 1984, BIOL BULL, V166, P537, DOI 10.2307/1541160; Pedersen TM, 2008, J MARINE SYST, V73, P185, DOI 10.1016/j.jmarsys.2007.10.008; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Penven P, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002945; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Risien CM, 2008, J PHYS OCEANOGR, V38, P2379, DOI 10.1175/2008JPO3881.1; Robins PE, 2013, LIMNOL OCEANOGR, V58, P505, DOI 10.4319/lo.2013.58.2.0505; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; Rutllant JA, 2004, CONT SHELF RES, V24, P789, DOI 10.1016/j.csr.2004.02.004; Sakurai Y, 2000, ICES J MAR SCI, V57, P24, DOI 10.1006/jmsc.2000.0667; Shaffer G, 1999, J GEOPHYS RES-OCEANS, V104, P29951, DOI 10.1029/1999JC900253; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Shchepetkin AF, 2009, J COMPUT PHYS, V228, P8985, DOI 10.1016/j.jcp.2009.09.002; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Strub P.T., 1998, SEA, P273; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Veitch J, 2010, J PHYS OCEANOGR, V40, P1942, DOI 10.1175/2010JPO4382.1; White C, 2011, ECOL APPL, V21, P350, DOI 10.1890/09-1188.1; Yannicelli B, 2012, PROG OCEANOGR, V92-95, P206, DOI 10.1016/j.pocean.2011.07.005	73	8	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146418	10.1371/journal.pone.0146418	http://dx.doi.org/10.1371/journal.pone.0146418			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751574	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100078
J	Givon, LE; Lazar, AA				Givon, Lev E.; Lazar, Aurel A.			Neurokernel: An Open Source Platform for Emulating the Fruit Fly Brain	PLOS ONE			English	Article							NEURAL CIRCUITS; DROSOPHILA; VISUALIZATION; SYSTEM; NEUROSCIENCE; PRINCIPLES; NETWORKS; INPUTS; TOOL	We have developed an open software platform called Neurokernel for collaborative development of comprehensive models of the brain of the fruit fly Drosophila melanogaster and their execution and testing on multiple Graphics Processing Units (GPUs). Neurokernel provides a programming model that capitalizes upon the structural organization of the fly brain into a fixed number of functional modules to distinguish between these modules' local information processing capabilities and the connectivity patterns that link them. By defining mandatory communication interfaces that specify how data is transmitted between models of each of these modules regardless of their internal design, Neurokernel explicitly enables multiple researchers to collaboratively model the fruit fly's entire brain by integration of their independently developed models of its constituent processing units. We demonstrate the power of Neurokernel's model integration by combining independently developed models of the retina and lamina neuropils in the fly's visual system and by demonstrating their neuroinformation processing capability. We also illustrate Neurokernel's ability to take advantage of direct GPU-to-GPU data transfers with benchmarks that demonstrate scaling of Neurokernel's communication performance both over the number of interface ports exposed by an emulation's constituent modules and the total number of modules comprised by an emulation.	[Givon, Lev E.; Lazar, Aurel A.] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	Columbia University	Lazar, AA (corresponding author), Columbia Univ, Dept Elect Engn, New York, NY 10027 USA.	aurel@ee.columbia.edu	Givon, Lev E./AAG-8726-2020	Givon, Lev E./0000-0002-2736-730X; Lazar, Aurel A./0000-0003-4261-8709	Air Force Office of Scientific Research (AFOSR), AFOSR [FA9550-12-10232]; National Science Foundation (NSF), NSF [1544383]; Professional Scholarship of the Engineering Graduate Student Council at Columbia University; BBSRC [BB/M025527/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M025527/1] Funding Source: researchfish; Direct For Biological Sciences [1544383] Funding Source: National Science Foundation	Air Force Office of Scientific Research (AFOSR), AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation (NSF), NSF(National Science Foundation (NSF)); Professional Scholarship of the Engineering Graduate Student Council at Columbia University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Air Force Office of Scientific Research (AFOSR) (http://www.wpafb.af.mil/afrl/afosr/), AFOSR grant #FA9550-12-10232 (author: AAL); National Science Foundation (NSF) (http://www.nsf.gov), NSF grant #1544383 (author: AAL); and Professional Scholarship of the Engineering Graduate Student Council at Columbia University (http://engineering.columbia.edu) (author: LEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JD, 2009, PHILOS T R SOC A, V367, P2387, DOI 10.1098/rsta.2008.0308; Bernardet U, 2010, NEUROINFORMATICS, V8, P113, DOI 10.1007/s12021-010-9069-7; Bradner S, 1996, 2026 RFC; Brette R, 2012, NETWORK-COMP NEURAL, V23, P167, DOI 10.3109/0954898X.2012.730170; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Carnevale NT, 2006, NEURON BOOK; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Davison Andrew P, 2008, Front Neuroinform, V2, P11, DOI 10.3389/neuro.11.011.2008; Djurfeldt M, 2012, NEUROINFORMATICS, V10, P287, DOI 10.1007/s12021-012-9146-1; Djurfeldt M, 2010, NEUROINFORMATICS, V8, P43, DOI 10.1007/s12021-010-9064-z; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Fidjeland A.K., 2010, 2010 INT JOINT C NEU, P1, DOI DOI 10.1109/IJCNN.2010.5596678; Frye MA, 2004, CURR OPIN NEUROBIOL, V14, P729, DOI 10.1016/j.conb.2004.10.004; Gabriel E, 2004, LECT NOTES COMPUT SC, V3241, P97; Givon LE, 2014, FRONTIERS NEUROINFOR; Gleeson P, 2012, BMC NEUROSCIENCE S1, V13, pO7; Gleeson P, 2007, NEURON, V54, P219, DOI 10.1016/j.neuron.2007.03.025; Gleeson P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000815; Goodman DFM, 2009, FRONTIERS NEUROSCIEN; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Huston SJ, 2011, CURR OPIN NEUROBIOL, V21, P527, DOI 10.1016/j.conb.2011.05.030; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Karypis G, 1998, SIAM J SCI COMPUT, V20, P359, DOI 10.1137/S1064827595287997; Kim AJ, 2015, ELIFE, V4, DOI 10.7554/eLife.06651; Kim AJ, 2011, J COMPUT NEUROSCI, V30, P143, DOI 10.1007/s10827-010-0265-0; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Klockner A, 2012, PARALLEL COMPUT, V38, P157, DOI 10.1016/j.parco.2011.09.001; Lazar AA, 1997, IEEE NETWORK, V11, P8, DOI 10.1109/65.620517; Lazar AA, 2014, 2 NK RFC; Lazar AA, 2015, 3 NK RFC; Lazar AA, 2015, J COMPUT NEUROSCI, V38, P1, DOI 10.1007/s10827-014-0522-8; Lazar AA, 2015, NEURAL NETWORKS, V63, P254, DOI 10.1016/j.neunet.2014.10.014; Lazar AA, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00117; Lazar AA, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00095; Lazar AA, 2014, NEURAL COMPUT, V26, P264, DOI 10.1162/NECO_a_00543; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Minkovich K, 2014, IEEE T NEUR NET LEAR, V25, P316, DOI 10.1109/TNNLS.2013.2276056; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Mu LY, 2012, J NEUROSCI, V32, P6061, DOI 10.1523/JNEUROSCI.0221-12.2012; Mutch J., 2010, MITCSAILTR2010013; Nageswaran JM, 2009, NEURAL NETWORKS, V22, P791, DOI 10.1016/j.neunet.2009.06.028; Nere A, 2012, J PARALLEL IN PRESS; Nowotny T., 2011, BMC NEUROSCI, V12, pP239, DOI [10.1186/1471-2202-12-S1-P239, DOI 10.1186/1471-2202-12-S1-P239]; NVIDIA, 2012, KEPL GK 110 WHIT; NVIDIA, 2011, CUDA TOOLK 4 0 READ; Palyanov A, 2015, SIBERNETIC FLUID MEC; Pecevski Dejan, 2009, Front Neuroinform, V3, P11; Peng HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5342; Peng HC, 2014, NAT PROTOC, V9, P193, DOI 10.1038/nprot.2014.011; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Preissl R., 2012, P INT C HIGH PERF CO, P54; Rast AD, 2010, PROCEEDINGS OF THE 2010 COMPUTING FRONTIERS CONFERENCE (CF 2010), P21, DOI 10.1145/1787275.1787279; Richert M, 2011, FRONT NEUROINFORM, V5, P19, DOI [10.3389/fninf.2011.00019, DOI 10.3389/FNINF.2011.00019]; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Shih CT, 2015, CURRENT BIOL; Shreejoy T, 2013, FRONT NEUROINFORM, V7, DOI [10.3389/conf.fninf.2013.09.00070, DOI 10.3389/CONF.FNINF.2013.09.00070]; Silver R, 2007, J NEUROSCI, V27, P11807, DOI 10.1523/JNEUROSCI.3575-07.2007; Stewart Terrence C, 2009, Front Neuroinform, V3, P7, DOI 10.3389/neuro.11.007.2009; Szigeti B, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00137; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Thibeault C, 2011, P 3 INT C BIOINF COM; Wardill TJ, 2012, SCIENCE, V336, P925, DOI 10.1126/science.1215317; Warsaw B, 2000, PYTHON ENHANCEMENT P; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilson RI, 2011, CURR OPIN NEUROBIOL, V21, P254, DOI 10.1016/j.conb.2011.03.002	72	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146581	10.1371/journal.pone.0146581	http://dx.doi.org/10.1371/journal.pone.0146581			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751378	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100105
J	Shairp, R; Verssimo, D; Fraser, I; Challender, D; MacMillan, D				Shairp, Rachel; Verssimo, Diogo; Fraser, Iain; Challender, Daniel; MacMillan, Douglas			Understanding Urban Demand for Wild Meat in Vietnam: Implications for Conservation Actions	PLOS ONE			English	Article							TRADE; CONSUMPTION; CHOICE; FACE	Vietnam is a significant consumer of wildlife, particularly wild meat, in urban restaurant settings. To meet this demand, poaching of wildlife is widespread, threatening regional and international biodiversity. Previous interventions to tackle illegal and potentially unsustainable consumption of wild meat in Vietnam have generally focused on limiting supply. While critical, they have been impeded by a lack of resources, the presence of increasingly organised criminal networks and corruption. Attention is, therefore, turning to the consumer, but a paucity of research investigating consumer demand for wild meat will impede the creation of effective consumer-centred interventions. Here we used a mixed-methods research approach comprising a hypothetical choice modelling survey and qualitative interviews to explore the drivers of wild meat consumption and consumer preferences among residents of Ho Chi Minh City, Vietnam. Our findings indicate that demand for wild meat is heterogeneous and highly context specific. Wild-sourced, rare, and expensive wild meat-types are eaten by those situated towards the top of the societal hierarchy to convey wealth and status and are commonly consumed in lucrative business contexts. Cheaper, legal and farmed substitutes for wild-sourced meats are also consumed, but typically in more casual consumption or social drinking settings. We explore the implications of our results for current conservation interventions in Vietnam that attempt to tackle illegal and potentially unsustainable trade in and consumption of wild meat and detail how our research informs future consumer-centric conservation actions.	[Shairp, Rachel; Verssimo, Diogo; Challender, Daniel; MacMillan, Douglas] Univ Kent, Sch Anthropol & Conservat, DICE, Canterbury CT2 7NR, Kent, England; [Fraser, Iain] Univ Kent, Sch Econ, Canterbury CT2 7NP, Kent, England	University of Kent; University of Kent	Shairp, R (corresponding author), Univ Kent, Sch Anthropol & Conservat, DICE, Marlowe Bldg, Canterbury CT2 7NR, Kent, England.	rachelshairp@gmail.com		Challender, Dan/0000-0002-0606-1715; Verissimo, Diogo/0000-0002-3519-6782	Durrell Institute of Conservation and Ecology (DICE), School of Anthropology and Conservation, University of Kent	Durrell Institute of Conservation and Ecology (DICE), School of Anthropology and Conservation, University of Kent	RS received funding from the Durrell Institute of Conservation and Ecology (DICE), School of Anthropology and Conservation, University of Kent: http://www.kent.ac.uk/dice/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, S A P I E N S; Bank World, 2012, MARK EC MIDDL INC VI; Broad S, 2003, TRADE IN WILDLIFE: REGULATION FOR CONSERVATION, P3; Brooks EGE, 2010, BIOL CONSERV, V143, P2808, DOI 10.1016/j.biocon.2010.07.030; CHALLENDER D. W. S., 2012, TRAFFIC B, V24, P53; Challender DWS, 2014, CONSERV LETT, V7, P484, DOI 10.1111/conl.12082; Conrad K, 2012, TROP CONSERV SCI, V5, P245, DOI 10.1177/194008291200500302; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Damania R, 2007, ECOL ECON, V62, P461, DOI 10.1016/j.ecolecon.2006.07.007; Drury Rebecca, 2011, Conservation & Society, V9, P247, DOI 10.4103/0972-4923.86995; Drury R, 2009, CONSERV LETT, V2, P263, DOI 10.1111/j.1755-263X.2009.00078.x; Goffman E., 1967, INTERACTION RITUAL E; Gratwicke B, 2008, CONSERV BIOL, V22, P222, DOI 10.1111/j.1523-1739.2007.00802.x; Hanley N, 1998, J AGR ECON, V49, P1, DOI 10.1111/j.1477-9552.1998.tb01248.x; Homewood K., 2010, ANIMAL CONSERVATION, V14, P18; Jaeger SR, 2008, FOOD QUAL PREFER, V19, P539, DOI 10.1016/j.foodqual.2008.02.005; Li JJ, 2007, INT J MARKET RES, V49, P237; Lyons JA, 2011, BIOL CONSERV, V144, P3073, DOI 10.1016/j.biocon.2011.10.002; MacMillan DC, ORYX IN PRESS, DOI [10.1017/S0030605312001445, DOI 10.1017/S0030605312001445]; MacMillan DC, 2011, HUM ECOL, V39, P757, DOI 10.1007/s10745-011-9429-4; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Newing H, 2011, CONDUCTING RESEARCH IN CONSERVATION: SOCIAL SCIENCE METHODS AND PRACTICE, P1; Nguyen Van Song, 2008, Journal of Environment & Development, V17, P145, DOI 10.1177/1070496508316220; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Pratt DG, 2004, BIODIVERS CONSERV, V13, P591, DOI 10.1023/B:BIOC.0000009492.56373.cc; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Thanh H, 2011, CONSUMPTION WILD ANI; TRAFFIC, OUR WORK; TRAFFIC, 2014, INN CAMP PROM SUCC P; TRAFFIC, 2008, E AS PAC REG SUST DE; Venkataraman B., 2007, MATTER ATTITUDE CONS; Verissimo D., 2012, ASIAN J CONSERV BIOL, V1, P49; Verissimo D, 2013, CONSERVATION EVIDENC, V10, P1; WCS, 2008, COMM WILDL FARMS VIE; Wong NY, 1998, PSYCHOL MARKET, V15, P423, DOI 10.1002/(SICI)1520-6793(199808)15:5<423::AID-MAR2>3.0.CO;2-9	37	72	72	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0134787	10.1371/journal.pone.0134787	http://dx.doi.org/10.1371/journal.pone.0134787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26752642	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100003
J	Shaukat, I; Barre, L; Venkatesan, N; Li, D; Jaquinet, JC; Fournel-Gigleux, S; Ouzzine, M				Shaukat, Irfan; Barre, Lydia; Venkatesan, Narayanan; Li, Dong; Jaquinet, Jean-Claude; Fournel-Gigleux, Sylvie; Ouzzine, Mohamed			Targeting of Proteoglycan Synthesis Pathway: A New Strategy to Counteract Excessive Matrix Proteoglycan Deposition and Transforming Growth Factor-beta 1-Induced Fibrotic Phenotype in Lung Fibroblasts	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; MUSCLE ACTIN EXPRESSION; TGF-BETA; IN-VITRO; BLEOMYCIN; GENE; BINDING; FACTOR-BETA(1); ACTIVATION; SMAD3	Stimulation of proteoglycan (PG) synthesis and deposition plays an important role in the pathophysiology of fibrosis and is an early and dominant feature of pulmonary fibrosis. Transforming growth factor-beta 1 (TGF-beta 1) is a major cytokine associated with fibrosis that induces excessive synthesis of matrix proteins, particularly PGs. Owing to the importance of PGs in matrix assembly and in mediating cytokine and growth factor signaling, a strategy based on the inhibition of PG synthesis may prevent excessive matrix PG deposition and attenuates profibrotic effects of TGF-beta 1 in lung fibroblasts. Here, we showed that 4-MU4-deoxy-beta-D-xylopyranoside, a competitive inhibitor of beta 4-galactosyltransferase7, inhibited PG synthesis and secretion in a dose-dependent manner by decreasing the level of both chondroitin/dermatan- and heparin-sulfate PG in primary lung fibroblasts. Importantly, 4-MU4-deoxy-xyloside was able to counteract TGF-beta 1-induced synthesis of PGs, activation of fibroblast proliferation and fibroblast-myofibroblast differentiation. Mechanistically, 4-MU4-deoxy-xyloside treatment inhibited TGF-beta 1-induced activation of canonical Smads2/3 signaling pathway in lung primary fibroblasts. The knockdown of beta 4-galactosyltransferase7 mimicked 4-MU4-deoxy-xyloside effects, indicating selective inhibition of beta 4-galactosyltransferase7 by this compound. Collectively, this study reveals the anti-fibrotic activity of 4-MU4-deoxy-xyloside and indicates that inhibition of PG synthesis represents a novel strategy for the treatment of lung fibrosis.	[Shaukat, Irfan; Barre, Lydia; Venkatesan, Narayanan; Li, Dong; Fournel-Gigleux, Sylvie; Ouzzine, Mohamed] Univ Lorraine, CNRS, UMR 7365, Biopole Fac Med, F-54505 Vandoeuvre Les Nancy, France; [Jaquinet, Jean-Claude] Univ Orleans, Pole Chim, CNRS, Inst Chim Organ & Analyt,UMR 7311, F-45067 Orleans 02, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Ouzzine, M (corresponding author), Univ Lorraine, CNRS, UMR 7365, Biopole Fac Med, CS 50184, F-54505 Vandoeuvre Les Nancy, France.	Mohamed.ouzzine@univ-lorraine.fr	Ouzzine, Mohamed/G-4368-2013	OUZZINE, Mohamed/0000-0003-0058-4950	Region Lorraine	Region Lorraine(Region Grand-Est)	Funding provided by Region Lorraine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensadoun ES, 1996, AM J RESP CRIT CARE, V154, P1819, DOI 10.1164/ajrccm.154.6.8970376; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Clarke DL, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-20; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DEVRIES BJ, 1986, RHEUMATOL INT, V6, P273, DOI 10.1007/BF00541319; Ebihara T, 2000, AM J RESP CRIT CARE, V162, P1569, DOI 10.1164/ajrccm.162.4.9912011; Eneyskaya EV, 2005, ORG BIOMOL CHEM, V3, P146, DOI 10.1039/b409583a; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; George TJ, 2011, ARCH SURG-CHICAGO, V146, P1204, DOI 10.1001/archsurg.2011.239; Gill S, 2010, ANAT REC, V293, P968, DOI 10.1002/ar.21094; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Huang CL, 2014, NEPHROL DIAL TRANSPL, V29, P313, DOI 10.1093/ndt/gft431; Ishida W, 2006, J INVEST DERMATOL, V126, P1733, DOI 10.1038/sj.jid.5700303; Keane MP, 2005, CRIT REV IMMUNOL, V25, P429, DOI 10.1615/CritRevImmunol.v25.i6.10; Kliment CR, 2009, AM J RESP CRIT CARE, V179; Kluwe J, 2009, J MOL MED, V87, P125, DOI 10.1007/s00109-008-0426-z; Kolb M, 2001, AM J PHYSIOL-LUNG C, V280, pL1327, DOI 10.1152/ajplung.2001.280.6.L1327; Kuberan B, 2008, CHEMBIOCHEM, V9, P198, DOI 10.1002/cbic.200700494; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Leteux C, 2001, J BIOL CHEM, V276, P12539, DOI 10.1074/jbc.M010291200; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; Mason DP, 2007, ANN THORAC SURG, V84, P1121, DOI 10.1016/j.athoracsur.2007.04.096; Massague J, 2000, GENE DEV, V14, P627; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Saliba M, 2015, J BIOL CHEM, V290, P7658, DOI 10.1074/jbc.M114.628123; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Venkatesan N, 2000, AM J RESP CRIT CARE, V161, P2066, DOI 10.1164/ajrccm.161.6.9909098; Venkatesan N, 2002, AM J PHYSIOL-LUNG C, V283, pL806, DOI 10.1152/ajplung.00061.2002; Venkatesan N, 2014, AM J RESP CELL MOL, V50, P583, DOI 10.1165/rcmb.2012-0226OC; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; WESTERGRENTHORSSON G, 1993, J CLIN INVEST, V92, P632, DOI 10.1172/JCI116631; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551	39	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146499	10.1371/journal.pone.0146499	http://dx.doi.org/10.1371/journal.pone.0146499			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751072	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100089
J	Surujon, D; Ratner, DI				Surujon, Defne; Ratner, David I.			Use of a Probabilistic Motif Search to Identify Histidine Phosphotransfer Domain-Containing Proteins	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; PHOSPHORELAY; COMPONENT	The wealth of newly obtained proteomic information affords researchers the possibility of searching for proteins of a given structure or function. Here we describe a general method for the detection of a protein domain of interest in any species for which a complete proteome exists. In particular, we apply this approach to identify histidine phosphotransfer (HPt) domain-containing proteins across a range of eukaryotic species. From the sequences of known HPt domains, we created an amino acid occurrence matrix which we then used to define a conserved, probabilistic motif. Examination of various organisms either known to contain (plant and fungal species) or believed to lack (mammals) HPt domains established criteria by which new HPt candidates were identified and ranked. Search results using a probabilistic motif matrix compare favorably with data to be found in several commonly used protein structure/function databases: our method identified all known HPt proteins in the Arabidopsis thaliana proteome, confirmed the absence of such motifs in mice and humans, and suggests new candidate HPts in several organisms. Moreover, probabilistic motif searching can be applied more generally, in a manner both readily customized and computationally compact, to other protein domains; this utility is demonstrated by our identification of histones in a range of eukaryotic organisms.	[Surujon, Defne; Ratner, David I.] Amherst Coll, Program Biochem & Biophys, Amherst, MA 01002 USA; [Ratner, David I.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Amherst College; Amherst College	Ratner, DI (corresponding author), Amherst Coll, Program Biochem & Biophys, Amherst, MA 01002 USA.	diratner@amherst.edu		Surujon, Defne/0000-0001-7964-3057	Amherst College Faculty Research Award Program; H. Axel Schupf '57 Fund for Intellectual Life; Amherst College	Amherst College Faculty Research Award Program; H. Axel Schupf '57 Fund for Intellectual Life; Amherst College	This research was supported (in part) by a grant to DIR from the Amherst College Faculty Research Award Program, as funded by The H. Axel Schupf '57 Fund for Intellectual Life. DS received support from Amherst College to complete this work in partial fulfillment of the requirements for the degree Bachelor of Arts with Honors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2013, NUCLEIC ACIDS RES, V41, pD676, DOI 10.1093/nar/gks1064; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Besant PG, 2005, BBA-PROTEINS PROTEOM, V1754, P281, DOI 10.1016/j.bbapap.2005.07.026; Chang WT, 1998, EMBO J, V17, P2809, DOI 10.1093/emboj/17.10.2809; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fassler JS, 2013, EUKARYOT CELL, V12, P1052, DOI 10.1128/EC.00083-13; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Hall BP, 2012, PLANT PHYSIOL, V159, P682, DOI 10.1104/pp.112.196790; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; Jung KW, 2008, MOL CELLS, V25, P294; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Miyata S, 1998, FEBS LETT, V437, P11, DOI 10.1016/S0014-5793(98)01188-0; Mizuno T, 1998, J BIOCHEM, V123, P555; Moreira S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056370; Mourey L, 2001, J BIOL CHEM, V276, P31074, DOI 10.1074/jbc.M101943200; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Schaller GE, 2011, CURR BIOL, V21, pR320, DOI 10.1016/j.cub.2011.02.045; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Song HK, 1999, J MOL BIOL, V293, P753, DOI 10.1006/jmbi.1999.3215; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sugawara H, 2005, PROTEIN SCI, V14, P202, DOI 10.1110/ps.041076905; Suzuki T, 1998, PLANT CELL PHYSIOL, V39, P1258, DOI 10.1093/oxfordjournals.pcp.a029329; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Tekinay T, 2003, EUKARYOT CELL, V2, P618, DOI 10.1128/EC.2.3.618-626.2003; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Thomason P, 2000, J CELL SCI, V113, P3141; Thompson W, 2003, NUCLEIC ACIDS RES, V31, P3580, DOI 10.1093/nar/gkg608; Tsuzuki M, 1995, MOL MICROBIOL, V18, P953, DOI 10.1111/j.1365-2958.1995.18050953.x	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146577	10.1371/journal.pone.0146577	http://dx.doi.org/10.1371/journal.pone.0146577			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751210	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100104
J	Tsai, JS; Chao, CH; Lin, LY				Tsai, Jia-Shiuan; Chao, Cheng-Han; Lin, Lih-Yuan			Cadmium Activates Multiple Signaling Pathways That Coordinately Stimulate Akt Activity to Enhance c-Myc mRNA Stability	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; INDUCED APOPTOSIS; MALIGNANT-TRANSFORMATION; GENE-REGULATION; COMPLEX 2; CELLS; PHOSPHORYLATION; EXPRESSION; SURVIVAL; KINASE	Cadmium is a known environmental carcinogen. Exposure of Cd leads to the activation of several proto-oncogenes in cells. We investigated here the mechanism of c-Myc expression in hepatic cells under Cd treatment. The c-Myc protein and mRNA levels increased in dose- and time-dependent manners in HepG2 cells with Cd treatment. This increase was due to an increase in c-Myc mRNA stability. To explore the mechanism involved in enhancing the mRNA stability, several cellular signaling factors that evoked by Cd treatment were analyzed. PI3K, p38, ERK and JNK were activated by Cd. However, ERK did not participate in the Cd-induced c-Myc expression. Further analysis revealed that mTORC2 was a downstream factor of p38. PI3K, JNK and mTORC2 coordinately activated Akt. Akt was phosphorylated at Thr450 in the untreated cells. Cd treatment led to additional phosphorylation at Thr308 and Ser473. Blocking any of the three signaling factors resulted in the reduction of phosphorylation level at all three Akt sites. The activated Akt phosphorylated Foxo1 and allowed the modified protein to translocate into the cytoplasm. We conclude that Cd-induced accumulation of c-Myc requires the activation of several signaling pathways. The signals act coordinately for Akt activation and drive the Foxo1 from the nucleus to the cytoplasm. Reduction of Foxo1 in the nucleus reduces the transcription of its target genes that may affect c-Myc mRNA stability, resulting in a higher accumulation of the c-Myc proteins.	[Tsai, Jia-Shiuan; Lin, Lih-Yuan] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Tsai, Jia-Shiuan; Lin, Lih-Yuan] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Chao, Cheng-Han] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Taiwan University; National Taiwan University Hospital	Lin, LY (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	lylin@life.nthu.edu.tw		CHAO, CHENG-HAN/0000-0003-1215-8588; Lin, Lih-Yuan/0000-0001-9827-3434	Ministry of Science and Technology [NSC100-2313-B-007-002]; National Tsing Hua University [NTHU-HCH 102-04]; Hsinchu Hospital	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Tsing Hua University; Hsinchu Hospital	This work was supported by grants NSC100-2313-B-007-002 from the Ministry of Science and Technology (https://www.most.gov.tw/) and NTHU-HCH 102-04 from National Tsing Hua University (http://www.nthu.edu.tw/) and Hsinchu Hospital (https://www.hch.gov.tw/). L-Y. Lin received all of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; Bowen C, 2002, J BIOL CHEM, V277, P44969, DOI 10.1074/jbc.M202000200; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Cai WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115602; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Eneman JD, 2000, TOXICOLOGY, V147, P215, DOI 10.1016/S0300-483X(00)00215-8; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hartwig A, 2010, BIOMETALS, V23, P951, DOI 10.1007/s10534-010-9330-4; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Komoike Y, 2012, ARCH TOXICOL, V86, P37, DOI 10.1007/s00204-011-0742-x; Kress TR, 2011, MOL CELL, V41, P445, DOI 10.1016/j.molcel.2011.01.023; Lafon I, 1998, ONCOGENE, V16, P3413, DOI 10.1038/sj.onc.1201895; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu Y, 2008, J CELL PHYSIOL, V217, P307, DOI 10.1002/jcp.21499; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; Flores KM, 2013, TOXICOL IN VITRO, V27, P1031, DOI 10.1016/j.tiv.2013.01.017; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Naimi M, 2007, ENDOCRINOLOGY, V148, P2424, DOI 10.1210/en.2006-1411; Nair AR, 2013, INT J MOL SCI, V14, P6116, DOI 10.3390/ijms14036116; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Ouwens DM, 2001, BBA-MOL CELL RES, V1540, P97, DOI 10.1016/S0167-4889(01)00126-4; Pereira L, 2013, EMBO MOL MED, V5, P1759, DOI 10.1002/emmm.201302732; Qu W, 2006, MOL CARCINOGEN, V45, P561, DOI 10.1002/mc.20185; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; TANG N, 1993, TOXICOLOGY, V81, P155, DOI 10.1016/0300-483X(93)90007-F; WHO INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V58, P119; Xiao L, 2010, CELL DEATH DIFFER, V17, P1448, DOI 10.1038/cdd.2010.16; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yamashita T, 2008, BIOCHEM BIOPH RES CO, V365, P252, DOI 10.1016/j.bbrc.2007.10.169; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	54	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0147011	10.1371/journal.pone.0147011	http://dx.doi.org/10.1371/journal.pone.0147011			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751215	Green Published, gold			2022-12-27	WOS:000367888100188
J	Wang, XMK; Agarwal, M; Parobchak, N; Rosen, A; Vetrano, AM; Srinivasan, A; Wang, BB; Rosen, T				Wang, Ximi K.; Agarwal, Monica; Parobchak, Nataliya; Rosen, Alex; Vetrano, Anna M.; Srinivasan, Aarthi; Wang, Bingbing; Rosen, Todd			Mono-(2-Ethylhexyl) Phthalate Promotes Pro-Labor Gene Expression in the Human Placenta	PLOS ONE			English	Article							OXIDATIVE STRESS; PRETERM BIRTH; HUMAN-PREGNANCY; EXPOSURE; BIOMARKERS; METABOLITES; ACTIVATION; PATHWAY; ALPHA; P100	Women exposed to phthalates during pregnancy are at increased risk for delivering preterm, but the mechanism behind this relationship is unknown. Placental corticotropinreleasing hormone (CRH) and cyclooxygenase-2 (COX-2) are key mediators of parturition and are regulated by the non-canonical NF-kB (RelB/p52) signaling pathway. In this study, we demonstrate that one of the major phthalate metabolites, mono-(2-ethylhexyl)-phthalate (MEHP), increased CRH and COX-2 mRNA and protein abundance in a dose-dependent manner in primary cultures of cytotrophoblast. This was coupled with an increase in nuclear import of RelB/p52 and its association with the CRH and COX-2 promoters. Silencing of NFkB inducing kinase, a central signaling component of the non-canonical NF-kB pathway, blocked MEHP-induced upregulation of CRH and COX-2. These results suggest a potential mechanism mediated by RelB/p52 by which phthalates could prematurely induce pro-labor gene activity and lead to preterm birth.	[Wang, Ximi K.] Rutgers Robert Wood Johnson Med Sch, Biomed Sci Grad Program, Piscataway, NJ USA; [Wang, Ximi K.; Agarwal, Monica; Parobchak, Nataliya; Rosen, Alex; Srinivasan, Aarthi; Wang, Bingbing; Rosen, Todd] Rutgers Robert Wood Johnson Med Sch, Dept Obstet Gynecol & Reprod Sci, New Brunswick, NJ 08901 USA; [Vetrano, Anna M.] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wang, BB (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Obstet Gynecol & Reprod Sci, New Brunswick, NJ 08901 USA.	wangbi@rwjms.rutgers.edu; rosentj@rwjms.rutgers.edu			Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School; Rutgers Robert Wood Johnson Medical School; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School; Rutgers Robert Wood Johnson Medical School; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	An internal grant from Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School supports this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M.A. is a recipient of 2014 Summer Research Fellowship Program of Rutgers Robert Wood Johnson Medical School.	Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Challis JRG, 2002, REPRODUCTION, V124, P1; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Ferguson KK, 2015, ENVIRON HEALTH PERSP, V123, P210, DOI 10.1289/ehp.1307996; Ferguson KK, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.007; Ferguson KK, 2014, ENVIRON INT, V70, P118, DOI 10.1016/j.envint.2014.05.016; Ferguson KK, 2014, ENVIRON SCI TECHNOL, V48, P7018, DOI 10.1021/es502076j; Ferguson KK, 2014, JAMA PEDIATR, V168, P61, DOI 10.1001/jamapediatrics.2013.3699; Huang YJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087430, 10.1371/journal.pone.0102910]; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Li LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062526; Lin Ling, 2008, Zhonghua Yufang Yixue Zazhi, V42, P177; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Loftin Ryan W, 2010, Rev Obstet Gynecol, V3, P10; Marie C, 2015, ENVIRON INT, V83, P116, DOI 10.1016/j.envint.2015.06.003; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Norwitz ER, 1999, NEW ENGL J MED, V341, P660, DOI 10.1056/NEJM199908263410906; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; ROBINSON BG, 1988, P NATL ACAD SCI USA, V85, P5244, DOI 10.1073/pnas.85.14.5244; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tetz LM, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0046-8; Tetz LM, 2013, TOXICOL APPL PHARM, V268, P47, DOI 10.1016/j.taap.2013.01.020; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vetrano AM, 2010, PEDIATR RES, V68, P134, DOI 10.1203/00006450-201011001-00260; Wang BB, 2014, J CLIN ENDOCR METAB, V99, pE320, DOI 10.1210/jc.2013-2721; Wang BB, 2013, MOL ENDOCRINOL, V27, P203, DOI 10.1210/me.2012-1309; Wang BB, 2012, MOL ENDOCRINOL, V26, P1356, DOI 10.1210/me.2012-1035; Weinberger B, 2014, J MATERN-FETAL NEO M, V27, P323, DOI 10.3109/14767058.2013.815718; Woythaler MA, 2011, PEDIATRICS, V127, pE622, DOI 10.1542/peds.2009-3598; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yu LJ, 2015, PLACENTA, V36, P581, DOI 10.1016/j.placenta.2015.02.013	34	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0147013	10.1371/journal.pone.0147013	http://dx.doi.org/10.1371/journal.pone.0147013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751383	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100189
J	Lyte, M; Chapel, A; Lyte, JM; Ai, YF; Proctor, A; Jane, JL; Phillips, GJ				Lyte, Mark; Chapel, Ashley; Lyte, Joshua M.; Ai, Yongfeng; Proctor, Alexandra; Jane, Jay-Lin; Phillips, Gregory J.			Resistant Starch Alters the Microbiota-Gut Brain Axis: Implications for Dietary Modulation of Behavior	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; INFECTION; MICE; GREENGENES; EXPRESSION; SEQUENCES; COMMUNITY; HORMONES; INFANTIS	The increasing recognition that the gut microbiota plays a central role in behavior and cognition suggests that the manipulation of microbial taxa through diet may provide a means by which behavior may be altered in a reproducible and consistent manner in order to achieve a beneficial outcome for the host. Resistant starch continues to receive attention as a dietary intervention that can benefit the host through mechanisms that include altering the intestinal microbiota. Given the interest in dietary approaches to improve health, the aim of this study was to investigate whether the use of dietary resistant starch in mice to alter the gut microbiota also results in a change in behavior. Forty-eight 6 week-old male Swiss-Webster mice were randomly assigned to 3 treatment groups (n = 16 per group) and fed either a normal corn starch diet (NCS) or diets rich in resistant starches HA7 diet (HA7) or octenyl-succinate HA7 diet (OS-HA7) for 6 week and monitored for weight, behavior and fecal microbiota composition. Animals fed an HA7 diet displayed comparable weight gain over the feeding period to that recorded for NCS-fed animals while OS-HA7 displayed a lower weight gain as compared to either NCS or HA7 animals (ANOVA p = 0.0001; NCS:HA7 p = 0.244; HA7:OS-HA7 p<0.0001; NCS:OS-HA7 p<0.0001). Analysis of fecal microbiota using 16s rRNA gene taxonomic profiling revealed that each diet corresponded with a unique gut microbiota. The distribution of taxonomic classes was dynamic over the 6 week feeding period for each of the diets. At the end of the feeding periods, the distribution of taxa included statistically significant increases in members of the phylum Proteobacteria in OSHA7NCS:OS-HA7 p = 1.000; HA7:OS-HA7 p = 0.0001) as well as entries in the open arm (ANOVA p = 0.039; NCS:HA7 p = 0.041; HA7:OS-HA7 p = 0.221; NCS:OS-HA7 p = 1.000). Open-field behavior, a measure of general locomotion and exploration, revealed statistically significant differences between groups in locomotion as a measure of transitions across quadrant boundaries. Additionally, the open-field assay revealed decreased exploration as well as decreased rearing in HA7 and OS-HA7 fed mice demonstrating a consistent pattern of increased anxiety-like behavior among these groups. Critically, behavior was not correlated with weight. These results indicate that diets based on resistant starch can be utilized to produce quantifiable changes in the gut microbiota and should be useful to "dial-in" a specific microbiome that is unique to a particular starch composition. However, undesirable effects can also be associated with resistant starch, including lack of weight gain and increased anxiety-like behaviors. These observations warrant careful consideration when developing diets rich in resistant starch in humans and animal models. fed mice, while the Verrucomicrobia increased in HA7 fed mice over that of mice fed OS-HA7. At the class level, members of the class Bacilli decreased in the OS-HA7 fed group, and Actinobacteria, which includes the genus Bifidobacteria, was enriched in the HA7 fed group compared to the control diet. Behavioral analysis revealed that animals demonstrated profound anxiety-like behavior as observed by performance on the elevated-plus maze with time spent by the mice in the open arm (ANOVA p = 0.000; NCS:HA7 p = 0.004;	[Lyte, Mark] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Immunotherapeut & Biotechnol, Abilene, TX 79606 USA; [Chapel, Ashley] Texas Tech Univ, Sch Med, Hlth Sci Ctr, El Paso, TX 79905 USA; [Lyte, Joshua M.; Ai, Yongfeng; Jane, Jay-Lin] Iowa State Univ, Coll Human Sci, Dept Food Sci & Human Nutr, Ames, IA 50011 USA; [Lyte, Mark; Proctor, Alexandra; Phillips, Gregory J.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Coll Vet Med, Ames, IA 50011 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Iowa State University; Iowa State University	Lyte, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Immunotherapeut & Biotechnol, Abilene, TX 79606 USA.	mlyte@iastate.edu	Lyte, Mark/AAI-7602-2020	Lyte, Mark/0000-0001-8512-2581; Lyte, Joshua/0000-0002-1679-6854	National Institutes of Health [R01GM099537]; Institute for Clinical and Translational Research; University of Wisconsin-Madison Clinical and Translational Science Award (CSTA) program; National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; Wisconsin Primate Research Center through NIH [P51RR000167/P51OD11106]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH104198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Clinical and Translational Research(Ohio State University); University of Wisconsin-Madison Clinical and Translational Science Award (CSTA) program; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Wisconsin Primate Research Center through NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded in part by the National Institutes of Health grant R01GM099537 (GJP). The Institute for Clinical and Translational Research and the University of Wisconsin-Madison Clinical and Translational Science Award (CSTA) program and the National Center for Advancing Translational Sciences (NCATS) grant UL1TR000427 and the Wisconsin Primate Research Center through base funding NIH P51RR000167/P51OD11106 also provided the service for the hair hormone analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai YF, 2013, CARBOHYD POLYM, V98, P1266, DOI 10.1016/j.carbpol.2013.07.057; Anderson TJ, 2014, ANAL BIOANAL CHEM, V406, P745, DOI 10.1007/s00216-013-7523-8; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Birt DF, 2014, TOXICOL PATHOL, V42, P182, DOI 10.1177/0192623313506791; Birt DF, 2013, ADV NUTR, V4, P587, DOI 10.3945/an.113.004325; Borre YE, 2014, NEUROPHARMACOLOGY, V79, P738, DOI 10.1016/j.neuropharm.2013.11.009; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Collins SM, 2013, CURR OPIN MICROBIOL, V16, P240, DOI 10.1016/j.mib.2013.06.004; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cryan JF, 2015, NEUROPSYCHOPHARMACOL, V40, P241, DOI 10.1038/npp.2014.224; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Desbonnet L, 2010, NEUROSCIENCE, V170, P1179, DOI 10.1016/j.neuroscience.2010.08.005; Desbonnet L, 2008, J PSYCHIATR RES, V43, P164, DOI 10.1016/j.jpsychires.2008.03.009; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gaykema RPA, 2004, BRAIN BEHAV IMMUN, V18, P238, DOI 10.1016/j.bbi.2003.08.002; Goehler LE, 2005, BRAIN BEHAV IMMUN, V19, P334, DOI 10.1016/j.bbi.2004.09.002; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Han A, 2011, WOUND REPAIR REGEN, V19, P532, DOI 10.1111/j.1524-475X.2011.00720.x; Irvine EJ, 2004, ALIMENT PHARM THER, V20, P54, DOI 10.1111/j.1365-2036.2004.02053.x; Kalmokoff M, 2013, J APPL MICROBIOL, V114, P1516, DOI 10.1111/jam.12157; Kapoor A, 2014, PEDIATR RES, V75, P476, DOI 10.1038/pr.2014.1; Keenan MJ, 2012, J NUTRIGENET NUTRIGE, V5, P26, DOI 10.1159/000335319; Kwak JH, 2012, ATHEROSCLEROSIS, V224, P457, DOI 10.1016/j.atherosclerosis.2012.08.003; Li W, 2009, PHYSIOL BEHAV, V96, P557, DOI 10.1016/j.physbeh.2008.12.004; Liang S, 2015, NEUROSCIENCE, V310, P561, DOI 10.1016/j.neuroscience.2015.09.033; Looft T, 2012, GUT MICROBES, V3, P463, DOI 10.4161/gmic.21288; Lyte M, 1998, PHYSIOL BEHAV, V65, P63, DOI 10.1016/S0031-9384(98)00145-0; Lyte Mark, 2013, PharmaNutrition, V1, P35, DOI 10.1016/j.phanu.2012.11.002; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nugent AP, 2005, NUTR BULL, V30, P27, DOI 10.1111/j.1467-3010.2005.00481.x; Ohland CL, 2013, PSYCHONEUROENDOCRINO, V38, P1738, DOI 10.1016/j.psyneuen.2013.02.008; PHILLIPS J, 1995, AM J CLIN NUTR, V62, P121; R Core Team, 2021, R LANGUAGE ENV STAT; Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x; TOMLIN J, 1990, BRIT J NUTR, V64, P589, DOI 10.1079/BJN19900058; Vidrine K, 2014, OBESITY, V22, P344, DOI 10.1002/oby.20501; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang T, 2015, BENEF MICROBES, V6, P707, DOI 10.3920/BM2014.0177; Young W, 2012, APPL ENVIRON MICROB, V78, P6656, DOI 10.1128/AEM.01536-12; Zhang B, 2011, CARBOHYD POLYM, V84, P1276, DOI 10.1016/j.carbpol.2011.01.020; Zhou J, 2013, MOL NUTR FOOD RES, V57, P2071, DOI 10.1002/mnfr.201300135	54	35	35	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146406	10.1371/journal.pone.0146406	http://dx.doi.org/10.1371/journal.pone.0146406			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745269	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600046
J	Machado, BAS; Silva, RPD; Barreto, GD; Costa, SS; da Silva, DF; Brandao, HN; da Rocha, JLC; Dellagostin, OA; Henriques, JAP; Umsza-Guez, MA; Padilha, FF				Souza Machado, Bruna Aparecida; Dantas Silva, Rejane Pina; Barreto, Gabriele de Abreu; Costa, Samantha Serra; da Silva, Danielle Figueredo; Brandao, Hugo Neves; Carneiro da Rocha, Jose Luiz; Dellagostin, Odir Antonio; Pegas Henriques, Joao Antonio; Umsza-Guez, Marcelo Andres; Padilha, Francine Ferreira			Chemical Composition and Biological Activity of Extracts Obtained by Supercritical Extraction and Ethanolic Extraction of Brown, Green and Red Propolis Derived from Different Geographic Regions in Brazil	PLOS ONE			English	Article							FORMONONETIN-INDUCED APOPTOSIS; VITRO ANTIMICROBIAL ACTIVITY; CINNAMIC ACID-DERIVATIVES; ACTIVATED PROTEIN-KINASE; PROSTATE-CANCER CELLS; ARTEPILLIN-C; IN-VITRO; 3,5-DIPRENYL-4-HYDROXYCINNAMIC ACID; ANTIOXIDANT ACTIVITY; PHENOLIC-COMPOUNDS	The variations in the chemical composition, and consequently, on the biological activity of the propolis, are associated with its type and geographic origin. Considering this fact, this study evaluated propolis extracts obtained by supercritical extraction (SCO2) and ethanolic extraction (EtOH), in eight samples of different types of propolis (red, green and brown), collected from different regions in Brazil. The content of phenolic compounds, flavonoids, in vitro antioxidant activity (DPPH and ABTS), Artepillin C, p-coumaric acid and antimicrobial activity against two bacteria were determined for all extracts. For the EtOH extracts, the anti-proliferative activity regarding the cell lines of B16F10, were also evaluated. Amongst the samples evaluated, the red propolis from the Brazilian Northeast (states of Sergipe and Alagoas) showed the higher biological potential, as well as the larger content of antioxidant compounds. The best results were shown for the extracts obtained through the conventional extraction method (EtOH). However, the highest concentrations of Artepillin C and pcoumaric acid were identified in the extracts from SCO2, indicating a higher selectivity for the extraction of these compounds. It was verified that the composition and biological activity of the Brazilian propolis vary significantly, depending on the type of sample and geographical area of collection.	[Souza Machado, Bruna Aparecida; Padilha, Francine Ferreira] Univ Tiradentes, Inst Res & Technol, Aracaju, Sergipe, Brazil; [Souza Machado, Bruna Aparecida; Dantas Silva, Rejane Pina; Barreto, Gabriele de Abreu; Costa, Samantha Serra] Natl Serv Ind Learning SENAI, Fac Technol, SENAI CIMATEC, Salvador, BA, Brazil; [da Silva, Danielle Figueredo; Brandao, Hugo Neves; Carneiro da Rocha, Jose Luiz] State Univ Feira de Santana, Fac Pharm, Feira De Santana, BA, Brazil; [Dellagostin, Odir Antonio] Univ Fed Pelotas, Technol Dev Ctr, Pelotas, RS, Brazil; [Pegas Henriques, Joao Antonio] Univ Caixias do Sul, Biotechnol, Caixias Do Sul, RS, Brazil; [Umsza-Guez, Marcelo Andres] Univ Fed Bahia, Biotechnol, Salvador, BA, Brazil	Universidade Tiradentes; Faculdade de Tecnologia Senai Cimatec; Universidade Estadual de Feira de Santana; Universidade Federal de Pelotas; Universidade Federal da Bahia	Machado, BAS (corresponding author), Univ Tiradentes, Inst Res & Technol, Aracaju, Sergipe, Brazil.	brunamachado17@hotmail.com	Umsza-Guez, Marcelo/AAV-8564-2020; padilha, francine/C-1349-2014; Neves Brandão, Hugo/C-4553-2018; Machado, Bruna Aparecida Souza/C-3130-2016; Machado, Bruna/AAP-6877-2021; Umsza-Guez, Marcelo Andrés/AAL-1315-2020; Dellagostin, Odir/C-2331-2009; Umsza-Guez, Marcelo Andres/I-3117-2016	padilha, francine/0000-0002-5892-4252; Neves Brandão, Hugo/0000-0001-5198-5039; Machado, Bruna Aparecida Souza/0000-0003-1655-0325; Dellagostin, Odir/0000-0003-2803-4088; Umsza-Guez, Marcelo Andres/0000-0003-3145-6935; Barreto, Gabriele/0000-0002-0180-281X	Servico Nacional de Aprendizagem Industrial - Departamento Nacional (SENAI DN) [BA-15011]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Electronic Microscopy Department of the Goncalo Moniz Research Centre - FIOCRUZ (Bahia)	Servico Nacional de Aprendizagem Industrial - Departamento Nacional (SENAI DN); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Electronic Microscopy Department of the Goncalo Moniz Research Centre - FIOCRUZ (Bahia)	This work was supported by: Servico Nacional de Aprendizagem Industrial - Departamento Nacional (SENAI DN) (BA-15011), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Electronic Microscopy Department of the Goncalo Moniz Research Centre - FIOCRUZ (Bahia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MR, 2007, FOOD CHEM, V101, P1383, DOI 10.1016/j.foodchem.2006.03.045; Akao Y, 2003, BIOL PHARM BULL, V26, P1057, DOI 10.1248/bpb.26.1057; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; Ali FH, 2010, VET ITAL, V46, P167; AOAC, 1997, OFFICIAL METHODS ANA; Attia YA, 2014, LIVEST SCI, V164, P87, DOI 10.1016/j.livsci.2014.03.005; Bankova V., 2007, Pharmacognosy Reviews, V1, P88; Bankova V, 2005, J ETHNOPHARMACOL, V100, P114, DOI 10.1016/j.jep.2005.05.004; BANKOVA V, 1988, Acta Microbiologica Bulgarica, V23, P52; Bankova V, 1998, APIDOLOGIE, V29, P361, DOI 10.1051/apido:19980406; Bankova V, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-28; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; Bastos EMAF, 2011, BRAZ J BIOL, V71, P727, DOI 10.1590/S1519-69842011000400018; Begnini KR, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/639856; Biscaia D, 2009, J SUPERCRIT FLUID, V51, P17, DOI 10.1016/j.supflu.2009.07.011; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BONVEHI JS, 1994, J AM OIL CHEM SOC, V71, P529, DOI 10.1007/BF02540666; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Budel JM, 2008, REV BRAS FARMACOGN, V18, P761, DOI 10.1590/S0102-695X2008000500022; Budel Jane Manfron, 2004, Acta Farmaceutica Bonaerense, V23, P477; Buriol L, 2009, QUIM NOVA, V32, P296, DOI 10.1590/S0100-40422009000200006; Busatti HGNO, 2007, PARASITOL RES, V101, P819, DOI 10.1007/s00436-007-0525-8; Carvalho AA, 2011, FOOD CHEM, V126, P1239, DOI 10.1016/j.foodchem.2010.12.035; Castaldo S, 2002, FITOTERAPIA, V73, pS1, DOI 10.1016/S0367-326X(02)00185-5; Chaillou LL, 2009, LWT-FOOD SCI TECHNOL, V42, P1422, DOI 10.1016/j.lwt.2009.03.002; Chen CR, 2009, J SUPERCRIT FLUID, V50, P176, DOI 10.1016/j.supflu.2009.06.001; Chen CR, 2009, J TAIWAN INST CHEM E, V40, P130, DOI 10.1016/j.jtice.2008.07.014; Chen J, 2012, HORM METAB RES, V44, P943, DOI 10.1055/s-0032-1321818; Cheung KW, 2011, J ETHNOPHARMACOL, V138, P463, DOI 10.1016/j.jep.2011.09.031; Choi YM, 2006, LWT-FOOD SCI TECHNOL, V39, P756, DOI 10.1016/j.lwt.2005.05.015; Christov R, 2005, NAT PROD RES, V19, P673, DOI 10.1080/14786410512331328159; Costa SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112554; Cottica SM, 2015, LWT-FOOD SCI TECHNOL, V60, P609, DOI 10.1016/j.lwt.2014.08.045; Cuesta-Rubio O, 2002, Z NATURFORSCH C, V57, P372; Frozza COD, 2014, FOOD CHEM TOXICOL, V63, P195, DOI 10.1016/j.fct.2013.11.003; Frozza COD, 2013, FOOD CHEM TOXICOL, V52, P137, DOI 10.1016/j.fct.2012.11.013; Daugsch A., 2007, THESIS; de Barros MP, 2007, J ETHNOPHARMACOL, V110, P567, DOI 10.1016/j.jep.2006.10.022; de Barros MP, 2008, J ETHNOPHARMACOL, V120, P372, DOI 10.1016/j.jep.2008.09.015; De Zordi N, 2014, J SUPERCRIT FLUID, V95, P491, DOI 10.1016/j.supflu.2014.10.006; Dias LG, 2012, FOOD CHEM TOXICOL, V50, P4246, DOI 10.1016/j.fct.2012.08.056; Donelian A, 2009, J SUPERCRIT FLUID, V48, P15, DOI 10.1016/j.supflu.2008.09.020; Falcao SI, 2013, PHYTOCHEM ANALYSIS, V24, P309, DOI 10.1002/pca.2412; Fernandes FH, 2014, FOOD RES INT, V62, P20, DOI 10.1016/j.foodres.2014.02.029; Fischer G, 2007, VACCINE, V25, P1250, DOI 10.1016/j.vaccine.2006.10.005; Franchi GC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/918956; Funakoshi-Tago M, 2015, INT IMMUNOPHARMACOL, V25, P189, DOI 10.1016/j.intimp.2015.01.012; Funari Cristiano S., 2006, Food Sci. Technol (Campinas), V26, P171, DOI 10.1590/S0101-20612006000100028; Garmus TT, 2015, J SUPERCRIT FLUID, V99, P68, DOI 10.1016/j.supflu.2015.01.016; Ghasem Yousef-Beigi, 2007, Pak J Biol Sci, V10, P1343, DOI 10.3923/pjbs.2007.1343.1345; Glisic S, 2010, J SUPERCRIT FLUID, V52, P62, DOI 10.1016/j.supflu.2009.11.009; Hata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048072; Hayacibara MF, 2005, J ETHNOPHARMACOL, V101, P110, DOI 10.1016/j.jep.2005.04.001; Hegazi AG, 2002, Z NATURFORSCH C, V57, P395; Ikeda R, 2011, BBA-GEN SUBJECTS, V1810, P695, DOI 10.1016/j.bbagen.2011.04.007; Ixtaina VY, 2010, J SUPERCRIT FLUID, V55, P192, DOI 10.1016/j.supflu.2010.06.003; Jug M, 2014, LWT-FOOD SCI TECHNOL, V57, P530, DOI 10.1016/j.lwt.2014.02.006; Kalogeropoulos N, 2009, FOOD CHEM, V116, P452, DOI 10.1016/j.foodchem.2009.02.060; Kim DO, 2003, J AGR FOOD CHEM, V51, P6509, DOI 10.1021/jf0343074; Kim YH, 2011, NEW BIOTECHNOL, V28, P713, DOI 10.1016/j.nbt.2010.12.006; Kimoto N, 1999, CANCER LETT, V147, P221, DOI 10.1016/S0304-3835(99)00305-5; Kimoto T, 2001, ANTICANCER RES, V21, P221; Kimoto T, 2001, VIRCHOWS ARCH, V438, P259, DOI 10.1007/s004280000350; Kimoto T, 1998, CANCER DETECT PREV, V22, P506, DOI 10.1046/j.1525-1500.1998.00020.x; Koo H, 2000, CURR MICROBIOL, V41, P192, DOI 10.1007/s0028400101170; Koru O, 2007, ANAEROBE, V13, P140, DOI 10.1016/j.anaerobe.2007.02.001; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Laskar RA, 2010, FOOD CHEM, V122, P233, DOI 10.1016/j.foodchem.2010.02.068; Lee YN, 2007, SEP PURIF TECHNOL, V54, P130, DOI 10.1016/j.seppur.2006.08.028; Lopez BGC, 2014, FOOD CHEM, V146, P174, DOI 10.1016/j.foodchem.2013.09.063; Lotti C, 2010, J AGR FOOD CHEM, V58, P2209, DOI 10.1021/jf100070w; Machado BAS, 2014, Brazilian patent, Patent No. [BR1020140320121, 1020140320121]; Marcucci MC, 1998, Z NATURFORSCH C, V53, P117; Marcucci MC, 2001, J ETHNOPHARMACOL, V74, P105, DOI 10.1016/S0378-8741(00)00326-3; Massaro FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081297; Matsumoto K, 2003, BIOL PHARM BULL, V26, P569, DOI 10.1248/bpb.26.569; Matsuno T, 1997, ANTICANCER RES, V17, P3565; Mattea F, 2009, J FOOD ENG, V93, P255, DOI 10.1016/j.jfoodeng.2009.01.030; Melliou E, 2007, FOOD CHEM, V103, P375, DOI 10.1016/j.foodchem.2006.07.033; Mendiola JA, 2007, J CHROMATOGR A, V1152, P234, DOI 10.1016/j.chroma.2007.02.046; Miguel MG, 2010, FOOD CHEM TOXICOL, V48, P3418, DOI 10.1016/j.fct.2010.09.014; Mohammadzadeh S, 2007, FOOD CHEM, V103, P1097, DOI 10.1016/j.foodchem.2006.10.006; Molyneux P., 2004, SONGKLANAKARIN J SCI, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; Moreira T. F., 1986, Rev. Bras. Farmacogn., V1, P12; Nagai T, 2003, FOOD CHEM, V80, P29, DOI 10.1016/S0308-8146(02)00231-5; Narbona E, 2010, INT J FOOD SCI TECH, V45, P569, DOI 10.1111/j.1365-2621.2009.02167.x; [National Institute of Metrology Standardization and Industrial Quality INMETRO], 2011, GUID CHEM TEST METH; NCCLS, 2000, M100S10M7 NCCLS, V5; Ngatu NR, 2011, EUR J INTEGR MED, V3, pE275, DOI 10.1016/j.eujim.2011.10.001; Novak EM, 2014, J FUNCT FOODS, V11, P91, DOI 10.1016/j.jff.2014.09.008; Ozcan M, 2003, J FOOD QUALITY, V26, P65, DOI 10.1111/j.1745-4557.2003.tb00227.x; Pardo-Castano C, 2015, J SUPERCRIT FLUID, V97, P165, DOI 10.1016/j.supflu.2014.09.044; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Patel J, 2015, INTEGR MED RES, V4, P94, DOI 10.1016/j.imr.2014.10.004; Paulino N, 2008, EUR J PHARMACOL, V587, P296, DOI 10.1016/j.ejphar.2008.02.067; Petelinc T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056104; Piantino CR, 2008, J SUPERCRIT FLUID, V47, P209, DOI 10.1016/j.supflu.2008.07.012; Piccinelli AL, 2011, J AGR FOOD CHEM, V59, P6484, DOI 10.1021/jf201280z; Popolo A, 2009, NAT PROD COMMUN, V4, P1711; Popova MP, 2007, APIDOLOGIE, V38, P306, DOI 10.1051/apido:2007013; Reverchon E, 2006, J SUPERCRIT FLUID, V38, P146, DOI 10.1016/j.supflu.2006.03.020; Uribe JAR, 2011, J SUPERCRIT FLUID, V56, P174, DOI 10.1016/j.supflu.2010.12.007; Sawaya ACHF, 2004, BRAZ J MICROBIOL, V35, P104, DOI 10.1590/S1517-83822004000100017; Sawaya ACHF, 2006, APIDOLOGIE, V37, P398, DOI 10.1051/apido:2006011; Shimizu K, 2004, ARCH BIOCHEM BIOPHYS, V424, P181, DOI 10.1016/j.abb.2004.02.021; Silici S, 2005, J ETHNOPHARMACOL, V99, P69, DOI 10.1016/j.jep.2005.01.046; Silva BB, 2008, EVID-BASED COMPL ALT, V5, P313, DOI 10.1093/ecam/nem059; Silva JC, 2012, FOOD CHEM TOXICOL, V50, P1790, DOI 10.1016/j.fct.2012.02.097; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Machado BAS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134489; Machado BAS, 2013, SEP SCI TECHNOL, V48, P2741, DOI 10.1080/01496395.2013.811422; Sun YS, 2008, SEP PURIF TECHNOL, V64, P221, DOI 10.1016/j.seppur.2008.10.007; TAKAISIKIKUNI NB, 1994, PLANTA MED, V60, P222, DOI 10.1055/s-2006-959463; Tazawa S, 2000, J NAT MED, V54, P306; Teixeira EW, 2005, EVID-BASED COMPL ALT, V2, P85, DOI 10.1093/ecam/neh055; Teles F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116535; Toreti VC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/697390; Tsuchiya H, 2000, PHYTOMEDICINE, V7, P161, DOI 10.1016/S0944-7113(00)80089-6; Tylkowski B, 2010, J MEMBRANE SCI, V348, P124, DOI 10.1016/j.memsci.2009.10.049; Valencia D, 2012, FOOD CHEM, V131, P645, DOI 10.1016/j.foodchem.2011.08.086; van den Berg R, 1999, FOOD CHEM, V66, P511, DOI 10.1016/S0308-8146(99)00089-8; VANSOEST PJ, 1967, J ASSOC OFF ANA CHEM, V50, P50; Vardar-Unlu G, 2008, WORLD J MICROB BIOT, V24, P1011, DOI 10.1007/s11274-007-9566-5; Vargas CE, 2010, J SUPERCRIT FLUID, V54, P171, DOI 10.1016/j.supflu.2009.12.007; Wang BJ, 2004, FOOD CHEM, V86, P237, DOI 10.1016/j.foodchem.2003.09.031; Wilson MB, 2015, J INVERTEBR PATHOL, V124, P44, DOI 10.1016/j.jip.2014.10.005; Wu J, 2000, CN Patent, Patent No. [CN1258511, 1258511]; Ye Y, 2012, HORM METAB RES, V44, P263, DOI 10.1055/s-0032-1301922; Zhang X, 2014, NUTR CANCER, V66, P656, DOI 10.1080/01635581.2014.894098; Zhao SW, 2014, SEP PURIF TECHNOL, V133, P443, DOI 10.1016/j.seppur.2014.07.018	132	105	107	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145954	10.1371/journal.pone.0145954	http://dx.doi.org/10.1371/journal.pone.0145954			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745799	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600021
J	Ali, SA; Teow, SY; Omar, TC; Khoo, ASB; Choon, TS; Yusoff, NM				Ali, Syed A.; Teow, Sin-Yeang; Omar, Tasyriq Che; Khoo, Alan Soo-Beng; Choon, Tan Soo; Yusoff, Narazah Mohd			A Cell Internalizing Antibody Targeting Capsid Protein (p24) Inhibits the Replication of HIV-1 in T Cells Lines and PBMCs: A Proof of Concept Study	PLOS ONE			English	Article							N-TERMINAL DOMAIN; PENETRATING ANTIBODIES; ANTIVIRAL ACTIVITY; PEPTIDES; DISCOVERY; INFECTION; SITE; RNA; CA	There remains a need for newer therapeutic approaches to combat HIV/AIDS. Viral capsid protein p24 plays important roles in HIV pathogenesis. Peptides and small molecule inhibitors targeting p24 have shown to inhibit virus replication in treated cell. High specificity and biological stability of monoclonal antibodies (mAbs) make them an attractive contender for in vivo treatments. However, mAbs do not enter into cells, thus are restricted to target surface molecules. This also makes targeting intracellular HIV-1 p24 a challenge. A mAb specific to p24 that can internalize into the HIV-infected cells is hypothesized to inhibit the virus replication. We selected a mAb that has previously shown to inhibit p24 polymerization in an in vitro assay and chemically conjugated it with cell penetrating peptides (CPP) to generate cell internalizing anti-p24 mAbs. Out of 8 CPPs tested, kappa FGF-MTS -conjugated mAbs internalized T cells most efficiently. At nontoxic concentration, the kappa FGF-MTS-anti-p24-mAbs reduced the HIV-1 replication up to 73 and 49% in T-lymphocyte and PBMCs respectively. Marked inhibition of HIV-1 replication in relevant cells by kappa FGF-MTS-anti-p24-mAbs represents a viable strategy to target HIV proteins present inside the cells.	[Ali, Syed A.; Teow, Sin-Yeang; Omar, Tasyriq Che] Univ Sains Malaysia, Oncol & Radiol Sci, Adv Med & Dent Inst, Kepala Batas 13200, Pulau Pinang, Malaysia; [Khoo, Alan Soo-Beng] Inst Med Res, Kuala Lumpur 50588, Malaysia; [Choon, Tan Soo] Univ Sains Malaysia, Inst Res Mol Med INFORMM, Penang 11800, Malaysia; [Yusoff, Narazah Mohd] Univ Sains Malaysia, Regenerat Med, Adv Med & Dent Inst, Kepala Batas 13200, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Kementerian Kesihatan Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Ali, SA (corresponding author), Univ Sains Malaysia, Oncol & Radiol Sci, Adv Med & Dent Inst, Kepala Batas 13200, Pulau Pinang, Malaysia.	alilabwork@gmail.com	Omar, Mohammad Tasyriq Che/L-3839-2017; Teow, Sin-Yeang/J-2253-2019; Omar, Mohammad Tasyriq Che/AFP-0240-2022; Teow, Sin-Yeang/L-3736-2016	Omar, Mohammad Tasyriq Che/0000-0002-1294-7520; Teow, Sin-Yeang/0000-0002-3824-0224; Omar, Mohammad Tasyriq Che/0000-0002-1294-7520; Teow, Sin-Yeang/0000-0002-3824-0224	FRGS grant from Ministry of Higher Education (MOHE), Government of Malaysia [203/CIPPT/6711206]; MOHE [KPT (B) 890416075223]; Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia (USM) [USM/IPPT/2000/G-2/xiv]; RU-PRGS grant from USM [1001/CIPPT/846048]	FRGS grant from Ministry of Higher Education (MOHE), Government of Malaysia; MOHE(Ministry of Higher Education & Scientific Research (MHESR)); Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia (USM); RU-PRGS grant from USM	This work was supported by the FRGS grant (203/CIPPT/6711206) from Ministry of Higher Education (MOHE), Government of Malaysia to Syed A Ali. Sin-Yeang Teow was a recipient of MyPhD scholarship (KPT (B) 890416075223) under MyBrain15 program of MOHE and part of that research was supported by Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia (USM) under a Research Student Fund (USM/IPPT/2000/G-2/xiv) and RU-PRGS grant (1001/CIPPT/846048) from USM.	Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Curreli F, 2011, BIOORGAN MED CHEM, V19, P77, DOI 10.1016/j.bmc.2010.11.045; Emamzadeh-Fard Sahra, 2013, Infectious Disorders - Drug Targets, V13, P330; Ensoli B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00417; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Goudreau N, 2013, ACS CHEM BIOL, V8, P1074, DOI 10.1021/cb400075f; Jin YX, 2010, BIOORGAN MED CHEM, V18, P2135, DOI 10.1016/j.bmc.2010.02.003; Kabouridis PS, 2003, TRENDS BIOTECHNOL, V21, P498, DOI 10.1016/j.tibtech.2003.09.008; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; Kortagere S, 2014, J CHEM INF MODEL, V54, P3080, DOI 10.1021/ci500437r; Kortagere S, 2012, J VIROL, V86, P8472, DOI 10.1128/JVI.05006-11; Lemke CT, 2012, J VIROL, V86, P6643, DOI 10.1128/JVI.00493-12; Loftus JC, 2009, MOL CANCER THER, V8, P1505, DOI 10.1158/1535-7163.MCT-08-1055; Muller S, 2005, EXPERT OPIN BIOL TH, V5, P237, DOI 10.1517/14712598.5.2.237; Munyendo WL, 2012, BIOMOLECULES, V2, P187, DOI 10.3390/biom2020187; Orange JS, 2008, CELL MOL LIFE SCI, V65, P3564, DOI 10.1007/s00018-008-8222-z; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Teow SY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-107; Tian BH, 2009, BIOORG MED CHEM LETT, V19, P2162, DOI 10.1016/j.bmcl.2009.02.116; Vandegraaff N, 2001, J VIROL, V75, P11253, DOI 10.1128/JVI.75.22.11253-11260.2001; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200; Willows S, 2013, FUTURE VIROL, V8, P435, DOI 10.2217/FVL.13.32; Wu Feng, 2010, World J Biol Chem, V1, P188, DOI 10.4331/wjbc.v1.i5.188; Zhang H, 2008, J MOL BIOL, V378, P565, DOI 10.1016/j.jmb.2008.02.066; Zhang HT, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-136; Zhang HT, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-28; Zhao Y, 2003, APOPTOSIS, V8, P631, DOI 10.1023/A:1026139627930; Zhao YF, 2001, J IMMUNOL METHODS, V254, P137, DOI 10.1016/S0022-1759(01)00410-0; Zhuang XL, 2014, J BIOL CHEM, V289, P20222, DOI 10.1074/jbc.M114.581090	35	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145986	10.1371/journal.pone.0145986	http://dx.doi.org/10.1371/journal.pone.0145986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741963	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600016
J	Hsu, CW; Weng, CH; Lin-Tan, DT; Chu, PH; Yen, TH; Chen, KH; Lin, CY; Huang, WH				Hsu, Ching-Wei; Weng, Cheng-Hao; Lin-Tan, Dan-Tzu; Chu, Pao-Hsien; Yen, Tzung-Hai; Chen, Kuan-Hsing; Lin, Chung-Yin; Huang, Wen-Hung			Association of Urinary Cadmium with Mortality in Patients at a Coronary Care Unit	PLOS ONE			English	Article							HOSPITAL MORTALITY; CRITICALLY-ILL; APACHE-II; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ACUTE PHYSIOLOGY; SERUM-ALBUMIN; ALL-CAUSE; SYSTEM; FAILURE	Background Determine the effect of the day 1 urinary excretion of cadmium (D1-UE-Cd) on mortality of patients admitted to a coronary care unit (CCU). Methods A total of 323 patients were enrolled in this 6-month study. Urine and blood samples were taken within 24 h after CCU admission. Demographic data, clinical diagnoses, and hospital mortality were recorded. The scores of established systems for prediction of mortality in critically ill patients were calculated. Results Compared with survivors (n = 289), non-survivors (n = 34) had higher levels of D1-UE-Cd. Stepwise multiple linear regression analysis indicated that D1-UE-Cd was positively associated with pulse rate and level of aspartate aminotransferase, but negatively associated with serum albumin level. Multivariate Cox analysis, with adjustment for other significant variables and measurements from mortality scoring systems, indicated that respiratory rate and D1-UE-Cd were independent and significant predictors of mortality. For each 1 mu g/day increase of D1-UE-Cd, the hazard ratio for CCU mortality was 3.160 (95% confidence interval: 1.944-5.136, p < 0.001). The chi-square value of Hosmer-Lemeshow goodness-of-fit test for D1-UE-Cd was 10.869 (p = 0.213). The area under the receiver operating characteristic curve for D1-UE-Cd was 0.87 (95% confidence interval: 0.81-0.93). Conclusions The D1-UE-Cd, an objective variable with no inter-observer variability, accurately predicted hospital mortality of CCU patients and outperformed other established scoring systems. Further studies are needed to determine the physiological mechanism of the effect of cadmium on mortality in CCU patients.	[Hsu, Ching-Wei; Weng, Cheng-Hao; Lin-Tan, Dan-Tzu; Yen, Tzung-Hai; Chen, Kuan-Hsing; Lin, Chung-Yin; Huang, Wen-Hung] Chang Gung Mem Hosp, Dept Nephrol, Div Clin Toxicol, Taipei 10591, Taiwan; [Hsu, Ching-Wei; Weng, Cheng-Hao; Lin-Tan, Dan-Tzu; Yen, Tzung-Hai; Chen, Kuan-Hsing; Lin, Chung-Yin; Huang, Wen-Hung] Lin Kou Med Ctr, Div Clin Toxicol, Dept Nephrol, Taoyuan, Taiwan; [Hsu, Ching-Wei; Weng, Cheng-Hao; Lin-Tan, Dan-Tzu; Chu, Pao-Hsien; Yen, Tzung-Hai; Chen, Kuan-Hsing; Lin, Chung-Yin; Huang, Wen-Hung] Chang Gung Univ, Taoyuan, Taiwan; [Hsu, Ching-Wei; Weng, Cheng-Hao; Lin-Tan, Dan-Tzu; Chu, Pao-Hsien; Yen, Tzung-Hai; Chen, Kuan-Hsing; Lin, Chung-Yin; Huang, Wen-Hung] Sch Med, Taoyuan, Taiwan; [Chu, Pao-Hsien] Chang Gung Mem Hosp, Lin Kou Med Ctr, Div Cardiol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, WH (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Div Clin Toxicol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	williammedia@yahoo.com.tw	Chu, Pao-Hsien/G-3685-2010; Yen, Tzung-Hai/AAQ-4525-2020; Chu, Pao-Hsien/P-5249-2019; huang, wen/GXW-0661-2022	Yen, Tzung-Hai/0000-0002-0907-1505; Chu, Pao-Hsien/0000-0003-0361-6348; Lin, Chung-Yin/0000-0001-9775-1510				Angus DC, 2000, CRIT CARE MED, V28, P150, DOI 10.1097/00003246-200001000-00025; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bernard A., 1986, HDB EXPT PHARM, P135, DOI DOI 10.1007/978-3-642-70856-5; BUCHET JP, 1990, LANCET, V336, P699, DOI 10.1016/0140-6736(90)92201-R; Cheung MR, 2014, ASIAN PAC J CANCER P, V15, P483, DOI 10.7314/APJCP.2014.15.1.483; Djousse L, 2002, CIRCULATION, V106, P2919, DOI 10.1161/01.CIR.0000042673.07632.76; Ferramola ML, 2012, TOXICOL APPL PHARM, V265, P380, DOI 10.1016/j.taap.2012.09.009; Gena P, 2010, ENVIRON HEALTH PERSP, V118, P1551, DOI 10.1289/ehp.0901874; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hein OV, 2006, ANN THORAC SURG, V81, P880, DOI 10.1016/j.athoracsur.2005.09.077; Jarup L, 2000, OCCUP ENVIRON MED, V57, P668, DOI 10.1136/oem.57.10.668; Jarup L., 1998, SCAND J WORK ENV HEA, V24, P1; Jarup L, 2002, NEPHROL DIAL TRAN S9, V17; Jin TY, 2002, BIOMETALS, V15, P397, DOI 10.1023/A:1020229923095; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Ladenson JH, 2012, CLIN CHEM, V58, P21, DOI 10.1373/clinchem.2011.165852; Lakkireddy D, 2005, MED SCI MONITOR, V11, pCR95; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Li Q, 2011, CHINESE MED J-PEKING, V124, P3504, DOI 10.3760/cma.j.issn.0366-6999.2011.21.013; Lin JL, 2009, CRIT CARE MED, V37, P957, DOI 10.1097/CCM.0b013e318198675c; Ferramola ML, 2011, ENVIRON TOXICOL PHAR, V32, P17, DOI 10.1016/j.etap.2011.03.002; Menke A, 2009, ENVIRON HEALTH PERSP, V117, P190, DOI 10.1289/ehp.11236; Ozturk IM, 2009, TOXICOL MECH METHOD, V19, P308, DOI 10.1080/15376510802662751; Pettila V, 2002, CRIT CARE MED, V30, P1705, DOI 10.1097/00003246-200208000-00005; Polderman KH, 2001, INTENS CARE MED, V27, P1365, DOI 10.1007/s001340101012; Polderman KH, 2001, ANAESTHESIA, V56, P47, DOI 10.1046/j.1365-2044.2001.01763.x; PONTEVA M, 1979, EUR J CARDIOL, V9, P379; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Rosenberg Andrew L, 2002, Curr Opin Crit Care, V8, P321, DOI 10.1097/00075198-200208000-00009; Ryan TA, 1997, CHEST, V112, P1035, DOI 10.1378/chest.112.4.1035; Shah H, 2007, INDIAN J CLIN BIOCHE, V22, P33, DOI 10.1007/BF02912878; SMETANA R, 1985, WIEN KLIN WOCHENSCHR, V97, P697; Tellez-Plaza M, 2013, EPIDEMIOLOGY, V24, P421, DOI 10.1097/EDE.0b013e31828b0631; TRAN DD, 1990, CRIT CARE MED, V18, P474, DOI 10.1097/00003246-199005000-00002; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; ZWEIG MH, 1993, CLIN CHEM, V39, P561	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146173	10.1371/journal.pone.0146173	http://dx.doi.org/10.1371/journal.pone.0146173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741992	gold, Green Submitted, Green Published			2022-12-27	WOS:000367810600023
J	Xie, ZH; Pan, D; Teichroew, J; An, JD				Xie, Zhenghua; Pan, Dongdong; Teichroew, Jonathan; An, Jiandong			The Potential Influence of Bumble Bee Visitation on Foraging Behaviors and Assemblages of Honey Bees on Squash Flowers in Highland Agricultural Ecosystems	PLOS ONE			English	Article							CROP POLLINATION; BOMBUS SPP.; NATIVE BEES; LANDSCAPE; PLANT; HYMENOPTERA; DIVERSITY; RESPONSES; SERVICES; APIDAE	Bee species interactions can benefit plant pollination through synergistic effects and complementary effects, or can be of detriment to plant pollination through competition effects by reducing visitation by effective pollinators. Since specific bee interactions influence the foraging performance of bees on flowers, they also act as drivers to regulate the assemblage of flower visitors. We selected squash (Cucurbita pepo L.) and its pollinators as a model system to study the foraging response of honey bees to the occurrence of bumble bees at two types of sites surrounded by a high amount of natural habitats (>= 58% of land cover) and a low amount of natural habitats (<= 12% of land cover) in a highland agricultural ecosystem in China. At the individual level, we measured the elapsed time from the departure of prior pollinator(s) to the arrival of another pollinator, the selection of honey bees for flowers occupied by bumble bees, and the length of time used by honey bees to explore floral resources at the two types of sites. At the community level, we explored the effect of bumble bee visitation on the distribution patterns of honey bees on squash flowers. Conclusively, bumble bee visitation caused an increase in elapsed time before flowers were visited again by a honey bee, a behavioral avoidance by a newly-arriving honey bee to select flowers occupied by bumble bees, and a shortened length of time the honey bee takes to examine and collect floral resources. The number of overall bumble bees on squash flowers was the most important factor explaining the difference in the distribution patterns of honey bees at the community level. Furthermore, decline in the number of overall bumble bees on the squash flowers resulted in an increase in the number of overall honey bees. Therefore, our study suggests that bee interactions provide an opportunity to enhance the resilience of ecosystem pollination services against the decline in pollinator diversity.	[Xie, Zhenghua] Chinese Acad Forestry, Res Inst Insect Resources, Dept Environm Entomol, Kunming, Yunnan, Peoples R China; [Pan, Dongdong] Yunnan Univ, Dept Stat, Kunming, Yunnan, Peoples R China; [Teichroew, Jonathan] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Yunnan, Peoples R China; [Teichroew, Jonathan] Univ Chinese Acad Sci, Beijing, Peoples R China; [An, Jiandong] Chinese Acad Agr Sci, Inst Apicultural Res, Beijing 100193, Peoples R China	Chinese Academy of Forestry; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS	Xie, ZH (corresponding author), Chinese Acad Forestry, Res Inst Insect Resources, Dept Environm Entomol, Kunming, Yunnan, Peoples R China.	cnbees@gmail.com; anjiandong@caas.cn	Xie, Zhenghua/B-1845-2014		Applied Basic Program of Yunnan Province [2013FB088]; Special Fund for Agro-scientific Research in the Public Interest [201203080-4]; Youth Program of Applied Basic Research Programs of Yunnan Province [2013FD001]	Applied Basic Program of Yunnan Province; Special Fund for Agro-scientific Research in the Public Interest; Youth Program of Applied Basic Research Programs of Yunnan Province	The study was partially supported by the Applied Basic Program of Yunnan Province (2013FB088), the Special Fund for Agro-scientific Research in the Public Interest (201203080-4) and the Youth Program of Applied Basic Research Programs of Yunnan Province (2013FD001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen W, 2012, PLANT SOIL, V354, P157, DOI 10.1007/s11104-011-1052-z; Albrecht M, 2012, P ROY SOC B-BIOL SCI, V279, P4845, DOI 10.1098/rspb.2012.1621; Artz DR, 2011, J ECON ENTOMOL, V104, P1153, DOI 10.1603/EC10431; Ayasse M, 2014, ANNU REV ENTOMOL, V59, P299, DOI 10.1146/annurev-ento-011613-161949; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baude M, 2011, P ROY SOC B-BIOL SCI, V278, P2806, DOI 10.1098/rspb.2010.2659; Benjamin FE, 2014, J APPL ECOL, V51, P440, DOI 10.1111/1365-2664.12198; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Brosi BJ, 2013, P NATL ACAD SCI USA, V110, P13044, DOI 10.1073/pnas.1307438110; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Carvell C, 2002, BIOL CONSERV, V103, P33, DOI 10.1016/S0006-3207(01)00114-8; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; Dawson CW, 2007, ENVIRON MODELL SOFTW, V22, P1034, DOI 10.1016/j.envsoft.2006.06.008; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Garibaldi LA, 2014, FRONT ECOL ENVIRON, V12, P439, DOI 10.1890/130330; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hijmans R.J., 2014, DISMO SPECIES DISTRI; Hingston AB, 1999, AUST J ZOOL, V47, P59, DOI 10.1071/ZO98016; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Junqueira CN, 2013, APIDOLOGIE, V44, P729, DOI 10.1007/s13592-013-0219-4; Klein AM, 2002, CONSERV BIOL, V16, P1003, DOI 10.1046/j.1523-1739.2002.00499.x; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kuznetsova A., 2013, LMERTEST TESTS RANDO; Morandin LA, 2013, ECOL APPL, V23, P829, DOI 10.1890/12-1051.1; NEPI M, 1993, ANN BOT-LONDON, V72, P527, DOI 10.1006/anbo.1993.1141; Oksanen J., 2007, COMMUN ECOL PACK, P631; R Core Team, 2021, R LANGUAGE ENV STAT; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Ridgeway G, 2012, BBM GEN BOOSTED REGR; Ridgeway G., 1999, COMPUT SCI STAT, P172; Rigot T, 2014, ECOGRAPHY, V37, P648, DOI 10.1111/j.1600-0587.2013.00447.x; Rogers SR, 2013, APIDOLOGIE, V44, P621, DOI 10.1007/s13592-013-0210-0; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; Stout JC, 2001, ANIM BEHAV, V62, P183, DOI 10.1006/anbe.2001.1729; SUMNER D. A., 2006, AGR RESOURCE EC UPDA, V9, P9; Verboven HAF, 2014, PERSPECT PLANT ECOL, V16, P121, DOI 10.1016/j.ppees.2014.03.002; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Williams CS, 1998, ANIM BEHAV, V56, P673, DOI 10.1006/anbe.1998.0794; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Wolf S, 2008, APIDOLOGIE, V39, P419, DOI 10.1051/apido:2008020; Xie Z, 2014, J APPL ENTOMOL, V138, P555, DOI 10.1111/jen.12122	48	7	8	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0144590	10.1371/journal.pone.0144590	http://dx.doi.org/10.1371/journal.pone.0144590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765140	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300004
J	Casarin, E; Lucchese, L; Grazioli, S; Facchin, S; Realdon, N; Brocchi, E; Morpurgo, M; Nardelli, S				Casarin, Elisabetta; Lucchese, Laura; Grazioli, Santina; Facchin, Sonia; Realdon, Nicola; Brocchi, Emiliana; Morpurgo, Margherita; Nardelli, Stefano			A New ELISA Using the ANANAS Technology Showing High Sensitivity to diagnose the Bovine Rhinotracheitis from Individual Sera to Pooled Milk	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; NUCLEIC-ACID NANOASSEMBLIES; BULK MILK; AVIDIN; HERPESVIRUS-1; ANTIBODIES; COWS; IBR	Diagnostic tests for veterinary surveillance programs should be efficient, easy to use and, possibly, economical. In this context, classic Enzyme linked ImmunoSorbent Assay (ELISA) remains the most common analytical platform employed for serological analyses. The analysis of pooled samples instead of individual ones is a common procedure that permits to certify, with one single test, entire herds as "disease-free". However, diagnostic tests for pooled samples need to be particularly sensitive, especially when the levels of disease markers are low, as in the case of anti-BoHV1 antibodies in milk as markers of Infectious Bovine Rhinotracheitis (IBR) disease. The avidin-nucleic-acid-nanoassembly (ANANAS) is a novel kind of signal amplification platform for immunodiagnostics based on colloidal polyavidin nanoparticles that, using model analytes, was shown to strongly increase ELISA test performance as compared to monomeric avidin. Here, for the first time, we applied the ANANAS reagent integration in a real diagnostic context. The monoclonal 1G10 anti-bovine IgG1 antibody was biotinylated and integrated with the ANANAS reagents for indirect IBR diagnosis from pooled milk mimicking tank samples from herds with IBR prevalence between 1 to 8%. The sensitivity and specificity of the ANANAS integrated method was compared to that of a classic test based on the same 1G10 antibody directly linked to horseradish peroxidase, and a commercial IDEXX kit recently introduced in the market. ANANAS integration increased by 5-fold the sensitivity of the 1G10 mAb-based conventional ELISA without loosing specificity. When compared to the commercial kit, the 1G10-ANANAS integrated method was capable to detect the presence of anti-BHV1 antibodies from bulk milk of gE antibody positive animals with 2-fold higher sensitivity and similar specificity. The results demonstrate the potentials of this new amplification technology, which permits improving current classic ELISA sensitivity limits without the need for new hardware investments.	[Casarin, Elisabetta; Realdon, Nicola; Morpurgo, Margherita] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Lucchese, Laura; Nardelli, Stefano] Ist Zooprofilatt Sperimentale Venezie IZSVe, Legnaro, PD, Italy; [Grazioli, Santina; Brocchi, Emiliana] Ist Zooprofilatt Sperimentale Lombardia Emilia Ro, Brescia, Italy; [Facchin, Sonia] ANANAS Nanotech Srl, Padua, Italy	University of Padua; IZS delle Venezie; IZS Lombardia e Emilia	Morpurgo, M (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	margherita.morpurgo@unipd.it; snardelli@izsvenezie.it	Brocchi, Emiliana/G-1810-2019; Lucchese, Laura/G-4215-2019; morpurgo, margherita/I-7911-2012	Brocchi, Emiliana/0000-0003-1864-080X; Lucchese, Laura/0000-0003-4255-9024; morpurgo, margherita/0000-0002-8767-1995; Nardelli, Stefano/0000-0002-0344-3101	Ministry of Health [RF IZS LER 2318002-2010]; ANANAS nanotech, S.r.l.	Ministry of Health; ANANAS nanotech, S.r.l.	The study was financially supported by the Ministry of Health through a research grant in common between UNIPD, IZSLER and IZSVe (RF IZS LER 2318002-2010 "Novel multiplexing and signal-amplification strategies for the development of advanced diagnostic platforms for animal health and food safety control"). In addition ANANAS nanotech kindly provided the ANANAS nanoparticles used for the analyses. ANANAS nanotech, S.r.l., provided support in the form of salaries for author SF but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The study was financially supported by the Ministry of Health through a research grant in common between UNIPD, IZSLER and IZSVe (RF IZS LER 2318002-2010 "Novel multiplexing and signal-amplification strategies for the development of advanced diagnostic platforms for animal health and food safety control"). In addition ANANAS nanotech kindly provided the ANANAS nanoparticles used for the analyses. ANANAS nanotech, S.r.l., provided support in the form of salaries for author SF but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors gratefully acknowledge the statistical support provided by Dr Katia Capello, from the Istituto Zoo-profilattico Sperimentale delle Venezie-Legnaro PD (Italy)-, who carried out the ROC analysis.	Bashir S, 2011, ASIAN PAC J TROP MED, V4, P363, DOI 10.1016/S1995-7645(11)60104-1; Beer M, 2015, MANUAL DIAGNOSTIC TE, V1; Bigini P, 2014, ACS NANO, V8, P175, DOI 10.1021/nn402669w; Buda A, 2015, INT J NANOMED, V10, P399, DOI 10.2147/IJN.S70153; Butler JE, 1998, REV SCI TECH OIE, V17, P43, DOI 10.20506/rst.17.1.1096; Casonato A, 2015, BR J HAEMATOL; Casonato A, 2013, THROMB HAEMOST, V109; de Wit JJ, 1998, VET MICROBIOL, V61, P153, DOI 10.1016/S0378-1135(98)00166-7; Gibbs E. P. J., 1977, Veterinary Bulletin, V47, P317; Godhardt-Cooper JA, 2009, J VET DIAGN INVEST, V21, P523, DOI 10.1177/104063870902100416; Korhonen H, 2000, BRIT J NUTR, V84, pS75; KRAMPS JA, 1994, J CLIN MICROBIOL, V32, P2175, DOI 10.1128/JCM.32.9.2175-2181.1994; Liu GL, 2009, VET J, V182, P79, DOI 10.1016/j.tvjl.2008.05.019; Ludwig H., 1983, HERPESVIRUSES, V2, P135; MANET G, 1993, REV MED VET-TOULOUSE, V144, P591; Mayers J, 2012, J VET DIAGN INVEST, V24, P725, DOI 10.1177/1040638712446506; Mezo M, 2010, PARASITOL INT, V59, P610, DOI 10.1016/j.parint.2010.09.001; Morpurgo M, 2004, J MOL RECOGNIT, V17, P558, DOI 10.1002/jmr.689; Morpurgo M, 2012, ANAL CHEM, V84, P3433, DOI 10.1021/ac300276u; Pignatto M, 2010, BIOCONJUGATE CHEM, V21, P1254, DOI 10.1021/bc100044u; Raaperi K, 2014, VET J, V201, P249, DOI 10.1016/j.tvjl.2014.05.040; Schroeder C, 2012, BERL MUNCH TIERARZTL, V125, P290, DOI 10.2376/0005-9366-125-290; WYLER R, 1989, INFECT BOVINE RHINOT; YATES WDG, 1982, CAN J COMP MED, V46, P225	24	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145912	10.1371/journal.pone.0145912	http://dx.doi.org/10.1371/journal.pone.0145912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26761815	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100022
J	Gustafson, CT; Boakye-Agyeman, F; Brinkman, CL; Reid, JM; Patel, R; Bajzer, Z; Dadsetan, M; Yaszemski, MJ				Gustafson, Carl T.; Boakye-Agyeman, Felix; Brinkman, Cassandra L.; Reid, Joel M.; Patel, Robin; Bajzer, Zeljko; Dadsetan, Mahrokh; Yaszemski, Michael J.			Controlled Delivery of Vancomycin via Charged Hydrogels	PLOS ONE			English	Article							SURGICAL-SITE INFECTION; CONTROLLED-RELEASE; IN-VITRO; RESISTANCE; SUSCEPTIBILITY; MECHANISMS; DIAGNOSIS; SYSTEM	Surgical site infection (SSI) remains a significant risk for any clean orthopedic surgical procedure. Complications resulting from an SSI often require a second surgery and lengthen patient recovery time. The efficacy of antimicrobial agents delivered to combat SSI is diminished by systemic toxicity, bacterial resistance, and patient compliance to dosing schedules. We submit that development of localized, controlled release formulations for antimicrobial compounds would improve the effectiveness of prophylactic surgical wound antibiotic treatment while decreasing systemic side effects. Our research group developed and characterized oligo(poly(ethylene glycol) fumarate) / sodium methacrylate (OPF/SMA) charged copolymers as biocompatible hydrogel matrices. Here, we report the engineering of this copolymer for use as an antibiotic delivery vehicle in surgical applications. We demonstrate that these hydrogels can be efficiently loaded with vancomycin (over 500 mu g drug per mg hydrogel) and this loading mechanism is both time-and charge-dependent. Vancomycin release kinetics are shown to be dependent on copolymer negative charge. In the first 6 hours, we achieved as low as 33.7% release. In the first 24 hours, under 80% of total loaded drug was released. Further, vancomycin release from this system can be extended past four days. Finally, we show that the antimicrobial activity of released vancomycin is equivalent to stock vancomycin in inhibiting the growth of colonies of a clinically derived strain of methicillin-resistant Staphylococcus aureus. In summary, our work demonstrates that OPF/SMA hydrogels are appropriate candidates to deliver local antibiotic therapy for prophylaxis of surgical site infection.	[Gustafson, Carl T.; Reid, Joel M.; Yaszemski, Michael J.] Mayo Clin, Coll Med, Mayo Grad Sch, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55902 USA; [Boakye-Agyeman, Felix] Duke Clin Res Inst, Pharmacometr Ctr, Durham, NC 27705 USA; [Brinkman, Cassandra L.; Patel, Robin] Mayo Clin, Infect Dis Res Lab, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55902 USA; [Bajzer, Zeljko] Mayo Clin, Coll Med, Div Biomath, Dept Biochem & Mol Biol, Rochester, MN 55902 USA; [Bajzer, Zeljko] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Div Biomath, Rochester, MN 55902 USA; [Dadsetan, Mahrokh; Yaszemski, Michael J.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Div Orthopaed Res, Rochester, MN 55902 USA	Mayo Clinic; Duke University; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Gustafson, CT (corresponding author), Mayo Clin, Coll Med, Mayo Grad Sch, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55902 USA.	Gustafson.carl@mayo.edu			Orthopedic Surgery and Biomedical Engineering; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056647, T32AR056950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	Orthopedic Surgery and Biomedical Engineering; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by The John and Posy Krehbiel Endowed Professorship of Orthopedic Surgery and Biomedical Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Bakhsheshian J, 2015, WORLD NEUROSURG, V83, P816, DOI 10.1016/j.wneu.2014.12.033; Boyanova L, 2015, ANAEROBE, V31, P4, DOI 10.1016/j.anaerobe.2014.05.004; Brooks BD, 2014, ADV DRUG DELIVER REV, V78, P14, DOI 10.1016/j.addr.2014.10.027; Cavallaro A, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4866697; Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9; Dadsetan M, 2013, ACTA BIOMATER, V9, P5438, DOI 10.1016/j.actbio.2012.09.019; Dadsetan M, 2010, BIOMATERIALS, V31, P8051, DOI 10.1016/j.biomaterials.2010.06.054; Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018; Daly WT, 2013, BIOMATERIALS, V34, P8630, DOI 10.1016/j.biomaterials.2013.07.086; Dhawan S, 2002, PEPTIDES, V23, P2099, DOI 10.1016/S0196-9781(02)00253-X; Esposito S, 2008, INT J ANTIMICROB AG, V32, P287, DOI 10.1016/j.ijantimicag.2008.03.010; Fish R, 2012, PERITON DIALYSIS INT, V32, P332, DOI 10.3747/pdi.2010.00294; Gardete S, 2014, J CLIN INVEST, V124, P2836, DOI 10.1172/JCI68834; Golden AL, 2010, BIOCONJUGATE CHEM, V21, P1820, DOI 10.1021/bc100169y; Hamada Y, 2015, J ANTIMICROB CHEMOTH, V70, P2064, DOI 10.1093/jac/dkv074; Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b; Hill BW, 2014, ACTA NEUROCHIR, V156, P749, DOI 10.1007/s00701-014-2022-z; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Joglekar M, 2013, BIOTECHNOL J, V8, P931, DOI 10.1002/biot.201300073; Kazanowski M, 2014, TECH COLOPROCTOL, V18, P223, DOI 10.1007/s10151-013-1081-0; Khan NR, 2014, J NEUROSURG-SPINE, V21, P974, DOI 10.3171/2014.8.SPINE1445; Kinard LA, 2012, NAT PROTOC, V7, P1219, DOI 10.1038/nprot.2012.055; Koppula S, 2015, AM J MED SCI, V349, P137, DOI 10.1097/MAJ.0000000000000368; Koyamatsu Y, 2014, J CONTROL RELEASE, V173, P89, DOI 10.1016/j.jconrel.2013.10.035; Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022; Lakes AL, 2014, BIOMACROMOLECULES, V15, P3009, DOI 10.1021/bm5006323; Laxminarayan R, 2014, SCIENCE, V345, P1299, DOI 10.1126/science.1254163; Leone S, 2010, INT J INFECT DIS, V14, pS67, DOI 10.1016/j.ijid.2010.05.005; Lodise TP, 2011, ANTIMICROB AGENTS CH, V55, P5507, DOI 10.1128/AAC.00712-11; Nakayama M, 2014, J DRUG TARGET, V22, P584, DOI 10.3109/1061186X.2014.936872; Noren T, 2010, CLIN MICROBIOL INFEC, V16, P1104, DOI 10.1111/j.1469-0691.2009.03048.x; Overstreet D, 2015, CLIN ORTHOP RELAT R, V473, P337, DOI 10.1007/s11999-014-3935-9; Press WH, 2007, NUMERICAL RECIPES AR, Vxxi; Rineh A, 2014, EXPERT REV ANTI-INFE, V12, P131, DOI 10.1586/14787210.2014.866515; Rubinstein E, 2014, FRONT PUBLIC HLTH, V2, P217, DOI DOI 10.3389/FPUBH.2014.00217; Runge MB, 2010, BIOMACROMOLECULES, V11, P2845, DOI 10.1021/bm100526a; SANDERS WE, 1979, ANNU REV PHARMACOL, V19, P53, DOI 10.1146/annurev.pa.19.040179.000413; Seltman Ann K, 2012, Clin Colon Rectal Surg, V25, P204, DOI 10.1055/s-0032-1329390; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Soontornworajit B, 2011, BIOMATERIALS, V32, P6839, DOI 10.1016/j.biomaterials.2011.05.074; STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0; Strom RG, 2013, CLIN NEUROL NEUROSUR, V115, P1766, DOI 10.1016/j.clineuro.2013.04.005; Tian HY, 2014, J CONTROL RELEASE, V174, P117, DOI 10.1016/j.jconrel.2013.11.008; Trouche E, 2010, CELL TRANSPLANT, V19, P1623, DOI 10.3727/096368910X514297; van Dishoeck AM, 2013, BRIT J SURG, V100, P628, DOI 10.1002/bjs.9039; Venkatesh MP, 2013, CURR DRUG DELIV, V10, P188, DOI 10.2174/1567201811310020005; Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013; Zhang XL, 2012, BIOMACROMOLECULES, V13, P2202, DOI 10.1021/bm3006227; Zhou X, 2010, J AM CHEM SOC, V132, P4161, DOI 10.1021/ja9081827; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	51	45	46	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146401	10.1371/journal.pone.0146401	http://dx.doi.org/10.1371/journal.pone.0146401			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	26760034	Green Published, Green Submitted, gold			2022-12-27	WOS:000368033100032
J	Ishiki, A; Okinaga, S; Tomita, N; Kawahara, R; Tsuji, I; Nagatomi, R; Taki, Y; Takahashi, T; Kuzuya, M; Morimoto, S; Iijima, K; Koseki, T; Arai, H; Furukawa, K				Ishiki, Aiko; Okinaga, Shoji; Tomita, Naoki; Kawahara, Reiko; Tsuji, Ichiro; Nagatomi, Ryoichi; Taki, Yasuyuki; Takahashi, Takashi; Kuzuya, Masafumi; Morimoto, Shigeto; Iijima, Katsuya; Koseki, Takeyoshi; Arai, Hiroyuki; Furukawa, Katsutoshi			Changes in Cognitive Functions in the Elderly Living in Temporary Housing after the Great East Japan Earthquake	PLOS ONE			English	Article							OLDER-ADULTS; DEMENTIA; TSUNAMI; PREVALENCE; IMPAIRMENT; DISEASES; IWATE; RISK	On March 11, 2011, Japan experienced an earthquake of magnitude 9.0 and subsequent enormous tsunamis. This disaster destroyed many coastal cities and caused nearly 20,000 casualties. In the aftermath of the disaster, many tsunami survivors who lost their homes were forced to live in small temporary apartments. Although all tsunami survivors were at risk of deteriorating health, the elderly people were particularly at a great risk with regard to not only their physical health but also their mental health. In the present study, we performed a longitudinal cohort study to investigate and analyze health conditions and cognitive functions at 28, 32, and 42 months after the disaster in the elderly people who were forced to reside in temporary apartments in Kesennuma, a city severely damaged by the tsunamis. The ratio of people considered to be cognitively impaired significantly increased during the research period. On the other hand, the mean scores of the Kessler Psychological Distress Scale-6 and Athens Insomnia Scale improved based on the comparison between the data at 24 and 42 months. The multiple logistic regression analysis revealed that frequency of "out-of-home activities" and "walking duration" were independently associated with an increase in the ratio of people with cognitive impairment. We concluded that the elderly people living in temporary apartments were at a high risk of cognitive impairment and "out-of-home activities" and "walking" could possibly maintain the stability of cognitive functions.	[Ishiki, Aiko; Okinaga, Shoji; Tomita, Naoki; Arai, Hiroyuki; Furukawa, Katsutoshi] Tohoku Univ, Dept Geriatr & Gerontol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawahara, Reiko] Tohoku Univ, Sch Med, Dept Gerontol Nursing, Sendai, Miyagi 980, Japan; [Tsuji, Ichiro] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Sendai, Miyagi 980, Japan; [Nagatomi, Ryoichi] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Engn Hlth & Welf, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Takahashi, Takashi] Kitasato Univ, Dept Infect Control & Immunol, Kitasato Inst Life Sci, Tokyo, Japan; [Takahashi, Takashi] Kitasato Univ, Grad Sch Infect Control Sci, Kitasato Inst Life Sci, Tokyo, Japan; [Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Dept Community Healthcare & Geriatr, Nagoya, Aichi 4648601, Japan; [Morimoto, Shigeto] Kanazawa Med Univ, Dept Geriatr Med, Uchinada, Ishikawa 92002, Japan; [Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Tokyo, Japan; [Koseki, Takeyoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Kitasato University; Kitasato University; Nagoya University; Kanazawa Medical University; University of Tokyo; Tohoku University	Furukawa, K (corresponding author), Tohoku Univ, Dept Geriatr & Gerontol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	kfurukawa-ns@umin.ac.jp	Nagatomi, Ryoichi/T-5296-2019; Nagatomi, Ryoichi/Q-8792-2016	Nagatomi, Ryoichi/0000-0003-3038-7202; Takahashi, Takashi/0000-0003-4131-2062	Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study is supported by the funding of the Ministry of Health, Labor and Welfare, and the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Abbott RD, 2004, JAMA-J AM MED ASSOC, V292, P1447, DOI 10.1001/jama.292.12.1447; Cloyd E, 2010, CRIT CARE NURS CLIN, V22, P501, DOI 10.1016/j.ccell.2010.10.003; Dyer CB, 2008, DISASTER MED PUBLIC, V2, pS45, DOI 10.1097/DMP.0b013e3181647b81; Furukawa K, 2013, GERIATR GERONTOL INT, V13, P1081, DOI 10.1111/ggi.12085; Furukawa K, 2012, J NEUROL, V259, P1243, DOI 10.1007/s00415-011-6329-x; Furukawa K, 2011, LANCET, V377, P1652, DOI 10.1016/S0140-6736(11)60671-5; Ikejima C, 2012, PSYCHOGERIATRICS, V12, P120, DOI 10.1111/j.1479-8301.2012.00415.x; Inoue M, 2009, AM J ALZHEIMERS DIS, V24, P129, DOI 10.1177/1533317508330222; Ishiki A, 2015, GERIATR GERONTOL INT, V15, P232, DOI 10.1111/ggi.12290; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; Kaspar R, 2015, J APPL GERONTOL, V34, P26, DOI 10.1177/0733464812466290; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Nakaya N, 2015, DISASTER MED PUBLIC, V9, P374, DOI 10.1017/dmp.2015.52; Omama S, 2014, CEREBROVASC DIS, V37, P451, DOI 10.1159/000363278; Omama S, 2013, STROKE, V44, P1518, DOI 10.1161/STROKEAHA.111.000442; Sakuma A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0440-y; Shibahara I, 2013, EPILEPSIA, V54, pe49, DOI 10.1111/epi.12070; Tomata Y, 2014, J EPIDEMIOL COMMUN H, V68, P530, DOI 10.1136/jech-2013-203541; Urakami K, 2008, NIHON RINSHO S1, V66, P573; Urakami Katsuya, 2007, Nihon Ronen Igakkai Zasshi, V44, P312, DOI 10.3143/geriatrics.44.312; Wettstein M, 2015, J APPL GERONTOL, V34, P3, DOI 10.1177/0733464812459373	21	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0147025	10.1371/journal.pone.0147025	http://dx.doi.org/10.1371/journal.pone.0147025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA8CX	26760971	Green Published, gold			2022-12-27	WOS:000368033100063
J	Liu, YJ; Zhang, YH; Li, LF; Du, RQ; Zhang, JH; Zhang, JX				Liu, Ying-Juan; Zhang, Yao-Hua; Li, Lai-Fu; Du, Rui-Qing; Zhang, Jin-Hua; Zhang, Jian-Xu			Cross-Fostering of Male Mice Subtly Affects Female Olfactory Preferences	PLOS ONE			English	Article							SEXUAL ATTRACTIVENESS; MAMMALIAN PHEROMONES; CHEMICAL SIGNALS; PREPUTIAL GLAND; GENETIC-BASIS; MATE CHOICE; MOUSE; ODOR; RECOGNITION; URINE	The maternal environment has been shown to influence female olfactory preferences through early chemosensory experience. However, little is known about the influence of the maternal environment on chemosignals. In this study, we used two inbred mouse strains, C57BL/6 (C57) and BALB/c (BALB), and explored whether adoption could alter male chemosignals and thus influence female olfactory preferences. In Experiment 1, C57 pups were placed with BALB dams. Adult BALB females then served as the subjects in binary choice tests between paired male urine odours (BALB vs. C57, BALB vs. adopted C57 and C57 vs. adopted C57). In Experiment 2, BALB pups were placed with C57 dams, and C57 females served as the subjects in binary choice tests between paired male urine odours (C57 vs. BALB, C57 vs. adopted BALB, and BALB vs. adopted BALB). In both experiments, we found that females preferred the urine of males from different genetic backgrounds, suggesting that female olfactory preferences may be driven by genetic compatibility. Cross-fostering had subtle effects on female olfactory preferences. Although the females showed no preference between the urine odours of adopted and non-adopted males of the other strain, the BALB females preferred the urine odour of BALB males to that of adopted C57 males, whereas the C57 females showed no preference between the urine odour of C57 and adopted BALB males. Using gas chromatography-mass spectrometry (GC-MS) and stepwise discriminant analysis, we found that the ratios of volatile chemicals from urine and preputial gland secretions were altered in the fostered male mice; these changes may have resulted in the behavioural changes observed in the females. Overall, the results suggest that female mice prefer urine odours from males with different genetic backgrounds; this preference may be driven by genetic compatibility. The early maternal environment influences the chemosignals of males and thus may influence the olfactory preferences of females. Our study provides additional evidence in support of genotype-dependent maternal influences on phenotypic variability in adulthood.	[Liu, Ying-Juan; Li, Lai-Fu; Du, Rui-Qing] Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Henan Province, Peoples R China; [Liu, Ying-Juan; Zhang, Yao-Hua; Zhang, Jin-Hua; Zhang, Jian-Xu] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Nanyang Normal College; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhang, JX (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	zhangjx@ioz.ac.cn		Zhang, Yao-Hua/0000-0002-6318-413X	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11010400]; China National Science Foundation [31272322]; State Key Laboratory of Integrated Management of Pest Insects and Rodents [Chinese] [IPM1403]; Key Scientific Research Project of Henan Colleges and Universities [15A180053]; School-level Research Project of Nanyang Normal University [Zx2014063]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China National Science Foundation(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Integrated Management of Pest Insects and Rodents [Chinese]; Key Scientific Research Project of Henan Colleges and Universities; School-level Research Project of Nanyang Normal University	This work was mainly supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11010400, J-XZ], the China National Science Foundation [31272322, J-XZ, http://www.nsfc.gov.cn/], the State Key Laboratory of Integrated Management of Pest Insects and Rodents [Chinese IPM1403, http://www.ioz.ac.cn/, Y-JL], the Key Scientific Research Project of Henan Colleges and Universities [15A180053, Y-JL], and the School-level Research Project of Nanyang Normal University [No.: Zx2014063, Y-JL, http://www.nynu.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; [Anonymous], 2014, PHEROMONES ANIMAL BE; Asaba A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00231; Bartolomucci A, 2004, GENES BRAIN BEHAV, V3, P115, DOI 10.1111/j.1601-183X.2003.00059.x; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Daft JG, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0080-y; Fortes-Marco L, 2013, ANAT REC, V296, P1346, DOI 10.1002/ar.22745; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Hager R, 2003, NATURE, V421, P533, DOI 10.1038/nature01239; Hager R, 2009, P ROY SOC B-BIOL SCI, V276, P2949, DOI 10.1098/rspb.2009.0515; Isles AR, 2001, NATURE, V409, P783, DOI 10.1038/35057323; Janotova K, 2011, J CHEM ECOL, V37, P647, DOI 10.1007/s10886-011-9966-8; Johnston RE, 2003, J MAMMAL, V84, P1141, DOI 10.1644/BLe-010; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Lalonde R, 2008, J NEUROSCI METH, V171, P48, DOI 10.1016/j.jneumeth.2008.02.003; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Lerch S, 2014, BEHAV BRAIN RES, V274, P270, DOI 10.1016/j.bbr.2014.08.021; Liberles SD, 2014, ANNU REV PHYSIOL, V76, P151, DOI 10.1146/annurev-physiol-021113-170334; Lu LL, 2009, BEHAV BRAIN RES, V198, P172, DOI 10.1016/j.bbr.2008.10.031; Luchetti A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00093; Maestripieri D., 2009, MATERNAL EFFECTS MAM; Martinez-Ricos J, 2008, NEUROSCIENCE, V153, P383, DOI 10.1016/j.neuroscience.2008.02.002; Martinez-Ricos J, 2007, CHEM SENSES, V32, P139, DOI 10.1093/chemse/bjl039; Novotny M.V., 1999, ADV CHEM SIGNALS VER, P99, DOI [10.1007/978-1-4615, DOI 10.1007/978-1-4615, 10.1007/978-1-4615-4733-4_7, DOI 10.1007/978-1-4615-4733-4_7]; Penn D, 1998, P ROY SOC B-BIOL SCI, V265, P1299, DOI 10.1098/rspb.1998.0433; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Roberts SC, 2005, CHEM SENSES, V30, P651, DOI 10.1093/chemse/bji058; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; ROWLEY I, 1986, BEHAVIOUR, V96, P1, DOI 10.1163/156853986X00180; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Simo C, 2004, ELECTROPHORESIS, V25, P2885, DOI 10.1002/elps.200305838; Stowers L, 2015, CURR OPIN NEUROBIOL, V34, P103, DOI 10.1016/j.conb.2015.02.005; Sun LX, 1998, BEHAV ECOL SOCIOBIOL, V44, P199, DOI 10.1007/s002650050532; Thom MD, 2008, CURR BIOL, V18, P619, DOI 10.1016/j.cub.2008.03.056; van der Veen R, 2008, GENES BRAIN BEHAV, V7, P184, DOI 10.1111/j.1601-183X.2007.00337.x; Yamazaki K, 2000, P NATL ACAD SCI USA, V97, P10500, DOI 10.1073/pnas.180320997; Yano S, 2012, J VET MED SCI, V74, P1311, DOI 10.1292/jvms.12-0067; Yoshikawa K, 2013, NAT CHEM BIOL, V9, P160, DOI [10.1038/NCHEMBIO.1164, 10.1038/nchembio.1164]; Zhang JX, 2008, PHYSIOL BEHAV, V95, P388, DOI 10.1016/j.physbeh.2008.07.002; Zhang JX, 2008, J ETHOL, V26, P279, DOI 10.1007/s10164-007-0060-1; Zhang JX, 2007, CHEM SENSES, V32, P293, DOI 10.1093/chemse/bjl058; Zhang JX, 2010, CHEM SENSES, V35, P47, DOI 10.1093/chemse/bjp081; Zhang YH, 2011, CHEM SENSES, V36, P125, DOI 10.1093/chemse/bjq103	46	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146662	10.1371/journal.pone.0146662	http://dx.doi.org/10.1371/journal.pone.0146662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756471	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888800024
J	Alanazi, AM; Abdelhameed, AS				Alanazi, Amer M.; Abdelhameed, Ali Saber			A Spectroscopic Approach to Investigate the Molecular Interactions between the Newly Approved Irreversible ErbB blocker "Afatinib" and Bovine Serum Albumin	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; BINDING INTERACTION; FLUORESCENCE; OXYGEN; SITES	The interaction of afatinib (AFB) with bovine serum albumin (BSA) was examined via fluorescence and UV-Vis spectroscopy. Spectrofluorimetric measurements revealed that AFB can strongly quench the BSA intrinsic fluorescence through producing a non-fluorescent complex. This quenching mechanism was thoroughly investigated with regard to the type of quenching, binding constant, number of binding locations and the fundamental thermodynamic parameters. Subsequently, the association constant of AFB with BSA was computed at three different temperatures and was found to range from 7.34 to 13.19 x 10(5) L mol(-1). Thermodynamic parameters calculations demonstrated a positive Delta S-circle minus value with both negative Delta H-circle minus and Delta G(circle minus) values for AFB-BSA complex, which in turn infers thata spontaneous binding is taking place with both electrostatic bonding and hydrophobic interactions participating in the binding of AFB and BSA. Similarly, the UV absorption spectra of AFB-BSA system were studied and confirmed the interaction. Conformational alteration of the protein upon binding to AFB was elaborated with the aid of three dimensional fluorescence measurements as well as synchronous fluorescence spectra.	[Alanazi, Amer M.; Abdelhameed, Ali Saber] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh 11451, Saudi Arabia	King Saud University	Abdelhameed, AS (corresponding author), King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia.	asaber@ksu.edu.sa	Alanazi, Amer/GQY-8440-2022; Abdelhameed, Ali/A-1333-2012	Abdelhameed, Ali/0000-0002-5910-2832	Deanship of Scientific Research at King Saud University [RG-1435-025]	Deanship of Scientific Research at King Saud University(King Saud University)	This study was funded by the Deanship of Scientific Research at King Saud University through research group No. RG-1435-025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding this Research Group No. RG-1435-025	Abdelhameed A.S., 2015, ANAL METHODS; Abdelhameed AS, 2015, J SPECTROSCOPY 2015; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; BLAUER G, 1970, J BIOL CHEM, V245, P372; Bolel P, 2012, J AGR FOOD CHEM, V60, P3727, DOI 10.1021/jf205219w; Borissevitch IE, 1996, J LUMIN, V69, P65, DOI 10.1016/0022-2313(96)00037-3; Bourassa P, 2013, J PHYS CHEM B, V117, P1287, DOI 10.1021/jp3114557; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Chen G.-Z., 1990, SPECTROFLUORIMETRIC; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Forster T., 1996, MODERN QUANTUM CHEM; GLAZER AN, 1961, J BIOL CHEM, V236, P2942; Gong AQ, 2007, TALANTA, V73, P668, DOI 10.1016/j.talanta.2007.04.041; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hu YD, 2014, SPECTROCHIM ACTA A, V121, P230, DOI 10.1016/j.saa.2013.09.078; Huang YM, 2001, TALANTA, V53, P835, DOI 10.1016/S0039-9140(00)00569-5; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Lakowicz JR, 1999, PRINCIPLE OF FLUORES; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu JQ, 2004, J PHARMACEUT BIOMED, V35, P671, DOI 10.1016/j.jpba.2004.02.010; Liu JQ, 2003, ANAL BIOANAL CHEM, V376, P864, DOI 10.1007/s00216-003-2017-8; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Rub MA, 2014, J LUMIN, V155, P39, DOI 10.1016/j.jlumin.2014.06.009; Sattar Z, 2012, SPECTROCHIM ACTA A, V97, P1089, DOI 10.1016/j.saa.2012.07.034; Shcharbin D, 2005, J FLUORESC, V15, P21, DOI 10.1007/s10895-005-0209-7; Shen GF, 2015, J PHOTOCH PHOTOBIO B, V153, P380, DOI 10.1016/j.jphotobiol.2015.10.023; Shi JH, 2015, SPECTROCHIM ACTA A, V149, P630, DOI 10.1016/j.saa.2015.04.034; SPECTOR AA, 1969, J LIPID RES, V10, P56; Stern O, 1919, PHYS Z, V20, P183; Stopfer P, 2012, CANCER CHEMOTH PHARM, V69, P1051, DOI 10.1007/s00280-011-1803-9; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Sulkowska A, 2002, J MOL STRUCT, V614, P227, DOI 10.1016/S0022-2860(02)00256-9; Tian JN, 2005, BIOORGAN MED CHEM, V13, P4124, DOI 10.1016/j.bmc.2005.02.065; Wang HL, 2013, J FLUORESC, V23, P323, DOI 10.1007/s10895-012-1150-1; Wang YQ, 2007, J PHARMACEUT BIOMED, V43, P1869, DOI 10.1016/j.jpba.2007.01.001; Wang YP, 2006, J PHOTOCH PHOTOBIO A, V177, P6, DOI 10.1016/j.jphotochem.2005.04.040; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Yan H, 2009, J SOLUTION CHEM, V38, P1183, DOI 10.1007/s10953-009-9438-8; Zhang HX, 2008, J SOLUTION CHEM, V37, P631, DOI 10.1007/s10953-008-9268-0; Zhang HX, 2009, MOL BIOL REP, V36, P1405, DOI 10.1007/s11033-008-9329-x; Zhou B, 2007, J BIOCHEM BIOPH METH, V70, P743, DOI 10.1016/j.jbbm.2007.04.001; Zhou N, 2007, J PHOTOCH PHOTOBIO A, V185, P271, DOI 10.1016/j.jphotochem.2006.06.019; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	46	31	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146297	10.1371/journal.pone.0146297	http://dx.doi.org/10.1371/journal.pone.0146297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751077	Green Submitted, Green Published, gold			2022-12-27	WOS:000367888100061
J	Hedermann, G; Vissing, CR; Heje, K; Preisler, N; Witting, N; Vissing, J				Hedermann, Gitte; Vissing, Christoffer Rasmus; Heje, Karen; Preisler, Nicolai; Witting, Nanna; Vissing, John			Aerobic Training in Patients with Congenital Myopathy	PLOS ONE			English	Article							EXERCISE; FITNESS; FATIGUE	Introduction Congenital myopathies (CM) often affect contractile proteins of the sarcomere, which could render patients susceptible to exercise-induced muscle damage. We investigated if exercise is safe and beneficial in patients with CM. Methods Patients exercised on a stationary bike for 30 minutes, three times weekly, for 10 weeks at 70% of their maximal oxygen uptake (VO2max). Creatine kinase (CK) was monitored as a marker of muscle damage. VO2max, functional tests, and questionnaires evaluated efficacy. Results Sixteen patients with CM were included in a controlled study. VO2max increased by 14% (range, 6-25%; 95% CI 7-20; p < 0.001) in the seven patients who completed training, and tended to decrease in a non-intervention group (n = 7; change -3.5%; range, -11-3%, p = 0.083). CK levels were normal and remained stable during training. Baseline Fatigue Severity Scale scores were high, 4.9 (SE 1.9), and tended to decrease (to 4.4 (SE 1.7); p = 0.08) with training. Nine patients dropped out of the training program. Fatigue was themajor single reason. Conclusions Ten weeks of endurance training is safe and improves fitness in patients with congenital myopathies. The training did not cause sarcomeric injury, even though sarcomeric function is affected by the genetic abnormalities in most patients with CM. Severe fatigue, which characterizes patients with CM, is a limiting factor for initiating training in CM, but tends to improve in those who train.	[Hedermann, Gitte; Vissing, Christoffer Rasmus; Heje, Karen; Preisler, Nicolai; Witting, Nanna; Vissing, John] Univ Copenhagen, Rigshosp, Dept Neurol, Copenhagen Neuromuscular Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Hedermann, G (corresponding author), Univ Copenhagen, Rigshosp, Dept Neurol, Copenhagen Neuromuscular Ctr, DK-2100 Copenhagen, Denmark.	hedermann@gmail.com	Christensen, Gitte Hedermann/GRY-3412-2022; Vissing, Christoffer/AAX-2530-2020	Christensen, Gitte Hedermann/0000-0001-8853-0986; Witting, Nanna/0000-0002-0664-0709; Vissing, Christoffer/0000-0002-0834-206X	Direktor Jacob Madsen & Hustru Olga Madsen foundation [5289]	Direktor Jacob Madsen & Hustru Olga Madsen foundation	Funding provided by Direktor Jacob Madsen & Hustru Olga Madsen foundation. Grant no. 5289. No website. Received by GH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkens S, 2005, ARCH PHYS MED REHAB, V86, P1030, DOI 10.1016/j.apmr.2004.09.012; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Iannaccone Susan T, 2013, Continuum (Minneap Minn), V19, P1509, DOI 10.1212/01.CON.0000440658.03557.f1; Madsen KL, 2015, MUSCLE NERVE, V52, P240, DOI 10.1002/mus.24527; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; North KN, 2014, NEUROMUSCULAR DISORD, V24, P97, DOI 10.1016/j.nmd.2013.11.003; Olsen DB, 2005, NEUROLOGY, V64, P1064, DOI 10.1212/01.WNL.0000150584.45055.27; Orngreen MC, 2005, ANN NEUROL, V57, P754, DOI 10.1002/ana.20460; Preisler N, 2009, NEUROLOGY, V72, P317, DOI 10.1212/01.wnl.0000341274.61236.02; Sveen ML, 2007, NEUROLOGY, V68, P59, DOI 10.1212/01.wnl.0000250358.32199.24; Sveen ML, 2008, BRAIN, V131, P2824, DOI 10.1093/brain/awn189; Vissing CR, 2014, MUSCLE NERVE, V50, P119, DOI 10.1002/mus.24112; Voet N, 2014, NEUROLOGY, V83, P1914, DOI 10.1212/WNL.0000000000001008; Werlauff U, 2014, QUAL LIFE RES, V23, P1479, DOI 10.1007/s11136-013-0565-8	14	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146036	10.1371/journal.pone.0146036	http://dx.doi.org/10.1371/journal.pone.0146036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751952	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100039
J	Jueng, RN; Tsai, DC; Chen, IJ				Jueng, Ruo-Nan; Tsai, Der-Chong; Chen, I-Ju			Sense of Coherence among Older Adult Residents of Long-Term Care Facilities in Taiwan: A Cross-Sectional Analysis	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; QUALITY-OF-LIFE; COGNITIVE IMPAIRMENT; ANTONOVSKYS SENSE; MENTAL-HEALTH; FOLLOW-UP; SCALE; SELF; EXPERIENCES; EDUCATION	Background Growing evidence shows that sense of coherence (SOC) is related to health promotion. Knowledge of SOC among older adults in Taiwan is limited. The present study aimed to investigate SOC status and its relationship to personal and environmental factors among older adult residents of long-term care facilities (LTCFs) in northeastern Taiwan. Methods This cross-sectional study was performed in Yilan, Taiwan. With face-to-face interviews, we obtained data from 104 LTCF residents (aged 65 years and older) using the Chinese version of Antonovsky's short 13-item SOC scale. We also collected the information on personal characteristics, physical and social environmental resources. Multiple linear regression was used to analyze factors potentially influencing SOC. Results Of the participants, the mean score (+/- standard deviation) of SOC was 58.3 (+/- 8.8), while scores on SOC subscales (comprehensibility, manageability, and meaningfulness) were 23.4 +/- 4.5, 17.9 +/- 3.8, and 17.0 +/- 3.2, respectively. Education level, activities of daily living and number of LTCF staff were found to be independently associated with SOC status after adjusting for demographic characteristics, health status, and environmental resources. In addition, interactions between personal and environmental factors had a crucial influence on SOC status. Conclusions Participants in this study had relatively low SOC scores compared to their counterparts in Western countries. In addition to personal factors, environmental factors can play a significant role in SOC status among older adult LTCF residents. Comprehensive evaluation of SOC status should consider person-environment interaction effects.	[Jueng, Ruo-Nan; Chen, I-Ju] Natl Yang Ming Univ, Inst & Dept Nursing, Taipei 112, Taiwan; [Jueng, Ruo-Nan] Natl Yang Ming Univ Hosp, Dept Nursing, Yilan, Taiwan; [Tsai, Der-Chong] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Tsai, Der-Chong] Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, IJ (corresponding author), Natl Yang Ming Univ, Inst & Dept Nursing, Taipei 112, Taiwan.	ijchen@ym.edu.tw			National Yang-Ming University Hospital [2010B045]	National Yang-Ming University Hospital	This work was supported by the National Yang-Ming University Hospital under Grant 2010B045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Antonovsky A, 1996, HEALTH PROMOT INT, V11, P11, DOI 10.1093/heapro/11.1.11; Antonovsky A., 1987, UNRAVELING MYSTERY H; Antonovsky A., 1979, HLTH STRESS COPING N; Borglin G, 2006, HEALTH SOC CARE COMM, V14, P136, DOI 10.1111/j.1365-2524.2006.00603.x; Calkins M.P., 2003, J HOUS ELDER, V17, P67, DOI [10.1300/J081v17n01_06, DOI 10.1300/J081V17N01_06]; Chang EC, 2003, J PERS SOC PSYCHOL, V84, P569, DOI 10.1037/0022-3514.84.3.569; Cole CS, 2007, J HOLIST NURS, V25, P96, DOI 10.1177/0898010106295187; Drageset J, 2014, AGING MENT HEALTH, V18, P889, DOI 10.1080/13607863.2014.896866; Drageset J, 2012, J CLIN NURS, V21, P965, DOI 10.1111/j.1365-2702.2011.03932.x; Drageset J, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-85; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; Eriksson M, 2006, J EPIDEMIOL COMMUN H, V60, P376, DOI 10.1136/jech.2005.041616; Eriksson M, 2008, HEALTH PROMOT INT, V23, P190, DOI 10.1093/heapro/dan014; Giglio RE, 2015, INT PSYCHOGERIATR, V27, P621, DOI 10.1017/S1041610214002440; Helvik AS, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-82; Hill EE, 2009, RES GERONTOL NURS, V2, P287, DOI 10.3928/19404921-20090527-02; Hwang HL, 2013, SCAND J CARING SCI, V27, P695, DOI 10.1111/j.1471-6712.2012.01082.x; Lawton M., 1982, AGING ENV THEORETICA, P33; Lee DTF, 2002, J ADV NURS, V37, P19, DOI 10.1046/j.1365-2648.2002.02060.x; Lindstrom B, 2005, J EPIDEMIOL COMMUN H, V59, P440, DOI 10.1136/jech.2005.034777; Lovheim H, 2013, SCAND J CARING SCI, V27, P13, DOI 10.1111/j.1471-6712.2012.00988.x; Meeks S, 2001, J AGING HEALTH, V13, P92, DOI 10.1177/089826430101300105; Ministry of Health and Welfare, EST STAND SEN CIT WE; Murrell SA, 2002, J AGING HEALTH, V14, P527, DOI 10.1177/089826402237182; Naaldenberg J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-37; Nilsson B, 2000, SCAND J PRIM HEALTH, V18, P14; Nygren B, 2005, AGING MENT HEALTH, V9, P354, DOI 10.1080/1360500114415; Posadzki P, 2010, SCAND J PSYCHOL, V51, P246, DOI 10.1111/j.1467-9450.2009.00764.x; Shiu ATY, 2004, INT J NURS STUD, V41, P387, DOI 10.1016/j.ijnurstu.2003.10.010; Soderhamn Olle, 2010, Br J Community Nurs, V15, P376; Tang Siew Tzuh, 2002, J Nurs Meas, V10, P59, DOI 10.1891/jnum.10.1.59.52544; Thygesen E, 2009, INT J OLDER PEOPLE N, V4, P12, DOI 10.1111/j.1748-3743.2008.00132.x; Thygesen E, 2009, AGING MENT HEALTH, V13, P319, DOI 10.1080/13607860802534591; Tsuno YS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1107; Wang Chia-Hui, 2006, J Nurs Res, V14, P123; Wiesmann U, 2008, AGING MENT HEALTH, V12, P56, DOI 10.1080/13607860701365998; Wiesmann U, 2009, BRIT J HEALTH PSYCH, V14, P767, DOI 10.1348/135910709X413124; Xu DJ, 2013, ARCH GERONTOL GERIAT, V57, P127, DOI 10.1016/j.archger.2013.03.015; Young HM, 2006, GERIATR NURS, V27, P346, DOI 10.1016/j.gerinurse.2006.08.014	41	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146912	10.1371/journal.pone.0146912	http://dx.doi.org/10.1371/journal.pone.0146912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26751949	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100179
J	Ngamprasertwong, P; Dong, M; Niu, J; Venkatasubramanian, R; Vinks, AA; Sadhasivam, S				Ngamprasertwong, Pornswan; Dong, Min; Niu, Jing; Venkatasubramanian, Raja; Vinks, Alexander A.; Sadhasivam, Senthilkumar			Propofol Pharmacokinetics and Estimation of Fetal Propofol Exposure during Mid-Gestational Fetal Surgery: A Maternal-Fetal Sheep Model	PLOS ONE			English	Article							ELECTIVE CESAREAN-SECTION; PLACENTAL-TRANSFER; IN-VITRO; PREGNANT EWES; CLINICAL USE; ANESTHESIA; PHARMACODYNAMICS; ALFENTANIL; INDUCTION; BINDING	Background Measuring fetal drug concentrations is extremely difficult in humans. We conducted a study in pregnant sheep to simultaneously describe maternal and fetal concentrations of propofol, a common intravenous anesthetic agent used in humans. Compared to inhalational anesthesia, propofol supplemented anesthesia lowered the dose of desflurane required to provide adequate uterine relaxation during open fetal surgery. This resulted in better intraoperative fetal cardiac outcome. This study describes maternal and fetal propofol pharmacokinetics (PK) using a chronically instrumented maternal-fetal sheep model. Methods Fetal and maternal blood samples were simultaneously collected from eight mid-gestational pregnant ewes during general anesthesia with propofol, remifentanil and desflurane. Nonlinear mixed-effects modeling was performed by using NONMEM software. Total body weight, gestational age and hemodynamic parameters were tested in the covariate analysis. The final model was validated by bootstrapping and visual predictive check. Results A total of 160 propofol samples were collected. A 2-compartment maternal PK model with a third fetal compartment appropriately described the data. Mean population parameter estimates for maternal propofol clearance and central volume of distribution were 4.17 L/min and 37.7 L, respectively, in a typical ewe with a median heart rate of 135 beats/min. Increase in maternal heart rate significantly correlated with increase in propofol clearance. The estimated population maternal-fetal inter-compartment clearance was 0.0138 L/min and the volume of distribution of propofol in the fetus was 0.144 L. Fetal propofol clearance was found to be almost negligible compared to maternal clearance and could not be robustly estimated. Conclusions For the first time, a maternal-fetal PK model of propofol in pregnant ewes was successfully developed. This study narrows the gap in our knowledge in maternal-fetal PK model in human. Our study confirms that maternal heart rate has an important influence on the pharmacokinetics of propofol during pregnancy. Much lower propofol concentration in the fetus compared to maternal concentrations explain limited placental transfer in in-vivo paired model, and less direct fetal cardiac depression we observed earlier with propofol supplemented inhalational anesthesia compared to higher dose inhalational anesthesia in humans and sheep.	[Ngamprasertwong, Pornswan; Niu, Jing; Venkatasubramanian, Raja; Sadhasivam, Senthilkumar] Cincinnati Childrens Hosp Med Ctr, Dept Anesthesiol, Cincinnati, OH 45229 USA; [Dong, Min; Niu, Jing; Venkatasubramanian, Raja; Vinks, Alexander A.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Clin Pharmacol, Cincinnati, OH 45229 USA; [Niu, Jing] Shanghai Childrens Med Ctr, Dept Anesthesia, Shanghai, Peoples R China	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Shanghai Jiao Tong University	Ngamprasertwong, P (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Anesthesiol, Cincinnati, OH 45229 USA.	pornswan.ngamprasertwong@cchmc.org	Venkatasubramanian, Raja/J-5959-2012; Niu, Jing/AAX-9502-2020	Venkatasubramanian, Raja/0000-0003-2764-0254; Vinks, Alexander/0000-0003-4224-2967	Foundation of Anesthesia Research and Education, Rochester, MN, USA; Department of Anesthesiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; NIH [5T32HD069054]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD069054] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER	Foundation of Anesthesia Research and Education, Rochester, MN, USA; Department of Anesthesiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work is supported in part by Research Fellowship Grant (PN, 7/1/2010 to 6/30/2011) from Foundation of Anesthesia Research and Education, Rochester, MN, USA; and the Department of Anesthesiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. The authors also acknowledge funding support from NIH grant 5T32HD069054 (MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegaert K, 2007, BRIT J ANAESTH, V99, P864, DOI 10.1093/bja/aem294; Andaluz A, 2003, VET J, V166, P198, DOI 10.1016/S1090-0233(02)00259-9; Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021; Bergstrand M, 2011, AAPS J, V13, P143, DOI 10.1208/s12248-011-9255-z; Boat A, 2010, PEDIATR ANESTH, V20, P748, DOI 10.1111/j.1460-9592.2010.03350.x; Correia D, 1996, RES VET SCI, V60, P213, DOI 10.1016/S0034-5288(96)90041-7; Coughtrie MW., 2015, DRUG METAB LETT; DAILLAND P, 1989, ANESTHESIOLOGY, V71, P827, DOI 10.1097/00000542-198912000-00003; Favetta P, 2002, BRIT J ANAESTH, V88, P653, DOI 10.1093/bja/88.5.653; Gill KL, 2012, DRUG METAB DISPOS, V40, P825, DOI 10.1124/dmd.111.043984; GIN T, 1990, BRIT J ANAESTH, V64, P148, DOI 10.1093/bja/64.2.148; GIN T, 1991, BRIT J ANAESTH, V67, P49, DOI 10.1093/bja/67.1.49; He YL, 2001, ANESTH ANALG, V93, P151; He YL, 2000, BRIT J ANAESTH, V85, P281, DOI 10.1093/bja/85.2.281; KANTO J, 1990, METHOD FIND EXP CLIN, V12, P707; KANTO J, 1989, CLIN PHARMACOKINET, V17, P308, DOI 10.2165/00003088-198917050-00002; Ludbrook GL, 1996, ANAESTH INTENS CARE, V24, P445, DOI 10.1177/0310057X9602400406; Ludbrook GL, 1999, J PHARMACOKINET BIOP, V27, P329, DOI 10.1023/A:1020903315017; Mazoit JX, 1999, BRIT J CLIN PHARMACO, V47, P35, DOI 10.1046/j.1365-2125.1999.00860.x; Mertens MJ, 2004, ANESTHESIOLOGY, V100, P795, DOI 10.1097/00000542-200404000-00008; MOSTELLO D, 1991, AM J PHYSIOL, V261, pR1075, DOI 10.1152/ajpregu.1991.261.5.R1075; Ngamprasertwong P, 2013, ANESTHESIOLOGY, V118, P796, DOI 10.1097/ALN.0b013e318283c954; Pavlin DJ, 1996, ANESTHESIOLOGY, V84, P23, DOI 10.1097/00000542-199601000-00004; Sanchez-Alcaraz A, 1998, J CLIN PHARM THER, V23, P19, DOI 10.1046/j.1365-2710.1998.00124.x; SHAFER SL, 1993, J CLIN ANESTH, V5, pS14; Sherwin CMT, 2014, CURR CLIN PHARMACOL, V9, P64, DOI 10.2174/1574884708666131111200417; SMITH I, 1994, ANESTHESIOLOGY, V81, P1005; VALTONEN M, 1989, ANAESTHESIA, V44, P758, DOI 10.1111/j.1365-2044.1989.tb09264.x; Vuyk J, 1997, J CLIN ANESTH, V9, pS23, DOI 10.1016/S0952-8180(97)00117-7	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146563	10.1371/journal.pone.0146563	http://dx.doi.org/10.1371/journal.pone.0146563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752560	gold, Green Published, Green Submitted			2022-12-27	WOS:000367888100100
J	Nohr, MK; Dudele, A; Poulsen, MM; Ebbesen, LH; Radko, Y; Christensen, LP; Jessen, N; Richelsen, B; Lund, S; Pedersen, SB				Nohr, Mark K.; Dudele, Anete; Poulsen, Morten M.; Ebbesen, Lene H.; Radko, Yulia; Christensen, Lars P.; Jessen, Niels; Richelsen, Bjorn; Lund, Sten; Pedersen, Steen B.			LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SYSTEMIC INFLAMMATORY RESPONSE; VISCERAL ADIPOSE-TISSUE; NF-KAPPA-B; MITOCHONDRIAL-FUNCTION; INDUCED ACTIVATION; METABOLIC DISEASE; OBESE SUBJECTS; PPAR-GAMMA; TNF-ALPHA	Low-grade inflammation is seen with obesity and is suggested to be a mediator of insulin resistance. The eliciting factor of low-grade inflammation is unknown but increased permeability of gut bacteria-derived lipopolysaccharides (LPS) resulting in endotoxemia could be a candidate. Here we test the effect of LPS and the anti-inflammatory compound resveratrol on glucose homeostasis, insulin levels and inflammation. Mice were subcutaneously implanted with osmotic mini pumps infusing either low-dose LPS or saline for 28 days. Half of the mice were treated with resveratrol delivered through the diet. LPS caused increased inflammation of the liver and adipose tissue (epididymal and subcutaneous) together with enlarged spleens and increased number of leukocytes in the blood. Resveratrol specifically reduced the inflammatory status in epididymal fat (reduced expression of TNFa and Il1b, whereas the increased macrophage infiltration was unaltered) without affecting the other tissues investigated. By LC-MS, we were able to quantitate resveratrol metabolites in epididymal but not subcutaneous adipose tissue. LPS induced insulin resistance as the glucose-stimulated insulin secretion during an oral glucose tolerance test was increased despite similar plasma glucose level resulting in an increase in the insulinogenic index (IGI; delta(0-15)insulin/delta(0-15)glucose) from 13.73 to 22.40 pmol/mmol (P < 0.001). This aberration in insulin and glucose homeostasis was normalized by resveratrol. In conclusion: Low-dose LPS enhanced the glucose-stimulated insulin secretion without affecting the blood glucose suggesting increased insulin resistance. Resveratrol restored LPS-induced alteration of the insulin secretion and demonstrated anti-inflammatory effects specifically in epididymal adipose tissue possibly due to preferential accumulation of resveratrol metabolites pointing towards a possible important involvement of this tissue for the effects on insulin resistance and insulin secretion.	[Nohr, Mark K.; Poulsen, Morten M.; Richelsen, Bjorn; Lund, Sten; Pedersen, Steen B.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Nohr, Mark K.; Poulsen, Morten M.; Richelsen, Bjorn; Lund, Sten; Pedersen, Steen B.] Aarhus Univ Hosp, Dept Endocrinol & Metab C, DK-8000 Aarhus, Denmark; [Dudele, Anete] Aarhus Univ, Dept Biosci, Zoophysiol, Aarhus, Denmark; [Ebbesen, Lene H.] Aarhus Univ Hosp, Dept Hematol, DK-8000 Aarhus, Denmark; [Radko, Yulia; Christensen, Lars P.] Univ Southern Denmark, Dept Chem Engn Biotechnol & Environm Technol, Odense, Denmark; [Jessen, Niels] Aarhus Univ Hosp, Res Lab Biochem Pathol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of Southern Denmark; Aarhus University	Nohr, MK (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	mkln@clin.au.dk	Jessen, Niels/E-1731-2011; Christensen, Lars P./I-7011-2016; Pedersen, Steen B./AAB-3331-2019	Christensen, Lars P./0000-0002-5035-9201; Pedersen, Steen B./0000-0002-7838-8063; Jessen, Niels/0000-0001-5613-7274; Nohr, Mark Klitgaard/0000-0002-5536-654X; Richelsen, Bjoern/0000-0001-8886-9736; Lund, Sten/0000-0002-3805-6267	A.P. Moller Foundation; Graduate School of Health, Aarhus University; Danish Council for Strategic Research [10-093499]	A.P. Moller Foundation; Graduate School of Health, Aarhus University; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The project was supported by grants from The A.P. Moller Foundation for the Advancement of Medical Science (MKN). MKN was supported by a Ph.D. scholarship from the Graduate School of Health, Aarhus University. The study is part of the research program LIRMOI Research Center (www.LIRMOI.com), which is supported by the Danish Council for Strategic Research (Grant 10-093499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Nguyen AT, 2014, DIABETES, V63, P471, DOI 10.2337/db13-0903; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Brix-Christensen V, 2004, ANESTHESIOLOGY, V100, P861, DOI 10.1097/00000542-200404000-00016; Caesar R, 2012, GUT, V61, P1701, DOI 10.1136/gutjnl-2011-301689; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cullberg KB, 2013, EUR J PHARM SCI, V49, P251, DOI 10.1016/j.ejps.2013.02.014; Dao TMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020700; De La Rosa G, 2013, J TRAUMA ACUTE CARE, V74, P270, DOI 10.1097/TA.0b013e3182788042; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Gao XH, 2001, BIOCHEM PHARMACOL, V62, P1299, DOI 10.1016/S0006-2952(01)00775-4; Garidou L, 2015, CELL METAB, V22, P100, DOI 10.1016/j.cmet.2015.06.001; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Heynekamp JJ, 2006, J MED CHEM, V49, P7182, DOI 10.1021/jm060630x; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jeschke MG, 2004, ENDOCRINOLOGY, V145, P4084, DOI 10.1210/en.2004-0592; Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004; Kahles F, 2014, DIABETES, V63, P3221, DOI 10.2337/db14-0100; Kidd LB, 2008, J PHARMACOL EXP THER, V326, P348, DOI 10.1124/jpet.108.138891; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Knop FK, 2013, DIABETIC MED, V30, P1214, DOI 10.1111/dme.12231; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larrosa M, 2011, EUR J NUTR, V50, P673, DOI 10.1007/s00394-011-0178-3; Lihn AS, 2004, MOL CELL ENDOCRINOL, V219, P9, DOI 10.1016/j.mce.2004.03.002; Lihn AS, 2003, AM J PHYSIOL-ENDOC M, V285, pE1072, DOI 10.1152/ajpendo.00206.2003; Liu K, 2010, BIOCHIMIE, V92, P789, DOI 10.1016/j.biochi.2010.02.024; Luche E, 2013, MOL METAB, V2, P281, DOI 10.1016/j.molmet.2013.06.005; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Moller AB, 2015, J APPL PHYSIOL, V118, P971, DOI 10.1152/japplphysiol.01116.2014; Moschen AR, 2010, GUT, V59, P1259, DOI 10.1136/gut.2010.214577; Olholm J, 2010, INT J OBESITY, V34, P1546, DOI 10.1038/ijo.2010.98; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Radko Y, 2013, J CHROMATOGR B, V930, P54, DOI 10.1016/j.jchromb.2013.05.002; Sebai H, 2010, FOOD CHEM TOXICOL, V48, P1543, DOI 10.1016/j.fct.2010.03.022; Sebai H, 2009, ARCH TOXICOL, V83, P335, DOI 10.1007/s00204-008-0348-0; SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	54	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146840	10.1371/journal.pone.0146840	http://dx.doi.org/10.1371/journal.pone.0146840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751381	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100161
J	Yang, A; Currier, D; Poitras, JL; Reeves, RH				Yang, Annan; Currier, Duane; Poitras, Jennifer L.; Reeves, Roger H.			Increased Skin Tumor Incidence and Keratinocyte Hyper-Proliferation in a Mouse Model of Down Syndrome	PLOS ONE			English	Article							CALCINEURIN INHIBITOR DSCR1; PROTEIN-KINASE-C; GENE-EXPRESSION; SOLID TUMORS; ANGIOGENESIS; GROWTH; CANCER; TRANSCRIPTOME; LEUKEMIA; PATHWAY	Down syndrome (DS) is a genetic disorder caused by the presence of an extra copy of human chromosome 21 (Hsa21). People with DS display multiple clinical traits as a result of the dosage imbalance of several hundred genes. While many outcomes of trisomy are deleterious, epidemiological studies have shown a significant risk reduction for most solid tumors in DS. Reduced tumor incidence has also been demonstrated in functional studies using trisomic DS mouse models. Therefore, it was interesting to find that Ts1Rhr trisomic mice developed more papillomas than did their euploid littermates in a DMBA-TPA chemical carcinogenesis paradigm. Papillomas in Ts1Rhr mice also proliferated faster. The increased proliferation was likely caused by a stronger response of trisomy to TPA induction. Treatment with TPA caused hyperkeratosis to a greater degree in Ts1Rhr mice than in euploid, reminiscent of hyperkeratosis seen in people with DS. Cultured trisomic keratinocytes also showed increased TPA-induced proliferation compared to euploid controls. These outcomes suggest that altered gene expression in trisomy could elevate a proliferation signalling pathway. Gene expression analysis of cultured keratinocytes revealed upregulation of several trisomic and disomic genes may contribute to this hyperproliferation. The contributions of these genes to hyper-proliferation were further validated in a siRNA knockdown experiment. The unexpected findings reported here add a new aspect to our understanding of tumorigenesis with clinical implications for DS and demonstrates the complexity of the tumor repression phenotype in this frequent condition.	[Yang, Annan; Currier, Duane; Reeves, Roger H.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Yang, Annan; Currier, Duane; Reeves, Roger H.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Poitras, Jennifer L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Reeves, RH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rreeves@jhmi.edu		Currier, Duane/0000-0002-0123-0233	Eunice Kennedy Shriver National Institute of Child Health & Human Development [R01HD038384]; National Cancer Institute [R01HD038384]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038384, U54HD079123] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Award Number R01HD038384 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development and the National Cancer Institute (RHR).; The authors thank Pierre Coulombe and Daryle Depianto for providing K17 and vimentin antibodies, for assistance with keratinocyte cultures, and for many thoughtful suggestions during the course of this work. We thank Corey Brayton for expert advice on tumor histology. This work was supported Eunice Kennedy Shriver National Institute of Child Health & Human Development and the National Cancer Institute (R01HD038384 to RHR). Opinions expressed in this work reflect those of the authors.	Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Das I, 2011, DIS MODEL MECH, V4, P596, DOI 10.1242/dmm.007716; ELSON A, 1994, BIOL CELL, V81, P23, DOI 10.1016/0248-4900(94)90051-5; Filler RB, 2007, CSH PROTOCOLS, V2007; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; GSEA MSD, GEN CYT BAND CHR21Q2; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Khan Irum, 2011, Critical Reviews in Oncogenesis, V16, P25; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Lonnstedt I, 2005, BIOSTATISTICS, V6, P279, DOI 10.1093/biostatistics/kxi009; Man AK, 2003, MOL CELL BIOL, V23, P8614, DOI 10.1128/MCB.23.23.8614-8625.2003; MILLER SJ, 1993, J INVEST DERMATOL, V100, pS288, DOI 10.1111/1523-1747.ep12470169; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Patja K, 2006, INT J CANCER, V118, P1769, DOI 10.1002/ijc.21518; Qin LL, 2006, MOL CANCER RES, V4, P811, DOI 10.1158/1541-7786.MCR-06-0126; Reynolds LE, 2010, NATURE, V465, P813, DOI 10.1038/nature09106; Rickman DS, 2008, ONCOGENE, V27, P6607, DOI 10.1038/onc.2008.251; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Saran NG, 2003, HUM MOL GENET, V12, P2013, DOI 10.1093/hmg/ddg217; Satge D, 2011, CLIN GENET, V79, P289, DOI 10.1111/j.1399-0004.2010.01521.x; Siarey RJ, 2006, J NEUROCHEM, V98, P1266, DOI 10.1111/j.1471-4159.2006.03971.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Yang AN, 2011, CANCER RES, V71, P3573, DOI 10.1158/0008-5472.CAN-10-4489; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Yuspa SH, 2000, CARCINOGENESIS, V21, P341	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146570	10.1371/journal.pone.0146570	http://dx.doi.org/10.1371/journal.pone.0146570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752700	Green Published, gold			2022-12-27	WOS:000367888100102
J	Azria, E; Kayem, G; Langer, B; Marchand-Martin, L; Marret, S; Fresson, J; Pierrat, V; Arnaud, C; Goffinet, F; Kaminski, M; Ancel, PY				Azria, Elie; Kayem, Gilles; Langer, Bruno; Marchand-Martin, Laetitia; Marret, Stephane; Fresson, Jeanne; Pierrat, Veronique; Arnaud, Catherine; Goffinet, Francois; Kaminski, Monique; Ancel, Pierre-Yves		EPIPAGE Study Grp	Neonatal Mortality and Long-Term Outcome of Infants Born between 27 and 32 Weeks of Gestational Age in Breech Presentation: The EPIPAGE Cohort Study	PLOS ONE			English	Article							DELIVERY; PRETERM; BIRTH	Objective To determine whether breech presentation is an independent risk factor for neonatal morbidity, mortality, or long-term neurologic morbidity in very preterm infants. Design Prospective population-based cohort. Population Singletons infants without congenital malformations born from 27 to 32 completed weeks of gestation enrolled in France in 1997 in the EPIPAGE cohort. Methods The neonatal and long-term follow-up outcomes of preterm infants were compared between those in breech presentation and those in vertex presentation. The relation of fetal presentation with neonatal mortality and neurodevelopmental outcomes was assessed using multiple logistic regression models. Results Among the 1518 infants alive at onset of labor included in this analysis (351 in breech presentation), 1392 were alive at discharge. Among those eligible to follow up and alive at 8 years, follow-up data were available for 1188 children. Neonatal mortality was significantly higher among breech than vertex infants (10.8% vs. 7.5%, P = 0.05). However the differences were not significant after controlling for potential confounders. Neonatal morbidity did not differ significantly according to fetal presentation. Severe cerebral palsy was less frequent in the group born in breech compared to vertex presentation but there was no difference after adjustment. There was no difference according to fetal presentation in cognitive deficiencies/ learning disabilities or overall deficiencies. Conclusion Our data suggest that breech presentation is not an independent risk factor for neonatal mortality or long-term neurologic deficiencies among very preterm infants.	[Azria, Elie; Kayem, Gilles; Marchand-Martin, Laetitia; Fresson, Jeanne; Pierrat, Veronique; Goffinet, Francois; Kaminski, Monique; Ancel, Pierre-Yves] INSERM, Epidemiol & Biostat Sorbonne Paris Cite Ctr, Obstetr Perinatal & Pediat Epidemiol Team, U1153,DHU Risk Pregnancy, Paris, France; [Azria, Elie; Kayem, Gilles; Fresson, Jeanne; Pierrat, Veronique; Goffinet, Francois] Paris Descartes Univ, Grp Hosp Paris St Joseph, Dept Obstet, Paris, France; [Kayem, Gilles; Fresson, Jeanne; Pierrat, Veronique; Goffinet, Francois] Univ Paris 06, Hop Trousseau, AP HP, Dept Obstet & Gynecol, Paris, France; [Langer, Bruno; Fresson, Jeanne; Pierrat, Veronique; Goffinet, Francois] Strasbourg Univ Hosp, Hop Hautepierre, Dept Obstet Gynecol, Strasbourg, France; [Marret, Stephane; Fresson, Jeanne; Pierrat, Veronique; Goffinet, Francois] Rouen Univ Hosp, Dept Neonatal Med, Rouen, France; [Marret, Stephane; Fresson, Jeanne; Pierrat, Veronique; Goffinet, Francois] INSERM, AVENIR Res Grp, Rouen, France; [Marret, Stephane; Fresson, Jeanne; Pierrat, Veronique; Goffinet, Francois] Rouen Inst Biomed Res, Dept Neonatal Med & Intens Care, Rouen, France; [Marret, Stephane; Fresson, Jeanne; Pierrat, Veronique; Goffinet, Francois] Rouen Inst Biomed Res, Reg Ctr Diag & Res Dev Language & Behav Disorders, Rouen, France; [Fresson, Jeanne; Pierrat, Veronique; Goffinet, Francois] Reg Matern Univ Hosp, Dept Med Informat, Nancy, France; [Pierrat, Veronique; Goffinet, Francois] Hop Jeanne Flandre, Dept Neonatal Med, Lille, France; [Arnaud, Catherine; Goffinet, Francois] Univ Toulouse 3, INSERM, UMR 1027, F-31000 Toulouse, France; [Arnaud, Catherine; Goffinet, Francois] Univ Hosp, Clin Epidemiol Unit, F-31000 Toulouse, France; [Goffinet, Francois] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Dept Obstet & Gynecol, Port Royal Matern, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Azria, E (corresponding author), INSERM, Epidemiol & Biostat Sorbonne Paris Cite Ctr, Obstetr Perinatal & Pediat Epidemiol Team, U1153,DHU Risk Pregnancy, Paris, France.	eazria@hpsj.fr	ARNAUD, Catherine/AAC-5646-2019; kayem, gilles/I-1776-2017	ARNAUD, Catherine/0000-0002-4002-802X; kayem, gilles/0000-0002-8218-8814; Azria, Elie/0000-0002-6159-6253; GOFFINET, Francois/0000-0001-9643-0299; pierrat, veronique/0000-0001-7435-5144; Marret, Stephane/0000-0002-2858-148X; ANCEL, pierre-yves/0000-0001-9632-7494; Marchand-Martin, Laetitia/0000-0002-8036-8387	INSERM (National Institute of Health and Medical Research); Directorate General for Health at the Ministry for Social Affairs; Merck-Sharp; Dohme-Chibret; Medical Research Foundation; Hospital Program for Clinical Research of the French Department of Health [AOM01117, 2004/054/HP]; Wyeth Foundation for Children and Adolescents	INSERM (National Institute of Health and Medical Research)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Directorate General for Health at the Ministry for Social Affairs; Merck-Sharp(Merck & Company); Dohme-Chibret; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hospital Program for Clinical Research of the French Department of Health; Wyeth Foundation for Children and Adolescents	The EPIPAGE cohort was supported by grants from INSERM (National Institute of Health and Medical Research) (http://www.inserm.fr), the Directorate General for Health at the Ministry for Social Affairs, Merck-Sharp and Dohme-Chibret (http://www.msd-france.com/content/corporate/index.html), Medical Research Foundation (http://www.frm.org/), and "Hospital Program for Clinical Research of the French Department of Health (http://www.sante.gouv.fr/le-programme-hospitalier-de-rechercheclinique-phrc.html) 2001 no AOM01117". and 2004/054/HP", and the Wyeth Foundation for Children and Adolescents (http://www.fondation-pfizer.org). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Arnaud C, 2007, ARCH PEDIAT ADOL MED, V161, P1053, DOI 10.1001/archpedi.161.11.1053; Berger TM, 2012, ARCH DIS CHILD FETAL; BIERMANVANEENDENBURG MEC, 1981, DEV MED CHILD NEUROL, V23, P296; BRENNER WE, 1974, AM J OBSTET GYNECOL, V118, P700, DOI 10.1016/S0002-9378(16)33744-9; Demol S, 2000, EUR J OBSTET GYN R B, V93, P47, DOI 10.1016/S0301-2115(00)00246-3; Edwards P, 2012, MATERN CHILD HLTH J; Eide MG, 2005, OBSTET GYNECOL, V105, P4, DOI 10.1097/01.AOG.0000149743.80837.d3; Gilbert WM, 2003, OBSTET GYNECOL, V102, P911, DOI 10.1016/S0029-7844(03)00809-3; Goodman JR, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.012; GRAVENHORST JB, 1993, BRIT J OBSTET GYNAEC, V100, P411, DOI 10.1111/j.1471-0528.1993.tb15263.x; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Hille ETM, 2005, PEDIATRICS, V116, pE662, DOI 10.1542/peds.2005-0682; Johanzon M, 2008, OBSTET GYNECOL, V111, P42, DOI 10.1097/01.AOG.0000295866.97499.35; KAUFMAN AS, 1987, J CHILD NEUROL, V2, P3, DOI 10.1177/088307388700200102; Kayem G, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.794; Kollee LAA, 2009, BJOG-INT J OBSTET GY, V116, P1481, DOI 10.1111/j.1471-0528.2009.02235.x; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Marret S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062683; Mitha A, 2013, PEDIATRICS, V132, pE372, DOI 10.1542/peds.2012-3979; Mostello D, 2014, J PERINATOL, V34, P11, DOI 10.1038/jp.2013.132; Patkai J, 2012, EUR J OBSTET GYNECOL; Prechtl H F, 1968, Maandschr Kindergeneeskd, V35, P377; Reddy UM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.023; SCHEER K, 1976, AM J OBSTET GYNECOL, V125, P269, DOI 10.1016/0002-9378(76)90609-8; SCHUTTE MF, 1985, EUR J OBSTET GYN R B, V19, P391, DOI 10.1016/0028-2243(85)90137-6; TETERIS NJ, 1970, AM J OBSTET GYNECOL, V107, P762; Touwen B C, 1968, Ned Tijdschr Geneeskd, V112, P1112; TOUWEN B C L, 1969, Maandschrift voor Kindergeneeskunde, V36, P280; Ulander VM, 2004, ACTA OBSTET GYN SCAN, V83, P180, DOI 10.1111/j.0001-6349.2004.00386.x	29	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145768	10.1371/journal.pone.0145768	http://dx.doi.org/10.1371/journal.pone.0145768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26744838	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600014
J	Jeffrey, B; Kuzhiyil, N; de Leon, N; Lubberstedt, T				Jeffrey, Brandon; Kuzhiyil, Najeeb; de Leon, Natalia; Luebberstedt, Thomas			Genetic and Quantitative Trait Locus Analysis for Bio-Oil Compounds after Fast Pyrolysis in Maize Cobs	PLOS ONE			English	Article							CELL-WALL COMPOSITION; MOLECULAR-BASIS; CORN STOVER; LIGNIN; DIGESTIBILITY; WOOD; SOIL; PRETREATMENT; PERFORMANCE; RESIDUES	Fast pyrolysis has been identified as one of the biorenewable conversion platforms that could be a part of an alternative energy future, but it has not yet received the same attention as cellulosic ethanol in the analysis of genetic inheritance within potential feedstocks such as maize. Ten bio-oil compounds were measured via pyrolysis/gas chromatography-mass spectrometry (Py/GC-MS) in maize cobs. 184 recombinant inbred lines (RILs) of the intermated B73 x Mo17 (IBM) Syn4 population were analyzed in two environments, using 1339 markers, for quantitative trait locus (QTL) mapping. QTL mapping was performed using composite interval mapping with significance thresholds established by 1000 permutations at alpha = 0.05. 50 QTL were found in total across those ten traits with R-2 values ranging from 1.7 to 5.8%, indicating a complex quantitative inheritance of these traits.	[Jeffrey, Brandon; Luebberstedt, Thomas] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Kuzhiyil, Najeeb] Iowa State Univ, Dept Mech Engn, Ames, IA USA; [de Leon, Natalia] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA	Iowa State University; Iowa State University; University of Wisconsin System; University of Wisconsin Madison	Jeffrey, B (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	Brandon.d.jeffrey@gmail.com		Lubberstedt, Thomas/0000-0002-0526-0798	Plant Sciences at Iowa State University	Plant Sciences at Iowa State University	The Plant Sciences at Iowa State University. The ConocoPhillips Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint-Kurti PJ, 2007, GENETICS, V176, P645, DOI 10.1534/genetics.106.067892; Barriere Y, 2008, PLANT SCI, V175, P585, DOI 10.1016/j.plantsci.2008.06.009; Barriere Y., 2007, GENES GENOMES GENOMI, V1, P133; Blanco-Canqui H, 2007, GEODERMA, V141, P355, DOI 10.1016/j.geoderma.2007.06.012; Bridgwater AV, 2007, INT J GLOBAL ENERGY, V27, P160, DOI 10.1504/IJGEI.2007.013654; Brown RC, 2007, APPL BIOCHEM BIOTECH, V137, P947, DOI 10.1007/s12010-007-9110-y; Chen YS, 2010, TRENDS PLANT SCI, V15, P454, DOI 10.1016/j.tplants.2010.05.004; Connor MR, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/541698; Czernik S, 2004, ENERG FUEL, V18, P590, DOI 10.1021/ef034067u; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Fahmi R, 2008, FUEL, V87, P1230, DOI 10.1016/j.fuel.2007.07.026; Fontaine AS, 2003, J AGR FOOD CHEM, V51, P8080, DOI 10.1021/jf034321g; Galletti GC, 1997, J AGR FOOD CHEM, V45, P1715, DOI 10.1021/jf960483j; Grabber JH, 2004, CR BIOL, V327, P455, DOI 10.1016/j.crvi.2004.02.009; Guo ZG, 2012, THEOR APPL GENET, V124, P261, DOI 10.1007/s00122-011-1702-9; Holland JB, 2002, PL BRED RE, V22, P9; Hosoya T, 2007, J ANAL APPL PYROL, V78, P328, DOI 10.1016/j.jaap.2006.08.008; JACQUET G, 1995, J AGR FOOD CHEM, V43, P2746, DOI 10.1021/jf00058a037; Jansen C, 2013, BIOENERG RES; Jansen C, 2012, BIOENERG RES, V5, P20, DOI 10.1007/s12155-011-9158-y; Jeffrey B, 2013, BIOENERG RES; Jung HJG, 2003, PHYTOCHEMISTRY, V63, P543, DOI 10.1016/S0031-9422(03)00221-8; Kearsey MJ, 1998, HEREDITY, V80, P137, DOI 10.1046/j.1365-2540.1998.00500.x; Laird DA, 2008, AGRON J, V100, P178, DOI 10.2134/agronj2007.0161; Lal R, 2008, WASTE MANAGE, V28, P747, DOI 10.1016/j.wasman.2007.09.023; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Lorenz AJ, 2010, CROP SCI, V50, P842, DOI 10.2135/cropsci2009.04.0168; Lorenzana RE, 2010, CROP SCI, V50, P541, DOI 10.2135/cropsci2009.04.0182; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Lv GJ, 2010, BIORESOURCES, V5, P2051; Meuwissen THE, 2001, GENETICS, V157, P1819; Nonier MF, 2006, J ANAL APPL PYROL, V75, P181, DOI 10.1016/j.jaap.2005.05.006; Nowakowski DJ, 2010, J ANAL APPL PYROL, V88, P53, DOI 10.1016/j.jaap.2010.02.009; Oasmaa A, 2010, ENERG FUEL, V24, P1380, DOI 10.1021/ef901107f; Patwardhan PR, 2009, J ANAL APPL PYROL, V86, P323, DOI 10.1016/j.jaap.2009.08.007; PISKORZ J, 1986, J ANAL APPL PYROL, V9, P121, DOI 10.1016/0165-2370(86)85003-3; RALPH J, 1995, CARBOHYD RES, V275, P167, DOI 10.1016/0008-6215(95)00237-N; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Shen DK, 2010, CARBOHYD POLYM, V82, P39, DOI 10.1016/j.carbpol.2010.04.018; Sokhansanj S, 2002, BIOMASS BIOENERG, V23, P347, DOI 10.1016/S0961-9534(02)00063-6; Truntzler M, 2010, THEOR APPL GENET, V121, P1465, DOI 10.1007/s00122-010-1402-x; VANDERKAADEN A, 1983, J ANAL APPL PYROL, V5, P199, DOI 10.1016/0165-2370(83)80028-X; Wang S., 2007, WINDOWS QTL CARTOGRA; Yang B, 2004, BIOTECHNOL BIOENG, V86, P88, DOI 10.1002/bit.20043; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	45	1	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0145845	10.1371/journal.pone.0145845	http://dx.doi.org/10.1371/journal.pone.0145845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745365	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600017
J	Nambron, R; Silajdzic, E; Kalliolia, E; Ottolenghi, C; Hindmarsh, P; Hill, NR; Costelloe, SJ; Martin, NG; Positano, V; Watt, HC; Frost, C; Bjorkqvist, M; Warner, TT				Nambron, Rajasree; Silajdzic, Edina; Kalliolia, Eirini; Ottolenghi, Chris; Hindmarsh, Peter; Hill, Nathan R.; Costelloe, Sean J.; Martin, Nicholas G.; Positano, Vincenzo; Watt, Hilary C.; Frost, Chris; Bjorkqvist, Maria; Warner, Thomas T.			A Metabolic Study of Huntington's Disease	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; ENERGY-METABOLISM; GROWTH-HORMONE; DIABETES-MELLITUS; SKELETAL-MUSCLE; OBESITY WARS; RATING-SCALE; PRE-MANIFEST; BODY-WEIGHT; AMINO-ACIDS	Background Huntington's disease patients have a number of peripheral manifestations suggestive of metabolic and endocrine abnormalities. We, therefore, investigated a number of metabolic factors in a 24-hour study of Huntington's disease gene carriers (premanifest and moderate stage II/III) and controls. Methods Control (n = 15), premanifest (n = 14) and stage II/III (n = 13) participants were studied with blood sampling over a 24-hour period. A battery of clinical tests including neurological rating and function scales were performed. Visceral and subcutaneous adipose distribution was measured using magnetic resonance imaging. We quantified fasting baseline concentrations of glucose, insulin, cholesterol, triglycerides, lipoprotein (a), fatty acids, amino acids, lactate and osteokines. Leptin and ghrelin were quantified in fasting samples and after a standardised meal. We assessed glucose, insulin, growth hormone and cortisol concentrations during a prolonged oral glucose tolerance test. Results We found no highly significant differences in carbohydrate, protein or lipid metabolism markers between healthy controls, premanifest and stage II/III Huntington's disease subjects. For some markers (osteoprotegerin, tyrosine, lysine, phenylalanine and arginine) there is a suggestion (p values between 0.02 and 0.05) that levels are higher in patients with premanifest HD, but not moderate HD. However, given the large number of statistical tests performed interpretation of these findings must be cautious. Conclusions Contrary to previous studies that showed altered levels of metabolic markers in patients with Huntington's disease, our study did not demonstrate convincing evidence of abnormalities in any of the markers examined. Our analyses were restricted to Huntington's disease patients not taking neuroleptics, anti-depressants or other medication affecting metabolic pathways. Even with the modest sample sizes studied, the lack of highly significant results, despite many being tested, suggests that the majority of these markers do not differ markedly by disease status.	[Nambron, Rajasree; Kalliolia, Eirini; Warner, Thomas T.] UCL Inst Neurol, Dept Clin Neurosci, London, England; [Silajdzic, Edina; Bjorkqvist, Maria] Lund Univ, Dept Expt Med Sci, Brain Dis Biomarker Unit, Wallenberg Neurosci Ctr, Lund, Sweden; [Ottolenghi, Chris] Hop Necker Enfants Malad, AP HP, Dept Metab Biochem, Paris, France; [Hindmarsh, Peter] UCL Inst Child Hlth, Dev Endocrinol Res Grp, London, England; [Hill, Nathan R.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Costelloe, Sean J.; Martin, Nicholas G.] Royal Free London NHS Fdn Trust, Dept Clin Biochem, London, England; [Positano, Vincenzo] Fdn CNR Reg Toscana G Monasterio, Pisa, Italy; [Watt, Hilary C.] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London, England; [Frost, Chris] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Warner, Thomas T.] UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, London, England	University of London; University College London; Lund University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of Oxford; University of London; University College London; Royal Free London NHS Foundation Trust; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Warner, TT (corresponding author), UCL Inst Neurol, Dept Clin Neurosci, London, England.	t.warner@ucl.ac.uk	Warner, Thomas T/A-1454-2013; Positano, Vincenzo/A-6953-2008; Ottolenghi, Chris/H-3745-2017; Hill, Nathan/B-9679-2014	Warner, Thomas T/0000-0001-6195-6995; Positano, Vincenzo/0000-0001-6955-9572; Ottolenghi, Chris/0000-0002-0734-344X; Frost, Chris/0000-0003-0098-9915; Hill, Nathan/0000-0001-7927-8678; Bjorkqvist, Maria/0000-0001-8550-0431	Cure Huntington's Disease Initiative [A-2377]	Cure Huntington's Disease Initiative	The study was funded by a contract from Cure Huntington's Disease Initiative # A-2377. Scientific advisors from CHDI contributed to study design.	Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; Aziz NA, 2010, EUR J NEUROL, V17, P280, DOI 10.1111/j.1468-1331.2009.02798.x; Aziz NA, 2010, CLIN ENDOCRINOL, V73, P206, DOI 10.1111/j.1365-2265.2009.03661.x; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Bjorkqvist M, 2006, HUM MOL GENET, V15, P1713, DOI 10.1093/hmg/ddl094; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Block RC, 2010, J CLIN LIPIDOL, V4, P17, DOI 10.1016/j.jacl.2009.11.003; Boesgaard TW, 2009, J NEUROENDOCRINOL, V21, P770, DOI 10.1111/j.1365-2826.2009.01898.x; Choi ST, 2008, RHEUMATOLOGY, V47, P1775, DOI 10.1093/rheumatology/ken385; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; DAVIDSON MB, 1974, J LAB CLIN MED, V84, P807; Demerath EW, 2007, INT J OBESITY, V31, P285, DOI 10.1038/sj.ijo.0803409; DiGirolamo DJ, 2012, NAT REV RHEUMATOL, V8, P674, DOI 10.1038/nrrheum.2012.157; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Fain JN, 2001, HUM MOL GENET, V10, P145, DOI 10.1093/hmg/10.2.145; FARRER LA, 1985, CLIN GENET, V27, P62; FARRER LA, 1985, AM J MED GENET, V21, P307, DOI 10.1002/ajmg.1320210213; FARRER LA, 1985, AM J PHYS ANTHROPOL, V67, P185, DOI 10.1002/ajpa.1330670304; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaba AM, 2005, AM J CLIN NUTR, V81, P1335; Goodman AOG, 2008, EXP NEUROL, V210, P691, DOI 10.1016/j.expneurol.2007.12.026; Goodman Anna O G, 2011, PLoS Curr, V3, pRRN1214, DOI 10.1371/currents.RRN1214; Hill NR, 2013, DIABETES CARE, V36, P2324, DOI 10.2337/dc12-0607; Hill Nathan R, 2013, J Diabetes Sci Technol, V7, P640; Hunt MJ, 2005, EXP BRAIN RES, V166, P220, DOI 10.1007/s00221-005-2357-z; Huntington Study Group, 1999, UN HUNT DIS RAT SCAL; Kalliolia E, 2014, MOVEMENT DISORD, V29, P1511, DOI 10.1002/mds.26003; KEOGH HJ, 1976, J NEUROL NEUROSUR PS, V39, P244, DOI 10.1136/jnnp.39.3.244; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Koroshetz WJ, 1997, ANN NEUROL, V41, P160, DOI 10.1002/ana.410410206; KREMER HPH, 1989, J NEUROL SCI, V90, P335, DOI 10.1016/0022-510X(89)90120-2; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; LAVIN PJM, 1981, J NEUROL NEUROSUR PS, V44, P414, DOI 10.1136/jnnp.44.5.414; Leoni V, 2011, NEUROSCI LETT, V494, P245, DOI 10.1016/j.neulet.2011.03.025; Leoni V, 2008, BRAIN, V131, P2851, DOI 10.1093/brain/awn212; Lodi R, 2000, ANN NEUROL, V48, P72; Markianos M, 2008, MOL GENET METAB, V93, P341, DOI 10.1016/j.ymgme.2007.10.002; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Mochel F, 2010, EUR J HUM GENET, V18, P1057, DOI 10.1038/ejhg.2010.72; Naylor K, 2012, NAT REV RHEUMATOL, V8, P379, DOI 10.1038/nrrheum.2012.86; Nogueiras R, 2008, ANN NY ACAD SCI, V1126, P14, DOI 10.1196/annals.1433.054; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; OTTOSSON JO, 1971, ACTA PSYCHIAT SCAND, P89; Ottosson JO, 1973, AMINO ACIDS HUNTINGT; PERRY TL, 1969, LANCET, V1, P806; Perry TL, 1973, AMINO ACIDS PLASMA C; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; PHILLIPSON OT, 1977, CLIN SCI MOL MED, V52, P311, DOI 10.1042/cs0520311; PODOLSKY S, 1974, J CLIN ENDOCR METAB, V39, P36, DOI 10.1210/jcem-39-1-36; PODOLSKY S, 1977, GERONTOLOGY, V23, P55, DOI 10.1159/000212174; PODOLSKY S, 1972, LANCET, V1, P1356; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; Positano V, 2004, J MAGN RESON IMAGING, V20, P684, DOI 10.1002/jmri.20167; Pratley RE, 2000, ANN NEUROL, V47, P64, DOI 10.1002/1531-8249(200001)47:1<64::AID-ANA11>3.3.CO;2-J; REILMANN R, 1995, ACTA NEUROL SCAND, V91, P222; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373; Schoppet M, 2002, ARTERIOSCL THROM VAS, V22, P549, DOI 10.1161/01.ATV.0000012303.37971.DA; SHOULSON I, 1979, NEUROLOGY, V29, P1, DOI 10.1212/WNL.29.1.1; Siesling S, 1998, MOVEMENT DISORD, V13, P915, DOI 10.1002/mds.870130609; Silajdzic E., 2013, NEUROREPORT, V2, P125, DOI DOI 10.3233/JHD-130049; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Stoy N, 2005, J NEUROCHEM, V93, P611, DOI 10.1111/j.1471-4159.2005.03070.x; Trejo A, 2004, NUTRITION, V20, P192, DOI 10.1016/j.nut.2003.10.007; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Valenza M, 2006, PROG NEUROBIOL, V80, P165, DOI 10.1016/j.pneurobio.2006.09.005; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Wang R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00231; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; YATES CM, 1973, CLIN CHIM ACTA, V44, P139, DOI 10.1016/0009-8981(73)90169-1	74	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146480	10.1371/journal.pone.0146480	http://dx.doi.org/10.1371/journal.pone.0146480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26744893	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000367815600054
J	Zheng, Z; Bao, ML; Wu, FN; Chen, JC; Deng, XL				Zheng, Zheng; Bao, Minli; Wu, Fengnian; Chen, Jianchi; Deng, Xiaoling			Predominance of Single Prophage Carrying a CRISPR/cas System in "Candidatus Liberibacter asiaticus" Strains in Southern China	PLOS ONE			English	Article							HUANGLONGBING BACTERIUM; SEQUENCE; IDENTIFICATION; POPULATIONS; EVOLUTION; GENOME; CITRUS; GENES; LOCUS; HOST	"Candidatus Liberibacter asiaticus" (CLas) is an uncultureable alpha-proteobacterium associated with citrus Huanglongbing (HLB, yellow shoot disease), a highly destructive disease affecting citrus production worldwide. HLB was observed in Guangdong Province of China over a hundred years ago and remains endemic there. Little is known about CLas biology due to its uncultureable nature. This study began with the genome sequence analysis of CLas Strain A4 from Guangdong in the prophage region. Within the two currently known prophage types, Type 1 (SC1-like) and Type 2 (SC2-like), A4 genome contained only a Type 2 prophage, CGdP2, namely. An analysis on CLas strains collected in Guangdong showed that Type 2 prophage dominated the bacterial population (82.6%, 71/86). An extended survey covering five provinces in southern China also revealed the predominance of single prophage (Type 1 or Type 2) in the CLas population (90.4%, 169/187). CLas strains with two and no prophage types accounted for 7.2% and 2.8%, respectively. In silico analyses on CGdP2 identified a CRISPR (clustered regularly interspaced short palindromic repeats)/cas (CRISPR-associated protein genes) system, consisting of four 22 bp repeats, three 23 bp spacers and 9 predicted cas. Similar CRISPR/cas systems were detected in all 10 published CLas prophages as well as 13 CLas field strains in southern China. Both Type 1 and Type 2 prophages shared almost identical sequences in spacer 1 and 3 but not spacer 2. Considering that the function of a CRISPR/cas system was to destroy invading DNA, it was hypothesized that a pre-established CLas prophage could use its CRISPR/cas system guided by spacer 1 and/or 3 to defeat the invasion of the other phage/prophage. This hypothesis explained the predominance of single prophage type in the CLas population in southern China. This is the first report of CRISPR/cas system in the "Ca. Liberibacter" genera.	[Zheng, Zheng; Bao, Minli; Wu, Fengnian; Deng, Xiaoling] South China Agr Univ, Coll Agr, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China; [Zheng, Zheng; Wu, Fengnian; Chen, Jianchi] ARS, San Joaquin Valley Agr Sci Ctr, USDA, Parlier, CA USA	South China Agricultural University; United States Department of Agriculture (USDA)	Deng, XL (corresponding author), South China Agr Univ, Coll Agr, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China.	xldeng@scau.edu.cn	Wu, Fengnian/L-5598-2018	Wu, Fengnian/0000-0003-1788-1628	California Citrus Research Board; Chinese Modern Agricultural Technology Systems [CARS-27]; Special Fund for Agro-Scientific Research in the Public Interest, China [2010003067]; ARS [ARS-0422946] Funding Source: Federal RePORTER	California Citrus Research Board; Chinese Modern Agricultural Technology Systems; Special Fund for Agro-Scientific Research in the Public Interest, China; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by California Citrus Research Board and Chinese Modern Agricultural Technology Systems (CARS-27) and the Special Fund for Agro-Scientific Research in the Public Interest, China (2010003067). We thank Christopher Wallis and Craig Ledbetter for critical editing of this manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bove JM, 2006, J PLANT PATHOL, V88, P7; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen J, 2010, PHYTOPATHOLOGY, V100, P567, DOI 10.1094/PHYTO-100-6-0567; Chen J, 2010, ACTA PHYTOPATHOLOGIC, V41, P113; Chen Q. B., 1943, NEW AGR Q B, V3, P142; Deng X, 2008, PLANT DIS, V92, P513, DOI 10.1094/PDIS-92-4-0513; Deng X, 2014, CURR MICROBIOL, V69, P554, DOI 10.1007/s00284-014-0621-9; Deng XL, 2008, MOL CELL PROBE, V22, P338, DOI 10.1016/j.mcp.2008.09.002; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fleites LA, 2014, APPL ENVIRON MICROB, V80, P6023, DOI 10.1128/AEM.01958-14; Garcia-Heredia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033802; Ghosh DK, 2015, PHYTOPATHOLOGY, V105, P1043, DOI 10.1094/PHYTO-09-14-0253-R; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jain M, 2015, MOL PLANT MICROBE IN, V105, P1043; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Katoh H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106109; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; LIN H, 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0060516; LIN K. -H., 1956, Acta Phytopathologica Sinica, V2, P1; Lin K-H., 1956, ACTA PHYTOPATHOL SIN, V2, P12; Liu R, 2011, PLANT DIS, V95, P431, DOI 10.1094/PDIS-04-10-0300; Ma W, 2014, PHYTOPATHOLOGY, V104, P158, DOI 10.1094/PHYTO-04-13-0110-R; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Matos LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078994; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; REINKING O. A., 1919, Philippine Agriculturist, V8, P109; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Shan ZhenJu, 2008, Journal of South China Agricultural University, V29, P25; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian YaNan, 1996, Acta Phytopathologica Sinica, V26, P243; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang XF, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-18, 10.1186/1471-2105-13-113]; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu F, 2015, GENOME ANNOUNC IN PR; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047232; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256; Zheng Z, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00999-14; Zheng Z, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00273-14; Zheng Z, 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.00169-15, DOI 10.1128/GENOMEA.00169-15]; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	53	32	37	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146422	10.1371/journal.pone.0146422	http://dx.doi.org/10.1371/journal.pone.0146422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741827	Green Submitted, Green Published, gold			2022-12-27	WOS:000367810600043
J	Barnett-Vanes, A; Sharrock, A; Birrell, MA; Rankin, S				Barnett-Vanes, Ashton; Sharrock, Anna; Birrell, Mark A.; Rankin, Sara			A Single 9-Colour Flow Cytometric Method to Characterise Major Leukocyte Populations in the Rat: Validation in a Model of LPS-Induced Pulmonary Inflammation	PLOS ONE			English	Article							BONE-MARROW; IN-VIVO; MONOCYTE SUBPOPULATIONS; BLOOD; CELLS; CD43; MONOCYTES/MACROPHAGES; IDENTIFICATION; PHENOTYPE; INJURY	The rat is a commonly used model for immunological investigation. Yet basic research and characterisation of leukocyte populations and sub-sets lags far behind murine research, with inconsistency on reported leukocyte markers and their overlap. These shortcomings limit the opportunity for more complex and advanced rat immunology research. In this study, we developed a robust 9-colour flow-cytometric protocol to elucidate the major blood and tissue rat leukocyte populations, and validated it in a model of LPS-induced pulmonary inflammation. Blood and tissues (lung, BALF, spleen, liver, bone marrow) from naive Sprague-Dawley rats were collected and analysed by flow cytometry (FCM). Rats were exposed to aerosolised saline or LPS (1mg/mL), at 3 and 24hrs thereafter blood, lung and BALF were collected and analysed using FCM and ELISA. Neutrophils, two monocyte subsets, NK Cells, B Cells, CD4+, CD8+ T Cells and alveolar macrophages can be identified simultaneously across different tissues using a 9-colour panel. Neutrophils and monocytes can be distinguished based upon differential expression of CD43 and His48. Neutrophils and CD43Lo/His48Hi monocyte-macrophages are elevated in the lung at 3 and 24hrs during LPS-induced pulmonary inflammation. This validated method for leukocyte enumeration will offer a platform for greater consistency in future rat immunology and inflammation research.	[Barnett-Vanes, Ashton; Sharrock, Anna; Rankin, Sara] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Inflammat Repair & Dev Grp, London, England; [Barnett-Vanes, Ashton; Sharrock, Anna; Rankin, Sara] Univ London Imperial Coll Sci Technol & Med, Ctr Blast Injury Studies, London, England; [Sharrock, Anna] Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham, W Midlands, England; [Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Pharmacol Grp, London, England	Imperial College London; Imperial College London; Royal Centre for Defence Medicine; Imperial College London	Rankin, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Inflammat Repair & Dev Grp, London, England.	s.rankin@imperial.ac.uk		Barnett-Vanes, Ashton/0000-0002-8088-1068	Royal British Legion Centre for Blast injury Studies; Royal British Legion	Royal British Legion Centre for Blast injury Studies; Royal British Legion	This work was funded by the Royal British Legion Centre for Blast injury Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support of the Royal British Legion. The authors thank Bilel Dekkak and Abd el-ilah Dekkak for their technical assistance, and the technicians of the Flow Cytometry facility at South Kensington campus for their assistance and expertise.	AHUJA V, 1995, CELL IMMUNOL, V163, P59, DOI 10.1006/cimm.1995.1099; Baba T, 2006, BLOOD, V107, P2004, DOI 10.1182/blood-2005-06-2345; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Blocher S, 2007, CLIN IMMUNOL, V124, P98, DOI 10.1016/j.clim.2007.04.005; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Cote CH, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-359; Dhaliwal K, 2012, AM J RESP CRIT CARE, V186, P514, DOI 10.1164/rccm.201112-2132OC; Erben RG, 1998, AM J PHYSIOL-ENDOC M, V274, pE476; Fecho K, 2002, INFLAMMATION, V26, P259, DOI 10.1023/A:1021408500630; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059602; Haddad E, 2001, BRIT J PHARMACOL, V132, P1715, DOI 10.1038/sj.bjp.0704022; Hardy CL, 1997, IMMUNOLOGY, V90, P412, DOI 10.1111/j.1365-2567.1997.00412.x; Hohsfield LA, 2013, J NEUROIMMUNOL, V258, P17, DOI 10.1016/j.jneuroim.2013.02.005; Iscache AL, 2011, INT IMMUNOL, V23, P625, DOI 10.1093/intimm/dxr071; Kim E, 2014, J CEREBR BLOOD F MET, V34, P1411, DOI 10.1038/jcbfm.2014.101; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kyriakou D, 2001, INT J HEMATOL, V73, P483, DOI 10.1007/BF02994011; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li XC, 1998, J IMMUNOL, V161, P6258; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Lobato-Pascual A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057406; Matsumoto M, 2008, J IMMUNOL, V181, P3628, DOI 10.4049/jimmunol.181.5.3628; Melgert BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045229; Miyajima S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05171; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H; Scriba A, 1997, J LEUKOCYTE BIOL, V62, P741, DOI 10.1002/jlb.62.6.741; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Skrajnar S, 2009, J AM ASSOC LAB ANIM, V48, P152; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Watkins TR, 2013, AM J RESP CRIT CARE, V188, P407, DOI 10.1164/rccm.201307-1208ED; Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155; Zassler B, 2006, EXP NEUROL, V198, P391, DOI 10.1016/j.expneurol.2005.12.009; Zhou X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074390	42	40	40	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0142520	10.1371/journal.pone.0142520	http://dx.doi.org/10.1371/journal.pone.0142520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764486	gold, Green Published, Green Submitted			2022-12-27	WOS:000368459300002
J	Nielsen, EA; Sun, M; Honjo, O; Hjortdal, VE; Redington, AN; Friedberg, MK				Nielsen, Eva Amalie; Sun, Mei; Honjo, Osami; Hjortdal, Vibeke E.; Redington, Andrew N.; Friedberg, Mark K.			Dual Endothelin Receptor Blockade Abrogates Right Ventricular Remodeling and Biventricular Fibrosis in Isolated Elevated Right Ventricular Afterload	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; SYSTOLIC FUNCTION; ANTAGONIST; PHARMACOLOGY; HYPERTROPHY; ANGIOTENSIN; ACTIVATION; MECHANISMS; MACITENTAN; PLASMA	Background Pulmonary arterial hypertension is usually fatal due to right ventricular failure and is frequently associated with co-existing left ventricular dysfunction. Endothelin-1 is a powerful pro-fibrotic mediator and vasoconstrictor that is elevated in pulmonary arterial hypertension. Endothelin receptor blockers are commonly used as pulmonary vasodilators, however their effect on biventricular injury, remodeling and function, despite elevated isolated right ventricular afterload is unknown. Methods Elevated right ventricular afterload was induced by progressive pulmonary artery banding. Seven rabbits underwent pulmonary artery banding without macitentan; 13 received pulmonary artery banding + macitentan; and 5 did not undergo inflation of the pulmonary artery band (sham-operated controls). Results: Right and left ventricular collagen content was increased with pulmonary artery banding compared to sham-operated controls and ameliorated bymacitentan. Right ventricular fibrosis signaling (connective tissue growth factor and endothelin-1 protein levels); extra-cellular matrix remodeling (matrix-metalloproteinases 2 and 9), apoptosis and apoptosis-related peptides (caspases 3 and 8) were increased with pulmonary artery banding compared with sham-operated controls and decreased with macitentan. Conclusion Isolated right ventricular afterload causes biventricular fibrosis, right ventricular apoptosis and extra cellular matrix remodeling, mediated by up-regulation of endothelin-1 and connective tissue growth factor signaling. These pathological changes are ameliorated by dual endothelin receptor blockade despite persistent elevated right ventricular afterload.	[Nielsen, Eva Amalie; Sun, Mei; Redington, Andrew N.; Friedberg, Mark K.] Hosp Sick Children, Dept Cardiol, Toronto, ON M5G 1X8, Canada; [Honjo, Osami] Hosp Sick Children, Dept Cardiovasc Surg, Toronto, ON M5G 1X8, Canada; [Nielsen, Eva Amalie; Hjortdal, Vibeke E.] Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, DK-8000 Aarhus, Denmark; [Nielsen, Eva Amalie; Hjortdal, Vibeke E.] Aarhus Univ Hosp, Dept Clin Med, DK-8000 Aarhus, Denmark	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aarhus University; Aarhus University	Friedberg, MK (corresponding author), Hosp Sick Children, Dept Cardiol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mark.friedberg@sickkids.ca		Nielsen, Eva Amalie/0000-0003-3760-0352; Hjortdal, Vibeke/0000-0002-8047-0015; Friedberg, Mark/0000-0002-4108-5560	Actelion (Pharmaceuticals ltd. Allschwil, Switzerland)	Actelion (Pharmaceuticals ltd. Allschwil, Switzerland)	This work was supported by a research grant from Actelion (Pharmaceuticals ltd. Allschwil, Switzerland) who also provided macitentan for the study. Actelion had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apitz C, 2012, J THORAC CARDIOV SUR, V144, P1494, DOI 10.1016/j.jtcvs.2012.06.027; Babu-Narayan SV, 2006, CIRCULATION, V113, P405, DOI 10.1161/CIRCULATIONAHA.105.548727; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Budev MM, 2003, SEMIN RESP CRIT CARE, V24, P233; Chiong M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.130; DAMIANO RJ, 1991, AM J PHYSIOL, V261, pH1514, DOI 10.1152/ajpheart.1991.261.5.H1514; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Faber MJ, 2006, AM J PHYSIOL-HEART C, V291, pH1580, DOI 10.1152/ajpheart.00286.2006; Friedberg MK, 2013, AM J RESP CELL MOL, V49, P1019, DOI 10.1165/rcmb.2013-0149OC; Galie N, 2003, J AM COLL CARDIOL, V41, P1380, DOI 10.1016/S0735-1097(03)00121-9; Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976; Kitahori K, 2009, CIRC-HEART FAIL, V2, P599, DOI 10.1161/CIRCHEARTFAILURE.109.862664; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Langleben D, 2006, CHEST, V129, P689, DOI 10.1378/chest.129.3.689; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Liu C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004434.pub5; LOFFLER BM, 1993, FEBS LETT, V333, P108, DOI 10.1016/0014-5793(93)80384-7; Nagendran J, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300448; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Redington Andrew N, 2006, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P3; SANCHEZQUINTANA D, 1990, ACTA ANAT, V138, P352; Santamore WP, 1998, PROG CARDIOVASC DIS, V40, P289, DOI 10.1016/S0033-0620(98)80049-2; Smerup M, 2009, ANAT REC, V292, P1, DOI 10.1002/ar.20798; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Sun M, 2004, CIRCULATION, V110, P3221, DOI 10.1161/01.CIR.0000147233.10318.23; Thorin E, 2010, ADV PHARMACOL, V60, P1, DOI [10.1016/S1054-3589(10)60009-9, 10.1016/B978-0-12-385061-4.00001-5]; Valente AS, 2008, REV BRAS CIR CARDIOV, V23, P60, DOI 10.1590/S0102-76382008000100011; Wang JX, 2016, CARDIOVASC TOXICOL, V16, P235, DOI 10.1007/s12012-015-9331-1; Yao CX, 2015, INT J MASS SPECTROM, V378, P347, DOI 10.1016/j.ijms.2014.10.006	29	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146767	10.1371/journal.pone.0146767	http://dx.doi.org/10.1371/journal.pone.0146767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765263	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300041
J	Nishigawa, G; Maruo, Y; Irie, M; Maeda, N; Yoshihara, K; Nagaoka, N; Matsumoto, T; Minagi, S				Nishigawa, Goro; Maruo, Yukinori; Irie, Masao; Maeda, Naoto; Yoshihara, Kumiko; Nagaoka, Noriyuki; Matsumoto, Takuya; Minagi, Shogo			Various Effects of Sandblasting of Dental Restorative Materials	PLOS ONE			English	Article							PLASMA TREATMENT; BOND STRENGTH; ZIRCONIA; RESIN; SURFACE; ADHESION; REMOVAL	Background Sandblasting particles which remain on the surfaces of dental restorations are removed prior to cementation. It is probable that adhesive strength between luting material and sandblasting particle remnants might exceed that with restorative material. If that being the case, blasting particles adhere to sandblasted material surface could be instrumental to increasing adhesive strength like underlying bonding mechanism between luting material and silanized particles of tribochemical silica coating-treated surface. We hypothesize that ultrasonic cleaning of bonding surfaces, which were pretreated with sandblasting, may affect adhesive strength of a resin luting material to dental restorative materials. Methods We therefore observed adhesive strength of resin luting material to aluminum oxide was greater than those to zirconia ceramic and cobalt-chromium alloy beforehand. To measure the shear bond strengths of resin luting material to zirconia ceramic and cobalt-chromium alloy, forty specimens of each restorative material were prepared. Bonding surfaces were polished with silicon abrasive paper and then treated with sandblasting. For each restorative material, 40 sandblasted specimens were equally divided into two groups: ultrasonic cleaning (USC) group and non-ultrasonic cleaning (NUSC) group. After resin luting material was polymerized on bonding surface, shear test was performed to evaluate effect of ultrasonic cleaning of bonding surfaces pretreated with sandblasting on bond strength. Results For both zirconia ceramic and cobalt-chromium alloy, NUSC group showed significantly higher shear bond strength than USC group. Conclusions Ultrasonic cleaning of dental restorations after sandblasting should be avoided to retain improved bonding between these materials.	[Nishigawa, Goro; Maruo, Yukinori] Okayama Univ Hosp, Occlus & Removable Prosthodont, Okayama, Japan; [Irie, Masao; Matsumoto, Takuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Okayama 7008530, Japan; [Maeda, Naoto; Minagi, Shogo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Occlusal & Oral Funct Rehabil, Okayama 7008530, Japan; [Yoshihara, Kumiko] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Nagaoka, Noriyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Lab Electron Microscopy, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University; Okayama University; Okayama University	Nishigawa, G (corresponding author), Okayama Univ Hosp, Occlus & Removable Prosthodont, Okayama, Japan.	goro@md.okayama-u.ac.jp	Yoshihara, Kumiko/Q-4002-2019; Nagaoka, Noriyuyki/ABG-4576-2021; Minagi, Shogo/B-2473-2011; NISHIGAWA, Goro/B-1916-2011	Yoshihara, Kumiko/0000-0002-3483-6012; Nagaoka, Noriyuyki/0000-0002-3920-1278; Minagi, Shogo/0000-0002-7559-3627; 	JSPS KAKENHI Grant [26462920]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by JSPS KAKENHI Grant Number 26462920 to GN.	Anusavice KJ, 2013, PHILLIPS SCI DENT MA, V12th; Castle JE, 2008, J ADHESION, V84, P368, DOI 10.1080/00218460802004477; D'Arcangelo C, 2007, J ADHES DENT, V9, P319; Druck CC, 2015, J BIOMED MATER RES B, V103, P143, DOI 10.1002/jbm.b.33184; Inokoshi M, 2013, J DENT, V41, P170, DOI 10.1016/j.jdent.2012.10.017; KERN M, 1995, J PROSTHET DENT, V73, P240, DOI 10.1016/S0022-3913(05)80200-8; Kim J, 2008, WATER RES, V42, P2017, DOI 10.1016/j.watres.2007.12.017; Liu HL, 2008, J HAZARD MATER, V151, P616, DOI 10.1016/j.jhazmat.2007.06.033; Nishigawa G, 2004, DENT MATER J, V23, P545, DOI 10.4012/dmj.23.545; Nishigawa G, 2003, J ORAL REHABIL, V30, P1081, DOI 10.1046/j.1365-2842.2003.01198.x; Nishigawa G, 2008, DENT MATER J, V27, P842, DOI 10.4012/dmj.27.842; OBrien WJ, 2008, DENT MAT THEIR SELEC, V4th, P29; Rungruanganunt P, 2012, DENT MATER, V28, P939, DOI 10.1016/j.dental.2012.04.009; Sasse M, 2014, J DENT, V42, P660, DOI 10.1016/j.jdent.2014.02.021; Wang GQ, 2014, J DENT, V42, P808, DOI 10.1016/j.jdent.2014.04.005	15	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147077	10.1371/journal.pone.0147077	http://dx.doi.org/10.1371/journal.pone.0147077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26764913	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300063
J	Sobotka, KS; Hooper, SB; Crossley, KJ; Ong, T; Schmolzer, GM; Barton, SK; McDougall, ARA; Miller, SL; Tolcos, M; Klingenberg, C; Polglase, GR				Sobotka, Kristina S.; Hooper, Stuart B.; Crossley, Kelly J.; Ong, Tracey; Schmoelzer, Georg M.; Barton, Samantha K.; McDougall, Annie R. A.; Miller, Suzie L.; Tolcos, Mary; Klingenberg, Claus; Polglase, Graeme R.			Single Sustained Inflation followed by Ventilation Leads to Rapid Cardiorespiratory Recovery but Causes Cerebral Vascular Leakage in Asphyxiated Near-Term Lambs	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; FUNCTIONAL RESIDUAL CAPACITY; BIRTH-WEIGHT INFANTS; BLOOD-FLOW VELOCITY; PRETERM INFANTS; FETAL SHEEP; DELIVERY ROOM; BRAIN-INJURY; INTRAVENTRICULAR HEMORRHAGE; NEWBORN-INFANT	Background A sustained inflation (SI) rapidly restores cardiac function in asphyxic, bradycardic newborns but its effects on cerebral haemodynamics and brain injury are unknown. We determined the effect of different SI strategies on carotid blood flow (CaBF) and cerebral vascular integrity in asphyxiated near-term lambs. Methods Lambs were instrumented and delivered at 139 +/- 2 d gestation and asphyxia was induced by delaying ventilation onset. Lambs were randomised to receive 5 consecutive 3 s SI (multiple SI; n = 6), a single 30 s SI (single SI; n = 6) or conventional ventilation (no SI; n = 6). Ventilation continued for 30 min in all lambs while CaBF and respiratory function parameters were recorded. Brains were assessed for gross histopathology and vascular leakage. Results CaBF increased more rapidly and to a greater extent during a single SI (p = 0.01), which then decreased below both other groups by 10 min, due to a higher cerebral oxygen delivery (p = 0.01). Blood brain barrier disruption was increased in single SI lambs as indicated by increased numbers of blood vessel profiles with plasma protein extravasation (p = 0.001) in the cerebral cortex. There were no differences in CaBF or cerebral oxygen delivery between the multiple SI and no SI lambs. Conclusions Ventilation with an initial single 30 s SI improves circulatory recovery, but is associated with greater disruption of blood brain barrier function, which may exacerbate brain injury suffered by asphyxiated newborns. This injury may occur as a direct result of the initial SI or to the higher tidal volumes delivered during subsequent ventilation.	[Sobotka, Kristina S.; Hooper, Stuart B.; Crossley, Kelly J.; Ong, Tracey; Barton, Samantha K.; McDougall, Annie R. A.; Miller, Suzie L.; Tolcos, Mary; Polglase, Graeme R.] Monash Univ, Ritchie Ctr, Melbourne, Vic 3004, Australia; [Sobotka, Kristina S.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Hooper, Stuart B.; Crossley, Kelly J.; Miller, Suzie L.; Tolcos, Mary; Polglase, Graeme R.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia; [Schmoelzer, Georg M.] Med Univ, Dept Pediat, Graz, Austria; [Schmoelzer, Georg M.] Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada; [Schmoelzer, Georg M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Klingenberg, Claus] Univ Hosp North Norway, Dept Paediat, Tromso, Norway; [Klingenberg, Claus] Univ Tromso, Fac Hlth Sci, Paediat Res Grp, Tromso, Norway	Monash University; University of Gothenburg; Monash University; Medical University of Graz; Royal Alexandra Hospital; University of Alberta; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sobotka, KS (corresponding author), Monash Univ, Ritchie Ctr, Melbourne, Vic 3004, Australia.	kristina.sobotka@gu.se	Klingenberg, Claus/AAH-4467-2019; Crossley, Kelly J/I-7407-2013; Schmölzer, Georg M/E-7883-2010	Crossley, Kelly J/0000-0002-1580-1156; Schmölzer, Georg M/0000-0001-9798-2415; Miller, Suzanne/0000-0002-0451-8304; Polglase, Graeme/0000-0002-8906-614X; McDougall, Annie/0000-0003-1182-6679; Barton, Samantha/0000-0001-7601-0238; Tolcos, Mary/0000-0001-6105-4553; Hooper, Stuart/0000-0003-1676-4825	National Health and Medical Research Council (NHMRC) of Australia [384100, 1026890, APP1043294, 545921]; Rebecca L. Cooper Medical Research Foundation Fellowship; Victorian Government's Operational Infrastructure Support Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072848] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation Fellowship; Victorian Government's Operational Infrastructure Support Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia program grant (No. 384100), fellowship (GRP: 1026890, TJM: APP1043294, SBH: 545921), a Rebecca L. Cooper Medical Research Foundation Fellowship (GRP), and the Victorian Government's Operational Infrastructure Support Program.	Bennet L, 1998, PEDIATR RES, V44, P951, DOI 10.1203/00006450-199812000-00022; Boyle DW, 2008, SEMIN FETAL NEONAT M, V13, P392, DOI 10.1016/j.siny.2008.04.026; Covert RF, 1996, REPROD FERT DEVELOP, V8, P157, DOI 10.1071/RD9960157; Crossley KJ, 2009, J PHYSIOL-LONDON, V587, P4695, DOI 10.1113/jphysiol.2009.174870; DELTORO J, 1991, PEDIATR NEUROL, V7, P3, DOI 10.1016/0887-8994(91)90098-6; Fellman V, 1997, PEDIATR RES, V41, P599, DOI 10.1203/00006450-199705000-00001; Fuchs H, 2011, PEDIATR RES, V70, P176, DOI 10.1203/PDR.0b013e318220c1e0; Fujii EY, 2003, AM J OBSTET GYNECOL, V188, P413, DOI 10.1067/mob.2003.40; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Grasso C, 2015, EARLY HUM DEV, V91, P71, DOI 10.1016/j.earlhumdev.2014.12.002; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; HOSKYNS EW, 1987, ARCH DIS CHILD, V62, P376, DOI 10.1136/adc.62.4.376; Klingenberg C, 2013, ARCH DIS CHILD-FETAL, V98, pF222, DOI 10.1136/archdischild-2012-301787; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF188, DOI 10.1136/fn.82.3.F188; Lindner W, 2005, ACTA PAEDIATR, V94, P303, DOI 10.1080/08035250410023647; Lindner W, 1999, PEDIATRICS, V103, P961, DOI 10.1542/peds.103.5.961; Lista G, 2011, NEONATOLOGY, V99, P45, DOI 10.1159/000298312; LISTER G, 1979, AM J PHYSIOL, V237, pH668, DOI 10.1152/ajpheart.1979.237.6.H668; LOU HC, 1979, J PEDIATR-US, V94, P118, DOI 10.1016/S0022-3476(79)80373-X; LOU HC, 1979, ACTA PAEDIATR SCAND, V68, P57, DOI 10.1111/j.1651-2227.1979.tb04430.x; MASON DT, 1971, CIRCULATION, V44, P47, DOI 10.1161/01.CIR.44.1.47; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; PERLMAN JM, 1983, NEW ENGL J MED, V309, P204, DOI 10.1056/NEJM198307283090402; Polglase GR, 2004, PEDIATR RES, V56, P932, DOI 10.1203/01.PDR.0000145254.66447.C0; Polglase GR, 2014, PEDIATR RES, V75, P682, DOI 10.1038/pr.2014.40; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Polglase GR, 2009, J APPL PHYSIOL, V106, P1347, DOI 10.1152/japplphysiol.91445.2008; Rees S, 2010, J NEUROPATH EXP NEUR, V69, P306, DOI 10.1097/NEN.0b013e3181d27138; Richmond S, 2010, RESUSCITATION, V81, P1389, DOI 10.1016/j.resuscitation.2010.08.018; Sobotka KS, 2011, PEDIATR RES, V70, P56, DOI 10.1203/PDR.0b013e31821d06a1; Pas ABT, 2007, PEDIATRICS, V120, P322, DOI 10.1542/peds.2007-0114; te Pas AB, 2009, PEDIATR RES, V66, P295, DOI 10.1203/PDR.0b013e3181b1bca4; te Pas AB, 2009, PEDIATR RES, V65, P537, DOI 10.1203/PDR.0b013e31819da21b; VANBEL F, 1994, PEDIATR RES, V35, P329; VANBEL F, 1987, DEV MED CHILD NEUROL, V29, P601; VANBEL F, 1990, ACTA PAEDIATR SCAND, V79, P756; VYAS H, 1981, J PEDIATR-US, V99, P635, DOI 10.1016/S0022-3476(81)80279-X	37	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146574	10.1371/journal.pone.0146574	http://dx.doi.org/10.1371/journal.pone.0146574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765258	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300029
J	Markowitz, SD; Nock, NL; Schmit, SL; Stadler, ZK; Joseph, V; Zhang, L; Willis, JE; Scacheri, P; Veigl, M; Adams, MD; Raskin, L; Sullivan, JF; Stratton, K; Shia, J; Ellis, N; Rennert, HS; Manschreck, C; Li, L; Offit, K; Elston, RC; Rennert, G; Gruber, SB				Markowitz, Sanford D.; Nock, Nora L.; Schmit, Stephanie L.; Stadler, Zsofia K.; Joseph, Vijai; Zhang, Lu; Willis, Joseph E.; Scacheri, Peter; Veigl, Martina; Adams, Mark D.; Raskin, Leon; Sullivan, John F.; Stratton, Kelly; Shia, Jinru; Ellis, Nathan; Rennert, Hedy S.; Manschreck, Christopher; Li, Li; Offit, Kenneth; Elston, Robert C.; Rennert, Gadi; Gruber, Stephen B.			A Germline Variant on Chromosome 4q31.1 Associates with Susceptibility to Developing Colon Cancer Metastasis	PLOS ONE			English	Article								We tested for germline variants showing association to colon cancer metastasis using a genome-wide association study that compared Ashkenazi Jewish individuals with stage IV metastatic colon cancers versus those with stage I or II non-metastatic colon cancers. In a two-stage study design, we demonstrated significant association to developing metastatic disease for rs60745952, that in Ashkenazi discovery and validation cohorts, respectively, showed an odds ratio (OR) = 2.3 (P = 2.73E-06) and OR = 1.89 (P = 8.05E-04) (exceeding validation threshold of 0.0044). Significant association to metastatic colon cancer was further confirmed by a meta-analysis of rs60745952 in these datasets plus an additional Ashkenazi validation cohort (OR = 1.92; 95% CI: 1.28-2.87), and by a permutation test that demonstrated a significantly longer haplotype surrounding rs60745952 in the stage IV samples. rs60745952, located in an intergenic region on chromosome 4q31.1, and not previously associated with cancer, is, thus, a germline genetic marker for susceptibility to developing colon cancer metastases among Ashkenazi Jews.	[Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Nock, Nora L.; Zhang, Lu; Li, Li; Elston, Robert C.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Markowitz, Sanford D.; Scacheri, Peter; Adams, Mark D.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Willis, Joseph E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Markowitz, Sanford D.; Nock, Nora L.; Willis, Joseph E.; Scacheri, Peter; Veigl, Martina; Li, Li; Elston, Robert C.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Schmit, Stephanie L.; Gruber, Stephen B.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Schmit, Stephanie L.] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Stadler, Zsofia K.; Joseph, Vijai; Sullivan, John F.; Stratton, Kelly; Manschreck, Christopher; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Shia, Jinru] Mem Sloan Kettering Canc Ctr, Dept Pathol, Clin Genet Serv, New York, NY 10065 USA; [Raskin, Leon] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Nashville, TN 37235 USA; [Ellis, Nathan] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Rennert, Hedy S.; Rennert, Gadi] Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel; [Rennert, Hedy S.; Rennert, Gadi] Natl Canc Control Ctr, Clalit Hlth Serv, Haifa, Israel; [Rennert, Hedy S.; Rennert, Gadi] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Southern California; University of Southern California; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Vanderbilt University; University of Arizona; Clalit Health Services; Carmel Medical Center; Clalit Health Services; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Markowitz, SD (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.	sanford.markowitz@case.edu; rennert@techunix.technion.ac.il; sgruber@med.usc.edu	Schmit, Stephanie/AAW-8980-2020; Schmit, Stephanie L./AAC-5916-2019; Nock, Nora L./Q-9396-2019; Joseph, Vijai/J-9158-2013; Raskin, Leon/P-5765-2015	Schmit, Stephanie L./0000-0001-5931-1194; Nock, Nora L./0000-0002-6476-6692; Joseph, Vijai/0000-0002-7933-151X; Rennert, Gad/0000-0002-8512-068X; Raskin, Leon/0000-0003-1195-7214; Shia, Jinru/0000-0002-4351-2511	National Institutes of Health [R01 CA144040, P50 CA150964, P30 CA043703, U19 CA148107, P30 CA014089, K07 CA129162, T32 ES013678, R01 CA160356, R01CA136726]; Leonard and Joan Horvitz Foundation; Richard Horvitz and Erica Hartman-Horvitz Foundation; Anton B. Burg Foundation at USC Norris; Sharon Levine Corzine Research Fund; Robert and Kate Niehaus Clinical Genetics Initiative at MSKCC; National Cancer Institute, National Institutes of Health under RFA [CA-09-002]; NATIONAL CANCER INSTITUTE [U01CA153060, P50CA150964, K07CA129162, R01CA160356, U19CA148107, P30CA043703, R01CA144040, P30CA014089, P30CA008748, R01CA136726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES013678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leonard and Joan Horvitz Foundation; Richard Horvitz and Erica Hartman-Horvitz Foundation; Anton B. Burg Foundation at USC Norris; Sharon Levine Corzine Research Fund; Robert and Kate Niehaus Clinical Genetics Initiative at MSKCC; National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants R01 CA144040 (S. D. M.), P50 CA150964 (S. D. M.), P30 CA043703, U19 CA148107 (S. B. G.), P30 CA014089 (S. B. G.), K07 CA129162 (N. L. N.), T32 ES013678 (S. L. S.), R01 CA160356 (P. S. and S. D. M.), and R01CA136726 (L. L.); and, by the Leonard and Joan Horvitz Foundation (S. D. M.), the Richard Horvitz and Erica Hartman-Horvitz Foundation (S. D. M.), the Anton B. Burg Foundation at USC Norris, the Sharon Levine Corzine Research Fund and, the Robert and Kate Niehaus Clinical Genetics Initiative at MSKCC. This work was supported in part by the National Cancer Institute, National Institutes of Health under RFA # CA-09-002. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CORECT consortium, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government or the CORECT consortium.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Niell BL, 2003, AM J HUM GENET, V73, P1250, DOI 10.1086/379926; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schmit SL, 2014, CARCINOGENESIS, V35, P2512, DOI 10.1093/carcin/bgu148; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegmund D, 2002, AM J HUM GENET, V71, P1183, DOI 10.1086/343819; Thompson CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064122; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	15	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146435	10.1371/journal.pone.0146435	http://dx.doi.org/10.1371/journal.pone.0146435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751797	gold, Green Submitted, Green Published			2022-12-27	WOS:000367888100080
J	Parisot, S; Darlix, A; Baumann, C; Zouaoui, S; Yordanova, Y; Blonski, M; Rigau, V; Chemouny, S; Taillandier, L; Bauchet, L; Duffau, H; Paragios, N				Parisot, Sarah; Darlix, Amelie; Baumann, Cedric; Zouaoui, Sonia; Yordanova, Yordanka; Blonski, Marie; Rigau, Valerie; Chemouny, Stephane; Taillandier, Luc; Bauchet, Luc; Duffau, Hugues; Paragios, Nikos			A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain	PLOS ONE			English	Article							TUMOR SEGMENTATION; CLINICAL ARTICLE; MR-IMAGES; CLASSIFICATION; PLASTICITY; SURGERY; REGISTRATION; VALIDATION; RESECTION; PATTERN	Diffuse WHO grade II gliomas are diffusively infiltrative brain tumors characterized by an unavoidable anaplastic transformation. Their management is strongly dependent on their location in the brain due to interactions with functional regions and potential differences in molecular biology. In this paper, we present the construction of a probabilistic atlas mapping the preferential locations of diffuse WHO grade II gliomas in the brain. This is carried out through a sparse graph whose nodes correspond to clusters of tumors clustered together based on their spatial proximity. The interest of such an atlas is illustrated via two applications. The first one correlates tumor location with the patient's age via a statistical analysis, highlighting the interest of the atlas for studying the origins and behavior of the tumors. The second exploits the fact that the tumors have preferential locations for automatic segmentation. Through a coupled decomposed Markov Random Field model, the atlas guides the segmentation process, and characterizes which preferential location the tumor belongs to and consequently which behavior it could be associated to. Leave-one-out cross validation experiments on a large database highlight the robustness of the graph, and yield promising segmentation results.	[Parisot, Sarah; Paragios, Nikos] Ecole Cent Paris, Ctr Visual Comp, Chatenay Malabry, France; [Parisot, Sarah; Paragios, Nikos] Saclay Ile de France Ctr, Galen Team, INRIA, Chatenay Malabry, France; [Parisot, Sarah; Chemouny, Stephane] Intrasense SAS, Montpellier, France; [Darlix, Amelie] Univ Hosp, Montpellier Neurosci Inst, INSERM, U1051, Montpellier, France; [Darlix, Amelie; Bauchet, Luc; Duffau, Hugues] Inst Reg Canc Montpellier Val dAurelle, Dept Med Oncol, Montpellier, France; [Baumann, Cedric] Univ Hosp, Dept Clin Epidemiol & Evaluat, Nancy, France; [Zouaoui, Sonia] Inst Reg Canc Montpellier Val dAurelle, Registre Tumeurs Herault, Dept Epidemiol, Grp Neurooncol Languedoc Roussillon, Montpellier, France; [Yordanova, Yordanka] HIA Val Grace, Dept Neurosurg, Paris, France; [Blonski, Marie; Taillandier, Luc] Hop Cent, Univ Hosp, Dept Neurol, Neurooncol Unit, Nancy, France; [Rigau, Valerie] Hop Gui De Chauliac, Univ Hosp, Dept Pathol, Montpellier, France; [Bauchet, Luc; Duffau, Hugues] Hop Gui De Chauliac, Dept Neurosurg, Univ Hosp, Montpellier, France	UDICE-French Research Universities; Universite Paris Saclay; Inria; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); CHU de Nancy; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Val-de-Grace Hospital; CHU de Nancy; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Parisot, S (corresponding author), Ecole Cent Paris, Ctr Visual Comp, Chatenay Malabry, France.	s.parisot@imperial.ac.uk		ZOUAOUI, Sonia/0000-0003-0467-3280; Yordanova, Yordanka Nikolova/0000-0003-1764-7161; Darlix, Amelie/0000-0003-1384-1709; Baumann, Cedric/0000-0003-4887-9459	ANRT [147/2010]; Intrasense SAS; European Research Council Starting Grant Diocles [ERC-STG-259112]; SAS	ANRT(French National Research Agency (ANR)); Intrasense SAS; European Research Council Starting Grant Diocles; SAS	This work was supported by ANRT (Grant 147/2010), Intrasense SAS, the European Research Council Starting Grant Diocles (ERC-STG-259112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial funder Intrasense SAS (www.intrasense.fr) provided support in the form of salaries for authors SP and SC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Bauer S, 2011, LECT NOTES COMPUT SC, V6893, P354, DOI 10.1007/978-3-642-23626-6_44; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Capelle L, 2013, J NEUROSURG, V118, P1157, DOI 10.3171/2013.1.JNS121; Chang EF, 2011, J NEUROSURG, V114, P814, DOI 10.3171/2010.5.JNS091159; Corso JJ, 2008, IEEE T MED IMAGING, V27, P629, DOI 10.1109/TMI.2007.912817; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Desmurget M, 2007, BRAIN, V130, P898, DOI 10.1093/brain/awl300; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Duffau H, 2004, CANCER-AM CANCER SOC, V100, P2622, DOI 10.1002/cncr.20297; Duffau H, 2005, LANCET NEUROL, V4, P476, DOI 10.1016/S1474-4422(05)70140-X; Duffau H, 2009, CURR OPIN ONCOL, V21, P543, DOI 10.1097/CCO.0b013e3283305996; Dunn J.C., 1974, J CYBERNETICS, V4, P95, DOI 10.1080/01969727408546059; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Garcia C, 2004, LECT NOTES ARTIF INT, V3315, P636; Gerin C, 2012, CELL PROLIFERAT, V45, P76, DOI 10.1111/j.1365-2184.2011.00790.x; Gering DT, 2002, LECT NOTES COMPUT SC, V2488, P388; Glocker B, 2008, MED IMAGE ANAL, V12, P731, DOI 10.1016/j.media.2008.03.006; Gooya A, 2011, LECT NOTES COMPUT SC, V6892, P532, DOI 10.1007/978-3-642-23629-7_65; Goze C, 2009, J NEURO-ONCOL, V91, P1, DOI 10.1007/s11060-008-9680-8; Ius T, 2011, NEUROIMAGE, V56, P992, DOI 10.1016/j.neuroimage.2011.03.022; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Kaus MR, 2001, RADIOLOGY, V218, P586, DOI 10.1148/radiology.218.2.r01fe44586; Komodakis N., 2008, ADV NEURAL INFORM PR, P865; Komodakis N, 2008, COMPUT VIS IMAGE UND, V112, P14, DOI 10.1016/j.cviu.2008.06.007; Laigle-Donadey F, 2004, NEUROLOGY, V63, P2360, DOI 10.1212/01.WNL.0000148642.26985.68; Lee CH, 2005, LECT NOTES COMPUT SC, V3765, P469; Lee CH, 2008, LECT NOTES COMPUT SC, V5241, P359; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Menze BH, 2010, LECT NOTES COMPUT SC, V6362, P151; Metellus P, 2010, ACTA NEUROPATHOL, V120, P719, DOI 10.1007/s00401-010-0777-8; Moon N, 2002, INT C PATT RECOG, P528, DOI 10.1109/ICPR.2002.1044787; Pal NR, 1997, PATTERN RECOGN, V30, P847, DOI 10.1016/S0031-3203(96)00127-6; Parisot S, 2014, MED IMAGE ANAL, V18, P647, DOI 10.1016/j.media.2014.02.006; Parisot S, 2011, LECT NOTES COMPUT SC, V6892, P508, DOI 10.1007/978-3-642-23629-7_62; Prastawa M, 2004, MED IMAGE ANAL, V8, P275, DOI 10.1016/j.media.2004.06.007; Prastawa M, 2003, ACAD RADIOL, V10, P1341, DOI 10.1016/S1076-6332(03)00506-3; Ren XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032764; Rigau V, 2011, BRAIN PATHOL, V21, P633, DOI 10.1111/j.1750-3639.2011.00491.x; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Sotiras A, 2009, LECT NOTES COMPUT SC, V5761, P672, DOI 10.1007/978-3-642-04268-3_83; Stockhammer F, 2012, SEIZURE-EUR J EPILEP, V21, P194, DOI 10.1016/j.seizure.2011.12.007; Torresani L, 2008, LECT NOTES COMPUT SC, V5303, P596, DOI 10.1007/978-3-540-88688-4_44; Verma R, 2008, ACAD RADIOL, V15, P966, DOI 10.1016/j.acra.2008.01.029; Vovk U, 2007, IEEE T MED IMAGING, V26, P405, DOI 10.1109/TMI.2006.891486; Wels M, 2008, LECT NOTES COMPUT SC, V5241, P67, DOI 10.1007/978-3-540-85988-8_9; Yordanova YN, 2011, J NEUROSURG, V115, P232, DOI 10.3171/2011.3.JNS101333; Zhang J., 2004, INT WORKSHOP ADV IMA, P207	51	36	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0144200	10.1371/journal.pone.0144200	http://dx.doi.org/10.1371/journal.pone.0144200			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751577	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100008
J	Pires, CV; Freitas, FCD; Cristino, AS; Dearden, PK; Simoes, ZLP				Pires, Camilla Valente; de Paula Freitas, Flavia Cristina; Cristino, Alexandre S.; Dearden, Peter K.; Paulino Simoes, Zila Luz			Transcriptome Analysis of Honeybee (Apis Mellifera) Haploid and Diploid Embryos Reveals Early Zygotic Transcription during Cleavage	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; DROSOPHILA-MELANOGASTER; DIFFERENTIAL REGULATION; SEX DETERMINATION; ACTIVATION; GENES; TRANSITION; EXPRESSION; EGG; ORTHODENTICLE	In honeybees, the haplodiploid sex determination system promotes a unique embryogenesis process wherein females develop from fertilized eggs and males develop from unfertilized eggs. However, the developmental strategies of honeybees during early embryogenesis are virtually unknown. Similar to most animals, the honeybee oocytes are supplied with proteins and regulatory elements that support early embryogenesis. As the embryo develops, the zygotic genome is activated and zygotic products gradually replace the preloaded maternal material. The analysis of small RNA and mRNA libraries of mature oocytes and embryos originated from fertilized and unfertilized eggs has allowed us to explore the gene expression dynamics in the first steps of development and during the maternal-to-zygotic transition (MZT). We localized a short sequence motif identified as TAGteam motif and hypothesized to play a similar role in honeybees as in fruit flies, which includes the timing of early zygotic expression (MZT), a function sustained by the presence of the zelda ortholog, which is the main regulator of genome activation. Predicted microRNA (miRNA)-target interactions indicated that there were specific regulators of haploid and diploid embryonic development and an overlap of maternal and zygotic gene expression during the early steps of embryogenesis. Although a number of functions are highly conserved during the early steps of honeybee embryogenesis, the results showed that zygotic genome activation occurs earlier in honeybees than in Drosophila based on the presence of three primary miRNAs (pri-miRNAs) (ame-mir-375, ame-mir-34 and ame-mir-263b) during the cleavage stage in haploid and diploid embryonic development.	[Pires, Camilla Valente; de Paula Freitas, Flavia Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049 Ribeirao Preto, Brazil; [Cristino, Alexandre S.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Dearden, Peter K.] Univ Otago, Dept Biochem, Natl Ctr Growth & Dev, Genet Otago & Gravida, Dunedin, New Zealand; [Paulino Simoes, Zila Luz] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, Brazil	Universidade de Sao Paulo; University of Queensland; University of Otago; Universidade de Sao Paulo	Simoes, ZLP (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, Brazil.	zlpsimoe@usp.br	Dearden, Peter/B-7607-2008; de Paula Freitas, Flavia Cristina/M-4720-2014; Cristino, Alexandre S/A-5834-2012	Dearden, Peter/0000-0001-7790-9675; de Paula Freitas, Flavia Cristina/0000-0002-3162-4890; Cristino, Alexandre S/0000-0002-3468-0919; Simoes, Zila Luz Paulino/0000-0003-2363-6178	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2011/03171-5, 2010/08150-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [research grant numbers 2011/03171-5], which also provided a fellowship [2010/08150-3] to CVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOLECULAR BIOLOGY OF, Vxxxiii, P1601; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bashirullah A, 1999, EMBO J, V18, P2610, DOI 10.1093/emboj/18.9.2610; Benoit B, 2009, DEVELOPMENT, V136, P923, DOI 10.1242/dev.031815; Bethune J, 2012, EMBO REP; Biedler JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033933; Campos-Ortega JA, 1997, THE EMBRYONIC DEVELO; Carlson JM, 2007, NUCLEIC ACIDS RES, V35, pW259, DOI 10.1093/nar/gkm310; Cristino AS, 2006, INSECT MOL BIOL, V15, P703, DOI 10.1111/j.1365-2583.2006.00696.x; Cristino AS, 2014, MOL PSYCHIATR, V19, P294, DOI 10.1038/mp.2013.16; Cruz-Landim Cd, 2009, ABELHAS MORFOLOGIAE; Darbo E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-226; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; Dearden PK, 2006, GENOME RES, V16, P1376, DOI 10.1101/gr.5108606; Dennis G, 2003, GENOME BIOL, V4; Dong H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-163; DuPraw E., 1967, METHODS DEV BIOL, P183; Enright AJ, 2004, GENOME BIOL, V5; Fu S, 2014, DEVELOPMENT EPRESS; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Gilbert SF, 2010, DEVELOPMENTAL BIOLOG; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grosshans J, 2003, DEV CELL, V5, P285, DOI 10.1016/S1534-5807(03)00208-9; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Horner VL, 2008, DEV DYNAM, V237, P527, DOI 10.1002/dvdy.21454; Horner VL, 2006, CURR BIOL, V16, P1441, DOI 10.1016/j.cub.2006.06.024; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Khila A, 2003, INSECT BIOCHEM MOLEC, V33, P691, DOI 10.1016/S0965-1748(03)00063-8; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krauchunas AR, 2012, DEV BIOL, V370, P125, DOI 10.1016/j.ydbio.2012.07.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lipshitz HD, 2001, MOL BIOL CELL, V12, p139A; Lourenco AP, 2013, INSECT BIOCHEM MOLEC, V43, P474, DOI 10.1016/j.ibmb.2013.03.001; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson JA, 1915, EMBRYOLOGY OF THE HO; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Nunes FMF, 2013, J EXP BIOL, V216, P3724, DOI 10.1242/jeb.089243; Osborne P, 2005, APIDOLOGIE, V36, P113, DOI 10.1051/apido:2004075; Pearson JC, 2012, DEV BIOL, V366, P420, DOI 10.1016/j.ydbio.2012.04.001; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schroder R, 2003, NATURE, V422, P621, DOI 10.1038/nature01536; Semotok JL, 2007, DIFFERENTIATION, V75, P482, DOI 10.1111/j.1432-0436.2007.00178.x; Siddiqui NU, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r11; Soni K, 2013, NUCLEIC ACIDS RES, V41, P4470, DOI 10.1093/nar/gkt139; Stetina JRV, 2011, PERSPECTIVES IN BIOL, V3; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Sung HW, 2013, CURR BIOL, V23, P133, DOI 10.1016/j.cub.2012.12.013; Tadros W, 2007, DEV CELL, V12; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Thompson GJ, 2008, INSECT MOL BIOL, V17, P657, DOI 10.1111/j.1365-2583.2008.00838.x; Thomsen S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r93; Tripathy R, 2014, DEV BIOL, V392, P193, DOI 10.1016/j.ydbio.2014.05.026; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Wang BB, 2007, METHODS, V43, P91, DOI 10.1016/j.ymeth.2007.04.003; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wilson MJ, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-11; Wilson MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046490; Wilson MJ, 2011, DEVELOPMENT, V138, P3497, DOI 10.1242/dev.067926; Wilson MJ, 2011, EVOL DEV, V13, P127, DOI 10.1111/j.1525-142X.2011.00463.x; Wilson MJ, 2010, DEV BIOL, V339, P200, DOI 10.1016/j.ydbio.2009.12.015; Wilson MJ, 2009, DEV BIOL, V335, P276, DOI 10.1016/j.ydbio.2009.09.002; Wilson MJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-120; Wilson MJ, 2010, DEVELOPMENT GENES AN, V220; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040130; Zondag L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-211	74	23	23	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146447	10.1371/journal.pone.0146447	http://dx.doi.org/10.1371/journal.pone.0146447			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751956	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100081
J	Wang, H; Yang, L; Ping, YH; Bai, YG; Luo, HY; Huang, HQ; Yao, B				Wang, Hui; Yang, Lian; Ping, Yanhai; Bai, Yingguo; Luo, Huiying; Huang, Huoqing; Yao, Bin			Engineering of a Bacillus amyloliquefaciens Strain with High Neutral Protease Producing Capacity and Optimization of Its Fermentation Conditions	PLOS ONE			English	Article							ESCHERICHIA-COLI; ELECTROTRANSFORMATION EFFICIENCY; NUCLEOTIDE-SEQUENCE; HIGH OSMOLARITY; GENE NPRE; EXPRESSION; SUBTILIS; CLONING; SECRETION; TRANSFORMATION	The neutral protease has high potential for industrial applications, and attempts to improve enzyme expression level have important application values. In the present study, a neutral protease-encoding gene, Banpr, was cloned from Bacillus amyloliquefaciens strain K11, and a genetic manipulation method specific for this difficult-to-transform strain was developed for the high-level expression of neutral protease. The recombinant plasmid pUB110-Banpr was constructed in Bacillus subtilis strain WB600 and then transformed into strain K11 under optimized conditions. A positive transformant 110N-6 with the highest protease secreting capacity on skim milk plates and great genetic stability for more than 100 generations was selected for further study. Optimization of the fermentation conditions increased the enzyme activity of strain 110N-6 to 8995 +/- 250 U/ml in flask culture and 28084 +/- 1282 U/ml in 15-l fermentor, which are significantly higher than that of the native strain K11 and industrial strain B. subtilis AS. 1398, respectively. The high expression level and extreme genetic stability make B. amyloliquefaciens strain 110N-6 more favorable for mass production of neutral protease for industrial uses.	[Wang, Hui; Yang, Lian; Ping, Yanhai; Bai, Yingguo; Luo, Huiying; Huang, Huoqing; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Huang, HQ (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	huanghuoqing@caas.cn; binyao@caas.cn			National Science and Technology Support Program of China [2013BAD10B01-2]; National High Technology Research and Development Program of China [2013AA102803]; National Science Foundation for Distinguished Young Scholars of China [31225026]; China Modern Agriculture Research System [CARS-42]	National Science and Technology Support Program of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Modern Agriculture Research System	This research was supported by the National Science and Technology Support Program of China (2013BAD10B01-2), and the National High Technology Research and Development Program of China (2013AA102803), and the National Science Foundation for Distinguished Young Scholars of China (31225026), and China Modern Agriculture Research System (CARS-42).	ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Bhaskar N, 2008, BIORESOURCE TECHNOL, V99, P4105, DOI 10.1016/j.biortech.2007.09.006; Cho SJ, 2003, J AGR FOOD CHEM, V51, P7664, DOI 10.1021/jf0259314; DEAN CR, 1991, APPL ENVIRON MICROB, V57, P1893, DOI 10.1128/AEM.57.7.1893-1898.1991; FUJII M, 1983, J BACTERIOL, V154, P831, DOI 10.1128/JB.154.2.831-837.1983; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; HONJO M, 1984, J BIOTECHNOL, V1, P265, DOI 10.1016/0168-1656(84)90018-X; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; Inouye K, 2006, PROTEIN EXPRES PURIF, V46, P248, DOI 10.1016/j.pep.2005.07.023; Ito M, 2001, BIOSCI BIOTECH BIOCH, V65, P2773, DOI 10.1271/bbb.65.2773; KUBO M, 1988, J GEN MICROBIOL, V134, P1883; Mansfeld J, 2005, PROTEIN EXPRES PURIF, V39, P219, DOI 10.1016/j.pep.2004.10.008; Niu QH, 2006, ARCH MICROBIOL, V185, P439, DOI 10.1007/s00203-006-0112-x; ODONOHUE MJ, 1994, BIOCHEM J, V300, P599, DOI 10.1042/bj3000599; PRIEST FG, 1977, BACTERIOL REV, V41, P711, DOI 10.1128/MMBR.41.3.711-753.1977; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Sandhya C, 2005, PROCESS BIOCHEM, V40, P2689, DOI 10.1016/j.procbio.2004.12.001; TAKAGI M, 1985, J BACTERIOL, V163, P824, DOI 10.1128/JB.163.3.824-831.1985; Thys RCS, 2006, PROCESS BIOCHEM, V41, P67, DOI 10.1016/j.procbio.2005.03.070; TRAN L, 1991, J BACTERIOL, V173, P6364, DOI 10.1128/jb.173.20.6364-6372.1991; VANDENBURG B, 1991, J BACTERIOL, V173, P4107, DOI 10.1128/jb.173.13.4107-4115.1991; VASANTHA N, 1984, J BACTERIOL, V159, P811, DOI 10.1128/JB.159.3.811-819.1984; VEHMAANPERA J, 1989, FEMS MICROBIOL LETT, V61, P165, DOI 10.1016/S0378-1097(98)00070-6; WANG LF, 1993, J GEN MICROBIOL, V139, P343, DOI 10.1099/00221287-139-2-343; WANG LF, 1990, BIOCHEM INT, V22, P1085; Wang LT, 2007, INT J SYST EVOL MICR, V57, P1846, DOI 10.1099/ijs.0.64685-0; WARD OP, 1985, PROTEOLYTIC ENZYMES, P789; WELLS JA, 1983, NUCLEIC ACIDS RES, V11, P7911, DOI 10.1093/nar/11.22.7911; WETMORE DR, 1992, MOL MICROBIOL, V6, P1593, DOI 10.1111/j.1365-2958.1992.tb00884.x; WU XC, 1991, J BACTERIOL, V173, P4952, DOI 10.1128/jb.173.16.4952-4958.1991; Xue GP, 1999, J MICROBIOL METH, V34, P183, DOI 10.1016/S0167-7012(98)00087-6; YANG MY, 1984, J BACTERIOL, V160, P15, DOI 10.1128/JB.160.1.15-21.1984; You C, 2012, APPL ENVIRON MICROB, V78, P1593, DOI 10.1128/AEM.07105-11; Zhang GQ, 2011, ANAL BIOCHEM, V409, P130, DOI 10.1016/j.ab.2010.10.013; Zhang GQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002987; Zhang HT, 2013, APPL MICROBIOL BIOT, V97, P9503, DOI 10.1007/s00253-013-5172-7	36	26	32	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146373	10.1371/journal.pone.0146373	http://dx.doi.org/10.1371/journal.pone.0146373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752595	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100072
J	Wedemeyer, H; Forns, X; Hezode, C; Lee, SS; Scalori, A; Voulgari, A; Le Pogam, S; Najera, I; Thommes, JA				Wedemeyer, Heiner; Forns, Xavier; Hezode, Christophe; Lee, Samuel S.; Scalori, Astrid; Voulgari, Athina; Le Pogam, Sophie; Najera, Isabel; Thommes, James A.			Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; RITONAVIR-BOOSTED DANOPREVIR; VIRUS-INFECTION; RESISTANT VARIANTS; HCV INFECTION; PROTEASE; POLYMERASE; THERAPY; RESTORATION; ASSOCIATION	Most patients with chronic hepatitis C virus (HCV) genotype 1 infection who have had a previous null response (<2-log(10) reduction in HCV RNA by treatment week 12) to peginterferon/ ribavirin (PegIFN/RBV) do not achieve a sustained virological response (SVR) when re-treated with a first-generation HCV protease inhibitor (PI) administered in combination with PegIFN/RBV. We studied the incremental benefits associated with adding mericitabine (nucleoside analog inhibitor of HCV polymerase) to PI plus PegIFN alfa-2a/RBV-based therapy in two double-blind randomized multicenter phase 2 trials (with boceprevir in DYNAMO 1, and with telaprevir in DYNAMO 2). The primary endpoint in both trials was SVR, defined as HCV RNA <25 IU/mL 12 weeks after the end of treatment (SVR12). Overall, the addition of mericitabine to PI plus PegIFN alfa-2a/RBV therapy resulted in SVR12 rates of 60-70% in DYNAMO 1 and of 71-96% in DYNAMO 2. SVR12 rates were similar in patients infected with HCV genotype 1a and 1b in both trials. The placebo control arms in both studies were stopped because of high rates of virological failure. Numerically lower relapse rates were associated with longer treatment with mericitabine (24 versus 12 weeks), telaprevir-containing regimens, and regimens that included 48 weeks of PegIFN alfa-2a/RBV therapy. No mericitabine resistance mutations were identified in any patient in either trial. The addition of mericitabine did not add to the safety burden associated with either telaprevir or boceprevir-based regimens. These studies demonstrate increased SVR rates and reduced relapse rates in difficult-to-treat patients when a nucleoside polymerase inhibitor with intermediate antiviral potency is added to regimens containing a first-generation PI.	[Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Forns, Xavier] IDIBAPS, Hosp Clin, Liver Unit, Barcelona, Spain; [Forns, Xavier] CIBEREHD, Barcelona, Spain; [Hezode, Christophe] Univ Paris Est, INSERM, U955, Dept Hepatol & Gastroenterol,Hop Henri Mondor, Creteil, France; [Lee, Samuel S.] Univ Calgary, Liver Unit, Calgary, AB, Canada; [Scalori, Astrid] Roche Prod Ltd, Global Prod Dev Immunol, Resp, Welwyn Garden City, England; [Voulgari, Athina] Roche Prod Ltd, Global Prod Dev Clin Sci, Welwyn Garden City, England; [Le Pogam, Sophie] Genentech Inc, Clin Dev Infect Dis, San Francisco, CA 94080 USA; [Najera, Isabel] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharma & Early Dev, Basel, Switzerland; [Thommes, James A.] Genentech Inc, Prod Dev Immunol, San Francisco, CA 94080 USA	Hannover Medical School; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Calgary; Roche Holding; Roche Holding; Roche Holding; Genentech; Roche Holding; Roche Holding; Genentech	Wedemeyer, H (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	wedemeyer.heiner@mh-hannover.de	Hezode, Christophe/U-4659-2018	Forns, Xavier/0000-0002-8188-1764	F. Hoffmann-La Roche Ltd.; Roche Products Ltd; Genentech Inc.	F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); Roche Products Ltd; Genentech Inc.(Roche HoldingGenentech)	These studies were funded by F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd and its subsidiaries Roche Products Ltd and Genentech Inc. provided support in the form of salaries for authors [AS, AV, SLP, IN, JAT]. The funders participated in the design and conduct of the study, in the analysis and interpretation of the data and in the preparation and review of the manuscript before submission. The specific roles of these authors are articulated in the 'author contributions' section. Third-party medical writing assistance, but not editorial content development sufficient to meet International Committee of Medical Journal Editors (ICMJE) authorship criteria, was funded by F. Hoffmann-La Roche Ltd.	[Anonymous], REC TEST MAN TREAT H; [Anonymous], 2015, J HEPATOL IN PRESS; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Colombo M, 2014, J HEPATOL, V61, P976, DOI 10.1016/j.jhep.2014.06.005; Feld JJ, 2015, J HEPATOL, V62, P294, DOI 10.1016/j.jhep.2014.09.013; Gane EJ, 2015, LIVER INT, V35, P79, DOI 10.1111/liv.12588; Gane EJ, 2014, ANTIMICROB AGENTS CH, V58, P1136, DOI 10.1128/AAC.01515-13; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Haseltine EL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003772; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Ho CKY, 2015, J VIROL METHODS, V219, P28, DOI 10.1016/j.jviromet.2015.03.018; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen DM, 2013, HEPATOLOGY, V58, p741A; Kalkeri G, 2013, ANTIMICROB AGENTS CH, V57, P4417, DOI 10.1128/AAC.00399-13; Le Pogam S, 2012, ANTIMICROB AGENTS CH, V56, P5494, DOI 10.1128/AAC.01035-12; Le Pogam S, 2010, J INFECT DIS, V202, P1510, DOI 10.1086/656774; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Merck and Co, 2013, VICTR PRESCR INF; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Pockros PJ, 2013, HEPATOLOGY, V58, P514, DOI 10.1002/hep.26275; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reddy KR, 2015, LANCET INFECT DIS, V15, P27, DOI 10.1016/S1473-3099(14)71002-3; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Tong X, 2014, J INFECT DIS, V209, P668, DOI 10.1093/infdis/jit562; van der Meer AJ, 2014, JAMA-J AM MED ASSOC, V312, P1927, DOI 10.1001/jama.2014.12627; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vierling JM, 2014, J HEPATOL, V60, P748, DOI 10.1016/j.jhep.2013.12.013; Wedemeyer H, 2013, HEPATOLOGY, V58, P524, DOI 10.1002/hep.26274; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhu ZW, 2013, J INFECT DIS, V208, P1653, DOI 10.1093/infdis/jit338	35	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145409	10.1371/journal.pone.0145409	http://dx.doi.org/10.1371/journal.pone.0145409			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752189	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100013
J	Yang, W; Xu, XN; Li, Y; Wang, YZ; Li, M; Wang, Y; Ding, XH; Chu, ZH				Yang, Wei; Xu, Xiaonan; Li, Yang; Wang, Yingzi; Li, Ming; Wang, Yong; Ding, Xinhua; Chu, Zhaohui			Rutin-Mediated Priming of Plant Resistance to Three Bacterial Pathogens Initiating the Early SA Signal Pathway	PLOS ONE			English	Article							SALICYLIC-ACID; TRANSCRIPTION FACTOR; FLAVONOL SYNTHESIS; DISEASE; TOBACCO; TOMATO; ANTIOXIDANT; INHIBITION; EXPRESSION; REQUIRES	Flavonoids are ubiquitous in the plant kingdom and have many diverse functions, including UV protection, auxin transport inhibition, allelopathy, flower coloring and insect resistance. Here we show that rutin, a proud member of the flavonoid family, could be functional as an activator to improve plant disease resistances. Three plant species pretreated with 2 mM rutin were found to enhance resistance to Xanthomonas oryzae pv. oryzae, Ralstonia solanacearum, and Pseudomonas syringae pv. tomato strain DC3000 in rice, tobacco and Arabidopsis thaliana respectively. While they were normally propagated on the cultural medium supplemented with 2 mM rutin for those pathogenic bacteria. The enhanced resistance was associated with primed expression of several pathogenesis-related genes. We also demonstrated that the rutin-mediated priming resistance was attenuated in npr1, eds1, eds5, pad4-1, ndr1 mutants, and NahG transgenic Arabidopsis plant, while not in either snc1-11, ein2-5 or jar1 mutants. We concluded that the rutin-priming defense signal was modulated by the salicylic acid (SA)-dependent pathway from an early stage upstream of NDR1 and EDS1.	[Yang, Wei; Xu, Xiaonan; Li, Yang; Li, Ming; Wang, Yong; Ding, Xinhua; Chu, Zhaohui] Shandong Agr Univ, State Key Lab Crop Biol, Shandong Prov Key Lab Agr Microbiol, Tai An 271018, Shandong, Peoples R China; [Wang, Yingzi] Yantai Acad Agr Sci, Inst Plant Protect, Yantai 265500, Shandong, Peoples R China; [Xu, Xiaonan] Tianjin Entry Exit Inspect & Quarantine Bur, Tianjin 300300, Peoples R China	Shandong Agricultural University	Ding, XH (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Shandong Prov Key Lab Agr Microbiol, Tai An 271018, Shandong, Peoples R China.	xhding@sdau.edu.cn; zchu@sdau.edu.cn	yang, wei/GZA-7712-2022; ding, xinhua/AAV-2612-2020; Chu, Zhaohui/AAX-9925-2021	ding, xinhua/0000-0002-6510-5992; Chu, Zhaohui/0000-0001-8320-7872	National Natural Science Foundation of China [31171836]; Special Fund for Agro-scientific Research in the Public Interest [201003004]; Shandong Province Modern Agricultural industry Technology System; Taishan Scholar Programme of Shandong Province; Program for Changjiang Scholars and Innovative Research Team in University [IRT1155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Shandong Province Modern Agricultural industry Technology System; Taishan Scholar Programme of Shandong Province; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by the National Natural Science Foundation of China (31171836), the Special Fund for Agro-scientific Research in the Public Interest (201003004) and by the Shandong Province Modern Agricultural industry Technology System. Z.C. was funded by the Taishan Scholar Programme of Shandong Province and by the Program for Changjiang Scholars and Innovative Research Team in University (Grant no. IRT1155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Erel SB, 2011, PHARM BIOL, V49, P840, DOI 10.3109/13880209.2010.551538; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Goellner K, 2008, EUR J PLANT PATHOL, V121, P233, DOI 10.1007/s10658-007-9251-4; Guerrero L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049493; Guo R, 2007, J PHARMACEUT BIOMED, V43, P1580, DOI 10.1016/j.jpba.2006.11.029; Hu Y, 2008, J INTEGR PLANT BIOL, V50, P1601, DOI 10.1111/j.1744-7909.2008.00789.x; Hunyadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050619; Jia ZH, 2010, BIOCHEM BIOPH RES CO, V396, P522, DOI 10.1016/j.bbrc.2010.04.131; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kato H, 2008, J GEN PLANT PATHOL, V74, P15, DOI 10.1007/s10327-007-0054-4; Kay E, 2002, APPL ENVIRON MICROB, V68, P3345, DOI 10.1128/AEM.68.7.3345-3351.2002; Kuntic V, 2011, MOLECULES, V16, P1378, DOI 10.3390/molecules16021378; Li N, 2013, PLANT CELL TISS ORG, V115, P429, DOI 10.1007/s11240-013-0374-3; Li Y, 2015, PLANT CELL TISS ORG, V122, P309, DOI 10.1007/s11240-015-0767-6; Li YQ, 2007, MOL PLANT MICROBE IN, V20, P1449, DOI 10.1094/MPMI-20-11-1449; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; Maddox CE, 2010, CURR MICROBIOL, V60, P53, DOI 10.1007/s00284-009-9501-0; Middleton E, 2000, PHARMACOL REV, V52, P673; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Murakami S, 1999, J ENZYM INHIB, V14, P151, DOI 10.3109/14756369909036551; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; Padmavati M, 1997, PHYTOCHEMISTRY, V46, P499, DOI 10.1016/S0031-9422(97)00325-7; Pandey A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05018; Pandey A, 2012, PLANT CELL REP, V31, P1867, DOI 10.1007/s00299-012-1300-6; Scalschi L, 2013, MOL PLANT PATHOL, V14, P342, DOI 10.1111/mpp.12010; Serrano M, 2013, PLANT PHYSIOL, V162, P1815, DOI 10.1104/pp.113.218156; Skadhauge B, 1997, HEREDITAS, V126, P147, DOI 10.1111/j.1601-5223.1997.00147.x; Taguri T, 2006, BIOL PHARM BULL, V29, P2226, DOI 10.1248/bpb.29.2226; Tapas AR, 2008, TROP J PHARM RES, V7, P1089; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842	42	61	63	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146910	10.1371/journal.pone.0146910	http://dx.doi.org/10.1371/journal.pone.0146910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751786	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100178
J	Gillmor, CS; Roeder, AHK; Sieber, P; Somerville, C; Lukowitz, W				Gillmor, C. Stewart; Roeder, Adrienne H. K.; Sieber, Patrick; Somerville, Chris; Lukowitz, Wolfgang			A Genetic Screen for Mutations Affecting Cell Division in the Arabidopsis thaliana Embryo Identifies Seven Loci Required for Cytokinesis	PLOS ONE			English	Article							ELECTRON TOMOGRAPHIC ANALYSIS; MALE MEIOTIC CYTOKINESIS; KINESIN-RELATED PROTEIN; ENDOSPERM CELLULARIZATION; ARABINOGALACTAN-PROTEINS; INSERTIONAL MUTAGENESIS; SEED DEVELOPMENT; MUTANTS; PLATE; WALL	Cytokinesis in plants involves the formation of unique cellular structures such as the phragmoplast and the cell plate, both of which are required to divide the cell after nuclear division. In order to isolate genes that are involved in de novo cell wall formation, we performed a large-scale, microscope-based screen for Arabidopsis mutants that severely impair cytokinesis in the embryo. We recovered 35 mutations that form abnormally enlarged cells with multiple, often polyploid nuclei and incomplete cell walls. These mutants represent seven genes, four of which have previously been implicated in phragmoplast or cell plate function. Mutations in two loci show strongly reduced transmission through the haploid gametophytic generation. Molecular cloning of both corresponding genes reveals that one is represented by hypomorphic alleles of the kinesin-5 gene RADIALLY SWOLLEN 7 (homologous to tobacco kinesin-related protein TKRP125), and that the other gene corresponds to the Arabidopsis FUSED ortholog TWO-IN-ONE (originally identified based on its function in pollen development). No mutations that completely abolish the formation of cross walls in diploid cells were found. Our results support the idea that cytokinesis in the diploid and haploid generations involve similar mechanisms.	[Gillmor, C. Stewart; Roeder, Adrienne H. K.; Sieber, Patrick; Somerville, Chris; Lukowitz, Wolfgang] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Gillmor, C. Stewart; Roeder, Adrienne H. K.; Somerville, Chris] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University	Lukowitz, W (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 20606 USA.	lukowitz@uga.edu	Roeder, Adrienne/ABF-5334-2021; Gillmor, Stewart/C-1965-2014	Gillmor, Stewart/0000-0003-1009-2167; Sieber, Patrick/0000-0003-4104-5312; Roeder, Adrienne/0000-0001-6685-2984	US Department of Energy [DOE-FG02-03ER20133]; US Department of Agriculture [CSREES 00-35304-9394]; National Science Foundation [IOB-0446103]; Human Frontier Science Program Organization [LT594-96]; US Department of Energy/National Science Foundation/US Department of Agriculture tri-agency training grant; Stanford University (President's Scholar undergraduate research grant); Direct For Biological Sciences [1257805] Funding Source: National Science Foundation	US Department of Energy(United States Department of Energy (DOE)); US Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program Organization(Human Frontier Science Program); US Department of Energy/National Science Foundation/US Department of Agriculture tri-agency training grant; Stanford University (President's Scholar undergraduate research grant); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the US Department of Energy (grant DOE-FG02-03ER20133 to CS); the US Department of Agriculture (grant CSREES 00-35304-9394 to CS and WL); the National Science Foundation (grant IOB-0446103 to WL); the Human Frontier Science Program Organization (fellowship LT594-96 to WL); the US Department of Energy/National Science Foundation/US Department of Agriculture tri-agency training grant (awarded to Stanford University Department of Biological Sciences; supported CSG); and Stanford University (President's Scholar undergraduate research grant to AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ASADA T, 1994, J CELL SCI, V107, P2249; Asada T, 1997, J CELL SCI, V110, P179; Assaad FF, 1996, MOL GEN GENET, V253, P267, DOI 10.1007/PL00008594; Assaad FF, 2001, J CELL BIOL, V152, P531, DOI 10.1083/jcb.152.3.531; Bannigan A, 2007, J CELL SCI, V120, P2819, DOI 10.1242/jcs.009506; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Cassimeris L, 2004, CURR BIOL, V14, pR1000, DOI 10.1016/j.cub.2004.11.022; Cutler SR, 2002, P NATL ACAD SCI USA, V99, P2812, DOI 10.1073/pnas.052712299; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; Gillmor CS, 2005, PLANT CELL, V17, P1128, DOI 10.1105/tpc.105.031815; Gillmor CS, 2002, J CELL BIOL, V156, P1003, DOI 10.1083/jcb.200111093; Graham LE, 2000, P NATL ACAD SCI USA, V97, P4535, DOI 10.1073/pnas.97.9.4535; His I, 2001, PLANTA, V212, P348, DOI 10.1007/s004250000437; Hulskamp M, 1997, DEV BIOL, V187, P114, DOI 10.1006/dbio.1997.8554; Jaber E, 2010, NEW PHYTOL, V187, P751, DOI 10.1111/j.1469-8137.2010.03331.x; Jang JC, 2000, GENE DEV, V14, P1485; Jeong S, 2011, CURR BIOL, V21, P1268, DOI 10.1016/j.cub.2011.06.049; Jurgens G, 2005, ANNU REV PLANT BIOL, V56, P281, DOI 10.1146/annurev.arplant.55.031903.141636; Krupnova T, 2013, PLANT J, V74, P781, DOI 10.1111/tpj.12160; Krupnova T, 2009, CURR BIOL, V19, P518, DOI 10.1016/j.cub.2009.02.021; Krysan PJ, 2002, PLANT CELL, V14, P1109, DOI 10.1105/tpc.001164; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lee YRJ, 2004, PLANT PHYSIOL, V136, P3877, DOI 10.1104/pp.104.052621; Lee YRJ, 2013, CURR OPIN PLANT BIOL, V16, P757, DOI 10.1016/j.pbi.2013.10.008; Li SW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00282; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; Lukowitz W, 2001, P NATL ACAD SCI USA, V98, P2262, DOI 10.1073/pnas.051625798; Mayer U, 1999, EUR J CELL BIOL, V78, P100, DOI 10.1016/S0171-9335(99)80011-9; McElver J, 2000, PLANT CELL, V12, P1379, DOI 10.1105/tpc.12.8.1379; McElver J, 2001, GENETICS, V159, P1751; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; MISERA S, 1994, MOL GEN GENET, V244, P242, DOI 10.1007/BF00285451; Monnier Veronique, 2002, BMC Dev Biol, V2, P4, DOI 10.1186/1471-213X-2-4; Muller S, 2004, CURR BIOL, V14, P412, DOI 10.1016/j.cub.2004.02.032; Muller S, 2002, PLANT PHYSIOL, V130, P312, DOI 10.1104/pp.004416; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Nishihama R, 2002, CELL, V109, P87, DOI 10.1016/S0092-8674(02)00691-8; Oh SA, 2005, CURR BIOL, V15, P2107, DOI 10.1016/j.cub.2005.10.044; Oh SA, 2008, MOL PLANT, V1, P794, DOI 10.1093/mp/ssn042; Otegui M, 2000, PLANT CELL, V12, P933, DOI 10.1105/tpc.12.6.933; Otegui M, 2000, CURR OPIN PLANT BIOL, V3, P493, DOI 10.1016/S1369-5266(00)00119-9; Otegui MS, 2004, PLANTA, V218, P501, DOI 10.1007/s00425-003-1125-1; Otegui MS, 2001, PLANT CELL, V13, P2033, DOI 10.1105/tpc.13.9.2033; Park M, 2012, DEV CELL, V22, P989, DOI 10.1016/j.devcel.2012.03.002; Pollock DD, 2004, GENETICS, V168, P489, DOI 10.1534/genetics.103.024430; Qi XY, 2011, PLANT J, V68, P234, DOI 10.1111/j.1365-313X.2011.04681.x; Reddy A S, 2001, BMC Genomics, V2, P2, DOI 10.1186/1471-2164-2-2; Redei G. P., 1992, Methods in Arabidopsis research., P16; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Sasabe M, 2006, GENE DEV, V20, P1004, DOI 10.1101/gad.1408106; Sasabe M, 2012, CYTOSKELETON, V69, P913, DOI 10.1002/cm.21072; Schrick K, 2000, GENE DEV, V14, P1471; Schrick K, 2002, PLANT J, V31, P61, DOI 10.1046/j.1365-313X.2002.01333.x; SCOTT TA, 1953, ANAL CHEM, V25, P1656, DOI 10.1021/ac60083a023; Segui-Simarro JM, 2004, PLANT CELL, V16, P836, DOI 10.1105/tpc.017749; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Sollner R, 2002, PLANT PHYSIOL, V129, P678, DOI 10.1104/pp.004184; Sorensen MB, 2002, DEVELOPMENT, V129, P5567, DOI 10.1242/dev.00152; Souter M, 2002, PLANT CELL, V14, P1017, DOI 10.1105/tpc.001248; Spielman M, 1997, DEVELOPMENT, V124, P2645; Steinborn K, 2002, GENE DEV, V16, P959, DOI 10.1101/gad.221702; Strompen G, 2002, CURR BIOL, V12, P153, DOI 10.1016/S0960-9822(01)00655-8; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Tanaka H, 2004, GENES CELLS, V9, P1199, DOI 10.1111/j.1365-2443.2004.00798.x; Thellmann M, 2010, PLANT PHYSIOL, V154, P720, DOI 10.1104/pp.110.154286; Thiele K, 2009, PLANT J, V58, P13, DOI 10.1111/j.1365-313X.2008.03760.x; Toller A, 2008, PLANT J, V54, P911, DOI 10.1111/j.1365-313X.2008.03462.x; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; van Hengel AJ, 2002, PHYSIOL PLANTARUM, V114, P637, DOI 10.1034/j.1399-3054.2002.1140418.x; Vanstraelen M, 2006, TRENDS PLANT SCI, V11, P167, DOI 10.1016/j.tplants.2006.02.004; Waizenegger I, 2000, CURR BIOL, V10, P1371, DOI 10.1016/S0960-9822(00)00775-2; Wiedemeier AMD, 2002, DEVELOPMENT, V129, P4821; Willemsen V, 2003, PLANT CELL, V15, P612, DOI 10.1105/tpc.008433; Yang CY, 2003, PLANT J, V34, P229, DOI 10.1046/j.1365-313X.2003.01713.x; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	84	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146492	10.1371/journal.pone.0146492	http://dx.doi.org/10.1371/journal.pone.0146492			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745275	Green Published, gold, Green Submitted			2022-12-27	WOS:000367815600056
J	Pang, J; Xi, C; Huang, XQ; Cui, J; Gong, H; Zhang, TM				Pang, Jing; Xi, Chao; Huang, Xiuqing; Cui, Ju; Gong, Huan; Zhang, Tiemei			Effects of Excess Energy Intake on Glucose and Lipid Metabolism in C57BL/6 Mice	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; HIGH-FRUCTOSE; STEATOSIS; OBESITY; DYSLIPIDEMIA; MODELS	Excess energy intake correlates with the development of metabolic disorders. However, different energy-dense foods have different effects on metabolism. To compare the effects of a high-fat diet, a high-fructose diet and a combination high-fat/high-fructose diet on glucose and lipid metabolism, male C57BL/6 mice were fed with one of four different diets for 3 months: standard chow; standard diet and access to fructose water; a high fat diet; and a high fat diet with fructose water. After 3 months of feeding, the high-fat and the combined high-fat/high-fructose groups showed significantly increased body weights, accompanied by hyperglycemia and insulin resistance; however, the high-fructose group was not different from the control group. All three energy-dense groups showed significantly higher visceral fat weights, total cholesterol concentrations, and low-density lipoprotein cholesterol concentrations compared with the control group. Assays of basal metabolism showed that the respiratory quotient of the high-fat, the high-fructose, and the high-fat/high-fructose groups decreased compared with the control group. The present study confirmed the deleterious effect of high energy diets on body weight and metabolism, but suggested that the energy efficiency of the high-fructose diet was much lower than that of the high-fat diet. In addition, fructose supplementation did not worsen the detrimental effects of high-fat feeding alone on metabolism in C57BL/6 mice.	[Pang, Jing; Huang, Xiuqing; Cui, Ju; Gong, Huan; Zhang, Tiemei] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Pang, Jing; Huang, Xiuqing; Cui, Ju; Gong, Huan; Zhang, Tiemei] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Xi, Chao] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Beijing Hospital; Beijing Normal University	Zhang, TM (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	tmzhang126@126.com			National Natural Science Foundation of China [81100570]; 12th five-year National Science and Technology Project [2012BAI10B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th five-year National Science and Technology Project	This work was supported by the National Natural Science Foundation of China (No: 81100570) to JP and 12th five-year National Science and Technology Project (No: 2012BAI10B01) to TZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaxter K, 1989, ENERGY METABOLISM AN; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Briand F, 2012, J NUTR, V142, P704, DOI 10.3945/jn.111.153197; Crescenzo R, 2014, EXP PHYSIOL, V99, P1203, DOI 10.1113/expphysiol.2014.079632; DeBosch BJ, 2013, MOL ENDOCRINOL, V27, P1887, DOI 10.1210/me.2013-1137; Deer J, 2015, METABOLISM, V64, P163, DOI 10.1016/j.metabol.2014.08.013; Dissard R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076703; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; GELDING SV, 1994, CLIN ENDOCRINOL, V40, P611, DOI 10.1111/j.1365-2265.1994.tb03012.x; Handayani D, 2011, J OBES, V2011, DOI 10.1155/2011/258051; Hara T, 1998, METABOLISM, V47, P149, DOI 10.1016/S0026-0495(98)90211-6; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Jaya C, 2010, FOOD CHEM TOXICOL, V48, P2021, DOI 10.1016/j.fct.2010.04.044; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; KasimKarakas SE, 1996, J LAB CLIN MED, V128, P208, DOI 10.1016/S0022-2143(96)90013-X; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Martins AR, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-30; Messier C, 2007, BEHAV BRAIN RES, V178, P139, DOI 10.1016/j.bbr.2006.12.011; Ren DY, 2014, FOOD FUNCT, V5, P2609, DOI 10.1039/c3fo60640f; So M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-99; Spruss A, 2012, LAB INVEST, V92, P1020, DOI 10.1038/labinvest.2012.75; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tillman EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107206; Tran LT, 2009, MOL CELL BIOCHEM, V332, P145, DOI 10.1007/s11010-009-0184-4	25	32	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146675	10.1371/journal.pone.0146675	http://dx.doi.org/10.1371/journal.pone.0146675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745179	Green Published, Green Submitted, gold			2022-12-27	WOS:000367815600075
J	Ithuralde, RE; Turjanski, AG				Esteban Ithuralde, Raul; Gustavo Turjanski, Adrian			Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; TRANSACTIVATION DOMAIN; FORCE-FIELD; BINDING; MODULATION; SIMULATIONS; MECHANISM; AFFINITIES	Disordered regions and Intrinsically Disordered Proteins (IDPs) are involved in critical cellular processes and may acquire a stable three-dimensional structure only upon binding to their partners. IDPs may follow a folding-after-binding process, known as induced folding, or a folding-before-binding process, known as conformational selection. The transcription factor p53 is involved in the regulation of cellular events that arise upon stress or DNA damage. The p53 domain structure is composed of an N-terminal transactivation domain (p53TAD), a DNA Binding Domain and a tetramerization domain. The activity of TAD is tightly regulated by interactions with cofactors, inhibitors and phosphorylation. To initiate transcription, p53TAD binds to the TAZ2 domain of CBP, a co-transcription factor, and undergoes a folding and binding process, as revealed by the recent NMR structure of the complex. The activity of p53 is regulated by phosphorylation at multiple sites on the TAD domain and recent studies have shown that modifications at three residues affect the binding towards TAZ2. However, we still do not know how these phosphorylations affect the structure of the bound state and, therefore, how they regulate the p53 function. In this work, we have used computational simulations to understand how phosphorylation affects the structure of the p53TAD: TAZ2 complex and regulates the recognition mechanism. Phosphorylation has been proposed to enhance binding by direct interaction with the folded protein or by changing the unbound conformation of IDPs, for example by pre-folding the protein favoring the recognition mechanism. Here, we show an interesting turn in the p53 case: phosphorylation mainly affects the bound structure of p53TAD, highlighting the complexity of IDP protein-protein interactions. Our results are in agreement with previous experimental studies, allowing a clear picture of how p53 is regulated by phosphorylation and giving new insights into how post-translational modifications can regulate the function of IDPs.	[Esteban Ithuralde, Raul; Gustavo Turjanski, Adrian] Univ Buenos Aires, Dept Quim Inorgan Analyt & Quim Fis, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Esteban Ithuralde, Raul; Gustavo Turjanski, Adrian] Univ Buenos Aires, Dept Quim Biol, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Esteban Ithuralde, Raul; Gustavo Turjanski, Adrian] Univ Buenos Aires, INQUIMAE, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Turjanski, AG (corresponding author), Univ Buenos Aires, Dept Quim Inorgan Analyt & Quim Fis, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina.	adrian@qi.fcen.uba.ar	Ithuralde, Raul/AAU-5092-2020	Ithuralde, Raul/0000-0002-9757-0530; Turjanski, Adrian/0000-0003-2190-137X	Universidad de Buenos Aires; Grant UBACyT (Universidad de Buenos Aires Ciencia y Tecnica) [20020110100061]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-PRH 01-01]; ANPCyT grant PRH; CONICET	Universidad de Buenos Aires(University of Buenos Aires); Grant UBACyT (Universidad de Buenos Aires Ciencia y Tecnica); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); ANPCyT grant PRH; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by Universidad de Buenos Aires, Grant UBACyT (Universidad de Buenos Aires Ciencia y Tecnica), Code: 20020110100061. http://www.uba.ar; Agencia Nacional de Promocion Cientifica y Tecnologica, Grant PICT-PRH 01-01. http://www.agencia.mincyt.gob.ar This study was also funded by ANPCyT grant PRH, and CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEKKER H, 1993, PHYSICS COMPUTING '92, P252; BERENDSEN HJC, 1991, NATO ADV SCI I E-APP, V205, P139; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cook PR, 2011, J MOL BIOL, V409, P384, DOI 10.1016/j.jmb.2011.04.003; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; Dogan J, 2014, PHYS CHEM CHEM PHYS, V16, P6323, DOI 10.1039/c3cp54226b; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Ganguly D, 2011, PROTEINS, V79, P1251, DOI 10.1002/prot.22960; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hatzakis NS, 2014, BIOPHYS CHEM, V186, P46, DOI 10.1016/j.bpc.2013.11.003; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kovacs D, 2013, ARCH BIOCHEM BIOPHYS, V531, P80, DOI 10.1016/j.abb.2012.09.010; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lum JK, 2012, J AM CHEM SOC, V134, P1617, DOI 10.1021/ja2078619; Mavinahalli JN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S5; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Schafmeister C. E. A. F., 1995, LEAP; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Stricher F., 2008, FOLDX 3 0 UNPUB; Suganuma T, 2008, J ORAL BIOSCI, V50, P115, DOI 10.2330/joralbiosci.50.115; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373	54	12	12	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0144284	10.1371/journal.pone.0144284	http://dx.doi.org/10.1371/journal.pone.0144284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26742101	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600003
J	Minguzzi, S; Terlizzi, F; Lanzoni, C; Pollini, CP; Ratti, C				Minguzzi, Stefano; Terlizzi, Federica; Lanzoni, Chiara; Pollini, Carlo Poggi; Ratti, Claudio			A Rapid Protocol of Crude RNA/DNA Extraction for RT-qPCR Detection and Quantification of 'Candidatus Phytoplasma prunorum'	PLOS ONE			English	Article							REAL-TIME PCR; FRUIT-YELLOWS PHYTOPLASMA; FLAVESCENCE-DOREE; QUANTITATIVE DETECTION; WOODY-PLANTS; GRAPEVINE; PATHOGENS; ORCHARDS; SEQUENCE; PHLOEM	Many efforts have been made to develop a rapid and sensitive method for phytoplasma and virus detection. Taking our cue from previous works, different rapid sample preparation methods have been tested and applied to Candidatus Phytoplasma prunorum ('Ca. P. prunorum') detection by RT-qPCR. A duplex RT-qPCR has been optimized using the crude sap as a template to simultaneously amplify a fragment of 16S rRNA of the pathogen and 18S rRNA of the host plant. The specific plant 18S rRNA internal control allows comparison and relative quantification of samples. A comparison between DNA and RNA contribution to qPCR detection is provided, showing higher contribution of the latter. The method presented here has been validated on more than a hundred samples of apricot, plum and peach trees. Since 2013, this method has been successfully applied to monitor 'Ca. P. prunorum' infections in field and nursery. A triplex RT-qPCR assay has also been optimized to simultaneously detect 'Ca. P. prunorum' and Plum pox virus (PPV) in Prunus.	[Minguzzi, Stefano; Terlizzi, Federica; Lanzoni, Chiara; Pollini, Carlo Poggi; Ratti, Claudio] Univ Bologna, DipSA Patol Vegetale, I-40127 Bologna, Italy	University of Bologna	Ratti, C (corresponding author), Univ Bologna, DipSA Patol Vegetale, Viale G Fanin 40, I-40127 Bologna, Italy.	claudio.ratti@unibo.it		RATTI, CLAUDIO/0000-0002-5640-2143				AHRENS U, 1992, PHYTOPATHOLOGY, V82, P828, DOI 10.1094/Phyto-82-828; Angelini E, 2001, VITIS, V40, P79; Baric S, 2004, J MICROBIOL METH, V57, P135, DOI 10.1016/j.mimet.2003.12.009; Bertolini E, 2014, PLANT PATHOL, V63, P1149, DOI 10.1111/ppa.12197; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Dovas CI, 2003, J VIROL METHODS, V107, P99, DOI 10.1016/S0166-0934(02)00197-0; Firrao G, 2004, INT J SYST EVOL MICR, V54, P1243, DOI 10.1099/ijs.0.02854-0; GOIDANICH GABRIELE, 1933, BOLL R STAZ PATOL VEG, V13, P160; Gundersen DE, 1996, INT J SYST BACTERIOL, V46, P64, DOI 10.1099/00207713-46-1-64; Heinrich M, 2001, PLANT MOL BIOL REP, V19, P169, DOI 10.1007/BF02772160; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; LaNotte P, 1997, J VIROL METHODS, V66, P103, DOI 10.1016/S0166-0934(97)00038-4; Levy L.E., 2000, PLUM POX POTYVIRUS D; MacKenzie DJ, 1997, PLANT DIS, V81, P222, DOI 10.1094/PDIS.1997.81.2.222; Marcone C, 2004, INT J SYST EVOL MICR, V54, P1025, DOI 10.1099/ijs.0.02838-0; Marcone C, 2010, J PLANT PATHOL, V92, P19; Margaria P, 2007, PLANT DIS, V91, P1496, DOI 10.1094/PDIS-91-11-1496; Margaria P, 2009, PLANT PATHOL, V58, P838, DOI 10.1111/j.1365-3059.2009.02119.x; Martini M., 2010, Julius-Kuhn-Archiv, P386; Nikolic P, 2010, MOL CELL PROBE, V24, P303, DOI 10.1016/j.mcp.2010.06.005; Olmos A, 2005, J VIROL METHODS, V128, P151, DOI 10.1016/j.jviromet.2005.05.011; Olmos A, 1996, NUCLEIC ACIDS RES, V24, P2192, DOI 10.1093/nar/24.11.2192; Osman F, 2006, J VIROL METHODS, V133, P130, DOI 10.1016/j.jviromet.2005.11.005; Osman F, 2007, J VIROL METHODS, V141, P22, DOI 10.1016/j.jviromet.2006.11.035; Pollini CP, 2001, J PHYTOPATHOL, V149, P725, DOI 10.1046/j.1439-0434.2001.00704.x; Ramel ME, 2004, ACTA HORTIC, P459, DOI 10.17660/ActaHortic.2004.657.74; Torres E, 2005, MOL CELL PROBE, V19, P334, DOI 10.1016/j.mcp.2005.06.002; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Yvon M, 2009, MOL CELL PROBE, V23, P227, DOI 10.1016/j.mcp.2009.04.005	29	13	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146515	10.1371/journal.pone.0146515	http://dx.doi.org/10.1371/journal.pone.0146515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26742106	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600052
J	Xu, XP; Gan, HY; Li, FX; Tian, Q; Zhang, J; Liang, RL; Li, M; Yang, XX; Wu, YS				Xu, Xu-Ping; Gan, Hai-Yan; Li, Fen-Xia; Tian, Qi; Zhang, Jun; Liang, Rong-Liang; Li, Ming; Yang, Xue-Xi; Wu, Ying-Song			A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection	PLOS ONE			English	Article							SIZE DISTRIBUTIONS; QUANTIFICATION	Objective The fraction of circulating cell-free fetal (cff) DNA in maternal plasma is a critical parameter for aneuploidy screening with non-invasive prenatal testing, especially for those samples located in equivocal zones. We developed an approach to quantify cff DNA fractions directly with sequencing data, and increased cff DNAs by optimizing library construction procedure. Methods Artificial DNA mixture samples (360), with known cff DNA fractions, were used to develop a method to determine cff DNA fraction through calculating the proportion of Y chromosomal unique reads, with sequencing data generated by Ion Proton. To validate our method, we investigated cff DNA fractions of 2,063 pregnant women with fetuses who were diagnosed as high risk of fetal defects. The z-score was calculated to determine aneuploidies for chromosomes 21, 18 and 13. The relationships between z-score and parameters of pregnancies were also analyzed. To improve cff DNA fractions in our samples, two groups were established as follows: in group A, the large-size DNA fragments were removed, and in group B these were retained, during library construction. Results A method to determine cff DNA fractions was successfully developed using 360 artificial mixture samples in which cff DNA fractions were known. A strong positive correlation was found between z-score and fetal DNA fraction in the artificial mixture samples of trisomy 21, 18 and 13, as well as in clinical maternal plasma samples. There was a positive correlation between gestational age and the cff DNA fraction in the clinical samples, but no correlation for maternal age. Moreover, increased fetal DNA fractions were found in group A compared to group B. Conclusion A relatively accurate method was developed to determine the cff DNA fraction in maternal plasma. By optimizing, we can improve cff DNA fractions in sequencing samples, which may contribute to improvements in detection rate and reliability.	[Xu, Xu-Ping; Liang, Rong-Liang; Li, Ming; Yang, Xue-Xi; Wu, Ying-Song] Southern Med Univ, Sch Biotechnol, Inst Antibody Engn, Guangzhou, Guangdong, Peoples R China; [Gan, Hai-Yan; Li, Fen-Xia] Guangzhou Darui Biotechnol Co LTD, Guangzhou, Guangdong, Peoples R China; [Tian, Qi; Zhang, Jun] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Southern Medical University - China; Sun Yat Sen University	Yang, XX (corresponding author), Southern Med Univ, Sch Biotechnol, Inst Antibody Engn, Guangzhou, Guangdong, Peoples R China.	yxxzb@sohu.com; wg@smu.edu.cn		Yang, Xuexi/0000-0002-3513-6501	Key Program for health care collaborative innovation of Guangzhou [201400000004-4, 201500000004-4]; Science and Technology Program of Guangzhou [2060404]; Guangzhou Darui Biotechnology Co. LTD	Key Program for health care collaborative innovation of Guangzhou; Science and Technology Program of Guangzhou; Guangzhou Darui Biotechnology Co. LTD	This study was supported by the Key Program for health care collaborative innovation of Guangzhou (Grant No. 201400000004-4), Science and Technology Program of Guangzhou (Grant No. 2060404), the Key Program for health care collaborative innovation of Guangzhou (Grant No. 201500000004-4). Guangzhou Darui Biotechnology Co. LTD provided support in the form of salaries for two authors (Hai-Yan Gan and Fen-Xia Li), furthermore, clinical samples testing were performed in their reference lab. However, Guangzhou Darui Biotechnology Co. LTD did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The work was financially supported by the Key Program for health care collaborative innovation of Guangzhou (Grant No. 201400000004-4), Science and Technology Program of Guangzhou (Grant No. 2060404), and the Key Program for health care collaborative innovation of Guangzhou (Grant No. 201500000004-4).	[Anonymous], 2012, OBSTET GYNECOL, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Ashoor G, 2013, ULTRASOUND OBST GYN, V41, P26, DOI 10.1002/uog.12331; Ashoor G, 2012, FETAL DIAGN THER, V31, P237, DOI 10.1159/000337373; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Gregg AR, 2013, GENET MED, V15, P395, DOI 10.1038/gim.2013.29; Han Rubing, 2011, Zhongguo Fei Ai Za Zhi, V14, P127, DOI 10.3779/j.issn.1009-3419.2011.02.04; Hudecova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088484; Jeon YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110240; Jiang PY, 2012, BIOINFORMATICS, V28, P2883, DOI 10.1093/bioinformatics/bts549; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Manokhina I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101500; McCullough RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109173; Niba ETE, 2014, CLIN CHIM ACTA, V436, P155, DOI 10.1016/j.cca.2014.05.018; Nicolaides KH, 2011, PRENATAL DIAG, V31, P7, DOI 10.1002/pd.2637; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Shi XL, 2015, CLIN CHIM ACTA, V439, P24, DOI 10.1016/j.cca.2014.09.032; Tsui NBY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048319; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; Yu SCY, 2014, P NATL ACAD SCI USA, V111, P8583, DOI 10.1073/pnas.1406103111; Yu SCY, 2013, CLIN CHEM, V59, P1228, DOI 10.1373/clinchem.2013.203679; Zeybek YG, 2013, J OBSTET GYNAECOL RE, V39, P632, DOI 10.1111/j.1447-0756.2012.02011.x	34	23	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146997	10.1371/journal.pone.0146997	http://dx.doi.org/10.1371/journal.pone.0146997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765738	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300056
J	Casiano, H; Bolton, SL; Hildahl, K; Katz, LY; Bolton, J; Sareen, J				Casiano, Hygiea; Bolton, Shay-Lee; Hildahl, Keith; Katz, Laurence Y.; Bolton, James; Sareen, Jitender			A Population-Based Study of the Prevalence and Correlates of Self-Harm in Juvenile Detention	PLOS ONE			English	Article							SUICIDE ATTEMPTS; RISK-FACTORS; BEHAVIOR; ADOLESCENTS; AGGRESSION; PREDICTORS; CHILDREN; DEATHS	Background Suicide is the number one cause of death among incarcerated youth. We examined the demographic and forensic risk factors for self-harm in youth in juvenile detention using a Canadian provincial correctional database. Method We analyzed data from de-identified youth aged 12 to 18 at the time of their offense who were in custody in a Manitoba youth correctional facility between January 1, 2005 and December 30, 2010 (N = 5,102). Univariate and multivariate logistic regression analyses determined the association between staff-identified self-harm events in custody and demographic and custodial variables. Time to the event was examined based on the admission date and date of event. Results Demographic variables associated with self-harm included female sex, lower educational achievement, older age, and child welfare involvement. Custodial variables associated with self-harm included higher criminal severity profiles, younger age at first incarceration, longer sentence length, disruptive institutional behavior, and a history of attempting escape. Youth identified at entry as being at risk for suicide were more likely to self-harm. Events tended to occur earlier in the custodial admission. Interpretation Self-harm events tended to occur within the first 3 months of an admission stay. Youth with more serious offenses and disruptive behaviors were more likely to self-harm. Individuals with problematic custodial profiles were more likely to self-harm. Suicide screening identified youth at risk for self-harm. Strategies to identify and help youth at risk are needed.	[Casiano, Hygiea; Bolton, Shay-Lee; Hildahl, Keith; Katz, Laurence Y.; Bolton, James; Sareen, Jitender] Univ Manitoba, Dept Psychiat, Winnipeg, MB R3T 2N2, Canada; [Bolton, Shay-Lee; Sareen, Jitender] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Sareen, Jitender] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Casiano, H (corresponding author), Univ Manitoba, Dept Psychiat, Winnipeg, MB R3T 2N2, Canada.	hygiea_casiano@hotmail.com	Lorente, Rosa/AAL-5850-2021; Bolton, Shay-Lee/AAE-1827-2020; Katz, Laurence/N-6698-2019	Bolton, Shay-Lee/0000-0002-0750-4266; Sareen, Jitender/0000-0001-8573-6495	Reclaiming Hope: Manitoba's Youth Suicide Prevention Strategy initiative	Reclaiming Hope: Manitoba's Youth Suicide Prevention Strategy initiative	This project was partially funded by the Reclaiming Hope: Manitoba's Youth Suicide Prevention Strategy initiative, which is connected to Manitoba Health and Healthy Living. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram KM, 2008, J AM ACAD CHILD PSY, V47, P291, DOI 10.1097/CHI.0b013e318160b3ce; Ali MM, 2011, J MENT HEALTH POLICY, V14, P3; [Anonymous], 2003, YOUTH RISK NEED ASSE; Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6; BOUDEWYN AC, 1995, J TRAUMA STRESS, V8, P445, DOI 10.1007/BF02102969; Butler AM, 2013, BRIT J PSYCHIAT, V202, P324, DOI 10.1192/bjp.bp.112.113506; Chapman JF, 2006, CHILD ADOL PSYCH CL, V15, P445, DOI 10.1016/j.chc.2005.11.002; Coccaro EF, 2010, NEUROPSYCHOPHARMACOL, V35, P435, DOI 10.1038/npp.2009.148; Czyz EK, 2013, J CLIN CHILD ADOLESC, P1; Fazel S, 2005, LANCET, V366, P1301, DOI 10.1016/S0140-6736(05)67325-4; Gallagher CA, 2006, SUICIDE LIFE-THREAT, V36, P363, DOI 10.1521/suli.2006.36.3.363; Gallagher CA, 2006, J ADOLESCENT HEALTH, V38, P662, DOI 10.1016/j.jadohealth.2005.01.002; GARRISON CZ, 1993, AM J PUBLIC HEALTH, V83, P179, DOI 10.2105/AJPH.83.2.179; Hawton K, 2003, J CHILD PSYCHOL PSYC, V44, P1191, DOI 10.1111/1469-7610.00200; Hayes LM, 2005, CRISIS, V26, P146, DOI 10.1027/0227-5910.26.3.146; Hayes LM, 2009, SUICIDE LIFE-THREAT, V39, P353, DOI 10.1521/suli.2009.39.4.353; HILLBRAND M, 1994, J NERV MENT DIS, V182, P9, DOI 10.1097/00005053-199401000-00003; HILLBRAND M, 1995, J CONSULT CLIN PSYCH, V63, P668, DOI 10.1037/0022-006X.63.4.668; Hillbrand M, 1996, PSYCHIAT QUART, V67, P33, DOI 10.1007/BF02244273; Hjern A, 2004, J EPIDEMIOL COMMUN H, V58, P412, DOI 10.1136/jech.2003.014282; Hockenberry S, 2009, JUVENILE RESIDENTIAL; Katz LY, 2011, CAN MED ASSOC J, V183, P1977, DOI 10.1503/cmaj.110749; Kenny DT, 2008, J FORENSIC PSYCHOL P, V8, P358, DOI 10.1080/15228930802199317; KERKHOF AJFM, 1990, SUICIDE LIFE-THREAT, V20, P123; Kessler R. C., 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI DOI 10.1001/JAMA.293.20.2487; Kiriakidis SP, 2008, CRISIS, V29, P216, DOI 10.1027/0227-5910.29.4.216; Klinge V, 1995, AM J FOREN PSYCH, V15, P53; LEWINSOHN PM, 1994, J CONSULT CLIN PSYCH, V62, P297, DOI 10.1037/0022-006X.62.2.297; Lohner J, 2006, INT J LAW PSYCHIAT, V29, P370, DOI 10.1016/j.ijlp.2006.03.004; Lorant V, 2005, SOC SCI MED, V60, P2431, DOI 10.1016/j.socscimed.2004.11.033; Matschnig T, 2006, PSYCHIAT PRAX, V33, P6, DOI 10.1055/s-2004-834784; Oquendo MA, 2000, PSYCHIAT CLIN N AM, V23, P11, DOI 10.1016/S0193-953X(05)70140-4; Putnins AL, 2005, INT J OFFENDER THER, V49, P143, DOI 10.1177/0306624X04269412; SHAFFER D, 1981, J AM ACAD CHILD PSY, V20, P545, DOI 10.1016/S0002-7138(09)61644-7; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Sourander A, 2012, SOC PSYCH PSYCH EPID, V47, P1391, DOI 10.1007/s00127-011-0455-8; Suyemoto KL, 1998, CLIN PSYCHOL REV, V18, P531, DOI 10.1016/S0272-7358(97)00105-0; Vinnerljung B, 2006, J CHILD PSYCHOL PSYC, V47, P723, DOI 10.1111/j.1469-7610.2005.01530.x	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0146918	10.1371/journal.pone.0146918	http://dx.doi.org/10.1371/journal.pone.0146918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA8CX	26760497	Green Submitted, Green Published, gold			2022-12-27	WOS:000368033100052
J	Hedgeland, MJ; Libruk, MA; Corbiere, NC; Ciani, MJ; Kuxhaus, L				Hedgeland, Mark J.; Libruk, Morgan A.; Corbiere, Nicole C.; Ciani, Mario J.; Kuxhaus, Laurel			The Odocoileus virginianus Femur: Mechanical Behavior and Morphology	PLOS ONE			English	Article							HUMAN KNEE; GEOMETRY; DESIGN	Biomechanical research relies heavily on laboratory evaluation and testing with osseous animal structures. While many femora models are currently in use, including those of the European red deer (Cervus elaphus), the Odocoileus virginianus femur remains undocumented, despite its regional abundance in North America. The objective of this study was to compare biomechanical and morphological properties of the Odocoileus virginianus femur with those of the human and commonly used animal models. Sixteen pairs of fresh-frozen cervine femora (10 male, 6 female, aged 2.1 +/- 0.9 years) were used for this study. Axial and torsional stiffnesses (whole bone) were calculated following compression and torsion to failure tests (at rates of 0.1 mm/sec and 0.2 degrees/sec). Lengths, angles, femoral head diameter and position, periosteal and endosteal diaphyseal dimensions, and condylar dimensions were measured. The results show that the cervine femur is closer in length, axial and torsional stiffness, torsional strength, and overall morphology to the human femur than many other commonly used animal femora models; additional morphological measurements are comparable to many other species' femora. The distal bicondylar width of 59.3mm suggests that cervine femora may be excellent models for use in total knee replacement simulations. Furthermore, the cervine femoral head is more ovoid than other commonly-used models for hip research, making it a more suitable model for studies of hip implants. Thus, with further, more application-specific investigations, the cervine femur could be a suitable model for biomechanical research, including the study of ballistic injuries and orthopaedic device development.	[Hedgeland, Mark J.; Corbiere, Nicole C.; Kuxhaus, Laurel] Clarkson Univ, Mech & Aeronaut Engn, Potsdam, NY 13676 USA; [Libruk, Morgan A.] Clarkson Univ, Phys Assistant Studies, Potsdam, NY USA; [Ciani, Mario J.] Clarkson Univ, Occupat Therapy, Potsdam, NY USA	Clarkson University; Clarkson University; Clarkson University	Kuxhaus, L (corresponding author), Clarkson Univ, Mech & Aeronaut Engn, Potsdam, NY 13676 USA.	lkuxhaus@clarkson.edu		Kuxhaus, Laurel/0000-0002-2160-8192				Adams B, 2012, COMP OSTEOLOGY, P71; Adams BJ, 2008, COMP SKELETAL ANATOM, P84; Arno S, 2012, CLIN BIOMECH, V27, P680, DOI 10.1016/j.clinbiomech.2012.03.006; BLOEBAUM RD, 1993, J BIOMED MATER RES, V27, P1149, DOI 10.1002/jbm.820270905; Corbiere NC, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027059; Cristofolini L, 1996, J BIOMECH, V29, P525, DOI 10.1016/0021-9290(95)00084-4; Dargel J, 2011, J ARTHROPLASTY, V26, P346, DOI 10.1016/j.arth.2009.12.019; Heiner AD, 2001, J BIOMECH, V34, P773, DOI 10.1016/S0021-9290(01)00015-X; Issa K, 2014, J ARTHROPLASTY, V29, P192, DOI 10.1016/j.arth.2013.04.029; Kieser DC, 2014, BIO-MED MATER ENG, V24, P1693, DOI 10.3233/BME-140981; Kieser DC, 2014, J ORTHOP SURG RES, P1; Kim DH, 2006, AM J SPORT MED, V34, P407, DOI 10.1177/0363546505281238; Lim HC, 2013, KNEE, V20, P26, DOI 10.1016/j.knee.2012.05.010; Macintosh AA, 2013, AM J PHYS ANTHROPOL, V150, P442, DOI 10.1002/ajpa.22218; Magalhaes K, 2013, MORPHOLOGICAL ANAL P; Massin P, 2000, J ARTHROPLASTY, V15, P93, DOI 10.1016/S0883-5403(00)91337-8; Muschler GF, 2010, TISSUE ENG PART B-RE, V16, P123, DOI [10.1089/ten.teb.2009.0658, 10.1089/ten.TEB.2009.0658]; National Institutes of Health (US). Office for protection from research risks, 1986, OFF PROT RES RISKS P; Osterhoff G, 2011, KNEE, V18, P98, DOI 10.1016/j.knee.2010.02.001; Proffen BL, 2012, KNEE, V19, P493, DOI 10.1016/j.knee.2011.07.005; RUBIN PJ, 1992, J BONE JOINT SURG BR, V74, P28, DOI 10.1302/0301-620X.74B1.1732260; SUMNER DR, 1990, J ORTHOP RES, V8, P671, DOI 10.1002/jor.1100080508; Throop ADW, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029302; Umer Masood, 2010, J Orthop Surg (Hong Kong), V18, P279; Yiannakopoulos CK, 2008, ARCH ORTHOP TRAUM SU, V128, P117, DOI 10.1007/s00402-007-0433-5	25	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0146611	10.1371/journal.pone.0146611	http://dx.doi.org/10.1371/journal.pone.0146611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26757205	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888800020
J	Azevedo, M; Sousa, A; de Sousa, JM; Thompson, JA; Proenca, JT; Gordo, I				Azevedo, M.; Sousa, A.; Moura de Sousa, J.; Thompson, J. A.; Proenca, J. T.; Gordo, I.			Trade-Offs of Escherichia coli Adaptation to an Intracellular Lifestyle in Macrophages	PLOS ONE			English	Article							BACTERIAL PATHOGENS; EXPERIMENTAL EVOLUTION; POSITIVE SELECTION; EPITHELIAL-CELLS; GENE LOSS; MUTATIONS; POPULATION; LIPOPOLYSACCHARIDE; RESISTANCE; SURVIVAL	The bacterium Escherichia coli exhibits remarkable genomic and phenotypic variation, with some pathogenic strains having evolved to survive and even replicate in the harsh intra-macrophage environment. The rate and effects of mutations that can cause pathoadaptation are key determinants of the pace at which E. coli can colonize such niches and become pathogenic. We used experimental evolution to determine the speed and evolutionary paths undertaken by a commensal strain of E. coli when adapting to intracellular life. We estimated the acquisition of pathoadaptive mutations at a rate of 10(-6) per genome per generation, resulting in the fixation of more virulent strains in less than a hundred generations. Whole genome sequencing of independently evolved clones showed that the main targets of intracellular adaptation involved loss of function mutations in genes implicated in the assembly of the lipopolysaccharide core, iron metabolism and di- and tri-peptide transport, namely rfaI, fhuA and tppB, respectively. We found a substantial amount of antagonistic pleiotropy in evolved populations, as well as metabolic trade-offs, commonly found in intracellular bacteria with reduced genome sizes. Overall, the low levels of clonal interference detected indicate that the first steps of the transition of a commensal E. coli into intracellular pathogens are dominated by a few pathoadaptive mutations with very strong effects.	[Azevedo, M.; Sousa, A.; Moura de Sousa, J.; Thompson, J. A.; Proenca, J. T.; Gordo, I.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Instituto Gulbenkian de Ciencia	Gordo, I (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, Oeiras, Portugal.	igordo@igc.gulbenkian.pt	Sousa, Ana/J-7271-2013; Proença, João T./Y-4088-2019; Thompson, Jessica/GXW-0323-2022; Gordo, Isabel/D-6770-2013	Sousa, Ana/0000-0002-7276-4195; Proença, João T./0000-0002-9861-8241; Gordo, Isabel/0000-0003-1622-5143; Thompson, Jessica/0000-0002-5578-9833; Sousa, Ana/0000-0001-8541-5720	European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC [260421 - ECOADAPT]; LAO/ITQB FCT	European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); LAO/ITQB FCT	The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 260421 - ECOADAPT. I.G. acknowledges the salary support of LAO/ITQB & FCT.	Adams J, 2014, GENOMICS, V104, P393, DOI 10.1016/j.ygeno.2014.10.004; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Barrick JE, 2010, MOL BIOL EVOL, V27, P1338, DOI 10.1093/molbev/msq024; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Barroso-Batista J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004182; Bateman SL, 2012, MOL MICROBIOL, V83, P908, DOI 10.1111/j.1365-2958.2012.07977.x; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bokil NJ, 2011, IMMUNOBIOLOGY, V216, P1164, DOI 10.1016/j.imbio.2011.05.011; Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Conde-Alvarez R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002675; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Dobzhansky T., 1950, EVOLUTION TROPICS; Feng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027754; Ferguson AD, 1998, SCIENCE; Girgis HS, 2012, P NATL ACAD SCI USA, V109, P12740, DOI 10.1073/pnas.1205124109; Gordo I, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0239; GUTTMAN DS, 1994, GENETICS, V138, P993; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HARTMANN A, 1981, ARCH MICROBIOL, V130, P353, DOI 10.1007/BF00414599; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Herron MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001490; Hershberg R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r164; Hoare A, 2006, INFECT IMMUN, V74, P1555, DOI 10.1128/IAI.74.3.1555-1564.2006; Illingworth CJR, 2012, BIOINFORMATICS, V28, P831, DOI 10.1093/bioinformatics/btr722; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Koeppel AF, 2013, ISME J, V7, P1080, DOI 10.1038/ismej.2013.3; Koli P, 2011, MBIO, V2, DOI 10.1128/mBio.00182-11; Lang GI, 2014, GENOMICS, V104, P412, DOI 10.1016/j.ygeno.2014.09.011; Leimbach A, 2013, CURR TOP MICROBIOL, V358, P3, DOI 10.1007/82_2012_303; Limoli DH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004083; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Maharjan RP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r41; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; Miskinyte M, 2014, FITNESS MEASUREMENTS; Miskinyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003802; Mittal R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001203; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; de Sousa JAM, 2013, GENOME BIOL EVOL, V5, P794, DOI 10.1093/gbe/evt045; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Perez JC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001510; Perfeito L, 2008, BIOL LETTERS, V4, P57, DOI 10.1098/rsbl.2007.0481; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Schoustra SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000250; Smith EJ, 2013, FUTURE MICROBIOL, V8, P1289, DOI 10.2217/fmb.13.94; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Sousa A, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0838; Sousa A, 2012, MOL BIOL EVOL, V29, P1417, DOI 10.1093/molbev/msr302; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005; Torres AG, 2003, INFECT IMMUNITY; Utaisincharoen P, 2002, CLIN EXP IMMUNOL, V128, P467, DOI 10.1046/j.1365-2249.2002.01866.x; van Ditmarsch D, 2013, CELL REP, V4, P697, DOI 10.1016/j.celrep.2013.07.026; VAUDAUX P, 1979, ANTIMICROB AGENTS CH, V16, P743, DOI 10.1128/AAC.16.6.743; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]	59	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146123	10.1371/journal.pone.0146123	http://dx.doi.org/10.1371/journal.pone.0146123			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26752723	Green Published, gold, Green Submitted			2022-12-27	WOS:000367888100046
J	Nishida, A; Cadar, D; Xu, MK; Croudace, T; Jones, PB; Kuh, D; Richards, M				Nishida, Atsushi; Cadar, Dorina; Xu, Man K.; Croudace, Timothy; Jones, Peter B.; Kuh, Diana; Richards, Marcus		MRC Natl Survey Hlth; Dev Sci Data Collection Team	Adolescent Self-Organization and Adult Smoking and Drinking over Fifty Years of Follow-Up: The British 1946 Birth Cohort	PLOS ONE			English	Article							CONDUCT PROBLEMS; CHILDHOOD; HEALTH; OUTCOMES; RISK; LIFE; BEHAVIORS; CESSATION; LINKING; PEOPLE	Variations in markers of adolescent self-organization predict a range of economic and health-related outcomes in general population studies. Using a population-based birth cohort study we investigated associations between adolescent self-organization and two common factors over adulthood influencing health, smoking and alcohol consumption. The MRC National Survey of Health and Development (the British 1946 birth cohort) was used to test associations between a dimensional measure of adolescent self-organization derived from teacher ratings, and summary longitudinal measures of smoking and alcohol consumption over the ensuing five decades. Multinomial regression models were adjusted for sex, adolescent emotional and conduct problems, occupational social class of origin, childhood cognition, educational attainment and adult occupational social class. With all covariates adjusted, higher adolescent self-organization was associated with fewer smoking pack years, although not with quitting; there was no association with alcohol consumption across adulthood (none or heavy compared with light to moderate). Adolescent selforganization appears to be protective against smoking, but not against heavy alcohol consumption. Interpretation of this differential effect should be embedded in an understanding of the social and sociodemographic context in which these health behaviours occur over time.	[Nishida, Atsushi] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo 113, Japan; [Nishida, Atsushi; Cadar, Dorina; Kuh, Diana; Richards, Marcus] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Xu, Man K.; Jones, Peter B.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Xu, Man K.] Univ Cambridge, Dept Publ Hlth, Cambridge, England; [Croudace, Timothy] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Croudace, Timothy] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Jones, Peter B.] Cambridgeshire & Peterborough NHS Fdn Trust, CAMEO, Cambridge, England	Tokyo Metropolitan Institute of Medical Science; University of London; University College London; University of Cambridge; University of Cambridge; University of York - UK; University of Hull; University of York - UK	Richards, M (corresponding author), UCL, MRC Unit Lifelong Hlth & Ageing, London, England.	m.richards@ucl.ac.uk	Kuh, Diana/L-6019-2014; Xu, Kate/K-7652-2018; Croudace, Tim/ABC-9681-2021; Cadar, Dorina/D-4510-2017; Andoh, Akira/AAB-9303-2022	Kuh, Diana/0000-0001-7386-2857; Cadar, Dorina/0000-0003-1398-5841; Croudace, Tim/0000-0001-8346-7463; Xu, Kate/0000-0002-1585-1938; Jones, Peter Brian/0000-0002-0387-880X; Richards, Marcus/0000-0001-9191-2192	Japanese Ministry of Education, Culture, Sports, Science and Technology (Japan Scientific Research Grant on Innovative Area) [23118004]; Japanese Ministry of Education, Culture, Sports, Science and Technology (Adolescent Mind & Self-Regulation); Japanese Society for the Promotion of Scientific Research Grant (Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation); UK Alzheimer's Society [144]; UK Medical Research Council [MC_UU_12019/1, MC_UU_12019/3, MC_UU_12019/4]; Wellcome Trust [095844/Z/11/Z, 088869/Z/09/Z]; National Institute for Health Research [RP-PG-0606-1335]; NIHR Cambridge BRC; NIHR CLAHRC East of England; UK Wellcome Trust; GlaxoSmithKline; MRC [MC_UU_12019/3, MC_UU_12019/1, MR/L023784/1, MC_UU_12019/4] Funding Source: UKRI; Medical Research Council [MC_UU_12019/3, G0001354, MC_UU_12019/1, G0001354B, MR/L023784/1, MC_UU_12019/4] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10134, NF-SI-0509-10215] Funding Source: researchfish	Japanese Ministry of Education, Culture, Sports, Science and Technology (Japan Scientific Research Grant on Innovative Area); Japanese Ministry of Education, Culture, Sports, Science and Technology (Adolescent Mind & Self-Regulation)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Scientific Research Grant (Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation); UK Alzheimer's Society; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Cambridge BRC; NIHR CLAHRC East of England; UK Wellcome Trust(Wellcome Trust); GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	AN is funded by the Japanese Ministry of Education, Culture, Sports, Science and Technology (Japan Scientific Research Grant on Innovative Area; 23118004; Adolescent Mind & Self-Regulation), and the Japanese Society for the Promotion of Scientific Research Grant (Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation). DC is funded by the UK Alzheimer's Society [Grant number 144] and by the UK Medical Research Council [Unit Programme number MC_UU_12019/1]. MR and DK are funded by the UK Medical Research Council [Unit Programme numbers MC_UU_12019/3 and 4, respectively]. PJ is supported by Wellcome Trust grants 095844/Z/11/Z and 088869/Z/09/Z, National Institute for Health Research grant RP-PG-0606-1335, by the NIHR Cambridge BRC and the NIHR CLAHRC East of England.; The authors are grateful to the UK Wellcome Trust for financial support during the derivation of the self-organization variable; and to the UK Medical Research Council for support of the NSHD, including provision of funding for the most recent data collection. The authors are grateful to NSHD study members who took part in this latest data collection for their continuing support. We thank members of the NSHD scientific and data collection team at the following centres: MRC Unit for Lifelong Health and Ageing; Wellcome Trust (WT) Clinical Research Facility (CRF) Manchester; WTCRF at the Western General Hospital in Edinburgh; WTCRF at University Hospital Birmingham; WTCRF at University College London Hospital; CRF at the University Hospital of Wales; CRF and Twin Research Unit at St Thomas' Hospital London. PJ has received research grant support from GlaxoSmithKline, a speaker's honorarium from Eli Lilly, and is a co-inventor of patent PCT/GB2005/003279 (methods for assessing psychotic disorders). This does not alter our adherence to PLOS ONE policies on sharing data and materials. AN, DC, KX, DK and MR report no competing interests. The MRC National Survey of Health and Development scientific and data collection team consisted of Rachel Cooper, Rebecca Hardy, Diana Kuh, Mary Pierce, Marcus Richards, Jane Abington and Andrew Wong. Bona fide researchers can apply to access the NSHD data via a standard application procedure (further details available at: http://www.nshd.mrc.ac.uk/data.aspx).	Barnett WS, 2008, EARLY CHILD RES Q, V23, P299, DOI 10.1016/j.ecresq.2008.03.001; Batty GD, 2008, AM J PUBLIC HEALTH, V98, P2237, DOI 10.2105/AJPH.2007.109488; Baumeister RF, 1996, PSYCHOL INQ, V7, P1, DOI 10.1207/s15327965pli0701_1; Berkowitz L, 1996, PSYCHOL INQ, V7, P25, DOI 10.1207/s15327965pli0701_4; Bodrova E., 2007, TOOLS MIND CASE STUD; Colman I, 2007, AM J PSYCHIAT, V164, P126, DOI 10.1176/appi.ajp.164.1.126; Colman I, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2981; Dignath C, 2008, EDUC RES REV-NETH, V3, P101, DOI 10.1016/j.edurev.2008.02.003; Duckworth AL, 2011, P NATL ACAD SCI USA, V108, P2639, DOI 10.1073/pnas.1019725108; Elander J, 1996, INT J METHOD PSYCH, V6, P63, DOI 10.1002/(SICI)1234-988X(199607)6:2<63::AID-MPR151>3.3.CO;2-M; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P837, DOI 10.1111/j.1469-7610.2004.00387.x; Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225; Gale CR, 2008, PSYCHOSOM MED, V70, P397, DOI 10.1097/PSY.0b013e31816a719e; Green CA, 2001, AM J PREV MED, V21, P298, DOI 10.1016/S0749-3797(01)00365-8; Hagger MS, 2010, HEALTH PSYCHOL REV, V4, P57, DOI 10.1080/17437199.2010.503594; Heather N, 2009, ALCOHOL ALCOHOLISM, V44, P226, DOI 10.1093/alcalc/agp021; Hemmingsson T, 2008, PSYCHOSOM MED, V70, P805, DOI 10.1097/PSY.0b013e31817b955f; Hobson H, 1948, THEATRE; Jefferis BJMH, 2008, J EPIDEMIOL COMMUN H, V62, P506, DOI 10.1136/jech.2007.059840; Koike S, J OBESITY IN PRESS; Mays D, 2014, PEDIATRICS, V133, P983, DOI 10.1542/peds.2013-3003; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Nishida A, 2014, SCHIZOPHRENIA BULL, V40, P1543, DOI 10.1093/schbul/sbu050; Office for National Statistics, 2000, LIV BRIT RES 1998 GE; Paul AA, 1978, MCCANE AND WIDDOWSON; Pearlin LI, 2007, J HEALTH SOC BEHAV, V48, P164, DOI 10.1177/002214650704800205; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pigeon DA, 1964, HOME SCH, P129; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Power C, 2005, INT J EPIDEMIOL, V34, P335, DOI 10.1093/ije/dyh394; Richards M, 2010, LONGITUD LIFE COURSE, V1, P281; Rossow I, 2016, ADDICTION, V111, P204, DOI 10.1111/add.13097; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Sjolund S, 2012, ADDICTION, V107, P89, DOI 10.1111/j.1360-0443.2011.03544.x; Stafford M, 2013, EUR J AGEING, V10, P145, DOI 10.1007/s10433-013-0258-8; Strand BH, 2011, J GERONTOL A-BIOL, V66, P142, DOI 10.1093/gerona/glq199; Taylor MD, 2003, J EPIDEMIOL COMMUN H, V57, P464, DOI 10.1136/jech.57.6.464; U. K. Department for Education, 2007, CHILDR PLAN BUILD BR; von Stumm S, 2011, J CHILD PSYCHOL PSYC, V52, P992, DOI 10.1111/j.1469-7610.2011.02373.x; White JW, 2012, ANN EPIDEMIOL, V22, P654, DOI 10.1016/j.annepidem.2012.06.001; Williams GP, 1980, DRINK GREAT BRITAIN; Xu MK, 2013, PSYCHOL AGING, V28, P958, DOI 10.1037/a0033787	43	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0146731	10.1371/journal.pone.0146731	http://dx.doi.org/10.1371/journal.pone.0146731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6CA	26752724	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100144
J	Wang, J; Lu, B; Zan, RG; Chai, J; Ma, W; Jin, W; Duan, RY; Luo, J; Murphy, RW; Xiao, H; Chen, ZM				Wang, Jing; Lu, Bin; Zan, Ruiguang; Chai, Jing; Ma, Wei; Jin, Wei; Duan, Rongyao; Luo, Jing; Murphy, Robert W.; Xiao, Heng; Chen, Ziming			Phylogenetic Relationships of Five Asian Schilbid Genera Including Clupisoma (Siluriformes: Schilbeidae)	PLOS ONE			English	Article							MOLECULAR EVIDENCE; TELEOSTEI; CYPRINIFORMES; MITOCHONDRIAL; CATFISH; CONFIDENCE; ALGORITHM	The phylogenetic relationships of Asian schilbid catfishes of the genera Clupisoma, Ailia, Horabagrus, Laides and Pseudeutropius are poorly understood, especially those of Clupisoma. Herein, we reconstruct the phylogeny of 38 species of catfishes belonging to 28 genera and 14 families using the concatenated mitochondrial genes COI, cytb, and 16S rRNA, as well as the nuclear genes RAG1 and RAG2. The resulting phylogenetic trees consistently place Clupisoma as the sister taxon of Laides, and the five representative Asian schilbid genera form two monophyletic groups with the relationships (Ailia (Laides, Clupisoma)) and (Horabagrus, Pseudeutropius). The so-called "Big Asia" lineage relates distantly to African schilbids. Independent analyses of the mitochondrial and nuclear DNA data yield differing trees for the two Asian schilbid groups. Analyses of the mitochondrial gene data support a sister-group relationship for (Ailia (Laides, Clupisoma)) and the Sisoroidea and a sister-taxon association of (Horabagrus, Pseudeutropius) and the Bagridae. In contrast, analyses of the combined nuclear data indicate (Ailia (Laides, Clupisoma)) to be the sister group to (Horabagrus, Pseudeutropius). Our results indicate that the Horabagridae, recognized by some authors as consisting of Horabagrus, Pseudeutropius and Clupisoma does not include the latter genus. We formally erect a new family, Ailiidae fam. nov. for a monophyletic Asian group comprised of the genera Ailia, Laides and Clupisoma.	[Wang, Jing; Lu, Bin; Chai, Jing; Ma, Wei; Jin, Wei; Luo, Jing] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources Y, Kunming 650091, Peoples R China; [Zan, Ruiguang; Duan, Rongyao; Luo, Jing; Xiao, Heng; Chen, Ziming] Yunnan Univ, Sch Life Sci, Kunming 650091, Peoples R China; [Chai, Jing; Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada	Yunnan University; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum	Xiao, H (corresponding author), Yunnan Univ, Sch Life Sci, Kunming 650091, Peoples R China.	hxiao58@126.com; fishynu123@163.com	Chai, Jing/AFE-1480-2022; Chai, Jing/AAE-9518-2022	Wang, Jing/0000-0002-2806-6517	973 program of China [2007CB411600]; National Natural Science Foundation of China [30870291, 30930071, 31272335]; National Basic Research Program of China. (973 Program) [2007CB411600]	973 program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China. (973 Program)(National Basic Research Program of China)	2007CB411600, http://www.most.gov.cn/cxfw/200806/t20080617_62500.htm, 973 program of China, Y.P.Z., contributed to the conceiving and designing of the experiments. 30870291, http://npd.nsfc.gov.cn/projectDetail.action?pid=30870291, National Natural Science Foundation of China, J.L., contributed to reparation and writing of the manuscript. 30930071, http://npd.nsfc.gov.cn/projectDetail.action?pid=30930071, National Natural Science Foundation of China, S.J.L., contributed to conceiving and designing the experiments. 31272335, http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action, National Natural Science Foundation of China, Z.M.C., contributed to the conceiving and designing of the experiments.; This work was supported by one grant from National Basic Research Program of China. (973 Program) (No. 2007CB411600), URL:http://www.most.gov.cn/cxfw/200806/t20080617_62500.htm, Yaping Zhang contributed to the conceiving and designing of the experiments in our manuscript. This work was also supported by three grants from National Natural Science Foundation of China. The first grant: No. 30870291, URL: http://npd.nsfc.gov.cn/projectDetail.action?pid=30870291, Jing Luo contributed to reparation and the writing of the manuscript; the second grant: No. 30930071, UTL: http://npd.nsfc.gov.cn/projectDetail.action?pid=30930071, Shaojun Liu contributed to the conceiving and designing of the experiments in our manuscript; the last one grant: No. 31272335, UTL: http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action, Ziming Chen contributed to reparation and the writing of the manuscript.	Chen XY, 2005, COPEIA, P566; Chu X.L., 1999, FAUNA SINICA OSTEICH, DOI DOI 10.1007/s11033-010-0107-1; Diogo R, 2004, ANIM BIOL, V54, P91, DOI 10.1163/157075604323010079; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferraris J., 2007, ZOOTAXA, V1418; GOLDMAN N, 1993, J MOL EVOL, V37, P650; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hardman M, 2005, MOL PHYLOGENET EVOL, V37, P700, DOI 10.1016/j.ympev.2005.04.029; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; Huang S.-y., 1981, Acta Zootaxonomica Sinica, V6, P437; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Li JB, 2008, MOL PHYLOGENET EVOL, V47, P472, DOI 10.1016/j.ympev.2007.09.012; Mo T., 1991, Theses Zoologicae, V17, P1; Na-Nakorn U, 2006, ANIM CONSERV, V9, P483, DOI 10.1111/j.1469-1795.2006.00064.x; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Ng H.H., 1999, Ichthyological Exploration of Freshwaters, V10, P381; Peng Zuo-Gang, 2005, Acta Genetica Sinica, V32, P145; Pinna M. C. C., 1993, THESIS; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Sullivan JP, 2008, P ACAD NAT SCI PHILA, V157, P51, DOI 10.1635/0097-3157(2008)157[51:MEFDOT]2.0.CO;2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Telford MJ, 2011, TRENDS GENET, V27, P186, DOI 10.1016/j.tig.2011.02.003; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; VRIJENHOEK RC, 1994, EXS, V68, P37; Wang J, 2013, CHINESE SCI BULL, V58, P3738, DOI 10.1007/s11434-013-5878-z; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wang XZ, 2007, MOL PHYLOGENET EVOL, V42, P157, DOI 10.1016/j.ympev.2006.06.014; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang L, 2010, YUNNAN WETLANDS BEIJ, P471; Yu L, 2011, BMC EVOL BIOL, V11, P1471	36	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0145675	10.1371/journal.pone.0145675	http://dx.doi.org/10.1371/journal.pone.0145675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751688	Green Published, Green Submitted, gold			2022-12-27	WOS:000367888100023
J	Mwangala, S; Musonda, KG; Monze, M; Musukwa, KK; Fylkesnes, K				Mwangala, Sheila; Musonda, Kunda G.; Monze, Mwaka; Musukwa, Katoba K.; Fylkesnes, Knut			Accuracy in HIV Rapid Testing among Laboratory and Non-laboratory Personnel in Zambia: Observations from the National HIV Proficiency Testing System	PLOS ONE			English	Article							QUALITY-ASSURANCE; YOUNG-PEOPLE; DEVELOPING-COUNTRIES; PREVALENCE; CARE; PERFORMANCE; ACCEPTANCE; ALGORITHMS; DECLINES; SERVICES	Background Despite rapid task-shifting and scale-up of HIV testing services in high HIV prevalence countries, studies evaluating accuracy remain limited. This study aimed to assess overall accuracy level and factors associated with accuracy in HIV rapid testing in Zambia. Methods Accuracy was investigated among rural and urban HIV testing sites participating in two annual national HIV proficiency testing (PT) exercises conducted in 2009 (n = 282 sites) and 2010 (n = 488 sites). Testers included lay counselors, nurses, laboratory personnel and others. PT panels of five dry tube specimens (DTS) were issued to testing sites by the national reference laboratory (NRL). Site accuracy level was assessed by comparison of reported results to the expected results. Non-parametric rank tests and multiple linear regression models were used to assess variation in accuracy between PT cycles and between tester groups, and to examine factors associated with accuracy respectively. Results Overall accuracy level was 93.1%(95% CI: 91.2-94.9) in 2009 and 96.9%(95% CI: 96.1-97.8) in 2010. Differences in accuracy were seen between the tester groups in 2009 with laboratory personnel being more accurate than non-laboratory personnel, while in 2010 no differences were seen. In both PT exercises, lay counselors and nurses had more difficulties interpreting results, with more occurrences of false-negative, false-positive and indeterminate results. Having received the standard HIV rapid testing training and adherence to the national HIV testing algorithm were positively associated with accuracy. Conclusion The study showed an improvement in tester group and overall accuracy from the first PT exercise to the next. Average number of incorrect test results per 1000 tests performed was reduced from 69 to 31. Further improvement is needed, however, and the national HIV proficiency testing system seems to be an important tool in this regard, which should be continued and needs to be urgently strengthened.	[Mwangala, Sheila; Musonda, Kunda G.; Monze, Mwaka; Musukwa, Katoba K.] Univ Teaching Hosp, Dept Pathol & Microbiol, Virol Lab, Lusaka, Zambia; [Mwangala, Sheila; Fylkesnes, Knut] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Musonda, Kunda G.] Univ London, London Sch Hyg & Trop Med, Pathogen Mol Biol Dept, London, England	University of Zambia; University of Bergen; University of London; London School of Hygiene & Tropical Medicine	Mwangala, S (corresponding author), Univ Teaching Hosp, Dept Pathol & Microbiol, Virol Lab, Lusaka, Zambia.	sheilamwangala@yahoo.com			Centres for Disease Control and Prevention (CDC)	Centres for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The authors acknowledge the Centres for Disease Control and Prevention (CDC) for funding the Zambia National Quality Assurance Program (ZANQAP). The funders of this study had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alemnji G, 2011, INDIAN J MED RES, V134, P779, DOI 10.4103/0971-5916.92625; [Anonymous], 1996, GUID ORG NAT EXT QUA; [Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2005, GUID ASS ACC REL HIV; Babalola S, 2007, AIDS BEHAV, V11, P759, DOI 10.1007/s10461-006-9189-0; Bukve T, 2015, CLIN CHEM LAB MED, V53, P45, DOI 10.1515/cclm-2014-0483; Central Statistical Office ( CSO) Ministry of Health ( MOH) University of Zambia MEASURE Evaluation, 2010, ZAMB SEX BEH SURV 20; Chang Denison, 2006, Expert Rev Anti Infect Ther, V4, P565, DOI 10.1586/14787210.4.4.565; Chiu YHC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018294; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; Fylkesnes K, 1999, AIDS, V13, P2469, DOI 10.1097/00002030-199912030-00019; Fylkesnes K, 2013, SOC SCI MED, V86, P9, DOI 10.1016/j.socscimed.2013.02.036; Jiang Y, 2010, INT J EPIDEMIOL, V39, pII72, DOI 10.1093/ije/dyq224; Jurgensen M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-2; Kanal Koum, 2005, AIDS Res Ther, V2, P5, DOI 10.1186/1742-6405-2-5; Kayeyi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033652; Koblavi-Deme S, 2001, J CLIN MICROBIOL, V39, P1808, DOI 10.1128/JCM.39.5.1808-1812.2001; Kruse GR, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-55; Learmonth KM, 2008, J CLIN MICROBIOL, V46, P1692, DOI 10.1128/JCM.01761-07; Makasa M, 2012, SEX TRANSM DIS, V39, P173, DOI 10.1097/OLQ.0b013e31823b23a4; Martin R, 2005, AIDS, V19, pS59, DOI 10.1097/01.aids.0000172878.20628.a8; Mbilinyi D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-266; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Michelo C, 2006, AIDS, V20, P1031, DOI 10.1097/01.aids.0000222076.91114.95; Ministry of Health, 2011, ACTION PLAN 2011, P6; Ministry of Health, 2007, NAT QUAL ASS STRAT H; Ministry of Health National HIV/AIDS/STI/TB Council, 2007, NAT HIV RAP TEST TRA; Molesworth AM, 2010, JAIDS-J ACQ IMM DEF, V55, P625, DOI 10.1097/QAI.0b013e3181f98628; Ndase P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123005; Parekh BS, 2010, AM J CLIN PATHOL, V134, P573, DOI 10.1309/AJCPTDIMFR00IKYX; Parekh BS, 2010, J VIROL METHODS, V163, P295, DOI 10.1016/j.jviromet.2009.10.013; Sandoy IF, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-60; Sandoy IF, 2006, TROP MED INT HEALTH, V11, P917, DOI 10.1111/j.1365-3156.2006.01629.x; Sanjana P, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-44; SCHALLA WO, 1990, PUBLIC HEALTH REP, V105, P167; Shanks L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0769-3; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; Sikasote J, 2008, ZAMBIA NATL QUANTIFI; Stull TM, 1998, JAMA-J AM MED ASSOC, V279, P463, DOI 10.1001/jama.279.6.463; Sushi KM, 2012, WORLD J AIDS, V2, P222; Tuturu, 2020, COMM CONS HLTH ED; [UNAIDS WHO], 2004, POL STAT HIV TEST; UNAIDS, 2002, HIV VOL COUNS TEST G; [Virology Laboratory Ministry of Health (MOH)], 2009, 1 PROF TEST TRIAL PR; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; *WHO, 2003, GUID APPR EV HIV TES; WHO, 2009, 16 WHO; [WHO/EHT UNAIDS WHO], 2002, 12 WHOEHT UNAIDS; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2008, TASK SHIFT RAT RED T; World Health Organization Deutsche Gesellschaft fur Technische Zusammenarbeit Joint United Nations Programme on HIV/AIDS International HIV/AIDS Alliance, 2005, SCAL HIV TEST COUNS; Yao K, 2010, AM J CLIN PATHOL, V134, P568, DOI 10.1309/AJCPOPXR8MNTZ5PY	53	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2016	11	1							e0146700	10.1371/journal.pone.0146700	http://dx.doi.org/10.1371/journal.pone.0146700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA5AX	26745508	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000367815600078
J	Li, LG; Vogel, J; He, ZL; Zou, XM; Ruan, HH; Huang, W; Wang, JS; Bianchi, TS				Li, Liguang; Vogel, Jason; He, Zhenli; Zou, Xiaoming; Ruan, Honghua; Huang, Wei; Wang, Jiashe; Bianchi, Thomas S.			Association of Soil Aggregation with the Distribution and Quality of Organic Carbon in Soil along an Elevation Gradient on Wuyi Mountain in China	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; SEASONAL-VARIATION; MICROBIAL BIOMASS; ALTITUDE GRADIENT; DENSITY FRACTIONS; CLIMATE-CHANGE; MATTER; STORAGE; FOREST; DECOMPOSITION	Forest soils play a critical role in the sequestration of atmospheric CO2 and subsequent attenuation of global warming. The nature and properties of organic matter in soils have an influence on the sequestration of carbon. In this study, soils were collected from representative forestlands, including a subtropical evergreen broad-leaved forest (EBF), a coniferous forest (CF), a subalpine dwarf forest (DF), and alpine meadow (AM) along an elevation gradient on Wuyi Mountain, which is located in a subtropical area of southeastern China. These soil samples were analyzed in the laboratory to examine the distribution and speciation of organic carbon (OC) within different size fractions of water-stable soil aggregates, and subsequently to determine effects on carbon sequestration. Soil aggregation rate increased with increasing elevation. Soil aggregation rate, rather than soil temperature, moisture or clay content, showed the strongest correlation with OC in bulk soil, indicating soil structure was the critical factor in carbon sequestration of Wuyi Mountain. The content of coarse particulate organic matter fraction, rather than the silt and clay particles, represented OC stock in bulk soil and different soil aggregate fractions. With increasing soil aggregation rate, more carbon was accumulated within the macroaggregates, particularly within the coarse particulate organic matter fraction (250-2000 mu m), rather than within the microaggregates (53-250 mu m) or silt and clay particles (<53 mu m). In consideration of the high instability of macroaggregates and the liability of SOC within them, further research is needed to verify whether highly-aggregated soils at higher altitudes are more likely to lose SOC under warmer conditions.	[Li, Liguang; Zou, Xiaoming; Ruan, Honghua] Nanjing Forestry Univ, Coll Biol & Environm, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing 210037, Jiangsu, Peoples R China; [Li, Liguang; He, Zhenli] Univ Florida, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL 34945 USA; [Vogel, Jason] Texas A&M Univ, Dept Ecosyst Sci & Management, 2126 TAMU, College Stn, TX 77843 USA; [Zou, Xiaoming; Huang, Wei] Univ Puerto Rico, Inst Trop Ecosyst Studies, POB 70377, San Juan, PR 00936 USA; [Wang, Jiashe] Adm Bur Wuyishan Natl Nat Reserve, Wuyishan 354300, Fujian, Peoples R China; [Bianchi, Thomas S.] Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA	Nanjing Forestry University; State University System of Florida; University of Florida; Texas A&M University System; Texas A&M University College Station; University of Puerto Rico; University of Puerto Rico Rio Piedras; State University System of Florida; University of Florida	Ruan, HH (corresponding author), Nanjing Forestry Univ, Coll Biol & Environm, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing 210037, Jiangsu, Peoples R China.	hhruan@njfu.edu.cn	Bianchi, Thomas S/L-4060-2014; Zou, Xiaoming/GWV-5608-2022; He, Zhenli/A-4773-2008; He, Zhenli/R-1494-2016; Li, Liguang/Q-2916-2019	Bianchi, Thomas S/0000-0002-3068-2933; Zou, Xiaoming/0000-0001-9023-3067; 	National Basic Research Program of China (973 Program) [2012CB416904]; National Natural Science Foundation of China [31170417]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was funded by the National Basic Research Program of China (973 Program, 2012CB416904), http://www.973.gov.cn/English/AreaList.aspx, to H.H.R.; the National Natural Science Foundation of China (No. 31170417), http://www.nsfc.gov.cn/, to H.H.R.; and the Priority Academic Program Development of Jiangsu Higher Education Institutions, to H.H.R.	Angers DA, 1997, EUR J SOIL SCI, V48, P295, DOI 10.1111/j.1365-2389.1997.tb00549.x; Bachmann J, 2008, J PLANT NUTR SOIL SC, V171, P14, DOI 10.1002/jpln.200700054; BIRDSEY RA, 1993, FOREST ECOL MANAG, V58, P33, DOI 10.1016/0378-1127(93)90129-B; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Bu XL, 2012, APPL SOIL ECOL, V52, P42, DOI 10.1016/j.apsoil.2011.10.005; Bu XL, 2011, EUR J SOIL BIOL, V47, P102, DOI 10.1016/j.ejsobi.2010.11.009; Bu XL, 2010, GEODERMA, V159, P139, DOI 10.1016/j.geoderma.2010.07.005; Chen JF, 2000, CHINESE J SOIL SCI, V31, P97; Chenu C, 2006, EUR J SOIL SCI, V57, P596, DOI 10.1111/j.1365-2389.2006.00834.x; CHRISTENSEN BT, 1985, ACTA AGR SCAND, V35, P175, DOI 10.1080/00015128509435773; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Djukic I, 2010, J PLANT NUTR SOIL SC, V173, P30, DOI 10.1002/jpln.200900027; Garten CT, 2006, GEODERMA, V136, P342, DOI 10.1016/j.geoderma.2006.03.049; Garten CT, 2011, GEODERMA, V167-68, P30, DOI 10.1016/j.geoderma.2011.08.007; GOLCHIN J, 1994, P HAZ WAST REMED, P187; Grandy AS, 2008, SCI TOTAL ENVIRON, V404, P297, DOI 10.1016/j.scitotenv.2007.11.013; Gregorich EG, 2006, SOIL SCI SOC AM J, V70, P975, DOI 10.2136/sssaj2005.0116; Gregorich EG, 2003, GEODERMA, V113, P237, DOI 10.1016/S0016-7061(02)00363-4; Griffiths RP, 2009, FOREST ECOL MANAG, V257, P1, DOI 10.1016/j.foreco.2008.08.010; Gruneberg E, 2013, FOREST ECOL MANAG, V303, P1, DOI 10.1016/j.foreco.2013.03.014; Gupta VVSR, 2015, SOIL BIOL BIOCHEM, V80, pA3, DOI 10.1016/j.soilbio.2014.09.002; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; He JY, 1994, NATURAL RESOURCE SER, P39; He Rong, 2009, Shengtaixue Zazhi, V28, P394; LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425, DOI 10.1111/j.1365-2389.1996.tb01843.x; Mao DH, 2015, BIOGEOSCIENCES, V12, P1635, DOI 10.5194/bg-12-1635-2015; Plante AF, 2011, SOIL BIOL BIOCHEM, V43, P1051, DOI 10.1016/j.soilbio.2011.01.024; Pulleman MM, 2005, EUR J SOIL SCI, V56, P453, DOI 10.1111/j.1365-2389.2004.00696.x; Rasmussen C, 2005, SOIL SCI SOC AM J, V69, P1711, DOI 10.2136/sssaj2005.0040; Schwendenmann L, 2006, PLANT SOIL, V288, P217, DOI 10.1007/s11104-006-9109-0; Shi Zheng, 2008, Yingyong Shengtai Xuebao, V19, P2357; Shrestha BM, 2007, SOIL SCI SOC AM J, V71, P1194, DOI 10.2136/sssaj2006.0405; Singh S, 1996, BIOL FERT SOILS, V22, P76, DOI 10.1007/BF00384436; Six J, 2002, SOIL SCI SOC AM J, V66, P1981, DOI 10.2136/sssaj2002.1981; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Six J, 2000, SOIL SCI SOC AM J, V64, P1042, DOI 10.2136/sssaj2000.6431042x; Smith P, 2008, ADV AGRON, V97, P1, DOI 10.1016/S0065-2113(07)00001-6; Smith R, 2015, AGR ECOSYST ENVIRON, V201, P92, DOI 10.1016/j.agee.2014.12.002; Spielvogel S, 2008, EUR J SOIL SCI, V59, P674, DOI 10.1111/j.1365-2389.2008.01030.x; Steffens M, 2009, EUR J SOIL SCI, V60, P198, DOI 10.1111/j.1365-2389.2008.01104.x; Virto I, 2008, GEODERMA, V146, P326, DOI 10.1016/j.geoderma.2008.05.021; von Lutzow M, 2009, BIOL FERT SOILS, V46, P1, DOI 10.1007/s00374-009-0413-8; Wan J, 2007, GEOCHIM COSMOCHIM AC, V71, P5439, DOI 10.1016/j.gca.2007.07.030; Wang SJ, 2010, ECOL RES, V25, P1113, DOI 10.1007/s11284-010-0736-9; Wang SJ, 2009, SOIL BIOL BIOCHEM, V41, P891, DOI 10.1016/j.soilbio.2008.12.016; Wiesmeier M, 2015, GLOBAL CHANGE BIOL, V21, P3836, DOI 10.1111/gcb.12957; Xie XL, 2004, PEDOSPHERE, V14, P491; Xu Xia, 2008, Yingyong Shengtai Xuebao, V19, P539; Zhou Xiao-yu, 2010, Yingyong Shengtai Xuebao, V21, P1867	50	107	117	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150898	10.1371/journal.pone.0150898	http://dx.doi.org/10.1371/journal.pone.0150898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26751695	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000074
J	Li, L; Tian, JH; Long, MKW; Chen, Y; Lu, JF; Zhou, CM; Wang, TL				Li, Li; Tian, Jinghua; Long, Mitchell King-Wei; Chen, Yong; Lu, Jianfei; Zhou, Changman; Wang, Tianlong			Protection against Experimental Stroke by Ganglioside GM1 Is Associated with the Inhibition of Autophagy	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; GUILLAIN-BARRE-SYNDROME; LOCAL HEALTH DISTRICT; CELL-DEATH; HYPERBARIC-OXYGEN; NEURON DEATH; DISEASE; BRAIN; SPHINGOLIPIDS; WITHDRAWAL	Ganglioside GM1, which is particularly abundant in the central nervous system (CNS), is closely associated with the protection against several CNS disorders. However, controversial findings have been reported on the role of GM1 following ischemic stroke. In the present study, using a rat middle cerebral artery occlusion (MCAO) model, we investigated whether GM1 can protect against ischemic brain injury and whether it targets the autophagy pathway. GM1 was delivered to Sprague-Dawley male rats at 3 doses (25 mg/kg, 50 mg/kg, 100 mg/kg) by intraperitoneal injection soon after reperfusion and then once daily for 2 days. The same volume of saline was given as a control. Tat-Beclin-1, a specific autophagy inducer, was administered by intraperitoneal injection at 24 and 48 hours post-MCAO. Infarction volume, mortality and neurological function were assessed at 72 hours after ischemic insult. Immunofluorescence and Western blotting were performed to determine the expression of autophagy-related proteins P62, LC3 and Beclin-1 in the penumbra area. No significant changes in mortality and physiological variables (heart rate, blood glucose levels and arterial blood gases) were observed between the different groups. However, MCAO resulted in enhanced conversion of LC3-I into LC3-II, P62 degradation, high levels of Beclin-1, a large area infarction (26.3 +/- 3.6%) and serious neurobehavioral deficits. GM1 (50 mg/kg) treatment significantly reduced the autophagy activation, neurobehavioral dysfunctions, and infarction volume (from 26.3% to 19.5%) without causing significant adverse side effects. However, this biological function could be abolished by Tat-Beclin-1. In conclusion: GM1 demonstrated safe and robust neuroprotective effects that are associated with the inhibition of autophagy following experimental stroke.	[Li, Li; Wang, Tianlong] Capital Med Univ, Xuanwu Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Tian, Jinghua] Heze Med Coll, Dept Anat, Jinan, Shandong, Peoples R China; [Long, Mitchell King-Wei] Des Moines Univ, Osteopath Med, Des Moines, IA USA; [Chen, Yong] Peoples Hosp Deyang City, Dept Neurol, Chengdu, Sichuan, Peoples R China; [Lu, Jianfei; Zhou, Changman] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Anat & Histol, Beijing 100871, Peoples R China	Capital Medical University; Peking University	Li, L (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Anesthesiol, Beijing, Peoples R China.	lili2009kaoyan@163.com; w_tl5595@hotmail.com	Bianchi, Thomas S/L-4060-2014; Zou, Xiaoming/GWV-5608-2022; He, Zhenli/A-4773-2008; He, Zhenli/R-1494-2016; Li, Liguang/Q-2916-2019	Bianchi, Thomas S/0000-0002-3068-2933; Zou, Xiaoming/0000-0001-9023-3067; 	National Natural Science Foundation of China [81500996, 31271280]; Beijing Postdoctoral Research Foundation; Beijing Municipal Administration of Hospitals' Ascent Plan [DFL 20150802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Postdoctoral Research Foundation(China Postdoctoral Science Foundation); Beijing Municipal Administration of Hospitals' Ascent Plan	This work was supported by the National Natural Science Foundation of China No. 81500996 to LL and 31271280 to CZ (http://www.nsfc.gov.cn/), Beijing Postdoctoral Research Foundation (2015) to LL (http://res.chinapostdoctor.org.cn/BshWeb/index.shtml), and Beijing Municipal Administration of Hospitals' Ascent Plan (DFL 20150802) to TW (http://www.bjah.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER M, 1994, STROKE, V25, P1141; Baek SH, 2009, AUTOPHAGY, V5, P277, DOI 10.4161/auto.5.2.7641; Baxter P, 2014, TRANSL STROKE RES, V5, P136, DOI 10.1007/s12975-013-0283-0; Bu QX, 2014, BRAIN RES, V1558, P100, DOI 10.1016/j.brainres.2014.02.034; de Chaves EP, 2010, FEBS LETT, V584, P1748, DOI 10.1016/j.febslet.2009.12.010; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; FIGUERAS A, 1992, BRIT MED J, V305, P1330, DOI 10.1136/bmj.305.6865.1330; Gao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046092; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Giraldi C, 1990, Acta Neurol (Napoli), V12, P214; Govoni V, 1997, BRAIN, V120, P1123, DOI 10.1093/brain/120.7.1123; Govoni V, 2003, J NEUROL SCI, V216, P99, DOI 10.1016/S0022-510X(03)00215-6; Gupta G, 2010, FEBS LETT, V584, P1634, DOI 10.1016/j.febslet.2009.11.070; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Iwabuchi K, 2010, FEBS LETT, V584, P1642, DOI 10.1016/j.febslet.2009.10.043; Jiang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048672; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang S, 2014, GENE, V539, P181, DOI 10.1016/j.gene.2014.02.017; Kashiwagi A, 2015, ANESTHESIOLOGY, V122, P1075, DOI 10.1097/ALN.0000000000000561; KAWAMURA S, 1991, ACTA NEUROCHIR, V109, P126, DOI 10.1007/BF01403007; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; LENZI GL, 1994, STROKE, V25, P1552, DOI 10.1161/01.STR.25.8.1552; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lippai M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832704; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Ohmi Y, 2009, P NATL ACAD SCI USA, V106, P22405, DOI 10.1073/pnas.0912336106; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rong X, 2013, ACTA NEUROBIOL EXP, V73, P379; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Schneider JS, 2010, J NEUROL SCI, V292, P45, DOI 10.1016/j.jns.2010.02.009; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; SVENNERHOLM L, 1994, LIFE SCI, V55, P2125, DOI 10.1016/0024-3205(94)00393-9; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Wei K, 2012, CNS NEUROSCI THER, V18, P879, DOI 10.1111/cns.12005; Whitehead SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020808; Wolinski P, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/727189; Yin W, 2002, BRAIN RES, V926, P165, DOI 10.1016/S0006-8993(01)03304-2; Yu RK, 2010, FEBS LETT, V584, P1694, DOI 10.1016/j.febslet.2009.08.026; Zamfir AD, 2014, ADV EXP MED BIOL, V806, P153, DOI 10.1007/978-3-319-06068-2_8; ZHU Y, 2013, BMC EVOL BIOL, V13, DOI DOI 10.1186/1477-7819-11-19	46	107	117	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0144219	10.1371/journal.pone.0144219	http://dx.doi.org/10.1371/journal.pone.0144219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751695	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100009
J	Xin, Y; Jiang, X; Wang, YS; Su, XJ; Sun, MY; Zhang, LH; Tan, Y; Wintergerst, KA; Li, Y; Li, YL				Xin, Ying; Jiang, Xin; Wang, Yishu; Su, Xuejin; Sun, Meiyu; Zhang, Lihong; Tan, Yi; Wintergerst, Kupper A.; Li, Yan; Li, Yulin			Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; TRANSPLANTATION; GENERATION; RAT; MANIPULATION; MECHANISM; PATHWAYS	Background The two major obstacles in the successful transplantation of islets for diabetes treatment are inadequate supply of insulin-producing tissue and immune rejection. Induction of the differentiation of human bone marrow-derived mesenchymal stem cells (hMSCs) into insulinproducing cells (IPCs) for autologous transplantation may alleviate those limitations. Methods hMSCs were isolated and induced to differentiate into IPCs through a three-stage differentiation protocol in a defined media with high glucose, nicotinamide, and exendin-4. The physiological characteristics and functions of IPCs were then evaluated. Next, about 3 x 10(6) differentiated cells were transplanted into the renal sub-capsular space of streptozotocin (STZ)-induced diabetic nude mice. Graft survival and function were assessed by immunohistochemistry, TUNEL staining and measurements of blood glucose levels in the mice. Results The differentiated IPCs were characterized by Dithizone (DTZ) positive staining, expression of pancreatic beta-cell markers, and human insulin secretion in response to glucose stimulation. Moreover, 43% of the IPCs showed L-type Ca2+ channel activity and similar changes in intracellular Ca2+ in response to glucose stimulation as that seen in pancreatic beta-cells in the process of glucose-stimulated insulin secretion. Transplantation of functional IPCs into the renal subcapsular space of STZ-induced diabetic nude mice ameliorated the hypergly-cemia. Immunofluorescence staining revealed that transplanted IPCs sustainably expressed insulin, c-peptide, and PDX-1 without apparent apoptosis in vivo. Conclusions IPCs derived from hMSCs in vitro can ameliorate STZ-induced diabetic hyperglycemia, which indicates that these hMSCs may be a promising approach to overcome the limitations of islet transplantation.	[Xin, Ying; Wang, Yishu; Su, Xuejin; Sun, Meiyu; Zhang, Lihong; Li, Yulin] Jilin Univ, Minist Educ, Key Lab Pathobiol, Changchun 130023, Peoples R China; [Jiang, Xin] Jilin Univ, Hosp 1, Dept Radiat Oncol, Changchun 130023, Peoples R China; [Xin, Ying; Tan, Yi; Wintergerst, Kupper A.] Univ Louisville, Dept Pediat, Div Endocrinol, Wendy L Novak Diabet Care Ctr, Louisville, KY 40292 USA; [Li, Yan] Karolinska Univ Hosp, Dept Orthoped Surg, Stockholm, Sweden	Jilin University; Jilin University; University of Louisville; Karolinska Institutet; Karolinska University Hospital	Li, Y (corresponding author), Karolinska Univ Hosp, Dept Orthoped Surg, Stockholm, Sweden.	Yan.Li@ki.se; ylli_jlu@126.com	Jiang, Xin/AHA-9454-2022	Jiang, Xin/0000-0002-4613-7438; Lin, Fu-Cheng/0000-0002-4127-8143	National Science Foundation of China [981201218]; Jilin Provincial Science & Technology Foundation [20130413032GH, 20110465, 20130522038JH, 20140414035GH]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial Science & Technology Foundation	This study was supported in part by Young Scientist Award from National Science Foundation of China (981201218, to YX), and the funds from Jilin Provincial Science & Technology Foundation (20130413032GH and 20110465, to YX; 20130522038JH and 20140414035GH, to XJ). The funders had roles in data collection and analysis, decision to publish, and preparation of the manuscript.	Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Calne RY, 2010, NAT REV ENDOCRINOL, V6, P173, DOI 10.1038/nrendo.2009.276; Choi KS, 2005, BIOCHEM BIOPH RES CO, V330, P1299, DOI 10.1016/j.bbrc.2005.03.111; De Miguel MP, 2012, CURR MOL MED, V12, P574; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Gabr MM, 2013, CELL TRANSPLANT, V22, P133, DOI 10.3727/096368912X647162; Ham DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079076; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; He X, 2005, CHINESE MED J-PEKING, V118, P1728; Jiang X, 2013, TOXICOL LETT, V219, P65, DOI 10.1016/j.toxlet.2013.02.022; Karaoz E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.14; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143416002001240; Kazantseva J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074799; Kolb H, 1999, DIABETES CARE, V22, pB16; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Li GR, 2005, STEM CELLS, V23, P371, DOI 10.1634/stemcells.2004-0213; Limbert C, 2009, PEDIATR DIABETES, V10, P413, DOI 10.1111/j.1399-5448.2009.00502.x; Mhanna R, 2014, TISSUE ENG PT A, V20, P1165, DOI [10.1089/ten.tea.2013.0519, 10.1089/ten.TEA.2013.0519]; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prabakar KR, 2012, CELL TRANSPLANT, V21, P1321, DOI 10.3727/096368911X612530; Rahmati S, 2013, BIOCHEM BIOPH RES CO, V437, P413, DOI 10.1016/j.bbrc.2013.06.092; Rajagopal J, 2003, SCIENCE, V299, P363; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sher E, 2003, J BIOENERG BIOMEMBR, V35, P687, DOI 10.1023/B:JOBB.0000008032.49504.48; Shi Y, 2005, STEM CELLS, V23, P656, DOI 10.1634/stemcells.2004-0241; Sun Y, 2007, CHINESE MED J-PEKING, V120, P771, DOI 10.1097/00029330-200705010-00007; Takemitsu H, 2013, GEN COMP ENDOCR, V189, P1, DOI 10.1016/j.ygcen.2013.04.009; Ueyama H, 2012, J CELL MOL MED, V16, P72, DOI 10.1111/j.1582-4934.2011.01303.x; Wang QC, 2012, ADV GENET ENG BIOTEC, V1, P1, DOI [DOI 10.4172/AGEB.1000E101, 10.4172/2324-9021.1000e101, DOI 10.4172/2324-9021.1000E101]; Wu XH, 2007, WORLD J GASTROENTERO, V13, P3342, DOI 10.3748/wjg.v13.i24.3342; Xie HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076056; Xie QP, 2009, DIFFERENTIATION, V77, P483, DOI 10.1016/j.diff.2009.01.001; Yang XF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-59; Zahanich I, 2005, J BONE MINER RES, V20, P1637, DOI 10.1359/JBMR.050521; Zhang H, 2003, ACTA PHARMACOL SIN, V24, P790; Zhang WJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt352	40	106	114	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0145838	10.1371/journal.pone.0145838	http://dx.doi.org/10.1371/journal.pone.0145838			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756576	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888800005
